PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Heinen, CD; Cyr, JL; Cook, C; Punja, N; Sakato, M; Forties, RA; Lopez, JM; Hingorani, MM; Fishel, R				Heinen, Christopher D.; Cyr, Jennifer L.; Cook, Christopher; Punja, Nidhi; Sakato, Miho; Forties, Robert A.; Lopez, Juana Martin; Hingorani, Manju M.; Fishel, Richard			Human MSH2 (hMSH2) Protein Controls ATP Processing by hMSH2-hMSH6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR PROTEIN; SACCHAROMYCES-CEREVISIAE MSH2-MSH6; DNA MISMATCH; MOLECULAR SWITCH; HMUTS-ALPHA; RECOGNITION COMPLEX; BINDING ACTIVITIES; LYNCH-SYNDROME; SLIDING CLAMP; MUTS	The mechanics of hMSH2-hMSH6 ATP binding and hydrolysis are critical to several proposed mechanisms for mismatch repair (MMR), which in turn rely on the detailed coordination of ATP processing between the individual hMSH2 and hMSH6 subunits. Here we show that hMSH2-hMSH6 is strictly controlled by hMSH2 and magnesium in a complex with ADP (hMSH2(magnesium-ADP)-hMSH6). Destabilization of magnesium results in ADP release from hMSH2 that allows high affinity ATP binding by hMSH6, which then enhances ATP binding by hMSH2. Both subunits must be ATP-bound to efficiently form a stable hMSH2-hMSH6 hydrolysis-independent sliding clamp required for MMR. In the presence of magnesium, the ATP-bound sliding clamps remain on the DNA for similar to 8 min. These results suggest a precise stepwise kinetic mechanism for hMSH2-hMSH6 functions that appears to mimic G protein switches, severely constrains models for MMR, and may partially explain the MSH2 allele frequency in Lynch syndrome or hereditary nonpolyposis colorectal cancer.	[Heinen, Christopher D.; Cyr, Jennifer L.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA; [Cook, Christopher; Punja, Nidhi; Lopez, Juana Martin; Fishel, Richard] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Heinen, Christopher D.; Cyr, Jennifer L.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; [Sakato, Miho; Hingorani, Manju M.] Wesleyan Univ, Mol Biol & Biochem Dept, Middletown, CT 06459 USA; [Forties, Robert A.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Cook, Christopher; Punja, Nidhi; Lopez, Juana Martin; Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Connecticut; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Connecticut; Wesleyan University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Heinen, CD (corresponding author), Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, 263 Farmington Ave,ML3101, Farmington, CT 06030 USA.	cheinen@uchc.edu; rfishel@osu.edu	MARTIN-LOPEZ, JUANA VICTORIA/AAB-2367-2021	MARTIN-LOPEZ, JUANA VICTORIA/0000-0003-2777-2740	National Institutes of Health [CA115783, CA67007]; National Science Foundation [MCB 1022203]; NATIONAL CANCER INSTITUTE [R01CA067007, R01CA115783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA115783 (to C. D. H.) and CA67007 (to R. F.). This work was also supported by National Science Foundation Grant MCB 1022203 (to M. M. H.).	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Bjornson KP, 2003, J BIOL CHEM, V278, P18557, DOI 10.1074/jbc.M301101200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Cheng JQ, 1998, BIOCHEMISTRY-US, V37, P5288, DOI 10.1021/bi972742j; Cyr JL, 2008, J BIOL CHEM, V283, P31641, DOI 10.1074/jbc.M806018200; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Drotschmann K, 2002, DNA REPAIR, V1, P743, DOI 10.1016/S1568-7864(02)00081-2; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; HABER LT, 1988, J BACTERIOL, V170, P197, DOI 10.1128/jb.170.1.197-202.1988; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Jiang JJ, 2005, MOL CELL, V20, P771, DOI 10.1016/j.molcel.2005.10.014; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kolodner RD, 2007, P NATL ACAD SCI USA, V104, P12953, DOI 10.1073/pnas.0705698104; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lebbink JHG, 2010, J BIOL CHEM, V285, P13131, DOI 10.1074/jbc.M109.066001; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	38	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40287	40295		10.1074/jbc.M111.297523	http://dx.doi.org/10.1074/jbc.M111.297523			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937421	Green Published, hybrid			2022-12-25	WOS:000296925700060
J	Sarma, NJ; Yaseen, NR				Sarma, Nayan J.; Yaseen, Nabeel R.			Amino-terminal Enhancer of Split (AES) Interacts with the Oncoprotein NUP98-HOXA9 and Enhances Its Transforming Ability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; NUCLEAR-PORE COMPLEX; HEMATOPOIETIC-CELLS; NUCLEOPORIN NUP98; DROSOPHILA-ENHANCER; KAPPA-B; MEDIATED TRANSCRIPTION; MYELOGENOUS LEUKEMIA; ONCOGENE NUP98-HOXA9; COREPRESSOR GROUCHO	NUP98-HOXA9 is the prototype of NUP98 fusion oncoproteins that cause acute myeloid leukemia. It consists of an N-terminal FG-rich portion of the nucleoporin NUP98 fused to the homeodomain region of the homeobox protein HOXA9, and acts as an aberrant transcription factor. To identify interacting partners of NUP98-HOXA9, we used a cytoplasmic yeast two-hybrid assay to avoid the nonspecific trans-activation that would occur with the traditional yeast two-hybrid assay due to the transactivating properties of NUP98-HOXA9. We identified amino-terminal enhancer of split (AES), a transcriptional regulator of the transducin-like enhancer/Groucho family as a novel interaction partner of NUP98-HOXA9. The interaction was confirmed by in vitro pulldown and co-immunoprecipitation assays and was shown to require the FG repeat region of NUP98-HOXA9. Immunofluorescence analysis showed that AES localizes primarily to the interior of the nucleus. AES also showed a strong interaction with wild-type NUP98. AES augmented the transcriptional activity of NUP98-HOXA9. In the presence of NUP98-HOXA9, AES caused an increase in long-term proliferation of primary human CD34+ cells with a marked increase in the numbers of primitive cells. These effects of AES were not observed in the absence of NUP98-HOXA9. AES knockdown diminished the transcriptional and proliferative effects of NUP98-HOXA9. AES caused a shift away from the erythroid lineage in cells expressing NUP98-HOXA9. These data establish AES as an interacting partner of NUP98-HOXA9 and show that it cooperates with NUP98-HOXA9 in transcriptional regulation and cell transformation.	[Sarma, Nayan J.; Yaseen, Nabeel R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Yaseen, NR (corresponding author), 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	nyaseen@wustl.edu		Yaseen, Nabeel/0000-0001-6902-5116	National Institutes of Health [R01 HL082549, K02 HL084179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082549, K02HL084179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL082549 and K02 HL084179 (to N. R. Y.).	Abdul-Nabi AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012464; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Courey AJ, 2001, GENE DEV, V15, P2786; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Gorello P, 2008, HAEMATOL-HEMATOL J, V93, P1398, DOI 10.3324/haematol.12945; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Ishikawa M, 2007, INT J HEMATOL, V86, P238, DOI 10.1007/BF03006927; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kaltenbach S, 2010, BLOOD, V116, P2332, DOI 10.1182/blood-2010-04-277806; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Liu JJ, 2003, J BIOL CHEM, V278, P19534, DOI 10.1074/jbc.M212278200; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Nebral K, 2005, CLIN CANCER RES, V11, P6489, DOI 10.1158/1078-0432.CCR-05-0150; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; Pan Q, 2008, ONCOGENE, V27, P3414, DOI 10.1038/sj.onc.1210999; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Petit A, 2010, LEUKEMIA, V24, P654, DOI 10.1038/leu.2009.241; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Reader JC, 2007, LEUKEMIA, V21, P842, DOI 10.1038/sj.leu.2404579; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Slape Christopher, 2008, J Natl Cancer Inst Monogr, P64, DOI 10.1093/jncimonographs/lgn014; Steffen B, 2011, BLOOD, V117, P4328, DOI 10.1182/blood-2009-09-242545; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; Tosi S, 2005, GENE CHROMOSOME CANC, V44, P225, DOI 10.1002/gcc.20233; van Zutven LJCM, 2006, GENE CHROMOSOME CANC, V45, P437, DOI 10.1002/gcc.20308; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang JCW, 2000, J BIOL CHEM, V275, P18418, DOI 10.1074/jbc.M910211199; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; Yamamoto M, 2005, CANCER GENET CYTOGEN, V157, P104, DOI 10.1016/j.cancergencyto.2004.06.014; Yassin ER, 2010, LEUKEMIA, V24, P1001, DOI 10.1038/leu.2010.42; Yassin ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006719; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhang H, 2002, GENETICS, V160, P799; Zhang MY, 1998, BLOOD, V91, P4136, DOI 10.1182/blood.V91.11.4136.411k26_4136_4144; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	69	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38989	39001		10.1074/jbc.M111.297952	http://dx.doi.org/10.1074/jbc.M111.297952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937451	Green Published, hybrid			2022-12-25	WOS:000296759800018
J	Cloern, JE; Knowles, N; Brown, LR; Cayan, D; Dettinger, MD; Morgan, TL; Schoellhamer, DH; Stacey, MT; van der Wegen, M; Wagner, RW; Jassby, AD				Cloern, James E.; Knowles, Noah; Brown, Larry R.; Cayan, Daniel; Dettinger, Michael D.; Morgan, Tara L.; Schoellhamer, David H.; Stacey, Mark T.; van der Wegen, Mick; Wagner, R. Wayne; Jassby, Alan D.			Projected Evolution of California's San Francisco Bay-Delta-River System in a Century of Climate Change	PLOS ONE			English	Article							CHANGE IMPACTS; WATER-RESOURCES; MODEL; STREAMFLOW; DATASET; COASTAL; FLUXES	Background: Accumulating evidence shows that the planet is warming as a response to human emissions of greenhouse gases. Strategies of adaptation to climate change will require quantitative projections of how altered regional patterns of temperature, precipitation and sea level could cascade to provoke local impacts such as modified water supplies, increasing risks of coastal flooding, and growing challenges to sustainability of native species. Methodology/Principal Findings: We linked a series of models to investigate responses of California's San Francisco Estuary-Watershed (SFEW) system to two contrasting scenarios of climate change. Model outputs for scenarios of fast and moderate warming are presented as 2010-2099 projections of nine indicators of changing climate, hydrology and habitat quality. Trends of these indicators measure rates of: increasing air and water temperatures, salinity and sea level; decreasing precipitation, runoff, snowmelt contribution to runoff, and suspended sediment concentrations; and increasing frequency of extreme environmental conditions such as water temperatures and sea level beyond the ranges of historical observations. Conclusions/Significance: Most of these environmental indicators change substantially over the 21(st) century, and many would present challenges to natural and managed systems. Adaptations to these changes will require flexible planning to cope with growing risks to humans and the challenges of meeting demands for fresh water and sustaining native biota. Programs of ecosystem rehabilitation and biodiversity conservation in coastal landscapes will be most likely to meet their objectives if they are designed from considerations that include: (1) an integrated perspective that river-estuary systems are influenced by effects of climate change operating on both watersheds and oceans; (2) varying sensitivity among environmental indicators to the uncertainty of future climates; (3) inevitability of biological community changes as responses to cumulative effects of climate change and other drivers of habitat transformations; and (4) anticipation and adaptation to the growing probability of ecosystem regime shifts.	[Cloern, James E.; Knowles, Noah] US Geol Survey, Menlo Pk, CA 94025 USA; [Brown, Larry R.; Morgan, Tara L.; Schoellhamer, David H.] US Geol Survey, Sacramento, CA USA; [Cayan, Daniel; Dettinger, Michael D.] US Geol Survey, Div Climate Res, Scripps Inst Oceanog, La Jolla, CA USA; [Stacey, Mark T.; Wagner, R. Wayne] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [van der Wegen, Mick] UNESCO, UNESCO IHE, Inst Water Educ, Delft, Netherlands; [Jassby, Alan D.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Berkeley; IHE Delft Institute for Water Education; University of California System; University of California Davis	Cloern, JE (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	jecloern@usgs.gov	Morgan, Tara/GZK-5739-2022; Van Der Wegen, Mick/C-6787-2009; Dettinger, Michael/AAW-5759-2020; Cloern, James E/C-1499-2011; Knowles, Noah/A-3911-2019	Van Der Wegen, Mick/0000-0002-5227-2679; Knowles, Noah/0000-0001-5652-1049; Wagner, Wayne/0000-0002-3978-2025; Cloern, James/0000-0002-5880-6862	CALFED Science Program [SCI-05-G01-84]; California Energy Commission; NOAA RISA; USGS; Priority Ecosystem Science; National Research Program of the Water Discipline	CALFED Science Program; California Energy Commission; NOAA RISA; USGS(United States Geological Survey); Priority Ecosystem Science; National Research Program of the Water Discipline	CALFED Science Program grant SCI-05-G01-84, California Energy Commission, NOAA RISA, USGS Programs of Toxic Substances Hydrology, Priority Ecosystem Science, and National Research Program of the Water Discipline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2008, CLIMATIC CHANGE, V87, pS91, DOI 10.1007/s10584-007-9353-1; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Bennett William A., 2005, San Francisco Estuary & Watershed Science, V3, P1; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Brekke LD, 2004, J AM WATER RESOUR AS, V40, P149, DOI 10.1111/j.1752-1688.2004.tb01016.x; Brekke LD, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006941; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS57, DOI 10.1007/s10584-007-9376-7; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS1, DOI 10.1007/s10584-007-9352-2; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Cherkauer KA, 2003, GLOBAL PLANET CHANGE, V38, P151, DOI 10.1016/S0921-8181(03)00025-0; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dettinger MD, 2008, SAN FRANCISCO ESTUAR, V6, P1; Dracup J.A., 2005, CEC5002005053 PIER E; Draper AJ, 2004, J WATER RES PLAN MAN, V130, P480, DOI 10.1061/(ASCE)0733-9496(2004)130:6(480); Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Feyrer F, 2011, ESTUAR COAST, V34, P120, DOI 10.1007/s12237-010-9343-9; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Helsel D. R., 1992, STAT METHODS WATER R; Hidalgo HG, 2008, DOWNSCALING CONSTRUC; IPCC, 2007, IPCC CLIM CHANG 2007; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Knowles N, 1996, THESIS U CALIFORNIA; Knowles N, 2000, MODELING HYDROCLIMAT; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Lehman PW, 2010, HYDROBIOLOGIA, V637, P229, DOI 10.1007/s10750-009-9999-y; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Maurer EP, 2010, HYDROL EARTH SYST SC, V14, P1125, DOI 10.5194/hess-14-1125-2010; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle Peter B., 2004, San Francisco Estuary & Watershed Science, V2, P1; Moyle Peter B., 2010, San Francisco Estuary & Watershed Science, V8, P1; NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567; Nobriga M. L., 2008, SAN FRANCISCO ESTUAR, V6; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Petersen JK, 2008, ECOL APPL, V18, P497, DOI 10.1890/07-0752.1; PETERSON D, 1995, AM SCI, V83, P58; Rahmstorf S., 2010, NAT CLIM CHANGE, V1004, P44, DOI [DOI 10.1038/CLIMATE.2010.29, 10.1038/climate.2010.29]; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Schoellhamer DH, 2011, ESTUAR COAST, V34, P885, DOI 10.1007/s12237-011-9382-x; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Service RF, 2007, SCIENCE, V317, P442, DOI 10.1126/science.317.5837.442; Sommer T, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:CYB>2.0.CO;2; Sommer T, 1997, T AM FISH SOC, V126, P961, DOI 10.1577/1548-8659(1997)126<0961:ROSITS>2.3.CO;2; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Swanson C, 2000, OECOLOGIA, V123, P384, DOI 10.1007/s004420051025; Theil H., 1992, HENRI THEILS CONTRIB, P345, DOI [DOI 10.1007/978-94-011-2546-8_20, DOI 10.1007/978-94-011-2546-820]; van der Wegen M, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2009JF001614; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Vicuna S, 2007, J AM WATER RESOUR AS, V43, P482, DOI 10.1111/j.1752-1688.2007.00038.x; Wagner RW, 2011, ESTUAR COAST, V34, P544, DOI 10.1007/s12237-010-9369-z; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Winder M, 2004, ECOLOGY, V85, P3178; Winder M, 2011, ECOL LETT, V14, P749, DOI 10.1111/j.1461-0248.2011.01635.x; Wright S.A., 2004, SAN FRANC ESTUARY WA; Yue S, 2002, HYDROL PROCESS, V16, P1807, DOI 10.1002/hyp.1095	62	161	162	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24465	10.1371/journal.pone.0024465	http://dx.doi.org/10.1371/journal.pone.0024465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957451	Green Submitted, gold, Green Published			2022-12-25	WOS:000295262100011
J	Kumar, G; Jones, NC; Morris, MJ; Rees, S; O'Brien, TJ; Salzberg, MR				Kumar, Gaurav; Jones, Nigel C.; Morris, Margaret J.; Rees, Sandra; O'Brien, Terence J.; Salzberg, Michael R.			Early Life Stress Enhancement of Limbic Epileptogenesis in Adult Rats: Mechanistic Insights	PLOS ONE			English	Article							LOW-DOSE CORTICOSTERONE; DENTATE GYRUS; LONG-TERM; CONVULSION SUSCEPTIBILITY; KINDLING EPILEPTOGENESIS; INDUCED NEUROGENESIS; HIPPOCAMPAL NEURON; STATUS EPILEPTICUS; ADRENAL-STEROIDS; CELL LOSS	Background: Exposure to early postnatal stress is known to hasten the progression of kindling epileptogenesis in adult rats. Despite the significance of this for understanding mesial temporal lobe epilepsy (MTLE) and its associated psychopathology, research findings regarding underlying mechanisms are sparse. Of several possibilities, one important candidate mechanism is early life 'programming' of the hypothalamic-pituitary-adrenal (HPA) axis by postnatal stress. Elevated corticosterone (CORT) in turn has consequences for neurogenesis and cell death relevant to epileptogenesis. Here we tested the hypotheses that MS would augment seizure-related corticosterone (CORT) release and enhance neuroplastic changes in the hippocampus. Methodology/Principal Findings: Eight-week old Wistar rats, previously exposed on postnatal days 2-14 to either maternal separation stress (MS) or control brief early handling (EH), underwent rapid amygdala kindling. We measured seizure-induced serum CORT levels and post-kindling neurogenesis (using BrdU). Three weeks post-kindling, rats were euthanized for histology of the hippocampal CA3c region (pyramidal cell counts) and dentate gyrus (DG) (to count BrdU-labelled cells and measure mossy fibre sprouting). As in our previous studies, rats exposed to MS had accelerated kindling rates in adulthood. Female MS rats had heightened CORT responses during and after kindling (p < 0.05), with a similar trend in males. In both sexes total CA3c pyramidal cell numbers were reduced in MS vs. EH rats post-kindling (p = 0.002). Dentate granule cell neurogenesis in female rats was significantly increased post-kindling in MS vs. EH rats. Conclusions/Significance: These data demonstrate that early life stress results in enduring enhancement of HPA axis responses to limbic seizures, with increased hippocampal CA3c cell loss and augmented neurogenesis, in a sex-dependent pattern. This implicates important candidate mechanisms through which early life stress may promote vulnerability to limbic epileptogenesis in rats as well as to human MTLE and its associated psychiatric disorders.	[Kumar, Gaurav; Jones, Nigel C.; O'Brien, Terence J.] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Rees, Sandra] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia; [O'Brien, Terence J.] Univ Melbourne, Dept Neurol, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3052, Australia; [Salzberg, Michael R.] St Vincents Hosp, St Vincents Mental Hlth Serv, Fitzroy, Vic 3065, Australia; [Salzberg, Michael R.] Univ Melbourne, Dept Psychiat, St Vincents Hosp, Fitzroy, Vic 3065, Australia	University of Melbourne; University of New South Wales Sydney; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Kumar, G (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia.	msalzber@bigpond.net.au	Morris, Margaret J/J-4285-2013; Jones, Nigel C/K-7773-2012; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439; Kumar, Gaurav/0000-0002-2638-6429; Morris, Margaret/0000-0003-2285-5117	Australian National Health and Medical Research Council [566843, 400088]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by Australian National Health and Medical Research Council Project Grants #566843 and #400088 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, PSYCHOPHARM IN PRESS; Ali I, 2011, PSYCHOPHARMACOLOGY, V214, P155, DOI 10.1007/s00213-010-2125-z; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Baram TZ, 1998, TRENDS NEUROSCI, V21, P471, DOI 10.1016/S0166-2236(98)01275-2; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Bowman RE, 2005, J NEUROENDOCRINOL, V17, P526, DOI 10.1111/j.1365-2826.2005.01335.x; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Brunson KL, 2001, P NATL ACAD SCI USA, V98, P8856, DOI 10.1073/pnas.151224898; BURCHFIEL JL, 1989, NEUROSCI BIOBEHAV R, V13, P289, DOI 10.1016/S0149-7634(89)80065-X; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAVAZOS JE, 1994, J NEUROSCI, V14, P3106; Champagne DL, 2009, SEMIN FETAL NEONAT M, V14, P136, DOI 10.1016/j.siny.2008.11.006; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Daniels WMU, 2004, METAB BRAIN DIS, V19, P3, DOI 10.1023/B:MEBR.0000027412.19664.b3; Edwards HE, 2002, HORM BEHAV, V42, P437, DOI 10.1006/hbeh.2002.1839; Ekstrand J, 2008, PROG NEURO-PSYCHOPH, V32, P1466, DOI 10.1016/j.pnpbp.2008.05.012; Engel J, 2007, EPILEPSY COMPREHENSI, P2479; Fenoglio KA, 2006, FRONT NEUROENDOCRIN, V27, P180, DOI 10.1016/j.yfrne.2006.02.001; Ferland RJ, 2002, NEUROSCIENCE, V115, P669, DOI 10.1016/S0306-4522(02)00514-6; FREEMAN FG, 1980, BEHAV NEURAL BIOL, V30, P231, DOI 10.1016/S0163-1047(80)91113-9; Goel N, 2009, J NEUROENDOCRINOL, V21, P415, DOI 10.1111/j.1365-2826.2009.01843.x; GOULD E, 1992, MOL CELL NEUROSCI, V3, P44, DOI 10.1016/1044-7431(92)90007-O; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Jacobson M., 1991, DEV NEUROBIOLOGY; Janszky J, 2004, J NEUROL NEUROSUR PS, V75, P773, DOI 10.1136/jnnp.2003.020941; Joels M, 2008, STRESS HIPPOCAMPUS E; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; Joels M, 2009, EPILEPSIA, V50, P586, DOI 10.1111/j.1528-1167.2008.01902.x; Joelving FC, 2006, HIPPOCAMPUS, V16, P826, DOI 10.1002/hipo.20212; Jones NC, 2009, BEHAV BRAIN RES, V203, P81, DOI 10.1016/j.bbr.2009.04.023; Kanner AM, 2008, CURR OPIN NEUROL, V21, P190, DOI 10.1097/WCO.0b013e3282f4e978; Kanner AM, 2009, CURR NEUROL NEUROSCI, V9, P307, DOI 10.1007/s11910-009-0046-1; Karst H, 1999, EUR J NEUROSCI, V11, P889, DOI 10.1046/j.1460-9568.1999.00495.x; Karst H, 1997, NEUROENDOCRINOLOGY, V66, P348, DOI 10.1159/000127258; KLING MA, 1993, BRAIN RES, V629, P163, DOI 10.1016/0006-8993(93)90497-B; Kling MA, 2009, DEPRESS ANXIETY, V26, P641, DOI 10.1002/da.20546; Koe AS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.024.2009; Krugers HJ, 2007, SYNAPSE, V61, P221, DOI 10.1002/syn.20359; Kumar G, 2007, PSYCHONEUROENDOCRINO, V32, P834, DOI 10.1016/j.psyneuen.2007.05.011; Lai MC, 2006, EPILEPSY RES, V68, P123, DOI 10.1016/j.eplepsyres.2005.10.005; Li S, 2002, NEUROSCIENCE, V115, P1221, DOI 10.1016/S0306-4522(02)00485-2; Liu DSH, 2009, NEUROBIOL DIS, V35, P337, DOI 10.1016/j.nbd.2009.05.009; Liu H, 2003, EXP NEUROL, V184, P196, DOI 10.1016/S0014-4886(03)00207-3; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; McCabe BK, 2001, J NEUROSCI, V21, P2094, DOI 10.1523/JNEUROSCI.21-06-02094.2001; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; MINABE Y, 1991, BRAIN RES, V561, P162, DOI 10.1016/0006-8993(91)90762-K; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Morris R, 2007, HIPPOCAMPUS BOOK, P751; Nickel J, 2003, EPILEPSIA, V44, P1551, DOI 10.1111/j.0013-9580.2003.13603.x; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; ROBERTS AJ, 1994, J PHARMACOL EXP THER, V270, P505; ROBERTS AJ, 1994, NEUROPHARMACOLOGY, V33, P1087, DOI 10.1016/0028-3908(94)90147-3; Roman E, 2006, HORM BEHAV, V50, P736, DOI 10.1016/j.yhbeh.2006.06.016; ROSE RP, 1979, BRAIN RES, V169, P303, DOI 10.1016/0006-8993(79)91032-1; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Savic I, 1998, J NEUROL NEUROSUR PS, V65, P910, DOI 10.1136/jnnp.65.6.910; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Scharfman HE, 2007, NEUROBIOLOGY OF DISEASE, P349, DOI 10.1016/B978-012088592-3/50035-9; Scott BW, 1998, NEUROSCI LETT, V248, P73, DOI 10.1016/S0304-3940(98)00355-3; Seckl JR, 2007, PROG BRAIN RES, V167, P17, DOI 10.1016/S0079-6123(07)67002-2; Smith PD, 2006, EUR J NEUROSCI, V24, P3195, DOI 10.1111/j.1460-9568.2006.05205.x; Sousa N, 1998, BRAIN RES, V794, P199, DOI 10.1016/S0006-8993(98)00218-2; Taher TR, 2005, NEUROPSYCHOPHARMACOL, V30, P1610, DOI 10.1038/sj.npp.1300709; Talmi M, 1995, BRAIN RES, V704, P97, DOI 10.1016/0006-8993(95)01123-4; Tata DA, 2006, J COMP NEUROL, V498, P363, DOI 10.1002/cne.21071; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; VollmannHonsdorf GK, 1997, NEUROSCI LETT, V233, P121, DOI 10.1016/S0304-3940(97)00647-2; Walker M, 2007, HIPPOCAMPUS BOOK, P769; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; Wasterlain CG, 1996, EPILEPSY RES, V26, P255, DOI 10.1016/S0920-1211(96)00058-7; Watson C., 2005, RAT BRAIN STEREOTACT; WEISS G, 1993, BRAIN RES, V612, P354, DOI 10.1016/0006-8993(93)91686-M; WEISS GK, 1993, NEUROSCI LETT, V157, P91, DOI 10.1016/0304-3940(93)90650-A; WEISS SRB, 1986, BRAIN RES, V372, P345, DOI 10.1016/0006-8993(86)91142-X; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Xu B, 2004, EUR J NEUROSCI, V20, P403, DOI 10.1111/j.1460-9568.2004.03489.x	102	55	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24033	10.1371/journal.pone.0024033	http://dx.doi.org/10.1371/journal.pone.0024033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957442	gold, Green Published			2022-12-25	WOS:000295262100004
J	Svensson, AC; Abel, K; Dalman, C; Magnusson, C				Svensson, Anna C.; Abel, Kathryn; Dalman, Christina; Magnusson, Cecilia			Implications of Advancing Paternal Age: Does It Affect Offspring School Performance?	PLOS ONE			English	Article							ACADEMIC-PERFORMANCE; CHILDBEARING; INTELLIGENCE; HEALTH; RISK; SCHIZOPHRENIA; PREDICTORS; OUTCOMES; FAMILY; CHILD	Average paternal age is increasing in many high income countries, but the implications of this demographic shift for child health and welfare are poorly understood. There is equivocal evidence that children of older fathers are at increased risk of neurodevelopmental disorders and reduced IQ. We therefore report here on the relationship between paternal age and a composite indicator of scholastic achievement during adolescence, i.e. compulsory school leaving grades, among recent birth cohorts in Stockholm County where delayed paternity is notably common. We performed a record-linkage study comprising all individuals in Stockholm County who finished 9 years of compulsory school from 2000 through 2007 (n = 155,875). Data on school leaving grades and parental characteristics were retrieved from administrative and health service registers and analyzed using multiple linear regression. Advancing paternal age at birth was not associated with a decrease in school leaving grades in adolescent offspring. After adjustment for year of graduation, maternal age and parental education, country of birth and parental mental health service use, offspring of fathers aged 50 years or older had on average 0.3 (95% CI -3.8, 4.4) points higher grades than those of fathers aged 30-34 years. In conclusion, advancing paternal age is not associated with poorer school performance in adolescence. Adverse effects of delayed paternity on offspring cognitive function, if any, may be counterbalanced by other potential advantages for children born to older fathers.	[Svensson, Anna C.; Dalman, Christina; Magnusson, Cecilia] Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden; [Abel, Kathryn] Univ Manchester, Ctr Womens Mental Hlth, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	Karolinska Institutet; University of Manchester	Svensson, AC (corresponding author), Karolinska Inst, Div Publ Hlth Epidemiol, Dept Publ Hlth Sci, Stockholm, Sweden.	Anna.Svensson@ki.se		Magnusson, Cecilia/0000-0002-8567-6725; Abel, Kathryn M/0000-0003-3538-8896; Dalman, Christina/0000-0002-3579-2357				AUROUX M, 1993, CONTRACEPT FERTIL S, V21, P382; AUROUX MR, 1989, HUM REPROD, V4, P794, DOI 10.1093/oxfordjournals.humrep.a136988; Bacete FJG, 2001, PSYCHOL REP, V88, P533, DOI 10.2466/PR0.88.2.533-547; Bewley S, 2005, BMJ-BRIT MED J, V331, P588, DOI 10.1136/bmj.331.7517.588; Caryn Rabin Roni, 2009, NY TIMES; CNATTINGIUS S, 1992, Journal of the American Medical Association, V268, P886, DOI 10.1001/jama.268.7.886; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; D'Apice MR, 2004, CLIN GENET, V65, P52, DOI 10.1111/j..2004.00181.x; Dalman C, 2002, AM J PSYCHIAT, V159, P1591, DOI 10.1176/appi.ajp.159.9.1591; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Furnham A, 2009, BRIT J EDUC PSYCHOL, V79, P769, DOI 10.1348/978185409X412147; GINSBURG GS, 1993, CHILD DEV, V64, P1461, DOI 10.2307/1131546; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; HEATH DT, 1994, J GENET PSYCHOL, V155, P511, DOI 10.1080/00221325.1994.9914799; Herd P, 2010, J HEALTH SOC BEHAV, V51, P478, DOI 10.1177/0022146510386796; HOFFMAN SD, 1993, DEMOGRAPHY, V30, P1, DOI 10.2307/2061859; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Johnson W, 2005, J EDUC PSYCHOL, V97, P391, DOI 10.1037/0022-0663.97.3.391; Kuhnert B, 2004, HUM REPROD UPDATE, V10, P327, DOI 10.1093/humupd/dmh030; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Nassar AH, 2009, AM J PERINAT, V26, P107, DOI 10.1055/s-0028-1090593; Noftle EE, 2007, J PERS SOC PSYCHOL, V93, P116, DOI 10.1037/0022-3514.93.1.116; Organisation for Economic Co-operation and Development (OECD), OECD FAM DAT; Petersen L, 2011, AM J PSYCHIAT, V168, P82, DOI 10.1176/appi.ajp.2010.10020252; Poropat AE, 2011, BRIT J EDUC PSYCHOL, V81, P41, DOI 10.1348/000709910X497671; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; SPIVAK H, 1987, JAMA-J AM MED ASSOC, V258, P1500, DOI 10.1001/jama.258.11.1500; Statistics Sweden, 2009, DEM AN DEM MEAN AG B; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Thacker PD, 2004, JAMA-J AM MED ASSOC, V291, P1683, DOI 10.1001/jama.291.14.1683	33	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24771	10.1371/journal.pone.0024771	http://dx.doi.org/10.1371/journal.pone.0024771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825HM	21957460	Green Published, gold			2022-12-25	WOS:000295262100019
J	Santorelli, CJ; Schaffner, CM; Aureli, F				Santorelli, Claire J.; Schaffner, Colleen M.; Aureli, Filippo			Universal Behaviors as Candidate Traditions in Wild Spider Monkeys	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; TOOL-USE; MACACA-FUSCATA; SCENT MARKING; HAND FUNCTION; CHIMPANZEES; LATERALITY; EVOLUTION; CULTURES; POPULATIONS	Candidate traditions were documented across three communities of wild spider monkeys (Ateles geoffroyi) using an a priori approach to identify behavioral variants and a statistical approach to examine differences in their proportional use. This methodology differs from previous studies of animal traditions, which used retrospective data and relied on the 'exclusion method' to identify candidate traditions. Our a priori approach increased the likelihood that behavior variants with equivalent functions were considered and our statistical approach enabled the proportional use of 'universal' behaviors, i.e., used across all communities, to be examined for the first time in any animal species as candidate traditions. Among universal behaviors we found 14 'community preferred' variants. After considering the extent to which community preferred variants were due to ecological and, to a lesser degree, genetic differences, we concluded that at least six were likely maintained through social learning. Our findings have two main implications: (i) tradition repertoires could be larger than assumed from previous studies using the exclusion method; (ii) the relative use of universal behavior variants can reinforce community membership.	[Santorelli, Claire J.; Schaffner, Colleen M.] Univ Chester, Dept Psychol, Chester, Cheshire, England; [Aureli, Filippo] Liverpool John Moores Univ, Res Ctr Evolutionary Anthropol & Palaeoecol, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England	University of Chester; Liverpool John Moores University	Santorelli, CJ (corresponding author), Univ Chester, Dept Psychol, Chester, Cheshire, England.	c.santorelli@chester.ac.uk		Aureli, Filippo/0000-0002-0671-013X	British Academy; Wenner-Gren Foundation; Leakey Foundation; North of England Zoological Society; University of Chester; Santander University	British Academy; Wenner-Gren Foundation; Leakey Foundation; North of England Zoological Society; University of Chester; Santander University	Field research was supported by The British Academy (www.britac.ac.uk), the Wenner-Gren Foundation (www.wennergren.org), the Leakey Foundation (www.leakeyfoundation.org), and the North of England Zoological Society (www.chesterzoo.org). CJS was supported by a University of Chester Gladstone bursary (www.chester.ac.uk) and the Santander University Scheme (www.santander.co.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio N, 2008, BEHAVIOUR, V145, P983, DOI 10.1163/156853908784089234; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Berger J, 2008, J PERS SOC PSYCHOL, V95, P593, DOI 10.1037/0022-3514.95.3.593; Boyd R., 2005, ORIGIN EVOLUTION CUL; Caldwell CA, 2009, LEARNING FROM ANIMALS: EXAMINING THE NATURE OF HUMAN UNIQUENESS, P173; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; DeWaal FBM, 1997, AM J PRIMATOL, V43, P339, DOI 10.1002/(SICI)1098-2345(1997)43:4<339::AID-AJP5>3.0.CO;2-Y; Di Fiore A, 2006, AM J PRIMATOL, V68, P637, DOI 10.1002/ajp.20257; Egnor SER, 2005, ENCY LANGUAGE LINGUI; Elsenberg J.F., 1972, Annual Rev Ecol Syst, V3, P1; Fletcher AW, 2005, LATERALITY, V10, P219, DOI 10.1080/13576500442000049; Fragaszy D.M., 2003, BIOL TRADITIONS MODE; Galef B.G. Jr, 1990, P74; Heymann EW, 2006, AM J PRIMATOL, V68, P650, DOI 10.1002/ajp.20258; HUFFMAN MA, 1986, PRIMATES, V27, P413, DOI 10.1007/BF02381887; HUFFMAN MA, 1984, J HUM EVOL, V13, P725, DOI 10.1016/S0047-2484(84)80022-6; Janzen D.H., 1986, GUANACASTE NATL PARK; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Lachlan RF, 2004, ANIM BEHAV, V68, P561, DOI 10.1016/j.anbehav.2003.11.015; Lacreuse A, 1999, INT J PRIMATOL, V20, P867, DOI 10.1023/A:1020874418033; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Laska M, 1996, CORTEX, V32, P717, DOI 10.1016/S0010-9452(96)80041-4; Matsusaka T, 2006, PRIMATES, V47, P113, DOI 10.1007/s10329-005-0158-4; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Nakamura M, 2006, PRIMATES, V47, P35, DOI 10.1007/s10329-005-0142-z; Nakamura M, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P71, DOI 10.1017/CBO9780511606397.008; Ottoni EB, 2005, ANIM COGN, V8, P215, DOI 10.1007/s10071-004-0245-8; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Ramos-Fernandez G, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P191; Rebecchini L, 2008, PRIMATE EYE, V96; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Schaffner CM, 2005, INT J PRIMATOL, V26, P1093, DOI 10.1007/s10764-005-6460-6; Shimooka Y, 2008, CAM S BIO EVOL ANTHR, V55, P329; Slater KY, 2007, ANIM BEHAV, V74, P455, DOI 10.1016/j.anbehav.2006.11.026; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Thornton A, 2010, P ROY SOC B-BIOL SCI, V277, P3623, DOI 10.1098/rspb.2010.0611; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Vick LG, 2008, CAM S BIO EVOL ANTHR, V55, P288; Watson CFI, 2009, INT J PRIMATOL, V30, P143, DOI 10.1007/s10764-009-9334-5; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2006, SOCIAL INFORM TRANSM, P188; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372	54	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24400	10.1371/journal.pone.0024400	http://dx.doi.org/10.1371/journal.pone.0024400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949715	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900012
J	Zanno, LE; Varricchio, DJ; O'Connor, PM; Titus, AL; Knell, MJ				Zanno, Lindsay E.; Varricchio, David J.; O'Connor, Patrick M.; Titus, Alan L.; Knell, Michael J.			A New Troodontid Theropod, Talos sampsoni gen. et sp nov., from the Upper Cretaceous Western Interior Basin of North America	PLOS ONE			English	Article							KAIPAROWITS FORMATION; OLDMAN FORMATION; EVOLUTION; DINOSAUR; ORIGIN; STENONYCHOSAURUS; SPECIMEN; PATTERNS; LENGTH; CHINA	Background: Troodontids are a predominantly small-bodied group of feathered theropod dinosaurs notable for their close evolutionary relationship with Avialae. Despite a diverse Asian representation with remarkable growth in recent years, the North American record of the clade remains poor, with only one controversial species-Troodon formosus-presently known from substantial skeletal remains. Methodology/Principal Findings: Here we report a gracile new troodontid theropod-Talos sampsoni gen. et sp. nov.-from the Upper Cretaceous Kaiparowits Formation, Utah, USA, representing one of the most complete troodontid skeletons described from North America to date. Histological assessment of the holotype specimen indicates that the adult body size of Talos was notably smaller than that of the contemporary genus Troodon. Phylogenetic analysis recovers Talos as a member of a derived, latest Cretaceous subclade, minimally containing Troodon, Saurornithoides, and Zanabazar. MicroCT scans reveal extreme pathological remodeling on pedal phalanx II-1 of the holotype specimen likely resulting from physical trauma and subsequent infectious processes. Conclusion/Significance: Talos sampsoni adds to the singularity of the Kaiparowits Formation dinosaur fauna, which is represented by at least 10 previously unrecognized species including the recently named ceratopsids Utahceratops and Kosmoceratops, the hadrosaurine Gryposaurus monumentensis, the tyrannosaurid Teratophoneus, and the oviraptorosaurian Hagryphus. The presence of a distinct troodontid taxon in the Kaiparowits Formation supports the hypothesis that late Campanian dinosaurs of the Western Interior Basin exhibited restricted geographic ranges and suggests that the taxonomic diversity of Late Cretaceous troodontids from North America is currently underestimated. An apparent traumatic injury to the foot of Talos with evidence of subsequent healing sheds new light on the paleobiology of deinonychosaurians by bolstering functional interpretations of prey grappling and/or intraspecific combat for the second pedal digit, and supporting trackway evidence indicating a minimal role in weight bearing.	[Zanno, Lindsay E.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Zanno, Lindsay E.] Univ Wisconsin Parkside, Dept Biol Sci, Kenosha, WI USA; [Varricchio, David J.; Knell, Michael J.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [O'Connor, Patrick M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [O'Connor, Patrick M.] Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Titus, Alan L.] Bur Land Management, Kanab, UT USA	Field Museum of Natural History (Chicago); University of Wisconsin System; University of Wisconsin Parkside; Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Zanno, LE (corresponding author), Field Museum Nat Hist, Chicago, IL 60605 USA.	lzanno@fieldmuseum.org	OConnor, Patrick M/I-9383-2012	OConnor, Patrick M/0000-0002-6762-3806; Zanno, Lindsay/0000-0002-1654-1990	National Science Foundation [EAR-0617561, EAR 0745454]; Grand Staircase-Escalante National Monument (GEMNM); Bureau of Land Management [JSA071004]; Caldwell-Meeker Postdoctoral Fellowship (LEZ); Bucksbaum Young Scientist Fellowship; Field Museum of Natural History; Ohio University College of Osteopathic Medicine; Montana State University	National Science Foundation(National Science Foundation (NSF)); Grand Staircase-Escalante National Monument (GEMNM); Bureau of Land Management; Caldwell-Meeker Postdoctoral Fellowship (LEZ); Bucksbaum Young Scientist Fellowship; Field Museum of Natural History; Ohio University College of Osteopathic Medicine; Montana State University	Funding provided by National Science Foundation EAR-0617561 (to PMO) and EAR 0745454, Grand Staircase-Escalante National Monument (GEMNM), the Bureau of Land Management's National Landscape Conservation System (Assistance Agreement JSA071004), as well as John Caldwell-Meeker Postdoctoral Fellowship (LEZ), Bucksbaum Young Scientist Fellowship (LEZ), Field Museum of Natural History, Ohio University College of Osteopathic Medicine (PMO), and Montana State University (DJV, MJK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, VERTEBRATE PALEONTOL; Aufderheide AC, 1998, CAMBRIDGE ENCY HUMAN; BARSBOLD R, 1987, Acta Palaeontologica Polonica, V32, P121; BEKOFF M, 1977, Mammalian Species, V79, P1; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; CARPENTER K, 1982, Contributions to Geology University of Wyoming, V20, P123; Carpenter K., 1999, EGGS NESTS BABY DINO; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, J VERTEBR PALEONTOL, V30, P1, DOI 10.1080/02724630903413032; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Chure Daniel J., 1994, Brigham Young University Geology Studies, V40, P11; CODDINGTON J, 1994, CLADISTICS, V10, P415; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie P. J., 1992, ASPECTS NONMARINE CR, P237; Currie PJ, 2005, LIFE O PAST, P367; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; Currie PJ, 2004, LIFE O PAST, P112; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; CURRIER M J P, 1983, Mammalian Species, P1, DOI 10.2307/3503951; Eaton J.G., 1999, UTAH GEOLOGICAL SURV, V99-1, P345; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Farlow J.O., 1991, Modern Geology, V16, P161; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FINDEN CR, 1985, J CLASSIF, V2, P255, DOI 10.1007/BF01908078; Folch A., 1992, P90; Fowler D, 2009, J VERTEBR PALEONTOL, V29, p98A; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates Terry A., 2005, P33; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gilmore C.W., 1924, U ALBERTA B, V1, P1; GILMORE CHARLES W., 1932, TRANS ROY SOC CANADA SECT 4, V26, P117; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Hartman S, 2005, J VERTEBR PALEONTOL, V25, p67A; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huene F.v., 1914, GEOLOGIE PALA ONTOLO, V13, P1; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P169, DOI 10.1006/zjls.2000.0267; HUTCHISON JH, 1997, LEARNING LAND GRAND, P391; Jinnah ZA, 2009, CRETACEOUS RES, V30, P287, DOI 10.1016/j.cretres.2008.07.012; Lambe L. M., 1902, Contributions to Canadian Palaeontology, Viii, pUnpaginated; Leidy J., 1856, P ACAD NAT SCI PHILA, V8, P72; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Longrich Nick, 2008, P135; Lucas S. G., 2006, NEW MEXICO MUSEUM NA, V35, P293; Maddison W.P., 2008, MESQUITE MODULAR SYS; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Mann R. W., 2005, PHOTOGRAPHIC REGIONA; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; McGowan P.J.K., 1994, HDB BIRDS WORLD, V2, P434; Morgan JP, 2004, ATLAS RADIOLOGY TRAU; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell MA, 2009, AM MUS NOVIT, P1; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Peng J-H, 2001, PROV MUS ALBERTA NAT, V25, P1, DOI DOI 10.5962/BHL.TITLE.115853; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; RUSSELL DA, 1969, CAN J EARTH SCI, V6, P595, DOI 10.1139/e69-059; Ryan Michael J., 2001, P279; Ryan MJ, 2005, LIFE O PAST, P312; Ryan Michael J., 2000, Gaia (Lisboa), V15, P123; Samman T, 2005, ACTA PALAEONTOL POL, V50, P757; Sampson S, 2004, J VERTEBR PALEONTOL, V24, p108A; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 2009, NEW PERSPECTIVES HOR, P405; Saurornithoididae BarsboldR., 1974, PALAENTOL POL, V30, P5; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014329; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sternberg C. M., 1932, Canadian Field Naturalist, V48, P99; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; WILSON MC, 1985, CAN J EARTH SCI, V22, P1813, DOI 10.1139/e85-192; Xu X, 2004, ACTA GEOL SIN-ENGL, V78, P22; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zanno LE, 2005, GEOL SOC AM ABSTR, V37, p115A; Zanno LE, ADV LATE CR IN PRESS; Zanno L, 2009, J VERTEBR PALEONTOL, V29, p205A; Zanno L, 2005, J VERTEBR PALEONTOL, V25, p133A	100	67	69	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24487	10.1371/journal.pone.0024487	http://dx.doi.org/10.1371/journal.pone.0024487			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949721	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900017
J	Chlenski, A; Guerrero, LJ; Salwen, HR; Yang, QW; Tian, YF; La Madrid, AM; Mirzoeva, S; Bouyer, PG; Xu, D; Walker, M; Cohn, SL				Chlenski, Alexandre; Guerrero, Lisa J.; Salwen, Helen R.; Yang, Qiwei; Tian, Yufeng; La Madrid, Andres Morales; Mirzoeva, Salida; Bouyer, Patrice G.; Xu, David; Walker, Matthew; Cohn, Susan L.			Secreted Protein Acidic and Rich in Cysteine Is a Matrix Scavenger Chaperone	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; GROWTH-FACTOR; CALCIUM-BINDING; SPARC; OSTEONECTIN; COLLAGEN; BM-40; GLYCOPROTEIN; MICE	Secreted Protein Acidic and Rich in Cysteine (SPARC) is one of the major non-structural proteins of the extracellular matrix (ECM) in remodeling tissues. The functional significance of SPARC is emphasized by its origin in the first multicellular organisms and its high degree of evolutionary conservation. Although SPARC has been shown to act as a critical modulator of ECM remodeling with profound effects on tissue physiology and architecture, no plausible molecular mechanism of its action has been proposed. In the present study, we demonstrate that SPARC mediates the disassembly and degradation of ECM networks by functioning as a matricellular chaperone. While it has low affinity to its targets inside the cells where the Ca(2+) concentrations are low, high extracellular concentrations of Ca(2+) activate binding to multiple ECM proteins, including collagens. We demonstrated that in vitro, this leads to the inhibition of collagen I fibrillogenesis and disassembly of preformed collagen I fibrils by SPARC at high Ca(2+) concentrations. In cell culture, exogenous SPARC was internalized by the fibroblast cells in a time-and concentration-dependent manner. Pulse-chase assay further revealed that internalized SPARC is quickly released outside the cell, demonstrating that SPARC shuttles between the cell and ECM. Fluorescently labeled collagen I, fibronectin, vitronectin, and laminin were co-internalized with SPARC by fibroblasts, and semi-quantitative Western blot showed that SPARC mediates internalization of collagen I. Using a novel 3-dimentional model of fluorescent ECM networks pre-deposited by live fibroblasts, we demonstrated that degradation of ECM depends on the chaperone activity of SPARC. These results indicate that SPARC may represent a new class of scavenger chaperones, which mediate ECM degradation, remodeling and repair by disassembling ECM networks and shuttling ECM proteins into the cell. Further understanding of this mechanism may provide insight into the pathogenesis of matrix-associated disorders and lead to the novel treatment strategies.	[Chlenski, Alexandre; Guerrero, Lisa J.; Salwen, Helen R.; Yang, Qiwei; Tian, Yufeng; La Madrid, Andres Morales; Xu, David; Cohn, Susan L.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Mirzoeva, Salida] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bouyer, Patrice G.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Walker, Matthew] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; Northwestern University; University of Chicago; University of Chicago	Chlenski, A (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	achlensk@uchicago.edu	Yang, Qiwei/AAI-7414-2021; Cohn, Susan/AAB-6010-2021	Cohn, Susan/0000-0001-5749-7650; , Qiwei Yang/0000-0001-7131-8946	Super Jake Foundation; Little Heroes Cancer Research Foundation; Neuroblastoma Children's Cancer Society; Elise Anderson Neuroblastoma Research Fund; Children's Neuroblastoma Cancer Foundation	Super Jake Foundation; Little Heroes Cancer Research Foundation; Neuroblastoma Children's Cancer Society; Elise Anderson Neuroblastoma Research Fund; Children's Neuroblastoma Cancer Foundation	This work was supported The Super Jake Foundation, Little Heroes Cancer Research Foundation, the Neuroblastoma Children's Cancer Society, the Elise Anderson Neuroblastoma Research Fund, and the Children's Neuroblastoma Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Busch E, 2000, J BIOL CHEM, V275, P25508, DOI 10.1074/jbc.M001770200; Chlenski A, 2007, ONCOGENE, V26, P4513, DOI 10.1038/sj.onc.1210247; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; Chlenski A, 2004, CANCER RES, V64, P7420, DOI 10.1158/0008-5472.CAN-04-2141; Chlenski A, 2002, CANCER RES, V62, P7357; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Christensen KA, 2002, J CELL SCI, V115, P599; CLEZARDIN P, 1988, EUR J BIOCHEM, V175, P275, DOI 10.1111/j.1432-1033.1988.tb14194.x; CLEZARDIN P, 1991, J BONE MINER RES, V6, P1059; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; Desai NP, 2008, ANTI-CANCER DRUG, V19, P899, DOI 10.1097/CAD.0b013e32830f9046; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Emerson RO, 2006, J CELL BIOCHEM, V98, P701, DOI 10.1002/jcb.20867; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; GOLDBLUM SE, 1994, P NATL ACAD SCI USA, V91, P3448, DOI 10.1073/pnas.91.8.3448; Gooden MD, 1999, J CELL BIOCHEM, V74, P152, DOI 10.1002/(SICI)1097-4644(19990801)74:2<152::AID-JCB2>3.0.CO;2-4; GROSS J, 1958, J BIOL CHEM, V233, P355; Hohenester E, 1996, NAT STRUCT BIOL, V3, P67, DOI 10.1038/nsb0196-67; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Kaufmann B, 2004, GLYCOBIOLOGY, V14, P609, DOI 10.1093/glycob/cwh063; Kawasaki K, 2006, J EXP ZOOL PART B, V306B, P295, DOI 10.1002/jez.b.21088; KUDO H, 1994, EXP CELL RES, V212, P219, DOI 10.1006/excr.1994.1137; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307; MURPHY G, 1985, BIOESSAYS, V2, P55, DOI 10.1002/bies.950020204; NERI M, 1992, EUR J BIOCHEM, V205, P569, DOI 10.1111/j.1432-1033.1992.tb16814.x; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Podgorski I, 2009, AM J PATHOL, V175, P1255, DOI 10.2353/ajpath.2009.080906; Postovit LM, 2006, STEM CELLS, V24, P501, DOI 10.1634/stemcells.2005-0459; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rosenblatt S, 1997, BIOCHEM J, V324, P311, DOI 10.1042/bj3240311; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAGE H, 1984, J BIOL CHEM, V259, P3993; Sasaki T, 1997, J BIOL CHEM, V272, P9237; Sasaki T, 1999, MATRIX BIOL, V18, P499, DOI 10.1016/S0945-053X(99)00041-4; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Trombetta JM, 2010, J HISTOCHEM CYTOCHEM, V58, P871, DOI 10.1369/jhc.2010.956144; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang H, 2006, MATRIX BIOL, V25, P20, DOI 10.1016/j.matbio.2005.09.004; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	61	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23880	10.1371/journal.pone.0023880	http://dx.doi.org/10.1371/journal.pone.0023880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949685	gold, Green Submitted, Green Published			2022-12-25	WOS:000295173800007
J	Coddens, A; Valis, E; Benktander, J; Angstrom, J; Breimer, ME; Cox, E; Teneberg, S				Coddens, Annelies; Valis, Erik; Benktander, John; Angstrom, Jonas; Breimer, Michael E.; Cox, Eric; Teneberg, Susann			Erythrocyte and Porcine Intestinal Glycosphingolipids Recognized by F4 Fimbriae of Enterotoxigenic Escherichia coli	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MASS-SPECTROMETRY; K88 FIMBRIAE; STRUCTURAL CHARACTERIZATION; CORRELATED SPECTROSCOPY; GLYCOLIPID RECEPTORS; HELICOBACTER-PYLORI; BINDING-SPECIFICITY; IDENTIFICATION; ADHESIN	Enterotoxigenic F4-fimbriated Escherichia coli is associated with diarrheal disease in neonatal and postweaning pigs. The F4 fimbriae mediate attachment of the bacteria to the pig intestinal epithelium, enabling an efficient delivery of diarrhea-inducing enterotoxins to the target epithelial cells. There are three variants of F4 fimbriae designated F4ab, F4ac and F4ad, respectively, having different antigenic and adhesive properties. In the present study, the binding of isolated F4ab, F4ac and F4ad fimbriae, and F4ab/ac/ad-fimbriated E. coli, to glycosphingolipids from erythrocytes and from porcine small intestinal epithelium was examined, in order to get a comprehensive view of the F4-binding glycosphingolipids involved in F4-mediated hemagglutination and adhesion to the epithelial cells of porcine intestine. Specific interactions between the F4ab, F4ac and F4ad fimbriae and both acid and non-acid glycosphingolipids were obtained, and after isolation of binding-active glycosphingolipids and characterization by mass spectrometry and proton NMR, distinct carbohydrate binding patterns were defined for each fimbrial subtype. Two novel glycosphingolipids were isolated from chicken erythrocytes, and characterized as GalNAc alpha 3GalNAc alpha beta 3Gal beta 4Glc beta 1Cer and GalNAc alpha 3GalNAc beta 3Gal beta 4GlcNAc beta 3Gal beta 4Glc beta 1Cer. These two compounds, and lactosylceramide (Gal beta 4Glc beta 1Cer) with phytosphingosine and hydroxy fatty acid, were recognized by all three variants of F4 fimbriae. No binding of the F4ad fimbriae or F4ad-fimbriated E. coli to the porcine intestinal glycosphingolipids occurred. However, for F4ab and F4ac two distinct binding patterns were observed. The F4ac fimbriae and the F4ac-expressing E. coli selectively bound to galactosylceramide (Gal beta 1Cer) with sphingosine and hydroxy 24: 0 fatty acid, while the porcine intestinal glycosphingolipids recognized by F4ab fimbriae and the F4ab-fimbriated bacteria were characterized as galactosylceramide, sulfatide (SO3-3Gal beta 1Cer), sulf-lactosylceramide (SO3-3Gal beta 4Glc beta 1Cer), and globotriaosylceramide (Gal alpha 4Gal beta 4Glc beta 1Cer) with phytosphingosine and hydroxy 24: 0 fatty acid. Finally, the F4ad fimbriae and the F4ad-fimbriated E. coli, but not the F4ab or F4ac subtypes, bound to reference gangliotriaosylceramide (GalNAc beta 4Gal beta 4Glc beta 1Cer), gangliotetraosylceramide (Gal beta 3GalNAc beta 4Gal beta 4Glc beta 1Cer), isoglobotriaosylceramide (Gal alpha 3-Gal beta 4Glc beta 1Cer), and neolactotetraosylceramide (Gal beta 4GlcNAc beta 3Gal beta 4Glc beta 1Cer).	[Coddens, Annelies; Cox, Eric] Univ Ghent, Fac Vet Med, Lab Vet Immunol, Merelbeke, Belgium; [Valis, Erik; Benktander, John; Angstrom, Jonas; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Breimer, Michael E.] Sahlgrens Univ Hosp, Dept Surg, Gothenburg, Sweden	Ghent University; University of Gothenburg; Sahlgrenska University Hospital	Coddens, A (corresponding author), Univ Ghent, Fac Vet Med, Lab Vet Immunol, Merelbeke, Belgium.	Susann.Teneberg@medkem.gu.se		Cox, Eric/0000-0003-4281-2990	Swedish Research Council/Medicine [12628]; Swedish Cancer Foundation; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO-Vlaanderen) [G.0389.07, G.0263.07]; agency for Innovation by Science and Technology (IWT); Mucosal Immunobiology and Vaccine Center/Swedish Foundation for Strategic Research	Swedish Research Council/Medicine(Swedish Research Council); Swedish Cancer Foundation; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO-Vlaanderen)(FWO); agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Mucosal Immunobiology and Vaccine Center/Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This study was supported by the Swedish Research Council/Medicine (S. T., Grant no. 12628), the Swedish Cancer Foundation (S. T.), and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO-Vlaanderen (Grant no. G.0389.07 and Grant no. G.0263.07)). A. C. is supported by the agency for Innovation by Science and Technology (IWT), and E. V. was supported by the Mucosal Immunobiology and Vaccine Center/Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; BAKKER D, 1991, MOL MICROBIOL, V5, P875, DOI 10.1111/j.1365-2958.1991.tb00761.x; BAKKER D, 1992, J BACTERIOL, V174, P6350, DOI 10.1128/JB.174.20.6350-6358.1992; BAKKER D, 1992, MOL MICROBIOL, V6, P247, DOI 10.1111/j.1365-2958.1992.tb02006.x; BLOMBERG L, 1993, INFECT IMMUN, V61, P2526, DOI 10.1128/IAI.61.6.2526-2531.1993; BOCK K, 1985, J BIOL CHEM, V260, P8545; BRENNAN MJ, 1991, J BIOL CHEM, V266, P18827; DABROWSKI J, 1980, BIOCHEMISTRY-US, V19, P5652, DOI 10.1021/bi00565a030; DABROWSKI J, 1980, CHEM PHYS LIPIDS, V26, P187, DOI 10.1016/0009-3084(80)90006-7; De Greve H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/j.sbi.2007.06.011; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; FALK P, 1986, BIOCHIM BIOPHYS ACTA, V878, P296, DOI 10.1016/0005-2760(86)90161-X; GAASTRA W, 1983, FEMS MICROBIOL LETT, V18, P177, DOI 10.1111/j.1574-6968.1983.tb00474.x; Grange PA, 1999, INFECT IMMUN, V67, P165, DOI 10.1128/IAI.67.1.165-172.1999; Grange PA, 2002, INFECT IMMUN, V70, P2336, DOI 10.1128/IAI.70.5.2336-2343.2002; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; HOLGERSSON J, 1991, J BIOCHEM-TOKYO, V110, P120, DOI 10.1093/oxfordjournals.jbchem.a123530; ITO M, 1989, J BIOL CHEM, V264, P9510; Jansson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004487; Jin LZ, 2000, APPL MICROBIOL BIOT, V54, P311, DOI 10.1007/s002530000404; Kamisago S, 1996, INFECT IMMUN, V64, P624, DOI 10.1128/IAI.64.2.624-628.1996; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KARLSSON KA, 1991, CARBOHYD RES, V221, P49, DOI 10.1016/0008-6215(91)80048-R; KARLSSON KA, 1974, J BIOL CHEM, V249, P4819; Khan AS, 1996, INFECT IMMUN, V64, P3688, DOI 10.1128/IAI.64.9.3688-3693.1996; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; KRIVAN HC, 1989, J BIOL CHEM, V264, P9283; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; OUDEGA B, 1989, MOL MICROBIOL, V3, P645, DOI 10.1111/j.1365-2958.1989.tb00212.x; PAYNE D, 1993, INFECT IMMUN, V61, P3673, DOI 10.1128/IAI.61.9.3673-3677.1993; POPPE L, 1990, EUR J BIOCHEM, V189, P313, DOI 10.1111/j.1432-1033.1990.tb15492.x; Rousset E, 1998, INFECT IMMUN, V66, P5650, DOI 10.1128/IAI.66.12.5650-5658.1998; SAITOH T, 1991, FEBS LETT, V282, P385, DOI 10.1016/0014-5793(91)80519-9; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; SEYAMA Y, 1974, J BIOCHEM-TOKYO, V75, P837, DOI 10.1093/oxfordjournals.jbchem.a130455; SHIRAISHI T, 1985, J LIPID RES, V26, P860; Teneberg S, 2004, GLYCOBIOLOGY, V14, P187, DOI 10.1093/glycob/cwh015; THORN JJ, 1992, BIOCHEMISTRY-US, V31, P6509, DOI 10.1021/bi00143a022; VALENT QA, 1995, MOL MICROBIOL, V16, P1243, DOI 10.1111/j.1365-2958.1995.tb02346.x; Van den Broeck W, 1999, VET MICROBIOL, V68, P255, DOI 10.1016/S0378-1135(99)00076-0; Van den Broeck W, 2000, VET MICROBIOL, V71, P223, DOI 10.1016/S0378-1135(99)00174-1; Verdonck F, 2004, VACCINE, V22, P4291, DOI 10.1016/j.vaccine.2004.04.016; Verdonck F, 2004, VET MICROBIOL, V102, P215, DOI 10.1016/j.vetmic.2004.06.002; WADDELL T, 1988, BIOCHEM BIOPH RES CO, V152, P674, DOI 10.1016/S0006-291X(88)80091-3; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Zhang WP, 2009, INFECT IMMUN, V77, P699, DOI 10.1128/IAI.01165-08	52	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23309	10.1371/journal.pone.0023309	http://dx.doi.org/10.1371/journal.pone.0023309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949679	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800002
J	Krajewska, M; You, ZR; Rong, J; Kress, C; Huang, XS; Yang, JS; Kyoda, T; Leyva, R; Banares, S; Hu, Y; Sze, CH; Whalen, MJ; Salmena, L; Hakem, R; Head, BP; Reed, JC; Krajewski, S				Krajewska, Maryla; You, Zerong; Rong, Juan; Kress, Christina; Huang, Xianshu; Yang, Jinsheng; Kyoda, Tiffany; Leyva, Ricardo; Banares, Steven; Hu, Yue; Sze, Chia-Hung; Whalen, Michael J.; Salmena, Leonardo; Hakem, Razqallah; Head, Brian P.; Reed, John C.; Krajewski, Stan			Neuronal Deletion of Caspase 8 Protects against Brain Injury in Mouse Models of Controlled Cortical Impact and Kainic Acid-Induced Excitotoxicity	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; FOCAL CEREBRAL-ISCHEMIA; C-JUN; HEAD-INJURY; IN-VITRO; ORGANOTYPIC CULTURES; NERVOUS-SYSTEM; JNK ACTIVATION; APOPTOSIS; MICE	Background: Acute brain injury is an important health problem. Given the critical position of caspase 8 at the crossroads of cell death pathways, we generated a new viable mouse line (Ncasp8(-/-)), in which the gene encoding caspase 8 was selectively deleted in neurons by cre-lox system. Methodology/Principal Findings: Caspase 8 deletion reduced rates of neuronal cell death in primary neuronal cultures and in whole brain organotypic coronal slice cultures prepared from 4 and 8 month old mice and cultivated up to 14 days in vitro. Treatments of cultures with recombinant murine TNF alpha (100 ng/ml) or TRAIL (250 ng/mL) plus cyclohexamide significantly protected neurons against cell death induced by these apoptosis-inducing ligands. A protective role of caspase 8 deletion in vivo was also demonstrated using a controlled cortical impact (CCI) model of traumatic brain injury (TBI) and seizure-induced brain injury caused by kainic acid (KA). Morphometric analyses were performed using digital imaging in conjunction with image analysis algorithms. By employing virtual images of hundreds of brain sections, we were able to perform quantitative morphometry of histological and immunohistochemical staining data in an unbiased manner. In the TBI model, homozygous deletion of caspase 8 resulted in reduced lesion volumes, improved post-injury motor performance, superior learning and memory retention, decreased apoptosis, diminished proteolytic processing of caspases and caspase substrates, and less neuronal degeneration, compared to wild type, homozygous cre, and caspase 8-floxed control mice. In the KA model, Ncasp8(-/-) mice demonstrated superior survival, reduced seizure severity, less apoptosis, and reduced caspase 3 processing. Uninjured aged knockout mice showed improved learning and memory, implicating a possible role for caspase 8 in cognitive decline with aging. Conclusions: Neuron-specific deletion of caspase 8 reduces brain damage and improves post-traumatic functional outcomes, suggesting an important role for this caspase in pathophysiology of acute brain trauma.	[Krajewska, Maryla; Rong, Juan; Kress, Christina; Huang, Xianshu; Kyoda, Tiffany; Leyva, Ricardo; Banares, Steven; Sze, Chia-Hung; Reed, John C.; Krajewski, Stan] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [You, Zerong; Yang, Jinsheng; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci, Charlestown, MA USA; [Hu, Yue; Head, Brian P.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Hu, Yue] VA San Diego Healthcare Syst, San Diego, CA USA; [Salmena, Leonardo; Hakem, Razqallah] Ontario Canc Inst, Dept Med Biophys, Toronto, ON M4X 1K9, Canada	Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Krajewska, M (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	jreed@sanfordburnham.org; stan@sanfordburnham.org		Hakem, Razqallah/0000-0001-5948-7931; Salmena, Leonardo/0000-0003-4023-658X	NIH [NS36821, CA69381]; DoD [W81XWH-08-2-0067, W81XWH-07-1-0569]; VA CDA-2; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064545, R01NS036821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); VA CDA-2; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the NIH grants (NS36821 [SK]; CA69381 [JCR]) and DoD grants (W81XWH-08-2-0067 [SK]; W81XWH-07-1-0569 [JCR]); VA CDA-2 [BPH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2005, J NEUROSCI METH, V149, P110, DOI 10.1016/j.jneumeth.2005.05.022; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bagnoli M, 2010, INT J BIOCHEM CELL B, V42, P210, DOI 10.1016/j.biocel.2009.11.015; Banares S, 2005, GENESIS, V42, P6, DOI 10.1002/gene.20117; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Ben Moshe T, 2008, CYTOKINE GROWTH F R, V19, P209, DOI 10.1016/j.cytogfr.2008.04.012; Bermpohl D, 2007, J CEREB BLOOD FLOW M; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Escartin C, 2008, MOL NEUROBIOL, V38, P231, DOI 10.1007/s12035-008-8043-y; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Feng YZ, 2003, EUR J PHARMACOL, V481, P169, DOI 10.1016/j.ejphar.2003.09.016; FERKANY JW, 1984, NATURE, V308, P561, DOI 10.1038/308561a0; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harrison DC, 2001, MOL BRAIN RES, V89, P133, DOI 10.1016/S0169-328X(01)00058-4; Henshall DC, 2001, P NATL ACAD SCI USA, V98, P15318; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Johnson V. E., 2010, NAT REV NEUROSCI; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim YE, 2010, NAT PROTOC, V5, P1396, DOI 10.1038/nprot.2010.101; Krajewska M, 2008, AM J PATHOL, V172, P1312, DOI 10.2353/ajpath.2008.070594; Krajewska M, 2009, J HISTOCHEM CYTOCHEM, V57, P649, DOI 10.1369/jhc.2009.952812; Krajewski S, 2009, METHODS MOL BIOL, V536, P473, DOI 10.1007/978-1-59745-542-8_48; Kumar S, 1997, INT J BIOCHEM CELL B, V29, P393, DOI 10.1016/S1357-2725(96)00146-X; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; Li TF, 2006, BRAIN RES, V1098, P204, DOI 10.1016/j.brainres.2006.04.131; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Qiu JH, 2002, J NEUROSCI, V22, P3504; Romito-DiGiacomo RR, 2007, J NEUROSCI, V27, P8496, DOI 10.1523/JNEUROSCI.1008-07.2007; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Xiang ZM, 2000, J NEUROSCI METH, V98, P145, DOI 10.1016/S0165-0270(00)00197-7; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yoon JJ, 2010, BRAIN RES, V1353, P194, DOI 10.1016/j.brainres.2010.07.005; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhang JH, 2001, BIOCHEM BIOPH RES CO, V285, P1143, DOI 10.1006/bbrc.2001.5313; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	89	49	52	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24341	10.1371/journal.pone.0024341	http://dx.doi.org/10.1371/journal.pone.0024341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21957448	gold, Green Submitted, Green Published			2022-12-25	WOS:000295173800020
J	Bankert, RB; Balu-Iyer, SV; Odunsi, K; Shultz, LD; Kelleher, RJ; Barnas, JL; Simpson-Abelson, M; Parsons, R; Yokota, SJ				Bankert, Richard B.; Balu-Iyer, Sathy V.; Odunsi, Kunle; Shultz, Leonard D.; Kelleher, Raymond J., Jr.; Barnas, Jennifer L.; Simpson-Abelson, Michelle; Parsons, Robert; Yokota, Sandra J.			Humanized Mouse Model of Ovarian Cancer Recapitulates Patient Solid Tumor Progression, Ascites Formation, and Metastasis	PLOS ONE			English	Article							HUMAN-LUNG-TUMOR; MEMORY T-CELLS; FIBROBLASTS; MICE; MICROENVIRONMENT; MICROSPHERES; CHEMOTHERAPY; LYMPHOCYTES; ERADICATION; ACTIVATION	Ovarian cancer is the most common cause of death from gynecological cancer. Understanding the biology of this disease, particularly how tumor-associated lymphocytes and fibroblasts contribute to the progression and metastasis of the tumor, has been impeded by the lack of a suitable tumor xenograft model. We report a simple and reproducible system in which the tumor and tumor stroma are successfully engrafted into NOD-scid IL2R gamma(null) (NSG) mice. This is achieved by injecting tumor cell aggregates derived from fresh ovarian tumor biopsy tissues (including tumor cells, and tumor-associated lymphocytes and fibroblasts) i.p. into NSG mice. Tumor progression in these mice closely parallels many of the events that are observed in ovarian cancer patients. Tumors establish in the omentum, ovaries, liver, spleen, uterus, and pancreas. Tumor growth is initially very slow and progressive within the peritoneal cavity with an ultimate development of tumor ascites, spontaneous metastasis to the lung, increasing serum and ascites levels of CA125, and the retention of tumor-associated human fibroblasts and lymphocytes that remain functional and responsive to cytokines for prolonged periods. With this model one will be able to determine how fibroblasts and lymphocytes within the tumor microenvironment may contribute to tumor growth and metastasis, and will make it possible to evaluate the efficacy of therapies that are designed to target these cells in the tumor stroma.	[Bankert, Richard B.; Kelleher, Raymond J., Jr.; Barnas, Jennifer L.; Simpson-Abelson, Michelle; Parsons, Robert; Yokota, Sandra J.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Balu-Iyer, Sathy V.] SUNY Buffalo, Amherst, NY USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Jackson Laboratory	Bankert, RB (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	rbankert@buffalo.edu	Karwasińska, Emilia/A-8903-2012	Barnas, Jennifer/0000-0002-6033-4403	NIH [CA34196, CA131407, CA108970, AI079188, T32AI1007614, HL-70227]; Ovarian Cancer Working Group of the Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA131407, R01CA108970, P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Working Group of the Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported in part by NIH grant CA34196 (LDS) and by NIH Grants CA131407, CA108970 and AI079188 (RBB), T32AI1007614 (MSA), Ovarian Cancer Working Group Grant of the Cancer Research Institute (KO) and NIH Grant HL-70227 (SB-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bankert RB, 2001, TRENDS IMMUNOL, V22, P386, DOI 10.1016/S1471-4906(01)01943-3; Barnas JL, 2010, CANCER MICROENVIRON, V3, P29, DOI 10.1007/s12307-010-0044-5; Barnas JL, 2010, J IMMUNOL, V185, P2681, DOI 10.4049/jimmunol.1000896; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; BOMBARA MP, 1993, J LEUKOCYTE BIOL, V54, P399, DOI 10.1002/jlb.54.5.399; Broderick L, 2006, CLIN IMMUNOL, V118, P159, DOI 10.1016/j.clim.2005.09.008; CHEN SS, 1991, J REPROD MED, V36, P627; Diniz PM, 2011, CLINICS, V66, P73, DOI 10.1590/S1807-59322011000100013; Egilmez NK, 2000, CANCER RES, V60, P3832; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Gupta D, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-13; Hill HC, 2002, CANCER RES, V62, P7254; Khan S, 2010, J ONCOL, V2010, DOI 10.1155/2010/286925; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Nair RE, 2006, J IMMUNOTHER, V29, P10, DOI 10.1097/01.cji.0000175489.19314.d2; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; RANVIER L, 1874, ARCH PHYSL, V1, P429; REDDY S, 1987, CANCER RES, V47, P2456; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Simpson-Abelson MR, 2008, EXPERT OPIN THER TAR, V12, P477, DOI 10.1517/14728222.12.4.477 ; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009, DOI 10.4049/jimmunol.180.10.7009; Simpson-Abelson MR, 2009, CLIN IMMUNOL, V132, P71, DOI 10.1016/j.clim.2009.03.516; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Sorensen EW, 2009, IMMUNOL RES, V45, P185, DOI 10.1007/s12026-009-8100-2; Usubutun A, 2007, ARCH PATHOL LAB MED, V131, P1578; van Dalen A, 2000, GYNECOL ONCOL, V79, P444, DOI 10.1006/gyno.2000.5982; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Woo EY, 2001, CANCER RES, V61, P4766; Yang S, 2008, CHINESE GERMAN J CLI, V7, P51; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	46	80	87	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24420	10.1371/journal.pone.0024420	http://dx.doi.org/10.1371/journal.pone.0024420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935406	gold, Green Published, Green Submitted			2022-12-25	WOS:000295041700031
J	Scala, E; Alessandri, C; Palazzo, P; Pomponi, D; Liso, M; Bernardi, ML; Ferrara, R; Zennaro, D; Santoro, M; Rasi, C; Mari, A				Scala, Enrico; Alessandri, Claudia; Palazzo, Paola; Pomponi, Debora; Liso, Marina; Bernardi, Maria Livia; Ferrara, Rosetta; Zennaro, Danila; Santoro, Mario; Rasi, Chiara; Mari, Adriano			IgE Recognition Patterns of Profilin, PR-10, and Tropomyosin Panallergens Tested in 3,113 Allergic Patients by Allergen Microarray-Based Technology	PLOS ONE			English	Article							LIPID-TRANSFER PROTEIN; CROSS-REACTIVITY; RECOMBINANT ALLERGENS; POLLEN SENSITIZATION; CLUSTER-ANALYSIS; FOOD ALLERGENS; DIAGNOSIS; IDENTIFICATION; PREVALENCE; MOLECULES	Background: IgE recognition of panallergens having highly conserved sequence regions, structure, and function and shared by inhalant and food allergen sources is often observed. Methods: We evaluated the IgE recognition profile of profilins (Bet v 2, Cyn d 12, Hel a 2, Hev b 8, Mer a 1, Ole e 2, Par j 3, Phl p 12, Pho d 2), PR-10 proteins (Aln g 1, Api g 1, Bet v 1.0101, Bet v 1.0401, Cor a 1, Dau c 1 and Mal d 1.0108) and tropomyosins (Ani s 3, Der p 10, Hel as 1, Pen i 1, Pen m 1, Per a 7) using the Immuno-Solid phase Allergen Chip (ISAC) microarray system. The three panallergen groups were well represented among the allergenic molecules immobilized on the ISAC. Moreover, they are distributed in several taxonomical allergenic sources, either close or distant, and have a route of exposure being either inhalation or ingestion. Results: 3,113 individuals (49.9% female) were selected on the basis of their reactivity to profilins, PR-10 or tropomyosins. 1,521 (48.8%) patients were reactive to profilins (77.6% Mer a 1 IgE(+)), 1,420 (45.6%) to PR-10 (92.5% Bet v 1 IgE(+)) and 632 (20.3%) to tropomyosins (68% Der p 10 IgE(+)). A significant direct relationship between different representative molecules within each group of panallergens was found. 2,688 patients (86.4%) recognized only one out of the three distinct groups of molecules as confirmed also by hierarchical clustering analysis. Conclusions: Unless exposed to most of the allergens in the same or related allergenic sources, a preferential IgE response to distinct panallergens has been recorded. Allergen microarray IgE testing increases our knowledge of the IgE immune response and related epidemiological features within and between homologous molecules better describing the patients' immunological phenotypes.	[Scala, Enrico; Alessandri, Claudia; Palazzo, Paola; Pomponi, Debora; Liso, Marina; Bernardi, Maria Livia; Ferrara, Rosetta; Zennaro, Danila; Santoro, Mario; Rasi, Chiara; Mari, Adriano] IDI IRCCS, Ctr Mol Allergol, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Scala, E (corresponding author), IDI IRCCS, Ctr Mol Allergol, Rome, Italy.	adriano.mari@idi.it	Santoro, Mario/GVU-5164-2022; Scala, Enrico/H-6997-2012; Alessandri, Claudia/ABG-7848-2021; Liso, Marina/AAB-3723-2019	Santoro, Mario/0000-0001-6626-9430; Scala, Enrico/0000-0002-9391-9168; Alessandri, Claudia/0000-0003-2466-6870; LISO, MARINA/0000-0002-8766-1869	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The study has been funded by the Italian Ministry of Health, Current Research Program 2006-2008. Extensive IgE testing carried out routinely by the ISAC microarray system has been made possible by using the reimbursement system established by the Regional Public Health Care Service for laboratory IgE detection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIANO R, 1993, ANN ALLERGY, V70, P249; Carrapatoso I, 2008, REV PORT IMUNOALERG, V16, P449; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Chapman Martin D, 2008, Clin Allergy Immunol, V21, P47; Ciardiello MA, 2010, ALLERGY, V65, P597, DOI 10.1111/j.1398-9995.2009.02277.x; Cuesta-Herranz J, 2010, INT ARCH ALLERGY IMM, V153, P182, DOI 10.1159/000312636; D'Avino R, 2011, ALLERGY, V66, P870, DOI 10.1111/j.1398-9995.2011.02555.x; Ebo DG, 2004, CLIN EXP ALLERGY, V34, P137, DOI 10.1111/j.1365-2222.2004.01837.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Gadermaier G, 2009, MOL IMMUNOL, V46, P1919, DOI 10.1016/j.molimm.2009.03.021; Gamboa PM, 2007, ALLERGY, V62, P408, DOI 10.1111/j.1398-9995.2006.01284.x; GRALL F, 1977, REV FR ALLERGOL, V17, P7, DOI 10.1016/S0335-7457(77)80003-8; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Harwanegg C, 2004, EXPERT REV MOL DIAGN, V4, P539, DOI 10.1586/14737159.4.4.539; Harwanegg C, 2003, CLIN EXP ALLERGY, V33, P7, DOI 10.1046/j.1365-2222.2003.01550.x; Harwanegg Ch, 2006, Eur Ann Allergy Clin Immunol, V38, P232; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Kerzel S, 2010, J IMMUNOL, V185, P2253, DOI 10.4049/jimmunol.0902942; Kleine-Tebbe J, 2002, J ALLERGY CLIN IMMUN, V110, P797, DOI 10.1067/mai.2002.128946; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Lehrer SB, 1998, REV FR ALLERGOL, V38, P846, DOI 10.1016/S0335-7457(98)80154-8; Leung PSC, 1996, J ALLERGY CLIN IMMUN, V98, P954, DOI 10.1016/S0091-6749(96)80012-1; Lidholm J, 2006, CURR OPIN ALLERGY CL, V6, P234, DOI 10.1097/01.all.0000225166.90768.d6; Lombardero M, 2004, CLIN EXP ALLERGY, V34, P1415, DOI 10.1111/j.1365-2222.2004.02053.x; Mari A, 2003, CLIN EXP ALLERGY, V33, P1419, DOI 10.1046/j.1365-2222.2003.01773.x; Mari A, 2001, INT ARCH ALLERGY IMM, V125, P57, DOI 10.1159/000053797; MARI A, 2005, ALLERGY CLIN IMMUNOL, V17, P205; Mari A, 2010, CURR ALLERGY ASTHM R, V10, P357, DOI 10.1007/s11882-010-0132-0; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; Moneret-Vautrin DA, 2005, B ACAD NAT MED PARIS, V189, P1491, DOI 10.1016/S0001-4079(19)33458-2; Pastorello EA, 2004, MOL NUTR FOOD RES, V48, P356, DOI 10.1002/mnfr.200400047; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2011, MOL IMMUNOL, V48, P600, DOI 10.1016/j.molimm.2010.10.019; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Simpson CR, 2008, J ROY SOC MED, V101, P558, DOI 10.1258/jrsm.2008.080196; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Valenta R, 2007, J INVEST ALLERG CLIN, V17, P36; Van Ree R, 2000, ALLERGY CLIN IMMUNOL, V12, P7; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Wagner S, 2002, BIOCHEM SOC T, V30, P935, DOI 10.1042/BST0300935; Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P435, DOI 10.1067/mai.2002.126380; Yeang HY, 2006, CLIN EXP ALLERGY, V36, P1078, DOI 10.1111/j.1365-2222.2006.02531.x	46	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24912	10.1371/journal.pone.0024912	http://dx.doi.org/10.1371/journal.pone.0024912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949785	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700076
J	She, K; Craig, AM				She, Kevin; Craig, Ann Marie			NMDA Receptors Mediate Synaptic Competition in Culture	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; KNOCKOUT MICE; IN-VIVO; DEPENDENT REGULATION; EXCITATORY SYNAPSES; BARREL CORTEX; N-CADHERIN; PLASTICITY; EXPRESSION; MECHANISMS	Background: Activity through NMDA type glutamate receptors sculpts connectivity in the developing nervous system. This topic is typically studied in the visual system in vivo, where activity of inputs can be differentially regulated, but in which individual synapses are difficult to visualize and mechanisms governing synaptic competition can be difficult to ascertain. Here, we develop a model of NMDA-receptor dependent synaptic competition in dissociated cultured hippocampal neurons. Methodology/Principal Findings: GluN1 -/- (KO) mouse hippocampal neurons lacking the essential NMDA receptor subunit were cultured alone or cultured in defined ratios with wild type (WT) neurons. The absence of functional NMDA receptors did not alter neuron survival. Synapse development was assessed by immunofluorescence for postsynaptic PSD-95 family scaffold and apposed presynaptic vesicular glutamate transporter VGlut1. Synapse density was specifically enhanced onto minority wild type neurons co-cultured with a majority of GluN1 -/- neighbour neurons, both relative to the GluN1 -/- neighbours and relative to sister pure wild type cultures. This form of synaptic competition was dependent on NMDA receptor activity and not conferred by the mere physical presence of GluN1. In contrast to these results in 10% WT and 90% KO co-cultures, synapse density did not differ by genotype in 50% WT and 50% KO co-cultures or in 90% WT and 10% KO co-cultures. Conclusions/Significance: The enhanced synaptic density onto NMDA receptor-competent neurons in minority coculture with GluN1 -/- neurons represents a cell culture paradigm for studying synaptic competition. Mechanisms involved may include a retrograde 'reward' signal generated by WT neurons, although in this paradigm there was no 'punishment' signal against GluN1 -/- neurons. Cell culture assays involving such defined circuits may help uncover the rules and mechanisms of activity-dependent synaptic competition in the developing nervous system.	[She, Kevin] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	She, K (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada.	amcraig@interchange.ubc.ca	Craig, Ann Marie/M-2054-2014		Canadian Institutes of Health Research (CIHR) [MOP-69096]; Canada Research Chair; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by Canadian Institutes of Health Research (CIHR) MOP-69096, a CIHR Frederick Banting and Charles Best Canadian Graduate Scholarship (KS), and Canada Research Chair and Michael Smith Foundation for Health Research Awards (AMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Lee LJ, 2005, J NEUROSCI, V25, P2304, DOI 10.1523/JNEUROSCI.4902-04.2005; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MURPHY TH, 1992, J NEUROSCI, V12, P4834; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuka N, 2008, P NATL ACAD SCI USA, V105, P12961, DOI 10.1073/pnas.0806180105; Okabe S, 1998, EUR J NEUROSCI, V10, P2192, DOI 10.1046/j.1460-9568.1998.00233.x; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rudhard Y, 2003, J NEUROSCI, V23, P2323; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Singh B, 2006, J NEUROSCI, V26, P7189, DOI 10.1523/JNEUROSCI.5474-05.2006; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tokita Y, 1996, EUR J NEUROSCI, V8, P69, DOI 10.1111/j.1460-9568.1996.tb01168.x; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Verderio C, 1999, EUR J NEUROSCI, V11, P2793, DOI 10.1046/j.1460-9568.1999.00697.x; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279	65	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24423	10.1371/journal.pone.0024423	http://dx.doi.org/10.1371/journal.pone.0024423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935408	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700032
J	Stern, DI; Gething, PW; Kabaria, CW; Temperley, WH; Noor, AM; Okiro, EA; Shanks, GD; Snow, RW; Hay, SI				Stern, David I.; Gething, Peter W.; Kabaria, Caroline W.; Temperley, William H.; Noor, Abdisalan M.; Okiro, Emelda A.; Shanks, G. Dennis; Snow, Robert W.; Hay, Simon I.			Temperature and Malaria Trends in Highland East Africa	PLOS ONE			English	Article							CLIMATE-CHANGE; RESURGENCE; ROBUST; DEBATE; GRIDS; AIR	There has been considerable debate on the existence of trends in climate in the highlands of East Africa and hypotheses about their potential effect on the trends in malaria in the region. We apply a new robust trend test to mean temperature time series data from three editions of the University of East Anglia's Climatic Research Unit database (CRU TS) for several relevant locations. We find significant trends in the data extracted from newer editions of the database but not in the older version for periods ending in 1996. The trends in the newer data are even more significant when post-1996 data are added to the samples. We also test for trends in the data from the Kericho meteorological station prepared by Omumbo et al. We find no significant trend in the 1979-1995 period but a highly significant trend in the full 1979-2009 sample. However, although the malaria cases observed at Kericho, Kenya rose during a period of resurgent epidemics (1994-2002) they have since returned to a low level. A large assembly of parasite rate surveys from the region, stratified by altitude, show that this decrease in malaria prevalence is not limited to Kericho.	[Stern, David I.] Australian Natl Univ, Crawford Sch Econ & Govt, Canberra, ACT, Australia; [Gething, Peter W.; Temperley, William H.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Kabaria, Caroline W.; Noor, Abdisalan M.; Okiro, Emelda A.; Snow, Robert W.] Univ Oxford, Wellcome Trust Collaborat Programme, Kenyatta Natl Hosp Grounds, Malaria Publ Hlth & Epidemiol Grp,Ctr Geog Med,Ke, Nairobi, Kenya; [Shanks, G. Dennis] Australian Army Malaria Inst, Enoggera, Qld, Australia	Australian National University; University of Oxford; Kenyatta National Hospital; QIMR Berghofer Medical Research Institute	Stern, DI (corresponding author), Australian Natl Univ, Crawford Sch Econ & Govt, Canberra, ACT, Australia.	david.stern@anu.edu.au	Stern, David I/B-4700-2009; Shanks, George Dennis/F-4056-2014; Gething, Peter/GQR-1884-2022; Hay, Simon Iain/F-8967-2015; Snow, Robert William/AFR-1436-2022; Gething, Peter/ABD-2110-2020	Stern, David I/0000-0001-6595-4268; Shanks, George Dennis/0000-0001-5763-8660; Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; Snow, Robert William/0000-0003-3725-6088; Okiro, Emelda/0000-0001-9543-8360; Kabaria, Caroline/0000-0002-5641-5243	Wellcome Trust [079091, 086166, 081829, 079080]; Wellcome Trust, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust, United Kingdom(Wellcome Trust)	This work was supported by the Wellcome Trust. SH is funded by a Senior Research Fellowship from the Wellcome Trust (# 079091) which also supports CK and PG. EO is supported by the Wellcome Trust as a Research Training Fellow (# 086166). AN is supported by the Wellcome Trust as a Research Training Fellow (# 081829). RS is supported by the Wellcome Trust as Principal Research Fellow (# 079080). This work forms part of the output of the Malaria Atlas Project (http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; Box GEP, 1970, J AM STAT ASSOC, V65, P1509, DOI DOI 10.2307/2284333; Bunzel H, 2005, J BUS ECON STAT, V23, P381, DOI 10.1198/073500104000000631; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; FOMBY TB, 2003, ADV ECONOMETRICS, V17; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391	20	59	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24524	10.1371/journal.pone.0024524	http://dx.doi.org/10.1371/journal.pone.0024524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935416	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700037
J	Hogg, K; Wood, C; McNeilly, AS; Duncan, WC				Hogg, Kirsten; Wood, Charlotte; McNeilly, Alan S.; Duncan, W. Colin			The In Utero Programming Effect of Increased Maternal Androgens and a Direct Fetal Intervention on Liver and Metabolic Function in Adult Sheep	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FACTOR-BINDING PROTEIN-1; INSULIN-RESISTANCE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; PRENATAL ANDROGEN; NONALCOHOLIC STEATOHEPATITIS; FEMALE SHEEP; YOUNG-WOMEN; DISEASE; TESTOSTERONE	Epigenetic changes in response to external stimuli are fast emerging as common underlying causes for the pre-disposition to adult disease. Prenatal androgenization is one such model that results in reproductive and metabolic features that are present in conditions such as polycystic ovary syndrome (PCOS). We examined the effect of prenatal androgens on liver function and metabolism of adult sheep. As non-alcoholic fatty liver disease is increased in PCOS we hypothesized that this, and other important liver pathways including metabolic function, insulin-like growth factor (IGF) and steroid receptivity, would be affected. Pregnant ewes received vehicle control (C; n = 5) or testosterone propionate (TP; n = 9) twice weekly (100 mg; i.m) from d62-102 (gestation 147 days). In a novel treatment paradigm, a second cohort received a direct C (n = 4) or TP (20 mg; n = 7) fetal injection at d62 and d82. In adults, maternal TP exposure resulted in increased insulin secretion to glucose load (P<0.05) and the histological presence of fatty liver (P<0.05) independent of central obesity. Additionally, hepatic androgen receptor (AR; P<0.05), glucocorticoid receptor (GR; P<0.05), UDP-glucose ceramide glucosyltransferase (UGCG; P<0.05) and IGF1 (P<0.01) expression were upregulated. The direct fetal intervention (C and TP) led to early fatty liver changes in all animals without differential changes in insulin secretion. Furthermore, hepatic phosphoenolpyruvate carboxykinase (PEPCK) was up-regulated in the fetal controls (P<0.05) and this was opposed by fetal TP (P<0.05). Hepatic estrogen receptor (ER alpha; P<0.05) and mitogen activated protein kinase kinase 4 (MAP2K4; P<0.05) were increased following fetal TP exposure. Adult liver metabolism and signaling can be altered by early exposure to sex steroids implicating epigenetic regulation of metabolic disturbances that are common in PCOS.	[Hogg, Kirsten; Wood, Charlotte; McNeilly, Alan S.; Duncan, W. Colin] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hogg, K (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	k.hogg@sms.ed.ac.uk			Medical Research Council [G0500717]; University of Edinburgh College of Medicine; Veterinary Medicine studentship; Scottish Funding Council; Medical Research Council [G1002033, MC_U127685843] Funding Source: researchfish; MRC [G0901807, G0500717, MC_U127685843, G1002033] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh College of Medicine; Veterinary Medicine studentship; Scottish Funding Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a project grant from the Medical Research Council (G0500717) to WCD and ASM. KH has a University of Edinburgh College of Medicine and Veterinary Medicine studentship. WCD is supported by a Scottish Senior Clinical Fellowship from the Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; Abbott DH, 1998, TRENDS ENDOCRIN MET, V9, P62, DOI 10.1016/S1043-2760(98)00019-8; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Birch RA, 2003, ENDOCRINOLOGY, V144, P1426, DOI 10.1210/en.2002-220965; Brzozowska MM, 2009, J GASTROEN HEPATOL, V24, P243, DOI 10.1111/j.1440-1746.2008.05740.x; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; BUYALOS RP, 1995, AM J OBSTET GYNECOL, V172, P932, DOI 10.1016/0002-9378(95)90024-1; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; CORKER CS, 1978, J STEROID BIOCHEM, V9, P373, DOI 10.1016/0022-4731(78)90634-9; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; Eisner JR, 2002, FERTIL STERIL, V77, P167, DOI 10.1016/S0015-0282(01)02947-8; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Gambarin-Gelwan M, 2007, CLIN GASTROENTEROL H, V5, P496, DOI 10.1016/j.cgh.2006.10.010; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hogg K, 2011, ENDOCRINOLOGY, V152, P2048, DOI 10.1210/en.2010-1219; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; KISSEBAH AH, 1989, DIABETES METAB REV, V5, P83, DOI 10.1002/dmr.5610050202; Lillycrop KA, 2011, INT J OBESITY, V35, P72, DOI 10.1038/ijo.2010.122; Lockman KA, 2010, CURR DIABETES REV, V6, P341, DOI 10.2174/157339910793360879; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Maric C, 2007, HYPERTENSION, V50, P605, DOI 10.1161/HYPERTENSIONAHA.107.096768; Masek KS, 1999, ENDOCRINOLOGY, V140, P3459, DOI 10.1210/en.140.8.3459; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; Mogul HR, 1996, J CLIN ENDOCR METAB, V81, P4492, DOI 10.1210/jc.81.12.4492; Nicoletto SF, 2011, EMBO REP, V12, P30, DOI 10.1038/embor.2010.199; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Rozen S, 2000, Methods Mol Biol, V132, P365; Sandhu MS, 2004, CANCER EPIDEM BIOMAR, V13, P166, DOI 10.1158/1055-9965.EPI-130-3; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Savabieasfahani M, 2005, BIOL REPROD, V72, P221, DOI 10.1095/biolreprod.104.031070; Schwimmer JB, 2005, FERTIL STERIL, V83, P494, DOI 10.1016/j.fertnstert.2004.08.020; Setji TL, 2006, J CLIN ENDOCR METAB, V91, P1741, DOI 10.1210/jc.2005-2774; Sharma TP, 2002, BIOL REPROD, V66, P924, DOI 10.1095/biolreprod66.4.924; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Steckler T, 2007, ENDOCRINOLOGY, V148, P3532, DOI 10.1210/en.2007-0339; SUIKKARI AM, 1989, HUM REPROD, V4, P136, DOI 10.1093/oxfordjournals.humrep.a136858; Targher G, 2009, J ENDOCRINOL INVEST, V32, P695, DOI [10.1007/BF03345743, 10.3275/6375]; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vassilatou E, 2010, HUM REPROD, V25, P212, DOI 10.1093/humrep/dep380; Veiga-Lopez A, 2008, BIOL REPROD, V78, P636, DOI 10.1095/biolreprod.107.065904; Veiga-Lopez A, 2011, BIOL REPROD, V84, P87, DOI 10.1095/biolreprod.110.086686; Veiga-Lopez A, 2009, BIOL REPROD, V80, P718, DOI 10.1095/biolreprod.108.074781; West C, 2001, MOL CELL ENDOCRINOL, V185, P51, DOI 10.1016/S0303-7207(01)00632-3; Wu Y, 2007, ENDOCRINOLOGY, V148, P2984, DOI 10.1210/en.2006-1653	55	66	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24877	10.1371/journal.pone.0024877	http://dx.doi.org/10.1371/journal.pone.0024877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935484	gold, Green Submitted, Green Published			2022-12-25	WOS:000295039700057
J	Tomiya, S				Tomiya, Susumu			A New Basal Caniform (Mammalia: Carnivora) from the Middle Eocene of North America and Remarks on the Phylogeny of Early Carnivorans	PLOS ONE			English	Article							RED FOX; CONSERVATION PRIORITIES; GEOGRAPHIC-VARIATION; MOLECULAR PHYLOGENY; FUNCTIONAL ANATOMY; MARTES-AMERICANA; FOSSIL SAMPLES; ARCTIC FOX; VIVERRIDAE; EVOLUTION	Background: Despite a long history of research, the phylogenetic origin and initial diversification of the mammalian crown-group Carnivora remain elusive. Well-preserved fossil materials of basal carnivorans are essential for resolving these issues, and for constraining the timing of the carnivoran origin, which constitutes an important time-calibration point in mammalian phylogenetics. Methodology/Principal Findings: A new carnivoramorphan from the middle Eocene of southern California, Lycophocyon hutchisoni, is described. The new taxon exhibits stages of dental and basicranial evolution that are intermediate between earlier carnivoramorphans and the earliest representatives of canoid carnivorans. The evolutionary affinity of the new taxon was determined by a cladistic analysis of previously-published and newly-acquired morphological data for 30 Paleogene carnivoramorphans. The most-parsimonious trees identified L. hutchisoni as a basal caniform carnivoran, and placed (1) Tapocyon robustus, Quercygale angustidens, "Miacis'' sylvestris, "M.'' uintensis, and "M.'' gracilis inside or outside the Carnivora, (2) nimravids within the Feliformia, and (3) the amphicyonid Daphoenus outside the crown-group Canoidea. Parsimony reconstructions of ancestral character states suggest that loss of the upper third molars and development of well-ossified entotympanics that are firmly fused to the basicranium (neither condition is observed in L. hutchisoni) are not associated with the origin of the Carnivora as traditionally thought, but instead occurred independently in the Caniformia and the Feliformia. A discriminant analysis of the estimated body weight and dental ecomorphology predicted a mesocarnivorous diet for L. hutchisoni, and the postcranial morphology suggests a scansorial habit. Conclusions/Significance: Lycophocyon hutchisoni illuminates the morphological evolution of early caniforms leading to the origin of crown-group canoids. Considerable uncertainty remains with respect to the phylogenetic origin of the Carnivora. The minimum date of caniform-feliform divergence is provisionally suggested to be either 47 million years ago or 38 million years ago, depending on the position of "Miacis'' sylvestris within or outside the Carnivora, respectively.	[Tomiya, Susumu] Univ Calif Berkeley, Museum Vertebrate Zool, Museum Paleontol, Berkeley, CA 94720 USA; [Tomiya, Susumu] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tomiya, S (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Museum Paleontol, Berkeley, CA 94720 USA.	stomiya@berkeley.edu		Tomiya, Susumu/0000-0001-6038-899X	Berkeley Chapter of Sigma Xi; The National Science Foundation [DDIG-1011474]; University of California Museum of Paleontology; The Berkeley Research Impact Initiative of the University of California, Berkeley; Direct For Biological Sciences [1011474] Funding Source: National Science Foundation	Berkeley Chapter of Sigma Xi; The National Science Foundation(National Science Foundation (NSF)); University of California Museum of Paleontology; The Berkeley Research Impact Initiative of the University of California, Berkeley; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported research cost: The Grant-in-Aid-of-Research program of the Berkeley Chapter of Sigma Xi The National Science Foundation grant DDIG-1011474. Supported author: The Annie M. Alexander Fellowship of the University of California Museum of Paleontology. Supported publication cost: The Berkeley Research Impact Initiative of the University of California, Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelici FM, 2000, REV ECOL-TERRE VIE, V55, P67; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Bryant HN, 1996, SYST BIOL, V45, P174, DOI 10.2307/2413614; BRYANT HN, 1992, J PALEONTOL, V66, P847, DOI 10.1017/S0022336000020850; BRYANT HN, 1991, J MAMMAL, V72, P56, DOI 10.2307/1381980; CARROLL RL, 1988, VERTEBRATE PALEONTOL; Clark Howard O. Jr., 2005, Mammalian Species, P1; Clark J., 1939, ANN CARNEGIE MUSEUM, V27, P349; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; CORNELI PS, 2003, J MAMM EVOL, V9, P281; CROOKS KR, 1995, OECOLOGIA, V104, P301, DOI 10.1007/BF00328365; Daitch DJ, 2007, J MAMMAL, V88, P384, DOI 10.1644/06-MAMM-A-139R1.1; Dayan T, 2002, PALEOBIOLOGY, V28, P508, DOI 10.1666/0094-8373(2002)028<0508:VACOSA>2.0.CO;2; Diniz JAF, 2004, CONSERV BIOL, V18, P698; DONOGHUE MJ, 1989, ANNU REV ECOL SYST, V20, P431, DOI 10.1146/annurev.es.20.110189.002243; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finarelli J, 2008, J MAMM EVOL, V15, P231, DOI 10.1007/s10914-008-9074-x; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; Flynn JJ, 1982, AM MUS NOVIT, V2725, P1; Flynn John J., 2005, P175; Friscia AR, 2007, J ZOOL, V272, P82, DOI 10.1111/j.1469-7998.2006.00246.x; FRITZELL EK, 1982, MAMMALIAN SPECIES, V189, P1, DOI DOI 10.2307/3503957; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gaubert P, 2005, SYST BIOL, V54, P865, DOI 10.1080/10635150500232769; Gaubert P, 2003, P ROY SOC B-BIOL SCI, V270, P2523, DOI 10.1098/rspb.2003.2521; Gaubert P, 2006, MOL PHYLOGENET EVOL, V41, P266, DOI 10.1016/j.ympev.2006.05.034; GINGERICH P D, 1983, Contributions from the Museum of Paleontology University of Michigan, V26, P197; GINGERICH PD, 1974, J PALEONTOL, V48, P895; GINGERICH PD, 1979, J MAMMAL, V60, P691, DOI 10.2307/1380186; Goloboff P.A., 2003, T N T TREE ANAL USIN; Goloboff P, 2008, CLADISTICS, V24, P91; GOLZ D J, 1976, Natural History Museum of Los Angeles County Science Bulletin, P1; Gompper Matthew E., 1995, Mammalian Species, V487, P1; GONYEA W, 1975, J MORPHOL, V145, P229, DOI 10.1002/jmor.1051450208; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Guilday J. E., 1962, Journal of Mammalogy, V43, P455, DOI 10.2307/1376907; Gustafson E.P., 1986, TEXAS MEML MUSEUM B, V33, P1; HALDANE JBS, 1955, EVOLUTION, V9, P484, DOI 10.2307/2405484; Hanson C. Bruce, 1996, P206, DOI 10.1017/CBO9780511665431.012; Hatcher J. B, 1902, MEM CARNEGIE MUS, V1, P65; Heinrich RE, 1997, PALAEONTOLOGY, V40, P279; Heinrich RE, 2008, J PALEONTOL, V82, P154, DOI 10.1666/05-118.1; Heinrich RE, 2006, J VERTEBR PALEONTOL, V26, P422, DOI 10.1671/0272-4634(2006)26[422:PAOVMC]2.0.CO;2; Hildebrand M., 2001, ANAL VERTEBRATE STRU; HOUGH J. R., 1948, JOUR PALEONTOL, V22, P573; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Hunt G, 2004, PALEOBIOLOGY, V30, P487, DOI 10.1666/0094-8373(2004)030<0487:PVIIFS>2.0.CO;2; Hunt G, 2004, PALEOBIOLOGY, V30, P426, DOI 10.1666/0094-8373(2004)030<0426:PVIFSM>2.0.CO;2; Hunt Jr R. M., 1996, CARNIVORE BEHAV ECOL, V2, P485; Hunt R.M, 1989, AM MUS NOVIT, V2930, P1, DOI DOI 10.1206/0003-0082(2001)330<0001:BAOTLL>2.0.CO;2; HUNT RM, 1977, J PALEONTOL, V51, P826; Hunt Robert M. Jr, 1996, P476, DOI 10.1017/CBO9780511665431.024; Hunt Robert M. Jr, 2001, American Museum Novitates, V3331, P1, DOI 10.1206/0003-0082(2001)331<0001:SOAFNA>2.0.CO;2; Hunt Robert M. Jr, 1998, P196; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; JENKINS FA, 1984, J MORPHOL, V182, P197, DOI 10.1002/jmor.1051820207; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Koepfli KP, 2007, MOL PHYLOGENET EVOL, V43, P1076, DOI 10.1016/j.ympev.2006.10.003; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; KOTSAKIS T, 1980, Bollettino della Societa Paleontologica Italiana, V19, P259; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander E. Bruce, 2006, Paleobios, V26, P19; LARSON SG, 1989, AM J PHYS ANTHROPOL, V79, P369, DOI 10.1002/ajpa.1330790313; LEACH D, 1977, CAN J ZOOL, V55, P199, DOI 10.1139/z77-023; Lockwood CA, 1996, J HUM EVOL, V31, P537, DOI 10.1006/jhev.1996.0078; MAC INTYRE GILES TERNAN, 1966, BULL AMER MUS NATUR HIST, V131, P117; Maddison, 2019, MESQUITE MODULAR SYS; Matthew W.D., 1909, MEMOIRS AM MUSEUM NA, V9, P289; McKenna MC, 1997, CLASSIFICATION MAMMA; Mellett J.S., 1977, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V1, P1; Mihlbachler Matthew C., 2009, Proceedings of the San Diego Society of Natural History, P1; MURPHEY PC, 1999, GEOLOGICAL SOC AM AB, V31, pA233; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Musser G G, 1993, MAMMAL SPECIES WORLD; PALOMARES F, 1993, REV ECOL-TERRE VIE, V48, P295; Pasitschniak-Arts Maria, 1995, Mammalian Species, V499, P1; Petter G., 1966, Annales de Paleontologie Vertebres, V52, P1; Phillips RB, 2007, J MAMMAL, V88, P173, DOI 10.1644/06-MAMM-A-015R2.1; Polly PD, 2006, PALAEONTOLOGY, V49, P1019, DOI 10.1111/j.1475-4983.2006.00586.x; Polly Paul David, 1997, Contributions from the Museum of Paleontology University of Michigan, V30, P1; Polly PD, 1996, J VERTEBR PALEONTOL, V16, P303, DOI 10.1080/02724634.1996.10011318; Polly PD, 1998, BIOL J LINN SOC, V64, P83; Poux C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-102; R Development Core Team, 2009, R FDN STAT COMP; Robinson Peter, 2004, P106; Rosalino LM, 2009, EUR J WILDLIFE RES, V55, P293, DOI 10.1007/s10344-008-0248-x; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SCOTT WB, 1898, T AM PHILOS SOC, V19, P325; Simpson G. G., 1960, QUANTITATIVE ZOOLOGY; Spaulding M, 2010, PALAEONTOLOGY, V53, P815, DOI 10.1111/j.1475-4983.2010.00963.x; Spaulding M, 2009, J VERTEBR PALEONTOL, V29, P1212, DOI 10.1671/039.029.0408; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; STUCKY RK, 1993, FOSS REC, V2, P739; Szalay F.S., 1974, P223; Szuma E, 2004, ACTA THERIOL, V49, P433, DOI 10.1007/BF03192588; Szuma E, 2008, ANN ZOOL FENN, V45, P185, DOI 10.5735/086.045.0304; Szuma E, 2007, BIOL J LINN SOC, V90, P61, DOI 10.1111/j.1095-8312.2007.00712.x; TAYLOR ME, 1976, J MORPHOL, V148, P227, DOI 10.1002/jmor.1051480208; TAYLOR ME, 1974, J MORPHOL, V143, P307, DOI 10.1002/jmor.1051430305; Teilhard de Chardin Pierre, 1914, ANN PALEONTOL, V9, P101; Van Valen L., 1964, Journal of Mammalogy, V45, P284, DOI 10.2307/1376993; VAN VALEN LEIGH, 1966, BULL AMER MUS NATUR HIST, V132, P1; van Valkenburgh B., 1990, P181; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; Venables W.N., 2010, MAIN PACKAGE VENABLE; Walsh Stephen L., 1996, P75, DOI 10.1017/CBO9780511665431.006; Wan QH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004147; WANG X, 1996, TERRESTRIAL EOCENE O, P433; WANG X, 1994, B AM MUS NAT HIST, V221, P1; Wang Xiaoming, 1994, American Museum Novitates, V3092, P1; Wang Xiaoming, 1993, American Museum Novitates, V3069, P1; Wang XM, 1999, B AM MUS NAT HIST, P1; Wang XM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)483[0001:AAAACF]2.0.CO;2; Wesley GD, 2003, J PALEONTOL, V77, P769, DOI 10.1666/0022-3360(2003)077<0769:AROTCI>2.0.CO;2; Wesley-Hunt GD, 2005, ACTA PALAEONTOL POL, V50, P837; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WILSON KL, 1972, THESIS U CALIFORNIA; WOOD ALBERT ELMER, 1933, AMER MIDLAND NAT, V14, P36, DOI 10.2307/2420049; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; WORTMAN JL, 1899, B AM MUS NAT HIST, V7, P109; WYSS AR, 1993, MAMMAL PHYLOGENY : PLACENTALS, P32; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Youlatos D, 2003, J ZOOL, V259, P423, DOI 10.1017/S0952836903003431; Zielinski WJ, 2004, J MAMMAL, V85, P470, DOI 10.1644/1545-1542(2004)085<0470:DOSPOA>2.0.CO;2	143	18	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24146	10.1371/journal.pone.0024146	http://dx.doi.org/10.1371/journal.pone.0024146			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935380	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700012
J	Joseph, B; Jeschke, G; Goetz, BA; Locher, KP; Bordignon, E				Joseph, Benesh; Jeschke, Gunnar; Goetz, Birke A.; Locher, Kaspar P.; Bordignon, Enrica			Transmembrane Gate Movements in the Type II ATP-binding Cassette (ABC) Importer BtuCD-F during Nucleotide Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; ESCHERICHIA-COLI; MALTOSE TRANSPORTER; VITAMIN-B12 TRANSPORT; CRYSTAL-STRUCTURE; PROTEIN; MECHANISM; DYNAMICS; MUTANTS; IDENTIFICATION	ATP-binding cassette (ABC) transporters are ubiquitous integral membrane proteins that translocate substrates across cell membranes. The alternating access of their transmembrane domains to opposite sides of the membrane powered by the closure and reopening of the nucleotide binding domains is proposed to drive the translocation events. Despite clear structural similarities, evidence for considerable mechanistic diversity starts to accumulate within the importers subfamily. We present here a detailed study of the gating mechanism of a ABC importer, the BtuCD-F vitamin B-12 importer from Escherichia coli, elucidated by EPR spectroscopy. Distance changes at key positions in the translocation gates in the nucleotide-free, ATP- and ADP-bound conformations of the transporter were measured in detergent micelles and liposomes. The translocation gates of the BtuCD-F complex undergo conformational changes in line with a "two-state" alternating access model. We provide the first direct evidence that binding of ATP drives the gates to an inward-facing conformation, in contrast to type I importers specific for maltose, molybdate, or methionine. Following ATP hydrolysis, the translocation gates restore to an apo-like conformation. In the presence of ATP, an excess of vitamin B-12 promotes the reopening of the gates toward the periplasm and the dislodgment of BtuF from the transporter. The EPR data allow a productive translocation cycle of the vitamin B-12 transporter to be modeled.	[Joseph, Benesh; Jeschke, Gunnar; Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Goetz, Birke A.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bordignon, E (corresponding author), ETH, Phys Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch	JOSEPH, BENESH/K-4628-2016; Joseph, Benesh/AAK-9039-2020	JOSEPH, BENESH/0000-0003-4968-889X; Joseph, Benesh/0000-0003-4968-889X; Jeschke, Gunnar/0000-0001-6853-8585; Bordignon, Enrica/0000-0003-2450-5161	ETH [ETH-21 09-1]; Swiss National Science Foundation (SNF) [31003A-131075/1]	ETH(ETH Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the ETH Research Grant ETH-21 09-1 (to G. J. and E. B.) and by Grant Swiss National Science Foundation (SNF) 31003A-131075/1 (to K. P. L.).	AUFRERE R, 1986, MOL GEN GENET, V205, P358, DOI 10.1007/BF00430451; BASSFORD PJ, 1976, J BACTERIOL, V128, P242, DOI 10.1128/JB.128.1.242-247.1976; BASSFORD PJ, 1977, J BACTERIOL, V132, P796, DOI 10.1128/JB.132.3.796-805.1977; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; DIGIROLA.PM, 1971, J BACTERIOL, V106, P751, DOI 10.1128/JB.106.3.751-757.1971; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; James KJ, 2009, BIOCHEMISTRY-US, V48, P9212, DOI 10.1021/bi900722p; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MERINO G, 1995, J THEOR BIOL, V177, P171, DOI 10.1006/jtbi.1995.0236; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; TAYLOR RT, 1972, ARCH BIOCHEM BIOPHYS, V148, P366, DOI 10.1016/0003-9861(72)90154-3; Tschaggelar R, 2009, J MAGN RESON, V200, P81, DOI 10.1016/j.jmr.2009.06.007; Van Bibber M, 1999, J BACTERIOL, V181, P5539, DOI 10.1128/JB.181.17.5539-5541.1999; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; WHITE JC, 1973, J BIOL CHEM, V248, P3978; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	39	48	49	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41008	41017		10.1074/jbc.M111.269472	http://dx.doi.org/10.1074/jbc.M111.269472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953468	hybrid, Green Published			2022-12-25	WOS:000297315400060
J	Orebaugh, CD; Fye, JM; Harvey, S; Hollis, T; Perrino, FW				Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Perrino, Fred W.			The TREX1 Exonuclease R114H Mutation in Aicardi-Goutieres Syndrome and Lupus Reveals Dimeric Structure Requirements for DNA Degradation Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; DOMINANT MUTATIONS; AUTOIMMUNE-DISEASE; 3' TERMINI; GENE; SUSCEPTIBILITY; IDENTIFICATION; ERYTHEMATOSUS; EXPRESSION	Mutations in the TREX1 gene cause Aicardi-Goutieres syndrome (AGS) and are linked to the autoimmune disease systemic lupus erythematosus. The TREX1 protein is a dimeric 3' DNA exonuclease that degrades DNA to prevent inappropriate immune activation. One of the most common TREX1 mutations, R114H, causes AGS as a homozygous and compound heterozygous mutation and is found as a heterozygous mutation in systemic lupus erythematosus. The TREX1 proteins containing R114H and the insertion mutations aspartate at position 201 (D201ins) and alanine at position 124 (A124ins), found in compound heterozygous AGS with R114H, were prepared and the DNA degradation activities were tested. The homodimer TREX1(R114H/R114H) exhibits a 23-fold reduced single-stranded DNA (ssDNA) exonuclease activity relative to TREX1(WT). The TREX1(D201ins/D201ins) and TREX1(A124ins/A124ins) exhibit more than 10,000-fold reduced ssDNA degradation activities. However, the TREX1(R114H/D201ins) and TREX1(R114H/A124ins) compound heterodimers exhibit activities 10-fold greater than the TREX1(R114H/R114H) homodimer during ssDNA and double-stranded DNA (dsDNA) degradation. These higher levels of activities measured in the TREX1(R114H/D201ins) and TREX1(R114H/A124ins) compound heterodimers are attributed to Arg-114 residues of TREX1(D201ins) and TREX1(A124ins) positioned at the dimer interface contributing to the active sites of the opposing TREX1(R114H) protomer. This interpretation is further supported by exonuclease activities measured for TREX1 enzymes containing R114A and R114K mutations. These biochemical data provide direct evidence for TREX1 residues in one protomer contributing to DNA degradation catalyzed in the opposing protomer and help to explain the dimeric TREX1 structure required for full catalytic competency.	[Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research Grant [179222]; American Heart Association [10GRNT3650033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.), Alliance for Lupus Research Grant 179222 (to F. W. P.), and American Heart Association Grant 10GRNT3650033 (to T. H.).	Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gunther C, 2009, DERMATOLOGY, V219, P162, DOI 10.1159/000222430; Haaxma CA, 2010, AM J MED GENET A, V152A, P2612, DOI 10.1002/ajmg.a.33620; Higuchi R., 1990, PCR PROTOCOLS GUIDE; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Kolivras A, 2008, J CUTAN PATHOL, V35, P774, DOI 10.1111/j.1600-0560.2007.00900.x; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Parra D, 2009, CANCER RES, V69, P6676, DOI 10.1158/0008-5472.CAN-09-1208; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	28	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40246	40254		10.1074/jbc.M111.297903	http://dx.doi.org/10.1074/jbc.M111.297903			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937424	Green Published, hybrid			2022-12-25	WOS:000296925700056
J	Wang, Y; Robertson, JD; Walcheck, B				Wang, Yue; Robertson, John D.; Walcheck, Bruce			Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; L-SELECTIN; CONVERTING-ENZYME; TNF-ALPHA; PROTEIN-KINASE; INTRACELLULAR MATURATION; POTENTIAL ROLE; GROWTH-FACTOR; RECEPTOR; CLEAVAGE	ADAM17 is a membrane-associated metalloprotease that cleaves proteins from the surface of neutrophils and modulates the density of various receptors and adhesion molecules. The protease activity of ADAM17 is highly inducible and occurs upon neutrophil activation as well as apoptosis. At this time, little is known about the signal transduction pathway that promotes ADAM17 activity in neutrophils upon the induction of apoptosis. We show that caspase-8 activation, Bid cleavage, and the release of mitochondrial reactive oxygen species are sequential transduction components of the Fas signaling cascade that induces ADAM17. This is different from ADAM17 stimulation upon overt neutrophil activation, which requires MAPK p38 or ERK, but not caspases and reactive oxygen species. ADAM17 activity in apoptotic neutrophils may serve to inactivate select effector molecules that promote the pro-inflammatory activity of recruited neutrophils. For instance, TNF alpha receptors TNF-RI and TNF-RII are substrates of ADAM17, and we show that they are shed during apoptosis, decreasing neutrophil sensitivity to TNF alpha. Altogether, our findings provide significant new insights into the signal transduction pathway that stimulates ADAM17 during induced neutrophil apoptosis. ADAM17 induction during apoptosis may rapidly diminish neutrophil sensitivity to the inflammatory environment, complementing other anti-inflammatory activities by these cells during inflammation resolution.	[Wang, Yue; Walcheck, Bruce] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Robertson, John D.] Univ Kansas, Med Ctr, Kansas Univ Canc Ctr, Kansas City, KS 66160 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Walcheck, B (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, 295J AS-VM Bldg,1988 Fitch Ave, St Paul, MN 55108 USA.	walch003@umn.edu			National Institutes of Health [HL61613, AI083521, AI082291]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082291, R21AI083521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL61613, AI083521, and AI082291 (to B. W.).	Akgul C, 2003, CELL MOL LIFE SCI, V60, P2402, DOI 10.1007/s00018-003-3110-z; Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Budd RC, 2002, J CLIN INVEST, V109, P437, DOI 10.1172/JC1200215077; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Long CM, 2010, J LEUKOCYTE BIOL, V87, P1097, DOI 10.1189/jlb.1109763; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maianski NA, 2003, ACTA HAEMATOL-BASEL, V111, P56, DOI 10.1159/000074486; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Mattila PE, 2005, AM J PHYSIOL-CELL PH, V289, pC323, DOI 10.1152/ajpcell.00603.2004; Melley DD, 2005, CLIN SCI, V108, P413, DOI 10.1042/CS20040228; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ott GR, 2008, BIOORG MED CHEM LETT, V18, P1577, DOI 10.1016/j.bmcl.2008.01.075; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Ryan JG, 2009, ARTHRITIS RHEUM, V60, P8, DOI 10.1002/art.24145; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; van Raam BJ, 2006, INT J HEMATOL, V84, P199, DOI 10.1532/IJH97.06131; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Wang Y, 2010, J IMMUNOL, V184, P4447, DOI 10.4049/jimmunol.0902925; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Watson RWG, 1999, FEBS LETT, V453, P67, DOI 10.1016/S0014-5793(99)00688-2; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Woska JR, 2003, J IMMUNOL METHODS, V277, P101, DOI 10.1016/S0022-1759(03)00176-5; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC	61	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38980	38988		10.1074/jbc.M111.277087	http://dx.doi.org/10.1074/jbc.M111.277087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949123	Green Published, hybrid			2022-12-25	WOS:000296759800017
J	He, XH; Zhang, YM				He, Xiao-Hong; Zhang, Yuan-Ming			A Complete Solution for Dissecting Pure Main and Epistatic Effects of QTL in Triple Testcross Design	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RECOMBINANT INBRED LINES; BIOMASS-RELATED TRAITS; NEAR-ISOGENIC LINES; GENETIC-BASIS; GENERAL METHOD; HETEROSIS; ARABIDOPSIS; COMPONENTS; DOMINANCE	Epistasis plays an important role in genetics, evolution and crop breeding. To detect the epistasis, triple test cross (TTC) design had been developed several decades ago. Classical procedures for the TTC design use only linear transformations Z(1), Z(2) and Z(3), calculated from the TTC family means of quantitative trait, to infer the nature of the collective additive, dominance and epistatic effects of all the genes. Although several quantitative trait loci (QTL) mapping approaches in the TTC design have been developed, these approaches do not provide a complete solution for dissecting pure main and epistatic effects. In this study, therefore, we developed a two-step approach to estimate all pure main and epistatic effects in the F-2-based TTC design under the F-2 and F-infinity metric models. In the first step, with Z(1) and Z(2) the augmented main and epistatic effects in the full genetic model that simultaneously considered all putative QTL on the whole genome were estimated using empirical Bayes approach, and with Z(3) three pure epistatic effects were obtained using two-dimensional genome scans. In the second step, the three pure epistatic effects obtained in the first step were integrated with the augmented epistatic and main effects for the further estimation of all other pure effects. A series of Monte Carlo simulation experiments has been carried out to confirm the proposed method. The results from simulation experiments show that: 1) the newly defined genetic parameters could be rightly identified with satisfactory statistical power and precision; 2) the F-2-based TTC design was superior to the F-2 and F-2:3 designs; 3) with Z(1) and Z(2) the statistical powers for the detection of augmented epistatic effects were substantively affected by the signs of pure epistatic effects; and 4) with Z(3) the estimation of pure epistatic effects required large sample size and family replication number. The extension of the proposed method in this study to other base populations was further discussed.	[He, Xiao-Hong; Zhang, Yuan-Ming] Nanjing Agr Univ, Sect Stat Genom, State Key Lab Crop Genet & Germplasm Enhancement, Chinese Natl Ctr Soybean Improvement,Coll Agr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, YM (corresponding author), Nanjing Agr Univ, Sect Stat Genom, State Key Lab Crop Genet & Germplasm Enhancement, Chinese Natl Ctr Soybean Improvement,Coll Agr, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AFQ-8637-2022; Zhang, Yuan-Ming/AAT-2899-2021	Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109300]; National Natural Science Foundation of China [30900842, 31000666, 30971848]; Fundamental Research Funds for the Central Universities [KYT201002]; Specialized Research Fund for the Doctoral Program of Higher Education [20100097110035]; 111 Project [B08025]; NAU [KJ08001]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); 111 Project(Ministry of Education, China - 111 Project); NAU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grant 2011CB109300 from the National Basic Research Program of China, grants 30900842, 31000666 and 30971848 from the National Natural Science Foundation of China, grant KYT201002 from the Fundamental Research Funds for the Central Universities, grant 20100097110035 from Specialized Research Fund for the Doctoral Program of Higher Education, grant B08025 from the 111 Project, grant KJ08001 from the NAU Youth Sci-Tech Innovation Fund and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Cockerham CC, 1996, GENETICS, V143, P1437; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; JIANG CJ, 1995, GENETICS, V140, P1111; JINKS JL, 1958, GENETICS, V43, P223; JINKS JL, 1970, HEREDITY, V25, P419, DOI 10.1038/hdy.1970.42; Kao CH, 2002, GENETICS, V160, P1243; Kearsey M.J., 1996, GENETIC ANAL QUANTIT, DOI [10.1007/978-1-4899-4441-2, DOI 10.1007/978-1-4899-4441-2]; KEARSEY MJ, 1968, HEREDITY, V23, P403, DOI 10.1038/hdy.1968.52; Kearsey MJ, 2003, HEREDITY, V91, P456, DOI 10.1038/sj.hdy.6800306; KEARSEY MJ, 1994, THEOR APPL GENET, V89, P698, DOI 10.1007/BF00223708; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; LANDER ES, 1989, GENETICS, V121, P185; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Melchinger AE, 2008, GENETICS, V178, P2265, DOI 10.1534/genetics.107.084871; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; PERKINS JM, 1970, HEREDITY, V25, P157, DOI 10.1038/hdy.1970.22; Reif JC, 2009, GENETICS, V181, P247, DOI 10.1534/genetics.108.093047; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang XF, 2009, J HERED, V100, P496, DOI 10.1093/jhered/esp009; WRIGHT S, 1980, EVOLUTION, V34, P825, DOI 10.1111/j.1558-5646.1980.tb04022.x; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Yang RC, 2004, GENETICS, V167, P1493, DOI 10.1534/genetics.103.020016; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; ZENG ZB, 1994, GENETICS, V136, P1457; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702; Zhu C, 2007, HEREDITY, V98, P401, DOI 10.1038/sj.hdy.6800956	35	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24575	10.1371/journal.pone.0024575	http://dx.doi.org/10.1371/journal.pone.0024575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949729	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900021
J	Wong, LC; Costa, A; McLeod, I; Sarkeshik, A; Yates, J; Kyin, S; Perlman, D; Schedl, P				Wong, Li Chin; Costa, Alexandre; McLeod, Ian; Sarkeshik, Ali; Yates, John, III; Kyin, Saw; Perlman, David; Schedl, Paul			The Functioning of the Drosophila CPEB Protein Orb Is Regulated by Phosphorylation and Requires Casein Kinase 2 Activity	PLOS ONE			English	Article							RNA-BINDING PROTEIN; CYTOPLASMIC POLYADENYLATION; MESSENGER-RNA; SEX-LETHAL; TRANSLATIONAL REGULATION; MEIOTIC PROGRESSION; OSKAR TRANSLATION; XENOPUS-OOCYTES; POLARITY; BRUNO	The Orb CPEB protein regulates translation of localized mRNAs in Drosophila ovaries. While there are multiple hypo-and hyperphosphorylated Orb isoforms in wild type ovaries, most are missing in orb(F303), which has an amino acid substitution in a buried region of the second RRM domain. Using a proteomics approach we identified a candidate Orb kinase, Casein Kinase 2 (CK2). In addition to being associated with Orb in vivo, we show that ck2 is required for orb functioning in gurken signaling and in the autoregulation of orb mRNA localization and translation. Supporting a role for ck2 in Orb phosphorylation, we find that the phosphorylation pattern is altered when ck2 activity is partially compromised. Finally, we show that the Orb hypophosphorylated isoforms are in slowly sedimenting complexes that contain the translational repressor Bruno, while the hyperphosphorylated isoforms assemble into large complexes that co-sediment with polysomes and contain the Wisp poly(A) polymerase.	[Wong, Li Chin; Costa, Alexandre; Kyin, Saw; Perlman, David; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [McLeod, Ian; Sarkeshik, Ali; Yates, John, III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Princeton University; Scripps Research Institute	Wong, LC (corresponding author), NYU, Sch Med, Smilow Neurosci Program, New York, NY 10012 USA.	pschedl@princeton.edu	Costa, Alexandre Augusto da/HCJ-0140-2022	Costa, Alexandre Augusto da/0000-0001-7558-5435; Dias Tavares Costa, Alexandre/0000-0001-8434-2152	National Institutes of Health (NIH) [GM56937, GM043432, P41 RR011823]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM043432, R01GM043432, R01GM056937] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge support for this research by National Institutes of Health (NIH) research grants GM56937 and GM043432 to PS and P41 RR011823 to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Barbosa V, 2007, GENETICS, V176, P1967, DOI 10.1534/genetics.106.069575; Barnard DC, 2005, MOL CELL BIOL, V25, P7605, DOI 10.1128/MCB.25.17.7605-7615.2005; Benoit P, 2008, DEVELOPMENT, V135, P1969, DOI 10.1242/dev.021444; Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Castagnetti S, 2003, DEVELOPMENT, V130, P835, DOI 10.1242/dev.00309; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Crowder SM, 1999, P NATL ACAD SCI USA, V96, P4892, DOI 10.1073/pnas.96.9.4892; Deshpande G, 1996, MOL CELL BIOL, V16, P5036; Gyenis L, 2008, MOL CELL BIOCHEM, V316, P5, DOI 10.1007/s11010-008-9830-5; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Mathew R, 2008, NAT STRUCT MOL BIOL, V15, P435, DOI 10.1038/nsmb.1415; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; Tan LH, 2001, DEVELOPMENT, V128, P1159; Tay J, 2003, GENE DEV, V17, P1457, DOI 10.1101/gad.1071403; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	41	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24355	10.1371/journal.pone.0024355	http://dx.doi.org/10.1371/journal.pone.0024355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949709	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900010
J	McSorley, HJ; Gaze, S; Daveson, J; Jones, D; Anderson, RP; Clouston, A; Ruyssers, NE; Speare, R; McCarthy, JS; Engwerda, CR; Croese, J; Loukas, A				McSorley, Henry J.; Gaze, Soraya; Daveson, James; Jones, Dianne; Anderson, Robert P.; Clouston, Andrew; Ruyssers, Nathalie E.; Speare, Richard; McCarthy, James S.; Engwerda, Christian R.; Croese, John; Loukas, Alex			Suppression of Inflammatory Immune Responses in Celiac Disease by Experimental Hookworm Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; NECATOR-AMERICANUS; PARASITE INFECTION; CHILDREN; INTERLEUKIN-10; EXPANSION; CYTOKINES; ETHIOPIA; PEPTIDE; GLIADIN	We present immunological data from two clinical trials where the effect of experimental human hookworm (Necator americanus) infection on the pathology of celiac disease was evaluated. We found that basal production of Interferon-(IFN-)gamma and Interleukin- (IL-)17A from duodenal biopsy culture was suppressed in hookworm-infected participants compared to uninfected controls. Increased levels of CD4+CD25+Foxp3+cells in the circulation and mucosa are associated with active celiac disease. We show that this accumulation also occurs during a short-term (1 week) oral gluten challenge, and that hookworm infection suppressed the increase of circulating CD4+CD25+Foxp3+cells during this challenge period. When duodenal biopsies from hookworm-infected participants were restimulated with the immunodominant gliadin peptide QE65, robust production of IL-2, IFN-gamma and IL-17A was detected, even prior to gluten challenge while participants were strictly adhering to a gluten-free diet. Intriguingly, IL-5 was produced only after hookworm infection in response to QE65. Thus we hypothesise that hookworm-induced TH2 and IL-10 cross-regulation of the TH1/TH17 inflammatory response may be responsible for the suppression of these responses during experimental hookworm infection.	[McSorley, Henry J.; Gaze, Soraya; Ruyssers, Nathalie E.; Speare, Richard; Loukas, Alex] James Cook Univ, Cairns, Qld, Australia; [McSorley, Henry J.; Gaze, Soraya; Ruyssers, Nathalie E.; Speare, Richard; Loukas, Alex] James Cook Univ, Townsville, Qld 4811, Australia; [Daveson, James; Jones, Dianne] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Anderson, Robert P.] Walter & Eliza Hall Inst Med Res, Melbourne, Australia; [Clouston, Andrew] Envoi Specialist Pathologists, Brisbane, Qld, Australia; [McCarthy, James S.; Engwerda, Christian R.] Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; [Croese, John] Townsville Hosp, Townsville, Qld, Australia	James Cook University; James Cook University; Walter & Eliza Hall Institute; QIMR Berghofer Medical Research Institute; University of Queensland	McSorley, HJ (corresponding author), James Cook Univ, Cairns, Qld, Australia.	Alex.Loukas@jcu.edu.au	Gaze, Soraya/B-9419-2013; Clouston, Andrew D/E-7199-2011; Daveson, Alfred/C-7136-2011; Daveson, A James M/O-8692-2017; Gaze, Soraya T/B-3085-2013; Loukas, Alex/B-7355-2014; Engwerda, Christian/I-3072-2015; McCarthy, James S/C-1681-2009	Gaze, Soraya/0000-0001-8600-2389; Clouston, Andrew D/0000-0002-9601-7952; Daveson, A James M/0000-0002-6042-5102; Gaze, Soraya T/0000-0001-8600-2389; Loukas, Alex/0000-0002-0896-8441; McCarthy, James/0000-0001-6596-9718; Anderson, Robert/0000-0002-0764-7267; Speare, Rick/0000-0002-9993-1213; Engwerda, Christian/0000-0003-2813-4804; McSorley, Henry/0000-0003-1300-7407	Broad Foundation; National Health and Medical Research Council	Broad Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was funded by the Broad Foundation and National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Araujo MI, 2000, INT ARCH ALLERGY IMM, V123, P145, DOI 10.1159/000024433; Bager P, 2010, J ALLERGY CLIN IMMUN, V125, P123, DOI 10.1016/j.jaci.2009.08.006; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Christodoulou MI, 2008, AM J PATHOL, V173, P1389, DOI 10.2353/ajpath.2008.080246; Ciccocioppo R, 2005, CLIN EXP IMMUNOL, V140, P408, DOI 10.1111/j.1365-2249.2005.02783.x; Cooper PJ, 2004, J INFECT DIS, V190, P1338, DOI 10.1086/423944; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; Dagoye D, 2003, AM J RESP CRIT CARE, V167, P1369, DOI 10.1164/rccm.200210-1204OC; Daveson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017366; Fantini MC, 2009, GASTROENTEROLOGY, V136, P1308, DOI 10.1053/j.gastro.2008.12.053; Feary J, 2009, CLIN EXP ALLERGY, V39, P1060, DOI 10.1111/j.1365-2222.2009.03187.x; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Flohr C., 2009, CLIN EXP ALLERGY; Forsberg G, 2007, INT IMMUNOL, V19, P993, DOI 10.1093/intimm/dxm077; Frisullo G, 2009, HUM IMMUNOL, V70, P430, DOI 10.1016/j.humimm.2009.04.006; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Guandalini S, 2008, CURR OPIN GASTROEN, V24, P707, DOI 10.1097/MOG.0b013e32830f4527; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; Lerner A, 2010, AUTOIMMUN REV, V9, P144, DOI 10.1016/j.autrev.2009.05.002; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; Meresse B, 2009, MUCOSAL IMMUNOL, V2, P8, DOI 10.1038/mi.2008.75; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mortimer K, 2006, AM J TROP MED HYG, V75, P914, DOI 10.4269/ajtmh.2006.75.914; Nyan OA, 2001, CLIN EXP ALLERGY, V31, P1672, DOI 10.1046/j.1365-2222.2001.00987.x; Schadenberg AWL, 2011, EUR J IMMUNOL, V41, P1132, DOI 10.1002/eji.201040363; Scrivener S, 2001, LANCET, V358, P1493, DOI 10.1016/S0140-6736(01)06579-5; Silano M, 2008, AM J CLIN NUTR, V87, P415, DOI 10.1093/ajcn/87.2.415; Singh KP, 2005, IMMUNOLOGY, V114, P410, DOI 10.1111/j.1365-2567.2004.02083.x; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Tiittanen M, 2008, CLIN EXP IMMUNOL, V152, P498, DOI 10.1111/j.1365-2249.2008.03662.x; TJON JM, 2010, IMMUNOGENETICS; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Yapici U, 2009, TRANSPLANTATION, V87, P1377, DOI 10.1097/TP.0b013e3181a24a4b	40	92	92	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24092	10.1371/journal.pone.0024092	http://dx.doi.org/10.1371/journal.pone.0024092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949691	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000295173800011
J	Sharma, P; Pandey, R; Kumari, K; Pandey, G; Jackson, CJ; Russell, RJ; Oakeshott, JG; Lal, R				Sharma, Pooja; Pandey, Rinku; Kumari, Kirti; Pandey, Gunjan; Jackson, Colin J.; Russell, Robyn J.; Oakeshott, John G.; Lal, Rup			Kinetic and Sequence-Structure-Function Analysis of Known LinA Variants with Different Hexachlorocyclohexane Isomers	PLOS ONE			English	Article							DEHYDROCHLORINASE LINA; PAUCIMOBILIS; PROTEIN; BIOREMEDIATION; DEGRADATION; GENES; SOIL	Background: Here we report specific activities of all seven naturally occurring LinA variants towards three different isomers, alpha, gamma and delta, of a priority persistent pollutant, hexachlorocyclohexane (HCH). Sequence-structure-function differences contributing to the differences in their stereospecificity for alpha-, gamma-, and delta-HCH and enantiospecificity for (+)- and (2)-alpha- HCH are also discussed. Methodology/Principal Findings: Enzyme kinetic studies were performed with purified LinA variants. Models of LinA2(B90A) A110T, A111C, A110T/A111C and LinA1(B90A) were constructed using the FoldX computer algorithm. Turnover rates (min(-1)) showed that the LinAs exhibited differential substrate affinity amongst the four HCH isomers tested. alpha-HCH was found to be the most preferred substrate by all LinA's, followed by the gamma and then delta isomer. Conclusions/Significance: The kinetic observations suggest that LinA-gamma 1-7 is the best variant for developing an enzyme-based bioremediation technology for HCH. The majority of the sequence variation in the various linA genes that have been isolated is not neutral, but alters the enantio-and stereoselectivity of the encoded proteins.	[Sharma, Pooja; Kumari, Kirti; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India; [Pandey, Rinku; Pandey, Gunjan; Russell, Robyn J.; Oakeshott, John G.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	University of Delhi; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Sharma, P (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	ruplal@gmail.com	Russell, Robyn/C-5449-2008; Pandey, Gunjan/I-6993-2019; Jackson, Colin J/C-1500-2008; Lal, Rup/AFP-1009-2022; Pandey, Gunjan/B-8133-2009; Oakeshott, John G/B-5365-2009	Russell, Robyn/0000-0001-5600-3305; Jackson, Colin J/0000-0001-6150-3822; Pandey, Gunjan/0000-0002-3514-4624; Oakeshott, John G/0000-0001-8324-7874	Department of Education Science and Technology (DEST), Australia; Department of Biotechnology (DBT), India	Department of Education Science and Technology (DEST), Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by the Indo-Australian Biotechnology Fund from the Department of Education Science and Technology (DEST), Australia and the Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; BRITTAIN DRB, 2011, CHEM COMMUN, V47, P976, DOI DOI 10.1039/c0cc02925d; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Lal R, 2006, TRENDS BIOTECHNOL, V24, P121, DOI 10.1016/j.tibtech.2006.01.005; Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09; NAGATA Y, 1993, BIOSCI BIOTECH BIOCH, V57, P1582, DOI 10.1271/bbb.57.1582; Nagata Y, 1999, J IND MICROBIOL BIOT, V23, P380, DOI 10.1038/sj.jim.2900736; Nagata Y, 2001, PROTEINS, V45, P471, DOI 10.1002/prot.10007; Okai M, 2010, J MOL BIOL, V403, P260, DOI 10.1016/j.jmb.2010.08.043; Phillips TM, 2006, J CHEM TECHNOL BIOT, V81, P289, DOI 10.1002/jctb.1390; Rubinos DA, 2007, WATER AIR SOIL POLL, V181, P385, DOI 10.1007/s11270-006-9309-5; Sambrook J., 2002, MOL CLONING LAB MANU; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; SLADE Roland E, 1945, CHEM IND-LONDON, V40, P314; Suar M, 2005, APPL ENVIRON MICROB, V71, P8514, DOI 10.1128/AEM.71.12.8514-8518.2005; Trantirek L, 2001, J BIOL CHEM, V276, P7734, DOI 10.1074/jbc.M007452200	16	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25128	10.1371/journal.pone.0025128	http://dx.doi.org/10.1371/journal.pone.0025128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949868	Green Published, gold			2022-12-25	WOS:000295173800066
J	Wang, K; Deubel, V				Wang, Kai; Deubel, Vincent			Mice with Different Susceptibility to Japanese Encephalitis Virus Infection Show Selective Neutralizing Antibody Response and Myeloid Cell Infectivity	PLOS ONE			English	Article							WEST-NILE-VIRUS; DENDRITIC CELLS; DENGUE VIRUS; FLAVIVIRUS ENCEPHALITIS; MOUSE; MACROPHAGES; RESISTANCE; EXPRESSION; RECEPTOR; MODEL	Background: Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes public health problems in Asian countries. Only a limited number of JEV-infected individuals show symptoms and develop severe encephalitis, indicating host-dependent susceptibilities. Methodology/Principal Findings: C3H/HeN and DBA/2 mice, which exhibit different mortalities when infected by intraperitoneal inoculation with JEV, were used as experimental models to compare viral pathogenesis and host responses. One hundred infectious virus particles killed 95% of C3H/HeN mice whereas only 40% of DBA/2 mice died. JEV RNA was detected with similar low levels in peripheral lymphoid organs and in the sera of both mouse strains. High levels of viral and cytokine RNA were observed simultaneously in the brains of C3H/HeN and DBA/2 mice starting on days 6 and 9 post-infection, respectively. The kinetics of the cytokines in sera correlated with the viral replication in the brain. Significantly earlier and higher titers of neutralizing antibodies were detected in the DBA/2 strain. Primary embryonic fibroblasts, bone marrow-derived dendritic cells and macrophages from the two mouse strains were cultured. Fibroblasts displayed similar JEV replication abilities, whereas DBA/2-derived myeloid antigen-presenting cells had lower viral infectivity and production compared to the C3H/HeN-derived cells. Conclusions/Significance: Mice with different susceptibilities to JEV neuroinvasion did not show changes in viral tropism and host innate immune responses prior to viral entry into the central nervous system. However, early and high neutralizing antibody responses may be crucial for preventing viral neuroinvasion and host fatality. In addition, low permissiveness of myeloid dendritic cells and macrophages to JEV infection in vitro may be elements associated with late and decreased mouse neuroinvasion.	[Wang, Kai; Deubel, Vincent] Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wang, K (corresponding author), Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	Evdeubel@pasteur-kh.org			Shanghai Pasteur Health Research Foundation	Shanghai Pasteur Health Research Foundation	This study was supported by the Shanghai Pasteur Health Research Foundation (www.foundation.org.cn/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyas AG, 2010, J IMMUNOL, V185, P1429, DOI 10.4049/jimmunol.0902536; Aleyas AG, 2009, J IMMUNOL, V183, P2462, DOI 10.4049/jimmunol.0801952; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310; Biswas SM, 2010, J MED VIROL, V82, P304, DOI 10.1002/jmv.21688; Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033; BURKE DS, 1985, AM J TROP MED HYG, V34, P1203, DOI 10.4269/ajtmh.1985.34.1203; CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chen CJ, 2004, J VIROL, V78, P12107, DOI 10.1128/JVI.78.22.12107-12119.2004; COLIGAN JE, 2005, SHORT PROTOCOLS IMMU, V1; Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dutta K, 2010, J NEUROIMMUNE PHARM, V5, P553, DOI 10.1007/s11481-010-9233-8; Dutta K, 2010, IMMUNOBIOLOGY, V215, P884, DOI 10.1016/j.imbio.2009.12.003; Fujii Y, 2008, JPN J INFECT DIS, V61, P40; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Hills SL, 2009, EMERG INFECT DIS, V15, P1333, DOI 10.3201/eid1508.090149; JACOBY RO, 1976, J INFECT DIS, V134, P158, DOI 10.1093/infdis/134.2.158; Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x; Kalita J, 2010, NEUROSCI LETT, V473, P48, DOI 10.1016/j.neulet.2010.02.017; KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; Kwan WH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000311; Libraty DH, 2002, T ROY SOC TROP MED H, V96, P173, DOI 10.1016/S0035-9203(02)90294-4; LINDERBACH TH, 2007, FIELDS VIROLOGY, P1101; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marianneau P, 1999, J VIROL, V73, P5201, DOI 10.1128/JVI.73.6.5201-5206.1999; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; MATHUR A, 1988, BRIT J EXP PATHOL, V69, P423; Matsuo S, 1994, Uirusu, V44, P205; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; MIURA K, 1990, ARCH VIROL, V112, P261, DOI 10.1007/BF01323170; MIURA K, 1988, EXP ANIM TOKYO, V37, P365, DOI 10.1538/expanim1978.37.4_365; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pantelic L, 2005, J VIROL, V79, P1753, DOI 10.1128/JVI.79.3.1753-1764.2005; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Saxena V, 2008, MICROBES INFECT, V10, P1210, DOI 10.1016/j.micinf.2008.06.015; Schell JB, 2007, J NEUROIMMUNOL, V189, P75, DOI 10.1016/j.jneuroim.2007.07.004; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001; Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Suzuki T, 2000, BBA-GENE STRUCT EXPR, V1517, P100, DOI 10.1016/S0167-4781(00)00262-1; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Yamanaka T, 2006, J VET MED SCI, V68, P293, DOI 10.1292/jvms.68.293; Yang KD, 2004, J GEN VIROL, V85, P635, DOI 10.1099/vir.0.19426-0; Yang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-80	65	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24744	10.1371/journal.pone.0024744	http://dx.doi.org/10.1371/journal.pone.0024744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949747	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800036
J	Assadi, M; Salimipour, H; Akbarzadeh, S; Nemati, R; Jafari, SM; Bargahi, A; Samani, Z; Seyedabadi, M; Sanjdideh, Z; Nabipour, I				Assadi, Majid; Salimipour, Hooman; Akbarzadeh, Samad; Nemati, Reza; Jafari, Syed Mojtaba; Bargahi, Afshar; Samani, Zahra; Seyedabadi, Mohammad; Sanjdideh, Zahra; Nabipour, Iraj			Correlation of Circulating Omentin-1 with Bone Mineral Density in Multiple Sclerosis: The Crosstalk between Bone and Adipose Tissue	PLOS ONE			English	Article							OSTEOPONTIN LEVELS; PLASMA-LEVELS; VITAMIN-D; LEPTIN; INSULIN; ADIPOKINE; EXPRESSION; HEALTH; OSTEOPROTEGERIN; ADIPOCYTOKINE	Background: Patients with multiple sclerosis (MS) are at increased risk of osteoporosis and fractures. Adipose tissue-derived adipokines may play important roles in the osteoimmunology of MS. In order to determine whether omentin-1 and vaspin may be related to bone health in MS patients, we compared circulating levels of these recently identified adipokines, between MS patients and healthy controls. Methods: A total of 35 ambulatory MS patients with relapsing-remitting courses were compared with 38 age- and sex-matched healthy controls. Bone mineral density (BMD) was determined for the lumbar spine (L2-L4) and the proximal femur using dual-energy x-ray absorptiometry. Circulating omentin-1, vaspin, osteocalcin, osteopontin, osteoprotegerin, the receptor activator of nuclear factor-kappa B ligand, matrix metalloproteinase 9, C-reactive protein and 25-hydroxy vitamin D levels were evaluated by highly specific enzyme-linked immunosorbent assay methods. Results: There was no significant difference between the two groups regarding bone-related cytokines, adipocytokines, and the BMD measurements of patients with MS and the healthy controls. However, in multiple regression analysis, serum omentin-1 levels were positively correlated with BMD at the femoral neck (beta = 0.49, p = 0.016), total hip (beta = 0.42, p = 0.035), osteopontin (beta = 0.42, p = 0.030) and osteocalcin (beta = 0.53, p = 0.004) in MS patients. No correlations were found between vaspin, biochemical, and BMD measures in both groups. Conclusions: Elevated omentin-1 serum levels are correlated with BMD at the femoral neck and the serum levels of osteocalcin and osteopontin in MS patients. Therefore, there is crosstalk between adipose tissue and bone in MS.	[Assadi, Majid] Bushehr Univ Med Sci, Persian Gulf Nucl Med Res Ctr, Bushehr, Iran; [Salimipour, Hooman; Nemati, Reza] Bushehr Univ Med Sci, Sch Med, Dept Neurol, Bushehr, Iran; [Akbarzadeh, Samad] Bushehr Univ Med Sci, Sch Med, Dept Biochem, Bushehr, Iran; [Jafari, Syed Mojtaba; Samani, Zahra; Seyedabadi, Mohammad; Sanjdideh, Zahra; Nabipour, Iraj] Bushehr Univ Med Sci, Dept Endocrine & Metab Dis, Persian Gulf Trop Med Res Ctr, Bushehr, Iran; [Bargahi, Afshar; Nabipour, Iraj] Bushehr Univ Med Sci, Persian Gulf Marine Biotechnol Res Ctr, Dept Biochem, Bushehr, Iran		Assadi, M (corresponding author), Bushehr Univ Med Sci, Persian Gulf Nucl Med Res Ctr, Bushehr, Iran.	inabipour@gmail.com	nabipour, Iraj/D-8924-2017; Akbarzadeh, Samad/H-2581-2018; Seyedabadi, Mohammad/C-7132-2009; bargahi, afshar/A-4769-2018; Samilipour, Hooman/E-9335-2018; Assadi, Majid/H-2812-2017; Bargahi, Afshar/A-8083-2019	nabipour, Iraj/0000-0002-1785-0883; Nemati, Reza/0000-0001-8155-8855; Seyedabadi, Mohammad/0000-0003-0044-8270; bargahi, afshar/0000-0001-5265-9278; Samilipour, Hooman/0000-0001-6369-8619; Assadi, Majid/0000-0003-3862-9472; Bargahi, Afshar/0000-0002-5768-2263	Bushehr Province Technology and Research Committee and Research Deputy of Bushehr University of Medical Science [1389/PGIBMR110]	Bushehr Province Technology and Research Committee and Research Deputy of Bushehr University of Medical Science	This study was supported by a grant from Bushehr Province Technology and Research Committee and Research Deputy of Bushehr University of Medical Science (1389/PGIBMR110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas A, 2009, J NEUROL SCI, V276, P41, DOI 10.1016/j.jns.2008.08.031; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Batocchi AP, 2003, J NEUROIMMUNOL, V139, P150, DOI 10.1016/S0165-5728(03)00154-1; Chang IC, 2010, OSTEOPOROSIS INT, V21, P1401, DOI 10.1007/s00198-009-1107-7; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Gomez R, 2009, J MOL ENDOCRINOL, V43, P11, DOI 10.1677/JME-08-0131; Heshmat R, 2008, IRAN J PUBLIC HEALTH, P72; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Kurban S, 2008, MULT SCLER, V14, P431, DOI 10.1177/1352458507084028; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Lee MA, 1999, BRAIN, V122, P191, DOI 10.1093/brain/122.2.191; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lichtinghagen R, 1999, J NEUROIMMUNOL, V99, P19, DOI 10.1016/S0165-5728(99)00094-6; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Magni P, 2010, CURR MOL MED, V10, P522; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; Marrie RA, 2009, NEUROLOGY, V73, P1394, DOI 10.1212/WNL.0b013e3181beece8; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Matarese G, 2008, J LEUKOCYTE BIOL, V84, P893, DOI 10.1189/jlb.0108022; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mojtahedi MC, 2008, J REHABIL RES DEV, V45, P851, DOI 10.1682/JRRD.2007.10.0159; Nabipour I, 2009, MENOPAUSE, V16, P950, DOI 10.1097/gme.0b013e3181a181b8; Nakashima T, 2009, J BONE MINER METAB, V27, P519, DOI 10.1007/s00774-009-0089-z; Ozgocmen S, 2005, J BONE MINER METAB, V23, P309, DOI 10.1007/s00774-005-0604-9; Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sioka C, 2009, J NEUROL SCI, V287, P1, DOI 10.1016/j.jns.2009.09.012; Soilu-Hanninen M, 2008, J NEUROL NEUROSUR PS, V79, P152, DOI 10.1136/jnnp.2006.105320; Soilu-Hanninen M, 2005, NEUROLOGY, V65, P153, DOI 10.1212/01.WNL.0000167129.90918.f5; Steffensen LH, 2010, J NEUROL, V257, P410, DOI 10.1007/s00415-009-5337-6; Tan BK, 2008, DIABETES, V57, P801, DOI 10.2337/db07-0990; Terzi T, 2010, J CLIN NEUROSCI, V17, P1260, DOI 10.1016/j.jocn.2010.01.044; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Vogt MHJ, 2010, MULT SCLER J, V16, P443, DOI 10.1177/1352458509359723; Vogt MHJ, 2004, J NEUROIMMUNOL, V155, P155, DOI 10.1016/j.jneuroim.2004.06.007; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Wada J, 2008, EXPERT OPIN INV DRUG, V17, P327, DOI 10.1517/13543784.17.3.327 ; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004	49	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24240	10.1371/journal.pone.0024240	http://dx.doi.org/10.1371/journal.pone.0024240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935388	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000295041700018
J	Biktashev, VN; Biktasheva, IV; Sarvazyan, NA				Biktashev, Vadim N.; Biktasheva, Irina V.; Sarvazyan, Narine A.			Evolution of Spiral and Scroll Waves of Excitation in a Mathematical Model of Ischaemic Border Zone	PLOS ONE			English	Article							RECTIFYING POTASSIUM CURRENT; 3-DIMENSIONAL ACTIVE MEDIA; ISOLATED RABBIT HEART; VENTRICULAR-TACHYCARDIA; REPERFUSION ARRHYTHMIAS; REENTRANT ACTIVITY; EXCITABLE MEDIA; CARDIAC TISSUE; ECTOPIC WAVES; MECHANISM	Abnormal electrical activity from the boundaries of ischemic cardiac tissue is recognized as one of the major causes in generation of ischemia-reperfusion arrhythmias. Here we present theoretical analysis of the waves of electrical activity that can rise on the boundary of cardiac cell network upon its recovery from ischaemia-like conditions. The main factors included in our analysis are macroscopic gradients of the cell-to-cell coupling and cell excitability and microscopic heterogeneity of individual cells. The interplay between these factors allows one to explain how spirals form, drift together with the moving boundary, get transiently pinned to local inhomogeneities, and finally penetrate into the bulk of the well-coupled tissue where they reach macroscopic scale. The asymptotic theory of the drift of spiral and scroll waves based on response functions provides explanation of the drifts involved in this mechanism, with the exception of effects due to the discreteness of cardiac tissue. In particular, this asymptotic theory allows an extrapolation of 2D events into 3D, which has shown that cells within the border zone can give rise to 3D analogues of spirals, the scroll waves. When and if such scroll waves escape into a better coupled tissue, they are likely to collapse due to the positive filament tension. However, our simulations have shown that such collapse of newly generated scrolls is not inevitable and that under certain conditions filament tension becomes negative, leading to scroll filaments to expand and multiply leading to a fibrillation-like state within small areas of cardiac tissue.	[Biktashev, Vadim N.] Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England; [Biktasheva, Irina V.] Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England; [Sarvazyan, Narine A.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA	University of Liverpool; University of Liverpool; George Washington University	Biktashev, VN (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England.	vnb@liv.ac.uk		Sarvazyan, Narine/0000-0002-2002-5630; Biktasheva, Irina/0000-0003-2906-2881	Engineering and Physical Sciences Research Council, UK (EPSRC) [EP/D074789/1, EP/I029664/1]; NIH [HL095828, HL076722]; EPSRC [EP/E018548/1, EP/I029664/1, EP/D074789/1, EP/I030158/1, EP/D074746/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D074789/1, EP/I030158/1, EP/I029664/1, EP/E018548/1, EP/D074746/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076722, R01HL095828] Funding Source: NIH RePORTER	Engineering and Physical Sciences Research Council, UK (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Engineering and Physical Sciences Research Council, UK (EPSRC) grants EP/D074789/1 and EP/I029664/1, http://www.epsrc.ac.uk (UK) and NIH grants HL095828 and HL076722, http://www.nih.gov (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2011, CHAOS, V21, DOI 10.1063/1.3551500; Arutunyan A, 2003, AM J PHYSIOL-HEART C, V285, pH2531, DOI 10.1152/ajpheart.00381.2003; Arutunyan A, 2002, AM J PHYSIOL-HEART C, V283, pH741, DOI 10.1152/ajpheart.00096.2002; Arutunyan A, 2001, AM J PHYSIOL-HEART C, V280, pH1905, DOI 10.1152/ajpheart.2001.280.4.H1905; Bansagi T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.045202; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Biktashev VN, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058302; Biktashev VN, 2008, BIOPHYS J, V94, P3726, DOI 10.1529/biophysj.107.117630; Biktashev VN, 1998, INT J BIFURCAT CHAOS, V8, P677, DOI 10.1142/S0218127498000474; BIKTASHEV VN, 1994, PHILOS T R SOC A, V347, P611, DOI 10.1098/rsta.1994.0070; BIKTASHEV VN, 1995, CHAOS SOLITON FRACT, V5, P575, DOI 10.1016/0960-0779(93)E0044-C; Biktashev VN, 1989, THESIS MOSCOW I PHYS; Biktasheva IV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066202; Biktasheva IV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056702; Biktasheva IV, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026221; Brazhnik P. K., 1987, Soviet Physics - JETP, V66, P984; Chen PS, 1997, PACE, V20, P414, DOI 10.1111/j.1540-8159.1997.tb06200.x; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dierckx H, 2009, PHYSICA D, V238, P941, DOI 10.1016/j.physd.2008.09.006; Dutta S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055202; Efimov IR, 1999, J CARDIOVASC ELECTR, V10, P1452, DOI 10.1111/j.1540-8167.1999.tb00204.x; Foulkes AJ, 2010, CHAOS, V20, DOI 10.1063/1.3517079; GRAY RA, 1995, CIRCULATION, V91, P2454, DOI 10.1161/01.CIR.91.9.2454; Kay M, 2008, AM J PHYSIOL-HEART C, V294, pH2400, DOI 10.1152/ajpheart.01158.2007; KEENER JP, 1988, PHYSICA D, V31, P269, DOI 10.1016/0167-2789(88)90080-2; Luengviriya C, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056214; Luengviriya C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148302; MASUDA H, 1993, AM J PHYSIOL, V265, pH1107, DOI 10.1152/ajpheart.1993.265.4.H1107; PANFILOV AV, 1984, DOKL AKAD NAUK SSSR+, V274, P1500; PANFILOV AV, 1986, BIOFIZIKA+, V31, P850; PANFILOV AV, 1987, PHYSICA D, V28, P215, DOI 10.1016/0167-2789(87)90132-1; Pazo D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.168303; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Pumir A, 2005, BIOPHYS J, V89, P2332, DOI 10.1529/biophysj.105.061820; RUDENKO AN, 1983, STUD BIOPHYS, V98, P183; Silva J, 2003, CIRC RES, V92, P261, DOI 10.1161/01.RES.0000057996.20414.C6; Sridhar S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051908; Ten Tusscher KHWJ, 2003, AM J PHYSIOL-HEART C, V284, pH542, DOI 10.1152/ajpheart.00608.2002; WAHLER GM, 1992, AM J PHYSIOL, V262, pC1266, DOI 10.1152/ajpcell.1992.262.5.C1266; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Wit AL, 2001, CIRC RES, V89, P741, DOI 10.1161/res.89.9.741; YAKUSHEVICH LV, 1984, STUD BIOPHYS, V100, P195	42	18	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24388	10.1371/journal.pone.0024388	http://dx.doi.org/10.1371/journal.pone.0024388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935402	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700028
J	Gomez-Campos, E; Borrell, A; Cardona, L; Forcada, J; Aguilar, A				Gomez-Campos, Encarna; Borrell, Assumpcio; Cardona, Luis; Forcada, Jaume; Aguilar, Alex			Overfishing of Small Pelagic Fishes Increases Trophic Overlap between Immature and Mature Striped Dolphins in the Mediterranean Sea	PLOS ONE			English	Article							HAKE MERLUCCIUS MERLUCCIUS; STABLE-ISOTOPE ANALYSES; LONG-TERM CHANGES; STENELLA-COERULEOALBA; MARINE MAMMALS; PHOCOENA-PHOCOENA; CARBON ISOTOPES; FEEDING ECOLOGY; NORTH-SEA; FOOD-WEB	The interactions among diet, ecology, physiology, and biochemistry affect N and C stable isotope signatures in animal tissues. Here, we examined if ecological segregation among animals in relation to sex and age existed by analyzing the signatures of delta N-15 and delta C-13 in the muscle of Western Mediterranean striped dolphins. Moreover, we used a Bayesian mixing model to study diet composition and investigated potential dietary changes over the last two decades in this population. For this, we compared isotope signatures in samples of stranded dolphins obtained during two epizootic events occurring in 1990 and 2007-2008. Mean delta C-13 values for females and males were not significantly different, but age-related variation indicated delta C-13 enrichment in both sexes, suggesting that females and males most likely fed in the same general areas, increasing their consumption of benthic prey with age. Enrichment of delta N-15 was only observed in females, suggesting a preference for larger or higher trophic level prey than males, which could reflect different nutritional requirements. delta C-13 values showed no temporal variation, although the mean delta N-15 signature decreased from 1990 to 2007-2008, which could indicate a dietary shift in the striped dolphin over the last two decades. The results of SIAR indicated that in 1990, hake and sardine together contributed to 60% on the diet of immature striped dolphins, and close to 90% for mature striped dolphins. Conversely, the diet of both groups in 2007-2008 was more diverse, as hake and sardine contributed to less than 40% of the entire diet. These results suggest a dietary change that was possibly related to changes in food availability, which is consistent with the depletion of sardine stocks by fishing.	[Gomez-Campos, Encarna; Borrell, Assumpcio; Cardona, Luis; Aguilar, Alex] Univ Barcelona, Fac Biol, Inst Biodivers Res, Dept Anim Biol Vertebrates, Barcelona, Spain; [Forcada, Jaume] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	University of Barcelona; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Gomez-Campos, E (corresponding author), Univ Barcelona, Fac Biol, Inst Biodivers Res, Dept Anim Biol Vertebrates, Barcelona, Spain.	engomez@ub.edu	Cardona, Luis/L-1680-2014; Aguilar, Alex/L-1283-2014; Borrell, Asunción/B-8257-2009; Cardona, Luis/AAL-1354-2021; Forcada, Jaume/GYU-0677-2022	Cardona, Luis/0000-0002-7892-1323; Aguilar, Alex/0000-0002-5751-2512; Borrell, Asunción/0000-0002-6714-0724; Cardona, Luis/0000-0002-7892-1323; 	Ministerio de Educacion y Ciencia of Spain [CGL2005-00922/BOS]; "Zoo de Barcelona", Ajuntament de Barcelona; University of Barcelona; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Ministerio de Educacion y Ciencia of Spain(Spanish Government); "Zoo de Barcelona", Ajuntament de Barcelona; University of Barcelona; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was funded by the Programa Nacional de Biodiversidad, Ciencias de la Tierra y Cambio Global of the Ministerio de Educacion y Ciencia of Spain (project CGL2005-00922/BOS) and the "Zoo de Barcelona", Ajuntament de Barcelona. The economic costs of publication of this article have been funded by the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend AG, 1997, ICES J MAR SCI, V54, P500, DOI 10.1006/jmsc.1996.0192; Adams LG, 2005, J MAMMAL, V86, P506, DOI 10.1644/1545-1542(2005)86[506:EOMCAC]2.0.CO;2; Aguilar A, 2005, MAR ENVIRON RES, V59, P391, DOI 10.1016/j.marenvres.2004.06.004; AGUILAR A, 1993, AMBIO, V22, P524; AGUILAR A, 1994, SCI TOTAL ENVIRON, V154, P237, DOI 10.1016/0048-9697(94)90091-4; Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; Nino-Torres CA, 2006, MAR MAMMAL SCI, V22, P831, DOI 10.1111/j.1748-7692.2006.00065.x; Aldebert Y, 1996, AQUAT LIVING RESOUR, V9, P13, DOI 10.1051/alr:1996003; [Anonymous], SCI REPORTS WHALES R; Astruc G., 2005, THESIS ECOLE PRATIQU; Atkinson S, 2008, MAR MAMMAL SCI, V24, P276, DOI 10.1111/j.1748-7692.2008.00188.x; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Azzellino A, 2008, J MAR BIOL ASSOC UK, V88, P1145, DOI 10.1017/S0025315408000751; Bakun A., 1996, OCEAN PROCESSES MARI; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Bas C, 2003, 135 I EST CAT SEC CI, V135; Bearzi G, 2006, BIOL CONSERV, V127, P373, DOI 10.1016/j.biocon.2005.08.017; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; BLANCO C, 1995, J ZOOL, V237, P151, DOI 10.1111/j.1469-7998.1995.tb02753.x; Borrell A, 1996, CHEMOSPHERE, V32, P2359, DOI 10.1016/0045-6535(96)00143-9; Bowen WD, 2000, CAN J FISH AQUAT SCI, V57, P898, DOI 10.1139/cjfas-57-5-898; Bozzano A, 1997, SCI MAR, V61, P1; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; Breier BH, 2000, RUMINANT PHYSL DIGES, P347; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Burns JM, 1998, POLAR BIOL, V19, P272, DOI 10.1007/s003000050245; Caddy J, 1997, REV STATE WORLD FISH, V920, P44; CALZADA N, 1994, MAR MAMMAL SCI, V10, P299, DOI 10.1111/j.1748-7692.1994.tb00484.x; Calzada N, 1996, THESIS U BARCELONA; Castrillon J, 2010, CHEMOSPHERE, V81, P459, DOI 10.1016/j.chemosphere.2010.08.008; Christensen JT, 2008, MAR ECOL PROG SER, V368, P1, DOI 10.3354/meps07635; Coll M, 2008, ECOL MODEL, V217, P95, DOI 10.1016/j.ecolmodel.2008.06.013; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Cotte Cedric, 2010, Endangered Species Research, V12, P203, DOI 10.3354/esr00301; Dalerum F, 2007, RAPID COMMUN MASS SP, V21, P1889, DOI 10.1002/rcm.3032; Das K, 2004, MAR ECOL PROG SER, V281, P283, DOI 10.3354/meps281283; Das K, 2003, MAR ECOL PROG SER, V263, P287, DOI 10.3354/meps263287; Dehn LA, 2007, POLAR BIOL, V30, P167, DOI 10.1007/s00300-006-0171-0; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Desportes G., 1985, THESIS U POITIERS; Di-Meglio Nathalie, 1996, Aquatic Mammals, V22, P11; DOMINGO M, 1990, NATURE, V348, P21, DOI 10.1038/348021a0; Drago M, 2009, J ZOOL, V279, P251, DOI 10.1111/j.1469-7998.2009.00613.x; Duncan CJ, 2004, NUTR RES REV, V17, P163, DOI 10.1079/NRR200491; Evermann JF, 2001, VET PATHOL, V38, P311, DOI 10.1354/vp.38-3-311; Fiorentino F, 2000, EDTNFF40600REL1; Forcada J, 1998, J SEA RES, V39, P313, DOI 10.1016/S1385-1101(97)00063-4; FORCADA J, 1994, MAR MAMMAL SCI, V10, P137, DOI 10.1111/j.1748-7692.1994.tb00256.x; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Fry B., 2006, STABLE ISOTOPE ECOLO; GALES NJ, 1992, WILDLIFE RES, V19, P447, DOI 10.1071/WR9920447; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gannier A, 2005, REV ECOL-TERRE VIE, V60, P223; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; de Segura AG, 2006, MAR BIOL, V150, P149, DOI 10.1007/s00227-006-0334-0; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Haramis GM, 2001, AUK, V118, P1008, DOI 10.1642/0004-8038(2001)118[1008:SIAOCW]2.0.CO;2; Hassani Sami, 1997, Journal of Northwest Atlantic Fishery Science, V22, P119; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2003, CAN J ZOOL, V81, P1630, DOI 10.1139/Z03-140; Hobson KA, 1997, MAR MAMMAL SCI, V13, P114, DOI 10.1111/j.1748-7692.1997.tb00615.x; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hobson KA, 1998, CAN J FISH AQUAT SCI, V55, P2601, DOI 10.1139/cjfas-55-12-2601; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Hooker SK, 2001, CAN J ZOOL, V79, P1442, DOI 10.1139/cjz-79-8-1442; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Jackson JBC, 2001, SCI MAR, V65, P273, DOI 10.3989/scimar.2001.65s2273; Karakoltsidis Pavlos A., 1995, Journal of Food Composition and Analysis, V8, P258, DOI 10.1006/jfca.1995.1019; Kastelein RA, 2002, MAR ENVIRON RES, V53, P199, DOI 10.1016/S0141-1136(01)00123-4; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kirsch PE, 2000, PHYSIOL BIOCHEM ZOOL, V73, P45, DOI 10.1086/316723; Lawson JW, 2000, MAR MAMMAL SCI, V16, P578, DOI 10.1111/j.1748-7692.2000.tb00953.x; Lee SH, 2005, MAR ECOL PROG SER, V285, P271, DOI 10.3354/meps285271; Lesage V, 2001, MAR ECOL PROG SER, V210, P203, DOI 10.3354/meps210203; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; Mateo MA, 2010, PALAEOGEOGR PALAEOCL, V291, P286, DOI 10.1016/j.palaeo.2010.03.001; Meotti C, 1997, ATTI SOC IT SCI NAT, V137, P5; Miyazaki N., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P265; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; MURIE DJ, 1986, CAN J ZOOL, V64, P1152, DOI 10.1139/z86-174; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Ozturk B, 2007, VIE MILIEU, V57, P57; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; Papaconstantinou C., 2000, Mediterranean Marine Science, V1, P5; Parnell A., 2008, SIAR STABLE ISOTOPE; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perrin WF, 1994, INT WHALING COMMISSI, V5, P1; Pierce Graham J., 2004, CIESM Workshop Monographs, V25, P29; Pinnegar JK, 2004, ECOL MODEL, V172, P249, DOI 10.1016/j.ecolmodel.2003.09.010; Pipitone C, 2000, FISH RES, V48, P23, DOI 10.1016/S0165-7836(00)00114-4; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Pulcini M., 1992, European Research on Cetaceans, V6, P194; Quetglas A, 1998, SCI MAR, V62, P73; R Development Core Team, 2009, R FDN STAT COMP; Raga JA, 2008, EMERG INFECT DIS, V14, P471, DOI 10.3201/eid1403.071230; RECCHIA CA, 1989, CAN J ZOOL, V67, P2140, DOI 10.1139/z89-304; Relini LO, 2002, SCI MAR, V66, P21; Ringelstein J, 2006, J MAR BIOL ASSOC UK, V86, P909, DOI 10.1017/S0025315406013865; ROFFE TJ, 1993, J WILDLIFE DIS, V29, P295, DOI 10.7589/0090-3558-29.2.295; Rosen DAS, 2005, J COMP PHYSYOL B, V175, P2151; Rosen DAS, 2009, MAMMAL REV, V39, P284, DOI 10.1111/j.1365-2907.2009.00150.x; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Ruiz-Cooley RI, 2004, MAR ECOL PROG SER, V277, P275, DOI 10.3354/meps277275; Santos MB, 2008, J MAR BIOL ASSOC UK, V88, P1175, DOI 10.1017/S0025315408000155; Santos MB, 2003, OCEANOGR MAR BIOL, V41, P355; Santos MB, 2001, FISH RES, V52, P121, DOI 10.1016/S0165-7836(01)00236-3; SEKIGUCHI K, 1992, S AFR J MARINE SCI, V12, P843; Sheffield G, 2001, MAR MAMMAL SCI, V17, P310, DOI 10.1111/j.1748-7692.2001.tb01273.x; Sheffield G, 2009, MAR MAMMAL SCI, V25, P761, DOI 10.1111/j.1748-7692.2009.00316.x; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Spitz J, 2006, J SEA RES, V55, P309, DOI 10.1016/j.seares.2006.02.001; Sponheimer M, 2006, RAPID COMMUN MASS SP, V20, P1395, DOI 10.1002/rcm.2454; Stanberry K, 2003, THESIS U HAWAII; Staniland IJ, 2002, MAR MAMMAL SCI, V18, P223, DOI 10.1111/j.1748-7692.2002.tb01030.x; Steinheim G, 2002, J ZOOL, V258, P515, DOI 10.1017/S095283690200167X; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Trites Andrew W., 1997, Journal of Northwest Atlantic Fishery Science, V22, P173; TRITES AW, 1991, CAN J ZOOL, V69, P2608, DOI 10.1139/z91-367; Trumble SJ, 2003, J COMP PHYSIOL B, V173, P501, DOI 10.1007/s00360-003-0358-4; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; WARING GT, 1990, FISH B-NOAA, V88, P347; Wild SH, 2004, NUTR RES REV, V17, P153, DOI 10.1079/NRR200487; WURTZ M, 1993, J MAR BIOL ASSOC UK, V73, P571, DOI 10.1017/S0025315400033117; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	134	34	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24554	10.1371/journal.pone.0024554	http://dx.doi.org/10.1371/journal.pone.0024554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935424	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295041700042
J	Venesky, MD; Kerby, JL; Storfer, A; Parris, MJ				Venesky, Matthew D.; Kerby, Jacob L.; Storfer, Andrew; Parris, Matthew J.			Can Differences in Host Behavior Drive Patterns of Disease Prevalence in Tadpoles?	PLOS ONE			English	Article							AMPHIBIAN POPULATION DECLINES; BATRACHOCHYTRIUM-DENDROBATIDIS; FUNGAL PATHOGEN; FEEDING KINEMATICS; INFECTIOUS-DISEASE; BUFO-AMERICANUS; CHYTRIDIOMYCOSIS; PARASITES; COMMUNITIES; COMPETITION	Differences in host behavior and resistance to disease can influence the outcome of host-pathogen interactions. We capitalized on the variation in aggregation behavior of Fowler's toads (Anaxyrus [ = Bufo] fowleri) and grey treefrogs (Hyla versicolor) tadpoles and tested for differences in transmission of Batrachochytrium dendrobatidis (Bd) and host-specific fitness consequences (i.e., life history traits that imply fitness) of infection in single-species amphibian mesocosms. On average, A. fowleri mesocosms supported higher Bd prevalences and infection intensities relative to H. versicolor mesocosms. Higher Bd prevalence in A. fowleri mesocosms may result, in part, from higher intraspecific transmission due to the aggregation of tadpoles raised in Bd treatments. We also found that, independent of species, tadpoles raised in the presence of Bd were smaller and less developed than tadpoles raised in disease-free conditions. Our results indicate that aggregation behavior might increase Bd prevalence and that A. fowleri tadpoles carry heavier infections relative to H. versicolor tadpoles. However, our results demonstrate that Bd appears to negatively impact larval growth and developmental rates of A. fowleri and H. versicolor similarly, even in the absence of high Bd prevalence.	[Venesky, Matthew D.; Parris, Matthew J.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Venesky, Matthew D.] Univ S Florida, Dept Integrat Biol, Tampa, FL USA; [Kerby, Jacob L.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Storfer, Andrew] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of Memphis; State University System of Florida; University of South Florida; University of South Dakota; Washington State University	Venesky, MD (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	mvenesky@usf.edu			United States Environmental Protection Agency [MA-916980]	United States Environmental Protection Agency(United States Environmental Protection Agency)	This publication was developed, in part, under a GRO Research Assistance Agreement No. MA-916980 awarded by the United States Environmental Protection Agency to M. D. Venesky. Bd qPCR analysis was performed on instrumentation provided by NSF (MRI-0923419) to J. Kerby. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; BEISWENGER RE, 1977, ECOLOGY, V58, P98, DOI 10.2307/1935111; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 2007, BIOSCIENCE, V57, P437, DOI 10.1641/B570517; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brunner JL, 2004, ECOLOGY, V85, P560, DOI 10.1890/02-0374; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Deacon JW, 1997, MYCOL RES, V101, P513, DOI 10.1017/S0953756296003085; Elliot SL, 2002, P ROY SOC B-BIOL SCI, V269, P1599, DOI 10.1098/rspb.2002.2067; GARNER TWJ, 2009, OIKOS; GOATER CP, 1994, ECOLOGY, V75, P2264, DOI 10.2307/1940882; Gosner K. L., 1960, Herpetologica, V16, P183; Hajek AE, 2001, OECOLOGIA, V126, P285, DOI 10.1007/s004420000509; Han BA, 2008, BEHAV ECOL SOCIOBIOL, V63, P241, DOI 10.1007/s00265-008-0655-8; Hatcher MJ, 2008, BIOL LETTERS, V4, P534, DOI 10.1098/rsbl.2008.0178; HENSLEY FR, 1993, ECOLOGY, V74, P2405, DOI 10.2307/1939591; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson PTJ, 2009, ECOLOGY, V90, P132, DOI 10.1890/07-2071.1; Kohler SL, 1997, ECOLOGY, V78, P2164, DOI 10.2307/2265953; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; LEIPS J, 1994, ECOLOGY, V75, P1345, DOI 10.2307/1937459; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; Otterstatter MC, 2005, BEHAV ECOL SOCIOBIOL, V58, P383, DOI 10.1007/s00265-005-0945-3; Parris MJ, 2004, EVOL ECOL RES, V6, P457; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Parris MJ, 2004, COPEIA, P344, DOI 10.1643/CE-03-116R1; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Radder RS, 2007, J EXP ZOOL PART A, V307A, P500, DOI 10.1002/jez.403; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Searle CL, 2010, OECOLOGIA, V162, P237, DOI 10.1007/s00442-009-1440-8; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Thiemann GW, 2000, BIOL J LINN SOC, V71, P513, DOI [10.1111/j.1095-8312.2000.tb01272.x, 10.1006/bijl.2000.0459]; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Venesky MD, 2010, BIOL BULL-US, V218, P160, DOI 10.1086/BBLv218n2p160; WASSERSUG RJ, 1983, J EXP BIOL, V105, P173; WILBUR HM, 1985, ECOLOGY, V66, P1106, DOI 10.2307/1939162; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x	46	24	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24991	10.1371/journal.pone.0024991	http://dx.doi.org/10.1371/journal.pone.0024991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949824	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700089
J	Zhang, Y; Yang, JY; Bao, R; Chen, YQ; Zhou, DH; He, BX; Zhong, MH; Li, YM; Liu, F; Li, QL; Yang, Y; Han, C; Sun, Y; Cao, Y; Yan, HM				Zhang, Yan; Yang, Jingyi; Bao, Rong; Chen, Yaoqing; Zhou, Dihan; He, Benxia; Zhong, Maohua; Li, Yaoming; Liu, Fang; Li, Qiaoli; Yang, Yi; Han, Chen; Sun, Ying; Cao, Yuan; Yan, Huimin			Unpolarized Release of Vaccinia Virus and HIV Antigen by Colchicine Treatment Enhances Intranasal HIV Antigen Expression and Mucosal Humoral Responses	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; HUMAN AIRWAY EPITHELIA; IMMUNODEFICIENCY-VIRUS; BASOLATERAL SURFACE; TIANTAN VACCINIA; SEX WORKERS; INFECTION; ENTRY; VACCINATION; IMMUNITY	The induction of a strong mucosal immune response is essential to building successful HIV vaccines. Highly attenuated recombinant HIV vaccinia virus can be administered mucosally, but even high doses of immunization have been found unable to induce strong mucosal antibody responses. In order to solve this problem, we studied the interactions of recombinant HIV vaccinia virus Tiantan strain (rVTT-gagpol) in mucosal epithelial cells (specifically Caco-2 cell layers) and in BALB/c mice. We evaluated the impact of this virus on HIV antigen delivery and specific immune responses. The results demonstrated that rVTT-gagpol was able to infect Caco-2 cell layers and both the nasal and lung epithelia in BALB/c mice. The progeny viruses and expressed p24 were released mainly from apical surfaces. In BALB/c mice, the infection was limited to the respiratory system and was not observed in the blood. This showed that polarized distribution limited antigen delivery into the whole body and thus limited immune response. To see if this could be improved upon, we stimulated unpolarized budding of the virus and HIV antigens by treating both Caco-2 cells and BALB/c mice with colchicine. We found that, in BALB/c mice, the degree of infection and antigen expression in the epithelia went up. As a result, specific immune responses increased correspondingly. Together, these data suggest that polarized budding limits antigen delivery and immune responses, but unpolarized distribution can increase antigen expression and delivery and thus enhance specific immune responses. This conclusion can be used to optimize mucosal HIV vaccine strategies.	[Zhang, Yan; Yang, Jingyi; Bao, Rong; Zhou, Dihan; He, Benxia; Zhong, Maohua; Li, Yaoming; Liu, Fang; Li, Qiaoli; Yang, Yi; Han, Chen; Sun, Ying; Cao, Yuan; Yan, Huimin] Chinese Acad Sci, Mucosal Immun Res Grp, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China; [Chen, Yaoqing; Yan, Huimin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Chen, Yaoqing; Yan, Huimin] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; Wuhan University	Zhang, Y (corresponding author), Chinese Acad Sci, Mucosal Immun Res Grp, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.	hmyan@wh.iov.cn	chen, yaoqing/S-2623-2016	chen, yaoqing/0000-0002-1278-3327; Yan, Huimin/0000-0002-7243-8429	National Natural Science Foundation of China [30471584, 30670097]; Ministry of Science and Technology of the People's Republic of China (973 Program) [2005CB522903, 2012CB518904]; National Key RD Program [2007BAI28B04]; National S&T Major Project on Major Infectious Diseases [2008ZX10001-010, 2008ZX10001-015, 2012ZX10001-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China (973 Program)(National Basic Research Program of China); National Key RD Program; National S&T Major Project on Major Infectious Diseases	This work was financially supported by grants from the National Natural Science Foundation of China (Nos. 30471584 and 30670097) and the Ministry of Science and Technology of the People's Republic of China (973 Program, Nos. 2005CB522903 and 2012CB518904; the National Key R&D Program, No. 2007BAI28B04; and the National S&T Major Project on Major Infectious Diseases, Nos. 2008ZX10001-010, 2008ZX10001-015, 2012ZX10001-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 2009, EUR J IMMUNOL, V39, P2657, DOI 10.1002/eji.200939269; Belyakov IM, 2004, IMMUNITY, V20, P247, DOI 10.1016/S1074-7613(04)00053-6; BERGMANN JE, 1988, J CELL BIOL, V107, P1707, DOI 10.1083/jcb.107.5.1707; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Compans RW, 1995, CURR TOP MICROBIOL, V202, P209; Cordo SM, 2005, J GEN VIROL, V86, P1475, DOI 10.1099/vir.0.80473-0; Cornish TE, 2001, VET PATHOL, V38, P396, DOI 10.1354/vp.38-4-396; Cripps AW, 2001, VACCINE, V19, P2513, DOI 10.1016/S0264-410X(00)00481-3; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; Eriksson K, 2002, CURR OPIN IMMUNOL, V14, P666, DOI 10.1016/S0952-7915(02)00384-9; Frey A, 2000, J IMMUNOL METHODS, V233, P47, DOI 10.1016/S0022-1759(99)00166-0; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; HU SL, 1986, NATURE, V320, P537, DOI 10.1038/320537a0; Huang XG, 2007, VACCINE, V25, P8874, DOI 10.1016/j.vaccine.2007.08.066; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Huang YT, 1999, VIROLOGY, V257, P24, DOI 10.1006/viro.1999.9637; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2001, AIDS, V15, P431, DOI 10.1097/00002030-200102160-00026; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kresina TF, 1999, J INFECT DIS, V179, pS392, DOI 10.1086/314815; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; Ma JKC, 1998, NAT MED, V4, P601, DOI 10.1038/nm0598-601; Mackett M, 1992, Biotechnology, V24, P495; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Mizumoto N, 2005, BLOOD, V106, P3082, DOI 10.1182/blood-2005-03-1161; MOSS B, 1992, CURR TOP MICROBIOL, V158, P25; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; OWENS RJ, 1991, P NATL ACAD SCI USA, V88, P3987, DOI 10.1073/pnas.88.9.3987; Peacock JW, 2004, J VIROL, V78, P13163, DOI 10.1128/JVI.78.23.13163-13172.2004; Ramirez JC, 2003, ARCH VIROL, V148, P827, DOI 10.1007/s00705-003-0006-z; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; Sinn PL, 2002, J VIROL, V76, P2403, DOI 10.1128/JVI.76.5.2403-2409.2002; Takao SI, 1997, J VIROL, V71, P832, DOI 10.1128/JVI.71.1.832-838.1997; Vermeer PD, 2007, J VIROL, V81, P9891, DOI 10.1128/JVI.00601-07; Vogel U, 1998, J CELL SCI, V111, P825; XIONG Z, 2000, CHINESE J DIAGNOSTIC, V7, P45; Yin L, 2008, VACCINE, V26, P762, DOI 10.1016/j.vaccine.2007.11.091; Yu WB, 2010, VACCINE, V28, P2088, DOI 10.1016/j.vaccine.2009.12.038; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012; Zimmer G, 2002, J VIROL, V76, P4103, DOI 10.1128/JVI.76.8.4103-4107.2002	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24296	10.1371/journal.pone.0024296	http://dx.doi.org/10.1371/journal.pone.0024296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935396	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700024
J	Libal, NS; Belant, JL; Leopold, BD; Wang, GM; Owen, PA				Libal, Nathan S.; Belant, Jerrold L.; Leopold, Bruce D.; Wang, Guiming; Owen, Patricia A.			Despotism and Risk of Infanticide Influence Grizzly Bear Den-Site Selection	PLOS ONE			English	Article							WILDLIFE RESOURCE USE; BROWN BEARS; BLACK BEARS; BODY-SIZE; REPRODUCTIVE STRATEGIES; DENNING ECOLOGY; SPACE-USE; AGGRESSION; DISPERSAL; PREDATION	Given documented social dominance and intraspecific predation in bear populations, the ideal despotic distribution model and sex hypothesis of sexual segregation predict adult female grizzly bears (Ursus arctos) will avoid areas occupied by adult males to reduce risk of infanticide. Under ideal despotic distribution, juveniles should similarly avoid adult males to reduce predation risk. Den-site selection and use is an important component of grizzly bear ecology and may be influenced by multiple factors, including risk from conspecifics. To test the role of predation risk and the sex hypothesis of sexual segregation, we compared adult female (n = 142), adult male (n = 36), and juvenile (n = 35) den locations in Denali National Park and Preserve, Alaska, USA. We measured elevation, aspect, slope, and dominant land cover for each den site, and used maximum entropy modeling to determine which variables best predicted den sites. We identified the global model as the best-fitting model for adult female (area under curve (AUC) = 0.926) and elevation as the best predictive variable for adult male (AUC = 0.880) den sites. The model containing land cover and elevation best-predicted juvenile (AUC = 0.841) den sites. Adult females spatially segregated from adult males, with dens characterized by higher elevations ((x) over bar = 1,412 m, SE = 52) and steeper slopes ((x) over bar = 21.9 degrees, SE = 1.1) than adult male (elevation: (x) over bar = 1,209 m, SE = 76; slope: (x) over bar = 15.6 degrees, SE = 1.9) den sites. Juveniles used a broad range of landscape attributes but did not avoid adult male denning areas. Observed spatial segregation by adult females supports the sex hypothesis of sexual segregation and we suggest is a mechanism to reduce risk of infanticide. Den site selection of adult males is likely related to distribution of food resources during spring.	[Libal, Nathan S.; Belant, Jerrold L.; Leopold, Bruce D.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Wang, Guiming] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA; [Owen, Patricia A.] Denali Natl Pk & Preserve, Denali Natl Pk, AK USA	Mississippi State University; Mississippi State University	Libal, NS (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	nl187@msstate.edu	Belant, Jerrold/HDM-7749-2022; Wang, Guiming/O-8925-2019; Wang, Guiming/E-4582-2011	Wang, Guiming/0000-0001-5002-0120; Wang, Guiming/0000-0001-5002-0120	The National Park Service; Mississippi State University Forest and Wildlife Research Center	The National Park Service; Mississippi State University Forest and Wildlife Research Center	The National Park Service and the Mississippi State University Forest and Wildlife Research Center provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RA, 2008, J WILDLIFE MANAGE, V72, P1717, DOI 10.2193/2007-393; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Belant JL, 2006, ECOL APPL, V16, P2333, DOI 10.1890/1051-0761(2006)016[2333:IRPISU]2.0.CO;2; Belant JL, 2010, POLAR BIOL, V33, P31, DOI 10.1007/s00300-009-0682-6; Bellemain E, 2006, P ROY SOC B-BIOL SCI, V273, P283, DOI 10.1098/rspb.2005.3331; BELLEMAIN E, 2006, ETHOLOGY, V111, P1; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; BERGERUD AT, 1990, ANIM BEHAV, V39, P360, DOI 10.1016/S0003-3472(05)80882-6; BUNNELL FL, 1981, DYNAMICS LARGE MAMMA; Chi D.K., 1999, THESIS UTAH STATE U; COLLEY SA, 1989, COPEIA, P1; COULON J, 1995, ETHOL ECOL EVOL, V7, P191, DOI 10.1080/08927014.1995.9522965; CRAIGHEAD JJ, 1970, J WILDLIFE MANAGE, V34, P353, DOI 10.2307/3799022; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; DEROCHER AE, 1990, CAN J ZOOL, V68, P1395, DOI 10.1139/z90-208; Ebensperger LA, 1998, BIOL REV, V73, P321, DOI 10.1017/S0006323198005209; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferreras P, 2004, BEHAV ECOL, V15, P31, DOI 10.1093/beheco/arg097; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Folk GE., 1974, TXB ENV PHYSL; FRETWELL S D, 1972, P217; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Glenn L.P., 1980, Bear Biology Association Conference Series, P307; GOTCEITAS V, 1993, OECOLOGIA, V93, P31, DOI 10.1007/BF00321187; GUNTHER KA, 1990, INT C BEAR, V8, P73; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HARDING LE, 1976, CAN J ZOOL, V54, P1357, DOI 10.1139/z76-153; Haroldson MA, 2002, URSUS, V13, P29; Hilderbrand GV, 2000, J WILDLIFE MANAGE, V64, P178, DOI 10.2307/3802988; Hilderbrand GV, 1999, CAN J ZOOL, V77, P1623, DOI 10.1139/cjz-77-10-1623; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; JOHNSON KG, 1981, J WILDLIFE MANAGE, V45, P111, DOI 10.2307/3807879; KEEHNER JR, 2009, THESIS WASHINGTON ST; Kovach AI, 2003, CAN J ZOOL, V81, P1257, DOI 10.1139/Z03-111; Krebs J, 2004, J WILDLIFE MANAGE, V68, P493, DOI 10.2193/0022-541X(2004)068[0493:SOSRAC]2.0.CO;2; LUQUE MH, 1976, INT C BEAR RES MANAG, V3, P71; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; MATTSON D.J., 1987, INT C BEAR RES MANAG, V7, P259; MATTSON DJ, 1990, INT C BEAR, V8, P33; MCCANN TS, 1981, J ZOOL, V195, P295; MCCLELLAN B, 1994, INT C BEAR RES MANAG, V3, P15; McLoughlin PD, 2002, J MAMMAL, V83, P188, DOI 10.1644/1545-1542(2002)083<0188:DEOBGG>2.0.CO;2; Mech LD., 1998, WOLVES DENALI; Montgomery RA, 2011, J WILDLIFE MANAGE, V75, P702, DOI 10.1002/jwmg.96; Montgomery RA, 2010, J WILDLIFE MANAGE, V74, P1917, DOI 10.2193/2010-019; Murray CM, 2007, ANIM BEHAV, V74, P1795, DOI 10.1016/j.anbehav.2007.03.024; MYLLYMAKI A, 1977, OIKOS, V29, P553, DOI 10.2307/3543594; NELSON RA, 1980, FED PROC, V39, P2955; NELSON RA, 1973, MAYO CLIN PROC, V48, P733; Oli MK, 1997, J WILDLIFE MANAGE, V61, P700, DOI 10.2307/3802177; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; OWEN PA, 2006, ALASKA PARK SCI CROS, V6, P67; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PEARSON AM, 1975, CANADIAN WILDLIFE SE, V34; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pierce BM, 2000, J MAMMAL, V81, P462, DOI 10.1644/1545-1542(2000)081<0462:SOMDBM>2.0.CO;2; Purchase CF, 2008, CAN J FISH AQUAT SCI, V65, P382, DOI 10.1139/F07-171; REID ML, 1995, CAN J ZOOL, V73, P1396, DOI 10.1139/z95-164; REYNOLDS HV, 1976, INT C BEAR RES MAN, V3, P403; Rode KD, 2006, ECOLOGY, V87, P2636, DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; RUBY DE, 1984, HERPETOLOGICA, V40, P272; Schauber EM, 1999, CAN J ZOOL, V77, P68, DOI 10.1139/cjz-77-1-68; Schoen JW, 1987, INT C BEAR RES MANAG, V7, P293, DOI DOI 10.2307/3872636; Servheen C., 1983, INT C BEAR RES MANAG, V5, P201, DOI 10.2307/3872539; SHELDON C, 1930, WILDERNESS DENALI EX; Sjoberg M, 2000, CAN J ZOOL, V78, P1661, DOI 10.1139/cjz-78-9-1661; Smith JAM, 2011, AUK, V128, P53, DOI 10.1525/auk.2011.10241; STONOROV D, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P232; Swenson JE, 2001, URSUS-SERIES, V12, P81; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; TAYLOR M, 1985, ARCTIC, V38, P303; TAYLOR WP, 1989, J WILDLIFE MANAGE, V53, P978, DOI 10.2307/3809598; VanSchaik CP, 1997, P ROY SOC B-BIOL SCI, V264, P1687, DOI 10.1098/rspb.1997.0234; VROOM GW, 1980, INT C BEAR RES MANAG, V4, P321; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; [No title captured]	77	36	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24133	10.1371/journal.pone.0024133	http://dx.doi.org/10.1371/journal.pone.0024133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935378	Green Published, gold			2022-12-25	WOS:000295039700010
J	Podvin, S; Gonzalez, AM; Miller, MC; Dang, XT; Botfield, H; Donahue, JE; Kurabi, A; Boissaud-Cooke, M; Rossi, R; Leadbeater, WE; Johanson, CE; Coimbra, R; Stopa, EG; Eliceiri, BP; Baird, A				Podvin, Sonia; Gonzalez, Ana-Maria; Miller, Miles C.; Dang, Xitong; Botfield, Hannah; Donahue, John E.; Kurabi, Arwa; Boissaud-Cooke, Matthew; Rossi, Ryan; Leadbeater, Wendy E.; Johanson, Conrad E.; Coimbra, Raul; Stopa, Edward G.; Eliceiri, Brian P.; Baird, Andrew			Esophageal Cancer Related Gene-4 Is a Choroid Plexus-Derived Injury Response Gene: Evidence for a Biphasic Response in Early and Late Brain Injury	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; SQUAMOUS-CELL CARCINOMA; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; RAT; EXPRESSION; ECRG4; HYPERMETHYLATION; PROLIFERATION; TRAFFICKING	By virtue of its ability to regulate the composition of cerebrospinal fluid (CSF), the choroid plexus (CP) is ideally suited to instigate a rapid response to traumatic brain injury (TBI) by producing growth regulatory proteins. For example, Esophageal Cancer Related Gene-4 (Ecrg4) is a tumor suppressor gene that encodes a hormone-like peptide called augurin that is present in large concentrations in CP epithelia (CPe). Because augurin is thought to regulate senescence, neuroprogenitor cell growth and differentiation in the CNS, we evaluated the kinetics of Ecrg4 expression and augurin immunoreactivity in CPe after CNS injury. Adult rats were injured with a penetrating cortical lesion and alterations in augurin immunoreactivity were examined by immunohistochemistry. Ecrg4 gene expression was characterized by in situ hybridization. Cell surface augurin was identified histologically by confocal microscopy and biochemically by sub-cellular fractionation. Both Ecrg4 gene expression and augurin protein levels were decreased 24-72 hrs post-injury but restored to uninjured levels by day 7 post-injury. Protein staining in the supraoptic nucleus of the hypothalamus, used as a control brain region, did not show a decrease of auguin immunoreactivity. Ecrg4 gene expression localized to CPe cells, and augurin protein to the CPe ventricular face. Extracellular cell surface tethering of 14 kDa augurin was confirmed by cell surface fractionation of primary human CPe cells in vitro while a 6-8 kDa fragment of augurin was detected in conditioned media, indicating release from the cell surface by proteolytic processing. In rat CSF however, 14 kDa augurin was detected. We hypothesize the initial release and proteolytic processing of augurin participates in the activation phase of injury while sustained Ecrg4 down-regulation is dysinhibitory during the proliferative phase. Accordingly, augurin would play a constitutive inhibitory function in normal CNS while down regulation of Ecrg4 gene expression in injury, like in cancer, dysinhibits proliferation.	[Podvin, Sonia; Dang, Xitong; Kurabi, Arwa; Coimbra, Raul; Eliceiri, Brian P.; Baird, Andrew] Univ Calif San Diego, Dept Surg, Sch Med, San Diego, CA 92103 USA; [Gonzalez, Ana-Maria; Botfield, Hannah; Boissaud-Cooke, Matthew; Leadbeater, Wendy E.] Univ Birmingham, Sch Clin & Expt Med, Dept Neuropharmacol & Neurobiol, Birmingham, W Midlands, England; [Miller, Miles C.; Donahue, John E.; Rossi, Ryan; Johanson, Conrad E.; Stopa, Edward G.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02903 USA; [Miller, Miles C.; Donahue, John E.; Rossi, Ryan; Johanson, Conrad E.; Stopa, Edward G.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Pathol, Providence, RI 02903 USA	University of California System; University of California San Diego; University of Birmingham; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Podvin, S (corresponding author), Univ Calif San Diego, Dept Surg, Sch Med, San Diego, CA 92103 USA.	anbaird@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Donahue, John E/A-3000-2008	Coimbra, Raul/0000-0002-3759-6851; Donahue, John E/0000-0001-7186-2562; Johanson, Conrad/0000-0002-1297-5484; Eliceiri, Brian/0000-0003-1811-1916; Baird, Andrew/0000-0003-0027-9905	Hydrocephalus Association; United States National Institutes of Health; United States National Institute of General Medical Sciences [P20 GM078421]; National Institutes of Health (NIH) [EY018479, HL073396, AG027910]; American Recovery and Reinvestment Act (ARRA); NATIONAL EYE INSTITUTE [R21EY018479] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027910] Funding Source: NIH RePORTER	Hydrocephalus Association; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (ARRA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Podvin is supported by a Mentored Young Investigator Award from the Hydrocephalus Association (www.hydroassoc.org). Dr. Baird, Dr. Eliceiri and Dr. Coimbra are supported by a United States National Institutes of Health (www.nih.gov) P20 Exploratory Center Grant for Would Healing Research from the United States National Institute of General Medical Sciences (www.nigms.nih.gov; P20 GM078421) and are also supported by the National Institutes of Health (NIH) EY018479 (Dr. Baird), (NIH) HL073396 (Dr. Eliceiri) and by supplemental funding through the American Recovery and Reinvestment Act (ARRA). No external funding was received for these studies for Dr. Miller, Dr. Dang, Dr. Donahue, Dr. Rossi or Dr. Stopa. Conrad Johanson is supported by NIH AG027910. All of the studies conducted at the University of Birmingham by Dr. Gonzalez, Dr. Botfield, Dr. Boissaud-Cooke and Dr. Leadbeater were funded by a grant from the School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (www.medicine.bham.ac.uk). The funders had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript.	Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Allen Brain Atlas Resources, 2009, ALL BRAIN ATL RES; Baird A, 2011, METHODS MOL BIOL, V686, P483, DOI 10.1007/978-1-60761-938-3_25; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Boulougouris P, 2001, ANTICANCER RES, V21, P2769; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Clarke WE, 2001, MOL CELL NEUROSCI, V17, P17, DOI 10.1006/mcne.2000.0920; Ennis SR, 2006, J CEREBR BLOOD F MET, V26, P675, DOI 10.1038/sj.jcbfm.9600224; Ghabriel MN, 2010, ACTA NEUROCHIR SUPPL, V106, P239, DOI 10.1007/978-3-211-98811-4_45; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Johanson CE, 2000, CELL MOL NEUROBIOL, V20, P197, DOI 10.1023/A:1007097622590; Johanson C, 2011, TOXICOL PATHOL, V39, P186, DOI 10.1177/0192623310394214; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kujuro Y, 2010, P NATL ACAD SCI USA, V107, P8259, DOI 10.1073/pnas.0911446107; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; LOGAN A, 1992, J NEUROSCI, V12, P3828; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Mori Y, 2007, ONCOL REP, V18, P981; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; Ozawa A, 2011, MOL ENDOCRINOL, V25, P776, DOI 10.1210/me.2010-0389; PALM D, 1995, AM J PHYSIOL-REG I, V269, pR73, DOI 10.1152/ajpregu.1995.269.1.R73; Popovic Matija, 2011, J Mol Recognit, V24, P245, DOI 10.1002/jmr.1042; Qureshi IA, 2010, ARCH NEUROL-CHICAGO, V67, P1316, DOI 10.1001/archneurol.2010.275; ROBERTON A, 2009, SOC END BES 2009 HAR, V15, pS82; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Su Tao, 1998, Zhonghua Zhongliu Zazhi, V20, P254; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tadross JA, 2010, BRIT J PHARMACOL, V159, P1663, DOI 10.1111/j.1476-5381.2010.00655.x; Trudel C, 2000, J CELL PHYSIOL, V185, P260, DOI 10.1002/1097-4652(200011)185:2<260::AID-JCP11>3.0.CO;2-X; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Yue CM, 2003, WORLD J GASTROENTERO, V9, P1174, DOI 10.3748/wjg.v9.i6.1174; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	39	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24609	10.1371/journal.pone.0024609	http://dx.doi.org/10.1371/journal.pone.0024609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935431	Green Published, Green Accepted, gold			2022-12-25	WOS:000295039700031
J	Royo, JL; Hidalgo, C; Roncero, Y; Seda, MA; Akalin, A; Lenhard, B; Casares, F; Gomez-Skarmeta, JL				Luis Royo, Jose; Hidalgo, Carmen; Roncero, Yolanda; Angeles Seda, Maria; Akalin, Altuna; Lenhard, Boris; Casares, Fernando; Luis Gomez-Skarmeta, Jose			Dissecting the Transcriptional Regulatory Properties of Human Chromosome 16 Highly Conserved Non-Coding Regions	PLOS ONE			English	Article							VERTEBRATE GENOMES; ENHANCER DETECTION; IROQUOIS GENES; ZEBRAFISH; IDENTIFICATION; EXPRESSION; ELEMENTS; TRANSGENESIS; EVOLUTION; SEQUENCES	Non-coding DNA conservation across species has been often used as a predictor for transcriptional enhancer activity. However, only a few systematic analyses of the function of these highly conserved non-coding regions (HCNRs) have been performed. Here we use zebrafish transgenic assays to perform a systematic study of 113 HCNRs from human chromosome 16. By comparing transient and stable transgenesis, we show that the first method is highly inefficient, leading to 40% of false positives and 20% of false negatives. When analyzed in stable transgenic lines, a great majority of HCNRs were active in the central nervous system, although some of them drove expression in other organs such as the eye and the excretory system. Finally, by testing a fraction of the HCNRs lacking enhancer activity for in vivo insulator activity, we find that 20% of them may contain enhancer-blocking function. Altogether our data indicate that HCNRs may contain different types of cis-regulatory activity, including enhancer, insulators as well as other not yet discovered functions.	[Luis Royo, Jose; Hidalgo, Carmen; Roncero, Yolanda; Angeles Seda, Maria; Casares, Fernando; Luis Gomez-Skarmeta, Jose] Univ Pablo de Olavide Junta de Andaluci, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Akalin, Altuna; Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway; [Lenhard, Boris] Univ Bergen, Sars Ctr Marine Mol Biol, Bergen, Norway	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University of Bergen; University of Bergen	Royo, JL (corresponding author), Univ Pablo de Olavide Junta de Andaluci, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.	jlgomska@upo.es	Gomez-Skarmeta, Jose Luis/B-5268-2014; AKALIN, ALTUNA/A-4424-2012; Casares, Fernando/M-5451-2019; Royo, Jose Luis/H-6935-2012	Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; AKALIN, ALTUNA/0000-0002-0468-0117; Casares, Fernando/0000-0002-2181-3858; Royo, Jose Luis/0000-0003-2024-4363; Lenhard, Boris/0000-0002-1114-1509; Marian, Seda/0000-0002-5634-3585	Spanish and Andalusian Governments [BFU2010-14839, BFU2009-07044, CSD2007-00008]; Proyecto de Excelencia [CVI-3488, CVI-2658]	Spanish and Andalusian Governments; Proyecto de Excelencia	This work was funded by the Spanish and Andalusian Governments, grants BFU2010-14839, BFU2009-07044, CSD2007-00008, Proyecto de Excelencia CVI-3488 and CVI-2658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2006, METHODS, V39, P212, DOI 10.1016/j.ymeth.2005.12.005; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Roman AC, 2011, GENOME RES, V21, P422, DOI 10.1101/gr.111203.110; Creyghton MP, 2010, P NATL ACAD SCI US; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; ERNST J, 2011, NATURE; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Goode DK, 2011, DEVELOPMENT, V138, P879, DOI 10.1242/dev.055996; Haeussler M, 2011, DEV BIOL, V350, P239, DOI 10.1016/j.ydbio.2010.11.026; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komisarczuk AZ, 2009, DEV BIOL, V336, P301, DOI 10.1016/j.ydbio.2009.09.029; Lecaudey V, 2005, J COMP NEUROL, V492, P289, DOI 10.1002/cne.20765; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Martin D, 2011, NAT STRUCT MOL BIOL; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Molto Eduardo, 2009, Briefings in Functional Genomics & Proteomics, V8, P283, DOI 10.1093/bfgp/elp031; NARLIKAR L, 2009, BRIEF FUNCT GENOMIC; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Navratilova P, 2010, MOL GENET GENOMICS, V283, P171, DOI 10.1007/s00438-009-0503-1; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; RADAIGLESIAS A, 2010, NATURE; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Vavouri T, 2009, BIOESSAYS, V31, P727, DOI 10.1002/bies.200900014; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	49	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24824	10.1371/journal.pone.0024824	http://dx.doi.org/10.1371/journal.pone.0024824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21935474	Green Published, Green Accepted, gold			2022-12-25	WOS:000295321800068
J	Lin, YH; Jones, BW; Liu, AH; Tucker, JF; Rapp, K; Luo, L; Baehr, W; Bernstein, PS; Watt, CB; Yang, JH; Shaw, MV; Marc, RE				Lin, Yanhua; Jones, Bryan W.; Liu, Aihua; Tucker, James F.; Rapp, Kevin; Luo, Ling; Baehr, Wolfgang; Bernstein, Paul S.; Watt, Carl B.; Yang, Jia-Hui; Shaw, Marguerite V.; Marc, Robert E.			Retinoid receptors trigger neuritogenesis in retinal degenerations	FASEB JOURNAL			English	Article						retinoic acid; Ca2+/calmodulin-dependent protein kinase II; ionotropic glutamate receptor	CENTRAL-NERVOUS-SYSTEM; PROTEIN-KINASE-II; RETINITIS-PIGMENTOSA; ALL-TRANS; MOUSE RETINA; LIGHT DAMAGE; X-RECEPTOR; PHOTORECEPTOR DEGENERATIONS; MACULAR DEGENERATION; SYNAPTIC PLASTICITY	Anomalous neuritogenesis is a hallmark of neurodegenerative disorders, including retinal degenerations, epilepsy, and Alzheimer's disease. The neuritogenesis processes result in a partial reinnervation, new circuitry, and functional changes within the deafferented retina and brain regions. Using the light-induced retinal degeneration (LIRD) mouse model, which provides a unique platform for exploring the mechanisms underlying neuritogenesis, we found that retinoid X receptors (RXRs) control neuritogenesis. LIRD rapidly triggered retinal neuron neuritogenesis and up-regulated several key elements of retinoic acid (RA) signaling, including retinoid X receptors (RXRs). Exogenous RA initiated neuritogenesis in normal adult retinas and primary retinal cultures and exacerbated it in LIRD retinas. However, LIRD-induced neuritogenesis was partly attenuated in retinol dehydrogenase knockout (Rdh12(-/-)) mice and by aldehyde dehydrogenase inhibitors. We further found that LIRD rapidly increased the expression of glutamate receptor 2 and beta Ca2+/calmodulin-dependent protein kinase II (beta CaMKII). Pull-down assays demonstrated interaction between beta CaMKII and RXRs, suggesting that CaMKII pathway regulates the activities of RXRs. RXR antagonists completely prevented and RXR agonists were more effective than RA in inducing neuritogenesis. Thus, RXRs are in the final common path and may be therapeutic targets to attenuate retinal remodeling and facilitate global intervention methods in blinding diseases and other neurodegenerative disorders.-Lin, Y., Jones, B. W., Liu, A., Tucker, J. F., Rapp, K., Luo, L., Baehr, W., Bernstein, P. S., Watt, C. B., Yang, J.-H., Shaw, M. V., Marc, R. E. Retinoid receptors trigger neuritogenesis in retinal degenerations. FASEB J. 26, 81-92 (2012). www.fasebj.org	[Lin, Yanhua; Jones, Bryan W.; Liu, Aihua; Tucker, James F.; Rapp, Kevin; Luo, Ling; Baehr, Wolfgang; Bernstein, Paul S.; Watt, Carl B.; Yang, Jia-Hui; Shaw, Marguerite V.; Marc, Robert E.] Univ Utah, Dept Ophthalmol, John A Moran Eye Ctr, Sch Med, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Neurobiol & Anat, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Marc, RE (corresponding author), Univ Utah, Dept Ophthalmol, John A Moran Eye Ctr, Sch Med, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	robert.marc@hsc.utah.edu		Jones, Bryan/0000-0001-5527-6643	U.S. National Eye Institute [EY002576, EY015128, EY014800, EY08123, EY019298]; Research to Prevent Blindness; Edward N. and Della L. Thome Memorial Foundation; Moran Eye Center Tiger Team; Fight For Sight; Knights Templar Eye Foundation; International Retinal Research Foundation; Foundation Fighting Blindness, Inc. (Columbia, MD, USA); NATIONAL EYE INSTITUTE [R01EY008123, R01EY002576, R01EY015128, P30EY014800, R01EY019298] Funding Source: NIH RePORTER	U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Edward N. and Della L. Thome Memorial Foundation; Moran Eye Center Tiger Team; Fight For Sight; Knights Templar Eye Foundation; International Retinal Research Foundation; Foundation Fighting Blindness, Inc. (Columbia, MD, USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was supported by U.S. National Eye Institute grants EY002576, EY015128, and EY014800 Vision Core (R. E. M.), EY08123 and EY019298 (W. B.); Research to Prevent Blindness (R. E. M. and B.W.J.); the Edward N. and Della L. Thome Memorial Foundation (B.W.J.), a Moran Eye Center Tiger Team Translational Medicine Award (B.W.J.), Fight For Sight (Y.H.L.), the Knights Templar Eye Foundation (Y.H.L.), the International Retinal Research Foundation (Y.H.L.), and a center grant by the Foundation Fighting Blindness, Inc. (Columbia, MD, USA), to the University of Utah. The authors thank Changjiang Zou for assisting with cell culture and immunoprecipitation; Dr. Ning Tian and Dr. Yingbin Fu for advice on manuscript revision; Cecilia Gerstner for breeding the Rdh12 mutation mice; Dr. Bala Ambati for assistance with retinal injection; Dr. Felix Vazquez-Chona for advice on manuscript organization; and Drew Ferrell for assistance on imaging.	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Bastie JN, 2001, FEBS LETT, V507, P67, DOI 10.1016/S0014-5793(01)02938-6; Beltowski J, 2008, CARDIOVASC THER, V26, P297, DOI 10.1111/j.1755-5922.2008.00062.x; Benav H, 2010, IEEE ENG MED BIO, P5919, DOI 10.1109/IEMBS.2010.5627549; Berry DC, 2010, J BIOL CHEM, V285, P15324, DOI 10.1074/jbc.M110.110635; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Chader GJ, 2009, PROG BRAIN RES, V175, P317, DOI 10.1016/S0079-6123(09)17522-2; Chrispell JD, 2009, J BIOL CHEM, V284, P21468, DOI 10.1074/jbc.M109.020966; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Deller T, 2006, ADV EXP MED BIOL, V557, P101; Dmetrichuk JM, 2005, DEV BIOL, V281, P112, DOI 10.1016/j.ydbio.2005.02.019; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Duncan T, 1999, MOL VIS, V5, pU1; Duncan T, 2006, PHOTOCHEM PHOTOBIOL, V82, P741, DOI 10.1562/2005-10-05-RA-712; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Elliott RC, 2003, J NEUROSCI, V23, P2218; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Guizzetti M, 2008, J BIOL CHEM, V283, P31884, DOI 10.1074/jbc.M801316200; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Horsager A, 2010, INVEST OPHTH VIS SCI, V51, P1223, DOI 10.1167/iovs.09-3746; Hyatt GA, 1997, INVEST OPHTH VIS SCI, V38, P1471; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jones BW, 2006, ADV EXP MED BIOL, V572, P405; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Kikonyogo A, 1999, EUR J BIOCHEM, V262, P704, DOI 10.1046/j.1432-1327.1999.00415.x; Koulen P, 1998, J NEUROSCI, V18, P10136; LARNER AJ, 1995, SEIZURE, V4, P249, DOI 10.1016/S1059-1311(95)80001-8; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Liets LC, 2006, P NATL ACAD SCI USA, V103, P12156, DOI 10.1073/pnas.0605211103; Liu LO, 2000, MOL BRAIN RES, V82, P150, DOI 10.1016/S0169-328X(00)00203-5; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Marc RE, 2003, MOL NEUROBIOL, V28, P139, DOI 10.1385/MN:28:2:139; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Marc RE, 2010, ENCY EYE, P414; Marc Robert E., 2006, P33, DOI 10.1007/0-387-28190-8_3; Marc RE, 2008, MOL VIS, V14, P782; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; NORRIS AW, 1994, BBA-PROTEIN STRUCT M, V1209, P10, DOI 10.1016/0167-4838(94)90130-9; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Pan F, 2010, J COMP NEUROL, V518, P911, DOI 10.1002/cne.22254; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; SCHEIBEL AB, 1978, EXP NEUROL, V60, P1, DOI 10.1016/0014-4886(78)90164-4; Si JT, 2007, J CLIN INVEST, V117, P1412, DOI 10.1172/JCI30779; Sigulinsky CL, 2008, DEV BIOL, V317, P560, DOI 10.1016/j.ydbio.2008.02.055; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Strettoi E, 2002, J NEUROSCI, V22, P5492; Sullivan RKP, 2007, INVEST OPHTH VIS SCI, V48, P2782, DOI 10.1167/iovs.06-1283; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Uehara H, 2010, VISION RES, V50, P674, DOI 10.1016/j.visres.2009.12.003; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Weiler R, 1998, P NATL ACAD SCI USA, V95, P7139, DOI 10.1073/pnas.95.12.7139; WEILER R, 1995, EUR J NEUROSCI, V7, P1914, DOI 10.1111/j.1460-9568.1995.tb00713.x; Yang PB, 2010, EXP EYE RES, V91, P727, DOI 10.1016/j.exer.2010.08.022; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	84	21	24	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					81	92		10.1096/fj.11-192914	http://dx.doi.org/10.1096/fj.11-192914			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21940995	Green Published			2022-12-25	WOS:000299202200010
J	Colbert, JD; Matthews, SP; Kos, J; Watts, C				Colbert, Jeff D.; Matthews, Stephen P.; Kos, Janko; Watts, Colin			Internalization of Exogenous Cystatin F Supresses Cysteine Proteases and Induces the Accumulation of Single-chain Cathepsin L by Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINYL ENDOPEPTIDASE; PROTEINASE-INHIBITOR; LYSOSOMAL PROTEASES; MAMMALIAN LEGUMAIN; INVARIANT CHAIN; MACROPHAGES; EXPRESSION; DISEASE; CANCER; ROLES	Cystatin F is an unusual member of the cystatin family of protease inhibitors, which is made as an inactive dimer and becomes activated by proteolysis in the endo/lysosome pathway of the immune cells that produce it. However a proportion is secreted and can be taken up and activated by other cells. We show here that cystatin F acquired in this way induces a dramatic accumulation of the single-chain form of cathepsin L (CatL). Cystatin F was observed in the same cellular compartments as CatL and was tightly complexed with CatL as determined by co-precipitation studies. The observed accumulation of single-chain CatL was partly due to cystatin F-mediated inhibition of the putative single-chain to two-chain CatL convertase AEP/legumain and partly to general suppression of cathepsin activity. Thus, cystatin F stabilizes CatL leading to the dramatic accumulation of an inactive complex composed either of the single-chain or two-chain form depending on the capacity of cystatin F to inhibit AEP. Cross-transfer of cystatin F from one cell to another may therefore attenuate potentially harmful effects of excessive CatL activity while paradoxically, inducing accumulation of CatL protein. Finally, we confirmed earlier data (Beers, C., Honey, K., Fink, S., Forbush, K., and Rudensky, A. (2003) J. Exp. Med. 197, 169-179) showing a loss of CatL activity, but not of CatL protein, in macrophages activated with IFN gamma. However, we found equivalent loss of CatL activity in wild type and cystatin F-null macrophages suggesting that an inhibitory activity other than cystatin F quenches CatL activity in activated macrophages.	[Colbert, Jeff D.; Matthews, Stephen P.; Watts, Colin] Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland; [Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia	University of Dundee; University of Ljubljana	Watts, C (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk		Matthews, Stephen/0000-0003-3556-962X; Watts, Colin/0000-0001-6183-2087	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Programme grant (to C. W.).	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Bogyo M, 2004, CURR PROTOC PROTEIN; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Cappello F, 2004, EXP CELL RES, V297, P607, DOI 10.1016/j.yexcr.2004.03.048; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Colbert JD, 2009, TRAFFIC, V10, P425, DOI 10.1111/j.1600-0854.2009.00881.x; Fiebiger E, 2002, J EXP MED, V196, P1263, DOI 10.1084/jem.20020762; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Halfon S, 1998, J BIOL CHEM, V273, P16400, DOI 10.1074/jbc.273.26.16400; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Honey K, 2002, NAT IMMUNOL, V3, P1069, DOI 10.1038/ni844; KOS J, 1995, BIOL CHEM H-S, V376, P401, DOI 10.1515/bchm3.1995.376.7.401; Langerholc T, 2005, FEBS J, V272, P1535, DOI 10.1111/j.1742-4658.2005.04594.x; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; Loak K, 2003, BIOL CHEM, V384, P1239, DOI 10.1515/BC.2003.136; Matthews SP, 2010, J IMMUNOL, V184, P2423, DOI 10.4049/jimmunol.0901486; Mattock KL, 2010, ATHEROSCLEROSIS, V208, P83, DOI 10.1016/j.atherosclerosis.2009.07.022; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nathanson CM, 2002, EUR J BIOCHEM, V269, P5502, DOI 10.1046/j.1432-1033.2002.03252.x; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Ni J, 1998, J BIOL CHEM, V273, P24797, DOI 10.1074/jbc.273.38.24797; Ni J, 1997, J BIOL CHEM, V272, P10853; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Petermann I, 2006, FASEB J, V20, P1266, DOI 10.1096/fj.05-5517fje; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Zeeuwen PLJM, 2002, HUM MOL GENET, V11, P2867, DOI 10.1093/hmg/11.23.2867; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	44	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42082	42090		10.1074/jbc.M111.253914	http://dx.doi.org/10.1074/jbc.M111.253914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21956111	Green Published, hybrid			2022-12-25	WOS:000298180900018
J	Erokhova, L; Horner, A; Kugler, P; Pohl, P				Erokhova, Liudmila; Horner, Andreas; Kuegler, Philipp; Pohl, Peter			Monitoring Single-channel Water Permeability in Polarized Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; RENAL PRINCIPAL CELLS; EPITHELIAL-CELLS; DIFFUSION-COEFFICIENTS; TIGHT JUNCTIONS; MDCK CELLS; AQUAPORINS; TRANSPORT; PHOSPHORYLATION; RECONSTITUTION	So far the determination of unitary permeability (p(f)) of water channels that are expressed in polarized cells is subject to large errors because the opening of a single water channel does not noticeably increase the water permeability of a membrane patch above the background. That is, in contrast to the patch clamp technique, where the single ion channel conductance may be derived from a single experiment, two experiments separated in time and/or space are required to obtain the single-channel water permeability p(f) as a function of the incremental water permeability (p(f, c)) and the number (n) of water channels that contributed to p(f, c). Although the unitary conductance of ion channels is measured in the native environment of the channel, p(f) is so far derived from reconstituted channels or channels expressed in oocytes. To determine the p(f) of channels from live epithelial monolayers, we exploit the fact that osmotic volume flow alters the concentration of aqueous reporter dyes adjacent to the epithelia. We measure these changes by fluorescence correlation spectroscopy, which allows the calculation of both p(f, c) and osmolyte dilution within the unstirred layer. Shifting the focus of the laser from the aqueous solution to the apical and basolateral membranes allowed the FCS-based determination of n. Here we validate the new technique by determining the p(f) of aquaporin 5 in Madin-Darby canine kidney cell monolayers. Because inhibition and subsequent activity rescue are monitored on the same sample, drug effects on exocytosis or endocytosis can be dissected from those on p(f).	[Erokhova, Liudmila; Horner, Andreas; Pohl, Peter] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Kuegler, Philipp] Austrian Acad Sci, Radon Inst Computat & Appl Math, A-4040 Linz, Austria	Johannes Kepler University Linz; Austrian Academy of Sciences	Pohl, P (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	peter.pohl@jku.at	Horner, Andreas/F-6427-2013; Pohl, Peter/A-5361-2008; Kügler, Philipp/B-4444-2015	Horner, Andreas/0000-0002-5328-1745; Pohl, Peter/0000-0002-1792-2314; Kügler, Philipp/0000-0002-1041-9265	Austrian Science Fund (FWF) [W1201, P23466]; Austrian Science Fund (FWF) [P 23466] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grants W1201 and P23466 from the Austrian Science Fund (FWF) (to P. P.).	Chou CL, 2008, AM J PHYSIOL-RENAL, V295, pF192, DOI 10.1152/ajprenal.00011.2008; Eto K, 2010, J BIOL CHEM, V285, P40777, DOI 10.1074/jbc.M110.151928; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Heo J, 2008, ANAL CHEM, V80, P6974, DOI 10.1021/ac8008498; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hub JS, 2010, BIOPHYS J, V99, pL97, DOI 10.1016/j.bpj.2010.11.003; Kovbasnjuk O, 1998, P NATL ACAD SCI USA, V95, P6526, DOI 10.1073/pnas.95.11.6526; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Maric K, 2001, BIOPHYS J, V80, P1783, DOI 10.1016/S0006-3495(01)76148-6; Matsui H, 2000, J CLIN INVEST, V105, P1419, DOI 10.1172/JCI4546; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Mollajew R, 2010, BIOPHYS J, V99, P3647, DOI 10.1016/j.bpj.2010.10.021; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Pohl P, 2001, P NATL ACAD SCI USA, V98, P9624, DOI 10.1073/pnas.161299398; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; STRANGE K, 1987, SCIENCE, V235, P1068, DOI 10.1126/science.3823867; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Tsunoda SP, 2004, J BIOL CHEM, V279, P11364, DOI 10.1074/jbc.M310881200; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; VANHOEK AN, 1992, J BIOL CHEM, V267, P18267; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; Wan XC, 2004, J EXP BOT, V55, P411, DOI 10.1093/jxb/erh051; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002	32	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39926	39932		10.1074/jbc.M111.291864	http://dx.doi.org/10.1074/jbc.M111.291864			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940624	Green Published, hybrid			2022-12-25	WOS:000296925700026
J	Steiner, LA; Schulz, VP; Maksimova, Y; Wong, C; Gallagher, PG				Steiner, Laurie A.; Schulz, Vincent P.; Maksimova, Yelena; Wong, Clara; Gallagher, Patrick G.			Patterns of Histone H3 Lysine 27 Monomethylation and Erythroid Cell Type-specific Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT ANNOTATION SYSTEM; HUMAN GENOME; METHYLTRANSFERASE ACTIVITY; MAMMALIAN CHROMATIN; STEM-CELLS; METHYLATION; POLYCOMB; DROSOPHILA; COMPLEXES; EPIGENETICS	Post-translational histone modifications, acting alone or in a context-dependent manner, influence numerous cellular processes via their regulation of gene expression. Monomethylation of histone H3 lysine 27 (K27me1) is a poorly understood histone modification. Some reports describe depletion of K27Me1 at promoters and transcription start sites (TSS), implying its depletion at TSS is necessary for active transcription, while others have associated enrichment of H3K27me1 at TSS with increased levels of mRNA expression. Tissue- and gene-specific patterns of H3K27me1 enrichment and their correlation with gene expression were determined via chromatin immunoprecipitation on chip microarray (ChIP-chip) and human mRNA expression array analyses. Results from erythroid cells were compared with those in neural and muscle cells. H3K27me1 enrichment varied depending on levels of cell-type specific gene expression, with highest enrichment over transcriptionally active genes. Over individual genes, the highest levels of H3K27me1 enrichment were found over the gene bodies of highly expressed genes. In contrast to H3K4me3, which was highly enriched at the TSS of actively transcribing genes, H3K27me1 was selectively depleted at the TSS of actively transcribed genes. There was markedly decreased to no H3K27me1 enrichment in genes with low expression. At some locations, H3K27 monomethylation was also found to be associated with chromatin signatures of gene enhancers.	[Steiner, Laurie A.; Schulz, Vincent P.; Maksimova, Yelena; Wong, Clara; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Gallagher, PG (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	patrick.gallagher@yale.edu		Schulz, Vincent/0000-0001-6333-4284; Steiner, Laurie/0000-0002-2923-4105	National Institutes of Health [K12HD000850, HL65448, DK62039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062039, K08DK090153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants K12HD000850, HL65448, and DK62039 from the National Institutes of Health.	Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Gallagher PG, 1997, J BIOL CHEM, V272, P19220, DOI 10.1074/jbc.272.31.19220; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; Goecks J., GENOME BIOL, V11, pR86; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jacob Y, 2009, EPIGENETICS-US, V4, P266, DOI 10.4161/epi.4.6.9713; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Steiner LA, 2009, MOL CELL BIOL, V29, P5399, DOI 10.1128/MCB.00777-09; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	40	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39457	39465		10.1074/jbc.M111.243006	http://dx.doi.org/10.1074/jbc.M111.243006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937433	hybrid, Green Published			2022-12-25	WOS:000296759800063
J	Arndt, B; Krieger, T; Kalinski, T; Thielitz, A; Reinhold, D; Roessner, A; Schraven, B; Simeoni, L				Arndt, Boerge; Krieger, Tina; Kalinski, Thomas; Thielitz, Anja; Reinhold, Dirk; Roessner, Albert; Schraven, Burkhart; Simeoni, Luca			The Transmembrane Adaptor Protein SIT Inhibits TCR-Mediated Signaling	PLOS ONE			English	Article							T-CELL DEVELOPMENT; NEGATIVE REGULATION; ACTIVATION; HOMEOSTASIS; RECEPTOR; FOXO1; LAX	Transmembrane adaptor proteins (TRAPs) organize signaling complexes at the plasma membrane, and thus function as critical linkers and integrators of signaling cascades downstream of antigen receptors. We have previously shown that the transmembrane adaptor protein SIT regulates the threshold for thymocyte selection. Moreover, T cells from SIT-deficient mice are hyperresponsive to CD3 stimulation and undergo enhanced lymphopenia-induced homeostatic proliferation, thus indicating that SIT inhibits TCR-mediated signaling. Here, we have further addressed how SIT regulates signaling cascades in T cells. We demonstrate that the loss of SIT enhances TCR-mediated Akt activation and increased phosphorylation/inactivation of Foxo1, a transcription factor of the Forkhead family that inhibits cell cycle progression and regulates T-cell homeostasis. We have also shown that CD4(+) T cells from SIT-deficient mice display increased CD69 and CD40L expression indicating an altered activation status. Additional biochemical analyses further revealed that suppression of SIT expression by RNAi in human T cells resulted in an enhanced proximal TCR signaling. In summary, the data identify SIT as an important modulator of TCR-mediated signaling that regulates T-cell activation, homeostasis and tolerance.	[Arndt, Boerge; Krieger, Tina; Reinhold, Dirk; Schraven, Burkhart; Simeoni, Luca] Univ Magdeburg, Inst Mol & Clin Immunol, D-39106 Magdeburg, Germany; [Kalinski, Thomas; Roessner, Albert] Univ Magdeburg, Inst Pathol, D-39106 Magdeburg, Germany; [Thielitz, Anja] Univ Magdeburg, Clin Dermatol & Venerol, D-39106 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University	Arndt, B (corresponding author), Univ Munich, Dept Med Innenstadt, Ctr Diabet, Munich, Germany.	luca.simeoni@med.ovgu.de	Simeoni, Luca/G-2121-2013		German Research Foundation (DFG) [FOR-521 [SI861/1], GRK-1167 [TP12], SFB-854 [TP19]]	German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by grants from the German Research Foundation (DFG), FOR-521 [SI861/1], GRK-1167 [TP12] and SFB-854 [TP19] to BS and LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Horn J, 2009, J IMMUNOL, V183, P5756, DOI 10.4049/jimmunol.0900649; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Koelsch U, 2008, J IMMUNOL, V181, P5930, DOI 10.4049/jimmunol.181.9.5930; Kolsch U, 2006, MOL CELL BIOL, V26, P3639, DOI 10.1128/MCB.26.9.3639-3648.2006; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Marie-Cardine A, 1999, J EXP MED, V189, P1181, DOI 10.1084/jem.189.8.1181; Pfrepper KI, 2001, EUR J IMMUNOL, V31, P1825, DOI 10.1002/1521-4141(200106)31:6<1825::AID-IMMU1825>3.0.CO;2-V; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Simeoni L, 2005, MOL CELL BIOL, V25, P7557, DOI 10.1128/MCB.25.17.7557-7568.2005; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhu MH, 2005, J IMMUNOL, V174, P5612, DOI 10.4049/jimmunol.174.9.5612; Zhu MH, 2006, IMMUNITY, V25, P757, DOI 10.1016/j.immuni.2006.08.025; Zhu MH, 2006, J BIOL CHEM, V281, P18408, DOI 10.1074/jbc.M601535200	20	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e23761	10.1371/journal.pone.0023761	http://dx.doi.org/10.1371/journal.pone.0023761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957439	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100002
J	Almeida, CR; Ashkenazi, A; Shahaf, G; Kaplan, D; Davis, DM; Mehr, R				Almeida, Catarina R.; Ashkenazi, Amit; Shahaf, Gitit; Kaplan, Deborah; Davis, Daniel M.; Mehr, Ramit			Human NK Cells Differ More in Their KIR2DL1-Dependent Thresholds for HLA-Cw6-Mediated Inhibition than in Their Maximal Killing Capacity	PLOS ONE			English	Article							MHC CLASS-I; NATURAL-KILLER-CELLS; HLA-C; IMMUNE SYNAPSES; TUMOR-CELLS; RECEPTORS; EXPRESSION; MOLECULES; EDUCATION; RESPONSIVENESS	In this study we have addressed the question of how activation and inhibition of human NK cells is regulated by the expression level of MHC class I protein on target cells. Using target cell transfectants sorted to stably express different levels of the MHC class I protein HLA-Cw6, we show that induction of degranulation and that of IFN-gamma secretion are not correlated. In contrast, the inhibition of these two processes by MHC class-I occurs at the same level of class I MHC protein. Primary human NK cell clones were found to differ in the amount of target MHC class I protein required for their inhibition, rather than in their maximum killing capacity. Importantly, we show that KIR2DL1 expression determines the thresholds (in terms of MHC I protein levels) required for NK cell inhibition, while the expression of other receptors such as LIR1 is less important. Furthermore, using mathematical models to explore the dynamics of target cell killing, we found that the observed delay in target cell killing is exhibited by a model in which NK cells require some activation or priming, such that each cell can lyse a target cell only after being activated by a first encounter with the same or a different target cell, but not by models which lack this feature.	[Almeida, Catarina R.; Davis, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Ashkenazi, Amit; Shahaf, Gitit; Kaplan, Deborah; Mehr, Ramit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Imperial College London; Bar Ilan University	Almeida, CR (corresponding author), Univ Porto, Inst Engn Biomed INEB, NEWTherapies Grp, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ramit.mehr@biu.ac.il	Almeida, Catarina R/A-7018-2012	Almeida, Catarina R/0000-0001-6670-6004; Mehr, Ramit/0000-0002-4303-6834; Davis, Daniel/0000-0002-9182-291X	Medical Research Council (UK); Biotechnology and Biological Research Council; Wolfram Royal Society; Human Frontiers Science Program Young Investigator Grant; Swedish Foundation for Strategic Research; Karolinska Institute, Stockholm, Sweden; Israel Science Foundation [759/01-1, 546, 270/09]; Israel Cancer Research Fund; Human Frontiers Science Program; Teva Pharmaceuticals; Fundacao para a Ciencia e a Tecnologia; Medical Research Council [G0500563, G1001044] Funding Source: researchfish; MRC [G0500563, G1001044] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wolfram Royal Society; Human Frontiers Science Program Young Investigator Grant(Human Frontier Science Program); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institute, Stockholm, Sweden(Karolinska Institutet); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Human Frontiers Science Program(Human Frontier Science Program); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in parts by the following grants: grants from the Medical Research Council (UK) and the Biotechnology and Biological Research Council, and a Wolfram Royal Society Research Merit Award (to DMD); a Human Frontiers Science Program Young Investigator Grant (to DMD and RM); a Swedish Foundation for Strategic Research grant funding the Strategic Research Center for studies on Integrative Recognition in the Immune System (IRIS), Karolinska Institute, Stockholm, Sweden, an Israel Science Foundation Bikura program grant, and indirectly by Israel Science Foundation grants 759/01-1, 546 and 270/09, an Israel Cancer Research Fund project grant, a Human Frontiers Science Program project grant and a Systems Biology prize grant from Teva Pharmaceuticals (to RM). CRA was supported by Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brodin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013174; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Chua HL, 2004, HUM IMMUNOL, V65, P317, DOI 10.1016/j.humimm.2004.01.004; Endt J, 2007, J IMMUNOL, V178, P5606, DOI 10.4049/jimmunol.178.9.5606; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Feuchtinger T, 2009, BONE MARROW TRANSPL, V43, P875, DOI 10.1038/bmt.2008.398; Gruda R, 2007, J IMMUNOL, V179, P3655, DOI 10.4049/jimmunol.179.6.3655; Holmes TD, 2011, J IMMUNOL, V186, P1538, DOI 10.4049/jimmunol.1000951; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Johansson S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006046; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Jonsson AH, 2010, J IMMUNOL, V184, P3424, DOI 10.4049/jimmunol.0904057; Kambayashi T, 2001, EUR J IMMUNOL, V31, P869, DOI 10.1002/1521-4141(200103)31:3<869::AID-IMMU869>3.3.CO;2-1; Kaplan A, 2011, J IMMUNOL, V187, P760, DOI 10.4049/jimmunol.1002208; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Kubota A, 1999, J IMMUNOL, V163, P6488; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; OlssonAlheim MY, 1997, J IMMUNOL, V159, P3189; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Vyas YM, 2004, J IMMUNOL, V173, P1571, DOI 10.4049/jimmunol.173.3.1571; Warren HS, 1999, IMMUNOL CELL BIOL, V77, P544, DOI 10.1046/j.1440-1711.1999.00865.x; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Yu J, 2007, J IMMUNOL, V179, P5977, DOI 10.4049/jimmunol.179.9.5977; Zanoni I, 2007, IMMUNOL LETT, V110, P6, DOI 10.1016/j.imlet.2007.03.001	38	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24927	10.1371/journal.pone.0024927	http://dx.doi.org/10.1371/journal.pone.0024927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949790	Green Submitted, Green Published, gold			2022-12-25	WOS:000295257900035
J	Deacon, AE; Ramnarine, IW; Magurran, AE				Deacon, Amy E.; Ramnarine, Indar W.; Magurran, Anne E.			How Reproductive Ecology Contributes to the Spread of a Globally Invasive Fish	PLOS ONE			English	Article							GUPPIES POECILIA-RETICULATA; GENETIC DIVERSITY; SCHOOLING BEHAVIOR; CLIMATE-CHANGE; WATER; POPULATIONS; EVOLUTION; AQUARIUM; SUCCESS; HOMOGENIZATION	Invasive freshwater fish represent a major threat to biodiversity. Here, we first demonstrate the dramatic, human-mediated range expansion of the Trinidadian guppy (Poecilia reticulata), an invasive fish with a reputation for negatively impacting native freshwater communities. Next, we explore possible mechanisms that might explain successful global establishment of this species. Guppies, along with some other notable invasive fish species such as mosquitofish (Gambusia spp.), have reproductive adaptations to ephemeral habitats that may enable introductions of very small numbers of founders to succeed. The remarkable ability of single pregnant guppies to routinely establish viable populations is demonstrated using a replicated mesocosm set up. In 86% of cases, these populations persisted for two years (the duration of the experiment). Establishment success was independent of founder origin (high and low predation habitats), and there was no loss of behavioural performance amongst mesocosm juveniles. Behavioural "signatures" of the founding locality were, however, evident in mesocosm fish. Our results demonstrate that introductions consisting of a single individual can lead to thriving populations of this invasive fish and suggest that particular caution should be exercised when introducing this species, or other livebearers, to natural water bodies.	[Deacon, Amy E.; Magurran, Anne E.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland; [Ramnarine, Indar W.] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago	University of St Andrews; University West Indies Mona Jamaica; University West Indies Saint Augustine	Deacon, AE (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland.	aed32@st-andrews.ac.uk	Magurran, Anne E/D-7463-2013	Magurran, Anne/0000-0002-0036-2795; Deacon, Amy/0000-0002-7739-2925	Natural Environment Research Council (NERC) (UK); European Research Council	Natural Environment Research Council (NERC) (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission)	The work was funded by Natural Environment Research Council (NERC) (UK) and the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOB INV SPEC DAT; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Arthington AH, 1989, ASIAN FISH SCI, V2, P193; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 1986, ECOLOGY BIOL INVASIO; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Carvalho GR, 1996, BIOL J LINN SOC, V57, P219, DOI 10.1111/j.1095-8312.1996.tb00310.x; Casatti L, 2006, ENVIRON MANAGE, V38, P974, DOI 10.1007/s00267-005-0212-4; Chandra G, 2008, INDIAN J MED RES, V127, P13; Courtenay W. R., 1989, ECOLOGY EVOLUTION LI; Dash AP, 2009, LARVIVOROUS FISH MOS; Duggan IC, 2006, BIOL INVASIONS, V8, P377, DOI 10.1007/s10530-004-2310-2; Eakley AL, 2004, P ROY SOC B-BIOL SCI, V271, pS299, DOI 10.1098/rsbl.2004.0165; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Food and Agricultural Organisation of the United Nations, 2010, INV SPEC DAT; Froese R., 2014, FISHBASE; Gasparini C, 2011, P ROYAL SOC B; Ghosh SK, 2005, T ROY SOC TROP MED H, V99, P101, DOI 10.1016/j.trstmh.2004.03.009; Grapputo A, 2006, ITAL J ZOOL, V73, P67, DOI 10.1080/11250000500502111; Hain TJA, 2007, MOL ECOL, V16, P3938, DOI 10.1111/j.1365-294X.2007.03443.x; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; HORN MH, 1972, FISH B-NOAA, V70, P1295; KAUFMAN L, 1992, BIOSCIENCE, V42, P846, DOI 10.2307/1312084; Kelley JL, 2003, ANIM BEHAV, V65, P655, DOI 10.1006/anbe.2003.2076; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Liang Shih-Hisung, 2006, Taiwania, V51, P93; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V255, P31, DOI 10.1098/rspb.1994.0005; MAGURRAN AE, 1995, ADV STUD BEHAV, V24, P155, DOI 10.1016/S0065-3454(08)60394-0; MAGURRAN AE, 1990, ETHOLOGY, V84, P334, DOI 10.1111/j.1439-0310.1990.tb00807.x; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Magurran AE, 2009, SCIENCE, V325, P1215, DOI 10.1126/science.1177215; Mariette M, 2006, ETHOLOGY, V112, P807, DOI 10.1111/j.1439-0310.2006.01236.x; McDowall RM, 2004, NEW ZEAL J MAR FRESH, V38, P503, DOI 10.1080/00288330.2004.9517256; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Meffe G.K., 1989, P13; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; Nelson JS, 1984, FISHES WORLD; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; Shoji A, 2007, CONSERV GENET, V8, P261, DOI 10.1007/s10592-006-9166-1; Smith C., 1991, Reviews in Fish Biology and Fisheries, V1, P41, DOI 10.1007/BF00042661; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Vila-Gispert A, 2005, BIOL INVASIONS, V7, P107, DOI 10.1007/s10530-004-9640-y; Vipan, 1910, P ZOOL SOC LOND, P146; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Winge O, 1937, NATURE, V140, P467, DOI 10.1038/140467b0	59	119	121	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24416	10.1371/journal.pone.0024416	http://dx.doi.org/10.1371/journal.pone.0024416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21957449	Green Submitted, Green Published, gold			2022-12-25	WOS:000295257900014
J	Ichihashi, T; Yoshida, R; Sugimoto, C; Takada, A; Kajino, K				Ichihashi, Toru; Yoshida, Reiko; Sugimoto, Chihiro; Takada, Ayato; Kajino, Kiichi			Cross-Protective Peptide Vaccine against Influenza A Viruses Developed in HLA-A*2402 Human Immunity Model	PLOS ONE			English	Article							CD8(+) T-CELLS; MHC CLASS-I; INACTIVATED VIRUS; HETEROSUBTYPIC IMMUNITY; INTRANASAL VACCINATION; INFECTION; MICE; LYMPHOCYTES; ANTIGEN; PREDICTION	Background: The virus-specific cytotoxic T lymphocyte (CTL) induction is an important target for the development of a broadly protective human influenza vaccine, since most CTL epitopes are found on internal viral proteins and relatively conserved. In this study, the possibility of developing a strain/subtype-independent human influenza vaccine was explored by taking a bioinformatics approach to establish an immunogenic HLA-A24 restricted CTL epitope screening system in HLA-transgenic mice. Methodology/Principal Findings: HLA-A24 restricted CTL epitope peptides derived from internal proteins of the H5N1 highly pathogenic avian influenza A virus were predicted by CTL epitope peptide prediction programs. Of 35 predicted peptides, six peptides exhibited remarkable cytotoxic activity in vivo. More than half of the mice which were subcutaneously vaccinated with the three most immunogenic and highly conserved epitopes among three different influenza A virus subtypes (H1N1, H3N2 and H5N1) survived lethal influenza virus challenge during both effector and memory CTL phases. Furthermore, mice that were intranasally vaccinated with these peptides remained free of clinical signs after lethal virus challenge during the effector phase. Conclusions/Significance: This CTL epitope peptide selection system can be used as an effective tool for the development of a cross-protective human influenza vaccine. Furthermore this vaccine strategy can be applicable to the development of all intracellular pathogens vaccines to induce epitope-specific CTL that effectively eliminate infected cells.	[Ichihashi, Toru; Sugimoto, Chihiro; Kajino, Kiichi] Hokkaido Univ, Dept Collaborat & Educ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Yoshida, Reiko; Takada, Ayato] Hokkaido Univ, Dept Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ichihashi, T (corresponding author), Hokkaido Univ, Dept Collaborat & Educ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	kiichi@czc.hokudai.ac.jp	Kajino, Kiichi/F-6873-2012; Takada, Ayato/A-6679-2012; Sugimoto, Chihiro/F-6583-2012; YOSHIDA, Reiko/F-6883-2012	Sugimoto, Chihiro/0000-0002-8708-0140; 	Japan Initiative for Global Research Network on Infections Diseases (J-GRID); Health Labour Sciences Research Grant, Japan	Japan Initiative for Global Research Network on Infections Diseases (J-GRID); Health Labour Sciences Research Grant, Japan	Financial support for this study was provided by the Japan Initiative for Global Research Network on Infections Diseases (J-GRID) programmed by MEXT, Japan (http://www.crnid.riken.jp/jgrid/en/index.html) and also supported by the Health Labour Sciences Research Grant, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Alsharifi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005336; Belyakov IM, 1998, J CLIN INVEST, V102, P2072, DOI 10.1172/JCI5102; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Day EB, 2007, J IMMUNOL, V179, P2187, DOI 10.4049/jimmunol.179.4.2187; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Deliyannis G, 2006, EUR J IMMUNOL, V36, P770, DOI 10.1002/eji.200535217; Deliyannis G, 2002, J VIROL, V76, P4212, DOI 10.1128/JVI.76.9.4212-4221.2002; DOHERTY PC, 1989, J INFECT DIS, V159, P1119, DOI 10.1093/infdis/159.6.1119; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gohara R, 2002, J IMMUNOTHER, V25, P439, DOI 10.1097/00002371-200209000-00008; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; KEES U, 1984, J EXP MED, V159, P365, DOI 10.1084/jem.159.2.365; KOS FJ, 1992, IMMUNOBIOLOGY, V186, P410, DOI 10.1016/S0171-2985(11)80394-3; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; LIANG SH, 1994, J IMMUNOL, V152, P1653; LIN YL, 1981, J EXP MED, V154, P225, DOI 10.1084/jem.154.2.225; LIU Y, 1989, P NATL ACAD SCI USA, V86, P4629, DOI 10.1073/pnas.86.12.4629; LUKACHER AE, 1984, J EXP MED, V160, P814, DOI 10.1084/jem.160.3.814; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Nagata T, 2007, VACCINE, V25, P4914, DOI 10.1016/j.vaccine.2007.04.010; Nakano Y, 1999, INT ARCH ALLERGY IMM, V120, P199, DOI 10.1159/000024268; Nakano Y, 2001, BIOCONJUGATE CHEM, V12, P391, DOI 10.1021/bc0001185; NARUSE H, 1994, P NATL ACAD SCI USA, V91, P9588, DOI 10.1073/pnas.91.20.9588; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Takada A, 1996, VET MICROBIOL, V50, P17, DOI 10.1016/0378-1135(96)00004-1; TAKADA A, 1994, J VET MED SCI, V56, P633, DOI 10.1292/jvms.56.633; Taneichi M, 2006, J IMMUNOL, V177, P2324, DOI 10.4049/jimmunol.177.4.2324; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Wang F, 1999, CLIN CANCER RES, V5, P2756; WELLS MA, 1981, J IMMUNOL, V126, P1042; YAP KL, 1978, SCAND J IMMUNOL, V7, P389, DOI 10.1111/j.1365-3083.1978.tb00469.x; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; ZWEERINK HJ, 1977, NATURE, V267, P354, DOI 10.1038/267354a0	50	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24626	10.1371/journal.pone.0024626	http://dx.doi.org/10.1371/journal.pone.0024626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949735	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900022
J	Li, L; Li, Y; Browning, SR; Browning, BL; Slater, AJ; Kong, XY; Aponte, JL; Mooser, VE; Chissoe, SL; Whittaker, JC; Nelson, MR; Ehm, MG				Li, Li; Li, Yun; Browning, Sharon R.; Browning, Brian L.; Slater, Andrew J.; Kong, Xiangyang; Aponte, Jennifer L.; Mooser, Vincent E.; Chissoe, Stephanie L.; Whittaker, John C.; Nelson, Matthew R.; Ehm, Margaret Gelder			Performance of Genotype Imputation for Rare Variants Identified in Exons and Flanking Regions of Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; DISEASE	Genotype imputation has the potential to assess human genetic variation at a lower cost than assaying the variants using laboratory techniques. The performance of imputation for rare variants has not been comprehensively studied. We utilized 8865 human samples with high depth resequencing data for the exons and flanking regions of 202 genes and Genome-Wide Association Study (GWAS) data to characterize the performance of genotype imputation for rare variants. We evaluated reference sets ranging from 100 to 3713 subjects for imputing into samples typed for the Affymetrix (500K and 6.0) and Illumina 550K GWAS panels. The proportion of variants that could be well imputed (true r(2)>0.7) with a reference panel of 3713 individuals was: 31% (Illumina 550K) or 25% (Affymetrix 500K) with MAF (Minor Allele Frequency) less than or equal 0.001, 48% or 35% with 0.001<MAF<= 0.005, 54% or 38% with 0.005<MAF<= 0.01, 78% or 57% with 0.01<MAF<= 0.05, and 97% or 86% with MAF>0.05. The performance for common SNPs (MAF>0.05) within exons and flanking regions is comparable to imputation of more uniformly distributed SNPs. The performance for rare SNPs (0.01<MAF<= 0.05) was much more dependent on the GWAS panel and the number of reference samples. These results suggest routine use of genotype imputation for extending the assessment of common variants identified in humans via targeted exon resequencing into additional samples with GWAS data, but imputation of very rare variants (MAF<= 0.005) will require reference panels with thousands of subjects.	[Li, Li; Slater, Andrew J.; Kong, Xiangyang; Aponte, Jennifer L.; Mooser, Vincent E.; Chissoe, Stephanie L.; Whittaker, John C.; Nelson, Matthew R.; Ehm, Margaret Gelder] GlaxoSmithKline, Genet, Res Triangle Pk, NC 27709 USA; [Li, Li; Slater, Andrew J.; Kong, Xiangyang; Aponte, Jennifer L.; Mooser, Vincent E.; Chissoe, Stephanie L.; Whittaker, John C.; Nelson, Matthew R.; Ehm, Margaret Gelder] GlaxoSmithKline, Genet, King Of Prussia, PA USA; [Li, Li; Slater, Andrew J.; Kong, Xiangyang; Aponte, Jennifer L.; Mooser, Vincent E.; Chissoe, Stephanie L.; Whittaker, John C.; Nelson, Matthew R.; Ehm, Margaret Gelder] GlaxoSmithKline, Genet, Stevenage, Herts, England; [Li, Yun] Univ N Carolina, Dept Biostat, Dept Genet, Chapel Hill, NC USA; [Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Li, L (corresponding author), GlaxoSmithKline, Genet, Res Triangle Pk, NC 27709 USA.	meg.g.ehm@gsk.com	Whittaker, John C/B-8609-2012; Browning, Brian L/A-1178-2010; Browning, Sharon/B-1530-2008	Whittaker, John C/0000-0002-3529-2379; Browning, Brian L/0000-0001-6454-6633; Browning, Sharon/0000-0001-7251-9715; Kong, xiangyang/0000-0001-8184-2493; Slater, Andrew/0000-0002-2467-0231	GlaxoSmithKline; National Institutes of Health [R01HG004960, R01HG005701]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004960, R01HG005701] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work described in this manuscript was funded by GlaxoSmithKline. MGE, LL, AJS, XK, JLA, VEM, SLC, JCW, MRN are employees and stock owners of GlaxoSmithKline. This work was supported by National Institutes of Health awards R01HG004960 (to BLB) and R01HG005701 (to SRB and BLB) and by a grant from GlaxoSmithKline (YL). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Assimes TL, 2010, J AM COLL CARDIOL, V56, P1552, DOI 10.1016/j.jacc.2010.06.022; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Francks C, 2010, MOL PSYCHIATR, V15, P319, DOI 10.1038/mp.2008.100; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kasperaviciute D, 2010, BRAIN, V133, P2136, DOI 10.1093/brain/awq130; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li MY, 2008, EUR J HUM GENET, V16, P635, DOI 10.1038/sj.ejhg.5202007; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421	21	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24945	10.1371/journal.pone.0024945	http://dx.doi.org/10.1371/journal.pone.0024945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949800	Green Published, gold, Green Accepted			2022-12-25	WOS:000295257900038
J	Ren, JP; Kolli, D; Liu, TS; Xu, RL; Garofalo, RP; Casola, A; Bao, XY				Ren, Junping; Kolli, Deepthi; Liu, Tianshuang; Xu, Renling; Garofalo, Roberto P.; Casola, Antonella; Bao, Xiaoyong			Human Metapneumovirus Inhibits IFN-beta Signaling by Downregulating Jak1 and Tyk2 Cellular Levels	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INTERFERON-ALPHA RECEPTOR; ALVEOLAR EPITHELIAL-CELLS; TYROSINE KINASE; GAMMA-INTERFERON; V-PROTEINS; PHOSPHATASE SHP-1; VIRAL-INFECTIONS; GENE-EXPRESSION; TRACT DISEASE	Human metapneumovirus (hMPV), a leading cause of respiratory tract infections in infants, inhibits type I interferon (IFN) signaling by an unidentified mechanism. In this study, we showed that infection of airway epithelial cells with hMPV decreased cellular level of Janus tyrosine kinase (Jak1) and tyrosine kinase 2 (Tyk2), due to enhanced proteosomal degradation and reduced gene transcription. In addition, hMPV infection also reduced the surface expression of type I IFN receptor (IFNAR). These inhibitory mechanisms are different from the ones employed by respiratory syncytial virus (RSV), which does not affect Jak1, Tyk2 or IFNAR expression, but degrades downstream signal transducer and activator of transcription proteins 2 (STAT2), although both viruses are pneumoviruses belonging to the Paramyxoviridae family. Our study identifies a novel mechanism by which hMPV inhibits STAT1 and 2 activation, ultimately leading to viral evasion of host IFN responses.	[Ren, Junping; Kolli, Deepthi; Liu, Tianshuang; Xu, Renling; Casola, Antonella; Bao, Xiaoyong] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Dept Microbiol, Galveston, TX USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Dept Immunol, Galveston, TX USA; [Garofalo, Roberto P.; Casola, Antonella] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Ren, JP (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	ancasola@utmb.edu; xibao@utmb.edu	Garofalo, Roberto P./ABL-2322-2022; Garofalo, Roberto P./AAF-7385-2022		National Institutes of Health-National Institute of Allergy and Infectious Diseases [P01 062885, NIAID AI079246, NIAID K22 (KAI074829A)]; Parker B. Francis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI074829, R01AI079246] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Parker B. Francis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health-National Institute of Allergy and Infectious Diseases (P01 062885) to AC and RPG, NIAID AI079246 to AC, and NIAID K22 (KAI074829A) and Parker B. Francis Foundation to XB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Bao X, 2007, VIROLOGY, V368, P91, DOI 10.1016/j.virol.2007.06.023; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; Brasier AR, 2004, J VIROL, V78, P11461, DOI 10.1128/JVI.78.21.11461-11476.2004; Casola A, 2001, J BIOL CHEM, V276, P19715, DOI 10.1074/jbc.M101526200; Casola A, 2002, AM J PHYSIOL-LUNG C, V283, pL1280, DOI 10.1152/ajplung.00162.2002; Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001; Casola A, 2000, J IMMUNOL, V164, P5944, DOI 10.4049/jimmunol.164.11.5944; Christophi GP, 2009, J VIROL, V83, P522, DOI 10.1128/JVI.01210-08; COLAMONICI O, 1994, MOL CELL BIOL, V14, P8133, DOI 10.1128/MCB.14.12.8133; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; Crowe James E Jr, 2004, Pediatr Infect Dis J, V23, pS215, DOI 10.1097/01.inf.0000144668.81573.6d; Dinwiddie DL, 2008, AM J RESP CELL MOL B; Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06; Englund JA, 2006, ANN INTERN MED, V144, P344, DOI 10.7326/0003-4819-144-5-200603070-00010; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gotoh B, 2002, REV MED VIROL, V12, P337, DOI 10.1002/rmv.357; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Haller O, 2009, Verh K Acad Geneeskd Belg, V71, P73; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Horvath CM, 2004, CYTOKINE GROWTH F R, V15, P117, DOI 10.1016/j.cytogfr.2004.02.003; Jamaluddin M, 2000, J IMMUNOL; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Lee BH, 2003, VIRUS RES, V98, P83, DOI 10.1016/j.virusres.2003.09.001; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Li XX, 1998, BIOCHIMIE, V80, P703, DOI 10.1016/S0300-9084(99)80023-6; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Massa PT, 2002, J VIROL, V76, P8335, DOI 10.1128/JVI.76.16.8335-8346.2002; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Principi N, 2006, CLIN MICROBIOL INFEC, V12, P301, DOI 10.1111/j.1469-0691.2005.01325.x; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Ramaswamy M, 2006, VIROLOGY, V344, P328, DOI 10.1016/j.virol.2005.09.009; Ramaswamy M, 2004, AM J RESP CELL MOL, V30, P893, DOI 10.1165/rcmb.2003-0410OC; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SIMMONS JD, 2009, J VIROL; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0; Young DF, 2000, VIROLOGY, V269, P383, DOI 10.1006/viro.2000.0240	62	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24496	10.1371/journal.pone.0024496	http://dx.doi.org/10.1371/journal.pone.0024496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949722	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900018
J	Camarasa, C; Sanchez, I; Brial, P; Bigey, F; Dequin, S				Camarasa, Carole; Sanchez, Isabelle; Brial, Pascale; Bigey, Frederic; Dequin, Sylvie			Phenotypic Landscape of Saccharomyces cerevisiae during Wine Fermentation: Evidence for Origin-Dependent Metabolic Traits	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; ALCOHOLIC FERMENTATION; POPULATION-STRUCTURE; ETHANOL TOLERANCE; GENETIC DIVERSITY; SUGAR-TRANSPORT; YEAST; STRAINS; GENOME; STUCK	The species Saccharomyces cerevisiae includes natural strains, clinical isolates, and a large number of strains used in human activities. The aim of this work was to investigate how the adaptation to a broad range of ecological niches may have selectively shaped the yeast metabolic network to generate specific phenotypes. Using 72 S. cerevisiae strains collected from various sources, we provide, for the first time, a population-scale picture of the fermentative metabolic traits found in the S. cerevisiae species under wine making conditions. Considerable phenotypic variation was found suggesting that this yeast employs diverse metabolic strategies to face environmental constraints. Several groups of strains can be distinguished from the entire population on the basis of specific traits. Strains accustomed to growing in the presence of high sugar concentrations, such as wine yeasts and strains obtained from fruits, were able to achieve fermentation, whereas natural yeasts isolated from "poor-sugar" environments, such as oak trees or plants, were not. Commercial wine yeasts clearly appeared as a subset of vineyard isolates, and were mainly differentiated by their fermentative performances as well as their low acetate production. Overall, the emergence of the origin-dependent properties of the strains provides evidence for a phenotypic evolution driven by environmental constraints and/or human selection within S. cerevisiae.	[Camarasa, Carole; Sanchez, Isabelle; Brial, Pascale; Bigey, Frederic; Dequin, Sylvie] INRA, UMR1083, F-34060 Montpellier, France; [Camarasa, Carole; Sanchez, Isabelle; Brial, Pascale; Bigey, Frederic; Dequin, Sylvie] SupAgro, UMR1083, Montpellier, France; [Camarasa, Carole; Sanchez, Isabelle; Brial, Pascale; Bigey, Frederic; Dequin, Sylvie] Univ Montpellier 1, UMR1083, Montpellier, France	INRAE; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier	Camarasa, C (corresponding author), INRA, UMR1083, F-34060 Montpellier, France.	camarasa@supagro.inra.fr	Bigey, Frédéric/F-2517-2010	Bigey, Frédéric/0000-0002-6240-3038				Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; Albertin W, 2011, APPL ENVIRON MICROB, V77, P2772, DOI 10.1128/AEM.02547-10; Alexandre H, 1996, MICROBIOL-SGM, V142, P469, DOI 10.1099/13500872-142-3-469; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Azumi M, 2001, YEAST, V18, P1145, DOI 10.1002/yea.767; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Blateyron L, 2001, J BIOSCI BIOENG, V91, P184, DOI 10.1263/jbb.91.184; Cavalieri D, 2003, J MOL EVOL, V57, pS226, DOI 10.1007/s00239-003-0031-2; Codon AC, 1998, APPL MICROBIOL BIOT, V49, P154, DOI 10.1007/s002530051152; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Diezmann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005317; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ezeronye OU, 2009, J APPL MICROBIOL, V106, P1569, DOI 10.1111/j.1365-2672.2008.04118.x; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Gilbert H, 2009, 249 U CAL; Hennequin C, 2001, J CLIN MICROBIOL, V39, P551, DOI 10.1128/JCM.39.2.551-559.2001; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Kim HS, 2009, FEMS YEAST RES, V9, P713, DOI 10.1111/j.1567-1364.2009.00516.x; Kim J, 1996, APPL ENVIRON MICROB, V62, P1563, DOI 10.1128/AEM.62.5.1563-1569.1996; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Magwene PM, 1987, P NATL ACAD SCI USA, V108, P1987; Manginot C, 1998, ENZYME MICROB TECH, V23, P511, DOI 10.1016/S0141-0229(98)00080-5; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Muller LAH, 2009, MOL ECOL, V18, P2779, DOI 10.1111/j.1365-294X.2009.04234.x; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Palkova Z, 2004, EMBO REP, V5, P470, DOI 10.1038/sj.embor.7400145; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Quan H, 1996, BIOMETRICS, V52, P1195, DOI 10.2307/2532835; Sablayrolles JM, 1996, J FERMENT BIOENG, V82, P377, DOI 10.1016/0922-338X(96)89154-9; SALMON JM, 1989, APPL ENVIRON MICROB, V55, P953, DOI 10.1128/AEM.55.4.953-958.1989; Santos J, 2008, MICROBIOL-SGM, V154, P422, DOI 10.1099/mic.0.2007/011445-0; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Spor A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-296; Spor A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001579; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Varela C, 2004, APPL ENVIRON MICROB, V70, P3392, DOI 10.1128/AEM.70.6.3392-3400.2004; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Winzeler EA, 2003, GENETICS, V163, P79	54	77	77	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25147	10.1371/journal.pone.0025147	http://dx.doi.org/10.1371/journal.pone.0025147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949874	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800068
J	Lin, WZ; Fang, JA; Xiao, X; Chou, KC				Lin, Wei-Zhong; Fang, Jian-An; Xiao, Xuan; Chou, Kuo-Chen			iDNA-Prot: Identification of DNA Binding Proteins Using Random Forest with Grey Model	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; RIBOSOMAL-RNA-BINDING; SECONDARY STRUCTURE; PREDICTION; SEQUENCE; CLASSIFICATION; RESIDUES; PISCES; SITES	DNA-binding proteins play crucial roles in various cellular processes. Developing high throughput tools for rapidly and effectively identifying DNA-binding proteins is one of the major challenges in the field of genome annotation. Although many efforts have been made in this regard, further effort is needed to enhance the prediction power. By incorporating the features into the general form of pseudo amino acid composition that were extracted from protein sequences via the "grey model" and by adopting the random forest operation engine, we proposed a new predictor, called iDNA-Prot, for identifying uncharacterized proteins as DNA-binding proteins or non-DNA binding proteins based on their amino acid sequences information alone. The overall success rate by iDNA-Prot was 83.96% that was obtained via jackknife tests on a newly constructed stringent benchmark dataset in which none of the proteins included has >= 25% pairwise sequence identity to any other in a same subset. In addition to achieving high success rate, the computational time for iDNA-Prot is remarkably shorter in comparison with the relevant existing predictors. Hence it is anticipated that iDNA-Prot may become a useful high throughput tool for large-scale analysis of DNA-binding proteins. As a user-friendly web-server, iDNA-Prot is freely accessible to the public at the web-site on http://icpr.jci.edu.cn/bioinfo/iDNA-Prot or http://www.jci-bioinfo.cn/iDNA-Prot. Moreover, for the convenience of the vast majority of experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results.	[Lin, Wei-Zhong; Fang, Jian-An] Donghua Univ, Informat Sci & Technol Sch, Shanghai, Peoples R China; [Lin, Wei-Zhong; Xiao, Xuan] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Donghua University; Jingdezhen Ceramic Institute	Lin, WZ (corresponding author), Donghua Univ, Informat Sci & Technol Sch, Shanghai, Peoples R China.	xxiao@gordonlifescience.org			National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2009GZS0064, 2010GZS0122]; department of education of Jiang-Xi Province [GJJ09271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; department of education of Jiang-Xi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of JiangXi (2009GZS0064 and 2010GZS0122), and the department of education of Jiang-Xi Province (No. GJJ09271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2000, MACH LEARN, V40, P229, DOI 10.1023/A:1007682208299; Brown JB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-25; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Dehzangi A, 2010, J INF SCI ENG, V26, P1941; Deng Julong, 1989, Journal of Grey Systems, V1, P1; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Keil M, 2004, J COMPUT CHEM, V25, P779, DOI 10.1002/jcc.10361; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Langlois RE, 2010, NUCLEIC ACIDS RES, V38, P3149, DOI 10.1093/nar/gkq061; Liu ZP, 2010, BIOINFORMATICS, V26, P1616, DOI 10.1093/bioinformatics/btq253; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Molparia Bhuvan, 2010, Genomics Proteomics & Bioinformatics, V8, P122, DOI 10.1016/S1672-0229(10)60013-7; Nanni L, 2008, AMINO ACIDS, V34, P635, DOI 10.1007/s00726-007-0016-3; Nanni L, 2009, AMINO ACIDS, V36, P167, DOI 10.1007/s00726-008-0044-7; Neumann A, 2004, ARTIF INTELL MED, V32, P97, DOI 10.1016/j.artmed.2004.06.001; Nimrod G, 2010, BIOINFORMATICS, V26, P692, DOI 10.1093/bioinformatics/btq019; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; Patel AK, 2010, DIG J NANOMATER BIOS, V5, P191; Patel AK, 2009, DIG J NANOMATER BIOS, V4, P775; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Rogers J, 2006, LECT NOTES COMPUT SC, V3940, P173; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shanahan HP, 2004, NUCLEIC ACIDS RES, V32, P4732, DOI 10.1093/nar/gkh803; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	57	232	251	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24756	10.1371/journal.pone.0024756	http://dx.doi.org/10.1371/journal.pone.0024756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935457	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700056
J	Liu, JG; Jolly, RA; Smith, AT; Searfoss, GH; Goldstein, KM; Uversky, VN; Dunker, K; Li, SY; Thomas, CE; Wei, T				Liu, Jiangang; Jolly, Robert A.; Smith, Aaron T.; Searfoss, George H.; Goldstein, Keith M.; Uversky, Vladimir N.; Dunker, Keith; Li, Shuyu; Thomas, Craig E.; Wei, Tao			Predictive Power Estimation Algorithm (PPEA) - A New Algorithm to Reduce Overfitting for Genomic Biomarker Discovery	PLOS ONE			English	Article							GENE; CANCER; CLASSIFICATION; SELECTION; SIGNATURE; HEPATOTOXICITY; MECHANISMS; OPINION; EVENTS	Toxicogenomics promises to aid in predicting adverse effects, understanding the mechanisms of drug action or toxicity, and uncovering unexpected or secondary pharmacology. However, modeling adverse effects using high dimensional and high noise genomic data is prone to over-fitting. Models constructed from such data sets often consist of a large number of genes with no obvious functional relevance to the biological effect the model intends to predict that can make it challenging to interpret the modeling results. To address these issues, we developed a novel algorithm, Predictive Power Estimation Algorithm (PPEA), which estimates the predictive power of each individual transcript through an iterative two-way bootstrapping procedure. By repeatedly enforcing that the sample number is larger than the transcript number, in each iteration of modeling and testing, PPEA reduces the potential risk of overfitting. We show with three different cases studies that: (1) PPEA can quickly derive a reliable rank order of predictive power of individual transcripts in a relatively small number of iterations, (2) the top ranked transcripts tend to be functionally related to the phenotype they are intended to predict, (3) using only the most predictive top ranked transcripts greatly facilitates development of multiplex assay such as qRT-PCR as a biomarker, and (4) more importantly, we were able to demonstrate that a small number of genes identified from the top-ranked transcripts are highly predictive of phenotype as their expression changes distinguished adverse from nonadverse effects of compounds in completely independent tests. Thus, we believe that the PPEA model effectively addresses the over-fitting problem and can be used to facilitate genomic biomarker discovery for predictive toxicology and drug responses.	[Liu, Jiangang; Li, Shuyu; Wei, Tao] Lilly Res Labs, Translat Sci, Indianapolis, IN USA; [Jolly, Robert A.; Smith, Aaron T.; Searfoss, George H.; Goldstein, Keith M.; Thomas, Craig E.] Lilly Res Labs, Toxicol, Indianapolis, IN USA; [Liu, Jiangang; Dunker, Keith] Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA; [Liu, Jiangang; Uversky, Vladimir N.; Dunker, Keith] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	Eli Lilly; Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of South Florida; Russian Academy of Sciences	Liu, JG (corresponding author), Lilly Res Labs, Translat Sci, Indianapolis, IN USA.	cthomas@lilly.com; weita@lilly.com	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This study is funded by Eli Lilly and Company as part of the company's business. The funding source does not compromise the objectivity or validity of the research, analyses, and interpretations presented in the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; [Anonymous], J ARTIFICIAL EVOLUTI; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Bo TH, 2002, GENOME BIOL, V3; BROSS IDJ, 1958, BIOMETRICS, V14, P18, DOI 10.2307/2527727; Bushel PR, 2007, P NATL ACAD SCI USA, V104, P18211, DOI 10.1073/pnas.0706987104; Cai JH, 2007, BIOTECHNIQUES, V42, P503, DOI 10.2144/000112400; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Das S., 2001, ICML, P74; Donaldson GW, 1998, EUR J PAIN-LONDON, V2, P221, DOI 10.1016/S1090-3801(98)90018-0; Dougherty ER, 2009, CURR GENOMICS, V10, P365, DOI 10.2174/138920209789177629; Eun JW, 2008, TOXICOLOGY, V249, P176, DOI 10.1016/j.tox.2008.05.001; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fan X, 2010, PHARMACOGENOMICS J, V10, P247, DOI 10.1038/tpj.2010.34; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Liu JG, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-39; Lu C, 2009, BIOINFORMATICS, V25, P2020, DOI 10.1093/bioinformatics/btp360; Luo W, 2005, CHEM RES TOXICOL, V18, P619, DOI 10.1021/tx049828f; Mendrick DL, 2008, TOXICOLOGY, V245, P175, DOI 10.1016/j.tox.2007.11.013; Moreau A, 2008, MOL PHARM, V5, P35, DOI 10.1021/mp700103m; Natsoulis G, 2005, GENOME RES, V15, P724, DOI 10.1101/gr.2807605; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Olayioye MA, 2001, BREAST CANCER RES, V3, P385, DOI 10.1186/bcr327; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Pachot A, 2004, J BIOTECHNOL, V114, P121, DOI 10.1016/j.jbiotec.2004.07.001; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PETERSON JE, 1990, PATHOLOGY, V22, P213, DOI 10.3109/00313029009086665; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Ryan TP, 2008, CURR OPIN PHARMACOL, V8, P654, DOI 10.1016/j.coph.2008.07.011; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sima C, 2008, PATTERN RECOGN LETT, V29, P1667, DOI 10.1016/j.patrec.2008.04.010; Sistare FD, 2007, CLIN PHARMACOL THER, V82, P210, DOI 10.1038/sj.clpt.6100243; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197; Zidek N, 2007, TOXICOL SCI, V99, P289, DOI 10.1093/toxsci/kfm131	45	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24233	10.1371/journal.pone.0024233	http://dx.doi.org/10.1371/journal.pone.0024233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935387	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700017
J	Navadgi-Patil, VM; Kumar, S; Burgers, PM				Navadgi-Patil, Vasundhara M.; Kumar, Sandeep; Burgers, Peter M.			The Unstructured C-terminal Tail of Yeast Dpb11 (Human TopBP1) Protein Is Dispensable for DNA Replication and the S Phase Checkpoint but Required for the G(2)/M Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; BUDDING YEAST; DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; ACTIVATION; COMPLEX; KINASE; POLYMERASE; PATHWAY	Budding yeast Dpb11 (human TopBP1, fission yeast Cut5) is an essential protein required for replisome assembly and for the DNA damage checkpoint. Previous studies with the temperature-sensitive dpb11-1 allele, truncated at amino acid 583 of the 764-amino acid protein, have suggested the model that Dpb11 couples DNA replication to the replication checkpoint. However, the dpb11-1 allele shows distinct replication defects even at permissive temperatures. Here, we determine that the 1-600-amino acid domain of DPB11 is both required and sufficient for full replication function of Dpb11 but that this domain is defecfive for activation of the principal checkpoint kinase Mec1 (human ataxia telarigiectasia and Rad3-related) in vitro and in vivo. Remarkably, mutants of DPB11 that leave its replication function intact but abrogate its ability to activate Mec1 are proficient for the replication checkpoint, but they are compromised for the G(2)/M DNA damage checkpoint. These data suggest that replication checkpoint defects may result indirectly from defects in replisome assembly. Two conserved aromatic amino acids in the C terminus of Dpb11 are critical for Mec1 activation in vitro and for the G(2)/M checkpoint in yeast. Together with aromatic motifs identified previously in the Ddc1 subunit of 9-1-1, another activator of Mec1 kinase, they define a consensus structure for Mec1 activation.	[Navadgi-Patil, Vasundhara M.; Kumar, Sandeep; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021	Kumar, Sandeep/0000-0003-1249-1743	National Institutes of Health [GM032431, GM083970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083970, R01GM032431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM032431 and GM083970.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Cobb JA, 2004, CURR OPIN GENET DEV, V14, P292, DOI 10.1016/j.gde.2004.04.001; DURSO G, 1995, J CELL SCI, V108, P3109; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kondo T, 1999, MOL CELL BIOL, V19, P1136; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2011, BIOCHEM SOC T, V39, P600, DOI 10.1042/BST0390600; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogiwara H, 2006, NUCLEIC ACIDS RES, V34, P3389, DOI 10.1093/nar/gkl411; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; Puddu F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002022; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taricani L, 2006, MOL BIOL CELL, V17, P3456, DOI 10.1091/mbc.E06-01-0056; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wang H, 2002, GENETICS, V160, P1295; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	43	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40999	41007		10.1074/jbc.M111.283994	http://dx.doi.org/10.1074/jbc.M111.283994			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956112	Green Published, hybrid			2022-12-25	WOS:000297315400059
J	Santangelo, MD; Gest, PM; Guerin, ME; Coincon, M; Pham, H; Ryan, G; Puckett, SE; Spencer, JS; Gonzalez-Juarrero, M; Daher, R; Lenaerts, AJ; Schnappinger, D; Therisod, M; Ehrt, S; Sygusch, J; Jackson, M				de la Paz Santangelo, Maria; Gest, Petra M.; Guerin, Marcelo E.; Coincon, Mathieu; Ha Pham; Ryan, Gavin; Puckett, Susan E.; Spencer, John S.; Gonzalez-Juarrero, Mercedes; Daher, Racha; Lenaerts, Anne J.; Schnappinger, Dirk; Therisod, Michel; Ehrt, Sabine; Sygusch, Jurgen; Jackson, Mary			Glycolytic and Non-glycolytic Functions of Mycobacterium tuberculosis Fructose-1,6-bisphosphate Aldolase, an Essential Enzyme Produced by Replicating and Non-replicating Bacilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE-BISPHOSPHATE ALDOLASES; CLASS-II; SELECTIVE INHIBITORS; MOLECULAR-CLONING; PROTEOME ANALYSIS; CANDIDA-ALBICANS; BOVIS BCG; PERSISTENCE; EXPRESSION; GROWTH	The search for antituberculosis drugs active against persistent bacilli has led to our interest in metallodependent class II fructose-1,6-bisphosphate aldolase (FBA-tb), a key enzyme of gluconeogenesis absent from mammalian cells. Knock-out experiments at the fba-tb locus indicated that this gene is required for the growth of Mycobacterium tuberculosis on gluconeogenetic substrates and in glucose-containing medium. Surface labeling and enzymatic activity measurements revealed that this enzyme was exported to the cell surface of M. tuberculosis and produced under various axenic growth conditions including oxygen depletion and hence by non-replicating bacilli. Importantly, FBA-tb was also produced in vivo in the lungs of infected guinea pigs and mice. FBA-tb bound human plasmin(ogen) and protected FBA-tb-bound plasmin from regulation by alpha(2)-antiplasmin, suggestive of an involvement of this enzyme in host/pathogen interactions. The crystal structures of FBA-tb in the native form and in complex with a hydroxamate substrate analog were determined to 2.35- and 1.9-angstrom resolution, respectively. Whereas inhibitor attachment had no effect on the plasminogen binding activity of FBA-tb, it competed with the natural substrate of the enzyme, fructose 1,6-bisphosphate, and substantiated a previously unknown reaction mechanism associated with metallodependent aldolases involving recruitment of the catalytic zinc ion by the substrate upon active site binding. Altogether, our results highlight the potential of FBA-tb as a novel therapeutic target against both replicating and non-replicating bacilli.	[de la Paz Santangelo, Maria; Gest, Petra M.; Ha Pham; Ryan, Gavin; Spencer, John S.; Gonzalez-Juarrero, Mercedes; Lenaerts, Anne J.; Jackson, Mary] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Guerin, Marcelo E.] Univ Basque Country, Unidad Biofis, Ctr Mixto, CSIC,EHU, Leioa 48940, Bizkaia, Spain; [Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain; [Guerin, Marcelo E.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Coincon, Mathieu; Sygusch, Jurgen] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Puckett, Susan E.; Schnappinger, Dirk; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Daher, Racha; Therisod, Michel] Univ Paris 11, Lab Chim Bioorgan & Bioinorgan, Inst Chim Mol & Mat Orsay, UMR 8182, F-91405 Orsay, France; [de la Paz Santangelo, Maria] Inst Nacl Tecnol Agropecuaria, Inst Biotecnol, Ctr Invest Ciencias Vet & Agron, RA-1686 Buenos Aires, DF, Argentina	Colorado State University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Universite de Montreal; Cornell University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Jackson, M (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	Guerin, Marcelo M/N-7245-2016; Ehrt, Sabine/AAU-6449-2020; Spencer, John S/G-6968-2017; Jackson, Mary/D-5345-2017	Guerin, Marcelo M/0000-0001-9524-3184; Spencer, John S/0000-0002-8051-3038; Jackson, Mary/0000-0002-9212-0258; Santangelo, Maria de la Paz/0000-0001-7865-7035; gonzalez-juarrero, mercedes/0000-0002-4045-2365	National Institutes of Health from the NIAID [AI078126]; National Institutes of Health from the NINDS [NS066438 from the]; Natural Science and Engineering Research Council (Canada); Canadian Institutes for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066438] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from the NINDS; Natural Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI078126 from the NIAID and NS066438 from the NINDS.; Supported by the Natural Science and Engineering Research Council (Canada) and Canadian Institutes for Health Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAI NJ, 1982, METHOD ENZYMOL, V90, P241; BAI NJ, 1974, FEBS LETT, V45, P68, DOI 10.1016/0014-5793(74)80812-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; Blumenthal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015667; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Daher R, 2010, J MED CHEM, V53, P7836, DOI 10.1021/jm1009814; Dax C, 2006, J MED CHEM, V49, P1499, DOI 10.1021/jm050237b; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Elkington PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001847; Fonvielle M, 2008, CHEM-EUR J, V14, P8521, DOI 10.1002/chem.200800857; Galkin A, 2007, J BIOL CHEM, V282, P4859, DOI 10.1074/jbc.M609534200; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gerber SS, 2010, CELL MOL LIFE SCI, V67, P1505, DOI 10.1007/s00018-010-0264-3; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; JAGANNATHAN V, 1956, BIOCHEM J, V63, P94, DOI 10.1042/bj0630094; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Labbe G., 2011, PROTEIN EXP IN PRESS; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; MARSH JJ, 1989, PLANT PHYSIOL, V91, P1393, DOI 10.1104/pp.91.4.1393; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Moritz B, 2000, EUR J BIOCHEM, V267, P3442, DOI 10.1046/j.1432-1327.2000.01354.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; Owen BB, 1938, J AM CHEM SOC, V60, P3074, DOI 10.1021/ja01279a068; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pegan SD, 2009, J MOL BIOL, V386, P1038, DOI 10.1016/j.jmb.2009.01.003; Ramsaywak PC, 2004, PROTEIN EXPRES PURIF, V37, P220, DOI 10.1016/j.pep.2004.05.011; Rellos P, 2000, J BIOL CHEM, V275, P1145, DOI 10.1074/jbc.275.2.1145; RICHARDS OC, 1961, J BIOL CHEM, V236, P3177; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; SINGER M, 1991, J BACTERIOL, V173, P6249, DOI 10.1128/jb.173.19.6249-6257.1991; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wehmeier UF, 2001, FEMS MICROBIOL LETT, V197, P53, DOI 10.1111/j.1574-6968.2001.tb10582.x; *WHO, 2009, WHO REP 2009 GLOB TU; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200; Wu ZF, 2008, FEMS IMMUNOL MED MIC, V53, P52, DOI 10.1111/j.1574-695X.2008.00401.x; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	70	60	61	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40219	40231		10.1074/jbc.M111.259440	http://dx.doi.org/10.1074/jbc.M111.259440			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949126	Green Published, hybrid			2022-12-25	WOS:000296925700054
J	Wang, Y; Gilbreath, TM; Kukutla, P; Yan, GY; Xu, JN				Wang, Ying; Gilbreath, Thomas M., III; Kukutla, Phanidhar; Yan, Guiyun; Xu, Jiannong			Dynamic Gut Microbiome across Life History of the Malaria Mosquito Anopheles gambiae in Kenya	PLOS ONE			English	Article							NITRIC-OXIDE DIOXYGENASE; MECONIAL PERITROPHIC MEMBRANES; ESCHERICHIA-COLI; MIDGUT BACTERIA; THORSELLIA-ANOPHELIS; TRANSCRIPTION FACTOR; DIPTERA-CULICIDAE; GENE-EXPRESSION; HEME; INSECT	The mosquito gut represents an ecosystem that accommodates a complex, intimately associated microbiome. It is increasingly clear that the gut microbiome influences a wide variety of host traits, such as fitness and immunity. Understanding the microbial community structure and its dynamics across mosquito life is a prerequisite for comprehending the symbiotic relationship between the mosquito and its gut microbial residents. Here we characterized gut bacterial communities across larvae, pupae and adults of Anopheles gambiae reared in semi-natural habitats in Kenya by pyrosequencing bacterial 16S rRNA fragments. Immatures and adults showed distinctive gut community structures. Photosynthetic Cyanobacteria were predominant in the larval and pupal guts while Proteobacteria and Bacteroidetes dominated the adult guts, with core taxa of Enterobacteriaceae and Flavobacteriaceae. At the adult stage, diet regime (sugar meal and blood meal) significantly affects the microbial structure. Intriguingly, blood meals drastically reduced the community diversity and favored enteric bacteria. Comparative genomic analysis revealed that the enriched enteric bacteria possess large genetic redox capacity of coping with oxidative and nitrosative stresses that are associated with the catabolism of blood meal, suggesting a beneficial role in maintaining gut redox homeostasis. Interestingly, gut community structure was similar in the adult stage between the field and laboratory mosquitoes, indicating that mosquito gut is a selective eco-environment for its microbiome. This comprehensive gut metatgenomic profile suggests a concerted symbiotic genetic association between gut inhabitants and host.	[Wang, Ying; Kukutla, Phanidhar; Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Gilbreath, Thomas M., III; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	New Mexico State University; University of California System; University of California Irvine	Wang, Y (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Pathogen Biol, Chongqing, Peoples R China.	jxu@nmsu.edu	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; Wang, Ying/0000-0003-1368-6497; KUKUTLA, PHANIDHAR/0000-0002-4790-386X	New Mexico State University; National Institutes of Health [1SC2GM092789-01A1, R01AI050243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092789] Funding Source: NIH RePORTER	New Mexico State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by New Mexico State University Startup funds to JX and by grants from the National Institutes of Health (1SC2GM092789-01A1 to JX and R01AI050243 to GY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Bonamore A, 2008, IUBMB LIFE, V60, P19, DOI 10.1002/iub.9; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; Bush M, 2011, BIOCHEM SOC T, V39, P289, DOI 10.1042/BST0390289; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Hishinuma S, 2006, ENVIRON MICROBIOL, V8, P2115, DOI 10.1111/j.1462-2920.2006.01088.x; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Kajla MK, 2010, COMP BIOCHEM PHYS B, V155, P201, DOI 10.1016/j.cbpb.2009.11.012; Kampfer P, 2006, INT J SYST EVOL MICR, V56, P335, DOI 10.1099/ijs.0.63999-0; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Koch AL, 2001, BIOESSAYS, V23, P657, DOI 10.1002/bies.1091; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Linser PJ, 2009, J EXP BIOL, V212, P1662, DOI 10.1242/jeb.028084; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x; Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Peterson TML, 2006, FREE RADICAL BIO MED, V40, P1067, DOI 10.1016/j.freeradbiomed.2005.10.059; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Romoser WS, 2000, J MED ENTOMOL, V37, P893, DOI 10.1603/0022-2585-37.6.893; SACKTOR B, 1966, J BIOL CHEM, V241, P624; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schopfer MP, 2010, INORG CHEM, V49, P6267, DOI 10.1021/ic100033y; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Souza AVG, 1997, FREE RADICAL BIO MED, V22, P209, DOI 10.1016/S0891-5849(96)00293-6; Spiro S, 2006, BIOCHEM SOC T, V34, P200, DOI 10.1042/BST0340200; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Vazquez-Martinez MG, 2002, J MED ENTOMOL, V39, P825, DOI 10.1603/0022-2585-39.6.825; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	83	276	287	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24767	10.1371/journal.pone.0024767	http://dx.doi.org/10.1371/journal.pone.0024767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957459	Green Published, gold			2022-12-25	WOS:000295262100018
J	Foote, AD; Morin, PA; Durban, JW; Willerslev, E; Orlando, L; Gilbert, MTP				Foote, Andrew D.; Morin, Phillip A.; Durban, John W.; Willerslev, Eske; Orlando, Ludovic; Gilbert, M. Thomas P.			Out of the Pacific and Back Again: Insights into the Matrilineal History of Pacific Killer Whale Ecotypes	PLOS ONE			English	Article							EASTERN NORTH PACIFIC; ORCINUS-ORCA; SYMPATRIC SPECIATION; GENETIC DIFFERENTIATION; ECOLOGICAL SPECIATION; DIVERGENCE; ORIGIN; POPULATIONS; PHYLOGENIES; FLOW	Killer whales (Orcinus orca) are the most widely distributed marine mammals and have radiated to occupy a range of ecological niches. Disparate sympatric types are found in the North Atlantic, Antarctic and North Pacific oceans, however, little is known about the underlying mechanisms driving divergence. Previous phylogeographic analysis using complete mitogenomes yielded a bifurcating tree of clades corresponding to described ecotypes. However, there was low support at two nodes at which two Pacific and two Atlantic clades diverged. Here we apply further phylogenetic and coalescent analyses to partitioned mitochondrial genome sequences to better resolve the pattern of past radiations in this species. Our phylogenetic reconstructions indicate that in the North Pacific, sympatry between the maternal lineages that make up each ecotype arises from secondary contact. Both the phylogenetic reconstructions and a clinal decrease in diversity suggest a North Pacific to North Atlantic founding event, and the later return of killer whales to the North Pacific. Therefore, ecological divergence could have occurred during the allopatric phase through drift or selection and/or may have either commenced or have been consolidated upon secondary contact due to resource competition. The estimated timing of bidirectional migration between the North Pacific and North Atlantic coincided with the previous inter-glacial when the leakage of fauna from the Indo-Pacific into the Atlantic via the Agulhas current was particularly vigorous.	[Foote, Andrew D.; Willerslev, Eske; Orlando, Ludovic; Gilbert, M. Thomas P.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Morin, Phillip A.; Durban, John W.] Natl Marine Fisheries Serv, Protected Resources Div, SW Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, La Jolla, CA 92038 USA; [Durban, John W.] Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Seattle, WA USA	University of Copenhagen; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Foote, AD (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark.	FooteAD@gmail.com	Willerslev, Eske/A-9619-2011; Morin, Phillip A/E-9515-2010; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/AAA-5686-2019; Gilbert, Marcus TP/A-8936-2013	Willerslev, Eske/0000-0002-7081-6748; Orlando, Ludovic/0000-0003-3936-1850; Gilbert, Marcus TP/0000-0002-5805-7195; Morin, Phillip/0000-0002-3279-1519; Foote, Andrew/0000-0001-7384-1634	ERC FroSPECTS; EU	ERC FroSPECTS; EU(European Commission)	Andrew Foote was supported by an ERC FroSPECTS exchange fellowship and an EU Marie Curie Intra-European Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD RW, 1988, CAN J ZOOL, V66, P2582, DOI 10.1139/z88-380; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Dahlheim ME, 2008, MAR MAMMAL SCI, V24, P719, DOI 10.1111/j.1748-7692.2008.00206.x; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; DOBZHANSKY T., 1951, Genetics and the origin of species.; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Foote AD, 2007, DISTRIBUTION ABUNDAN; Foote AD, 2011, MOL ECOL, V20, P629, DOI 10.1111/j.1365-294X.2010.04957.x; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K. B., 2000, KILLER WHALES NATURA; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2011, AQUAT BIOL, V11, P213, DOI 10.3354/ab00307; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Grant PR, 2009, P NATL ACAD SCI USA, V106, P20141, DOI 10.1073/pnas.0911761106; Gubili C, 2011, P ROY SOC B-BIOL SCI, V278, P1679, DOI 10.1098/rspb.2010.1856; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hare MP, 2002, EVOLUTION, V56, P804; Herman DP, 2005, MAR ECOL PROG SER, V302, P275, DOI 10.3354/meps302275; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mayr E., 1942, P1; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Pastene LA, 2007, MOL ECOL, V16, P1481, DOI 10.1111/j.1365-294X.2007.03244.x; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pitman RL, 2007, J MAMMAL, V88, P43, DOI 10.1644/06-MAMM-A-118R1.1; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Saulitis E, 2000, MAR MAMMAL SCI, V16, P94, DOI 10.1111/j.1748-7692.2000.tb00906.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; TAJIMA F, 1989, GENETICS, V123, P585; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Zerbini AN, 2007, MAR BIOL, V150, P1033, DOI 10.1007/s00227-006-0347-8	61	30	31	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24980	10.1371/journal.pone.0024980	http://dx.doi.org/10.1371/journal.pone.0024980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949818	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400028
J	Jones, FA; Erickson, DL; Bernal, MA; Bermingham, E; Kress, WJ; Herre, EA; Muller-Landau, HC; Turner, BL				Jones, F. Andrew; Erickson, David L.; Bernal, Moises A.; Bermingham, Eldredge; Kress, W. John; Herre, Edward Allen; Muller-Landau, Helene C.; Turner, Benjamin L.			The Roots of Diversity: Below Ground Species Richness and Rooting Distributions in a Tropical Forest Revealed by DNA Barcodes and Inverse Modeling	PLOS ONE			English	Article							SEED DISPERSAL; DENSITY-DEPENDENCE; PLANT DIVERSITY; IDENTIFICATION; NEIGHBORHOOD; RECRUITMENT; ABUNDANCE; PATTERNS; IDENTIFY; PCR	Background: Plants interact with each other, nutrients, and microbial communities in soils through extensive root networks. Understanding these below ground interactions has been difficult in natural systems, particularly those with high plant species diversity where morphological identification of fine roots is difficult. We combine DNA-based root identification with a DNA barcode database and above ground stem locations in a floristically diverse lowland tropical wet forest on Barro Colorado Island, Panama, where all trees and lianas >1 cm diameter have been mapped to investigate richness patterns below ground and model rooting distributions. Methodology/Principal Findings: DNA barcode loci, particularly the cpDNA locus trnH-psba, can be used to identify fine and small coarse roots to species. We recovered 33 species of roots from 117 fragments sequenced from 12 soil cores. Despite limited sampling, we recovered a high proportion of the known species in the focal hectare, representing approximately 14% of the measured woody plant richness. This high value is emphasized by the fact that we would need to sample on average 13 m(2) at the seedling layer and 45 m(2) for woody plants >1 cm diameter to obtain the same number of species above ground. Results from inverse models parameterized with the locations and sizes of adults and the species identifications of roots and sampling locations indicates a high potential for distal underground interactions among plants. Conclusions: DNA barcoding techniques coupled with modeling approaches should be broadly applicable to studying root distributions in any mapped vegetation plot. We discuss the implications of our results and outline how second-generation sequencing technology and environmental sampling can be combined to increase our understanding of how root distributions influence the potential for plant interactions in natural ecosystems.	[Jones, F. Andrew; Bernal, Moises A.; Bermingham, Eldredge; Herre, Edward Allen; Muller-Landau, Helene C.; Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Erickson, David L.; Kress, W. John] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Bernal, Moises A.] Univ Texas Austin, Dept Marine Sci, Inst Marine Sci, Port Aransas, TX USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Texas System; University of Texas Austin	Jones, FA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	f.jones@imperial.ac.uk	Turner, Benjamin L/E-5940-2011; Bernal, Moises/D-9006-2012; Turner, Benjamin/AAZ-1465-2021	Turner, Benjamin L/0000-0002-6585-0722; Turner, Benjamin/0000-0002-6585-0722; Bernal, Moises/0000-0002-3236-8403; Muller-Landau, Helene C./0000-0002-3526-9021	Tupper postdoctoral fellowship in tropical biology; National Science Foundation [DEB 0453665]; Smithsonian Institution Global Earth Observatory; Smithsonian Tropical Research Institute/Center for Tropical Forest Sciences; Smithsonian Tropical Research Institute	Tupper postdoctoral fellowship in tropical biology; National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution Global Earth Observatory; Smithsonian Tropical Research Institute/Center for Tropical Forest Sciences(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	FAJ acknowledges the support of a Tupper postdoctoral fellowship in tropical biology and the National Science Foundation (DEB 0453665). Funding was provided by the Smithsonian Institution Global Earth Observatory, the Smithsonian Tropical Research Institute/Center for Tropical Forest Sciences endowment fund, and the Smithsonian Tropical Research Institute/Frank Levinson fund. We would like to thank Autoridad Nacional del Ambiente and the Smithsonian Tropical Research Institute for processing research permits. We thank S. Hubbell and R. Condit for access to plot data, S. Schnitzer for liana census data (NSF DEB 0613666), and L. Comita and S. Hubbell for access to seedling data (NSF DEB 0075102 and DEB 0823728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bobowski BR, 1999, MOL ECOL, V8, P485, DOI 10.1046/j.1365-294X.1999.00603.x; Brisson J, 1997, ECOLOGY, V78, P2378; Brunner I, 2001, MOL ECOL, V10, P2079, DOI 10.1046/j.1365-294X.2001.01325.x; Casper BB, 2003, ECOLOGY, V84, P2313, DOI 10.1890/02-0287; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herre Edward Allen, 2005, P204, DOI 10.1017/CBO9780511541971.009; HUBBELL SP, 1987, REV BIOL TROP, V35, P7; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Jackson RB, 1999, P NATL ACAD SCI USA, V96, P11387, DOI 10.1073/pnas.96.20.11387; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Jones FA, 2008, J ECOL, V96, P642, DOI 10.1111/j.1365-2745.2008.01400.x; Jones FA, 2005, AM NAT, V166, P543, DOI 10.1086/491661; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McNickle GG, 2009, TRENDS ECOL EVOL, V24, P419, DOI 10.1016/j.tree.2009.03.004; Mommer L, 2010, J ECOL, V98, P1117, DOI 10.1111/j.1365-2745.2010.01702.x; Moore LA, 2005, J VEG SCI, V16, P131, DOI 10.1111/j.1654-1103.2005.tb02346.x; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Pizano C, 2011, ECOLOGY, V92, P47, DOI 10.1890/09-1715.1; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Ridgway Karyn P, 2003, BMC Ecol, V3, P8, DOI 10.1186/1472-6785-3-8; Robledo-Arnuncio JJ, 2008, MOL ECOL, V17, P1883, DOI 10.1111/j.1365-294X.2008.03759.x; Shinozaki K, 1964, JAPANESE J ECOL, V14, P133, DOI DOI 10.18960/SEITAI.14.4_133; Silman MR, 2006, J TROP ECOL, V22, P727, DOI 10.1017/S0266467406003658; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Stork NE, 1997, TRENDS ECOL EVOL, V12, P418, DOI 10.1016/S0169-5347(97)01205-6; Svenning JC, 2008, OECOLOGIA, V155, P143, DOI 10.1007/s00442-007-0884-y; Taggart JM, 2010, MOL ECOLOGY RESOURCE, V9999; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Valentini A., 2010, Diversity, V2, P610; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WEINER J, 1984, J ECOL, V72, P183, DOI 10.2307/2260012; Weiner J, 2001, AM NATURALIST, V148; WRIGHT SJ, 1992, OECOLOGIA, V89, P457, DOI 10.1007/BF00317149; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yastrebov AB, 1996, RUSS J ECOL+, V27, P1; Yavitt JB, 2001, BIOTROPICA, V33, P421, DOI 10.1111/j.1744-7429.2001.tb00196.x	55	56	57	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24506	10.1371/journal.pone.0024506	http://dx.doi.org/10.1371/journal.pone.0024506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949723	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900019
J	Lewald, J; Getzmann, S				Lewald, Joerg; Getzmann, Stephan			When and Where of Auditory Spatial Processing in Cortex: A Novel Approach Using Electrotomography	PLOS ONE			English	Article							SINGLE-UNIT RESPONSES; TOP-DOWN FACILITATION; SOUND LOCALIZATION; HUMAN BRAIN; NEUROMAGNETIC RESPONSES; HEADPHONE SIMULATION; INFERIOR COLLICULUS; OCCASIONAL CHANGES; PARIETAL CORTEX; INTERAURAL TIME	The modulation of brain activity as a function of auditory location was investigated using electro-encephalography in combination with standardized low-resolution brain electromagnetic tomography. Auditory stimuli were presented at various positions under anechoic conditions in free-field space, thus providing the complete set of natural spatial cues. Variation of electrical activity in cortical areas depending on sound location was analyzed by contrasts between sound locations at the time of the N1 and P2 responses of the auditory evoked potential. A clear-cut double dissociation with respect to the cortical locations and the points in time was found, indicating spatial processing (1) in the primary auditory cortex and posterodorsal auditory cortical pathway at the time of the N1, and (2) in the anteroventral pathway regions about 100 ms later at the time of the P2. Thus, it seems as if both auditory pathways are involved in spatial analysis but at different points in time. It is possible that the late processing in the anteroventral auditory network reflected the sharing of this region by analysis of object-feature information and spectral localization cues or even the integration of spatial and non-spatial sound features.	[Lewald, Joerg] Ruhr Univ Bochum, Fac Psychol, Dept Cognit Psychol, Bochum, Germany; [Lewald, Joerg; Getzmann, Stephan] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Lewald, J (corresponding author), Ruhr Univ Bochum, Fac Psychol, Dept Cognit Psychol, Bochum, Germany.	joerg.lewald@rub.de	Lewald, Jörg/D-3034-2009	Lewald, Jörg/0000-0001-9351-0170; Getzmann, Stephan/0000-0002-6382-0183	Deutsche Forschungsgemeinschaft [Ge1920/2-2, Fa211/24-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Ge1920/2-2; Fa211/24-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alain C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00202; Altmann CF, 2007, NEUROIMAGE, V35, P1192, DOI 10.1016/j.neuroimage.2007.01.007; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Bai XX, 2007, NEUROIMAGE, V35, P598, DOI 10.1016/j.neuroimage.2006.12.026; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barrett DJK, 2006, NEUROIMAGE, V32, P968, DOI 10.1016/j.neuroimage.2006.03.050; Bellmann A, 2001, BRAIN, V124, P676, DOI 10.1093/brain/124.4.676; Bidet-Caulet A, 2005, J COGNITIVE NEUROSCI, V17, P1691, DOI 10.1162/089892905774589244; Biermann S, 2000, J NEUROPHYSIOL, V84, P2426, DOI 10.1152/jn.2000.84.5.2426; BISIACH E, 1984, BRAIN, V107, P37, DOI 10.1093/brain/107.1.37; Blauert J., 1997, SPATIAL HEARING PSYC; Brunetti M, 2008, CEREB CORTEX, V18, P1139, DOI 10.1093/cercor/bhm145; Brunetti M, 2005, HUM BRAIN MAPP, V26, P251, DOI 10.1002/hbm.20164; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Chase SM, 2005, J NEUROSCI, V25, P7575, DOI 10.1523/JNEUROSCI.0915-05.2005; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Cohen YE, 2004, J NEUROSCI, V24, P11307, DOI 10.1523/JNEUROSCI.3935-04.2004; Davis KA, 1999, J NEUROPHYSIOL, V82, P164, DOI 10.1152/jn.1999.82.1.164; Davis KA, 2005, JARO-J ASSOC RES OTO, V6, P280, DOI 10.1007/s10162-005-0008-5; Davis KA, 2003, JARO-J ASSOC RES OTO, V4, P148, DOI 10.1007/s10162-002-2002-5; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Efron B., 1994, INTRO BOOTSTRAP; EFRON R, 1983, BRAIN LANG, V19, P254, DOI 10.1016/0093-934X(83)90069-X; Fujiki N, 2002, EUR J NEUROSCI, V16, P2207, DOI 10.1046/j.1460-9568.2002.02276.x; Getzmann S, EUR J NEURO IN PRESS; Getzmann S, 2010, HEARING RES, V259, P44, DOI 10.1016/j.heares.2009.09.021; Gifford GW, 2005, EXP BRAIN RES, V162, P509, DOI 10.1007/s00221-005-2220-2; Goodale MA, 2000, NEW COGNITIVE NEUROS; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Griffiths TD, 1999, NEUROIMAGE, V10, P84, DOI 10.1006/nimg.1999.0464; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HARI R, 1987, AUDIOLOGY, V26, P31; Hausmann M, 2005, COGNITIVE BRAIN RES, V25, P537, DOI 10.1016/j.cogbrainres.2005.08.008; HILLYARD SA, 1978, PERCEPT PSYCHOPHYS, V24, P391, DOI 10.3758/BF03199736; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; Imig TJ, 2000, J NEUROPHYSIOL, V83, P907, DOI 10.1152/jn.2000.83.2.907; Jin C, 2004, J ACOUST SOC AM, V115, P3124, DOI 10.1121/1.1736649; Kaiser J, 2000, J NEUROSCI, V20, P6631, DOI 10.1523/JNEUROSCI.20-17-06631.2000; Kulkarni A, 1998, NATURE, V396, P747, DOI 10.1038/25526; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lewald J, 2006, HEARING RES, V213, P99, DOI 10.1016/j.heares.2006.01.001; Lewald J, 2004, NEUROPSYCHOLOGIA, V42, P1598, DOI 10.1016/j.neuropsychologia.2004.04.012; Lewald J, 2004, J COGNITIVE NEUROSCI, V16, P828, DOI 10.1162/089892904970834; Lewald J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0005.2002; Lewald J, 2008, EUR J NEUROSCI, V27, P1261, DOI 10.1111/j.1460-9568.2008.06094.x; Lewald J, 2009, NEUROPSYCHOLOGIA, V47, P962, DOI 10.1016/j.neuropsychologia.2008.10.016; Lipschutz B, 2002, NEUROIMAGE, V17, P643, DOI 10.1006/nimg.2002.1184; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; Luck S.J., 2005, INTRO EVENT RELATED; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Martinkauppi S, 2000, CEREB CORTEX, V10, P889, DOI 10.1093/cercor/10.9.889; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; Milner A. D., 1995, VISUAL BRAIN ACTION; MOLLER H, 1992, APPL ACOUST, V36, P171, DOI 10.1016/0003-682X(92)90046-U; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; ONISHI S, 1968, J ACOUST SOC AM, V44, P582, DOI 10.1121/1.1911124; Palomaki K, 2000, NEUROREPORT, V11, P1535, DOI 10.1097/00001756-200005150-00033; Palomaki KJ, 2005, COGNITIVE BRAIN RES, V24, P364, DOI 10.1016/j.cogbrainres.2005.02.013; Pantev C, 1996, EAR HEARING, V17, P255, DOI 10.1097/00003446-199606000-00008; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; PINEK B, 1989, CORTEX, V25, P175, DOI 10.1016/S0010-9452(89)80035-8; POIRIER P, 1993, BRAIN, V116, P53, DOI 10.1093/brain/116.1.53; Pratt CC, 1930, J EXP PSYCHOL, V13, P278, DOI 10.1037/h0072651; Ramachandran R, 1999, J NEUROPHYSIOL, V82, P152, DOI 10.1152/jn.1999.82.1.152; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; Rauschecker JP, 2009, 3 INT C AUD CORT CUR, P47; Recanzone GH, 2010, BEHAV BRAIN RES, V206, P1, DOI 10.1016/j.bbr.2009.08.015; Reiss LAJ, 2005, J NEUROSCI, V25, P3680, DOI 10.1523/JNEUROSCI.4963-04.2005; RIF J, 1991, ELECTROEN CLIN NEURO, V79, P464, DOI 10.1016/0013-4694(91)90166-2; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Ross B, 2009, HEARING RES, V248, P48, DOI 10.1016/j.heares.2008.11.012; RUFF RM, 1981, NEUROPSYCHOLOGIA, V19, P435, DOI 10.1016/0028-3932(81)90073-7; Salminen NH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007600; SAMS M, 1985, ELECTROEN CLIN NEURO, V61, P254, DOI 10.1016/0013-4694(85)91092-2; Schroger E, 1996, HEARING RES, V96, P191, DOI 10.1016/0378-5955(96)00066-4; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Shahin A, 2005, NEUROREPORT, V16, P1781, DOI 10.1097/01.wnr.0000185017.29316.63; Sonnadara RR, 2006, BRAIN RES, V1076, P187, DOI 10.1016/j.brainres.2005.12.093; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka H, 1999, J NEUROL NEUROSUR PS, V67, P481, DOI 10.1136/jnnp.67.4.481; Tardif E, 2006, BRAIN RES, V1092, P161, DOI 10.1016/j.brainres.2006.03.095; Tata MS, 2005, EXP BRAIN RES, V167, P481, DOI 10.1007/s00221-005-0183-y; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tiitinen H, 2006, NEUROSCI LETT, V396, P17, DOI 10.1016/j.neulet.2005.11.018; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Ungan P, 2001, CLIN NEUROPHYSIOL, V112, P485, DOI 10.1016/S1388-2457(00)00550-2; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VALLAR G, 1995, BRAIN, V118, P467, DOI 10.1093/brain/118.2.467; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Weeks R, 2000, J NEUROSCI, V20, P2664; Weeks RA, 1999, NEUROSCI LETT, V262, P155, DOI 10.1016/S0304-3940(99)00062-2; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; YOUNG ED, 1992, PHILOS T ROY SOC B, V336, P407, DOI 10.1098/rstb.1992.0076; Zatorre RJ, 2001, J NEUROSCI, V21, P6321, DOI 10.1523/JNEUROSCI.21-16-06321.2001; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004; Zimmer U, 2006, NEUROPSYCHOLOGIA, V44, P454, DOI 10.1016/j.neuropsychologia.2005.05.021; Zimmer U, 2004, EUR J NEUROSCI, V20, P3148, DOI 10.1111/j.1460-9568.2004.03766.x; Zimmer U, 2003, J COGNITIVE NEUROSCI, V15, P694, DOI 10.1162/089892903322307410	122	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25146	10.1371/journal.pone.0025146	http://dx.doi.org/10.1371/journal.pone.0025146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949873	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900054
J	Foucaud-Vignault, M; Soayfane, Z; Menez, C; Bertrand-Michel, J; Guy, P; Martin, P; Guillou, H; Collet, X; Lespine, A				Foucaud-Vignault, Magali; Soayfane, Zeina; Menez, Cecile; Bertrand-Michel, Justine; Guy, Pascal; Martin, Pierre; Guillou, Herve; Collet, Xavier; Lespine, Anne			P-glycoprotein Dysfunction Contributes to Hepatic Steatosis and Obesity in Mice	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; CONSTITUTIVE-ANDROSTANE RECEPTOR; MULTIDRUG-RESISTANCE GENE; MEMBRANE CHOLESTEROL; CYCLOSPORINE-A; IN-VIVO; EXPRESSION; MDR1; POLYMORPHISMS; IVERMECTIN	Although the main role of P-glycoprotein (Pgp) is to extrude a broad range of xenochemicals and to protect the organism against xenotoxicity, it also transports a large range of endogenous lipids. Using mice lacking Pgp, we have investigated the possible involvement of Pgp in lipid homeostasis in vivo. In a long term study, we have followed the food intake, body status and lipid markers in plasma and liver of wild-type and mdr1ab(-/-) mice over 35 weeks. Pgp-deficient mice showed excess weight, hypertrophy of adipose mass, high insulin and glucose levels in plasma. Some of these metabolic disruptions appeared earlier in Pgp-deficient mice fed high-fat diet. Moreover, hepatosteatosis with increased expression of genes involved in liver detoxification and in de novo lipid synthesis occurred in Pgp-deficient mice. Overall, Pgp deficiency clearly induced obesity in FVB genetic background, which is known to be resistant to diet-induced obesity. These data reinforce the finding that Pgp gene could be a contributing factor and possibly a relevant marker for lipid disorder and obesity. Subsequent to Pgp deficiency, changes in body availabilities of lipids or any Pgp substrates may affect metabolic pathways that favour the occurrence of obesity. This is of special concern because people are often facing simultaneous exposition to many xenochemicals, which inhibits Pgp, and an excess in lipid dietary intake that may contribute to the high prevalence of obesity in our occidental societies.	[Foucaud-Vignault, Magali; Soayfane, Zeina; Menez, Cecile; Guy, Pascal; Martin, Pierre; Guillou, Herve; Lespine, Anne] INRA, TOXALIM, UPS, INP,UMR1331, F-31931 Toulouse, France; [Soayfane, Zeina; Collet, Xavier] NSERM, UMR 1048I, Toulouse, France; [Soayfane, Zeina; Collet, Xavier] Fac Med Toulouse, INSERM, UPS, Inst Malad Metab & Cardiovasc, F-31073 Toulouse, France; [Bertrand-Michel, Justine] IFR150, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Foucaud-Vignault, M (corresponding author), INRA, TOXALIM, UPS, INP,UMR1331, F-31931 Toulouse, France.	anne.lespine@toulouse.inra.fr	Guillou, Herve/AAG-2826-2020; Collet, Xavier/M-6938-2017; Martin, Pascal/K-8184-2019; Guillou, Hervé/AGL-0750-2022	Guillou, Herve/0000-0002-5363-9081; Martin, Pascal/0000-0002-4271-658X; Guillou, Hervé/0000-0002-5363-9081	Rangueil University; Region Midi-Pyrenees	Rangueil University; Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	This research has been supported by Rangueil University through Zeina Soayfane PhD MESR grant and by the Region Midi-Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye ILMH, 2009, CHEM-BIOL INTERACT, V180, P327, DOI 10.1016/j.cbi.2009.04.012; BATT RAL, 1978, INT J OBESITY, V2, P303; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breuker C, 2010, ENDOCRINOLOGY, V151, P1653, DOI 10.1210/en.2009-1435; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Casabar RCT, 2010, TOXICOL APPL PHARM, V245, P335, DOI 10.1016/j.taap.2010.03.017; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; COX JE, 1977, J COMP PHYSIOL PSYCH, V91, P347, DOI 10.1037/h0077322; Ducheix S, 2011, CHEM PHYS LIPIDS, V164, P500, DOI 10.1016/j.chemphyslip.2011.06.004; Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399; Gayet L, 2005, BIOCHEMISTRY-US, V44, P4499, DOI 10.1021/bi048669w; Giralt M, 2010, CURR PHARM DESIGN, V16, P3372, DOI 10.2174/138161210793563527; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Honig SM, 2003, J CLIN INVEST, V111, P627, DOI 10.1172/JCI200316200; Hu CC, 2004, OBES RES, V12, P1264, DOI 10.1038/oby.2004.160; Ichihara S, 2008, GENOMICS, V91, P512, DOI 10.1016/j.ygeno.2008.03.004; Jeannesson E, 2009, CLIN CHIM ACTA, V403, P198, DOI 10.1016/j.cca.2009.02.019; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kohle C, 2009, BIOCHEM PHARMACOL, V77, P689, DOI 10.1016/j.bcp.2008.05.020; Kwei GY, 1999, DRUG METAB DISPOS, V27, P581; Le Lay S, 2001, BIOCHEM BIOPH RES CO, V289, P564, DOI 10.1006/bbrc.2001.6015; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Mealey KL, 2001, PHARMACOGENETICS, V11, P727, DOI 10.1097/00008571-200111000-00012; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Okura T, 2010, BIOL PHARM BULL, V33, P255, DOI 10.1248/bpb.33.255; Rodrigues AC, 2005, BRAZ J MED BIOL RES, V38, P1389, DOI 10.1590/S0100-879X2005000900014; Rogue A, 2010, PPAR RES, V2010, DOI 10.1155/2010/325183; Rothnie A, 2001, EUR BIOPHYS J BIOPHY, V30, P430, DOI 10.1007/s002490100156; Roulet A, 2003, EUR J PHARMACOL, V460, P85, DOI 10.1016/S0014-2999(02)02955-2; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schuetz EG, 2000, MOL PHARMACOL, V57, P188; Terpstra V, 2000, ARTERIOSCL THROM VAS, V20, P1860, DOI 10.1161/01.ATV.20.8.1860; Tessner TG, 2000, BIOCHEM BIOPH RES CO, V267, P565, DOI 10.1006/bbrc.1999.1996; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Thornton SJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-21; Vieu C, 1996, J LIPID RES, V37, P1153; Wang HW, 2008, MOL ENDOCRINOL, V22, P838, DOI 10.1210/me.2007-0218; Yanase T, 2008, J STEROID BIOCHEM, V109, P254, DOI 10.1016/j.jsbmb.2008.03.017; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	47	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23614	10.1371/journal.pone.0023614	http://dx.doi.org/10.1371/journal.pone.0023614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949682	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800004
J	Lin, JZ; Zhang, LM; Lai, SM; Ye, KQ				Lin, Jinzhong; Zhang, Liman; Lai, Shaomei; Ye, Keqiong			Structure and Molecular Evolution of CDGSH Iron-Sulfur Domains	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; MULTIPLE SEQUENCE ALIGNMENT; 2FE-2S CLUSTER; CRYSTAL-STRUCTURE; MITONEET; MUTATION; BINDING	The recently discovered CDGSH iron-sulfur domains (CISDs) are classified into seven major types with a wide distribution throughout the three domains of life. The type 1 protein mitoNEET has been shown to fold into a dimer with the signature CDGSH motif binding to a [2Fe-2S] cluster. However, the structures of all other types of CISDs were unknown. Here we report the crystal structures of type 3, 4, and 6 CISDs determined at 1.5 angstrom, 1.8 angstrom and 1.15 angstrom resolution, respectively. The type 3 and 4 CISD each contain one CDGSH motif and adopt a dimeric structure. Although similar to each other, the two structures have permutated topologies, and both are distinct from the type 1 structure. The type 6 CISD contains tandem CDGSH motifs and adopts a monomeric structure with an internal pseudo dyad symmetry. All currently known CISD structures share dual iron-sulfur binding modules and a beta-sandwich for either intermolecular or intramolecular dimerization. The iron-sulfur binding module, the beta-strand N-terminal to the module and a proline motif are conserved among different type structures, but the dimerization module and the interface and orientation between the two iron-sulfur binding modules are divergent. Sequence analysis further shows resemblance between CISD types 4 and 7 and between 1 and 2. Our findings suggest that all CISDs share common ancestry and diverged into three primary folds with a characteristic phylogenetic distribution: a eukaryote-specific fold adopted by types 1 and 2 proteins, a prokaryote-specific fold adopted by types 3, 4 and 7 proteins, and a tandem-motif fold adopted by types 5 and 6 proteins. Our comprehensive structural, sequential and phylogenetic analysis provides significant insight into the assembly principles and evolutionary relationship of CISDs.	[Lin, Jinzhong; Zhang, Liman; Lai, Shaomei; Ye, Keqiong] Natl Inst Biol Sci, Beijing, Peoples R China; [Zhang, Liman] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Zhang, Liman] Peking Union Med Coll, Beijing 100021, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lin, JZ (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	yekeqiong@nibs.ac.cn	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526	Chinese Ministry of Science and Technology [2008AA022310]; Beijing Municipal Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government	This research was supported by the Chinese Ministry of Science and Technology through 863 grant 2008AA022310 and 973 project and the Beijing Municipal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2011, ACTA CRYSTALLOGR D, V67, P516, DOI 10.1107/S0907444911011577; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; DeLano WL, 2002, PYMOL USERS MANUAL; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Iwasaki T, 2009, J AM CHEM SOC, V131, P13659, DOI 10.1021/ja903228w; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kounosu A, 2008, ACTA CRYSTALLOGR F, V64, P1146, DOI 10.1107/S1744309108035975; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacedoRibeiro S, 1996, STRUCTURE, V4, P1291, DOI 10.1016/S0969-2126(96)00137-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zuris JA, 2010, J AM CHEM SOC, V132, P13120, DOI 10.1021/ja103920k	33	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24790	10.1371/journal.pone.0024790	http://dx.doi.org/10.1371/journal.pone.0024790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949752	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800038
J	Liu, W; Niranjan, M				Liu, Wei; Niranjan, Mahesan			The Role of Regulated mRNA Stability in Establishing Bicoid Morphogen Gradient in Drosophila Embryonic Development	PLOS ONE			English	Article							POSITIONAL INFORMATION; PARAMETER-ESTIMATION; GENE-EXPRESSION; DIFFUSION; PROTEIN; NUCLEAR; PATTERN; SIMULATION; PRECISION; HUNCHBACK	The Bicoid morphogen is amongst the earliest triggers of differential spatial pattern of gene expression and subsequent cell fate determination in the embryonic development of Drosophila. This maternally deposited morphogen is thought to diffuse in the embryo, establishing a concentration gradient which is sensed by downstream genes. In most model based analyses of this process, the translation of the bicoid mRNA is thought to take place at a fixed rate from the anterior pole of the embryo and a supply of the resulting protein at a constant rate is assumed. Is this process of morphogen generation a passive one as assumed in the modelling literature so far, or would available data support an alternate hypothesis that the stability of the mRNA is regulated by active processes? We introduce a model in which the stability of the maternal mRNA is regulated by being held constant for a length of time, followed by rapid degradation. With this more realistic model of the source, we have analysed three computational models of spatial morphogen propagation along the anterior-posterior axis: (a) passive diffusion modelled as a deterministic differential equation, (b) diffusion enhanced by a cytoplasmic flow term; and (c) diffusion modelled by stochastic simulation of the corresponding chemical reactions. Parameter estimation on these models by matching to publicly available data on spatio-temporal Bicoid profiles suggests strong support for regulated stability over either a constant supply rate or one where the maternal mRNA is permitted to degrade in a passive manner.	[Liu, Wei; Niranjan, Mahesan] Univ Southampton, Sch Elect & Comp Sci, Southampton, Hants, England	University of Southampton	Liu, W (corresponding author), Univ Southampton, Sch Elect & Comp Sci, Southampton, Hants, England.	wl08r@ecs.soton.ac.uk		Niranjan, Mahesan/0000-0001-7021-140X				Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Cheung D, 2011, DEVELOPMENT, V138, P2741, DOI 10.1242/dev.064402; Cooperstock RL, 1997, SEMIN CELL DEV BIOL, V8, P541, DOI 10.1006/scdb.1997.0179; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; Coppey M, 2007, DEV BIOL, V312, P623, DOI 10.1016/j.ydbio.2007.09.058; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Dewar MA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-21; Dilao R, 2010, J THEOR BIOL, V264, P847, DOI 10.1016/j.jtbi.2010.03.012; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Erban R., 2007, ARXIV07041908; FOE VE, 1983, J CELL SCI, V61, P31; Fomekong-Nanfack Y, 2007, BIOINFORMATICS, V23, P3356, DOI 10.1093/bioinformatics/btm433; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; He F, 2010, BIOPHYS J, V99, P697, DOI 10.1016/j.bpj.2010.04.073; Hecht I, 2009, P NATL ACAD SCI USA, V106, P1710, DOI 10.1073/pnas.0807655106; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kavousanakis ME, 2010, DEV BIOL, V345, P12, DOI 10.1016/j.ydbio.2010.05.491; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Lohr U, 2010, FLY, V4, P236, DOI 10.4161/fly.4.3.11862; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; Porcher A, 2010, CURR BIOL, V20, pR249, DOI 10.1016/j.cub.2010.01.026; Poustelnikova E, 2004, BIOINFORMATICS, V20, P2212, DOI 10.1093/bioinformatics/bth222; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Surdej P, 1998, MOL CELL BIOL, V18, P2892, DOI 10.1128/MCB.18.5.2892; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu YF, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-52	45	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24896	10.1371/journal.pone.0024896	http://dx.doi.org/10.1371/journal.pone.0024896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949782	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000295173800047
J	Reiss, LK; Kowallik, A; Uhlig, S				Reiss, Lucy Kathleen; Kowallik, Anke; Uhlig, Stefan			Recurrent Recruitment Manoeuvres Improve Lung Mechanics and Minimize Lung Injury during Mechanical Ventilation of Healthy Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; TIDAL VOLUME VENTILATION; PROTECTIVE VENTILATION; PULMONARY; ALVEOLAR; STRATEGY; INFLAMMATION; IMPAIRMENT; MODEL	Introduction: Mechanical ventilation (MV) of mice is increasingly required in experimental studies, but the conditions that allow stable ventilation of mice over several hours have not yet been fully defined. In addition, most previous studies documented vital parameters and lung mechanics only incompletely. The aim of the present study was to establish experimental conditions that keep these parameters within their physiological range over a period of 6 h. For this purpose, we also examined the effects of frequent short recruitment manoeuvres (RM) in healthy mice. Methods: Mice were ventilated at low tidal volume V-T = 8 mL/kg or high tidal volume V-T = 16 mL/kg and a positive end-expiratory pressure (PEEP) of 2 or 6 cmH(2)O. RM were performed every 5 min, 60 min or not at all. Lung mechanics were followed by the forced oscillation technique. Blood pressure (BP), electrocardiogram (ECG), heart frequency (HF), oxygen saturation and body temperature were monitored. Blood gases, neutrophil-recruitment, microvascular permeability and pro-inflammatory cytokines in bronchoalveolar lavage (BAL) and blood serum as well as histopathology of the lung were examined. Results: MV with repetitive RM every 5 min resulted in stable respiratory mechanics. Ventilation without RM worsened lung mechanics due to alveolar collapse, leading to impaired gas exchange. HF and BP were affected by anaesthesia, but not by ventilation. Microvascular permeability was highest in atelectatic lungs, whereas neutrophil-recruitment and structural changes were strongest in lungs ventilated with high tidal volume. The cytokines IL-6 and KC, but neither TNF nor IP-10, were elevated in the BAL and serum of all ventilated mice and were reduced by recurrent RM. Lung mechanics, oxygenation and pulmonary inflammation were improved by increased PEEP. Conclusions: Recurrent RM maintain lung mechanics in their physiological range during low tidal volume ventilation of healthy mice by preventing atelectasis and reduce the development of pulmonary inflammation.	[Reiss, Lucy Kathleen; Kowallik, Anke; Uhlig, Stefan] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany	RWTH Aachen University	Reiss, LK (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany.	kreiss@ukaachen.de	Uhlig, Stefan/A-7290-2014	Uhlig, Stefan/0000-0003-2332-1280	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work has been funded by the Deutsche Forschungsgemeinschaft (www.dfg.de). The funders have no role in study design, data collection and analysis, decision to pubish, or preparation of the manuscript.	Allen GB, 2006, AM J PHYSIOL-LUNG C, V291, pL710, DOI 10.1152/ajplung.00532.2005; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bates JHT, 2009, IEEE ENG MED BIO, P170, DOI 10.1109/IEMBS.2009.5333302; Bates JHT, 2006, ANN BIOMED ENG, V34, P384, DOI 10.1007/s10439-005-9056-6; Beck-Schimmer B, 2010, BEST PRACT RES-CLIN, V24, P199, DOI 10.1016/j.bpa.2010.02.005; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Boker A, 2004, ANESTHESIOLOGY, V100, P608, DOI 10.1097/00000542-200403000-00022; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Cannizzaro V, 2009, RESP PHYSIOL NEUROBI, V169, P243, DOI 10.1016/j.resp.2009.09.012; Chavolla-Calderon M, 2003, J CLIN INVEST, V111, P973, DOI 10.1172/JCI200317458; Cuellar JM, 2004, BRAIN RES PROTOC, V13, P126, DOI 10.1016/j.brainresprot.2004.03.002; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; dos Santos CC, 2006, ANNU REV PHYSIOL, V68, P585, DOI 10.1146/annurev.physiol.68.072304.113443; Finigan JH, 2009, AM J PHYSIOL-LUNG C, V296, pL1002, DOI 10.1152/ajplung.90555.2008; Futier E, 2010, ANESTHESIOLOGY, V113, P1310, DOI 10.1097/ALN.0b013e3181fc640a; Gharib SA, 2009, PHYSIOL GENOMICS, V37, P239, DOI 10.1152/physiolgenomics.00027.2009; Haitsma JJ, 2006, MINERVA ANESTESIOL, V72, P117; Haitsma JJ, 2000, INTENS CARE MED, V26, P1515, DOI 10.1007/s001340000648; Halbertsma FJJ, 2008, CRIT CARE MED, V36, P2403, DOI 10.1097/CCM.0b013e318180266e; Halter JM, 2007, CRIT CARE, V11, DOI 10.1186/cc5695; Hauber HP, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-21; Hodgson C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006667.pub2; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; Hubmayr RD, 2002, AM J RESP CRIT CARE, V165, P1647, DOI 10.1164/rccm.2001080-01CP; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Kacmarek RM, 2007, RESP CARE, V52, P622; Laffey JG, 2003, CRIT CARE MED, V31, P2634, DOI 10.1097/01.CCM.0000089646.52395.BA; Lim SC, 2004, CRIT CARE MED, V32, P2371, DOI 10.1097/01.CCM.0000147445.73344.3A; Maniatis NA, 2009, AM J RESP CELL MOL, V41, P426, DOI 10.1165/rcmb.2008-0144OC; MEAD J, 1959, J APPL PHYSIOL, V14, P669, DOI 10.1152/jappl.1959.14.5.669; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Meier T, 2008, ANESTH ANALG, V107, P1265, DOI 10.1213/ane.0b013e3181806212; Muller HC, 2010, CRIT CARE, V14, DOI 10.1186/cc9209; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Pinheiro de Oliveira Roselaine, 2010, Crit Care, V14, pR39, DOI 10.1186/cc8919; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Seah AS, 2011, ANN BIOMED ENG, V39, P1505, DOI 10.1007/s10439-010-0237-6; Soutiere SE, 2004, J APPL PHYSIOL, V96, P1658, DOI 10.1152/japplphysiol.01098.2003; Spieth PM, 2009, AM J RESP CRIT CARE, V179, P684, DOI 10.1164/rccm.200806-975OC; Thammanomai A, 2008, J APPL PHYSIOL, V104, P1329, DOI 10.1152/japplphysiol.01002.2007; Thammanomai A, 2007, J APPL PHYSIOL, V103, P1551, DOI 10.1152/japplphysiol.00006.2007; Tsangaris I, 2003, EUR RESPIR J, V21, P495, DOI 10.1183/09031936.03.00037902; Uhlig S, 2004, AM J RESP CRIT CARE, V169, P314, DOI 10.1164/ajrccm.169.2.950; UHLIG S, 1994, J PHARMACOL TOXICOL, V31, P85, DOI 10.1016/1056-8719(94)90047-7; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Uhlig U, 2011, COMPR PHYSIOL, V1, P635, DOI 10.1002/cphy.c100004; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Vaporidi K, 2008, CRIT CARE MED, V36, P1277, DOI 10.1097/CCM.0b013e318169f30e; Verbrugge SJC, 2007, CLIN PHYSIOL FUNCT I, V27, P67, DOI 10.1111/j.1475-097X.2007.00722.x; Verbrugge SJC, 1998, BRIT J ANAESTH, V80, P360, DOI 10.1093/bja/80.3.360; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; von Bethmann AN, 1998, AM J RESP CRIT CARE, V157, P263, DOI 10.1164/ajrccm.157.1.9608052; Weingarten TN, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.032; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yamamoto N, 2011, INT J CLIN ONCOL, V16, P84, DOI 10.1007/s10147-011-0201-y; Zosky GR, 2008, J APPL PHYSIOL, V105, P685, DOI 10.1152/japplphysiol.90328.2008	61	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24527	10.1371/journal.pone.0024527	http://dx.doi.org/10.1371/journal.pone.0024527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935418	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700039
J	Seol, J; Oh, M; Kim, JS; Jin, SH; Kim, SI; Chung, CK				Seol, Jaeho; Oh, MiAe; Kim, June Sic; Jin, Seung-Hyun; Kim, Sun Il; Chung, Chun Kee			Discrimination of Timbre in Early Auditory Responses of the Human Brain	PLOS ONE			English	Article							EVOKED-RESPONSES; TONOTOPIC ORGANIZATION; SPECTRAL COMPLEXITY; P50 SUPPRESSION; SPEECH STIMULI; CORTEX; SOUNDS; SENSITIVITY; FIELDS; PITCH	Background: The issue of how differences in timbre are represented in the neural response still has not been well addressed, particularly with regard to the relevant brain mechanisms. Here we employ phasing and clipping of tones to produce auditory stimuli differing to describe the multidimensional nature of timbre. We investigated the auditory response and sensory gating as well, using by magnetoencephalography (MEG). Methodology/Principal Findings: Thirty-five healthy subjects without hearing deficit participated in the experiments. Two different or same tones in timbre were presented through conditioning (S1) - testing (S2) paradigm as a pair with an interval of 500 ms. As a result, the magnitudes of auditory M50 and M100 responses were different with timbre in both hemispheres. This result might support that timbre, at least by phasing and clipping, is discriminated in the auditory early processing. The second response in a pair affected by S1 in the consecutive stimuli occurred in M100 of the left hemisphere, whereas both M50 and M100 responses to S2 only in the right hemisphere reflected whether two stimuli in a pair were the same or not. Both M50 and M100 magnitudes were different with the presenting order (S1 vs. S2) for both same and different conditions in the both hemispheres. Conclusions/Significances: Our results demonstrate that the auditory response depends on timbre characteristics. Moreover, it was revealed that the auditory sensory gating is determined not by the stimulus that directly evokes the response, but rather by whether or not the two stimuli are identical in timbre.	[Seol, Jaeho; Chung, Chun Kee] Seoul Natl Univ, Coll Humanities, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Seol, Jaeho; Kim, June Sic; Jin, Seung-Hyun; Chung, Chun Kee] Seoul Natl Univ Hosp, MEG Ctr, Dept Neurosurg, Seoul 110744, South Korea; [Oh, MiAe] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea; [Kim, June Sic; Jin, Seung-Hyun; Chung, Chun Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul 151742, South Korea; [Kim, Sun Il] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Hanyang University	Seol, J (corresponding author), Seoul Natl Univ, Coll Humanities, Interdisciplinary Program Cognit Sci, Seoul, South Korea.	chungc@snu.ac.kr	Seol, Jaeho/L-2811-2013; Seol, Jaeho/O-4110-2019; Kim, June Sic/F-8069-2013; Chung, Chun Kee/J-5650-2012	Seol, Jaeho/0000-0002-7953-6179; Seol, Jaeho/0000-0002-7953-6179; Chung, Chun Kee/0000-0003-3485-2327	National Research Foundation of Korea (NRF) [KRF-2007-313-H00006, 2011-0000378]; Korean government (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by grants from the National Research Foundation of Korea (NRF), numbers KRF-2007-313-H00006 and 2011-0000378, funded by the Korean government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; [Anonymous], S111994 ANSI; Bizley JK, 2010, NEUROSCIENTIST, V16, P453, DOI 10.1177/1073858410371009; Bizley JK, 2009, J NEUROSCI, V29, P2064, DOI 10.1523/JNEUROSCI.4755-08.2009; Boutros NN, 1999, BIOL PSYCHIAT, V45, P917, DOI 10.1016/S0006-3223(98)00253-4; BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; Cardenas VA, 1997, BIOL PSYCHIAT, V41, P891, DOI 10.1016/S0006-3223(96)00186-2; Cardy JEO, 2004, NEUROREPORT, V15, P1867, DOI 10.1097/00001756-200408260-00006; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Chait M, 2004, NEUROREPORT, V15, P2455, DOI 10.1097/00001756-200411150-00004; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Devlin JT, 2003, J NEUROSCI, V23, P11516; Ermutlu MN, 2007, NEUROSCI LETT, V412, P1, DOI 10.1016/j.neulet.2006.09.006; GREY JM, 1977, J ACOUST SOC AM, V61, P1270, DOI 10.1121/1.381428; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hertrich I, 2003, COGNITIVE BRAIN RES, V17, P130, DOI 10.1016/S0926-6410(03)00087-9; Hertrich I, 2000, NEUROREPORT, V11, P4017, DOI 10.1097/00001756-200012180-00023; Kanno A, 2000, NEUROSCI LETT, V293, P187, DOI 10.1016/S0304-3940(00)01525-1; Kizkin S, 2006, BRAIN COGNITION, V61, P249, DOI 10.1016/j.bandc.2006.01.006; Kuriki S, 2007, CEREB CORTEX, V17, P2725, DOI 10.1093/cercor/bhl182; LENHARDT ML, 1972, J COMMUN DISORD, V5, P51, DOI 10.1016/0021-9924(72)90030-5; Marshall PJ, 2004, INT J PSYCHOPHYSIOL, V51, P135, DOI 10.1016/j.ijpsycho.2003.08.004; Meyer M, 2006, NEUROIMAGE, V32, P1510, DOI 10.1016/j.neuroimage.2006.04.193; Mizuochi T, 2005, NEUROREPORT, V16, P555, DOI 10.1097/00001756-200504250-00007; Mizuochi T, 2007, NEUROREPORT, V18, P1945, DOI 10.1097/WNR.0b013e3282f202c6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onitsuka T, 2000, CLIN NEUROPHYSIOL, V111, P237, DOI 10.1016/S1388-2457(99)00241-2; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; PLOMP R, 1969, J ACOUST SOC AM, V46, P409, DOI 10.1121/1.1911705; Ritter S, 2007, CLIN NEUROPHYSIOL, V118, P2276, DOI 10.1016/j.clinph.2007.06.017; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; Shahin A, 2005, NEUROREPORT, V16, P1781, DOI 10.1097/01.wnr.0000185017.29316.63; Shahin AJ, 2007, BRAIN TOPOGR, V20, P55, DOI 10.1007/s10548-007-0031-4; STEINSCHNEIDER M, 1994, ELECTROEN CLIN NEURO, V92, P30, DOI 10.1016/0168-5597(94)90005-1; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Tavabi K, 2007, EUR J NEUROSCI, V25, P3155, DOI 10.1111/j.1460-9568.2007.05572.x; Teismann IK, 2004, NEUROREPORT, V15, P1267, DOI 10.1097/01.wnr.0000129856.58404.2d; Thoma RJ, 2003, AM J PSYCHIAT, V160, P1595, DOI 10.1176/appi.ajp.160.9.1595; WALDO MC, 1986, PSYCHIAT RES, V19, P233, DOI 10.1016/0165-1781(86)90102-2; White PM, 2006, PSYCHOPHYSIOLOGY, V43, P320, DOI 10.1111/j.1469-8986.2006.00408.x; Zaehle T, 2004, EUR J NEUROSCI, V20, P2447, DOI 10.1111/j.1460-9568.2004.03687.x; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	45	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24959	10.1371/journal.pone.0024959	http://dx.doi.org/10.1371/journal.pone.0024959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822JR	21949807	gold, Green Published, Green Submitted			2022-12-25	WOS:000295041700083
J	Ziats, MN; Rennert, OM				Ziats, Mark N.; Rennert, Owen M.			Expression Profiling of Autism Candidate Genes during Human Brain Development Implicates Central Immune Signaling Pathways	PLOS ONE			English	Article							SPECTRUM DISORDERS; NEURODEVELOPMENTAL DISORDERS; RETT-SYNDROME; GENETICS; ACTIVATION; DISEASE; TWIN; SCHIZOPHRENIA; ASSOCIATION; GLUTAMATE	The Autism Spectrum Disorders (ASD) represent a clinically heterogeneous set of conditions with strong hereditary components. Despite substantial efforts to uncover the genetic basis of ASD, the genomic etiology appears complex and a clear understanding of the molecular mechanisms underlying Autism remains elusive. We hypothesized that focusing gene interaction networks on ASD-implicated genes that are highly expressed in the developing brain may reveal core mechanisms that are otherwise obscured by the genomic heterogeneity of the disorder. Here we report an in silico study of the gene expression profile from ASD-implicated genes in the unaffected developing human brain. By implementing a biologically relevant approach, we identified a subset of highly expressed ASD-candidate genes from which interactome networks were derived. Strikingly, immune signaling through NF kappa B, Tnf, and Jnk was central to ASD networks at multiple levels of our analysis, and cell-type specific expression suggested glia-in addition to neurons-deserve consideration. This work provides integrated genomic evidence that ASD-implicated genes may converge on central cytokine signaling pathways.	[Ziats, Mark N.; Rennert, Owen M.] NICHHD, Lab Clin & Dev Genom, NIH, Bethesda, MD 20892 USA; [Ziats, Mark N.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Ziats, Mark N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Natl Inst Hlth, Biomed Scholars Program, Cambridge, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Baylor College of Medicine; University of Cambridge	Ziats, MN (corresponding author), NICHHD, Lab Clin & Dev Genom, NIH, Bethesda, MD 20892 USA.	ziatsm@mail.nih.gov	Rennert, owen/AAI-7374-2020		National Institute of Child Health and Human Development; National Institutes of Health (NIH); NIH-University of Cambridge; Baylor College of Medicine MSTP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008822] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-University of Cambridge(University of CambridgeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine MSTP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program at National Institute of Child Health and Human Development, National Institutes of Health (NIH). MNZ was also supported by the NIH-University of Cambridge Biomedical Scholars Program and Baylor College of Medicine MSTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bolton MM, 2009, CURR OPIN NEUROBIOL, V19, P491, DOI 10.1016/j.conb.2009.09.007; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Buxbaum JD, 2002, MOL PSYCHIATR, V7, P311, DOI 10.1038/sj.mp.4001011; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Croonenberghs J, 2002, NEUROPSYCHOBIOLOGY, V45, P1, DOI 10.1159/000048665; Derecki NC, 2010, MOL PSYCHIATR, V15, P355, DOI 10.1038/mp.2010.21; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Galperin MY, 2005, NUCLEIC ACIDS RES, V33, pD5, DOI 10.1093/nar/gki139; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goines P, 2010, CURR OPIN NEUROL, V23, P111, DOI 10.1097/WCO.0b013e3283373514; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Holt R, 2010, EUR J HUM GENET, V18, P1013, DOI 10.1038/ejhg.2010.69; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lintas C, 2012, NEUROBIOL DIS, V45, P57, DOI 10.1016/j.nbd.2010.11.010; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009; Molloy CA, 2006, J NEUROIMMUNOL, V172, P198, DOI 10.1016/j.jneuroim.2005.11.007; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Peters J, 2008, ADV EXP MED BIOL, V626, P16; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Piven J, 1997, J CHILD PSYCHOL PSYC, V38, P1011, DOI 10.1111/j.1469-7610.1997.tb01618.x; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Schaefer GB, 2008, GENET MED, V10, P301, DOI 10.1097/GIM.0b013e31816b5cc9; Schumann CM, 2011, BRAIN RES, V1380, P175, DOI 10.1016/j.brainres.2010.09.061; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tebbenkamp ATN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013675; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	64	56	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24691	10.1371/journal.pone.0024691	http://dx.doi.org/10.1371/journal.pone.0024691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935439	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700050
J	Oyang, EL; Davidson, BC; Lee, W; Poon, MM				Oyang, Elaine L.; Davidson, Bonnie C.; Lee, Winfong; Poon, Michael M.			Functional Characterization of the Dendritically Localized mRNA Neuronatin in Hippocampal Neurons	PLOS ONE			English	Article							X MENTAL-RETARDATION; LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; RETINOIC ACID; SYNAPTIC PLASTICITY; RAT-BRAIN; CALCIUM; SPINES; GENE; FMRP	Local translation of dendritic mRNAs plays an important role in neuronal development and synaptic plasticity. Although several hundred putative dendritic transcripts have been identified in the hippocampus, relatively few have been verified by in situ hybridization and thus remain uncharacterized. One such transcript encodes the protein neuronatin. Neuronatin has been shown to regulate calcium levels in non-neuronal cells such as pancreatic or embryonic stem cells, but its function in mature neurons remains unclear. Here we report that neuronatin is translated in hippocampal dendrites in response to blockade of action potentials and NMDA-receptor dependent synaptic transmission by TTX and APV. Our study also reveals that neuronatin can adjust dendritic calcium levels by regulating intracellular calcium storage. We propose that neuronatin may impact synaptic plasticity by modulating dendritic calcium levels during homeostatic plasticity, thereby potentially regulating neuronal excitability, receptor trafficking, and calcium dependent signaling.	[Oyang, Elaine L.; Davidson, Bonnie C.; Lee, Winfong; Poon, Michael M.] Harvey Mudd Coll Claremont, Dept Biol, Claremont, CA 91711 USA	Claremont Colleges; Harvey Mudd College	Oyang, EL (corresponding author), Harvey Mudd Coll Claremont, Dept Biol, Claremont, CA 91711 USA.	mpoon@inceptionsci.com			Howard Hughes Medical Institute [52006301]	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by a Howard Hughes Medical Institute Teaching and Research Postdoctoral Fellowship (Award# 52006301) to M. M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berry FB, 1996, J NEUROSCI RES, V43, P565, DOI 10.1002/(SICI)1097-4547(19960301)43:5<565::AID-JNR6>3.0.CO;2-G; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolsover S, 2001, BIOCHEM J, V356, P345, DOI 10.1042/0264-6021:3560345; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Collins E, 1998, METH MOL B, V93, P79; Colyer J, 1998, ANN NY ACAD SCI, V853, P79, DOI 10.1111/j.1749-6632.1998.tb08258.x; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dou DX, 1996, BRAIN RES, V723, P8, DOI 10.1016/0006-8993(96)00167-9; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Feng Y, 1997, J NEUROSCI, V17, P1539; Goel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018264; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; GURD JW, 1974, J NEUROCHEM, V22, P281, DOI 10.1111/j.1471-4159.1974.tb11591.x; Harris KM, 1999, P NATL ACAD SCI USA, V96, P12213, DOI 10.1073/pnas.96.22.12213; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; JOSEPH R, 1995, BRAIN RES, V690, P92, DOI 10.1016/0006-8993(95)00621-V; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; LIN HH, 2010, STEM CELLS; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Lohmann C, 2009, PROG BRAIN RES, V175, P443, DOI 10.1016/S0079-6123(09)17529-5; Majewska A, 2000, J NEUROSCI, V20, P1722; Mattson MP, 2007, NEUROCHEM RES, V32, P707, DOI 10.1007/s11064-006-9170-3; Meredith RM, 2007, NEURON, V54, P627, DOI 10.1016/j.neuron.2007.04.028; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Nath S, 2011, MOL CELL NEUROSCI, V46, P516, DOI 10.1016/j.mcn.2010.12.004; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Poon MM, 2008, P NATL ACAD SCI USA, V105, P20303, DOI 10.1073/pnas.0807740105; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Soden ME, 2010, J NEUROSCI, V30, P16910, DOI 10.1523/JNEUROSCI.3660-10.2010; STEWARD O, 1982, J NEUROSCI, V2, P284; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Surendran S, 2005, NEUROCHEM INT, V46, P595, DOI 10.1016/j.neuint.2005.02.010; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tian QB, 1999, MOL BRAIN RES, V72, P147, DOI 10.1016/S0169-328X(99)00214-4; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; WEILER I J, 1991, Molecular and Cellular Neuroscience, V2, P305, DOI 10.1016/1044-7431(91)90060-2; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	77	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24879	10.1371/journal.pone.0024879	http://dx.doi.org/10.1371/journal.pone.0024879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935485	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700058
J	Piston, F; Gil-Humanes, J; Rodriguez-Quijano, M; Barro, F				Piston, Fernando; Gil-Humanes, Javier; Rodriguez-Quijano, Marta; Barro, Francisco			Down-Regulating gamma-Gliadins in Bread Wheat Leads to Non-Specific Increases in Other Gluten Proteins and Has No Major Effect on Dough Gluten Strength	PLOS ONE			English	Article							SDS-SEDIMENTATION TEST; ALLELIC VARIATION; STORAGE PROTEINS; MIXOGRAPH PARAMETERS; ANEUPLOID LINES; QUALITY; GENE; SUBUNITS; MAIZE; EXPRESSION	Background: Gliadins are a major component of gluten proteins but their role in the mixing of dough is not well understood because their contribution to wheat flour functional properties are not as clear as for the glutenin fraction. Methodology/Principal Findings: Transgenic lines of bread wheat with gamma-gliadins suppressed by RNAi are reported. The effects on the gluten protein composition and on technological properties of flour were analyzed by RP-HPLC, by sodium dodecyl sulfate sedimentation (SDSS) test and by Mixograph analysis. The silencing of gamma-gliadins by RNAi in wheat lines results in an increase in content of all other gluten proteins. Despite the gluten proteins compensation, in silico analysis of amino acid content showed no difference in the gamma-gliadins silenced lines. The SDSS test and Mixograph parameters were slightly affected by the suppression of gamma-gliadins. Conclusions/Significance: Therefore, it is concluded that gamma-gliadins do not have an essential functional contribution to the bread-making quality of wheat dough, and their role can be replaced by other gluten proteins.	[Piston, Fernando; Gil-Humanes, Javier; Barro, Francisco] CSIC, Inst Agr Sostenible, Cordoba, Spain; [Rodriguez-Quijano, Marta] Univ Politecn Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad Politecnica de Madrid	Piston, F (corresponding author), CSIC, Inst Agr Sostenible, Cordoba, Spain.	fpiston@ias.csic.es	Barro, Francisco/E-8572-2017; Gil-Humanes, Javier/AAU-4381-2020; Barro, Francisco/J-3254-2014; Piston, Fernando/AAD-6975-2020	Barro, Francisco/0000-0002-7652-229X; Piston, Fernando/0000-0002-5496-0205; Gil Humanes, Javier/0000-0002-7283-6945	Spanish Comision Interministerial de Ciencia y Tecnologia [AGL2010-19643-C02-02, TRA2009_0047]; European Regional Development Fund (FEDER); Junta de Andalucia [P09-AGR-4783]	Spanish Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Comision Interministerial de Ciencia y Tecnologia (AGL2010-19643-C02-02 and TRA2009_0047), the European Regional Development Fund (FEDER), and Junta de Andalucia (Project P09-AGR-4783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1999, 5440A AACC, P1; AYOUB M, 1993, CAN J PLANT SCI, V73, P995, DOI 10.4141/cjps93-130; BURNOUF T, 1985, THEOR APPL GENET, V70, P610, DOI 10.1007/BF00252286; Carter BP, 1999, CEREAL CHEM, V76, P907, DOI 10.1094/CCHEM.1999.76.6.907; Dumur J, 2004, PROTEOMICS, V4, P2685, DOI 10.1002/pmic.200300800; ECKERT B, 1993, Z LEBENSM UNTERS FOR, V196, P122, DOI 10.1007/BF01185570; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; GALILI G, 1986, P NATL ACAD SCI USA, V83, P6524, DOI 10.1073/pnas.83.17.6524; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; GUPTA RB, 1994, J CEREAL SCI, V19, P19, DOI 10.1006/jcrs.1994.1004; Hagan ND, 2003, PLANT J, V34, P1, DOI 10.1046/j.1365-313X.2003.01699.x; HAMER RJ, 2009, STRUCTURE FUNCTIONAL, P153; Hansen M, 2007, J EXP BOT, V58, P3987, DOI 10.1093/jxb/erm254; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; Huang SS, 2004, J AGR FOOD CHEM, V52, P1958, DOI 10.1021/jf0342223; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; IIDA S, 1993, THEOR APPL GENET, V87, P374, DOI 10.1007/BF01184926; Kawakatsu T, 2010, PLANT PHYSIOL, V154, P1842, DOI 10.1104/pp.110.164343; Khatkar BS, 1996, J SCI FOOD AGR, V72, P71, DOI 10.1002/(SICI)1097-0010(199609)72:1<71::AID-JSFA625>3.0.CO;2-4; Leon E, 2010, J CEREAL SCI, V51, P13, DOI 10.1016/j.jcs.2009.09.001; LORENZO A, 1987, CROP SCI, V27, P253, DOI 10.2135/cropsci1987.0011183X002700020026x; LORENZO A, 1987, CROP SCI, V27, P247, DOI 10.2135/cropsci1987.0011183X002700020025x; Martinant JP, 1998, J CEREAL SCI, V27, P179, DOI 10.1006/jcrs.1997.0156; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Morris CF, 2007, J SCI FOOD AGR, V87, P607, DOI 10.1002/jsfa.2740; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1987, J CEREAL SCI, V6, P103, DOI 10.1016/S0733-5210(87)80047-4; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; Piston F, 2008, EUPHYTICA, V162, P371, DOI 10.1007/s10681-007-9530-3; Piston F, 2009, MOL BREEDING, V23, P655, DOI 10.1007/s11032-009-9263-1; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; Scossa F, 2008, PROTEOMICS, V8, P2948, DOI 10.1002/pmic.200700861; Segal G, 2003, GENETICS, V165, P387; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; SHEWRY PR, 1990, BIOCHEM J, V267, P1; Uthayakumaran S, 1999, CEREAL CHEM, V76, P389, DOI 10.1094/CCHEM.1999.76.3.389; van den Broeck HC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-41; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; Williams P, 1988, CROP QUALITY EVALUAT; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690; Zhang PP, 2007, J CEREAL SCI, V46, P1, DOI 10.1016/j.jcs.2006.10.007; Zhang Y, 2009, J CEREAL SCI, V50, P219, DOI 10.1016/j.jcs.2009.05.005	44	60	62	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24754	10.1371/journal.pone.0024754	http://dx.doi.org/10.1371/journal.pone.0024754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21935456	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000295321800060
J	Noujaim, SF; Kaur, K; Milstein, M; Jones, JM; Furspan, P; Jiang, D; Auerbach, DS; Herron, T; Meisler, MH; Jalife, J				Noujaim, Sami F.; Kaur, Kuljeet; Milstein, Michelle; Jones, Julie M.; Furspan, Philip; Jiang, Daniel; Auerbach, David S.; Herron, Todd; Meisler, Miriam H.; Jalife, Jose			A null mutation of the neuronal sodium channel Na(V)1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart	FASEB JOURNAL			English	Article						ataxia3; brain-type sodium channels; hyperkalemia; optical mapping	RAT VENTRICULAR MYOCYTES; MOLECULAR-BASIS; SINOATRIAL NODE; SCN8A; BRAIN; REQUIREMENT; ARRHYTHMIAS; MECHANISMS; SUBUNITS; EPILEPSY	Evidence supports the expression of brain-type sodium channels in the heart. Their functional role, however, remains controversial. We used global Na(V)1.6-null mice to test the hypothesis that Na(V)1.6 contributes to the maintenance of propagation in the myocardium and to excitation-contraction (EC) coupling. We demonstrated expression of transcripts encoding full-length Na(V)1.6 in isolated ventricular myocytes and confirmed the striated pattern of Na(V)1.6 fluorescence in myocytes. On the ECG, the PR and QRS intervals were prolonged in the null mice, and the Ca2+ transients were longer in the null cells. Under patch clamping, at holding potential (HP) = -120 mV, the peak I-Na was similar in both phenotypes. However, at HP = -70 mV, the peak I-Na was smaller in the nulls. In optical mapping, at 4 mM [K+](o), 17 null hearts showed slight (7%) reduction of ventricular conduction velocity (CV) compared to 16 wild-type hearts. At 12 mM [K+](o), CV was 25% slower in a subset of 9 null vs. 9 wild-type hearts. These results highlight the importance of neuronal sodium channels in the heart, whereby Na(V)1.6 participates in EC coupling, and represents an intrinsic depolarizing reserve that contributes to excitation.-Noujaim, S. F., Kaur, K., Milstein, M., Jones, J. M., Furspan, P., Jiang, D., Auerbach, D. S., Herron, T., Meisler, M. H., Jalife, J. A null mutation of the neuronal sodium channel Na(V)1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart. FASEB J. 26, 63-72 (2012). www.fasebj.org	[Noujaim, Sami F.; Kaur, Kuljeet; Milstein, Michelle; Furspan, Philip; Jiang, Daniel; Auerbach, David S.; Herron, Todd; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48108 USA; [Jones, Julie M.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jalife, J (corresponding author), Univ Michigan, Ctr Arrhythmia Res, 5025 Venture Dr, Ann Arbor, MI 48108 USA.	jjalife@umich.edu	Auerbach, David/AAA-5466-2020; Jalife, Jose/L-4833-2015; Kaur, Kuljeet/R-4564-2017; Jalife, Jose/AAJ-9156-2021	Auerbach, David/0000-0001-9198-3847; Jalife, Jose/0000-0003-0080-3500; Kaur, Kuljeet/0000-0002-8075-5678; Jalife, Jose/0000-0003-0080-3500; Furspan, Philip/0000-0001-9306-3403; Jiang, Daniel/0000-0001-5021-8225	U.S. National Heart, Blood, and Lung Institute [P01-HL039707, P01-HL087226, K99-HL105574]; Leducq Foundation; National Institute of Neurological Disorders and Stroke [R01-NS34509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL105574, P01HL087226, P01HL039707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034509] Funding Source: NIH RePORTER	U.S. National Heart, Blood, and Lung Institute; Leducq Foundation(Leducq Foundation); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by U.S. National Heart, Blood, and Lung Institute grants P01-HL039707 and P01-HL087226 (J.J.) and K99-HL105574 (S.F.N.), the Leducq Foundation (J.J.), and National Institute of Neurological Disorders and Stroke grant R01-NS34509 (M. M.). The authors thank Dr. Nidhi Talwar (Center for Statistical Consultation and Research, University of Michigan).	Brette F, 2006, CIRC RES, V98, P667, DOI 10.1161/01.RES.0000209963.02720.70; Brette F, 2006, BIOCHEM BIOPH RES CO, V348, P1163, DOI 10.1016/j.bbrc.2006.07.189; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; CATTERALL WA, 1984, SCIENCE, V223, P653, DOI 10.1126/science.6320365; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Cerrone M, 2007, CIRC RES, V101, P1039, DOI 10.1161/CIRCRESAHA.107.148064; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Christidis D, 2006, SEIZURE-EUR J EPILEP, V15, P64, DOI 10.1016/j.seizure.2005.10.002; Cote PD, 2005, J NEUROSCI, V25, P5046, DOI 10.1523/JNEUROSCI.4692-04.2005; De Repentigny Y, 2001, HUM MOL GENET, V10, P1819, DOI 10.1093/hmg/10.17.1819; Du Y, 2007, PFLUG ARCH EUR J PHY, V454, P451, DOI 10.1007/s00424-007-0216-4; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Haufe V, 2007, J MOL CELL CARDIOL, V42, P469, DOI 10.1016/j.yjmcc.2006.12.005; Haufe V, 2005, CARDIOVASC RES, V65, P117, DOI 10.1016/j.cardiores.2004.08.017; HEINEMANN SH, 1992, PFLUG ARCH EUR J PHY, V422, P90, DOI 10.1007/BF00381519; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Maier SKG, 2002, P NATL ACAD SCI USA, V99, P4073, DOI 10.1073/pnas.261705699; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meisler MH, 2004, GENETICA, V122, P37, DOI 10.1007/s10709-004-1441-9; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Morley GE, 2000, J CARDIOVASC ELECTR, V11, P375, DOI 10.1111/j.1540-8167.2000.tb01811.x; Morley GE, 1999, J CARDIOVASC ELECTR, V10, P1361, DOI 10.1111/j.1540-8167.1999.tb00192.x; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Plummer NW, 1997, J BIOL CHEM, V272, P24008, DOI 10.1074/jbc.272.38.24008; Priori SG, 2004, ANN NY ACAD SCI, V1015, P96, DOI 10.1196/annals.1302.008; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Torres NS, 2010, J PHYSIOL-LONDON, V588, P4249, DOI 10.1113/jphysiol.2010.194688; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Vaidya D, 1999, CIRC RES, V85, P174, DOI 10.1161/01.RES.85.2.174; Vaitkevicius R, 2009, HEART RHYTHM, V6, P221, DOI 10.1016/j.hrthm.2008.10.027; YU FH, 2004, SCI STKE	37	47	49	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					63	72		10.1096/fj.10-179770	http://dx.doi.org/10.1096/fj.10-179770			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21948246	Green Published, Green Submitted			2022-12-25	WOS:000299202200008
J	Suman, SK; Mishra, A; Ravindra, D; Yeramala, L; Sharma, Y				Suman, Shashi Kumar; Mishra, Amita; Ravindra, Daddali; Yeramala, Lahari; Sharma, Yogendra			Evolutionary Remodeling of beta gamma-Crystallins for Domain Stability at Cost of Ca2+ Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORE COAT PROTEIN; VERTEBRATE EYE LENS; X-RAY-ANALYSIS; MYXOCOCCUS-XANTHUS; GENETICS; RESOLUTION	The topologically similar beta gamma-crystallins that are prevalent in all kingdoms of life have evolved for high innate domain stability to perform their specialized functions. The evolution of stability and its control in beta gamma-crystallins that possess either a canonical (mostly from microorganisms) or degenerate (principally found in vertebrate homologues) Ca2+-binding motif is not known. Using equilibrium unfolding of beta gamma-crystallin domains (26 wildtype domains and their mutants) in apo- and holo-forms, we demonstrate the presence of a stability gradient across these members, which is attained by the choice of residues in the (N/D)(N/D)XX(S/T)S Ca2+-binding motif. The occurrence of a polar, hydrophobic, or Ser residue at the 1st, 3rd, or 5th position of the motif is likely linked to a higher domain stability. Partial conversion of a microbe-type domain (with a canonical Ca2+-binding motif) to a vertebrate-type domain (with a degenerate Ca2+-binding motif) by mutating serine to arginine/lysine disables the Ca2+-binding but significantly augments its stability. Conversely, stability is compromised when arginine (in a vertebrate-type disabled domain) is replaced by serine (as a microbe type). Our results suggest that such conversions were acquired as a strategy for desired stability in vertebrate members at the cost of Ca2+-binding. In a physiological context, we demonstrate that a mutation such as an arginine to serine (R77S) mutation in this motif of gamma-crystallin (partial conversion to microbe-type), implicated in cataracts, decreases the domain stability. Thus, this motif acts as a "central tuning knob" for innate as well as Ca2+-induced gain in stability, incorporating a stability gradient across beta gamma-crystallin members critical for their specialized functions.	[Suman, Shashi Kumar; Mishra, Amita; Ravindra, Daddali; Yeramala, Lahari; Sharma, Yogendra] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sharma, Y (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	yogendra@ccmb.res.in		SUMAN, Shashi Kumar/0000-0002-7668-5515	Department of Science and Technology (Science and Engineering Research Council); Department of Biotechnology; Department of Biotechnology, India	Department of Science and Technology (Science and Engineering Research Council)(Department of Science & Technology (India)); Department of Biotechnology; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported in part by grants from Department of Science and Technology (Science and Engineering Research Council) and Department of Biotechnology (to Y. S.).; Supported by a postdoctoral fellowship of the Department of Biotechnology, India.	Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Aravind P, 2009, J MOL BIOL, V385, P163, DOI 10.1016/j.jmb.2008.10.035; BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Clout NJ, 2000, J MOL BIOL, V304, P253, DOI 10.1006/jmbi.2000.4197; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; JAENICKE R, 1994, NATURWISSENSCHAFTEN, V81, P423; KAISER D, 1979, ANNU REV MICROBIOL, V33, P595, DOI 10.1146/annurev.mi.33.100179.003115; Kannabiran C, 2000, Indian J Ophthalmol, V48, P5; Kappe G, 2010, J MOL EVOL, V71, P219, DOI 10.1007/s00239-010-9379-2; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kretschmar W, 1999, J MOL BIOL, V289, P701, DOI 10.1006/jmbi.1999.2833; LAPATTO R, 1991, J MOL BIOL, V222, P1067, DOI 10.1016/0022-2836(91)90594-V; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Pace C N, 1986, Methods Enzymol, V131, P266; Palme S, 1997, PROTEIN SCI, V6, P1529; Roshan M, 2010, MOL VIS, V16, P887; Shimeld SM, 2005, CURR BIOL, V15, P1684, DOI 10.1016/j.cub.2005.08.046; Srivastava AK, 2010, BIOCHEMISTRY-US, V49, P9746, DOI 10.1021/bi101000m; Wenk M, 1999, J MOL BIOL, V293, P117, DOI 10.1006/jmbi.1999.3146; Wenk M, 1998, EUR J BIOCHEM, V255, P604, DOI 10.1046/j.1432-1327.1998.2550604.x; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; WISTOW G, 1985, NATURE, V315, P771, DOI 10.1038/315771a0; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403	32	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43891	43901		10.1074/jbc.M111.247890	http://dx.doi.org/10.1074/jbc.M111.247890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21949186	Green Published, hybrid			2022-12-25	WOS:000298402300030
J	Wen, KK; McKane, M; Stokasirnov, E; Rubenstein, PA				Wen, Kuo-Kuang; McKane, Melissa; Stokasirnov, Ema; Rubenstein, Peter A.			Mutant Profilin Suppresses Mutant Actin-dependent Mitochondrial Phenotype in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE; YEAST ACTIN; BUDDING YEAST; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; STRUCTURAL BASIS; NONMUSCLE CELLS; BETA-ACTIN; ATP-ACTIN; ADP-ACTIN	In the Saccharomyces cerevisiae actin-profilin interface, Ala(167) of the actin barbed end W-loop and His(372) near the C terminus form a clamp around a profilin segment containing residue Arg(81) and Tyr(79). Modeling suggests that altering steric packing in this interface regulates actin activity. An actin A167E mutation could increase interface crowding and alter actin regulation, and A167E does cause growth defects and mitochondrial dysfunction. We assessed whether a profilin Y79S mutation with its decreased mass could compensate for actin A167E crowding and rescue the mutant phenotype. Y79S profilin alone caused no growth defect in WT actin cells under standard conditions in rich medium and rescued the mitochondrial phenotype resulting from both the A167E and H372R actin mutations in vivo consistent with our model. Rescue did not result from effects of profilin on actin nucleotide exchange or direct effects of profilin on actin polymerization. Polymerization of A167E actin was less stimulated by formin Bni1 FH1-FH2 fragment than was WT actin. Addition of WT profilin to mixtures of A167E actin and formin fragment significantly altered polymerization kinetics from hyperbolic to a decidedly more sigmoidal behavior. Substitution of Y79S profilin in this system produced A167E behavior nearly identical to that of WT actin. A167E actin caused more dynamic actin cable behavior in vivo than observed with WT actin. Introduction of Y79S restored cable movement to a more normal phenotype. Our studies implicate the importance of the actin-profilin interface for formin-dependent actin and point to the involvement of formin and profilin in the maintenance of mitochondrial integrity and function.	[Wen, Kuo-Kuang; McKane, Melissa; Stokasirnov, Ema; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689, DC8803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33689 and DC8803 (to P. A. R.).	BABCOCK G, 1993, CELL MOTIL CYTOSKEL, V24, P179, DOI 10.1002/cm.970240305; Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Bettinger BT, 2007, GENETICS, V175, P1637, DOI 10.1534/genetics.106.063370; BLOMBERG A, 1992, ADV MICROB PHYSIOL, V33, P145, DOI 10.1016/S0065-2911(08)60217-9; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Christensen HEM, 1996, PLANT J, V10, P269, DOI 10.1046/j.1365-313X.1996.10020269.x; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Fortsch J, 2011, J CELL BIOL, V194, P473, DOI 10.1083/jcb.201012088; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; GREER C, 1982, MOL CELL BIOL, V2, P1270, DOI 10.1128/MCB.2.10.1270; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Hales KG, 2004, MITOCHONDRION, V4, P285, DOI 10.1016/j.mito.2004.05.007; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Kim T, 2010, J MOL BIOL, V404, P794, DOI 10.1016/j.jmb.2010.10.017; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2001, J CELL SCI, V114, P4293; Kudryashov DS, 2010, J BIOL CHEM, V285, P25591, DOI 10.1074/jbc.M110.123869; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Stark BC, 2011, J BIOL CHEM, V286, P30384, DOI 10.1074/jbc.M111.262899; Stokasimov E, 2009, J BIOL CHEM, V284, P25421, DOI 10.1074/jbc.M109.013078; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; Ti SC, 2011, J BIOL CHEM, V286, P5784, DOI 10.1074/jbc.M110.199794; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yarmola EG, 2001, J BIOL CHEM, V276, P45555, DOI 10.1074/jbc.M105723200; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	56	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41745	41757		10.1074/jbc.M110.217661	http://dx.doi.org/10.1074/jbc.M110.217661			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21956104	hybrid, Green Published			2022-12-25	WOS:000298057500058
J	Moss, ML; Powell, G; Miller, MA; Edwards, L; Qi, B; Sang, QXA; De Strooper, B; Tesseur, I; Lichtenthaler, SF; Taverna, M; Zhong, JL; Dingwall, C; Ferdous, T; Schlomann, U; Zhou, P; Griffith, LG; Lauffenburger, DA; Petrovich, R; Bartsch, JW				Moss, Marcia L.; Powell, Gary; Miller, Miles A.; Edwards, Lori; Qi, Bin; Sang, Qing-Xiang Amy; De Strooper, Bart; Tesseur, Ina; Lichtenthaler, Stefan F.; Taverna, Mara; Zhong, Julia Li; Dingwall, Colin; Ferdous, Taheera; Schlomann, Uwe; Zhou, Pei; Griffith, Linda G.; Lauffenburger, Douglas A.; Petrovich, Robert; Bartsch, Joerg W.			ADAM9 Inhibition Increases Membrane Activity of ADAM10 and Controls alpha-Secretase Processing of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CONVERTING-ENZYME TACE; DISINTEGRIN-METALLOPROTEINASE; RHEUMATOID-ARTHRITIS; SELECTIVE-INHIBITION; SOLUBLE NEUROPILIN-2; THERAPEUTIC TARGET; TISSUE INHIBITOR; RECEPTOR CD23; CANCER	Prodomains of A disintegrin and metalloproteinase (ADAM) metallopeptidases can act as highly specific intra- and intermolecular inhibitors of ADAM catalytic activity. The mouse ADAM9 prodomain (proA9; amino acids 24-204), expressed and characterized from Escherichia coli, is a competitive inhibitor of human ADAM9 catalyticidisintegrin domain with an overall inhibition constant of 280 +/- 34 nM and high specificity toward ADAM9. In SY5Y neuroblastoma cells overexpressing amyloid precursor protein, proA9 treatment reduces the amount of endogenous ADAM 10 enzyme in the medium while increasing membrane-bound ADAM10, as shown both by Western and activity assays with selective fluorescent peptide substrates using proteolytic activity matrix analysis. An increase in membrane-bound ADAM 10 generates higher levels of soluble amyloid precursor protein alpha in the medium, whereas soluble amyloid precursor protein beta levels are decreased, demonstrating that inhibition of ADAM9 increases alpha-secretase activity on the cell membrane. Quantification of physiological ADAM10 substrates by a proteomic approach revealed that substrates, such as epidermal growth factor (EGF), HER2, osteoactivin, and CD40-ligand, are increased in the medium of BT474 breast tumor cells that were incubated with proA9, demonstrating that the regulation of ADAM10 by ADAM9 applies for many ADAM10 substrates. Taken together, our results demonstrate that ADAM 10 activity is regulated by inhibition of ADAM9, and this regulation may be used to control shedding of amyloid precursor protein by enhancing alpha-secretase activity, a key regulatory step in the etiology of Alzheimer disease.	[Moss, Marcia L.] BioZyme Inc, Apex, NC 27523 USA; [Powell, Gary; Edwards, Lori; Petrovich, Robert] NIEHS, NIH, Durham, NC 27709 USA; [Miller, Miles A.; Griffith, Linda G.; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Qi, Bin; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [De Strooper, Bart; Tesseur, Ina] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Lichtenthaler, Stefan F.; Taverna, Mara] DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Dingwall, Colin; Ferdous, Taheera; Schlomann, Uwe; Bartsch, Joerg W.] Kings Coll London, Inst Pharm, London SE1 9NH, England; [Zhong, Julia Li] Chongqing Univ, Coll Bioengn, Chongqing 400044, Peoples R China; [Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Bartsch, Joerg W.] Univ Marburg, Univ Hosp, Dept Neurosurg, D-35053 Marburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT); State University System of Florida; Florida State University; Universite Catholique Louvain; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of London; King's College London; Chongqing University; Duke University; Philipps University Marburg	Bartsch, JW (corresponding author), Univ Hosp, Dept Neurosurg, Baldingerstr, D-35033 Marburg, Germany.	jbartsch@med.uni-marburg.de	de+Strooper, Bart/Z-1638-2019; Lichtenthaler, Stefan F/B-6587-2016; De Strooper, Bart/F-6507-2012; Bartsch, Joerg Walter/AAB-2951-2020; Schlomann, Uwe/F-6419-2012; Zhou, Pei/O-6704-2019; Wyss-Coray, Tony/AAF-3380-2019	Lichtenthaler, Stefan F/0000-0003-2211-2575; De Strooper, Bart/0000-0001-5455-5819; Zhou, Pei/0000-0002-7823-3416; Wyss-Coray, Tony/0000-0001-5893-0831; Bartsch, Prof. Joerg Walter/0000-0002-2773-3357; Miller, Miles/0000-0001-7638-8898; Griffith, Linda/0000-0002-1801-5548	National Institutes of Health [R01EB010246, R01GM081336]; Heptagon Fund London; Cancer Research Technology UK; Whitehead Foundation; Duke Bridge Fund for Research Resources; Bundesministerium fur Bildung und Forschung: Krankheitsbezogene Kompetenznetz Degenerative Demenzen; Chinese Scholarship Council, People's Republic of China; Florida State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heptagon Fund London; Cancer Research Technology UK; Whitehead Foundation; Duke Bridge Fund for Research Resources; Bundesministerium fur Bildung und Forschung: Krankheitsbezogene Kompetenznetz Degenerative Demenzen(Federal Ministry of Education & Research (BMBF)); Chinese Scholarship Council, People's Republic of China; Florida State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EB010246 (to L. G. G.) and R01GM081336 (to D. A. L.). This work was also supported by the Heptagon Fund London and Cancer Research Technology UK (to J. W. B.), the Whitehead Foundation and the Duke Bridge Fund for Research Resources (to P. Z.), the Bundesministerium fur Bildung und Forschung: Krankheitsbezogene Kompetenznetz Degenerative Demenzen (to S. F. L.), a National Fellowship from the Chinese Scholarship Council, People's Republic of China (to B. Q.), and grants from Florida State University (to Q. X. A. S.).	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Bartsch JW, 2010, J NEUROSCI, V30, P12210, DOI 10.1523/JNEUROSCI.1520-10.2010; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fassold A, 2009, ARTHRITIS RHEUM-US, V60, P2892, DOI 10.1002/art.24860; Geretti E, 2010, MOL CANCER RES, V8, P1063, DOI 10.1158/1541-7786.MCR-10-0157; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; GRAY PW, 1989, J BIOL CHEM, V264, P9505; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Koller G, 2009, CURR PHARM DESIGN, V15, P2272, DOI 10.2174/138161209788682361; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kveiborg M, 2010, BIOCHEM J, V430, P79, DOI 10.1042/BJ20100649; Lee D C, 1992, Cancer Treat Res, V63, P233; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Liu XD, 2006, CANCER BIOL THER, V5, P648, DOI 10.4161/cbt.5.6.2707; Matei D, 2006, ONCOGENE, V25, P2060, DOI 10.1038/sj.onc.1209232; Miller MA, 2011, INTEGR BIOL-UK, V3, P422, DOI 10.1039/c0ib00083c; Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, CANCER, V8, P929; Nasarre C, 2009, CELL ADHES MIGR, V3, P383, DOI 10.4161/cam.3.4.9934; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nous S, 2010, AM J RESP CRIT CARE, V181, P1318, DOI 10.1164/rccm.200909-1396OC; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rose AAN, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1791; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Turner SL, 2009, BRIT J BIOMED SCI, V66, P117, DOI 10.1080/09674845.2009.11730257; Turtinen LW, 2005, IMMUNOPHARM IMMUNOT, V27, P85, DOI [10.1081/IPH-200051749, 10.1081/IPH-51749]; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou BBS, 2005, EXPERT OPIN INV DRUG, V14, P591, DOI 10.1517/13543784.14.6.591; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	52	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40443	40451		10.1074/jbc.M111.280495	http://dx.doi.org/10.1074/jbc.M111.280495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956108	Green Published, hybrid			2022-12-25	WOS:000297315400004
J	Colinet, D; Cazes, D; Belghazi, M; Gatti, JL; Poirie, M				Colinet, Dominique; Cazes, Dominique; Belghazi, Maya; Gatti, Jean-Luc; Poirie, Marylene			Extracellular Superoxide Dismutase in Insects CHARACTERIZATION, FUNCTION, AND INTERSPECIFIC VARIATION IN PARASITOID WASP VENOM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR IMMUNE-RESPONSE; PTEROMALUS-PUPARUM HYMENOPTERA; DROSOPHILA-MELANOGASTER; LEPTOPILINA-BOULARDI; HONEY-BEE; INVERTEBRATE IMMUNITY; PROTEOMIC ANALYSIS; PROTEIN; PHENOLOXIDASE; VIRULENCE	Endoparasitoid wasps inject venom proteins with their eggs to protect them from the host immune response and ensure successful parasitism. Here we report identification of Cu,Zn superoxide dismutase (SOD) transcripts for both intracellular SOD1 and extracellular SOD3 in the venom apparatus of two Leptopilina species, parasitoids of Drosophila. Leptopilina SODs show sequence and structure similarity to human SODs, but phylogenetic analyses indicate that the extracellular SODs are more related to cytoplasmic vertebrate SODs than to extracellular SODs, a feature shared by predicted insect extracellular SODs. We demonstrate that L. boulardi SOD3 is indeed secreted and active as monomeric glycosylated forms in venom. Our results also evidence quantitative variation in SOD3 venom contents between closely related parasitoid species, as sod3 is 100-fold less expressed in Leptopilina heterotoma venom apparatus and no protein and SOD activity are detected in its venom. Leptopilina recombinant SOD3s as well as a mammalian SOD in vitro inhibit the Drosophila phenoloxidase activity in a dose-dependent manner, demonstrating that SODs may interfere with the Drosophila melanization process and, therefore, with production of cytotoxic compounds. Although the recombinant L. boulardi SOD3 quantity needed to observe this effect precludes a systemic effect of the wasp venom SOD3, it is still consistent with a local action at oviposition. This work provides the first demonstration that insect extracellular SODs are indeed secreted and active in an insect fluid and can be used as virulence factors to counteract the host immune response, a strategy largely used by bacterial and fungal pathogens but also protozoan parasites during infection.	[Colinet, Dominique; Cazes, Dominique; Gatti, Jean-Luc; Poirie, Marylene] INRA PACA, UMR Biot Interact & Plant Hlth 1301, Inst Natl Rech Agron, F-06903 Sophia Antipolis, France; [Colinet, Dominique; Cazes, Dominique; Gatti, Jean-Luc; Poirie, Marylene] CNRS, UMR 6243, F-06903 Sophia Antipolis, France; [Colinet, Dominique; Cazes, Dominique; Gatti, Jean-Luc; Poirie, Marylene] Univ Nice Sophia Antipolis, UFR Sci, F-06903 Sophia Antipolis, France; [Belghazi, Maya] Univ Aix Marseille 2, Ctr Anal Prote Marseille, IFR Jean Roche, Fac Med Secteur Nord, F-13344 Marseille, France	INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Aix-Marseille Universite	Colinet, D (corresponding author), INRA PACA, UMR Biot Interact & Plant Hlth 1301, Inst Natl Rech Agron, 400 Route Chappes, F-06903 Sophia Antipolis, France.	Dominique.Colinet@sophia.inra.fr	Gatti, jean-luc/ABB-3294-2020; Colinet, Dominique/C-8738-2012	Gatti, jean-luc/0000-0001-7683-718X; Colinet, Dominique/0000-0001-5122-5072	French National Agency for Research [ANR-08-BLAN-0231, ANR-09-BLAN-0243-01]; Department of Plant Health and Environment from the French National Institute for Agricultural Research	French National Agency for Research(French National Research Agency (ANR)); Department of Plant Health and Environment from the French National Institute for Agricultural Research	This work was supported by Grants CLIMEVOL (ANR-08-BLAN-0231) and PARATOXOSE (ANR-09-BLAN-0243-01) from the French National Agency for Research and grants from the Department of Plant Health and Environment from the French National Institute for Agricultural Research.	Ammendola S, 2008, J BIOL CHEM, V283, P13688, DOI 10.1074/jbc.M710499200; Antonyuk SV, 2009, J MOL BIOL, V388, P310, DOI 10.1016/j.jmb.2009.03.026; Asgari S, 2002, INSECT MOL BIOL, V11, P477, DOI 10.1046/j.1365-2583.2002.00356.x; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Colinet D, 2007, PLOS PATHOG, V3, P2029, DOI 10.1371/journal.ppat.0030203; Colinet D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001206; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Crawford AM, 2008, INSECT MOL BIOL, V17, P313, DOI 10.1111/j.1365-2583.2008.00802.x; de Graaf DC, 2010, INSECT MOL BIOL, V19, P11, DOI 10.1111/j.1365-2583.2009.00914.x; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Dubuffet A, 2009, ADV PARASIT, V70, P147, DOI 10.1016/S0065-308X(09)70006-5; Dupas S, 1998, J HERED, V89, P306, DOI 10.1093/jhered/89.4.306; Dupas S, 2003, HEREDITY, V90, P84, DOI 10.1038/sj.hdy.6800182; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kohler LJ, 2007, ARCH INSECT BIOCHEM, V66, P64, DOI 10.1002/arch.20199; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2005, INSECT BIOCHEM MOLEC, V35, P93, DOI 10.1016/j.ibmb.2004.10.004; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Nam HJ, 2008, MOL CELLS, V26, P606; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2010, ISJ-INVERT SURVIV J, V7, P198; Nappi AJ, 1998, J PARASITOL, V84, P1150, DOI 10.2307/3284664; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Parker JD, 2004, INSECT MOL BIOL, V13, P587, DOI 10.1111/j.0962-1075.2004.00515.x; Parkinson N, 2001, INSECT BIOCHEM MOLEC, V31, P57, DOI 10.1016/S0965-1748(00)00105-3; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Petersen SV, 2003, P NATL ACAD SCI USA, V100, P13875, DOI 10.1073/pnas.2436143100; Poirie M, 2009, CR BIOL, V332, P311, DOI 10.1016/j.crvi.2008.09.004; Price DRG, 2009, INSECT MOL BIOL, V18, P195, DOI 10.1111/j.1365-2583.2009.00864.x; Reumer A, 2010, ISJ-INVERT SURVIV J, V7, P32; Stenlund P, 2002, BIOCHEMISTRY-US, V41, P3168, DOI 10.1021/bi011454r; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Vincent B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-693; Vinchon S, 2010, INSECT BIOCHEM MOLEC, V40, P38, DOI 10.1016/j.ibmb.2009.12.007; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Werren J.H., 2009, CSH PROTOC; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; Zhang GM, 2006, DEV COMP IMMUNOL, V30, P756, DOI 10.1016/j.dci.2005.11.001; Zhu JY, 2008, TOXICON, V51, P1391, DOI 10.1016/j.toxicon.2008.03.008; Zhu JY, 2010, ARCH INSECT BIOCHEM, V75, P28, DOI 10.1002/arch.20380; Zufelato MS, 2004, INSECT BIOCHEM MOLEC, V34, P1257, DOI 10.1016/j.ibmb.2004.08.005	59	64	67	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40110	40121		10.1074/jbc.M111.288845	http://dx.doi.org/10.1074/jbc.M111.288845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937434	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000296925700044
J	McMillan, DGG; Ferguson, SA; Dey, D; Schroder, K; Aung, HL; Carbone, V; Attwood, GT; Ronimus, RS; Meier, T; Janssen, PH; Cook, GM				McMillan, Duncan G. G.; Ferguson, Scott A.; Dey, Debjit; Schroeder, Katja; Aung, Htin Lin; Carbone, Vincenzo; Attwood, Graeme T.; Ronimus, Ron S.; Meier, Thomas; Janssen, Peter H.; Cook, Gregory M.			A(1)A(o)-ATP Synthase of Methanobrevibacter ruminantium Couples Sodium Ions for ATP Synthesis under Physiological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOSARCINA-MAZEI GO1; NA+-TRANSLOCATING F1F0-ATPASE; PROPIONIGENIUM-MODESTUM; ESCHERICHIA-COLI; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOGENIC ARCHAEA; ROTOR RING; ILYOBACTER-TARTARICUS; ACETOBACTERIUM-WOODII; METHANOCOCCUS-VOLTAE	An unresolved question in the bioenergetics of methanogenic archaea is how the generation of proton-motive and sodium-motive forces during methane production is used to synthesize ATP by the membrane-bound A(1)A(o)-ATP synthase, with both proton- and sodium-coupled enzymes being reported in methanogens. To address this question, we investigated the biochemical characteristics of the A(1)A(o)-ATP synthase (MbbrA(1)A(o)) of Methanobrevibacter ruminantium M1, a predominant methanogen in the rumen. Growth of M. ruminantium M1 was inhibited by protonophores and sodium ionophores, demonstrating that both ion gradients were essential for growth. To study the role of these ions in ATP synthesis, the ahaHIKECFABD operon encoding the MbbrA1Ao was expressed in Escherichia coli strain DK8 (Delta atp) and purified yielding a 9-subunit protein with an SDS-stable c oligomer. Analysis of the c subunit amino acid sequence revealed that it consisted of four transmembrane helices, and each hairpin displayed a complete Na+-binding signature made up of identical amino acid residues. The purified MbbrA(1)A(o) was stimulated by sodium ions, and Na+ provided pH-dependent protection against inhibition by dicyclohexylcarbodiimide but not tributyltin chloride. ATP synthesis in inverted membrane vesicles lacking sodium ions was driven by a membrane potential that was sensitive to cyanide m-chlorophenylhydrazone but not to monensin. ATP synthesis could not be driven by a chemical gradient of sodium ions unless a membrane potential was imposed. ATP synthesis under these conditions was sensitive to monensin but not cyanide m-chlorophenylhydrazone. These data suggest that the M. ruminantium M1 A(1)A(o-)ATP synthase exhibits all the properties of a sodium-coupled enzyme, but it is also able to use protons to drive ATP synthesis under conditions that favor proton coupling, such as low pH and low levels of sodium ions.	[McMillan, Duncan G. G.; Ferguson, Scott A.; Schroeder, Katja; Aung, Htin Lin; Cook, Gregory M.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Dey, Debjit; Carbone, Vincenzo; Attwood, Graeme T.; Ronimus, Ron S.; Janssen, Peter H.] AgResearch, Grasslands Res Ctr, Palmerston North 4442, New Zealand; [Meier, Thomas] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	University of Otago; AgResearch - New Zealand; Max Planck Society	Cook, GM (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand.	gregory.cook@otago.ac.nz	McMillan, Duncan/AAT-7415-2021; Ferguson, Scott/AAB-4142-2019; Meier, Thomas/AAV-6912-2021; Cook, Gregory/E-5665-2011	McMillan, Duncan/0000-0001-6614-4494; Ferguson, Scott/0000-0001-7937-8273; Meier, Thomas/0000-0003-3364-3320; Ronimus, Ron/0000-0001-8669-5840; Janssen, Peter/0000-0002-1022-3502; carbone, vincenzo/0000-0003-4231-2785; Attwood, Graeme Trevor/0000-0002-6443-8760	Pastoral Greenhouse Gas Research Consortium; University of Otago; AgResearch-University	Pastoral Greenhouse Gas Research Consortium; University of Otago; AgResearch-University	This work was supported by a contract from the Pastoral Greenhouse Gas Research Consortium and in part by a University of Otago research grant and by the AgResearch-University of Otago Collaborative Research Fund.	BECHER B, 1994, J BACTERIOL, V176, P2543, DOI 10.1128/JB.176.9.2543-2550.1994; CRIDER BP, 1985, P NATL ACAD SCI USA, V82, P6793, DOI 10.1073/pnas.82.20.6793; de Jonge MR, 2007, PROTEINS, V67, P971, DOI 10.1002/prot.21376; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Deppenmeier U, 1999, FEBS LETT, V457, P291, DOI 10.1016/S0014-5793(99)01026-1; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; Dmitriev OY, 2004, FEBS LETT, V556, P35, DOI 10.1016/S0014-5793(03)01360-7; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; DYBAS M, 1992, J BACTERIOL, V174, P5575, DOI 10.1128/JB.174.17.5575-5583.1992; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson SA, 2006, J BACTERIOL, V188, P5045, DOI 10.1128/JB.00128-06; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; KAESLER B, 1988, EUR J BIOCHEM, V174, P189, DOI 10.1111/j.1432-1033.1988.tb14081.x; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KLUGE C, 1993, BIOCHEMISTRY-US, V32, P10378, DOI 10.1021/bi00090a013; KLUGE C, 1993, J BIOL CHEM, V268, P14557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCASTER JR, 1989, J BIOENERG BIOMEMBR, V21, P717, DOI 10.1007/BF00762689; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Lemker T, 2001, EUR J BIOCHEM, V268, P3744, DOI 10.1046/j.1432-1327.2001.02284.x; Lingl A, 2003, EXTREMOPHILES, V7, P249, DOI 10.1007/s00792-003-0318-7; Linnett P E, 1979, Methods Enzymol, V55, P472; LUNDIN A, 1975, APPL MICROBIOL, V30, P713, DOI 10.1128/AEM.30.5.713-721.1975; Matthey UH, 1997, EUR J BIOCHEM, V247, P820, DOI 10.1111/j.1432-1033.1997.t01-1-00820.x; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Muller V, 2005, J BIOENERG BIOMEMBR, V37, P455, DOI 10.1007/s10863-005-9491-y; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Neumann S, 1998, J BACTERIOL, V180, P3312, DOI 10.1128/JB.180.13.3312-3316.1998; Pisa KY, 2007, FEMS MICROBIOL LETT, V277, P56, DOI 10.1111/j.1574-6968.2007.00939.x; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; REIDLINGER J, 1994, FEBS LETT, V356, P17, DOI 10.1016/0014-5793(94)01222-9; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saum R, 2009, FEMS MICROBIOL LETT, V300, P230, DOI 10.1111/j.1574-6968.2009.01785.x; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; SCHONHEIT P, 1985, EUR J BIOCHEM, V148, P545, DOI 10.1111/j.1432-1033.1985.tb08874.x; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; SMIGAN P, 1994, FEBS LETT, V349, P424, DOI 10.1016/0014-5793(94)00716-0; SMIGAN P, 1995, FEBS LETT, V371, P119, DOI 10.1016/0014-5793(95)00866-8; SMITH PH, 1958, J BACTERIOL, V75, P713, DOI 10.1128/JB.75.6.713-718.1958; SPARLING R, 1993, CAN J MICROBIOL, V39, P742, DOI 10.1139/m93-109; SPRUTH M, 1995, BBA-BIOENERGETICS, V1229, P96, DOI 10.1016/0005-2728(94)00192-8; Surin S, 2006, FOLIA MICROBIOL, V51, P313, DOI 10.1007/BF02931822; Surin S, 2007, FEMS MICROBIOL LETT, V269, P301, DOI 10.1111/j.1574-6968.2007.00655.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; Wedlock DN, 2010, NEW ZEAL VET J, V58, P29, DOI 10.1080/00480169.2010.65058; Wiedenmann A, 2009, MOL MICROBIOL, V72, P479, DOI 10.1111/j.1365-2958.2009.06658.x; Wilms R, 1996, J BIOL CHEM, V271, P18843, DOI 10.1074/jbc.271.31.18843; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	69	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39882	39892		10.1074/jbc.M111.281675	http://dx.doi.org/10.1074/jbc.M111.281675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953465	Green Published, hybrid			2022-12-25	WOS:000296925700022
J	Thevenot, E; Moreau, AW; Rousseau, V; Combeau, G; Domenichini, F; Jacquet, C; Goupille, O; Amar, M; Kreis, P; Fossier, P; Barnier, JV				Thevenot, Emmanuel; Moreau, Alexandre William; Rousseau, Veronique; Combeau, Gaelle; Domenichini, Florence; Jacquet, Claire; Goupille, Olivier; Amar, Muriel; Kreis, Patricia; Fossier, Philippe; Barnier, Jean-Vianney			p21-activated Kinase 3 (PAK3) Protein Regulates Synaptic Transmission through Its Interaction with the Nck2/Grb4 Protein Adaptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSPECIFIC MENTAL-RETARDATION; EXCITATION-INHIBITION BALANCE; SPINE MORPHOGENESIS; BIOLOGICAL-PROPERTIES; CORTICAL NETWORKS; REVERSE SIGNALS; NCK-BETA; ACTIVATION; PLASTICITY; NEURONS	Mutations in the p21-activated kinase 3 gene (pak3) are responsible for nonsyndromic forms of mental retardation. Expression of mutated PAK3 proteins in hippocampal neurons induces abnormal dendritic spine morphology and long term potentiation anomalies, whereas pak3 gene invalidation leads to cognitive impairments. How PAK3 regulates synaptic plasticity is still largely unknown. To better understand how PAK3 affects neuronal synaptic plasticity, we focused on its interaction with the Nck adaptors that play a crucial role in PAK signaling. We report here that PAK3 interacts preferentially with Nck2/Grb4 in brain extracts and in transfected cells. This interaction is independent of PAK3 kinase activity. Selective uncoupling of the Nck2 interactions in acute cortical slices using an interfering peptide leads to a rapid increase in evoked transmission to pyramidal neurons. The P12A mutation in the PAK3 protein strongly decreases the interaction with Nck2 but only slightly with Nck1. In transfected hippocampal cultures, expression of the P12A-mutated protein has no effect on spine morphogenesis or synaptic density. The PAK3-P12A mutant does not affect synaptic transmission, whereas the expression of the wild-type PAK3 protein decreases the amplitude of spontaneous miniature excitatory currents. Altogether, these data show that PAK3 down-regulates synaptic transmission through its interaction with Nck2.	[Barnier, Jean-Vianney] Univ Paris 11, Ctr Univ Orsay, Ctr Neurosci Paris Sud, UMR 8195, F-91405 Orsay, France; [Thevenot, Emmanuel; Moreau, Alexandre William; Rousseau, Veronique; Combeau, Gaelle; Domenichini, Florence; Jacquet, Claire; Goupille, Olivier; Amar, Muriel; Kreis, Patricia; Fossier, Philippe; Barnier, Jean-Vianney] CNRS, Inst Neurobiol Alfred Fessard, Neurobiol Cellulaire & Mol Lab, F-91190 Gif Sur Yvette, France; [Rousseau, Veronique; Combeau, Gaelle; Domenichini, Florence; Jacquet, Claire; Amar, Muriel; Fossier, Philippe; Barnier, Jean-Vianney] CNRS, UMR 8195, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Barnier, JV (corresponding author), Univ Paris 11, Ctr Univ Orsay, Ctr Neurosci Paris Sud, UMR 8195, Bat 444, F-91405 Orsay, France.	jean-vianney.barnier@u-psud.fr	Kreis, Patricia/GYJ-3521-2022; Goupille, Olivier/AAO-2716-2020	Kreis, Patricia/0000-0002-1702-4805	Agence Nationale de la Recherche [ANR-MNP-2009]; Fondation Jerome Lejeune; Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Jerome Lejeune; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported in part by Agence Nationale de la Recherche Grant ANR-MNP-2009, the Fondation Jerome Lejeune, and by a fellowship from Association pour la Recherche sur le Cancer (to E. T.).	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Boda B, 2002, NEUROSCIENCE, V114, P13, DOI 10.1016/S0306-4522(02)00218-X; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Boda B, 2006, MOL NEUROBIOL, V34, P67, DOI 10.1385/MN:34:1:67; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Fryer BH, 2006, J BIOL CHEM, V281, P11487, DOI 10.1074/jbc.M600279200; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Guan S, 2007, MOL CELL BIOL, V27, P6001, DOI 10.1128/MCB.01807-06; Guan SX, 2009, J INVEST DERMATOL, V129, P1909, DOI 10.1038/jid.2008.457; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Konig S, 2001, CR ACAD SCI III-VIE, V324, P673, DOI 10.1016/S0764-4469(01)01356-7; Kreis P, 2008, J NEUROCHEM, V106, P1184, DOI 10.1111/j.1471-4159.2008.05474.x; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Le Roux N, 2008, EUR J NEUROSCI, V27, P3244, DOI 10.1111/j.1460-9568.2008.06288.x; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Lee HW, 2010, J NEUROSCI, V30, P5508, DOI 10.1523/JNEUROSCI.4283-09.2010; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Pilpel Y, 2005, J NEUROCHEM, V95, P1401, DOI 10.1111/j.1471-4159.2005.03467.x; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Round JE, 2011, MOL CELL NEUROSCI, V47, P265, DOI 10.1016/j.mcn.2011.04.009; Rousseau V, 2003, J BIOL CHEM, V278, P3912, DOI 10.1074/jbc.M207251200; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Tao J, 2011, MOL ENDOCRINOL, V25, P1565, DOI 10.1210/me.2011-0062; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	55	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40044	40059		10.1074/jbc.M111.262246	http://dx.doi.org/10.1074/jbc.M111.262246			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949127	Green Published, hybrid			2022-12-25	WOS:000296925700037
J	Kinlough, CL; Poland, PA; Gendler, SJ; Mattila, PE; Mo, D; Weisz, OA; Hughey, RP				Kinlough, Carol L.; Poland, Paul A.; Gendler, Sandra J.; Mattila, Polly E.; Mo, Di; Weisz, Ora A.; Hughey, Rebecca P.			Core-glycosylated Mucin-like Repeats from MUC1 Are an Apical Targeting Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED MDCK CELLS; BIOSYNTHETIC-PATHWAY; EPITHELIAL-CELLS; BREAST-CANCER; TANDEM REPEAT; O-GLYCAN; HT-29 CELLS; MEMBRANE; PROTEINS; LOCALIZATION	MUC1 is efficiently delivered to the apical surface of polarized Madin-Darby canine kidney (MDCK) cells by transit through apical recycling endosomes, a route associated with delivery of apical proteins with glycan-dependent targeting signals. However, a role for glycans in MUC1 sorting has not been established. A key feature of MUC1 is a heavily O-glycosylated mucin-like domain with a variable number of nearly perfect tandem repeats and adjacent imperfect repeats. Metabolic labeling, cell surface biotinylation, immobilized lectins, and confocal immunofluorescence microscopy were used to characterize the polarized delivery of MUC1 mutants and chimeras in MDCK cells to identify the apical targeting signal. Both the interleukin-2 receptor alpha subunit (Tac) and a chimera where the Tac ectodomain replaced that of MUC1 were delivered primarily to the basolateral surface. Attachment of the MUC1 mucin-like domain to the N terminus of Tac enhanced apical but not basolateral delivery when compared with Tac. Conversely, deletions within the mucin-like domain in MUC1 reduced apical but not basolateral delivery when compared with MUC1. In pull-down assays with lectins, we found a notable difference in the presence of core 1 O-glycans, but not poly-N-acetyllactosamine, in apically targeted MUC1 and chimeras when compared with Tac. Consistent with these data, we found no effect on MUC1 targeting when galectin-3, with preference for poly-N-acetyllactosamine, was depleted from polarized MDCK cells. However, we did block the apical targeting activity of the mucin-like repeats when we over expressed CMP-Neu5Ac:GalNAc-R alpha 2,6-sialyltransferase-1 to block core O-glycan synthesis. The cumulative data indicate that the core-glycosylated mucin-like repeats of MUC1 constitute an apical targeting signal.	[Kinlough, Carol L.; Poland, Paul A.; Mattila, Polly E.; Mo, Di; Weisz, Ora A.; Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Gendler, Sandra J.] Mayo Clin Scottsdale, Mayo Clin Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Gendler, Sandra J.] Mayo Clin Scottsdale, Mayo Clin Coll Med, Tumor Biol Program, Scottsdale, AZ 85259 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Hughey, RP (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, S933 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu			National Institutes of Health [DK54787, DK054407, CA64389, P30 DK079307]; Genzyme Renal Innovations Program; NRSA [F32DK082109]; NATIONAL CANCER INSTITUTE [R01CA064389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054787, P30DK079307, F32DK082109, R01DK054407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Renal Innovations Program(Sanofi-AventisGenzyme Corporation); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54787 (to R. P. H.), DK054407 (to O. A. W.), CA64389 (to S. J. G.) and P30 DK079307 (Pittsburgh Center for Kidney Research Core C). This work was also supported by the Genzyme Renal Innovations Program (to R. P. H.).; Supported by individual NRSA F32DK082109.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Cramm-Behrens CI, 2008, TRAFFIC, V9, P2206, DOI 10.1111/j.1600-0854.2008.00829.x; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2003, J BIOL CHEM, V278, P37799, DOI 10.1074/jbc.M305755200; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Folsch H, 2009, TRAFFIC, V10, P972, DOI 10.1111/j.1600-0854.2009.00927.x; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Guerriero CJ, 2008, J BIOL CHEM, V283, P18040, DOI 10.1074/jbc.M802048200; Hanisch FG, 2000, GLYCOBIOLOGY, V10, P439, DOI 10.1093/glycob/10.5.439; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Jacob R, 2000, J BIOL CHEM, V275, P6566, DOI 10.1074/jbc.275.9.6566; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee SH, 2010, J BIOL CHEM, V285, P37683, DOI 10.1074/jbc.M110.162735; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Mattila PE, 2009, BIOL CHEM, V390, P551, DOI 10.1515/BC.2009.088; MCGUCKIN MA, 1995, HUM PATHOL, V26, P432, DOI 10.1016/0046-8177(95)90146-9; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Mo D, 2010, AM J PHYSIOL-RENAL, V299, pF1178, DOI 10.1152/ajprenal.00152.2010; Muller S, 1997, J BIOL CHEM, V272, P24780, DOI 10.1074/jbc.272.40.24780; Muller S, 1999, J BIOL CHEM, V274, P18165, DOI 10.1074/jbc.274.26.18165; PARCZYK K, 1991, FEBS LETT, V278, P267, DOI 10.1016/0014-5793(91)80132-M; Pemberton LF, 1996, J BIOL CHEM, V271, P2332, DOI 10.1074/jbc.271.4.2332; Poland PA, 1997, GLYCOCONJUGATE J, V14, P89, DOI 10.1023/A:1018569100438; Poland PA, 2011, J BIOL CHEM, V286, P6780, DOI 10.1074/jbc.M110.179002; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Potter BA, 2004, MOL BIOL CELL, V15, P1407, DOI 10.1091/mbc.E03-08-0550; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929	44	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39072	39081		10.1074/jbc.M111.289504	http://dx.doi.org/10.1074/jbc.M111.289504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937430	Green Published, hybrid			2022-12-25	WOS:000296759800026
J	Seth, S; Qiu, Q; Danisch, S; Maier, MK; Braun, A; Ravens, I; Czeloth, N; Hyde, R; Dittrich-Breiholz, O; Forster, R; Bernhardt, G				Seth, Sebastian; Qiu, Quan; Danisch, Simon; Maier, Michael K.; Braun, Asolina; Ravens, Inga; Czeloth, Niklas; Hyde, Rebecca; Dittrich-Breiholz, Oliver; Foerster, Reinhold; Bernhardt, Guenter			Intranodal Interaction with Dendritic Cells Dynamically Regulates Surface Expression of the Co-stimulatory Receptor CD226 Protein on Murine T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFT RECRUITMENT; POLIOVIRUS RECEPTOR; ADHESION MOLECULE; DNAM-1 CD226; CCR7-DEFICIENT MICE; NEGATIVE SELECTION; CENTRAL TOLERANCE; LYMPHOID ORGANS; NECTIN-2 CD112; STEADY-STATE	Dendritic cells (DCs) are the most potent antigen-presenting cells of the immune system. Depending on their maturation status, they prime T cells to induce adaptive immunity or tolerance. DCs express CD155, an immunoglobulin-like receptor binding CD226 present on T and natural killer (NK) cells. CD226 represents an important co-stimulator during T cell priming but also serves as an activating receptor on cytotoxic T and NK cells. Here, we report that cells of the T and NK cell lineage of CD155(-/-) mice express markedly elevated protein levels of CD226 compared with wild type (WT). On heterozygous CD155(+/-) T cells, CD226 up-regulation is half-maximal, implying an inverse gene-dosis effect. Moreover, CD226 up-regulation is independent of antigen-driven activation because it occurs already in thymocytes and native peripheral T cells. In vivo, neutralizing anti-CD155 antibody elicits up-regulation of CD226 on T cells demonstrating, that the observed modulation can be triggered by interrupting CD155-CD226 contacts. Adoptive transfers of WT or CD155(-/-) T cells into CD155(-/-) or WT recipients, respectively, revealed that CD226 modulation is accomplished in trans. Analysis of bone marrow chimeras showed that regulators in trans are of hematopoietic origin. We demonstrate that DCs are capable of manipulating CD226 levels on T cells in vivo but not in vitro, suggesting that the process of T cells actively scanning antigen-presenting DCs inside secondary lymphoid organs is required for CD226 modulation. Hence, a CD226 level divergent from WT may be exploited as a sensor to detect abnormal DC/T-cell cross-talk as illustrated for T cells in mice lacking CCR7.	[Seth, Sebastian; Qiu, Quan; Danisch, Simon; Maier, Michael K.; Braun, Asolina; Ravens, Inga; Czeloth, Niklas; Hyde, Rebecca; Foerster, Reinhold; Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Dittrich-Breiholz, Oliver] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Bernhardt, G (corresponding author), Carl Neuberg Str 1, D-30625 Hannover, Germany.	bernhardt.guenter@mh-hannover.de	Bernhardt, Günter/F-6946-2012; Förster, Reinhold/D-6770-2011	Bernhardt, Günter/0000-0002-0510-2853; Forster, Reinhold/0000-0001-6190-7923; Braun, Asolina/0000-0002-2646-5362	Deutsche Forschungsgemeinschaft [BE1886/2-1, BE1886/2-2]; Hannover Biomedical Research School; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hannover Biomedical Research School; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by Deutsche Forschungsgemeinschaft Grants BE1886/2-1 and BE1886/2-2 (to G. B.).; Scholarship holder of Hannover Biomedical Research School program "Infection Biology."; Scholarship holder of the Boehringer Ingelheim Fonds.	Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Cella M, 2010, EUR J IMMUNOL, V40, P949, DOI 10.1002/eji.200940234; Chan CJ, 2010, J IMMUNOL, V184, P902, DOI 10.4049/jimmunol.0903225; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Davalos-Misslitz ACM, 2007, BLOOD, V110, P4351, DOI 10.1182/blood-2007-01-070284; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Enloe BM, 2011, J NEURO-ONCOL, V102, P225, DOI 10.1007/s11060-010-0323-5; Erickson BM, 2006, HEPATOLOGY, V43, P325, DOI 10.1002/hep.21021; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Merrill MK, 2004, NEURO-ONCOLOGY, V6, P208, DOI 10.1215/S1152851703000577; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Morimoto K, 2008, ONCOGENE, V27, P264, DOI 10.1038/sj.onc.1210645; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Nakai R, 2010, CANCER SCI, V101, P1326, DOI 10.1111/j.1349-7006.2010.01530.x; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Ogita H, 2008, J MICROSC-OXFORD, V231, P455, DOI 10.1111/j.1365-2818.2008.02058.x; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Qiu Q, 2010, J IMMUNOL, V184, P1681, DOI 10.4049/jimmunol.0900062; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Ravens I, 2003, BIOCHEM BIOPH RES CO, V312, P1364, DOI 10.1016/j.bbrc.2003.11.067; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Seth S, 2009, J LEUKOCYTE BIOL, V86, P91, DOI [10.1189/JLB.1208745, 10.1189/jlb.1208745]; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Seth S, 2009, EUR J IMMUNOL, V39, P3160, DOI 10.1002/eji.200939470; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Shirakawa J, 2005, INT IMMUNOL, V17, P217, DOI 10.1093/intimm/dxh199; Shirakawa J, 2006, INT IMMUNOL, V18, P951, DOI 10.1093/intimm/dxl031; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Textor S, 2008, INT J CANCER, V123, P2343, DOI 10.1002/ijc.23733; Toutirais O, 2009, EUR J IMMUNOL, V39, P1361, DOI 10.1002/eji.200838409; Worbs T, 2009, CURR TOP MICROBIOL, V334, P71, DOI 10.1007/978-3-540-93864-4_4; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001	56	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39153	39163		10.1074/jbc.M111.264697	http://dx.doi.org/10.1074/jbc.M111.264697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937446	hybrid, Green Published			2022-12-25	WOS:000296759800034
J	Dixson, BJ; Haywood, J; Lester, PJ; Ormsby, DK				Dixson, Barnaby J.; Haywood, John; Lester, Philip J.; Ormsby, Diane K.			Whatever the Weather: Ambient Temperature Does Not Influence the Proportion of Males Born in New Zealand	PLOS ONE			English	Article							BIRTH SEX-RATIO; HUMAN-REPRODUCTION; ANNUAL RHYTHM; SEASONALITY; HUMANS; TIME; POPULATIONS; ADJUSTMENT; CONCEPTION; FERTILITY	Background: The proportion of male births has been shown to be over 50% in temperate climates around the world. Given that fluctuations in ambient temperature have previously been shown to affect sex allocation in humans, we examined the hypothesis that ambient temperature predicts fluctuations in the proportion of male births in New Zealand. Methodology/Principal Findings: We tested three main hypotheses using time series analyses. Firstly, we used historical annual data in New Zealand spanning 1876-2009 to test for a positive effect of ambient temperature on the proportion of male births. The proportion of males born ranged by 3.17%, from 0.504 to 0.520, but no significant relationship was observed between male birth rates and mean annual temperature in the concurrent or previous years. Secondly, we examined whether changes in annual ambient temperature were negatively related to the proportion of male stillbirths from 1929-2009 and whether the proportion of male stillbirths negatively affected the proportion of male live births. We found no evidence that fewer male stillbirths occurred during warmer concurrent or previous years, though a declining trend in the proportion of male stillbirths was observed throughout the data. Thirdly, we tested whether seasonal ambient temperatures, or deviations from those seasonal patterns, were positively related to the proportion of male births using monthly data from 1980-2009. Patterns of male and female births are seasonal, but very similar throughout the year, resulting in a non-seasonal proportion of male births. However, no cross correlations between proportion of male births and lags of temperature were significant. Conclusions: Results showed, across all hypotheses under examination, that ambient temperatures were not related to the proportion of male births or the proportion of male stillbirths in New Zealand. While there is evidence that temperature may influence human sex allocation elsewhere, such effects of temperature are not universal.	[Dixson, Barnaby J.; Lester, Philip J.; Ormsby, Diane K.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Haywood, John] Victoria Univ Wellington, Sch Math Stat & Operat Res, Wellington, New Zealand	Victoria University Wellington; Victoria University Wellington	Dixson, BJ (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	Barnaby.Dixson@vuw.ac.nz	Lester, Phil/A-1296-2008	Lester, Phil/0000-0002-1801-5687; Ormsby, Diane/0000-0002-3074-4639; Dixson, Barnaby/0000-0003-0911-1244	Victoria University of Wellington, New Zealand	Victoria University of Wellington, New Zealand	The source of funding was an internal grant at Victoria University of Wellington, New Zealand. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2010, AM J EPIDEMIOL, V172, P1108, DOI 10.1093/aje/kwq170; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Cagnacci A, 2003, HUM REPROD, V18, P885, DOI 10.1093/humrep/deg185; Catalano R, 2008, P NATL ACAD SCI USA, V105, P2244, DOI 10.1073/pnas.0710711104; Findley DF, 1998, J BUS ECON STAT, V16, P127, DOI 10.2307/1392565; Fisher R.A., 1930, GENETICAL THEORY NAT; FRENCH LJ, 2006 WINDS C UK COMF; Garenne M, 2002, HUM BIOL, V74, P889, DOI 10.1353/hub.2003.0003; Grech V, 2002, BRIT MED J, V324, P1010, DOI 10.1136/bmj.324.7344.1010; Harvey AC, 1990, FORECASTING STRUCTUR; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; Helle S, 2009, J ANIM ECOL, V78, P1226, DOI 10.1111/j.1365-2656.2009.01598.x; James WH, 2010, J BIOSOC SCI, V42, P587, DOI 10.1017/S002193201000012X; James WH, 2009, J THEOR BIOL, V257, P116, DOI 10.1016/j.jtbi.2008.09.028; JASILIONIS D, MORTALITY DATA NZ HU; Kaba Amadu Jacky, 2008, Afr J Reprod Health, V12, P139; LAM DA, 1994, ANN NY ACAD SCI, V709, P9, DOI 10.1111/j.1749-6632.1994.tb30385.x; Lerchl A, 1998, HUM REPROD, V13, P1401, DOI 10.1093/humrep/13.5.1401; Lerchl A, 1999, NATURWISSENSCHAFTEN, V86, P340, DOI 10.1007/s001140050630; Lerchl A, 1998, INT J BIOMETEOROL, V42, P84, DOI 10.1007/s004840050089; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Makridakis S., 1998, FORECASTING METHODS; McLachlan JC, 2003, J THEOR BIOL, V222, P71, DOI 10.1016/S0022-5193(03)00014-6; Navara KJ, 2010, J COMP PHYSIOL B, V180, P785, DOI 10.1007/s00360-010-0483-9; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; PAPPS T, 1985, EC SOCIAL COMMISSION, V12, P10; RHOADES DA, 1993, INT J CLIMATOL, V13, P899, DOI 10.1002/joc.3370130807; Rizzi EL, 2007, DEMOGRAPHY, V44, P705, DOI 10.1353/dem.2007.0040; ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P217, DOI 10.1177/074873049000500304; ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303; SCEATS J, 1985, EC SOCIAL COMMISSION, V12, P243; SPSS Inc, 2009, PASW STAT REL VERS 1; Statistics New Zealand, 2006, HIST SURV NZ COH LIF; Statistics New Zealand, 2004, REP REV MEAS ETHN; Statistics New Zealand, 2010, LAT BIRTH REG; Thonneau P, 1998, HUM REPROD, V13, P2122, DOI 10.1093/humrep/13.8.2122; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; TSAY RS, 1986, J AM STAT ASSOC, V81, P132, DOI 10.2307/2287980; Young TK, 2010, AM J HUM BIOL, V22, P129, DOI 10.1002/ajhb.20968	41	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25064	10.1371/journal.pone.0025064	http://dx.doi.org/10.1371/journal.pone.0025064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957476	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100036
J	Rosenfeld, AB				Rosenfeld, Amy B.			Suppression of Cellular Transformation by Poly (A) Binding Protein Interacting Protein 2 (Paip2)	PLOS ONE			English	Article							TRANSLATION INITIATION; POLY(A)-BINDING PROTEIN; EUKARYOTIC TRANSLATION; MESSENGER-RNA; GROWTH; EIF4G; PHOSPHORYLATION; EXPRESSION; REPRESSION; KINASE	Controlling translation is crucial for the homeostasis of a cell. Its deregulation can facilitate the development and progression of many diseases including cancer. Poly (A) binding protein interacting protein 2 (Paip2) inhibits efficient initiation of translation by impairing formation of the necessary closed loop of mRNA. The over production of Paip2 in the presence of a constitutively active form of hRas(V12) can reduce colony formation in a semi-solid matrix and focus formation on a cell monolayer. The ability of Paip2 to bind to Pabp is required to suppress the transformed phenotype mediated by hRas(V12). These observations indicate that Paip2 is able to function as a tumor suppressor.	Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Rosenfeld, AB (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.	amy.abrosenfeld@gmail.com			McGill University [2R01GM066157]; Canadian Institutes of Health Research Cancer Centre Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066157] Funding Source: NIH RePORTER	McGill University; Canadian Institutes of Health Research Cancer Centre Consortium(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 2R01GM066157 at McGill University. AR was the recipient of a Canadian Institutes of Health Research Cancer Centre Consortium Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; DOWLING RJ, SCIENCE, V328, P1172; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; FREDERICKSON RM, 1992, MOL CELL BIOL, V12, P1239, DOI 10.1128/MCB.12.3.1239; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Rousseau D, 1996, ONCOGENE, V13, P2415; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Verlaet M, 2001, BIOCHEM BIOPH RES CO, V283, P12, DOI 10.1006/bbrc.2001.4731; Wakiyama M, 2000, CURR BIOL, V10, P1147, DOI 10.1016/S0960-9822(00)00701-6; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25116	10.1371/journal.pone.0025116	http://dx.doi.org/10.1371/journal.pone.0025116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957478	gold, Green Published, Green Submitted			2022-12-25	WOS:000295262100038
J	Song, XW; Dong, ZY; Long, XY; Li, SF; Zuo, XN; Zhu, CZ; He, Y; Yan, CG; Zang, YF				Song, Xiao-Wei; Dong, Zhang-Ye; Long, Xiang-Yu; Li, Su-Fang; Zuo, Xi-Nian; Zhu, Chao-Zhe; He, Yong; Yan, Chao-Gan; Zang, Yu-Feng			REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; ABNORMAL NEURAL ACTIVITY; DEFAULT-MODE NETWORK; REGIONAL HOMOGENEITY; BRAIN-FUNCTION; ALZHEIMERS-DISEASE; SIGNAL SOURCES; GLOBAL SIGNAL; FMRI SIGNAL; MRI	Resting-state fMRI (RS-fMRI) has been drawing more and more attention in recent years. However, a publicly available, systematically integrated and easy-to-use tool for RS-fMRI data processing is still lacking. We developed a toolkit for the analysis of RS-fMRI data, namely the RESting-state fMRI data analysis Toolkit (REST). REST was developed in MATLAB with graphical user interface (GUI). After data preprocessing with SPM or AFNI, a few analytic methods can be performed in REST, including functional connectivity analysis based on linear correlation, regional homogeneity, amplitude of low frequency fluctuation (ALFF), and fractional ALFF. A few additional functions were implemented in REST, including a DICOM sorter, linear trend removal, bandpass filtering, time course extraction, regression of covariates, image calculator, statistical analysis, and slice viewer (for result visualization, multiple comparison correction, etc.). REST is an open-source package and is freely available at http://www.restfmri.net.	[Song, Xiao-Wei; Dong, Zhang-Ye; Long, Xiang-Yu; Li, Su-Fang; Zhu, Chao-Zhe; He, Yong; Yan, Chao-Gan; Zang, Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Song, Xiao-Wei] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Zang, Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Hangzhou Normal University; Hangzhou Normal University	Song, XW (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@gmail.com	Song, Xiaowei/E-8173-2011; Zuo, Xi-Nian/A-7273-2009; ZANG, Yu-Feng/J-1558-2012; He, Yong/Q-5756-2018; Yan, Chao-Gan/D-1713-2015; Chaozhe, Zhu/AAK-7737-2020; Li, Sufang/N-5697-2016; He, Yong/C-2161-2009	Song, Xiaowei/0000-0001-9694-6594; Zuo, Xi-Nian/0000-0001-9110-585X; ZANG, Yu-Feng/0000-0003-1833-8010; Yan, Chao-Gan/0000-0003-3413-5977; Chaozhe, Zhu/0000-0002-9247-9607; Li, Sufang/0000-0002-4716-4761; 宋, 晓伟/0000-0002-3101-2771	National High Technology Program of China (863) [2008AA02Z405]; Natural Science Foundation of China [30770594, 81020108022]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)	National High Technology Program of China (863)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was funded by the National High Technology Program of China (863, No. 2008AA02Z405), the Natural Science Foundation of China (30770594, 81020108022), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2004, LECT NOTES COMPUT SC, V3217, P907; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lowe MJ, 1999, J COMPUT ASSIST TOMO, V23, P463, DOI 10.1097/00004728-199905000-00025; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Press W. H., 1992, ART SCI COMPUTING; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Turner R, 1997, ADV EXP MED BIOL, V413, P19; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang T, 2010, NEUROREPORT, V21, P786, DOI 10.1097/WNR.0b013e32833cadf0; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; ZANG ZX, 2010, 16 ANN M ORG HUM BRA; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040; Zhou DL, 2009, NEUROIMAGE, V47, P1590, DOI 10.1016/j.neuroimage.2009.05.089; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	54	1548	1636	6	215	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25031	10.1371/journal.pone.0025031	http://dx.doi.org/10.1371/journal.pone.0025031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949842	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400038
J	Alexander, JM; Jenison, RL; Kluender, KR				Alexander, Joshua M.; Jenison, Rick L.; Kluender, Keith R.			Real-Time Contrast Enhancement to Improve Speech Recognition	PLOS ONE			English	Article							HEARING-IMPAIRED LISTENERS; STOP-CONSONANT PERCEPTION; AUDITORY FILTER SHAPES; FREQUENCY-SELECTIVITY; SPECTRAL ENHANCEMENT; COCHLEAR IMPAIRMENTS; PSYCHOPHYSICAL DATA; PRECEDING LIQUID; TUNING CURVES; AID DELAYS	An algorithm that operates in real-time to enhance the salient features of speech is described and its efficacy is evaluated. The Contrast Enhancement (CE) algorithm implements dynamic compressive gain and lateral inhibitory sidebands across channels in a modified winner-take-all circuit, which together produce a form of suppression that sharpens the dynamic spectrum. Normal-hearing listeners identified spectrally smeared consonants (VCVs) and vowels (hVds) in quiet and in noise. Consonant and vowel identification, especially in noise, were improved by the processing. The amount of improvement did not depend on the degree of spectral smearing or talker characteristics. For consonants, when results were analyzed according to phonetic feature, the most consistent improvement was for place of articulation. This is encouraging for hearing aid applications because confusions between consonants differing in place are a persistent problem for listeners with sensorineural hearing loss.	[Alexander, Joshua M.] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA; [Jenison, Rick L.; Kluender, Keith R.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison	Alexander, JM (corresponding author), Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA.	alexan14@purdue.edu		Jenison, Rick/0000-0002-3712-300X	National Institutes of Health, NIDCD [R01DC04072]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004072] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support provided by the National Institutes of Health, NIDCD (R01DC04072), http://www.nidcd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 1977, SYSTEMS NEUROSCIENCE, V119, P165, DOI [DOI 10.1016/B978-0-12-491850-4.50009-X, 10.1007/978-3-642-46466-9]; BAER T, 1993, J REHABIL RES DEV, V30, P49; BAER T, 1993, J ACOUST SOC AM, V94, P1229, DOI 10.1121/1.408176; BONDING P, 1979, Scandinavian Audiology, V8, P205, DOI 10.3109/01050397909076322; CHENG YM, 1991, IEEE T SIGNAL PROCES, V39, P1943, DOI 10.1109/78.134427; Delgutte B., 1997, HDB PHONETIC SCI, P507; DRESCHLER WA, 1980, J ACOUST SOC AM, V68, P1608, DOI 10.1121/1.385215; DRESCHLER WA, 1985, J ACOUST SOC AM, V78, P1261, DOI 10.1121/1.392895; DUBNO JR, 1982, J SPEECH HEAR RES, V25, P141, DOI 10.1044/jshr.2501.141; FESTEN JM, 1983, J ACOUST SOC AM, V73, P652, DOI 10.1121/1.388957; FOWLER CA, 1990, PERCEPT PSYCHOPHYS, V48, P559, DOI 10.3758/BF03211602; Franck BAM, 1999, J ACOUST SOC AM, V106, P1452, DOI 10.1121/1.428055; GLASBERG BR, 1986, J ACOUST SOC AM, V79, P1020, DOI 10.1121/1.393374; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Holt LL, 2000, J ACOUST SOC AM, V108, P710, DOI 10.1121/1.429604; HORST JW, 1987, J ACOUST SOC AM, V82, P874, DOI 10.1121/1.395286; HOUTGAST T, 1974, ACUSTICA, V31, P320; JESTEADT W, 1985, J ACOUST SOC AM, V78, P365, DOI 10.1121/1.392500; KATES JM, 2008, DIGITAL HEARING AIDS, P319; Kluender KR, 2003, SPEECH COMMUN, V41, P59, DOI 10.1016/S0167-6393(02)00093-6; Kohonen T., 1997, SELF ORGANIZING MAPS; LEEK MR, 1993, J ACOUST SOC AM, V94, P3127, DOI 10.1121/1.407218; LESHOWITZ B, 1977, PSYCHOPHYSICS PHYSL, P283; LINDBLOM B, 1963, J ACOUST SOC AM, V35, P1773, DOI 10.1121/1.1918816; LINDBLOM BE, 1967, J ACOUST SOC AM, V42, P830, DOI 10.1121/1.1910655; Lotto AJ, 1998, PERCEPT PSYCHOPHYS, V60, P602, DOI 10.3758/BF03206049; Lotto AJ, 1997, J ACOUST SOC AM, V102, P1134, DOI 10.1121/1.419865; Lyzenga J, 2002, J ACOUST SOC AM, V112, P1145, DOI 10.1121/1.1497619; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; MANN VA, 1981, J ACOUST SOC AM, V69, P548, DOI 10.1121/1.385483; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; MOORE BCJ, 1986, J ACOUST SOC AM, V80, P93, DOI 10.1121/1.394087; MOORE BCJ, 1992, J ACOUST SOC AM, V91, P3402, DOI 10.1121/1.402830; OHMAN SEG, 1966, J ACOUST SOC AM, V39, P151, DOI 10.1121/1.1909864; Ozimek E, 2004, APPL ACOUST, V65, P473, DOI 10.1016/j.apacoust.2003.11.004; SIDWELL A, 1985, J ACOUST SOC AM, V78, P495, DOI 10.1121/1.392471; SIMPSON AM, 1990, ACTA OTO-LARYNGOL, P101; STELMACHOWICZ PG, 1985, J ACOUST SOC AM, V77, P620, DOI 10.1121/1.392378; Stone MA, 2005, EAR HEARING, V26, P225, DOI 10.1097/00003446-200504000-00009; Stone MA, 2003, EAR HEARING, V24, P175, DOI 10.1097/01.AUD.0000058106.68049.9C; STONE MA, 1992, J REHABIL RES DEV, V29, P39, DOI 10.1682/JRRD.1992.04.0039; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; SUMMERFIELD Q, 1984, PERCEPT PSYCHOPHYS, V35, P203, DOI 10.3758/BF03205933; SUMMERFIELD Q, 1987, J ACOUST SOC AM, V81, P700, DOI 10.1121/1.394838; TYLER RS, 1984, J ACOUST SOC AM, V76, P1363, DOI 10.1121/1.391452; VANVEEN TM, 1985, J ACOUST SOC AM, V77, P628, DOI 10.1121/1.391880; WANG MD, 1973, J ACOUST SOC AM, V54, P1248, DOI 10.1121/1.1914417; WIGHTMAN FL, 1977, PSYCHOPHYSICS PHYSL, P295; Yuille AL, 1989, NEURAL COMPUT, V1, P334, DOI 10.1162/neco.1989.1.3.334; ZWICKER E, 1978, AUDIOLOGY, V17, P120	50	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24630	10.1371/journal.pone.0024630	http://dx.doi.org/10.1371/journal.pone.0024630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949736	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900023
J	Braunstein, SL; Ingabire, CM; Geubbels, E; Vyankandondera, J; Umulisa, MM; Gahiro, E; Uwineza, M; Tuijn, CJ; Nash, D; van de Wijgert, JHHM				Braunstein, Sarah L.; Ingabire, Chantal M.; Geubbels, Eveline; Vyankandondera, Joseph; Umulisa, Marie-Michele; Gahiro, Elysee; Uwineza, Mireille; Tuijn, Coosje J.; Nash, Denis; van de Wijgert, Janneke H. H. M.			High Burden of Prevalent and Recently Acquired HIV among Female Sex Workers and Female HIV Voluntary Testing Center Clients in Kigali, Rwanda	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; COMMERCIAL SEX; CONDOM USE; TRENDS; EPIDEMICS; HIV/AIDS; BEHAVIOR; WOMEN	Objectives: To estimate HIV prevalence and risk factors in population-based samples of female sex workers (FSW) and female voluntary counseling and testing (VCT) clients in Rwanda. Methods: We conducted a cross-sectional survey of 800 FSW and 1,250 female VCT clients in Rwanda, which included interviewing and testing for HIV-1/2, HSV-2 and pregnancy, and BED-CEIA and Avidity Index (AI) to identify recent infections among HIV-infected women. Results: Prevalence of HIV-1, HSV-2, and pregnancy were 24% (95% CI: 21.0-27.0), 59.8% (56.4-63.2), and 7.6% (5.8-9.5) among FSW, and 12.8% (10.9-14.6), 43.2% (40.4-46.0), and 11.4% (9.7-13.3) among VCT clients, respectively. Thirty-five percent of FSW and 25% of VCT clients had never been HIV tested. Per national guidelines, 33% of newly HIV-diagnosed FSW and 36% of VCT clients were already eligible for ART based on CD4,350 cells/ml. Condom use at last sex was higher among FSW (74%) than VCT clients (12%). In age and district of residence-adjusted models, HIV-1 seropositivity was associated with HSV-2 co-infection; recent treatment for sexually transmitted infection (STI); genital symptoms; forced sex; imprisonment; widowhood; and alcohol consumption. Eleven percent of FSW and 12% of VCT clients had recently acquired HIV-1 per BED-CEIA and AI. HSV-2 infection and recent STI treatment were associated with recent HIV infection in both groups, and being married and vaginal cleansing were associated with recent infection before last sex among VCT clients. Conclusions: This population-based survey reveals a high HIV prevalence and incidence among FSW and female VCT clients in Kigali, the scale of which is masked by the low general-population HIV prevalence in Rwanda. HIV/STI and family planning services should be strengthened.	[Braunstein, Sarah L.; Nash, Denis] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Ingabire, Chantal M.; Geubbels, Eveline; Vyankandondera, Joseph; Umulisa, Marie-Michele; Gahiro, Elysee; Uwineza, Mireille; Tuijn, Coosje J.; van de Wijgert, Janneke H. H. M.] Projet Ubuzima, Kigali, Rwanda; [Geubbels, Eveline; Tuijn, Coosje J.; van de Wijgert, Janneke H. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Geubbels, Eveline; Tuijn, Coosje J.; van de Wijgert, Janneke H. H. M.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Vyankandondera, Joseph] Belgian Dev Agcy, Kigali, Rwanda	Columbia University; University of Amsterdam; Academic Medical Center Amsterdam	Braunstein, SL (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.	braunstein.sarah@gmail.com	Nash, Denis/AFI-7485-2022	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Nash, Denis/0000-0002-3280-5386; Geubbels, Eveline/0000-0002-9702-5460	International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention; United States National Institutes of Health	International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP), through a project entitled: "Preparing for Phase III vaginal microbicide trials in Rwanda and Kenya: Preparedness studies, capacity building, and strengthening of medical referral systems"; United States Centers for Disease Control and Prevention; and United States National Institutes of Health (Institutional Training Grant). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the European and Developing Countries Clinical Trials Partnership (EDCTP) or US Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Aral SO, 2004, SEX TRANSM INFECT, V80, P8, DOI 10.1136/sti.2004.011866; Arthur G, 2007, SEX TRANSM INFECT, V83, P541, DOI 10.1136/sti.2007.026732; Baryarama F, 2008, JAIDS-J ACQ IMM DEF, V49, P183, DOI 10.1097/QAI.0b013e31818455b8; Baryarama F, 2007, JAIDS-J ACQ IMM DEF, V44, P99, DOI 10.1097/01.qai.0000245879.36015.54; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018402; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Chu HY, 2005, INT J STD AIDS, V16, P691, DOI 10.1258/095646205774357307; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V38, P202, DOI 10.1097/00126334-200502010-00012; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fonck K, 2000, INT J STD AIDS, V11, P804, DOI 10.1258/0956462001915327; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; Ghys PD, 2001, AIDS, V15, pS33, DOI 10.1097/00002030-200104003-00005; Grassly NC, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010637; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Horyniak D, 2010, INT J STD AIDS, V21, P305, DOI 10.1258/ijsa.2009.009427; *I NAT STAT RWAND, 2006, RWAND DEM HLTH SURV; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kayembe PK, 2008, SEX TRANSM INFECT, V84, P202, DOI 10.1136/sti.2007.028324; Kayirangwa E, 2006, SEX TRANSM INFECT, V82, pI27, DOI 10.1136/sti.2006.019588; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Kumogola Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-553; Leclerc PM, 2008, INT J STD AIDS, V19, P660, DOI 10.1258/ijsa.2008.008099; Ministry of Health, 2007, GUID PRIS CHARG PERS; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P454, DOI 10.1097/01.qai.0000152399.54648.b9; National AIDS Control Commission, 2008, RWAND US GEN ASS SPE; Oyugi J O, 2009, East Afr Med J, V86, P212; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; UNAIDS, 2008, EP FACT SHEET; VANDEPERRE P, 1989, LANCET, V1, P941; VANDEPERRE P, 1985, LANCET, V2, P524; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151	36	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24321	10.1371/journal.pone.0024321	http://dx.doi.org/10.1371/journal.pone.0024321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949704	gold, Green Published			2022-12-25	WOS:000295257900009
J	Niles, KM; Chan, D; La Salle, S; Oakes, CC; Trasler, JM				Niles, Kirsten M.; Chan, Donovan; La Salle, Sophie; Oakes, Christopher C.; Trasler, Jacquetta M.			Critical Period of Nonpromoter DNA Methylation Acquisition during Prenatal Male Germ Cell Development	PLOS ONE			English	Article							DE-NOVO METHYLATION; METHYLTRANSFERASE EXPRESSION; INITIAL-CHARACTERIZATION; EPIGENETIC INHERITANCE; REPETITIVE SEQUENCES; PARENTAL ALLELES; DNMT3 FAMILY; HUMAN GENOME; MALE-MICE; MOUSE	The prenatal period of germ cell development is a key time of epigenetic programming in the male, a window of development that has been shown to be influenced by maternal factors such as dietary methyl donor supply. DNA methylation occurring outside of promoter regions differs significantly between sperm and somatic tissues and has recently been linked with the regulation of gene expression during development as well as successful germline development. We examined DNA methylation at nonpromoter, intergenic sequences in purified prenatal and postnatal germ cells isolated from wildtype mice and mice deficient in the DNA methyltransferase cofactor DNMT3L. Erasure of the parental DNA methylation pattern occurred by 13.5 days post coitum (dpc) with the exception of approximately 8% of loci demonstrating incomplete erasure. For most loci, DNA methylation acquisition occurred between embryonic day 13.5 to 16.5 indicating that the key phase of epigenetic pattern establishment for intergenic sequences in male germ cells occurs prior to birth. In DNMT3L-deficient germ cells at 16.5 dpc, average DNA methylation levels were low, about 30% of wildtype levels; however, by postnatal day 6, about half of the DNMT3L deficiency-specific hypomethylated loci had acquired normal methylation levels. Those loci normally methylated earliest in the prenatal period were the least affected in the DNMT3L-deficient mice, suggesting that some loci may be more susceptible than others to perturbations occurring prenatally. These results indicate that the critical period of DNA methylation programming of nonpromoter, intergenic sequences occurs in male germline progenitor cells in the prenatal period, a time when external perturbations of epigenetic patterns could result in diminished fertility.	[Niles, Kirsten M.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Montreal Childrens Hosp, Res Inst, Ctr Hlth, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University; McGill University; McGill University	Niles, KM (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	jacquetta.trasler@mcgill.ca	Oakes, Christopher C/H-7288-2014	Oakes, Christopher C/0000-0001-8000-9694; Niles, Kirsten M./0000-0002-3128-913X	Canadian Institutes of Health Research (CIHR) [11362]; CIHR Institute of Genetics; Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant (number 11362) from the Canadian Institutes of Health Research (CIHR) to J.M.T. K.M.N. is a recipient of the CIHR Institute of Genetics Walter and Jessie Boyd & Charles Scriver MD/PhD Studentship Award. D. C. is a recipient of Fonds de la recherche en sante du Quebec (FRSQ) and CIHR Doctoral Research Awards. S. L. and C.C.O. were recipients of CIHR Doctoral Research Awards. J.M.T. is a James McGill Professor of McGill University. At the time of the work presented here, all authors were members of the Research Institute of The McGill University Health Centre, which is supported in part by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Aapola U, 2001, CYTOGENET CELL GENET, V92, P122, DOI 10.1159/000056881; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; Hata K, 2002, DEVELOPMENT, V129, P1983; Hata K, 2006, MOL REPROD DEV, V73, P116, DOI 10.1002/mrd.20387; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kelly TLJ, 2005, BIOL REPROD, V72, P667, DOI 10.1095/biolreprod.104.035238; Kim TM, 2007, MAMM GENOME, V18, P277, DOI 10.1007/s00335-007-9016-6; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; La Salle S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-104; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Lucifero D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-36; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Oakes CC, 2006, EPIGENETICS-US, V1, P146, DOI 10.4161/epi.1.3.3392; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Shovlin TC, 2007, HUM REPROD, V22, P457, DOI 10.1093/humrep/del379; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	58	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24156	10.1371/journal.pone.0024156	http://dx.doi.org/10.1371/journal.pone.0024156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949694	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900005
J	Polajeva, J; Sjosten, AM; Lager, N; Kastemar, M; Waern, I; Alafuzoff, I; Smits, A; Westermark, B; Pejler, G; Uhrbom, L; Tchougounova, E				Polajeva, Jelena; Sjosten, Anna M.; Lager, Nina; Kastemar, Marianne; Waern, Ida; Alafuzoff, Irina; Smits, Anja; Westermark, Bengt; Pejler, Gunnar; Uhrbom, Lene; Tchougounova, Elena			Mast Cell Accumulation in Glioblastoma with a Potential Role for Stem Cell Factor and Chemokine CXCL12	PLOS ONE			English	Article							NEURAL PROGENITORS; RECEPTOR CXCR4; GROWTH-FACTOR; ANGIOGENESIS; GLIOMA; ACTIVATION; EXPRESSION; SURVIVAL; NUMBER; LIGAND	Glioblastoma multiforme (GBM) is the most common and malignant form of glioma with high mortality and no cure. Many human cancers maintain a complex inflammatory program triggering rapid recruitment of inflammatory cells, including mast cells (MCs), to the tumor site. However, the potential contribution of MCs in glioma has not been addressed previously. Here we report for the first time that MCs infiltrate KRas+Akt-induced gliomas, using the RCAS/TV-a system, where KRas and Akt are transduced by RCAS into the brains of neonatal Gtv-a-or Ntv-a transgenic mice lacking Ink4a or Arf. The most abundant MC infiltration was observed in high-grade gliomas of Arf(-/-) mice. MC accumulation could be localized to the vicinity of glioma-associated vessels but also within the tumor mass. Importantly, proliferating MCs were detected, suggesting that the MC accumulation was caused by local expansion of the MC population. In line with these findings, strong expression of stem cell factor (SCF), i.e. the main MC growth factor, was detected, in particular around tumor blood vessels. Further, glioma cells expressed the MC chemotaxin CXCL12 and MCs expressed the corresponding receptor, i.e. CXCR4, suggesting that MCs could be attracted to the tumor through the CXCL12/CXCR4 axis. Supporting a role for MCs in glioma, strong MC infiltration was detected in human glioma, where GBMs contained significantly higher MC numbers than grade II tumors did. Moreover, human GBMs were positive for CXCL12 and the infiltrating MCs were positive for CXCR4. In conclusion, we provide the first evidence for a role for MCs in glioma.	[Polajeva, Jelena; Sjosten, Anna M.; Kastemar, Marianne; Alafuzoff, Irina; Westermark, Bengt; Uhrbom, Lene; Tchougounova, Elena] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Waern, Ida; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Uppsala, Sweden; [Smits, Anja] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University Hospital	Polajeva, J (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	elena.chugunova@igp.uu.se		Westermark, Bengt/0000-0001-7153-5545	Swedish Research Council; Swedish Cancer Society; Gunvor and Josef Aners Foundation; Lions Cancer foundation; P. O. Zetterlings Foundation; Department of Immunology, Genetics and Pathology; Medical Faculty of Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Gunvor and Josef Aners Foundation; Lions Cancer foundation; P. O. Zetterlings Foundation; Department of Immunology, Genetics and Pathology; Medical Faculty of Uppsala University	This work has been supported by grants from the Swedish Research Council, the Swedish Cancer Society, Gunvor and Josef Aners Foundation, Lions Cancer foundation, P. O. Zetterlings Foundation, the Department of Immunology, Genetics and Pathology and the Medical Faculty of Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini RM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-165; Anderson Joshua C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000768; Ara T, 2005, BLOOD, V105, P3155, DOI 10.1182/blood-2004-07-2563; Bian XW, 2007, NEUROSURGERY, V61, P570, DOI 10.1227/01.NEU.0000290905.53685.A2; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; de Paulis A, 1999, J IMMUNOL, V163, P2799; Finotto S, 1997, J CLIN INVEST, V99, P1721, DOI 10.1172/JCI119336; Ghosh A, 2010, IMMUNOL LETT, V131, P3, DOI 10.1016/j.imlet.2010.03.003; GOLLI SJ, 1995, INT ARCH ALLERGY IMM, V107, P51; Grimbaldeston MA, 2006, PHOTOCH PHOTOBIO SCI, V5, P177, DOI 10.1039/b504344a; Gulubova M, 2009, J GASTROEN HEPATOL, V24, P1265, DOI 10.1111/j.1440-1746.2007.05009.x; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Juremalm M, 2000, EUR J IMMUNOL, V30, P3614, DOI 10.1002/1521-4141(200012)30:12<3614::AID-IMMU3614>3.0.CO;2-B; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kong LY, 2010, CLIN CANCER RES, V16, P5722, DOI 10.1158/1078-0432.CCR-10-1693; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Mohle R, 1998, Stem Cells, V16 Suppl 1, P159; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; QU ZH, 1995, AM J PATHOL, V147, P564; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Ribatti D, 2009, INT REV CEL MOL BIO, V275, P89, DOI 10.1016/S1937-6448(09)75004-X; Ronnberg E, 2011, METHODS MOL BIOL; Silverman AJ, 2000, J NEUROSCI, V20, P401, DOI 10.1523/JNEUROSCI.20-01-00401.2000; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Terasaki M, 2011, BRAIN TUMOR PATHOL, V28, P89, DOI 10.1007/s10014-010-0013-1; Thang NNT, 2010, CANCER RES, V70, P4829, DOI 10.1158/0008-5472.CAN-09-3074; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Uhrbom L, 2002, CANCER RES, V62, P5551; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197	43	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25222	10.1371/journal.pone.0025222	http://dx.doi.org/10.1371/journal.pone.0025222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949886	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900060
J	Dumas, MD; Polson, SW; Ritter, D; Ravel, J; Gelb, J; Morgan, R; Wommack, KE				Dumas, Michael D.; Polson, Shawn W.; Ritter, Don; Ravel, Jacques; Gelb, Jack, Jr.; Morgan, Robin; Wommack, K. Eric			Impacts of Poultry House Environment on Poultry Litter Bacterial Community Composition	PLOS ONE			English	Article							RIBOSOMAL DATABASE PROJECT; POSITIVE ANAEROBIC COCCI; GANGRENOUS DERMATITIS; MICROBIAL DIVERSITY; BROILER-CHICKENS; SP-NOV.; SOIL; ARCOBACTER; MICROFLORA; BIOSPHERE	Viral and bacterial pathogens are a significant economic concern to the US broiler industry and the ecological epicenter for poultry pathogens is the mixture of bedding material, chicken excrement and feathers that comprises the litter of a poultry house. This study used high-throughput sequencing to assess the richness and diversity of poultry litter bacterial communities, and to look for connections between these communities and the environmental characteristics of a poultry house including its history of gangrenous dermatitis (GD). Cluster analysis of 16S rRNA gene sequences revealed differences in the distribution of bacterial phylotypes between Wet and Dry litter samples and between houses. Wet litter contained greater diversity with 90% of total bacterial abundance occurring within the top 214 OTU clusters. In contrast, only 50 clusters accounted for 90% of Dry litter bacterial abundance. The sixth largest OTU cluster across all samples classified as an Arcobacter sp., an emerging human pathogen, occurring in only the Wet litter samples of a house with a modern evaporative cooling system. Ironically, the primary pathogenic clostridial and staphylococcal species associated with GD were not found in any house; however, there were thirteen 16S rRNA gene phylotypes of mostly Gram-positive phyla that were unique to GD-affected houses and primarily occurred in Wet litter samples. Overall, the poultry house environment appeared to substantially impact the composition of litter bacterial communities and may play a key role in the emergence of food-borne pathogens.	[Dumas, Michael D.; Polson, Shawn W.; Wommack, K. Eric] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Wommack, K. Eric] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Polson, Shawn W.; Wommack, K. Eric] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19717 USA; [Ritter, Don] Mountaire Farms Inc, Millsboro, DE USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Gelb, Jack, Jr.; Morgan, Robin] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA; [Polson, Shawn W.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE USA	University of Delaware; University of Delaware; University of Delaware; University System of Maryland; University of Maryland Baltimore; University of Delaware; University of Delaware	Dumas, MD (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	wommack@dbi.udel.edu	Ravel, Jacques/D-2530-2009; Smith, Liz/C-5867-2011; Polson, Shawn W./B-7696-2011	Polson, Shawn W./0000-0002-3398-6932; Ravel, Jacques/0000-0002-0851-2233	University of Delaware, Avian Biosciences Center	University of Delaware, Avian Biosciences Center	The authors gratefully acknowledge the support of the University of Delaware, Avian Biosciences Center (http://ag.udel.edu/abc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HS, 2007, INT J SYST EVOL MICR, V57, P1521, DOI 10.1099/ijs.0.64965-0; Boyd W, 2001, TECHNOL CULT, V42, P631, DOI 10.1353/tech.2001.0150; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Coates JD, 1999, APPL ENVIRON MICROB, V65, P5234; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins LM, 2007, J R SOC INTERFACE, V4, P65, DOI 10.1098/rsif.2006.0157; Collins SP, NEW STRATEGIEST COCC, P10; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elsas J. D. van, 1997, Manual of environmental microbiology., P383; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P4105, DOI 10.1128/AEM.02694-05; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; FRAZIER MN, 1964, AVIAN DIS, V8, P269, DOI 10.2307/1588070; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Fries R, 2005, BRIT POULTRY SCI, V46, P668, DOI 10.1080/00071660500395483; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Ghidan A, 2008, ACTA VET HUNG, V56, P13, DOI 10.1556/AVet.56.2008.1.3; Graham JP, 2009, ENVIRON RES, V109, P682, DOI 10.1016/j.envres.2009.05.005; Gude A, 2005, LETT APPL MICROBIOL, V41, P82, DOI 10.1111/j.1472-765X.2005.01708.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hayes JR, 2004, APPL ENVIRON MICROB, V70, P6005, DOI 10.1128/AEM.70.10.6005-6011.2004; Helton RR, 2006, APPL ENVIRON MICROB, V72, P4767, DOI 10.1128/AEM.00297-06; Hewson I, 2003, MICROB ECOL, V46, P337, DOI 10.1007/s00248-002-1041-0; Ho HTK, 2008, INT J FOOD MICROBIOL, V125, P223, DOI 10.1016/j.ijfoodmicro.2008.02.012; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hunter WJ, 2007, CURR MICROBIOL, V54, P376, DOI 10.1007/s00284-006-0474-y; Johansen CH, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-30; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kabell S, 2005, ACTA VET SCAND, V46, P219, DOI 10.1186/1751-0147-46-219; Kaul MK, 2001, INDIAN VET J, V78, P282; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; LARSEN N, 1993, NUCLEIC ACIDS RES, V21, P3021, DOI 10.1093/nar/21.13.3021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003; Lovanh N, 2007, POULTRY SCI, V86, P1840, DOI 10.1093/ps/86.9.1840; Lu JR, 2008, J MICROBIOL, V46, P469, DOI 10.1007/s12275-008-0117-z; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin SA, 1998, J APPL POULTRY RES, V7, P90, DOI 10.1093/japr/7.1.90; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Mendum TA, 1999, APPL ENVIRON MICROB, V65, P4155; Monard C, 2008, APPL ENVIRON MICROB, V74, P5589, DOI 10.1128/AEM.00333-08; Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81, DOI 10.1128/CMR.11.1.81; Novakova D, 2006, FEMS MICROBIOL LETT, V263, P163, DOI 10.1111/j.1574-6968.2006.00408.x; Ollinger M, 2005, AM J AGR ECON, V87, P116, DOI 10.1111/j.0002-9092.2005.00706.x; Omeira N, 2006, SCI TOTAL ENVIRON, V367, P156, DOI 10.1016/j.scitotenv.2006.02.019; Onraedt A, 2005, BIOTECHNOL LETT, V27, P527, DOI 10.1007/s10529-005-2878-3; Pascual C, 1999, INT J SYST BACTERIOL, V49, P1527, DOI 10.1099/00207713-49-4-1527; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; RAVEL J, 2010, P NATL ACAD SCI US; Rothrock MJ, 2008, POULTRY SCI, V87, P1493, DOI 10.3382/ps.2007-00491; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schloss PD, 2006, PLOS COMPUTATIONAL B, V2; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Song YL, 2003, J CLIN MICROBIOL, V41, P1363, DOI 10.1128/JCM.41.4.1363-1369.2003; Song YL, 2007, J CLIN MICROBIOL, V45, P1746, DOI 10.1128/JCM.00213-07; Srinivasan S, 2008, INTERDISCIPLINARY PE, V2008; Tan ZY, 2003, INT J SYST EVOL MICR, V53, P1139, DOI 10.1099/ijs.0.02606-0; Team RDC, 2010, R LANG ENV STAT COMP; Teixeira LC, 2010, ISME J; Terzich M, 2000, J APPL POULTRY RES, V9, P287, DOI 10.1093/japr/9.3.287; Thaxton YV, 2003, J APPL POULTRY RES, V12, P81, DOI 10.1093/japr/12.1.81; United States Department of Agriculture NSS, 2010, POULTR PROD VAL 2009; Van Driessche E, 2007, POULTRY SCI, V86, P744, DOI 10.1093/ps/86.4.744; Van Trump JI, 2009, ISME J, V3, P466, DOI 10.1038/ismej.2008.119; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P451, DOI 10.1099/00207713-41-3-451; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P6776, DOI 10.1128/AEM.71.11.6776-6783.2005; Wilder TD, 2001, AVIAN DIS, V45, P659, DOI 10.2307/1592908; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Williamson KE, 2003, APPL ENVIRON MICROB, V69, P6628, DOI 10.1128/AEM.69.11.6628-6633.2003; Williamson KE, 2007, ENVIRON MICROBIOL, V9, P2563, DOI 10.1111/j.1462-2920.2007.01374.x; Willoughby DH, 1996, J VET DIAGN INVEST, V8, P259, DOI 10.1177/104063879600800222; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Wybo I, 2004, J CLIN MICROBIOL, V42, P1851, DOI 10.1128/JCM.42.4.1851-1852.2004	85	67	70	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24785	10.1371/journal.pone.0024785	http://dx.doi.org/10.1371/journal.pone.0024785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949751	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800037
J	Granne, I; Southcombe, JH; Snider, JV; Tannetta, DS; Child, T; Redman, CWG; Sargent, IL				Granne, Ingrid; Southcombe, Jennifer H.; Snider, James V.; Tannetta, Dionne S.; Child, Tim; Redman, Christopher W. G.; Sargent, Ian L.			ST2 and IL-33 in Pregnancy and Pre-Eclampsia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IL-1-LIKE CYTOKINE IL-33; FAMILY-MEMBER ST2; SOLUBLE ST2; HUMAN PLACENTA; CELL-SURFACE; IN-VIVO; RECEPTOR; PROTEIN; EXPRESSION	Normal pregnancy is associated with a mild systemic inflammatory response and an immune bias towards type 2 cytokine production, whereas pre-eclampsia is characterized by a more intense inflammatory response, associated with endothelial dysfunction and a type 1 cytokine dominance. Interleukin (IL)-33 is a newly described member of the IL-1 family, which binds its receptor ST2L to induce type 2 cytokines. A soluble variant of ST2 (sST2) acts as a decoy receptor to regulate the activity of IL-33. In this study circulating IL-33 and sST2 were measured in each trimester of normal pregnancy and in women with pre-eclampsia. While IL-33 did not change throughout normal pregnancy, or between non-pregnant, normal pregnant or pre-eclamptic women, sST2 was significantly altered. sST2 was increased in the third trimester of normal pregnancy (p<0.001) and was further increased in pre-eclampsia (p<0.001). This increase was seen prior to the onset of disease (p<0.01). Pre-eclampsia is a disease caused by placental derived factors, and we show that IL-33 and ST2 can be detected in lysates from both normal and pre-eclampsia placentas. ST2, but not IL-33, was identified on the syncytiotrophoblast layer, whereas IL-33 was expressed on perivascular tissue. In an in vitro placental perfusion model, sST2 was secreted by the placenta into the 'maternal' eluate, and placental explants treated with pro-inflammatory cytokines or subjected to hypoxia/reperfusion injury release more sST2, suggesting the origin of at least some of the increased amounts of circulating sST2 in pre-eclamptic women is the placenta. These results suggest that sST2 may play a significant role in pregnancies complicated by pre-eclampsia and increased sST2 could contribute to the type 1 bias seen in this disorder.	[Granne, Ingrid; Child, Tim] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford Fertil Unit, Oxford, England; [Snider, James V.] Crit Diagnost, San Diego, CA USA	University of Oxford	Granne, I (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford Fertil Unit, Oxford, England.	jen.southcombe@obs-gyn.ox.ac.uk		Southcombe, Jennifer/0000-0003-0699-650X	Wellcome Trust [GR079862]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust programme grant GR079862 http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J IMMUNOL; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Angelo LS, 2007, CLIN CANCER RES, V13, P2825, DOI 10.1158/1078-0432.CCR-06-2416; Aoki S, 2010, MOL CELL BIOCHEM, V335, P75, DOI 10.1007/s11010-009-0244-9; Bartunek J, 2008, J AM COLL CARDIOL, V52, P2166, DOI 10.1016/j.jacc.2008.09.027; BELTRAN CJ, 2009, INFLAMM BOWEL DIS; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Borzychowski AM, 2005, EUR J IMMUNOL, V35, P3054, DOI 10.1002/eji.200425929; Brunner M, 2004, INTENS CARE MED, V30, P1468, DOI 10.1007/s00134-004-2184-x; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Foidart JM, 2009, J REPROD IMMUNOL, V82, P106, DOI 10.1016/j.jri.2009.09.001; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Houghton-Trivino N, 2010, J GEN VIROL, V91, P697, DOI 10.1099/vir.0.012971-0; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P474, DOI 10.1006/bbrc.1997.6810; Kuroiwa K, 2001, BIOCHEM BIOPH RES CO, V284, P1104, DOI 10.1006/bbrc.2001.5090; Lecart S, 2002, EUR J IMMUNOL, V32, P2979, DOI 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5; Liew F., 2010, NAT REV IMMUNOL; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Melchiorre K, 2011, HYPERTENSION, V57, P85, DOI 10.1161/HYPERTENSIONAHA.110.162321; Mildner M, 2010, CARDIOVASC RES, V87, P769, DOI 10.1093/cvr/cvq104; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Poon LCY, 2010, ULTRASOUND OBST GYN, V35, P662, DOI 10.1002/uog.7628; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Socrates T, 2010, J INTERN MED, V268, P493, DOI 10.1111/j.1365-2796.2010.02263.x; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	44	57	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24463	10.1371/journal.pone.0024463	http://dx.doi.org/10.1371/journal.pone.0024463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949719	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800023
J	Mondia, JP; Levin, M; Omenetto, FG; Orendorff, RD; Branch, MR; Adams, DS				Mondia, Jessica P.; Levin, Michael; Omenetto, Fiorenzo G.; Orendorff, Ryan D.; Branch, Mary Rose; Adams, Dany Spencer			Long-Distance Signals Are Required for Morphogenesis of the Regenerating Xenopus Tadpole Tail, as Shown by Femtosecond-Laser Ablation	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; LIMB REGENERATION; SPINAL-CORD; IN-VIVO; LAEVIS; MICROSURGERY; MODULATION; VERTEBRATE; ZEBRAFISH; EMBRYOS	Background: With the goal of learning to induce regeneration in human beings as a treatment for tissue loss, research is being conducted into the molecular and physiological details of the regeneration process. The tail of Xenopus laevis tadpoles has recently emerged as an important model for these studies; we explored the role of the spinal cord during tadpole tail regeneration. Methods and Results: Using ultrafast lasers to ablate cells, and Geometric Morphometrics to quantitatively analyze regenerate morphology, we explored the influence of different cell populations. For at least twenty-four hours after amputation (hpa), laser-induced damage to the dorsal midline affected the morphology of the regenerated tail; damage induced 48 hpa or later did not. Targeting different positions along the anterior-posterior (AP) axis caused different shape changes in the regenerate. Interestingly, damaging two positions affected regenerate morphology in a qualitatively different way than did damaging either position alone. Quantitative comparison of regenerate shapes provided strong evidence against a gradient and for the existence of position-specific morphogenetic information along the entire AP axis. Conclusions: We infer that there is a conduit of morphology-influencing information that requires a continuous dorsal midline, particularly an undamaged spinal cord. Contrary to expectation, this information is not in a gradient and it is not localized to the regeneration bud. We present a model of morphogenetic information flow from tissue undamaged by amputation and conclude that studies of information coming from far outside the amputation plane and regeneration bud will be critical for understanding regeneration and for translating fundamental understanding into biomedical approaches.	[Mondia, Jessica P.; Omenetto, Fiorenzo G.; Orendorff, Ryan D.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Levin, Michael; Branch, Mary Rose; Adams, Dany Spencer] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Levin, Michael; Branch, Mary Rose; Adams, Dany Spencer] Tufts Univ, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA	Tufts University; Tufts University; Tufts University	Mondia, JP (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	Dany.Adams@Tufts.edu	Adams, Dany/AAB-1150-2021; Adams, Dany/HGD-6044-2022; Levin, Michael/A-5918-2011	Adams, Dany/0000-0003-2024-9746; Levin, Michael/0000-0001-7292-8084	NIH [GM078484, K22 DE016633]; Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) [W81XWH-10-2-0058]; AFOSR [FA9550-09-1-0513]; LANL LEEG [L09/429]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE016633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); LANL LEEG; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ML gratefully acknowledges the funding support of NIH grant GM078484, and of the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) through award W81XWH-10-2-0058; FGO acknowledges partial support from AFOSR under contract FA9550-09-1-0513 and LANL LEEG# L09/429; DSA gratefully acknowledges the support of NIH K22 DE016633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; ADAMS DS, 1990, DEVELOPMENT, V110, P115; Albertson RC, 2001, J EXP ZOOL, V289, P385, DOI 10.1002/jez.1020; ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297; Beck C, 2009, DEV DYN; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Blackiston D, 2010, DIS MODELS IN PRESS; Chung SH, 2009, J BIOPHOTONICS, V2, P557, DOI 10.1002/jbio.200910053; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; HAUSER R, 1972, ROUX ARCH DEV BIOL, V169, P170, DOI 10.1007/BF00649890; Ho DM, 2008, DEV BIOL, V315, P203, DOI 10.1016/j.ydbio.2007.12.031; JURAND A., 1954, FOLIA BIOL, V2, P3; Kimmel CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009475; Klingenberg C. P., 2010, MOL ECOLOGY RESOURCE, P1; Kolahi KS, 2009, DEV BIOL, V331, P129, DOI 10.1016/j.ydbio.2009.04.028; KONIECZNA B., 1954, FOLIA BIOL, V2, P215; Kuetemeyer K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463012; Larson PM, 2002, J MORPHOL, V252, P131, DOI 10.1002/jmor.1095; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lin GF, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-56; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; Mondia JP, 2011, BIOMED OPT EXPRESS, V2, P2383, DOI 10.1364/BOE.2.002383; Morokuma J, 2008, P NATL ACAD SCI USA, V105, P16608, DOI 10.1073/pnas.0808328105; Ozkucur N, 2010, DEV DYNAM, V239, P2048, DOI 10.1002/dvdy.22323; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Rasband W., 2006, IMAGEJ; Reid B, 2009, DEV BIOL, V335, P198, DOI 10.1016/j.ydbio.2009.08.028; ROGUSKI HENRYK, 1954, FOLIA BIOL, V2, P189; SINGER M, 1967, J EXP ZOOL, V166, P89, DOI 10.1002/jez.1401660110; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; Slack JMW, 2004, PHILOS T R SOC B, V359, P745, DOI 10.1098/rstb.2004.1463; Sugiura T, 2009, MECH DEVELOP, V126, P56, DOI 10.1016/j.mod.2008.10.002; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Supatto W, 2008, BIOPHYS J, V95, pL29, DOI 10.1529/biophysj.108.137786; Taban C H, 1988, Monogr Dev Biol, V21, P30; Taniguchi Y, 2008, DEV GROWTH DIFFER, V50, P109, DOI [10.1111/j.1440-169X.2007.00981.x, 10.1111/j.1440-169x.2007.00981.x]; Thayil AKN, 2008, J MICROSC-OXFORD, V232, P362, DOI 10.1111/j.1365-2818.2008.02107.x; THORNTON CS, 1970, AM ZOOL, V10, P113; Tseng AS, 2008, J DENT RES, V87, P806, DOI 10.1177/154405910808700909; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Yalcin HC, 2010, AM J PHYSIOL-HEART C, V299, pH1728, DOI 10.1152/ajpheart.00495.2010; YNTEMA CL, 1959, J EXP ZOOL, V142, P423, DOI 10.1002/jez.1401420119	49	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24953	10.1371/journal.pone.0024953	http://dx.doi.org/10.1371/journal.pone.0024953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949803	gold, Green Published, Green Submitted			2022-12-25	WOS:000295173800051
J	Soderholm, N; Vielfort, K; Hultenby, K; Aro, H				Soderholm, Niklas; Vielfort, Katarina; Hultenby, Kjell; Aro, Helena			Pathogenic Neisseria Hitchhike on the Uropod of Human Neutrophils	PLOS ONE			English	Article							PILUS-MEDIATED ADHERENCE; NECROSIS-FACTOR-ALPHA; COFACTOR PROTEIN MCP; IV PILI; GONOCOCCUS INFECTION; EPITHELIAL-CELLS; PHASE VARIATION; GONORRHOEAE; MENINGITIDIS; CD46	Polymorphonuclear neutrophils (PMNs) are important components of the human innate immune system and are rapidly recruited at the site of bacterial infection. Despite the effective phagocytic activity of PMNs, Neisseria gonorrhoeae infections are characterized by high survival within PMNs. We reveal a novel type IV pilus-mediated adherence of pathogenic Neisseria to the uropod (the rear) of polarized PMNs. The direct pilus-uropod interaction was visualized by scanning electron microscopy and total internal reflection fluorescence (TIRF) microscopy. We showed that N. meningitidis adhesion to the PMN uropod depended on both pilus-associated proteins PilC1 and PilC2, while N. gonorrhoeae adhesion did not. Bacterial adhesion elicited accumulation of the complement regulator CD46, but not I-domain-containing integrins, beneath the adherent bacterial microcolony. Electrographs and live-cell imaging of PMNs suggested that bacterial adherence to the uropod is followed by internalization into PMNs via the uropod. We also present data showing that pathogenic Neisseria can hitchhike on PMNs to hide from their phagocytic activity as well as to facilitate the spread of the pathogen through the epithelial cell layer.	[Soderholm, Niklas; Vielfort, Katarina; Aro, Helena] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Huddinge, Sweden	Stockholm University; Karolinska Institutet	Soderholm, N (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	Helena.Aro@gmt.su.se		Vielfort, Katarina/0000-0002-9988-6336	Swedish Society for Medicine; Ake Wibergs stiftelse Magnus Bergwalls Stiftelse; Stiftelsen Lars Hiertas Minne; Harald Jeanssons Stiftelse; Petrus och Augusta Hedlunds Stiftelse; Granholms stiftelse; Stockholm University; Swedish Medical Research Council [2006-2911, 2006-6304]	Swedish Society for Medicine; Ake Wibergs stiftelse Magnus Bergwalls Stiftelse; Stiftelsen Lars Hiertas Minne; Harald Jeanssons Stiftelse; Petrus och Augusta Hedlunds Stiftelse; Granholms stiftelse; Stockholm University; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work was supported by the Swedish Society for Medicine, Ake Wibergs stiftelse Magnus Bergwalls Stiftelse, Stiftelsen Lars Hiertas Minne, Harald Jeanssons Stiftelse, Petrus och Augusta Hedlunds Stiftelse, Granholms stiftelse, Stockholm University and the Swedish Medical Research Council (Dnr. 2006-2911, 2006-6304). We thank Kjell Jansson at the Electron Microscopy Center (EMC) at the Department of Materials and Environmental Chemistry (MMK), Stockholm University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman M, 1998, MICROBIOL-UK, V144, P149, DOI 10.1099/00221287-144-1-149; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Chin AC, 2007, ANNU REV PATHOL-MECH, V2, P111, DOI 10.1146/annurev.pathol.2.010506.091944; CHO SW, 1991, CLIN EXP IMMUNOL, V83, P257; Christodoulides M, 2002, INFECT IMMUN, V70, P4035, DOI 10.1128/IAI.70.8.4035-4044.2002; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; DENSEN P, 1978, J CLIN INVEST, V62, P1161, DOI 10.1172/JCI109235; Edwards JL, 2005, CELL MICROBIOL, V7, P1197, DOI 10.1111/j.1462-5822.2005.00547.x; Edwards JL, 2001, CELL MICROBIOL, V3, P611, DOI 10.1046/j.1462-5822.2001.00140.x; ESTABROOK MM, 1992, J INFECT DIS, V166, P1079, DOI 10.1093/infdis/166.5.1079; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gill DB, 2004, TRENDS MOL MED, V10, P459, DOI 10.1016/j.molmed.2004.07.002; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; JOHNSON JR, 1995, INFECT IMMUN, V63, P309, DOI 10.1128/IAI.63.1.309-316.1995; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kallstrom H, 2001, CELL MICROBIOL, V3, P133, DOI 10.1046/j.1462-5822.2001.00095.x; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; Kragsbjerg P, 2000, APMIS, V108, P276, DOI 10.1034/j.1600-0463.2000.d01-56.x; Lapinet JA, 2000, INFECT IMMUN, V68, P6917, DOI 10.1128/IAI.68.12.6917-6923.2000; Lee SW, 2002, J CELL BIOL, V156, P951, DOI 10.1083/jcb.200109005; Lin L, 1997, MOL MICROBIOL, V24, P1083, DOI 10.1046/j.1365-2958.1997.4191776.x; Da Silva PSL, 2007, ANN TROP PAEDIATR, V27, P25, DOI 10.1179/146532807X170475; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; MOORE TDE, 1995, INFECT IMMUN, V63, P1603, DOI 10.1128/IAI.63.4.1603-1607.1995; Morand PC, 2001, MOL MICROBIOL, V40, P846, DOI 10.1046/j.1365-2958.2001.02452.x; Morand PC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006834; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; NASSIF X, 1995, CLIN MICROBIOL REV, V8, P376, DOI 10.1128/CMR.8.3.376; Naumann M, 1997, J EXP MED, V186, P247, DOI 10.1084/jem.186.2.247; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Peters MJ, 2003, J LEUKOCYTE BIOL, V73, P722, DOI 10.1189/jlb.1002509; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; PUNSALANG AP, 1973, INFECT IMMUN, V8, P255, DOI 10.1128/IAI.8.2.255-263.1973; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; RUDEL T, 1992, MOL MICROBIOL, V6, P3439, DOI 10.1111/j.1365-2958.1992.tb02211.x; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Russell S, 2004, TISSUE ANTIGENS, V64, P111, DOI 10.1111/j.1399-0039.2004.00277.x; Ryll RR, 1997, MOL MICROBIOL, V23, P879, DOI 10.1046/j.1365-2958.1997.2631630.x; Rytkonen A, 2004, J INFECT DIS, V189, P402, DOI 10.1086/381271; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; SIMON SI, 1990, BIOPHYS J, V58, P319, DOI 10.1016/S0006-3495(90)82379-1; Simons MP, 2005, INFECT IMMUN, V73, P1971, DOI 10.1128/IAI.73.4.1971-1977.2005; Sjolinder H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014034; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; SMITH CW, 1980, J CLIN INVEST, V65, P804, DOI 10.1172/JCI109731; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; SWANSON J, 1973, J EXP MED, V137, P571, DOI 10.1084/jem.137.3.571; SWANSON J, 1974, INFECT IMMUN, V10, P633, DOI 10.1128/IAI.10.3.633-644.1974; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; VIRJI M, 1986, J GEN MICROBIOL, V132, P503; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006	62	14	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24353	10.1371/journal.pone.0024353	http://dx.doi.org/10.1371/journal.pone.0024353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949708	gold, Green Published, Green Submitted			2022-12-25	WOS:000295173800021
J	Zhou, L; Yang, HF				Zhou, Liang; Yang, Haifeng			The von Hippel-Lindau Tumor Suppressor Protein Promotes c-Cbl-Independent Poly-Ubiquitylation and Degradation of the Activated EGFR	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RENAL-CELL CARCINOMA; HYPOXIA-INDUCIBLE FACTOR; TYROSINE KINASES; HIF-ALPHA; ENDOCYTOSIS; UBIQUITINATION; CANCER; INHIBITION; PHOSPHORYLATION	Somatic mutations or reduced expression of the von Hippel-Lindau (VHL) tumor suppressor occurs in the majority of the clear cell renal cell carcinoma (ccRCC) and is a causal factor for the pathogenesis of ccRCC. pVHL was reported to suppress the oncogenic activity of Epidermal Growth Factor Receptor (EGFR) by reducing the expression of the EGFR agonist TGF-alpha and by reducing the translation efficiency of EGFR itself. Furthermore, it was reported that pVHL down-regulates activated EGFR by promoting efficient lysosomal degradation of the receptor. These modes of negative regulation of EGFR by pVHL were dependent on Hypoxia Inducible Factor (HIF). In this study, we report that HIF was not the only factor stabilizing the activated EGFR in VHL-deficient ccRCC cells. Down-regulation of endogenous HIF in these cells had little effect on the turnover rates of the activated EGFR. Furthermore, neither pretreatment with lysomomal inhibitors pretreatment nor downregulation of c-Cbl, a major E3 ubiquitin ligase that targets the activated EGFR for lysosomal degradation, significantly increased the stabilities of EGFR in VHL-expressing ccRCC cells. In contrast, pretreatment with proteasomal inhibitors extended EGFR lifetime and led to similar EGFR half-lives in VHL-expressing and VHL-deficient ccRCC cells. Down-regulation of c-Cbl in VHL-deficient ccRCC cells revealed that the c-Cbl and pVHL collaborated to down-regulate the activated EGFR. Finally, we found that pVHL promoted the poly-ubiquitylation of the activated EGFR, and this function was c-Cbl-independent. Thus these results indicate that pVHL limits EGFR signaling by promoting c-Cbl-independent poly-ubiquitylation of the activated receptor, which likely results in its degradation by proteasome.	[Zhou, Liang; Yang, Haifeng] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Zhou, L (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA.	yangh2@ccf.org	Zhou, Liang/F-7201-2014; Zhou, Liang/N-8220-2013		American Cancer Society; Cleveland Clinic	American Cancer Society(American Cancer Society); Cleveland Clinic	This work was supported by American Cancer Society Pilot Award and the seed fund from Cleveland Clinic to Haifeng Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paulsen N, 2001, P NATL ACAD SCI USA, V98, P1387, DOI 10.1073/pnas.031587498; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lee SJ, 2008, EUR UROL, V54, P845, DOI 10.1016/j.eururo.2008.01.010; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Linehan WM, 2004, CLIN CANCER RES, V10, p6282S, DOI 10.1158/1078-0432.CCR-050013; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Rini BI, 2005, ONCOLOGIST, V10, P191, DOI 10.1634/theoncologist.10-3-191; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zimmer M, 2004, MOL CANCER RES, V2, P89	41	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23936	10.1371/journal.pone.0023936	http://dx.doi.org/10.1371/journal.pone.0023936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949687	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800009
J	Challacombe, JF; Eichorst, SA; Hauser, L; Land, M; Xie, G; Kuske, CR				Challacombe, Jean F.; Eichorst, Stephanie A.; Hauser, Loren; Land, Miriam; Xie, Gary; Kuske, Cheryl R.			Biological Consequences of Ancient Gene Acquisition and Duplication in the Large Genome of Candidatus Solibacter usitatus Ellin6076	PLOS ONE			English	Article							SIGMA-FACTOR SIGMA(E); 16S RIBOSOMAL-RNA; SP-NOV.; PHYLOGENETIC ANALYSIS; INVERTED REPEATS; BACTERIAL; DIVERSITY; SEQUENCE; ACIDOBACTERIA; PHYLUM	Members of the bacterial phylum Acidobacteria are widespread in soils and sediments worldwide, and are abundant in many soils. Acidobacteria are challenging to culture in vitro, and many basic features of their biology and functional roles in the soil have not been determined. Candidatus Solibacter usitatus strain Ellin6076 has a 9.9 Mb genome that is approximately 2-5 times as large as the other sequenced Acidobacteria genomes. Bacterial genome sizes typically range from 0.5 to 10 Mb and are influenced by gene duplication, horizontal gene transfer, gene loss and other evolutionary processes. Our comparative genome analyses indicate that the Ellin6076 large genome has arisen by horizontal gene transfer via ancient bacteriophage and/or plasmid-mediated transduction, and widespread small-scale gene duplications, resulting in an increased number of paralogs. Low amino acid sequence identities among functional group members, and lack of conserved gene order and orientation in regions containing similar groups of paralogs, suggest that most of the paralogs are not the result of recent duplication events. The genome sizes of additional cultured Acidobacteria strains were estimated using pulsed-field gel electrophoresis to determine the prevalence of the large genome trait within the phylum. Members of subdivision 3 had larger genomes than those of subdivision 1, but none were as large as the Ellin6076 genome. The large genome of Ellin6076 may not be typical of the phylum, and encodes traits that could provide a selective metabolic, defensive and regulatory advantage in the soil environment.	[Challacombe, Jean F.; Eichorst, Stephanie A.; Xie, Gary; Kuske, Cheryl R.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Hauser, Loren; Land, Miriam] Oak Ridge Natl Lab, Biosci Div, Genome Anal & Syst Modeling Grp, Oak Ridge, TN USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Challacombe, JF (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.	jchalla@lanl.gov	Eichorst, Stephanie A./A-1079-2017; Hauser, Loren J/H-3881-2012; Land, Miriam L/A-6200-2011	Eichorst, Stephanie A./0000-0002-9017-7461; Land, Miriam L/0000-0001-7102-0031; xie, gary/0000-0002-9176-924X	United States Department of Energy (US DOE) [W-7405-ENG-36]; US DOE Joint Genome Institute	United States Department of Energy (US DOE)(United States Department of Energy (DOE)); US DOE Joint Genome Institute(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy (US DOE) Microbial Genome program (under US DOE contract number W-7405-ENG-36 to CRK). Genome sequencing was conducted by the US DOE Joint Genome Institute through a Laboratory Sequencing Program grant to CRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2003, GENETICS, V164, P1279; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BERGTHORSSON U, 1995, J BACTERIOL, V177, P5784, DOI 10.1128/jb.177.20.5784-5789.1995; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Coates JD, 1999, INT J SYST BACTERIOL, V49, P1615, DOI 10.1099/00207713-49-4-1615; Crocetti GR, 2002, MICROBIOL-SGM, V148, P3353, DOI 10.1099/00221287-148-11-3353; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devescovi G, 2006, CAN J MICROBIOL, V52, P260, DOI 10.1139/W05-119; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; Eichorst SA, 2007, APPL ENVIRON MICROB, V73, P2708, DOI 10.1128/AEM.02140-06; Eichorst SA, 2011, APPL ENVIRON MICROB, V77, P586, DOI 10.1128/AEM.01080-10; Fukunaga Y, 2008, INT J SYST EVOL MICR, V58, P2597, DOI 10.1099/ijs.0.65589-0; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Hobel CFV, 2005, APPL ENVIRON MICROB, V71, P2771, DOI 10.1128/AEM.71.5.2771-2776.2005; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jeong H, 2005, NUCLEIC ACIDS RES, V33, P7066, DOI 10.1093/nar/gki1016; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kenyon WJ, 2005, MICROBIOL-SGM, V151, P2373, DOI 10.1099/mic.0.27649-0; KISHIMOTO N, 1991, CURR MICROBIOL, V22, P1, DOI 10.1007/BF02106205; Koch IH, 2008, INT J SYST EVOL MICR, V58, P1114, DOI 10.1099/ijs.0.65303-0; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kulichevskaya IS, 2010, INT J SYST EVOL MICR, V60, P301, DOI 10.1099/ijs.0.013250-0; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LaPara TM, 2000, APPL ENVIRON MICROB, V66, P3951, DOI 10.1128/AEM.66.9.3951-3959.2000; LIESACK W, 1994, ARCH MICROBIOL, V162, P85; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; MARTIN DW, 1993, J BACTERIOL, V175, P1153, DOI 10.1128/JB.175.4.1153-1164.1993; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Nei M., 2000, MOL EVOLUTION PHYLOG; Ochman H, 2006, SCIENCE, V311, P1730, DOI 10.1126/science.1119966; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Okamura K, 2011, FEMS MICROBIOL LETT, V317, P138, DOI 10.1111/j.1574-6968.2011.02224.x; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Pankratov TA, 2010, INT J SYST EVOL MICR, V60, P2951, DOI 10.1099/ijs.0.021824-0; Pham VD, 2008, ENVIRON MICROBIOL, V10, P2313, DOI 10.1111/j.1462-2920.2008.01657.x; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Prim N, 2000, RES MICROBIOL, V151, P303, DOI 10.1016/S0923-2508(00)00150-9; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2008, ENVIRON MICROBIOL, V10, P2704, DOI 10.1111/j.1462-2920.2008.01691.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Ranea JAG, 2004, J MOL BIOL, V336, P871, DOI 10.1016/j.jmb.2003.12.044; Redder P, 2006, J BACTERIOL, V188, P4198, DOI 10.1128/JB.00061-06; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Sait M, 2008, ISOLATION CHARACTERI; Sanchez-Perez G, 2008, TRENDS GENET, V24, P154, DOI 10.1016/j.tig.2008.01.002; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stott MB, 2008, ENVIRON MICROBIOL, V10, P2030, DOI 10.1111/j.1462-2920.2008.01621.x; Taghavi S, 2009, ANTON LEEUW INT J G, V96, P171, DOI 10.1007/s10482-008-9289-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Testerman TL, 2002, MOL MICROBIOL, V43, P771, DOI 10.1046/j.1365-2958.2002.02787.x; Thirunavukkarasu N, 2008, MICROBIOL-SGM, V154, P2096, DOI 10.1099/mic.0.2008/016428-0; Van Elsas J.D., 2019, MODERN SOIL MICROBIO, VThird; Wackett LP, 2008, ENVIRON MICROBIOL, V10, P3423; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zhou FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-36; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	85	40	40	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24882	10.1371/journal.pone.0024882	http://dx.doi.org/10.1371/journal.pone.0024882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949776	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700071
J	Chen, J; Schooling, CM; Johnston, JM; Hedley, AJ; McGhee, SM				Chen, Jing; Schooling, Catherine Mary; Johnston, Janice Mary; Hedley, Anthony Johnson; McGhee, Sarah Morag			How Does Socioeconomic Development Affect COPD Mortality? An Age-Period-Cohort Analysis from a Recently Transitioned Population in China	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BREAST-CANCER INCIDENCE; HONG-KONG; GENDER-DIFFERENCES; RISK; BURDEN; TRENDS	Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of death, particularly in developing countries. Little is known about the effects of economic development on COPD mortality, although economic development may potentially have positive and negative influences over the life course on COPD. We took advantage of a unique population whose rapid and recent economic development is marked by changes at clearly delineated and identifiable time points, and where few women smoke, to examine the effect of macro-level events on COPD mortality. Methods: We used Poisson regression to decompose sex-specific COPD mortality rates in Hong Kong from 1981 to 2005 into the effects of age, period and cohort. Results: COPD mortality declined strongly over generations for people born from the early to mid 20th century, which was particularly evident for the first generation to grow up in a more economically developed environment for both sexes. Population wide COPD mortality decreased when air quality improved and increased with increasing air pollution. COPD mortality increased with age, particularly after menopause among women. Conclusions: Economic development may reduce vulnerability to COPD by reducing long-lasting insults to the respiratory system, such as infections, poor nutrition and indoor air pollution. However, some of these gains may be offset if economic development results in increasing air pollution or increasing smoking.	[Chen, Jing] Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chen, J (corresponding author), Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	McGhee, Sarah M/A-6460-2013; Hedley, Anthony J/A-9113-2013; Johnston, Janice Mary/C-4288-2009	McGhee, Sarah M/0000-0003-1025-5915; Chen, Jing/0000-0001-5972-3623; Johnston, Janice Mary/0000-0002-6624-867X; Schooling, Mary/0000-0001-9933-5887				Annesi-Maesano I, 2006, EUR RESP MON, P41; [Anonymous], 2007, RELATIVE SIGNIFICANC; Blanc RD, 2007, INT J TUBERC LUNG D, V11, P251; Butters H.R., 1939, REPORT LABOUR LABOUR; Census and Statistics Department, 2007, POP AG GROUP SEX; Census and Statistics Department, 2010, TOB US HONG KONG 201; Chan-Yeung M, 2007, INT J TUBERC LUNG D, V11, P502; Chung RY, 2010, AM J EPIDEMIOL, V171, P345, DOI 10.1093/aje/kwp378; Department of Health, 2010, HEALTHYHK VIT STAT D; Fischer P, 2003, EUR RESPIR J, V21, p34S, DOI 10.1183/09031936.03.00402503; Gan WQ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-52; Garcia-Aymerich J, 2000, J EPIDEMIOL COMMUN H, V54, P73, DOI 10.1136/jech.54.1.73; GOLD Executive Committee, 2009, GLOB IN CHRON OBSTR; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Hong Kong Government, 1950, HONG KONG REP YEAR 1; Janssen F, 2005, INT J EPIDEMIOL, V34, P1149, DOI 10.1093/ije/dyi123; Leung GM, 2006, J EPIDEMIOL COMMUN H, V60, P712, DOI 10.1136/jech.2005.042275; Leung GM, 2002, BRIT J CANCER, V87, P982, DOI 10.1038/sj.bjc.6600583; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; Mathers CD, 2006, SCIENCE, V3, pe442; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; Song YM, 2008, AM J EPIDEMIOL, V168, P497, DOI 10.1093/aje/kwn187; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Surveillance and Epidemiology Branch, 2005, COMP CAUS OF DEATH C; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; Tse G. M. K., 2000, Hong Kong Medical Journal, V6, P190; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507; Wong IOL, 2007, INT J CANCER, V121, P1556, DOI 10.1002/ijc.22731; World Bank, 2009, WORLD DEV REP RESH E; World Health Organization, 2011, BURD CHRON RESP DIS; Wu P, 2008, THORAX, V63, P312, DOI 10.1136/thx.2007.082354; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zanobetti A, 2008, ENV HLTH, P7	37	8	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24348	10.1371/journal.pone.0024348	http://dx.doi.org/10.1371/journal.pone.0024348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935399	Green Published, gold			2022-12-25	WOS:000295041700026
J	Hou, XW; Sun, L; Li, ZM; Mou, HW; Yu, ZJ; Li, HX; Jiang, PZ; Yu, DX; Wu, HY; Ye, XW; Lin, X; Le, YY				Hou, Xinwei; Sun, Liang; Li, Zongmeng; Mou, Haiwei; Yu, Zhijie; Li, Huaixing; Jiang, Peizhen; Yu, Danxia; Wu, Hongyu; Ye, Xingwang; Lin, Xu; Le, Yingying			Associations of Amylin with Inflammatory Markers and Metabolic Syndrome in Apparently Healthy Chinese	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; OPTIMAL CUTOFF POINTS; C-REACTIVE PROTEIN; BODY-MASS INDEX; INSULIN; SECRETION; GLUCOSE; PEPTIDE; OBESITY; ADULTS	Background: Cellular and animal studies implicate multiple roles of amylin in regulating insulin action, glucose and lipid metabolisms. However, the role of amylin in obesity related metabolic disorders has not been thoroughly investigated in humans. Therefore, we aimed to evaluate the distribution of circulating amylin and its association with metabolic syndrome (MetS) and explore if this association is influenced by obesity, inflammatory markers or insulin resistance in apparently healthy Chinese. Methods: A population-based sample of 1,011 Chinese men and women aged 35-54 years was employed to measure plasma amylin, inflammatory markers (C-reactive protein [CRP] and interleukin-6 [IL-6]), insulin, glucose and lipid profiles. MetS was defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian-Americans. Results: Plasma amylin concentrations were higher in overweight/obese participants than normal-weight counterparts (P<0.001) without sex difference. Circulating amylin was positively associated with CRP, IL-6, BMI, waist circumference, blood pressure, fasting glucose, insulin, amylin/insulin ratio, HOMA-IR, LDL cholesterol and triglycerides, while negatively associated with HDL cholesterol (all P<0.001). After multiple adjustments, the risk of MetS was significantly higher (odds ratio 3.71; 95% confidence interval: 2.53 to 5.46) comparing the highest with the lowest amylin quartile. The association remained significant even further controlling for BMI, inflammatory markers, insulin or HOMA-IR. Conclusions: Our study suggests that amylin is strongly associated with inflammatory markers and MetS. The amylin-MetS association is independent of established risk factors of MetS, including obesity, inflammatory markers and insulin resistance. The causal role of hyperamylinemia in the development of MetS needs to be confirmed prospectively.	[Hou, Xinwei; Sun, Liang; Li, Zongmeng; Mou, Haiwei; Yu, Zhijie; Li, Huaixing; Yu, Danxia; Wu, Hongyu; Ye, Xingwang; Lin, Xu; Le, Yingying] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Jiang, Peizhen] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Center for Disease Control & Prevention	Hou, XW (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.	xlin@sibs.ac.cn; yyle@sibs.ac.cn	MOU, Haiwei/AAC-5272-2020; Le, Yingying/L-9785-2017	Le, Yingying/0000-0002-7990-3899; Mou, Haiwei/0000-0002-1710-1882; Yu, Danxia/0000-0002-1710-9382	National Basic Research Program of China (973 Program) [2011CB504002]; Shanghai Institutes for Biological Sciences [SIBS2008006]; Chinese Academy of Sciences [KSCX2-EW-R-10]; Science & Technology Commission of Shanghai Municipality [03JC14079, 04DZ14007]; National Natural Science Foundation of China [30930081, 81021002]; Ministry of Science and Technology of China [2009AA022704, 2008DFA31960]; China Postdoctoral Science Foundation	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by research grants from the National Basic Research Program of China (973 Program) (2011CB504002); the Chief Scientist Program of Shanghai Institutes for Biological Sciences (SIBS2008006); the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-10); the One Hundred Talents Program of the Chinese Academy of Sciences; the Science & Technology Commission of Shanghai Municipality (03JC14079 and 04DZ14007); the National Natural Science Foundation of China (30930081 and 81021002) and the Ministry of Science and Technology of China (2009AA022704 and 2008DFA31960) and the China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	BUTLER PC, 1990, DIABETES, V39, P752, DOI 10.2337/diabetes.39.6.752; Cai K, 2011, DIABETOLOGIA, V54, P617, DOI 10.1007/s00125-010-1972-9; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; CIARALDI TP, 1992, DIABETES, V41, P975, DOI 10.2337/diabetes.41.8.975; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DENKE MA, 1993, ARCH INTERN MED, V153, P1093, DOI 10.1001/archinte.153.9.1093; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; ENOKI S, 1992, DIABETES RES CLIN PR, V15, P97, DOI 10.1016/0168-8227(92)90074-2; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016; HANABUSA T, 1992, DIABETES RES CLIN PR, V15, P89, DOI 10.1016/0168-8227(92)90073-Z; James S, 2010, FERTIL STERIL, V94, P211, DOI 10.1016/j.fertnstert.2009.02.086; Kairamkonda VR, 2008, ARCH DIS CHILD-FETAL, V93, pF265, DOI 10.1136/adc.2007.120816; Leckstrom A, 1996, PANCREAS, V13, P259, DOI 10.1097/00006676-199610000-00008; LEIGHTON B, 1988, NATURE, V335, P632, DOI 10.1038/335632a0; Lutz TA, 2006, PHYSIOL BEHAV, V89, P465, DOI 10.1016/j.physbeh.2006.04.001; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672; MITSUKAWA T, 1990, DIABETES, V39, P639, DOI 10.2337/diabetes.39.5.639; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; OBRIEN TD, 1991, DIABETES, V40, P1701, DOI 10.2337/diabetes.40.12.1701; Qi DF, 2010, AM J PHYSIOL-ENDOC M, V298, pE99, DOI 10.1152/ajpendo.00242.2009; Reinehr T, 2007, OBESITY, V15, P2006, DOI 10.1038/oby.2007.239; SANKE T, 1991, DIABETOLOGIA, V34, P129, DOI 10.1007/BF00500385; Smith D, 2000, CLIN EXP PHARMACOL P, V27, P345, DOI 10.1046/j.1440-1681.2000.03255.x; SOWA R, 1990, DIABETOLOGIA, V33, P118, DOI 10.1007/BF00401051; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Tataranni PA, 2005, DIABETES, V54, P917, DOI 10.2337/diabetes.54.4.917; WESTERMARK P, 1987, AM J PATHOL, V127, P414; Wielinga PY, 2010, PHYSIOL BEHAV, V101, P45, DOI 10.1016/j.physbeh.2010.04.012; Ye JM, 2001, AM J PHYSIOL-ENDOC M, V280, pE562, DOI 10.1152/ajpendo.2001.280.4.E562; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	37	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24815	10.1371/journal.pone.0024815	http://dx.doi.org/10.1371/journal.pone.0024815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935471	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700062
J	O'Leary, JC; Dharia, S; Blair, LJ; Brady, S; Johnson, AG; Peters, M; Cheung-Flynn, J; Cox, MB; de Erausquin, G; Weeber, EJ; Jinwal, UK; Dickey, CA				O'Leary, John C., III; Dharia, Sheetal; Blair, Laura J.; Brady, Sarah; Johnson, Amelia G.; Peters, Melinda; Cheung-Flynn, Joyce; Cox, Marc B.; de Erausquin, Gabriel; Weeber, Edwin J.; Jinwal, Umesh K.; Dickey, Chad A.			A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR GENE; FKBP5; STRESS; POLYMORPHISMS; ASSOCIATION; COCHAPERONE; EXPRESSION; HAPLOTYPE; RISK	The gene FKBP5 codes for FKBP51, a co-chaperone protein of the Hsp90 complex that increases with age. Through its association with Hsp90, FKBP51 regulates the glucocorticoid receptor (GR). Single nucleotide polymorphisms (SNPs) in the FKBP5 gene associate with increased recurrence of depressive episodes, increased susceptibility to post-traumatic stress disorder, bipolar disorder, attempt of suicide, and major depressive disorder in HIV patients. Variation in one of these SNPs correlates with increased levels of FKBP51. FKBP51 is also increased in HIV patients. Moreover, increases in FKBP51 in the amygdala produce an anxiety phenotype in mice. Therefore, we tested the behavioral consequences of FKBP5 deletion in aged mice. Similar to that of naive animals treated with classical antidepressants FKBP5-/- mice showed antidepressant behavior without affecting cognition and other basic motor functions. Reduced corticosterone levels following stress accompanied these observed effects on depression. Age-dependent anxiety was also modulated by FKBP5 deletion. Therefore, drug discovery efforts focused on depleting FKBP51 levels may yield novel antidepressant therapies.	[O'Leary, John C., III; Blair, Laura J.; Brady, Sarah; Johnson, Amelia G.; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA; [Peters, Melinda; Weeber, Edwin J.] Univ S Florida, Dept Physiol & Pharmacol, Byrd Alzheimers Res Inst, Tampa, FL USA; [Cheung-Flynn, Joyce] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Dharia, Sheetal; Jinwal, Umesh K.] Univ S Florida, Coll Pharm, Byrd Alzheimers Res Inst, Tampa, FL USA; [de Erausquin, Gabriel] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Vanderbilt University; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	O'Leary, JC (corresponding author), Univ S Florida, Dept Mol Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA.	cdickey@health.usf.edu	de Erausquin, Gabriel A./Z-1952-2019; Weeber, Edwin J/A-5396-2012; de Erausquin, Gabriel A/G-5840-2010; Dickey, Chad A/H-4441-2011	de Erausquin, Gabriel A./0000-0001-6423-4461; de Erausquin, Gabriel A/0000-0001-6423-4461; Blair, Laura/0000-0002-4981-5564; Cox, Marc/0000-0001-7854-2676	National Institutes of Health [R01NS073899, R00AG031291]; Alzheimer's association [IIRG-09-130689, NIRG-10-174517]; Rosalinde and Arthur Gilbert New Investigator Awards in Alzheimer's Disease/American Federation for Aging Research; Irene and Abe Pollin Fund for Corticobasal Degeneration Research/CurePSP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's association(Alzheimer's Association); Rosalinde and Arthur Gilbert New Investigator Awards in Alzheimer's Disease/American Federation for Aging Research; Irene and Abe Pollin Fund for Corticobasal Degeneration Research/CurePSP; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the following grants: National Institutes of Health R01NS073899 and R00AG031291, Alzheimer's association IIRG-09-130689 and NIRG-10-174517, Rosalinde and Arthur Gilbert New Investigator Awards in Alzheimer's Disease/American Federation for Aging Research and Irene and Abe Pollin Fund for Corticobasal Degeneration Research/CurePSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood BK, 2011, NATURE, V464, P1201; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Denny WB, 2005, ENDOCRINOLOGY, V146, P3194, DOI 10.1210/en.2005-0027; DeRijk RH, 2008, EUR J PHARMACOL, V585, P492, DOI 10.1016/j.ejphar.2008.03.012; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Frazer A, 2005, NEUROSCI BIOBEHAV R, V29, P515, DOI 10.1016/j.neubiorev.2005.03.006; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; HOLSBOER F, 1987, BIOL PSYCHIAT, V22, P228, DOI 10.1016/0006-3223(87)90237-X; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; KAKIHANA R, 1976, PSYCHOPHARMACOLOGIA, V46, P301, DOI 10.1007/BF00421118; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Lahti J, 2011, J PSYCHIATR RES, V45, P1160, DOI 10.1016/j.jpsychires.2011.03.008; Liu ZC, 2006, NEUROSCI LETT, V404, P358, DOI 10.1016/j.neulet.2006.06.016; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Scharf SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016883; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tatro ET, 2010, J NEUROVIROL, V16, P399, DOI 10.3109/13550284.2010.504248; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Westberry JM, 2006, J STEROID BIOCHEM, V100, P34, DOI 10.1016/j.jsbmb.2006.03.004; Willour VL, 2009, MOL PSYCHIATR, V14, P261, DOI 10.1038/sj.mp.4002141; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37	29	89	89	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24840	10.1371/journal.pone.0024840	http://dx.doi.org/10.1371/journal.pone.0024840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935478	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700063
J	Wang, D; Liu, YH; Han, J; Zai, DX; Ji, M; Cheng, W; Xu, L; Yang, LX; He, MX; Ni, J; Cai, ZL; Yu, CQ				Wang, Dan; Liu, Yuhuan; Han, Jie; Zai, Dongxia; Ji, Mei; Cheng, Wen; Xu, Ling; Yang, Luxi; He, Miaoxia; Ni, Jian; Cai, Zailong; Yu, Chaoqin			Puerarin Suppresses Invasion and Vascularization of Endometriosis Tissue Stimulated by 17 beta-Estradiol	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STROMAL CELLS; MATRIX METALLOPROTEINASES; MATRIX-METALLOPROTEINASE-9; PATHOGENESIS; EXPRESSION; BETA; INTEGRITY; APOPTOSIS; INJURY	Background: Puerarin, a phytoestrogen with a weak estrogenic effect, binds to estrogen receptors, thereby competing with 17 beta-estradiol (E2) and producing an anti-estrogenic effect. This study was to investigate whether puerarin could suppress the invasion and vascularization of E2-stimulated endometriotic tissue. Methodology/Principal Findings: The endometriotic stromal cells (ESCs) were successfully established and their invasive ability under different treatments was assessed through a Transwell Assay. Simultaneously, matrix metallopeptidase 9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1) were detected by western blotting. Vascularization of endometriotic tissues was observed by chicken chorioallantoic membrane (CAM) assay. The staining of MMP-9, intercellular adhesion molecule 1 (ICAM-1), TIMP-1, and vascular endothelial growth factor (VEGF) in grafted endometriotic tissues was examined using immunohistochemistry analysis. The purity of ESCs in isolated cells was >95%, as determined by the fluoroimmunoassay of vimentin. E2 (10(-8) mol/L) promoted the invasiveness of ESCs by increasing MMP-9 accumulation and decreasing TIMP-1 accumulation. Interestingly, puerarin (10(-9) mol/L) significantly reversed these effects (P<0.01). The CAM assay indicated that puerarin (10(-9) mol/L) also inhibited the angiopoiesis of endometriotic tissue stimulated by the E2 (10(-8) mol/L) treatment (P<0.05). Accordingly, immunohistochemistry showed that the accumulation of MMP-9, ICAM-1, and VEGF was reduced whereas that of TIMP-1 increased in the combination treatment group compared with the E2 treatment group. Conclusions/Significance: This study demonstrated that puerarin could suppress the tissue invasion by ESCs and the vascularization of ectopic endometrial tissues stimulated by E2, suggesting that puerarin may be a potential drug for the treatment of endometriosis.	[Wang, Dan; Liu, Yuhuan; Ji, Mei] Second Mil Med Univ, Changhai Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Han, Jie; Zai, Dongxia; Cheng, Wen; Xu, Ling; Yu, Chaoqin] Second Mil Med Univ, Changhai Hosp, Dept Chinese Tradit Med, Shanghai, Peoples R China; [Yang, Luxi; Cai, Zailong] Second Mil Med Univ, Changhai Hosp, Clin Res Ctr, Shanghai, Peoples R China; [He, Miaoxia] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Ni, Jian] Shanghai Jiao Tong Univ, Inst Micro Nano Sci & Technol, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University	Wang, D (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China.	czl8003@hotmail.com; chqyu81@gmail.com		Yu, Chaoqin/0000-0003-1614-2655	National Natural Science Foundation of China [30672742, 30873353, 30930113]; 973 project [2010CB933902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	This work was supported by a grant from the National Natural Science Foundation of China (Project No. 30672742, 30873353, 30930113) and 973 project (2010CB933902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergqvist A, 2000, GYNECOL ENDOCRINOL, V14, P425, DOI 10.3109/09513590009167714; Boonchird C, 2010, BRAZ J MED BIOL RES, V43, P195, DOI 10.1590/S0100-879X2009007500026; Bruner KL, 1997, J CLIN INVEST, V99, P2851, DOI 10.1172/JCI119478; Bruner KL, 1999, STEROIDS, V64, P648, DOI 10.1016/S0039-128X(99)00048-3; Collette T, 2006, HUM REPROD, V21, P3059, DOI 10.1093/humrep/del297; Collins BM, 1997, STEROIDS, V62, P365, DOI 10.1016/S0039-128X(96)00246-2; Defrere S, 2005, AM J REPROD IMMUNOL, V54, P5, DOI 10.1111/j.1600-0897.2005.00272.x; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; FOLMAN Y, 1966, J ENDOCRINOL, V34, P215, DOI 10.1677/joe.0.0340215; Han YJ, 2009, FERTIL STERIL, V91, P2324, DOI 10.1016/j.fertnstert.2008.03.047; Hwang YP, 2008, TOXICOL APPL PHARM, V233, P371, DOI 10.1016/j.taap.2008.09.006; Katzenellenbogen BS, 1997, ENDOCRINOLOGY, V100, P1252; Lessey BA, 2000, FERTIL STERIL, V73, P1089, DOI 10.1016/S0015-0282(00)00519-7; Li Yan-Wei, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P1017, DOI 10.3736/jcim20081006; Li YW, 2008, FOOD CHEM TOXICOL, V46, P3671, DOI 10.1016/j.fct.2008.09.045; Moromizato Y, 2000, AM J PATHOL, V157, P1277, DOI 10.1016/S0002-9440(10)64643-3; Nap AW, 2003, HUM REPROD, V18, P30, DOI 10.1093/humrep/deg033; Nasu K, 2005, MOL HUM REPROD, V11, P817, DOI 10.1093/molehr/gah249; OLIVE DL, 1993, NEW ENGL J MED, V328, P1759, DOI 10.1056/NEJM199306173282407; Olive DL, 2004, BEST PRACT RES CL OB, V18, P319, DOI 10.1016/j.bpobgyn.2004.03.005; Overstreet DH, 2003, ALCOHOL CLIN EXP RES, V27, P177, DOI 10.1097/01.ALC.0000051022.26489.CF; Paul S, 2008, J PINEAL RES, V44, P439, DOI 10.1111/j.1600-079X.2007.00547.x; Practice Comm American Soc, 2004, FERTIL STERIL, V81, P1441, DOI 10.1016/j.fertnstert.2004.01.019; Rice S, 2006, J STEROID BIOCHEM, V101, P216, DOI 10.1016/j.jsbmb.2006.06.021; Rice VM, 2002, ANN NY ACAD SCI, V955, P343, DOI 10.1111/j.1749-6632.2002.tb02795.x; Richardson Mary, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P155, DOI 10.2174/1568006033481492; Shaco-Levy R, 2008, EUR J OBSTET GYN R B, V139, P226, DOI 10.1016/j.ejogrb.2008.01.004; Shifren JL, 1996, J CLIN ENDOCR METAB, V81, P3112, DOI 10.1210/jc.81.8.3112; Sillem M, 1996, FERTIL STERIL, V66, P468, DOI 10.1016/S0015-0282(16)58521-5; Szamatowicz J, 2002, HUM REPROD, V17, P284, DOI 10.1093/humrep/17.2.284; Valle RF, 2003, ANN NY ACAD SCI, V997, P229, DOI 10.1196/annals.1290.026; Wang CF, 1997, NUTR CANCER, V28, P236, DOI 10.1080/01635589709514582; Wang Y, 2010, CELL MOL IMMUNOL, V7, P51, DOI 10.1038/cmi.2009.102; Xu XH, 2005, PLANTA MED, V71, P585, DOI 10.1055/s-2005-871261	34	47	48	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e25011	10.1371/journal.pone.0025011	http://dx.doi.org/10.1371/journal.pone.0025011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949833	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700090
J	Atsou, K; Chouaid, C; Hejblum, G				Atsou, Kokuvi; Chouaid, Christos; Hejblum, Gilles			Simulation-Based Estimates of Effectiveness and Cost-Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							LUNG-DISEASE; COPD; MORTALITY; PREVALENCE; IMPACT; MODEL; RISK; INTERVENTIONS; DEPENDENCE; BURDEN	Background: The medico-economic impact of smoking cessation considering a smoking patient with chronic obstructive pulmonary disease (COPD) is poorly documented. Objective: Here, considering a COPD smoking patient, the specific burden of continuous smoking was estimated, as well as the effectiveness and the cost-effectiveness of smoking cessation. Methods: A multi-state Markov model adopting society's perspective was developed. Simulated cohorts of English COPD patients who are active smokers (all severity stages combined or patients with the same initial severity stage) were compared to identical cohorts of patients who quit smoking at cohort initialization. Life expectancy, quality adjusted life-years (QALY), disease-related costs, and incremental cost-effectiveness ratio (ICER: pound/QALY) were estimated, considering smoking cessation programs with various possible scenarios of success rates and costs. Sensitivity analyses included the variation of model key parameters. Principal Findings: At the horizon of a smoking COPD patient's remaining lifetime, smoking cessation at cohort intitialization, relapses being allowed as observed in practice, would result in gains (mean) of 1.27 life-years and 0.68 QALY, and induce savings of 21824 pound/patient in the disease-related costs. The corresponding ICER was 22686 pound/QALY. Smoking cessation resulted in 0.72, 0.69, 0.64 and 0.42 QALY respectively gained per mild, moderate, severe, and very severe COPD patient, but was nevertheless cost-effective for mild to severe COPD patients in most scenarios, even when hypothesizing expensive smoking cessation intervention programmes associated with low success rates. Considering a ten-year time horizon, the burden of continuous smoking in English COPD patients was estimated to cost a total of 1657 M pound while 452516 QALY would be simultaneously lost. Conclusions: The study results are a useful support for the setting of smoking cessation programmes specifically targeted to COPD patients.	[Atsou, Kokuvi; Chouaid, Christos; Hejblum, Gilles] INSERM, U707, Paris, France; [Atsou, Kokuvi; Chouaid, Christos; Hejblum, Gilles] Univ Paris 06, UPMC, UMR S 707, Paris, France; [Chouaid, Christos] Hop St Antoine, AP HP, Serv Pneumol, F-75571 Paris, France; [Hejblum, Gilles] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Atsou, K (corresponding author), INSERM, U707, Paris, France.	gilles.hejblum@inserm.fr	christos, chouaid/R-4477-2018; Hejblum, Gilles/N-6337-2017	christos, chouaid/0000-0002-4290-5524; Hejblum, Gilles/0000-0003-0127-1964	Office Francais de Prevention du Tabagisme (OFT); Organisation Pneumologique pour la Recherche et l'Amelioration des Soins (OPRAS); Association CARDIF-L'Assistance Respiratoire	Office Francais de Prevention du Tabagisme (OFT); Organisation Pneumologique pour la Recherche et l'Amelioration des Soins (OPRAS); Association CARDIF-L'Assistance Respiratoire	This work was supported, in part, by Office Francais de Prevention du Tabagisme (OFT); Organisation Pneumologique pour la Recherche et l'Amelioration des Soins (OPRAS); and Association CARDIF-L'Assistance Respiratoire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOB STRAT DIAGN MAN; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Atsou K, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-7; Borg S, 2004, VALUE HEALTH, V7, P153, DOI 10.1111/j.1524-4733.2004.72318.x; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; *EC, 2010, EC BIG MAC IND BIG M; Ekberg-Aronsson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-98; *EUR, 2007, EUR STAT DAT; Feenstra TL, 2001, AM J RESP CRIT CARE, V164, P590, DOI 10.1164/ajrccm.164.4.2003167; Goodman PG, 2009, INT J PUBLIC HEALTH, V54, P367, DOI 10.1007/s00038-009-0089-8; Hoogendoorn M, 2005, EUR RESPIR J, V26, P223, DOI 10.1183/09031936.05.00122004; Hoogendoorn M, 2010, THORAX, V65, P711, DOI 10.1136/thx.2009.131631; Jansson SA, 2002, CHEST, V122, P1994, DOI 10.1378/chest.122.6.1994; Jensen HH, 2006, EUR RESPIR J, V28, P781, DOI 10.1183/09031936.06.00152205; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mannino David M, 2006, Int J Chron Obstruct Pulmon Dis, V1, P219; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; National Institute for Health and Clinical Excellence, GUID METH TECHN APPR; Nielsen R, 2009, EUR RESPIR J, V34, P850, DOI 10.1183/09031936.00166108; *OFF NAT STAT, 2008, POP EST ENGL MID YEA; ORLEANS CT, 1994, CANCER-AM CANCER SOC, V74, P2055, DOI 10.1002/1097-0142(19941001)74:7+<2055::AID-CNCR2820741712>3.0.CO;2-Q; Parrott S, 2004, BMJ-BRIT MED J, V328, P947, DOI 10.1136/bmj.328.7445.947; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Shahab L, 2006, THORAX, V61, P1043, DOI 10.1136/thx.2006.064410; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Strassmann R, 2009, EUR RESPIR J, V34, P634, DOI 10.1183/09031936.00167708; Taylor DCA, 2009, VALUE HEALTH, V12, P28, DOI 10.1111/j.1524-4733.2008.00395.x; Tonnesen P, 2006, CHEST, V130, P334, DOI 10.1378/chest.130.2.334; Wagena EJ, 2005, ARCH INTERN MED, V165, P2286, DOI 10.1001/archinte.165.19.2286	35	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24870	10.1371/journal.pone.0024870	http://dx.doi.org/10.1371/journal.pone.0024870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21949774	Green Published, gold			2022-12-25	WOS:000295039700056
J	Hussmann, GP; Yasuda, RP; Xiao, YX; Wolfe, BB; Kellar, KJ				Hussmann, Gregory P.; Yasuda, Robert P.; Xiao, Yingxian; Wolfe, Barry B.; Kellar, Kenneth J.			Endogenously Expressed Muscarinic Receptors in HEK293 Cells Augment Up-regulation of Stably Expressed alpha 4 beta 2 Nicotinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE BINDING-SITES; RAT-BRAIN; CHOLINERGIC-RECEPTORS; ALZHEIMERS-DISEASE; PHARMACOLOGICAL-PROPERTIES; DIFFERENTIAL REGULATION; FUNCTIONAL-ACTIVITY; CEREBRAL-CORTEX; LIGAND-BINDING; LONG-TERM	Nicotine-induced up-regulation of neuronal nicotinic receptors (nAChRs) has been known and studied for more than 25 years. Other nAChR ligands can also up-regulate nAChRs, but it is not known if these ligands induce up-regulation by mechanisms similar to that of nicotine. In this study, we compared up-regulation by three different nicotinic agonists and a competitive antagonist of several different nAChR subtypes expressed in HEK293 cells. Nicotine markedly increased alpha 4 beta 2 nAChR binding site density and beta 2 subunit protein. Carbachol, a known nAChR and muscarinic receptor agonist, up-regulated both alpha 4 beta 2 nAChR binding sites and subunit protein 2-fold more than did nicotine. This increased up-regulation was shown pharmacologically to involve endogenously expressed muscarinic receptors, and stimulation of these muscarinic receptors also correlated with a 2-fold increase in alpha 4 and beta 2 mRNA. Muscarinic receptor activation in these cells appears to affect CMV promoter activity only minimally (similar to 1.2 fold), suggesting that the increase in alpha 4 and beta 2 nAChR mRNA may not be dependent on enhanced transcription. Instead, other mechanisms may contribute to the increase in mRNA and a consequent increase in receptor subunits and binding site density. These studies demonstrate the possibility of augmentingn ChR expression in a cell model through mechanisms and targets other than the nAChR receptor itself.	[Hussmann, Gregory P.; Yasuda, Robert P.; Xiao, Yingxian; Wolfe, Barry B.; Kellar, Kenneth J.] Georgetown Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20057 USA	Georgetown University	Kellar, KJ (corresponding author), Georgetown Univ, Sch Med, Dept Physiol & Pharmacol, 3900 Reservoir Rd NW, Washington, DC 20057 USA.	kellark@georgetown.edu			National Institutes of Health [DA012976, T32DA007291]; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012976, R01DA012976, T32DA007291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA012976 and T32DA007291.	Ancellin N, 1999, CELL SIGNAL, V11, P743, DOI 10.1016/S0898-6568(99)00035-2; Avila AM, 2003, MOL PHARMACOL, V64, P974, DOI 10.1124/mol.64.4.974; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Davila-Garcia MI, 2003, J NEUROCHEM, V85, P1237, DOI 10.1046/j.1471-4159.2003.01774.x; Del Signore A, 2004, J NEUROPATH EXP NEUR, V63, P138, DOI 10.1093/jnen/63.2.138; Eaton JB, 2003, MOL PHARMACOL, V64, P1283, DOI 10.1124/mol.64.6.1283; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Flores CM, 1997, J NEUROCHEM, V69, P2216; FLORES CM, 1992, MOL PHARMACOL, V41, P31; FLYNN DD, 1986, J NEUROCHEM, V47, P1948, DOI 10.1111/j.1471-4159.1986.tb13113.x; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gahring LC, 2010, J BIOL CHEM, V285, P19793, DOI 10.1074/jbc.M110.108803; GIL DW, 1985, J PHARMACOL EXP THER, V232, P608; Gopalakrishnan M, 1996, J PHARMACOL EXP THER, V276, P289; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Griffiths R, 1997, BRIT J ANAESTH, V79, P389, DOI 10.1093/bja/79.3.389; Hakak Y, 2003, FEBS LETT, V550, P11, DOI 10.1016/S0014-5793(03)00762-2; HANCOCK K, 1983, ANAL BIOCHEM, V133, P157, DOI 10.1016/0003-2697(83)90237-3; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; KELLAR KJ, 1987, BRAIN RES, V436, P62, DOI 10.1016/0006-8993(87)91556-3; Kishi M, 2006, MOL PHARMACOL, V70, P2037, DOI 10.1124/mol.106.029298; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; LEK LH, 1995, J BIOCHEM BIOPH METH, V30, P9, DOI 10.1016/0165-022X(94)00059-M; Lomazzo E, 2010, J NEUROCHEM, V115, P625, DOI 10.1111/j.1471-4159.2010.06967.x; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MALTHESORENSSEN D, 1972, BIOCHEM J, V127, P229, DOI 10.1042/bj1270229; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Mao D, 2006, MOL PHARMACOL, V70, P1693, DOI 10.1124/mol.106.027458; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; MARKS MJ, 1993, J PHARMACOL EXP THER, V264, P542; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Meyer EL, 2001, MOL PHARMACOL, V60, P568; MINDEL JS, 1976, INVEST OPHTH VISUAL, V15, P808; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nguyen HN, 2004, J NEUROCHEM, V90, P40, DOI 10.1111/j.1471-4159.2004.02482.x; Nguyen HN, 2003, J PHARMACOL EXP THER, V307, P1090, DOI 10.1124/jpet.103.056408; NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4; Peng X, 1997, MOL PHARMACOL, V51, P776, DOI 10.1124/mol.51.5.776; PENG X, 1994, MOL PHARMACOL, V46, P523; Perry DC, 2007, J PHARMACOL EXP THER, V322, P306, DOI 10.1124/jpet.107.121228; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROWELL PP, 1990, J NEUROCHEM, V55, P2105, DOI 10.1111/j.1471-4159.1990.tb05802.x; Rumenapp U, 2001, J BIOL CHEM, V276, P2474, DOI 10.1074/jbc.M004957200; Sallette J, 2004, J BIOL CHEM, V279, P18767, DOI 10.1074/jbc.M308260200; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; SHIMOHAMA S, 1986, J NEUROCHEM, V46, P288, DOI 10.1111/j.1471-4159.1986.tb12960.x; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Wecker L, 2010, NEUROSCIENCE, V171, P12, DOI 10.1016/j.neuroscience.2010.09.005; Whiteaker P, 1998, MOL PHARMACOL, V53, P950; WHITEHOUSE PJ, 1986, BRAIN RES, V371, P146, DOI 10.1016/0006-8993(86)90819-X; Xiao YX, 2009, ACTA PHARMACOL SIN, V30, P842, DOI 10.1038/aps.2009.69; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Xu W, 1999, J NEUROSCI, V19, P9298; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zoli M, 2002, J NEUROSCI, V22, P8785	71	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39726	39737		10.1074/jbc.M111.289546	http://dx.doi.org/10.1074/jbc.M111.289546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940627	Green Published, hybrid			2022-12-25	WOS:000296925700006
J	Karim, AF; Chandra, P; Chopra, A; Siddiqui, Z; Bhaskar, A; Singh, A; Kumar, D				Karim, Ahmad Faisal; Chandra, Pallavi; Chopra, Aanchal; Siddiqui, Zaved; Bhaskar, Ashima; Singh, Amit; Kumar, Dhiraj			Express Path Analysis Identifies a Tyrosine Kinase Src-centric Network Regulating Divergent Host Responses to Mycobacterium tuberculosis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-EDGED-SWORD; GENE-EXPRESSION; INTRACELLULAR MYCOBACTERIA; SIGNAL-TRANSDUCTION; HUMAN MACROPHAGES; CLUSTER-ANALYSIS; FAMILY KINASES; AUTOPHAGY; SURVIVAL; TRANSCRIPTION	Global gene expression profiling has emerged as a major tool in understanding complex response patterns of biological systems to perturbations. However, a lack of unbiased analytical approaches has restricted the utility of complex microarray data to gain novel system level insights. Here we report a strategy, express path analysis (EPA), that helps to establish various pathways differentially recruited to achieve specific cellular responses under contrasting environmental conditions in an unbiased manner. The analysis superimposes differentially regulated genes between contrasting environments onto the network of functional protein associations followed by a series of iterative enrichments and network analysis. To test the utility of the approach, we infected THP1 macrophage cells with a virulent Mycobacterium tuberculosis strain (H37Rv) or the attenuated non-virulent strain H37Ra as contrasting perturbations and generated the temporal global expression profiles. EPA of the results provided details of response-specific and time-dependent host molecular network perturbations. Further analysis identified tyrosine kinase Src as the major regulatory hub discriminating the responses between wildtype and attenuated Mtb infection. We were then able to verify this novel role of Src experimentally and show that Src executes its role through regulating two vital antimicrobial processes of the host cells (i.e. autophagy and acidification of phagolysosome). These results bear significant potential for developing novel anti-tuberculosis therapy. We propose that EPA could prove extremely useful in understanding complex cellular responses for a variety of perturbations, including pathogenic infections.	[Karim, Ahmad Faisal; Chandra, Pallavi; Chopra, Aanchal; Siddiqui, Zaved; Bhaskar, Ashima; Singh, Amit; Kumar, Dhiraj] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	dhiraj@icgeb.res.in	Ismail, Hanafi/A-3564-2009; ismail, hanafi/AAH-9159-2020	Singh, Amit/0000-0001-6761-1664; BHASKAR, ASHIMA/0000-0002-7367-874X	IYBA [DB01/DK/10/363]; Centre of Excellence from the Department of Biotechnology, Government of India; Indian Council of Medical Research; Wellcome-DBT Alliance [WTA01/10/355]; NIH [P30AI027767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	IYBA; Centre of Excellence from the Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Wellcome-DBT Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an IYBA Grant (DB01/DK/10/363) and a Centre of Excellence grant from the Department of Biotechnology, Government of India, and an Indian Council of Medical Research Grant (to D. K.). This work was also supported in part by a Wellcome-DBT Alliance Grant WTA01/10/355 and an NIH developmental supplement grant P30AI027767 entitled "Creative and Novel Ideas in HIV Research" (to A. S.).	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Behr M, 2010, CELL, V140, P615, DOI 10.1016/j.cell.2010.02.030; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Coombes BK, 2001, INFECT IMMUN, V69, P1420, DOI 10.1128/IAI.69.3.1420-1427.2001; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2009, VET IMMUNOL IMMUNOP, V128, P37, DOI 10.1016/j.vetimm.2008.10.293; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; Keller C, 2004, TUBERCULOSIS, V84, P144, DOI 10.1016/j.tube.2003.12.003; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McGarvey JA, 2004, CLIN EXP IMMUNOL, V136, P490, DOI 10.1111/j.1365-2249.2004.02490.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Porcelli SA, 2008, NAT IMMUNOL, V9, P1101, DOI 10.1038/ni1008-1101; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Volpe E, 2006, IMMUNOLOGY, V118, P449, DOI 10.1111/j.1365-2567.2006.02378.x; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Xu D, 2003, NUCLEIC ACIDS RES, V31, P5582, DOI 10.1093/nar/gkg783; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	55	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40307	40319		10.1074/jbc.M111.266239	http://dx.doi.org/10.1074/jbc.M111.266239			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953458	hybrid, Green Published			2022-12-25	WOS:000296925700062
J	Lee, JE; Jeong, PY; Joo, HJ; Kim, H; Lee, T; Koo, HS; Paik, YK				Lee, Jeong-Eui; Jeong, Pan-Young; Joo, Hyoe-Jin; Kim, Heekyeong; Lee, Taehoon; Koo, Hyeon-Sook; Paik, Young-Ki			STR-33, a Novel G Protein-coupled Receptor That Regulates Locomotion and Egg Laying in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-SYSTEM; DEG/ENAC CHANNEL; SEROTONIN; NEURONS; TOUCH; GENETICS; MUTANTS; CIRCUIT; CALCIUM; PATHWAY	Despite their predicted functional importance, most G protein-coupled receptors (GPCRs) in Caenorhabditis elegans have remained largely uncharacterized. Here, we focused on one GPCR, STR-33, encoded by the str-33 gene, which was discovered through a ligand-based screening procedure. To characterize STR-33 function, we performed UV-trimethylpsolaren mutagenesis and isolated an str-33-null mutant. The resulting mutant showed hypersinusoidal movement and a hyperactive egg-laying phenotype. Two types of egg laying-related mutations have been characterized: egg laying-deficient (Egl-d) and hyperactive egg laying (Egl-c). The defect responsible for the egg laying-deficient Egl-d phenotype is related to G alpha(q) signaling, whereas that responsible for the opposite, hyperactive egg-laying Egl-c phenotype is related to G alpha(o) signaling. We found that the hyperactive egg-laying defect of the str-33(ykp001) mutant is dependent on the G protein GOA-1/G alpha(o). Endogenous acetylcholine suppressed egg laying in C. elegans via a G alpha(o)-signaling pathway by inhibiting serotonin biosynthesis or release from the hermaphrodite-specific neuron. Consistent with this, in vivo expression of the serotonin biosynthetic enzyme, TPH-1, was up-regulated in the str-33(ykp001) mutant. Taken together, these results suggest that the GPCR, STR-33, may be one of the neurotransmitter receptors that regulates locomotion and egg laying in C. elegans.	[Lee, Jeong-Eui; Jeong, Pan-Young; Joo, Hyoe-Jin; Kim, Heekyeong; Lee, Taehoon; Koo, Hyeon-Sook; Paik, Young-Ki] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Lee, Jeong-Eui; Jeong, Pan-Young; Joo, Hyoe-Jin; Kim, Heekyeong; Lee, Taehoon; Koo, Hyeon-Sook; Paik, Young-Ki] Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Paik, Young-Ki] Yonsei Univ, Dept Integrated Omi Biomed Sci, World Class Univ Program, Grad Sch, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University	Paik, YK (corresponding author), Yonsei Univ, Dept Biochem, 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		LEE, TAE HOON/0000-0001-6396-9378	National Research Foundation of Korea [2011-0028112]; World Class University Program [R31-2008-000-10086-0]; Korean government (Ministry of Education, Science and Technology); National Project for Personalized Genomic Medicine Grant [A111218-11-CP01]	National Research Foundation of Korea(National Research Foundation of Korea); World Class University Program; Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National Project for Personalized Genomic Medicine Grant	This work was supported by National Research Foundation of Korea Grant 2011-0028112 (to Y.-K. P.) and World Class University Program Grant R31-2008-000-10086-0 funded by the Korean government (Ministry of Education, Science and Technology) and National Project for Personalized Genomic Medicine Grant A111218-11-CP01 (to Y.-K. P.).	Bany IA, 2003, J NEUROSCI, V23, P8060; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Dittman JS, 2008, J NEUROSCI, V28, P7104, DOI 10.1523/JNEUROSCI.0378-08.2008; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Govorunova EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010368; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jose AM, 2007, GENETICS, V175, P93, DOI 10.1534/genetics.106.065516; Jospin M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000265; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Moresco JJ, 2004, J NEUROSCI, V24, P8522, DOI 10.1523/JNEUROSCI.1915-04.2004; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; OLIVEIRA L, 1993, J COMPUT AID MOL DES, V7, P649, DOI 10.1007/BF00125323; RAND JB, 1984, GENETICS, V106, P227; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Robertson H. M, 2006, WORMBOOK C ELEGANS R, DOI [doi/10.1895/wormbook.1.66.1, DOI 10.1895/WORMB00K.1.66.1]; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; Steger KA, 2004, GENETICS, V167, P633, DOI 10.1534/genetics.103.020230; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; TRENT C, 1983, GENETICS, V104, P619; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Zhang M, 2008, CURR BIOL, V18, P1445, DOI 10.1016/j.cub.2008.08.047	37	3	5	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39860	39870		10.1074/jbc.M111.241000	http://dx.doi.org/10.1074/jbc.M111.241000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937442	Green Published, hybrid			2022-12-25	WOS:000296925700020
J	Rezvanpour, A; Santamaria-Kisiel, L; Shaw, GS				Rezvanpour, Atoosa; Santamaria-Kisiel, Liliana; Shaw, Gary S.			The S100A10-Annexin A2 Complex Provides a Novel Asymmetric Platform for Membrane Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S100 TARGET SPECIFICITY; N-TERMINAL DOMAIN; ANNEXIN-II; GLUTAMATE-DECARBOXYLASE; STRUCTURAL BASIS; EARLY ENDOSOMES; BINDING-SITE; PROTEIN; DYSFERLIN; PEPTIDE	Membrane repair is mediated by multiprotein complexes, such as that formed between the dimeric EF-hand protein S100A10, the calcium- and phospholipid-binding protein annexin A2, the enlargeosome protein AHNAK, and members of the transmembrane ferlin family. Although interactions between these proteins have been shown, little is known about their structural arrangement and mechanisms of formation. In this work, we used a non-covalent complex between S100A10 and the N terminus of annexin A2 (residues 1-15) and a designed hybrid protein (A10A2), where S100A10 is linked in tandem to the N-terminal region of annexin A2, to explore the binding region, stoichiometry, and affinity with a synthetic peptide from the C terminus of AHNAK. Using multiple biophysical methods, we identified a novel asymmetric arrangement between a single AHNAK peptide and the A10A2 dimer. The AHNAK peptide was shown to require the annexin A2 N terminus, indicating that the AHNAK binding site comprises regions on both S100A10 and annexin proteins. NMR spectroscopy was used to show that the AHNAK binding surface comprised residues from helix IV in S100A10 and the C-terminal portion from the annexin A2 peptide. This novel surface maps to the exposed side of helices IV and IV' of the S100 dimeric structure, a region not identified in any previous S100 target protein structures. The results provide the first structural details of the ternary S100A10 protein complex required for membrane repair.	[Rezvanpour, Atoosa; Santamaria-Kisiel, Liliana; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625	Canadian Institutes of Health Research [95320]; Canada Research Chairs Program; Ontario Graduate Student Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Graduate Student Scholarship	This work was supported by grant FRN #95320 from the Canadian Institutes of Health Research (to G. S. S.) and the Canada Research Chairs Program (to G. S. S.) and an Ontario Graduate Student Scholarship (to A. R.).	Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Beaton AR, 2002, P NATL ACAD SCI USA, V99, P13154, DOI 10.1073/pnas.192432299; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Cacciottolo M, 2011, J BIOL CHEM, V286, P5404, DOI 10.1074/jbc.M110.173559; Charpentier TH, 2010, J MOL BIOL, V396, P1227, DOI 10.1016/j.jmb.2009.12.057; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854; De Seranno S, 2006, J BIOL CHEM, V281, P35030, DOI 10.1074/jbc.M606545200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diakonova M, 1997, J CELL SCI, V110, P1199; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Illien F, 2010, BBA-BIOMEMBRANES, V1798, P1790, DOI 10.1016/j.bbamem.2010.05.001; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jost M, 1997, J CELL SCI, V110, P221; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Kouno M, 2004, J INVEST DERMATOL, V123, P700, DOI 10.1111/j.0022-202X.2004.23412.x; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Morigasaki S, 2000, BIOCHEM BIOPH RES CO, V273, P261, DOI 10.1006/bbrc.2000.2945; Nebgen DR, 1999, J DENT RES, V78, P1484, DOI 10.1177/00220345990780090201; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Rety S, 2000, STRUCTURE, V8, P175, DOI 10.1016/S0969-2126(00)00093-9; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rezvanpour A, 2009, GEN PHYSIOL BIOPHYS, V28, pF39; Rezvanpour A, 2009, PROTEIN SCI, V18, P2528, DOI 10.1002/pro.267; Rintala-Dempsey AC, 2006, BIOCHEMISTRY-US, V45, P14695, DOI 10.1021/bi061754e; Rosengarth A, 2003, J MOL BIOL, V326, P1317, DOI 10.1016/S0022-2836(03)00027-5; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Smith SP, 1998, BIOCHEM CELL BIOL, V76, P324, DOI 10.1139/bcb-76-2-3-324; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Umbrecht-Jenck E, 2010, TRAFFIC, V11, P958, DOI 10.1111/j.1600-0854.2010.01065.x; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Wright NT, 2009, J MOL BIOL, V386, P1265, DOI 10.1016/j.jmb.2009.01.022; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200	58	46	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40174	40183		10.1074/jbc.M111.244038	http://dx.doi.org/10.1074/jbc.M111.244038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949189	Green Published, hybrid			2022-12-25	WOS:000296925700050
J	Busillo, JM; Azzam, KM; Cidlowski, JA				Busillo, John M.; Azzam, Kathleen M.; Cidlowski, John A.			Glucocorticoids Sensitize the Innate Immune System through Regulation of the NLRP3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; OXIDATIVE STRESS; CUTTING EDGE; RECEPTOR; ACTIVATION; ATP; RELEASE; GENE	Glucocorticoids have long been recognized as powerful anti-inflammatory compounds that are one of the most widely prescribed classes of drugs in the world. However, their role in the regulation of innate immunity is not well understood. We sought to examine the effects of glucocorticoids on the NOD-like receptors (NLRs), a central component of the inflammasome and innate immunity. Surprisingly, we show that glucocorticoids induce both NLRP3 messenger RNA and protein, which is a critical component of the inflammasome. The glucocorticoid-dependent induction of NLRP3 sensitizes the cells to extracellular ATP and significantly enhances the ATP-mediated release of proinflammatory molecules, including mature IL-1 beta, TNF-alpha, and IL-6. This effect was specific for glucocorticoids and dependent on the glucocorticoid receptor. These studies demonstrate a novel role for glucocorticoids in sensitizing the initial inflammatory response by the innate immune system.	[Busillo, John M.; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Azzam, Kathleen M.] NIEHS, Lab Resp Biol, Dept Hlth & Human Serv, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), 111 TW Alexander Dr,Rm F349, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	National Institutes of Health of the NIEHS [1ZIAES090057-15]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057] Funding Source: NIH RePORTER	National Institutes of Health of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by a National Institutes of Health grant 1ZIAES090057-15 (intramural research program of the NIEHS).	Anderson JP, 2008, GENES IMMUN, V9, P721, DOI 10.1038/gene.2008.66; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bodin P, 1998, INFLAMM RES, V47, P351, DOI 10.1007/s000110050341; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chanson P, 2010, NEUROENDOCRINOLOGY, V92, P96, DOI 10.1159/000314272; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Ding Y, 2010, J PHARMACOL EXP THER, V335, P693, DOI 10.1124/jpet.110.171975; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; JOELS M, 1989, SCIENCE, V245, P1502, DOI 10.1126/science.2781292; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; KNUDSEN PJ, 1987, J IMMUNOL, V139, P4129; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McIntosh LJ, 1996, EXP NEUROL, V141, P201, DOI 10.1006/exnr.1996.0154; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perretti M, 2000, MICROCIRCULATION, V7, P147, DOI 10.1038/sj.mn.7300108; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Smith LK, 2010, PROG BRAIN RES, V182, P1, DOI 10.1016/S0079-6123(10)82001-1; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Smyth GP, 2004, J SURG RES, V116, P253, DOI 10.1016/S0022-4804(03)00300-7; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; WURTMAN RJ, 1966, J BIOL CHEM, V241, P2301; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	61	162	167	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38703	38713		10.1074/jbc.M111.275370	http://dx.doi.org/10.1074/jbc.M111.275370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21940629	hybrid, Green Published			2022-12-25	WOS:000296594200082
J	Ma, MJ; Huang, Y; Gong, ZD; Zhuang, L; Li, C; Yang, H; Tong, YG; Liu, W; Cao, WC				Ma, Maijuan; Huang, Yong; Gong, Zhengda; Zhuang, Lu; Li, Cun; Yang, Hong; Tong, Yigang; Liu, Wei; Cao, Wuchun			Discovery of DNA Viruses in Wild-Caught Mosquitoes Using Small RNA High throughput Sequencing	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENOMIC ORGANIZATION; DENSOVIRUS; DIAGNOSIS	Background: Mosquito-borne infectious diseases pose a severe threat to public health in many areas of the world. Current methods for pathogen detection and surveillance are usually dependent on prior knowledge of the etiologic agents involved. Hence, efficient approaches are required for screening wild mosquito populations to detect known and unknown pathogens. Methodology/principal findings: In this study, we explored the use of Next Generation Sequencing to identify viral agents in wild-caught mosquitoes. We extracted total RNA from different mosquito species from South China. Small 18-30 bp length RNA molecules were purified, reverse-transcribed into cDNA and sequenced using Illumina GAIIx instrumentation. Bioinformatic analyses to identify putative viral agents were conducted and the results confirmed by PCR. We identified a non-enveloped single-stranded DNA densovirus in the wild-caught Culex pipiens molestus mosquitoes. The majority of the viral transcripts (.>80% of the region) were covered by the small viral RNAs, with a few peaks of very high coverage obtained. The +/- strand sequence ratio of the small RNAs was approximately 7:1, indicating that the molecules were mainly derived from the viral RNA transcripts. The small viral RNAs overlapped, enabling contig assembly of the viral genome sequence. We identified some small RNAs in the reverse repeat regions of the viral 5'- and 3'-untranslated regions where no transcripts were expected. Conclusions/significance: Our results demonstrate for the first time that high throughput sequencing of small RNA is feasible for identifying viral agents in wild-caught mosquitoes. Our results show that it is possible to detect DNA viruses by sequencing the small RNAs obtained from insects, although the underlying mechanism of small viral RNA biogenesis is unclear. Our data and those of other researchers show that high throughput small RNA sequencing can be used for pathogen surveillance in wild mosquito vectors.	[Ma, Maijuan; Huang, Yong; Zhuang, Lu; Li, Cun; Yang, Hong; Tong, Yigang; Liu, Wei; Cao, Wuchun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Gong, Zhengda] Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Yunnan Institute for Endemic Disease Control & Prevention	Ma, MJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	tong.yigang@gmail.com	Li, Cun/ABD-9346-2020	Tong, Yigang/0000-0002-8503-8045; Ma, Mai-Juan/0000-0002-8105-462X	National Science Fund for Distinguished Young Scholars [30725032]; National Science Fund [30872223, 81072250, 81072350]; Hi-Tech Research and Development (863) Program of China [2009AA02Z111]; National "973" Program [2010 CB530201]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Fund; Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); National "973" Program(National Basic Research Program of China)	This study was supported by grants from the National Science Fund for Distinguished Young Scholars 30725032), the National Science Fund (30872223, 81072250, 81072350), the Hi-Tech Research and Development (863) Program of China (2009AA02Z111) and National "973" Program (2010 CB530201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFANASIEV BN, 1991, VIROLOGY, V185, P323, DOI 10.1016/0042-6822(91)90780-F; Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; Bishop-Lilly KA, 2010, PLOS NEGLECT TROP D, V4, P1101; BOUBLIK Y, 1994, VIROLOGY, V200, P752, DOI 10.1006/viro.1994.1239; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013; Costa J. V., 1990, Molecular Biology of Iridoviruses., P247; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; DUMAS B, 1992, VIROLOGY, V191, P202, DOI 10.1016/0042-6822(92)90182-O; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Hirunkanokpun S, 2008, AM J TROP MED HYG, V78, P784, DOI 10.4269/ajtmh.2008.78.784; Inc I, 2008, PREPARING SAMPLES AN; Jiang H, 2007, ARCH VIROL, V152, P383, DOI 10.1007/s00705-006-0844-6; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Mumford R, 2006, EUR J PLANT PATHOL, V116, P1, DOI 10.1007/s10658-006-9037-0; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Mosimann ALP, 2011, MEM I OSWALDO CRUZ, V106, P285, DOI 10.1590/S0074-02762011000300006; Paterson A, 2005, VIROLOGY, V337, P253, DOI 10.1016/j.virol.2005.04.037; Quan PL, 2008, ANTIVIR RES, V79, P1, DOI 10.1016/j.antiviral.2008.02.002; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Sivaram A, 2009, INTERVIROLOGY, V52, P1, DOI 10.1159/000210044; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; van Mierlo JT, 2010, CELL HOST MICROBE, V7, P87, DOI 10.1016/j.chom.2010.02.001; Ward TW, 2001, J VIROL, V75, P1325, DOI 10.1128/JVI.75.3.1325-1331.2001; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0	33	55	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24758	10.1371/journal.pone.0024758	http://dx.doi.org/10.1371/journal.pone.0024758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949749	gold, Green Published, Green Submitted			2022-12-25	WOS:000295260400012
J	Moro, H; Otero, DC; Tanabe, Y; David, M				Moro, Hiroshi; Otero, Dennis C.; Tanabe, Yoshinari; David, Michael			T Cell-Intrinsic and -Extrinsic Contributions of the IFNAR/STAT1-Axis to Thymocyte Survival	PLOS ONE			English	Article							RECEPTOR TRANSGENIC MICE; NEGATIVE SELECTION; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION; POSITIVE SELECTION; THYMIC SELECTION; B-LYMPHOCYTES; AUTOIMMUNITY; DELETION; STAT1	STAT1 is an essential part of interferon signaling, and STAT1-deficiency results in heightened susceptibility to infections or autoimmunity in both mice and humans. Here we report that mice lacking the IFN alpha/beta-receptor (IFNAR1) or STAT1 display impaired deletion of autoreactive CD4(+)CD8(+)-T-cells. Strikingly, co-existence of WT T cells restored thymic elimination of self-reactive STAT1-deficient CD4(+)CD8(+)-T cells. Analysis of STAT1-deficient thymocytes further revealed reduced Bim expression, which was restored in the presence of WT T cells. These results indicate that type I interferons and STAT1 play an important role in the survival of MHC class I-restricted T cells in a T cell intrinsic and non-cell intrinsic manner that involves regulation of Bim expression through feedback provided by mature STAT1-competent T cells.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Moro, H (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Infect Control & Prevent, Niigata, Japan.	midavid@ucsd.edu		Moro, Hiroshi/0000-0003-4588-5845	National Institute of Allergy and Infectious Diseases [AI71233]; National Multiple Sclerosis Society [RG3948]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071233] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (AI71233) and The National Multiple Sclerosis Society (RG3948) to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; David M, 2002, BIOTECHNIQUES, P58; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Hu Q, 2009, J IMMUNOL, V183, P7761, DOI 10.4049/jimmunol.0902181; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Karp CL, 2000, IMMUNOL TODAY, V21, P24, DOI 10.1016/S0167-5699(99)01541-8; Kirberg J, 2008, J IMMUNOL, V181, P1207, DOI 10.4049/jimmunol.181.2.1207; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lee CK, 1999, J EXP MED, V190, P1451, DOI 10.1084/jem.190.10.1451; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; MULLER U, 1994, SCIENCE, V264; Nishibori T, 2004, J EXP MED, V199, P25, DOI 10.1084/jem.20020509; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24972	10.1371/journal.pone.0024972	http://dx.doi.org/10.1371/journal.pone.0024972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949815	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400026
J	Albanna, AS; Reed, MB; Kotar, KV; Fallow, A; McIntosh, FA; Behr, MA; Menzies, D				Albanna, Amr S.; Reed, Michael B.; Kotar, Kimberley V.; Fallow, Ashley; McIntosh, Fiona A.; Behr, Marcel A.; Menzies, Dick			Reduced Transmissibility of East African Indian Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; INFECTION; VIRULENCE; EMERGENCE; LINEAGE; FAMILY	Background: Mycobacterium tuberculosis (MTB) has been classified into 4 main lineages. Some reports have associated certain lineages with particular clinical phenotypes, but there is still insufficient information regarding the clinical and epidemiologic implications of MTB lineage variation. Methods: Using large sequence polymorphisms we classified MTB isolates from a population-based study in Montreal, Canada into the 4 major lineages, and identified the associated clinical and epidemiologic features. In addition, IS6110-RFLP and spoligotyping were used as indicators of recent TB transmission. The study population was divided into a derivation cohort, diagnosed between 2001 and 2007, and a separate validation cohort, diagnosed between 1996 and 2000. Results: In the derivation cohort, when compared to the other MTB lineages, the East African-Indian (EAI) lineage was associated with lower rates of TB transmission, as measured by: positive TST among close contacts of pulmonary TB cases (adjusted odds ratio 0.6: [95% confidence interval 0.4-0.9]), and clustered TB cases (0.3: [<0.001-0.6]). Severe forms of TB were also less likely among the EAI group (0.4: [<0.001-0.8]). There were no significant differences when comparing patients with the other MTB lineages. In the validation cohort, the EAI lineage was associated with lower rates of positive TST among contacts (0.5: [0.3-0.9]) and a trend towards less clustered TB cases (0.5: [0.1-1.8]) when compared to the other lineages. Disease severity among the different groups was not significantly different in the validation cohort. Conclusions: We conclude that in Montreal, EAI strains were associated with reduced transmission compared to other MTB lineages.	[Albanna, Amr S.; Kotar, Kimberley V.; Menzies, Dick] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Reed, Michael B.; Fallow, Ashley; McIntosh, Fiona A.; Behr, Marcel A.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Albanna, AS (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.	dick.menzies@mcgill.ca		Albanna, Amr/0000-0001-8242-0145	Canadian Institutes of Health Research (CIHR) [RRD153877, MOP82931]; Ministry of Higher Education, Government of Saudi Arabia; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Higher Education, Government of Saudi Arabia; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was funded by Canadian Institutes of Health Research (CIHR) grants RRD153877 (D. M.) and MOP82931 (M. R.). A. A. received salary support from the Ministry of Higher Education, Government of Saudi Arabia. M. R. is supported by a New Investigator Salary Award from the CIHR. M. B. and D. M. received salary support from the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; BHATIA AL, 1961, B WORLD HEALTH ORGAN, V25, P313; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Lopez-Granados E, 2003, CLIN EXP IMMUNOL, V133, P123, DOI 10.1046/j.1365-2249.2003.02184.x; Manca C, 1999, J IMMUNOL, V162, P6740; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Pando RH, 2010, TUBERCULOSIS, V90, P268, DOI 10.1016/j.tube.2010.05.002; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Rajakumar K, 2004, J CLIN MICROBIOL, V42, P1890, DOI 10.1128/JCM.42.5.1890-1896.2004; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rieder H, 2005, EUR RESPIR J, V25, P181, DOI 10.1183/09031936.04.00103804; Schmaltz CAS, 2009, JAIDS-J ACQ IMM DEF, V52, P623, DOI 10.1097/QAI.0b013e3181b31e56; Styblo K., 1985, B INT UNION TUBERC, V60, P117; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; WHO, 2009, WHOHTMTB2009411	27	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25075	10.1371/journal.pone.0025075	http://dx.doi.org/10.1371/journal.pone.0025075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949856	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900049
J	Arble, DM; Vitaterna, MH; Turek, FW				Arble, Deanna Marie; Vitaterna, Martha Hotz; Turek, Fred W.			Rhythmic Leptin Is Required for Weight Gain from Circadian Desynchronized Feeding in the Mouse	PLOS ONE			English	Article							PLASMA LEPTIN; GENE-EXPRESSION; BODY-WEIGHT; FOOD-INTAKE; NIGHT-WORK; TIME; RECEPTOR; OBESITY; RATS; OSCILLATORS	The neuroendocrine and metabolic effects of leptin have been extensively researched since the discovery, and the later identification, of the leptin gene mutated within the ob/ob mouse. Leptin is required for optimal health in a number of physiological systems (e. g. fertility, bone density, body weight regulation). Despite the extensive leptin literature and many observations of leptin's cyclical pattern over the 24-hour day, few studies have specifically examined how the circadian rhythm of leptin may be essential to leptin signaling and health. Here we present data indicating that a rhythmic leptin profile (e. g. 1 peak every 24 hours) leads to excessive weight gain during desynchronized feeding whereas non-rhythmic leptin provided in a continuous manner does not lead to excessive body weight gain under similar feeding conditions. This study suggests that feeding time can interact with leptin's endogenous rhythm to influence metabolic signals, specifically leading to excessive body weight gains during 'wrongly' timed feeding.	[Arble, Deanna Marie; Vitaterna, Martha Hotz; Turek, Fred W.] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA	Northwestern University	Arble, DM (corresponding author), Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA.	fturek@northwestern.edu		Arble, Deanna/0000-0002-3993-5984	NIH/NIA [F31 AG035621, P01 AG114212]; NIH/NHLBI [T32 HL007909]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG035621] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project described was supported by (NIH/NIA) grant F31 AG035621, NIH/NIA grant P01 AG114212, and NIH/NHLBI grant T32 HL007909. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Baskin DG, 1999, BRAIN RES, V828, P154, DOI 10.1016/S0006-8993(99)01252-4; Baskin DG, 1998, DIABETES, V47, P538, DOI 10.2337/diabetes.47.4.538; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bray MS, 2010, INT J OBESITY, V34, P1589, DOI 10.1038/ijo.2010.63; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Elimam A, 2002, EUR J ENDOCRINOL, V147, P181, DOI 10.1530/eje.0.1470181; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Holmback U, 2003, EUR J NUTR, V42, P75, DOI 10.1007/s00394-003-0386-6; Kalra SP, 2003, REGUL PEPTIDES, V111, P1, DOI 10.1016/S0167-0115(02)00305-1; KNIGHT ZA, PLOS ONE, V5; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Mitchell SE, 2009, J PHYSIOL-LONDON, V587, P3573, DOI 10.1113/jphysiol.2009.173328; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Otway DT, 2009, CHRONOBIOL INT, V26, P1340, DOI 10.3109/07420520903412368; Prosser RA, 2003, NEUROSCI LETT, V336, P139, DOI 10.1016/s0304-3940(02)01234-X; Saad MF, 1998, J CLIN ENDOCR METAB, V83, P453, DOI 10.1210/jc.83.2.453; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Simon C, 1998, J CLIN ENDOCR METAB, V83, P1893, DOI 10.1210/jc.83.6.1893; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2007, SLEEP MED, V8, P656, DOI 10.1016/j.sleep.2006.12.010; Zelissen PMJ, 2005, DIABETES OBES METAB, V7, P755, DOI 10.1111/j.1463-1326.2005.00468.x	34	37	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25079	10.1371/journal.pone.0025079	http://dx.doi.org/10.1371/journal.pone.0025079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949859	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900050
J	Lepore, N; Lafontaine, DLJ				Lepore, Nathalie; Lafontaine, Denis L. J.			A Functional Interface at the rDNA Connects rRNA Synthesis, Pre-rRNA Processing and Nucleolar Surveillance in Budding Yeast	PLOS ONE			English	Article							TRANSCRIPTION ELONGATION-FACTOR; POLYMERASE-II TRANSCRIPTS; SACCHAROMYCES-CEREVISIAE; TERMINAL REPEAT; SPT5; COMPLEX; DEGRADATION; PROTEINS; EXOSOME; ROLES	Ribogenesis is a multistep error-prone process that is actively monitored by quality control mechanisms. How ribosomal RNA synthesis, pre-rRNA processing and nucleolar surveillance are integrated is unclear. Nor is it understood how defective ribosomes are recognized. We report in budding yeast that, in vivo, the interaction between the transcription elongation factor Spt5 and Rpa190, the largest subunit of RNA polymerase (Pol) I, requires the Spt5 C-terminal region (CTR), a conserved and highly repetitive domain that is reminiscent of the RNA Pol II C-terminal domain (CTD). We show that this sequence is also required for the interaction between Spt5 and Nrd1, an RNA specific binding protein, and an exosome cofactor. Both the Spt4-Spt5, and the Nrd1-Nab3 complexes interact functionally with Rrp6, and colocalize at the rDNA. Mutations in the RNA binding domain of Nrd1, but not in its RNA Pol II CTD-interacting domain, and mutations in the RRM of Nab3 led to the accumulation of normal and aberrant polyadenylated pre-rRNAs. Altogether these results indicate that Nrd1-Nab3 contributes to recruiting the nucleolar surveillance to elongating polymerases to survey nascent rRNA transcripts.	[Lepore, Nathalie; Lafontaine, Denis L. J.] Univ Libre Bruxelles, Fonds Rech Sci FRS FNRS, RNA Metab, Gosselies, Belgium; [Lafontaine, Denis L. J.] Acad Wallonie Bruxelles, CMMI, Gosselies, Belgium	Fonds de la Recherche Scientifique - FNRS; Universite Libre de Bruxelles	Lepore, N (corresponding author), Univ Libre Bruxelles, Fonds Rech Sci FRS FNRS, RNA Metab, Gosselies, Belgium.	denis.lafontaine@ulb.ac.be	Lafontaine, Denis/I-7673-2013	Lafontaine, Denis/0000-0001-7295-6288	FRS/F.N.R.S.; Communaute francaise de Belgique; Region Wallonne	FRS/F.N.R.S.(Fonds de la Recherche Scientifique - FNRS); Communaute francaise de Belgique(Australian Research Council); Region Wallonne	This work was funded by the FRS/F.N.R.S. (http://www2.frs-fnrs.be/), Communaute francaise de Belgique (Programme ARC, http://www.cfwb.be/) and Region Wallonne (Programme Cibles, http://recherche-technologie.wallonie.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S.J., 2011, J BIOL CHEM; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Braglia P, 2010, EMBO REP, V11, P758, DOI 10.1038/embor.2010.130; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Colau G, 2004, MOL CELL BIOL, V24, P7976, DOI 10.1128/MCB.24.18.7976-7986.2004; Conrad NK, 2000, GENETICS, V154, P557; Dez C, 2007, RNA, V13, P1516, DOI 10.1261/rna.609807; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; Fang F, 2005, RNA, V11, P1571, DOI 10.1261/rna.2900205; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Honorine R, 2010, NUCL ACIDS RES; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kwapisz M, 2008, EMBO J, V27, P2411, DOI 10.1038/emboj.2008.165; Lafontaine DLJ, 2010, TRENDS BIOCHEM SCI, V35, P267, DOI 10.1016/j.tibs.2009.12.006; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; SWANSON MS, 1992, GENETICS, V132, P325; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Viktorovskaya O.V., 2011, J BIOL CHEM; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; WANG M, 2010, NUCLEIC ACIDS RES, P1811; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Wery M, 2009, RNA, V15, P406, DOI 10.1261/rna.1402709; WLOTZKA W, 2011, EMBO J; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2001, J BIOCHEM, V129, P185, DOI 10.1093/oxfordjournals.jbchem.a002842; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106; Zhu WY, 2007, NUCLEIC ACIDS RES, V35, P4064, DOI 10.1093/nar/gkm430	54	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24962	10.1371/journal.pone.0024962	http://dx.doi.org/10.1371/journal.pone.0024962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949810	Green Submitted, gold, Green Published			2022-12-25	WOS:000295257900041
J	Ivanovska, I; Zhang, CS; Liu, AM; Wong, KF; Lee, NP; Lewis, P; Philippar, U; Bansal, D; Buser, C; Scott, M; Mao, M; Poon, RTP; Fan, ST; Cleary, MA; Luk, JM; Dai, HY				Ivanovska, Irena; Zhang, Chunsheng; Liu, Angela M.; Wong, Kwong F.; Lee, Nikki P.; Lewis, Patrick; Philippar, Ulrike; Bansal, Dimple; Buser, Carolyn; Scott, Martin; Mao, Mao; Poon, Ronnie T. P.; Fan, Sheung Tat; Cleary, Michele A.; Luk, John M.; Dai, Hongyue			Gene Signatures Derived from a c-MET-Driven Liver Cancer Mouse Model Predict Survival of Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; SIGNALING PATHWAY; TUMOR-GROWTH; EXPRESSION; PROGNOSIS; RECONSTRUCTION; HETEROGENEITY; PROGRESSION; ACTIVATION; METAGENE	Biomarkers derived from gene expression profiling data may have a high false-positive rate and must be rigorously validated using independent clinical data sets, which are not always available. Although animal model systems could provide alternative data sets to formulate hypotheses and limit the number of signatures to be tested in clinical samples, the predictive power of such an approach is not yet proven. The present study aims to analyze the molecular signatures of liver cancer in a c-MET-transgenic mouse model and investigate its prognostic relevance to human hepatocellular carcinoma (HCC). Tissue samples were obtained from tumor (TU), adjacent non-tumor (AN) and distant normal (DN) liver in Tet-operator regulated (TRE) human c-MET transgenic mice (n = 21) as well as from a Chinese cohort of 272 HBV- and 9 HCV-associated HCC patients. Whole genome microarray expression profiling was conducted in Affymetrix gene expression chips, and prognostic significances of gene expression signatures were evaluated across the two species. Our data revealed parallels between mouse and human liver tumors, including down-regulation of metabolic pathways and up-regulation of cell cycle processes. The mouse tumors were most similar to a subset of patient samples characterized by activation of the Wnt pathway, but distinctive in the p53 pathway signals. Of potential clinical utility, we identified a set of genes that were down regulated in both mouse tumors and human HCC having significant predictive power on overall and disease-free survival, which were highly enriched for metabolic functions. In conclusions, this study provides evidence that a disease model can serve as a possible platform for generating hypotheses to be tested in human tissues and highlights an efficient method for generating biomarker signatures before extensive clinical trials have been initiated.	[Ivanovska, Irena; Zhang, Chunsheng; Lewis, Patrick; Mao, Mao; Cleary, Michele A.; Dai, Hongyue] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98104 USA; [Liu, Angela M.; Lee, Nikki P.; Poon, Ronnie T. P.; Fan, Sheung Tat; Luk, John M.] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Liu, Angela M.; Wong, Kwong F.; Luk, John M.] Natl Univ Singapore, Dept Pharmacol, Dept Surg, Singapore 117548, Singapore; [Liu, Angela M.; Wong, Kwong F.; Luk, John M.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Ivanovska, Irena; Zhang, Chunsheng; Philippar, Ulrike; Bansal, Dimple; Scott, Martin; Dai, Hongyue] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Buser, Carolyn] Merck & Co Inc, Mol Profiling & Pharmacol, N Wales, PA USA	Merck & Company; University of Hong Kong; National University of Singapore; National University of Singapore; Merck & Company; Merck & Company	Ivanovska, I (corresponding author), Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98104 USA.	Irena_Ivanovska@merck.com; jmluk@nus.edu.sg; Hongyue_dai@merck.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940; Lewis, Patrick/0000-0003-4537-0489				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Chau BN, 2009, CANCER RES, V69, P1368, DOI 10.1158/0008-5472.CAN-08-2742; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Hui CK, 2006, J CLIN VIROL, V35, P185, DOI 10.1016/j.jcv.2005.07.003; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Lee JS, 2006, ONCOGENE, V25, P3801, DOI 10.1038/sj.onc.1209561; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee NPY, 2007, BIOMARK MED, V1, P273, DOI 10.2217/17520363.1.2.273; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Luk JM, 2011, J BIOL CHEM IN PRESS; Luk JM, 2011, OMICS, V15, P261, DOI 10.1089/omi.2010.0099; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Midorikawa Y, 2007, WORLD J GASTROENTERO, V13, P1487, DOI 10.3748/wjg.v13.i10.1487; NISHIDA N, 1993, CANCER RES, V53, P368; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun S, 2007, LIVER INT, V27, P1021, DOI 10.1111/j.1478-3231.2007.01533.x; Sun S, 2010, J PROTEOME RES, V9, P1923, DOI 10.1021/pr901085z; Sweet-Cordero A, 2006, GENE CHROMOSOME CANC, V45, P338, DOI 10.1002/gcc.20296; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; UNSAL H, 1994, P NATL ACAD SCI USA, V91, P822, DOI 10.1073/pnas.91.2.822; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	41	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24582	10.1371/journal.pone.0024582	http://dx.doi.org/10.1371/journal.pone.0024582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949730	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800028
J	Park, SY; Gupta, D; Kim, CH; Dziarski, R				Park, Shin Yong; Gupta, Dipika; Kim, Chang H.; Dziarski, Roman			Differential Effects of Peptidoglycan Recognition Proteins on Experimental Atopic and Contact Dermatitis Mediated by Treg and Th17 Cells	PLOS ONE			English	Article							L-ALANINE AMIDASE; REGULATORY T-CELLS; AUTOIMMUNE INFLAMMATION; HYPERSENSITIVITY REACTIONS; FUNCTIONAL SPECIALIZATION; IMMUNE-RESPONSES; HELPER-CELLS; PSORS4 LOCUS; MICE; INNATE	Skin protects the body from the environment and is an important component of the innate and adaptive immune systems. Atopic dermatitis and contact dermatitis are among the most frequent inflammatory skin diseases and are both determined by multigenic predisposition, environmental factors, and aberrant immune response. Peptidoglycan Recognition Proteins (Pglyrps) are expressed in the skin and we report here that they modulate sensitivity to experimentally-induced atopic dermatitis and contact dermatitis. Pglyrp3(-/-) and Pglyrp4(-/-) mice (but not Pglyrp2(-/-) mice) develop more severe oxazolone-induced atopic dermatitis than wild type (WT) mice. The common mechanism underlying this increased sensitivity of Pglyrp3(-/-) and Pglyrp4(-/-) mice to atopic dermatitis is reduced recruitment of Treg cells to the skin and enhanced production and activation Th17 cells in Pglyrp3(-/-) and Pglyrp4(-/-) mice, which results in more severe inflammation and keratinocyte proliferation. This mechanism is supported by decreased inflammation in Pglyrp3(-/-) mice following in vivo induction of Treg cells by vitamin D or after neutralization of IL-17. By contrast, Pglyrp1(-/-) mice develop less severe oxazolone-induced atopic dermatitis and also oxazolone-induced contact dermatitis than WT mice. Thus, Pglyrp3 and Pglyrp4 limit over-activation of Th17 cells by promoting accumulation of Treg cells at the site of chronic inflammation, which protects the skin from exaggerated inflammatory response to cell activators and allergens, whereas Pglyrp1 has an opposite pro-inflammatory effect in the skin.	[Park, Shin Yong; Gupta, Dipika; Dziarski, Roman] Indiana Univ Sch Med NW, Gary, IN 46408 USA; [Kim, Chang H.] Purdue Univ, Sch Vet Med, W Lafayette, IN 47907 USA	Indiana University System; Indiana University Northwest; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Park, SY (corresponding author), Indiana Univ Sch Med NW, Gary, IN 46408 USA.	dgupta@iun.edu; rdziar@iun.edu	Kim, Chang/ABG-8200-2020	Kim, Chang/0000-0003-4618-9139	National Institutes of Health [AI028797, AI073290]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028797, R01AI073290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Services Grants AI028797 and AI073290 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Fonacier LS, 2010, J ALLERGY CLIN IMMUN, V125, pS138, DOI 10.1016/j.jaci.2009.05.039; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Kainu K, 2009, EXP DERMATOL, V18, P109, DOI 10.1111/j.1600-0625.2008.00769.x; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lange-Asschenfeldt B, 2002, BLOOD, V99, P538, DOI 10.1182/blood.V99.2.538; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li XN, 2006, J BIOL CHEM, V281, P20738, DOI 10.1074/jbc.M601017200; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Man MQ, 2008, J INVEST DERMATOL, V128, P79, DOI 10.1038/sj.jid.5701011; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; Mathur P, 2004, GENOMICS, V83, P1151, DOI 10.1016/j.ygeno.2004.01.003; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Sun C, 2006, HUM GENET, V119, P113, DOI 10.1007/s00439-005-0115-8; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; Wang BH, 2001, J LEUKOCYTE BIOL, V70, P185; Wang HT, 2005, INFECT IMMUN, V73, P7216, DOI 10.1128/IAI.73.11.7216-7225.2005; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu M, 2004, MOL CELL BIOL, V24, P7949, DOI 10.1128/MCB.24.18.7949-7957.2004; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhang YO, 2005, BBA-PROTEINS PROTEOM, V1752, P34, DOI 10.1016/j.bbapap.2005.07.001; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	46	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24961	10.1371/journal.pone.0024961	http://dx.doi.org/10.1371/journal.pone.0024961			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949809	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800053
J	Santiago, MF; Veliskova, J; Patel, NK; Lutz, SE; Caille, D; Charollais, A; Meda, P; Scemes, E				Santiago, Marcelo F.; Veliskova, Jana; Patel, Naman K.; Lutz, Sarah E.; Caille, Dorothee; Charollais, Anne; Meda, Paolo; Scemes, Eliana			Targeting Pannexin1 Improves Seizure Outcome	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL SLICES; RAT HIPPOCAMPUS; ATP RELEASE; ASTROCYTE PROGENITORS; ADENOSINE KINASE; P2X(7) RECEPTOR; HEMICHANNELS; CHANNELS	Imbalance of the excitatory neurotransmitter glutamate and of the inhibitory neurotransmitter GABA is one of several causes of seizures. ATP has also been implicated in epilepsy. However, little is known about the mechanisms involved in the release of ATP from cells and the consequences of the altered ATP signaling during seizures. Pannexin1 (Panx1) is found in astrocytes and in neurons at high levels in the embryonic and young postnatal brain, declining in adulthood. Panx1 forms large-conductance voltage sensitive plasma membrane channels permeable to ATP that are also activated by elevated extracellular K(+) and following P2 receptor stimulation. Based on these properties, we hypothesized that Panx1 channels may contribute to seizures by increasing the levels of extracellular ATP. Using pharmacological tools and two transgenic mice deficient for Panx1 we show here that interference with Panx1 ameliorates the outcome and shortens the duration of kainic acid-induced status epilepticus. These data thus indicate that the activation of Panx1 in juvenile mouse hippocampi contributes to neuronal hyperactivity in seizures.	[Santiago, Marcelo F.; Veliskova, Jana; Patel, Naman K.; Lutz, Sarah E.; Scemes, Eliana] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA; [Santiago, Marcelo F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Veliskova, Jana] Albert Einstein Coll Med, Saul R Korey Dept Neurol, New York, NY USA; [Caille, Dorothee; Charollais, Anne; Meda, Paolo] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland	Yeshiva University; Universidade Federal do Rio de Janeiro; Yeshiva University; University of Geneva	Santiago, MF (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA.	eliana.scemes@einstein.yu.edu	Scemes, Eliana/K-6257-2019; Fisiologia, Ciencias Biologicas/C-2407-2012; Santiago, Marcelo F/H-3943-2011; Santiago, Marcelo Felippe/AAZ-3553-2020	Scemes, Eliana/0000-0002-6650-3976; Santiago, Marcelo F/0000-0003-2428-9606; Santiago, Marcelo Felippe/0000-0003-2428-9606; E Lutz, Sarah/0000-0002-6388-753X	National Institutes of Health [NS052245, NS056093]; Intercellular Communication Training Grant [NS007439]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [4143-09-4]; Swiss National Science Foundation [40-2011-11]; Juvenile Diabetes Research Foundation [BETAIMAGE 222980, IMIDIA, C2008-17]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007439, R01NS052245, R01NS056093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intercellular Communication Training Grant; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, grants NS052245 (ES), NS056093 (JV) and the Intercellular Communication Training Grant NS007439 (SEL); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship bex#4143-09-4 (MFS); the Swiss National Science Foundation, grant 40-2011-11 (PM); and the Juvenile Diabetes Research Foundation, grants BETAIMAGE 222980, IMIDIA, C2008-17 (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Avsar E, 2004, NEUROPHARMACOLOGY, V47, P427, DOI 10.1016/j.neuropharm.2004.04.015; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Etherington LAV, 2009, NEUROPHARMACOLOGY, V56, P429, DOI 10.1016/j.neuropharm.2008.09.016; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lopatar J, 2011, NEUROPHARMACOLOGY, V61, P25, DOI 10.1016/j.neuropharm.2011.02.011; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; SOMJEN GG, 1979, ANNU REV PHYSIOL, V41, P159, DOI 10.1146/annurev.ph.41.030179.001111; Striedinger K, 2008, J NEUROIMMUNOL, V196, P116, DOI 10.1016/j.jneuroim.2008.03.014; Striedinger K, 2007, GLIA, V55, P652, DOI 10.1002/glia.20494; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; WHITTINGTON MA, 1995, J PHYSIOL-LONDON, V486, P723, DOI 10.1113/jphysiol.1995.sp020848; WIERASZKO A, 1989, NEUROSCI LETT, V106, P287, DOI 10.1016/0304-3940(89)90178-X; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	36	129	130	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25178	10.1371/journal.pone.0025178	http://dx.doi.org/10.1371/journal.pone.0025178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949881	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800070
J	van Vuren, PJ; Tiemessen, CT; Paweska, JT				van Vuren, Petrus Jansen; Tiemessen, Caroline T.; Paweska, Janusz T.			Anti-Nucleocapsid Protein Immune Responses Counteract Pathogenic Effects of Rift Valley Fever Virus Infection in Mice	PLOS ONE			English	Article							IN-VIVO; T-CELLS; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; INNATE IMMUNITY; IGM ANTIBODIES; INDIRECT ELISA; NITRIC-OXIDE; NSS PROTEIN	The known virulence factor of Rift Valley fever virus (RVFV), the NSs protein, counteracts the antiviral effects of the type I interferon response. In this study we evaluated the expression of several genes in the liver and spleen involved in innate and adaptive immunity of mice immunized with a RVFV recombinant nucleocapsid protein (recNP) combined with Alhydrogel adjuvant and control animals after challenge with wild type RVFV. Mice immunized with recNP elicited an earlier IFN beta response after challenge compared to non-immunized controls. In the acute phase of liver infection in non-immunized mice there was a massive upregulation of type I and II interferon, accompanied by high viral titers, and the up-and downregulation of several genes involved in the activation of B- and T-cells, indicating that both humoral and cellular immunity is modulated during RVFV infection. Various genes involved in pro-inflammatory responses and with proapoptotic effects were strongly upregulated and anti-apoptotic genes were downregulated in liver of non-immunized mice. Expression of many genes involved in B- and T-cell immunity were downregulated in spleen of non-immunized mice but normal in immunized mice. A strong bias towards apoptosis and inflammation in non-immunized mice at an acute stage of liver infection associated with suppression of several genes involved in activation of humoral and cellular immunity in spleen, suggests that RVFV evades the host immune response in more ways than only by inhibition of type I interferon, and that immunopathology of the liver plays a crucial role in RVF disease progression.	[van Vuren, Petrus Jansen; Paweska, Janusz T.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Special Pathogens Unit, Johannesburg, South Africa; [van Vuren, Petrus Jansen; Tiemessen, Caroline T.; Paweska, Janusz T.] Univ Witwatersrand, Sch Pathol, Div Virol & Communicable Dis Surveillance, Johannesburg, South Africa; [Tiemessen, Caroline T.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Cell Biol AIDS Virus Res Unit, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	van Vuren, PJ (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Special Pathogens Unit, Johannesburg, South Africa.	januszp@nicd.ac.za	Jansen van Vuren, Petrus/AAW-6963-2020; Ibrahim, Essam Hassan/G-1960-2018	Jansen van Vuren, Petrus/0000-0003-2862-7983; Ibrahim, Essam Hassan/0000-0003-0130-2257; Tiemessen, Caroline/0000-0002-0991-1690	Poliomyelitis Research Foundation (PRF) [08/14]	Poliomyelitis Research Foundation (PRF)	This work was supported by the Poliomyelitis Research Foundation (PRF Grant number 08/14) (www.prf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; ANDERSON GW, 1988, MICROB PATHOGENESIS, V5, P241, DOI 10.1016/0882-4010(88)90096-4; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Boesteanu AC, 2009, SEMIN IMMUNOL, V21, P69, DOI 10.1016/j.smim.2009.02.005; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy Michele, 2010, Open Virol J, V4, P8, DOI 10.2174/1874357901004020008; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Ceredig R, 2006, BLOOD, V108, P1216, DOI 10.1182/blood-2005-10-006643; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Choi YL, 2001, J KOREAN MED SCI, V16, P424, DOI 10.3346/jkms.2001.16.4.424; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Coleman JW, 2002, CLIN EXP IMMUNOL, V129, P4, DOI 10.1046/j.1365-2249.2002.01918.x; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Curnow SJ, 2004, J IMMUNOL, V172, P7154, DOI 10.4049/jimmunol.172.11.7154; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; do Valle TZ, 2010, J IMMUNOL, V185, P6146, DOI 10.4049/jimmunol.1000949; Dong C, 2005, BLOOD, V105, P1187, DOI 10.1182/blood-2004-06-2188; Durand CA, 2009, J IMMUNOL, V183, P5673, DOI 10.4049/jimmunol.0900432; Duttagupta PA, 2009, CRIT REV IMMUNOL, V29, P469, DOI 10.1615/CritRevImmunol.v29.i6.20; Fafetine JM, 2007, VET MICROBIOL, V121, P29, DOI 10.1016/j.vetmic.2006.11.008; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gauliard N, 2006, VIROLOGY, V351, P170, DOI 10.1016/j.virol.2006.03.018; Gibbings D, 2009, J LEUKOCYTE BIOL, V86, P251, DOI 10.1189/jlb.0109040; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Gold JA, 2003, INFECT IMMUN, V71, P3521, DOI 10.1128/IAI.71.6.3521-3528.2003; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Haller O, 2009, Verh K Acad Geneeskd Belg, V71, P73; Heise MT, 2009, EPIDEMIOL INFECT, V137, P1309, DOI 10.1017/S0950268808001696; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; Hung JH, 2008, CANCER RES, V68, P1204, DOI 10.1158/0008-5472.CAN-07-2621; IHARA T, 1985, VIROLOGY, V144, P246, DOI 10.1016/0042-6822(85)90321-6; Jackson LN, 2008, AM J PHYSIOL-GASTR L, V294, pG1401, DOI 10.1152/ajpgi.00062.2008; Jansen Van Vuren P, 2010, OPEN VACCINE J, V3, P114; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kasler HG, 2007, MOL CELL BIOL, V27, P5184, DOI 10.1128/MCB.02091-06; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kortekaas J, 2010, VACCINE, V28, P4394, DOI 10.1016/j.vaccine.2010.04.048; Kunisaki Y, 2006, J IMMUNOL, V176, P4640, DOI 10.4049/jimmunol.176.8.4640; Lagerqvist N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-6; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee CG, 2008, AM J RESP CELL MOL, V39, P739, DOI 10.1165/rcmb.2008-0053OC; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Li JR, 1999, AM J PHYSIOL-GASTR L, V276, pG1069, DOI 10.1152/ajpgi.1999.276.5.G1069; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Liu L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-82; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Lorenzo G, 2010, VACCINE, V28, P2937, DOI 10.1016/j.vaccine.2010.02.018; Lorenzo G, 2008, VACCINE, V26, P5255, DOI 10.1016/j.vaccine.2008.07.042; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Magurano F, 1999, CLIN DIAGN LAB IMMUN, V6, P55, DOI 10.1128/CDLI.6.1.55-60.1999; Mandell RB, 2010, VIROLOGY, V397, P187, DOI 10.1016/j.virol.2009.11.001; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; Matsui H, 2002, J BIOL CHEM, V277, P50054, DOI 10.1074/jbc.M206562200; Mavoungou E, 2005, CLIN EXP IMMUNOL, V139, P287, DOI 10.1111/j.1365-2249.2004.02686.x; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; Meroni L, 2007, CLIN EXP IMMUNOL, V147, P53, DOI 10.1111/j.1365-2249.2006.03250.x; Miletic AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006599; Mollereau B, 1996, J IMMUNOL, V156, P3184; MORRILL JC, 1991, J INTERFERON RES, V11, P297, DOI 10.1089/jir.1991.11.297; MORRILL JC, 1990, ARCH VIROL, V110, P195, DOI 10.1007/BF01311288; Nguku P., 2007, Morbidity and Mortality Weekly Report, V56, P73; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x; Palmer MJ, 2008, CELL MOL IMMUNOL, V5, P79, DOI 10.1038/cmi.2008.10; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; PETERS CJ, 1988, ARCH VIROL, V99, P31, DOI 10.1007/BF01311021; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Qiao GL, 2008, MOL CELL BIOL, V28, P2470, DOI 10.1128/MCB.01505-07; Qiao GL, 2007, J IMMUNOL, V179, P4473, DOI 10.4049/jimmunol.179.7.4473; Renukaradhya GJ, 2005, J IMMUNOL, V175, P4301, DOI 10.4049/jimmunol.175.7.4301; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Sandrock M, 2001, J INTERF CYTOK RES, V21, P663, DOI 10.1089/107999001753124390; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Spencer CI, 2000, J MOL CELL CARDIOL, V32, P1285, DOI 10.1006/jmcc.2000.1162; Strauss JH, 2008, VIRUSES HUMAN DIS, P468; SWANEPOEL R, 1986, J HYG-CAMBRIDGE, V97, P331, DOI 10.1017/S0022172400065426; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; van Putten SM, 2009, BIOMATERIALS, V30, P730, DOI 10.1016/j.biomaterials.2008.10.043; van Vuren PJ, 2007, J VIROL METHODS, V140, P106, DOI 10.1016/j.jviromet.2006.11.005; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Wallace DB, 2006, VACCINE, V24, P7181, DOI 10.1016/j.vaccine.2006.06.041; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023; Wu MY, 2002, WORLD J GASTROENTERO, V8, P971, DOI 10.3748/wjg.v8.i6.971; Yu-Lee LY, 2002, RECENT PROG HORM RES, V57, P435, DOI 10.1210/rp.57.1.435; Zhang R, 2008, J IMMUNOL, V181, P5331, DOI 10.4049/jimmunol.181.8.5331; Zhao YM, 2008, CANCER BIOL THER, V7, P1867, DOI 10.4161/cbt.7.12.6945; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004; Zhu R, 2007, J IMMUNOL, V178, P5435, DOI 10.4049/jimmunol.178.9.5435	107	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25027	10.1371/journal.pone.0025027	http://dx.doi.org/10.1371/journal.pone.0025027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949840	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800059
J	van Wietmarschen, HA; Reijmers, TH; van der Kooij, AJ; Schroen, J; Wei, H; Hankemeier, T; Meulman, JJ; van der Greef, J				van Wietmarschen, Herman A.; Reijmers, Theo H.; van der Kooij, Anita J.; Schroen, Jan; Wei, Heng; Hankemeier, Thomas; Meulman, Jacqueline J.; van der Greef, Jan			Sub-Typing of Rheumatic Diseases Based on a Systems Diagnosis Questionnaire	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; MULTIVARIATE DATA; NETWORK ANALYSIS; ARTHRITIS; BIOLOGY; CLASSIFICATION; COMPONENTS; PROTEOMICS; SCIENCES; PATTERNS	Background: The future of personalized medicine depends on advanced diagnostic tools to characterize responders and non-responders to treatment. Systems diagnosis is a new approach which aims to capture a large amount of symptom information from patients to characterize relevant sub-groups. Methodology: 49 patients with a rheumatic disease were characterized using a systems diagnosis questionnaire containing 106 questions based on Chinese and Western medicine symptoms. Categorical principal component analysis (CATPCA) was used to discover differences in symptom patterns between the patients. Two Chinese medicine experts where subsequently asked to rank the Cold and Heat status of all the patients based on the questionnaires. These rankings were used to study the Cold and Heat symptoms used by these practitioners. Findings: The CATPCA analysis results in three dimensions. The first dimension is a general factor (40.2% explained variance). In the second dimension (12.5% explained variance) 'anxious', 'worrying', 'uneasy feeling' and 'distressed' were interpreted as the Internal disease stage, and 'aggravate in wind', 'fear of wind' and 'aversion to cold' as the External disease stage. In the third dimension (10.4% explained variance) 'panting s', 'superficial breathing', 'shortness of breath s', 'shortness of breath f' and 'aversion to cold' were interpreted as Cold and 'restless', 'nervous', 'warm feeling', 'dry mouth s' and 'thirst' as Heat related. 'Aversion to cold', 'fear of wind' and 'pain aggravates with cold' are most related to the experts Cold rankings and 'aversion to heat', 'fullness of chest' and 'dry mouth' to the Heat rankings. Conclusions: This study shows that the presented systems diagnosis questionnaire is able to identify groups of symptoms that are relevant for sub-typing patients with a rheumatic disease.	[van Wietmarschen, Herman A.; Reijmers, Theo H.; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, Div Analyt Biosci, LACDR, Leiden, Netherlands; [van Wietmarschen, Herman A.; Schroen, Jan; Wei, Heng; Hankemeier, Thomas; van der Greef, Jan] Sino Dutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [Reijmers, Theo H.; Hankemeier, Thomas] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [van der Kooij, Anita J.; Meulman, Jacqueline J.] Leiden Univ, Math Inst, Leiden, Netherlands; [Schroen, Jan] Oxrider Educ & Res, Nieuwegein, Netherlands; [Wei, Heng; van der Greef, Jan] TNO, NL-3700 AJ Zeist, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	van Wietmarschen, HA (corresponding author), Leiden Univ, Div Analyt Biosci, LACDR, Leiden, Netherlands.	h.vanwietmarschen@lacdr.leidenuniv.nl	Hankemeier, Thomas/V-5407-2019; van Wietmarschen, Herman/E-1806-2011	Hankemeier, Thomas/0000-0001-7871-2073; 	Netherlands Genomics Initiative; Chinese Academy of Sciences; Ministry of Science and Technology (China) [2009DFA41250, 2007DFA31060, 2006BAI11B07]; TNO (NL); Netherlands Metabolomics Center; Sino-Dutch Centre for Preventive and Personalized Medicine; National Genomics Initiative; Osteo- and Rheumatoid Arthritis Foundation (NL)	Netherlands Genomics Initiative; Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); TNO (NL); Netherlands Metabolomics Center; Sino-Dutch Centre for Preventive and Personalized Medicine; National Genomics Initiative; Osteo- and Rheumatoid Arthritis Foundation (NL)	This work was sponsored by the Netherlands Genomics Initiative, Chinese Academy of Sciences, Ministry of Science and Technology (China) (Grant No.: 2009DFA41250, 2007DFA31060, 2006BAI11B07), TNO (NL), Netherlands Metabolomics Center, The Sino-Dutch Centre for Preventive and Personalized Medicine, the National Genomics Initiative and the Osteo- and Rheumatoid Arthritis Foundation (NL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, NAT CLIN PRACT RHEUM, V1, P62, DOI 10.1038/ncprheum0050; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Ganter B, 2008, PHARMACOGENOMICS, V9, P35, DOI 10.2217/14622416.9.1.35; Gaston JSH, 2008, RHEUMATOLOGY, V47, P8, DOI 10.1093/rheumatology/kem203; Gifi A., 1990, NONLINEAR MULTIVARIA; Glocker MO, 2006, MED RES REV, V26, P63, DOI 10.1002/med.20045; Hendriks MMWB, 2007, PROTEOMICS, V7, P3672, DOI 10.1002/pmic.200700046; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Lindstrom B, 2005, J EPIDEMIOL COMMUN H, V59, P440, DOI 10.1136/jech.2005.034777; Lundy SK, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2107; Maciocia G., 2005, FDN CHINESE MED COMP; MEULMAN, 2004, SAGE HDB QUANTITATIV, pCH3; Meulman JJ, 2009, SPSS CATEGORIES 17 0; Ni M., 1995, YELLOW EMPERORS CLAS; Rindfleisch JA, 2005, AM FAM PHYSICIAN, V72, P1037; SAS Institute Inc., 2009, SAS STAT SOFTW; SAS INSTITUTE INC, 2009, SAS STAT 9 2 US GUID; SPSS Inc, 2009, PASW STAT 17 0; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Treharne GJ, 2007, BRIT J HEALTH PSYCH, V12, P323, DOI 10.1348/135910706X109288; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; van der Greef J, 2004, CURR OPIN CHEM BIOL, V8, P559, DOI 10.1016/j.cbpa.2004.08.013; van der Greef J, 2010, PLANTA MED, V76, P2036, DOI 10.1055/s-0030-1250450; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P1728, DOI 10.1002/art.22716; van Hoogmoed D, 2010, RHEUMATOLOGY, V49, P1294, DOI 10.1093/rheumatology/keq043; van Middendorp H, 2009, PSYCHOTHER PSYCHOSOM, V78, P145, DOI 10.1159/000206868; van Wietmarschen H, 2009, JCR-J CLIN RHEUMATOL, V15, P330, DOI 10.1097/RHU.0b013e3181ba3926; Vandeginste B.G.M., 1998, DATA HANDLING SCI TE, V20, P57, DOI [10.1016/S0922-3487(98)80040-3, DOI 10.1016/S0922-3487(98)80040-3]; VANGERMEERSCH L, 1994, BISYNDROMES; Verhoeckx KCM, 2004, INT IMMUNOPHARMACOL, V4, P1499, DOI 10.1016/j.intimp.2004.07.008; Wells GA, 2009, J RHEUMATOL, V36, P33, DOI 10.3899/jrheum.090129; YOUNG FW, 1978, PSYCHOMETRIKA, V43, P279, DOI 10.1007/BF02293871; Zhou XZ, 2007, ARTIF INTELL MED, V41, P87, DOI 10.1016/j.artmed.2007.07.007; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24846	10.1371/journal.pone.0024846	http://dx.doi.org/10.1371/journal.pone.0024846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	824BI	21949766	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800043
J	Dash, PK; Johnson, D; Clark, J; Orsi, SA; Zhang, M; Zhao, J; Grill, RJ; Moore, AN; Pati, S				Dash, Pramod K.; Johnson, Daniel; Clark, Jordan; Orsi, Sara A.; Zhang, Min; Zhao, Jing; Grill, Raymond J.; Moore, Anthony N.; Pati, Shibani			Involvement of the Glycogen Synthase Kinase-3 Signaling Pathway in TBI Pathology and Neurocognitive Outcome	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; SPATIAL MEMORY DEFICITS; N-ACETYL-ASPARTATE; INCREASED PHOSPHORYLATION; CHRONIC LITHIUM; NEURONAL DEATH; VALPROIC ACID; GRANULE CELLS; IN-VIVO	Background: Traumatic brain injury (TBI) sets in motion cascades of biochemical changes that result in delayed cell death and altered neuronal architecture. Studies have demonstrated that inhibition of glycogen synthase kinase-3 (GSK-3) effectively reduces apoptosis following a number of stimuli. The Wnt family of proteins, and growth factors are two major factors that regulate GSK-3 activity. In the absence of stimuli, GSK-3 is constitutively active and is complexed with Axin, adenomatous polyposis coli (APC), and casein kinase I alpha (CK1 alpha) and phosphorylates ss-Catenin leading to its degradation. Binding of Wnt to Frizzled receptors causes the translocation of GSK-3 to the plasma membrane, where it phosphorylates and inactivates the Frizzled co-receptor lipoprotein-related protein 6 (LRP6). Furthermore, the translocation of GSK-3 reduces ss-Catenin phosphorylation and degradation, leading to ss-Catenin accumulation and gene expression. Growth factors activate Akt, which in turn inhibits GSK-3 activity by direct phosphorylation, leading to a reduction in apoptosis. Methodology/Principal Findings: Using a rodent model, we found that TBI caused a rapid, but transient, increase in LRP6 phosphorylation that is followed by a modest decrease in ss-Catenin phosphorylation. Phospho-GSK-3 beta immunoreactivity was found to increase three days post injury, a time point at which increased Akt activity following TBI has been observed. Lithium influences several neurochemical cascades, including inhibiting GSK-3. When the efficacy of daily lithium was assessed, reduced hippocampal neuronal cell loss and learning and memory improvements were observed. These influences were partially mimicked by administration of the GSK-3-selective inhibitor SB-216763, as this drug resulted in improved motor function, but only a modest improvement in memory retention and no overt neuroprotection. Conclusion/Significance: Taken together, our findings suggest that selective inhibition of GSK-3 may offer partial cognitive improvement. As a broad spectrum inhibitor of GSK-3, lithium offers neuroprotection and robust cognitive improvement, supporting its clinical testing as a treatment for TBI.	[Dash, Pramod K.; Johnson, Daniel; Clark, Jordan; Orsi, Sara A.; Zhang, Min; Zhao, Jing; Moore, Anthony N.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrated Biol & Pharmacol, Houston, TX USA; [Pati, Shibani] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Dash, PK (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA.	P.Dash@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	Department of Defense [W81XWH-08-2-0134, W81XWH-08-2-0150]	Department of Defense(United States Department of Defense)	This research was made possible by funding support from the Department of Defense (W81XWH-08-2-0134 and W81XWH-08-2-0150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam SY, 2007, CURR ALZHEIMER RES, V4, P21; ATACK JR, 1992, J NEUROCHEM, V59, P1946, DOI 10.1111/j.1471-4159.1992.tb11031.x; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Castro AA, 2009, PEPTIDES, V30, P1914, DOI 10.1016/j.peptides.2009.07.004; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; de Sousa RT, 2011, NEUROSCI LETT, V494, P54, DOI 10.1016/j.neulet.2011.02.054; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Facci L, 2003, NEUROREPORT, V14, P1467, DOI 10.1097/00001756-200308060-00012; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Grandjean EM, 2009, CNS DRUGS, V23, P397, DOI 10.2165/00023210-200923050-00004; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Haddad PM, 2009, EXPERT OPIN DRUG MET, V5, P539, DOI [10.1517/17425250902911455 , 10.1517/17425250902911455]; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Hayes RL, 1998, DRUG NEWS PERSPECT, V11, P215; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Lin D, 2006, CNS DRUGS, V20, P29, DOI 10.2165/00023210-200620010-00003; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Moore GJ, 2000, BIOL PSYCHIAT, V48, P1, DOI 10.1016/S0006-3223(00)00252-3; Mora A, 2001, J NEUROCHEM, V78, P199, DOI 10.1046/j.1471-4159.2001.00410.x; Neary JT, 2006, J NEUROSCI RES, V84, P515, DOI 10.1002/jnr.20969; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Silverstone PH, 2003, INT CLIN PSYCHOPHARM, V18, P73, DOI 10.1097/00004850-200303000-00002; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Spiegelberg BD, 1999, J BIOL CHEM, V274, P13619, DOI 10.1074/jbc.274.19.13619; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sullivan PG, 1999, J NEUROSCI, V19, P6248; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takadera T, 2004, EUR J PHARMACOL, V499, P239, DOI 10.1016/j.ejphar.2004.07.115; Takadera T, 2004, BRAIN RES, V1020, P196, DOI 10.1016/j.brainres.2004.06.035; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WRAAE O, 1978, BRIT J PHARMACOL, V64, P273, DOI 10.1111/j.1476-5381.1978.tb17300.x; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	70	66	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24648	10.1371/journal.pone.0024648	http://dx.doi.org/10.1371/journal.pone.0024648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935433	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700046
J	Kuwano, Y; Kamio, Y; Kawai, T; Katsuura, S; Inada, N; Takaki, A; Rokutan, K				Kuwano, Yuki; Kamio, Yoko; Kawai, Tomoko; Katsuura, Sakurako; Inada, Naoko; Takaki, Akiko; Rokutan, Kazuhito			Autism-Associated Gene Expression in Peripheral Leucocytes Commonly Observed between Subjects with Autism and Healthy Women Having Autistic Children	PLOS ONE			English	Article							LYMPHOBLASTOID CELL-LINES; SEVERE MENTAL-RETARDATION; RECEPTOR TYROSINE KINASE; SUBUNIT GENES; RETT-SYNDROME; MECP2 GENE; LINKAGE; VARIANTS; SUSCEPTIBILITY; IDENTIFICATION	Autism spectrum disorder (ASD) is a severe neuropsychiatric disorder which has complex pathobiology with profound influences of genetic factors in its development. Although the numerous autism susceptible genes were identified, the etiology of autism is not fully explained. Using DNA microarray, we examined gene expression profiling in peripheral blood from 21 individuals in each of the four groups; young adults with ASD, age-and gender-matched healthy subjects (ASD control), healthy mothers having children with ASD (asdMO), and asdMO control. There was no blood relationship between ASD and asdMO. Comparing the ASD group with control, 19 genes were found to be significantly changed. These genes were mainly involved in cell morphology, cellular assembly and organization, and nerve system development and function. In addition, the asdMO group possessed a unique gene expression signature shown as significant alterations of protein synthesis despite of their nonautistic diagnostic status. Moreover, an ASD-associated gene expression signature was commonly observed in both individuals with ASD and asdMO. This unique gene expression profiling detected in peripheral leukocytes from affected subjects with ASD and unaffected mothers having ASD children suggest that a genetic predisposition to ASD may be detectable even in peripheral cells. Altered expression of several autism candidate genes such as FMR-1 and MECP2, could be detected in leukocytes. Taken together, these findings suggest that the ASD-associated genes identified in leukocytes are informative to explore the genetic, epigenetic, and environmental background of ASD and might become potential tools to assess the crucial factors related to the clinical onset of the disorder.	[Kuwano, Yuki; Kawai, Tomoko; Katsuura, Sakurako; Rokutan, Kazuhito] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, Tokushima 770, Japan; [Kamio, Yoko; Inada, Naoko] Natl Ctr Neurol & Psychiat, Natl Inst Psychiat, Dept Child & Adolescent Mental Hlth, Tokyo, Japan; [Takaki, Akiko] Natl Rehabil Ctr Persons Disabil, Clin Intellectually Disabled Children, Saitama, Japan; [Takaki, Akiko] Natl Rehabil Ctr Persons Disabil, Chichibu Gakuen Inst, Saitama, Japan	Tokushima University; National Center for Neurology & Psychiatry - Japan	Kuwano, Y (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, Tokushima 770, Japan.	kuwanoy@basic.med.tokushima-u.ac.jp		Kawai, Tomoko/0000-0001-8137-0334	Japan Society for the Promotion of Science (JSPS) [10016093, 10003128]; Grants-in-Aid for Scientific Research [22591311, 22390146] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from Grants-in-Aid for Young Scientists B (10016093) from Japan Society for the Promotion of Science (JSPS) (to YK), and from Grants-in-Aid for Scientific Research B (10003128) from the JSPS (to KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baron CA, 2006, J AUTISM DEV DISORD, V36, P973, DOI 10.1007/s10803-006-0134-x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bittel DC, 2007, GENET MED, V9, P464, DOI 10.1097/GIM.0b013e3180ca9a9a; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; BRAY PF, 1988, P NATL ACAD SCI USA, V85, P8683, DOI 10.1073/pnas.85.22.8683; Caldarola S, 2009, FEBS J, V276, P3199, DOI 10.1111/j.1742-4658.2009.07036.x; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Ingram JL, 2000, TERATOLOGY, V62, P393, DOI 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; Judson MC, 2009, J COMP NEUROL, V513, P511, DOI 10.1002/cne.21969; Kamio Y, 2006, J AUTISM DEV DISORD, V36, P155, DOI 10.1007/s10803-005-0056-z; Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117; Kurita H, 2005, PSYCHIAT CLIN NEUROS, V59, P490, DOI 10.1111/j.1440-1819.2005.01403.x; Lauritsen MB, 2001, ACTA PSYCHIAT SCAND, V103, P411, DOI 10.1034/j.1600-0447.2001.00086.x; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Loat CS, 2008, GENES BRAIN BEHAV, V7, P754, DOI 10.1111/j.1601-183X.2008.00414.x; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Sutcliffe JS, 2008, SCIENCE, V321, P208, DOI 10.1126/science.1160555; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Twiss JL, 2009, TRENDS CELL BIOL, V19, P236, DOI 10.1016/j.tcb.2009.02.007; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wassink TH, 2001, AM J MED GENET, V105, P406, DOI 10.1002/ajmg.1401; Weiss LA, 2006, HUM GENET, V120, P93, DOI 10.1007/s00439-006-0196-z; Zappella M, 2003, AM J MED GENET B, V119B, P102, DOI 10.1002/ajmg.b.10070	43	53	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24723	10.1371/journal.pone.0024723	http://dx.doi.org/10.1371/journal.pone.0024723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935445	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700052
J	Chen, KJ; Lin, SZ; Zhou, L; Xie, HY; Zhou, WH; Taki-Eldin, A; Zheng, SS				Chen, Kang-Jie; Lin, Sheng-Zhang; Zhou, Lin; Xie, Hai-Yang; Zhou, Wu-Hua; Taki-Eldin, Ahmed; Zheng, Shu-Sen			Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CHEMOKINES; MIGRATION; COMPARTMENTALIZATION; EXPRESSION; LIVER	Background: Regulatory T cells (Tregs) are highly prevalent in tumor tissue and can suppress effective anti-tumor immune responses. However, the source of the increased tumor-infiltrating Tregs and their contribution to cancer progression remain poorly understood. Methodology/Principal Finding: We here investigated the frequency, phenotype and trafficking property of Tregs and their prognostic value in patients with hepatocellular carcinoma (HCC). Our results showed that FoxP3(+) Tregs highly aggregated and were in an activated phenotype (CD69(+)HLA-DRhigh) in the tumor site, where they can suppress the proliferation and INF-gamma secretion of CD4(+)CD25(-) T cells. These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20. In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P = 0.011) and tumor differentiation (P = 0.003), and was an independent prognostic factor for overall survival (HR = 2.408, P = 0.013) and disease-free survival (HR = 2.204, P = 0.041). The increased tumor-infiltrating Tregs predicted poorer prognosis in HCC patients. Conclusions: The CCL20-CCR6 axis mediates the migration of circulating Tregs into tumor microenvironment, which in turn results in tumor progression and poor prognosis in HCC patients. Thus, blocking CCL20-CCR6 axis-mediated Treg migration may be a novel therapeutic target for HCC.	[Chen, Kang-Jie; Lin, Sheng-Zhang; Zhou, Lin; Xie, Hai-Yang; Zhou, Wu-Hua; Taki-Eldin, Ahmed; Zheng, Shu-Sen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Sheng-Zhang] Second Affiliated Hosp, Wenzhou Med Coll, Dept Gen Surg, Wenzhou, Peoples R China	Zhejiang University; Wenzhou Medical University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China.	zysxswzsz@zju.edu.cn	Taki-Eldin, Ahmed/AAF-9788-2021		Major State Basic Research Development Program [2009CB522403]; Major National ST Program [2008ZX10002-026]; National Natural Science Foundation of China [30730085]	Major State Basic Research Development Program(National Basic Research Program of China); Major National ST Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Major State Basic Research Development Program (No. 2009CB522403), the Major National S&T Program (No. 2008ZX10002-026) and the Key Program of National Natural Science Foundation of China (No. 30730085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Enarsson K, 2006, CLIN IMMUNOL, V121, P358, DOI 10.1016/j.clim.2006.07.002; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Lu J, 2010, J PATHOL, V222, P199, DOI 10.1002/path.2754; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Wilke CM, 2010, INT J CANCER, V127, P748, DOI 10.1002/ijc.25464; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XH, 2006, J HEPATOL, V45, P254, DOI 10.1016/j.jhep.2006.01.036; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Zhou J, 2009, INT J CANCER, V125, P1640, DOI 10.1002/ijc.24556; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	37	153	161	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24671	10.1371/journal.pone.0024671	http://dx.doi.org/10.1371/journal.pone.0024671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935436	Green Submitted, Green Published, gold			2022-12-25	WOS:000295039700034
J	Brown, RV; Danford, FL; Gokhale, V; Hurley, LH; Brooks, TA				Brown, Robert V.; Danford, Forest L.; Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.			Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN C-MYC; NUCLEASE HYPERSENSITIVE ELEMENT; ACID-BINDING-PROTEIN; TETRAPLEX FORMATION; Z-DNA; EXPRESSION; ONCOGENE; GENE; REGION; IDENTIFICATION	Most transcription of the MITC proto-oncogene initiates in the near upstream promoter, within which lies the nuclease hypersensitive element (NHE) III1 region containing the CT-element. This dynamic stretch of DNA can form at least three different topologies: single-stranded DNA, double-stranded DNA, or higher order secondary structures that silence transcription. In the current report, we identify the ellipticine analog GQC-05 (NSC338258) as a high affinity, potent, and selective stabilizer of the MYC G-quadruplex (G4). In cells, GQC-05 induced cytotoxicity with corresponding decreased MYC mRNA and altered protein binding to the NHE III1 region, in agreement with a G4 stabilizing compound. We further describe a unique feature of the Burkitt's lymphoma cell line CA46 that allowed us to clearly demonstrate the mechanism and location of action of GQC-05 within this region of DNA and through the G4. Most importantly, these data present, as far as we are aware, the most direct evidence of intracellular G4-mediated control of a particular promoter.	[Brown, Robert V.; Danford, Forest L.; Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; Arizona Center Cancer Care; University of Arizona	Brooks, TA (corresponding author), 1657 E Helen St,Room 421, Tucson, AZ 85721 USA.	brooks@pharmacy.arizona.edu			National Institutes of Health [GM085585]; Leukemia & Lymphoma Society [6225-8]; National Foundation for Cancer Research [VONHOFF0601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM085585. This work was also supported by grants from the Leukemia & Lymphoma Society (6225-8) and the National Foundation for Cancer Research (VONHOFF0601).	Alarcon-Vargas D, 2004, J BIOL CHEM, V279, P5008, DOI 10.1074/jbc.M312054200; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; BAZAR L, 1995, J BIOL CHEM, V270, P8241, DOI 10.1074/jbc.270.14.8241; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Brooks Tracy A, 2010, Genes Cancer, V1, P641; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Chaires J. B., 2003, CURR PROTOC NUCL ACI, P831; Cheng M, 1999, J BIOL CHEM, V274, P6553, DOI 10.1074/jbc.274.10.6553; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dang Chi V, 2010, Genes Cancer, V1, P526; Dang CV, 1995, C MYC FUNCTION NEOPL; De Cian A, 2007, METHODS, V42, P183, DOI 10.1016/j.ymeth.2006.10.004; Dexheimer TS, 2009, MOL CANCER THER, V8, P1363, DOI 10.1158/1535-7163.MCT-08-1093; FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746; Fernando H, 2008, BIOCHEMISTRY-US, V47, P9365, DOI 10.1021/bi800983u; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Izbicka E, 1999, CANCER RES, V59, P639; Kang HJ, 2009, BIOCHEMISTRY-US, V48, P7392, DOI 10.1021/bi9006836; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Mathur V, 2004, BIOCHEM BIOPH RES CO, V320, P1220, DOI 10.1016/j.bbrc.2004.06.074; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Qin Y, 2010, BIOCHEMISTRY-US, V49, P4208, DOI 10.1021/bi100330w; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; SHOWE LC, 1985, MOL CELL BIOL, V5, P501, DOI 10.1128/MCB.5.3.501; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; TOFFOLI G, 1989, LEUKEMIA RES, V13, P279, DOI 10.1016/0145-2126(89)90064-7; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; WITTIG B, 1992, EMBO J, V11, P4653, DOI 10.1002/j.1460-2075.1992.tb05567.x; WITTIG B, 1991, P NATL ACAD SCI USA, V88, P2259, DOI 10.1073/pnas.88.6.2259; Wolfl S, 1997, BBA-GENE STRUCT EXPR, V1352, P213, DOI 10.1016/S0167-4781(97)00015-8; Zimonjic DB, 2001, LEUKEMIA, V15, P1582, DOI 10.1038/sj.leu.2402281	56	129	131	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41018	41027		10.1074/jbc.M111.274720	http://dx.doi.org/10.1074/jbc.M111.274720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956115	Green Published, hybrid			2022-12-25	WOS:000297315400061
J	Tang, HZ; Yao, YX; Zhang, DK; Meng, XZ; Wang, LJ; Yu, H; Ma, LY; Xu, P				Tang, Hongzhi; Yao, Yuxiang; Zhang, Dake; Meng, Xiangzhou; Wang, Lijuan; Yu, Hao; Ma, Lanying; Xu, Ping			A Novel NADH-dependent and FAD-containing Hydroxylase Is Crucial for Nicotine Degradation by Pseudomonas putida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASTE; GENE; BIODEGRADATION; PURIFICATION; PROTEINS	Nicotine, the main alkaloid produced by Nicotiana tabacum and other Solanaceae, is very toxic and may be a leading toxicant causing preventable disease and death, with the rise in global tobacco consumption. Several different microbial pathways of nicotine metabolism have been reported: Arthrobacter uses the pyridine pathway, and Pseudomonas, like mammals, uses the pyrrolidine pathway. We identified and characterized a novel 6-hydroxy-3-succinoyl-pyridine (HSP) hydroxylase (HspB) using enzyme purification, peptide sequencing, and sequencing of the Pseudomonas putida S16 genome. The HSP hydroxylase has no known orthologs and converts HSP to 2,5-dihydroxy-pyridine and succinic semialdehyde, using NADH. O-18(2) labeling experiments provided direct evidence for the incorporation of oxygen from O-2 into 2,5-dihydroxy-pyridine. The hspB gene deletion showed that this enzyme is essential for nicotine degradation, and site-directed mutagenesis identified an FAD-binding domain. This study demonstrates the importance of the newly discovered enzyme HspB, which is crucial for nicotine degradation by the Pseudomonas strain.	[Tang, Hongzhi; Yao, Yuxiang; Meng, Xiangzhou; Wang, Lijuan; Yu, Hao; Ma, Lanying; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Tang, Hongzhi; Yao, Yuxiang; Meng, Xiangzhou; Wang, Lijuan; Yu, Hao; Ma, Lanying; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Zhang, Dake] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Xu, P (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.	pingxu@sjtu.edu.cn	Meng, Xiangzhou/M-1583-2019; Zhang, Dake/H-3210-2019	Meng, Xiangzhou/0000-0003-2827-7661; Zhang, Dake/0000-0001-9508-8209	Chinese National Natural Science Foundation [30900042, 30821005]; Ministry of Science and Technology of China [2009CB118906]; Shanghai Municipal Education Commission [10CG10]; Key Basic Research Program of Shanghai [09JC1407700]; Shanghai Education Development Foundation	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Key Basic Research Program of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Education Development Foundation	This work was supported in part by Chinese National Natural Science Foundation Grants 30900042 and 30821005 and from Ministry of Science and Technology of China National Basic Research Program Grant 2009CB118906. This work was also supported by Key Basic Research Program of Shanghai Grant 09JC1407700 and Grant 10CG10 from the Chen Guang Project from the Shanghai Municipal Education Commission and the Shanghai Education Development Foundation.	Brandsch R, 2006, APPL MICROBIOL BIOT, V69, P493, DOI 10.1007/s00253-005-0226-0; Civilini M, 1997, WASTE MANAGE RES, V15, P349, DOI 10.1177/0734242X9701500403; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diaz E, 2004, INT MICROBIOL, V7, P173; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Eberhardt Hans-Jochen, 1995, Beitraege zur Tabakforschung International, V16, P119; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; GRIFFITH IP, 1972, BIOCHEM J, V126, P553, DOI 10.1042/bj1260553; Hecht SS, 2000, P NATL ACAD SCI USA, V97, P12493, DOI 10.1073/pnas.220207697; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Hunter GR, 2000, MOL BIOCHEM PARASIT, V105, P203, DOI 10.1016/S0166-6851(99)00176-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HJ, 2010, APPL MICROBIOL BIOT, V86, P11, DOI 10.1007/s00253-009-2427-4; Meng XJ, 2010, RES MICROBIOL, V161, P626, DOI 10.1016/j.resmic.2010.05.017; Nakano H, 1999, EUR J BIOCHEM, V260, P120, DOI 10.1046/j.1432-1327.1999.00124.x; Novotny TE, 1999, TOB CONTROL, V8, P75, DOI 10.1136/tc.8.1.75; Sambrook J, 2001, MOL CLONING LAB MANU; Tang HZ, 2008, APPL ENVIRON MICROB, V74, P1567, DOI 10.1128/AEM.02529-07; Tang HZ, 2009, APPL ENVIRON MICROB, V75, P772, DOI 10.1128/AEM.02300-08; Tao F, 2006, APPL ENVIRON MICROB, V72, P4604, DOI 10.1128/AEM.00081-06; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wang SN, 2005, ENVIRON SCI TECHNOL, V39, P6877, DOI 10.1021/es0500759; Wang SN, 2004, BIOTECHNOL LETT, V26, P1493, DOI 10.1023/B:BILE.0000044450.16235.65; Wei Q, 2010, BIODEGRADATION, V21, P575, DOI 10.1007/s10532-009-9325-4; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	26	52	60	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39179	39187		10.1074/jbc.M111.283929	http://dx.doi.org/10.1074/jbc.M111.283929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949128	hybrid, Green Published			2022-12-25	WOS:000296759800037
J	Prandovszky, E; Gaskell, E; Martin, H; Dubey, JP; Webster, JP; McConkey, GA				Prandovszky, Emese; Gaskell, Elizabeth; Martin, Heather; Dubey, J. P.; Webster, Joanne P.; McConkey, Glenn A.			The Neurotropic Parasite Toxoplasma Gondii Increases Dopamine Metabolism	PLOS ONE			English	Article							SCHIZOPHRENIA; INFECTION; CELLS; RATS; MICE; BEHAVIOR; NEURONS; STORAGE; IMPACT; RISK	The highly prevalent parasite Toxoplasma gondii manipulates its host's behavior. In infected rodents, the behavioral changes increase the likelihood that the parasite will be transmitted back to its definitive cat host, an essential step in completion of the parasite's life cycle. The mechanism(s) responsible for behavioral changes in the host is unknown but two lines of published evidence suggest that the parasite alters neurotransmitter signal transduction: the disruption of the parasite-induced behavioral changes with medications used to treat psychiatric disease (specifically dopamine antagonists) and identification of a tyrosine hydroxylase encoded in the parasite genome. In this study, infection of mammalian dopaminergic cells with T. gondii enhanced the levels of K+-induced release of dopamine several-fold, with a direct correlation between the number of infected cells and the quantity of dopamine released. Immunostaining brain sections of infected mice with dopamine antibody showed intense staining of encysted parasites. Based on these analyses, T. gondii orchestrates a significant increase in dopamine metabolism in neural cells. Tyrosine hydroxylase, the rate-limiting enzyme for dopamine synthesis, was also found in intracellular tissue cysts in brain tissue with antibodies specific for the parasite-encoded tyrosine hydroxylase. These observations provide a mechanism for parasite-induced behavioral changes. The observed effects on dopamine metabolism could also be relevant in interpreting reports of psychobehavioral changes in toxoplasmosis-infected humans.	[Prandovszky, Emese; Gaskell, Elizabeth; Martin, Heather; McConkey, Glenn A.] Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Dubey, J. P.] ARS, Anim Parasit Dis Lab, USDA, ANRI,BARC E, Beltsville, MD USA; [Webster, Joanne P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, London, England	University of Leeds; United States Department of Agriculture (USDA); Imperial College London	Prandovszky, E (corresponding author), Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	G.A.McConkey@Leeds.ac.uk	McConkey, Glenn A./I-4062-2019	McConkey, Glenn/0000-0001-6529-794X; Webster, Joanne P./0000-0001-8616-4919; Martin, Heather/0000-0002-5455-4434	Stanley Medical Research Institute; USDA [CRIS 1265-32000-076]; BBSRC [BB/D524875/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish	Stanley Medical Research Institute; USDA(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the Stanley Medical Research Institute (to JPW, GAM) and the USDA CRIS 1265-32000-076 (to JPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; BREIER A, 1992, ARCH GEN PSYCHIAT, V49, P921; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brynska A, 2001, EUR CHILD ADOLES PSY, V10, P200, DOI 10.1007/s007870170027; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Coppin A, 2003, BIOCHIMIE, V85, P353, DOI 10.1016/S0300-9084(03)00076-2; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; FERGUSON DJP, 1991, INT J EXP PATHOL, V72, P463; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; Horacek J., 2011, WORLD J BIOL PSYCHIA; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Lagrue C, 2010, VET J, V184, P9, DOI 10.1016/j.tvjl.2009.01.015; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; Lefevre T, 2009, ADV PARASIT, V68, P45, DOI 10.1016/S0065-308X(08)00603-9; LENT CM, 1982, HISTOCHEMISTRY, V75, P77, DOI 10.1007/BF00492535; Melzer TC, 2010, J NEUROPARASITOLOGY, V1; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Mortensen PB, 2007, SCHIZOPHRENIA BULL, V33, P741, DOI 10.1093/schbul/sbm009; Ogawa N, 2005, J NEUROL, V252, P23, DOI 10.1007/s00415-005-4006-7; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Silva NM, 2002, INFECT IMMUN, V70, P859, DOI 10.1128/IAI.70.2.859-868.2002; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Yamboliev IA, 2009, EUR J NEUROSCI, V30, P756, DOI 10.1111/j.1460-9568.2009.06869.x	34	300	312	1	205	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e23866	10.1371/journal.pone.0023866	http://dx.doi.org/10.1371/journal.pone.0023866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957440	Green Published, gold			2022-12-25	WOS:000295262100003
J	Yu, JD; Qian, H; Chen, N; Wang, JH				Yu, Jiandong; Qian, Hao; Chen, Na; Wang, Jin-Hui			Quantal Glutamate Release Is Essential for Reliable Neuronal Encodings in Cerebral Networks	PLOS ONE			English	Article							KISS-AND-RUN; SYNAPTIC-TRANSMISSION; DEPENDENT PLASTICITY; THRESHOLD POTENTIALS; REFRACTORY PERIODS; SEQUENTIAL SPIKES; UNITARY SYNAPSES; FACILITATION; CALCIUM; TRANSPORTERS	Background: The neurons and synapses work coordinately to program the brain codes of controlling cognition and behaviors. Spike patterns at the presynaptic neurons regulate synaptic transmission. The quantitative regulations of synapse dynamics in spike encoding at the postsynaptic neurons remain unclear. Methodology/Principal Findings: With dual whole-cell recordings at synapse-paired cells in mouse cortical slices, we have investigated the regulation of synapse dynamics to neuronal spike encoding at cerebral circuits assembled by pyramidal neurons and GABAergic ones. Our studies at unitary synapses show that postsynaptic responses are constant over time, such as glutamate receptor-channel currents at GABAergic neurons and glutamate transport currents at astrocytes, indicating quantal glutamate release. In terms of its physiological impact, our results demonstrate that the signals integrated from quantal glutamatergic synapses drive spike encoding at GABAergic neurons reliably, which in turn precisely set spike encoding at pyramidal neurons through feedback inhibition. Conclusion/Significance: Our studies provide the evidences for the quantal glutamate release to drive the spike encodings precisely in cortical circuits, which may be essential for programming the reliable codes in the brain to manage well-organized behaviors.	[Yu, Jiandong; Qian, Hao; Chen, Na; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Yu, Jiandong; Qian, Hao; Wang, Jin-Hui] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, JD (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	jhw@sun5.ibp.ac.cn	QIAN, HAO/AAE-6741-2020	QIAN, HAO/0000-0001-5771-5865	National Basic Research Program [2011CB504405]; Natural Science Foundation China [30870517, 30990261]; National Award for Outstanding Young Scientist [30325021]	National Basic Research Program(National Basic Research Program of China); Natural Science Foundation China(National Natural Science Foundation of China (NSFC)); National Award for Outstanding Young Scientist	This study is granted by National Basic Research Program (2011CB504405), Natural Science Foundation China (30870517 and 30990261) and the National Award for Outstanding Young Scientist (30325021) to JHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; BLISS T V P, 1988, P3; Bridges RJ, 2005, PHARMACOL THERAPEUT, V107, P271, DOI 10.1016/j.pharmthera.2005.01.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campanac E, 2007, ARCH ITAL BIOL, V145, P277; Chen CF, 1999, J NEUROSCI, V19, P6257; Chen G, 2004, P NATL ACAD SCI USA, V101, P1063, DOI 10.1073/pnas.0307149101; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P938, DOI 10.1016/j.bbrc.2006.06.003; Chen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011868; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debanne Dominique, 2010, Front Synaptic Neurosci, V2, P21, DOI 10.3389/fnsyn.2010.00021; Franks KM, 2003, J NEUROSCI, V23, P3186; Fykse EM, 1996, NEUROCHEM RES, V21, P1053, DOI 10.1007/BF02532415; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Grillner S, 2005, TRENDS NEUROSCI, V28, P525, DOI 10.1016/j.tins.2005.08.003; He LM, 2007, TRENDS NEUROSCI, V30, P447, DOI 10.1016/j.tins.2007.06.012; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Katz B., 1969, RELEASE NEURAL TRANS; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Ni H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013736; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Regehr WG, 2001, PHYSL SYNAPTIC TRANS; Reimer RJ, 2001, CURR OPIN CELL BIOL, V13, P417, DOI 10.1016/S0955-0674(00)00230-1; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Toledo-Rodriguez M, 2005, TRENDS NEUROSCI, V28, P534, DOI 10.1016/j.tins.2005.08.001; Trappenburg TP, 2002, SPIKING NEURONS RESP, P39; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; TSIEN RW, 1991, ANN NY ACAD SCI, V635, P208, DOI 10.1111/j.1749-6632.1991.tb36493.x; Wadiche JI, 2006, P NATL ACAD SCI USA, V103, P1083, DOI 10.1073/pnas.0510476103; Wang JH, 1996, J NEUROPHYSIOL, V76, P276, DOI 10.1152/jn.1996.76.1.276; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wang L, 2005, J NEUROSCI RES, V82, P778, DOI 10.1002/jnr.20694; Wang LY, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-36; Wang LY, 2000, J NEUROSCI, V20; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007; Zhang M, 2004, J NEUROBIOL, V61, P277, DOI 10.1002/neu.20045; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	54	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25219	10.1371/journal.pone.0025219	http://dx.doi.org/10.1371/journal.pone.0025219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949885	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400054
J	Godinot, C; Houlbreque, F; Grover, R; Ferrier-Pages, C				Godinot, Claire; Houlbreque, Fanny; Grover, Renaud; Ferrier-Pages, Christine			Coral Uptake of Inorganic Phosphorus and Nitrogen Negatively Affected by Simultaneous Changes in Temperature and pH	PLOS ONE			English	Article							DEPENDENT GLUTAMATE-DEHYDROGENASE; NUTRIENT-UPTAKE KINETICS; OCEAN ACIDIFICATION; PHOSPHATE-UPTAKE; CLIMATE-CHANGE; ELEVATED CO2; STYLOPHORA-PISTILLATA; AMMONIUM ASSIMILATION; SCLERACTINIAN CORALS; ZOOXANTHELLATE CORAL	The effects of ocean acidification and elevated seawater temperature on coral calcification and photosynthesis have been extensively investigated over the last two decades, whereas they are still unknown on nutrient uptake, despite their importance for coral energetics. We therefore studied the separate and combined impacts of increases in temperature and pCO(2) on phosphate, ammonium, and nitrate uptake rates by the scleractinian coral S. pistillata. Three experiments were performed, during 10 days i) at three pHT conditions (8.1, 7.8, and 7.5) and normal temperature (26 degrees C), ii) at three temperature conditions (26 degrees, 29 degrees C, and 33 degrees C) and normal pH(T) (8.1), and iii) at three pH(T) conditions (8.1, 7.8, and 7.5) and elevated temperature (33 degrees C). After 10 days of incubation, corals had not bleached, as protein, chlorophyll, and zooxanthellae contents were the same in all treatments. However, photosynthetic rates significantly decreased at 33 degrees C, and were further reduced for the pH(T) 7.5. The photosynthetic efficiency of PSII was only decreased by elevated temperature. Nutrient uptake rates were not affected by a change in pH alone. Conversely, elevated temperature (33 degrees C) alone induced an increase in phosphate uptake but a severe decrease in nitrate and ammonium uptake rates, even leading to a release of nitrogen into seawater. Combination of high temperature (33 degrees C) and low pH(T) (7.5) resulted in a significant decrease in phosphate and nitrate uptake rates compared to control corals (26 degrees C, pH(T) = 8.1). These results indicate that both inorganic nitrogen and phosphorus metabolism may be negatively affected by the cumulative effects of ocean warming and acidification.	[Godinot, Claire; Grover, Renaud; Ferrier-Pages, Christine] Ctr Sci Monaco, Monaco, Monaco; [Houlbreque, Fanny] IAEA, Marine Environm Labs, Monaco, Monaco; [Houlbreque, Fanny] Inst Rech Dev, Noumea, New Caledonia	Institut de Recherche pour le Developpement (IRD)	Godinot, C (corresponding author), Ctr Sci Monaco, Monaco, Monaco.	cgodinot@centrescientifique.mc	Houlbreque, Fanny/L-9072-2017	Houlbreque, Fanny/0000-0002-3976-6690; Godinot, Claire/0000-0002-6792-7930; Ferrier-Pages, Christine/0000-0002-0357-4486	government of the Principality of Monaco; CSM; IAEA	government of the Principality of Monaco; CSM; IAEA(International Atomic Energy Agency)	This research was funded by the government of the Principality of Monaco, the CSM (http://www.centrescientifique.mc/), and the IAEA (http://www.iaea.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; AlMoghrabi S, 1996, J EXP MAR BIOL ECOL, V199, P227, DOI 10.1016/0022-0981(95)00202-2; Aminot A., 2007, DOSAGE AUTOMATIQUE N; ANDERSON SL, 1987, MAR BIOL, V94, P451, DOI 10.1007/BF00428252; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; BURRIS JE, 1983, MAR BIOL, V75, P113, DOI 10.1007/BF00405992; Bythell J.C., 1988, P535; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; CATMULL J, 1987, MAR BIOL, V95, P559, DOI 10.1007/BF00393099; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; CONROY JP, 1990, PLANT PHYSIOL, V92, P977, DOI 10.1104/pp.92.4.977; Cotrufo MF, 1998, GLOBAL CHANGE BIOL, V4, P43, DOI 10.1046/j.1365-2486.1998.00101.x; CROSSLAND CJ, 1983, AUST J MAR FRESH RES, V34, P835; Cui LJ, 2006, PLANT GROWTH REGUL, V49, P127, DOI 10.1007/s10725-006-9002-0; DELIA CF, 1977, LIMNOL OCEANOGR, V22, P301, DOI 10.4319/lo.1977.22.2.0301; DELIA CF, 1983, MAR BIOL, V75, P157, DOI 10.1007/BF00405998; DELIA CF, 1988, LIMNOL OCEANOGR, V33, P1153, DOI 10.4319/lo.1988.33.5.1153; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DOMOTOR SL, 1984, MAR BIOL, V80, P93, DOI 10.1007/BF00393132; Dove S, 2004, MAR ECOL PROG SER, V272, P99, DOI 10.3354/meps272099; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; ERTAN H, 1992, ARCH MICROBIOL, V158, P35, DOI 10.1007/BF00249063; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fersht AR., 1977, ENZYME STRUCTURE MEC; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; FITT WK, 1995, LIMNOL OCEANOGR, V40, P976, DOI 10.4319/lo.1995.40.5.0976; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Gerencser GA, 2002, ZOOL SCI, V19, P163, DOI 10.2108/zsj.19.163; Godinot C, 2009, LIMNOL OCEANOGR, V54, P1627, DOI 10.4319/lo.2009.54.5.1627; Godinot C, 2011, J EXP BIOL, V214, P2749, DOI 10.1242/jeb.054239; Goiran C, 1996, J EXP MAR BIOL ECOL, V199, P207, DOI 10.1016/0022-0981(95)00201-4; GOODMAN M, 1953, J AM CHEM SOC, V75, P1962, DOI 10.1021/ja01104a052; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grover R, 2006, J EXP MAR BIOL ECOL, V332, P216, DOI 10.1016/j.jembe.2005.11.020; Grover R, 2003, LIMNOL OCEANOGR, V48, P2266, DOI 10.4319/lo.2003.48.6.2266; Grover R, 2002, LIMNOL OCEANOGR, V47, P782, DOI 10.4319/lo.2002.47.3.0782; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Hall D. O., 1987, PHOTOSYNTHESIS; Herfort L, 2008, J PHYCOL, V44, P91, DOI 10.1111/j.1529-8817.2007.00445.x; Hii Yii-Siang, 2009, Journal of Marine Biology, V2009, P1; Hoegh-Guldberg O, 1999, MAR BIOL, V133, P561, DOI 10.1007/s002270050496; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Houlbreque F, 2011, CORAL REEFS IN PRESS; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Hutchins DA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1627, DOI 10.1016/B978-0-12-372522-6.00038-4; IglesiasPrieto R, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL IV, P793; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; JACKSON AE, 1990, P ROY SOC B-BIOL SCI, V242, P201, DOI 10.1098/rspb.1990.0125; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822, DOI 10.4319/lo.1970.15.5.0822; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kajiwara Kenji, 1995, Journal of the Faculty of Marine Science and Technology Tokai University, V40, P95; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Leclercq N, 2002, LIMNOL OCEANOGR, V47, P558, DOI 10.4319/lo.2002.47.2.0558; Lehninger AL, 1985, PRINCIPLES BIOCH, P207; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Markovich D, 2010, EPITHELIAL TRANSPORT PHYSIOLOGY, P165, DOI 10.1007/978-1-60327-229-2_8; MARTINEZBILBAO M, 1988, J BACTERIOL, V170, P4897, DOI 10.1128/jb.170.10.4897-4902.1988; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MUSCATINE L, 1978, LIMNOL OCEANOGR, V23, P725, DOI 10.4319/lo.1978.23.4.0725; Muscatine L., 1990, P75; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; RAHAV O, 1989, PROC R SOC SER B-BIO, V236, P325, DOI 10.1098/rspb.1989.0026; Raven J, 2005, OCEAN ACIDIFICATION; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Roberts JM, 1999, MAR BIOL, V135, P223, DOI 10.1007/s002270050620; ROGERS GS, 1993, PLANT SOIL, V155, P231, DOI 10.1007/BF00025026; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Solomon S, 2007, CLIMATE CHANGEE 2007; SOROKIN YI, 1992, HYDROBIOLOGIA, V242, P105, DOI 10.1007/BF00018066; Tambutte Eric, 1995, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P79; TOETZ DW, 1981, HYDROBIOLOGIA, V76, P23, DOI 10.1007/BF00014029; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Warner ME, 1996, PLANT CELL ENVIRON, V19, P291, DOI 10.1111/j.1365-3040.1996.tb00251.x; WILKERSON FP, 1984, PROC R SOC SER B-BIO, V221, P71, DOI 10.1098/rspb.1984.0023; WILKERSON FP, 1986, MAR BIOL, V93, P237, DOI 10.1007/BF00508261; Williams GJ, 2010, MAR POLLUT BULL, V60, P1467, DOI 10.1016/j.marpolbul.2010.05.009; Xu ZG, 2010, BOT MAR, V53, P123, DOI 10.1515/BOT.2010.012; Yellowlees D., 1994, Pacific Science, V48, P291; Zou DH, 2005, AQUACULTURE, V250, P726, DOI 10.1016/j.aquaculture.2005.05.014	102	57	59	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25024	10.1371/journal.pone.0025024	http://dx.doi.org/10.1371/journal.pone.0025024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949839	Green Published, gold			2022-12-25	WOS:000295173800058
J	Griffing, SM; Mixson-Hayden, T; Sridaran, S; Alam, MT; McCollum, AM; Cabezas, C; Quezada, WM; Barnwell, JW; De Oliveira, AM; Lucas, C; Arrospide, N; Escalante, AA; Bacon, DJ; Udhayakumar, V				Griffing, Sean M.; Mixson-Hayden, Tonya; Sridaran, Sankar; Alam, Md Tauqeer; McCollum, Andrea M.; Cabezas, Cesar; Marquino Quezada, Wilmer; Barnwell, John W.; De Oliveira, Alexandre Macedo; Lucas, Carmen; Arrospide, Nancy; Escalante, Ananias A.; Bacon, David J.; Udhayakumar, Venkatachalam			South American Plasmodium falciparum after the Malaria Eradication Era: Clonal Population Expansion and Survival of the Fittest Hybrids	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE RESISTANCE; CHLOROQUINE-RESISTANCE; DRUG-RESISTANCE; MICROSATELLITE MARKERS; GENETIC DIVERSITY; MUTATIONS; PATTERNS; ORIGIN; DISSEMINATION; TRANSMISSION	Malaria has reemerged in many regions where once it was nearly eliminated. Yet the source of these parasites, the process of repopulation, their population structure, and dynamics are ill defined. Peru was one of malaria eradication's successes, where Plasmodium falciparum was nearly eliminated for two decades. It reemerged in the 1990s. In the new era of malaria elimination, Peruvian P. falciparum is a model of malaria reinvasion. We investigated its population structure and drug resistance profiles. We hypothesized that only populations adapted to local ecological niches could expand and repopulate and originated as vestigial populations or recent introductions. We investigated the genetic structure (using microsatellites) and drug resistant genotypes of 220 parasites collected from patients immediately after peak epidemic expansion (19992000) from seven sites across the country. The majority of parasites could be grouped into five clonal lineages by networks and AMOVA. The distribution of clonal lineages and their drug sensitivity profiles suggested geographic structure. In 2001, artesunate combination therapy was introduced in Peru. We tested 62 parasites collected in 2006-2007 for changes in genetic structure. Clonal lineages had recombined under selection for the fittest parasites. Our findings illustrate that local adaptations in the post-eradication era have contributed to clonal lineage expansion. Within the shifting confluence of drug policy and malaria incidence, populations continue to evolve through genetic outcrossing influenced by antimalarial selection pressure. Understanding the population substructure of P. falciparum has implications for vaccine, drug, and epidemiologic studies, including monitoring malaria during and after the elimination phase.	[Griffing, Sean M.; Mixson-Hayden, Tonya; Sridaran, Sankar; Alam, Md Tauqeer; McCollum, Andrea M.; Barnwell, John W.; De Oliveira, Alexandre Macedo; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Griffing, Sean M.; Mixson-Hayden, Tonya; Alam, Md Tauqeer; McCollum, Andrea M.] Atlanta Res & Educ Fdn, Decatur, GA USA; [Griffing, Sean M.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA; [Sridaran, Sankar] Assoc Publ Hlth Labs, Silver Spring, MD USA; [Cabezas, Cesar; Marquino Quezada, Wilmer; Arrospide, Nancy] Inst Nacl Salud, Lima, Peru; [Lucas, Carmen; Bacon, David J.] Naval Med Res Ctr Detachment, Parasitol Program, Lima, Peru; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Centers for Disease Control & Prevention - USA; Emory University; Instituto Nacional de Salud - Peru; Arizona State University; Arizona State University-Tempe	Griffing, SM (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30333 USA.	vxu0@cdc.gov		ARROSPIDE, NANCY/0000-0001-5031-5850; Escalante, Ananias/0000-0002-1532-3430; CABEZAS, CESAR/0000-0001-5120-0713	National Science Foundation; Association of Public Health Laboratories; American Society for Microbiology; Coordination Centers for Infectious Disease; National Institutes of Health [R01GM084320]; United States Agency for International Development supported Amazon Malaria Initiative; CDC Antimalarial Resistance Working Group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Association of Public Health Laboratories; American Society for Microbiology; Coordination Centers for Infectious Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Agency for International Development supported Amazon Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); CDC Antimalarial Resistance Working Group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SMG was supported under a National Science Foundation Graduate Research Fellowship. SS was supported by Emerging Infectious Diseases fellowships from the Association of Public Health Laboratories. TMH and MTA were supported by American Society for Microbiology and Coordination Centers for Infectious Disease postdoctoral fellowship. AAE was supported by grant R01GM084320 from the National Institutes of Health. The authors also thank the United States Agency for International Development supported Amazon Malaria Initiative and the CDC Antimalarial Resistance Working Group for their funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Ariey F, 1999, AM J TROP MED HYG, V61, P978, DOI 10.4269/ajtmh.1999.61.978; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Branch OH, 2011, MOL BIOL EVOL, V28, P1973, DOI 10.1093/molbev/msq311; Chauca H, 1993, REV PERUANA EPIDEMIO, V6, P34; Chowell G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-142; Clyde D. F., 1987, Medicina Tropicale nella Cooperazione allo Sviluppo, V3, P41; COLBOURNE M. J., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P179, DOI 10.1016/0035-9203(62)90153-0; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Cornuet JM, 1996, GENETICS, V144, P2001; Corredor V, 2010, ANTIMICROB AGENTS CH, V54, P3121, DOI 10.1128/AAC.00036-10; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; DESOUZA JM, 1992, MEM I OSWALDO CRUZ, V87, P343, DOI 10.1590/S0074-02761992000700058; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; Durand S, 2007, AM J TROP MED HYG, V76, P614, DOI 10.4269/ajtmh.2007.76.614; Escalante AA, 2004, TRENDS PARASITOL, V20, P388, DOI 10.1016/j.pt.2004.06.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferreira MU, 1998, AM J TROP MED HYG, V59, P474, DOI 10.4269/ajtmh.1998.59.474; GABALDON A, 1983, AM J TROP MED HYG, V32, P203, DOI 10.4269/ajtmh.1983.32.203; GARCIAMARTIN G, 1972, AM J TROP MED HYG, V21, P617, DOI 10.4269/ajtmh.1972.21.617; Griffing S, 2010, ANTIMICROB AGENTS CH, V54, P1572, DOI 10.1128/AAC.01243-09; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Huaman MC, 2004, AM J TROP MED HYG, V70, P461, DOI 10.4269/ajtmh.2004.70.461; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Magill A, 2004, REV SOC BRASILEIRA M, V37, P273; MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0; Marquino W, 2005, AM J TROP MED HYG, V72, P568, DOI 10.4269/ajtmh.2005.72.568; Marquino W, 2003, AM J TROP MED HYG, V68, P120, DOI 10.4269/ajtmh.2003.68.120; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; Mehlotra RK, 2008, ANTIMICROB AGENTS CH, V52, P2212, DOI 10.1128/AAC.00089-08; MOORE DV, 1961, AM J TROP MED HYG, V10, P5, DOI 10.4269/ajtmh.1961.10.5; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Organizacion Mundial de la Salud-OMS, 1991, SIT PROGR MAL AM; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Ruebush TK, 2004, J PUBLIC HEALTH POL, V25, P328, DOI 10.1057/palgrave.jphp.3190032; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; SLATKIN M, 1995, GENETICS, V139, P457; Tami A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-7; Tami A, 2002, PARASITOLOGY, V124, P569, DOI 10.1017/S0031182002001713; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; TIBAYRENC M, 1991, PARASITOL TODAY, V7, P228, DOI 10.1016/0169-4758(91)90234-F; Uhlemann A, 2005, MOL APPROACHES MALAR; Urdaneta L, 1999, AM J TROP MED HYG, V61, P457, DOI 10.4269/ajtmh.1999.61.457; Urdaneta L, 2001, P NATL ACAD SCI USA, V98, P6725, DOI 10.1073/pnas.111144998; Vieira PP, 2004, J INFECT DIS, V190, P417, DOI 10.1086/422006; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; World Health Organization, 1985, WORLD HLTH STAT Q, V38, P192; Wright S, 1943, GENETICS, V28, P114; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; Zhou ZY, 2008, ANTIMICROB AGENTS CH, V52, P739, DOI 10.1128/AAC.00975-07	58	54	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23486	10.1371/journal.pone.0023486	http://dx.doi.org/10.1371/journal.pone.0023486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949680	Green Submitted, gold, Green Published			2022-12-25	WOS:000295173800003
J	Hondo, M; Furutani, N; Yamasaki, M; Watanabe, M; Sakurai, T				Hondo, Mari; Furutani, Naoki; Yamasaki, Miwako; Watanabe, Masahiko; Sakurai, Takeshi			Orexin Neurons Receive Glycinergic Innervations	PLOS ONE			English	Article							OREXIN/HYPOCRETIN NEURONS; LUMBAR MOTONEURONS; ACTIVE SLEEP; RECEPTORS; MOUSE; MICE; NARCOLEPSY; ATONIA; BRAIN; CAT	Glycine, a nonessential amino-acid that acts as an inhibitory neurotransmitter in the central nervous system, is currently used as a dietary supplement to improve the quality of sleep, but its mechanism of action is poorly understood. We confirmed the effects of glycine on sleep/wakefulness behavior in mice when administered peripherally. Glycine administration increased non-rapid eye movement (NREM) sleep time and decreased the amount and mean episode duration of wakefulness when administered in the dark period. Since peripheral administration of glycine induced fragmentation of sleep/wakefulness states, which is a characteristic of orexin deficiency, we examined the effects of glycine on orexin neurons. The number of Fos-positive orexin neurons markedly decreased after intraperitoneal administration of glycine to mice. To examine whether glycine acts directly on orexin neurons, we examined the effects of glycine on orexin neurons by patch-clamp electrophysiology. Glycine directly induced hyperpolarization and cessation of firing of orexin neurons. These responses were inhibited by a specific glycine receptor antagonist, strychnine. Triple-labeling immunofluorescent analysis showed close apposition of glycine transporter 2 (GlyT2)-immunoreactive glycinergic fibers onto orexin-immunoreactive neurons. Immunoelectron microscopic analysis revealed that GlyT2-immunoreactive terminals made symmetrical synaptic contacts with somata and dendrites of orexin neurons. Double-labeling immunoelectron microscopy demonstrated that glycine receptor alpha subunits were localized in the postsynaptic membrane of symmetrical inhibitory synapses on orexin neurons. Considering the importance of glycinergic regulation during REM sleep, our observations suggest that glycine injection might affect the activity of orexin neurons, and that glycinergic inhibition of orexin neurons might play a role in physiological sleep regulation.	[Hondo, Mari; Furutani, Naoki; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan; [Yamasaki, Miwako; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat & Embryol, Sapporo, Hokkaido, Japan	Kanazawa University; Hokkaido University	Hondo, M (corresponding author), Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan.	tsakurai@med.kanazawa-u.ac.jp	Yamasaki, Miwako/I-8053-2014; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019	Yamasaki, Miwako/0000-0003-4974-9349; WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138	Japan Society for the Promotion of Science; Cabinet Office, Government of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cabinet Office, Government of Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded in part by Grants-in-Aid for Scientific Research (B), Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists, the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers", and the Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI T, 1988, NEUROSCIENCE, V25, P613, DOI 10.1016/0306-4522(88)90263-1; Bannai M, 2011, PSYCHIAT CLIN NEUROS, V65, P142, DOI 10.1111/j.1440-1819.2010.02181.x; CHASE MH, 1989, J NEUROSCI, V9, P743; Chase MH, 2008, SLEEP, V31, P1487, DOI 10.1093/sleep/31.11.1487; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CURTIS DR, 1968, EXP BRAIN RES, V6, P1; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karnani MM, 2011, J PHYSIOL-LONDON, V589, P639, DOI 10.1113/jphysiol.2010.198457; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morales FR, 2006, NEUROSCIENCE, V142, P37, DOI 10.1016/j.neuroscience.2006.05.066; Muraki Y, 2004, J NEUROSCI, V24, P7159, DOI 10.1523/JNEUROSCI.1027-04.2004; NAKAMURA Y, 1978, SCIENCE, V199, P204, DOI 10.1126/science.202025; PROBST A, 1986, NEUROSCIENCE, V17, P11, DOI 10.1016/0306-4522(86)90222-8; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; SOJA PJ, 1987, BRAIN RES, V423, P353, DOI 10.1016/0006-8993(87)90862-6; SOJA PJ, 1991, J NEUROSCI, V11, P2804; Taepavarapruk N, 2008, J NEUROPHYSIOL, V100, P598, DOI 10.1152/jn.01231.2007; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Takasaki C, 2010, EUR J NEUROSCI, V32, P1326, DOI 10.1111/j.1460-9568.2010.07377.x; Yamadera W, 2007, SLEEP BIOL RHYTHMS, V5, P126, DOI 10.1111/j.1479-8425.2007.00262.x; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	30	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25076	10.1371/journal.pone.0025076	http://dx.doi.org/10.1371/journal.pone.0025076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949857	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800062
J	Korvald, H; Moe, AMM; Cederkvist, FH; Thiede, B; Laerdahl, JK; Bjoras, M; Alseth, I				Korvald, Hanne; Moe, Anne Margrethe Molstad; Cederkvist, F. Henning; Thiede, Bernd; Laerdahl, Jon K.; Bjoras, Magnar; Alseth, Ingrun			Schizosaccharomyces pombe Ofd2 Is a Nuclear 2-Oxoglutarate and Iron Dependent Dioxygenase Interacting with Histones	PLOS ONE			English	Article							HUMAN ALKB PROTEINS; REPAIR ENZYME ALKB; OXIDATIVE DEMETHYLATION; ESCHERICHIA-COLI; FISSION YEAST; TRANSFER-RNA; DNA-DAMAGE; LESIONS; EXPRESSION; BACTERIAL	2-oxoglutarate (2OG) dependent dioxygenases are ubiquitous iron containing enzymes that couple substrate oxidation to the conversion of 2OG to succinate and carbon dioxide. They participate in a wide range of biological processes including collagen biosynthesis, fatty acid metabolism, hypoxic sensing and demethylation of nucleic acids and histones. Although substantial progress has been made in elucidating their function, the role of many 2OG dioxygenases remains enigmatic. Here we have studied the 2OG and iron (Fe(II)) dependent dioxygenase Ofd2 in Schizosaccharomyces pombe, a member of the AlkB subfamily of dioxygenases. We show that decarboxylation of 2OG by recombinant Ofd2 is dependent on Fe(II) and a histidine residue predicted to be involved in Fe(II) coordination. The decarboxylase activity of Ofd2 is stimulated by histones, and H2A has the strongest effect. Ofd2 interacts with all four core histones, however, only very weakly with H4. Our results define a new subclass of AlkB proteins interacting with histones, which also might comprise some of the human AlkB homologs with unknown function.	[Korvald, Hanne; Moe, Anne Margrethe Molstad; Cederkvist, F. Henning; Laerdahl, Jon K.; Bjoras, Magnar; Alseth, Ingrun] Oslo Univ Hosp HF Rikshosp, Dept Microbiol, Oslo, Norway; [Korvald, Hanne; Moe, Anne Margrethe Molstad; Cederkvist, F. Henning; Laerdahl, Jon K.; Bjoras, Magnar; Alseth, Ingrun] Univ Oslo, CMBN, Oslo, Norway; [Cederkvist, F. Henning; Bjoras, Magnar] Univ Oslo, Dept Med Biochem, Oslo, Norway; [Thiede, Bernd] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo	Korvald, H (corresponding author), Oslo Univ Hosp HF Rikshosp, Dept Microbiol, Oslo, Norway.	ingrun.alseth@rr-research.no	Bjørås, Magnar/N-9286-2017	Laerdahl, Jon Kristen/0000-0002-0826-9464	Research Council of Norway [NFR 160530/V40]; Polish-Norwegian Research Fund [PNRF-143-AI-1/079]	Research Council of Norway(Research Council of Norway); Polish-Norwegian Research Fund	This work was supported by grants from the Research Council of Norway (NFR 160530/V40) and from the Polish-Norwegian Research Fund (Grant PNRF-143-AI-1/079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Frick LE, 2007, P NATL ACAD SCI USA, V104, P755, DOI 10.1073/pnas.0607377104; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; HUTTON JJ, 1966, BIOCHEM BIOPH RES CO, V24, P179, DOI 10.1016/0006-291X(66)90716-9; Iyer LM, 2001, GENOME BIOL, V2; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; KAULE G, 1990, ANAL BIOCHEM, V184, P291, DOI 10.1016/0003-2697(90)90683-Z; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106	49	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25188	10.1371/journal.pone.0025188	http://dx.doi.org/10.1371/journal.pone.0025188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949882	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800071
J	Meester-Smoor, MA; Janssen, MJFW; ter Haar, WM; van Wely, KHM; Aarnoudse, AJLHJ; van Oord, G; van Tilburg, GBA; Zwarthoff, EC				Meester-Smoor, Magda A.; Janssen, Marjolein J. F. W.; ter Haar, W. Martijn; van Wely, Karel H. M.; Aarnoudse, Albert-Jan L. H. J.; van Oord, Gertine; van Tilburg, Gabrielle B. A.; Zwarthoff, Ellen C.			The ETS Family Member TEL Binds to Nuclear Receptors RAR and RXR and Represses Gene Activation	PLOS ONE			English	Article							LONG TERMINAL REPEAT; DNA-BINDING; TRANSCRIPTIONAL REPRESSOR; MEDIATED TRANSCRIPTION; MYELOID-LEUKEMIA; FUSION PROTEIN; N-COR; ONCOPROTEIN; TRANSLOCATION; COACTIVATORS	Retinoic acid receptor (RAR) signaling is important for regulating transcriptional activity of genes involved in growth, differentiation, metabolism and reproduction. Defects in RAR signaling have been implicated in cancer. TEL, a member of the ETS family of transcription factors, is a DNA-binding transcriptional repressor. Here, we identify TEL as a transcriptional repressor of RAR signaling by its direct binding to both RAR and its dimerisation partner, the retinoid x receptor (RXR) in a ligand-independent fashion. TEL is found in two isoforms, created by the use of an alternative startcodon at amino acid 43. Although both isoforms bind to RAR and RXR in vitro and in vivo, the shorter form of TEL represses RAR signaling much more efficiently. Binding studies revealed that TEL binds closely to the DNA binding domain of RAR and that both Helix Loop Helix (HLH) and DNA binding domains of TEL are mandatory for interaction. We have shown that repression by TEL does not involve recruitment of histone deacetylases and suggest that polycomb group proteins participate in the process.	[Meester-Smoor, Magda A.; Janssen, Marjolein J. F. W.; ter Haar, W. Martijn; van Wely, Karel H. M.; Aarnoudse, Albert-Jan L. H. J.; van Oord, Gertine; van Tilburg, Gabrielle B. A.; Zwarthoff, Ellen C.] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Meester-Smoor, MA (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl		van Wely, Karel Hermanus Martinus/0000-0001-8431-8072; van Tilburg, Gabrielle/0000-0002-1574-1069	Dutch Cancer Society [DDHK 2003-2869]	Dutch Cancer Society(KWF Kankerbestrijding)	This project was funded by the Dutch Cancer Society, grant DDHK 2003-2869 (www.kwf.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Baek SH, 2004, BIOCHEM BIOPH RES CO, V319, P707, DOI 10.1016/j.bbrc.2004.04.169; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bommer M, 2002, J BIOL CHEM, V277, P37961, DOI 10.1074/jbc.M206001200; BUIJS A, 1995, ONCOGENE, V10, P1511; Buijs A, 2000, MOL CELL BIOL, V20, P9281, DOI 10.1128/MCB.20.24.9281-9293.2000; Carlberg C, 2010, CHROMOSOMA, V119, P479, DOI 10.1007/s00412-010-0283-8; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Clarke Nicole, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008488; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Granger SW, 1998, J VIROL, V72, P8961, DOI 10.1128/JVI.72.11.8961-8970.1998; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Guidez F, 2000, BLOOD, V96, P2557; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; Kakizawa T, 1999, J BIOL CHEM, V274, P19103, DOI 10.1074/jbc.274.27.19103; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kolodziej KE, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-6; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li HJ, 2007, J CELL BIOCHEM, V102, P1021, DOI 10.1002/jcb.21340; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Meester-Smoor MA, 2008, CARCINOGENESIS, V29, P2025, DOI 10.1093/carcin/bgn168; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Oesterreich S, 2000, MOL ENDOCRINOL, V14, P369, DOI 10.1210/me.14.3.369; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Pfitzner E, 1998, P NATL ACAD SCI USA, V95, P5539, DOI 10.1073/pnas.95.10.5539; Poirel H, 1997, ONCOGENE, V14, P349, DOI 10.1038/sj.onc.1200829; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Schick N, 2004, J BIOL CHEM, V279, P38787, DOI 10.1074/jbc.M312581200; van Wely K, 2007, ONCOGENE, V26, P5733, DOI 10.1038/sj.onc.1210382; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Zhao JH, 2009, J CELL BIOCHEM, V107, P482, DOI 10.1002/jcb.22146	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23620	10.1371/journal.pone.0023620	http://dx.doi.org/10.1371/journal.pone.0023620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949683	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800005
J	Burns, DA; Heeg, D; Cartman, ST; Minton, NP				Burns, David A.; Heeg, Daniela; Cartman, Stephen T.; Minton, Nigel P.			Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027	PLOS ONE			English	Article							TOXIN PRODUCTION; EPIDEMIC; STRAINS; SPORES; TAUROCHOLATE; INFECTION; DISEASE	Clostridium difficile is the leading cause of antibiotic-associated diarrhoea and a major burden to healthcare services worldwide. In recent years, C. difficile strains belonging to the BI/NAP1/027 type have become highly represented among clinical isolates. These so-called 'hypervirulent' strains are associated with outbreaks of increased disease severity, higher relapse rates and an expanded repertoire of antibiotic resistance. Spores, formed during sporulation, play a pivotal role in disease transmission and it has been suggested that BI/NAP1/027 strains are more prolific in terms of sporulation in vitro than 'non-epidemic' C. difficile types. Work in our laboratory has since provided credible evidence to the contrary suggesting that the strain-to-strain variation in C. difficile sporulation characteristics is not type-associated. However, the BI/NAP1/027 type is still widely stated to have an increased rate of sporulation. In this study, we analysed the sporulation rates of 53 C. difficile strains, the largest sample size used to-date in such a study, including 28 BI/NAP1/027 isolates. Our data confirm that significant variation exists in the rate at which different C. difficile strains form spores. However, we clearly show that the sporulation rate of the BI/NAP1/027 type was no higher than that of non-BI/NAP1/027 strains. In addition, we observed substantial variation in sporulation characteristics within the BI/NAP1/027 type. This work highlights the danger of assuming that all strains of one type behave similarly without studying adequate sample sizes. Furthermore, we stress the need for more rigorous experimental procedures in order to quantify C. difficile sporulation more accurately in the future.	[Burns, David A.; Heeg, Daniela; Cartman, Stephen T.; Minton, Nigel P.] Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Clostridia Res Grp, Nottingham NG7 2RD, England	University of Nottingham	Burns, DA (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Clostridia Res Grp, Nottingham NG7 2RD, England.	nigel.minton@nottingham.ac.uk		Minton, Nigel/0000-0002-9277-1261	UK Medical Research Council [G0601176]; European Community [PEOPLE-ITN-2008-237942, HEALTH-F3-2008-223585]; Medical Research Council [G0601176] Funding Source: researchfish; MRC [G0601176] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to these results has received funding from the UK Medical Research Council (grant G0601176) and the European Community's Seventh Framework Programmes 'CLOSTNET' (PEOPLE-ITN-2008-237942) and 'HYPERDIFF' (HEALTH-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Burns DA, 2011, J MICROBIOL IN PRESS; Burns DA, 2010, ANAEROBE, V16, P618, DOI 10.1016/j.anaerobe.2010.10.001; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; Carroll KC, 2010, ANN REV MICROBIOLOGY; Cheng V, 2011, EUR J CLIN IN PRESS; Cloud J, 2007, CURR OPIN GASTROEN, V23, P4; Cohen S, 2010, INFECT CONTROL HOSP, V31; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Morgan OW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001812; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; SULLIVAN NM, 1982, INFECT IMMUN, V35, P1032, DOI 10.1128/IAI.35.3.1032-1040.1982; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilcox MH, 2000, LANCET, V356, P1324, DOI 10.1016/S0140-6736(00)02819-1; WILSON KH, 1982, J CLIN MICROBIOL, V15, P443, DOI 10.1128/JCM.15.3.443-446.1982	27	68	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24894	10.1371/journal.pone.0024894	http://dx.doi.org/10.1371/journal.pone.0024894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949780	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700074
J	Hole, K; Van Damme, P; Dalva, M; Aksnes, H; Glomnes, N; Varhaug, JE; Lillehaug, JR; Gevaert, K; Arnesen, T				Hole, Kristine; Van Damme, Petra; Dalva, Monica; Aksnes, Henriette; Glomnes, Nina; Varhaug, Jan Erik; Lillehaug, Johan R.; Gevaert, Kris; Arnesen, Thomas			The Human N-Alpha-Acetyltransferase 40 (hNaa40p/hNatD) Is Conserved from Yeast and N-Terminally Acetylates Histones H2A and H4	PLOS ONE			English	Article							ARF-LIKE GTPASE; PROTEIN; IDENTIFICATION; COMPLEX; REQUIRES; ARL3P; NATA; SAN	Protein N-alpha-terminal acetylation (Nt-acetylation) is considered one of the most common protein modification in eukaryotes, and 80-90% of all soluble human proteins are modified in this way, with functional implications ranging from altered protein function and stability to translocation potency amongst others. Nt-acetylation is catalyzed by N-terminal acetyltransferases (NATs), and in yeast five NAT types are identified and denoted NatA-NatE. Higher eukaryotes additionally express NatF. Except for NatD, human orthologues for all yeast NATs are identified. yNatD is defined as the catalytic unit Naa40p (Nat4) which co-translationally Nt-acetylates histones H2A and H4. In this study we identified and characterized hNaa40p/hNatD, the human orthologue of the yeast Naa40p. An in vitro proteome-derived peptide library Nt-acetylation assay indicated that recombinant hNaa40p acetylates N-termini starting with the consensus sequence Ser-Gly-Gly-Gly-Lys-, strongly resembling the N-termini of the human histones H2A and H4. This was confirmed as recombinant hNaa40p Nt-acetylated the oligopeptides derived from the N-termini of both histones. In contrast, a synthetically Nt-acetylated H4 N-terminal peptide with all lysines being non-acetylated, was not significantly acetylated by hNaa40p, indicating that hNaa40p catalyzed H4 N-alpha-acetylation and not H4 lysine N-epsilon-acetylation. Also, immunoprecipitated hNaa40p specifically Nt-acetylated H4 in vitro. Heterologous expression of hNaa40p in a yeast naa40-Delta strain restored Nt-acetylation of yeast histone H4, but not H2A in vivo, probably reflecting the fact that the N-terminal sequences of human H2A and H4 are highly similar to each other and to yeast H4 while the N-terminal sequence of yeast H2A differs. Thus, Naa40p seems to have co-evolved with the human H2A sequence. Finally, a partial co-sedimentation with ribosomes indicates that hNaa40p co-translationally acetylates H2A and H4. Combined, our results strongly suggest that human Naa40p/NatD is conserved from yeast. Thus, the NATs of all classes of N-terminally acetylated proteins in humans now appear to be accounted for.	[Hole, Kristine; Dalva, Monica; Aksnes, Henriette; Glomnes, Nina; Lillehaug, Johan R.; Arnesen, Thomas] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Hole, Kristine; Glomnes, Nina; Varhaug, Jan Erik] Univ Bergen, Dept Surg Sci, Bergen, Norway; [Van Damme, Petra; Gevaert, Kris] Univ Ghent VIB, Dept Med Prot Res, Ghent, Belgium; [Van Damme, Petra; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Varhaug, Jan Erik; Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Bergen; Haukeland University Hospital	Hole, K (corresponding author), Univ Bergen, Dept Mol Biol, Bergen, Norway.	Thomas.Arnesen@mbi.uib.no	Gevaert, Kris/D-6489-2017; Arnesen, Thomas/J-7139-2017; Aksnes, Henriette/AAD-6290-2020; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019; Arnesen, Thomas/Q-8117-2019; Van Damme, Petra/C-7269-2008	Gevaert, Kris/0000-0002-4237-0283; Arnesen, Thomas/0000-0002-3005-147X; Aksnes, Henriette/0000-0003-4968-2324; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Arnesen, Thomas/0000-0002-3005-147X; Van Damme, Petra/0000-0001-9090-027X	Norwegian Research Council [197136]; Norwegian Cancer Society; Fund for Scientific Research - Flanders (Belgium) [G.0042.07, G.0440.10]; Concerted Research Actions from the Ghent University [BOF07/GOA/012]; Inter University Attraction Poles [IUAP06]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Fund for Scientific Research - Flanders (Belgium)(FWO); Concerted Research Actions from the Ghent University; Inter University Attraction Poles(Belgian Federal Science Policy Office)	The work was supported by The Norwegian Research Council (project number 197136 to TA), The Norwegian Cancer Society (to JEV, JL and TA), the Fund for Scientific Research - Flanders (Belgium) (project numbers G.0042.07 and G.0440.10), the Concerted Research Actions (project BOF07/GOA/012) from the Ghent University and the Inter University Attraction Poles (IUAP06). PVD is a Postdoctoral Fellow of the Research Foundation - Flanders (FWO-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; BROWN JL, 1976, J BIOL CHEM, V251, P1009; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chu CW, 2011, MOL BIOL CELL, V22, P448, DOI 10.1091/mbc.E10-03-0203; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; DRIESSEN HPC, 1985, CRIT REV BIOCHEM MOL, V18, P281, DOI 10.3109/10409238509086784; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Lu L, 1996, J BIOL CHEM, V271, P18920, DOI 10.1074/jbc.271.31.18920; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Pimenta-Marques A, 2008, DEV BIOL, V323, P197, DOI 10.1016/j.ydbio.2008.08.021; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Polevoda B, 2009, MOL CELL BIOL, V29, P2913, DOI 10.1128/MCB.00147-08; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shin DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007451; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	48	74	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24713	10.1371/journal.pone.0024713	http://dx.doi.org/10.1371/journal.pone.0024713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935442	Green Published, gold			2022-12-25	WOS:000295041700051
J	Low, HQ; Chen, CPLH; Kasiman, K; Thalamuthu, A; Ng, SS; Foo, JN; Chang, HM; Wong, MC; Tai, ES; Liu, JJ				Low, Hui-Qi; Chen, Christopher P. L. H.; Kasiman, Katherine; Thalamuthu, Anbupalam; Ng, Seok-Shin; Foo, Jia-Nee; Chang, Hui-Meng; Wong, Meng-Cheong; Tai, E-Shyong; Liu, Jianjun			A Comprehensive Association Analysis of Homocysteine Metabolic Pathway Genes in Singaporean Chinese with Ischemic Stroke	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; RISK-FACTOR; CARDIOVASCULAR-DISEASE; VASCULAR-DISEASE; CONFERS RISK; METAANALYSIS	Background: The effect of genetic factors, apart from 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms, on elevated plasma homocysteine levels and increasing ischemic stroke risk have not been fully elucidated. We conducted a comprehensive analysis of 25 genes involved in homocysteine metabolism to investigate association of common variants within these genes with ischemic stroke risk. Methodology/Principal Findings: The study was done in two stages. In the initial study, SNP and haplotype-based association analyses were performed using 147 tagging Single Nucleotide Polymorphisms (SNPs) in 360 stroke patients and 354 non-stroke controls of Singaporean Chinese ethnicity. Joint association analysis of significant SNPs was then performed to assess the cumulative effect of these variants on ischemic stroke risk. In the replication study, 8 SNPs were selected for validation in an independent set of 420 matched case-control pairs of Singaporean Chinese ethnicity. SNP analysis from the initial study suggested 3 risk variants in the MTRR, SHMT1 and TCN2 genes which were moderately associated with ischemic stroke risk, independent of known stroke risk factors. Although the replication study failed to support single-SNP associations observed in the initial study, joint association analysis of the 3 variants in combined initial and replication samples revealed a trend of elevated risk with an increased number of risk alleles (Joint P-trend = 1.2 x 10(-6)). Conclusions: Our study did not find direct evidence of associations between any single polymorphisms of homocysteine metabolic pathway genes and ischemic stroke, but suggests that the cumulative effect of several small to moderate risk variants from genes involved in homocysteine metabolism may jointly confer a significant impact on ischemic stroke risk.	[Low, Hui-Qi; Thalamuthu, Anbupalam; Ng, Seok-Shin; Foo, Jia-Nee; Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Chen, Christopher P. L. H.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Kasiman, Katherine; Tai, E-Shyong] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Kasiman, Katherine] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chang, Hui-Meng] Natl Inst Neurosci, Dept Neurol, Singapore, Singapore; [Wong, Meng-Cheong] Natl Canc Ctr, Div Med Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Karolinska Institutet; National Neuroscience Institute (NNI); National Cancer Centre Singapore (NCCS)	Low, HQ (corresponding author), Genome Inst Singapore, Singapore, Singapore.	liuj3@gis.a-star.edu.sg	Tai, E Shyong/J-9831-2013; Chen, Christopher/E-7023-2013; Thalamuthu, Anbupalam/Z-5545-2019; Liu, Jianjun/AAK-4989-2020; Foo, Jia Nee/D-6069-2014	Chen, Christopher/0000-0002-1047-9225; Thalamuthu, Anbupalam/0000-0002-7114-1260; Liu, Jianjun/0000-0002-3255-3019; Foo, Jia Nee/0000-0001-9899-2308; Tai, E Shyong/0000-0003-2929-8966	National Medical Research Council (NMRC) [NMRC/0816/2003]; Agency for Science, Technology and Research	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	This study was supported by funding from the National Medical Research Council (NMRC) (NMRC/0816/2003) and the Agency for Science, Technology and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, QUANTO 1 1 A COMPUTE; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Harmon DL, 1999, GENET EPIDEMIOL, V17, P298, DOI 10.1002/(SICI)1098-2272(199911)17:4<298::AID-GEPI5>3.0.CO;2-V; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; KANG SS, 1988, AM J HUM GENET, V43, P414; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Kullo IJ, 2006, STROKE, V37, P1703, DOI 10.1161/01.STR.0000225929.96190.b3; Laraqui A, 2006, ACTA CARDIOL, V61, P51, DOI 10.2143/AC.61.1.2005140; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Matarin M, 2009, STROKE, V40, P3436, DOI 10.1161/STROKEAHA.109.558015; Moller J, 2000, SCAND J CLIN LAB INV, V60, P491; R Development Core Team, 2005, R LANG ENV STAT COMP; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Souto JC, 2005, AM J HUM GENET, V76, P925, DOI 10.1086/430409; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sudlow C, 2006, STROKE, V37, P364, DOI 10.1161/01.STR.0000199065.12908.62; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	34	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24757	10.1371/journal.pone.0024757	http://dx.doi.org/10.1371/journal.pone.0024757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935458	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700057
J	O'Rourke, PEF; Eadsforth, TC; Fyfe, PK; Shepherd, SM; Hunter, WN				O'Rourke, Patrick E. F.; Eadsforth, Thomas C.; Fyfe, Paul K.; Shepherd, Sharon M.; Hunter, William N.			Pseudomonas aeruginosa 4-Amino-4-Deoxychorismate Lyase: Spatial Conservation of an Active Site Tyrosine and Classification of Two Types of Enzyme	PLOS ONE			English	Article							PARA-AMINOBENZOATE SYNTHESIS; ESCHERICHIA-COLI; AMINODEOXYCHORISMATE LYASE; SEQUENCE ALIGNMENT; FOLIC-ACID; GENE; BIOSYNTHESIS; SYNTHASE; DESIGN; PURIFICATION	4-Amino-4-deoxychorismate lyase (PabC) catalyzes the formation of 4-aminobenzoate, and release of pyruvate, during folate biosynthesis. This is an essential activity for the growth of Gram-negative bacteria, including important pathogens such as Pseudomonas aeruginosa. A high-resolution (1.75 angstrom) crystal structure of PabC from P. aeruginosa has been determined, and sequence-structure comparisons with orthologous structures are reported. Residues around the pyridoxal 5'-phosphate cofactor are highly conserved adding support to aspects of a mechanism generic for enzymes carrying that cofactor. However, we suggest that PabC can be classified into two groups depending upon whether an active site and structurally conserved tyrosine is provided from the polypeptide that mainly forms an active site or from the partner subunit in the dimeric assembly. We considered that the conserved tyrosine might indicate a direct role in catalysis: that of providing a proton to reduce the olefin moiety of substrate as pyruvate is released. A threonine had previously been suggested to fulfill such a role prior to our observation of the structurally conserved tyrosine. We have been unable to elucidate an experimentally determined structure of PabC in complex with ligands to inform on mechanism and substrate specificity. Therefore we constructed a computational model of the catalytic intermediate docked into the enzyme active site. The model suggests that the conserved tyrosine helps to create a hydrophobic wall on one side of the active site that provides important interactions to bind the catalytic intermediate. However, this residue does not appear to participate in interactions with the C atom that undergoes an sp(2) to sp(3) conversion as pyruvate is produced. The model and our comparisons rather support the hypothesis that an active site threonine hydroxyl contributes a proton used in the reduction of the substrate methylene to pyruvate methyl in the final stage of the mechanism.	[O'Rourke, Patrick E. F.; Eadsforth, Thomas C.; Fyfe, Paul K.; Shepherd, Sharon M.; Hunter, William N.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee, Scotland	University of Dundee	O'Rourke, PEF (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee, Scotland.	w.n.hunter@dundee.ac.uk	Hunter, William/AAE-3947-2019	Fyfe, Paul/0000-0003-3541-2294	Wellcome Trust [082596, 083481]; European Commission [FP7/2007-2013]; AEROPATH [223461]	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); AEROPATH	This research has been funded by the Wellcome Trust (grant no. 082596 and 083481) and European Commission Seventh Framework Programme (FP7/2007-2013, AEROPATH grant no. 223461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KS, 1991, J AM CHEM SOC, V113, P3198, DOI 10.1021/ja00008a073; Aparicio JF, 2003, APPL MICROBIOL BIOT, V61, P179, DOI 10.1007/s00253-002-1183-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; BROWN GM, 1962, J BIOL CHEM, V237, P536; Castell A, 2010, ACTA CRYSTALLOGR D, V66, P549, DOI 10.1107/S0907444910004877; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; GREEN JM, 1991, J BIOL CHEM, V266, P12971; GREEN JM, 1992, J BACTERIOL, V174, P5317, DOI 10.1128/JB.174.16.5317-5323.1992; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hu LY, 2006, BIOORG MED CHEM LETT, V16, P2337, DOI 10.1016/j.bmcl.2005.07.058; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Jhee KH, 2000, J BIOCHEM-TOKYO, V128, P679, DOI 10.1093/oxfordjournals.jbchem.a022801; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEONARD GA, 1995, ACTA CRYSTALLOGR D, V51, P136, DOI 10.1107/S0907444994004713; Lepore BW, 2010, BIOCHEMISTRY-US, V49, P3138, DOI 10.1021/bi902052x; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2000, J BIOCHEM, V128, P29, DOI 10.1093/oxfordjournals.jbchem.a022727; NICHOLS BP, 1989, J BIOL CHEM, V264, P8597; Padmanabhan B, 2009, ACTA CRYSTALLOGR F, V65, P1234, DOI 10.1107/S1744309109050052; Parsons JF, 2002, BIOCHEMISTRY-US, V41, P2198, DOI 10.1021/bi015791b; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Schadt HS, 2009, J AM CHEM SOC, V131, P3481, DOI 10.1021/ja809283u; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLOCK J, 1990, J BACTERIOL, V172, P7211, DOI 10.1128/jb.172.12.7211-7226.1990; SOPER TS, 1981, J BIOL CHEM, V256, P4263; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YE QZ, 1990, P NATL ACAD SCI USA, V87, P9391, DOI 10.1073/pnas.87.23.9391; Zhang YR, 2009, MICROBIOL-SGM, V155, P2450, DOI 10.1099/mic.0.026336-0	39	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24158	10.1371/journal.pone.0024158	http://dx.doi.org/10.1371/journal.pone.0024158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935381	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700013
J	Pavlovicz, RE; Henderson, BJ; Bonnell, AB; Boyd, RT; Mckay, DB; Li, CL				Pavlovicz, Ryan E.; Henderson, Brandon J.; Bonnell, Andrew B.; Boyd, R. Thomas; McKay, Dennis B.; Li, Chenglong			Identification of a Negative Allosteric Site on Human alpha 4 beta 2 and alpha 3 beta 4 Neuronal Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; BINDING-PROTEIN; PHARMACOLOGICAL CHARACTERIZATION; STRUCTURAL DETERMINANTS; EXTRACELLULAR DOMAIN; MOLECULAR-MECHANICS; ALPHA 3; BETA 4; AGONISTS	Acetylcholine-based neurotransmission is regulated by cationic, ligand-gated ion channels called nicotinic acetylcholine receptors (nAChRs). These receptors have been linked to numerous neurological diseases and disorders such as Alzheimer's disease, Parkinson's disease, and nicotine addiction. Recently, a class of compounds has been discovered that antagonize nAChR function in an allosteric fashion. Models of human alpha 4 beta 2 and alpha 3 beta 4 nicotinic acetylcholine receptor (nAChR) extracellular domains have been developed to computationally explore the binding of these compounds, including the dynamics and free energy changes associated with ligand binding. Through a blind docking study to multiple receptor conformations, the models were used to determine a putative binding mode for the negative allosteric modulators. This mode, in close proximity to the agonist binding site, is presented in addition to a hypothetical mode of antagonism that involves obstruction of C loop closure. Molecular dynamics simulations and MM-PBSA free energy of binding calculations were used as computational validation of the predicted binding mode, while functional assays on wild-type and mutated receptors provided experimental support. Based on the proposed binding mode, two residues on the beta 2 subunit were independently mutated to the corresponding residues found on the beta 4 subunit. The T58K mutation resulted in an eight-fold decrease in the potency of KAB-18, a compound that exhibits preferential antagonism for human alpha 4 beta 2 over alpha 3 beta 4 nAChRs, while the F118L mutation resulted in a loss of inhibitory activity for KAB-18 at concentrations up to 100 mu M. These results demonstrate the selectivity of KAB-18 for human alpha 4 beta 2 nAChRs and validate the methods used for identifying the nAChR modulator binding site. Exploitation of this site may lead to the development of more potent and subtype-selective nAChR antagonists which may be used in the treatment of a number of neurological diseases and disorders.	[Pavlovicz, Ryan E.; Li, Chenglong] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Henderson, Brandon J.; McKay, Dennis B.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA; [Bonnell, Andrew B.; Boyd, R. Thomas] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Li, Chenglong] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Pavlovicz, RE (corresponding author), Ohio State Univ, Biophys Program, Columbus, OH 43210 USA.	li.728@osu.edu	Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719; Henderson, Brandon/0000-0003-0381-028X	faculty startup fund; NIH/NIDA [R21DA029433]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029433] Funding Source: NIH RePORTER	faculty startup fund; NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The funding of this study is supported by a faculty startup fund to Chenglong Li and a NIH/NIDA R21 grant (R21DA029433) to Dennis McKay and Chenglong Li. The NIDA website is: http://www.nida.nih.gov/nidahome.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ANAND R, 1991, J BIOL CHEM, V266, P11192; Babakhani A, 2009, COMPUT BIOL CHEM, V33, P160, DOI 10.1016/j.compbiolchem.2008.12.002; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chavez-Noriega LE, 2000, NEUROPHARMACOLOGY, V39, P2543, DOI 10.1016/S0028-3908(00)00134-9; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Damaj MI, 2000, NEUROPHARMACOLOGY, V39, P2785, DOI 10.1016/S0028-3908(00)00139-8; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Gonzalez-Cestari TF, 2009, J PHARMACOL EXP THER, V328, P504, DOI 10.1124/jpet.108.144576; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grazioso G, 2008, J COMPUT CHEM, V29, P2593, DOI 10.1002/jcc.21019; Haddadian EJ, 2008, J PHYS CHEM B, V112, P13981, DOI 10.1021/jp804868s; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Henderson BJ, 2010, J PHARMACOL EXP THER, V334, P761, DOI 10.1124/jpet.110.168211; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Huang XQ, 2008, J MED CHEM, V51, P6293, DOI 10.1021/jm800607u; Huang XQ, 2006, J MED CHEM, V49, P7661, DOI 10.1021/jm0606701; Huang XQ, 2005, J AM CHEM SOC, V127, P14401, DOI 10.1021/ja052681+; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Iorga B, 2006, J MOL MODEL, V12, P366, DOI 10.1007/s00894-005-0057-z; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Levin ED, 1998, PSYCHOPHARMACOLOGY, V138, P217, DOI 10.1007/s002130050667; Mckay DB, 2007, MOL PHARMACOL, V71, P1288, DOI 10.1124/mol.106.033233; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radek RJ, 2010, CURR PHARM DESIGN, V16, P309, DOI 10.2174/138161210790170166; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Simmerling C, 1998, J AM CHEM SOC, V120, P7149, DOI 10.1021/ja9727023; Stauderman KA, 1998, J PHARMACOL EXP THER, V284, P777; Steinlein OK, 2010, PFLUG ARCH EUR J PHY, V460, P495, DOI 10.1007/s00424-009-0766-8; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768	53	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24949	10.1371/journal.pone.0024949	http://dx.doi.org/10.1371/journal.pone.0024949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949802	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700080
J	Yau, SY; Lau, BWM; Tong, JB; Wong, R; Ching, YP; Qiu, G; Tang, SW; Lee, TMC; So, KF				Yau, Suk-Yu; Lau, Benson Wui-Man; Tong, Jian-Bin; Wong, Richard; Ching, Yick-Pang; Qiu, Guang; Tang, Siu-Wa; Lee, Tatia M. C.; So, Kwok-Fai			Hippocampal Neurogenesis and Dendritic Plasticity Support Running-Improved Spatial Learning and Depression-Like Behaviour in Stressed Rats	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; ADULT NEUROGENESIS; CELL-PROLIFERATION; DENTATE GYRUS; NEURONAL DIFFERENTIATION; MESSENGER-RNA; GRANULE CELLS; GROWTH-FACTOR; BRAIN HEALTH	Exercise promotes hippocampal neurogenesis and dendritic plasticity while stress shows the opposite effects, suggesting a possible mechanism for exercise to counteract stress. Changes in hippocampal neurogenesis and dendritic modification occur simultaneously in rats with stress or exercise; however, it is unclear whether neurogenesis or dendritic remodeling has a greater impact on mediating the effect of exercise on stress since they have been separately examined. Here we examined hippocampal cell proliferation in runners treated with different doses (low: 30 mg/kg; moderate: 40 mg/kg; high: 50 mg/kg) of corticosterone (CORT) for 14 days. Water maze task and forced swim tests were applied to assess hippocampal-dependent learning and depression-like behaviour respectively the day after the treatment. Repeated CORT treatment resulted in a graded increase in depression-like behaviour and impaired spatial learning that is associated with decreased hippocampal cell proliferation and BDNF levels. Running reversed these effects in rats treated with low or moderate, but not high doses of CORT. Using 40 mg/kg CORT-treated rats, we further studied the role of neurogenesis and dendritic remodeling in mediating the effects of exercise on stress. Co-labelling with BrdU (thymidine analog)/doublecortin (immature neuronal marker) showed that running increased neuronal differentiation in vehicle-and CORT-treated rats. Running also increased dendritic length and spine density in CA3 pyramidal neurons in 40 mg/kg CORT-treated rats. Ablation of neurogenesis with Ara-c infusion diminished the effect of running on restoring spatial learning and decreasing depression-like behaviour in 40 mg/kg CORT-treated animals in spite of dendritic and spine enhancement. but not normal runners with enhanced dendritic length. The results indicate that both restored hippocampal neurogenesis and dendritic remodelling within the hippocampus are essential for running to counteract stress.	[Yau, Suk-Yu; Lau, Benson Wui-Man; Tong, Jian-Bin; Wong, Richard; Ching, Yick-Pang; Qiu, Guang; Tang, Siu-Wa; So, Kwok-Fai] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yau, Suk-Yu; Lau, Benson Wui-Man; Wong, Richard; Ching, Yick-Pang; Qiu, Guang; Lee, Tatia M. C.; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Jinan Univ, Joint Lab Brain Funct & Hlth BFAH, Guangzhou, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Guangzhou, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University; University of Hong Kong	Yau, SY (corresponding author), Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	tmclee@hkusua.hku.hk; hrmaskf@hkucc.hku.hk		CHING, Yick Pang/0000-0002-6461-8358; Yau, Sonata Suk Yu/0000-0002-7425-6741; So, Kwok-Fai/0000-0003-4039-4246; Wong, Ricky Wing Kit/0000-0002-1941-388X; LAU, Wui Man/0000-0002-4552-2780	University of Hong Kong Foundation for Educational Development and Research Limited; National Natural Science Foundation of China; University Grants Committee of the Hong Kong; University of Hong Kong; Fundamental Research Fund for the Central Universities [21609101]	University of Hong Kong Foundation for Educational Development and Research Limited; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Grants Committee of the Hong Kong; University of Hong Kong(University of Hong Kong); Fundamental Research Fund for the Central Universities	This study was supported by funding from the Jessie Ho Professorship in Neuroscience (The University of Hong Kong Foundation for Educational Development and Research Limited), the National Natural Science Foundation of China, the Areas of Excellence (AoE) Scheme established under the University Grants Committee of the Hong Kong and AoE Matching Fund from the University of Hong Kong and the Fundamental Research Fund for the Central Universities (21609101, K-FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; Berchtold NC, 2002, J NEUROSCI RES, V68, P511, DOI 10.1002/jnr.10256; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1997, J NEUROSCI, V17, P2492; Hellsten J, 2002, EUR J NEUROSCI, V16, P283, DOI 10.1046/j.1460-9568.2002.02093.x; Jung KH, 2004, EUR J NEUROSCI, V19, P3219, DOI 10.1111/j.0953-816X.2004.03412.x; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Lafenetre P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.034.2009; Lau BWM, 2011, J SEX MED, V8, P1390, DOI 10.1111/j.1743-6109.2010.02081.x; Lau BWM, 2011, CELL TRANSPLANT, V20, P21, DOI 10.3727/096368910X532765; Lau WM, 2007, RESTOR NEUROL NEUROS, V25, P17; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Marks W, 2009, PHYSIOL BEHAV, V98, P67, DOI 10.1016/j.physbeh.2009.04.014; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; MCEWEN BS, 1993, CELL MOL NEUROBIOL, V13, P457, DOI 10.1007/BF00711583; McEwen BS, 2010, ANN N Y ACAD SC SE38, V1204, P59; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Redila VA, 2006, NEUROSCIENCE, V137, P1299, DOI 10.1016/j.neuroscience.2005.10.050; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schaaf M J, 2000, Stress, V3, P201, DOI 10.3109/10253890009001124; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vollmayr B, 2003, BIOL PSYCHIAT, V54, P1035, DOI 10.1016/S0006-3223(03)00527-4; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wojtowicz JM, 2008, EUR J NEUROSCI, V27, P1494, DOI 10.1111/j.1460-9568.2008.06128.x; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Zhao Y, 2008, EUR J PHARMACOL, V581, P113, DOI 10.1016/j.ejphar.2007.12.005	62	106	111	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24263	10.1371/journal.pone.0024263	http://dx.doi.org/10.1371/journal.pone.0024263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935393	gold, Green Published, Green Submitted			2022-12-25	WOS:000295041700021
J	Rosenblatt-Velin, N; Ogay, S; Felley, A; Stanford, WL; Pedrazzini, T				Rosenblatt-Velin, Nathalie; Ogay, Sandy; Felley, Allison; Stanford, William L.; Pedrazzini, Thierry			Cardiac dysfunction and impaired compensatory response to pressure overload in mice deficient in stem cell antigen-1	FASEB JOURNAL			English	Article						heart; regeneration; precursors; differentiation	PROGENITOR CELLS; MYOCARDIAL REGENERATION; SMOOTH-MUSCLE; HEART-DISEASE; NULL MICE; MULTIPOTENT; SCA-1; DIFFERENTIATION; CARDIOMYOCYTES; REPAIR	Stem cell antigen-1 (Sca-1) has been used to identify cardiac stem cells in the mouse heart. To investigate the function of Sca-1 in aging and during the cardiac adaptation to stress, we used Sca-1-deficient mice. These mice developed dilated cardiomyopathy [end-diastolic left ventricular diameter at 18 wk of age: wild-type (WT) mice, 4.2 mm +/- 0.3; Sca-1-knockout (Sca-1-KO) mice, 4.6 mm +/- 0.1; ejection fraction: WT mice, 51.1 +/- 2.7%; Sca-1-KO mice, 42.9 +/- 2.7%]. Furthermore, the hearts of mice lacking Sca-1 demonstrated exacerbated susceptibility to pressure overload [ejection fraction after transaortic constriction (TAC): WT mice, 43.5 +/- 3.2%; Sca-1-KO mice, 30.8% +/- 4.0] and increased apoptosis, as shown by the 2.5-fold increase in TUNEL(+) cells in Sca-1-deficient hearts under stress. Sca-1 deficiency affected primarily the nonmyocyte cell fraction. Indeed, the number of Nkx2.5(+) nonmyocyte cells, which represent a population of cardiac precursor cells (CPCs), was 2-fold smaller in Sca-1 deficient neonatal hearts. In vitro, the ability of CPCs to differentiate into cardiomyocytes was not affected by Sca-1 deletion. In contrast, these cells demonstrated unrestricted differentiation into cardiomyocytes. Interestingly, proliferation of cardiac nonmyocyte cells in response to stress, as judged by BrdU incorporation, was higher in mice lacking Sca-1 (percentages of BrdU(+) cells in the heart after TAC: WT mice, 4.4 +/- 2.1%; Sca-1-KO mice, 19.3 +/- 4.2%). These data demonstrate the crucial role of Sca-1 in the maintenance of cardiac integrity and suggest that Sca-1 restrains spontaneous differentiation in the precursor population. The absence of Sca-1 results in uncontrolled precursor recruitment, exhaustion of the precursor pool, and cardiac dysfunction.-Rosenblatt-Velin, N., Ogay, S., Felley, A., Stanford, W. L., Pedrazzini, T. Cardiac dysfunction and impaired compensatory response to pressure overload in mice deficient in stem cell antigen-1. FASEB J. 26, 229-239 (2012). www.fasebj.org	[Rosenblatt-Velin, Nathalie; Ogay, Sandy; Pedrazzini, Thierry] Univ Lausanne, Sch Med, Expt Cardiol Unit, Dept Med, CH-1011 Lausanne, Switzerland; [Felley, Allison] Univ Lausanne, Cardiovasc Assessment Facil, CH-1011 Lausanne, Switzerland; [Stanford, William L.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada	University of Lausanne; University of Lausanne; University of Ottawa; Ottawa Hospital Research Institute	Pedrazzini, T (corresponding author), Univ Lausanne, Sch Med, Expt Cardiol Unit, Dept Med, Rue Bugnon 27, CH-1011 Lausanne, Switzerland.	thierry.pedrazzini@chuv.ch		Rosenblatt, Nathalie/0000-0003-2011-2862; Stanford, William/0000-0002-5813-8016	Swiss National Science Foundation [PMPDB-110269, PMPDB-118627, 320000-114026]; Canadian Institutes of Health Research [FRN 62788]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Swiss National Science Foundation (PMPDB-110269 and PMPDB-118627 to N.R. and 320000-114026 to T. P.), and Sca-1 research in the W. L. S. laboratory is supported by the Canadian Institutes of Health Research (FRN 62788). The authors are grateful to Francois Feihl and Bernard Waeber for critical reading of the manuscript and Jeff Kiernan for helpful discussions. The authors declare no conflicts of interest.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Boudoulas KD, 2009, DIS MODEL MECH, V2, P344, DOI 10.1242/dmm.000240; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Epting CL, 2004, J CELL SCI, V117, P6185, DOI 10.1242/jcs.01548; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Petersen BE, 2003, HEPATOLOGY, V37, P632, DOI 10.1053/jhep.2003.50104; Rosenblatt-Velin N, 2005, J CLIN INVEST, V115, P1724, DOI 10.1172/JCI23418; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Tateishi K, 2007, J CELL SCI, V120, P1791, DOI 10.1242/jcs.006122; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; YUTOKU M, 1974, J IMMUNOL, V112, P1774; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559	39	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					229	239		10.1096/fj.11-189605	http://dx.doi.org/10.1096/fj.11-189605			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21957128				2022-12-25	WOS:000299202200024
J	Georgiades, K; Madoui, MA; Le, P; Robert, C; Raoult, D				Georgiades, Kalliopi; Madoui, Mohammed-Amine; Le, Phuong; Robert, Catherine; Raoult, Didier			Phylogenomic Analysis of Odyssella thessalonicensis Fortifies the Common Origin of Rickettsiales, Pelagibacter ubique and Reclimonas americana Mitochondrion	PLOS ONE			English	Article							GENOME; EVOLUTION; SEQUENCE	Background: The evolution of the Alphaproteobacteria and origin of the mitochondria are topics of considerable debate. Most studies have placed the mitochondria ancestor within the Rickettsiales order. Ten years ago, the bacterium Odyssella thessalonicensis was isolated from Acanthamoeba spp., and the 16S rDNA phylogeny placed it within the Rickettsiales. Recently, the whole genome of O. thessalonicensis has been sequenced, and 16S rDNA phylogeny and more robust and accurate phylogenomic analyses have been performed with 65 highly conserved proteins. Methodology/Principal Findings: The results suggested that the O. thessalonicensis emerged between the Rickettsiales and other Alphaproteobacteria. The mitochondrial proteins of the Reclinomonas americana have been used to locate the phylogenetic position of the mitochondrion ancestor within the Alphaproteobacteria tree. Using the K tree score method, nine mitochondrion-encoded proteins, whose phylogenies were congruent with the Alphaproteobacteria phylogenomic tree, have been selected and concatenated for Bayesian and Maximum Likelihood phylogenies. The Reclinomonas americana mitochondrion is a sister taxon to the free-living bacteria Candidatus Pelagibacter ubique, and together, they form a clade that is deeply rooted in the Rickettsiales clade. Conclusions/Significance: The Reclinomonas americana mitochondrion phylogenomic study confirmed that mitochondria emerged deeply in the Rickettsiales clade and that they are closely related to Candidatus Pelagibacter ubique.	[Georgiades, Kalliopi; Madoui, Mohammed-Amine; Le, Phuong; Robert, Catherine; Raoult, Didier] Univ Mediterranee, Fac Med, URMITE, CNRS IRD UMR 6236, Marseille, France; [Le, Phuong] Univ Aix Marseille 1, LATP UMR CNRS 6632, FR 3098, IFR48, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Georgiades, K (corresponding author), Univ Mediterranee, Fac Med, URMITE, CNRS IRD UMR 6236, Marseille, France.	didier.raoult@gmail.com	Madoui, Mohammed-Amin/AAF-3374-2021; RAOULT, Didier/A-8434-2008; Le, Phuong/E-5622-2019; Madoui, Mohammed-Amin/GYD-9411-2022; Madoui, Mohammed-Amin/ABC-1017-2020	Madoui, Mohammed-Amin/0000-0003-4809-2971; RAOULT, Didier/0000-0002-0633-5974; Le, Phuong/0000-0002-8738-6705				Abhishek A, 2011, CAN J MICROBIOL, V57, P49, DOI [10.1139/W10-099, 10.1139/w10-099]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Birtles RJ, 2000, INT J SYST EVOL MICR, V50, P63, DOI 10.1099/00207713-50-1-63; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emelyanov VV, 2001, BIOSCIENCE REP, V21, P1, DOI 10.1023/A:1010409415723; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Esser C, 2007, TRENDS MICROBIOL, V15, P435, DOI 10.1016/j.tim.2007.09.001; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; LARSEN N, 1993, NUCLEIC ACIDS RES, V21, P3021, DOI 10.1093/nar/21.13.3021; Merhej V, 2009, CLIN MICROBIOL INFEC, V15, P336, DOI 10.1111/j.1469-0691.2008.02265.x; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Moliner Claire, 2009, BMC Res Notes, V2, P51, DOI 10.1186/1756-0500-2-51; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Rodriguez Ezpeleta I, 2011, MOL BIOL EVOL, DOI [10.5061/dryad.6477p, DOI 10.5061/DRYAD.6477P]; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Soltis PS, 2003, STAT SCI, V18, P256; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069	35	40	41	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24857	10.1371/journal.pone.0024857	http://dx.doi.org/10.1371/journal.pone.0024857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957463	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100022
J	Shima, K; Morikawa, T; Yamauchi, M; Kuchiba, A; Imamura, Y; Liao, XY; Meyerhardt, JA; Fuchs, CS; Ogino, S				Shima, Kaori; Morikawa, Teppei; Yamauchi, Mai; Kuchiba, Aya; Imamura, Yu; Liao, Xiaoyun; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji			TGFBR2 and BAX Mononucleotide Tract Mutations, Microsatellite Instability, and Prognosis in 1072 Colorectal Cancers	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; POPULATION-BASED SAMPLE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; III COLON-CANCER; DNA METHYLATION; LINE-1 HYPOMETHYLATION; ADJUVANT CHEMOTHERAPY; KRAS MUTATION; BRAF MUTATION; BETA RECEPTOR	Background: Mononucleotide tracts in the coding regions of the TGFBR2 and BAX genes are commonly mutated in microsatellite instability-high (MSI-high) colon cancers. The receptor TGFBR2 plays an important role in the TGFB1 (transforming growth factor-beta, TGF-beta) signaling pathway, and BAX plays a key role in apoptosis. However, a role of TGFBR2 or BAX mononucleotide mutation in colorectal cancer as a prognostic biomarker remains uncertain. Methodology/Principal Findings: We utilized a database of 1072 rectal and colon cancers in two prospective cohort studies (the Nurses' Health Study and the Health Professionals Follow-up Study). Cox proportional hazards model was used to compute mortality hazard ratio (HR), adjusted for clinical, pathological and molecular features including the CpG island methylator phenotype (CIMP), LINE-1 methylation, and KRAS, BRAF and PIK3CA mutations. MSI-high was observed in 15% (162/1072) of all colorectal cancers. TGFBR2 and BAX mononucleotide mutations were detected in 74% (117/159) and 30% (48/158) of MSI-high tumors, respectively. In Kaplan-Meier analysis as well as univariate and multivariate Cox regression analyses, compared to microsatellite stable (MSS)/MSI-low cases, MSI-high cases were associated with superior colorectal cancer-specific survival [adjusted HR, 0.34; 95% confidence interval (CI), 0.20-0.57] regardless of TGFBR2 or BAX mutation status. Among MSI-high tumors, TGFBR2 mononucleotide mutation was associated with CIMP-high independent of other variables [multivariate odds ratio, 3.57; 95% CI, 1.66-7.66; p = 0.0011]. Conclusions: TGFBR2 or BAX mononucleotide mutations are not associated with the patient survival outcome in MSI-high colorectal cancer. Our data do not support those mutations as prognostic biomarkers (beyond MSI) in colorectal carcinoma.	[Shima, Kaori; Morikawa, Teppei; Yamauchi, Mai; Kuchiba, Aya; Imamura, Yu; Liao, Xiaoyun; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shima, Kaori; Morikawa, Teppei; Yamauchi, Mai; Kuchiba, Aya; Imamura, Yu; Liao, Xiaoyun; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Shima, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	shuji_ogino@dfci.harvard.edu		Ogino, Shuji/0000-0002-3909-2323	United States National Institutes of Health (NIH) [P01CA87969, P01CA55075, P50CA127003, K07CA122826, R01CA151993]; Bennett Family Fund; Entertainment Industry Foundation through National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE [P01CA055075, P01CA087969, K07CA122826, R01CA149222, P50CA127003, R01CA151993] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation through National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States National Institutes of Health (NIH) grants P01CA87969 (to SE Hankinson), P01CA55075 (to WC Willett), P50CA127003 (to CSF), K07CA122826 (to SO) and R01CA151993 (to SO), and in part by grants from the Bennett Family Fund and from the Entertainment Industry Foundation through National Colorectal Cancer Research Alliance. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 1999, ONCOGENE, V18, P2139, DOI 10.1038/sj.onc.1202589; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Bacman D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-156; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Biswas S, 2004, CANCER RES, V64, P4687, DOI 10.1158/0008-5472.CAN-03-3255; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chowdhury Sanjib, 2009, Mol Cell Pharmacol, V1, P57; Curtin K, 2011, PATHOLOG RES INT, V2011, DOI DOI 10.4061/2011/902674; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; de Maat MFG, 2010, AM J PATHOL, V177, P2347, DOI 10.2353/ajpath.2010.091103; de Vogel S, 2011, CANCER CAUSE CONTROL, V22, P1, DOI 10.1007/s10552-010-9659-6; Duval A, 2002, CANCER RES, V62, P2447; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Fernandez-Peralta AM, 2005, CANCER GENET CYTOGEN, V157, P18, DOI 10.1016/j.cancergencyto.2004.05.008; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; Grabowski P, 2006, INT J COLORECTAL DIS, V21, P221, DOI 10.1007/s00384-005-0779-5; Hector S, 2009, BBA-REV CANCER, V1795, P117, DOI 10.1016/j.bbcan.2008.12.002; Hughes LAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018571; Iacopetta B, 2010, ASIA-PAC J CLIN ONCO, V6, P260, DOI 10.1111/j.1743-7563.2010.01335.x; Iacopetta BJ, 1998, J PATHOL, V184, P390; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kim GP, 2007, J CLIN ONCOL, V25, P767, DOI 10.1200/JCO.2006.05.8172; Kim JC, 2010, ANN SURG ONCOL, V17, P1767, DOI 10.1245/s10434-009-0901-y; Kim JH, 2009, VIRCHOWS ARCH, V455, P485, DOI 10.1007/s00428-009-0857-0; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mishra L, 2005, ONCOGENE, V24, P5775, DOI 10.1038/sj.onc.1208924; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nehls O, 2007, BRIT J CANCER, V96, P1409, DOI 10.1038/sj.bjc.6603728; Ng K, 2011, J NATL CANC I; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2011, NAT REV CLI IN PRESS, DOI [10.1038/nrclinonc.2011.1122, DOI 10.1038/NRCLINONC.2011.1122)]; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2007, HUM PATHOL, V38, P614, DOI 10.1016/j.humpath.2006.10.005; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Ogino S, 2008, J CLIN ONCOL, V26, P5713, DOI [10.1200/JCO.2008.18.2675, 10.1200/JCO.2009.22.8858]; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Samowitz WS, 2002, GENE CHROMOSOME CANC, V35, P368, DOI 10.1002/gcc.10125; Schernhammer ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021102; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Shima K, 2011, CANCER CAUSE CONTROL, V22, P301, DOI 10.1007/s10552-010-9698-z; Shima K, 2011, INT J CANCER, V128, P1080, DOI 10.1002/ijc.25432; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; Slattery ML, 2011, CARCINOGENESIS, V32, P318, DOI 10.1093/carcin/bgq245; Tanaka N, 2010, AM J PATHOL, V177, P2731, DOI 10.2353/ajpath.2010.100361; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Zlobec I, 2011, J PATHOL IN PRESS	72	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25062	10.1371/journal.pone.0025062	http://dx.doi.org/10.1371/journal.pone.0025062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949851	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400043
J	Pierce, BG; Hourai, Y; Weng, ZP				Pierce, Brian G.; Hourai, Yuichiro; Weng, Zhiping			Accelerating Protein Docking in ZDOCK Using an Advanced 3D Convolution Library	PLOS ONE			English	Article							SHAPE COMPLEMENTARITY; PERFORMANCE; DESOLVATION; PREDICTION; ZRANK; FIT	Computational prediction of the 3D structures of molecular interactions is a challenging area, often requiring significant computational resources to produce structural predictions with atomic-level accuracy. This can be particularly burdensome when modeling large sets of interactions, macromolecular assemblies, or interactions between flexible proteins. We previously developed a protein docking program, ZDOCK, which uses a fast Fourier transform to perform a 3D search of the spatial degrees of freedom between two molecules. By utilizing a pairwise statistical potential in the ZDOCK scoring function, there were notable gains in docking accuracy over previous versions, but this improvement in accuracy came at a substantial computational cost. In this study, we incorporated a recently developed 3D convolution library into ZDOCK, and additionally modified ZDOCK to dynamically orient the input proteins for more efficient convolution. These modifications resulted in an average of over 8.5-fold improvement in running time when tested on 176 cases in a newly released protein docking benchmark, as well as substantially less memory usage, with no loss in docking accuracy. We also applied these improvements to a previous version of ZDOCK that uses a simpler non-pairwise atomic potential, yielding an average speed improvement of over 5-fold on the docking benchmark, while maintaining predictive success. This permits the utilization of ZDOCK for more intensive tasks such as docking flexible molecules and modeling of interactomes, and can be run more readily by those with limited computational resources.	[Pierce, Brian G.; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01609 USA; [Hourai, Yuichiro] Natl Inst Adv Ind Sci & Technol, CBRC, Tokyo, Japan	University of Massachusetts System; University of Massachusetts Worcester; National Institute of Advanced Industrial Science & Technology (AIST)	Pierce, BG (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01609 USA.	zhiping.weng@umassmed.edu	Pierce, Brian/AAB-8965-2022	Pierce, Brian/0000-0003-4821-0368	National Institutes of Health [GM084884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant GM084884. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chaudhury S, 2008, J MOL BIOL, V381, P1068, DOI 10.1016/j.jmb.2008.05.042; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Fanelli F, 2006, J STRUCT BIOL, V153, P278, DOI 10.1016/j.jsb.2005.12.002; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Hwang H, 2010, PROTEINS, V78, P3104, DOI 10.1002/prot.22764; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Karaca E, 2011, STRUCTURE, V19, P555, DOI 10.1016/j.str.2011.01.014; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krol M, 2007, PROTEINS, V69, P750, DOI 10.1002/prot.21698; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Moreira IS, 2010, J COMPUT CHEM, V31, P317, DOI 10.1002/jcc.21276; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Nukada A, 2007, LECT NOTES COMPUT SC, V4742, P958; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Ritter J., 1990, GRAPH GEMS, P301; Schneidman-Duhovny D, 2007, PROTEINS, V69, P764, DOI 10.1002/prot.21759; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	26	377	385	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24657	10.1371/journal.pone.0024657	http://dx.doi.org/10.1371/journal.pone.0024657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949741	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900026
J	Xie, CC; Sun, JH; Qiao, WD; Lu, DY; Wei, LL; Na, M; Song, YY; Hou, XH; Lin, ZG				Xie, Chuncheng; Sun, Jiahang; Qiao, Weidong; Lu, Dunyue; Wei, Lanlan; Na, Meng; Song, Yuanyuan; Hou, Xiaohua; Lin, Zhiguo			Administration of Simvastatin after Kainic Acid-Induced Status Epilepticus Restrains Chronic Temporal Lobe Epilepsy	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENTATE GRANULE CELLS; REDUCTASE INHIBITORS; RAT HIPPOCAMPUS; INDUCED EXCITOTOXICITY; REDUCES INFLAMMATION; SPONTANEOUS SEIZURES; GLIA ACTIVATION; BRAIN-INJURY; CA3 REGION	In this study, we examined the effect of chronic administration of simvastatin immediately after status epilepticus (SE) on rat brain with temporal lobe epilepsy (TLE). First, we evaluated cytokines expression at 3 days post KA-lesion in hippocampus and found that simvastatin-treatment suppressed lesion-induced expression of interleukin (IL)-1 beta and tumor necrosis factor-alpha (TNF-alpha). Further, we quantified reactive astrocytosis using glial fibrillary acidic protein (GFAP) staining and neuron loss using Nissl staining in hippocampus at 4-6 months after KA-lesion. We found that simvastatin suppressed reactive astrocytosis demonstrated by a significant decrease in GFAP-positive cells, and attenuated loss of pyramidal neurons in CA3 and interneurons in dentate hilar (DH). We next assessed aberrant mossy fiber sprouting (MFS) that is known to contribute to recurrence of spontaneous seizure in epileptic brain. In contrast to the robust MFS observed in saline-treated animals, the extent of MFS was restrained by simvastatin in epileptic rats. Attenuated MFS was related to decreased neuronal loss in CA3 and DH, which is possibly a mechanism underlying decreased hippocampal susceptibility in animal treated with simvastatin. Electronic encephalography (EEG) was recorded during 4 to 6 months after KA-lesion. The frequency of abnormal spikes in rats with simvastatin-treatment decreased significantly compared to the saline group. In summary, simvastatin treatment suppressed cytokines expression and reactive astrocytosis and decreased the frequency of discharges of epileptic brain, which might be due to the inhibition of MFS in DH. Our study suggests that simvastatin administration might be a possible intervention and promising strategy for preventing SE exacerbating to chronic epilepsy.	[Xie, Chuncheng; Qiao, Weidong; Na, Meng; Song, Yuanyuan; Lin, Zhiguo] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin, Peoples R China; [Sun, Jiahang] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China; [Lu, Dunyue] Suny Downstate Med Ctr, Dept Psychiat, Brooklyn, NY 11203 USA; [Wei, Lanlan] Harbin Med Univ, Dept Microbiol, Harbin, Heilongjiang, Peoples R China; [Hou, Xiaohua] Harbin Med Univ, Affiliated Hosp 1, Dept Neurol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Harbin Medical University; Harbin Medical University	Lin, ZG (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin, Peoples R China.	linzhiguo@hotmail.com			National Natural Science Foundation of China [81071215]; Science Foundation of Heilongjiang Province [D201062]; Foreign Collaboration Project of Heilongjiang Province [WB10B104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Heilongjiang Province; Foreign Collaboration Project of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (81071215), the Science Foundation of Heilongjiang Province (D201062) and the Foreign Collaboration Project of Heilongjiang Province (WB10B104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth C, 2003, HIPPOCAMPUS, V13, P375, DOI 10.1002/hipo.10090; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; Bovolenta R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-81; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Buckmaster PS, 2004, EPILEPSIA, V45, P452, DOI 10.1111/j.0013-9580.2004.67103.x; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Cersosimo R, 2011, SEIZURE-EUR J EPILEP, V20, P131, DOI 10.1016/j.seizure.2010.11.002; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Devaraj S, 2006, J CLIN ENDOCR METAB, V91, P4489, DOI 10.1210/jc.2006-0299; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Fabene PF, 2010, J NEUROIMMUNOL, V224, P22, DOI 10.1016/j.jneuroim.2010.05.016; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Gouveia TLF, 2011, EPILEPSY BEHAV, V20, P1, DOI 10.1016/j.yebeh.2010.10.001; Galic MA, 2009, NEUROBIOL DIS, V36, P343, DOI 10.1016/j.nbd.2009.07.025; Gibson RM, 2004, VET J, V168, P230, DOI 10.1016/j.tvjl.2003.10.016; Hailer NP, 2005, EUR J NEUROSCI, V21, P2347, DOI 10.1111/j.1460-9568.2005.04067.x; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; He XP, 2001, NEUROSCI RES, V39, P455, DOI 10.1016/S0168-0102(01)00200-0; HOUSER CR, 1990, J NEUROSCI, V10, P267; Jankowsky JL, 2001, PROG NEUROBIOL, V63, P125, DOI 10.1016/S0301-0082(00)00022-8; Joukhadar C, 2001, THROMB HAEMOSTASIS, V85, P47, DOI 10.1055/s-0037-1612902; Kanemoto K, 2000, ANN NEUROL, V47, P571, DOI 10.1002/1531-8249(200005)47:5<571::AID-ANA3>3.3.CO;2-1; Kirsch C, 2003, PHARMACOPSYCHIATRY, V36, pS113; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; LIEB JP, 1989, EPILEPSIA, V30, P147, DOI 10.1111/j.1528-1157.1989.tb05447.x; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; MANFORD M, 1992, NEUROLOGY, V42, P1911; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; NAITOH Y, 1988, BIOCHEM BIOPH RES CO, V155, P1459, DOI 10.1016/S0006-291X(88)81305-6; Nath N, 2004, J IMMUNOL, V172, P1273, DOI 10.4049/jimmunol.172.2.1273; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Paintlia AS, 2004, J NEUROSCI RES, V77, P63, DOI 10.1002/jnr.20130; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Rajanikant GK, 2007, CURR MED CHEM, V14, P103, DOI 10.2174/092986707779313462; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Rangel P, 2005, ARQ NEURO-PSIQUIAT, V63, P972, DOI 10.1590/S0004-282X2005000600013; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Rao RS, 2008, EUR NEUROPSYCHOPHARM, V18, P760, DOI 10.1016/j.euroneuro.2008.06.008; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Ravizza T, 2008, NEUROBIOL DIS, V31, P327, DOI 10.1016/j.nbd.2008.05.007; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shetty AK, 1999, J COMP NEUROL, V414, P238, DOI 10.1002/(SICI)1096-9861(19991115)414:2<238::AID-CNE7>3.0.CO;2-A; Shetty AK, 1997, EXP NEUROL, V143, P231, DOI 10.1006/exnr.1996.6363; Shumate MD, 1998, EPILEPSY RES, V32, P114, DOI 10.1016/S0920-1211(98)00045-X; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Singh I, 1998, FEBS LETT, V426, P342, DOI 10.1016/S0014-5793(98)00370-6; Stanislaus R, 2002, NEUROSCI LETT, V333, P167, DOI 10.1016/S0304-3940(02)00943-6; Stanley DP, 2004, J NEUROCHEM, V89, P204, DOI 10.1111/j.1471-4159.2004.02318.x; Strine TW, 2005, EPILEPSIA, V46, P1133, DOI 10.1111/j.1528-1167.2005.01605.x; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Uzum G, 2010, EPILEPSY BEHAV, V19, P284, DOI 10.1016/j.yebeh.2010.07.024; van Vliet EA, 2004, EXP NEUROL, V187, P367, DOI 10.1016/j.expneurol.2004.01.016; Vezzani A, 2010, CURR OPIN INVEST DR, V11, P43; White CM, 1999, J CLIN PHARMACOL, V39, P111, DOI 10.1177/00912709922007642; Wood WG, 2010, ANN NY ACAD SCI, V1199, P69, DOI 10.1111/j.1749-6632.2009.05359.x; Zacco A, 2003, J NEUROSCI, V23, P11104; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang X, 2002, J NEUROSCI, V22, P6052	78	64	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24966	10.1371/journal.pone.0024966	http://dx.doi.org/10.1371/journal.pone.0024966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949812	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900042
J	Zhi, B; Wang, L; Wang, GY; Zhang, XB				Zhi, Bin; Wang, Lei; Wang, Guangyi; Zhang, Xiaobo			Contribution of the Caspase Gene Sequence Diversification to the Specifically Antiviral Defense in Invertebrate	PLOS ONE			English	Article							SHRIMP; IMMUNITY; PHAGOCYTOSIS; DROSOPHILA; APOPTOSIS; MECHANISMS; COMPLEX	Vertebrates achieve adaptive immunity of all sorts against pathogens through the diversification of antibodies. However the mechanism of invertebrates' innate immune defense against various pathogens remains largely unknown. Our study used shrimp and white spot syndrome virus (WSSV) to show that PjCaspase, a caspase gene of shrimp that is crucial in apoptosis, possessed gene sequence diversity. At present, the role of gene sequence diversity in immunity has not been characterized. To address this issue, we compared the PjCaspase gene sequence diversities from WSSV-free and WSSV-resistant shrimp. The sequence analysis indicated that the PjCaspase gene from the WSSV-resistant shrimp contained a special fragment, designated as fragment 3 (221-229 aa). Down-regulation or overexpression of the PjCaspase gene containing fragment 3 led to significant inhibition or enhancement of virus-induced apoptosis, but had no effect on bacterium challenge. We found evidence that the silencing or overexpression of this gene led to a 7-fold increase or 11-fold decrease of WSSV copies, respectively. Our results suggested that the PjCaspase gene containing fragment 3 provided the molecular basis for the antiviral defense of shrimp. This study represented the first report of the role of gene sequence diversity in the immunity of an invertebrate against virus infection. Invertebrates may employ this gene sequence diversity as a system to avoid pathogen interference with their immune response.	[Zhi, Bin; Wang, Lei] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China; [Zhang, Xiaobo] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Minist Agr,Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Guangyi] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	State Oceanic Administration; Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University; University of Hawaii System; University of Hawaii Manoa	Zhi, B (corresponding author), State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China.	zxb0812@zju.edu.cn			National Natural Science Foundation of China [30830084]; Hi-Tech Research and Development Program of China (863 program of China) [2010AA09Z403]; Ministry of Agriculture, China [201103034]; Chinese Universities Scientific Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China (863 program of China)(National High Technology Research and Development Program of China); Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Chinese Universities Scientific Fund	This work was financially supported by National Natural Science Foundation of China (30830084), Hi-Tech Research and Development Program of China (863 program of China) (2010AA09Z403), Project of Ministry of Agriculture, China (201103034) and Chinese Universities Scientific Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Khurana T, 2005, EMBO J, V24, P2254, DOI 10.1038/sj.emboj.7600716; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Leu JH, 2010, DEV COMP IMMUNOL, V34, P1068, DOI 10.1016/j.dci.2010.05.010; Litman GW, 2005, ADV IMMUNOL, V87, P209, DOI 10.1016/S0065-2776(05)87006-3; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Balcazar JL, 2007, J INVERTEBR PATHOL, V96, P147, DOI 10.1016/j.jip.2007.04.008; Mahowald GK, 2008, CELL, V135, P1009, DOI 10.1016/j.cell.2008.11.024; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Roitt I., 2001, ROITTS ESSENTIAL IMM; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Xu JY, 2007, ANTIVIR RES, V73, P126, DOI 10.1016/j.antiviral.2006.08.007; Zhang Aiqun, 2004, Neuroembryology, V3, P47, DOI 10.1159/000085404; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zuo HL, 2011, FISH SHELLFISH IMMUN, V30, P1188, DOI 10.1016/j.fsi.2011.02.021	28	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24955	10.1371/journal.pone.0024955	http://dx.doi.org/10.1371/journal.pone.0024955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949804	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900040
J	Barnitz, RA; Chaigne-Delalande, B; Bolton, DL; Lenardo, MJ				Barnitz, R. Anthony; Chaigne-Delalande, Benjamin; Bolton, Diane L.; Lenardo, Michael J.			Exposed Hydrophobic Residues in Human Immunodeficiency Virus Type 1 Vpr Helix-1 Are Important for Cell Cycle Arrest and Cell Death	PLOS ONE			English	Article							INDUCED G(2) ARREST; HIV-1 VPR; NUCLEAR-LOCALIZATION; VIRION INCORPORATION; PROTEIN VPR; T-CELLS; UBIQUITIN LIGASE; MUTATIONAL ANALYSIS; REGULATORY PROTEIN; ACCESSORY PROTEIN	The human immunodeficiency virus type 1 (HIV-1) accessory protein viral protein R (Vpr) is a major determinant for virus-induced G2/M cell cycle arrest and cytopathicity. Vpr is thought to perform these functions through the interaction with partner proteins. The NMR structure of Vpr revealed solvent exposed hydrophobic amino acids along helices 1 and 3 of Vpr, which could be putative protein binding domains. We previously showed that the hydrophobic patch along helix-3 was important for G2/M blockade and cytopathicity. Mutations of the exposed hydrophobic residues along helix-1 were found to reduce Vpr-induced cell cycle arrest and cell death as well. The levels of toxicity during virion delivery of Vpr correlated with G2/M arrest. Thus, the exposed hydrophobic amino acids in the amino-terminal helix-1 are important for the cell cycle arrest and cytopathicity functions of Vpr.	[Barnitz, R. Anthony; Chaigne-Delalande, Benjamin; Bolton, Diane L.; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Barnitz, R. Anthony; Lenardo, Michael J.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Barnitz, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	lenardo@nih.gov		Barnitz, Tony/0000-0002-9634-4558; Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000718] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; Barnitz RA, 2010, J VIROL, V84, P6410, DOI 10.1128/JVI.02273-09; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bolton DL, 2007, J VIROL, V81, P8878, DOI 10.1128/JVI.00122-07; Bolton DL, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-17; Bolton DL, 2002, J VIROL, V76, P5094, DOI 10.1128/JVI.76.10.5094-5107.2002; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Kamata M, 2000, J VIROL, V74, P7179, DOI 10.1128/JVI.74.15.7179-7186.2000; Kino T, 2005, J VIROL, V79, P2780, DOI 10.1128/JVI.79.5.2780-2787.2005; Kino T, 2004, DNA CELL BIOL, V23, P193, DOI 10.1089/104454904773819789; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lenardo MJ, 2002, J VIROL, V76, P5082, DOI 10.1128/JVI.76.10.5082-5093.2002; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; Mahalingam S, 1997, J VIROL, V71, P6339, DOI 10.1128/JVI.71.9.6339-6347.1997; MAHALINGAM S, 1995, P NATL ACAD SCI USA, V92, P3794, DOI 10.1073/pnas.92.9.3794; MAHALINGAM S, 1995, VIROLOGY, V207, P297, DOI 10.1006/viro.1995.1081; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Nie ZL, 1998, J VIROL, V72, P4104, DOI 10.1128/JVI.72.5.4104-4115.1998; Pandey RC, 2009, CURR HIV RES, V7, P114, DOI 10.2174/157016209787581508; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Sawaya BE, 2000, J VIROL, V74, P4877, DOI 10.1128/JVI.74.10.4877-4881.2000; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Stewart SA, 1999, P NATL ACAD SCI USA, V96, P12039, DOI 10.1073/pnas.96.21.12039; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Thotala D, 2004, VIROLOGY, V328, P89, DOI 10.1016/j.virol.2004.07.013; WANG LL, 1995, J BIOL CHEM, V270, P25564, DOI 10.1074/jbc.270.43.25564; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Zhou Y, 1998, VIROLOGY, V242, P414, DOI 10.1006/viro.1998.9028	56	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24924	10.1371/journal.pone.0024924	http://dx.doi.org/10.1371/journal.pone.0024924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949789	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800049
J	Bigham, AW; Buckingham, KJ; Husain, S; Emond, MJ; Bofferding, KM; Gildersleeve, H; Rutherford, A; Astakhova, N; Perelygin, AA; Busch, MP; Murray, KO; Sejvar, JJ; Green, S; Kriesel, J; Brinton, MA; Bamshad, M				Bigham, Abigail W.; Buckingham, Kati J.; Husain, Sofia; Emond, Mary J.; Bofferding, Kathryn M.; Gildersleeve, Heidi; Rutherford, Ann; Astakhova, NataliaM.; Perelygin, Andrey A.; Busch, Michael P.; Murray, Kristy O.; Sejvar, James J.; Green, Sharone; Kriesel, John; Brinton, Margo A.; Bamshad, Michael			Host Genetic Risk Factors for West Nile Virus Infection and Disease Progression	PLOS ONE			English	Article							RECEPTOR 5 GENE; NEW-YORK; IMMUNODEFICIENCY-VIRUS; UNITED-STATES; ENCEPHALITIS; OUTBREAK; EPIDEMIC; ASSOCIATION; DEFICIENCY; DELETION	West Nile virus (WNV), a category B pathogen endemic in parts of Africa, Asia and Europe, emerged in North America in 1999, and spread rapidly across the continental U. S. Outcomes of infection with WNV range from asymptomatic to severe neuroinvasive disease manifested as encephalitis, paralysis, and/or death. Neuroinvasive WNV disease occurs in less than one percent of cases, and although host genetic factors are thought to influence risk for symptomatic disease, the identity of these factors remains largely unknown. We tested 360 common haplotype tagging and/or functional SNPs in 86 genes that encode key regulators of immune function in 753 individuals infected with WNV including: 422 symptomatic WNV cases and 331 cases with asymptomatic infections. After applying a Bonferroni correction for multiple tests and controlling for population stratification, SNPs in IRF3 (OR 0.54, p = 0.035) and MX1, (OR 0.19, p = 0.014) were associated with symptomatic WNV infection and a single SNP in OAS1 (OR 9.79, p = 0.003) was associated with increased risk for West Nile encephalitis and paralysis (WNE/P). Together, these results suggest that genetic variation in the interferon response pathway is associated with both risk for symptomatic WNV infection and WNV disease progression.	[Bigham, Abigail W.; Buckingham, Kati J.; Husain, Sofia; Bofferding, Kathryn M.; Gildersleeve, Heidi; Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Emond, Mary J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rutherford, Ann; Kriesel, John] Univ Utah, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84112 USA; [Astakhova, NataliaM.; Perelygin, Andrey A.; Brinton, Margo A.] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Busch, Michael P.] Blood Syst, San Francisco, CA USA; [Murray, Kristy O.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX USA; [Sejvar, James J.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA; [Green, Sharone] Univ Massachusetts, Sch Med, Dept Med, Ctr Infect Dis & Vaccine Res, Worcester, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University System of Georgia; Georgia State University; Vitalant; Vitalant Research Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Centers for Disease Control & Prevention - USA; University of Massachusetts System; University of Massachusetts Worcester	Bigham, AW (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	awb150@u.washington.edu; mbamshad@u.washington.edu			Rocky Mountain Regional Center of Excellence (National Institutes of Health [NIH]) [U54 AI-065357]; Centers for Infectious Diseases (CDC) [CI000216]; National Institute of Allergy and Infectious Diseases (NIH) [AI057341]; NIH/National Human Genome Research Institute [T32 HG00035]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000216] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357, R01AI091816, K23AI057341] Funding Source: NIH RePORTER	Rocky Mountain Regional Center of Excellence (National Institutes of Health [NIH])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Infectious Diseases (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Rocky Mountain Regional Center of Excellence (National Institutes of Health [NIH] grant # U54 AI-065357), the Centers for Infectious Diseases (CDC grant # CI000216), and the National Institute of Allergy and Infectious Diseases (NIH grant # AI057341). AWB was supported by a training fellowship from the NIH/National Human Genome Research Institute (T32 HG00035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Asnis DS, 2001, ANN NY ACAD SCI, V951, P161; Craven RB, 2001, JAMA-J AM MED ASSOC, V286, P651, DOI 10.1001/jama.286.6.651; Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Elbahesh H, 2011, VIROLOGY, V409, P262, DOI 10.1016/j.virol.2010.10.016; Emig M, 2004, CLIN INFECT DIS, V38, P289, DOI 10.1086/380458; Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scherbik SV, 2007, VIROLOGY, V368, P232, DOI 10.1016/j.virol.2007.08.017; Sejvar JJ, 2006, REV MED VIROL, V16, P209, DOI 10.1002/rmv.501; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340	33	84	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24745	10.1371/journal.pone.0024745	http://dx.doi.org/10.1371/journal.pone.0024745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935451	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700054
J	Chaudhari, A; Braem, A; Vleugels, J; Martens, JA; Naert, I; Cardoso, MV; Duyck, J				Chaudhari, Amol; Braem, Annabel; Vleugels, Jozef; Martens, Johan A.; Naert, Ignace; Cardoso, Marcio Vivan; Duyck, Joke			Bone Tissue Response to Porous and Functionalized Titanium and Silica Based Coatings	PLOS ONE			English	Article							AMORPHOUS MICROPOROUS SILICA; CONTROLLED-RELEASE; SURFACE-ROUGHNESS; OXIDE THICKNESS; IMPLANTS; DISSOLUTION; CHEMISTRY; METALS; CELLS; 45S5	Background: Topography and presence of bio-mimetic coatings are known to improve osseointegration. The objective of this study was to evaluate the bone regeneration potential of porous and osteogenic coatings. Methodology: Six-implants [Control (CTR); porous titanium coatings (T1, T2); thickened titanium (Ti) dioxide layer (TiO2); Amorphous Microporous Silica (AMS) and Bio-active Glass (BAG)] were implanted randomly in tibiae of 20-New Zealand white rabbits. The animals were sacrificed after 2 or 4 weeks. The samples were analyzed histologically and histomorphometrically. In the initial bone-free areas (bone regeneration areas (BRAs)), the bone area fraction (BAF) was evaluated in the whole cavity (500 mu m, BAF-500), in the implant vicinity (100 mu m, BAF-100) and further away (100-500 mu m, BAF-400) from the implant. Bone-to-implant contact (BIC-BAA) was measured in the areas where the implants were installed in contact to the host bone (bone adaptation areas (BAAs)) to understand and compare the bone adaptation. Mixed models were used for statistical analysis. Principal Findings: After 2 weeks, the differences in BAF-500 for different surfaces were not significant (p>0.05). After 4 weeks, a higher BAF-500 was observed for BAG than CTR. BAF-100 for AMS was higher than BAG and BAF-400 for BAG was higher than CTR and AMS. For T1 and AMS, the bone regeneration was faster in the 100-mu m compared to the 400-mu m zone. BIC-BAA for AMS and BAG was lower after 4 than 2 weeks. After 4 weeks, BIC-BAA for BAG was lower than AMS and CTR. Conclusions: BAG is highly osteogenic at a distance from the implant. The porous titanium coatings didn't stimulate bone regeneration but allowed bone growth into the pores. Although AMS didn't stimulate higher bone response, it has a potential of faster bone growth in the vicinity compared to further away from the surface. BIC-BAA data were inconclusive to understand the bone adaptation.	[Chaudhari, Amol; Naert, Ignace; Cardoso, Marcio Vivan; Duyck, Joke] Katholieke Univ Leuven, Dept Prosthet Dent, BIOMAT Res Grp, Louvain, Belgium; [Braem, Annabel; Vleugels, Jozef] Katholieke Univ Leuven, Dept Met & Mat Engn MTM, Heverlee, Belgium; [Martens, Johan A.] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, Heverlee, Belgium	KU Leuven; KU Leuven; KU Leuven	Chaudhari, A (corresponding author), Katholieke Univ Leuven, Dept Prosthet Dent, BIOMAT Res Grp, Louvain, Belgium.	Joke.Duyck@uz.kuleuven.be	Vleugels, Jozef/C-8262-2017; Braem, Annabel/A-4343-2017; Braem, Annabel/AAX-1845-2021	Vleugels, Jozef/0000-0003-4432-4675; Braem, Annabel/0000-0002-4890-0177; Braem, Annabel/0000-0002-4890-0177; Duyck, Joke/0000-0002-8698-1692; Martens, Johan/0000-0002-9292-2357; Naert, Ignace/0000-0001-7007-1443; Cardoso, Marcio Vivan/0000-0003-4551-9300	K. U. Leuven [IDO/06/013]; Commission of the European Communities [NMP3-CT-2006-026501]	K. U. Leuven(KU Leuven); Commission of the European Communities(European Commission)	This work was supported by the research fund of K. U. Leuven under project IDO/06/013 and the 6th Framework of the Commission of the European Communities under project contract no. NMP3-CT-2006-026501 (Meddelcoat). JAM acknowledges the Flemish Government for long-term structural support (Methusalem). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347; Aerts CA, 2010, INT J PHARMACEUT, V397, P84, DOI 10.1016/j.ijpharm.2010.06.053; Aerts CA, 2007, J PHYS CHEM C, V111, P13404, DOI 10.1021/jp0735076; Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012; Braem A, 2011, ADV ENG MATER, V13, P509, DOI 10.1002/adem.201100011; BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81; Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; DAVID A, 1995, ARCH ORTHOP TRAUM SU, V114, P112, DOI 10.1007/BF00422838; Ehlert N, 2001, J MATER CHEM, V21, P752; Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003; Esposito M, 2009, COCHRANE DB SYST REV, V21, DOI DOI 10.1002/14651858.CD003878.PUB4; Gomez-Vega JM, 2001, J MATER SCI-MATER M, V12, P923, DOI 10.1023/A:1012888410936; HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013; Kaysinger KK, 1998, J CELL BIOCHEM, V68, P83, DOI 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S; Kim KH, 2009, DENT MATER J, V28, P20, DOI 10.4012/dmj.28.20; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lefebvre LP, 2008, ADV ENG MATER, V10, P775, DOI 10.1002/adem.200800241; MAIER WF, 1993, ADV MATER, V5, P726, DOI 10.1002/adma.19930051008; Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012; Meyer U, 2006, BRIT J ORAL MAX SURG, V44, P289, DOI 10.1016/j.bjoms.2005.06.026; Misch CE, 2008, IMPLANT DENT, V17, P5, DOI 10.1097/ID.0b013e3181676059; Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q; Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P520, DOI 10.1111/j.1600-0501.2004.01059.x; Neirinck B, 2008, ADV ENG MATER, V10, P246, DOI 10.1002/adem.200700273; Paquette David W, 2006, Dent Clin North Am, V50, P361, DOI 10.1016/j.cden.2006.05.002; Polarz S, 2002, J NANOSCI NANOTECHNO, V2, P581, DOI 10.1166/jnn.2002.151; Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038; Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002; Schiefer H, 2009, J MATER SCI-MATER M, V20, P1763, DOI 10.1007/s10856-009-3733-1; Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207; Slaets E, 2006, J PERIODONTOL, V77, P1015, DOI 10.1902/jop.2006.050196; Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4; Sul YT, 2005, INT J ORAL MAX IMPL, V20, P349; Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4; Vallet-Regi M, 2006, MATERIALWISS WERKST, V37, P478, DOI 10.1002/mawe.200600023; Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488; Vallet-Regi Maria, 2008, Open Biomed Eng J, V2, P1, DOI 10.2174/1874120700802010001; Vercaigne S, 1998, CLIN ORAL IMPLAN RES, V9, P261, DOI 10.1034/j.1600-0501.1998.090407.x; Verraedt E, 2010, J CONTROL RELEASE, V142, P47, DOI 10.1016/j.jconrel.2009.09.022; Vitale-Brovarone C, 2008, J MATER SCI-MATER M, V19, P471, DOI 10.1007/s10856-006-0111-0; Vitte J, 2004, Eur Cell Mater, V7, P52; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503; Zhou W, 2010, BIOMATERIALS, V31, P3212, DOI 10.1016/j.biomaterials.2010.01.036; Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111	49	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24186	10.1371/journal.pone.0024186	http://dx.doi.org/10.1371/journal.pone.0024186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935382	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700014
J	Icimoto, MY; Barros, NM; Ferreira, JC; Marcondes, MF; Andrade, D; Machado, MF; Juliano, MA; Judice, WA; Juliano, L; Oliveira, V				Icimoto, Marcelo Y.; Barros, Nilana M.; Ferreira, Juliana C.; Marcondes, Marcelo F.; Andrade, Douglas; Machado, Mauricio F.; Juliano, Maria A.; Judice, Wagner A.; Juliano, Luiz; Oliveira, Vitor			Hysteretic Behavior of Proprotein Convertase 1/3 (PC1/3)	PLOS ONE			English	Article							PROHORMONE CONVERTASE-1; NEUROENDOCRINE CELLS; PROCESSING ENZYMES; PC2; BUTYRYLCHOLINESTERASE; PROOPIOMELANOCORTIN; ACTIVATION; FAMILY; FURIN	The proprotein convertases (PCs) are calcium-dependent proteases responsible for processing precursor proteins into their active forms in eukariotes. The PC1/3 is a pivotal enzyme of this family that participates in the proteolytic maturation of prohormones and neuropeptides inside the regulated secretory pathway. In this paper we demonstrate that mouse proprotein convertase 1/3 (mPC1/3) has a lag phase of activation by substrates that can be interpreted as a hysteretic behavior of the enzyme for their hydrolysis. This is an unprecedented observation in peptidases, but is frequent in regulatory enzymes with physiological relevance. The lag phase of mPC1/3 is dependent on substrate, calcium concentration and pH. This hysteretic behavior may have implications in the physiological processes in which PC1/3 participates and could be considered an additional control step in the peptide hormone maturation processes as for instance in the transformation of proinsulin to insulin.	[Icimoto, Marcelo Y.; Ferreira, Juliana C.; Marcondes, Marcelo F.; Andrade, Douglas; Machado, Mauricio F.; Juliano, Maria A.; Juliano, Luiz; Oliveira, Vitor] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Judice, Wagner A.] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Mogi das Cruzes	Icimoto, MY (corresponding author), Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.	vitor.oliveira@unifesp.br	Oliveira, Vitor/AAT-5981-2020; Marcondes, Marcelo FM/I-2234-2013; DE SOUZ A S JUDICE, WAGNER ALVES/O-1050-2013; Barros, Nilana/E-2589-2012; Ferreira, Juliana/O-7542-2014; Oliveira, Vitor/L-3709-2013; Icimoto, Marcelo Yudi/L-6275-2016; Complexos, INCT Fluidos/H-9172-2013; Machado, Mauricio Ferreira Marcondes/E-5662-2010; Juliano, Luiz/D-7204-2012; DE SOUZA JUDICE, WAGNER ALVES/AAG-3225-2020	DE SOUZ A S JUDICE, WAGNER ALVES/0000-0002-1608-9105; Oliveira, Vitor/0000-0002-4662-1377; Icimoto, Marcelo Yudi/0000-0002-0746-5279; Machado, Mauricio Ferreira Marcondes/0000-0003-0313-0866; Juliano, Luiz/0000-0002-5589-2822; 	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Instituto Nacional de Fluidos complexos (INCT-Fx)	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Instituto Nacional de Fluidos complexos (INCT-Fx)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Instituto Nacional de Fluidos complexos (INCT-Fx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MC, 2000, BIOCHEMISTRY-US, V39, P8519, DOI 10.1021/bi9928905; Basak A, 1997, J PEPT RES, V49, P596; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davidson HW, 2004, CELL BIOCHEM BIOPHYS, P143, DOI 10.1385/CBB:40:3:143; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Dikeakos JD, 2007, FEBS J, V274, P4094, DOI 10.1111/j.1742-4658.2007.05937.x; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; GOODMAN LJ, 1994, BIOCHEM BIOPH RES CO, V201, P795, DOI 10.1006/bbrc.1994.1771; Hirata I, 1994, LETT PEPT SCI, V27, P299; Hoshino A, 2011, ENDOCRINOLOGY, V152, P1402, DOI 10.1210/en.2010-1170; Izidoro MA, 2010, BIOL CHEM, V391, P1105, DOI 10.1515/BC.2010.114; Izidoro MA, 2009, ARCH BIOCHEM BIOPHYS, V487, P105, DOI 10.1016/j.abb.2009.05.013; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; KURGANOV BI, 1976, J THEOR BIOL, V60, P287, DOI 10.1016/0022-5193(76)90061-8; Lindberg I., 1995, METH NEUROSCI, V23, P94; Madan G, 1996, Indian J Med Sci, V50, P318; Masson P, 2004, EUR J BIOCHEM, V271, P220, DOI 10.1046/j.1432-1033.2003.03924.x; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; Neet K E, 1980, Methods Enzymol, V64, P192; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; VANDEVEN WJM, 1993, CRIT REV ONCOGENESIS, V4, P115; YI Z, 1993, J BIOL CHEM, V268, P5615; Zhang DN, 2005, J AM CHEM SOC, V127, P3760, DOI 10.1021/ja043258o; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHOU Y, 1995, J BIOL CHEM, V270, P24702, DOI 10.1074/jbc.270.42.24702	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24545	10.1371/journal.pone.0024545	http://dx.doi.org/10.1371/journal.pone.0024545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935423	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700041
J	Vadwai, V; Daver, G; Udwadia, Z; Sadani, M; Shetty, A; Rodrigues, C				Vadwai, Viral; Daver, Gustad; Udwadia, Zarir; Sadani, Meeta; Shetty, Anjali; Rodrigues, Camilla			Clonal Population of Mycobacterium tuberculosis Strains Reside within Multiple Lung Cavities	PLOS ONE			English	Article							AMINOSALICYLIC ACID RESISTANCE; EMBB306 MUTATIONS; OUTBREAK; REGION	Background: Unsuccessful treatment outcomes among patients with multi-/extensively- drug resistant tuberculosis (TB) have hampered efforts involved in eradicating this disease. In order to better understand the etiology of this disease, we aimed to determine whether single or multiple strains of Mycobacterium tuberculosis (MTB) are localized within lung cavities of patients suffering from chronic progressive TB. Methodology/Findings: Multiple cavity isolates from lung of 5 patients who had undergone pulmonary resection surgery were analyzed on the basis of their drug susceptibility profile, and genotyped by spoligotyping and 24-loci MIRU-VNTR. The patients past history including treatment was studied. Three of the 5 patients had extensive drug resistant TB. Heteroresistance was also reported within different cavity isolates of the lung. Both genotyping methods reported the presence of clonal population of MTB strain within different cavities of the each patient, even those reporting heteroresistance. Four of the 5 patients were infected with a population of the Beijing genotype. Post-surgery they were prescribed a drug regimen consisting of cycloserine, a fluoroquinolone and an injectable drug. A 6 month post-surgery follow-up reported only 2 patients with positive clinical outcome, showing sputum conversion. Conclusion: Identical spoligotype patterns and MIRU-VNTR profiles between multiple cavities of each patient, characterize the presence of clonal population of MTB strains (and absence of multiple MTB infection).	[Vadwai, Viral] PD Hinduja Natl Hosp, Bombay, Maharashtra, India; Med Res Ctr, Bombay, Maharashtra, India		Vadwai, V (corresponding author), PD Hinduja Natl Hosp, Bombay, Maharashtra, India.	dr_crodrigues@hindujahospital.com			National Health and Education Society; P. D. Hinduja National Hospital and Medical Research Centre	National Health and Education Society; P. D. Hinduja National Hospital and Medical Research Centre	We thank National Health and Education Society, P. D. Hinduja National Hospital and Medical Research Centre for their encouragement and support.	Ajbani K, 2011, J CLIN MICROBIOL, V49, P2546, DOI 10.1128/JCM.02511-10; Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Barco P, 2006, J ANTIMICROB CHEMOTH, V58, P930, DOI 10.1093/jac/dkl363; BATES JH, 1976, AM REV RESPIR DIS, V114, P353; CURRY FJ, 2008, DRUG RESISTANT TUBER, P32; du Plessis DG, 2001, TUBERCULOSIS, V81, P211, DOI 10.1054/tube.2000.0278; Feuerriegel S, 2010, ANTIMICROB AGENTS CH, V54, P4794, DOI 10.1128/AAC.00738-10; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; ISEMAN MD, 1990, AM REV RESPIR DIS, V141, P623, DOI 10.1164/ajrccm/141.3.623; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kent PT, 1985, GUIDE LEVEL 3 LAB; MANKIEWICZ E, 1975, AM REV RESPIR DIS, V111, P307; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; Mitchison DA, 2004, SEMIN RESP CRIT CARE, V25, P307, DOI 10.1055/s-2004-829503; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P3810, DOI 10.1128/JCM.40.10.3810-3813.2002; Perdigao J, 2009, INT J ANTIMICROB AG, V33, P334, DOI 10.1016/j.ijantimicag.2008.09.021; POMERANTZ M, 1991, ANN THORAC SURG, V52, P1108, DOI 10.1016/0003-4975(91)91289-8; Rinder H, 2001, INT J TUBERC LUNG D, V5, P339; Rodrigues C, 2008, INT J TUBERC LUNG D, V12, P1449; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Weyer K, 1998, LAB SERVICES TUBER 3	25	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24770	10.1371/journal.pone.0024770	http://dx.doi.org/10.1371/journal.pone.0024770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935462	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700045
J	Minobe, E; Asmara, H; Saud, ZA; Kameyama, M				Minobe, Etsuko; Asmara, Hadhimulya; Saud, Zahangir A.; Kameyama, Masaki			Calpastatin Domain L Is a Partial Agonist of the Calmodulin-binding Site for Channel Activation in Cav1.2 Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; PIG VENTRICULAR MYOCYTES; CALCIUM-CHANNELS; CA2+-DEPENDENT INACTIVATION; CA(V)1.2 CHANNEL; RUN-DOWN; FACILITATION; CALPAIN; HEART; ALPHA(1C)	Cav1.2 Ca2+ channel activity diminishes in inside-out patches (run-down). Previously, we have found that with ATP, calpastatin domain L (CSL) and calmodulin (CaM) recover channel activity from the run-down in guinea pig cardiac myocytes. Because the potency of the CSL repriming effect was smaller than that of CaM, we hypothesized that CSL might act as a partial agonist of CaM in the channel-repriming effect. To examine this hypothesis, we investigated the effect of the competitions between CSL and CaM on channel activity and on binding in the channel. We found that CSL suppressed the channel-activating effect of CaM in a reversible and concentration-dependent manner. The channel-inactivating effect of CaM seen at high concentrations of CaM, however, did not seem to be affected by CSL. In the GST pull-down assay, CSL suppressed binding of CaM to GST fusion peptides derived from C-terminal regions in a competitive manner. The inhibition of CaM binding by CSL was observed with the IQ peptide but not the PreIQ peptide, which is the CaM-binding domain in the C terminus. The results are consistent with the hypothesis that CSL competes with CaM as a partial agonist for the site in the IQ domain in the C-terminal region of the Cav1.2	[Minobe, Etsuko; Asmara, Hadhimulya; Saud, Zahangir A.; Kameyama, Masaki] Kagoshima Univ, Dept Physiol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	Kagoshima University	Kameyama, M (corresponding author), 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	kame@m.kufm.kagoshima-u.ac.jp	Saud, Zahangir Alam/ADC-1753-2022	Saud, Zahangir Alam/0000-0003-0019-053X	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Kodama Memorial Foundation for Medical Research	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kodama Memorial Foundation for Medical Research	This work was supported by a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science, and Technology (to E. M.), a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to M. K.), and a grant from the Kodama Memorial Foundation for Medical Research (to E. M.).	Asmara H, 2010, J PHARMACOL SCI, V112, P397, DOI 10.1254/jphs.09342FP; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; De Tullio R, 2000, FEBS LETT, V475, P17, DOI 10.1016/S0014-5793(00)01613-6; Ding S, 1999, J BIOCHEM, V125, P750, DOI 10.1093/oxfordjournals.jbchem.a022346; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Enns D., 2002, Molecular and Cellular Biochemistry, V241, P29, DOI 10.1023/A:1020861120368; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans TIA, 2011, BIOPHYS CHEM, V159, P172, DOI 10.1016/j.bpc.2011.06.007; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Guo F, 2010, BIOCHEM BIOPH RES CO, V391, P1170, DOI 10.1016/j.bbrc.2009.11.171; Han DY, 2010, J PHARMACOL SCI, V112, P310, DOI 10.1254/jphs.09282FP; Hao LY, 2000, BIOCHEM BIOPH RES CO, V279, P756, DOI 10.1006/bbrc.2000.4040; Hao LY, 1999, J PHYSIOL-LONDON, V514, P687, DOI 10.1111/j.1469-7793.1999.687ad.x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hofer GF, 1997, BIOPHYS J, V73, P1857, DOI 10.1016/S0006-3495(97)78216-X; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Kepplinger KJF, 2000, J PHYSIOL-LONDON, V529, P119, DOI 10.1111/j.1469-7793.2000.00119.x; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; LANE RD, 1985, J MOL CELL CARDIOL, V17, P863, DOI 10.1016/S0022-2828(85)80100-0; LEE WJ, 1992, J BIOL CHEM, V267, P8437; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; Minobe E, 2006, BIOCHEM BIOPH RES CO, V348, P288, DOI 10.1016/j.bbrc.2006.07.052; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; OROURKE B, 1992, SCIENCE, V257, P245, DOI 10.1126/science.1321495; OTSUKA Y, 1987, J BIOL CHEM, V262, P5839; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Saud ZA, 2007, BIOCHEM BIOPH RES CO, V364, P372, DOI 10.1016/j.bbrc.2007.10.017; SEYDL K, 1995, PFLUG ARCH EUR J PHY, V429, P503, DOI 10.1007/BF00704155; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Xu JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1717, DOI 10.1152/ajpcell.00105.2004; Yazawa K, 1997, PFLUG ARCH EUR J PHY, V433, P557, DOI 10.1007/s004240050314; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	45	23	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39013	39022		10.1074/jbc.M111.242248	http://dx.doi.org/10.1074/jbc.M111.242248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937422	Green Published, hybrid			2022-12-25	WOS:000296759800020
J	Xu, WX; Zhang, C; Derreumaux, P; Graslund, A; Morozova-Roche, L; Mu, YG				Xu, Weixin; Zhang, Ce; Derreumaux, Philippe; Graslund, Astrid; Morozova-Roche, Ludmilla; Mu, Yuguang			Intrinsic Determinants of A beta(12-24) pH-Dependent Self-Assembly Revealed by Combined Computational and Experimental Studies	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; SOLID-STATE NMR; FIBRIL FORMATION; ALZHEIMERS-DISEASE; ENERGY LANDSCAPE; INTRACELLULAR PH; SHEET REGISTRY; PEPTIDE; AGGREGATION	The propensity of amyloid-beta (A beta) peptide to self-assemble into highly ordered amyloid structures lies at the core of their accumulation in the brain during Alzheimer's disease. By using all-atom explicit solvent replica exchange molecular dynamics simulations, we elucidated at the atomic level the intrinsic determinants of the pH-dependent dimerization of the central hydrophobic segment A beta(12-24) and related these with the propensity to form amyloid fibrils measured by experimental tools such as atomic force microscopy and fluorescence. The process of A beta(12-24) dimerization was evaluated in terms of free energy landscape, side-chain two-dimensional contact probability maps, beta-sheet registries, potential mean force as a function of inter-chain distances, secondary structure development and radial solvation distributions. We showed that dimerization is a key event in A beta(12-24) amyloid formation; it is highly prompted in the order of pH 5.0 > 2.9 > > 8.4 and determines further amyloid growth. The dimerization is governed by a dynamic interplay of hydrophobic, electrostatic and solvation interactions permitting some variability of beta-sheets at each pH. These results provide atomistic insight into the complex process of molecular recognition detrimental for amyloid growth and pave the way for better understanding of the molecular basis of amyloid diseases.	[Xu, Weixin] E China Normal Univ, State Key Lab Precis Spect, Inst Theoret & Computat Sci, Shanghai 200062, Peoples R China; [Xu, Weixin; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Zhang, Ce; Morozova-Roche, Ludmilla] Umea Univ, Dept Med Biochem, Umea, Sweden; [Zhang, Ce; Morozova-Roche, Ludmilla] Umea Univ, Dept Biophys, Umea, Sweden; [Derreumaux, Philippe] Inst Biol Physicochim, CNRS UPR9080, Lab Biochim Theor, F-75005 Paris, France; [Graslund, Astrid] Stockholm Univ, Dept Biophys, S-10691 Stockholm, Sweden	East China Normal University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Umea University; Umea University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Stockholm University	Xu, WX (corresponding author), E China Normal Univ, State Key Lab Precis Spect, Inst Theoret & Computat Sci, Shanghai 200062, Peoples R China.	ludmilla.morozova-roche@medchem.umu.se; ygmu@ntu.edu.sg	Morozova-Roche, Ludmilla/AAV-9983-2021; Mu, Yuguang/A-9558-2010; Morozova-Roche, Ludmilla A./AAU-9044-2021; xu, weixin/B-5519-2011; Derreumaux, Philippe/E-9036-2019; ZHANG, CE/G-4969-2012	Morozova-Roche, Ludmilla/0000-0001-5886-2023; 	Ministry of Education [T206B3210RS]; French-Singapore MERLION Programme; Centre National de la Recherche Scientifique; Swedish Medical Research Council; Swedish Brain Fund; Insamlingsstiftelsen	Ministry of Education; French-Singapore MERLION Programme; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Brain Fund; Insamlingsstiftelsen	The support of research grants, academic research fund Tier2 by the Ministry of Education (T206B3210RS), French-Singapore MERLION Programme 2009, the Centre National de la Recherche Scientifique, and the generous computation time providing by High Performance Computer Center in Nanyang Technological University, is gratefully acknowledged. LMR's and ZC's research was supported by the Swedish Medical Research Council, Swedish Brain Fund and Insamlingsstiftelsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Baumketner A, 2007, J MOL BIOL, V366, P275, DOI 10.1016/j.jmb.2006.11.015; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Boucher G, 2006, PROTEINS, V65, P877, DOI 10.1002/prot.21134; Bu ZM, 2007, BIOPHYS J, V92, P594, DOI 10.1529/biophysj.106.091017; Cecchini M, 2004, J CHEM PHYS, V121, P10748, DOI 10.1063/1.1809588; Chebaro Y, 2009, J PHYS CHEM B, V113, P7668, DOI 10.1021/jp900425e; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; CHOW SY, 1991, DEV BRAIN RES, V60, P69, DOI 10.1016/0165-3806(91)90156-D; CONNOR JA, 1984, J PHYSIOL-LONDON, V354, P163, DOI 10.1113/jphysiol.1984.sp015369; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; De Simone A, 2007, BIOPHYS J, V93, P1284, DOI 10.1529/biophysj.107.108613; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong J, 2007, P NATL ACAD SCI USA, V104, P13313, DOI 10.1073/pnas.0702669104; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Favrin G, 2004, BIOPHYS J, V87, P3657, DOI 10.1529/biophysj.104.046839; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Garcia AE, 2003, P NATL ACAD SCI USA, V100, P13898, DOI 10.1073/pnas.2335541100; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Gregori M, 2010, EUR BIOPHYS J BIOPHY, V39, P1613, DOI 10.1007/s00249-010-0619-6; Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Huet A, 2006, BIOPHYS J, V91, P3829, DOI 10.1529/biophysj.106.090993; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khandogin J, 2007, P NATL ACAD SCI USA, V104, P16880, DOI 10.1073/pnas.0703832104; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Lu Y, 2009, PROTEINS, V75, P954, DOI 10.1002/prot.22305; Meyer TM, 2000, NEUROREPORT, V11, P33, DOI 10.1097/00001756-200001170-00007; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Mu YG, 2002, J PHYS CHEM B, V106, P5294, DOI 10.1021/jp013977e; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Mu YG, 2006, BIOPHYS J, V90, P3983, DOI 10.1529/biophysj.105.076406; Negureanu L, 2009, J MOL BIOL, V389, P921, DOI 10.1016/j.jmb.2009.04.058; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Pasternak SH, 2004, J ALZHEIMERS DIS, V6, P53; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106; Shivji AP, 1996, PROTEIN PEPTIDE LETT, V3, P407; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Topilina NI, 2010, BIOMACROMOLECULES, V11, P1721, DOI 10.1021/bm901467a; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Wallace JA, 2010, BIOCHEMISTRY-US, V49, P5290, DOI 10.1021/bi100137y; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wei GH, 2006, BIOPHYS J, V91, P1638, DOI 10.1529/biophysj.105.079186; Xu WX, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2911693; Xu WX, 2009, J PHYS CHEM B, V113, P7308, DOI 10.1021/jp8106827; Xu WX, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3123532; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	72	21	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24329	10.1371/journal.pone.0024329	http://dx.doi.org/10.1371/journal.pone.0024329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957446	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100008
J	Galand, C; Donnou, S; Crozet, L; Brunet, S; Touitou, V; Ouakrim, H; Fridman, WH; Sautes-Fridman, C; Fisson, S				Galand, Claire; Donnou, Sabrina; Crozet, Lucile; Brunet, Severine; Touitou, Valerie; Ouakrim, Hanane; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Fisson, Sylvain			Th17 Cells Are Involved in the Local Control of Tumor Progression in Primary Intraocular Lymphoma	PLOS ONE			English	Article							IL-21 RECEPTOR EXPRESSION; T(H)17 CELLS; T-CELLS; INTERLEUKIN-17; LYMPHOCYTES; PHENOTYPE; EXPANSION; CYTOKINE; FEATURES	Background: Th17 cells play an important role in the pathogenesis of many autoimmune diseases, but despite some reports of their antitumor properties, too little is known about their presence and role in cancers. Specifically, knowledge is sparse about the relation of Th17 to lymphoma microenvironments and, more particularly, to the microenvironment of primary intraocular B-cell lymphoma (PIOL), an aggressive lymphoma with a poor prognosis. Methods and Principal Findings: In this work, we investigated the presence of Th17 cells and their related cytokines in a syngeneic model of PIOL, a subtype of non-Hodgkin lymphoma. The very small number of lymphocytes trafficking in normal eyes, which represent a low background as compared to tumor-bearing eyes, allows us to develop the present model to characterize the different lymphocyte subsets present when a tumor is developing. IL-21 mRNA was expressed concomitantly with IL-17 mRNA in tumor-bearing eyes and intracellular expression of IL-17A and IL-21 in infiltrating CD4(+) T lymphocytes. Interestingly, IL-17A production by T cells was negatively correlated with tumor burden. We also showed that IL-21 but not IL-17 inhibits tumor cell proliferation in vitro. Conclusions: These data demonstrate that IL-17A and IL-21-producing CD4(+) T cells, referred as Th17 cells, infiltrate this tumor locally and suggest that Th17-related cytokines may counteract tumor progression via IL-21 production. Thus, Th17 cells or their related cytokines could be considered to be a new therapeutic approach for non-Hodgkin B-cell lymphomas, particularly those with an ocular localization.	[Galand, Claire; Donnou, Sabrina; Crozet, Lucile; Brunet, Severine; Touitou, Valerie; Ouakrim, Hanane; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Fisson, Sylvain] INSERM, UMRS872, Ctr Rech Cordeliers, Paris, France; [Galand, Claire; Donnou, Sabrina; Crozet, Lucile; Brunet, Severine; Touitou, Valerie; Ouakrim, Hanane; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Fisson, Sylvain] Univ Paris 06, UMRS 872, Paris, France; [Galand, Claire; Donnou, Sabrina; Crozet, Lucile; Brunet, Severine; Touitou, Valerie; Ouakrim, Hanane; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Fisson, Sylvain] Univ Paris 05, UMRS 872, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Galand, C (corresponding author), INSERM, UMRS872, Ctr Rech Cordeliers, Paris, France.	sylvain.fisson@crc.jussieu.fr	FISSON, Sylvain/J-8003-2013	FISSON, Sylvain/0000-0002-0057-363X; Galand, Claire/0000-0001-8005-4831; sautes-fridman, catherine/0000-0003-1735-8722; fridman, wolf herman/0000-0002-1332-0973	Institut National du Cancer [RC013-C06N631-2005, C06N748-2006]; Institut National de la Sante et de la Recherche Medicale; University Pierre and Marie Curie; University Paris-Descartes; Association pour la Recherche contre le Cancer; Institut National du Cancer	Institut National du Cancer(Institut National du Cancer (INCA) France); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Pierre and Marie Curie; University Paris-Descartes; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by the Institut National du Cancer (Grants RC013-C06N631-2005 and C06N748-2006), the Institut National de la Sante et de la Recherche Medicale, the University Pierre and Marie Curie, the University Paris-Descartes and the Association pour la Recherche contre le Cancer. SD was recipient of grants from the Institut National du Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu N, 2007, CANCER LETT, V256, P196, DOI 10.1016/j.canlet.2007.06.001; Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Andorsky DJ, 2008, EXPERT OPIN BIOL TH, V8, P1295, DOI [10.1517/14712598.8.9.1295, 10.1517/14712598.8.9.1295 ]; Annunziato F, 2009, EUR J IMMUNOL, V39, P637, DOI 10.1002/eji.200839050; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Cassoux N, 2000, OCUL IMMUNOL INFLAMM, V8, P243, DOI 10.1076/ocii.8.4.243.6463; Chan CC, 2009, OCUL IMMUNOL INFLAMM, V17, P375, DOI 10.3109/09273940903434804; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; JONES B, 1986, J IMMUNOL, V136, P348; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Monteleone G, 2006, GUT, V55, P1774, DOI 10.1136/gut.2006.093187; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pongcharoen S, 2006, AM J REPROD IMMUNOL, V55, P291, DOI 10.1111/j.1600-0897.2006.00366.x; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tartour E, 1999, CANCER RES, V59, P3698; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Touitou V, 2008, OPHTHAL RES, V40, P208, DOI 10.1159/000119878; Touitou V, 2007, INVEST OPHTH VIS SCI, V48, P3223, DOI 10.1167/iovs.07-0008; Tzartos JS, 2011, AM J PATHOL, V178, P794, DOI 10.1016/j.ajpath.2010.10.043; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776; Wainwright DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015390; Yang ZZ, 2009, CANCER RES, V69, P5522, DOI 10.1158/0008-5472.CAN-09-0266; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	32	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24622	10.1371/journal.pone.0024622	http://dx.doi.org/10.1371/journal.pone.0024622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949734	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400008
J	Olsson, L; Paulsson, K; Bovee, JVMG; Nord, KH				Olsson, Linda; Paulsson, Kajsa; Bovee, Judith V. M. G.; Nord, Karolin H.			Clonal Evolution through Loss of Chromosomes and Subsequent Polyploidization in Chondrosarcoma	PLOS ONE			English	Article							GENETIC ALTERATIONS; HETEROZYGOSITY; PROGRESSION; MECHANISM	Near-haploid chromosome numbers have been found in less than 1% of cytogenetically reported tumors, but seem to be more common in certain neoplasms including the malignant cartilage-producing tumor chondrosarcoma. By a literature survey of published karyotypes from chondrosarcomas we could confirm that loss of chromosomes resulting in hyperhaploid-hypodiploid cells is common and that these cells may polyploidize. Sixteen chondrosarcomas were investigated by single nucleotide polymorphism (SNP) array and the majority displayed SNP patterns indicative of a hyperhaploid-hypodiploid origin, with or without subsequent polyploidization. Except for chromosomes 5, 7, 19, 20 and 21, autosomal loss of heterozygosity was commonly found, resulting from chromosome loss and subsequent duplication of monosomic chromosomes giving rise to uniparental disomy. Additional gains, losses and rearrangements of genetic material, and even repeated rounds of polyploidization, may affect chondrosarcoma cells resulting in highly complex karyotypes. Loss of chromosomes and subsequent polyploidization was not restricted to a particular chondrosarcoma subtype and, although commonly found in chondrosarcoma, binucleated cells did not seem to be involved in these events.	[Olsson, Linda; Paulsson, Kajsa; Nord, Karolin H.] Lund Univ, Dept Clin Genet, Univ & Reg Labs, Skane Univ Hosp, Lund, Sweden; [Bovee, Judith V. M. G.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Lund University; Skane University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Olsson, L (corresponding author), Lund Univ, Dept Clin Genet, Univ & Reg Labs, Skane Univ Hosp, Lund, Sweden.	Karolin.Hansen_Nord@med.lu.se	Paulsson, Kajsa/I-5571-2013	Hansen Nord, Karolin/0000-0002-2397-2254; Paulsson, Kajsa/0000-0001-7950-222X; Bovee, Judith/0000-0003-1155-0481	Swedish Cancer Society; Netherlands Organization for Scientific Research [917-76-315]; European Commission	Swedish Cancer Society(Swedish Cancer Society); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Swedish Cancer Society and The Netherlands Organization for Scientific Research [917-76-315 to JVMGB]. The Department of Clinical Genetics, Lund University and the Department of Pathology, Leiden University Medical Center are partners of the EuroBoNeT consortium, a network of excellence granted by the European Commission for studying the pathology and genetics of bone tumors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni F., 2002, WHO CLASSIFICATION T, P247; Bovee JVMG, 2000, AM J PATHOL, V157, P1587, DOI 10.1016/S0002-9440(10)64796-7; Bovee JVMG, 1999, GENE CHROMOSOME CANC, V26, P237; Celton-Morizur S, 2010, CELL CYCLE, V9, P460, DOI 10.4161/cc.9.3.10542; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Eefting D, 2009, AM J SURG PATHOL, V33, P50, DOI 10.1097/PAS.0b013e31817eec2b; EVANS HL, 1977, CANCER-AM CANCER SOC, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Harrison CJ, 2004, BRIT J HAEMATOL, V125, P552, DOI 10.1111/j.1365-2141.2004.04948.x; Jones KB, 2007, J BONE JOINT SURG AM, V89A, P2113, DOI 10.2106/JBJS.F.01530; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Mattsson G, 2007, J MOL DIAGN, V9, P479, DOI 10.2353/jmoldx.2007.070041; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; Mitelman F, 2010, DATABASE CHROMOSOME; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Schrage YM, 2009, J CELL MOL MED, V13, P2843, DOI 10.1111/j.1582-4934.2008.00406.x; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; van Beerendonk HM, 2004, J PATHOL, V202, P359, DOI 10.1002/path.1517	25	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24977	10.1371/journal.pone.0024977	http://dx.doi.org/10.1371/journal.pone.0024977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949816	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400027
J	Raude, J; Setbon, M				Raude, Jocelyn; Setbon, Michel			Predicting the Lay Preventive Strategies in Response to Avian Influenza from Perceptions of the Threat	PLOS ONE			English	Article							RISK PERCEPTION; INFORMATION; INFECTION; KNOWLEDGE; FARMS; SARS	Background: The identification of patterns of behaviors that lay people would engage in to protect themselves from the risk of infection in the case of avian influenza outbreak, as well as the lay perceptions of the threat that underlie these risk reduction strategies. Methodology/Principal Findings: A population-based survey (N = 1003) was conducted in 2008 to understand and describe how the French public might respond to a possible outbreak. Factor analyses highlighted three main categories of risk reduction strategies consisting of food quality assurance, food avoidance, and animal avoidance. In combination with the fear of contracting avian influenza, mental representations associated with the manifestation and/or transmission of the disease were found to significantly and systematically shape the behavioral responses to the perceived threat. Conclusions/Significance: This survey provides insight into the nature and predictors of the protective patterns that might be expected from the general public during a novel domestic outbreak of avian influenza.	[Raude, Jocelyn; Setbon, Michel] Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France		Raude, J (corresponding author), Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France.	Jocelyn.Raude@ehesp.fr		Raude, Jocelyn/0000-0001-8020-4975	French Agence Inter-etablissement pour la Recherche et le Developpement	French Agence Inter-etablissement pour la Recherche et le Developpement	This work was financially supported by the Research Fund devoted to 'avian influenza' of the French Agence Inter-etablissement pour la Recherche et le Developpement (http://www.aird.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi T, 2006, ENCY MEASUREMENT STA, P651; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Condry SC, 2007, PUBLICATION STATE U; de Zwart O, 2007, EMERG INFECT DIS, V13, P290, DOI 10.3201/eid1302.060303; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; European Commission, 2006, 257 EUR COMM; Everitt B. S., 2001, APPL MULTIVARIATE DA; Fasina FO, 2011, PREV VET MED, V98, P204, DOI 10.1016/j.prevetmed.2010.11.007; Figueiras MJ, 2007, PSYCHOL HEALTH, V22, P143, DOI 10.1080/14768320600774462; Figuie M, 2008, RISK ANAL, V28, P441, DOI 10.1111/j.1539-6924.2008.01039.x; Gochman DS, 1997, HDB HLTH BEHAV RES, VI; Greenacre MJ, 2004, CORRES ANAL SOCIAL S; Gstraunthaler T, 2008, BRIT FOOD J, V110, P260, DOI 10.1108/00070700810858673; International Food Safety Authorities Network, 2005, 72005 INFOSAN; Joffe H, 2003, BRIT J SOC PSYCHOL, V42, P55, DOI 10.1348/014466603763276126; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Leventhal H, 1999, J Natl Cancer Inst Monogr, P81; Leventhal H, 1980, CONTRIBUTIONS MED PS, P17; Marteau TM, 2006, SOC SCI MED, V62, P1360, DOI 10.1016/j.socscimed.2005.08.005; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nerlich B, 2007, SOCIOL HEALTH ILL, V29, P46, DOI 10.1111/j.1467-9566.2007.00517.x; Paul M, 2011, ACTA TROP, V118, P209, DOI 10.1016/j.actatropica.2011.03.009; Petrie AW, 1997, PERCEPTIONS HLTH ILL; Raude J, 2009, EUR J EPIDEMIOL, V24, P339, DOI 10.1007/s10654-009-9351-x; ROSELIUS T, 1971, J MARKETING, V35, P56, DOI 10.2307/1250565; Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; *WHO, 2009, CUM NUMB CONF HUM CA; Yeung R. M. W., 2001, British Food Journal, V103, P170, DOI 10.1108/00070700110386728	31	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24943	10.1371/journal.pone.0024943	http://dx.doi.org/10.1371/journal.pone.0024943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825GY	21949799	Green Submitted, gold, Green Published			2022-12-25	WOS:000295260400024
J	Barliya, T; Mandel, M; Livnat, T; Weinberger, D; Lavie, G				Barliya, Tilda; Mandel, Mathilda; Livnat, Tami; Weinberger, Dov; Lavie, Gad			Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy	PLOS ONE			English	Article							INTRACELLULAR PH; GROWTH-FACTOR; PROTEIN; ACTIVATION; BINDING; HEAT-SHOCK-PROTEIN-90; STABILIZATION; TRANSCRIPTION; HIF-1-ALPHA; INHIBITORS	The perihydroxylated perylene quinone hypericin has been reported to possess potent anti-metastatic and antiangiogenic activities, generated by targeting diverse crossroads of cancer-promoting processes via unique mechanisms. Hypericin is the only known exogenous reagent that can induce forced poly-ubiquitination and accelerated degradation of heat shock protein 90 (Hsp90) in cancer cells. Hsp90 client proteins are thereby destabilized and rapidly degraded. Hsp70 client proteins may potentially be also affected via preventing formation of hsp90-hsp70 intermediate complexes. We show here that hypericin also induces enhanced degradation of hypoxia-inducible factor 1 alpha (HIF-1 alpha) in two human tumor cell lines, U87-MG glioblastoma and RCC-C2VHL(-/-) renal cell carcinoma and in the non-malignant ARPE19 retinal pigment epithelial cell line. The hypericin-accelerated turnover of HIF-1 alpha, the regulatory precursor of the HIF-1 transcription factor which promotes hypoxic stress and angiogenic responses, overcomes the physiologic HIF-1 alpha protein stabilization which occurs in hypoxic cells. The hypericin effect also eliminates the high HIF-1 alpha levels expressed constitutively in the von-Hippel Lindau protein (pVHL)-deficient RCC-C2VHL(-/-) renal cell carcinoma cell line. Unlike the normal ubiquitin-proteasome pathway-dependent turnover of HIF-alpha proteins which occurs in normoxia, the hypericin-induced HIF-1 alpha catabolism can occur independently of cellular oxygen levels or pVHL-promoted ubiquitin ligation of HIF-1 alpha. It is mediated by lysosomal cathepsin-B enzymes with cathepsin-B activity being optimized in the cells through hypericin-mediated reduction in intracellular pH. Our findings suggest that hypericin may potentially be useful in preventing growth of tumors in which HIF-1 alpha plays pivotal roles, and in pVHL ablated tumor cells such as renal cell carcinoma through elimination of elevated HIF-1 alpha contents in these cells, scaling down the excessive angiogenesis which characterizes these tumors.	[Barliya, Tilda; Mandel, Mathilda; Lavie, Gad] Sheba Med Ctr, Ctr Blood, Ramat Gan, Israel; [Lavie, Gad] Tel Aviv Univ, Sackler Sch Med, Dept Cellular & Dev Biol, IL-69978 Tel Aviv, Israel; [Weinberger, Dov] Beilinson Med Ctr, Dept Ophthalmol, Petah Tiqwa, Israel; [Weinberger, Dov] Tel Aviv Univ, Sackler Sch Med, Dept Ophthalmol, IL-69978 Tel Aviv, Israel; [Livnat, Tami] Sheba Med Ctr, Inst Hematol, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Barliya, T (corresponding author), Sheba Med Ctr, Ctr Blood, Ramat Gan, Israel.	gad.lavie@sheba.health.gov.il			Israel Cancer Association [20090033]; Tel Aviv University; Maratier Foundation; Elsa and Leo Abramson Foundation	Israel Cancer Association; Tel Aviv University; Maratier Foundation; Elsa and Leo Abramson Foundation	This research was funded by the Israel Cancer Association, Grant 20090033 (http://ica.cancer.org.il/english/) thanks to a contribution by Rick and Rita Weinstein, and two competitive grants from Tel Aviv University: The Maratier Foundation and the Elsa and Leo Abramson Foundation, Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 2005, TRENDS CELL BIOL, V15, P565, DOI 10.1016/j.tcb.2005.09.003; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Blank M, 2004, INT J CANCER, V111, P596, DOI 10.1002/ijc.20285; Blank M, 2003, CANCER RES, V63, P8241; Blank M, 2001, PHOTOCHEM PHOTOBIOL, V74, P120, DOI 10.1562/0031-8655(2001)074&lt;0120:ACAOHI&gt;2.0.CO;2; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CORTESE JD, 1989, P NATL ACAD SCI USA, V86, P5773, DOI 10.1073/pnas.86.15.5773; Couldwell WT, 2011, CANCER-AM CANCER SOC, V117, P4905, DOI 10.1002/cncr.26123; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; GERSON F, 1995, J AM CHEM SOC, V117, P11861, DOI 10.1021/ja00153a007; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; HO AK, 1992, J NEUROCHEM, V59, P2304; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hur E, 2002, MOL PHARMACOL, V62, P975, DOI 10.1124/mol.62.5.975; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Koga F, 2007, CELL CYCLE, V6, P1393, DOI 10.4161/cc.6.11.4296; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kubis HP, 2005, BBA-MOL CELL RES, V1745, P187, DOI 10.1016/j.bbamcr.2005.05.007; Kubota H, 2010, CELL STRESS CHAPERON, V15, P1003, DOI 10.1007/s12192-010-0211-0; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lavie Gad, 2005, Angiogenesis, V8, P35, DOI 10.1007/s10456-005-3828-3; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; Masson-Gadais B, 2003, CELL STRESS CHAPERON, V8, P37, DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Messaoudi S, 2008, ANTI-CANCER AGENT ME, V8, P761, DOI 10.2174/187152008785914824; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Ochel HJ, 1999, MOL GENET METAB, V66, P24, DOI 10.1006/mgme.1998.2774; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Quintero M, 2006, CANCER RES, V66, P770, DOI 10.1158/0008-5472.CAN-05-0333; REDEPENNING J, 1993, PHOTOCHEM PHOTOBIOL, V58, P532, DOI 10.1111/j.1751-1097.1993.tb04927.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2000, GENE DEV, V14, P1983; Sureau F, 1996, J AM CHEM SOC, V118, P9484, DOI 10.1021/ja961783k; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Yang XJ, 1996, J NEUROSCI, V16, P6089; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; ZORATTI M, 1984, BIOCHIM BIOPHYS ACTA, V767, P231, DOI 10.1016/0005-2728(84)90192-0	44	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e22849	10.1371/journal.pone.0022849	http://dx.doi.org/10.1371/journal.pone.0022849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949677	Green Submitted, gold, Green Published			2022-12-25	WOS:000295257900001
J	Dharmani, P; Leung, P; Chadee, K				Dharmani, Poonam; Leung, Pearl; Chadee, Kris			Tumor Necrosis Factor-alpha and Muc2 Mucin Play Major Roles in Disease Onset and Progression in Dextran Sodium Sulphate-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; PROINFLAMMATORY CYTOKINES; CLINICAL-ASPECTS; CROHNS-DISEASE; HOST-DEFENSE; TNF-ALPHA; RAT COLON; CANCER; PERMEABILITY	The sequential events and the inflammatory mediators that characterize disease onset and progression of ulcerative colitis (UC) are not well known. In this study, we evaluated the early pathologic events in the pathogenesis of colonic ulcers in rats treated with dextran sodium sulfate (DSS). Following a lag phase, day 5 of DSS treatment was found clinically most critical as disease activity index (DAI) exhibited an exponential rise with severe weight loss and rectal bleeding. Surprisingly, on days 1-2, colonic TNF-alpha expression (70-80-fold) and tissue protein (50-fold) were increased, whereas IL-1 beta only increased on days 7-9 (60-90-fold). Days 3-6 of DSS treatment were characterized by a prominent down regulation in the expression of regulatory cytokines (40-fold for IL-10 and TGF beta) and mucin genes (15-18 fold for Muc2 and Muc3) concomitant with depletion of goblet cell and adherent mucin. Remarkably, treatment with TNF-alpha neutralizing antibody markedly altered DSS injury with reduced DAI, restoration of the adherent and goblet cell mucin and IL-1 beta and mucin gene expression. We conclude that early onset colitis is dependent on TNF-alpha that preceded depletion of adherent and goblet cell mucin prior to epithelial cell damage and these biomarkers can be used as therapeutic targets for UC.	[Dharmani, Poonam; Leung, Pearl; Chadee, Kris] Univ Calgary, Hlth Sci Ctr, Dept Microbiol Immunol & Infect Dis, Gastrointestinal Res Grp, Calgary, AB, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Dharmani, P (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Microbiol Immunol & Infect Dis, Gastrointestinal Res Grp, Calgary, AB, Canada.	kchadee@ucalgary.ca			Canadian Institute for Health Research (CIHR); Canadian Association of Gastroenterology-AstraZeneca-CIHR	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology-AstraZeneca-CIHR(Canadian Institutes of Health Research (CIHR)AstraZeneca)	This work was supported by a grant from the Canadian Institute for Health Research (CIHR, KC). PD is funded by a Canadian Association of Gastroenterology-AstraZeneca-CIHR Research and Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; CHADEE K, 1991, GASTROENTEROLOGY, V100, P986, DOI 10.1016/0016-5085(91)90274-O; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Dharmani Poonam, 2008, Curr Mol Pharmacol, V1, P195; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dieleman LA, 1997, SCAND J GASTROENTERO, V32, P99; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Iwashita J, 2003, IMMUNOL CELL BIOL, V81, P275, DOI 10.1046/j.1440-1711.2003.t01-1-01163.x; Keshavarzian A, 2001, J PHARMACOL EXP THER, V299, P442; Kim YD, 2002, J KOREAN MED SCI, V17, P765, DOI 10.3346/jkms.2002.17.6.765; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leeb SN, 2003, GASTROENTEROLOGY, V125, P1341, DOI 10.1016/j.gastro.2003.07.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; Renes IB, 2002, AM J PHYSIOL-GASTR L, V282, pG382, DOI 10.1152/ajpgi.00229.2001; Shekels LL, 2001, DIGEST DIS SCI, V46, P1757, DOI 10.1023/A:1010622125040; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Sun Y, 2004, GUT, V53, P362, DOI 10.1136/gut.2003.015867; Toshina K, 2000, SCAND J IMMUNOL, V52, P570, DOI 10.1046/j.1365-3083.2000.00815.x; Xu YH, 2007, IMMUNOL CELL BIOL, V85, P633, DOI 10.1038/sj.icb.7100112; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	29	67	68	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25058	10.1371/journal.pone.0025058	http://dx.doi.org/10.1371/journal.pone.0025058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949848	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900046
J	Santis, G; Angell, R; Nickless, G; Quinn, A; Herbert, A; Cane, P; Spicer, J; Breen, R; McLean, E; Tobal, K				Santis, George; Angell, Roger; Nickless, Guillermina; Quinn, Alison; Herbert, Amanda; Cane, Paul; Spicer, James; Breen, Ronan; McLean, Emma; Tobal, Khalid			Screening for EGFR and KRAS Mutations in Endobronchial Ultrasound Derived Transbronchial Needle Aspirates in Non-Small Cell Lung Cancer Using COLD-PCR	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; SENSITIVE METHOD; GEFITINIB; FREQUENCY	EGFR mutations correlate with improved clinical outcome whereas KRAS mutations are associated with lack of response to tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). Endobronchial ultrasound (EBUS)-transbronchial needle aspiration (TBNA) is being increasingly used in the management of NSCLC. Co-amplification at lower denaturation temperature (COLD)-polymerase chain reaction (PCR) (COLD-PCR) is a sensitive assay for the detection of genetic mutations in solid tumours. This study assessed the feasibility of using COLD-PCR to screen for EGFR and KRAS mutations in cytology samples obtained by EBUS-TBNA in routine clinical practice. Samples obtained from NSCLC patients undergoing EBUS-TBNA were evaluated according to our standard clinical protocols. DNA extracted from these samples was subjected to COLD-PCR to amplify exons 18-21 of EGFR and exons two and three of KRAS followed by direct sequencing. Mutation analysis was performed in 131 of 132 (99.3%) NSCLC patients (70F/62M) with confirmed lymph node metastases (94/132 (71.2%) adenocarcinoma; 17/132 (12.8%) squamous cell; 2/132 (0.15%) large cell neuroendocrine; 1/132 (0.07%) large cell carcinoma; 18/132 (13.6%) NSCL-not otherwise specified (NOS)). Molecular analysis of all EGFR and KRAS target sequences was achieved in 126 of 132 (95.5%) and 130 of 132 (98.4%) of cases respectively. EGFR mutations were identified in 13 (10.5%) of fully evaluated cases (11 in adenocarcinoma and two in NSCLC-NOS) including two novel mutations. KRAS mutations were identified in 23 (17.5%) of fully analysed patient samples (18 adenocarcinoma and five NSCLC-NOS). We conclude that EBUS-TBNA of lymph nodes infiltrated by NSCLC can provide sufficient tumour material for EGFR and KRAS mutation analysis in most patients, and that COLD-PCR and sequencing is a robust screening assay for EGFR and KRAS mutation analysis in this clinical context.	[Santis, George] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Angell, Roger; Nickless, Guillermina; Tobal, Khalid] Guys & St Thomas Natl Hlth Serv Fdn Trust, Mol Oncol Diagnost Unit, London, England; [Quinn, Alison; Breen, Ronan] Guys & St Thomas Natl Hlth Serv Fdn Trust, Dept Resp Med, London, England; [Herbert, Amanda; Cane, Paul; McLean, Emma] Guys & St Thomas Natl Hlth Serv Fdn Trust, Dept Pathol, London, England; [Spicer, James] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Santis, G (corresponding author), Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England.	george.santis@kcl.ac.uk		Spicer, James/0000-0003-3732-8491	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G006911/1]; Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre; St Thomas' National Health Service Foundation Trust; Experimental Cancer Medicine Centre Network; BBSRC [BB/G007160/1, BB/G006911/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006911/1, BB/G007160/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre; St Thomas' National Health Service Foundation Trust; Experimental Cancer Medicine Centre Network; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/G006911/1 to GS), from the Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' National Health Service Foundation Trust in partnership with King's College London (to GS & JS), and from the Experimental Cancer Medicine Centre Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams K, 2009, THORAX, V64, P757, DOI 10.1136/thx.2008.109868; Annema JT, 2010, JAMA-J AM MED ASSOC, V304, P2245, DOI 10.1001/jama.2010.1705; Cane P, 2011, J THORAC ONCOL, V6, pS568; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cortot AB, 2010, CANCER-AM CANCER SOC, V116, P2682, DOI 10.1002/cncr.25014; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Galbiati S, 2011, CLIN CHEM, V57, P136, DOI 10.1373/clinchem.2010.155671; Garcia-Olive I, 2010, EUR RESPIR J, V35, P391, DOI 10.1183/09031936.00028109; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Li J, 2009, HUM MUTAT, V30, P1583, DOI 10.1002/humu.21112; Li J, 2009, BIOCHEM SOC T, V37, P427, DOI 10.1042/BST0370427; Luthra R, 2009, CLIN CHEM, V55, P2077, DOI 10.1373/clinchem.2009.136143; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Marchetti A, 2006, NEW ENGL J MED, V354, P526; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Micames CG, 2007, CHEST, V131, P539, DOI 10.1378/chest.06-1437; Milbury CA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq899; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Monaco SE, 2010, HUM PATHOL, V41, P94, DOI 10.1016/j.humpath.2009.06.019; Nakajima T, 2007, CHEST, V132, P597, DOI 10.1378/chest.07-0095; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2005, NEW ENGL J MED, V353, P1740; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Park K, 2006, CURR MED RES OPIN, V22, P561, DOI 10.1185/030079906X89847; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Putnam E A, 1992, Surg Oncol, V1, P49, DOI 10.1016/0960-7404(92)90056-Q; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; RUSCH V, 1993, CANCER RES, V53, P2379; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Schuurbiers OCJ, 2010, J THORAC ONCOL, V5, P1664, DOI 10.1097/JTO.0b013e3181f0bd93; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Wu JY, 2008, CLIN CANCER RES, V14, P4877, DOI 10.1158/1078-0432.CCR-07-5123; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Yang TY, 2011, J CLIN ONCOL, V29, pE468, DOI 10.1200/JCO.2010.33.5802; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	49	80	86	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25191	10.1371/journal.pone.0025191	http://dx.doi.org/10.1371/journal.pone.0025191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949883	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900059
J	Korhonen, HM; Meikar, O; Yadav, RP; Papaioannou, MD; Romero, Y; Da Ros, M; Herrera, PL; Toppari, J; Nef, S; Kotaja, N				Korhonen, Hanna M.; Meikar, Oliver; Yadav, Ram Prakash; Papaioannou, Marilena D.; Romero, Yannick; Da Ros, Matteo; Herrera, Pedro L.; Toppari, Jorma; Nef, Serge; Kotaja, Noora			Dicer Is Required for Haploid Male Germ Cell Differentiation in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SMALL RNAS; NUCLEAR-LOCALIZATION; MICRORNA BIOGENESIS; ENDOGENOUS SIRNAS; CRE RECOMBINASE; GENOME DEFENSE; MOUSE OOCYTES; SPERMATOGENESIS; TESTIS	Background: The RNase III endonuclease Dicer is an important regulator of gene expression that processes microRNAs (miRNAs) and small interfering RNAs (siRNAs). The best-characterized function of miRNAs is gene repression at the post-transcriptional level through the pairing with mRNAs of protein-encoding genes. Small RNAs can also act at the transcriptional level by controlling the epigenetic status of chromatin. Dicer and other mediators of small RNA pathways are present in mouse male germ cells, and several miRNAs and endogenous siRNAs are expressed in the testis, suggesting that Dicer-dependent small RNAs are involved in the control of the precisely timed and highly organised process of spermatogenesis. Principal Findings: Being interested in the Dicer-mediated functions during spermatogenesis, we have analysed here a male germ cell-specific Dicer1 knockout mouse model, in which the deletion of Dicer1 takes place during early postnatal development in spermatogonia. We found that Dicer1 knockout testes were reduced in size and spermatogenesis within the seminiferous tubules was disrupted. Dicer1 knockout epididymides contained very low number of mature sperm with pronounced morphological abnormalities. Spermatogonial differentiation appeared unaffected. However, the number of haploid cells was decreased in knockout testes, and an increased number of apoptotic spermatocytes was observed. The most prominent defects were found during late haploid differentiation, and Dicer was demonstrated to be critical for the normal organization of chromatin and nuclear shaping of elongating spermatids. Conclusions/Significance: We demonstrate that Dicer and Dicer-dependent small RNAs are imperative regulators of haploid spermatid differentiation and essential for male fertility.	[Korhonen, Hanna M.; Meikar, Oliver; Yadav, Ram Prakash; Da Ros, Matteo; Toppari, Jorma; Kotaja, Noora] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland; [Papaioannou, Marilena D.; Romero, Yannick; Nef, Serge] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Herrera, Pedro L.] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Toppari, Jorma] Univ Turku, Dept Pediat, Turku, Finland	University of Turku; University of Geneva; University of Geneva; University of Turku	Korhonen, HM (corresponding author), Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland.	noora.kotaja@utu.fi	Da Ros, Matteo/G-4542-2017; Nef, Serge/AAV-6445-2020; Da Ros, Matteo/K-8177-2019	Da Ros, Matteo/0000-0002-8941-9187; Nef, Serge/0000-0001-5462-0676; Herrera Merino, Pedro Luis/0000-0003-0771-9504; Kotaja, Noora/0000-0003-1503-9170; Yadav, Ram Prakash/0000-0001-8309-1224	Academy of Finland; Emil Aaltonen Foundation; Sigrid Juselius Foundation; Turku University Hospital; Turku Doctoral Programme of Biomedical Sciences; Swiss National Science Foundation [3100A0-119862]	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital; Turku Doctoral Programme of Biomedical Sciences; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by research grants from the Academy of Finland (http://www.aka.fi/en-GB/A/), Emil Aaltonen Foundation (http://www.emilaaltonen.fi/brieflyeng.html), Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), and Turku University Hospital. HK, OM and MDR are supported by the Turku Doctoral Programme of Biomedical Sciences. SN, YR and MDP are supported by a grant from Swiss National Science Foundation (3100A0-119862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Castaneda J, 2011, MUTAT RES       0511; Catena R, 2006, DEV BIOL, V296, P231, DOI 10.1016/j.ydbio.2006.04.458; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gonzalez-Gonzalez E, 2008, BBA-GENE REGUL MECH, V1779, P306, DOI 10.1016/j.bbagrm.2008.01.007; Guerif F, 2002, INT J ANDROL, V25, P358, DOI 10.1046/j.1365-2605.2002.00382.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Khalil AM, 2010, CYTOGENET GENOME RES, V129, P280, DOI 10.1159/000315903; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kimmins S, 2004, REPRODUCTION, V128, P5, DOI 10.1530/rep.1.00170; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Martianov I, 2002, DEVELOPMENT, V129, P945; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036	48	113	118	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24821	10.1371/journal.pone.0024821	http://dx.doi.org/10.1371/journal.pone.0024821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949761	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800040
J	Fernandez-Trillo, J; Barros, F; Machin, A; Carretero, L; Dominguez, P; de la Pena, P				Fernandez-Trillo, Jorge; Barros, Francisco; Machin, Angeles; Carretero, Luis; Dominguez, Pedro; de la Pena, Pilar			Molecular Determinants of Interactions between the N-Terminal Domain and the Transmembrane Core That Modulate hERG K+ Channel Gating	PLOS ONE			English	Article							LONG-QT SYNDROME; HUMAN INWARD RECTIFIER; S4-S5 LINKER; POTASSIUM CHANNELS; ACTIVATION; DEACTIVATION; INACTIVATION; MUTATIONS; RECEPTOR; RECTIFICATION	A conserved eag domain in the cytoplasmic amino terminus of the human ether-a-go-go-related gene (hERG) potassium channel is critical for its slow deactivation gating. Introduction of gene fragments encoding the eag domain are able to restore normal deactivation properties of channels from which most of the amino terminus has been deleted, and also those lacking exclusively the eag domain or carrying a single point mutation in the initial residues of the N-terminus. Deactivation slowing in the presence of the recombinant domain is not observed with channels carrying a specific Y542C point mutation in the S4-S5 linker. On the other hand, mutations in some initial positions of the recombinant fragment also impair its ability to restore normal deactivation. Fluorescence resonance energy transfer (FRET) analysis of fluorophore-tagged proteins under total internal reflection fluorescence (TIRF) conditions revealed a substantial level of FRET between the introduced N-terminal eag fragments and the eag domain-deleted channels expressed at the membrane, but not between the recombinant eag domain and full-length channels with an intact amino terminus. The FRET signals were also minimized when the recombinant eag fragments carried single point mutations in the initial portion of their amino end, and when Y542C mutated channels were used. These data suggest that the restoration of normal deactivation gating by the N-terminal recombinant eag fragment is an intrinsic effect of this domain directed by the interaction of its N-terminal segment with the gating machinery, likely at the level of the S4-S5 linker.	[Fernandez-Trillo, Jorge; Barros, Francisco; Machin, Angeles; Carretero, Luis; Dominguez, Pedro; de la Pena, Pilar] Univ Oviedo, Dept Biochem & Mol Biol, Oviedo, Spain	University of Oviedo	Fernandez-Trillo, J (corresponding author), Univ Oviedo, Dept Biochem & Mol Biol, Oviedo, Spain.	fbarros@uniovi.es; pdelapena@uniovi.es	Barros, Francisco/O-6647-2019; Dominguez, Pedro/A-8266-2012; De-la-Pena-Cortines, Pilar/B-1453-2012; Barros, Francisco/H-3297-2015	Barros, Francisco/0000-0001-9040-1948; Dominguez, Pedro/0000-0003-4788-1071; De-la-Pena-Cortines, Pilar/0000-0002-3915-730X; Barros, Francisco/0000-0001-9040-1948; Carretero, Luis/0000-0001-7850-7440; Fernandez-Trillo, Jorge/0000-0002-2086-1727	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2009-11262]; Consolider-Ingenio project (SICI) [CSD2008-00005]; Ministerio de Educacion y Ciencia (MEC); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) of Spain; SICI-Consolider	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio project (SICI); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) of Spain; SICI-Consolider	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN) by grant BFU2009-11262 and a Consolider-Ingenio project (SICI; CSD2008-00005). J.F.-T. and L. C. hold predoctoral fellowships from Ministerio de Educacion y Ciencia (MEC) and Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) of Spain. A. M. holds a postdoctoral contract from SICI-Consolider 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Ron C, 2008, BIOPHYS J, V94, P3893, DOI 10.1529/biophysj.107.116731; Alonso-Ron C, 2009, PFLUG ARCH EUR J PHY, V457, P1237, DOI 10.1007/s00424-008-0599-x; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Barros F, 1998, J PHYSIOL-LONDON, V511, P333, DOI 10.1111/j.1469-7793.1998.333bh.x; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; Chouard T, 2011, NATURE, V471, P151, DOI 10.1038/471151a; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; DELAPENA P, 1992, BIOCHEM J, V284, P891, DOI 10.1042/bj2840891; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gomez-Varela D, 2003, FEBS LETT, V535, P125, DOI 10.1016/S0014-5793(02)03888-7; Gomez-Varela D, 2002, J MEMBRANE BIOL, V187, P117, DOI 10.1007/s00232-001-0156-4; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Miranda P, 2005, J PHYSIOL-LONDON, V566, P717, DOI 10.1113/jphysiol.2005.085803; Miranda P, 2008, BBA-MOL CELL RES, V1783, P1681, DOI 10.1016/j.bbamcr.2008.06.009; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Saenen JB, 2006, BIOPHYS J, V91, P4381, DOI 10.1529/biophysj.106.087247; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Sanguinetti MC, 2010, PFLUG ARCH EUR J PHY, V460, P265, DOI 10.1007/s00424-009-0758-8; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Schwartz PJ, 2005, NAT CLIN PRACT CARD, V2, P346, DOI 10.1038/ncpcardio0239; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Thomas D, 2003, CARDIOVASC RES, V59, P14, DOI 10.1016/S0008-6363(03)00386-9; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wanke E, 2007, TOXICON, V49, P239, DOI 10.1016/j.toxicon.2006.09.025; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	54	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24674	10.1371/journal.pone.0024674	http://dx.doi.org/10.1371/journal.pone.0024674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935437	gold, Green Submitted, Green Published			2022-12-25	WOS:000295041700048
J	Kadokura, M; Maekawa, S; Sueki, R; Miura, M; Komase, K; Shindo, H; Amemiya, F; Uetake, T; Inoue, T; Sakamoto, M; Nakagawa, M; Sakamoto, N; Watanabe, M; Enomoto, N				Kadokura, Makoto; Maekawa, Shinya; Sueki, Ryota; Miura, Mika; Komase, Kazuki; Shindo, Hiroko; Amemiya, Fumitake; Uetake, Tomoyoshi; Inoue, Taisuke; Sakamoto, Minoru; Nakagawa, Mina; Sakamoto, Naoya; Watanabe, Mamoru; Enomoto, Nobuyuki			Analysis of the Complete Open Reading Frame of Genotype 2b Hepatitis C Virus in Association with the Response to Peginterferon and Ribavirin Therapy	PLOS ONE			English	Article							PEGYLATED-INTERFERON-ALPHA; ACID SUBSTITUTION PATTERN; PROTEIN 5A GENE; HIGH VIRAL LOAD; COMBINATION THERAPY; VIROLOGICAL RESPONSE; AMERICAN PATIENTS; PLUS RIBAVIRIN; CORE PROTEIN; MUTATIONS	Background and Aims: Patients infected with genotype 2b hepatitis C virus (HCV) generally can achieve favorable responses to pegylated-interferon plus ribavirin therapy (PEG-IFN/RBV). However, a proportion of patients show poorer responses and the correlation between viral sequence variation and treatment outcome remains unclear. Methods: The pretreatment complete open reading frame (ORF) sequences of genotype 2b HCV determined by direct sequencing were investigated for correlation with the final outcome in a total of 60 patients. Results: In this study group, 87.5% (14/16) of non-sustained virological response (non-SVR) patients (n = 16) were relapsers. Compared to sustained virological response (SVR) patients (n = 44), non-SVR patients were older and could not achieve prompt viral clearance after the therapy induction. Comparing each viral protein between the two groups, viral sequences were more diverse in SVR patients and that diversity was found primarily in the E1, p7, and NS5A proteins. In searching for specific viral regions associated with the final outcome, several regions in E2, p7, NS2, NS5A, and NS5B were extracted. Among these regions, part of the interferon sensitivity determining region (ISDR) was included. In these regions, amino acid substitutions were associated with the final outcome in an incremental manner, depending upon the number of substitutions. Conclusions: Viral sequences are more diverse in SVR patients than non-SVR patients receiving PEG-IFN/RBV therapy for genotype-2b HCV infection. Through systematic comparison of viral sequences, several specific regions, including part of the ISDR, were extracted as having significant correlation with the final outcome.	[Kadokura, Makoto; Maekawa, Shinya; Sueki, Ryota; Miura, Mika; Komase, Kazuki; Shindo, Hiroko; Amemiya, Fumitake; Uetake, Tomoyoshi; Inoue, Taisuke; Sakamoto, Minoru; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi, Japan; [Nakagawa, Mina; Sakamoto, Naoya; Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo, Japan	University of Yamanashi; Tokyo Medical & Dental University (TMDU)	Kadokura, M (corresponding author), Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi, Japan.	maekawa@yamanashi.ac.jp	Maekawa, Shinya/AAF-1349-2019; nakagawa, mina/AAH-8088-2020; Watanabe, Mamoru/AHE-0489-2022; Sakamoto, Naoya/G-2734-2012; Nakagawa, Mina/AAO-4589-2020	Sakamoto, Naoya/0000-0003-0061-059X; 	Ministry of Education, Science, Sports and Culture [20390206]; Ministry of Health, Labour, and Welfare of Japan [H19-kanen-002]; Grants-in-Aid for Scientific Research [21390226] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant-in-aid scientific research fund of the Ministry of Education, Science, Sports and Culture number 20390206 and in part by a grant-in-aid from the Ministry of Health, Labour, and Welfare of Japan (H19-kanen-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2009, INTERVIROLOGY, V52, P301, DOI 10.1159/000235909; Chayama K, 2000, HEPATOLOGY, V32, P1138, DOI 10.1053/jhep.2000.19364; DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; Donlin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009032; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hamano K, 2005, J GASTROEN HEPATOL, V20, P1401, DOI 10.1111/j.1440-1746.2005.04024.x; Hayashi K, 2009, J MED VIROL, V81, P459, DOI 10.1002/jmv.21407; Haydon GH, 1998, GUT, V42, P570, DOI 10.1136/gut.42.4.570; Hofgartner WT, 1997, J MED VIROL, V53, P118, DOI 10.1002/(SICI)1096-9071(199710)53:2<118::AID-JMV3>3.0.CO;2-C; Kadokura M, 2011, HEPATOL INT IN PRESS; Kobayashi M, 2002, AM J GASTROENTEROL, V97, P988, DOI 10.1111/j.1572-0241.2002.05619.x; Kurosaki M, 2010, J HEPATOL; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Murakami T, 1999, HEPATOLOGY, V30, P1045, DOI 10.1002/hep.510300405; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Simmonds P, 1997, GUT, V40, P291, DOI 10.1136/gut.40.3.291; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Zeuzem S, 1997, HEPATOLOGY, V25, P740, DOI 10.1002/hep.510250341	26	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24514	10.1371/journal.pone.0024514	http://dx.doi.org/10.1371/journal.pone.0024514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935415	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700036
J	Kumar, S; Gupta, R; Kumar, S; Ali, S				Kumar, Sudeep; Gupta, Ruchi; Kumar, Sudhir; Ali, Sher			Molecular Mining of Alleles in Water Buffalo Bubalus bubalis and Characterization of the TSPY1 and COL6A1 Genes	PLOS ONE			English	Article							TESTIS-SPECIFIC PROTEIN; HUMAN Y-CHROMOSOME; COPY NUMBER; TRINUCLEOTIDE REPEATS; HUMAN SPERMATOZOA; MESSENGER-RNA; ENCODED TSPY; EXPRESSION; DNA; SEQUENCES	Background: Minisatellites are an integral part of eukaryotic genomes and show variation in the complexity of their organization. Besides their presence in non-coding regions, a small fraction of them are part of the transcriptome, possibly participating in gene regulation, expression and silencing. We studied the minisatellite (TGG)(n) tagged transcriptome in the water buffalo Bubalus bubalis across various tissues and the spermatozoa, and characterized the genes TSPY1 and COL6A1 discovered in the process. Results: Minisatellite associated sequence amplification (MASA) conducted using cDNA and oligonucleotide primer (TGG)(5) uncovered 38 different mRNA transcripts from somatic tissues and gonads and 15 from spermatozoa. These mRNA transcripts corresponded to several known and novel genes. The majority of the transcripts showed the highest level of expression either in the testes or spermatozoa with exception of a few showing higher expression levels in the lungs and liver. Transcript SR1, which is expressed in all the somatic tissues and gonads, was found to be similar to the Bos taurus collagen type VI alpha 1 gene (COL6A1). Similarly, SR29, a testis-specific transcript, was found to be similar to the Bos taurus testis-specific Y-encoded protein-1 representing cancer/testis antigen 78 (CT78). Subsequently, full length coding sequences (cds) of these two transcripts were obtained. Quantitative PCR (q-PCR) revealed 182-202 copies of theTSPY1 gene in water buffalo, which localized to the Y chromosome. Conclusions: The MASA approach enabled us to identify several genes, including two of clinical significance, without screening an entire cDNA library. Genes identified with TGG repeats are not part of a specific family of proteins and instead are distributed randomly throughout the genome. Genes showing elevated expression in the testes and spermatozoa may prove to be potential candidates for in-depth characterization. Furthermore, their possible involvement in fertility or lack thereof would augment animal biotechnology.	[Kumar, Sudeep; Gupta, Ruchi; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, Delhi, India; [Kumar, Sudhir] Univ Lucknow, Dept Zool, Lucknow 226007, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Lucknow University	Kumar, S (corresponding author), Natl Inst Immunol, Mol Genet Lab, Delhi, India.	alisher@nii.res.in	KUMAR, SUDEEP/AAC-8483-2021; Kumar, Sudhir/AAS-2602-2020	KUMAR, SUDEEP/0000-0002-1820-2423; 	Department of Biotechnology (DBT) in India [BT/PR8476/AAQ/01/315/2006, BT/PR14102/AAQ/01/438/2010]	Department of Biotechnology (DBT) in India(Department of Biotechnology (DBT) India)	The funding has been provided by the Department of Biotechnology (DBT) in India (http://dbtindia.nic.in) under DBT Grant Nos. BT/PR8476/AAQ/01/315/2006 and BT/PR14102/AAQ/01/438/2010 to SA, and a core grant from DBT India to the National Institute of Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; [Anonymous], CONSERVED DOMAIN DAT; [Anonymous], BLAST BASIC LOCAL AL; [Anonymous], TRANS NUCL PROT SEQ; Bashamboo A, 2005, MOL HUM REPROD, V11, P117, DOI 10.1093/molehr/gah135; Bena F, 2010, HUM MOL GENET, V19, P1967, DOI 10.1093/hmg/ddq075; Bennett P, 2000, J CLIN PATHOL-MOL PA, V53, P177; Bertini Enrico, 2002, Eur J Paediatr Neurol, V6, P193, DOI 10.1053/ejpn.2002.0593; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; De Grassi A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r137; Dechend F, 1998, CYTOGENET CELL GENET, V83, P270, DOI 10.1159/000015169; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; GRAHAM GJ, 1995, J THEOR BIOL, V175, P71, DOI 10.1006/jtbi.1995.0122; Hall SE, 2003, GENOME RES, V13, P195, DOI 10.1101/gr.593403; Hamilton CK, 2009, SEX DEV, V3, P205, DOI 10.1159/000228721; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hilario E, 2009, MOL BIOTECHNOL, V42, P320, DOI 10.1007/s12033-009-9157-9; JAKUBICZKA S, 1993, GENOMICS, V17, P732, DOI 10.1006/geno.1993.1394; Jasinska A, 2004, FEBS LETT, V567, P136, DOI 10.1016/j.febslet.2004.03.109; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krick R, 2006, BIOCHEM BIOPH RES CO, V341, P343, DOI 10.1016/j.bbrc.2005.12.190; Lalancette C, 2008, BIOL REPROD, V78, P618, DOI 10.1095/biolreprod.106.059030; Lambard S, 2004, MOL HUM REPROD, V10, P535, DOI 10.1093/molehr/gah064; Lau YFC, 1999, AM J HUM GENET, V64, P921, DOI 10.1086/302353; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; LINDBLAD K, 1994, NAT GENET, V7, P124, DOI 10.1038/ng0694-124; MANZ E, 1993, GENOMICS, V17, P726, DOI 10.1006/geno.1993.1393; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; Metzgar D, 2000, GENOME RES, V10, P72; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; Miller D, 2000, MOL REPROD DEV, V56, P259, DOI 10.1002/(SICI)1098-2795(200006)56:2+<259::AID-MRD10>3.0.CO;2-R; MILLER D, 1994, HUM REPROD, V9, P864, DOI 10.1093/oxfordjournals.humrep.a138607; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; Ostermeier GC, 2005, J ANDROL, V26, P70; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pathak D, 2010, CHROMOSOME RES, V18, P441, DOI 10.1007/s10577-010-9132-0; Rahman MM, 2004, DNA CELL BIOL, V23, P561, DOI 10.1089/1044549041939269; Richards RI, 2001, HUM MOL GENET, V10, P2187, DOI 10.1093/hmg/10.20.2187; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rodriguez P, 1997, GENOMICS, V44, P253, DOI 10.1006/geno.1997.4868; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Schnieders F, 1996, HUM MOL GENET, V5, P1801, DOI 10.1093/hmg/5.11.1801; Schubert S, 2000, CYTOGENET CELL GENET, V91, P239, DOI 10.1159/000056852; SIMERLY C, 1995, NAT MED, V1, P47, DOI 10.1038/nm0195-47; Srivastava J, 2006, DNA CELL BIOL, V25, P31, DOI 10.1089/dna.2006.25.31; Srivastava J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-132; Srivastava J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-303; Srivastava J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-436; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; Ugarkovic D, 2002, EMBO J, V21, P5955, DOI 10.1093/emboj/cdf612; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Vijayakumar S, 2006, CANCER RES, V66, P4055, DOI 10.1158/0008-5472.CAN-05-3822; Vodicka R, 2007, REPROD BIOMED ONLINE, V14, P579, DOI 10.1016/S1472-6483(10)61049-8; Vogel T, 1998, CYTOGENET CELL GENET, V80, P209, DOI 10.1159/000014982; Vogel T, 1997, CHROMOSOME RES, V5, P182, DOI 10.1023/A:1018494914182; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wykes SM, 1997, MOL HUM REPROD, V3, P15, DOI 10.1093/molehr/3.1.15; Zemanek M, 2005, INT J BIOL MACROMOL, V36, P23, DOI 10.1016/j.ijbiomac.2005.03.005	65	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24958	10.1371/journal.pone.0024958	http://dx.doi.org/10.1371/journal.pone.0024958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949806	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700082
J	Mailloux, RJ; Adjeitey, CNK; Xuan, JY; Harper, ME				Mailloux, Ryan J.; Adjeitey, Cyril Nii-Klu; Xuan, Jian Ying; Harper, Mary-Ellen			Crucial yet divergent roles of mitochondrial redox state in skeletal muscle vs. brown adipose tissue energetics	FASEB JOURNAL			English	Article						glutathione; thermogenesis; uncoupling proteins	COMPLEX-I; REVERSIBLE GLUTATHIONYLATION; PROTEIN GLUTATHIONYLATION; OXIDATIVE-PHOSPHORYLATION; UNCOUPLING PROTEIN; PROTON LEAK; CELL; IDENTIFICATION; DEHYDROGENASE; GLUTAREDOXIN	Reduced glutathione (GSH) is the major determinant of redox balance in mitochondria and as such is fundamental in the control of cellular bioenergetics. GSH is also the most important nonprotein antioxidant molecule in cells. Surprisingly, the effect of redox environment has never been examined in skeletal muscle and brown adipose tissue (BAT), two tissues that have exceptional dynamic range and that are relevant to the development of obesity and related diseases. Here, we show that the redox environment plays crucial, yet divergent, roles in modulating mitochondrial bioenergetics in skeletal muscle and BAT. Skeletal muscle mitochondria were found to naturally have a highly reduced environment (GSH/GSSG approximate to 46), and this was associated with fairly high (similar to 40%) rates of state 4 (nonphosphorylating) respiration and decreased reactive oxygen species (ROS) emission. The deglutathionylation of uncoupling protein 3 (UCP3) following an increase in the reductive potential of mitochondria results in a further increase in nonphosphorylating respiration (similar to 20% in situ). BAT mitochondria were found to have a much more oxidized status (GSH/GSSG approximate to 13) and had basal reactive oxygen species emission that was higher (similar to 250% increase in ROS generation) than that in skeletal muscle mitochondria. When redox status was subsequently increased (i.e., more reduced), UCP1-mediated uncoupling was more sensitive to GDP inhibition. Surprisingly, BAT was found to be devoid of glutaredoxin-2 (Grx2) expression, while there was abundant expression in skeletal muscle. Taken together, these findings reveal the importance of redox environment in controlling bioenergetic functions in both tissues, and the highly unique characteristics of BAT in this regard.-Mailloux, R. J., Adjeitey, C. N.-K., Xuan, J. Y., and Harper, M.-E. Crucial yet divergent roles of mitochondrial redox state in skeletal muscle vs. brown adipose tissue energetics. FASEB J. 26, 363-375 (2012). www.fasebj.org	[Mailloux, Ryan J.; Adjeitey, Cyril Nii-Klu; Xuan, Jian Ying; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	maryellen.harper@uottawa.ca		Mailloux, Ryan/0000-0003-3986-9830; Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research (CIHR); CIHR (Institute of Nutrition, Metabolism, and Diabetes)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR (Institute of Nutrition, Metabolism, and Diabetes)(Canadian Institutes of Health Research (CIHR))	The authors thank Mahmoud Salkhordeh for the isolation and purification of the primary myoblasts. R.J.M. was funded by a postdoctoral fellowship provided by the Canadian Institutes of Health Research (CIHR). Operating funding for this research was provided by CIHR (Institute of Nutrition, Metabolism, and Diabetes; to M. E. H.).	Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caprioli Joseph, 2009, Trans Am Ophthalmol Soc, V107, P161; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DEQUIROGA GB, 1991, BIOCHEM J, V277, P289, DOI 10.1042/bj2770289; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; GOUBERN M, 1990, BIOCHIM BIOPHYS ACTA, V1015, P334, DOI 10.1016/0005-2728(90)90038-6; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; HAUGAARD N, 1969, BIOCHEM PHARMACOL, V18, P2385, DOI 10.1016/0006-2952(69)90353-0; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Mailloux R. J., 2011, BIOCHEM J, V437, P21865; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mracek T, 2009, ARCH BIOCHEM BIOPHYS, V481, P30, DOI 10.1016/j.abb.2008.10.011; Naoi M, 2009, J NEURAL TRANSM, V116, P1371, DOI 10.1007/s00702-009-0309-7; Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Oelkrug R, 2010, J BIOL CHEM, V285, P21961, DOI 10.1074/jbc.M110.122861; Parker N, 2009, J BIOENERG BIOMEMBR, V41, P335, DOI 10.1007/s10863-009-9232-8; Petrovic V, 2010, GENES NUTR, V5, P225, DOI 10.1007/s12263-009-0162-1; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rolfe DFS, 1996, BBA-BIOENERGETICS, V1276, P45, DOI 10.1016/0005-2728(96)00029-1; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; SASTRE J, 1989, LIFE SCI, V45, P183, DOI 10.1016/0024-3205(89)90293-2; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; SHAKED Z, 1980, BIOCHEMISTRY-US, V19, P4156, DOI 10.1021/bi00559a004; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003	55	48	49	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					363	375		10.1096/fj.11-189639	http://dx.doi.org/10.1096/fj.11-189639			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21940996				2022-12-25	WOS:000299202200036
J	Jensen, MB; Bhatia, VK; Jao, CC; Rasmussen, JE; Pedersen, SL; Jensen, KJ; Langen, R; Stamou, D				Jensen, Martin Borch; Bhatia, Vikram Kjoller; Jao, Christine C.; Rasmussen, Jakob Ewald; Pedersen, Soren L.; Jensen, Knud J.; Langen, Ralf; Stamou, Dimitrios			Membrane Curvature Sensing by Amphipathic Helices A SINGLE LIPOSOME STUDY USING alpha-SYNUCLEIN AND ANNEXIN B12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN BINDING; EPSIN-RELATED PROTEINS; LIPID-MEMBRANES; BAR DOMAINS; SIZE DISTRIBUTIONS; STRUCTURAL-CHANGES; ANCHORED PROTEINS; CURVED MEMBRANES; EXTENDED HELIX; ANNEXIN B12	Preferential binding of proteins on curved membranes (membrane curvature sensing) is increasingly emerging as a general mechanism whereby cells may effect protein localization and trafficking. Here we use a novel single liposome fluorescence microscopy assay to examine a common sensing motif, the amphipathic helix (AH), and provide quantitative measures describing and distinguishing membrane binding and sensing behavior. By studying two AH-containing proteins, alpha-synuclein and annexin B12, as well as a range of AH peptide mutants, we reveal that both the hydrophobic and hydrophilic faces of the helix greatly influence binding and sensing. Although increased hydrophobic and electrostatic interactions with the membrane both lead to greater densities of bound protein, the former yields membrane curvature-sensitive binding, whereas the latter is not curvature-dependent. However, the relative contributions of both components determine the sensing of AHs. In contrast, charge density in the lipid membrane seems important primarily in attracting AHs to the membrane but does not significantly influence sensing. These observations were made possible by the ability of our assay to distinguish within our samples liposomes with and without bound protein as well as the density of bound protein. Our findings suggest that the description of membrane curvature-sensing requires consideration of several factors such as short and long range electrostatic interactions, hydrogen bonding, and the volume and structure of inserted hydrophobic residues.	[Jensen, Martin Borch; Bhatia, Vikram Kjoller; Stamou, Dimitrios] Univ Copenhagen, Bionanotechnol & Nanomed Lab, Dept Neurosci & Pharmacol, DK-2100 Copenhagen, Denmark; [Jensen, Martin Borch; Bhatia, Vikram Kjoller; Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, DK-2100 Copenhagen, Denmark; [Bhatia, Vikram Kjoller; Stamou, Dimitrios] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, DK-2100 Copenhagen, Denmark; [Jao, Christine C.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Rasmussen, Jakob Ewald; Pedersen, Soren L.; Jensen, Knud J.] Univ Copenhagen, IGM Bioorgan Chem, Fac Life Sci, DK-1871 Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen; Lundbeckfonden; University of Copenhagen; University of Southern California; University of Copenhagen	Stamou, D (corresponding author), Univ Copenhagen, Bionanotechnol & Nanomed Lab, Dept Neurosci & Pharmacol, Univ Sparken 5, DK-2100 Copenhagen, Denmark.	stamou@nano.ku.dk	Stamou, Dimitrios/D-5042-2016; Jensen, Knud J/D-1145-2016	Stamou, Dimitrios/0000-0001-8456-8995; Jensen, Knud J/0000-0003-3525-5452; Pedersen, Soren Ljungberg/0000-0002-6130-955X	National Institutes of Health [GM063915]; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Councils for Independent and Strategic Research; University of Copenhagen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Councils for Independent and Strategic Research; University of Copenhagen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063915. This work was also supported by the Lundbeck Foundation Center for Biomembranes in Nanomedicine, the Danish Councils for Independent and Strategic Research, and the University of Copenhagen program of excellence "BioScaRT."	Ambroggio E, 2010, EMBO J, V29, P292, DOI 10.1038/emboj.2009.341; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; Bendix PM, 2009, P NATL ACAD SCI USA, V106, P12341, DOI 10.1073/pnas.0903052106; BENFENATI F, 1989, CELL BIOL INT REP, V13, P1007, DOI 10.1016/0309-1651(89)90016-7; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DEMATTEIS MA, 1993, NATURE, V364, P818, DOI 10.1038/364818a0; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Donnelly SR, 1997, CELL MOL LIFE SCI, V53, P533, DOI 10.1007/s000180050068; Drin G, 2005, NATURE, V437, P1247, DOI 10.1038/4371247a; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fischer T, 2007, J BIOL CHEM, V282, P9996, DOI 10.1074/jbc.M611180200; Furuya T, 2003, BIOPHYS J, V84, P1950, DOI 10.1016/S0006-3495(03)75003-6; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hegde BG, 2006, BIOCHEMISTRY-US, V45, P934, DOI 10.1021/bi052143+; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Isas JM, 2003, J BIOL CHEM, V278, P30227, DOI 10.1074/jbc.M301228200; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langen R, 1998, J BIOL CHEM, V273, P22453, DOI 10.1074/jbc.273.35.22453; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lohr C, 2009, METHOD ENZYMOL, V465, P143, DOI 10.1016/S0076-6879(09)65008-4; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Mailliard WS, 1997, BIOCHEMISTRY-US, V36, P9045, DOI 10.1021/bi970749v; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5	64	92	93	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42603	42614		10.1074/jbc.M111.271130	http://dx.doi.org/10.1074/jbc.M111.271130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21953452	Green Published, hybrid			2022-12-25	WOS:000298180900068
J	Li, Q; Spencer, NY; Pantazis, NJ; Engelhardt, JF				Li, Qiang; Spencer, Netanya Y.; Pantazis, Nicholas J.; Engelhardt, John F.			Alsin and SOD1(G93A) Proteins Regulate Endosomal Reactive Oxygen Species Production by Glial Cells and Proinflammatory Pathways Responsible for Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEOTIDE EXCHANGE FACTOR; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; NADPH OXIDASE; CEREBROSPINAL-FLUID; MOTOR-NEURONS; ACTIVATION; GENE; ALS2/ALSIN	Recent studies have implicated enhanced Nox2-mediated reactive oxygen species (ROS) by microglia in the pathogenesis of motor neuron death observed in familial amyotrophic lateral sclerosis (ALS). In this context, ALS mutant forms of SOD1 enhance Rac1 activation, leading to increased Nox2-dependent microglial ROS production and neuron cell death in mice. It remains unclear if other genetic mutations that cause ALS also function through similar Nox-dependent pathways to enhance ROS-mediate motor neuron death. In the present study, we sought to understand whether alsin, which is mutated in an inherited juvenile form of ALS, functionally converges on Rac1-dependent pathways acted upon by SOD1(G93A) to regulate Nox-dependent ROS production. Our studies demonstrate that glial cell expression of SOD1(G93A) or wild type alsin induces ROS production, Rac1 activation, secretion of TNF alpha, and activation of NF kappa B, leading to decreased motor neuron survival in co-culture. Interestingly, coexpression of alsin, or shRNA against Nox2, with SOD1(G93A) in glial cells attenuated these proinflammatory indicators and protected motor neurons in co-culture, although shRNAs against Nox1 and Nox4 had little effect. SOD1(G93A) expression dramatically enhanced TNF alpha-mediated endosomal ROS in glial cells in a Rac1-dependent manner and alsin overexpression inhibited SOD1(G93A)-induced endosomal ROS and Rac1 activation. SOD1(G93A) expression enhanced recruitment of alsin to the endomembrane compartment in glial cells, suggesting that these two proteins act to modulate Nox2-dependent endosomal ROS and proinflammatory signals that modulate NF kappa B. These studies suggest that glial proinflammatory signals regulated by endosomal ROS are influenced by two gene products known to cause ALS.	[Li, Qiang; Spencer, Netanya Y.; Pantazis, Nicholas J.; Engelhardt, John F.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Rm 1-111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu	Spencer, Netanya/AAS-7999-2020	Spencer, Netanya/0000-0003-1010-5458; Engelhardt, John/0000-0003-2389-9277	National Institutes of Health [DK51315, DK054759]; Department of Defense [W81XWH-08-1-0645]; Roy J. Carver Chair in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK083429, R01DK051315, P30DK054759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Roy J. Carver Chair in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51315 and DK054759, Department of Defense Grant W81XWH-08-1-0645, and a grant from the Roy J. Carver Chair in Molecular Medicine (to J. F. E.).	Carter BJ, 2009, ANTIOXID REDOX SIGN, V11, P1569, DOI 10.1089/ARS.2008.2414; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chandran J, 2007, MOL NEUROBIOL, V36, P224, DOI 10.1007/s12035-007-0034-x; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Fiala M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-76; Ford LS, 2004, AMYOTROPH LATERAL SC, V5, P118, DOI 10.1080/14660820410019125; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; KRIEGER C, 1992, CAN J NEUROL SCI, V19, P357, DOI 10.1017/S0317167100041998; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee S, 2009, FREE RADICAL BIO MED, V47, P145, DOI 10.1016/j.freeradbiomed.2009.04.013; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Ono S, 2001, J NEUROL SCI, V187, P27, DOI 10.1016/S0022-510X(01)00514-7; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Otomo A, 2008, BIOCHEM BIOPH RES CO, V370, P87, DOI 10.1016/j.bbrc.2008.01.177; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Peterson JR, 2009, HYPERTENSION, V54, P1106, DOI 10.1161/HYPERTENSIONAHA.109.140087; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; Rey FE, 2002, CIRCULATION, V106, P2497, DOI 10.1161/01.CIR.0000038108.71560.70; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sekizawa T, 1998, J NEUROL SCI, V154, P194, DOI 10.1016/S0022-510X(97)00228-1; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Tolosa L, 2011, MOL CELL NEUROSCI, V46, P176, DOI 10.1016/j.mcn.2010.09.001; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	52	61	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40151	40162		10.1074/jbc.M111.279711	http://dx.doi.org/10.1074/jbc.M111.279711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937428	Green Published, hybrid			2022-12-25	WOS:000296925700048
J	Rudnick, JA; Arendt, LM; Klebba, I; Hinds, JW; Iyer, V; Gupta, PB; Naber, SP; Kuperwasser, C				Rudnick, Jenny A.; Arendt, Lisa M.; Klebba, Ina; Hinds, John W.; Iyer, Vandana; Gupta, Piyush B.; Naber, Stephen P.; Kuperwasser, Charlotte			Functional Heterogeneity of Breast Fibroblasts Is Defined by a Prostaglandin Secretory Phenotype that Promotes Expansion of Cancer-Stem Like Cells	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; STROMAL FIBROBLASTS; TUMOR-GROWTH; MICROENVIRONMENT; MYOFIBROBLASTS; GENERATION; FIBROSIS; MODEL; GLAND; DIFFERENTIATION	Fibroblasts are important in orchestrating various functions necessary for maintaining normal tissue homeostasis as well as promoting malignant tumor growth. Significant evidence indicates that fibroblasts are functionally heterogeneous with respect to their ability to promote tumor growth, but markers that can be used to distinguish growth promoting from growth suppressing fibroblasts remain ill-defined. Here we show that human breast fibroblasts are functionally heterogeneous with respect to tumor-promoting activity regardless of whether they were isolated from normal or cancerous breast tissues. Rather than significant differences in fibroblast marker expression, we show that fibroblasts secreting abundant levels of prostaglandin (PGE2), when isolated from either reduction mammoplasty or carcinoma tissues, were both capable of enhancing tumor growth in vivo and could increase the number of cancer stem-like cells. PGE2 further enhanced the tumor promoting properties of fibroblasts by increasing secretion of IL-6, which was necessary, but not sufficient, for expansion of breast cancer stem-like cells. These findings identify a population of fibroblasts which both produce and respond to PGE2, and that are functionally distinct from other fibroblasts. Identifying markers of these cells could allow for the targeted ablation of tumor-promoting and inflammatory fibroblasts in human breast cancers.	[Arendt, Lisa M.; Klebba, Ina; Hinds, John W.; Iyer, Vandana; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Gupta, Piyush B.] Massachusetts Inst Technol & Harvard, Whitehead Inst Biomed Res, Broad Inst, Dept Biol, Cambridge, MA USA; [Naber, Stephen P.] Tufts Med Ctr, Dept Pathol, Boston, MA USA	Tufts Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Whitehead Institute; Tufts Medical Center	Rudnick, JA (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Cell,Mol & Dev Biol Program, Boston, MA 02111 USA.	Charlotte.Kuperwasser@tufts.edu		Arendt, Lisa/0000-0002-7954-3635	Department of Defense; Raymond and Beverly Sackler Foundation; Breast Cancer Research Foundation; Silvian Foundation; National Institutes of Health/National Cancer Institute [CA125554, CA092644]; NATIONAL CANCER INSTITUTE [R01CA125554, P01CA092644] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Raymond and Beverly Sackler Foundation; Breast Cancer Research Foundation; Silvian Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Department of Defense Breast Cancer Research Program Pre-doctoral Traineeship Award (to JR), the Raymond and Beverly Sackler Foundation, the Breast Cancer Research Foundation, the Silvian Foundation, and the National Institutes of Health/National Cancer Institute (CA125554, CA092644; to CK). CK is a Raymond and Beverly Sackler Foundation Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; DESMOULIERE A, 1992, EXP CELL RES, V201, P64, DOI 10.1016/0014-4827(92)90348-C; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Huang MZ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-80; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jelaska A, 1999, SPRINGER SEMIN IMMUN, V21, P385, DOI 10.1007/BF00870301; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; KO SD, 1977, P NATL ACAD SCI USA, V74, P3429, DOI 10.1073/pnas.74.8.3429; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; KORN JH, 1984, ARTHRITIS RHEUM, V27, P174, DOI 10.1002/art.1780270208; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Meric JB, 2006, CRIT REV ONCOL HEMAT, V59, P51, DOI 10.1016/j.critrevonc.2006.01.003; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Proia DA, 2005, CELL CYCLE, V4, P1022, DOI 10.4161/cc.4.8.1903; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; RONNOVJESSEN L, 1990, LAB INVEST, V63, P532; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Singh A, 1999, ENDOCR-RELAT CANCER, V6, P139, DOI 10.1677/erc.0.0060139; Sotgia F, 2009, AM J PATHOL, V174, P746, DOI 10.2353/ajpath.2009.080658; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; TIPTON DA, 1991, J CELL BIOCHEM, V46, P152, DOI 10.1002/jcb.240460209; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trimmer C, 2011, CANCER BIOL THER, V11, P383, DOI 10.4161/cbt.11.4.14101; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873	57	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24605	10.1371/journal.pone.0024605	http://dx.doi.org/10.1371/journal.pone.0024605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957456	Green Published, gold			2022-12-25	WOS:000295262100015
J	Ghosn, J; Delaugerre, C; Flandre, P; Galimand, J; Cohen-Codar, I; Raffi, F; Delfraissy, JF; Rouzioux, C; Chaix, ML				Ghosn, Jade; Delaugerre, Constance; Flandre, Philippe; Galimand, Julie; Cohen-Codar, Isabelle; Raffi, Francois; Delfraissy, Jean-Francois; Rouzioux, Christine; Chaix, Marie-Laure			Polymorphism in Gag Gene Cleavage Sites of HIV-1 Non-B Subtype and Virological Outcome of a First-Line Lopinavir/Ritonavir Single Drug Regimen	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEASE INHIBITOR; COMPENSATORY MUTATIONS; NATURAL POLYMORPHISMS; INITIAL TREATMENT; PLUS ZIDOVUDINE; THERAPY-NAIVE; VIRAL FITNESS; IN-VIVO; RESISTANCE	Virological failure on a boosted-protease inhibitor (PI/r) first-line triple combination is usually not associated with the detection of resistance mutations in the protease gene. Thus, other resistance pathways are being investigated. First-line PI/r monotherapy is the best model to investigate in vivo if the presence of mutations in the cleavage sites (CS) of gag gene prior to any antiretroviral treatment might influence PI/r efficacy. 83 patients were assigned to initiate antiretroviral treatment with first-line lopinavir/r monotherapy in the randomised Monark trial. We compared baseline sequence of gag CS between patients harbouring B or non-B HIV-1 subtype, and between those who achieved viral suppression and those who experienced virological failure while on LPV/r monotherapy up to Week 96. Baseline sequence of gag CS was available for 82/83 isolates; 81/82 carried at least one substitution in gag CS compared to HXB2 sequence. At baseline, non-B subtype isolates were significantly more likely to harbour mutations in gag CS than B subtype isolates (p<0.0001). Twenty-three patients experienced virological failure while on lopinavir/r monotherapy. The presence of more than two substitutions in p2/NC site at baseline significantly predicted virological failure (p = 0.0479), non-B subtype isolates being more likely to harbour more than two substitutions in this specific site. In conclusion, gag cleavage site was highly polymorphic in antiretroviral-naive patients harbouring a non-B HIV-1 strain. We show that pre-therapy mutations in gag cleavage site sequence were significantly associated with the virological outcome of a first-line LPV/r single drug regimen in the Monark trial.	[Ghosn, Jade; Delaugerre, Constance; Galimand, Julie; Rouzioux, Christine; Chaix, Marie-Laure] Paris Descartes Univ, Necker Univ Hosp, EA 3620, Paris, France; [Ghosn, Jade; Delfraissy, Jean-Francois] Bicetre Univ Hosp, AP HP, Dept Internal Med & Infect Dis, Le Kremlin Bicetre, France; [Delaugerre, Constance; Rouzioux, Christine; Chaix, Marie-Laure] Necker Univ Hosp, AP HP, Dept Virol, Paris, France; [Flandre, Philippe] Hop La Pitie Salpetriere, Dept Virol, INSERM, UMR S 943, Paris, France; [Flandre, Philippe] Univ Paris 06, Paris, France; [Cohen-Codar, Isabelle] Abbott France, Rungis, France; [Raffi, Francois] Hop Hotel Dieu, Dept Infect Dis, Nantes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes	Ghosn, J (corresponding author), Paris Descartes Univ, Necker Univ Hosp, EA 3620, Paris, France.	jade.ghosn@bct.aphp.fr	Flandre, Philippe/N-6314-2017	Flandre, Philippe/0000-0002-2612-3522	Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	This study was supported by a grant from Abbott Laboratories. The funder had no role in the design of this substudy of the Monark trial, no role in data collection and analysis. The funder was involved in reviewing the manuscript. One of the co-authors is employed by the funder.	Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bartlett J, 2011, 18 C RETR OPP INF BO; Bunupuradah T, 2011, 18 C RETR OPP INF BO; Chang SY, 1999, AIDS RES HUM RETROV, V15, P1591, DOI 10.1089/088922299309892; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; Cote HCF, 2001, J VIROL, V75, P589, DOI 10.1128/JVI.75.2.589-594.2001; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; de Mendoza C, 2008, AIDS, V22, P311, DOI 10.1097/QAD.0b013e3282f4244f; Delaugerre C, 2009, ANTIMICROB AGENTS CH, V53, P2934, DOI 10.1128/AAC.01643-08; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; Dinman JD, 2002, P NATL ACAD SCI USA, V99, P5331, DOI 10.1073/pnas.082102199; Doyon L, 1996, J VIROL, V70, P1; ERON, 2006, LANCET, V368, P476, DOI DOI 10.1016/S0140-6736(06)69155-1; Flandre P, 2009, ANTIVIR THER, V14, P93; Ghosn J, 2010, HIV MED, V11, P137, DOI 10.1111/j.1468-1293.2009.00752.x; Girnary R, 2007, J GEN VIROL, V88, P226, DOI 10.1099/vir.0.82064-0; Gupta RK, 2010, AIDS, V24, P1651, DOI 10.1097/QAD.0b013e3283398216; Holguin A, 2004, J CLIN VIROL, V31, P215, DOI 10.1016/j.jcv.2004.03.015; Holguin A, 2006, J CLIN VIROL, V36, P264, DOI 10.1016/j.jcv.2006.05.001; Jinnopat P, 2009, JAIDS-J ACQ IMM DEF, V52, P320, DOI 10.1097/QAI.0b013e3181b4b18c; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Knops E, 2010, AIDS, V24, P779, DOI 10.1097/QAD.0b013e328336784d; Kolli M, 2006, VIROLOGY, V347, P405, DOI 10.1016/j.virol.2005.11.049; Larrouy L, 2010, ANTIMICROB AGENTS CH, V54, P2910, DOI 10.1128/AAC.00194-10; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Maguire MF, 2002, J VIROL, V76, P7398, DOI 10.1128/JVI.76.15.7398-7406.2002; Malet I, 2007, J INFECTION, V54, P367, DOI 10.1016/j.jinf.2006.06.012; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Nijhuis M, 2009, J INFECT DIS, V200, P698, DOI 10.1086/605329; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; PARKIN NT, 1992, J VIROL, V66, P5147, DOI 10.1128/JVI.66.8.5147-5151.1992; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; Pieniazek D, 2000, AIDS, V14, P1489, DOI 10.1097/00002030-200007280-00004; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Soulie C, 2009, AIDS, V23, P1605, DOI 10.1097/QAD.0b013e32832d9031; Telenti A, 2002, J VIROL, V76, P7868, DOI 10.1128/JVI.76.15.7868-7873.2002; Touloumi G, 2011, 18 C RETR OPP INF BO; Verheyen J, 2006, ANTIVIR THER, V11, P879; Verheyen J, 2009, J INFECTION, V58, P61, DOI 10.1016/j.jinf.2008.11.009; Zhang YM, 1997, J VIROL, V71, P6662, DOI 10.1128/JVI.71.9.6662-6670.1997	47	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24798	10.1371/journal.pone.0024798	http://dx.doi.org/10.1371/journal.pone.0024798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949754	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400015
J	Heikkila, T; Wheatley, E; Crighton, D; Schroder, E; Boakes, A; Kaye, SJ; Mezna, M; Pang, L; Rushbrooke, M; Turnbull, A; Olson, MF				Heikkila, Timo; Wheatley, Edward; Crighton, Diane; Schroder, Ewald; Boakes, Alexandra; Kaye, Sarah J.; Mezna, Mokdad; Pang, Leon; Rushbrooke, Mathew; Turnbull, Andrew; Olson, Michael F.			Co-Crystal Structures of Inhibitors with MRCK beta, a Key Regulator of Tumor Cell Invasion	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; DYSTROPHY PROTEIN-KINASE; RHO-KINASE; INTRAHEPATIC METASTASIS; CANCER; MECHANISM; PHOSPHORYLATION; EXPRESSION; MOTILITY; GTPASES	MRCK alpha and MRCK beta (myotonic dystrophy kinase-related Cdc42-binding kinases) belong to a subfamily of Rho GTPase activated serine/threonine kinases within the AGC-family that regulate the actomyosin cytoskeleton. Reflecting their roles in myosin light chain (MLC) phosphorylation, MRCK alpha and MRCK beta influence cell shape and motility. We report further evidence for MRCK alpha and MRCK beta contributions to the invasion of cancer cells in 3-dimensional matrix invasion assays. In particular, our results indicate that the combined inhibition of MRCK alpha and MRCK beta together with inhibition of ROCK kinases results in significantly greater effects on reducing cancer cell invasion than blocking either MRCK or ROCK kinases alone. To probe the kinase ligand pocket, we screened 159 kinase inhibitors in an in vitro MRCK beta kinase assay and found 11 compounds that inhibited enzyme activity >80% at 3 mu M. Further analysis of three hits, Y-27632, Fasudil and TPCA-1, revealed low micromolar IC(50) values for MRCK alpha and MRCK beta. We also describe the crystal structure of MRCK beta in complex with inhibitors Fasudil and TPCA-1 bound to the active site of the kinase. These high-resolution structures reveal a highly conserved AGC kinase fold in a typical dimeric arrangement. The kinase domain is in an active conformation with a fully-ordered and correctly positioned alpha C helix and catalytic residues in a conformation competent for catalysis. Together, these results provide further validation for MRCK involvement in regulation of cancer cell invasion and present a valuable starting point for future structure-based drug discovery efforts.	[Heikkila, Timo; Wheatley, Edward; Schroder, Ewald; Boakes, Alexandra; Kaye, Sarah J.; Pang, Leon; Rushbrooke, Mathew; Turnbull, Andrew] Wolfson Inst Biomed Res, Canc Res Technol Discovery Labs, London, England; [Crighton, Diane; Mezna, Mokdad; Olson, Michael F.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of London; University College London; Beatson Institute	Heikkila, T (corresponding author), Wolfson Inst Biomed Res, Canc Res Technol Discovery Labs, London, England.	m.olson@beatson.gla.ac.uk	Olson, Michael/ABA-4240-2021; Olson, Michael F/A-3240-2011	Olson, Michael/0000-0003-3428-3507; 	Cancer Research UK	Cancer Research UK(Cancer Research UK)	Cancer Research UK funded this research directly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Breitenlechner C, 2003, STRUCTURE, V11, P1595, DOI 10.1016/j.str.2003.11.002; Croft DR, 2008, CANCER CELL, V14, P349, DOI 10.1016/j.ccr.2008.10.009; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Elkins JM, 2009, PROTEIN SCI, V18, P782, DOI 10.1002/pro.82; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher KE, 2009, J CELL SCI, V122, P4558, DOI 10.1242/jcs.050724; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Genda T, 1999, HEPATOLOGY, V30, P1027, DOI 10.1002/hep.510300420; Groeger G, 2007, BIOCHEM J, V404, P23, DOI 10.1042/BJ20070146; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lam LT, 2000, HUM MOL GENET, V9, P2167, DOI 10.1093/hmg/9.14.2167; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lochhead PA, 2010, ONCOGENE, V29, P2591, DOI 10.1038/onc.2010.3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakajima M, 2003, CANCER CHEMOTH PHARM, V52, P319, DOI 10.1007/s00280-003-0641-9; Nakajima M, 2003, CLIN EXP PHARMACOL P, V30, P457, DOI 10.1046/j.1440-1681.2003.03855.x; Nakajima M, 2003, EUR J PHARMACOL, V459, P113, DOI 10.1016/S0014-2999(02)02869-8; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Pham YCN, 1998, HUM MOL GENET, V7, P1957, DOI 10.1093/hmg/7.12.1957; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Schueller O, 2006, CIRCULATION, V114, P228; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; SHIFRIN V, 2005, AACR M 2005, P158; Somlyo AV, 2003, FASEB J, V17, P223, DOI 10.1096/fj.02-0655com; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Takamura M, 2001, HEPATOLOGY, V33, P577, DOI 10.1053/jhep.2001.22652; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Tanaka J, 1998, BIOCHEMISTRY-US, V37, P16697, DOI 10.1021/bi980782x; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wickman GR, 2010, RHO GTPASES IN CANCER, P163, DOI 10.1007/978-1-4419-1111-7_11; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x; Yamaguchi H, 2006, STRUCTURE, V14, P589, DOI 10.1016/j.str.2005.11.024; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	53	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24825	10.1371/journal.pone.0024825	http://dx.doi.org/10.1371/journal.pone.0024825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949762	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295260400019
J	Pan, CJ; Chen, SY; Jun, HS; Lin, SR; Mansfield, BC; Chou, JY				Pan, Chi-Jiunn; Chen, Shih-Yin; Jun, Hyun Sik; Lin, Su Ru; Mansfield, Brian C.; Chou, Janice Y.			SLC37A1 and SLC37A2 Are Phosphate-Linked, Glucose-6-Phosphate Antiporters	PLOS ONE			English	Article							DISEASE TYPE 1B; ESCHERICHIA-COLI; TRANSPORT-SYSTEMS; GENE; IB; DEFICIENT; RECONSTITUTION; SUPERFAMILY; THERAPY; MOUSE	Blood glucose homeostasis between meals depends upon production of glucose within the endoplasmic reticulum (ER) of the liver and kidney by hydrolysis of glucose-6-phosphate (G6P) into glucose and phosphate (Pi). This reaction depends on coupling the G6P transporter (G6PT) with glucose-6-phosphatase-alpha (G6Pase-alpha). Only one G6PT, also known as SLC37A4, has been characterized, and it acts as a Pi-linked G6P antiporter. The other three SLC37 family members, predicted to be sugar-phosphate: Pi exchangers, have not been characterized functionally. Using reconstituted proteoliposomes, we examine the antiporter activity of the other SLC37 members along with their ability to couple with G6Pase-alpha. G6PT- and mock-proteoliposomes are used as positive and negative controls, respectively. We show that SLC37A1 and SLC37A2 are ER-associated, Pi-linked antiporters, that can transport G6P. Unlike G6PT, neither is sensitive to chlorogenic acid, a competitive inhibitor of physiological ER G6P transport, and neither couples to G6Pase-alpha. We conclude that three of the four SLC37 family members are functional sugar-phosphate antiporters. However, only G6PT/SLC37A4 matches the characteristics of the physiological ER G6P transporter, suggesting the other SLC37 proteins have roles independent of blood glucose homeostasis.	[Pan, Chi-Jiunn; Chen, Shih-Yin; Jun, Hyun Sik; Lin, Su Ru; Mansfield, Brian C.; Chou, Janice Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Differentiat, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pan, CJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Differentiat, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA.	chouja@mail.nih.gov	Jun, Hyun Sik/C-6799-2013	Mansfield, Brian/0000-0002-8533-2789	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000912] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBUDKAR SV, 1986, J BIOL CHEM, V261, P9083; AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; Annabi B, 1998, AM J HUM GENET, V62, P400, DOI 10.1086/301727; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; Bartoloni L, 2004, PFLUG ARCH EUR J PHY, V447, P780, DOI 10.1007/s00424-003-1105-0; Bartoloni L, 2000, GENOMICS, V70, P190, DOI 10.1006/geno.2000.6395; Brunner Y, 2009, J PROTEOMICS, V71, P576, DOI 10.1016/j.jprot.2008.10.002; Chen LY, 2000, J BIOL CHEM, V275, P34280, DOI 10.1074/jbc.M006439200; Chen LY, 2002, HUM MOL GENET, V11, P3199, DOI 10.1093/hmg/11.25.3199; Chen SY, 2008, FASEB J, V22, P2206, DOI 10.1096/fj.07-104851; Chou JY, 2010, NAT REV ENDOCRINOL, V6, P676, DOI 10.1038/nrendo.2010.189; Chou Janice Yang, 2002, Current Molecular Medicine (Hilversum), V2, P121, DOI 10.2174/1566524024605798; Gerin I, 1997, FEBS LETT, V419, P235, DOI 10.1016/S0014-5793(97)01463-4; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; He Lei, 2009, Human Genomics, V3, P195; Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532; Iacopetta D, 2010, BREAST CANCER RES TR, V122, P755, DOI 10.1007/s10549-009-0620-x; Kim JY, 2007, AM J PHYSIOL-ENDOC M, V293, pE110, DOI 10.1152/ajpendo.00404.2006; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Leuzzi R, 2001, BIOCHEM J, V357, P557, DOI 10.1042/0264-6021:3570557; MALONEY PC, 1989, ARCH BIOCHEM BIOPHYS, V269, P1, DOI 10.1016/0003-9861(89)90080-5; Melis D, 2005, EUR J PEDIATR, V164, P501, DOI 10.1007/s00431-005-1657-4; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mithieux G, 2004, J BIOL CHEM, V279, P44231, DOI 10.1074/jbc.R400011200; Pan CJ, 2009, MOL GENET METAB, V96, P32, DOI 10.1016/j.ymgme.2008.10.005; Pan CJ, 1999, J BIOL CHEM, V274, P13865, DOI 10.1074/jbc.274.20.13865; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200; SINGH J, 1981, BIOCHIM BIOPHYS ACTA, V678, P477, DOI 10.1016/0304-4165(81)90129-X; SONNA LA, 1988, J BIOL CHEM, V263, P6625; Takahashi Y, 2000, BBA-GENE STRUCT EXPR, V1492, P385, DOI 10.1016/S0167-4781(00)00133-0; Zingone A, 2000, J BIOL CHEM, V275, P828, DOI 10.1074/jbc.275.2.828	33	56	61	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e23157	10.1371/journal.pone.0023157	http://dx.doi.org/10.1371/journal.pone.0023157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949678	gold, Green Published, Green Submitted			2022-12-25	WOS:000295260400001
J	Pink, CJ; Hurst, LD				Pink, Catherine J.; Hurst, Laurence D.			Late Replicating Domains Are Highly Recombining in Females but Have Low Male Recombination Rates: Implications for Isochore Evolution	PLOS ONE			English	Article							BIASED GENE CONVERSION; SUBSTITUTION RATES; LOCAL SIMILARITY; MUTATION-RATES; TIME ZONES; GC-CONTENT; MOUSE; GENOME; DNA; SCALE	In mammals sequences that are either late replicating or highly recombining have high rates of evolution at putatively neutral sites. As early replicating domains and highly recombining domains both tend to be GC rich we a priori expect these two variables to covary. If so, the relative contribution of either of these variables to the local neutral substitution rate might have been wrongly estimated owing to covariance with the other. Against our expectations, we find that sex-averaged recombination rates show little or no correlation with replication timing, suggesting that they are independent determinants of substitution rates. However, this result masks significant sex-specific complexity: late replicating domains tend to have high recombination rates in females but low recombination rates in males. That these trends are antagonistic explains why sex-averaged recombination is not correlated with replication timing. This unexpected result has several important implications. First, although both male and female recombination rates covary significantly with intronic substitution rates, the magnitude of this correlation is moderately underestimated for male recombination and slightly overestimated for female recombination, owing to covariance with replicating timing. Second, the result could explain why male recombination is strongly correlated with GC content but female recombination is not. If to explain the correlation between GC content and replication timing we suppose that late replication forces reduced GC content, then GC promotion by biased gene conversion during female recombination is partly countered by the antagonistic effect of later replicating sequence tending increase AT content. Indeed, the strength of the correlation between female recombination rate and local GC content is more than doubled by control for replication timing. Our results underpin the need to consider sex-specific recombination rates and potential covariates in analysis of GC content and rates of evolution.	[Pink, Catherine J.; Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Pink, CJ (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	L.D.Hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054	Royal Society; MRC	Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LDH is a Royal Society Wolfson Research Merit award Holder. CJP is funded by an MRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chamary JV, 2004, MOL BIOL EVOL, V21, P1014, DOI 10.1093/molbev/msh087; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Clement Y, 2011, GENOME BIOL EVOL, V3, P236, DOI 10.1093/gbe/evr011; Costantini M, 2008, P NATL ACAD SCI USA, V105, P3433, DOI 10.1073/pnas.0710587105; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Crow JF, 1999, MUTAT RES-REV MUTAT, V437, P5, DOI 10.1016/S1383-5742(99)00063-0; Crow JF, 1997, NAT GENET, V17, P129, DOI 10.1038/ng1097-129; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Dumont BL, 2011, GENOME RES, V21, P114, DOI 10.1101/gr.111252.110; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Gaffney DJ, 2005, GENOME RES, V15, P1086, DOI 10.1101/gr.3895005; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Keightley PD, 2003, P NATL ACAD SCI USA, V100, P13402, DOI 10.1073/pnas.2233252100; Lang GI, 2011, GENOME BIOL IN PRESS; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Lercher MJ, 2001, MOL BIOL EVOL, V18, P2032, DOI 10.1093/oxfordjournals.molbev.a003744; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; MAGNI GE, 1963, P NATL ACAD SCI USA, V50, P975, DOI 10.1073/pnas.50.5.975; MAGNI GE, 1962, GENETICS, V47, P1097; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Marsolier-Kergoat MC, 2009, GENETICS, V183, P31, DOI 10.1534/genetics.109.105049; McVicker G, 2010, GENOME RES, V20, P1503, DOI 10.1101/gr.106666.110; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Necsulea A, 2009, TRENDS GENET, V25, P519, DOI 10.1016/j.tig.2009.10.001; Perry J, 1999, CURR BIOL, V9, P987, DOI 10.1016/S0960-9822(99)80430-8; Piganeau G, 2002, J MOL EVOL, V54, P129, DOI 10.1007/s00239-001-0011-3; Pink CJ, 2009, GENOME BIOL EVOL, V1, P13, DOI 10.1093/gbe/evp001; Pink CJ, 2010, MOL BIOL EVOL, V27, P1077, DOI 10.1093/molbev/msp314; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ramsdell CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-65; Schmegner C, 2007, CYTOGENET GENOME RES, V116, P167, DOI 10.1159/000098182; Schmegner C, 2005, GENOMICS, V86, P439, DOI 10.1016/j.ygeno.2005.06.011; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; STRATHERN JN, 1995, GENETICS, V140, P965; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Touchon M, 2004, NUCLEIC ACIDS RES, V32, P4969, DOI 10.1093/nar/gkh823; Tyekucheva S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r76; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Webster MT, 2005, MOL BIOL EVOL, V22, P1468, DOI 10.1093/molbev/msi136; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yaffe E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001011	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24480	10.1371/journal.pone.0024480	http://dx.doi.org/10.1371/journal.pone.0024480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949720	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400006
J	Hutz, JE; Manning, WA; Province, MA; McLeod, HL				Hutz, Janna E.; Manning, W. Aaron; Province, Michael A.; McLeod, Howard L.			Genomewide Analysis of Inherited Variation Associated with Phosphorylation of PI3K/AKT/mTOR Signaling Proteins	PLOS ONE			English	Article							HUMAN GENE-EXPRESSION; WIDE ASSOCIATION; CELL-LINES; INDUCED CYTOTOXICITY; DRUG DISCOVERY; PLASMA-LEVELS; PATHWAY; CANCER; VARIANTS; LOCI	While there exists a wealth of information about genetic influences on gene expression, less is known about how inherited variation influences the expression and post-translational modifications of proteins, especially those involved in intracellular signaling. The PI3K/AKT/mTOR signaling pathway contains several such proteins that have been implicated in a number of diseases, including a variety of cancers and some psychiatric disorders. To assess whether the activation of this pathway is influenced by genetic factors, we measured phosphorylated and total levels of three key proteins in the pathway (AKT1, p70S6K, 4E-BP1) by ELISA in 122 lymphoblastoid cell lines from 14 families. Interestingly, the phenotypes with the highest proportion of genetic influence were the ratios of phosphorylated to total protein for two of the pathway members: AKT1 and p70S6K. Genomewide linkage analysis suggested several loci of interest for these phenotypes, including a linkage peak for the AKT1 phenotype that contained the AKT1 gene on chromosome 14. Linkage peaks for the phosphorylated: total protein ratios of AKT1 and p70S6K also overlapped on chromosome 3. We selected and genotyped candidate genes from under the linkage peaks, and several statistically significant associations were found. One polymorphism in HSP90AA1 was associated with the ratio of phosphorylated to total AKT1, and polymorphisms in RAF1 and GRM7 were associated with the ratio of phosphorylated to total p70S6K. These findings, representing the first genomewide search for variants influencing human protein phosphorylation, provide useful information about the PI3K/AKT/mTOR pathway and serve as a valuable proof of concept for studies integrating human genomics and proteomics.	[Hutz, Janna E.; Manning, W. Aaron; McLeod, Howard L.] Univ N Carolina, Inst Pharmacogenom & Individualized Therapy, Chapel Hill, NC 27514 USA; [Hutz, Janna E.; Province, Michael A.] Washington Univ, Div Stat Genom, St Louis, MO USA	University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL)	Hutz, JE (corresponding author), Univ N Carolina, Inst Pharmacogenom & Individualized Therapy, Chapel Hill, NC 27514 USA.	hmcleod@unc.edu	McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	National Institutes of Health Pharmacogenetics Research Network [U01 GM63340]; National Defense Science and Engineering Graduate Fellowship; Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340] Funding Source: NIH RePORTER	National Institutes of Health Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Defense Science and Engineering Graduate Fellowship; Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health Pharmacogenetics Research Network (U01 GM63340). JEH was supported by a National Defense Science and Engineering Graduate Fellowship and a Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; Calafell F, 2010, HUM MOL GENET, V19, P517, DOI 10.1093/hmg/ddp517; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gao ZH, 2010, CURR OPIN DRUG DISC, V13, P193; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Garge N, 2010, MOL CELL PROTEOMICS, V9, P1383, DOI 10.1074/mcp.M900378-MCP200; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Greenwood TA, 2004, PHYSIOL GENOMICS, V18, P119, DOI 10.1152/physiolgenomics.00104.2003; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; He MA, 2010, ARTERIOSCL THROM VAS, V30, P885, DOI 10.1161/ATVBAHA.109.199422; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2008, CANCER RES, V68, P3161, DOI 10.1158/0008-5472.CAN-07-6381; Huang Song, 2007, BMC Proc, V1 Suppl 1, pS86; Hutz JE, 2008, GENET EPIDEMIOL, V32, P779, DOI 10.1002/gepi.20346; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; KAREGE F, 2010, GENES BRAIN BEHAV; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; KUMAR A, 1995, HUM MOL GENET, V4, P1471, DOI 10.1093/hmg/4.8.1471; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Massey AJ, 2010, MOL CANCER THER, V9, P906, DOI 10.1158/1535-7163.MCT-10-0055; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SUN Q, 2010, HUM MOL GENET; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Yu CF, 2002, J BIOL CHEM, V277, P19382, DOI 10.1074/jbc.M200732200; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24873	10.1371/journal.pone.0024873	http://dx.doi.org/10.1371/journal.pone.0024873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949775	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900032
J	Machilsen, B; Novitskiy, N; Vancleef, K; Wagemans, J				Machilsen, Bart; Novitskiy, Nikolay; Vancleef, Kathleen; Wagemans, Johan			Context Modulates the ERP Signature of Contour Integration	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ELECTROPHYSIOLOGICAL CORRELATE; PERCEPTION; ORGANIZATION; ATTENTION; LUMINANCE; SYSTEM; EEG	We investigated how the electrophysiological signature of contour integration is changed by the context in which a contour is embedded. Specifically, we manipulated the orientations of Gabor elements surrounding an embedded shape outline. The amplitudes of early visual components over posterior scalp regions were changed by the presence of a contour, and by the orientation of elements surrounding the contour. Differences in context type had an effect on the early P1 and N1 components, but not on the later P2 component. The presence of a contour had an effect on the N1 and P2 components, but not on the earlier P1 component. A modulatory effect of context on contour integration was observed on the N1 component. These results highlight the importance of the context in which contour integration takes place.	[Machilsen, Bart; Novitskiy, Nikolay; Vancleef, Kathleen; Wagemans, Johan] Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium	KU Leuven	Wagemans, J (corresponding author), Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium.	johan.wagemans@psy.kuleuven.be	Novitskiy, Nikolay/ABF-3029-2020; Vancleef, Kathleen/I-8586-2019; Wagemans, Johan/M-3878-2019; Novitskiy, Nikolay/G-8703-2015	Novitskiy, Nikolay/0000-0002-4039-5209; Vancleef, Kathleen/0000-0002-9943-9341; Novitskiy, Nikolay/0000-0002-4039-5209; Wagemans, Johan/0000-0002-7970-1541	Research Foundation-Flanders (FWO); Flemish Government [METH/08/02]	Research Foundation-Flanders (FWO)(FWO); Flemish Government(European Commission)	This research was supported by a postdoctoral fellowship from Research Foundation-Flanders (FWO) to N.N., and a Methusalem grant from the Flemish Government awarded to J.W. (METH/08/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bach M, 1997, VISION RES, V37, P1409, DOI 10.1016/S0042-6989(96)00322-7; Caputo G, 1999, VISION RES, V39, P1597, DOI 10.1016/S0042-6989(98)00270-3; Claessens PME, 2008, J VISION, V8, DOI 10.1167/8.7.33; Claessens PM, 2005, PERCEPT PSYCHOPHYS, V67, P1446, DOI 10.3758/BF03193649; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Han SH, 2001, PSYCHOPHYSIOLOGY, V38, P926, DOI 10.1111/1469-8986.3860926; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Herrmann CS, 2001, NEUROREPORT, V12, P901, DOI 10.1097/00001756-200104170-00007; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; Klemm M, 2009, MED BIOL ENG COMPUT, V47, P413, DOI 10.1007/s11517-009-0452-1; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Machilsen B, 2011, VISION RES, V51, P179, DOI 10.1016/j.visres.2010.11.005; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mathes B, 2007, PSYCHOPHYSIOLOGY, V44, P305, DOI 10.1111/j.1469-8986.2007.00501.x; Mathes B, 2006, BRAIN RES, V1114, P98, DOI 10.1016/j.brainres.2006.07.068; Norcia AM, 2002, J VISION, V2, P132, DOI 10.1167/2.2.1; Nygard GE, 2009, VISION RES, V49, P2475, DOI 10.1016/j.visres.2009.08.002; Ohla K, 2005, VISION RES, V45, P2668, DOI 10.1016/j.visres.2005.03.015; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pettet MW, 1998, VISION RES, V38, P865, DOI 10.1016/S0042-6989(97)00238-1; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sassi M, 2010, I-PERCEPTION, V1, P121, DOI 10.1068/i0384; Sayim B, 2010, PSYCHOL SCI, V21, P641, DOI 10.1177/0956797610368811; Straube S, 2010, VISION RES, V50, P509, DOI 10.1016/j.visres.2009.12.013; Straube S, 2010, BRAIN RES, V1307, P89, DOI 10.1016/j.brainres.2009.10.043; Tanskanen T, 2008, J VISION, V8, DOI 10.1167/8.7.15; Verbeke G, 2000, LINEAR MIXED MODELS	37	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25151	10.1371/journal.pone.0025151	http://dx.doi.org/10.1371/journal.pone.0025151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825FZ	21949875	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900055
J	Schweizer, S; Hampshire, A; Dalgleish, T				Schweizer, Susanne; Hampshire, Adam; Dalgleish, Tim			Extending Brain-Training to the Affective Domain: Increasing Cognitive and Affective Executive Control through Emotional Working Memory Training	PLOS ONE			English	Article							FACIAL EXPRESSIONS; FLUID INTELLIGENCE; ANXIETY; TASK; FMRI; MODULATION; CHILDREN; CORTEX; LEVEL; ADHD	So-called 'brain-training' programs are a huge commercial success. However, empirical evidence regarding their effectiveness and generalizability remains equivocal. This study investigated whether brain-training (working memory [WM] training) improves cognitive functions beyond the training task (transfer effects), especially regarding the control of emotional material since it constitutes much of the information we process daily. Forty-five participants received WM training using either emotional or neutral material, or an undemanding control task. WM training, regardless of training material, led to transfer gains on another WM task and in fluid intelligence. However, only brain-training with emotional material yielded transferable gains to improved control over affective information on an emotional Stroop task. The data support the reality of transferable benefits of demanding WM training and suggest that transferable gains across to affective contexts require training with material congruent to those contexts. These findings constitute preliminary evidence that intensive cognitively demanding brain-training can improve not only our abstract problem-solving capacity, but also ameliorate cognitive control processes (e. g. decision-making) in our daily emotive environments.	[Schweizer, Susanne; Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Hampshire, Adam] Univ Western Ontario, Ctr Brain & Mind, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Schweizer, S (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge, England.	susanne.schweizer@mrc-cbu.cam.ac.uk	Schweizer, Susanne/X-4313-2018; Dalgleish, Tim/E-8341-2010	Schweizer, Susanne/0000-0001-6153-8291; Dalgleish, Tim/0000-0002-7304-2231	United Kingdom Medical Research Council; Medical Research Council [MC_U105579215] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the United Kingdom Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, J NEUROSCI, V26, P4930, DOI [10.1523/JNEUROSCI.5480-05, DOI 10.1523/JNEUROSCI.5480-05, DOI 10.1523/JNEUROSCI.1312-06.2006]; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Becker ES, 2001, J ANXIETY DISORD, V15, P147, DOI 10.1016/S0887-6185(01)00055-X; Bell M, 2003, ACTA PSYCHIAT SCAND, V108, P101, DOI 10.1034/j.1600-0447.2003.00090.x; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Cervilla J, 2004, J NEUROL NEUROSUR PS, V75, P1100, DOI 10.1136/jnnp.2003.028076; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Dichter GS, 2009, J AFFECT DISORDERS, V114, P131, DOI 10.1016/j.jad.2008.06.027; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JACOBS N, 2007, TWIN RES HUM GENET, V10, P11, DOI DOI 10.1375/twin.10.supp.11; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Levens SA, 2008, EMOTION, V8, P267, DOI 10.1037/1528-3542.8.2.267; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Mikels JA, 2008, EMOTION, V8, P256, DOI 10.1037/1528-3542.8.2.256; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Preston SD, 2008, COGN AFFECT BEHAV NE, V8, P54, DOI 10.3758/CABN.8.1.54; Raven J.C., 1960, GUIDE STANDARD PROGR; Rindermann H, 2008, INTELLIGENCE, V36, P127, DOI 10.1016/j.intell.2007.02.002; Rohde TE, 2007, INTELLIGENCE, V35, P83, DOI 10.1016/j.intell.2006.05.004; Sommer M, 2008, ACTA NEUROBIOL EXP, V68, P193; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	34	121	127	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24372	10.1371/journal.pone.0024372	http://dx.doi.org/10.1371/journal.pone.0024372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825FZ	21949712	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900011
J	Chakraborty, SA; Simpson, RT; Grigoryev, SA				Chakraborty, Sangita A.; Simpson, Robert T.; Grigoryev, Sergei A.			A Single Heterochromatin Boundary Element Imposes Position-Independent Antisilencing Activity in Saccharomyces cerevisiae Minichromosomes	PLOS ONE			English	Article							SILENCED CHROMATIN; ENHANCER ACTION; BUDDING YEAST; REPRESSION; NUCLEOSOME; DNA; DOMAINS; INHERITANCE; INSULATORS; LOCUS	Chromatin boundary elements serve as cis-acting regulatory DNA signals required to protect genes from the effects of the neighboring heterochromatin. In the yeast genome, boundary elements act by establishing barriers for heterochromatin spreading and are sufficient to protect a reporter gene from transcriptional silencing when inserted between the silencer and the reporter gene. Here we dissected functional topography of silencers and boundary elements within circular minichromosomes in Saccharomyces cerevisiae. We found that both HML-E and HML-I silencers can efficiently repress the URA3 reporter on a multi-copy yeast minichromosome and we further showed that two distinct heterochromatin boundary elements STAR and TEF2-UASrpg are able to limit the heterochromatin spreading in circular minichromosomes. In surprising contrast to what had been observed in the yeast genome, we found that in minichromosomes the heterochromatin boundary elements inhibit silencing of the reporter gene even when just one boundary element is positioned at the distal end of the URA3 reporter or upstream of the silencer elements. Thus the STAR and TEF2-UASrpg boundary elements inhibit chromatin silencing through an antisilencing activity independently of their position or orientation in S. cerevisiae minichromosomes rather than by creating a position-specific barrier as seen in the genome. We propose that the circular DNA topology facilitates interactions between the boundary and silencing elements in the minichromosomes.	[Chakraborty, Sangita A.; Grigoryev, Sergei A.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Simpson, Robert T.] Penn State Univ, Eberly Coll Sci, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chakraborty, SA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	szc104@psu.edu; sag17@psu.edu	Chakraborty, subhadeep/I-5701-2013	Chakraborty, subhadeep/0000-0001-5035-9925	National Science Foundation [MCB-1021681]; American Association of University; Department of Biochemistry and Molecular Biology (Penn State, University Park); Pennsylvania Department of Health	National Science Foundation(National Science Foundation (NSF)); American Association of University; Department of Biochemistry and Molecular Biology (Penn State, University Park); Pennsylvania Department of Health	Funding support was received from National Science Foundation grant MCB-1021681 to SAG and by the American Association of University Women International Doctoral Fellowship Award to SAC. This project was also funded, in part, by the Department of Biochemistry and Molecular Biology (Penn State, University Park) and a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM J, 1984, J MOL BIOL, V176, P307, DOI 10.1016/0022-2836(84)90492-3; Ausubel F., 1999, CURRENT PROTOCOLS MO; Bi X, 1999, P NATL ACAD SCI USA, V96, P11934, DOI 10.1073/pnas.96.21.11934; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 2002, GENETICS, V160, P1401; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bondarenko VA, 2003, EMBO J, V22, P4728, DOI 10.1093/emboj/cdg468; Boscheron C, 1996, EMBO J, V15, P2184, DOI 10.1002/j.1460-2075.1996.tb00572.x; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 2002, BIOESSAYS, V24, P344, DOI 10.1002/bies.10072; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; FELDMAN JB, 1984, J MOL BIOL, V178, P815, DOI 10.1016/0022-2836(84)90313-9; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fourel G, 2004, BIOESSAYS, V26, P523, DOI 10.1002/bies.20028; Fourel G, 2001, EMBO REP, V2, P124, DOI 10.1093/embo-reports/kve024; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; GILES KE, 2010, COLD SPRING HARB SYM, V75; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Huang J, 2001, P NATL ACAD SCI USA, V98, P968, DOI 10.1073/pnas.98.3.968; Ishii K, 2003, MOL CELL, V11, P237, DOI 10.1016/S1097-2765(03)00010-8; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kamakaka RT, 1997, TRENDS BIOCHEM SCI, V22, P124, DOI 10.1016/S0968-0004(96)10074-8; Kamakaka RT, 2002, CURR BIOL, V12, pR535, DOI 10.1016/S0960-9822(02)01032-1; Kim YJ, 2004, METHODS, V33, P59, DOI 10.1016/j.ymeth.2003.10.021; Kornberg RD, 2007, NAT STRUCT MOL BIOL, V14, P986, DOI 10.1038/nsmb1107-986; Lebrun E, 2003, MOL CELL BIOL, V23, P1498, DOI 10.1128/MCB.23.5.1498-1508.2003; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; MAHONEY DJ, 1991, GENE DEV, V5, P605, DOI 10.1101/gad.5.4.605; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; MORSE RH, 1993, SCIENCE, V262, P1563, DOI 10.1126/science.8248805; Oliver Brian, 2002, J Biol, V1, P4; PATTERSON HG, 1994, MOL CELL BIOL, V14, P4002, DOI 10.1128/MCB.14.6.4002; Rossmann MP, 2011, MOL CELL, V42, P127, DOI 10.1016/j.molcel.2011.03.007; Rubtsov MA, 2006, P NATL ACAD SCI USA, V103, P17690, DOI 10.1073/pnas.0603819103; Rusche LN, 2009, J CELL PHYSIOL, V219, P525, DOI 10.1002/jcp.21749; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Schedl P, 2003, NAT STRUCT BIOL, V10, P241, DOI 10.1038/nsb0403-241; SHEI GJ, 1995, MOL CELL BIOL, V15, P3496; SIKORSKI RS, 1989, GENETICS, V122, P19; Simpson RT, 2004, METHOD ENZYMOL, V375, P158; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; STOVER DM, 1992, MOL CELL BIOL, V12, P2230, DOI 10.1128/MCB.12.5.2230; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Takahashi YH, 2011, MOL CELL, V42, P118, DOI 10.1016/j.molcel.2011.03.006; Valenzuela L, 2008, MOL CELL BIOL, V28, P1924, DOI 10.1128/MCB.01647-07	57	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24835	10.1371/journal.pone.0024835	http://dx.doi.org/10.1371/journal.pone.0024835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949764	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800042
J	Chan, PA; Mermel, LA; Andrea, SB; McCulloh, R; Mills, JP; Echenique, I; Leveen, E; Rybak, N; Cunha, C; Machan, JT; Healey, TT; Chapin, KC				Chan, Philip A.; Mermel, Leonard A.; Andrea, Sarah B.; McCulloh, Russell; Mills, John P.; Echenique, Ignacio; Leveen, Emily; Rybak, Natasha; Cunha, Cheston; Machan, Jason T.; Healey, Terrance T.; Chapin, Kimberle C.			Distinguishing Characteristics between Pandemic 2009-2010 Influenza A (H1N1) and Other Viruses in Patients Hospitalized with Respiratory Illness	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CLINICAL-FEATURES; A(H1N1) INFECTION; UNITED-STATES; PNEUMONIA; OUTBREAK; DIAGNOSIS; HUMANS	Background: Differences in clinical presentation and outcomes among patients infected with pandemic 2009 influenza A H1N1 (pH1N1) compared to other respiratory viruses have not been fully elucidated. Methodology/Principal Findings: A retrospective study was performed of all hospitalized patients at the peak of the pH1N1 season in whom a single respiratory virus was detected by a molecular assay targeting 18 viruses/subtypes (RVP, Luminex xTAG). Fifty-two percent (615/1192) of patients from October, 2009 to December, 2009 had a single respiratory virus (291 pH1N1; 207 rhinovirus; 45 RSV A/B; 37 parainfluenza; 27 adenovirus; 6 coronavirus; and 2 metapneumovirus). No seasonal influenza A or B was detected. Individuals with pH1N1, compared to other viruses, were more likely to present with fever (92% & 70%), cough (92% & 86%), sore throat (32% & 16%), nausea (31% & 8%), vomiting (39% & 30%), abdominal pain (14% & 7%), and a lower white blood count (8,500/L & 13,600/L, all p-values<0.05). In patients with cough and gastrointestinal complaints, the presence of subjective fever/chills independently raised the likelihood of pH1N1 (OR 10). Fifty-five percent (336/615) of our cohort received antibacterial agents, 63% (385/615) received oseltamivir, and 41% (252/615) received steroids. The mortality rate of our cohort was 1% (7/615) and was higher in individuals with pH1N1 compared to other viruses (2.1% & 0.3%, respectively; p = 0.04). Conclusions/Significance: During the peak pandemic 2009-2010 influenza season in Rhode Island, nearly half of patients admitted with influenza-like symptoms had respiratory viruses other than influenza A. A high proportion of patients were treated with antibiotics and pH1N1 infection had higher mortality compared to other respiratory viruses.	[Chan, Philip A.; Mermel, Leonard A.] Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA; [Chan, Philip A.; Mermel, Leonard A.; Mills, John P.; Echenique, Ignacio; Leveen, Emily; Rybak, Natasha; Cunha, Cheston; Chapin, Kimberle C.] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Andrea, Sarah B.; Chapin, Kimberle C.] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA; [McCulloh, Russell] Rhode Isl Hosp, Div Pediat Infect Dis, Providence, RI 02902 USA; [McCulloh, Russell] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Machan, Jason T.] Rhode Isl Hosp, Dept Orthoped & Surg, Providence, RI USA; [Healey, Terrance T.] Rhode Isl Hosp, Dept Radiol, Providence, RI USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital	Chan, PA (corresponding author), Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA.	kchapin@lifespan.org	Cunha, Cheston/Z-2779-2019; Mermel, Leonard/Z-1475-2019; McCulloh, Russell/GVU-6139-2022; McCulloh, Russell/W-6128-2019; Machan, Jason/D-3897-2013	Cunha, Cheston/0000-0003-4149-9146; McCulloh, Russell/0000-0002-0403-6639; Machan, Jason/0000-0003-2048-4914; Mills, John/0000-0001-6529-2911; Echenique, Ignacio A./0000-0002-6301-0121; Chan, Philip/0000-0003-0964-5895				Babcock HM, 2008, INFECT CONT HOSP EP, V29, P921, DOI 10.1086/590663; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Boggild AK, 2010, CRIT CARE MED, V38, pE38, DOI 10.1097/CCM.0b013e3181cd7bb2; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bryant PA, 2010, PEDIATR INFECT DIS J, V29, P694, DOI 10.1097/INF.0b013e3181de4b9c; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carcione D, 2010, EMERG INFECT DIS, V16, P1388, DOI 10.3201/eid1609.100076; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Cunha BA, 2010, HEART LUNG, V39, P461, DOI 10.1016/j.hrtlng.2010.01.005; Cunha BA, 2010, INFECT DIS CLIN N AM, V24, P203, DOI 10.1016/j.idc.2009.10.001; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Ganzenmueller T, 2010, J MED MICROBIOL, V59, P713, DOI 10.1099/jmm.0.017244-0; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Gordon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010364; Greenberg S B, 1991, Infect Dis Clin North Am, V5, P603; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Landry ML, 2011, CURR OPIN PEDIATR, V23, P91, DOI 10.1097/MOP.0b013e328341ebd9; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Leonardi GP, 2010, J CLIN MICROBIOL, V48, P1189, DOI 10.1128/JCM.01657-09; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Medina RA, 2011, J CLIN MICROBIOL, V49, P335, DOI 10.1128/JCM.01142-10; Park S. Y., 2010, Morbidity and Mortality Weekly Report, V58, P1440; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Welch DF, 2010, J CLIN MICROBIOL, V48, P22, DOI 10.1128/JCM.02268-09; Wigton RS, 2008, J GEN INTERN MED, V23, P1615, DOI 10.1007/s11606-008-0707-9	40	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24734	10.1371/journal.pone.0024734	http://dx.doi.org/10.1371/journal.pone.0024734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949746	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800035
J	Pysek, P; Jarosik, V; Pergl, J				Pysek, Petr; Jarosik, Vojtech; Pergl, Jan			Alien Plants Introduced by Different Pathways Differ in Invasion Success: Unintentional Introductions as a Threat to Natural Areas	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; DISPERSAL; IMPACTS; FLORA; NEOPHYTES; FRAMEWORK; TRAITS; TRADE; TIME	Background: Understanding the dimensions of pathways of introduction of alien plants is important for regulating species invasions, but how particular pathways differ in terms of post-invasion success of species they deliver has never been rigorously tested. We asked whether invasion status, distribution and habitat range of 1,007 alien plant species introduced after 1500 A. D. to the Czech Republic differ among four basic pathways of introduction recognized for plants. Principal Findings: Pathways introducing alien species deliberately as commodities (direct release into the wild; escape from cultivation) result in easier naturalization and invasion than pathways of unintentional introduction (contaminant of a commodity; stowaway arriving without association with it). The proportion of naturalized and invasive species among all introductions delivered by a particular pathway decreases with a decreasing level of direct assistance from humans associated with that pathway, from release and escape to contaminant and stowaway. However, those species that are introduced via unintentional pathways and become invasive are as widely distributed as deliberately introduced species, and those introduced as contaminants invade an even wider range of seminatural habitats. Conclusions: Pathways associated with deliberate species introductions with commodities and pathways whereby species are unintentionally introduced are contrasting modes of introductions in terms of invasion success. However, various measures of the outcome of the invasion process, in terms of species' invasion success, need to be considered to accurately evaluate the role of and threat imposed by individual pathways. By employing various measures we show that invasions by unintentionally introduced plant species need to be considered by management as seriously as those introduced by horticulture, because they invade a wide range of seminatural habitats, hence representing even a greater threat to natural areas.	[Pysek, Petr; Jarosik, Vojtech; Pergl, Jan] Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic; [Pysek, Petr; Jarosik, Vojtech] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Pergl, Jan] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; University of Bern	Pysek, P (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic.	pysek@ibot.cas.cz	Pergl, Jan/H-1071-2011; Pysek, Petr/B-1957-2012	Pergl, Jan/0000-0002-0045-1974; 	Academy of Sciences of the Czech Republic [AV0Z60050516]; Czech Science Foundation [P504/11/1028]; Ministry of Education of the Czech Republic [MSM0021620828, LC06073]; SCIEX	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); SCIEX	The study was supported by the projects no. AV0Z60050516 (Academy of Sciences of the Czech Republic), P504/11/1028 (Czech Science Foundation), MSM0021620828 and LC06073 (Ministry of Education of the Czech Republic). PP acknowledges support by the Praemium Academiae award from the Academy of Sciences of the Czech Republic, and JP support from SCIEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, S PLUS 4 GUID STAT; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; BREIMAN L., 1984, CRC PRESS; Carlton James T., 2005, SCOPE, V63, P36; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Chytry M, 2009, PRESLIA, V81, P187; Clement EJ, 1994, ALIEN PLANTS BRIT IS; Cleveland W. S., 1985, ELEMENTS GRAPHING DA; Cleveland W.S., 1993, STAT METHODS S, P309; Collet D., 1991, MODELLING BINARY DAT, V2nd; Crawley M.J., 1993, GLIM ECOLOGISTS; Crawley M. J, 2002, STAT COMPUTING INTRO; DAISIE, 2009, HDB AL SPEC EUR; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; di Castri F., 1989, SCOPE, V37, P1; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Foxcroft LC, 2008, ENVIRON MANAGE, V41, P32, DOI 10.1007/s00267-007-9027-9; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gosper CR, 2009, RESTOR ECOL, V17, P196, DOI 10.1111/j.1526-100X.2008.00374.x; Grime JP., 2014, COMP PLANT ECOLOGY F; Groves R. H., 1991, Biogeography of mediterranean invasions., P427, DOI 10.1017/CBO9780511525544.034; Groves RH, 1998, CRC WEED MANAGEMENT; Hanspach J, 2008, PERSPECT PLANT ECOL, V10, P241, DOI 10.1016/j.ppees.2008.05.001; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heywood V, 2008, EUROPEAN CODE CONDUC; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hulme PE, 2009, NEOBIOTA-SER, V8, P3; Jarosik V, 2011, ENCY BIOL INVASIONS, P104; Kowarik I, 2005, CROP FERALITY AND VOLUNTEERISM, P97; Kowarik I., 2011, NeoBiota, P49, DOI 10.3897/neobiota.9.1469; KOWARIK I, 1995, PLANT INVASIONS, P15; Kowarik Ingo, 2003, Biological Invasions, V5, P293; Kowarik Ingo, 2007, V193, P29; Krivanek M., 2008, Plant invasions: human perception, ecological impacts and management, P21; Krivanek M, 2006, CONSERV BIOL, V20, P1487, DOI 10.1111/j.1523-1739.2006.00477.x; Kubesova M, 2010, PRESLIA, V82, P81; Kuhn I, 2004, DIVERS DISTRIB, V10, P363, DOI 10.1111/j.1366-9516.2004.00106.x; Kuhn I., 2002, BIOLFLOR DATENBANK B, P47; Lambdon PW, 2008, PRESLIA, V80, P101; Lee JE, 2009, ANTARCT SCI, V21, P471, DOI 10.1017/S0954102009990162; Lee JE, 2009, ECOL APPL, V19, P1944, DOI 10.1890/08-2157.1; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Mack R.N., 2000, BIOL INVASIONS, V2, P111, DOI DOI 10.1023/A:1010088422771; Moravcova L, 2010, PRESLIA, V82, P365; MYERS RL, 1983, J APPL ECOL, V20, P645, DOI 10.2307/2403532; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Phillips ML, 2010, PRESLIA, V82, P465; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; Pysek P, 2005, BIOL INVASIONS, V7, P567, DOI 10.1007/s10530-004-7566-z; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; Pysek P, 2003, CONSERV BIOL, V17, P1414, DOI 10.1046/j.1523-1739.2003.02248.x; Pysek P, 2003, OECOLOGIA, V135, P122, DOI 10.1007/s00442-002-1170-7; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek P, 2008, DIVERS DISTRIB, V14, P355, DOI 10.1111/j.1472-4642.2007.00431.x; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Pysek P, 2011, ECOL MONOGR, V81, P277, DOI 10.1890/10-0630.1; Pysek Petr, 2002, Preslia (Prague), V74, P97; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Pysek Petr, 2001, Diversity and Distributions, V7, P145, DOI 10.1046/j.1366-9516.2001.00107.x; Pysek P, 2009, ECOLOGY, V90, P2734, DOI 10.1890/08-0857.1; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Reaser JK, 2008, BIOL INVASIONS, V10, P1085, DOI 10.1007/s10530-007-9186-x; Rehak J, 1986, ANAL CATEGORICAL DAT; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Ruiz G. M, 2003, INVASIVE SPECIES VEC; Ryves TB, 1996, ALIEN GRASSES BRIT I; Sadlo J, 2007, PRESLIA, V79, P303; Schoenfelder Peter, 1999, Acta Botanica Fennica, V162, P43; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Sokal RR, 1995, BIOMETRY; Stajerova K, 2009, PRESLIA, V81, P341; Steinberg D., 1995, CART TREE STRUCTURED; STEINBERG G, 1997, CART CLASSIFICATION; Steinberg G, 2006, CART 60 USERS MANUAL; Thellung, 1912, MEM SOC SCI NAT CHER, V38, P622; Thellung A, 1915, BEIBL BOT JB, V3, P37; TREXLER JC, 1993, ECOLOGY, V74, P1629, DOI 10.2307/1939921; Verbeke G, 2000, LINEAR MIXED MODELS; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zuur Alain F., 2009, P1	94	104	110	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24890	10.1371/journal.pone.0024890	http://dx.doi.org/10.1371/journal.pone.0024890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949778	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700072
J	Tang, TT; Zhu, ZF; Wang, J; Zhang, WC; Tu, X; Xiao, H; Du, XL; Xia, JH; Dong, NG; Su, W; Xia, N; Yan, XX; Nie, SF; Liu, J; Zhou, SF; Yao, R; Xie, JJ; Jevallee, H; Wang, X; Liao, MY; Shi, GP; Fu, M; Liao, YH; Cheng, X				Tang, Ting-Ting; Zhu, Zheng-Feng; Wang, Jun; Zhang, Wen-Cai; Tu, Xin; Xiao, Hong; Du, Xin-Ling; Xia, Jia-Hong; Dong, Nian-Guo; Su, Wei; Xia, Ni; Yan, Xing-Xing; Nie, Shao-Fang; Liu, Juan; Zhou, Su-Feng; Yao, Rui; Xie, Jiang-Jiao; Jevallee, Harish; Wang, Xiang; Liao, Meng-Yang; Shi, Guo-Ping; Fu, Michael; Liao, Yu-Hua; Cheng, Xiang			Impaired Thymic Export and Apoptosis Contribute to Regulatory T-Cell Defects in Patients with Chronic Heart Failure	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; MULTIPLE-SCLEROSIS; CLINICAL-IMPLICATIONS; SUPPRESSIVE FUNCTION; AUTOIMMUNE-DISEASE; ADOPTIVE TRANSFER; TNF-ALPHA; AUTOANTIBODIES; INFLAMMATION	Objective: Animal studies suggest that regulatory T (T(reg)) cells play a beneficial role in ventricular remodeling and our previous data have demonstrated defects of T(reg) cells in patients with chronic heart failure (CHF). However, the mechanisms behind T(reg)-cell defects remained unknown. We here sought to elucidate the mechanism of T(reg)-cell defects in CHF patients. Methods and Results: We performed flow cytometry analysis and demonstrated reduced numbers of peripheral blood CD4(+)CD25(+)FOXP3(+)CD45RO(-)CD45RA(+) naive T(reg) (nT(reg)) cells and CD4(+)CD25(+)FOXP3(+)CD45RO(+)CD45RA(-) memory T(reg) (mT(reg)) cells in CHF patients as compared with non-CHF controls. Moreover, the nT(reg)/mT(reg) ratio (p<0.01), CD4(+)CD25(+)FOXP3(+)CD45RO(-) CD45RA(+)CD31(+) recent thymic emigrant T(reg) cell (RTE-T(reg)) frequency (p<0.01), and T-cell receptor excision circle levels in T(reg) cells (p<0.01) were lower in CHF patients than in non-CHF controls. Combined annexin-V and 7-AAD staining showed that peripheral T(reg) cells from CHF patients exhibited increased spontaneous apoptosis and were more prone to interleukin (IL)-2 deprivation-and CD95 ligand-mediated apoptosis than those from non-CHF individuals. Furthermore, analyses by both flow cytometry and real-time polymerase chain reaction showed that T(reg)-cell frequency in the mediastinal lymph nodes or Foxp3 expression in hearts of CHF patients was no higher than that of the non-CHF controls. Conclusion: Our data suggested that the T(reg)-cell defects of CHF patients were likely caused by decreased thymic output of nascent T(reg) cells and increased susceptibility to apoptosis in the periphery.	[Tang, Ting-Ting; Zhu, Zheng-Feng; Zhang, Wen-Cai; Du, Xin-Ling; Xia, Jia-Hong; Dong, Nian-Guo; Su, Wei; Xia, Ni; Yan, Xing-Xing; Nie, Shao-Fang; Liu, Juan; Zhou, Su-Feng; Yao, Rui; Xie, Jiang-Jiao; Jevallee, Harish; Wang, Xiang; Liao, Meng-Yang; Liao, Yu-Hua; Cheng, Xiang] Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Key Lab Biol Targeted Therapy, Minist Educ,Inst Cardiol,Union Hosp,Med Coll, Wuhan 430074, Peoples R China; [Wang, Jun] Yangzhou 1 Peoples Hosp, Dept Cardiol, Yangzhou, Peoples R China; [Tu, Xin] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Cardio X Inst,Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Tu, Xin] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Xiao, Hong] First Hosp Wuhan, Wuhan, Peoples R China; [Du, Xin-Ling; Xia, Jia-Hong; Dong, Nian-Guo; Su, Wei] Huazhong Univ Sci & Technol, Dept Cardiovasc Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Shi, Guo-Ping] Harvard Univ, Sch Med, Boston, MA USA; [Fu, Michael] Sahlgrens Univ Hosp, Dept Med, Gothenburg, Sweden	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Sahlgrenska University Hospital	Tang, TT (corresponding author), Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Key Lab Biol Targeted Therapy, Minist Educ,Inst Cardiol,Union Hosp,Med Coll, Wuhan 430074, Peoples R China.	nathancx@mail.hust.edu.cn	Cheng, Xiang/K-2190-2012; He, Ximiao/AFM-6566-2022	He, Ximiao/0000-0003-1253-5275; yan, wei/0000-0001-5575-7017	National Natural Science Foundation of China [30600234, 30871067, 81070106]; Program for New Century Excellent Talents in the University of China [NCET-09-0380]; National Basic Research Program of China (973 Program) [2007CB512000, 2007CB5 12005, 2012CB517805]; National Institutes of Health (USA) [HL60942, HL81090, HL88547]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060942, R01HL081090, R01HL088547] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in the University of China(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Natural Science Foundation of China (nos. 30600234 and 30871067 to XC; 81070106 to XT); the Program for New Century Excellent Talents in the University of China (NCET-09-0380 to XC); the National Basic Research Program of China (973 Program: 2007CB512000 and 2007CB5 12005 to YHL; 2012CB517805 to YHL and XC); and the National Institutes of Health (USA) (HL60942, HL81090, and HL88547 to GPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 2003, EUR HEART J, V24, P2186, DOI 10.1016/S0195-668X(03)00480-9; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; [Anonymous], 2007, CHIN J CARDIOL, V35, P390; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Caforio ALP, 2008, AUTOIMMUNITY, V41, P35, DOI 10.1080/08916930701619235; Chen X, 2009, J IMMUNOL, V183, P6135, DOI 10.4049/jimmunol.0901576; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Deubner N, 2010, EUR J HEART FAIL, V12, P753, DOI 10.1093/eurjhf/hfq072; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Dungen HD, 2010, EUR J HEART FAIL, V12, P668, DOI 10.1093/eurjhf/hfq088; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Fritzsching B, 2006, J NEUROL SCI, V251, P91, DOI 10.1016/j.jns.2006.09.006; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luppi P, 1998, CIRCULATION, V98, P777, DOI 10.1161/01.CIR.98.8.777; Maisel A, 1998, CIRC RES, V82, P458, DOI 10.1161/01.RES.82.4.458; Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nakano A, 2007, THYROID, V17, P25, DOI 10.1089/thy.2006.0231; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Omerovic E, 2000, AUTOIMMUNITY, V32, P271, DOI 10.3109/08916930008994101; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Stanzer S, 2008, J CLIN IMMUNOL, V28, P107, DOI 10.1007/s10875-007-9139-2; Stumpf C, 2003, CLIN SCI, V105, P45, DOI 10.1042/CS20020359; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Teplyakov AT, 2008, TERAPEVT ARKH, V80, P52; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Varda-Bloom N, 2000, J MOL CELL CARDIOL, V32, P2141, DOI 10.1006/jmcc.2000.1261; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; VIGLIETTA V, 2004, J EXP MED, V971, P9; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Yamaguchi S, 1999, AM J CARDIOL, V83, P1500, DOI 10.1016/S0002-9149(99)00133-2; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2	56	24	30	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24272	10.1371/journal.pone.0024272	http://dx.doi.org/10.1371/journal.pone.0024272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935395	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700023
J	Yan, H; Chen, X; Zhang, QP; Qin, JC; Li, HW; Liu, C; Calhoun-Davis, T; Della Coletta, L; Klostergaard, J; Fokt, I; Skora, S; Priebe, W; Bi, YY; Tang, DG				Yan, Hong; Chen, Xin; Zhang, Qiuping; Qin, Jichao; Li, Hangwen; Liu, Can; Calhoun-Davis, Tammy; Della Coletta, Luis; Klostergaard, Jim; Fokt, Izabela; Skora, Stanislaw; Priebe, Waldemar; Bi, Yongyi; Tang, Dean G.			Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44(+) Cells and Evidence for Epigenetic Mechanisms	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1; LEUKEMIC STEM-CELLS; LUNG-CANCER; PROSPECTIVE IDENTIFICATION; PANCREATIC-CANCER; PROGENITOR CELLS; SIDE POPULATION; SELF-RENEWAL; LIVER-CANCER; IN-VIVO	Cancer stem cells (CSCs) possess high tumor-initiating capacity and have been reported to be resistant to therapeutics. Vice versa, therapy-resistant cancer cells seem to manifest CSC phenotypes and properties. It has been generally assumed that drug-resistant cancer cells may all be CSCs although the generality of this assumption is unknown. Here, we chronically treated Du145 prostate cancer cells with etoposide, paclitaxel and some experimental drugs (i.e., staurosporine and 2 paclitaxel analogs), which led to populations of drug-tolerant cells (DTCs). Surprisingly, these DTCs, when implanted either subcutaneously or orthotopically into NOD/SCID mice, exhibited much reduced tumorigenicity or were even non-tumorigenic. Drug-tolerant DLD1 colon cancer cells selected by a similar chronic selection protocol also displayed reduced tumorigenicity whereas drug-tolerant UC14 bladder cancer cells demonstrated either increased or decreased tumor-regenerating capacity. Drug-tolerant Du145 cells demonstrated low proliferative and clonogenic potential and were virtually devoid of CD44(+) cells. Prospective knockdown of CD44 in Du145 cells inhibited cell proliferation and tumor regeneration, whereas restoration of CD44 expression in drug-tolerant Du145 cells increased cell proliferation and partially increased tumorigenicity. Interestingly, drug-tolerant Du145 cells showed both increases and decreases in many "stemness" genes. Finally, evidence was provided that chronic drug exposure generated DTCs via epigenetic mechanisms involving molecules such as CD44 and KDM5A. Our results thus reveal that 1) not all DTCs are necessarily CSCs; 2) conventional chemotherapeutic drugs such as taxol and etoposide may directly target CD44+ tumor-initiating cells; and 3) DTCs generated via chronic drug selection involve epigenetic mechanisms.	[Yan, Hong; Chen, Xin; Zhang, Qiuping; Qin, Jichao; Li, Hangwen; Liu, Can; Calhoun-Davis, Tammy; Della Coletta, Luis; Bi, Yongyi; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Yan, Hong] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China; [Chen, Xin; Tang, Dean G.] Univ Texas Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX USA; [Zhang, Qiuping] Wuhan Univ, Dept Immunol, Sch Basic Med Sci, Wuhan 430072, Hubei, Peoples R China; [Klostergaard, Jim] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Fokt, Izabela; Skora, Stanislaw; Priebe, Waldemar] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet Stem Cell & Dev Biol, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Ctr Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Wuhan University; Wuhan University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yan, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020; zhang, qiu/GXG-5600-2022	Tang, Dean/0000-0001-5029-1174; Qin, Jichao/0000-0002-2961-7624; Chen, Xin/0000-0002-0566-7678	National Institutes of Health (NIH) [R01-ES015888, NIH 1R21CA 150009]; Department of Defense, [W81XWH-08-1-0472]; Department of Defense [W81XWH-11-1-0331]; Elsa Pardee Foundation; MDACC Center for Cancer Epigenetics; Tang lab; NATIONAL CANCER INSTITUTE [R21CA150009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense,(United States Department of Defense); Department of Defense(United States Department of Defense); Elsa Pardee Foundation; MDACC Center for Cancer Epigenetics; Tang lab; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was funded by National Institutes of Health (NIH) R01-ES015888, NIH 1R21CA 150009, Department of Defense, W81XWH-08-1-0472, Department of Defense, W81XWH-11-1-0331, Elsa Pardee Foundation, MDACC Center for Cancer Epigenetics. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We thank the Research Animal Support Facility-Smithville for tumor-related experiments and other members of the Tang lab for support and helpful discussions.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Aulmann S, 2010, HUM PATHOL, V41, P574, DOI 10.1016/j.humpath.2009.08.023; Auzenne E, 2007, NEOPLASIA, V9, P479, DOI 10.1593/neo.07229; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; He KJ, 2011, MOL CANCER THER, V10, P938, DOI 10.1158/1535-7163.MCT-10-1120; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Jeter C, 2011, ONCOGENE        0418; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Moserle L, 2008, CANCER RES, V68, P5658, DOI 10.1158/0008-5472.CAN-07-6341; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Strobel T, 1997, CANCER RES, V57, P1228; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Thompson CB, 2009, CELL, V138, P1051, DOI 10.1016/j.cell.2009.09.002; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	64	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24397	10.1371/journal.pone.0024397	http://dx.doi.org/10.1371/journal.pone.0024397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935404	gold, Green Submitted, Green Published			2022-12-25	WOS:000295041700029
J	Bhattacharya, P; Gupta, G; Majumder, S; Adhikari, A; Banerjee, S; Halder, K; Majumdar, SB; Ghosh, M; Chaudhuri, S; Roy, S; Majumdar, S				Bhattacharya, Parna; Gupta, Gaurav; Majumder, Saikat; Adhikari, Anupam; Banerjee, Sayantan; Halder, Kuntal; Majumdar, Suchandra Bhattacharya; Ghosh, Moumita; Chaudhuri, Shubho; Roy, Syamal; Majumdar, Subrata			Arabinosylated Lipoarabinomannan Skews Th2 Phenotype towards Th1 during Leishmania Infection by Chromatin Modification: Involvement of MAPK Signaling	PLOS ONE			English	Article							KAPPA-B RECRUITMENT; NITRIC-OXIDE; VISCERAL LEISHMANIASIS; MURINE MACROPHAGES; IMMUNE-RESPONSE; GENE-EXPRESSION; DENDRITIC CELLS; IN-VIVO; ACTIVATION; KINASE	The parasitic protozoan Leishmania donovani is the causative organism for visceral leishmaniasis (VL) which persists in the host macrophages by deactivating its signaling machinery resulting in a critical shift from proinflammatory (Th1) to an anti-inflammatory (Th2) response. The severity of this disease is mainly determined by the production of IL-12 and IL-10 which could be reversed by use of effective immunoprophylactics. In this study we have evaluated the potential of Arabinosylated Lipoarabinomannan (Ara-LAM), a cell wall glycolipid isolated from non pathogenic Mycobacterium smegmatis, in regulating the host effector response via effective regulation of mitogen-activated protein kinases (MAPK) signaling cascades in Leishmania donovani infected macrophages isolated from BALB/C mice. Ara-LAM, a Toll-like receptor 2 (TLR2) specific ligand, was found to activate p38 MAPK signaling along with subsequent abrogation of extracellular signal-regulated kinase (ERKs) signaling. The use of pharmacological inhibitors of p38MAPK and ERK signaling showed the importance of these signaling pathways in the regulation of IL-10 and IL-12 in Ara-LAM pretreated parasitized macrophages. Molecular characterization of this regulation of IL-10 and IL-12 was revealed by chromatin immunoprecipitation assay (CHIP) which showed that in Ara-LAM pretreated parasitized murine macrophages there was a significant induction of IL-12 by selective phosphorylation and acetylation of histone H3 residues at its promoter region. While, IL-10 production was attenuated by Ara-LAM pretreatment via abrogation of histone H3 phosphorylation and acetylation at its promoter region. This Ara-LAM mediated antagonistic regulations in the induction of IL-10 and IL-12 genes were further correlated to changes in the transcriptional regulators Signal transducer and activator of transcription 3 (STAT3) and Suppressor of cytokine signaling 3 (SOCS3). These results demonstrate the crucial role played by Ara-LAM in regulating the MAPK signaling pathway along with subsequent changes in host effector response during VL which might provide crucial clues in understanding the Ara-LAM mediated protection during Leishmania induced pathogenesis.	[Bhattacharya, Parna; Gupta, Gaurav; Majumder, Saikat; Adhikari, Anupam; Banerjee, Sayantan; Halder, Kuntal; Majumdar, Suchandra Bhattacharya; Chaudhuri, Shubho; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Ghosh, Moumita; Roy, Syamal] CSIR, Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India	Department of Science & Technology (India); Bose Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharya, P (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@bic.boseinst.ernet.in	Gupta, Gaurav/F-7519-2012; Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019	Gupta, Gaurav/0000-0003-4533-6272; Majumder, Saikat/0000-0002-6591-9515; 	Council of Scientifc Industrial Research, India [37/1280/07/EMR-II]; Division of Molecular Medicine	Council of Scientifc Industrial Research, India; Division of Molecular Medicine	This study was funded by Council of Scientifc Industrial Research, India (Grant No 37/1280/07/EMR-II) and Division of Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi A, 2003, J EXP MED, V197, P1037, DOI 10.1084/jem.20022033; Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694; Bhattacharjee S, 2007, INDIAN J BIOCHEM BIO, V44, P366; Bhattacharya P, 2010, J INFECT DIS, V202, P145, DOI 10.1086/653210; Bhattacharyya S, 2002, J INFECT DIS, V185, P1704, DOI 10.1086/340820; Bohsali A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-237; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Chakraborty D, 2005, J IMMUNOL, V175, P3214, DOI 10.4049/jimmunol.175.5.3214; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; DESCOTEAUX A, 1989, MOL CELL BIOL, V9, P5223, DOI 10.1128/MCB.9.11.5223; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Feng GJ, 1999, J IMMUNOL, V163, P6403; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HART DT, 1981, PARASITOLOGY, V82, P345, DOI 10.1017/S0031182000066889; Hoentjen F, 2005, BLOOD, V105, P689, DOI 10.1182/blood-2004-04-1309; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; Li YH, 2006, J IMMUNOL, V177, P1679, DOI 10.4049/jimmunol.177.3.1679; LIEW FY, 1990, J IMMUNOL, V144, P4794; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; MURRAY HW, 1985, J IMMUNOL, V134, P1619; MURRAY HW, 1982, J IMMUNOL, V129, P351; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; Pan ZXK, 2004, AM J PHYSIOL-LUNG C, V286, pL918, DOI 10.1152/ajplung.00381.2003; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; REINER NE, 1994, IMMUNOL TODAY, V15, P374, DOI 10.1016/0167-5699(94)90176-7; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; ROY S, 1989, SCIENCE, V244, P572, DOI 10.1126/science.2470147; RUSSELL DG, 1989, IMMUNOL TODAY, V10, P328, DOI 10.1016/0167-5699(89)90188-6; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sambrook J., 2002, MOL CLONING LAB MANU; Stoiber D, 2001, J IMMUNOL, V166, P466, DOI 10.4049/jimmunol.166.1.466; Suhrbier A, 2003, TRENDS IMMUNOL, V24, P165, DOI 10.1016/S1471-4906(03)00065-6; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; Yang ZY, 2007, J IMMUNOL, V178, P1077, DOI 10.4049/jimmunol.178.2.1077; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486	43	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24141	10.1371/journal.pone.0024141	http://dx.doi.org/10.1371/journal.pone.0024141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935379	gold, Green Published, Green Submitted			2022-12-25	WOS:000295039700011
J	Garrido, JM; Sevilla, IA; Beltran-Beck, B; Minguijon, E; Ballesteros, C; Galindo, RC; Boadella, M; Lyashchenko, KP; Romero, B; Geijo, MV; Ruiz-Fons, F; Aranaz, A; Juste, RA; Vicente, J; de la Fuente, J; Gortazar, C				Garrido, Joseba M.; Sevilla, Iker A.; Beltran-Beck, Beatriz; Minguijon, Esmeralda; Ballesteros, Cristina; Galindo, Ruth C.; Boadella, Mariana; Lyashchenko, Konstantin P.; Romero, Beatriz; Victoria Geijo, Maria; Ruiz-Fons, Francisco; Aranaz, Alicia; Juste, Ramon A.; Vicente, Joaquin; de la Fuente, Jose; Gortazar, Christian			Protection against Tuberculosis in Eurasian Wild Boar Vaccinated with Heat-Inactivated Mycobacterium bovis	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; BADGERS MELES-MELES; ORAL VACCINATION; BRUSHTAIL POSSUMS; TRICHOSURUS-VULPECULA; SUS-SCROFA; BCG; EFFICACY; INFECTION; IMMUNITY	Tuberculosis (TB) caused by Mycobacterium bovis and closely related members of the Mycobacterium tuberculosis complex continues to affect humans and animals worldwide and its control requires vaccination of wildlife reservoir species such as Eurasian wild boar (Sus scrofa). Vaccination efforts for TB control in wildlife have been based primarily on oral live BCG formulations. However, this is the first report of the use of oral inactivated vaccines for controlling TB in wildlife. In this study, four groups of 5 wild boar each were vaccinated with inactivated M. bovis by the oral and intramuscular routes, vaccinated with oral BCG or left unvaccinated as controls. All groups were later challenged with a field strain of M. bovis. The results of the IFN-gamma response, serum antibody levels, M. bovis culture, TB lesion scores, and the expression of C3 and MUT genes were compared between these four groups. The results suggested that vaccination with heat-inactivated M. bovis or BCG protect wild boar from TB. These results also encouraged testing combinations of BCG and inactivated M. bovis to vaccinate wild boar against TB. Vaccine formulations using heat-inactivated M. bovis for TB control in wildlife would have the advantage of being environmentally safe and more stable under field conditions when compared to live BCG vaccines. The antibody response and MUT expression levels can help differentiating between vaccinated and infected wild boar and as correlates of protective response in vaccinated animals. These results suggest that vaccine studies in free-living wild boar are now possible to reveal the full potential of protecting against TB using oral M. bovis inactivated and BCG vaccines.	[Garrido, Joseba M.; Sevilla, Iker A.; Minguijon, Esmeralda; Victoria Geijo, Maria; Juste, Ramon A.] NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain; [Beltran-Beck, Beatriz; Ballesteros, Cristina; Galindo, Ruth C.; Boadella, Mariana; Ruiz-Fons, Francisco; Vicente, Joaquin; de la Fuente, Jose; Gortazar, Christian] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Lyashchenko, Konstantin P.] Chembio Diagnost Syst Inc, Medford, NY USA; [Romero, Beatriz; Aranaz, Alicia] Univ Complutense Madrid, Fac Vet, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain; [de la Fuente, Jose] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Complutense University of Madrid; Oklahoma State University System; Oklahoma State University - Stillwater	Garrido, JM (corresponding author), NEIKER Tecnalia, Dept Anim Hlth, Derio, Bizkaia, Spain.	Christian.Gortazar@uclm.es	GARRIDO, JOSEBA M/L-3202-2014; Juste, Ramon A./C-3570-2008; studies, IT VISAVET Account for bibliometric/C-3115-2014; de la Fuente, José/AAU-1197-2020; Romero, Beatriz/J-5942-2015; Vicente, Joaquín/K-7822-2013; Sevilla, Iker A/O-6060-2014; Geijo, Maria V./K-6717-2014; Ruiz-Fons, Francisco/K-3161-2014; Geijo, Maria V./ABC-5808-2021; Gortazar, Christian/E-7918-2012; Boadella, Mariana/I-8029-2012	Juste, Ramon A./0000-0001-6037-5873; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; de la Fuente, José/0000-0001-7383-9649; Romero, Beatriz/0000-0001-5263-1806; Vicente, Joaquín/0000-0001-8416-3672; Sevilla, Iker A/0000-0003-3968-3390; Geijo, Maria V./0000-0002-3120-1038; Ruiz-Fons, Francisco/0000-0002-0820-5292; Geijo, Maria V./0000-0002-3120-1038; Gortazar, Christian/0000-0003-0012-4006; Boadella, Mariana/0000-0001-6402-9927; Beltran-Beck, Beatriz/0000-0001-6689-5773; Minguijon, Esmeralda/0000-0002-7801-7625; Joseba M., Garrido/0000-0002-7559-0653	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA MCINN) [FAU 2006-00017-C03-01]; EU [TB-STEP 212414]; Santander - Fundacion Marcelino Botin, Spain	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA MCINN)(Instituto de Investigacion Agropecuaria (INIA)); EU(European Commission); Santander - Fundacion Marcelino Botin, Spain	This study was supported by grants from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA MCINN; Project FAU 2006-00017-C03-01), EU FP7 Grant TB-STEP 212414, and Santander - Fundacion Marcelino Botin, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanfu W, 2006, TUBERCULOSIS, V86, P330, DOI 10.1016/j.tube.2006.01.007; Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Ballesteros C, 2011, PREV VET MED, V98, P198, DOI 10.1016/j.prevetmed.2010.10.012; Ballesteros C, 2010, J CHROMATOGR B, V878, P1997, DOI 10.1016/j.jchromb.2010.05.035; Ballesteros C, 2009, RES VET SCI, V86, P388, DOI 10.1016/j.rvsc.2008.09.003; Ballesteros C, 2009, WILDLIFE RES, V36, P203, DOI 10.1071/WR08127; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Buddle BM, 2006, NEW ZEAL VET J, V54, P224, DOI 10.1080/00480169.2006.36701; BUDDLE BM, 1995, RES VET SCI, V59, P10, DOI 10.1016/0034-5288(95)90023-3; Chambers MA, 2004, VACCINE, V22, P1063, DOI 10.1016/j.vaccine.2003.05.002; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Corner LAL, 2002, RES VET SCI, V73, P145, DOI 10.1016/S0034-5288(02)00038-3; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de Klerk LM, 2010, VET IMMUNOL IMMUNOP, V137, P84, DOI 10.1016/j.vetimm.2010.04.013; de la Fuente J, 2011, MED HYPOTHESES, V76, P361, DOI 10.1016/j.mehy.2010.10.040; Delahay RJ, 2003, VET J, V166, P43, DOI 10.1016/S1090-0233(03)00071-6; Derrick SC, 2007, IMMUNOLOGY, V120, P192, DOI 10.1111/j.1365-2567.2006.02491.x; Foyle KL, 2010, VET REC, V166, P663, DOI 10.1136/vr.c2681; Garrido JM, 2010, VET MICROBIOL, V144, P240, DOI 10.1016/j.vetmic.2009.12.041; Gartner T, 2008, VACCINE, V26, P1458, DOI 10.1016/j.vaccine.2007.12.056; Gormley E, 2006, VET MICROBIOL, V112, P171, DOI 10.1016/j.vetmic.2005.11.029; Gortazar C, 2010, WILDLIFE RES, V37, P668, DOI 10.1071/WR10031; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Greenwald R, 2009, CLIN VACCINE IMMUNOL, V16, P605, DOI 10.1128/CVI.00038-09; Griffin J. F. T., 1999, Tubercle and Lung Disease, V79, P135, DOI 10.1054/tuld.1998.0202; Gupta UD, 2009, INDIAN J MED RES, V129, P11; Hope JC, 2008, COMP IMMUNOL MICROB, V31, P77, DOI 10.1016/j.cimid.2007.07.003; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Katoch K, 2008, VACCINE, V26, P1228, DOI 10.1016/j.vaccine.2007.12.025; Lahey T, 2010, VACCINE, V28, P7652, DOI 10.1016/j.vaccine.2010.09.041; Lesellier S, 2009, VACCINE, V27, P402, DOI 10.1016/j.vaccine.2008.10.068; Liebana E, 1998, AUST VET J, V76, P50, DOI 10.1111/j.1751-0813.1998.tb15686.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; de la Lastra JMP, 2009, VET MICROBIOL, V134, P334, DOI 10.1016/j.vetmic.2008.08.026; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Naranjo V, 2008, ANIM GENET, V39, P316, DOI 10.1111/j.1365-2052.2008.01725.x; Naranjo V, 2006, FEMS IMMUNOL MED MIC, V46, P298, DOI 10.1111/j.1574-695X.2005.00035.x; Naranjo Victoria, 2007, Animal Health Research Reviews, V8, P81, DOI 10.1017/S1466252307001260; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Naranjo V, 2006, VET MICROBIOL, V116, P224, DOI 10.1016/j.vetmic.2006.03.013; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Nugent G, 2011, VET MICROBIOL, V151, P34, DOI 10.1016/j.vetmic.2011.02.023; Qureshi T, 1999, INT J TUBERC LUNG D, V3, P1025; Reidy MM, 2008, J WILDLIFE MANAGE, V72, P1012, DOI 10.2193/2007-158; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; ROTHEL JS, 1990, AUST VET J, V67, P134, DOI 10.1111/j.1751-0813.1990.tb07730.x; Skinner MA, 2002, TUBERCULOSIS, V82, P15, DOI 10.1054/tube.2001.0318; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Vordermeier HM, 2006, VET J, V171, P229, DOI 10.1016/j.tvjl.2004.11.001; Wedlock DN, 2005, NEW ZEAL VET J, V53, P301, DOI 10.1080/00480169.2005.36564	53	95	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24905	10.1371/journal.pone.0024905	http://dx.doi.org/10.1371/journal.pone.0024905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935486	Green Published, gold, Green Accepted			2022-12-25	WOS:000295039700059
J	Jaramillo, J; Muchugu, E; Vega, FE; Davis, A; Borgemeister, C; Chabi-Olaye, A				Jaramillo, Juliana; Muchugu, Eric; Vega, Fernando E.; Davis, Aaron; Borgemeister, Christian; Chabi-Olaye, Adenirin			Some Like It Hot: The Influence and Implications of Climate Change on Coffee Berry Borer (Hypothenemus hampei) and Coffee Production in East Africa	PLOS ONE			English	Article							IMPACTS; BIODIVERSITY; AGRICULTURE; PREDICTION; COLEOPTERA; MANAGEMENT; DIVERSITY; ABUNDANCE; PESTS	The negative effects of climate change are already evident for many of the 25 million coffee farmers across the tropics and the 90 billion dollar (US) coffee industry. The coffee berry borer (Hypothenemus hampei), the most important pest of coffee worldwide, has already benefited from the temperature rise in East Africa: increased damage to coffee crops and expansion in its distribution range have been reported. In order to anticipate threats and prioritize management actions for H. hampei we present here, maps on future distributions of H. hampei in coffee producing areas of East Africa. Using the CLIMEX model we relate present-day insect distributions to current climate and then project the fitted climatic envelopes under future scenarios A2A and B2B (for HADCM3 model). In both scenarios, the situation with H. hampei is forecasted to worsen in the current Coffea arabica producing areas of Ethiopia, the Ugandan part of the Lake Victoria and Mt. Elgon regions, Mt. Kenya and the Kenyan side of Mt. Elgon, and most of Rwanda and Burundi. The calculated hypothetical number of generations per year of H. hampei is predicted to increase in all C. arabica-producing areas from five to ten. These outcomes will have serious implications for C. arabica production and livelihoods in East Africa. We suggest that the best way to adapt to a rise of temperatures in coffee plantations could be via the introduction of shade trees in sun grown plantations. The aims of this study are to fill knowledge gaps existing in the coffee industry, and to draft an outline for the development of an adaptation strategy package for climate change on coffee production. An abstract in Spanish is provided as Abstract S1.	[Jaramillo, Juliana] Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, Hannover, Germany; [Jaramillo, Juliana; Muchugu, Eric; Borgemeister, Christian; Chabi-Olaye, Adenirin] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Vega, Fernando E.] ARS, Sustainable Perennial Crops Lab, USDA, Beltsville, MD USA; [Davis, Aaron] Kew, Royal Bot Gardens, Surrey, England	Leibniz University Hannover; International Centre of Insect Physiology & Ecology (ICIPE); United States Department of Agriculture (USDA); Royal Botanic Gardens, Kew	Jaramillo, J (corresponding author), Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, Hannover, Germany.	jjaramillo@icipe.org	Vega, Fernando E./AAM-5536-2021	Vega, Fernando E./0000-0001-8103-5640	German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)	German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was partly funded by the German Research Foundation - Deutsche Forschungsgemeinschaft (DFG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEBE M, 1998, 2 INT C COFF BERR BO, P75; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Assad ED, 2004, PESQUI AGROPECU BRAS, V39, P1057, DOI 10.1590/S0100-204X2004001100001; Assessment M.E., 2005, EC HUM WELL BEING SY, P534, DOI [10.1119/1.2344558, DOI 10.1119/1.2344558]; Baker P. S., 1984, FOLIA ENTOMOL MEX, V61, P9; Baker P.S., 2002, NATURAL ENEMIES NATU; BAKER PS, 1992, J APPL ECOL, V29, P656, DOI 10.2307/2404473; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; BIGGER M, 2009, GEOGRAPHICAL DISTRIB; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Cammell M, 1997, ADV ECOL RES, V22, P117; *CIAT, 2007, COFF FARM WELF NIC M; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; EITZINGER A, 2010, CLIMATE CHANGE ADAPT; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; *FAO, 2001, FAOCLIM 2 0 WORLDW A; Gauthier N, 2010, BIOL J LINN SOC, V101, P113, DOI 10.1111/j.1095-8312.2010.01483.x; Gay C, 2006, CLIMATIC CHANGE, V79, P259, DOI 10.1007/s10584-006-9066-x; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; *GRID, 2002, VIT CLIM GRAPH AFR; Hope KR, 2009, INT J SUST DEV WORLD, V16, P451, DOI 10.1080/13504500903354424; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; *ICO, 2009, INT COFF COUNC 103 S; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIMATE CHANGE 2007, P9; Jaramillo A., 2005, ANDEAN CLIMATE COFFE; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Jaramillo R. A., 2005, REV ACAD COLOMB CIEN, V29, P371; Kyamanywa S., 2009, ARABICA COFFEE PEST; LEPELLEY RH, 1968, PESTS COFFEE; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Mainka SA, 2010, INTEGR ZOOL, V5, P102, DOI 10.1111/j.1749-4877.2010.00193.x; MANGINA FL, 2010, 23 INT C COFF SCI BA; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mendelsohn R, 2000, CLIMATIC CHANGE, V45, P553, DOI 10.1023/A:1005598717174; Mendesil E., 2003, ETHIOPIAN J BIOL SCI, V2, P61; MEYER FG, 1968, COFFEE MISSION ETHIO; Murphy S. T., 1990, Biocontrol News and Information, V11, P107; Muschler RG, 2001, AGROFOREST SYST, V51, P131, DOI 10.1023/A:1010603320653; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; Richter A, 2007, AGROFOREST SYST, V69, P175, DOI 10.1007/s10457-006-9020-y; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; ROSENTHAL E, 2011, NY TIMES        0309; Ruiz-Cardenas R, 2010, SCI AGR, V67, P658, DOI 10.1590/S0103-90162010000600007; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Sutherst RW, 2000, AUST J AGR RES, V51, P467, DOI 10.1071/AR98203; Teodoro A, 2009, AGR FOREST ENTOMOL, V11, P295, DOI 10.1111/j.1461-9563.2008.00417.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; WALLER J.M, 2007, COFFEE PESTS DIS THE; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x	68	162	166	3	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24528	10.1371/journal.pone.0024528	http://dx.doi.org/10.1371/journal.pone.0024528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935419	gold, Green Published, Green Submitted			2022-12-25	WOS:000295039700024
J	Sakai, D; Kii, I; Nakagawa, K; Matsumoto, HN; Takahashi, M; Yoshida, S; Hosoya, T; Takakuda, K; Kudo, A				Sakai, Daisuke; Kii, Isao; Nakagawa, Kazuki; Matsumoto, Hiroko N.; Takahashi, Masateru; Yoshida, Suguru; Hosoya, Takamitsu; Takakuda, Kazuo; Kudo, Akira			Remodeling of Actin Cytoskeleton in Mouse Periosteal Cells under Mechanical Loading Induces Periosteal Cell Proliferation during Bone Formation	PLOS ONE			English	Article							RHO-KINASE INHIBITORS; IN-VIVO MODEL; GENE-EXPRESSION; TENASCIN-C; PROTEIN; STRAIN; MATRIX; TIBIA; SHAPE	Background: The adaptive nature of bone formation under mechanical loading is well known; however, the molecular and cellular mechanisms in vivo of mechanical loading in bone formation are not fully understood. To investigate both mechanisms at the early response against mechanotransduction in vivo, we employed a noninvasive 3-point bone bending method for mouse tibiae. It is important to investigate periosteal woven bone formation to elucidate the adaptive nature against mechanical stress. We hypothesize that cell morphological alteration at the early stage of mechanical loading is essential for bone formation in vivo. Principal Findings: We found the significant bone formation on the bone surface subjected to change of the stress toward compression by this method. The histological analysis revealed the proliferation of periosteal cells, and we successively observed the appearance of ALP-positive osteoblasts and increase of mature BMP-2, resulting in woven bone formation in the hypertrophic area. To investigate the mechanism underlying the response to mechanical loading at the molecular level, we established an in-situ immunofluorescence imaging method to visualize molecules in these periosteal cells, and with it examined their cytoskeletal actin and nuclei and the extracellular matrix proteins produced by them. The results demonstrated that the actin cytoskeleton of the periosteal cells was disorganized, and the shapes of their nuclei were drastically changed, under the mechanical loading. Moreover, the disorganized actin cytoskeleton was reorganized after release from the load. Further, inhibition of onset of the actin remodeling blocked the proliferation of the periosteal cells. Conclusions: These results suggest that the structural change in cell shape via disorganization and remodeling of the actin cytoskeleton played an important role in the mechanical loading-dependent proliferation of cells in the periosteum during bone formation.	[Sakai, Daisuke; Kii, Isao; Nakagawa, Kazuki; Takahashi, Masateru; Hosoya, Takamitsu; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Matsumoto, Hiroko N.; Takakuda, Kazuo] Tokyo Med & Dent Univ, Div Biosyst, Dept Biodesign, Inst Biomat & Bioengn, Tokyo, Japan; [Yoshida, Suguru; Hosoya, Takamitsu] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Biol Chem Lab, Inst Biomat & Bioengn, Tokyo, Japan	Tokyo Institute of Technology; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sakai, D (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 227, Japan.	akudo@bio.titech.ac.jp	KII, Isao/C-4117-2017; Matsumoto, Hiroko N/B-8335-2011; Hosoya, Takamitsu/N-7762-2015; Sakai, Daisuke/X-9164-2019; Kudo, Akira/C-7340-2015	KII, Isao/0000-0002-6153-6250; Hosoya, Takamitsu/0000-0002-7270-351X; Sakai, Daisuke/0000-0003-4189-9270; Kudo, Akira/0000-0001-6289-3391; Yoshida, Suguru/0000-0001-5888-9330	Ministry of Education, Science, Culture, and Sports of Japan; Ground-based Research Program for Space Utilization	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ground-based Research Program for Space Utilization	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan, and by grants from the Ground-based Research Program for Space Utilization promoted by Japan Space Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Breitenlechner C, 2003, STRUCTURE, V11, P1595, DOI 10.1016/j.str.2003.11.002; BURR DB, 2003, BIOMECHANICS BONE PR, pCH8; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Kawaguchi J, 2001, J BONE MINER RES, V16, P260, DOI 10.1359/jbmr.2001.16.2.260; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Matsumoto HN., 2008, J BIOMECH SCI ENG, V3, P176, DOI [10.1299/jbse.3.176, DOI 10.1299/JBSE.3.176]; MATTHEW J, 2008, CALCIFIED TISSUE INT, V82, DOI DOI 10.1007/S00223-008-9142-5; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Robling AG, 2002, MED SCI SPORT EXER, V34, P196, DOI 10.1097/00005768-200202000-00003; Robling AG, 2001, J EXP BIOL, V204, P3389; Sarasa-Renedo A, 2006, EXP CELL RES, V312, P1361, DOI 10.1016/j.yexcr.2005.12.025; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Silva MJ, 2005, ANAT REC PART A, V283A, P380, DOI 10.1002/ar.a.20171; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Szulc P, 2009, OSTEOPOROSIS INT, V20, P1281, DOI 10.1007/s00198-009-0994-y; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686; TURNER CH, 1994, J BONE MINER RES, V9, P87; TURNER CH, 1991, BONE, V12, P73, DOI 10.1016/8756-3282(91)90003-2; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang Q, 2011, BONE, V48, P524, DOI 10.1016/j.bone.2010.10.178; WEINREB M, 1990, J BONE MINER RES, V5, P831; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	37	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24847	10.1371/journal.pone.0024847	http://dx.doi.org/10.1371/journal.pone.0024847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935480	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700054
J	Struiksma, ME; Noordzij, ML; Neggers, SFW; Bosker, WM; Postma, A				Struiksma, Marijn E.; Noordzij, Matthijs L.; Neggers, Sebastiaan F. W.; Bosker, Wendy M.; Postma, Albert			Spatial Language Processing in the Blind: Evidence for a Supramodal Representation and Cortical Reorganization	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VISUAL-CORTEX ACTIVATION; CROSS-MODAL PLASTICITY; CONGENITALLY BLIND; FUNCTIONAL MRI; OCCIPITAL CORTEX; ADAPTIVE-CHANGES; WORKING-MEMORY; MENTAL-IMAGERY; HUMAN BRAIN	Neuropsychological and imaging studies have shown that the left supramarginal gyrus (SMG) is specifically involved in processing spatial terms (e.g. above, left of), which locate places and objects in the world. The current fMRI study focused on the nature and specificity of representing spatial language in the left SMG by combining behavioral and neuronal activation data in blind and sighted individuals. Data from the blind provide an elegant way to test the supramodal representation hypothesis, i.e. abstract codes representing spatial relations yielding no activation differences between blind and sighted. Indeed, the left SMG was activated during spatial language processing in both blind and sighted individuals implying a supramodal representation of spatial and other dimensional relations which does not require visual experience to develop. However, in the absence of vision functional reorganization of the visual cortex is known to take place. An important consideration with respect to our finding is the amount of functional reorganization during language processing in our blind participants. Therefore, the participants also performed a verb generation task. We observed that only in the blind occipital areas were activated during covert language generation. Additionally, in the first task there was functional reorganization observed for processing language with a high linguistic load. As the visual cortex was not specifically active for spatial contents in the first task, and no reorganization was observed in the SMG, the latter finding further supports the notion that the left SMG is the main node for a supramodal representation of verbal spatial relations.	[Struiksma, Marijn E.; Postma, Albert] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Struiksma, Marijn E.] Univ Utrecht, Utrecht Inst Linguist OTS, Utrecht, Netherlands; [Noordzij, Matthijs L.] Univ Twente, Dept Cognit Psychol & Ergon, NL-7500 AE Enschede, Netherlands; [Neggers, Sebastiaan F. W.] Univ Utrecht, Med Ctr, Dept Psychiat, Div Brain Res, Utrecht, Netherlands; [Bosker, Wendy M.] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands; [Postma, Albert] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University; University of Twente; Utrecht University; Maastricht University; Utrecht University; Utrecht University Medical Center	Struiksma, ME (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	m.struiksma@uu.nl	Noordzij, Matthijs/AAC-4097-2019	Struiksma, Marijn/0000-0002-1166-1424; Noordzij, Matthijs/0000-0002-5013-9225	Netherlands Organization for Scientific Research (NWO) [277-80-002]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work of the first author was partly supported by a VICI grant number 277-80-002 by the Netherlands Organization for Scientific Research (NWO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 1998, NEUROSCI LETT, V247, P187, DOI 10.1016/S0304-3940(98)00328-0; Aleman A, 2001, NEUROREPORT, V12, P2601, DOI 10.1097/00001756-200108080-00061; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2004, NAT NEUROSCI, V7, P1266, DOI 10.1038/nn1328; Amorapanth PX, 2010, J COGNITIVE NEUROSCI, V22, P1739, DOI 10.1162/jocn.2009.21322; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bonino D, 2008, ARCH ITAL BIOL, V146, P133; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cattaneo Z., 2011, BLIND VISION NEUROSC; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Coventry KR, 2004, ESSAYS COGN PSYCHOL, P1; CUENOD CA, 1995, NEUROLOGY, V45, P1821, DOI 10.1212/WNL.45.10.1821; Damasio H, 2001, NEUROIMAGE, V13, P1053, DOI 10.1006/nimg.2001.0775; Emmorey K, 2002, NEUROIMAGE, V17, P812, DOI 10.1006/nimg.2002.1187; FARAH MJ, 1988, COGNITIVE PSYCHOL, V20, P439, DOI 10.1016/0010-0285(88)90012-6; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Hamilton R, 2000, NEUROREPORT, V11, P237, DOI 10.1097/00001756-200002070-00003; Haspelmath M., 1997, SPACE TIME TEMPORAL; Heine Bernd, 1991, GRAMMATICALIZATION; Held R, 2011, NAT NEUROSCI, V14, P551, DOI 10.1038/nn.2795; Jackendoff R.S., 1996, LANGUAGE SPACE, P1; Kemmerer D, 2005, NEUROPSYCHOLOGIA, V43, P797, DOI 10.1016/j.neuropsychologia.2004.06.025; KERR NH, 1983, J EXP PSYCHOL GEN, V112, P265, DOI 10.1037/0096-3445.112.2.265; Klarhofer M, 2003, MAGNET RESON MED, V50, P830, DOI 10.1002/mrm.10599; KLATZKY RL, 1995, J VISUAL IMPAIR BLIN, V89, P70; Knauff M, 2006, Q J EXP PSYCHOL, V59, P161, DOI 10.1080/17470210500149992; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kupers R, 2006, P NATL ACAD SCI USA, V103, P13256, DOI 10.1073/pnas.0602925103; Lacey S, 2007, PERCEPTION, V36, P1513, DOI 10.1068/p5850; Logan GD, 1996, J EXP PSYCHOL HUMAN, V22, P159, DOI 10.1037/0096-1523.22.1.159; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; Melzer P, 2001, HUM BRAIN MAPP, V14, P186, DOI 10.1002/hbm.1051; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Noordzij ML, 2008, NEUROPSYCHOLOGIA, V46, P1576, DOI 10.1016/j.neuropsychologia.2007.12.022; Noordzij ML, 2006, PSYCHOPHYSIOLOGY, V43, P277, DOI 10.1111/j.1469-8986.2006.00399.x; Noordzij ML, 2005, ACTA PSYCHOL, V119, P1, DOI 10.1016/j.actpsy.2004.10.013; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Noppeney U, 2007, NEUROSCI BIOBEHAV R, V31, P1169, DOI 10.1016/j.neubiorev.2007.04.012; Ofan RH, 2007, CEREB CORTEX, V17, P1249, DOI 10.1093/cercor/bhl039; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; Ricciardi E, 2008, SPRINGER TRAC ADV RO, V45, P7, DOI 10.1007/978-3-540-79035-8_2; Ricciardi E, 2009, J NEUROSCI, V29, P9719, DOI 10.1523/JNEUROSCI.0274-09.2009; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Stilla R, 2008, J VISION, V8, DOI 10.1167/8.10.13; Struiksma ME, 2009, ACTA PSYCHOL, V132, P145, DOI 10.1016/j.actpsy.2009.04.002; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Tranel D, 2004, COGN NEUROPSYCHOL, V21, P719, DOI 10.1080/02643290342000627; UHL F, 1991, NEUROSCI LETT, V124, P256, DOI 10.1016/0304-3940(91)90107-5; Van der Lubbe RHJ, 2010, J COGNITIVE NEUROSCI, V22, P1541, DOI 10.1162/jocn.2009.21285; Vanlierde A, 2004, ACTA PSYCHOL, V116, P205, DOI 10.1016/j.actpsy.2004.03.001; Vanlierde A, 2003, NEUROIMAGE, V19, P698, DOI 10.1016/S1053-8119(03)00153-8; Vecchi T, 2004, NEUROREPORT, V15, P2787; VONSENDEN M, 1932, RAUM GESTALT AUFFASS; ZIMLER J, 1983, J EXP PSYCHOL LEARN, V9, P269, DOI 10.1037/0278-7393.9.2.269	78	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24253	10.1371/journal.pone.0024253	http://dx.doi.org/10.1371/journal.pone.0024253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822JC	21935391	Green Published, gold			2022-12-25	WOS:000295039700015
J	Tare, M; Modi, RM; Nainaparampil, JJ; Puli, OR; Bedi, S; Fernandez-Funez, P; Kango-Singh, M; Singh, A				Tare, Meghana; Modi, Rohan M.; Nainaparampil, Jaison J.; Puli, Oorvashi Roy; Bedi, Shimpi; Fernandez-Funez, Pedro; Kango-Singh, Madhuri; Singh, Amit			Activation of JNK Signaling Mediates Amyloid-beta-Dependent Cell Death	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; ALZHEIMERS-DISEASE; EYE; APOPTOSIS; PROTEIN; INHIBITION; MECHANISMS; WINGLESS; SURVIVAL; REAPER	Background: Alzheimer's disease (AD) is an age related progressive neurodegenerative disorder. One of the reasons for Alzheimer's neuropathology is the generation of large aggregates of A beta 42 that are toxic in nature and induce oxidative stress, aberrant signaling and many other cellular alterations that trigger neuronal cell death. However, the exact mechanisms leading to cell death are not clearly understood. Methodology/Principal Findings: We employed a Drosophila eye model of AD to study how A beta 42 causes cell death. Misexpression of higher levels of A beta 42 in the differentiating photoreceptors of fly retina rapidly induced aberrant cellular phenotypes and cell death. We found that blocking caspase-dependent cell death initially blocked cell death but did not lead to a significant rescue in the adult eye. However, blocking the levels of c-Jun NH (2)-terminal kinase (JNK) signaling pathway significantly rescued the neurodegeneration phenotype of A beta 42 misexpression both in eye imaginal disc as well as the adult eye. Misexpression of A beta 42 induced transcriptional upregulation of puckered (puc), a downstream target and functional read out of JNK signaling. Moreover, a three-fold increase in phospho-Jun (activated Jun) protein levels was seen in A beta 42 retina as compared to the wild-type retina. When we blocked both caspases and JNK signaling simultaneously in the fly retina, the rescue of the neurodegenerative phenotype is comparable to that caused by blocking JNK signaling pathway alone. Conclusions/Significance: Our data suggests that (i) accumulation of A beta 42 plaques induces JNK signaling in neurons and (ii) induction of JNK contributes to A beta 42 mediated cell death. Therefore, inappropriate JNK activation may indeed be relevant to the AD neuropathology, thus making JNK a key target for AD therapies.	[Tare, Meghana; Puli, Oorvashi Roy; Bedi, Shimpi; Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Modi, Rohan M.; Nainaparampil, Jaison J.; Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Premed Program, Dayton, OH 45469 USA; [Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA; [Fernandez-Funez, Pedro] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL USA; [Fernandez-Funez, Pedro] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA	University of Dayton; University of Dayton; University of Dayton; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tare, M (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	kangosmz@notes.udayton.edu; amit.singh@notes.udayton.edu	Puli, Oorvashi G./N-7671-2017	Puli, Oorvashi G./0000-0003-0358-7428; Bedi, Shimpi/0000-0003-3277-7845; Singh, Amit/0000-0002-2962-2255	NIH [DP2 OD002721-01, 1R15 HD064557-01]; Knight's Templar Eye Foundation; University of Dayton; Ohio Cancer Research Associates; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD064557] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knight's Templar Eye Foundation; University of Dayton; Ohio Cancer Research Associates; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	PF-F is supported by the NIH grant DP2 OD002721-01. MKS is supported by the Knight's Templar Eye Foundation. This work is supported by a NIH grant (1R15 HD064557-01), start-up support from the University of Dayton, and the Ohio Cancer Research Associates seed grant awarded to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Atkins M, 2009, DEV DYNAM, V238, P2139, DOI 10.1002/dvdy.22034; Benitez S, 2010, INT J DEV BIOL, V54, P643, DOI 10.1387/ijdb.082724sb; Bentley P, 2008, BRAIN, V131, P409, DOI 10.1093/brain/awm299; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Brachmann CB, 2003, TRENDS GENET, V19, P91, DOI 10.1016/S0168-9525(02)00041-0; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Cordero J, 2004, MECH DEVELOP, V121, P1523, DOI 10.1016/j.mod.2004.07.004; Cowan CM, 2010, BIOCHEM SOC T, V38, P988, DOI 10.1042/BST0380988; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; DICKSON B, 1996, COMMUNICATION; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; Lin HV, 2004, DEVELOPMENT, V131, P2409, DOI 10.1242/dev.01104; Lisi S, 2000, GENETICS, V154, P669; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Mehlen P, 2005, J NEUROBIOL, V64, P357, DOI 10.1002/neu.20167; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; O'Brien RJ, 2010, ANN REV NEUROSCI; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Singh A, 2003, DEVELOPMENT, V130, P6351, DOI 10.1242/dev.00864; Singh A, 2002, DEVELOPMENT, V129, P4271; Singh A, 2006, DEVELOPMENT, V133, P4771, DOI 10.1242/dev.02686; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wolff Tanya, 1993, P1277; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Yoon SY, 2010, NEUROBIOL DIS, V40, P449, DOI 10.1016/j.nbd.2010.07.005; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x	63	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24361	10.1371/journal.pone.0024361	http://dx.doi.org/10.1371/journal.pone.0024361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21949710	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700018
J	Deshmukh, L; Meller, N; Alder, N; Byzova, T; Vinogradova, O				Deshmukh, Lalit; Meller, Nahum; Alder, Nathan; Byzova, Tatiana; Vinogradova, Olga			Tyrosine Phosphorylation as a Conformational Switch A CASE STUDY OF INTEGRIN beta(3) CYTOPLASMIC TAIL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; STRUCTURAL BASIS; ALPHA-IIB-BETA-3; TRANSMEMBRANE; ACTIVATION; COMPLEX; SYSTEM; ALPHA(IIB)BETA(3); MECHANISM; DYNAMICS	Reversible protein phosphorylation is vital for many fundamental cellular processes. The actual impact of adding and removing phosphate group(s) is 3-fold: changes in the local/global geometry, alterations in the electrostatic potential and, as the result of both, modified protein-target interactions. Here we present a comprehensive structural investigation of the effects of phosphorylation on the conformational as well as functional states of a crucial cell surface receptor, alpha(IIb)beta(3) integrin. We have analyzed phosphorylated (Tyr(747) and Tyr(759)) beta(3) integrin cytoplasmic tail (CT) primarily by NMR, and our data demonstrate that under both aqueous and membrane-mimetic conditions, phosphorylation causes substantial conformational rearrangements. These changes originate from novel ionic interactions and revised phospholipid binding. Under aqueous conditions, the critical Tyr(747) phosphorylation prevents beta 3CT from binding to its heterodimer partner alpha IIbCT, thus likely maintaining an activated state of the receptor. This conclusion was tested in vivo and confirmed by integrin-dependent endothelial cells adhesion assay. Under membrane-mimetic conditions, phosphorylation results in a modified membrane embedding characterized by significant changes in the secondary structure pattern and the overall fold of beta 3CT. Collectively these data provide unique molecular insights into multiple regulatory roles of phosphorylation.	[Deshmukh, Lalit; Vinogradova, Olga] Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, Storrs, CT 06269 USA; [Alder, Nathan] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Meller, Nahum; Byzova, Tatiana] Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Deshmukh, Lalit] NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA	University of Connecticut; University of Connecticut; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Vinogradova, O (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	olga.vinogradova@uconn.edu	Vinogradova, Olga/ABE-8367-2020; Deshmukh, Lalit/C-5073-2015	Vinogradova, Olga/0000-0001-5101-7361; Byzova, Tatiana/0000-0002-2615-875X	American Heart Association; National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098777] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by American Heart Association and National Institutes of Health (NIH) Grants (to O. V.) and NIH grants (to T. B.).	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshmukh L, 2007, J BIOL CHEM, V282, P32349, DOI 10.1074/jbc.M704666200; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Guuntert P, 2004, METHOD MOL BIOL, V278, P353; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2002, BIOCHEMISTRY-US, V41, P15618, DOI 10.1021/bi026822l; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Qin J, 2001, METHOD ENZYMOL, V339, P377, DOI 10.1016/S0076-6879(01)39323-0; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106	32	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40943	40953		10.1074/jbc.M111.231951	http://dx.doi.org/10.1074/jbc.M111.231951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956114	hybrid, Green Published			2022-12-25	WOS:000297315400054
J	Wang, WM; Wu, SY; Lee, AY; Chiang, CM				Wang, Wei-Ming; Wu, Shwu-Yuan; Lee, A-Young; Chiang, Cheng-Ming			Binding Site Specificity and Factor Redundancy in Activator Protein-1-driven Human Papillomavirus Chromatin-dependent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; TYPE-18 PROMOTER; EPITHELIAL-CELLS; C-FOS; AP-1; JUN; EXPRESSION; FAMILY; AP1; TUMORIGENESIS	Activator protein-1 (AP-1) regulates diverse gene responses triggered by environmental cues and virus-induced cellular stress. Although many signaling events leading to AP-1 activation have been described, the fundamental features underlying binding site selection and factor recruitment of dimeric AP-1 complexes to their target genes remain mostly uncharacterized. Using recombinant full-length human AP-1 dimers formed between c-Jun and Fos family members (c-Fos, FosB, Fra-1, Fra-2) for DNA binding and transcriptional analysis, we found that each of these AP-1 complex exhibits differential activity for distinct non-consensus AP-1 sites present in human papillomavirus (HPV), and each AP-1 complex is capable of activating transcription from in vitro-reconstituted HPV chromatin in a p300- and acetyl-CoA-dependent manner. Transcription from HPV chromatin requires AP-1-dependent and contact-driven recruitment of p300. Acetylation of dimeric AP-1 complexes by p300 enhances AP-1 binding to DNA. Using a human C-33A cervical cancer-derived cell line harboring the episomal HPV type 11 genome, we illustrate binding site selectivity recognized by c-Jun, JunB, JunD, and various Fos family members in a combinatorial and unique pattern, highlighting the diversity and importance of non-canonical binding site recognition by various AP-1 family proteins.	[Wang, Wei-Ming; Wu, Shwu-Yuan; Lee, A-Young; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lee, A-Young; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wang, Wei-Ming; Chiang, Cheng-Ming] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Wang, Wei-Ming] Triserv Gen Hosp, Dept Dermatol, Natl Def Med Ctr, Taipei 114, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; National Defense Medical Center; Tri-Service General Hospital	Chiang, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Bldg ND2-210H,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	cheng-ming.chiang@utsouthwestern.edu			National Institutes of Health [CA103867, CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760. This work is Report CSCN 064 from University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center.	ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Antinore MJ, 1996, EMBO J, V15, P1950, DOI 10.1002/j.1460-2075.1996.tb00546.x; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; BAUKNECHT T, 1992, EMBO J, V11, P4607, DOI 10.1002/j.1460-2075.1992.tb05563.x; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bouallaga I, 2003, MOL CELL BIOL, V23, P2329, DOI 10.1128/MCB.23.7.2329-2340.2003; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; CHAN WK, 1990, NUCLEIC ACIDS RES, V18, P763, DOI 10.1093/nar/18.4.763; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; CHONG T, 1991, J VIROL, V65, P5933, DOI 10.1128/JVI.65.11.5933-5943.1991; CRIPE T P, 1990, New Biologist, V2, P450; de Wilde J, 2008, CELL ONCOL, V30, P77; DOLLARD SC, 1992, GENE DEV, V6, P1131, DOI 10.1101/gad.6.7.1131; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; GIUS D, 1989, J VIROL, V63, P555, DOI 10.1128/JVI.63.2.555-563.1989; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HERBER B, 1994, ONCOGENE, V9, P1295; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; Hou SY, 2000, MOL CELL BIOL, V20, P113, DOI 10.1128/MCB.20.1.113-125.2000; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kyo S, 1997, J GEN VIROL, V78, P401, DOI 10.1099/0022-1317-78-2-401; Lee AY, 2009, J BIOL CHEM, V284, P2778, DOI 10.1074/jbc.M805835200; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Lee W, 1987, Cell, V49, P741; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; MACK DH, 1991, P NATL ACAD SCI USA, V88, P9102, DOI 10.1073/pnas.88.20.9102; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; OFFORD EA, 1990, J VIROL, V64, P4792, DOI 10.1128/JVI.64.10.4792-4798.1990; Rosl F, 1997, J VIROL, V71, P362; Sahu G, 2010, J BIOL CHEM, V285, P1321, DOI 10.1074/jbc.M109.081182; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Vries RGJ, 2001, EMBO J, V20, P6095, DOI 10.1093/emboj/20.21.6095; Wang WM, 2008, PROTEIN EXPRES PURIF, V59, P144, DOI 10.1016/j.pep.2008.01.016; Welter JF, 1995, ONCOGENE, V11, P2681; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Wu SY, 1996, BIOTECHNIQUES, V21, P718; Zhao W, 1997, J VIROL, V71, P8832, DOI 10.1128/JVI.71.11.8832-8840.1997; Zhou X, 2011, MOL CELL, V42, P826, DOI 10.1016/j.molcel.2011.05.025	56	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40974	40986		10.1074/jbc.M111.290874	http://dx.doi.org/10.1074/jbc.M111.290874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937452	hybrid, Green Published			2022-12-25	WOS:000297315400057
J	Lommel, M; Schott, A; Jank, T; Hofmann, V; Strahl, S				Lommel, Mark; Schott, Andrea; Jank, Thomas; Hofmann, Verena; Strahl, Sabine			A Conserved Acidic Motif Is Crucial for Enzymatic Activity of Protein O-Mannosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOLICHYL PHOSPHATE-MANNOSE; SACCHAROMYCES-CEREVISIAE; GENE FAMILY; GLYCOSYLATION; YEAST; MANNOSYLATION; POMT1; GLYCOSYLTRANSFERASES; MEMBERS; PMT1P	Protein O-mannosylation is an essential modification in fungi and mammals. It is initiated at the endoplasmic reticulum by a conserved family of dolichyl phosphate mannose-dependent protein O-mannosyltransferases (PMTs). PMTs are integral membrane proteins with two hydrophilic loops (loops 1 and 5) facing the endoplasmic reticulum lumen. Formation of dimeric PMT complexes is crucial for mannosyltransferase activity, but the direct cause is not known to date. In bakers' yeast, O-mannosylation is catalyzed largely by heterodimeric Pmt1p-Pmt2p and homodimeric Pmt4p complexes. To further characterize Pmt1p-Pmt2p complexes, we developed a photoaffinity probe based on the artificial mannosyl acceptor substrate Tyr-Ala-Thr-Ala-Val. The photoreactive probe was preferentially crosslinked to Pmt1p, and deletion of the loop 1 (but not loop 5) region abolished this interaction. Analysis of Pmt1p loop 1 mutants revealed that especially Glu-78 is crucial for binding of the photoreactive probe. Glu-78 belongs to an Asp-Glu motif that is highly conserved among PMTs. We further demonstrate that single amino acid substitutions in this motif completely abolish activity of Pmt4p complexes. In contrast, both acidic residues need to be exchanged to eliminate activity of Pmt1p-Pmt2p complexes. On the basis of our data, we propose that the loop 1 regions of dimeric complexes form part of the catalytic site.	[Lommel, Mark; Schott, Andrea; Jank, Thomas; Hofmann, Verena; Strahl, Sabine] Heidelberg Univ, Ctr Organismal Studies Heidelberg, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Strahl, S (corresponding author), Heidelberg Univ, Ctr Organismal Studies Heidelberg, Neuenheimer Feld 360, D-69120 Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de	Jank, Thomas/R-9627-2017; Lommel, Mark/E-3836-2014	Lommel, Mark/0000-0001-6954-3714	Deutsche Forschungsgemeinschaft [SFB638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB638.	Arroyo J, 2011, MOL MICROBIOL, V79, P1529, DOI 10.1111/j.1365-2958.2011.07537.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Endo T, 2005, Acta Myol, V24, P64; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Goder V, 2011, J CELL SCI, V124, P144, DOI 10.1242/jcs.072181; Hendershot LL, 2002, ANAL BIOCHEM, V307, P273, DOI 10.1016/S0003-2697(02)00059-3; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; IMMERVOLL T, 1995, YEAST, V11, P1345, DOI 10.1002/yea.320111403; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Kang JY, 2005, J BIOL CHEM, V280, P9489, DOI 10.1074/jbc.M413867200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lommel M, 2010, METHOD ENZYMOL, V479, P323, DOI 10.1016/S0076-6879(10)79018-2; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; LUSSIER M, 1995, J BIOL CHEM, V270, P2770, DOI 10.1074/jbc.270.6.2770; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Sambrook J, 2001, MOL CLONING LAB MANU; SHARMA C B, 1991, Glycobiology, V1, P367, DOI 10.1093/glycob/1.4.367; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; STRAHLBOLSINGER S, 1991, EUR J BIOCHEM, V196, P185, DOI 10.1111/j.1432-1033.1991.tb15802.x; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086	39	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39768	39775		10.1074/jbc.M111.281196	http://dx.doi.org/10.1074/jbc.M111.281196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21956107	Green Published, hybrid			2022-12-25	WOS:000296925700010
J	Rajesh, S; Bago, R; Odintsova, E; Muratov, G; Baldwin, G; Sridhar, P; Rajesh, S; Overduin, M; Berditchevski, F				Rajesh, Sundaresan; Bago, Ruzica; Odintsova, Elena; Muratov, Gayrat; Baldwin, Gouri; Sridhar, Pooja; Rajesh, Sandya; Overduin, Michael; Berditchevski, Fedor			Binding to Syntenin-1 Protein Defines a New Mode of Ubiquitin-based Interactions Regulated by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA CELLS; PDZ PROTEIN; MDA-9/SYNTENIN; SYNDECAN; DOMAINS; RECOGNITION; ADHESION; TETRASPANINS; TRAFFICKING; DEGRADATION	Syntenin-1 is a PDZ domain-containing adaptor that controls trafficking of transmembrane proteins including those associated with tetraspanin-enriched microdomains. We describe the interaction of syntenin-1 with ubiquitin through a novel binding site spanning the C terminus of ubiquitin, centered on Arg72, Leu73, and Arg74. A conserved LYPSL sequence in the N terminus, as well as the C-terminal region of syntenin-1, are essential for binding to ubiquitin. We present evidence for the regulation of this interaction through syntenin-1 dimerization. We have also established that syntenin-1 is phosphorylated downstream of Ulk1, a serine/threonine kinase that plays a critical role in autophagy and regulates endocytic trafficking. Importantly, Ulk1-dependent phosphorylation of Ser6 in the LYPSL prevents the interaction of syntenin-1 with ubiquitin. These results define an unprecedented ubiquitin-dependent pathway involving syntenin-1 that is regulated by Ulk1.	[Rajesh, Sundaresan; Bago, Ruzica; Odintsova, Elena; Muratov, Gayrat; Baldwin, Gouri; Sridhar, Pooja; Rajesh, Sandya; Overduin, Michael; Berditchevski, Fedor] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Overduin, M (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	m.overduin@bham.ac.uk; f.berditchevski@bham.ac.uk		Odintsova, Elena/0000-0002-4098-5559; Overduin, Michael/0000-0002-3114-6585	Breast Cancer Campaign; Cancer Research UK; Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust; MRC [G0601073] Funding Source: UKRI; Medical Research Council [G0601073] Funding Source: researchfish	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Breast Cancer Campaign (to F. B.), Cancer Research UK (to F. B. and M.O.), and the Medical Research Council and the Biotechnology and Biological Sciences Research Council (to M.O.).; We thank Dr. D. Powner for generating a FLAG-tagged syntenin-1 construct, Prof. J. Baz Jackson for isothermal calorimetry access, and Drs. T. Cierpicki and Z. Derewenda (University of Virginia) for their GST-syntenin-1 expression plasmid. NMR data were collected at the Wellcome Trust-funded Henry Wellcome Building for Nuclear Magnetic Resonance.	Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Carvallo L, 2010, J BIOL CHEM, V285, P29546, DOI 10.1074/jbc.M110.155812; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; de Juan-Sanz J., 2011, TRAFFIC         0912, DOI [10.1111/j.1600-0854.2011.01278.x, DOI 10.1111/J.1600-0854.2011.01278.X]; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hwangbo C, 2011, J BIOL CHEM, V286, P33601, DOI 10.1074/jbc.M110.206789; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Ko JW, 2006, J NEUROSCI, V26, P963, DOI 10.1523/JNEUROSCI.4475-05.2006; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Okumura F, 2011, MOL CELL BIOCHEM, V352, P163, DOI 10.1007/s11010-011-0750-4; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sakamoto T, 1999, BIOCHEMISTRY-US, V38, P11634, DOI 10.1021/bi990310y; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Urena JM, 1999, J CELL SCI, V112, P773; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	40	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39606	39614		10.1074/jbc.M111.262402	http://dx.doi.org/10.1074/jbc.M111.262402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949238	hybrid, Green Published			2022-12-25	WOS:000296759800077
J	Yamaguchi, Y; Du, XY; Zhao, L; Morser, J; Leung, LLK				Yamaguchi, Yasuto; Du, Xiao-Yan; Zhao, Lei; Morser, John; Leung, Lawrence L. K.			Proteolytic Cleavage of Chemerin Protein Is Necessary for Activation to the Active Form, Chem157S, Which Functions as a Signaling Molecule in Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; RECEPTOR; INFLAMMATION; EXPRESSION; PROTEASES; ADIPOKINE; CHEMR23; LIGAND; ADIPOGENESIS; CASCADES	Chemerin is a chemoattractant involved in innate and adaptive immunity as well as an adipokine implicated in adipocyte differentiation. Chemerin circulates as an inactive precursor in blood whose bioactivity is closely regulated through proteolytic processing at its C terminus. We developed methodology for production of different recombinant chemerin isoforms (chem163S, chem157S, and chem155A) which allowed us to obtain large quantities of these proteins with purity of >95%. Chem158K was generated from chem163S by plasmin cleavage. Characterization by mass spectrometry and Edman degradation demonstrated that both the N and C termini were correct for weach isoform. Ca2+ mobilization assays showed that the EC50 values for chem163S and chem158K were 54.2 +/- 19.9 nM and 65.2 +/- 13.2 nM, respectively, whereas chem157S had a similar to 50-fold higher potency with an EC50 of 1.2 +/- 0.7 nM. Chem155A had no agonist activity and weak antagonist activity, causing a 50% reduction of chem157S activity at a molar ratio of 100:1. Similar results were obtained in a chemotaxis assay. Because chem158K is the dominant form in cerebrospinal fluid from patients with glioblastoma (GBM), we examined the significance of chemerin in GBM biology. In silico analysis showed chemerin mRNA was significantly increased in tissue from grade III and IV gliomas. Furthermore, U-87 MG cells, a human GBM line, express the chemerin receptors, chemokine-like receptor 1 and chemokine receptor-like 2, and chem157S triggered Ca2+ flux. This study emphasized the necessity of appropriate C-terminal proteolytic processing to generate the likely physiologic form of active chemerin, chem157S, and suggested a possible role in malignant GBM.	[Yamaguchi, Yasuto; Du, Xiao-Yan; Zhao, Lei; Morser, John] Stanford Univ, Div Hematol, Dept Med, Sch Med, Stanford, CA 94305 USA; [Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Morser, J (corresponding author), 269 Campus Dr,CCSR 1155,MC5156, Stanford, CA 94305 USA.	jmorser@stanford.edu; lawrence.leung@stanford.edu			National Institutes of Health [HL057530, AI085268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057530 and AI085268.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Benton T, 2002, CYTOTECHNOLOGY, V38, P43, DOI 10.1023/A:1021141712344; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cash JL, 2010, J IMMUNOL, V184, P5315, DOI 10.4049/jimmunol.0903378; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fernandez-Ranvier GG, 2008, ARCH SURG-CHICAGO, V143, P841, DOI 10.1001/archsurg.143.9.841; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Miao ZH, 2007, J IMMUNOL, V178, P7395, DOI 10.4049/jimmunol.178.11.7395; Mohr S, 2004, BIOCHIMIE, V86, P13, DOI 10.1016/j.biochi.2003.11.008; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Shimamura K, 2009, PEPTIDES, V30, P1529, DOI 10.1016/j.peptides.2009.05.030; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Xiang D, 2010, PROTEIN EXPRES PURIF, V69, P153, DOI 10.1016/j.pep.2009.07.013; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	31	51	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39510	39519		10.1074/jbc.M111.258921	http://dx.doi.org/10.1074/jbc.M111.258921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949124	Green Published, hybrid			2022-12-25	WOS:000296759800068
J	Belleudi, F; Purpura, V; Torrisi, MR				Belleudi, Francesca; Purpura, Valeria; Torrisi, Maria Rosaria			The Receptor Tyrosine Kinase FGFR2b/KGFR Controls Early Differentiation of Human Keratinocytes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-GROWTH; INHIBITION; ACTIVATION; PROLIFERATION; THAPSIGARGIN; SPECIFICITY; RESTORATION; MODULATION; EXPRESSION	The FGFRs trigger divergent responses, such as proliferation and differentiation, and the cell type as well as the context-dependent signaling are crucial for the functional outcome. The FGFR2b/KGFR is expressed exclusively on epithelial cells and plays a key role in skin homeostasis. Here we analyzed in vitro the role of KGFR in the early differentiation of keratinocytes modulating its expression by KGFR cDNA transient transfection or KGFR siRNA microinjection and inducing a synchronous wave of differentiation in pre-confluent cells. Immunofluorescence, biochemical and molecular approaches demonstrated that KGFR overexpression increased the early differentiation marker keratin 1 at both transcriptional and translational levels, while receptor depletion reduced it. Ligand-dependent receptor activation and signaling were required for this differentiative effect. Overexpression of kinase negative KGFR mutant or Tyr769 KGFR signaling mutant, which is not able to recruit and activate PLC-gamma, showed that the receptor kinase activity, but not its PLC gamma-mediated signaling, is required for differentiation. Reduction of K1 expression, obtained by AKT inhibition, demonstrated that the PI3K/Akt signaling pathway is involved in the control of KGFR-mediated keratinocyte differentiation. This in vitro experimental model indicates that FGFR2b/KGFR expression represents a key event regulating keratinocyte early differentiation during the switch from undifferentiated to differentiating cells.	[Belleudi, Francesca; Purpura, Valeria; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Dipartimento Med Clin & Mol, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy; [Torrisi, Maria Rosaria] Azienda Osped S Andrea, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Belleudi, F (corresponding author), Univ Roma La Sapienza, Dipartimento Med Clin & Mol, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy.	francesca.belleudi@uniroma1.it	Purpura, Valeria/K-3052-2018	PURPURA, VALERIA/0000-0002-1272-313X	Minstero dell'Instruzione, dell'Universita e della Ricerca; Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]	Minstero dell'Instruzione, dell'Universita e della Ricerca; Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from the Minstero dell'Instruzione, dell'Universita e della Ricerca and from Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Dabernat S, 2008, J CELL PHYSIOL, V216, P261, DOI 10.1002/jcp.21401; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Belleudi F, 2006, FASEB J, V20, P395, DOI 10.1096/fj.05-3934fje; Bernard-Pierrot I, 2004, ONCOGENE, V23, P9201, DOI 10.1038/sj.onc.1208150; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Capone A, 2000, CELL GROWTH DIFFER, V11, P607; Ceridono M, 2005, BIOCHEM BIOPH RES CO, V327, P523, DOI 10.1016/j.bbrc.2004.12.031; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Feng S, 1997, CANCER RES, V58, P1509; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Grose R, 2007, EMBO J, V26, P1268, DOI 10.1038/sj.emboj.7601583; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hines MD, 1996, J BIOL CHEM, V271, P6245, DOI 10.1074/jbc.271.11.6245; Hong JH, 2008, J INVEST DERMATOL, V128, P2166, DOI 10.1038/jid.2008.66; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; LAROCHELLE WJ, 1995, J CELL BIOL, V129, P357, DOI 10.1083/jcb.129.2.357; Lotti LV, 2007, J CELL PHYSIOL, V212, P633, DOI 10.1002/jcp.21056; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; Marchese C, 1997, CELL GROWTH DIFFER, V8, P989; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Marchese C, 2001, J INVEST DERMATOL, V116, P623, DOI 10.1046/j.0022-202x.2001.01280.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsubara A, 1998, CANCER RES, V58, P1509; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Muller M, 2008, J BIOL CHEM, V283, P33942, DOI 10.1074/jbc.M801844200; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Ricol D, 1999, ONCOGENE, V18, P7234, DOI 10.1038/sj.onc.1203186; Rosenberger S, 2007, J BIOL CHEM, V282, P6126, DOI 10.1074/jbc.M610529200; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SCHWARTZ PM, 1992, P NATL ACAD SCI USA, V89, P594, DOI 10.1073/pnas.89.2.594; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Visco V, 2004, J CELL PHYSIOL, V200, P31, DOI 10.1002/jcp.10385; Xie ZJ, 2009, MOL BIOL CELL, V20, P1695, DOI 10.1091/mbc.E08-07-0756; Xie ZJ, 1999, J BIOL CHEM, V274, P20421, DOI 10.1074/jbc.274.29.20421; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Yasumoto H, 2004, PROSTATE, V61, P236, DOI 10.1002/pros.20093; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P11336, DOI 10.1073/pnas.191377098	47	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24194	10.1371/journal.pone.0024194	http://dx.doi.org/10.1371/journal.pone.0024194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957444	Green Submitted, Green Published, gold			2022-12-25	WOS:000295262100006
J	Wizen, G; Gasith, A				Wizen, Gil; Gasith, Avital			An Unprecedented Role Reversal: Ground Beetle Larvae (Coleoptera: Carabidae) Lure Amphibians and Prey upon Them	PLOS ONE			English	Article							MECHANISMS; PREDATION; BEHAVIOR; ANURANS; ECOLOGY	Amphibians often feed on beetle larvae, including those of ground beetles (Carabidae). Preliminary reports have detailed an unusual trophic interaction in which, in contrast, larvae of the ground beetle Epomis prey upon juvenile and adult amphibians. While it is known that these larvae feed exclusively on amphibians, how the predator-prey encounter occurs to the advantage of the beetle larvae had been unknown to date. Using laboratory observations and controlled experiments, we recorded the feeding behavior of Epomis larvae, as well as the behavior of their amphibian prey. Here we reveal that larvae of two species of Epomis (E. circumscriptus and E. dejeani) lure their potential predator, taking advantage of the amphibian's predation behavior. The Epomis larva combines a sit-and-wait strategy with unique movements of its antennae and mandibles to draw the attention of the amphibian to the presence of a potential prey. The intensity of this enticement increases with decreasing distance between the larva and the amphibian. When the amphibian attacks, the larva almost always manages to avoid the predator's protracted tongue, exploiting the opportunity to attach itself to the amphibian's body and initiate feeding. Our findings suggest that the trophic interaction between Epomis larvae and amphibians is one of the only natural cases of obligatory predator-prey role reversal. Moreover, this interaction involves a small insect larva that successfully lures and preys on a larger vertebrate. Such role reversal is exceptional in the animal world, extending our perspective of co-evolution in the arms race between predator and prey, and suggesting that counterattack defense behavior has evolved into predator-prey role reversal.	[Wizen, Gil; Gasith, Avital] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	Tel Aviv University	Wizen, G (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	wizentrop@gmail.com						BARKAI A, 1988, SCIENCE, V242, P62, DOI 10.1126/science.242.4875.62; Brandmayr P, 2010, ZOOTAXA, P49; Brandmayr TZ, 2004, ETHOL ECOL EVOL, V16, P351; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DODD C K, 1976, Herpetologica, V32, P269; Dodd C.K. Jr., 1976, Smithsonian Herpetological Information Service, VNo. 37, P1; Dorn NJ, 1999, VIE MILIEU, V49, P229; Elron Eldad, 2007, Herpetological Review, V38, P30; EVANS DL, 1990, INSECT DEFENCE ADAPT; Ewert J.-P., 1976, P141; EWERT JP, 1987, BEHAV BRAIN SCI, V10, P337, DOI 10.1017/S0140525X00023128; EWERT JP, 1970, BRAIN BEHAV EVOLUT, V3, P36, DOI 10.1159/000125462; GROBECKER DB, 1983, ENVIRON BIOL FISH, V8, P191, DOI 10.1007/BF00001085; Hagman M, 2008, ANIM BEHAV, V75, P123, DOI 10.1016/j.anbehav.2007.04.020; Hatle JD, 2001, ENVIRON ENTOMOL, V30, P51, DOI 10.1603/0046-225X-30.1.51; INGLE D, 1968, BRAIN BEHAV EVOLUT, V1, P500, DOI 10.1159/000125522; Kuzmin S.L., 1999, AMPHIBIANS FORMER SO; Lawrence J.F., 1991, IMMATURE INSECTS, V2, P144; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Magalhaes S, 2005, P ROY SOC B-BIOL SCI, V272, P1929, DOI 10.1098/rspb.2005.3127; Nishikawa KC, 1996, J EXP BIOL, V199, P2511; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; SAITO Y, 1986, Experimental and Applied Acarology, V2, P47, DOI 10.1007/BF01193354; SHIINA M, 1988, 48 ANN M ENT SOC JAP; SILVA A, 2009, FROGLOG, V91, P5; TACHIKAWA S, 1994, AMAZING LIFE INSECTS; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; Toledo Luis Felipe, 2009, International Journal of Zoology, V2009, P1, DOI 10.1155/2009/910892; TOSHIAKI H, 2000, ZOOL SCI, V17, P977; Wizen G, 2011, ZOOKEYS, P181, DOI 10.3897/zookeys.100.1526	33	20	28	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25161	10.1371/journal.pone.0025161	http://dx.doi.org/10.1371/journal.pone.0025161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957480	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100040
J	Bian, CF; Zhang, Y; Sun, H; Li, DF; Wang, DC				Bian, Cheng-Feng; Zhang, Ying; Sun, Hui; Li, De-Feng; Wang, Da-Cheng			Structural Basis for Distinct Binding Properties of the Human Galectins to Thomsen-Friedenreich Antigen	PLOS ONE			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; RAY CRYSTAL-STRUCTURE; CIRCULATING GALECTIN-3; IN-VITRO; LECTIN; PROTEIN; INHIBITORS; PROGRESSION; RESOLUTION; COMPLEXES	The Thomsen-Friedenreich (TF or T) antigen, Gal beta 1-3GalNAc alpha 1-O-Ser/Thr, is the core 1 structure of O-linked mucin type glycans appearing in tumor-associated glycosylation. The TF antigen occurs in about 90% of human cancer cells and is a potential ligand for the human endogenous galectins. It has been reported that human galectin-1 (Gal-1) and galectin-3 (Gal-3) can perform their cancer-related functions via specifically recognizing TF antigen. However, the detailed binding properties have not been clarified and structurally characterized. In this work, first we identified the distinct TF-binding abilities of Gal-1 and Gal-3. The affinity to TF antigen for Gal-3 is two orders of magnitude higher than that for Gal-1. The structures of Gal-3 carbohydrate recognition domain (CRD) complexed with TF antigen and derivatives, TFN and GM1, were then determined. These structures show a unique Glu-water-Arg-water motif-based mode as previously observed in the mushroom galectin AAL. The observation demonstrates that this recognition mode is commonly adopted by TF-binding galectins, either as endogenous or exogenous ones. The detailed structural comparisons between Gal-1 and Gal-3 CRD and mutagenesis experiments reveal that a pentad residue motif ((51)AHGDA(55)) at the loop (g1-L4) connecting beta-strands 4 and 5 of Gal-1 produces a serious steric hindrance for TF binding. This motif is the main structural basis for Gal-1 with the low affinity to TF antigen. These findings provide the intrinsic structural elements for regulating the TF-binding activity of Gal-1 in some special conditions and also show certain target and approach for mediating some tumor-related bioactivities of human galectins.	[Bian, Cheng-Feng; Zhang, Ying; Li, De-Feng; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Bian, Cheng-Feng] Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China; [Sun, Hui] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University	Bian, CF (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	lidefeng@moon.ibp.ac.cn; dcwang@ibp.ac.cn			National Basic Research Program of China [2011CB910304]; Ministry of Public Health, China [2009ZX09103-676]; National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Ministry of Public Health, China; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants from National Basic Research Program of China (2011CB910304) and the Ministry of Public Health, China (2009ZX09103-676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The TF antigen and biotin labeled GM1 were provided by the Carbohydrate Synthesis/Protein Expression Core of the Consortium for Functional Glycomics (CFG) funded by the National Institute of General Medical Sciences grant GM62116. We also thank Dr. Jamal Gibbs of the Core for his helpful advice and assistance with the information of the carbohydrate compounds. We are grateful to the staffs at Beamline 17 U, Shanghai Synchrotron Radiation Facility and Yi Han, Shengquan Liu and Yuanyuan Chen at the Institute of Biophysics, CAS, for their technical supports in X-ray data collections, ITC and SPR assay. CF Bian sincerely thanks Dr. Yonglin Hu and Dr. Deyu Zhu for their computational help in this work.	Andre S, 2005, INT J CANCER, V114, P46, DOI 10.1002/ijc.20699; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bianchet MA, 2000, PROTEINS, V40, P378, DOI 10.1002/1097-0134(20000815)40:3<378::AID-PROT40>3.0.CO;2-7; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Collins PM, 2007, ACTA CRYSTALLOGR D, V63, P415, DOI 10.1107/S090744490605270X; Cumpstey I, 2005, ORG BIOMOL CHEM, V3, P1922, DOI 10.1039/b502354h; Diehl C, 2010, J AM CHEM SOC, V132, P14577, DOI 10.1021/ja105852y; Feng L, 2010, FASEB J, V24, P3861, DOI 10.1096/fj.10-159111; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jeschke U, 2006, HISTOCHEM CELL BIOL, V126, P437, DOI 10.1007/s00418-006-0178-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lahm H, 2003, GLYCOCONJUGATE J, V20, P227, DOI 10.1023/B:GLYC.0000025817.24297.17; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Nakahara S, 2006, J BIOL CHEM, V281, P39649, DOI 10.1074/jbc.M608069200; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Slovin SF, 2005, CANCER IMMUNOL IMMUN, V54, P694, DOI 10.1007/s00262-004-0598-5; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Tejler J, 2007, CARBOHYD RES, V342, P1869, DOI 10.1016/j.carres.2007.03.012; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	38	52	53	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25007	10.1371/journal.pone.0025007	http://dx.doi.org/10.1371/journal.pone.0025007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949831	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400032
J	Blank, M; Wollberg, J; Gerlach, F; Reimann, K; Roesner, A; Hankeln, T; Fago, A; Weber, RE; Burmester, T				Blank, Miriam; Wollberg, Jessica; Gerlach, Frank; Reimann, Katja; Roesner, Anja; Hankeln, Thomas; Fago, Angela; Weber, Roy E.; Burmester, Thorsten			A Membrane-Bound Vertebrate Globin	PLOS ONE			English	Article							RESPIRATORY-PROTEIN; HUMAN NEUROGLOBIN; COUPLED SENSORS; CYTOGLOBIN; PALMITOYLATION; BINDING; MYRISTOYLATION; LOCALIZATION; EXPRESSION; STATE	The family of vertebrate globins includes hemoglobin, myoglobin, and other O-2-binding proteins of yet unclear functions. Among these, globin X is restricted to fish and amphibians. Zebrafish (Danio rerio) globin X is expressed at low levels in neurons of the central nervous system and appears to be associated with the sensory system. The protein harbors a unique N-terminal extension with putative N-myristoylation and S-palmitoylation sites, suggesting membrane-association. Intracellular localization and transport of globin X was studied in 3T3 cells employing green fluorescence protein fusion constructs. Both myristoylation and palmitoylation sites are required for correct targeting and membrane localization of globin X. To the best of our knowledge, this is the first time that a vertebrate globin has been identified as component of the cell membrane. Globin X has a hexacoordinate binding scheme and displays cooperative O-2 binding with a variable affinity (P-50 similar to 1.3-12.5 torr), depending on buffer conditions. A respiratory function of globin X is unlikely, but analogous to some prokaryotic membrane-globins it may either protect the lipids in cell membrane from oxidation or may act as a redoxsensing or signaling protein.	[Blank, Miriam; Wollberg, Jessica; Gerlach, Frank; Reimann, Katja; Burmester, Thorsten] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Roesner, Anja] Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany; [Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, Mainz, Germany; [Fago, Angela; Weber, Roy E.] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	University of Hamburg; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Aarhus University	Blank, M (corresponding author), Univ Hamburg, Bioctr Grindel, Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Fago, Angela/J-5946-2013; Götting, Miriam/I-8222-2014; Burmester, Thorsten/I-7225-2013	Fago, Angela/0000-0001-7315-2628; Götting, Miriam/0000-0001-5336-1422; Burmester, Thorsten/0000-0002-5772-7863	DFG; BMBF	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	We would like to acknowledge the assistance of Dr. Maria Trusch and Prof. Dr. Hartmut Schluter from the Core Facility Mass Spectrometric Proteomics of the UKE supported in part by the DFG and the BMBF.	Acker H, 2005, PHILOS T R SOC B, V360, P2201, DOI 10.1098/rstb.2005.1760; Bentmann A, 2005, J BIOL CHEM, V280, P20660, DOI 10.1074/jbc.M501338200; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Blank M, 2011, J BIOL CHEM, V286, P26507, DOI 10.1074/jbc.M111.224634; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, IUBMB LIFE, V56, P703, DOI 10.1080/15216540500037257; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Di Giulio A, 2008, METHOD ENZYMOL, V436, P239, DOI 10.1016/S0076-6879(08)36013-3; Dickerson AE, 1983, HEMOGLOBIN STRUCTURE; Dowling J. E., 1987, RETINA APPROACHABLE; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Ehleben W, 1998, RESP PHYSIOL, V114, P25, DOI 10.1016/S0034-5687(98)00078-4; Ertas B, 2011, J BIOL CHEM, V286, P3185, DOI 10.1074/jbc.M110.160341; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu C, 2004, BIOCHEM BIOPH RES CO, V316, P1163, DOI 10.1016/j.bbrc.2004.02.170; Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x; Mitz SA, 2009, NEUROSCIENCE, V163, P552, DOI 10.1016/j.neuroscience.2009.06.058; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Ramandeep, 2001, J BIOL CHEM, V276, P24781, DOI 10.1074/jbc.M009808200; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Roesner A, 2006, J EXP BIOL, V209, P2129, DOI 10.1242/jeb.02243; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243	44	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25292	10.1371/journal.pone.0025292	http://dx.doi.org/10.1371/journal.pone.0025292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949889	Green Submitted, Green Published, gold			2022-12-25	WOS:000295260400057
J	Dhingra, S; Bagchi, AK; Ludke, AL; Sharma, AK; Singal, PK				Dhingra, Sanjiv; Bagchi, Ashim K.; Ludke, Ana L.; Sharma, Anita K.; Singal, Pawan K.			Akt Regulates IL-10 Mediated Suppression of TNF alpha-Induced Cardiomyocyte Apoptosis by Upregulating Stat3 Phosphorylation	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; TUMOR-NECROSIS-FACTOR; CARDIAC MYOCYTE APOPTOSIS; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; IN-VITRO; PHOSPHATIDYLINOSITOL 3'-KINASE; TRANSCRIPTION FACTOR; INHIBITS APOPTOSIS; TRANSGENIC MICE	Background: We have already reported that TNF-alpha increases cardiomyocyte apoptosis and IL-10 treatment prevented these effects of TNF-alpha. Present study investigates the role of Akt and Jak/Stat pathway in the IL-10 modulation of TNF-alpha induced cardiomyocyte apoptosis. Methodology/Principal findings: Cardiomyocytes isolated from adult Sprague Dawley rats were exposed to TNF-alpha (10 ng/ml), IL-10 (10 ng/ml) and TNF-alpha+IL-10 (ratio 1) for 4 h. Exposure to TNF-alpha resulted in an increase in cardiomyocyte apoptosis as measured by flow cytometry and TUNEL assay. IL-10 by itself had no effect, but it prevented TNF-alpha induced apoptosis. IL-10 treatment increased Akt levels within cardiomyocytes and this change was associated with an increase in Jak1 and Stat3 phosphorylation. Pre-exposure of cells to Akt inhibitor prevented IL-10 induced Stat3 phosphorylation. Furthermore, in the presence of Akt or Stat3 inhibitor, IL-10 treatment was unable to block TNF-alpha induced cardiomyocyte apoptosis. Conclusion: It is suggested that IL-10 modulation of TNF-alpha induced cardiomyocyte apoptosis is mediated by Akt via Stat3 activation.	[Dhingra, Sanjiv; Bagchi, Ashim K.; Ludke, Ana L.; Sharma, Anita K.; Singal, Pawan K.] Univ Manitoba, Fac Med, Dept Physiol, Inst Cardiovasc Sci,St Boniface Gen Hosp,Res Ctr, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Dhingra, S (corresponding author), Univ Manitoba, Fac Med, Dept Physiol, Inst Cardiovasc Sci,St Boniface Gen Hosp,Res Ctr, Winnipeg, MB, Canada.	psingal@sbrc.ca	Bagchi, Ashim/AAY-8074-2020; Dhingra, Sanjiv/D-8766-2014	Dhingra, Sanjiv/0000-0002-2664-7633; Bagchi, Ashim Kumar/0000-0003-1537-1309	Canadian Institute of Health Research; Manitoba Health Research Council (MHRC); St. Boniface Hospital & Research Foundation	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC); St. Boniface Hospital & Research Foundation	The study was supported by an operating grant from Canadian Institute of Health Research. Dr. Dhingra was supported by a Postdoctoral Fellowship from CIHR-(Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT) Strategic Program. Dr. Ludke is supported by a studentship award by Manitoba Health Research Council (MHRC). Dr. Singal is the holder of the Naranjan S. Dhalla Chair in Cardiovascular Research supported by the St. Boniface Hospital & Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Arokium H, 2007, J BIOL CHEM, V282, P35104, DOI 10.1074/jbc.M704891200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bolger AP, 2002, AM J CARDIOL, V90, P384, DOI 10.1016/S0002-9149(02)02494-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Coletta AP, 2002, EUR J HEART FAIL, V4, P559, DOI 10.1016/S1388-9842(02)00121-6; Dhingra S, 2007, AM J PHYSIOL-HEART C, V293, pH3524, DOI 10.1152/ajpheart.00919.2007; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Engel D, 2004, AM J PHYSIOL-HEART C, V287, pH1303, DOI 10.1152/ajpheart.00053.2004; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Ho A S, 1994, Ther Immunol, V1, P173; JAMES TN, 1994, CIRCULATION, V90, P556, DOI 10.1161/01.CIR.90.1.556; John T, 2007, CYTOKINE, V40, P226, DOI 10.1016/j.cyto.2007.10.002; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kaur K, 2006, AM J PHYSIOL-HEART C, V291, pH106, DOI 10.1152/ajpheart.01327.2005; Kaur K, 2006, J MOL CELL CARDIOL, V41, P1023, DOI 10.1016/j.yjmcc.2006.08.005; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li XQ, 2009, INT IMMUNOPHARMACOL, V9, P1032, DOI 10.1016/j.intimp.2009.04.010; Lu YJ, 2008, CELL PHYSIOL BIOCHEM, V21, P305, DOI 10.1159/000129389; Makuta Y, 2003, BIOL PHARM BULL, V26, P1076, DOI 10.1248/bpb.26.1076; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Marini M, 2003, P NATL ACAD SCI USA, V100, P8366, DOI 10.1073/pnas.1432897100; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577, DOI 10.1152/ajpregu.1998.274.3.R577; Miao WF, 2000, J MOL CELL CARDIOL, V32, P2397, DOI 10.1006/jmcc.2000.1283; Negoro S, 2001, CIRCULATION, V103, P555, DOI 10.1161/01.CIR.103.4.555; PACKER M, 1995, CIRCULATION, V92, P1379, DOI 10.1161/01.CIR.92.6.1379; Pahan K, 2000, J NEUROCHEM, V75, P576, DOI 10.1046/j.1471-4159.2000.0750576.x; Stumpf C, 2003, CLIN SCI, V105, P45, DOI 10.1042/CS20020359; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Zhou JH, 2001, J IMMUNOL, V167, P4436, DOI 10.4049/jimmunol.167.8.4436	37	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25009	10.1371/journal.pone.0025009	http://dx.doi.org/10.1371/journal.pone.0025009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949832	gold, Green Submitted, Green Published			2022-12-25	WOS:000295260400033
J	Brady, AK; Snyder, KA; Vize, PD				Brady, Aisling K.; Snyder, Kevin A.; Vize, Peter D.			Circadian Cycles of Gene Expression in the Coral, Acropora millepora	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; RHYTHMS; PERIOD	Background: Circadian rhythms regulate many physiological, behavioral and reproductive processes. These rhythms are often controlled by light, and daily cycles of solar illumination entrain many clock regulated processes. In scleractinian corals a number of different processes and behaviors are associated with specific periods of solar illumination or non-illumination-for example, skeletal deposition, feeding and both brooding and broadcast spawning. Methodology/Principal Findings: We have undertaken an analysis of diurnal expression of the whole transcriptome and more focused studies on a number of candidate circadian genes in the coral Acropora millepora using deep RNA sequencing and quantitative PCR. Many examples of diurnal cycles of RNA abundance were identified, some of which are light responsive and damped quickly under constant darkness, for example, cryptochrome 1 and timeless, but others that continue to cycle in a robust manner when kept in constant darkness, for example, clock, cryptochrome 2, cycle and eyes absent, indicating that their transcription is regulated by an endogenous clock entrained to the light-dark cycle. Many other biological processes that varied between day and night were also identified by a clustering analysis of gene ontology annotations. Conclusions/Significance: Corals exhibit diurnal patterns of gene expression that may participate in the regulation of circadian biological processes. Rhythmic cycles of gene expression occur under constant darkness in both populations of coral larvae that lack zooxanthellae and in individual adult tissue containing zooxanthellae, indicating that transcription is under the control of a biological clock. In addition to genes potentially involved in regulating circadian processes, many other pathways were found to display diel cycles of transcription.	[Brady, Aisling K.; Snyder, Kevin A.; Vize, Peter D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Brady, AK (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pvize@ucalgary.ca			National Institutes of Health [R01 HD45776, P41 HD064556]; Natural Sciences and Engineering Research Council (Canada); Alberta Innovates Scholarship; Natural Sciences and Engineering Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064556] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Scholarship; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institutes of Health R01 HD45776, P41 HD064556 and a Natural Sciences and Engineering Research Council (Canada) Discovery Grant to PDV, an Alberta Innovates Scholarship to AKB, and a Natural Sciences and Engineering Research Council Postgraduate Scholarship to AKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 1939, DANA PALAO TROP BIOL, V4, P651; Anctil M, 2007, GENE, V392, P14, DOI 10.1016/j.gene.2006.10.025; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; HASTINGS JW, 1958, BIOL BULL, V115, P440, DOI 10.2307/1539108; Hoadley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019755; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Rozen S, 2000, Methods Mol Biol, V132, P365; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SWEENEY BM, 1976, BIOL BULL, V151, P236, DOI 10.2307/1540717; Tamai SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003835; TAYLOR WC, 1989, PLANT CELL, V1, P259, DOI 10.1105/tpc.1.2.259; Toyama R, 2009, DEV DYNAM, V238, P1813, DOI 10.1002/dvdy.21988; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Van Gelder RN, 2002, J BIOL RHYTHM, V17, P110, DOI 10.1177/074873002129002401; van Oppen M, 2001, CORAL REEFS, V20, P200, DOI 10.1007/s003380100167; Vize PD, 2009, BIOL BULL-US, V216, P131; Willis B. L., 1985, P 5 INT COR REEF C, V4, P343; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	33	32	33	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25072	10.1371/journal.pone.0025072	http://dx.doi.org/10.1371/journal.pone.0025072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949855	Green Submitted, gold, Green Published			2022-12-25	WOS:000295257900048
J	Istivan, TS; Pirogova, E; Gan, E; Almansour, NM; Coloe, PJ; Cosic, I				Istivan, Taghrid S.; Pirogova, Elena; Gan, Emily; Almansour, Nahlah M.; Coloe, Peter J.; Cosic, Irena			Biological Effects of a De Novo Designed Myxoma Virus Peptide Analogue: Evaluation of Cytotoxicity on Tumor Cells	PLOS ONE			English	Article							RESONANT RECOGNITION MODEL; IN-VITRO; APOPTOSIS; PROTEIN; CANCER; M-T5; ONCOLYSIS; SIZE	Background: The Resonant Recognition Model (RRM) is a physico-mathematical model that interprets protein sequence linear information using digital signal processing methods. In this study the RRM concept was employed for structure-function analysis of myxoma virus (MV) proteins and the design of a short bioactive therapeutic peptide with MV-like antitumor/cytotoxic activity. Methodology/Principal Findings: The analogue RRM-MV was designed by RRM as a linear 18 aa 2.3 kDa peptide. The biological activity of this computationally designed peptide analogue against cancer and normal cell lines was investigated. The cellular cytotoxicity effects were confirmed by confocal immunofluorescence microscopy, by measuring the levels of cytoplasmic lactate dehydrogenase (LDH) and by Prestoblue cell viability assay for up to 72 hours in peptide treated and non-treated cell cultures. Our results revealed that RRM-MV induced a significant dose and time-dependent cytotoxic effect on murine and human cancer cell lines. Yet, when normal murine cell lines were similarly treated with RRM-MV, no cytotoxic effects were observed. Furthermore, the non-bioactive RRM designed peptide RRM-C produced negligible cytotoxic effects on these cancer and normal cell lines when used at similar concentrations. The presence/absence of phosphorylated Akt activity in B16F0 mouse melanoma cells was assessed to indicate the possible apoptosis signalling pathway that could be affected by the peptide treatment. So far, Akt activity did not seem to be significantly affected by RRM-MV as is the case for the original viral protein. Conclusions/Significance: Our findings indicate the successful application of the RRM concept to design a bioactive peptide analogue (RRM-MV) with cytotoxic effects on tumor cells only. This 2.345 kDa peptide analogue to a 49 kDa viral protein may be suitable to be developed as a potential cancer therapeutic. These results also open a new direction to the rational design of therapeutic agents for future cancer treatment.	[Istivan, Taghrid S.; Gan, Emily; Almansour, Nahlah M.; Coloe, Peter J.] RMIT Univ, Sci Engn & Hlth Coll, Sch Appl Sci, Melbourne, Vic, Australia; [Pirogova, Elena; Cosic, Irena] RMIT Univ, Sci Engn & Hlth Coll, Sch Elect & Comp Engn, Melbourne, Vic, Australia; [Istivan, Taghrid S.; Pirogova, Elena; Coloe, Peter J.; Cosic, Irena] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Istivan, TS (corresponding author), RMIT Univ, Sci Engn & Hlth Coll, Sch Appl Sci, Melbourne, Vic, Australia.	taghrid.istivan@rmit.edu.au	Almansour, Nahlah Makki/AHA-0675-2022; Almansour, Nahlah Makki/AAB-5520-2022	Almansour, Nahlah Makki/0000-0003-3907-7091; Almansour, Nahlah Makki/0000-0003-3907-7091; Cosic, Irena/0000-0002-4218-7390; Pirogova, Elena/0000-0001-9422-1370	Health Innovation Research Institute, RMIT University; Science Engineering and Health College, RMIT University	Health Innovation Research Institute, RMIT University; Science Engineering and Health College, RMIT University	This study was supported by Health Innovation Research Institute, RMIT University and by a Seeding fund from Science Engineering and Health College, RMIT University in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Carew JF, 2001, MOL THER, V4, P250, DOI 10.1006/mthe.2001.0448; COSIC I, 1992, EUR J BIOCHEM, V205, P613, DOI 10.1111/j.1432-1033.1992.tb16819.x; COSIC I, 1994, MOL CELL BIOCHEM, V130, P1, DOI 10.1007/BF01084262; COSIC I, 1994, IEEE T BIO-MED ENG, V41, P1101, DOI 10.1109/10.335859; COSIC I, 1991, EUR J BIOCHEM, V198, P113, DOI 10.1111/j.1432-1033.1991.tb15993.x; Cosic I, 1997, BIOMETHODS, V9; Cosic I, 1995, NAT BIOTECHNOL, V13, P236; Cosic Irena, 2007, Nonlinear Biomed Phys, V1, P7, DOI 10.1186/1753-4631-1-7; de Trad CH, 2002, PROTEIN ENG, V15, P193, DOI 10.1093/protein/15.3.193; de Trad CH, 2000, BIOPHYS CHEM, V84, P149, DOI 10.1016/S0301-4622(00)00109-5; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Everts B, 2005, CANCER GENE THER, V12, P141, DOI 10.1038/sj.cgt.7700771; Fenner Frank, 1994, P205; Fielding AK, 2005, REV MED VIROL, V15, P135, DOI 10.1002/rmv.455; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Harrington KJ, 2008, VIRAL THERAPY CANC, P95; Johnston JB, 2005, J VIROL, V79, P10750, DOI 10.1128/JVI.79.16.10750-10763.2005; Kandouz M, 1996, INT J ONCOL, V9, P563; Katoch Bandhana, 2002, Indian Journal of Experimental Biology, V40, P513; Krsmanovic V, 1998, J PEPT RES, V52, P410; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Mossman K, 1996, J VIROL, V70, P4394, DOI 10.1128/JVI.70.7.4394-4410.1996; Murakami R, 2000, J PROTEIN CHEM, V19, P609, DOI 10.1023/A:1007143113887; Paez Juan, 2003, Cancer Treat Res, V115, P145; Park YJ, 2005, FASEB J, V19, P1555, DOI 10.1096/fj.04-2322fje; Pirogova E, 2006, MOL SIMULAT, V32, P1195, DOI 10.1080/08927020601052997; Pirogova E, 2011, CURR PHARM BIOTECHNO, V12, P1117, DOI 10.2174/138920111796117436; Pirogova E, 2002, P IEEE, V90, P1859, DOI 10.1109/JPROC.2002.805305; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Shmulevitz M, 2005, ONCOGENE, V24, P7720, DOI 10.1038/sj.onc.1209041; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Stanford MM, 2008, MOL THER, V16, P52, DOI 10.1038/sj.mt.6300348; Sypula J., 2004, GENE THER MOL BIOL, V8, P103; VELJKOVIC V, 1972, PHYS REV LETT, V29, P105, DOI 10.1103/PhysRevLett.29.105; Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103; Werden SJ, 2008, BBA-PROTEINS PROTEOM, V1784, P228, DOI 10.1016/j.bbapap.2007.08.001; Zanon M, 2004, CANCER RES, V64, P7386, DOI 10.1158/0008-5472.CAN-04-1640	39	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24809	10.1371/journal.pone.0024809	http://dx.doi.org/10.1371/journal.pone.0024809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949758	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900029
J	Janardhan, SV; Praveen, K; Marks, R; Gajewski, TF				Janardhan, Sujit V.; Praveen, Kesavannair; Marks, Reinhard; Gajewski, Thomas F.			Evidence Implicating the Ras Pathway in Multiple CD28 Costimulatory Functions in CD4(+) T Cells	PLOS ONE			English	Article							SUPRAMOLECULAR ACTIVATION CLUSTER; PHOSPHATIDYLINOSITOL 3-KINASE; IFN-GAMMA; TRYPTOPHAN CATABOLISM; CUTTING EDGE; IL-2; EXPRESSION; INDUCTION; SIGNALS; EFFECTOR	CD28 costimulation is a critical event in the full activation of CD4(+) T cells that augments cytokine gene transcription, promotes cytokine mRNA stability, prevents induction of anergy, increases cellular metabolism, and increases cell survival. However, despite extensive biochemical analysis of the signaling events downstream of CD28, molecular pathways sufficient to functionally replace the diverse aspects of CD28-mediated costimulation in normal T cells have not been identified. Ras/MAPK signaling is a critical pathway downstream of T cell receptor stimulation, but its role in CD28-mediated costimulation has been controversial. We observed that physiologic CD28 costimulation caused a relocalization of the RasGEF RasGRP to the T cell-APC interface by confocal microscopy. In whole cell biochemical analysis, CD28 cross-linking with either anti-CD28 antibody or B7.1-Ig augmented TCR-induced Ras activation. To determine whether Ras signaling was sufficient to functionally mimic CD28 costimulation, we utilized an adenoviral vector encoding constitutively active H-Ras (61L) to transduce normal, Coxsackie-Adenovirus Receptor (CAR) transgenic CD4(+) T cells. Like costimulation via CD28, active Ras induced AKT, JNK and ERK phosphorylation. In addition, constitutive Ras signaling mimicked the ability of CD28 to costimulate IL-2 protein secretion, prevent anergy induction, increase glucose uptake, and promote cell survival. Importantly, we also found that active Ras mimicked the mechanism by which CD28 costimulates IL-2 production: by increasing IL-2 gene transcription, and promoting IL-2 mRNA stability. Finally, active Ras was able to induce IL-2 production when combined with ionomycin stimulation in a MEK-1-dependent fashion. Our results are consistent with a central role for Ras signaling in CD28-mediated costimulation.	[Janardhan, Sujit V.; Praveen, Kesavannair; Marks, Reinhard; Gajewski, Thomas F.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Gajewski, Thomas F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Janardhan, SV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu		Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health [R21 AI59818-01, P01 CA97296]; NATIONAL CANCER INSTITUTE [P01CA097296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R21 AI59818-01 and P01 CA97296 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2001, J IMMUNOL, V167, P5193, DOI 10.4049/jimmunol.167.9.5193; Bertram EM, 2004, SEMIN IMMUNOL, V16, P185, DOI 10.1016/j.smim.2004.02.006; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Crespi D, 2002, EUR J IMMUNOL, V32, P2500, DOI 10.1002/1521-4141(200209)32:9<2500::AID-IMMU2500>3.0.CO;2-S; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; JUNE CH, 1989, J AUTOIMMUN, V2, P55, DOI 10.1016/0896-8411(89)90117-0; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; O'Keefe JP, 2005, J IMMUNOL, V175, P5581, DOI 10.4049/jimmunol.175.9.5581; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Praveen K, 2009, J IMMUNOL, V182, P6022, DOI 10.4049/jimmunol.0800897; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; SAMSTAG Y, 1991, J IMMUNOL, V147, P788; SAMSTAG Y, 1992, INT IMMUNOL, V4, P1255, DOI 10.1093/intimm/4.11.1255; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000; Zha YY, 2007, CELL IMMUNOL, V247, P95, DOI 10.1016/j.cellimm.2007.07.006; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	50	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24931	10.1371/journal.pone.0024931	http://dx.doi.org/10.1371/journal.pone.0024931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949793	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900036
J	Cecchini, P; Tavano, R; de Laureto, PP; Franzoso, S; Mazzon, C; Montanari, P; Papini, E				Cecchini, Paola; Tavano, Regina; de Laureto, Patrizia Polverino; Franzoso, Susanna; Mazzon, Cristina; Montanari, Paolo; Papini, Emanuele			The Soluble Recombinant Neisseria meningitidis Adhesin NadA(Delta 351-405) Stimulates Human Monocytes by Binding to Extracellular Hsp90	PLOS ONE			English	Article							EPITHELIAL-CELLS; PROTEIN; SHOCK; NADA; ACTIVATION; MEMBRANE; RECEPTOR; VACCINE; GP96	The adhesin NadA favors cell adhesion/invasion by hypervirulent Neisseria meningitidis B (MenB). Its recombinant form NadA(Delta 351-405), devoid of the outer membrane domain, is an immunogenic candidate for an anti-MenB vaccine able to stimulate monocytes, macrophages and dendritic cells. In this study we investigated the molecular mechanism of NadA(Delta 351-405) cellular effects in monocytes. We show that NadA(Delta 351-405) (against which we obtained polyclonal antibodies in rabbits), binds to hsp90, but not to other extracellular homologous heat shock proteins grp94 and hsp70, in vitro and on the surface of monocytes, in a temperature dependent way. Pre-incubation of monocytes with the MenB soluble adhesin interfered with the binding of anti-hsp90 and anti-hsp70 antibodies to hsp90 and hsp70 at 37 degrees C, a condition in which specific cell-binding occurs, but not at 0 degrees C, a condition in which specific cell-binding is very diminished. Conversely, pre-incubation of monocytes with anti-hsp90 and anti-hsp70 antibodies did not affected NadA(Delta 351-405) cell binding in any temperature condition, indicating that it associates to another receptor on their plasma membrane and then laterally diffuses to encounter hsp90. Consistently, polymixin B interfered with NadA(Delta 351-405)/hsp90 association, abrogated the decrease of anti-hsp90 antibodies binding to the cell surface due to NadA(Delta 351-405) and inhibited adhesin-induced cytokine/chemokine secretion without affecting monocyte-adhesin binding. Co-stimulation of monocytes with anti-hsp90 antibodies and NadA(Delta 351-405) determined a stronger but polymixin B insensitive cell activation. This indicated that the formation of a recombinant NadA/hsp90/hsp70 complex, although essential for full monocyte stimulation, can be replaced by anti-hsp90 antibody/hsp90 binding. Finally, the activation of monocytes by NadA(Delta 351-405) alone or in the presence of anti-hsp90 antibodies were both inhibited by neutralizing anti-TLR4 antibodies, but not by anti-TLR2 antibodies. We propose that hsp90-dependent recruitment into an hsp90/hsp70/TLR4 transducing signal complex is necessary for the immune-stimulating activity of NadA(Delta 351-405) anti-MenB vaccine candidate.	[Cecchini, Paola; Tavano, Regina; de Laureto, Patrizia Polverino; Franzoso, Susanna; Mazzon, Cristina; Papini, Emanuele] Univ Padua, CRIBI, Padua, Italy; [Cecchini, Paola; Tavano, Regina; Franzoso, Susanna; Mazzon, Cristina; Papini, Emanuele] Univ Padua, Dept Biomed Sci, Padua, Italy; [de Laureto, Patrizia Polverino] Univ Padua, Dept Pharmaceut Sci, Padua, Italy; [Montanari, Paolo] Novartis Vaccine & Diagnost Srl, Siena, Italy	University of Padua; University of Padua; University of Padua; Novartis	Cecchini, P (corresponding author), Babraham Res Campus, Cambridge, England.	emanuele.papini@unipd.it	Papini, Emanuele/AAE-6961-2022	Papini, Emanuele/0000-0001-6033-4473; TAVANO, REGINA/0000-0002-0699-1859	Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca); Novartis Vaccine and Diagnostics srl	Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); Novartis Vaccine and Diagnostics srl	This work was supported by PRIN (Programmi di ricerca di Rilevante Interesse Nazionale) 2002 and 2003 grants from Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) and is in partial fulfilment of the PhD degree in Biotechnology of Paola Cecchini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Paolo Montanari participated to this work as a PhD student supported by Novartis Vaccine and Diagnostics srl. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Amedei A, 2006, J CLIN INVEST, V116, P1092, DOI 10.1172/JCI27177; Bozzo C, 2005, FEBS J, V272, P5771, DOI 10.1111/j.1742-4658.2005.04965.x; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Franzoso S, 2008, J LEUKOCYTE BIOL, V83, P1100, DOI 10.1189/jlb.1207810; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Guerrero CA, 2002, J VIROL, V76, P4096, DOI 10.1128/JVI.76.8.4096-4102.2002; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Jin SM, 2003, CELL MICROBIOL, V5, P165, DOI 10.1046/j.1462-5822.2003.00265.x; Mazzon C, 2007, J IMMUNOL, V179, P3904, DOI 10.4049/jimmunol.179.6.3904; MERCIER JC, 1988, CRIT CARE MED, V16, P27, DOI 10.1097/00003246-198801000-00006; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tavano R, 2009, J LEUKOCYTE BIOL, V86, P143, DOI [10.1189/JLB.0109030, 10.1189/jlb.0109030]; Triantafilou K, 2001, J CELL SCI, V114, P2535; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000	22	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25089	10.1371/journal.pone.0025089	http://dx.doi.org/10.1371/journal.pone.0025089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949862	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800065
J	Court, N; Rose, S; Bourigault, ML; Front, S; Martin, OR; Dowling, JK; Kenny, EF; O'Neill, L; Erard, F; Quesniaux, VFJ				Court, Nathalie; Rose, Stephanie; Bourigault, Marie-Laure; Front, Sophie; Martin, Olivier R.; Dowling, Jennifer K.; Kenny, Elaine F.; O'Neill, Luke; Erard, Francois; Quesniaux, Valerie F. J.			Mycobacterial PIMs Inhibit Host Inflammatory Responses through CD14-Dependent and CD14-Independent Mechanisms	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; HUMAN DENDRITIC CELLS; TOLL-LIKE RECEPTORS; DC-SIGN; PHOSPHATIDYLINOSITOL MANNOSIDE; IMMUNE-RESPONSES; IL-12 PRODUCTION; INNATE IMMUNITY; TNF-ALPHA; TUBERCULOSIS	Mycobacteria develop strategies to evade the host immune system. Among them, mycobacterial LAM or PIMs inhibit the expression of pro-inflammatory cytokines by activated macrophages. Here, using synthetic PIM analogues, we analyzed the mode of action of PIM anti-inflammatory effects. Synthetic PIM1 isomer and PIM2 mimetic potently inhibit TNF and IL-12 p40 expression induced by TLR2 or TLR4 pathways, but not by TLR9, in murine macrophages. We show inhibition of LPS binding to TLR4/MD2/CD14 expressing HEK cells by PIM1 and PIM2 analogues. More specifically, the binding of LPS to CD14 was inhibited by PIM1 and PIM2 analogues. CD14 was dispensable for PIM1 and PIM2 analogues functional inhibition of TLR2 agonists induced TNF, as shown in CD14-deficient macrophages. The use of rough-LPS, that stimulates TLR4 pathway independently of CD14, allowed to discriminate between CD14-dependent and CD14-independent anti-inflammatory effects of PIMs on LPS-induced macrophage responses. PIM1 and PIM2 analogues inhibited LPS-induced TNF release by a CD14-dependent pathway, while IL-12 p40 inhibition was CD14-independent, suggesting that PIMs have multifold inhibitory effects on the TLR4 signalling pathway.	[Court, Nathalie; Rose, Stephanie; Bourigault, Marie-Laure; Front, Sophie; Erard, Francois; Quesniaux, Valerie F. J.] Univ Orleans Mol Immunol & Embryol, Orleans, France; [Court, Nathalie; Rose, Stephanie; Bourigault, Marie-Laure; Front, Sophie; Erard, Francois; Quesniaux, Valerie F. J.] CNRS, UMR6218, F-45071 Orleans, France; [Martin, Olivier R.] Univ Orleans, Inst Chim Organ & Analyt, Orleans, France; [Martin, Olivier R.] CNRS, UMR6005, F-45071 Orleans, France; [Dowling, Jennifer K.; Kenny, Elaine F.; O'Neill, Luke] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Trinity College Dublin	Court, N (corresponding author), Univ Orleans Mol Immunol & Embryol, Orleans, France.	quesniaux@cnrs-orleans.fr	Dowling, Jennifer/ABA-6670-2020	Dowling, Jennifer/0000-0003-2842-1504; O'Neill, Luke/0000-0002-4333-2748	CNRS; University of Orleans; European Union [1649-32264]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Orleans; European Union(European Commission)	This work was supported by CNRS, University of Orleans and European Union FEDER N<SUP>o</SUP> 1649-32264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge GD, 2006, BIOORGAN MED CHEM, V14, P5632, DOI 10.1016/j.bmc.2006.04.037; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Bean AGD, 1999, J IMMUNOL, V162, P3504; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Elass E, 2007, FEBS LETT, V581, P1383, DOI 10.1016/j.febslet.2007.02.056; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Flynn JL, 2006, MICROBES INFECT; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2003, J BIOL CHEM; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Harper JL, 2010, BIOORG MED IN PRESS; Heldwein KA, 2002, MICROBES INFECT, V4, P937, DOI 10.1016/S1286-4579(02)01611-8; Hoppe HC, 1997, INFECT IMMUN, V65, P3896, DOI 10.1128/IAI.65.9.3896-3905.1997; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; ILANGUMARAN S, 1995, J IMMUNOL, V155, P1334; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Janot L, 2008, J INFECT DIS, V198, P115, DOI 10.1086/588815; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johansson U, 2001, IMMUNOL LETT, V77, P63, DOI 10.1016/S0165-2478(01)00190-0; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Kang BK, 1998, INFECT IMMUN, V66, P2769, DOI 10.1128/IAI.66.6.2769-2777.1998; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Knutson KL, 1998, J BIOL CHEM, V273, P645, DOI 10.1074/jbc.273.1.645; Lichtman SN, 1998, AM J PHYSIOL-GASTR L, V275, pG39, DOI 10.1152/ajpgi.1998.275.1.G39; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Perera PY, 1997, J IMMUNOL, V158, P4422; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Riviere M, 2004, J MOL BIOL, V344, P907, DOI 10.1016/j.jmb.2004.09.092; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Sayers I, 2004, J ALLERGY CLIN IMMUN, V114, P302, DOI 10.1016/j.jaci.2004.03.057; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; Shabaana AK, 2005, CELL MOL LIFE SCI, V62, P179, DOI 10.1007/s00018-004-4404-5; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Zajonc DM, 2006, J IMMUNOL, V177, P4577, DOI 10.4049/jimmunol.177.7.4577	64	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24631	10.1371/journal.pone.0024631	http://dx.doi.org/10.1371/journal.pone.0024631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949737	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800032
J	de Carvalho, EG; Bonin, M; Kremsner, PG; Kun, JFJ				de Carvalho, Elisandra Grangeiro; Bonin, Michael; Kremsner, Peter G.; Kun, Juergen F. J.			Plasmodium falciparum-Infected Erythrocytes and IL-12/IL-18 Induce Diverse Transcriptomes in Human NK Cells: IFN-alpha/beta Pathway versus TREM Signaling	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INNATE IMMUNE-RESPONSE; PERIPHERAL-BLOOD CELLS; GENE-EXPRESSION; INTERFERON-ALPHA; CEREBRAL MALARIA; IN-VITRO; T-CELLS; ACTIVATION; PARASITES	The protective immunity of natural killer (NK) cells against malarial infections is thought to be due to early production of type II interferon (IFN) and possibly direct NK cell cytotoxicity. To better understand this mechanism, a microarray analysis was conducted on NK cells from healthy donors PBMCs that were co-cultured with P. falciparum 3D7-infected erythrocytes. A very similar pattern of gene expression was observed among all donors for each treatment in three replicas. Parasites particularly modulated genes involved in IFN-alpha/beta signaling as well as molecules involved in the activation of interferon regulatory factors, pathways known to play a role in the antimicrobial immune response. This pattern of transcription was entirely different from that shown by NK cells treated with IL-12 and IL-18, in which IFN-gamma- and TREM-1-related genes were over-expressed. These results suggest that P. falciparum parasites and the cytokines IL-12 and IL-18 have diverse imprints on the transcriptome of human primary NK cells. IFN-alpha-related genes are the prominent molecules induced by parasites on NK cells and arise as candidate biomarkers that merit to be further investigated as potential new tools in malaria control.	[de Carvalho, Elisandra Grangeiro; Kremsner, Peter G.; Kun, Juergen F. J.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Bonin, Michael] Univ Tubingen, Inst Human Genet, Dept Med Genet, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	de Carvalho, EG (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	elisandragc@gmail.com						Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Baratin M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000228; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Buxbaum LU, 2010, PARASITE IMMUNOL, V32, P153, DOI 10.1111/j.1365-3024.2009.01167.x; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Kim CC, 2008, INFECT IMMUN, V76, P5873, DOI 10.1128/IAI.00640-08; Korbel DS, 2005, J IMMUNOL, V175, P7466, DOI 10.4049/jimmunol.175.11.7466; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Luty AJF, 2000, INFECT IMMUN, V68, P3909, DOI 10.1128/IAI.68.7.3909-3915.2000; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G; Mavoungou E, 2003, EUR CYTOKINE NETW, V14, P134; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; OJOAMAIZE EA, 1981, J IMMUNOL, V127, P2296; ORAGO ASS, 1991, CLIN EXP IMMUNOL, V86, P22, DOI 10.1111/j.1365-2249.1991.tb05768.x; Petri M, 2009, LUPUS, V18, P980, DOI 10.1177/0961203309105529; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; RONNBLOM L, 1983, PARASITE IMMUNOL, V5, P165, DOI 10.1111/j.1365-3024.1983.tb00734.x; SHARMA S, 2011, IMMUNITY; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Urban BC, 2005, CURR TOP MICROBIOL, V297, P25; Vigario AM, 2001, BLOOD, V97, P3966, DOI 10.1182/blood.V97.12.3966; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Weidanz WP, 2010, INFECT IMMUN, V78, P4331, DOI 10.1128/IAI.00539-10; Zhu JA, 2008, MOL THER, V16, P1300, DOI 10.1038/mt.2008.88; Zimmerer JM, 2008, CLIN CANCER RES, V14, P5900, DOI 10.1158/1078-0432.CCR-08-0846	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24963	10.1371/journal.pone.0024963	http://dx.doi.org/10.1371/journal.pone.0024963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949811	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800054
J	Elks, CM; Reed, SD; Mariappan, N; Shukitt-Hale, B; Joseph, JA; Ingram, DK; Francis, J				Elks, Carrie M.; Reed, Scott D.; Mariappan, Nithya; Shukitt-Hale, Barbara; Joseph, James A.; Ingram, Donald K.; Francis, Joseph			A Blueberry-Enriched Diet Attenuates Nephropathy in a Rat Model of Hypertension via Reduction in Oxidative Stress	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE; CARDIAC DYSFUNCTION; MITOCHONDRIAL; PRESSURE; EXTRACT; KIDNEY; DAMAGE; HEART	Objective and Background: To assess renoprotective effects of a blueberry-enriched diet in a rat model of hypertension. Oxidative stress (OS) appears to be involved in the development of hypertension and related renal injury. Pharmacological antioxidants can attenuate hypertension and hypertension-induced renal injury; however, attention has shifted recently to the therapeutic potential of natural products as antioxidants. Blueberries (BB) have among the highest antioxidant capacities of fruits and vegetables. Methods and Results: Male spontaneously hypertensive rats received a BB-enriched diet (2% w/w) or an isocaloric control diet for 6 or 12 weeks or 2 days. Compared to controls, rats fed BB-enriched diet for 6 or 12 weeks exhibited lower blood pressure, improved glomerular filtration rate, and decreased renovascular resistance. As measured by electron paramagnetic resonance spectroscopy, significant decreases in total reactive oxygen species (ROS), peroxynitrite, and superoxide production rates were observed in kidney tissues in rats on long-term dietary treatment, consistent with reduced pathology and improved function. Additionally, measures of antioxidant status improved; specifically, renal glutathione and catalase activities increased markedly. Contrasted to these observations indicating reduced OS in the BB group after long-term feeding, similar measurements made in rats fed the same diet for only 2 days yielded evidence of increased OS; specifically, significant increases in total ROS, peroxynitrite, and superoxide production rates in all tissues (kidney, brain, and liver) assayed in BB-fed rats. These results were evidence of "hormesis'' during brief exposure, which dissipated with time as indicated by enhanced levels of catalase in heart and liver of BB group. Conclusion: Long-term feeding of BB-enriched diet lowered blood pressure, preserved renal hemodynamics, and improved redox status in kidneys of hypertensive rats and concomitantly demonstrated the potential to delay or attenuate development of hypertension-induced renal injury, and these effects appear to be mediated by a short-term hormetic response.	[Elks, Carrie M.; Mariappan, Nithya; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA; [Reed, Scott D.] Louisiana State Univ Syst, Neurosignaling Lab, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Shukitt-Hale, Barbara; Joseph, James A.] Tufts Univ, USDA, Human Nutr Res Ctr Aging, Agr Res Serv, Boston, MA 02111 USA; [Elks, Carrie M.; Ingram, Donald K.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Nutr Neurosci & Aging Lab, Baton Rouge, LA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Tufts University; United States Department of Agriculture (USDA); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Elks, CM (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	donald.ingram@pbrc.edu; jfrancis@lsu.edu	Elks, Carrie Marie/N-1961-2017	Shukitt-Hale, Barbara/0000-0002-3810-1910	National Center for Complementary and Alternative Medicine (NCCAM) [2 P50AT002776]; Office of Dietary Supplements (ODS); National Heart, Lung, and Blood Institute [HL-80544-05]; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080544] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is funded by the National Institutes of Health Grant 2 P50AT002776 from the National Center for Complementary and Alternative Medicine (NCCAM) and by the Office of Dietary Supplements (ODS) pilot grant and National Heart, Lung, and Blood Institute grant HL-80544-05 to Dr. Joseph Francis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2009, HYPERTENSION, V54, P1393, DOI 10.1161/HYPERTENSIONAHA.109.135459; Ahmet I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007975; Ahmet I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005954; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Bickford PC, 2000, BRAIN RES, V866, P211, DOI 10.1016/S0006-8993(00)02280-0; Cardinale JP, 2010, HYPERTENSION, V56, P437, DOI 10.1161/HYPERTENSIONAHA.110.154567; Ebenezer PJ, 2009, OBESITY, V17, P1994, DOI 10.1038/oby.2009.137; Ebenezer PJ, 2009, LIFE SCI, V85, P357, DOI 10.1016/j.lfs.2009.06.019; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Goyarzu F, 2004, NUTR NEUROSCI, V7, P75, DOI 10.1080/10284150410001710410; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Joseph JA, 1999, J NEUROSCI, V19, P8114; Joseph JA, 2005, AM J CLIN NUTR, V81, p313S, DOI 10.1093/ajcn/81.1.313S; Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x; Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205; Ma XL, 2001, J PHARMACOL EXP THER, V298, P879; Majid DSA, 2007, CLIN EXP PHARMACOL P, V34, P946, DOI 10.1111/j.1440-1681.2007.04642.x; Malin DH, 2011, NUTRITION, V27, P338, DOI 10.1016/j.nut.2010.05.001; Manning RD, 2003, ACTA PHYSIOL SCAND, V179, P243, DOI 10.1046/j.0001-6772.2003.01204.x; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Shaughnessy KS, 2009, NUTR RES, V29, P130, DOI 10.1016/j.nutres.2009.01.001; Smith MAL, 2000, J FOOD SCI, V65, P352, DOI 10.1111/j.1365-2621.2000.tb16006.x; Spormann TM, 2008, CANCER EPIDEM BIOMAR, V17, P3372, DOI 10.1158/1055-9965.EPI-08-0364; Tian N, 2005, HYPERTENSION, V45, P934, DOI 10.1161/01.HYP.0000160404.08866.5a; Wang SY, 2000, J AGR FOOD CHEM, V48, P5677, DOI 10.1021/jf000766i; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005; Wilcox CS, 2001, EXP BIOL MED, V226, P619, DOI 10.1177/153537020222600702	35	73	76	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24028	10.1371/journal.pone.0024028	http://dx.doi.org/10.1371/journal.pone.0024028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949690	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700007
J	Liu, HN; Ohya, S; Nishizawa, Y; Sawamura, K; Iino, S; Syed, MM; Goto, K; Imaizumi, Y; Nakayama, S				Liu, Hong-Nian; Ohya, Susumu; Nishizawa, Yuji; Sawamura, Kenta; Iino, Satoshi; Syed, Mohsin Md; Goto, Kazunori; Imaizumi, Yuji; Nakayama, Shinsuke			Serotonin Augments Gut Pacemaker Activity via 5-HT3 Receptors	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IRRITABLE-BOWEL-SYNDROME; CAJAL-LIKE CELLS; INTERSTITIAL-CELLS; CA2+ ACTIVITY; C-KIT; WILD-TYPE; RYANODINE RECEPTORS; REQUIREMENT; ACTIVATION	Serotonin (5-hydroxytryptamine: 5-HT) affects numerous functions in the gut, such as secretion, muscle contraction, and enteric nervous activity, and therefore to clarify details of 5-HT's actions leads to good therapeutic strategies for gut functional disorders. The role of interstitial cells of Cajal (ICC), as pacemaker cells, has been recognised relatively recently. We thus investigated 5-HT actions on ICC pacemaker activity. Muscle preparations with myenteric plexus were isolated from the murine ileum. Spatio-temporal measurements of intracellular Ca2+ and electric activities in ICC were performed by employing fluorescent Ca2+ imaging and microelectrode array (MEA) systems, respectively. Dihydropyridine (DHP) Ca2+ antagonists and tetrodotoxin (TTX) were applied to suppress smooth muscle and nerve activities, respectively. 5-HT significantly enhanced spontaneous Ca2+ oscillations that are considered to underlie electric pacemaker activity in ICC. LY-278584, a 5-HT3 receptor antagonist suppressed spontaneous Ca2+ activity in ICC, while 2-methylserotonin (2-Me-5-HT), a 5-HT3 receptor agonist, restored it. GR113808, a selective antagonist for 5-HT4, and O-methyl-5-HT (O-Me-5-HT), a non-selective 5-HT receptor agonist lacking affinity for 5-HT3 receptors, had little effect on ICC Ca2+ activity. In MEA measurements of ICC electric activity, 5-HT and 2-Me-5-HT caused excitatory effects. RT-PCR and immunostaining confirmed expression of 5-HT3 receptors in ICC. The results indicate that 5-HT augments ICC pacemaker activity via 5-HT3 receptors. ICC appear to be a promising target for treatment of functional motility disorders of the gut, for example, irritable bowel syndrome.	[Liu, Hong-Nian; Sawamura, Kenta; Syed, Mohsin Md; Goto, Kazunori; Nakayama, Shinsuke] Nagoya Univ, Grad Sch Med, Dept Cell Physiol, Nagoya, Aichi 4648601, Japan; [Nishizawa, Yuji] Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Nagoya, Aichi 4648601, Japan; [Ohya, Susumu; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi, Japan; [Iino, Satoshi] Univ Fukui, Fac Med Sci, Dept Anat, Fukui 910, Japan	Nagoya University; Nagoya University; Nagoya City University; University of Fukui	Liu, HN (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Physiol, Nagoya, Aichi 4648601, Japan.	h44673a@nucc.cc.nagoya-u.ac.jp	Imaizumi, Yuji/AAF-6585-2020; Ohya, Susumu/AAB-3618-2020	Ohya, Susumu/0000-0002-5765-0667	Japan Society for the Promotion of Science; Japan Gut Club; Grants-in-Aid for Scientific Research [23136512, 21590098, 21590213, 23390020] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Gut Club; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, and a research grant from Japan Gut Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Boddy G, 2006, CAN J PHYSIOL PHARM, V84, P589, DOI 10.1139/Y06-009; Brading AF, 2005, NAT CLIN PRACT UROL, V2, P546, DOI 10.1038/ncpuro0340; BROCK JA, 1987, NATURE, V326, P605, DOI 10.1038/326605a0; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Camilleri M, 2001, NEUROGASTROENT MOTIL, V13, P277, DOI 10.1046/j.1365-2982.2001.00277.x; Camilleri M, 2007, GASTROENTEROLOGY, V132, P17, DOI 10.1053/j.gastro.2006.11.020; Crowell MD, 2007, EXPERT OPIN INV DRUG, V16, P761, DOI 10.1517/13543784.16.6.761; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; De Ponti F, 2004, GUT, V53, P1520, DOI 10.1136/gut.2003.035568; Du P, 2010, BIOPHYS J, V98, P1772, DOI 10.1016/j.bpj.2010.01.009; Fasching PA, 2008, J CANCER RES CLIN, V134, P1079, DOI 10.1007/s00432-008-0387-1; Faussone-Pellegrini MS, 1999, MICROSC RES TECHNIQ, V47, P248, DOI 10.1002/(SICI)1097-0029(19991115)47:4<248::AID-JEMT4>3.0.CO;2-W; Faville RA, 2008, BIOPHYS J, V95, P88, DOI 10.1529/biophysj.107.122507; Furness JB, 2006, ENTERIC NERVOUS SYSTEM, P1; Furuzono S, 2005, NEUROPHARMACOLOGY, V48, P264, DOI 10.1016/j.neuropharm.2004.10.007; Gan TJ, 2005, CNS DRUGS, V19, P225, DOI 10.2165/00023210-200519030-00004; Gershon MD, 1981, SMOOTH MUSCLE ASSESS, P263; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Goto K, 2004, J PHYSIOL-LONDON, V559, P411, DOI 10.1113/jphysiol.2004.063875; Huizinga JD, 2002, GASTROENTEROLOGY, V123, P1627, DOI 10.1053/gast.2002.36549; Huizinga JD, 1999, MICROSC RES TECHNIQ, V47, P239, DOI 10.1002/(SICI)1097-0029(19991115)47:4<239::AID-JEMT3>3.0.CO;2-0; Huizinga JD, 2005, J CELL MOL MED, V9, P468, DOI 10.1111/j.1582-4934.2005.tb00372.x; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iino S, 2004, J PHYSIOL-LONDON, V556, P521, DOI 10.1113/jphysiol.2003.058792; Iino S, 2007, ARCH HISTOL CYTOL, V70, P163, DOI 10.1679/aohc.70.163; Johanson JF, 2004, NEUROGASTROENT MOTIL, V16, P701, DOI 10.1111/j.1365-2982.2004.00550.x; Jordan K, 2005, EUR J CANCER, V41, P199, DOI 10.1016/j.ejca.2004.09.026; Kajioka S, 2005, AM J PHYSIOL-CELL PH, V288, pC100, DOI 10.1152/ajpcell.00161.2004; Kim YC, 2002, J PHYSIOL-LONDON, V541, P797, DOI 10.1113/jphysiol.2002.018796; Lang RJ, 2007, J PHYSIOL-LONDON, V583, P1049, DOI 10.1113/jphysiol.2007.137034; Lavoie B, 2007, J PHYSIOL-LONDON, V579, P487, DOI 10.1113/jphysiol.2006.122861; Liu HN, 2005, J BIOL RHYTHM, V20, P15, DOI 10.1177/0748730404269572; Liu M, 2005, AM J PHYSIOL-GASTR L, V289, pG1148, DOI 10.1152/ajpgi.00245.2005; MAEDA H, 1992, DEVELOPMENT, V116, P369; Matsuyoshi H, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01474.x; McCloskey KD, 2002, CELL TISSUE RES, V310, P77, DOI 10.1007/s00441-002-0623-y; Nakagawa T, 2005, AUTON NEUROSCI-BASIC, V119, P25, DOI 10.1016/j.autneu.2005.02.006; Nakayama S, 2005, J CELL SCI, V118, P4163, DOI 10.1242/jcs.02540; Nakayama S, 2002, JPN J PHYSIOL, V52, P217, DOI 10.2170/jjphysiol.52.217; Nakayama S, 2007, J CELL MOL MED, V11, P958, DOI 10.1111/j.1582-4934.2007.00107.x; Nakayama S, 2006, J PHYSIOL-LONDON, V576, P727, DOI 10.1113/jphysiol.2006.118893; Nakayama S, 2011, BIOSENS BIOELECTRON, V27, P34, DOI 10.1016/j.bios.2011.05.041; Nakayama S, 2009, BIOSENS BIOELECTRON, V25, P61, DOI 10.1016/j.bios.2009.06.006; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Niesler B, 2007, MOL PHARMACOL, V72, P8, DOI 10.1124/mol.106.032144; Ohya S, 2002, AM J PHYSIOL-GASTR L, V282, pG277, DOI 10.1152/ajpgi.00200.2001; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Sanders KM, 1999, NEUROGASTROENT MOTIL, V11, P311; Shimono K, 2000, J NEUROSCI, V20, P8462, DOI 10.1523/JNEUROSCI.20-22-08462.2000; Sperelakis N, 2004, AM J PHYSIOL-GASTR L, V286, pG234, DOI 10.1152/ajpgi.00301.2003; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; Takaki Miyako, 2003, Journal of Smooth Muscle Research, V39, P137, DOI 10.1540/jsmr.39.137; Takaki M, 2011, BIOCHEM BIOPH RES CO, V406, P529, DOI 10.1016/j.bbrc.2011.02.072; Takaki M, 2010, PROG BIOPHYS MOL BIO, V102, P129, DOI 10.1016/j.pbiomolbio.2010.05.007; Tharayil VS, 2010, NEUROGASTROENT MOTIL, V22, P462, DOI 10.1111/j.1365-2982.2009.01435.x; Tokutomi N, 1995, PFLUG ARCH EUR J PHY, V431, P169, DOI 10.1007/BF00410188; Torihashi S, 2002, J BIOL CHEM, V277, P19191, DOI 10.1074/jbc.M201728200; Tsuchida Y, 2011, GUT, V60, P638, DOI 10.1136/gut.2010.227546; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; van Helden DF, 2010, CLIN EXP PHARMACOL P, V37, P516, DOI 10.1111/j.1440-1681.2009.05331.x; Walker RL, 2002, AM J PHYSIOL-CELL PH, V283, pC1637, DOI 10.1152/ajpcell.00266.2002; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Wood JD, 2006, PHYSL GASTROINTESTIN, V2, P665; Wouters MM, 2007, GASTROENTEROLOGY, V133, P897, DOI 10.1053/j.gastro.2007.06.017; Yamazawa T, 2002, J PHYSIOL-LONDON, V538, P823, DOI 10.1113/jphysiol.2001.013045; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	71	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24928	10.1371/journal.pone.0024928	http://dx.doi.org/10.1371/journal.pone.0024928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949791	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700077
J	Primo, ME; Jakoncic, J; Noguera, ME; Risso, VA; Sosa, L; Sica, MP; Solimena, M; Poskus, E; Ermacora, MR				Primo, Maria E.; Jakoncic, Jean; Noguera, Martin E.; Risso, Valeria A.; Sosa, Laura; Sica, Mauricio P.; Solimena, Michele; Poskus, Edgardo; Ermacora, Mario R.			Protein-Protein Interactions in Crystals of the Human Receptor-Type Protein Tyrosine Phosphatase ICA512 Ectodomain	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; MOLECULAR-DYNAMICS; IA-2; IA-2-BETA; ALPHA; AUTOANTIGEN; INHIBITION; ACTIVATION; EXPRESSION; LINKAGE	ICA512 (or IA-2) is a transmembrane protein-tyrosine phosphatase located in secretory granules of neuroendocrine cells. Initially, it was identified as one of the main antigens of autoimmune diabetes. Later, it was found that during insulin secretion, the cytoplasmic domain of ICA512 is cleaved and relocated to the nucleus, where it stimulates the transcription of the insulin gene. The role of the other parts of the receptor in insulin secretion is yet to be unveiled. The structures of the intracellular pseudocatalytic and mature extracellular domains are known, but the transmembrane domain and several intracellular and extracellular parts of the receptor are poorly characterized. Moreover the overall structure of the receptor remains to be established. We started to address this issue studying by X-ray crystallography the structure of the mature ectodomain of ICA512 (ME ICA512) and variants thereof. The variants and crystallization conditions were chosen with the purpose of exploring putative association interfaces, metal binding sites and all other structural details that might help, in subsequent works, to build a model of the entire receptor. Several structural features were clarified and three main different association modes of ME ICA512 were identified. The results provide essential pieces of information for the design of new experiments aimed to assess the structure in vivo.	[Primo, Maria E.; Noguera, Martin E.; Risso, Valeria A.; Sosa, Laura; Sica, Mauricio P.; Poskus, Edgardo; Ermacora, Mario R.] Consejo Nacl Invest Cient & Tecn Conicet, Buenos Aires, DF, Argentina; [Primo, Maria E.; Sosa, Laura; Poskus, Edgardo] Fac Farm & Bioquim, Catedra Inmunol, Idehu, Argentina; [Primo, Maria E.; Sosa, Laura; Poskus, Edgardo] Univ Buenos Aires, CONICET, Div Endocrinol, Hosp Clin J de San Martin, Buenos Aires, DF, Argentina; [Jakoncic, Jean] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA; [Noguera, Martin E.; Risso, Valeria A.; Sica, Mauricio P.; Ermacora, Mario R.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; [Solimena, Michele] Univ Technol Dresden, Paul Langerhans Inst Dresden, Univ Klinikum Carl Gustav Carus, Dresden, Germany; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet Dresden, Dresden, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; United States Department of Energy (DOE); Brookhaven National Laboratory; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society	Primo, ME (corresponding author), Consejo Nacl Invest Cient & Tecn Conicet, Buenos Aires, DF, Argentina.	ermacora@unq.edu.ar	Solimena, Michele/E-1275-2011; Risso, Valeria/H-2921-2015; Solimena, Michele/GVS-5990-2022	Risso, Valeria/0000-0001-8262-8843; Primo, Maria Evangelina/0000-0002-6873-8867; Ermacora, Mario/0000-0002-1754-4202	Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina [PIP-GI 11220090100044]; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT) [PICT-2010-0580]; Universidad Nacional de Quilmes (UNQ) [53/1002]; DFG (Germany-Argentina) [N. 444ARG113/9/1-0]; DFG [SFB 655]	Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT)(ANPCyT); Universidad Nacional de Quilmes (UNQ); DFG (Germany-Argentina)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was financially supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (Conicet; PIP-GI 11220090100044), the Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (ANPCyT; PICT-2010-0580), the Universidad Nacional de Quilmes (UNQ; 53/1002), the DFG Research Exchange Program Germany-Argentina N. 444ARG113/9/1-0, and the DFG-SFB 655, project A7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; Chin CN, 2005, FEBS LETT, V579, P3855, DOI 10.1016/j.febslet.2005.05.071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kubosaki A, 2006, ENDOCRINOLOGY, V147, P811, DOI 10.1210/en.2005-0638; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Primo ME, 2008, J BIOL CHEM, V283, P4674, DOI 10.1074/jbc.M708144200; Primo ME, 2006, BBA-PROTEINS PROTEOM, V1764, P174, DOI 10.1016/j.bbapap.2005.11.014; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Suckalel J, 2010, TRENDS ENDOCRIN MET, V21, P599, DOI 10.1016/j.tem.2010.06.003; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	28	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24191	10.1371/journal.pone.0024191	http://dx.doi.org/10.1371/journal.pone.0024191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935384	gold, Green Submitted, Green Published			2022-12-25	WOS:000295041700015
J	Tedersoo, L; Abarenkov, K; Nilsson, RH; Schussler, A; Grelet, GA; Kohout, P; Oja, J; Bonito, GM; Veldre, V; Jairus, T; Ryberg, M; Larsson, KH; Koljalg, U				Tedersoo, Leho; Abarenkov, Kessy; Nilsson, R. Henrik; Schuessler, Arthur; Grelet, Gwen-Aelle; Kohout, Petr; Oja, Jane; Bonito, Gregory M.; Veldre, Vilmar; Jairus, Teele; Ryberg, Martin; Larsson, Karl-Henrik; Koeljalg, Urmas			Tidying Up International Nucleotide Sequence Databases: Ecological, Geographical and Sequence Quality Annotation of ITS Sequences of Mycorrhizal Fungi	PLOS ONE			English	Article							DIVERSITY; PATTERNS; GENBANK; ASSOCIATIONS; EXPLORATION; PROPOSAL; PLANTS	Sequence analysis of the ribosomal RNA operon, particularly the internal transcribed spacer (ITS) region, provides a powerful tool for identification of mycorrhizal fungi. The sequence data deposited in the International Nucleotide Sequence Databases (INSD) are, however, unfiltered for quality and are often poorly annotated with metadata. To detect chimeric and low-quality sequences and assign the ectomycorrhizal fungi to phylogenetic lineages, fungal ITS sequences were downloaded from INSD, aligned within family-level groups, and examined through phylogenetic analyses and BLAST searches. By combining the fungal sequence database UNITE and the annotation and search tool PlutoF, we also added metadata from the literature to these accessions. Altogether 35,632 sequences belonged to mycorrhizal fungi or originated from ericoid and orchid mycorrhizal roots. Of these sequences, 677 were considered chimeric and 2,174 of low read quality. Information detailing country of collection, geographical coordinates, interacting taxon and isolation source were supplemented to cover 78.0%, 33.0%, 41.7% and 96.4% of the sequences, respectively. These annotated sequences are publicly available via UNITE (http://unite.ut.ee/) for downstream biogeographic, ecological and taxonomic analyses. In European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/), the annotated sequences have a special link-out to UNITE. We intend to expand the data annotation to additional genes and all taxonomic groups and functional guilds of fungi.	[Tedersoo, Leho; Abarenkov, Kessy; Nilsson, R. Henrik; Oja, Jane; Veldre, Vilmar; Jairus, Teele; Koeljalg, Urmas] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Tedersoo, Leho] Univ Tartu, Nat Hist Museum, EE-50090 Tartu, Estonia; [Nilsson, R. Henrik] Univ Gothenburg, Dept Plant & Environm Sci, Gothenburg, Sweden; [Schuessler, Arthur] Univ Munich, Dept Biol 1, Munich, Germany; [Grelet, Gwen-Aelle] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Grelet, Gwen-Aelle] Landcare Res Manaaki Whenua, Lincoln, New Zealand; [Kohout, Petr] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Kohout, Petr] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Bonito, Gregory M.] Duke Univ, Dept Biol, Durham, NC USA; [Ryberg, Martin] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Larsson, Karl-Henrik] Univ Oslo, Nat Hist Museum, Oslo, Norway	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; University of Gothenburg; University of Munich; University of Aberdeen; Landcare Research - New Zealand; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Duke University; University of Tennessee System; University of Tennessee Knoxville; University of Oslo	Tedersoo, L (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	leho.tedersoo@ut.ee	Kohout, Petr/B-4975-2011; Ryberg, Martin/AHA-1804-2022; Kõljalg, Urmas/H-6925-2015; Tedersoo, Leho/H-3541-2012; Tedersoo, Leho/ABE-7452-2020; Kõljalg, Urmas/AAM-7828-2020; Schüßler, Arthur/F-1681-2011; Abarenkov, Kessy/H-9611-2015; Nilsson, R. Henrik/A-6062-2009	Kohout, Petr/0000-0002-3985-2310; Ryberg, Martin/0000-0002-6795-4349; Kõljalg, Urmas/0000-0002-5171-1668; Abarenkov, Kessy/0000-0001-5526-4845; Nilsson, R. Henrik/0000-0002-8052-0107	Frontiers In Biodiversity Research; ESF [7434, 8235, JD-92]; Marie Curie fellowship [IOF-GA-2010-252446]; Academy of Science of the Czech Republic [AV0Z60050516]; National Science Foundation (USA) [DEB-0949517]; Swedish Research Council [825-2009-6068]	Frontiers In Biodiversity Research; ESF(European Commission); Marie Curie fellowship(European Commission); Academy of Science of the Czech Republic(Czech Academy of Sciences); National Science Foundation (USA)(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work received support from Frontiers In Biodiversity Research and ESF grants (7434, 8235, JD-92) to UK and LT; Marie Curie fellowship (IOF-GA-2010-252446) to GG; the Academy of Science of the Czech Republic (AV0Z60050516) to PK; National Science Foundation (USA; DEB-0949517) to MR; and the Swedish Research Council (825-2009-6068) to K-HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; Agerer R, 2006, MYCOL PROG, V5, P67, DOI 10.1007/s11557-006-0505-x; Allen TR, 2003, NEW PHYTOL, V160, P255, DOI 10.1046/j.1469-8137.2003.00885.x; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hughes KW, 2009, NEW PHYTOL, V182, P795, DOI 10.1111/j.1469-8137.2009.02802.x; Huynh TT, 2009, ANN BOT-LONDON, V104, P757, DOI 10.1093/aob/mcp153; Kottke I, 2010, P ROY SOC B-BIOL SCI, V277, P1289, DOI 10.1098/rspb.2009.1884; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Lilleskov EA, 2007, NEW PHYTOL, V174, P250, DOI 10.1111/j.1469-8137.2007.02023.x; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MOORE RT, 1978, MYCOLOGIA, V70, P1007, DOI 10.2307/3759134; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Park B, 2011, NUCLEIC ACIDS RES, V39, pD640, DOI 10.1093/nar/gkq1166; Pennisi E, 2008, SCIENCE, V319, P1598, DOI 10.1126/science.319.5870.1598; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Ryberg M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-50; Schussler A., 2010, GLOMEROMYCOTA SPECIE; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Taylor Andy F. S., 2008, Coolia, V51, P197; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Walker JF, 2011, NEW PHYTOL, V191, P515, DOI 10.1111/j.1469-8137.2011.03703.x; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	44	45	48	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24940	10.1371/journal.pone.0024940	http://dx.doi.org/10.1371/journal.pone.0024940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949797	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700079
J	Jewkes, R; Sikweyiya, Y; Morrell, R; Dunkle, K				Jewkes, Rachel; Sikweyiya, Yandisa; Morrell, Robert; Dunkle, Kristin			The Relationship between Intimate Partner Violence, Rape and HIV amongst South African Men: A Cross-Sectional Study	PLOS ONE			English	Article							RELATIONSHIP POWER; RISK; INFECTION; SEXUALITY; BEHAVIOR; GENDER; YOUNG; CAPE	Objective: To investigate the associations between intimate partner violence, rape and HIV among South African men. Design: Cross-sectional study involving a randomly-selected sample of men. Methods: We tested hypotheses that perpetration of physical intimate partner violence and rape were associated with prevalent HIV infections in a cross-sectional household study of 1229 South African men aged 18-49. Violence perpetration was elicited in response to a questionnaire administered using an Audio-enhanced Personal Digital Assistant and blood samples were tested for HIV. A multivariable logistic regression model was built to identify factors associated with HIV. Results: 18.3% of men had HIV. 29.6% (358/1211) of men disclosed rape perpetration, 5.2% (63/1208) rape in the past year and 30.7% (362/1180) of had been physically violent towards an intimate partner more than once. Overall rape perpetration was not associated with HIV. The model of factors associated with having HIV showed men under 25 years who had been physically violent towards partners were more likely to have HIV than men under 25 who had not (aOR 2.08 95% CI 1.07-4.06, p = 0.03). We failed to detect any association in older men. Conclusions: Perpetration of physical IPV is associated with HIV sero-prevalence in young men, after adjusting for other risk factors. This contributes to our understanding of why women who experience violence have a higher HIV prevalence. Rape perpetration was not associated, but the HIV prevalence among men who had raped was very high. HIV prevention in young men must seek to change ideals of masculinity in which male partner violence is rooted.	[Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Jewkes, Rachel; Sikweyiya, Yandisa] Univ Witwatersrand, Gender & Hlth Res Unit, MRC, Pretoria, South Africa; [Morrell, Robert] Univ Cape Town, Res Off, ZA-7925 Cape Town, South Africa; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of Witwatersrand; University of Witwatersrand; University of Cape Town; Emory University; Rollins School Public Health	Jewkes, R (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	rjewkes@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Morrell, Robert/0000-0002-6096-486X; Jewkes, Rachel/0000-0002-4330-6267	UK Department For International Development (DFID); National Research Foundation	UK Department For International Development (DFID); National Research Foundation	This work was supported by UK Department For International Development (DFID). The grant was managed by their local partner Human Life Sciences Partnership (HLSP). Dr. Morrell participated in the project with funding from the National Research Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2004, B WORLD HEALTH ORGAN, V82, P330; Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Bourgois P, 1996, BRIT J CRIMINOL, V36, P412; Decker MR, 2009, SEX TRANSM INFECT, V85, P555, DOI 10.1136/sti.2009.036368; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Department of Health, 2004, S AFR DEM HLTH SURV; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; El-Bassel N, 2001, J SUBST ABUSE, V13, P29, DOI 10.1016/S0899-3289(01)00068-2; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1455, DOI 10.1093/ije/dyl217; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kim JC, 2003, REPROD HEALTH MATTER, V11, P101, DOI 10.1016/S0968-8080(03)02285-7; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; SHISANA O, 2009, NATL HIV PREVALENCE; Sikweyiya Y, 2007, AGENDA, V74, P48; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; UNAIDS, 2009, JOINT ACT RES UNAIDS; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wood K., 2001, CHANGING MEN SO AFRI, P317; World Health Organization, 2000, WHO MULTICOUNTRY STU	25	90	92	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24256	10.1371/journal.pone.0024256	http://dx.doi.org/10.1371/journal.pone.0024256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822JC	21935392	gold, Green Published			2022-12-25	WOS:000295039700016
J	Montoya-Burgos, JI				Montoya-Burgos, Juan I.			Patterns of Positive Selection and Neutral Evolution in the Protein-Coding Genes of Tetraodon and Takifugu	PLOS ONE			English	Article							FALSE DISCOVERY RATE; GENOME DUPLICATION; FISH; RATES; DIVERSIFICATION; REPERTOIRE; SPECIATION; CHIMPANZEE; MUTATIONS; SEQUENCE	Recent genome-wide analyses have revealed patterns of positive selection acting on protein-coding genes in humans and mammals. To assess whether the conclusions drawn from these analyses are valid for other vertebrates and to identify mammalian specificities, I have investigated the selective pressure acting on protein-coding genes of the puffer fishes Tetraodon and Takifugu. My results indicate that the strength of purifying selection in puffer fishes is similar to previous reports for murids but stronger in hominids, which have a smaller population size. Gene ontology analyses show that more than half of the biological processes targeted by positive selection in mammals are also targeted in puffer fishes, highlighting general patterns for vertebrates. Biological processes enriched with positively selected genes that are shared between mammals and fishes include immune and defense responses, signal transduction, regulation of transcription and several of their descendent terms. Mammalian-specific processes displaying an excess of positively selected genes are related to sensory perception and neurological processes. The comparative analyses also revealed that, for both mammals and fishes, genes encoding extracellular proteins are preferentially targeted by positive selection, indicating that adaptive evolution occurs more often in the extra-cellular environment rather than inside the cell. Moreover, I present here the first genome-wide characterization of neutrally-evolving regions of protein-coding genes. This analysis revealed an unexpectedly high proportion of genes containing both positively selected motifs and neutrally-evolving regions, uncovering a strong link between neutral evolution and positive selection. I speculate that neutrally-evolving regions are a major source of novelties screened by natural selection.	Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	University of Geneva	Montoya-Burgos, JI (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	Juan.Montoya@unige.ch		Montoya-Burgos, Juan I./0000-0001-9080-9820	Canton de Geneve; Claraz Foundation; Swiss National Science Foundation [31003A-122303]	Canton de Geneve; Claraz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by funds from the Canton de Geneve; the Claraz Foundation; and the Swiss National Science Foundation (31003A-122303 to JIMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Arbiza L, 2006, PLOS COMPUT BIOL, V2, P288, DOI 10.1371/journal.pcbi.0020038; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Brcic-Kostic K, 2005, GENET RES, V86, P53, DOI 10.1017/S0016672305007688; Carr W.E.S., 1988, P3; Christoffels A, 2006, COMP BIOCHEM PHYS D, V1, P13, DOI 10.1016/j.cbd.2005.06.001; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; CrnogoracJurcevic T, 1997, GENOMICS, V41, P177, DOI 10.1006/geno.1997.4646; da Fonseca RR, 2010, FEBS LETT, V584, P469, DOI 10.1016/j.febslet.2009.12.022; Derby CD, 2008, J CHEM ECOL, V34, P898, DOI 10.1007/s10886-008-9489-0; Ding K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001098; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Fraser HB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-13; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Liu J, 2010, PLOS ONE, V5; Luo F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S4-S8; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nickel GC, 2008, NUCLEIC ACIDS RES, V36, pD800, DOI 10.1093/nar/gkm764; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Trezise AEO, 2005, CURR BIOL, V15, pR794, DOI 10.1016/j.cub.2005.09.025; Wang DP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-20; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Young JM, 2005, GENOME RES, V15, P231, DOI 10.1101/gr.3339905; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang LQ, 2005, MOL BIOL EVOL, V22, P2504, DOI 10.1093/molbev/msi240; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang Z, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-44; ZHENG Q, 2008, NUCLEIC ACIDS RES, V36, DOI DOI 10.1093/NAR/GKN1276	59	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24800	10.1371/journal.pone.0024800	http://dx.doi.org/10.1371/journal.pone.0024800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21935469	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800066
J	Kim, J; Reed, JL; Maravelias, CT				Kim, Joonhoon; Reed, Jennifer L.; Maravelias, Christos T.			Large-Scale Bi-Level Strain Design Approaches and Mixed-Integer Programming Solution Techniques	PLOS ONE			English	Article							ESCHERICHIA-COLI; METABOLIC MODELS; TRANSCRIPTIONAL REGULATION; FRAMEWORK; SYSTEMS; OPTIMIZATION; STRATEGIES; NETWORKS; PATHWAYS; RECONSTRUCTION	The use of computational models in metabolic engineering has been increasing as more genome-scale metabolic models and computational approaches become available. Various computational approaches have been developed to predict how genetic perturbations affect metabolic behavior at a systems level, and have been successfully used to engineer microbial strains with improved primary or secondary metabolite production. However, identification of metabolic engineering strategies involving a large number of perturbations is currently limited by computational resources due to the size of genome-scale models and the combinatorial nature of the problem. In this study, we present (i) two new bi-level strain design approaches using mixed-integer programming (MIP), and (ii) general solution techniques that improve the performance of MIP-based bi-level approaches. The first approach (SimOptStrain) simultaneously considers gene deletion and non-native reaction addition, while the second approach (BiMOMA) uses minimization of metabolic adjustment to predict knockout behavior in a MIP-based bi-level problem for the first time. Our general MIP solution techniques significantly reduced the CPU times needed to find optimal strategies when applied to an existing strain design approach (OptORF) (e.g., from,10 days to,5 minutes for metabolic engineering strategies with 4 gene deletions), and identified strategies for producing compounds where previous studies could not (e.g., malate and serine). Additionally, we found novel strategies using SimOptStrain with higher predicted production levels (for succinate and glycerol) than could have been found using an existing approach that considers network additions and deletions in sequential steps rather than simultaneously. Finally, using BiMOMA we found novel strategies involving large numbers of modifications (for pyruvate and glutamate), which sequential search and genetic algorithms were unable to find. The approaches and solution techniques developed here will facilitate the strain design process and extend the scope of its application to metabolic engineering.	[Kim, Joonhoon; Reed, Jennifer L.; Maravelias, Christos T.] Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Kim, Joonhoon; Reed, Jennifer L.; Maravelias, Christos T.] Univ Wisconsin Madison, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Kim, J (corresponding author), Univ Wisconsin Madison, Dept Chem & Biol Engn, Madison, WI 53706 USA.	reed@engr.wisc.edu; christos@engr.wisc.edu	Reed, Jennifer L/E-5137-2011; Kim, Joonhoon/E-6253-2012; Maravelias, Christos/B-1376-2009	Reed, Jennifer L/0000-0001-7854-6220; Kim, Joonhoon/0000-0002-7425-1828; Maravelias, Christos/0000-0002-4929-1748	United States Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]	United States Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science)	This work was funded by the United States Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bard J. F, 2013, PRACTICAL BILEVEL OP, V30; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2003, BIOTECHNOL BIOENG, V82, P670, DOI 10.1002/bit.10617; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Ferris M., 2007, LINEAR PROGRAMMING M; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Gagneur J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-175; Gianchandani EP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-43; Hadicke O, 2011, METAB ENG, V13, P204, DOI 10.1016/j.ymben.2010.12.004; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Herrgard MJ, 2006, PLOS COMPUT BIOL, V2, P676, DOI 10.1371/journal.pcbi.0020072; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/207414; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rocha I, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-45; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Thiele I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.15; Trinh CT, 2008, APPL ENVIRON MICROB, V74, P3634, DOI 10.1128/AEM.02708-07; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Unrean P, 2010, METAB ENG, V12, P112, DOI 10.1016/j.ymben.2009.11.002; Yang L, 2011, METAB ENG, V13, P272, DOI 10.1016/j.ymben.2011.03.002; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; [No title captured], DOI DOI 10.1142/S0218339094000131	51	41	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24162	10.1371/journal.pone.0024162	http://dx.doi.org/10.1371/journal.pone.0024162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21949695	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803100013
J	Borjesson, SI; Englund, UH; Asif, MH; Willander, M; Elinder, F				Borjesson, Sara I.; Englund, Ulrika H.; Asif, Muhammad H.; Willander, Magnus; Elinder, Fredrik			Intracellular K+ Concentration Decrease Is Not Obligatory for Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION CHANNELS VDAC; CELL-DEATH; NEURONAL APOPTOSIS; CASPASE ACTIVATION; VOLUME DECREASE; ION CHANNELS; FLUXES; CONFORMATIONS; CYTOSKELETON	K+ efflux is observed as an early event in the apoptotic process in various cell types. Loss of intracellular K+ and subsequent reduction in ionic strength are suggested to release the inhibition of proapoptotic caspases. In this work, a new K+-specific microelectrode was used to study possible alterations in intracellular K+ in Xenopus laevis oocytes during chemically induced apoptosis. The accuracy of the microelectrode to detect changes in intracellular K+ was verified with parallel electrophysiological measurements. In concordance with previous studies on other cell types, apoptotic stimuli reduced the intracellular K+ concentration in Xenopus oocytes and increased caspase-3 activity. The reduction in intracellular K+ was prevented by dense expression of voltage-gated K (Kv) channels. Despite this, the caspase-3 activity was increased similarly in Kv channel-expressing oocytes as in oocytes not expressing Kv channels. Thus, in Xenopus oocytes caspase-3 activity is not dependent on the intracellular concentration of K+	[Borjesson, Sara I.; Englund, Ulrika H.; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, SE-58185 Linkoping, Sweden; [Asif, Muhammad H.; Willander, Magnus] Linkoping Univ, Dept Sci & Technol, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Elinder, F (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Campus Norrkoping, SE-58185 Linkoping, Sweden.	fredrik.elinder@liu.se	Liin, Sara/I-2941-2012	Elinder, Fredrik/0000-0001-9125-5583; Liin, Sara/0000-0001-8493-0114	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Brain Foundation; County Council of Ostergotland, King Gustaf V and Queen Victoria's Freemasons Foundation; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; County Council of Ostergotland, King Gustaf V and Queen Victoria's Freemasons Foundation; Swedish Society for Medical Research	This work was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Brain Foundation, the County Council of Ostergotland, King Gustaf V and Queen Victoria's Freemasons Foundation, and the Swedish Society for Medical Research.	Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Ali S. M. U., 2010, NANOTECHNOLOGY IEEE, V10, P913; Arrebola F, 2005, APOPTOSIS, V10, P1317, DOI 10.1007/s10495-005-2718-x; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; BARBIERO G, 1995, EXP CELL RES, V217, P410, DOI 10.1006/excr.1995.1104; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Bortner CD, 2008, J BIOL CHEM, V283, P7219, DOI 10.1074/jbc.M707809200; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Colina C, 2002, BIOCHEM J, V362, P247, DOI 10.1042/0264-6021:3620247; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; Hernandez-Enriquez B, 2010, NEUROSCIENCE, V167, P298, DOI 10.1016/j.neuroscience.2010.01.046; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Johnson CE, 2010, CELL DEATH DIFFER, V17, P170, DOI 10.1038/cdd.2009.120; Krumschnabel G, 2007, APOPTOSIS, V12, P1755, DOI 10.1007/s10495-007-0103-7; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; O'Reilly N, 2002, BRAIN RES, V943, P245, DOI 10.1016/S0006-8993(02)02655-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Small DL, 2002, NEUROSCI LETT, V334, P95, DOI 10.1016/S0304-3940(02)01107-2; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vanagas L, 2007, BBA-BIOMEMBRANES, V1768, P1641, DOI 10.1016/j.bbamem.2007.03.012; Wang L, 1999, J BIOL CHEM, V274, P3678, DOI 10.1074/jbc.274.6.3678; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yurinskaya VE, 2011, J PHYSIOL-LONDON, V589, P2197, DOI 10.1113/jphysiol.2011.207571	33	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39823	39828		10.1074/jbc.M111.262725	http://dx.doi.org/10.1074/jbc.M111.262725			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949184	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000296925700016
J	Huang, SB; Yang, ZNJ; Yu, CR; Sinicrope, FA				Huang, Shengbing; Yang, Zhineng J.; Yu, Chunrong; Sinicrope, Frank A.			Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy-induced Cell Death through Autophagy Induction and Down-regulation of p62/Sequestosome 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER CELLS; MAMMALIAN TARGET; COLORECTAL-CANCER; APOPTOSIS; PHOSPHORYLATION; ACTIVATION; GROWTH; TUMORIGENESIS; DEGRADATION; CASPASE-8	AZD8055 is an ATP-competitive inhibitor of mammalian target of rapamycin (mTOR) that forms two multiprotein complexes, mTORC1 and mTORC2, and negatively regulates autophagy. We demonstrate that AZD8055 stimulates and potentiates chemotherapy-mediated autophagy, as shown by LC3I-II conversion and down-regulation of the ubiquitin-binding protein p62/sequestosome 1. AZD8055-induced autophagy was pro-survival as shown by its ability to attenuate cell death and DNA damage (p-H2AX), and to enhance clonogenic survival by cytotoxic chemotherapy. Autophagy inhibition by siRNA against Beclin 1 or LC3B, or by chloroquine, partially reversed the cytoprotective effect of AZD8055 that was independent of cell cycle inhibition. The pro-survival role of autophagy was confirmed using ectopic expression of Beclin 1 that conferred cytoprotection. To determine whether autophagy-mediated down-regulation of p62/sequestosome 1 contributes to its pro-survival role, we generated p62 knockdown cells using shRNA that showed protection from chemotherapy-induced cell death and DNA damage. We also overexpressed wild-type (wt) p62 that promoted chemotherapy-induced cell death, whereas mutated p62 at functional domains (PB1, UBA) failed to do so. The ability of ectopic wt p62 to promote cell death was blocked by AZD8055. AZD8055 was shown to inhibit phosphorylation of the autophagy-initiating kinase ULK1 at Ser(757) and inhibited known targets of mTORC1 (p-mTOR Ser(2448), p70S6K, p-S6, p4EBP1) and mTORC2 (p-mTOR Ser(2481), p-AKT Ser(473)). Knockdown of mTOR, but not Raptor or Rictor, reduced p-ULK1 at Ser(757) and enhanced chemotherapy-induced autophagy that resulted in a similar cytoprotective effect as shown for AZD8055. In conclusion, AZD8055 inhibits mTOR kinase and ULK1 phosphorylation to induce autophagy whose pro-survival effect is due, in part, to down-regulation of p62.	[Sinicrope, Frank A.] Mayo Clin, Rochester, MN 55905 USA; Mayo Canc Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sinicrope, FA (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu			NCI, National Institutes of Health [1 K05 CA142885-01]; Mayo Cancer Center [CA15083]; NATIONAL CANCER INSTITUTE [P30CA015083, K05CA142885] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant 1 K05 CA142885-01 (Senior Scientist Award, to F. A. S.), and the Mayo Cancer Center core Grant CA15083.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Long XM, 2007, J BIOL CHEM, V282, P18542, DOI 10.1074/jbc.M610736200; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sudarsanam S, 2010, CURR OPIN DRUG DISC, V13, P31; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wilkes Gail, 2003, Clin J Oncol Nurs, V7, P353	41	56	58	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40002	40012		10.1074/jbc.M111.297432	http://dx.doi.org/10.1074/jbc.M111.297432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949121	hybrid, Green Published			2022-12-25	WOS:000296925700033
J	Karkusiewicz, I; Turowski, TW; Graczyk, D; Towpik, J; Dhungel, N; Hopper, AK; Boguta, M				Karkusiewicz, Iwona; Turowski, Tomasz W.; Graczyk, Damian; Towpik, Joanna; Dhungel, Nripesh; Hopper, Anita K.; Boguta, Magdalena			Maf1 Protein, Repressor of RNA Polymerase III, Indirectly Affects tRNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; DIVERSE SIGNALS; GLOBAL ANALYSIS; RIBOSOMAL-RNA; TRANSCRIPTION; GENE; LOCALIZATION; SUBUNIT	Maf1 is negative regulator of RNA polymerase III in yeast. We observed high levels of both primary transcript and end-matured, intron-containing pre-tRNAs in the maf1 Delta strain. This pre-tRNA accumulation could be overcome by transcription inhibition, arguing against a direct role of Maf1 in tRNA maturation and suggesting saturation of processing machinery by the increased amounts of primary transcripts. Saturation of the tRNA exportin, Los1, is one reason why end-matured introncontaining pre-tRNAs accumulate in maf1 Delta cells. However, it is likely possible that other components of the processing pathway are also limiting when tRNA transcription is increased. According to our model, Maf1-mediated transcription control and nuclear export by Los1 are two major stages of tRNA biosynthesis that are regulated by environmental conditions in a coordinated manner.	[Karkusiewicz, Iwona; Graczyk, Damian; Towpik, Joanna; Boguta, Magdalena] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Turowski, Tomasz W.; Boguta, Magdalena] Warsaw Univ Technol, Fac Chem, PL-00664 Warsaw, Poland; [Dhungel, Nripesh; Hopper, Anita K.] Ohio State Univ, Dept Mol Genet, Ctr RNA Biol, Columbus, OH 43210 USA	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Warsaw University of Technology; University System of Ohio; Ohio State University	Boguta, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland.	magda@ibb.waw.pl	Turowski, Tomasz/H-1870-2011; Graczyk, Damian/J-6494-2016	Graczyk, Damian/0000-0002-6006-647X; Turowski, Tomasz/0000-0002-7052-8682; Boguta, Magdalena/0000-0002-1545-0691	National Institutes of Health [27930]; Ministry of Science and Higher Education (Poland) [MNSIW N301 298837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 27930 (to A. K. H.). This work was also supported by Ministry of Science and Higher Education (Poland) Grant MNSIW N301 298837.	Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Boguta M, 2009, CELL CYCLE, V8, P4023, DOI 10.4161/cc.8.24.10534; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Conesa C, 2005, MOL CELL BIOL, V25, P8631, DOI 10.1128/MCB.25.19.8631-8642.2005; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Deprez E, 1999, MOL CELL BIOL, V19, P8042; Gajda A, 2010, J BIOL CHEM, V285, P35719, DOI 10.1074/jbc.M110.125286; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Graczyk D, 2011, P NATL ACAD SCI USA, V108, P4926, DOI 10.1073/pnas.1010010108; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hopper AK, 2006, CRIT REV BIOCHEM MOL, V41, P3, DOI 10.1080/10409230500405237; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; HURT DJ, 1987, MOL CELL BIOL, V7, P1208, DOI 10.1128/MCB.7.3.1208; Hurto RL, 2007, GENETICS, V176, P841, DOI 10.1534/genetics.106.069732; Huynh LN, 2010, CELL CYCLE, V9, P3112, DOI 10.4161/cc.9.15.12525; Ishiguro A, 2002, MOL CELL BIOL, V22, P3264, DOI 10.1128/MCB.22.10.3264-3275.2002; JIMENEZ A, 1973, ANTIMICROB AGENTS CH, V3, P729, DOI 10.1128/AAC.3.6.729; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kufel J, 2003, RNA, V9, P202, DOI 10.1261/rna.2145103; Kwapisz M, 2002, CURR GENET, V42, P147, DOI 10.1007/s00294-002-0342-7; LEFEBVRE O, 1994, J BIOL CHEM, V269, P23374; Lipowsky G, 1999, RNA, V5, P539, DOI 10.1017/S1355838299982134; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Murthi A, 2010, MOL BIOL CELL, V21, P639, DOI 10.1091/mbc.E09-07-0551; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; Quan XX, 2007, BBA-MOL CELL RES, V1773, P1052, DOI 10.1016/j.bbamcr.2007.04.014; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shaheen HH, 2005, P NATL ACAD SCI USA, V102, P11290, DOI 10.1073/pnas.0503836102; SHEN WC, 1993, J BIOL CHEM, V268, P19436; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Yoshihisa T, 2007, GENES CELLS, V12, P285, DOI 10.1111/j.1365-2443.2007.01056.x	52	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39478	39488		10.1074/jbc.M111.253310	http://dx.doi.org/10.1074/jbc.M111.253310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940626	Green Published, hybrid			2022-12-25	WOS:000296759800065
J	Muller, V; Lindenberger, U				Mueller, Viktor; Lindenberger, Ulman			Cardiac and Respiratory Patterns Synchronize between Persons during Choir Singing	PLOS ONE			English	Article							HEART-RATE; SINUS ARRHYTHMIA; CORTICAL NETWORK; OSCILLATIONS; CAUSALITY; POETRY	Dyadic and collective activities requiring temporally coordinated action are likely to be associated with cardiac and respiratory patterns that synchronize within and between people. However, the extent and functional significance of cardiac and respiratory between-person couplings have not been investigated thus far. Here, we report interpersonal oscillatory couplings among eleven singers and one conductor engaged in choir singing. We find that: (a) phase synchronization both in respiration and heart rate variability increase significantly during singing relative to a rest condition; (b) phase synchronization is higher when singing in unison than when singing pieces with multiple voice parts; (c) directed coupling measures are consistent with the presence of causal effects of the conductor on the singers at high modulation frequencies; (d) the different voices of the choir are reflected in network analyses of cardiac and respiratory activity based on graph theory. Our results suggest that oscillatory coupling of cardiac and respiratory patterns provide a physiological basis for interpersonal action coordination.	[Mueller, Viktor; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany	Max Planck Society	Muller, V (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	vmueller@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021; Lindenberger, Ulman/A-5846-2013	Muller, Viktor/0000-0002-3716-5445; Lindenberger, Ulman/0000-0001-8428-6453	Max Planck Society; German Research Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Max Planck Society and the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJB, 2007, BIOL PSYCHOL, V74, P243, DOI 10.1016/j.biopsycho.2006.08.005; Bettermann H, 2002, INT J CARDIOL, V84, P77, DOI 10.1016/S0167-5273(02)00137-7; BONSIGNORE MR, 1995, J SLEEP RES, V4, P68, DOI 10.1111/j.1365-2869.1995.tb00190.x; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Camm AJ, 1996, EUR HEART J, V17, P354; Censi F, 2000, MED BIOL ENG COMPUT, V38, P416, DOI 10.1007/BF02345011; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cysarz D, 2004, AM J PHYSIOL-HEART C, V287, pH579, DOI 10.1152/ajpheart.01131.2003; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Gourevitch B, 2006, BIOL CYBERN, V95, P349, DOI 10.1007/s00422-006-0098-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grape C, 2003, INTEGR PHYS BEH SCI, V38, P65; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Harmat L., 2010, MUSIC MED, V2, P10, DOI [DOI 10.1177/1943862109354598, 10.1177/1943862109354598]; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Ludwig C., 1847, ARCH ANAT PHYSL, V13, P242; Mizuhara H, 2005, NEUROIMAGE, V27, P553, DOI 10.1016/j.neuroimage.2005.04.030; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schafer C, 1998, NATURE, V392, P239, DOI 10.1038/32567; Tripathi KK, 2004, INDIAN J AEROSP MED, V48, P64; Tzeng YC, 2003, EXP PHYSIOL, V88, P775, DOI 10.1113/eph8802606; Van Leeuwen P, 2009, P NATL ACAD SCI USA, V106, P13661, DOI 10.1073/pnas.0901049106; Wiener N., 1956, MODERN MATH ENG, P165; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683	31	122	123	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24893	10.1371/journal.pone.0024893	http://dx.doi.org/10.1371/journal.pone.0024893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825HM	21957466	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100025
J	Norman, EB; Angell, CT; Chodash, PA				Norman, Eric B.; Angell, Christopher T.; Chodash, Perry A.			Observations of Fallout from the Fukushima Reactor Accident in San Francisco Bay Area Rainwater	PLOS ONE			English	Article								We have observed fallout from the recent Fukushima Dai-ichi reactor accident in samples of rainwater collected in the San Francisco Bay area. Gamma ray spectra measured from these samples show clear evidence of fission products - (131,132)I, (132)Te, and (134,137)Cs. The activity levels we have measured for these isotopes are very low and pose no health risk to the public.	[Norman, Eric B.; Angell, Christopher T.; Chodash, Perry A.] Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Norman, EB (corresponding author), Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA.	ebnorman@lbl.gov	Chodash, Perry/P-1840-2014	Chodash, Perry/0000-0002-4154-7219; Angell, Christopher/0000-0003-0333-6557	United States Department of Homeland Security; United States Department of Energy	United States Department of Homeland Security(United States Department of Homeland Security (DHS)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Homeland Security (www.dhs.gov), and by the United States Department of Energy (www.doe.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne E., 1986, TABLE RADIOACTIVE IS; England T. R., 1993, LAUR943106 LOS AL NA; Fujii T, 2004, J RADIOANAL NUCL CH, V262, P551, DOI 10.1007/s10967-004-0474-y; Isaac MCP, 1997, NUCL INSTRUM METH A, V397, P310, DOI 10.1016/S0168-9002(97)00754-7; Norman E.B., 2011, ARXIV11035954	5	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24330	10.1371/journal.pone.0024330	http://dx.doi.org/10.1371/journal.pone.0024330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957447	gold, Green Published, Green Submitted			2022-12-25	WOS:000295262100009
J	Robledo, C; Garcia, JL; Benito, R; Flores, T; Mollejo, M; Martinez-Climent, JA; Garcia, E; Gutierrez, NC; Piris, MA; Hernandez, JM				Robledo, Cristina; Garcia, Juan L.; Benito, Rocio; Flores, Teresa; Mollejo, Manuela; Angel Martinez-Climent, Jose; Garcia, Eva; Gutierrez, Norma C.; Piris, Miguel A.; Hernandez, Jesus M.			Molecular Characterization of the Region 7q22.1 in Splenic Marginal Zone Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CCAAT DISPLACEMENT PROTEIN; DNA COPY-NUMBER; GENE-EXPRESSION; VILLOUS LYMPHOCYTES; ALLELIC LOSS; 7Q DELETION; CUTL1 GENE; ARRAY CGH	Splenic marginal zone lymphomas (SMZL) are an uncommon type of B-cell non-Hodgkin's lymphoma (NHL-B) in which no specific chromosomal translocations have been described. In contrast, the most frequent cytogenetic abnormality is the loss of the long arm of chromosome 7 (7q). Previous reports have located this loss in the 7q32 region. In order to better characterize the genomic imbalances in SMZL, molecular studies were carried out in 73 patients with SMZL. To gain insight into the mapping at 7q a tiling array was also used. The results confirmed the loss of 7q as the most frequent change. In addition, several abnormalities, including 4q22.1, 1q21.3-q22, 6q25.3, 20q13.33, 3q28, 2q23.3-q24.1 and 17p13, were also present. A loss of 7q22.1 at 99925039-101348479 bp was observed in half of the cases. The region of 7q22.1 has not previously been characterised in SMZL. Our results confirmed the presence of a new region of loss on chromosome 7 in these NHL.	[Robledo, Cristina; Garcia, Juan L.; Benito, Rocio; Hernandez, Jesus M.] Univ Salamanca, CSIC, Unidad Diagnost Mol & Celular Canc, IBMCC,Ctr Invest Canc, E-37008 Salamanca, Spain; [Garcia, Juan L.] Inst Estudios Ciencias Salud Castilla & Leon, Salamanca, Spain; [Flores, Teresa] Hosp Univ Salamanca, Serv Patol, Salamanca, Spain; [Mollejo, Manuela] Hosp Virgen Salud, Serv Patol, Toledo, Spain; [Angel Martinez-Climent, Jose] Univ Navarra, Area Oncol, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain; [Garcia, Eva] Univ Salamanca, CSIC, Unidad Genom, Ctr Invest Canc, E-37008 Salamanca, Spain; [Gutierrez, Norma C.; Hernandez, Jesus M.] Hosp Univ Salamanca, Serv Hematol, E-37008 Salamanca, Spain; [Piris, Miguel A.] CNIO, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Complejo Hospitalario de Toledo; University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Centro Nacional de Investigaciones Oncologicas (CNIO)	Robledo, C (corresponding author), Univ Salamanca, CSIC, Unidad Diagnost Mol & Celular Canc, IBMCC,Ctr Invest Canc, E-37008 Salamanca, Spain.	jmhr@usal.es	Martinez-Climent, Jose A/I-9199-2012; Piris, Miguel A/AAP-1445-2020; Piris, Miguel A/B-7067-2008; Robledo Montero, Cristina/B-4495-2017; Hernández, Jesus M/B-5459-2017; BENITO, ROCIO/B-4271-2017; garcia, Juan/B-4617-2017	Martinez-Climent, Jose A/0000-0002-7938-3950; Piris, Miguel A/0000-0001-5839-3634; Piris, Miguel A/0000-0001-5839-3634; Robledo Montero, Cristina/0000-0003-0445-3210; Hernández, Jesus M/0000-0002-9661-9371; BENITO, ROCIO/0000-0001-9781-4198; Gutierrez, Norma/0000-0001-5834-9510; Mollejo, Manuela/0000-0001-5658-0532; garcia, Juan/0000-0002-2146-5726	Spanish Fondo de Investigaciones Sanitarias [02/1041, FIS 09/01543]; Fondo Social Caja de Burgos de Investigacion Clinica; Proyectos de Investigacion del SACYL [106/A/06]; Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Science and Innovation; Cancer Research Foundation of Salamanca University; Redes de Investigacion RTIIC (FIS)	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fondo Social Caja de Burgos de Investigacion Clinica; Proyectos de Investigacion del SACYL; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cancer Research Foundation of Salamanca University; Redes de Investigacion RTIIC (FIS)(Instituto de Salud Carlos III)	This work was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias 02/1041 and FIS 09/01543, Fondo Social Caja de Burgos de Investigacion Clinica, Proyectos de Investigacion del SACYL 106/A/06 and by the Accion Transversal del Cancer project, through an agreement between the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation, and the Cancer Research Foundation of Salamanca University and Redes de Investigacion RTIIC (FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algara P, 2002, BLOOD, V99, P1299, DOI 10.1182/blood.V99.4.1299; Andersen CL, 2005, CANCER GENET CYTOGEN, V156, P122, DOI 10.1016/j.cancergencyto.2004.04.026; Andersen CL, 2004, EUR J HAEMATOL, V72, P390, DOI 10.1111/j.1600-0609.2004.00243.x; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Boonstra R, 2003, MODERN PATHOL, V16, P1210, DOI 10.1097/01.MP.0000095895.19756.77; Bredel M, 2005, J MOL DIAGN, V7, P171, DOI 10.1016/S1525-1578(10)60543-0; Callet-Bauchu E, 2005, LEUKEMIA, V19, P1818, DOI 10.1038/sj.leu.2403909; Camacho FI, 2001, AM J SURG PATHOL, V25, P1268, DOI 10.1097/00000478-200110000-00007; Conde L, 2007, NUCLEIC ACIDS RES, V35, pW81, DOI 10.1093/nar/gkm257; Dierlamm J, 1997, LEUKEMIA, V11, P747, DOI 10.1038/sj.leu.2400635; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; Ferreira BI, 2008, HAEMATOLOGICA, V93, P670, DOI 10.3324/haematol.12221; Gazzo S, 2003, HAEMATOLOGICA, V88, P31; Gonzalez MB, 2004, HAEMATOLOGICA, V89, P1213; Gruszka-Westwood AM, 2001, BLOOD, V97, P3552, DOI 10.1182/blood.V97.11.3552; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; HARRIS NL, 1994, BLOOD, V84, P1361; Hernandez JN, 2001, AM J PATHOL, V158, P1843, DOI 10.1016/S0002-9440(10)64140-5; Herrero J, 2003, NUCLEIC ACIDS RES, V31, P3461, DOI 10.1093/nar/gkg591; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jaffe ES, 2008, BLOOD, V112, P4384, DOI 10.1182/blood-2008-07-077982; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Martinez-Climent JA, 2003, BLOOD, V101, P3109, DOI 10.1182/blood-2002-07-2119; Mateo M, 1999, AM J PATHOL, V154, P1583, DOI 10.1016/S0002-9440(10)65411-9; Matteucci C, 2003, J PATHOL, V200, P656, DOI 10.1002/path.1386; Matutes E, 2008, LEUKEMIA, V22, P487, DOI 10.1038/sj.leu.2405068; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Narahari J, 2006, VIROLOGY, V350, P302, DOI 10.1016/j.virol.2006.01.047; Neville PJ, 2001, INT J CANCER, V91, P345, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1050>3.0.CO;2-1; Novara F, 2009, HUM PATHOL, V40, P1628, DOI 10.1016/j.humpath.2009.01.025; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Oscier DG, 1996, CANCER GENET CYTOGEN, V92, P24, DOI 10.1016/S0165-4608(96)00025-8; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Robledo C, 2009, CANCER-AM CANCER SOC, V115, P3728, DOI 10.1002/cncr.24430; Salido M, 2010, BLOOD, V116, P1479, DOI 10.1182/blood-2010-02-267476; Sato K, 2007, VIRUS GENES, V35, P473, DOI 10.1007/s11262-006-0074-8; SCHMID C, 1992, AM J SURG PATHOL, V16, P455, DOI 10.1097/00000478-199205000-00004; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Sole F, 1997, BRIT J HAEMATOL, V98, P446, DOI 10.1046/j.1365-2141.1997.2163033.x; Sole F, 2001, HAEMATOLOGICA, V86, P71; Troussard X, 1998, BRIT J HAEMATOL, V101, P712; Ueda Y, 2007, MELANOMA RES, V17, P91, DOI 10.1097/CMR.0b013e3280a60888; Watkins AJ, 2010, J PATHOL, V220, P461, DOI 10.1002/path.2665; Zeng WR, 1999, ONCOGENE, V18, P2015, DOI 10.1038/sj.onc.1202519; Zeng WR, 1997, ONCOGENE, V14, P2355, DOI 10.1038/sj.onc.1201076	56	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24939	10.1371/journal.pone.0024939	http://dx.doi.org/10.1371/journal.pone.0024939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957467	Green Submitted, Green Published, gold			2022-12-25	WOS:000295262100026
J	Palonen, E; Lindstrom, M; Karttunen, R; Somervuo, P; Korkeala, H				Palonen, Eveliina; Lindstrom, Miia; Karttunen, Reija; Somervuo, Panu; Korkeala, Hannu			Expression of Signal Transduction System Encoding Genes of Yersinia pseudotuberculosis IP32953 at 28 degrees C and 3 degrees C	PLOS ONE			English	Article							RESPONSE REGULATOR PHOP; POLYMERASE-CHAIN-REACTION; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL REGULATION; LISTERIA-MONOCYTOGENES; PHENOTYPIC ANALYSIS; REGULON PLASTICITY; SWIMMING MOTILITY	Yersinia pseudotuberculosis is a significant psychrotrophic food pathogen whose cold tolerance mechanisms are poorly understood. Signal transduction systems serve to monitor the environment, but no systematic investigation of their role at cold temperatures in Y. pseudotuberculosis has yet been undertaken. The relative expression levels of 54 genes predicted to encode proteins belonging to signal transduction systems in Y. pseudotuberculosis IP32953 were determined at 28 degrees C and 3 degrees C by quantitative real-time reverse transcription-PCR. The relative expression levels of 44 genes were significantly (p < 0.05) higher at 3 degrees C than at 28 degrees C. Genes encoding the two-component system CheA/CheY had the highest relative expression levels at 3 degrees C. Mutational analysis revealed that cheA is important for growth and motility at 3 degrees C. The relative expression level of one gene, rssB, encoding an RpoS regulator, was significantly (p < 0.05) lower at 3 degrees C than at 28 degrees C. The results suggest that several signal transduction systems might be used during growth at low temperature, and at least, CheA/CheY two-component system is important for low-temperature growth.	[Palonen, Eveliina; Lindstrom, Miia; Karttunen, Reija; Somervuo, Panu; Korkeala, Hannu] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland	University of Helsinki	Palonen, E (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	eveliina.palonen@helsinki.fi		Korkeala, Hannu/0000-0003-0699-1290	Finnish Centre of Excellence in Microbial Food Safety Research of the Academy of Finland [118602, 141140]; Faculty of Veterinary Medicine of the University of Helsinki; Finnish Veterinary Foundation; Walter Ehrstrom Foundation; University of Helsinki	Finnish Centre of Excellence in Microbial Food Safety Research of the Academy of Finland; Faculty of Veterinary Medicine of the University of Helsinki; Finnish Veterinary Foundation; Walter Ehrstrom Foundation; University of Helsinki	This work was supported by the Finnish Centre of Excellence in Microbial Food Safety Research of the Academy of Finland (grants 118602, 141140) http://www.aka.fi/fi/A/; the Doctoral Program of the Faculty of Veterinary Medicine of the University of Helsinki http://www.vetmed.helsinki.fi/; the Finnish Veterinary Foundation http://www.sell.fi/elainlaakariliitto/linkkeja_ja_tietolahteita/suomen_elainlaaketieteen_saatio_/; the Walter Ehrstrom Foundation http://www.maitohygienialiitto.fi/walter_ehrstrom_alku.html; the Medical Fund of the University of Helsinki http://www.helsinki.fi/rahastot/lahjoitusrahastot/laaketieteen_rahasto.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2008, MOL MICROBIOL, V69, P137, DOI 10.1111/j.1365-2958.2008.06268.x; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Bottone E.J., 2005, BERGEYS MANUAL SYSTE, P838; Bresolin G, 2006, J BACTERIOL, V188, P2945, DOI 10.1128/JB.188.8.2945-2958.2006; Bresolin G, 2008, MICROBIOL-SGM, V154, P196, DOI 10.1099/mic.0.2007/008458-0; Brzostek K, 2007, FOLIA MICROBIOL, V52, P73, DOI 10.1007/BF02932142; Brzostek K, 2003, FEMS MICROBIOL LETT, V228, P265, DOI 10.1016/S0378-1097(03)00779-1; Brzostek K, 2007, MICROBIOL-SGM, V153, P2416, DOI 10.1099/mic.0.2006/003202-0; Carlsson KE, 2007, INFECT IMMUN, V75, P4386, DOI 10.1128/IAI.01450-06; Carlsson KE, 2007, INFECT IMMUN, V75, P3913, DOI 10.1128/IAI.01346-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chan YC, 2007, APPL ENVIRON MICROB, V73, P6484, DOI 10.1128/AEM.00897-07; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Dahiya I, 2010, VET MICROBIOL, V144, P399, DOI 10.1016/j.vetmic.2010.02.003; Dahiya I, 2010, ARCH MICROBIOL, V192, P541, DOI 10.1007/s00203-010-0582-8; Ding LS, 2009, MICROBIOL-SGM, V155, P1890, DOI 10.1099/mic.0.026294-0; Dorrell N, 1998, FEMS MICROBIOL LETT, V165, P145, DOI 10.1016/S0378-1097(98)00267-5; Fisher ML, 2007, INFECT IMMUN, V75, P429, DOI 10.1128/IAI.01287-06; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; Flamez C, 2007, ADV EXP MED BIOL, V603, P145; Fredriksson-Ahomaa M, 2003, CLIN MICROBIOL REV, V16, P220, DOI 10.1128/CMR.16.2.220-229.2003; Fredriksson-Ahomaa M, 2010, PATHOGENS AND TOXINS IN FOODS: CHALLENGES AND INTERVENTIONS, P164; FUKUSHIMA H, 1989, J CLIN MICROBIOL, V27, P2706, DOI 10.1128/JCM.27.12.2706-2709.1989; FUKUSHIMA H, 1988, J CLIN MICROBIOL, V26, P584, DOI 10.1128/JCM.26.3.584-585.1988; Gopel Y, 2011, NUCLEIC ACIDS RES, V39, P1294, DOI 10.1093/nar/gkq986; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Groban ES, 2009, J MOL BIOL, V390, P380, DOI 10.1016/j.jmb.2009.05.007; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heusipp G, 2004, FEMS MICROBIOL LETT, V231, P227, DOI 10.1016/S0378-1097(03)00962-5; Hinchliffe SJ, 2008, MICROBIOL-SGM, V154, P1117, DOI 10.1099/mic.0.2007/012534-0; Hitchen PG, 2002, MOL MICROBIOL, V44, P1637, DOI 10.1046/j.1365-2958.2002.02990.x; Horne SM, 2006, ARCH MICROBIOL, V185, P115, DOI 10.1007/s00203-005-0077-1; Hu YB, 2009, MICROBIOL-SGM, V155, P3622, DOI 10.1099/mic.0.030908-0; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; Huang YH, 2009, FEMS MICROBIOL LETT, V293, P248, DOI 10.1111/j.1574-6968.2009.01543.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; IRIARTE M, 1995, J BACTERIOL, V177, P2299, DOI 10.1128/jb.177.9.2299-2304.1995; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Kaneko S, 1995, CONTRIB TO MICROBIOL, V13, P153; Kapatral V, 1996, MOL MICROBIOL, V19, P1061, DOI 10.1046/j.1365-2958.1996.452978.x; Kapatral V, 2004, MICROBIOL-SGM, V150, P2289, DOI 10.1099/mic.0.26814-0; Karlyshev AV, 2001, INFECT IMMUN, V69, P7810, DOI 10.1128/IAI.69.12.7810-7819.2001; Kumar S, 2009, ANTON LEEUW INT J G, V95, P91, DOI 10.1007/s10482-008-9292-5; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Li YL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-143; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Marceau M, 2004, MICROBIOL-SGM, V150, P3947, DOI 10.1099/mic.0.27426-0; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Moen B, 2009, CAN J MICROBIOL, V55, P714, DOI [10.1139/W09-016, 10.1139/w09-016]; NAKAJIMA H, 1992, J CLIN MICROBIOL, V30, P2484, DOI 10.1128/JCM.30.9.2484-2486.1992; Nuorti JP, 2004, J INFECT DIS, V189, P766, DOI 10.1086/381766; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Palonen E, 2010, CRIT REV MICROBIOL, V36, P54, DOI 10.3109/10408410903382581; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Raczkowska Adrianna, 2004, Polish Journal of Microbiology, V53, P11; Raczkowska A, 2011, ANTON LEEUW INT J G, V99, P381, DOI 10.1007/s10482-010-9503-8; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Rimhanen-Finne R, 2009, EPIDEMIOL INFECT, V137, P342, DOI 10.1017/S0950268807000155; Ronnebaumer K, 2009, FEMS MICROBIOL LETT, V296, P274, DOI 10.1111/j.1574-6968.2009.01649.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; Sun YC, 2009, FEMS MICROBIOL LETT, V290, P85, DOI 10.1111/j.1574-6968.2008.01409.x; Tasara T, 2007, FEMS MICROBIOL LETT, V269, P265, DOI 10.1111/j.1574-6968.2007.00633.x; Tobe T, 2008, ADV EXP MED BIOL, V631, P189, DOI 10.1007/978-0-387-78885-2_13; Venecia K, 2005, INFECT IMMUN, V73, P5961, DOI 10.1128/IAI.73.9.5961-5977.2005; Wang YQ, 2007, SCI CHINA SER A, V50, P81, DOI 10.1007/s11434-007-2031-x; Weagant SD, 2001, J BACTERIOLOGICAL AN; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; Winfield MD, 2005, J BIOL CHEM, V280, P14765, DOI 10.1074/jbc.M413900200; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053	82	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25063	10.1371/journal.pone.0025063	http://dx.doi.org/10.1371/journal.pone.0025063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949852	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400044
J	Yasudo, H; Ando, T; Xiao, WB; Kawakami, Y; Kawakami, T				Yasudo, Hiroki; Ando, Tomoaki; Xiao, Wenbin; Kawakami, Yuko; Kawakami, Toshiaki			Short Stat5-Interacting Peptide Derived from Phospholipase C-beta 3 Inhibits Hematopoietic Cell Proliferation and Myeloid Differentiation	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; BETA-GAMMA-SUBUNITS; STEM-CELLS; C-BETA; STAT5; BINDING; DOMAINS; TRANSDUCTION; ACTIVATION; EXPRESSION	Constitutive activation of the transcription factor Stat5 in hematopoietic stem/progenitor cells leads to various hematopoietic malignancies including myeloproliferative neoplasm (MPN). Our recent study found that phospholipase C (PLC)-beta 3 is a novel tumor suppressor involved in MPN, lymphoma and other tumors. Stat5 activity is negatively regulated by the SH2 domain-containing protein phosphatase SHP-1 in a PLC-beta 3-dependent manner. PLC-beta 3 can form the multimolecular SPS complex together with SHP-1 and Stat5. The close physical proximity of SHP-1 and Stat5 brought about by interacting with the C-terminal segment of PLC-beta 3 (PLC-beta 3-CT) accelerates SHP-1-mediated dephosphorylation of Stat5. Here we identify the minimal sequences within PLC-beta 3-CT required for its tumor suppressor function. Two of the three Stat5-binding noncontiguous regions, one of which also binds SHP-1, substantially inhibited in vitro proliferation of Ba/F3 cells. Surprisingly, an 11-residue Stat5-binding peptide (residues 988-998) suppressed Stat5 activity in Ba/F3 cells and in vivo proliferation and myeloid differentiation of hematopoietic stem/progenitor cells. Therefore, this study further defines PLC-beta 3-CT as the Stat5- and SHP-1-binding domain by identifying minimal functional sequences of PLC-beta 3 for its tumor suppressor function and implies their potential utility in the control of hematopoietic malignancies.	[Yasudo, Hiroki; Ando, Tomoaki; Xiao, Wenbin; Kawakami, Yuko; Kawakami, Toshiaki] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA	La Jolla Institute for Immunology	Yasudo, H (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA.	toshi@liai.org	Kawakami, Toshiaki/O-1616-2015	Xiao, Wenbin/0000-0001-8586-8500	MPN Foundation	MPN Foundation	This study was funded in part by a grant from the MPN Foundation to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; FRORATH B, 1992, BIOTECHNIQUES, V12, P558; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kyba M, 2003, P NATL ACAD SCI USA, V100, P11904, DOI 10.1073/pnas.1734140100; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakayama J, 2009, BLOOD, V113, P1483, DOI 10.1182/blood-2008-07-166355; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103	30	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24995	10.1371/journal.pone.0024995	http://dx.doi.org/10.1371/journal.pone.0024995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949826	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400030
J	Lin, XD; Paskaleva, EE; Chang, W; Shekhtman, A; Canki, M				Lin, Xudong; Paskaleva, Elena E.; Chang, William; Shekhtman, Alexander; Canki, Mario			Inhibition of HIV-1 Infection in Ex Vivo Cervical Tissue Model of Human Vagina by Palmitic Acid; Implications for a Microbicide Development	PLOS ONE			English	Article							TOPICAL MICROBICIDES; SEXUAL TRANSMISSION; IN-VITRO; IMMUNODEFICIENCY; CULTURE; BINDING	Background: Approximately 80% of all new HIV-1 infections are acquired through sexual contact. Currently, there is no clinically approved microbicide, indicating a clear and urgent therapeutic need. We recently reported that palmitic acid (PA) is a novel and specific inhibitor of HIV-1 fusion and entry. Mechanistically, PA inhibits HIV-1 infection by binding to a novel pocket on the CD4 receptor and blocks efficient gp120-to-CD4 attachment. Here, we wanted to assess the ability of PA to inhibit HIV-1 infection in cervical tissue ex vivo model of human vagina, and determine its effect on Lactobacillus (L) species of probiotic vaginal flora. Principal Findings: Our results show that treatment with 100-200 mu M PA inhibited HIV-1 infection in cervical tissue by up to 50%, and this treatment was not toxic to the tissue or to L. crispatus and jensenii species of vaginal flora. In vitro, in a cell free system that is independent of in vivo cell associated CD4 receptor; we determined inhibition constant (Ki) to be similar to 2.53 mu M. Significance: These results demonstrate utility of PA as a model molecule for further preclinical development of a safe and potent HIV-1 entry microbicide inhibitor.	[Lin, Xudong; Paskaleva, Elena E.; Chang, William; Canki, Mario] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Paskaleva, Elena E.; Shekhtman, Alexander; Canki, Mario] Palm Biol LLC, Albany, NY USA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Lin, XD (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	cankim@mail.amc.edu		Shekhtman, Alexander/0000-0003-2649-2675	National Institutes of Health [AT003371, GM085006]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant number AT003371 to MC and GM085006 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; Buckheit RW, 2010, ANTIVIR RES, V85, P142, DOI 10.1016/j.antiviral.2009.10.013; Canki M, 2007, METHODS COMPOSITIONS; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lee DYW, 2009, AIDS RES HUM RETROV, V25, P1231, DOI 10.1089/aid.2009.0019; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Paskaleva EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012168; Paskaleva Elena E, 2006, AIDS Res Ther, V3, P15, DOI 10.1186/1742-6405-3-15; Paskaleva EE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-8; Ramjee Gita, 2006, AIDS Res Ther, V3, P25, DOI 10.1186/1742-6405-3-25; Ramjee Gita, 2008, AIDS Res Ther, V5, P19, DOI 10.1186/1742-6405-5-19; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; WOLFE RA, 1980, J CELL BIOL, V87, P434, DOI 10.1083/jcb.87.2.434	24	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24803	10.1371/journal.pone.0024803	http://dx.doi.org/10.1371/journal.pone.0024803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949756	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900028
J	Zhang, SP; Wang, XT; Zhao, CG; Liu, DH; Hu, YX; Zhao, JX; Zhang, GZ				Zhang, Shouping; Wang, Xiaoting; Zhao, Changguang; Liu, Dehua; Hu, Yanxin; Zhao, Jixun; Zhang, Guozhong			Phylogenetic and Pathotypical Analysis of Two Virulent Newcastle Disease Viruses Isolated from Domestic Ducks in China	PLOS ONE			English	Article							AVIAN PARAMYXOVIRUS TYPE-1; GENOTYPIC CHARACTERIZATION; WATERFOWL; STRAINS; SEQUENCES; CHICKENS; POULTRY	Two velogenic Newcastle disease viruses (NDV) obtained from outbreaks in domestic ducks in China were characterized in this study. Phylogenetic analysis revealed that both strains clustered with the class II viruses, with one phylogenetically close to the genotype VII NDVs and the other closer to genotype IX. The deduced amino acid sequence of the cleavage site of the fusion (F) protein confirmed that both isolates contained the virulent motif (112)RRQK/RRF117 at the cleavage site. The two NDVs had severe pathogenicity in fully susceptible chickens, resulting in 100% mortality. One of the isolates also demonstrated some pathogenicity in domestic ducks. The present study suggests that more than one genotype of NDV circulates in domestic ducks in China and viral transmission may occur among chickens and domestic ducks.	[Zhang, Shouping; Wang, Xiaoting; Zhao, Changguang; Liu, Dehua; Hu, Yanxin; Zhao, Jixun; Zhang, Guozhong] China Agr Univ, Minist Agr, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, SP (corresponding author), China Agr Univ, Minist Agr, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China.	zhanggz@cau.edu.cn			Chinese Universities Scientific Fund [2009-1-11]; National Natural Science Foundation of China [31001063]; earmarked fund for Modern Agro-industry Technology Research System [nycytx-45-11]; Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities [IRT0866]	Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System; Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities	This work was supported by the Chinese Universities Scientific Fund (2009-1-11), National Natural Science Foundation of China (31001063), the earmarked fund for Modern Agro-industry Technology Research System (nycytx-45-11), and the Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Alexander D. J., 1998, LAB MANUAL ISOLATION, V4, P156; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Jindal N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-191; Jorgensen PH, 2004, VET REC, V154, P497, DOI 10.1136/vr.154.16.497; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Lee EK, 2009, VET MICROBIOL, V134, P241, DOI 10.1016/j.vetmic.2008.08.020; Liu HL, 2008, AVIAN DIS, V52, P150, DOI 10.1637/8030-061507-Reg; Liu HL, 2010, VIRUS GENES, V40, P365, DOI 10.1007/s11262-010-0452-0; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Maminiaina OF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013987; Mase M, 2009, J VET MED SCI, V71, P1101, DOI 10.1292/jvms.71.1101; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Onapa MO, 2006, TROP ANIM HEALTH PRO, V38, P285, DOI 10.1007/s11250-006-4309-4; Peeters B, 2004, J GEN VIROL, V85, P2375, DOI 10.1099/vir.0.80160-0; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; Roy P, 2000, VET RES COMMUN, V24, P135, DOI 10.1023/A:1006416724050; Seal BS, 2005, VET MICROBIOL, V106, P7, DOI 10.1016/j.vetmic.2004.11.013; Seal BS, 2000, DEV COMP IMMUNOL, V24, P257, DOI 10.1016/S0145-305X(99)00077-4; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; Sinkovics JG, 2000, J CLIN VIROL, V16, P1, DOI 10.1016/S1386-6532(99)00072-4; Stanislawek WL, 2002, ARCH VIROL, V147, P1287, DOI 10.1007/s00705-002-0818-2; Takakuwa H, 1998, JPN J VET RES, V45, P207; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsai HJ, 2004, VET MICROBIOL, V104, P19, DOI 10.1016/j.vetmic.2004.09.005; Tsunekuni R, 2010, VIRUS GENES, V40, P252, DOI 10.1007/s11262-009-0427-1; Wakamatsu N, 2006, VIROLOGY, V353, P333, DOI 10.1016/j.virol.2006.06.013; Zhang R, 2010, VIRUS RES, V151, P45, DOI 10.1016/j.virusres.2010.03.015; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020	31	59	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25000	10.1371/journal.pone.0025000	http://dx.doi.org/10.1371/journal.pone.0025000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949828	Green Submitted, gold, Green Published			2022-12-25	WOS:000295257900044
J	Robertson, C; Sawford, K; Gunawardana, WSN; Nelson, TA; Nathoo, F; Stephen, C				Robertson, Colin; Sawford, Kate; Gunawardana, Walimunige S. N.; Nelson, Trisalyn A.; Nathoo, Farouk; Stephen, Craig			A Hidden Markov Model for Analysis of Frontline Veterinary Data for Emerging Zoonotic Disease Surveillance	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; FRAMEWORK; SYSTEM	Surveillance systems tracking health patterns in animals have potential for early warning of infectious disease in humans, yet there are many challenges that remain before this can be realized. Specifically, there remains the challenge of detecting early warning signals for diseases that are not known or are not part of routine surveillance for named diseases. This paper reports on the development of a hidden Markov model for analysis of frontline veterinary sentinel surveillance data from Sri Lanka. Field veterinarians collected data on syndromes and diagnoses using mobile phones. A model for submission patterns accounts for both sentinel-related and disease-related variability. Models for commonly reported cattle diagnoses were estimated separately. Region-specific weekly average prevalence was estimated for each diagnoses and partitioned into normal and abnormal periods. Visualization of state probabilities was used to indicate areas and times of unusual disease prevalence. The analysis suggests that hidden Markov modelling is a useful approach for surveillance datasets from novel populations and/or having little historical baselines.	[Robertson, Colin] Wilfrid Laurier Univ, Dept Geog & Environm Studies, Waterloo, ON N2L 3C5, Canada; [Robertson, Colin; Nelson, Trisalyn A.] Univ Victoria, Dept Geog, Spatial Pattern Anal & Res Lab, Victoria, BC, Canada; [Sawford, Kate; Stephen, Craig] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Gunawardana, Walimunige S. N.] Univ Peradeniya, Fac Vet Med & Anim Sci, Peradeniya, Central Provinc, Sri Lanka; [Nathoo, Farouk] Univ Victoria, Dept Math & Stat, Victoria, BC, Canada	Wilfrid Laurier University; University of Victoria; University of Calgary; University of Peradeniya; University of Victoria	Robertson, C (corresponding author), Wilfrid Laurier Univ, Dept Geog & Environm Studies, Waterloo, ON N2L 3C5, Canada.	crobertson@wlu.ca	Sawford, Katherine/B-9095-2014	Nelson, Trisalyn/0000-0003-2537-6971	Teasdale-corti Global Public Health Research Partnership Program; Canadian National Sciences and Engineering Research Council	Teasdale-corti Global Public Health Research Partnership Program; Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Teasdale-corti Global Public Health Research Partnership Program and the Canadian National Sciences and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2008, STAT METHODS MED RES, V17, P421, DOI 10.1177/0962280206078986; [Anonymous], 2004, CHANCE, DOI [10.1080/09332480.2004.10554882, DOI 10.1080/09332480.2004.10554882]; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Das Debjani, 2005, MMWR Suppl, V54, P41; Fearnley L, 2008, ENVIRON PLANN A, V40, P1615, DOI 10.1068/a4060; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; Gubernot DM, 2008, PUBLIC HEALTH REP, V123, P300, DOI 10.1177/003335490812300310; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kahn LH, 2006, EMERG INFECT DIS, V12, P556, DOI 10.3201/eid1204.050956; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; LAWSON AB, SPATIAL SYNDROMIC SU; Le Strat Y, 1999, STAT MED, V18, P3463, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3463::AID-SIM409>3.3.CO;2-9; Leblond A, 2007, VECTOR-BORNE ZOONOT, V7, P403, DOI 10.1089/vbz.2006.0593; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Madigan D, 2005, SPATIAL AND SYNDROMIC SURVEILLANCE FOR PUBLIC HEALTH, P203, DOI 10.1002/0470092505.ch12; Martinez-Beneito MA, 2008, STAT MED, V27, P4455, DOI 10.1002/sim.3320; Mostashari F, 2003, J URBAN HEALTH, V80, pI43; NAUS JI, 1965, J AM STAT ASSOC, V60, P532, DOI 10.2307/2282688; Rabinowitz PM, 2008, ECOHEALTH, V5, P224, DOI 10.1007/s10393-008-0170-4; Rath TM, 2003, LECT NOTES COMPUT SC, V2810, P521, DOI 10.1007/978-3-540-45231-7_48; Robertson C, 2010, EMERG INFECT DIS, V15, P1524; Sonesson C, 2003, J R STAT SOC A STAT, V166, P5, DOI 10.1111/1467-985X.00256; Van Metre DC, 2009, JAVMA-J AM VET MED A, V234, P658, DOI 10.2460/javma.234.5.658; Vrbova L, 2010, TRANSBOUND EMERG DIS, V57, P154, DOI 10.1111/j.1865-1682.2010.01100.x; Wagner MM., 2006, HDB BIOSURVEILLANCE; Wall MM, 2009, STAT MED, V28, P293, DOI 10.1002/sim.3463; Watkins RE, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-39; Xia H, 1998, STAT MED, V17, P2025, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2025::AID-SIM865>3.0.CO;2-M; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	36	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24833	10.1371/journal.pone.0024833	http://dx.doi.org/10.1371/journal.pone.0024833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949763	gold, Green Submitted, Green Published			2022-12-25	WOS:000295173800041
J	Yan, HM; Xia, MF; Chang, XX; Xu, Q; Bian, H; Zeng, MS; Rao, SX; Yao, XZ; Tu, YF; Jia, WP; Gao, X				Yan, Hongmei; Xia, Mingfeng; Chang, Xinxia; Xu, Qiong; Bian, Hua; Zeng, Mengsu; Rao, Shengxiang; Yao, Xiuzhong; Tu, Yinfang; Jia, Weiping; Gao, Xin			Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study	PLOS ONE			English	Article							SERUM FGF21 LEVELS; INSULIN SENSITIVITY; LIVER-DISEASE; PPAR-ALPHA; FIBROBLAST-GROWTH-FACTOR-21; STEATOSIS; METABOLISM; FGF-21; KLOTHO; IDENTIFICATION	Background and Aims: Fibroblasts growth factor 21 (FGF21), a liver-secreted endocrine factor involved in regulating glucose and lipid metabolism, has been shown to be elevated in patients with non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the quantitative correlation between serum FGF21 level and hepatic fat content. Methods: A total of 138 subjects (72 male and 66 female) aged from 18 to 65 years with abnormal glucose metabolism and B-ultrasonography diagnosed fatty liver were enrolled in the study. Serum FGF21 levels were determined by an in-house chemiluminescence immunoassay and hepatic fat contents were measured by proton magnetic resonance spectroscopy. Results: Serum FGF21 increased progressively with the increase of hepatic fat content, but when hepatic fat content increased to the fourth quartile, FGF21 tended to decline. Serum FGF21 concentrations were positively correlated with hepatic fat content especially in subjects with mild/moderate hepatic steatosis (r = 0.276, p = 0.009). Within the range of hepatic steatosis from the first to third quartile, FGF21 was superior to any other traditional clinical markers including ALT to reflect hepatic fat content. When the patients with severe hepatic steatosis (the fourth quartile) were included, the quantitative correlation between FGF21 and hepatic fat content was weakened. Conclusions: Serum FGF21 was a potential biomarker to reflect the hepatic fat content in patients with mild or moderate NAFLD. In severe NAFLD patients, FGF21 concentration might decrease due to liver inflammation or injury.	[Yan, Hongmei; Xia, Mingfeng; Chang, Xinxia; Xu, Qiong; Bian, Hua; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Zeng, Mengsu; Rao, Shengxiang; Yao, Xiuzhong] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Tu, Yinfang; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Yan, HM (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	zhongshan_endo@126.com	Rao, Sheng-Xiang/I-8612-2019; Rao, Sheng-Xiang/AGL-7232-2022; Xia, Ming-Feng/AAL-1403-2020	Rao, Sheng-Xiang/0000-0001-7722-8327; Rao, Sheng-Xiang/0000-0001-7722-8327; Xia, Ming-Feng/0000-0002-5650-0165; Gao, Xin/0000-0003-1864-7796; Bian, Hua/0000-0001-8449-0665	National Key Technologies RD Program [BAI52B03]; Shanghai Bureau of Health [08GWZX0203]; Science and Technology of Shanghai Municipality [07JC14011, 10411956400, 10411962600]; Shanghai Municipality for Basic Research [08dj1400601]; National Basic Research Program of China [2011CB504004]	National Key Technologies RD Program(National Key Technology R&D Program); Shanghai Bureau of Health; Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipality for Basic Research; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Key Technologies R&D Program (2008 BAI52B03; http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm), the Major Project of Subject Construction of Shanghai Bureau of Health (08GWZX0203; http://www.smhb.gov.cn/), the Project of Science and Technology of Shanghai Municipality (No. 07JC14011, No. 10411956400 and No. 10411962600; http://www.stcsm.gov.cn/structure/index.htm), the Major Program of Shanghai Municipality for Basic Research (Grant No. 08dj1400601; http://www.stcsm.gov.cn/structure/index.htm) and the National Basic Research Program of China (2011CB504004; http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bian H, 2011, DIABETES TECHNOL THE, V13, P149, DOI 10.1089/dia.2010.0101; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Cuevas-Ramos D, 2010, EUR J ENDOCRINOL, V163, P469, DOI 10.1530/EJE-10-0454; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kurosu H, 2009, BIOFACTORS, V35, P52, DOI 10.1002/biof.12; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Morris-Stiff G, 2010, J HEPATOL, V53, P795, DOI 10.1016/j.jhep.2010.07.003; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	32	61	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24895	10.1371/journal.pone.0024895	http://dx.doi.org/10.1371/journal.pone.0024895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949781	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800046
J	Eaves-Pyles, T; Bu, HF; Tan, XD; Cong, YZ; Patel, J; Davey, RA; Strasser, JE				Eaves-Pyles, Tonyia; Bu, Heng-Fu; Tan, Xiao-di; Cong, Yingzi; Patel, Jignesh; Davey, Robert A.; Strasser, Jane E.			Luminal-Applied Flagellin Is Internalized by Polarized Intestinal Epithelial Cells and Elicits Immune Responses via the TLR5 Dependent Mechanism	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; SALMONELLA-FLAGELLIN; VIRULENCE FACTORS; ACTIVATION; LIPOPOLYSACCHARIDE; EXPRESSION; INFLAMMATION; RECOGNITION; SECRETION	Bacteria release flagellin that elicits innate responses via Toll-like receptor 5 (TLR5). Here, we investigated the fate of apically administrated full length flagellin from virulent and avirulent bacteria, along with truncated recombinant flagellin proteins in intestinal epithelial cells and cellular responses. Flagellin was internalized by intestinal epithelial cell (IEC) monolayers of IEC-18. Additionally, apically applied flagellin was internalized by polarized human Caco-2BBe and T-84 cells in a TLR5 dependent mechanism. More, flagellin exposure did not affect the integrity of intestinal monolayers. With immunofluorescent staining, internalized flagellin was detected in both early endosomes as well as lysosomes. We found that apical exposure of polarized Caco-2BBe and T-84 to flagellin from purified Salmonella, Escherichia coli O83:H1 (isolate from Crohn's lesion) or avirulent E. coli K12 induced comparable levels of basolateral IL-8 secretion. A recombinant protein representing the conserved amino (N) and carboxyl (C) domains (D) of the flagellin protein (ND1/2ECHCD2/1) induced IL-8 secretion from IEC similar to levels elicited by full-length flagellins. However, a recombinant flagellin protein containing only the D3 hypervariable region elicited no IL-8 secretion in both cell lines compared to un-stimulated controls. Silencing or blocking TLR5 in Caco-2BBe cells resulted in a lack of flagellin internalization and decreased IL-8 secretion. Furthermore, apical exposure to flagellin stimulated transepithelial migration of neutrophils and dendritic cells. The novel findings in this study show that luminal-applied flagellin is internalized by normal IEC via TLR5 and co-localizes to endosomal and lysosomal compartments where it is likely degraded as flagellin was not detected on the basolateral side of IEC cultures.	[Eaves-Pyles, Tonyia; Cong, Yingzi; Patel, Jignesh; Davey, Robert A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Bu, Heng-Fu; Tan, Xiao-di] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Ctr Intestinal & Liver Inflammat Res, Chicago, IL 60611 USA; [Strasser, Jane E.] Univ Cincinnati, Sch Med, Cincinnati, OH USA	University of Texas System; University of Texas Medical Branch Galveston; Northwestern University; Feinberg School of Medicine; University System of Ohio; University of Cincinnati	Eaves-Pyles, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA.	tdeavesp@utmb.edu	Bu, Hengfu/H-3167-2011	Davey, Robert/0000-0001-9168-2892; Cong, Yingzi/0000-0003-4167-7395	National Institutes of Health (NIH)/National Institute of Allergies and Infectious Diseases (NIAID) [AI53540-2]; University of Texas Medical Branch [2513-04R1]; NIH [R01DK064240]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI053540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064240] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergies and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Texas Medical Branch; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health (NIH)/National Institute of Allergies and Infectious Diseases (NIAID) K22 grant (TE-P; AI53540-2), the University of Texas Medical Branch John Sealy New Recruitment Grant (TE-P; 2513-04R1) and NIH R01DK064240 (X-dT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Beatty WL, 1997, INFECT IMMUN, V65, P4395, DOI 10.1128/IAI.65.11.4395-4404.1997; Beatty WL, 1999, J CELL BIOL, V145, P689, DOI 10.1083/jcb.145.4.689; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Blagoveshchenskaya AD, 2000, MOL BIOL CELL, V11, P1801, DOI 10.1091/mbc.11.5.1801; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P2729, DOI 10.1074/jbc.273.5.2729; Bu HF, 2010, J CELL PHYSIOL, V222, P658, DOI 10.1002/jcp.21985; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Cerutti A, 2010, SCIENCE, V328, P1646, DOI 10.1126/science.1192488; Chabot SM, 2008, J INFECT DIS, V198, P907, DOI 10.1086/591056; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Eckmann L, 2006, CURR OPIN GASTROEN, V22, P95, DOI 10.1097/01.mog.0000208458.38772.2a; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Ge YM, 2000, J INFECT DIS, V182, P873, DOI 10.1086/315784; Gentry M, 2007, INFECT IMMUN, V75, P3969, DOI 10.1128/IAI.00157-07; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Gibson A, 1998, J CELL BIOL, V143, P81, DOI 10.1083/jcb.143.1.81; Harris G, 2006, WORLD J GASTROENTERO, V12, P2149, DOI 10.3748/wjg.v12.i14.2149; HE XS, 1994, J BACTERIOL, V176, P2406, DOI 10.1128/JB.176.8.2406-2414.1994; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Jenal U, 2002, CURR OPIN MICROBIOL, V5, P558, DOI 10.1016/S1369-5274(02)00378-8; Khan MAS, 2004, IMMUNOLOGY, V112, P651, DOI 10.1111/j.1365-2567.2004.01923.x; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Lu L, 2001, AM J CLIN NUTR, V73, p1124S; Mimori-Kiyosue Y, 1998, J MOL BIOL, V284, P521, DOI 10.1006/jmbi.1998.2184; Miyamoto Y, 2006, CELL MICROBIOL, V8, P869, DOI 10.1111/j.1462-5822.2005.00673.x; Mobley HLT, 1996, INFECT IMMUN, V64, P5332, DOI 10.1128/IAI.64.12.5332-5340.1996; NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648a0; NEWTON SMC, 1991, MOL MICROBIOL, V5, P419, DOI 10.1111/j.1365-2958.1991.tb02124.x; Norcott JP, 1996, J CELL BIOL, V134, P1229, DOI 10.1083/jcb.134.5.1229; OhtaTada U, 1997, SCAND J GASTROENTERO, V32, P455, DOI 10.3109/00365529709025080; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; PENN CW, 1992, FEMS MICROBIOL LETT, V100, P331, DOI 10.1016/0378-1097(92)90229-H; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Reading NC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00148; Salazar-Gonzalez RM, 2005, IMMUNOL LETT, V101, P117, DOI 10.1016/j.imlet.2005.05.004; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SRIKANTH CV, 2008, INTERDISCIP PERSPECT; Steele-Mortimer O, 2005, IMMUNOL LETT, V101, P117; Strasser JE, 1999, MOL BIOL CELL, V10, P2619, DOI 10.1091/mbc.10.8.2619; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Turley CB, 2011, VACCINE         0530; Wittkop U, 2006, MICROB PATHOGENESIS, V40, P101, DOI 10.1016/j.micpath.2005.11.006; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	53	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24869	10.1371/journal.pone.0024869	http://dx.doi.org/10.1371/journal.pone.0024869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949773	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700070
J	Montanari, F; Shields, DC; Khaldi, N				Montanari, Floriane; Shields, Denis C.; Khaldi, Nora			Differences in the Number of Intrinsically Disordered Regions between Yeast Duplicated Proteins, and Their Relationship with Functional Divergence	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; INTERACTION NETWORK; GENE DUPLICATION; UNSTRUCTURED PROTEINS; STRUCTURAL DISORDER; GENOME DUPLICATION; ENERGY CONTENT; LINEAR MOTIFS; EVOLUTION; PREDICTION	Background: Intrinsically disordered regions are enriched in short interaction motifs that play a critical role in many protein-protein interactions. Since new short interaction motifs may easily evolve, they have the potential to rapidly change protein interactions and cellular signaling. In this work we examined the dynamics of gain and loss of intrinsically disordered regions in duplicated proteins to inspect if changes after genome duplication can create functional divergence. For this purpose we used Saccharomyces cerevisiae and the outgroup species Lachancea kluyveri. Principal Findings: We find that genes duplicated as part of a genome duplication (ohnologs) are significantly more intrinsically disordered than singletons (p<2.2(e)-16, Wilcoxon), reflecting a preference for retaining intrinsically disordered proteins in duplicate. In addition, there have been marked changes in the extent of intrinsic disorder following duplication. A large number of duplicated genes have more intrinsic disorder than their L. kluyveri ortholog (29% for duplicates versus 25% for singletons) and an even greater number have less intrinsic disorder than the L. kluyveri ortholog (37% for duplicates versus 25% for singletons). Finally, we show that the number of physical interactions is significantly greater in the more intrinsically disordered ohnolog of a pair (p = 0.003, Wilcoxon). Conclusion: This work shows that intrinsic disorder gain and loss in a protein is a mechanism by which a genome can also diverge and innovate. The higher number of interactors for proteins that have gained intrinsic disorder compared with their duplicates may reflect the acquisition of new interaction partners or new functional roles.	[Montanari, Floriane] Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; Univ Coll Dublin, UCD Complex & Adapt Syst Lab, Dublin 2, Ireland	University College Dublin; University College Dublin	Montanari, F (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland.	nora.khaldi@ucd.ie		Shields, Denis/0000-0003-4015-2474; Montanari, Floriane/0000-0002-4676-6170	Irish Research Council for Science, Engineering and Technology; Marie Curie Actions; Science Foundation Ireland [08/IN.1/B1864]	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Marie Curie Actions(European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by the Irish Research Council for Science, Engineering and Technology, co-funded by Marie Curie Actions under FP7, and by Science Foundation Ireland (grant number 08/IN.1/B1864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudot A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r76; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Chain FJJ, 2006, PLOS GENET, V2, P478, DOI 10.1371/journal.pgen.0020056; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Force A, 1999, GENETICS, V151, P1531; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Goh GKM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-69; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Han PF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-8; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jiang HF, 2011, GENOME BIOL EVOL, V3, P295, DOI 10.1093/gbe/evr016; Jin L, 2008, GENE, V427, P19, DOI 10.1016/j.gene.2008.09.002; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim SH, 2006, MOL BIOL EVOL, V23, P1068, DOI 10.1093/molbev/msj115; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Makino T, 2006, GENE, V385, P57, DOI 10.1016/j.gene.2006.06.028; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; ROMERO P, 1997, INT C NEUR NETW HOUS, P90; Scannell DR, 2008, GENOME RES, V18, P137, DOI 10.1101/gr.6341207; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schmidt EE, 2007, BIOESSAYS, V29, P262, DOI 10.1002/bies.20546; Shimizu K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-78; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; Sugino RP, 2006, TRENDS GENET, V22, P642, DOI 10.1016/j.tig.2006.09.014; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Wagner A, 2002, MOL BIOL EVOL, V19, P1760, DOI 10.1093/oxfordjournals.molbev.a003998; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	60	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24989	10.1371/journal.pone.0024989	http://dx.doi.org/10.1371/journal.pone.0024989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949823	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700088
J	Pollier, J; Gonzalez-Guzman, M; Ardiles-Diaz, W; Geelen, D; Goossens, A				Pollier, Jacob; Gonzalez-Guzman, Miguel; Ardiles-Diaz, Wilson; Geelen, Danny; Goossens, Alain			An Integrated PCR Colony Hybridization Approach to Screen cDNA Libraries for Full-Length Coding Sequences	PLOS ONE			English	Article							GENOME-WIDE EXPRESSION; AFLP; AMPLIFICATION; FAMILY	Background: cDNA-Amplified Fragment Length Polymorphism (cDNA-AFLP) is a commonly used technique for genome-wide expression analysis that does not require prior sequence knowledge. Typically, quantitative expression data and sequence information are obtained for a large number of differentially expressed gene tags. However, most of the gene tags do not correspond to full-length (FL) coding sequences, which is a prerequisite for subsequent functional analysis. Methodology: A medium-throughput screening strategy, based on integration of polymerase chain reaction (PCR) and colony hybridization, was developed that allows in parallel screening of a cDNA library for FL clones corresponding to incomplete cDNAs. The method was applied to screen for the FL open reading frames of a selection of 163 cDNA-AFLP tags from three different medicinal plants, leading to the identification of 109 (67%) FL clones. Furthermore, the protocol allows for the use of multiple probes in a single hybridization event, thus significantly increasing the throughput when screening for rare transcripts. Conclusions: The presented strategy offers an efficient method for the conversion of incomplete expressed sequence tags (ESTs), such as cDNA-AFLP tags, to FL-coding sequences.	[Pollier, Jacob; Gonzalez-Guzman, Miguel; Ardiles-Diaz, Wilson; Goossens, Alain] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Pollier, Jacob; Gonzalez-Guzman, Miguel; Ardiles-Diaz, Wilson; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Geelen, Danny] Univ Ghent, Fac Biosci Engn, Dept Plant Prod, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Pollier, J (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	alain.goossens@psb.vib-ugent.be	Pollier, Jacob/B-3091-2012; Gonzalez-Guzman, Miguel/N-6878-2019; Gonzalez-Guzman, Miguel/F-2318-2014	Pollier, Jacob/0000-0002-1134-9238; Gonzalez-Guzman, Miguel/0000-0003-1000-9255; Gonzalez-Guzman, Miguel/0000-0003-1000-9255; Goossens, Alain/0000-0002-1599-551X	Agency for Innovation by Science and Technology in Flanders [SBO040093]	Agency for Innovation by Science and Technology in Flanders	This work was supported by the Agency for Innovation by Science and Technology in Flanders (http://www.iwt.be) ("Strategisch Basisonderzoek" project SBO040093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bower NI, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq816; Breyne P, 2003, MOL GENET GENOMICS, V269, P173, DOI 10.1007/s00438-003-0830-6; Chenchik A, 1996, BIOTECHNIQUES, V21, P526; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Hoskins RA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni184; MUNROE DJ, 1995, P NATL ACAD SCI USA, V92, P2209, DOI 10.1073/pnas.92.6.2209; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Rozen S, 2000, Methods Mol Biol, V132, P365; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 2006, PLANT J, V45, P439, DOI 10.1111/j.1365-313X.2005.02630.x; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wan KH, 2006, NAT PROTOC, V1, P624, DOI 10.1038/nprot.2006.90; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708	19	4	5	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24978	10.1371/journal.pone.0024978	http://dx.doi.org/10.1371/journal.pone.0024978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949817	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700085
J	Banegas, JR; Lundelin, K; de la Figuera, M; de la Cruz, JJ; Graciani, A; Rodriguez-Artalejo, F; Puig, JG				Banegas, Jose R.; Lundelin, Krista; de la Figuera, Mariano; de la Cruz, Juan J.; Graciani, Auxiliadora; Rodriguez-Artalejo, Fernando; Garcia Puig, Juan			Physician Perception of Blood Pressure Control and Treatment Behavior in High-Risk Hypertensive Patients: A Cross-Sectional Study	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; CLINICAL INERTIA; THERAPEUTIC INERTIA; UNCONTROLLED HYPERTENSION; EUROPEAN GUIDELINES; MANAGEMENT; COUNTRIES; PREVENTION; PREVALENCE; REASONS	Objective: We examined physician perception of blood pressure control and treatment behavior in patients with previous cardiovascular disease and uncontrolled hypertension as defined by European Guidelines. Methods: A cross-sectional study was conducted in which 321 primary care physicians throughout Spain consecutively studied 1,614 patients aged >= 18 years who had been diagnosed and treated for hypertension (blood pressure >= 140/90 mmHg), and had suffered a documented cardiovascular event. The mean value of three blood pressure measurements taken using standardized procedures was used for statistical analysis. Results: Mean blood pressure was 143.4/84.9 mmHg, and only 11.6% of these cardiovascular patients were controlled according to 2007 European Guidelines for Hypertension Management target of <130/80 mmHg. In 702 (49.2%) of the 1426 uncontrolled patients, antihypertensive medication was not changed, and in 480 (68.4%) of these cases this was due to the physicians judgment that blood pressure was adequately controlled. In 320 (66.7%) of the latter patients, blood pressure was 130-139/80-89 mmHg. Blood pressure level was the main factor associated (inversely) with no change in treatment due to physician perception of adequate control, irrespective of sociodemographic and clinical factors. Conclusions: Physicians do not change antihypertensive treatment in many uncontrolled cardiovascular patients because they considered it unnecessary, especially when the BP values are only slightly above the guideline target. It is possible that the guidelines may be correct, but there is also the possibility that the care by the physicians is appropriate since BP <130/80 mmHg is hard to achieve, and recent reviews suggest there is insufficient evidence to support such a low BP target.	[Banegas, Jose R.; Lundelin, Krista; de la Cruz, Juan J.; Graciani, Auxiliadora; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Banegas, Jose R.; Lundelin, Krista; de la Cruz, Juan J.; Graciani, Auxiliadora; Rodriguez-Artalejo, Fernando] Inst Salud Carlos III, Minist Sci & Innovat, Network Biomed Res Ctr Epidemiol & Publ Hlth CIBE, Madrid, Spain; [Banegas, Jose R.; Lundelin, Krista; de la Cruz, Juan J.; Graciani, Auxiliadora; Rodriguez-Artalejo, Fernando; Garcia Puig, Juan] Hosp Univ La Paz IdiPAZ, Inst Invest, Madrid, Spain; [Banegas, Jose R.; Lundelin, Krista; Garcia Puig, Juan] Hosp Univ La Paz, Div Internal Med, Vasc Metab Unit, Madrid, Spain; [de la Figuera, Mariano] Sardenya Primary Care Ctr, Family & Community Med Teaching Unit, Barcelona, Catalonia, Spain	Autonomous University of Madrid; Instituto de Salud Carlos III; Hospital Universitario La Paz; Hospital Universitario La Paz	Banegas, JR (corresponding author), Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain.	joseramon.banegas@uam.es	Graciani, Auxiliadora/D-8243-2013	Graciani, Auxiliadora/0000-0002-6211-587X	RECORDATI ESPANA, S.L; Ministry of Science and Innovation (Instituto de Salud Carlos III), Spain Government [CM10/00327]	RECORDATI ESPANA, S.L; Ministry of Science and Innovation (Instituto de Salud Carlos III), Spain Government(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding for this study was obtained from RECORDATI ESPANA, S.L through an unrestricted grant. Krista Lundelin has a "Rio Hortega'' research training contract (Expediente CM10/00327) from the Ministry of Science and Innovation (Instituto de Salud Carlos III), Spain Government. The funders had no role in the study design, or in the analysis and interpretation of data, or the writing of the report, or in the decision to submit the paper for publication.	Alonso-Moreno FJ, 2008, REV CLIN ESP, V208, P393, DOI 10.1157/13126341; Arguedas JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004349.pub2; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bramlage P, 2007, CURR MED RES OPIN, V23, P783, DOI 10.1185/030079907X182077; Ferrari P, 2009, J HUM HYPERTENS, V23, P151, DOI 10.1038/jhh.2008.117; Fodor GJ, 2005, J HYPERTENS, V23, P1261, DOI 10.1097/01.hjh.0000170390.07321.ca; Gil-Guillen V, 2010, BLOOD PRESSURE, V19, P3, DOI 10.3109/08037050903350762; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Hyman DJ, 2002, CLEV CLIN J MED, V69, P793, DOI 10.3949/ccjm.69.10.793; *I NAC EST, MOD SAL; Kannel WB, 2003, DRUG AGING, V20, P277, DOI 10.2165/00002512-200320040-00004; Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; LABARTHE DR, 1998, EPIDEMIOLOGY PREVENT; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Margolis KL, 2005, AM J HYPERTENS, V18, P566, DOI 10.1016/j.amjhyper.2004.10.030; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Oliveria SA, 2002, ARCH INTERN MED, V162, P413, DOI 10.1001/archinte.162.4.413; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Phillips LS, 2008, ANN INTERN MED, V148, P783, DOI 10.7326/0003-4819-148-10-200805200-00011; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Redon J, 2010, J HYPERTENS, V28, P1770, DOI 10.1097/HJH.0b013e32833b4953; Roa L, 2010, MED CLIN-BARCELONA, V134, P57, DOI 10.1016/j.medcli.2009.07.049; Rose AJ, 2008, J GEN INTERN MED, V23, P180, DOI 10.1007/s11606-007-0464-1; Safford MM, 2007, J GEN INTERN MED, V22, P1648, DOI 10.1007/s11606-007-0433-8; Steinman MA, 2004, AM J MED, V117, P747, DOI 10.1016/j.amjmed.2004.03.035; Viera AJ, 2010, J AM SOC HYPERTENS, V4, P244, DOI 10.1016/j.jash.2010.07.003; Wang TJ, 2005, CIRCULATION, V112, P1651, DOI 10.1161/CIRCULATIONAHA.104.490599; Wright JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001841.pub2	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24569	10.1371/journal.pone.0024569	http://dx.doi.org/10.1371/journal.pone.0024569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935425	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700027
J	Li, XC; Wei, L; Zhang, GQ; Bai, ZL; Hu, YY; Zhou, P; Bai, SH; Chai, Z; Lakatta, EG; Hao, XM; Wang, SQ				Li, Xiao-Chen; Wei, Ling; Zhang, Guang-Qin; Bai, Zai-Ling; Hu, Ying-Ying; Zhou, Peng; Bai, Shu-Hua; Chai, Zhen; Lakatta, Edward G.; Hao, Xue-Mei; Wang, Shi-Qiang			Ca2+ Cycling in Heart Cells from Ground Squirrels: Adaptive Strategies for Intracellular Ca2+ Homeostasis	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; SARCOPLASMIC-RETICULUM; HIBERNATING CHIPMUNKS; CARDIAC-HYPERTROPHY; CALCIUM; RAT; HYPOTHERMIA; CHANNEL; MYOCARDIUM; RYANODINE	Heart tissues from hibernating mammals, such as ground squirrels, are able to endure hypothermia, hypoxia and other extreme insulting factors that are fatal for human and nonhibernating mammals. This study was designed to understand adaptive mechanisms involved in intracellular Ca2+ homeostasis in cardiomyocytes from the mammalian hibernator, ground squirrel, compared to rat. Electrophysiological and confocal imaging experiments showed that the voltage-dependence of L-type Ca2+ current (I-Ca) was shifted to higher potentials in ventricular myocytes from ground squirrels vs. rats. The elevated threshold of I-Ca did not compromise the Ca2+-induced Ca2+ release, because a higher depolarization rate and a longer duration of action potential compensated the voltage shift of I-Ca. Both the caffeine-sensitive and caffeine-resistant components of cytosolic Ca2+ removal were more rapid in ground squirrels. Ca2+ sparks in ground squirrels exhibited larger amplitude/size and much lower frequency than in rats. Due to the high I-Ca threshold, low SR Ca2+ leak and rapid cytosolic Ca2+ clearance, heart cells from ground squirrels exhibited better capability in maintaining intracellular Ca2+ homeostasis than those from rats and other nonhibernating mammals. These findings not only reveal adaptive mechanisms of hibernation, but also provide novel strategies against Ca2+ overload-related heart diseases.	[Li, Xiao-Chen; Wei, Ling; Bai, Zai-Ling; Hu, Ying-Ying; Zhou, Peng; Bai, Shu-Hua; Chai, Zhen; Hao, Xue-Mei; Wang, Shi-Qiang] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Zhang, Guang-Qin] China Pharmaceut Univ, Res Div Pharmacol, Nanjing 210009, Peoples R China; [Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA	Peking University; China Pharmaceutical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Li, XC (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	wsq@pku.edu.cn	Zhou, Peng/M-3917-2013; Lakatta, Edward G/AAL-1447-2020	Wang, Shi-Qiang/0000-0001-7784-4461; Lakatta, Edward/0000-0002-4772-0035	973 Major State Basic Research Development Program of China [2011CB809101]; 863 Program [2007AA02Z457]; National Natural Science Foundation of China [30730013]; National Institutes of Health, USA [NIH R01 TW007269]; National Institute on Aging, NIH; FOGARTY INTERNATIONAL CENTER [R01TW007269] Funding Source: NIH RePORTER	973 Major State Basic Research Development Program of China(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the 973 Major State Basic Research Development Program of China (2011CB809101); the 863 Program (2007AA02Z457); the National Natural Science Foundation of China (30730013); the National Institutes of Health, USA (NIH R01 TW007269); and the Intramural Research Program of the National Institute on Aging, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev AE, 1996, BIOPHYS J, V70, P786, DOI 10.1016/S0006-3495(96)79618-2; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; CANNELL MB, 1987, SCIENCE, V238, P1419, DOI 10.1126/science.2446391; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CHIEN SF, 1991, J THORAC CARDIOV SUR, V102, P224; DALECY LG, 1990, COMP BIOCHEM PHYS B, V96, P189, DOI 10.1016/0305-0491(90)90361-V; Fu Y, 2005, BIOPHYS J, V89, P2533, DOI 10.1529/biophysj.105.067074; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Hara A, 2005, CIRCULATION, V112, P84, DOI 10.1161/CIRCULATIONAHA.104.527077; Harris DM, 2005, CIRC RES, V96, P543, DOI 10.1161/01.RES.0000158966.58380.37; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Hoffman BF, 1960, ELECTROPHYSIOLOGY HE; Johansson BW, 1996, CARDIOVASC RES, V31, P826, DOI 10.1016/S0008-6363(95)00192-1; KAMM KE, 1979, AM J PHYSIOL, V237, pC17, DOI 10.1152/ajpcell.1979.237.1.C17; KIHARA Y, 1991, CIRC RES, V68, P1378, DOI 10.1161/01.RES.68.5.1378; KITAKAZE M, 1988, CIRCULATION, V77, P685, DOI 10.1161/01.CIR.77.3.685; KONDO N, 1986, CIRC RES, V59, P221, DOI 10.1161/01.RES.59.2.221; KONDO N, 1984, SCIENCE, V225, P641, DOI 10.1126/science.6740332; LAKATTA EG, 1993, J CARDIOVASC ELECTR, V4, P473, DOI 10.1111/j.1540-8167.1993.tb01285.x; Lalli MJ, 2001, CIRC RES, V89, P160; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; LIU B, 1993, AM J PHYSIOL, V264, pR104, DOI 10.1152/ajpregu.1993.264.1.R104; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; LYMAN GP, 1982, HIBERNATION TORPORIN; NORDREHAUG JE, 1982, BRIT MED J, V284, P867, DOI 10.1136/bmj.284.6319.867-a; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Wang SQ, 1997, CRYOBIOLOGY, V35, P193, DOI 10.1006/cryo.1997.2040; Wang SQ, 2002, J EXP BIOL, V205, P2957; Wang SQ, 1999, LIFE SCI, V65, P871, DOI 10.1016/S0024-3205(99)00317-3; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; WEIR MR, 1991, AM J MED, V90, pS32, DOI 10.1016/0002-9343(91)90483-E; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Yatani A, 2004, AM J PHYSIOL-HEART C, V286, pH2219, DOI 10.1152/ajpheart.01096.2003	35	18	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24787	10.1371/journal.pone.0024787	http://dx.doi.org/10.1371/journal.pone.0024787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935466	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700048
J	Silva, VD; Cargnelutti, MT; Giesel, GM; Palmieri, LC; Monteiro, RQ; Verli, H; Lima, LMTR				Silva, Vivian de Almeira; Cargnelutti, Maria Thereza; Giesel, Guilherme M.; Palmieri, Leonardo C.; Monteiro, Robson Q.; Verli, Hugo; Lima, Luis Mauricio T. R.			Structure and Behavior of Human alpha-Thrombin upon Ligand Recognition: Thermodynamic and Molecular Dynamics Studies	PLOS ONE			English	Article							PRO-ARG CHLOROMETHYLKETONE; PARTICLE-MESH EWALD; X-RAY-SCATTERING; CRYSTAL-STRUCTURE; PROTEIN-STRUCTURE; BINDING; DENATURATION; STABILITY; PRESSURE; MODEL	Thrombin is a serine proteinase that plays a fundamental role in coagulation. In this study, we address the effects of ligand site recognition by alpha-thrombin on conformation and energetics in solution. Active site occupation induces large changes in secondary structure content in thrombin as shown by circular dichroism. Thrombin-D-Phe-Pro-Arg-chloromethyl ketone (PPACK) exhibits enhanced equilibrium and kinetic stability compared to free thrombin, whose difference is rooted in the unfolding step. Small-angle X-ray scattering (SAXS) measurements in solution reveal an overall similarity in the molecular envelope of thrombin and thrombin-PPACK, which differs from the crystal structure of thrombin. Molecular dynamics simulations performed with thrombin lead to different conformations than the one observed in the crystal structure. These data shed light on the diversity of thrombin conformers not previously observed in crystal structures with distinguished catalytic and conformational behaviors, which might have direct implications on novel strategies to design direct thrombin inhibitors.	[Silva, Vivian de Almeira; Cargnelutti, Maria Thereza; Palmieri, Leonardo C.; Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil; [Silva, Vivian de Almeira] Fed Inst Rio de Janeiro Sci & Technol Educ, Rio De Janeiro, Brazil; [Silva, Vivian de Almeira; Cargnelutti, Maria Thereza; Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil; [Giesel, Guilherme M.; Verli, Hugo] Univ Fed Rio Grande do Sul, Sch Pharm, Porto Alegre, RS, Brazil; [Giesel, Guilherme M.; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio de Janeiro; Instituto Federal do Rio de Janeiro (IFRJ); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Silva, VD (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil.	hverli@cbiot.ufrgs.br; mauricio@pharma.ufrj.br	Palmieri, Leonardo C/A-9341-2013; Menegon Giesel, Guilherme/C-5361-2013; de Queiroz Monteiro, Robson/M-7097-2019; Lima, Luis Mauricio/AAL-2098-2021; Verli, Hugo/G-8703-2012; Monteiro, Robson/GRX-0672-2022; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Verli, Hugo/AAZ-2148-2021	Verli, Hugo/0000-0002-4796-8620; Monteiro, Robson/0000-0002-5260-2332; TR Lima, Luis Mauricio/0000-0001-6020-0504	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Nanobiotec-CAPES [04/08]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); IMBEBB; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ); Brazillian Synchrotron Light Laboratory (LNLS)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Nanobiotec-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); IMBEBB; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazillian Synchrotron Light Laboratory (LNLS)	This research was supported by the following public funding agencies: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Nanobiotec-CAPES 04/08, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), IMBEBB, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ), Programa de Apoio a Nucleos de Excelencia ("PRONEX'', FAPERJ), and the Brazillian Synchrotron Light Laboratory (LNLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banner D. W., 2003, METHODS PRINCIPLES M, V19, P163; BAUER RS, 1980, J BIOL CHEM, V255, P5900; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERENDSEN HJC, 1981, INTERM, V224, P331; BERRY RS, 2000, PHYS CHEM, P876; BIERI OKT, 2000, PROTEIN FOLDING FRON; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, PROTEIN SCI, V1, P426; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; CHANG TL, 1980, J BIOL CHEM, V255, P5904; Croy CH, 2004, BIOCHEMISTRY-US, V43, P5246, DOI 10.1021/bi0499718; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DE FV, 2005, BIOCHEM J, V390, P485; de Groot BL, 2001, J MOL BIOL, V309, P299, DOI 10.1006/jmbi.2001.4655; de Souza ON, 1999, J BIOMOL STRUCT DYN, V16, P1205, DOI 10.1080/07391102.1999.10508328; Di CE, 1995, J BIOL CHEM, V270, P22089; Doerr A, 2010, NAT METHODS, V7, P426, DOI 10.1038/nmeth0610-426; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Giesel GM, 2008, FEBS LETT, V582, P3619, DOI 10.1016/j.febslet.2008.09.041; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Guinier A., 1955, SMALL ANGLE SCATTERI; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829; KETTNER C, 1979, THROMB RES, V14, P969, DOI 10.1016/0049-3848(79)90014-8; Kirste R. G., 1982, SMALL ANGLE XRAY SCA, P387; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Lima LMTR, 2004, EUR J BIOCHEM, V271, P3580, DOI 10.1111/j.0014-2956.2004.04295.x; Lima LMTR, 2009, BBA-PROTEINS PROTEOM, V1794, P873, DOI 10.1016/j.bbapap.2009.03.011; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; Mao XA, 2004, J BIOMOL STRUCT DYN, V22, P25, DOI 10.1080/07391102.2004.10506977; Melnikova I, 2009, NAT REV DRUG DISCOV, V8, P353, DOI 10.1038/nrd2851; Mohana-Borges R, 1999, P NATL ACAD SCI USA, V96, P7888, DOI 10.1073/pnas.96.14.7888; Mohana-Borges R, 1999, J BIOL CHEM, V274, P7732, DOI 10.1074/jbc.274.12.7732; Monteiro RQ, 2004, INT J BIOCHEM CELL B, V36, P2077, DOI 10.1016/j.biocel.2004.03.007; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nair DG, 2008, J BIOMOL STRUCT DYN, V26, P387, DOI 10.1080/07391102.2008.10507253; NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Srivastava S, 2005, MED RES REV, V25, P66, DOI 10.1002/med.20016; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANGUNSTEREN WF, 1995, PHILOS T R SOC B, V348, P49, DOI 10.1098/rstb.1995.0045; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Wolf A., 1986, CRC HDB CHEM PHYS; Wuthrich K, 2010, ACTA CRYSTALLOGR F, V66, P1365, DOI 10.1107/S1744309110030320	61	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24735	10.1371/journal.pone.0024735	http://dx.doi.org/10.1371/journal.pone.0024735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935446	Green Submitted, Green Published, gold			2022-12-25	WOS:000295039700038
J	Ridley, CE; Hangelbroek, HH; Wagenius, S; Stanton-Geddes, J; Shaw, RG				Ridley, Caroline E.; Hangelbroek, Helen H.; Wagenius, Stuart; Stanton-Geddes, John; Shaw, Ruth G.			The Effect of Plant Inbreeding and Stoichiometry on Interactions with Herbivores in Nature: Echinacea angustifolia and Its Specialist Aphid	PLOS ONE			English	Article							GENETIC-VARIATION; INSECT HERBIVORE; POLLEN DISPERSAL; MIMULUS-GUTTATUS; TOP-DOWN; RESISTANCE; HISTORY; NITROGEN; FITNESS; GROWTH	Fragmentation of once widespread communities may alter interspecific interactions by changing genetic composition of interacting populations as well as their abundances and spatial distributions. In a long-term study of a fragmented population of Echinacea angustifolia, a perennial plant native to the North American prairie, we investigated influences on its interaction with a specialist aphid and tending ants. We grew plant progeny of sib-matings (I), and of random pairings within (W) and between (B) seven remnants in a common field within 8 km of the source remnants. During the fifth growing season, we determined each plant's burden of aphids and ants, as well as its size and foliar elemental composition (C, N, P). We also assayed composition (C, N) of aphids and ants. Early in the season, progeny from genotypic classes B and I were twice as likely to harbor aphids, and in greater abundance, than genotypic class W; aphid loads were inversely related to foliar concentration of P and positively related to leaf N and plant size. At the end of the season, aphid loads were indistinguishable among genotypic classes. Ant abundance tracked aphid abundance throughout the season but showed no direct relationship with plant traits. Through its potential to alter the genotypic composition of remnant populations of Echinacea, fragmentation can increase Echinacea's susceptibility to herbivory by its specialist aphid and, in turn, perturb the abundance and distribution of aphids.	[Ridley, Caroline E.; Hangelbroek, Helen H.; Stanton-Geddes, John; Shaw, Ruth G.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Wagenius, Stuart] Chicago Bot Garden, Div Plant Sci & Conservat, Glencoe, IL USA	University of Minnesota System; University of Minnesota Twin Cities	Ridley, CE (corresponding author), US EPA, Natl Ctr Environm Assessment, Arlington, VA USA.	shawx016@umn.edu		Stanton-Geddes, John/0000-0003-4667-2542; Ridley, Caroline/0000-0003-2433-1325	University of Minnesota Center for Community Genetics; Bell Museum of Natural History; Graduate School of the University of Minnesota; NSF [DEB-0544970, DEB-0545072, DMS-0083468]	University of Minnesota Center for Community Genetics(University of Minnesota System); Bell Museum of Natural History; Graduate School of the University of Minnesota(University of Minnesota System); NSF(National Science Foundation (NSF))	This research was initiated with funding from the University of Minnesota Center for Community Genetics, the Dayton and Wilkie Funds of the Bell Museum of Natural History, and the Graduate School of the University of Minnesota. NSF grants DEB-0544970, DEB-0545072, and DMS-0083468 supported acquisition of the data for this study (http://nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; BERTRAM SM, 2008, J INSECT SCI, V26, P1; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Davies FT, 2004, J AM SOC HORTIC SCI, V129, P344, DOI 10.21273/JASHS.129.3.0344; Delphia CM, 2009, ECOL ENTOMOL, V34, P513, DOI 10.1111/j.1365-2311.2009.01097.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2007, APHIDS AS CROP PESTS, P115, DOI 10.1079/9780851998190.0115; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; FRITZ RS, 1992, PLANT RESISTANCE HER; GANGE AC, 1995, ECOLOGY, V76, P2074, DOI 10.2307/1941682; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; Grindeland JM, 2008, J EVOLUTION BIOL, V21, P716, DOI 10.1111/j.1420-9101.2008.01519.x; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Hull-Sanders HM, 2005, ECOLOGY, V86, P897, DOI 10.1890/04-0935; Ivey CT, 2009, HEREDITY, V102, P303, DOI 10.1038/hdy.2008.122; Jeyasingh PD, 2007, MOL ECOL, V16, P4649, DOI 10.1111/j.1365-294X.2007.03558.x; Jeyasingh PD, 2009, ECOL LETT, V12, P1229, DOI 10.1111/j.1461-0248.2009.01368.x; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kay AD, 2006, FUNCT ECOL, V20, P1037, DOI 10.1111/j.1365-2435.2006.01187.x; Kay AD, 2004, ECOL LETT, V7, P1024, DOI 10.1111/j.1461-0248.2004.00667.x; Lagos D. M., 2009, Great Lakes Entomologist, V42, P91; Leimu R, 2008, ECOL LETT, V11, P1101, DOI 10.1111/j.1461-0248.2008.01222.x; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; PRICE MV, 1979, NATURE, V277, P294, DOI 10.1038/277294a0; R Development Core Team, 2009, R FDN STAT COMP; RIZZI E, 1991, EUPHYTICA, V52, P91; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Schulke B, 2001, OECOLOGIA, V127, P239, DOI 10.1007/s004420000586; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; Stiling P, 1997, ECOLOGY, V78, P1602, DOI 10.1890/0012-9658(1997)078[1602:EMOTDA]2.0.CO;2; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Wagenius S, 2006, ECOLOGY, V87, P931, DOI 10.1890/0012-9658(2006)87[931:SDORFI]2.0.CO;2; Wagenius S, 2004, INT J PLANT SCI, V165, P595, DOI 10.1086/386376; WAGENIUS S, 2011, RESTORATION ECOLOGY; Wagenius S, 2007, AM NAT, V169, P383, DOI 10.1086/511313; Wagenius S, 2010, EVOLUTION, V64, P761, DOI 10.1111/j.1558-5646.2009.00860.x; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790	48	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24762	10.1371/journal.pone.0024762	http://dx.doi.org/10.1371/journal.pone.0024762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21935460	Green Submitted, gold, Green Published			2022-12-25	WOS:000295321800061
J	Oliveira, MT; Kaguni, LS				Oliveira, Marcos T.; Kaguni, Laurie S.			Reduced Stimulation of Recombinant DNA Polymerase gamma and Mitochondrial DNA (mtDNA) Helicase by Variants of Mitochondrial Single-stranded DNA-binding Protein (mtSSB) Correlates with Defects in mtDNA Replication in Animal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTIONS; DROSOPHILA EMBRYOS; TWINKLE; MUTATIONS; REGION; DOMAIN; PROCESSIVITY; MUTANTS	The mitochondrial single-stranded DNA-binding protein (mtSSB) is believed to coordinate the functions of DNA polymerase gamma (pot gamma) and the mitochondrial DNA (mtDNA) helicase at the mtDNA replication fork. We generated five variants of the human mtSSB bearing mutations in amino acid residues specific to metazoans that map on the protein surface, removed from the single-stranded DNA (ssDNA) binding groove. Although the mtSSB variants bound ssDNA with only slightly different affinities, they exhibited distinct capacities to stimulate the DNA polymerase activity of human pot gamma and the DNA unwinding activity of human mtDNA helicase in vitro. Interestingly, we observed that the variants with defects in stimulating pot gamma had unaltered capacities to stimulate the mtDNA helicase; at the same time, variants showing reduced stimulation of the mtDNA helicase activity promoted DNA synthesis by pot gamma similarly to the wild-type mtSSB. The overexpression of the equivalent variants of Drosophila inelanogaster mtSSB in S2 cells in culture caused mtDNA depletion under conditions of mitochondrial homeostasis. Furthermore, we observed more severe reduction of mtDNA copy number upon expression of these proteins during recovery from treatment with ethidium bromide, when mtDNA replication is stimulated in vivo. Our findings suggest that mtSSB uses distinct structural elements to interact functionally with its intDNA replisome partners and to promote proper mtDNA replication in animal cells.	[Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, 319 Biochem Bldg, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Oliveira, Marcos/B-3249-2014; Oliveira, Marcos Túlio/AAN-2804-2020	Oliveira, Marcos/0000-0003-4779-5755; 	National Institutes of Health [GM45295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45295.	Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bortot B, 2009, DIGEST LIVER DIS, V41, P494, DOI 10.1016/j.dld.2008.11.013; BUJALOWSKI W, 1991, J BIOL CHEM, V266, P1616; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109; Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618; Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779; Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Li K, 1997, J BIOL CHEM, V272, P8686, DOI 10.1074/jbc.272.13.8686; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026; Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379; Oliveira MT, 2009, METHODS MOL BIOL, V554, P37, DOI 10.1007/978-1-59745-521-3_3; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; WILLIAMS AJ, 1993, J BIOL CHEM, V268, P24855; Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d	43	37	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40649	40658		10.1074/jbc.M111.289983	http://dx.doi.org/10.1074/jbc.M111.289983			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953457	Green Published, hybrid			2022-12-25	WOS:000297315400026
J	Bolger, TA; Wente, SR				Bolger, Timothy A.; Wente, Susan R.			Gle1 Is a Multifunctional DEAD-box Protein Regulator That Modulates Ded1 in Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE COMPLEX; EUKARYOTIC TRANSLATION; SACCHAROMYCES-CEREVISIAE; INOSITOL HEXAKISPHOSPHATE; CYTOPLASMIC FIBRILS; CONSERVED MECHANISM; ATPASE ACTIVITY; START CODON; DBP5 CYCLE	DEAD-box protein (Dbp) family members are essential for gene expression; however, their precise roles and regulation are not fully defined. During messenger (m) RNA export, Gle1 bound to inositol hexakisphosphate (IP6) acts via Dbp5 to facilitate remodeling of mRNA-protein complexes. In contrast, here we define a novel Gle1 role in translation initiation through regulation of a different DEAD-box protein, the initiation factor Ded1. We find that Gle1 physically and genetically interacts with Ded1. Surprisingly, whereas Gle1 stimulates Dbp5, it inhibits Ded1 ATPase activity in vitro, and IP6 does not affect this inhibition. Functionally, a gle1-4 mutant specifically suppresses initiation defects in a ded1-120 mutant, and ded1 and gle1 mutants have complementary perturbations in AUG start site recognition. Consistent with this role in initiation, Gle1 inhibits translation in vitro in competent extracts. These results indicate that Gle1 has a direct role in initiation and negatively regulates Ded1. Together, the differential regulation of two distinct DEAD-box proteins by a common factor (Gle1) establishes a new paradigm for controlling gene expression and coupling translation with mRNA export.	[Bolger, Timothy A.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 465 21st Ave S, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu			National Institutes of Health [R37-GM51219, F32-GM082065]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082065, R37GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM51219 (to S. R. W.) and F32-GM082065 (to T. A. B.).	Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Del Priore V, 1997, J CELL SCI, V110, P2987; DONAHUE TF, 1988, MOL CELL BIOL, V8, P2955, DOI 10.1128/MCB.8.7.2955; Dossani ZY, 2009, P NATL ACAD SCI USA, V106, P16251, DOI 10.1073/pnas.0902251106; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Linder P, 2003, BIOL CELL, V95, P157, DOI 10.1016/S0248-4900(03)00032-7; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Marsden S, 2006, J MOL BIOL, V361, P327, DOI 10.1016/j.jmb.2006.06.016; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Mitchell SF, 2008, J BIOL CHEM, V283, P27345, DOI 10.1074/jbc.R800031200; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stewart M, 2010, TRENDS BIOCHEM SCI, V35, P609, DOI 10.1016/j.tibs.2010.07.001; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Watanabe R, 2010, J BIOL CHEM, V285, P21922, DOI 10.1074/jbc.M110.132027; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	52	32	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39750	39759		10.1074/jbc.M111.299321	http://dx.doi.org/10.1074/jbc.M111.299321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949122	hybrid, Green Published			2022-12-25	WOS:000296925700008
J	Lee, WS; Kang, C; Drayna, D; Kornfeld, S				Lee, Wang-Sik; Kang, Changsoo; Drayna, Dennis; Kornfeld, Stuart			Analysis of Mannose 6-Phosphate Uncovering Enzyme Mutations Associated with Persistent Stuttering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-N-ACETYLGLUCOSAMINIDASE	GlcNAc-1-phosphodiester-N-acetylglucosaminidase ("uncovering enzyme" (UCE); EC 3.1.4.45) is a Golgi enzyme that mediates the second step in the synthesis of the mannose 6-phosphate lysosomal targeting signal on acid hydrolases. Recently, three mutations (two missense and one deletion/frameshift) in the NAGPA gene that encodes UCE have been identified in individuals with persistent stuttering. We now demonstrate that each mutation leads to lower cellular UCE activity. The p.R328C mutation impairs folding in the endoplasmic reticulum, resulting in degradation of a significant portion by the proteasomal system. The p.H84Q mutation also impairs folding and, in addition, decreases the specific activity of the enzyme that folds sufficiently to traffic to the Golgi. The p.F513SfsX113 frameshift mutation adds 113 amino acids to the C terminus of the cytoplasmic tail of the protein, including a VWLL sequence that causes rapid degradation via the proteasomal system. These biochemical findings extend the genetic data implicating mutations	[Lee, Wang-Sik; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Kang, Changsoo; Drayna, Dennis] NIDCD, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@wustl.edu			National Institutes of Health (NIH), NIDCD [Grant Z01-00046-11]; NIH [CA08759]; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011332, ZIADC000046] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIDCD, Grant Z01-00046-11 (to D. D.) and by NIH Grant CA08759 (to S. K.).	Bloodstein O, 2007, HDB STUTTERING, Vsixth; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; Kang CS, 2011, ANNU REV GENOM HUM G, V12, P145, DOI 10.1146/annurev-genom-090810-183119; Kang C, 2010, NEW ENGL J MED, V362, P677, DOI 10.1056/NEJMoa0902630; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; KORNFELD S, 2000, METABOLIC MOL BASES, P3469; MULLIS KG, 1992, ANAL BIOCHEM, V205, P200, DOI 10.1016/0003-2697(92)90424-6; Park B, 2010, J EXP MED, V207, P2033, DOI 10.1084/jem.20091793; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5	13	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39786	39793		10.1074/jbc.M111.295899	http://dx.doi.org/10.1074/jbc.M111.295899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21956109	hybrid, Green Published			2022-12-25	WOS:000296925700012
J	Leskov, KS; Araki, S; Lavik, JP; Gomez, JA; Gama, V; Gonos, ES; Trougakos, IP; Matsuyama, S; Boothman, DA				Leskov, Konstantin S.; Araki, Shinako; Lavik, John-Paul; Gomez, Jose A.; Gama, Vivian; Gonos, Efstathios S.; Trougakos, Ioannis P.; Matsuyama, Shigemi; Boothman, David A.			CRM1 Protein-mediated Regulation of Nuclear Clusterin (nCLU), an Ionizing Radiation-stimulated, Bax-dependent Pro-death Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; INDUCED APOPTOSIS; EPITHELIAL-CELLS; IN-VITRO; EXPRESSION; CHAPERONE; EXPORT; LOCALIZATION; ACTIVATION; INDUCTION	Expression of the clusterin (CLU) gene results in the synthesis of a conventional secretory isoform set (pre- and mature secretory clusterin proteins, psCLU/sCLU), as well as another set of intracellular isoforms, appearing in the cytoplasm (pre-nuclear CLU, pnCLU) and in the nucleus as an similar to 55-kDa mature nuclear clusterin (nCLU) form. These two isoform sets have opposing cell functions: pro-survival and pro-death, respectively. Although much is known about the regulation and function of sCLU as a pro-survival factor, the regulation and function of endogenous nCLU in cell death are relatively unexplored. Here, we show that depletion of endogenous nCLU protein using siRNA specific to its truncated mRNA increased clonogenic survival of ionizing radiation (IR)-exposed cells. nCLU-mediated apoptosis was Bax-dependent, and lethality correlated with accumulation of mature nCLU protein. nCLU accumulation was regulated by CRM1 because binding between CRM1 and nCLU proteins was significantly diminished by leptomycin B (LMB), and nuclear levels of nCLU protein were significantly enhanced by LMB and IR co-treatment. Moreover, LMB treatment significantly enhanced IR-induced nCLU-mediated cell death responses. Importantly, bax(-/-) and bax(-/-)/bak(-/-) double knock-out cells were resistant to nCLU-mediated cell death, whereas bak(-/-) or wild-type bax(+/+)/bak(+/+) cells were hypersensitive. The regulation of nCLU by CRM1 nuclear export/import may explain recent clinical results showing that highly malignant tumors have lost the ability to accumulate nCLU levels, thereby avoiding growth inhibition and cell death.	[Leskov, Konstantin S.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44109 USA; [Lavik, John-Paul; Gomez, Jose A.; Gama, Vivian; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44109 USA; [Matsuyama, Shigemi] Case Western Reserve Univ, Dept Hematol Oncol, Cleveland, OH 44109 USA; [Gonos, Efstathios S.] Natl Hellen Res Fdn, Lab Mol & Cellular Aging, Inst Biol Res & Biotechnol, Athens 11635, Greece; [Trougakos, Ioannis P.] Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens 15784, Greece; [Araki, Shinako; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Lab Mol Cell Stress Responses, Program Cell Stress & Canc Nanomed,Simmons Compre, Dallas, TX 75390 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Hellenic Research Foundation; National & Kapodistrian University of Athens; University of Texas System; University of Texas Southwestern Medical Center Dallas	Leskov, KS (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44109 USA.	ksl9@case.edu; david.boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019; Trougakos, Ioannis/R-6149-2018; Leskov, Konstantin S/J-2339-2017	Trougakos, Ioannis/0000-0002-6179-2772; Leskov, Konstantin S/0000-0001-6201-5660; Gama, Vivian/0000-0002-1201-1394	Department of Energy [DE-FG02-09ER64789]; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA078530, R01CA139217] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Energy Grant DE-FG02-09ER64789 (to D. A. B.). This is paper CSCN070 from the University of Texas Southwestern program in cell stress and cancer nanomedicine.	BOOTHMAN DA, 1989, CANCER RES, V49, P605; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Caccamo AE, 2003, ANN NY ACAD SCI, V1010, P514, DOI 10.1196/annals.1299.095; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Debure L, 2003, J CELL SCI, V116, P3109, DOI 10.1242/jcs.00619; Feng ZH, 2004, J BIOL CHEM, V279, P28574, DOI 10.1074/jbc.M404137200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; He HZ, 2004, WORLD J GASTROENTERO, V10, P1387; July LV, 2004, MOL CANCER THER, V3, P223; Kim N., 2011, J CELL PHYSL    0512, DOI [10.1022/jcp.22836, DOI 10.1022/JCP.22836]; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee DH, 2011, BIOCHEM BIOPH RES CO, V408, P541, DOI 10.1016/j.bbrc.2011.04.054; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Markopoulou S, 2009, FEBS J, V276, P4208, DOI 10.1111/j.1742-4658.2009.07093.x; O'Sullivan J, 2003, CELL DEATH DIFFER, V10, P914, DOI 10.1038/sj.cdd.4401254; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Porter LA, 2003, BLOOD, V101, P1928, DOI 10.1182/blood-2002-04-1103; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Redondo M, 2000, AM J PATHOL, V157, P393, DOI 10.1016/S0002-9440(10)64552-X; Sutton D, 2006, INT J NANOMED, V1, P155, DOI 10.2147/nano.2006.1.2.155; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yang CR, 1999, NUCLEIC ACIDS RES, V27, P2165, DOI 10.1093/nar/27.10.2165; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	33	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40083	40090		10.1074/jbc.M111.252957	http://dx.doi.org/10.1074/jbc.M111.252957			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953454	hybrid, Green Published			2022-12-25	WOS:000296925700041
J	Levi, B; Wan, DC; Glotzbach, JP; Hyun, J; Januszyk, M; Montoro, D; Sorkin, M; James, AW; Nelson, ER; Li, SL; Quarto, N; Lee, M; Gurtner, GC; Longaker, MT				Levi, Benjamin; Wan, Derrick C.; Glotzbach, Jason P.; Hyun, Jeong; Januszyk, Michael; Montoro, Daniel; Sorkin, Michael; James, Aaron W.; Nelson, Emily R.; Li, Shuli; Quarto, Natalina; Lee, Min; Gurtner, Geoffrey C.; Longaker, Michael T.			CD105 Protein Depletion Enhances Human Adipose-derived Stromal Cell Osteogenesis through Reduction of Transforming Growth Factor beta 1 (TGF-beta 1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CALVARIAL DEFECTS; STEM-CELLS; ENDOTHELIAL-CELLS; TEMPORAL-CHANGES; IN-VITRO; BONE; ENDOGLIN; TISSUE; DIFFERENTIATION; MODULATION	Clinically available sources of bone for repair and reconstruction are limited by the accessibility of autologous grafts, infectious risks of cadaveric materials, and durability of synthetic substitutes. Cell-based approaches for skeletal regeneration can potentially fill this need, and adipose tissue represents a promising source for development of such therapies. Here, we enriched for an osteogenic subpopulation of cells derived from human subcutaneous adipose tissue utilizing microfluidic-based single cell transcriptional analysis and fluorescence-activated cell sorting (FACS). Statistical analysis of single cell transcriptional profiles demonstrated that low expression of endoglin (CD105) correlated with a subgroup of adipose-derived cells with increased osteogenic gene expression. FACS-sorted CD105(low) cells demonstrated significantly enhanced in vitro osteogenic differentiation and in vivo bone regeneration when compared with either CD105(high) or unsorted cells. Evaluation of the endoglin pathway suggested that enhanced osteogenesis among CD105(low) adipose-derived cells is likely due to identification of a subpopulation with lower TGF-beta 1/Smad2 signaling. These findings thus highlight a potential avenue to promote osteogenesis in adipose-derived mesenchymal cells for skeletal regeneration.	[Levi, Benjamin; Wan, Derrick C.; Glotzbach, Jason P.; Hyun, Jeong; Januszyk, Michael; Montoro, Daniel; Sorkin, Michael; James, Aaron W.; Nelson, Emily R.; Li, Shuli; Quarto, Natalina; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Sch Med, Dept Surg,Plast & Reconstruct Surg Div, Stanford, CA 94305 USA; [Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Lee, Min] Univ Calif Los Angeles, Sch Dent, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90095 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles	Gurtner, GC (corresponding author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Sch Med, Dept Surg,Plast & Reconstruct Surg Div, 257 Campus Dr, Stanford, CA 94305 USA.	ggurtner@stanford.edu; longaker@stanford.edu	Glotzbach, Jason P./O-4394-2019	Glotzbach, Jason P./0000-0002-8002-9422; Montoro, Daniel/0000-0002-6222-2149; Wan, Derrick/0000-0003-4666-1683	National Institutes of Health, NIDCR [1 R21 DE019274-01, 1 RC2 DE020771-01]; NIDDK [2 RO1 DK074095-07]; National Endowment for Plastic Surgery; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health through the NIAMS [1F32AR057302-02]; National Institutes of Health National Research Service [F32DK088448-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020771, R21DE019274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074095] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Endowment for Plastic Surgery; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 R21 DE019274-01 and 1 RC2 DE020771-01 from the NIDCR (to M. T. L.) and 2 RO1 DK074095-07 from the NIDDK (to G. C. G). This work was also supported by grants from the National Endowment for Plastic Surgery, the Oak Foundation, and the Hagey Laboratory for Pediatric Regenerative Medicine (to M. T. L.).; Supported by the National Institutes of Health Grant 1F32AR057302-02 through the NIAMS.; Supported by the National Institutes of Health National Research Service Award Grant F32DK088448-01.	[Anonymous], HCUP FACTS FIGURES S; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eadie W. T., 1971, STAT METHODS EXPT PH, P313; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Glotzbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021211; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Gupta DM, 2008, J CRANIOFAC SURG, V19, P192, DOI 10.1097/scs.0b013e31815c93b7; Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088; Holmes AM, 2011, J CELL COMMUN SIGNAL, V5, P173, DOI 10.1007/s12079-011-0140-4; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jiang T, 2010, BIOMATERIALS, V31, P3564, DOI 10.1016/j.biomaterials.2010.01.050; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kumar P, 1996, J PATHOL, V178, P363, DOI 10.1002/(SICI)1096-9896(199604)178:4<363::AID-PATH491>3.0.CO;2-8; Lee M, 2007, BIOMATERIALS, V28, P1862, DOI 10.1016/j.biomaterials.2006.12.006; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Levi B, 2011, STEM CELLS, V29, P1241, DOI 10.1002/stem.670; Levi B, 2010, PLAST RECONSTR SURG, V126, P822, DOI 10.1097/PRS.0b013e3181e5f892; Levi B, 2010, PLAST RECONSTR SURG, V126, P412, DOI 10.1097/PRS.0b013e3181df64dc; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li S, 2007, AM J PHYSIOL-CELL PH, V293, pC1834, DOI 10.1152/ajpcell.00135.2007; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nassiri F, 2011, ANTICANCER RES, V31, P2283; ONG LDY, 1968, HEALTH PHYS, V14, P376; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Peterson LE, 2008, INT J APPROX REASON, V47, P17, DOI 10.1016/j.ijar.2007.03.006; Pohl David, 2011, Acta Medica (Hradec Kralove), V54, P59; Rada T, 2011, J TISSUE ENG REGEN M, V5, P655, DOI 10.1002/term.364; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Wallace SA, 1999, PERCEPT MOTOR SKILL, V88, P759, DOI 10.2466/PMS.88.3.759-764; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Xu Y, 2009, TISSUE ENG PT A, V15, P3697, DOI [10.1089/ten.tea.2009.0213, 10.1089/ten.TEA.2009.0213]; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Yu G, 2010, CYTOTHERAPY, V12, P538, DOI 10.3109/14653241003649528; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhang LY, 2011, BLOOD, V118, P88, DOI 10.1182/blood-2010-12-325019; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	55	119	123	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39497	39509		10.1074/jbc.M111.256529	http://dx.doi.org/10.1074/jbc.M111.256529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949130	Green Published, hybrid			2022-12-25	WOS:000296759800067
J	Snyder, M; Huang, XY; Zhang, JJ				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			Signal Transducers and Activators of Transcription 3 (STAT3) Directly Regulates Cytokine-induced Fascin Expression and Is Required for Breast Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; TUMOR-METASTASIS; CARCINOMA-CELLS; BETA-CATENIN; ONCOSTATIN-M; INTERLEUKIN-6; GENE; MICE; PROGRESSION	The cytokines oncostatin M (OSM) and IL-6 promote breast cancer cell migration and metastasis. Both cytokines activate STAT3, a member of the STAT (signal transducers and activators of transcription) family of transcription factors. Through transcriptional regulation of its target genes, STAT3 controls a wide range of cellular processes, including cellular proliferation, oncogenesis, and cancer metastasis. Fascin is an actin-bundling protein involved in cell migration. Elevated levels of fascin expression are found in many metastatic cancers, and inhibition of fascin function by small chemical compounds leads to a block of tumor metastasis. In this work, we demonstrate that fascin is a direct STAT3 target gene in response to OSM and IL-6 in both mouse and human breast cancer cells. We show that NF kappa B also binds to the fascin promoter in response to cytokine treatment and this binding is STAT3-dependent. Both STAT3 and NF kappa B are required for the cytokine-induced expression of fascin in cancer cells. Furthermore, we demonstrate that STAT3, in directly controlling fascin expression, is both necessary and sufficient for breast cancer cell migration.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University	Zhang, JJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	jjz2002@med.cornell.edu			National Institutes of Health [CA136837]; NATIONAL CANCER INSTITUTE [R01CA136837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136837 ( to X.-Y.H.).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Aparicio OM, 2005, CURR PROTOC MOL BIOL; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hashimoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005130; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Jorcyk CL, 2006, CYTOKINE, V33, P323, DOI 10.1016/j.cyto.2006.03.004; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Said NABM, 2011, CELLS TISSUES ORGANS, V193, P85, DOI 10.1159/000320360; Santos CI, 2011, BBA-REV CANCER, V1816, P38, DOI 10.1016/j.bbcan.2011.03.003; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Snyder M, 2011, FEBS LETT, V585, P148, DOI 10.1016/j.febslet.2010.11.030; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	41	74	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38886	38893		10.1074/jbc.M111.286245	http://dx.doi.org/10.1074/jbc.M111.286245			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937440	Green Published, hybrid			2022-12-25	WOS:000296759800007
J	Belanger, MC; Di Cristo, G				Belanger, Marie-Claude; Di Cristo, Graziella			Sensory Experience Differentially Modulates the mRNA Expression of the Polysialyltransferases ST8SiaII and ST8SiaIV in Postnatal Mouse Visual Cortex	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CRITICAL PERIOD PLASTICITY; NMDA RECEPTOR ACTIVATION; CENTRAL-NERVOUS-SYSTEM; POLYSIALIC ACID; SYNAPTIC PLASTICITY; PSA-NCAM; GABAERGIC INNERVATION; BRAIN DEVELOPMENT; BRANCH FORMATION	Polysialic acid (PSA) is a unique carbohydrate composed of a linear homopolymer of alpha-2,8 linked sialic acid, and is mainly attached to the fifth immunoglobulin-like domain of the neural cell adhesion molecule (NCAM) in vertebrate neural system. In the brain, PSA is exclusively synthesized by the two polysialyltransferases ST8SiaII (also known as STX) and ST8SiaIV (also known as PST). By modulating adhesive property of NCAM, PSA plays a critical role in several neural development processes such as cell migration, neurite outgrowth, axon pathfinding, synaptogenesis and activity-dependent plasticity. The expression of PSA is temporally and spatially regulated during neural development and a tight regulation of PSA expression is essential to its biological function. In mouse visual cortex, PSA is downregulated following eye opening and its decrease allows the maturation of GABAergic synapses and the opening of the critical period for ocular dominance plasticity. Relatively little is known about how PSA levels are regulated by sensory experience and neuronal activity. Here, we demonstrate that while both ST8SiaII and ST8SiaIV mRNA levels decrease around the time of eye opening in mouse visual cortex, only ST8SiaII mRNA level reduction is regulated by sensory experience. Using an organotypic culture system from mouse visual cortex, we further show that ST8SiaII gene expression is regulated by spiking activity and NMDA-mediated excitation. Further, we show that both ST8SiaII and ST8SiaIV mRNA levels are positively regulated by PKC-mediated signaling. Therefore, sensory experience-dependent ST8SiaII gene expression regulates PSA levels in postnatal visual cortex, thus acting as molecular link between visual activity and PSA expression.	[Belanger, Marie-Claude] CHU St Justine, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Belanger, MC (corresponding author), CHU St Justine, Montreal, PQ, Canada.	graziella.dicristo@recherche-ste-justine.qc.ca			CIHR; NARSAD; Scottish Rite Charitable Foundation; CFI; Canada Research Chair program; Sainte-Justine Hospital Foundation; Foundation of the Stars	CIHR(Canadian Institutes of Health Research (CIHR)); NARSAD(NARSAD); Scottish Rite Charitable Foundation; CFI(Canada Foundation for Innovation); Canada Research Chair program(Canada Research Chairs); Sainte-Justine Hospital Foundation; Foundation of the Stars	GDC has support from CIHR, NARSAD, Scottish Rite Charitable Foundation, CFI and Canada Research Chair program. MCB has a fellowship from Sainte-Justine Hospital Foundation and Foundation of the Stars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bouzioukh F, 2001, EUR J NEUROSCI, V14, P1194, DOI 10.1046/j.0953-816x.2001.01748.x; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Burgess A, 2006, J NEUROCHEM, V99, P797, DOI 10.1111/j.1471-4159.2006.04110.x; Castillo-Gomez E, 2008, EXP NEUROL, V214, P97, DOI 10.1016/j.expneurol.2008.07.018; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Echevarria D, 2000, DEV BRAIN RES, V123, P151, DOI 10.1016/S0165-3806(00)00089-4; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Flint AC, 1997, J NEUROPHYSIOL, V78, P1990, DOI 10.1152/jn.1997.78.4.1990; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Gallagher HC, 2001, J NEUROCHEM, V77, P425, DOI 10.1046/j.1471-4159.2001.00235.x; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; MIRMIRAN M, 1982, DEV BRAIN RES, V3, P37, DOI 10.1016/0165-3806(82)90074-8; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nakagawa S, 2002, J NEUROSCI, V22, P9868; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Theodosis DT, 1999, J NEUROSCI, V19, P10228; Uesaka N, 2005, J NEUROSCI, V25, P1, DOI 10.1523/JNEUROSCI.3855-04.2005; Varea E, 2007, NEUROPSYCHOPHARMACOL, V32, P803, DOI 10.1038/sj.npp.1301183; Vo NK, 2010, CURR OPIN NEUROBIOL; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Wang CK, 1996, BRIT J DERMATOL, V135, P135; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamamoto N, 2000, J NEUROSCI, V20, P9145; Zieg J, 2008, CELL, V134, DOI 10.1016/j.cell.2008.09.010	57	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24874	10.1371/journal.pone.0024874	http://dx.doi.org/10.1371/journal.pone.0024874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957465	gold, Green Published, Green Submitted			2022-12-25	WOS:000295262100024
J	Dayal, S; Nedbal, J; Hobson, P; Cooper, AM; Gould, HJ; Gellert, M; Felsenfeld, G; Fear, DJ				Dayal, Sandeep; Nedbal, Jakub; Hobson, Philip; Cooper, Alison M.; Gould, Hannah J.; Gellert, Martin; Felsenfeld, Gary; Fear, David J.			High Resolution Analysis of the Chromatin Landscape of the IgE Switch Region in Human B Cells	PLOS ONE			English	Article							CYTIDINE DEAMINASE AID; RNA-POLYMERASE-II; HISTONE ACETYLATION; PLANT HOMEODOMAIN; GERMINAL CENTER; TARGETS DNA; TRANSCRIPTION; LYSINE-4; METHYLATION; GENES	Antibodies are assembled by a highly orchestrated series of recombination events during B cell development. One of these events, class switch recombination, is required to produce the IgG, IgE and IgA antibody isotypes characteristic of a secondary immune response. The action of the enzyme activation induced cytidine deaminase is now known to be essential for the initiation of this recombination event. Previous studies have demonstrated that the immunoglobulin switch regions acquire distinct histone modifications prior to recombination. We now present a high resolution analysis of these histone modifications across the IgE switch region prior to the initiation of class switch recombination in primary human B cells and the human CL-01 B cell line. These data show that upon stimulation with IL-4 and an anti-CD40 antibody that mimics T cell help, the nucleosomes of the switch regions are highly modified on histone H3, accumulating acetylation marks and tri-methylation of lysine 4. Distinct peaks of modified histones are found across the switch region, most notably at the 5' splice donor site of the germline (I) exon, which also accumulates AID. These data suggest that acetylation and K4 tri-methylation of histone H3 may represent marks of recombinationally active chromatin and further implicates splicing in the regulation of AID action.	[Dayal, Sandeep; Gellert, Martin; Felsenfeld, Gary] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Nedbal, Jakub; Hobson, Philip; Cooper, Alison M.; Gould, Hannah J.; Fear, David J.] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Nedbal, Jakub; Hobson, Philip; Cooper, Alison M.; Gould, Hannah J.; Fear, David J.] Kings Coll London, MRC, London WC2R 2LS, England; [Nedbal, Jakub; Hobson, Philip; Cooper, Alison M.; Gould, Hannah J.; Fear, David J.] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Nedbal, Jakub; Hobson, Philip; Cooper, Alison M.; Gould, Hannah J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Dayal, S (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	garyf@intra.niddk.nih.gov; david.fear@kcl.ac.uk		Gould, Hannah/0000-0003-0411-688X; Cooper, Alison/0000-0002-0815-0084; Fear, David/0000-0003-0239-8385	Asthma U.K.; Biotechnology and Biological Sciences Research Council [BB/H019634/1]; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA; UK Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; King's College London; Research Councils U.K.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036167, ZIADK036168] Funding Source: NIH RePORTER; BBSRC [BB/H019634/1] Funding Source: UKRI; MRC [G0400106, G0501494] Funding Source: UKRI; Medical Research Council [G0501494, G1000758B, G1000758, G0400106] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Asthma U.K.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Institute of Neurological Disorders & Stroke (NINDS)); UK Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; Research Councils U.K.(UK Research & Innovation (UKRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	D.F. is a Research Councils U.K. funded Fellow and has been further supported by Asthma U.K. funded core support for the MRC & Asthma U.K. Centre for Allergic Mechanisms of Asthma. This work has been supported by a Biotechnology and Biological Sciences Research Council grant BB/H019634/1, and the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA. The authors further acknowledge financial support from the UK Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chowdhury M, 2008, P NATL ACAD SCI USA, V105, P15872, DOI 10.1073/pnas.0808462105; Fear DJ, 2004, J IMMUNOL, V173, P4529, DOI 10.4049/jimmunol.173.7.4529; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GASCAN H, 1991, J IMMUNOL, V147, P8; GAUCHAT JF, 1992, J IMMUNOL, V148, P2291; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567; Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5; JUMPER MD, 1994, J IMMUNOL, V152, P438; KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li ZQ, 2004, P NATL ACAD SCI USA, V101, P15428, DOI 10.1073/pnas.0406827101; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; LUNDGREN M, 1989, EUR J IMMUNOL, V19, P1311, DOI 10.1002/eji.1830190724; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McCloskey N, 1999, EUR J IMMUNOL, V29, P3236, DOI 10.1002/(SICI)1521-4141(199910)29:10<3236::AID-IMMU3236>3.0.CO;2-T; Morris K, 2005, CELL MOL LIFE SCI, V62, P3057, DOI 10.1007/s00018-005-5182-4; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; SPLAWSKI JB, 1993, J IMMUNOL, V150, P1276; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wang LL, 2006, J EXP MED, V203, P215, DOI 10.1084/jem.20051774; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Zan H, 1998, J IMMUNOL, V161, P5217	51	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24571	10.1371/journal.pone.0024571	http://dx.doi.org/10.1371/journal.pone.0024571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949728	gold, Green Published			2022-12-25	WOS:000295260400007
J	Pepin, J; Deslandes, S; Giroux, G; Sobela, F; Khonde, N; Diakite, S; Demeule, S; Labbe, AC; Carrier, N; Frost, E				Pepin, Jacques; Deslandes, Sylvie; Giroux, Genevieve; Sobela, Francois; Khonde, Nzambi; Diakite, Soumaila; Demeule, Sophie; Labbe, Annie-Claude; Carrier, Nathalie; Frost, Eric			The Complex Vaginal Flora of West African Women with Bacterial Vaginosis	PLOS ONE			English	Article							RIBOSOMAL-RNA-GENE; GARDNERELLA-VAGINALIS; METRONIDAZOLE THERAPY; ATOPOBIUM-VAGINAE; ASSOCIATION; HIV; PCR; IDENTIFICATION; ACQUISITION; MICROFLORA	Background: The spectrum of bacteria associated with bacterial vaginosis (BV) has recently expanded through taxonomic changes and the use of molecular methods. These methods have yet to be used in large-scale epidemiological studies in Africa where BV is highly prevalent. Methods: An analysis of samples obtained during a clinical trial of the management of vaginal discharge in four West African countries. Samples were available from 1555 participants; 843 (54%) had BV. Nucleic acids of 13 bacterial genera or species potentially associated with BV were detected through the polymerase chain reaction. Results: The associations between various components of the vaginal flora were complex. Excluding Lactobacillus, the other 12 micro-organisms were all associated with each other at the p <= 0.001 level. The prevalence of various bacterial genera or species varied according to age, sexual activity and HIV status. In multivariate analysis, the presence of Gardnerella vaginalis, Bifidobacterium, Megasphaera elsdenii, Dialister, Mycoplasma hominis, Leptotrichia, and Prevotella were independently associated with BV as was the absence of Lactobacillus and Peptoniphilus. However, Mobiluncus, Atopobium vaginae, Anaerococcus, and Eggerthella were not independently associated with BV. Unexpectedly, after treatment with a regimen that included either metronidazole or tinidazole, the proportion of patients with a complete resolution of symptoms by day 14 increased with the number of bacterial genera or species present at enrolment. Conclusions: Numerous bacterial genera or species were strongly associated with each other in a pattern that suggested a symbiotic relationship. BV cases with a simpler flora were less likely to respond to treatment. Overall, the vaginal flora of West African women with BV was reminiscent of that of their counterparts in industrialized countries.	[Pepin, Jacques; Deslandes, Sylvie; Giroux, Genevieve; Sobela, Francois; Khonde, Nzambi; Demeule, Sophie; Frost, Eric] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada; [Diakite, Soumaila] Univ Montreal, Unite Sante Int, Montreal, PQ H3C 3J7, Canada; [Labbe, Annie-Claude] Hop Maison Neuve Rosemont, Dept Microbiol & Infect Dis, Montreal, PQ H1T 2M4, Canada; [Carrier, Nathalie] CHU Sherbrooke, Sherbrooke, PQ, Canada	University of Sherbrooke; Universite de Montreal; Universite de Montreal; University of Sherbrooke	Pepin, J (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada.	jacques.pepin@usherbrooke.ca		Frost, Eric/0000-0001-8958-4388	Canadian International Development Agency	Canadian International Development Agency	This study was funded by the Canadian International Development Agency through its West Africa Project to Combat AIDS and STI in West Africa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Austin MN, 2005, J CLIN MICROBIOL, V43, P4492, DOI 10.1128/JCM.43.9.4492-4497.2005; Beigi RH, 2004, AM J OBSTET GYNECOL, V191, P1124, DOI 10.1016/j.ajog.2004.05.033; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; BLANCHARD A, 1993, J CLIN MICROBIOL, V31, P1358, DOI 10.1128/JCM.31.5.1358-1361.1993; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Dols JAM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.012; Eckert LO, 2006, NEW ENGL J MED, V355, P1244, DOI 10.1056/NEJMcp053720; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; Ferris MJ, 2004, J CLIN MICROBIOL, V42, P5892, DOI [10.1128/JCM.42.12.5892-5894.2004, 10.1128/jcm.42.12.5892-5894.2004]; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Haggerty CL, 2009, SEX TRANSM INFECT, V85, P242, DOI 10.1136/sti.2008.032821; HILLIER SL, 1993, OBSTET GYNECOL, V81, P963; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Liebetrau A, 2003, ANTIMICROB AGENTS CH, V47, P3667, DOI 10.1128/AAC.47.11.3667-3671.2003; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mitchell CM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-89; Moodley P, 2002, J INFECT DIS, V185, P69, DOI 10.1086/338027; Morio F, 2007, ANTIMICROB AGENTS CH, V51, P4498, DOI 10.1128/AAC.00538-07; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Oduyebo OO, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006055.pub2; Pepin J, 2006, B WORLD HEALTH ORGAN, V84, P729, DOI 10.2471/BLT.06.029819; Ravel J., 2011, P NATL ACAD SCI USA, V108, P4680, DOI [10.1073/pnas.1002611107, DOI 10.1073/PNAS.1002611107]; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thorsen P, 1998, AM J OBSTET GYNECOL, V178, P580, DOI 10.1016/S0002-9378(98)70442-9; Tiveljung A, 1996, INT J SYST BACTERIOL, V46, P332, DOI 10.1099/00207713-46-1-332; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2004, AM J OBSTET GYNECOL, V191, P1130, DOI 10.1016/j.ajog.2004.04.013; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x	46	40	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25082	10.1371/journal.pone.0025082	http://dx.doi.org/10.1371/journal.pone.0025082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949860	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400046
J	Chen, B; Li, K; Zhang, FL; Zhai, GQ; Gong, W; Qiang, SJ; Xue, ZF				Chen, Bing; Li, Ke; Zhang, Fenli; Zhai, Guoqin; Gong, Wen; Qiang, Sujing; Xue, Zhengfeng			An ENU-Induced Mutation of Nrg1 Causes Dilated Pupils and a Reduction in Muscarinic Receptors in the Sphincter Pupillae	PLOS ONE			English	Article							GENE-FUNCTION; GENOME-WIDE; MUTAGENESIS; MOUSE; MICE; NEUREGULIN-1; MULTIPLE; IRIS; MAINTENANCE; PROTEIN	Background: N-ethyl-N-nitrosourea (ENU)-induced mutagenesis is a powerful tool for the study of gene function and the generation of human disease models. A large number of mouse mutants obtained by ENU-induced mutagenesis with a variety of phenotypes have been recovered. However, after genetic confirmation testing, only approximately 50% of the abnormal phenotypes were found to be heritable. Methodology/Principal Findings: A mouse mutant, Dp1, with a dilated pupil phenotype was induced with an N-ethyl-N-nitrosourea (ENU) mutagenesis strategy. Sequence analysis for Nrg1 reveals a G>A base substitution that flanks exon E59, encoding for an EGF beta domain, in the 5' splice donor site. The mutation affects but does not abolish the splicing of EGF beta-type Nrg1 mRNA in Dp1 mice and produces several different transcripts by activating other, cryptic splice sites. These types of protein isoforms are expected, and the result shows that, in the mutant, the effect is a decrease in but not an elimination of the high affinity EGF beta-type Nrg1 isoforms. This is partially compensated for by an increase in expression of the low affinity alpha forms or inactive proteins, suggesting that the mutation results in a hypomorphic allele. Interestingly, genetic model testing shows that Dp1 is a mutation that results in a dilated pupil phenotype that is inherited with very low penetrance when heterozygous and with complete penetrance when homozygous. Pharmacological and immunohistochemical tests show a reduction of muscarinic (M) receptors in the sphincter pupillae of Dp1 mice, which is a major cause of dilated pupils. Conclusions/Significance: This study is the first report of an Nrg1 mutation being associated with a dilated pupil phenotype and the reduction of M receptors. This report may help in establishing more mutant mouse lines and models of human genetic disease and can be applied to other organisms. Dp1 mice are a valuable resource for the further clarification of Nrg1 biological function.	[Chen, Bing; Xue, Zhengfeng] Yangzhou Univ, Comparat Med Ctr, Jiangsu, Yangzhou, Peoples R China; [Chen, Bing; Li, Ke; Zhang, Fenli; Zhai, Guoqin; Gong, Wen; Qiang, Sujing; Xue, Zhengfeng] Yangzhou Univ, Coll Vet Med, Jiangsu, Yangzhou, Peoples R China	Yangzhou University; Yangzhou University	Chen, B (corresponding author), Yangzhou Univ, Comparat Med Ctr, Jiangsu, Yangzhou, Peoples R China.	xuezfyz@yahoo.com.cn			National Natural Science Fund of China [31000987, 30670299]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Fund of China (31000987 and 30670299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balling R, 2001, ANNU REV GENOM HUM G, V2, P463, DOI 10.1146/annurev.genom.2.1.463; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Davis-Silberman N, 2008, BRAIN RES, V1192, P17, DOI 10.1016/j.brainres.2007.03.043; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; HILL CE, 1993, J AUTONOM NERV SYST, V45, P107, DOI 10.1016/0165-1838(93)90123-C; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Matsui M, 2002, J NEUROSCI, V22, P10627; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Thaung C, 2002, HUM MOL GENET, V11, P755, DOI 10.1093/hmg/11.7.755; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	24	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25176	10.1371/journal.pone.0025176	http://dx.doi.org/10.1371/journal.pone.0025176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949880	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900058
J	Tsai, HP; Holliday, CM				Tsai, Henry P.; Holliday, Casey M.			Ontogeny of the Alligator Cartilago Transiliens and Its Significance for Sauropsid Jaw Muscle Evolution	PLOS ONE			English	Article							TENDON; MORPHOLOGY	The cartilago transiliens is a fibrocartilaginous structure within the jaw muscles of crocodylians. The cartilago transiliens slides between the pterygoid buttress and coronoid region of the lower jaw and connects two muscles historically identified as m. pseudotemporalis superficialis and m. intramandibularis. However, the position of cartilago transiliens, and its anatomical similarities to tendon organs suggest the structure may be a sesamoid linking a single muscle. Incompressible sesamoids often form inside tendons that wrap around bone. However, such structures rarely ossify in reptiles and have thus far received scant attention. We tested the hypothesis that the cartilago transiliens is a sesamoid developed within in one muscle by investigating its structure in an ontogenetic series of Alligator mississippiensis using dissection, 3D imaging, and polarizing and standard light microscopy. In all animals studied, the cartilago transiliens receives collagen fibers and tendon insertions from its two main muscular attachments. However, whereas collagen fibers were continuous within the cartilaginous nodule of younger animals, such continuity decreased in older animals, where the fibrocartilaginous core grew to displace the fibrous region. Whereas several neighboring muscles attached to the fibrous capsule in older individuals, only two muscles had significant contributions to the structure in young animals. Our results indicate that the cartilago transiliens is likely a sesamoid formed within a single muscle (i.e., m. pseudotemporalis superficialis) as it wraps around the pterygoid buttress. This tendon organ is ubiquitous among fossil crocodyliforms indicating it is a relatively ancient, conserved structure associated with the development of the large pterygoid flanges in this clade. Finally, these findings indicate that similar tendon organs exist among potentially homologous muscle groups in birds and turtles, thus impacting inferences of jaw muscle homology and evolution in sauropsids in general.	[Tsai, Henry P.; Holliday, Casey M.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Tsai, HP (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	hollidayca@missouri.edu		Holliday, Casey/0000-0001-8210-8434	University of Missouri; University of Missouri Research Council [CR000305]; Department of Pathology and Anatomical Sciences	University of Missouri; University of Missouri Research Council; Department of Pathology and Anatomical Sciences	Funding was provided by University of Missouri's Life Sciences Fellowship program (to HPT), University of Missouri Research Council Award #CR000305 and the Department of Pathology and Anatomical Sciences (to CMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT CH, 1958, J ANAT, V92, P593; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; BRAMBLE DM, 1974, COPEIA, P102; Carvalho ID, 2005, GONDWANA RES, V8, P11, DOI 10.1016/S1342-937X(05)70259-8; Cong L, 1998, GROSS ANATOMY ALLIGA, P271; Diogo R, 2001, BELG J ZOOL, V131, P93; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Goessling R, 2008, J VERTEBR PALEONTOL, V28, p84A; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; IORDANSKY N. N., 1964, ANAT ANZ, V115, P256; Iordansky N.N., 1973, P201; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Jouve S, 2005, CAN J EARTH SCI, V42, P323, DOI 10.1139/E05-008; Kley NJ, 2010, J VERTEBR PALEONTOL, V30, P13, DOI 10.1080/02724634.2010.532674; Maisano JA, 2002, ZOOL J LINN SOC-LOND, V136, P277, DOI 10.1046/j.1096-3642.2002.00033.x; MERRILEES MJ, 1980, AM J ANAT, V157, P87, DOI 10.1002/aja.1001570109; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Parsons T.S., 1969, BIOL REPTILIA, VI, P81, DOI DOI 10.1093/ICB/ICP063; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Schumacher G. H., 1973, P101; Shaw HM, 2008, J ANAT, V213, P718, DOI 10.1111/j.1469-7580.2008.00997.x; Summers AP, 2003, CELL TISSUE RES, V312, P221, DOI 10.1007/s00441-003-0714-4; Summers AP, 2002, COMP BIOCHEM PHYS A, V133, P1159, DOI 10.1016/S1095-6433(02)00241-6; VANDRONGELEN W, 1982, ANAT ANZEIGER, V151, P337; Vickaryous Matthew K., 2007, P323; VOGEL KG, 1993, J ORTHOP RES, V11, P68, DOI 10.1002/jor.1100110109	27	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24935	10.1371/journal.pone.0024935	http://dx.doi.org/10.1371/journal.pone.0024935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949795	gold, Green Published, Green Submitted			2022-12-25	WOS:000295173800050
J	Elvenes, J; Thomassen, EIS; Johnsen, SS; Kaino, K; Sjottem, E; Johansen, T				Elvenes, Julianne; Thomassen, Ernst Ivan Simon; Johnsen, Sylvia Sagen; Kaino, Katrine; Sjottem, Eva; Johansen, Terje			Pax6 Represses Androgen Receptor-Mediated Transactivation by Inhibiting Recruitment of the Coactivator SPBP	PLOS ONE			English	Article							PAIRED DOMAIN; PROTEIN; EXPRESSION; CANCER; CELLS; GENE; DNA; IDENTIFICATION; HOMEODOMAIN; RECOGNITION	The androgen receptor (AR) has a central role in development and maintenance of the male reproductive system and in the etiology of prostate cancer. The transcription factor Pax6 has recently been reported to act as a repressor of AR and to be hypermethylated in prostate cancer cells. SPBP is a transcriptional regulator that previously has been shown to enhance the activity of Pax6. In this study we have identified SPBP to act as a transcriptional coactivator of AR. We also show that Pax6 inhibits SPBP-mediated enhancement of AR activity on the AR target gene probasin promoter, a repression that was partly reversed by increased expression of SPBP. Enhanced expression of Pax6 reduced the amount of SPBP associated with the probasin promoter when assayed by ChIP in HeLa cells. We mapped the interaction between both AR and SPBP, and AR and Pax6 to the DNA-binding domains of the involved proteins. Further binding studies revealed that Pax6 and SPBP compete for binding to AR. These results suggest that Pax6 represses AR activity by displacing and/or inhibiting recruitment of coactivators to AR target promoters. Understanding the mechanism for inhibition of AR coactivators can give rise to molecular targeted drugs for treatment of prostate cancer.	[Elvenes, Julianne; Thomassen, Ernst Ivan Simon; Johnsen, Sylvia Sagen; Kaino, Katrine; Sjottem, Eva; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso	Elvenes, J (corresponding author), Univ Tromso, Inst Med Biol, Mol Canc Res Grp, Tromso, Norway.	eva.sjottem@uit.no	Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Sjottem, Eva/0000-0003-2668-1708	Norwegian Cancer Society; Blix foundation	Norwegian Cancer Society(Norwegian Cancer Society); Blix foundation	This study was funded by grants from the Norwegian Cancer Society and the Blix foundation to TJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axlund SD, 2010, MOL CANCER RES, V8, P1643, DOI 10.1158/1541-7786.MCR-10-0111; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chang JY, 2007, J NEURO-ONCOL, V84, P9, DOI 10.1007/s11060-007-9347-x; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DonCarlos LL, 2006, NEUROSCIENCE, V138, P801, DOI 10.1016/j.neuroscience.2005.06.020; Elvenes J, 2010, CELL MOL LIFE SCI, V67, P4079, DOI 10.1007/s00018-010-0429-0; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Gao WQ, 2005, CHEM REV, V105, P3352, DOI 10.1021/cr020456u; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; Huang ZQ, 2002, MOL ENDOCRINOL, V16, P924, DOI 10.1210/me.16.5.924; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Keller Evan T., 1996, Frontiers in Bioscience (online), V1, pD59; Kirstein M, 1996, J BIOL CHEM, V271, P18231, DOI 10.1074/jbc.271.30.18231; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Luo YQ, 2006, STEM CELLS, V24, P865, DOI 10.1634/stemcells.2005-0392; Lyngso C, 2000, J BIOL CHEM, V275, P26144, DOI 10.1074/jbc.M003405200; MacLusky NJ, 2006, ENDOCRINOLOGY, V147, P2392, DOI 10.1210/en.2005-0673; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mikkola I, 2001, J BIOL CHEM, V276, P4109, DOI 10.1074/jbc.M008882200; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Patchev VK, 2004, EXP GERONTOL, V39, P1651, DOI 10.1016/j.exger.2004.07.011; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Singh RR, 2006, J BIOL CHEM, V281, P25612, DOI 10.1074/jbc.M604444200; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Zhou YH, 2005, J NEURO-ONCOL, V71, P223, DOI 10.1007/s11060-004-1720-4; Zhou YH, 2003, CLIN CANCER RES, V9, P3369; Zhou YH, 2010, J NEURO-ONCOL, V96, P191, DOI 10.1007/s11060-009-9963-8; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	53	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24659	10.1371/journal.pone.0024659	http://dx.doi.org/10.1371/journal.pone.0024659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935435	gold, Green Published			2022-12-25	WOS:000295041700047
J	Kirshberg, S; Izhar, U; Amir, G; Demma, J; Vernea, F; Beider, K; Shlomai, Z; Wald, H; Zamir, G; Shapira, OM; Peled, A; Wald, O				Kirshberg, Sophie; Izhar, Uzi; Amir, Gail; Demma, Jonathan; Vernea, Fiona; Beider, Katia; Shlomai, Zippora; Wald, Hanna; Zamir, Gideon; Shapira, Oz M.; Peled, Amnon; Wald, Ori			Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR6; CELL LUNG-CANCER; OBSTRUCTIVE PULMONARY-DISEASE; T-CELLS; COLORECTAL-CANCER; EXPRESSION LEVEL; DENDRITIC CELLS; TH17 CELLS; CCL20; SURVIVAL	Objectives: Autocrine and paracrine chemokine/chemokine receptor-based interactions promote non-small-cell-lung-cancer (NSCLC) carcinogenesis. CCL20/CCR6 interactions are involved in prostatic and colonic malignancy pathogenesis. The expression and function of CCL20/CCR6 and its related Th-17 type immune response in NSCLC is not yet defined. We sought to characterize the role of the CCL20/CCR6/IL-17 axis in NSCLC tumor growth. Methods: A specialized histopathologist blindly assessed CCL20/CCR6 expression levels in 49 tissue samples of NSCLC patients operated in our department. Results were correlated to disease progression. Colony assays, ERK signaling and chemokine production were measured to assess cancer cell responsiveness to CCL20 and IL-17 stimulation. Results: CCL20 was highly expressed in the majority (38/49, 77.5%) of tumor samples. Only a minority of samples (8/49, 16.5%) showed high CCR6 expression. High CCR6 expression was associated with a shorter disease-free survival (P = 0.008) and conferred a disease stage-independent 4.87-fold increased risk for disease recurrence (P = 0.0076, CI 95% 1.52-15.563). Cancerous cell colony-forming capacity was increased by CCL20 stimulation; this effect was dependent in part on ERK phosphorylation and signaling. IL-17 expression was detected in NSCLC; IL-17 potentiated the production of CCL20 by cancerous cells. Conclusion: Our findings suggest that the CCL20/CCR6 axis promotes NSCLC disease progression. CCR6 is identified as a potential new prognostic marker and the CCL20/CCR6/IL-17 axis as a potential new therapeutic target. Larger scale studies are required to consolidate these observations.	[Kirshberg, Sophie; Beider, Katia; Wald, Hanna; Peled, Amnon] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Izhar, Uzi; Shapira, Oz M.; Wald, Ori] Hadassah Univ Hosp, Dept Cardiothorac Surg, IL-91120 Jerusalem, Israel; [Amir, Gail; Vernea, Fiona] Hadassah Univ Hosp, Dept Pathol, IL-91120 Jerusalem, Israel; [Demma, Jonathan; Shlomai, Zippora; Zamir, Gideon] Hadassah Univ Hosp, Surg Res Lab, IL-91120 Jerusalem, Israel; [Demma, Jonathan; Zamir, Gideon] Hadassah Univ Hosp, Dept Surg, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Kirshberg, S (corresponding author), Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.	ori.wald@mail.huji.ac.il		DEMMA, Jonathan Abraham/0000-0003-3604-127X	Dalia Gridinger Cancer Research Fund	Dalia Gridinger Cancer Research Fund	This work was supported by the Dalia Gridinger Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Beider K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005125; Bracke Ken R., 2007, Inflammation & Allergy Drug Targets, V6, P75; Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822; Ghadjar P, 2008, J CANCER RES CLIN, V134, P1181, DOI 10.1007/s00432-008-0403-5; Ghadjar P, 2009, INT J CANCER, V125, P741, DOI 10.1002/ijc.24468; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Homey B, 2002, NAT REV IMMUNOL, V2, P175, DOI 10.1038/nri748; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Karra L, 2010, FERTIL STERIL, V93, P2646, DOI 10.1016/j.fertnstert.2009.03.100; Kimsey TF, 2004, CANCER J, V10, P374, DOI 10.1097/00130404-200411000-00007; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P147, DOI 10.1016/j.semcancer.2003.10.010; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Ouyang WJ, 2009, EUR J IMMUNOL, V39, P670, DOI 10.1002/eji.200839105; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Rabin RL, 2003, J IMMUNOL, V171, P2812, DOI 10.4049/jimmunol.171.6.2812; Radzikowska E, 2002, ANN ONCOL, V13, P1087, DOI 10.1093/annonc/mdf187; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Silva LM, 2001, BRAZ J MED BIOL RES, V34, P1405, DOI 10.1590/S0100-879X2001001100005; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Starner TD, 2003, AM J RESP CELL MOL, V29, P627, DOI 10.1165/rcmb.2002-0272OC; Wald O, 2006, J IMMUNOL, V177, P6983, DOI 10.4049/jimmunol.177.10.6983; Wald O, 2011, J THORAC CARDIOV SUR, V141, P1503, DOI 10.1016/j.jtcvs.2010.11.056; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zumsteg A, 2009, CURR OPIN ONCOL, V21, P60, DOI 10.1097/CCO.0b013e32831bed7e	37	63	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24856	10.1371/journal.pone.0024856	http://dx.doi.org/10.1371/journal.pone.0024856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949768	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700066
J	Falchi, A; Amoros, JP; Arena, C; Arrighi, J; Casabianca, F; Andreoletti, L; Turbelin, C; Flahault, A; Blanchon, T; Hanslik, T; Varesi, L				Falchi, Alessandra; Amoros, Jean Pierre; Arena, Christophe; Arrighi, Jean; Casabianca, Francois; Andreoletti, Laurent; Turbelin, Clement; Flahault, Antoine; Blanchon, Thierry; Hanslik, Thomas; Varesi, Laurent			Genetic Structure of Human A/H1N1 and A/H3N2 Influenza Virus on Corsica Island: Phylogenetic Analysis and Vaccine Strain Match, 2006-2010	PLOS ONE			English	Article							POSITIVE SELECTION; RT-PCR; EVOLUTION; H1N1; HEMAGGLUTININ; DYNAMICS	Background: The aim of this study was to analyse the genetic patterns of Hemagglutinin (HA) genes of influenza A strains circulating on Corsica Island during the 2006-2009 epidemic seasons and the 2009-2010 pandemic season. Methods: Nasopharyngeal samples from 371 patients with influenza-like illness (ILI) were collected by General Practitioners (GPs) of the Sentinelles Network through a randomised selection routine. Results: Phylogenetic analysis of HA revealed that A/H3N2 strains circulating on Corsica were closely related to the WHO recommended vaccine strains in each analyzed season (2006-2007 to 2008-2009). Seasonal Corsican influenza A/H1N1 isolated during the 2007-2008 season had drifted towards the A/Brisbane/59/2007 lineage, the A/H1N1 vaccine strain for the 2008-2009 season. The A/H1N1 2009 (A/H1N1pdm) strains isolated on Corsica Island were characterized by the S220T mutation specific to clade 7 isolates. It should be noted that Corsican isolates formed a separate sub-clade of clade 7 as a consequence of the presence of the fixed substitution D222E. The percentages of the perfect match vaccine efficacy, estimated by using the p(epitope) model, against influenza viruses circulating on Corsica Island varied substantially across the four seasons analyzed, and tend to be highest for A/H1N1 compared with A/H3N2 vaccines, suggesting that cross-immunity seems to be stronger for the H1 HA gene. Conclusion: The molecular analysis of the HA gene of influenza viruses that circulated on Corsica Island between 2006-2010 showed for each season the presence of a dominant lineage characterized by at least one fixed mutation. The A/H3N2 and A/H1N1pdm isolates were characterized by multiples fixation at antigenic sites. The fixation of specific mutations at each outbreak could be explained by the combination of a neutral phenomenon and a founder effect, favoring the presence of a dominant lineage in a closed environment such as Corsica Island.	[Falchi, Alessandra; Amoros, Jean Pierre; Arena, Christophe; Turbelin, Clement; Blanchon, Thierry; Hanslik, Thomas] INSERM, UMR S 707, F-75012 Paris, France; [Falchi, Alessandra; Amoros, Jean Pierre; Arena, Christophe; Turbelin, Clement; Blanchon, Thierry; Hanslik, Thomas] Univ Paris 06, UMR S U707, F-75012 Paris, France; [Falchi, Alessandra; Amoros, Jean Pierre; Arena, Christophe; Varesi, Laurent] Univ Corsica, Virol Lab, Corsica, France; [Falchi, Alessandra; Arena, Christophe; Arrighi, Jean] Observ Reg Sante, Ajaccio, France; [Casabianca, Francois] INRA, Corte, France; [Andreoletti, Laurent] Ctr Hosp Univ, Unite Virol Med & Mol, Reims, France; [Andreoletti, Laurent] Fac Med, EA DAT PPCIDH 4303, IFR 53, Reims, France; [Flahault, Antoine] EHESP Sch Publ Hlth, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; INRAE; CHU de Reims; Universite de Reims Champagne-Ardenne	Falchi, A (corresponding author), INSERM, UMR S 707, F-75012 Paris, France.	falchi@u707.jussieu.fr	BLANCHON, Thierry/AAK-6254-2020; Andreoletti, Laurent/AAQ-2756-2020; FALCHI, Alessandra/AAQ-8039-2020	ANDREOLETTI, LAURENT/0000-0002-7440-8880; Alessandra, FALCHI/0000-0003-0799-1460	Corsican Economic Development Agency; FEDER	Corsican Economic Development Agency; FEDER(European Commission)	Corsican Economic Development Agency and the FEDER programme provided funding and support for the design and conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATT S, 2011, MOL BIOL EVOL   0316; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; *CDCP, 2009, WKLY REP, V58, P431; Chi XS, 2007, J VIROL METHODS, V139, P90, DOI 10.1016/j.jviromet.2006.08.015; de Jong JC, 2000, J INFECTION, V40, P218, DOI 10.1053/jinf.2000.0652; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Deem MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.068101; Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x; Falchi A, 2009, J CLIN VIROL, V45, P265, DOI 10.1016/j.jcv.2009.05.004; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta R., 2004, RESEARCHGATE; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Hampson AW, 2006, MED J AUSTRALIA, V185, pS39; HUANG Y, 2011, BMC BIOINFORMATICS, V31, pS31; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Lee RTC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-297; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Lin YP, 2004, VIRUS RES, V103, P47, DOI 10.1016/j.virusres.2004.02.011; Lindstrom S, 1996, ARCH VIROL, V141, P1349, DOI 10.1007/BF01718836; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nelson Martha, 2009, PLoS Curr, V1, pRRN1126; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Puzelli S, 2010, EUROSURVEILLANCE, V15, P6; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; ROUSSET D, 2010, B EPIDEMIOLOGIQUE HE; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suwannakarn K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009717; Suzuki Y, 2008, GENE, V427, P111, DOI 10.1016/j.gene.2008.09.012; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, 2009, PAND H1N1 INFL LIK I; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053	44	13	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24471	10.1371/journal.pone.0024471	http://dx.doi.org/10.1371/journal.pone.0024471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935413	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700023
J	Fredman, G; Oh, SF; Ayilavarapu, S; Hasturk, H; Serhan, CN; Van Dyke, TE				Fredman, Gabrielle; Oh, Sungwhan F.; Ayilavarapu, Srinivas; Hasturk, Hatice; Serhan, Charles N.; Van Dyke, Thomas E.			Impaired Phagocytosis in Localized Aggressive Periodontitis: Rescue by Resolvin E1	PLOS ONE			English	Article							ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE; EDITORS CONSENSUS PERIODONTITIS; JOURNAL-OF-CARDIOLOGY; LIPID MEDIATORS; PORPHYROMONAS-GINGIVALIS; JUVENILE PERIODONTITIS; INFLAMMATORY RESPONSE; SUPEROXIDE PRODUCTION; ARACHIDONIC-ACID; TISSUE-DAMAGE	Resolution of inflammation is an active temporally orchestrated process demonstrated by the biosynthesis of novel proresolving mediators. Dysregulation of resolution pathways may underlie prevalent human inflammatory diseases such as cardiovascular diseases and periodontitis. Localized Aggressive Periodontitis (LAP) is an early onset, rapidly progressing form of inflammatory periodontal disease. Here, we report increased surface P-selectin on circulating LAP platelets, and elevated integrin (CD18) surface expression on neutrophils and monocytes compared to healthy, asymptomatic controls. Significantly more platelet-neutrophil and platelet-monocyte aggregates were identified in circulating whole blood of LAP patients compared with asymptomatic controls. LAP whole blood generates increased pro-inflammatory LTB4 with addition of divalent cation ionophore A23187 (5 mu M) and significantly less, 15-HETE, 12-HETE, 14-HDHA, and lipoxin A(4). Macrophages from LAP subjects exhibit reduced phagocytosis. The pro-resolving lipid mediator, Resolvin E1 (0.1-100 nM), rescues the impaired phagocytic activity in LAP macrophages. These abnormalities suggest compromised resolution pathways, which may contribute to persistent inflammation resulting in establishment of a chronic inflammatory lesion and periodontal disease progression.	[Fredman, Gabrielle; Ayilavarapu, Srinivas; Hasturk, Hatice; Van Dyke, Thomas E.] Forsyth Inst, Dept Periodontol, Cambridge, MA USA; [Fredman, Gabrielle; Oh, Sungwhan F.; Serhan, Charles N.] Harvard Univ, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Med, Ctr Expt Therapeut & Reperfus Injury,Sch Med, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fredman, G (corresponding author), Forsyth Inst, Dept Periodontol, Cambridge, MA USA.	tvandyke@forsyth.org		Ayilavarapu, Srinivas/0000-0002-1899-8900	National Institutes of Health [DE-019938, DE-015566, GM38765]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938, R01DE015566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R37GM038765, R29GM038765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health Grants DE-019938 (C.N. Serhan and T.E. Van Dyke), DE-015566 (T.E. Van Dyke) and GM38765 (C.N. Serhan). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Periodontology, 2000, J PERIODONTOL, V71, P867; [Anonymous], 2015, NAT REV IMMUNOL, DOI [DOI 10.1902/jop.2009.097001, DOI 10.1038/nri3785]; Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1; Dave Sheilesh, 2004, Compend Contin Educ Dent, V25, P26; Dennison DK, 1997, PERIODONTOL 2000, V14, P54, DOI 10.1111/j.1600-0757.1997.tb00192.x; DEWHIRST FE, 1983, J PERIODONTAL RES, V18, P156, DOI 10.1111/j.1600-0765.1983.tb00348.x; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; EI-Sharkawy H, 2010, J PERIODONTOL, V81, P1635, DOI 10.1902/jop.2010.090628; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; GOODSON JM, 1982, J CLIN PERIODONTOL, V9, P472, DOI 10.1111/j.1600-051X.1982.tb02108.x; Gronert K, 2004, J IMMUNOL, V172, P1856, DOI 10.4049/jimmunol.172.3.1856; HART TC, 1993, HUM GENET, V91, P416; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; HEASMAN PA, 1993, J PERIODONTAL RES, V28, P241, DOI 10.1111/j.1600-0765.1993.tb02090.x; Kantarci A, 2006, PERIODONTOL 2000, V40, P144, DOI 10.1111/j.1600-0757.2005.00145.x; Kantarci A, 2003, J PERIODONTOL, V74, P66, DOI 10.1902/jop.2003.74.1.66; Kinane DF, 2003, CRIT REV ORAL BIOL M, V14, P430, DOI 10.1177/154411130301400605; KRISHNAMOORTHY S, 2010, P NATL ACAD SCI US; Majno G., 2004, CELLS TISSUES DIS PR; Maney P, 2009, J PERIODONTOL, V80, P492, DOI [10.1902/jop.2009.080225, 10.1902/jop.2009.080225 ]; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meng HX, 2007, PERIODONTOL 2000, V43, P133, DOI 10.1111/j.1600-0757.2006.00204.x; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Nicu EA, 2009, J THROMB HAEMOST, V7, P162, DOI 10.1111/j.1538-7836.2008.03219.x; OFFENBACHER S, 1984, J PERIODONTAL RES, V19, P1, DOI 10.1111/j.1600-0765.1984.tb01190.x; Offenbacher S, 2006, OBSTET GYNECOL, V107, P29, DOI 10.1097/01.AOG.0000190212.87012.96; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; OHIRA T, 2009, J BIOL CHEM; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Requirand P, 2000, CLIN NUTR, V19, P271, DOI 10.1054/clnu.2000.0107; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seki H, 2010, J IMMUNOL, V184, P836, DOI 10.4049/jimmunol.0901809; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; SHAPIRA L, 1994, J PERIODONTOL, V65, P129, DOI 10.1902/jop.1994.65.2.129; SHAPIRA L, 1994, J PERIODONTAL RES, V29, P371, DOI 10.1111/j.1600-0765.1994.tb01236.x; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Taylor GW, 1996, J PERIODONTOL, V67, P1085, DOI 10.1902/jop.1996.67.10s.1085; THE J, 1991, J CLIN IMMUNOL, V11, P132, DOI 10.1007/BF00918681; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; VANDYKE TE, 1986, J PERIODONTOL, V57, P703, DOI 10.1902/jop.1986.57.11.703; VANDYKE TE, 1990, J PERIODONTOL, V61, P180, DOI 10.1902/jop.1990.61.3.180; Yamamoto K, 2004, J PERIODONTOL, V75, P517, DOI 10.1902/jop.2004.75.4.517; Yang R., 2011, CURR PROTOC IMMUNOL; Zhang Y, 2003, GENES IMMUN, V4, P22, DOI 10.1038/sj.gene.6363900	57	101	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24422	10.1371/journal.pone.0024422	http://dx.doi.org/10.1371/journal.pone.0024422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935407	gold, Green Published, Green Submitted			2022-12-25	WOS:000295039700021
J	Brackney, DE; Pesko, KN; Brown, IK; Deardorff, ER; Kawatachi, J; Ebel, GD				Brackney, Doug E.; Pesko, Kendra N.; Brown, Ivy K.; Deardorff, Eleanor R.; Kawatachi, Jon; Ebel, Gregory D.			West Nile Virus Genetic Diversity is Maintained during Transmission by Culex pipiens quinquefasciatus Mosquitoes	PLOS ONE			English	Article							NEW-YORK; ENCEPHALITIS-VIRUS; RNA; INFECTION; CELLS; EVOLUTION; GENOTYPE; DISEASE; SPREAD	Due to error-prone replication, RNA viruses exist within hosts as a heterogeneous population of non-identical, but related viral variants. These populations may undergo bottlenecks during transmission that stochastically reduce variability leading to fitness declines. Such bottlenecks have been documented for several single-host RNA viruses, but their role in the population biology of obligate two-host viruses such as arthropod-borne viruses (arboviruses) in vivo is unclear, but of central importance in understanding arbovirus persistence and emergence. Therefore, we tracked the composition of West Nile virus (WNV; Flaviviridae, Flavivirus) populations during infection of the vector mosquito, Culex pipiens quinquefasciatus to determine whether WNV populations undergo bottlenecks during transmission by this host. Quantitative, qualitative and phylogenetic analyses of WNV sequences in mosquito midguts, hemolymph and saliva failed to document reductions in genetic diversity during mosquito infection. Further, migration analysis of individual viral variants revealed that while there was some evidence of compartmentalization, anatomical barriers do not impose genetic bottlenecks on WNV populations. Together, these data suggest that the complexity of WNV populations are not significantly diminished during the extrinsic incubation period of mosquitoes.	[Brackney, Doug E.; Pesko, Kendra N.; Brown, Ivy K.; Deardorff, Eleanor R.; Kawatachi, Jon; Ebel, Gregory D.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA	University of New Mexico	Brackney, DE (corresponding author), Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA.	gebel@salud.unm.edu	Ebel, Gregory/ABG-1052-2021; Brackney, Doug/GWU-7912-2022; Ebel, Gregory/D-8324-2017		National Institute of Allergy and Infectious Disease, National Institutes of Health (NIH) [AI067380]; National Institute of General Medical Sciences [K12GM088021]; University of New Mexico; National Research Service [5T32-AI07538-13]; University of New Mexico Initiative; National Institute of General Medical Sciences, NIH [GM060201];  [5F32AI084432-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI084432, T32AI007538, R01AI067380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201, K12GM088021] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of New Mexico; National Research Service; University of New Mexico Initiative; National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of Allergy and Infectious Disease, National Institutes of Health (NIH) under grant AI067380. DEB was supported by 5F32AI084432-02. ERD was supported by Institutional Research and Academic Career Development Awards via Award K12GM088021 from the National Institute of General Medical Sciences and the University of New Mexico Academic Science Education and Research Training fellowship. KP was supported by National Research Service Award Institutional Training Grant 5T32-AI07538-13. IKB and JK were supported by the University of New Mexico Initiative to Maximize Student Diversity, which is funded by the National Institute of General Medical Sciences, NIH under grant GM060201. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Ali A, 2010, VIROLOGY, V404, P279, DOI 10.1016/j.virol.2010.05.017; Anderson JF, 2001, P NATL ACAD SCI USA, V98, P12885, DOI 10.1073/pnas.241472398; Beasley DWC, 2003, VIROLOGY, V309, P190, DOI 10.1016/S0042-6822(03)00150-8; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Davis CT, 2003, EMERG INFECT DIS, V9, P1423, DOI 10.3201/eid0911.030301; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; DUARTE E, 1992, P NATL ACAD SCI USA, V89, P6015, DOI 10.1073/pnas.89.13.6015; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Ebel GD, 2001, EMERG INFECT DIS, V7, P650; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fitzpatrick KA, 2010, VIROLOGY, V404, P89, DOI 10.1016/j.virol.2010.04.029; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HOUK EJ, 1979, ACTA TROP, V36, P267; Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kuss SK, 2008, PLOS PATH, V4, P13; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Monsion B, 2008, PLOS PATHOG, V4, P7; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Moudy RM, 2006, AM J TROP MED HYG, V75, P300; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salemi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000950; Sauder CJ, 2006, VIROLOGY, V350, P48, DOI 10.1016/j.virol.2006.01.035; Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004; SLATKIN M, 1989, GENETICS, V123, P603; Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011; Sullivan DG, 2007, J INFECT DIS, V196, P239, DOI 10.1086/518895; Tsai KN, 2007, VIRUS RES, V124, P139, DOI 10.1016/j.virusres.2006.10.013; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; WEAVER SC, 1991, AM J TROP MED HYG, V44, P250, DOI 10.4269/ajtmh.1991.44.250; Yoon SW, 2006, MOL CELLS, V21, P112	39	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24466	10.1371/journal.pone.0024466	http://dx.doi.org/10.1371/journal.pone.0024466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21935412	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803200021
J	Yamamoto, T; Iino, H; Kim, K; Kuramitsu, S; Fukui, K				Yamamoto, Tatsuya; Iino, Hitoshi; Kim, Kwang; Kuramitsu, Seiki; Fukui, Kenji			Evidence for ATP-dependent Structural Rearrangement of Nuclease Catalytic Site in DNA Mismatch Repair Endonuclease MutL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; C-TERMINAL DOMAIN; MASS-SPECTROMETRY; HYDROGEN/DEUTERIUM EXCHANGE; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; SWISS-MODEL; ALPHA; PROTEINS; BINDING	DNA mismatch repair (MMR) greatly contributes to genome integrity via the correction of mismatched bases that are mainly generated by replication errors. Postreplicative MMR excises a relatively long tract of error-containing single-stranded DNA. MutL is a widely conserved nicking endonuclease that directs the excision reaction to the error-containing strand of the duplex by specifically nicking the daughter strand. Because MutL apparently exhibits nonspecific nicking endonuclease activity in vitro, the regulatory mechanism of MutL has been argued. Recent studies suggest ATP-dependent conformational and functional changes of MutL, indicating that the regulatory mechanism involves the ATP binding and hydrolysis cycle. In this study, we investigated the effect of ATP binding on the structure of MutL. First, a cross-linking experiment confirmed that the N-terminal ATPase domain physically interacts with the C-terminal endonuclease domain. Next, hydrogen/deuterium exchange mass spectrometry clarified that the binding of ATP to the N-terminal domain induces local structural changes at the catalytic sites of MutL C-terminal domain. Finally, on the basis of the results of the hydrogen/deuterium exchange experiment, we successfully identified novel regions essential for the endonuclease activity of MutL. The results clearly show that ATP modulates the nicking endonuclease activity of MutL via structural rearrangements of the catalytic site. In addition, several Lynch syndrome-related mutations in human MutL homolog are located in the position corresponding to the newly identified catalytic region. Our data contribute toward understanding the relationship between mutations in MutL homolog and human disease.	[Yamamoto, Tatsuya; Iino, Hitoshi; Kuramitsu, Seiki; Fukui, Kenji] Harima Inst, RIKEN SPring Ctr 8, Sayo Cho, Hyogo 6795148, Japan; [Kim, Kwang; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	RIKEN; Osaka University	Fukui, K (corresponding author), Harima Inst, RIKEN SPring Ctr 8, 1-1-1 Kouto, Sayo Cho, Hyogo 6795148, Japan.	k.fukui@spring8.or.jp		Yamamoto, Tatsuya/0000-0001-8356-8248; Fukui, Kenji/0000-0003-2463-7578				Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Iino H, 2011, BIOSCIENCE REP, V31, P309, DOI 10.1042/BSR20100116; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; Mueller J, 2009, CANCER RES, V69, P7053, DOI 10.1158/0008-5472.CAN-09-0358; Namadurai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013726; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; VAJDA T, 1976, ACTA BIOCHIM BIOPHYS, V11, P287; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yamamoto T, 2004, J BIOCHEM, V135, P663, DOI 10.1093/jb/mvh080; Yamamoto T, 2006, FEBS LETT, V580, P3638, DOI 10.1016/j.febslet.2006.05.049; Yamamoto T, 2010, J BIOL CHEM, V285, P5646, DOI 10.1074/jbc.M109.081836; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021	43	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42337	42348		10.1074/jbc.M111.277335	http://dx.doi.org/10.1074/jbc.M111.277335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21953455	hybrid, Green Published			2022-12-25	WOS:000298180900043
J	Muscolini, M; Montagni, E; Palermo, V; Di Agostino, S; Gu, W; Abdelmoula-Souissi, S; Mazzoni, C; Blandino, G; Tuosto, L				Muscolini, Michela; Montagni, Elisa; Palermo, Vanessa; Di Agostino, Silvia; Gu, Wei; Abdelmoula-Souissi, Salma; Mazzoni, Cristina; Blandino, Giovanni; Tuosto, Loretta			The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAX-DEPENDENT APOPTOSIS; TETRAMERIZATION DOMAIN; NUCLEAR EXPORT; MDM2; DEGRADATION; ACTIVATION; DEATH; LOCALIZATION; DISRUPTION; PROMOTES	Stress-induced monoubiquitination of p53 is a crucial event for the nuclear-cytoplasm-mitochondria trafficking and transcription-independent pro-apoptotic functions of p53. Although an intact ubiquitination pathway and a functional nuclear export sequence are required for p53 nuclear export, the role of specific residues within this region in regulating both processes remains largely unknown. Here we characterize the mechanisms accounting for the nuclear accumulation of a new point mutation (Lys-351 to Asn) in the nuclear export sequence of p53 identified in a cisplatin-resistant ovarian carcinoma cell line (A2780 CIS). We found that K351N substitution abrogates the monoubiquitination of p53 induced by both Mdm2 and MSL2 E3-ligases. As a consequence, cells expressing p53 K351N mutant showed defects in cisplatin-induced translocation of p53 to mitochondria, Bax oligomerization, and mitochondrial membrane depolarization. These data identify K351N as a critical mutation of p53 that contributes	[Muscolini, Michela; Montagni, Elisa; Palermo, Vanessa; Mazzoni, Cristina; Tuosto, Loretta] Univ Roma La Sapienza, Dept Biol & Biotechnol, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Di Agostino, Silvia; Blandino, Giovanni] Ist Regina Elena IFO, Translat Oncogen Unit, I-00144 Rome, Italy; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10027 USA; [Abdelmoula-Souissi, Salma] Univ Sfax, Ctr Biotechnol Sfax, Sfax 3018, Tunisia	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Columbia University; Columbia University; Centre de Biotechnologie de Sfax; Universite de Sfax	Tuosto, L (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol, Ist Pasteur Fdn Cenci Bolognetti, Via Sardi 70, I-00185 Rome, Italy.	loretta.tuosto@uniroma1.it	Di Agostino, Silvia/S-8566-2019; Blandino, Giovanni/B-1137-2013; Mazzoni, Cristina/U-2658-2018; Di Agostino, Silvia/H-1121-2018; Tuosto, Loretta/F-7017-2011; Muscolini, Michela/AAB-3904-2019	Blandino, Giovanni/0000-0002-6970-2241; Mazzoni, Cristina/0000-0002-1504-6189; Di Agostino, Silvia/0000-0003-3730-1125; Tuosto, Loretta/0000-0001-9056-4077; Muscolini, Michela/0000-0003-4090-4779	Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome; Minister of University and Research; Istituto Pasteur-Fondazione Cenci Bolognetti; NATIONAL CANCER INSTITUTE [P01CA097403, P01CA080058, R01CA131439] Funding Source: NIH RePORTER	Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Minister of University and Research; Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grants from the Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome and the Minister of University and Research.; Supported by a fellowship from the Istituto Pasteur-Fondazione Cenci Bolognetti.	Abdelmoula-Souissi S, 2011, APOPTOSIS, V16, P746, DOI 10.1007/s10495-011-0607-z; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amor IYH, 2008, FEMS YEAST RES, V8, P1254, DOI 10.1111/j.1567-1364.2008.00445.x; BEHRENS BC, 1987, CANCER RES, V47, P414; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brachmann CB, 1998, YEAST, V14, P115; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Coutinho I, 2011, EXP CELL RES, V317, P1147, DOI 10.1016/j.yexcr.2011.02.007; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein I, 2009, CELL CYCLE, V8, P3259; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Lwin TZ, 2007, J MOL BIOL, V373, P1334, DOI 10.1016/j.jmb.2007.07.080; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Muscolini M, 2009, CELL CYCLE, V8, P3396, DOI 10.4161/cc.8.20.9910; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Palacios G, 2008, CELL CYCLE, V7, P2584, DOI 10.4161/cc.7.16.6070; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Pietsch EC, 2007, CANCER BIOL THER, V6, P1576, DOI 10.4161/cbt.6.10.4719; Raffo AJ, 2000, ONCOGENE, V19, P6216, DOI 10.1038/sj.onc.1203995; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Soussi T, 2005, 25 YEARS OF P53 RESEARCH, P255, DOI 10.1007/1-4020-2922-5_12; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waster PK, 2009, J INVEST DERMATOL, V129, P1769, DOI 10.1038/jid.2008.421; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	50	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39693	39702		10.1074/jbc.M111.279539	http://dx.doi.org/10.1074/jbc.M111.279539			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953469	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000296925700003
J	Wang, JR; Markova, D; Anderson, DG; Zheng, ZM; Shapiro, IM; Risbud, MV				Wang, Jianru; Markova, Dessislava; Anderson, D. Greg; Zheng, Zhaomin; Shapiro, Irving M.; Risbud, Makarand V.			TNF-alpha and IL-1 beta Promote a Disintegrin-like and Metalloprotease with Thrombospondin Type I Motif-5-mediated Aggrecan Degradation through Syndecan-4 in Intervertebral Disc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NUCLEUS PULPOSUS TISSUE; CYTOKINE EXPRESSION; GENE-EXPRESSION; HEPARAN-SULFATE; NITRIC-OXIDE; DEGENERATION; ACTIVATION; MATRIX; OSTEOARTHRITIS	Elevated levels of TNF-alpha, IL-1 beta and a resultant increase in ADAMTS (a disintegrin-like and metalloprotease with thrombospondin type I motifs) expression is seen during disc degeneration. However, if these pro-inflammatory cytokines control ADAMTS activity is not definitively known. The goal of the investigation was to study if TNF-alpha and IL-1 beta regulate syndecan-4 (SDC4) expression, and if SDC4 was responsible for promoting aggrecan degradation through controlling ADAMTS activity in nucleus pulposus cells of the intervertebral disc. Cytokine treatment increased SDC4 expression and promoter activity. Use of inhibitor, SM7368 and co-transfections with I kappa B alpha, RelA/p50 showed that NF-kappa B regulated both basal and cytokine-dependent SDC4 transcription. SDC4 promoter har-boring RelA binding site mutation was unresponsive to the cytokines. Moreover, cytokines failed to increase SDC4 promoter activity in RelA-null cells. Cytokines increased ADAMTS-4/5 expression and aggrecan degradation and promoted SDC4 interaction with ADAMTS-5. Treatment with heparinase-III and p-nitrophenyl-beta-D-xylopyranoside (PNPX), an inhibitor of heparan sulfate synthesis and transfection with SDC4-shRNA partially blocked cytokine mediated aggrecan degradation. Analysis of human tissues showed increased aggrecan degradation with a concomitant increase in SDC4 and ADAMTS-5 protein expression with severity of disc disease. Likewise, SDC4, TNF-alpha, IL-1 beta, ADAMTS-4, and ADAMTS-5 mRNA expression increased in degenerate tissues. We conclude that in nucleus pulposus, TNF-alpha and IL-1 beta regulate SDC4 expression, which plays a key role in pathogenesis of degenerative disc disease by promoting aggrecan degradation by ADAMTS-5.	[Wang, Jianru; Markova, Dessislava; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Wang, Jianru; Markova, Dessislava; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Wang, Jianru; Zheng, Zhaomin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou 510080, Guangdong, Peoples R China	Jefferson University; Jefferson University; Sun Yat Sen University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1015 Walnut St,Suite 501 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [R01-AR050087, R01-AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grants R01-AR050087 and R01-AR055655 from the National Institutes of Health.	Asplund A, 2009, J LEUKOCYTE BIOL, V86, P381, DOI 10.1189/jlb.0908536; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Barbir A, 2011, SPINE, V36, P607, DOI 10.1097/BRS.0b013e3181d9b58b; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Haschtmann D, 2008, EUR SPINE J, V17, P289, DOI 10.1007/s00586-007-0509-5; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Lee S, 2009, CLIN BIOCHEM, V42, P1504, DOI 10.1016/j.clinbiochem.2009.06.017; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Ng L, 2003, J STRUCT BIOL, V143, P242, DOI 10.1016/j.jsb.2003.08.006; Omlor GW, 2006, J ORTHOP RES, V24, P385, DOI 10.1002/jor.20055; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Smith MF, 2006, GLYCOBIOLOGY, V16, P221, DOI 10.1093/glycob/cwj061; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Yamashita M, 2008, SPINE, V33, P1836, DOI 10.1097/BRS.0b013e31817bab2a	29	194	215	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39738	39749		10.1074/jbc.M111.264549	http://dx.doi.org/10.1074/jbc.M111.264549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949132	Green Published, hybrid			2022-12-25	WOS:000296925700007
J	Hanada, Y; Sekimizu, K; Kaito, C				Hanada, Yuichi; Sekimizu, Kazuhisa; Kaito, Chikara			Silkworm Apolipophorin Protein Inhibits Staphylococcus aureus Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-B; BOMBYX-MORI; SIGNAL-TRANSDUCTION; 2-COMPONENT SYSTEM; PRECURSOR PROTEIN; BINDING; BACTERIAL; EXPRESSION; LIPOPHORIN; REGULATOR	Silkworm hemolymph inhibits hemolysin production by Staphylococcus aureus. We purified a factor in the silkworm hemolymph responsible for this inhibitory activity. The final fraction with the greatest specific activity contained 220- and 74-kDa proteins. Determination of the N-terminal amino acid sequence revealed that the 220- and 74-kDa proteins were apolipophorin I and apolipophorin II, respectively, indicating that the factor was apolipophorin (ApoLp). The purified ApoLp fraction showed decreased expression of S. aureus hla encoding alpha-hemolysin, hlb encoding beta-hemolysin, saeRS, and RNAIII, which activate the expression of these hemolysin genes. Injection of an anti-ApoLp antibody into the hemolymph increased the sensitivity of silkworms to the lethal effect of S. aureus. Hog gastric mucin, a mammalian homologue of ApoLp, decreased the expression of S. aureus hla and hlb. These findings suggest that ApoLp in the silkworm hemolymph inhibits S. aureus virulence and contributes to defense against S. aureus infection and that its activity is conserved in mammalian mucin.	[Hanada, Yuichi; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	National Institute of Biomedical Innovation (NIBIO); Genome Pharmaceutical Institute	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Genome Pharmaceutical Institute	This work was supported by grants-in-aid for scientific research and in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and the Genome Pharmaceutical Institute.	Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; Cheung AL, 2001, INFECT IMMUN, V69, P2448, DOI 10.1128/IAI.69.4.2448-2455.2001; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; CHINO H, 1969, BIOCHIM BIOPHYS ACTA, V176, P1; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Hossain MS, 2006, J BIOCHEM, V140, P439, DOI 10.1093/jb/mvj171; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Kutty RK, 1996, J BIOL CHEM, V271, P20641, DOI 10.1074/jbc.271.34.20641; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Matsumoto Y, 2010, STRUCTURE, V18, P537, DOI 10.1016/j.str.2010.02.007; Matsuo M, 2003, FEMS MICROBIOL LETT, V222, P107, DOI 10.1016/S0378-1097(03)00260-X; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; Niere M, 2001, BIOCHEMISTRY-US, V40, P11502, DOI 10.1021/bi010117f; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; OKADA M, 1983, BIOCHEM J, V211, P727, DOI 10.1042/bj2110727; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Pratt CC, 2004, BIOL CHEM, V385, P1113, DOI 10.1515/BC.2004.145; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Sakashita K, 2009, J FAC AGR KYUSHU U, V54, P401; Smolenaars MMW, 2005, J LIPID RES, V46, P412, DOI 10.1194/jlr.M400374-JLR200; Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003; Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4; Tsuchida K, 1998, INSECT BIOCHEM MOLEC, V28, P927, DOI 10.1016/S0965-1748(98)00036-8; WEERS PMM, 1993, J BIOL CHEM, V268, P4300; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O	45	34	38	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39360	39369		10.1074/jbc.M111.278416	http://dx.doi.org/10.1074/jbc.M111.278416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937431	Green Published, hybrid			2022-12-25	WOS:000296759800054
J	Yen, JH; Kocieda, VP; Jing, HE; Ganea, D				Yen, Jui-Hung; Kocieda, Virginia P.; Jing, Huie; Ganea, Doina			Prostaglandin E2 Induces Matrix Metalloproteinase 9 Expression in Dendritic Cells through Two Independent Signaling Pathways Leading to Activator Protein 1 (AP-1) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; IV COLLAGENASE GENE; FACTOR-KAPPA-B; MATRIX METALLOPROTEINASES; MMP-9 EXPRESSION; UP-REGULATION; TRANSCRIPTIONAL ACTIVITY; PROSTANOID RECEPTORS; REGULATED KINASES; LANGERHANS CELLS	Dendritic Cells (DCs) play an important role in the initiation of the immune response by migrating to regional lymph nodes and presenting antigen processed at the inflammatory site to antigen-specific naive T cells. Prostaglandin E2 (PGE2) has been reported to play an essential role in DC migration. We reported previously that PGE2 induces matrix metalloproteinase 9 (MMP-9) expression in DCs and that PGE2-induced MMP-9 is required for DC migration in vivo and in vitro. In this study, we investigated the signaling mechanisms involved in PGE2-induced MMP-9 expression in DCs. We show that PGE2-induced MMP-9 expression is mediated primarily through the EP2/EP4 -> cAMP -> protein kinase A (PKA)/PI3K -> ERK signaling pathway, leading to c-Fos expression, and through JNK-mediated activation of c-Jun in a PKA/PI3K/ERK-independent manner. EP2 and EP4 receptor agonists, as well as cAMP analogs, mimic the up-regulation of MMP-9 by PGE2. PKA, PI3K, and ERK inhibitors abolished PGE2- and cAMP-induced c-Fos and MMP-9 up-regulation, and ERK activation was required for the binding of activator protein 1 (AP-1) transcription factor to the MMP-9 promoter. Our results describe a new molecular mechanism for the effect of PGE2 on MMP-9 production in DCs that could lead to future therapeutic approaches using ERK inhibitors to regulate DC migration.	[Yen, Jui-Hung; Kocieda, Virginia P.; Ganea, Doina] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Jing, Huie] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yen, JH (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.	doina.ganea@temple.edu	Yen, Jui-Hung/AAV-3455-2020; Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252; Yen, Jui-Hung Jimmy/0000-0002-7325-9756				Chabot V, 2006, J LEUKOCYTE BIOL, V79, P767, DOI 10.1189/jlb.0804464; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; CORCORAN ML, 1992, J BIOL CHEM, V267, P515; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Hollender P, 2002, IMMUNOBIOLOGY, V206, P441, DOI 10.1078/0171-2985-00193; Holvoet S, 2003, EXP CELL RES, V290, P108, DOI 10.1016/S0014-4827(03)00293-3; Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC; Itatsu K, 2009, AM J PATHOL, V174, P829, DOI 10.2353/ajpath.2009.080012; Jing H, 2004, J BIOL CHEM, V279, P55176, DOI 10.1074/jbc.M409816200; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kim HS, 2004, ANTICANCER RES, V24, P747; Kim JH, 2008, BIOCHEM BIOPH RES CO, V377, P195, DOI 10.1016/j.bbrc.2008.09.095; Lan HC, 2007, MOL CELL BIOL, V27, P2027, DOI 10.1128/MCB.02253-06; Lee KW, 2005, ANTIOXID REDOX SIGN, V7, P1612, DOI 10.1089/ars.2005.7.1612; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Li W, 2007, BIOL REPROD, V76, P654, DOI 10.1095/biolreprod.106.057034; Lin CC, 2008, TOXICOL APPL PHARM, V229, P386, DOI 10.1016/j.taap.2008.01.032; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park MK, 2009, BIOCHEM BIOPH RES CO, V379, P1043, DOI 10.1016/j.bbrc.2009.01.005; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Reno F, 2005, PROSTAG OTH LIPID M, V75, P13, DOI 10.1016/j.prostaglandins.2004.08.001; Sanchez S, 2004, NEUROCHEM INT, V44, P231, DOI 10.1016/S0197-0186(03)00150-5; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; St-Pierre Y, 2004, EXPERT OPIN THER TAR, V8, P473, DOI 10.1517/14728222.8.5.473; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Vassiliou E, 2003, CELL IMMUNOL, V223, P120, DOI 10.1016/S0008-8749(03)00158-8; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang HH, 2009, GLIA, V57, P24, DOI 10.1002/glia.20732; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Xue J, 2010, BIOMED PHARMACOTHER, V64, P118, DOI 10.1016/j.biopha.2009.04.033; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Yue W., 2010, CLIN EXP PHARM PHYSL; Zhang BC, 2011, BBA-MOL CELL RES, V1813, P73, DOI 10.1016/j.bbamcr.2010.10.001; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	49	63	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38913	38923		10.1074/jbc.M111.252932	http://dx.doi.org/10.1074/jbc.M111.252932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940623	Green Published, hybrid			2022-12-25	WOS:000296759800010
J	Canetta, SE; Luca, E; Pertot, E; Role, LW; Talmage, DA				Canetta, Sarah E.; Luca, Edlira; Pertot, Elyse; Role, Lorna W.; Talmage, David A.			Type III Nrg1 Back Signaling Enhances Functional TRPV1 along Sensory Axons Contributing to Basal and Inflammatory Thermal Pain Sensation	PLOS ONE			English	Article							HEAT HYPERALGESIA; CAPSAICIN RECEPTOR; NEUREGULIN-1 GENE; SCHIZOPHRENIA; INSENSITIVITY; NEURONS; NGF; ASSOCIATION; MAINTENANCE; NOCICEPTION	Type III Nrg1, a member of the Nrg1 family of signaling proteins, is expressed in sensory neurons, where it can signal in a bi-directional manner via interactions with the ErbB family of receptor tyrosine kinases (ErbB RTKs) [1]. Type III Nrg1 signaling as a receptor (Type III Nrg1 back signaling) can acutely activate phosphatidylinositol-3-kinase (PtdIns3K) signaling, as well as regulate levels of alpha 7* nicotinic acetylcholine receptors, along sensory axons [2]. Transient receptor potential vanilloid 1 (TRPV1) is a cation-permeable ion channel found in primary sensory neurons that is necessary for the detection of thermal pain and for the development of thermal hypersensitivity to pain under inflammatory conditions [3]. Cell surface expression of TRPV1 can be enhanced by activation of PtdIns3K [4,5,6], making it a potential target for regulation by Type III Nrg1. We now show that Type III Nrg1 signaling in sensory neurons affects functional axonal TRPV1 in a PtdIns3K-dependent manner. Furthermore, mice heterozygous for Type III Nrg1 have specific deficits in their ability to respond to noxious thermal stimuli and to develop capsaicin-induced thermal hypersensitivity to pain. Cumulatively, these results implicate Type III Nrg1 as a novel regulator of TRPV1 and a molecular mediator of nociceptive function.	[Canetta, Sarah E.; Role, Lorna W.] Columbia Univ, Dept Neurobiol & Behav, New York, NY 10027 USA; [Luca, Edlira] Columbia Univ, Integrated Dept, New York, NY USA; [Canetta, Sarah E.; Luca, Edlira; Role, Lorna W.; Talmage, David A.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Pertot, Elyse] SUNY Stony Brook, Dept Biol Sci, Stony Brook, NY 11794 USA; [Canetta, Sarah E.; Luca, Edlira; Role, Lorna W.; Talmage, David A.] SUNY Stony Brook, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA; [Talmage, David A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Columbia University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Canetta, SE (corresponding author), Columbia Univ, Dept Neurobiol & Behav, New York, NY 10027 USA.	david.talmage@stonybrook.edu	babakinejad, babak/G-2674-2012; Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X; Talmage, David/0000-0003-4627-3007	National Alliance for Research on Schizophrenia and Depression/Baer Foundation; National Institutes of Health [TL1RR025158, T32 GM08224, NS29071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression/Baer Foundation(NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from: The National Alliance for Research on Schizophrenia and Depression/Baer Foundation, The National Institutes of Health Grants: TL1RR025158, T32 GM08224 and NS29071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Apter J T, 1981, J Med Soc N J, V78, P679; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Blumensohn R, 2002, J NERV MENT DIS, V190, P481, DOI 10.1097/00005053-200207000-00011; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Chen Y, 2010, J NEUROSCI, V30, P9199, DOI 10.1523/JNEUROSCI.0605-10.2010; DWORKIN RH, 1994, SCHIZOPHRENIA BULL, V20, P235, DOI 10.1093/schbul/20.2.235; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fricker FR, 2009, J NEUROSCI, V29, P7667, DOI 10.1523/JNEUROSCI.6053-08.2009; GESCHWIND N, 1977, NEW ENGL J MED, V296, P1480; Hancock ML, 2008, J CELL BIOL, V181, P511, DOI 10.1083/jcb.200710037; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Koplas PA, 1997, J NEUROSCI, V17, P3525; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Murthy BM, 2004, INJURY, V35, P1192, DOI 10.1016/j.injury.2003.08.011; Nicodemus KK, 2009, MOL PSYCHIATR, V14, P741, DOI 10.1038/mp.2008.150; ROSENTHAL SH, 1990, GEN HOSP PSYCHIAT, V12, P319, DOI 10.1016/0163-8343(90)90050-M; Singh Manpreet K, 2006, J Psychiatr Pract, V12, P90, DOI 10.1097/00131746-200603000-00004; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TORREY EF, 1979, NEW ENGL J MED, V301, P110; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2006, J GEN PHYSIOL, V128, P491, DOI 10.1085/jgp.200609676; Zhong CB, 2008, J NEUROSCI, V28, P9111, DOI 10.1523/JNEUROSCI.0381-08.2008	35	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25108	10.1371/journal.pone.0025108	http://dx.doi.org/10.1371/journal.pone.0025108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949864	gold, Green Submitted, Green Published			2022-12-25	WOS:000295260400048
J	Wallace, LE; Culley, TM; Weller, SG; Sakai, AK; Kuenzi, A; Roy, T; Wagner, WL; Nepokroeff, M				Wallace, Lisa E.; Culley, Theresa M.; Weller, Stephen G.; Sakai, Ann K.; Kuenzi, Ashley; Roy, Tilottama; Wagner, Warren L.; Nepokroeff, Molly			Asymmetrical Gene Flow in a Hybrid Zone of Hawaiian Schiedea (Caryophyllaceae) Species with Contrasting Mating Systems	PLOS ONE			English	Article							INBREEDING DEPRESSION; ADAPTIVE RADIATION; WIND POLLINATION; INTERSPECIFIC HYBRIDIZATION; SALICARIA CARYOPHYLLACEAE; PHYLOGENETIC ANALYSIS; SILVERSWORD ALLIANCE; NATURAL-POPULATIONS; MITOCHONDRIAL-DNA; DUBAUTIA-ARBOREA	Asymmetrical gene flow, which has frequently been documented in naturally occurring hybrid zones, can result from various genetic and demographic factors. Understanding these factors is important for determining the ecological conditions that permitted hybridization and the evolutionary potential inherent in hybrids. Here, we characterized morphological, nuclear, and chloroplast variation in a putative hybrid zone between Schiedea menziesii and S. salicaria, endemic Hawaiian species with contrasting breeding systems. Schiedea menziesii is hermaphroditic with moderate selfing; S. salicaria is gynodioecious and wind-pollinated, with partially selfing hermaphrodites and largely outcrossed females. We tested three hypotheses: 1) putative hybrids were derived from natural crosses between S. menziesii and S. salicaria, 2) gene flow via pollen is unidirectional from S. salicaria to S. menziesii and 3) in the hybrid zone, traits associated with wind pollination would be favored as a result of pollen-swamping by S. salicaria. Schiedea menziesii and S. salicaria have distinct morphologies and chloroplast genomes but are less differentiated at the nuclear loci. Hybrids are most similar to S. menziesii at chloroplast loci, exhibit nuclear allele frequencies in common with both parental species, and resemble S. salicaria in pollen production and pollen size, traits important to wind pollination. Additionally, unlike S. menziesii, the hybrid zone contains many females, suggesting that the nuclear gene responsible for male sterility in S. salicaria has been transferred to hybrid plants. Continued selection of nuclear genes in the hybrid zone may result in a population that resembles S. salicaria, but retains chloroplast lineage(s) of S. menziesii.	[Wallace, Lisa E.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Culley, Theresa M.; Kuenzi, Ashley] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Weller, Stephen G.; Sakai, Ann K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Roy, Tilottama] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Wagner, Warren L.] Smithsonian Inst, Dept Bot, Washington, DC 20560 USA; [Nepokroeff, Molly] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA	Mississippi State University; University System of Ohio; University of Cincinnati; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Smithsonian Institution; Smithsonian National Museum of Natural History; University of South Dakota	Wallace, LE (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.	lisawallace@biology.msstate.edu		Wagner, Warren/0000-0001-5012-8422; Culley, Theresa/0000-0001-8656-4330; Kuenzi Davis, Ashley/0000-0003-1162-3994	NSF [DEB-0445410, DEB-9207724]; National Tropical Botanical Garden	NSF(National Science Foundation (NSF)); National Tropical Botanical Garden	The authors acknowledge support from NSF grants DEB-0445410 to MN and LW and DEB-9207724 to AKS and SGW as well as the McBryde endowment of National Tropical Botanical Garden to MN and WLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin Bruce G., 1995, P259; Barrier M, 1999, MOL BIOL EVOL, V16, P1105, DOI 10.1093/oxfordjournals.molbev.a026200; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Borge T, 2005, J EVOLUTION BIOL, V18, P1416, DOI 10.1111/j.1420-9101.2005.00964.x; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Buggs RJA, 2006, CURR BIOL, V16, P996, DOI 10.1016/j.cub.2006.03.093; Campbell DR, 1997, AM NAT, V149, P295, DOI 10.1086/285991; Campbell DR, 2002, AM NAT, V159, P438, DOI 10.1086/339457; Cassens I, 2005, SYST BIOL, V54, P363, DOI 10.1080/10635150590945377; Chapman MA, 2007, EVOLUTION, V61, P1773, DOI 10.1111/j.1558-5646.2007.00134.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Culley TM, 2008, MOL ECOL RESOUR, V8, P1081, DOI 10.1111/j.1755-0998.2008.02161.x; Culley TM, 1999, AM J BOT, V86, P980, DOI 10.2307/2656615; Culley TM, 2002, TRENDS ECOL EVOL, V17, P361, DOI 10.1016/S0169-5347(02)02540-5; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FORBES SH, 1991, EVOLUTION, V45, P1332, DOI 10.1111/j.1558-5646.1991.tb02639.x; Friar EA, 2007, MOL ECOL, V16, P4028, DOI 10.1111/j.1365-294X.2007.03423.x; Friar EA, 2008, SYST BOT, V33, P589, DOI 10.1600/036364408785679815; Friedman J, 2008, INT J PLANT SCI, V169, P49, DOI 10.1086/523365; Gross BL, 2003, AM J BOT, V90, P1708, DOI 10.3732/ajb.90.12.1708; Hamzeh M, 2007, CAN J BOT, V85, P1227, DOI 10.1139/B07-105; Harbaugh DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004698; Harrison RG, 1993, HYBRID ZONES EVOLUTI; Hersch EI, 2007, EVOLUTION, V61, P111, DOI 10.1111/j.1558-5646.2007.00009.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hillebrand W., 1888, FLORA HAWAIIAN ISLAN, DOI [10.5962/bhl.title.15785, DOI 10.5962/BHL.TITLE.15785]; Howarth DG, 2005, EVOLUTION, V59, P948, DOI 10.1111/j.0014-3820.2005.tb01034.x; KIM I, 1990, SYST BOT, V15, P370, DOI 10.2307/2419350; Kimball S, 2008, OIKOS, V117, P1064, DOI 10.1111/j.0030-1299.2008.16573.x; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; LEHMAN N, 1991, EVOLUTION, V45, P104, DOI 10.1111/j.1558-5646.1991.tb05270.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; McGlaughlin ME, 2011, ANN BOT-LONDON, V107, P357, DOI 10.1093/aob/mcq252; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Obbard DJ, 2006, EVOLUTION, V60, P1801, DOI 10.1111/j.0014-3820.2006.tb00524.x; Pearl SA, 2009, MOL BIOL EVOL, V26, P537, DOI 10.1093/molbev/msn273; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Randell RA, 2004, CONSERV GENET, V5, P217, DOI 10.1023/B:COGE.0000030006.30410.5d; Rankin AE, 2002, EVOLUTION, V56, P1574, DOI 10.1111/j.0014-3820.2002.tb01469.x; Remington DL, 2007, MOL ECOL, V16, P4014, DOI 10.1111/j.1365-294X.2007.03447.x; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1990, P NATL ACAD SCI USA, V87, P593, DOI 10.1073/pnas.87.2.593; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Sakai AK, 2008, J EVOLUTION BIOL, V21, P18, DOI 10.1111/j.1420-9101.2007.01439.x; SAKAI AK, 1991, AM J BOT, V78, P1280, DOI 10.2307/2444931; SAKAI AK, 1989, AM J BOT, V76, P437, DOI 10.2307/2444614; Sakai AK, 2006, ANN MO BOT GARD, V93, P49, DOI 10.3417/0026-6493(2006)93[49:ARAEOB]2.0.CO;2; *SAS I INC, 2002, SAS VERS 9 1; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Sherff E. E., 1945, BRITTONIA, V5, P308, DOI 10.2307/2804886; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Smith JF, 1996, PLANT SYST EVOL, V200, P61, DOI 10.1007/BF00984748; Tate JA, 2009, AM J BOT, V96, P979, DOI 10.3732/ajb.0800299; Vamosi JC, 2003, J EVOLUTION BIOL, V16, P1006, DOI 10.1046/j.1420-9101.2003.00559.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wagner W.L., 2005, SYST BOT MONOGR, V72, P1; WAGNER WL, 1990, MANUAL FLOWERING PLA, P1853; Wallace LE, 2006, AM J BOT, V93, P1001, DOI 10.3732/ajb.93.7.1001; Welch ME, 2002, EVOLUTION, V56, P2126, DOI 10.1111/j.0014-3820.2002.tb00138.x; Weller SG, 2006, J EVOLUTION BIOL, V19, P331, DOI 10.1111/j.1420-9101.2005.01038.x; Weller SG, 2005, J EVOLUTION BIOL, V18, P1434, DOI 10.1111/j.1420-9101.2005.00965.x; Weller SG, 2005, J EVOLUTION BIOL, V18, P301, DOI 10.1111/j.1420-9101.2004.00835.x; WELLER SG, 1990, SYST BOT, V15, P266, DOI 10.2307/2419182; WELLER SG, 1991, HEREDITY, V67, P265, DOI 10.1038/hdy.1991.89; Weller SG, 1998, AM J BOT, V85, P1377, DOI 10.2307/2446396; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Willyard A, 2011, MOL PHYLOGENET EVOL, V60, P29, DOI 10.1016/j.ympev.2011.04.001; WOLFE AD, 1995, SYST BOT, V20, P395, DOI 10.2307/2419800; Wu CA, 2005, MOL ECOL, V14, P781, DOI 10.1111/j.1365-294X.2005.02441.x; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121	84	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24845	10.1371/journal.pone.0024845	http://dx.doi.org/10.1371/journal.pone.0024845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949765	Green Submitted, Green Published, gold			2022-12-25	WOS:000295257900030
J	White, JP; Baynes, JW; Welle, SL; Kostek, MC; Matesic, LE; Sato, S; Carson, JA				White, James P.; Baynes, John W.; Welle, Stephen L.; Kostek, Matthew C.; Matesic, Lydia E.; Sato, Shuichi; Carson, James A.			The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TUMOR-BEARING RATS; FOXO TRANSCRIPTION FACTORS; APC(MIN/+) MICE; AMPK ACTIVATION; MESSENGER-RNA; GROWTH-FACTOR; PROTEOLYTIC SYSTEMS; MAMMALIAN TARGET; BINDING-PROTEINS	Muscle wasting that occurs with cancer cachexia is caused by an imbalance in the rates of muscle protein synthesis and degradation. The Apc(Min/+) mouse is a model of colorectal cancer that develops cachexia that is dependent on circulating IL-6. However, the IL-6 regulation of muscle protein turnover during the initiation and progression of cachexia in the Apc(Min/+) mouse is not known. Cachexia progression was studied in Apc(Min/+) mice that were either weight stable (WS) or had initial (<= 5%), intermediate (6-19%), or extreme (>= 20%) body weight loss. The initiation of cachexia reduced % MPS 19% and a further similar to 50% with additional weight loss. Muscle IGF-1 mRNA expression and mTOR targets were suppressed with the progression of body weight loss, while muscle AMPK phosphorylation (Thr 172), AMPK activity, and raptor phosphorylation (Ser 792) were not increased with the initiation of weight loss, but were induced as cachexia progressed. ATP dependent protein degradation increased during the initiation and progression of cachexia. However, ATP independent protein degradation was not increased until cachexia had progressed beyond the initial phase. IL-6 receptor antibody administration prevented body weight loss and suppressed muscle protein degradation, without any effect on muscle % MPS or IGF-1 associated signaling. In summary, the % MPS reduction during the initiation of cachexia is associated with IGF-1/mTOR signaling repression, while muscle AMPK activation and activation of ATP independent protein degradation occur later in the progression of cachexia. IL-6 receptor antibody treatment blocked cachexia progression through the suppression of muscle protein degradation, while not rescuing the suppression of muscle protein synthesis. Attenuation of IL-6 signaling was effective in blocking the progression of cachexia, but not sufficient to reverse the process.	[White, James P.; Baynes, John W.; Kostek, Matthew C.; Sato, Shuichi; Carson, James A.] Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Welle, Stephen L.] Univ Rochester, Sch Med, Dept Med, Rochester, NY USA; [Matesic, Lydia E.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Rochester; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	White, JP (corresponding author), Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA.	carsonj@mailbox.sc.edu	Carson, James/Q-5693-2019	Carson, James/0000-0003-3733-8796	Nation Institutes of Health (NIH) [5R01CA121249]; National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE [R01CA121249] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER	Nation Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by grant 5R01CA121249 from the Nation Institutes of Health (NIH) and the National Cancer Institute (NCI) to Dr. Carson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Asp ML, 2010, INT J CANCER, V126, P756, DOI 10.1002/ijc.24784; Attard-Montalto SP, 1998, ACTA PAEDIATR, V87, P54, DOI 10.1080/08035259850157877; Baltgalvis KA, 2008, J APPL PHYSIOL, V104, P1137, DOI 10.1152/japplphysiol.00955.2007; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Baltgalvis KA, 2009, CANCER PREV RES, V2, P641, DOI 10.1158/1940-6207.CAPR-09-0017; Baltgalvis KA, 2009, PFLUG ARCH EUR J PHY, V457, P989, DOI 10.1007/s00424-008-0574-6; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Bossola M, 2001, AM J PHYSIOL-REG I, V280, pR1518, DOI 10.1152/ajpregu.2001.280.5.R1518; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Carson JA, 2010, EXERC SPORT SCI REV, V38, P168, DOI 10.1097/JES.0b013e3181f44f11; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; CLARK AS, 1983, J CLIN INVEST, V72, P836, DOI 10.1172/JCI111054; Combaret L, 1999, MOL BIOL REP, V26, P95, DOI 10.1023/A:1006955832323; Costelli P, 2002, CYTOKINE, V19, P1, DOI 10.1006/cyto.2002.1036; Costelli P, 2006, AM J PHYSIOL-REG I, V291, pR674, DOI 10.1152/ajpregu.00104.2006; Dworzak F, 1998, CANCER, V82, P42, DOI 10.1002/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M; Eley HL, 2007, BIOCHEM J, V407, P113, DOI 10.1042/BJ20070651; EMERY PW, 1984, CANCER RES, V44, P2779; EMERY PW, 1984, BRIT MED J, V289, P584, DOI 10.1136/bmj.289.6445.584; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FAN J, 1994, ENDOCRINOLOGY, V134, P1685, DOI 10.1210/en.134.4.1685; Frost RA, 2007, J APPL PHYSIOL, V103, P378, DOI 10.1152/japplphysiol.00089.2007; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GLASS DJ, 2010, CURR TOP MICROBIOL I; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Hu JP, 2008, ENDOCRINOLOGY, V149, P5384, DOI 10.1210/en.2008-0132; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; KATUNUMA N, 1987, REV PHYSIOL BIOCH P, V108, P1, DOI 10.1007/BFb0034070; Khal J, 2005, BRIT J CANCER, V93, P774, DOI 10.1038/sj.bjc.6602780; Khal J, 2005, INT J BIOCHEM CELL B, V37, P2196, DOI 10.1016/j.biocel.2004.10.017; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Llovera M, 1998, CANCER LETT, V130, P19, DOI 10.1016/S0304-3835(98)00137-2; LLovera M, 1998, INT J MOL MED, V2, P69; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; MCCLUNG JM, 2009, AM J PHYSL CELL PHYS; Mehl KA, 2005, J APPL PHYSIOL, V98, P2219, DOI 10.1152/japplphysiol.00975.2004; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Penna F, 2010, INT J CANCER, V127, P1706, DOI 10.1002/ijc.25146; Pruznak AM, 2008, J NUTR, V138, P1887, DOI 10.1093/jn/138.10.1887; RENNIE MJ, 1983, CLIN PHYSIOL, V3, P387, DOI 10.1111/j.1475-097X.1983.tb00847.x; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Russell ST, 2009, CANCER CHEMOTH PHARM, V64, P517, DOI 10.1007/s00280-008-0899-z; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHERSTE.T, 1972, CANCER, V30, P1246, DOI 10.1002/1097-0142(197211)30:5<1246::AID-CNCR2820300516>3.0.CO;2-O; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; STRELKOV AB, 1989, AM J PHYSIOL, V257, pC261, DOI 10.1152/ajpcell.1989.257.2.C261; Thomson DM, 2008, J APPL PHYSIOL, V104, P625, DOI 10.1152/japplphysiol.00915.2007; Tisdale Michael J, 2006, Nutr Clin Pract, V21, P168, DOI 10.1177/0115426506021002168; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V207, P168, DOI 10.1006/bbrc.1995.1168; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; van Hall G, 2008, J CLIN ENDOCR METAB, V93, P2851, DOI 10.1210/jc.2007-2223; Wang H, 2005, KIDNEY INT, V68, P352, DOI 10.1111/j.1523-1755.2005.00409.x; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; White JP, 2009, ACTA PHYSIOL, V197, P321, DOI 10.1111/j.1748-1716.2009.02029.x; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; White JP, 2009, J APPL PHYSIOL, V107, P1420, DOI 10.1152/japplphysiol.00668.2009; Wigmore SJ, 1997, BRIT J CANCER, V75, P106, DOI 10.1038/bjc.1997.17; Williamson DL, 2006, AM J PHYSIOL-ENDOC M, V291, pE80, DOI 10.1152/ajpendo.00566.2005; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	79	127	128	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24650	10.1371/journal.pone.0024650	http://dx.doi.org/10.1371/journal.pone.0024650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949739	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900025
J	Sonenshine, DE; Bissinger, BW; Egekwu, N; Donohue, KV; Khalil, SM; Roe, RM				Sonenshine, Daniel E.; Bissinger, Brooke W.; Egekwu, Noble; Donohue, Kevin V.; Khalil, Sayed M.; Roe, R. Michael			First Transcriptome of the Testis-Vas Deferens-Male Accessory Gland and Proteome of the Spermatophore from Dermacentor variabilis (Acari: Ixodidae)	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MOLECULAR-BASIS; SEX-PEPTIDE; TICK; PROTEINS; GENES; REPRODUCTION; IDENTIFICATION; SYNGANGLION; ANNOTATION	Ticks are important vectors of numerous human diseases and animal diseases. Feeding stimulates spermatogenesis, mating and insemination of male factors that trigger female reproduction. The physiology of male reproduction and its regulation of female development are essentially a black box. Several transcriptomes have catalogued expression of tick genes in the salivary glands, synganglion and midgut but no comprehensive investigation has addressed male reproduction and mating. Consequently, a new global approach using transcriptomics, proteomics, and quantitative gene expression is needed to understand male reproduction and stimulation of female reproduction. This first transcriptome to the reproductive biology of fed male ticks, Dermacentor variabilis, was obtained by 454 pyrosequencing (563,093 reads, 12,804 contigs). Gene Ontology (Biological Processes level III) recognized 3,866 transcripts in 73 different categories; spermiogenesis; spermatogenesis; peptidases, lipases and hydrolases; oxidative and environmental stress; immune defense; and protein binding. Reproduction-associated genes included serine/threonine kinase, metalloendoproteinases, ferritins, serine proteases, trypsin, cysteine proteases, serpins, a cystatin, GPCR and others. qRT-PCR showed significant upregulation from unfed versus fed adult male reproductive organs of zinc metalloprotease, astacin metalloprotease and serine protease, enzymes important in spermiogenesis and mating activity in insects, as well as a GPCR with the greatest similarity to a SIFamide receptor known to be important in regulating courtship behavior in Drosophila. Proteomics on these organs and the spermatophore by tryptic digestion/Liquid chromatography/Mass spectrometry/Mass spectrometry (LC/MS/MS) demonstrated expression of many of the same messages found by 454 sequencing, supporting their identification, and revealed differences in protein distribution in the reproductive system versus the spermatophore. We found Ef alpha but no EF beta in the transcriptome and neither of these proteins in the spermatophore. Thus, the previously described model for male regulation of female reproduction may not apply to other ticks. A new paradigm is needed to explain male stimulation of female tick reproduction.	[Sonenshine, Daniel E.; Egekwu, Noble] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Bissinger, Brooke W.; Donohue, Kevin V.; Khalil, Sayed M.; Roe, R. Michael] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	Old Dominion University; University of North Carolina; North Carolina State University	Sonenshine, DE (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	dsonensh@odu.edu	Khalil, Sayed/AAJ-5597-2020; Sonenshine, Daniel/AAF-3625-2020	Khalil, Sayed/0000-0003-4433-4953; Roe, Richard/0000-0002-6386-0994; Noble, Noble/0000-0002-8380-6792	National Science Foundation [IBN-0315179, IOS-0949194]; Department of Entomology	National Science Foundation(National Science Foundation (NSF)); Department of Entomology	Funding for the laboratory of D. E. S. and R. M. R. was provided by a grant from the National Science Foundation (IBN-0315179 and IOS-0949194). B. W. B. was supported by a research and teaching assistantship from the Department of Entomology under the administration of George Kennedy. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aljamali M, 2002, INSECT BIOCHEM MOLEC, V32, P331, DOI 10.1016/S0965-1748(01)00113-8; Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Belardinelli M, 2007, ANN TROP MED PARASIT, V101, P611, DOI 10.1179/136485907X193879; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENOFF S, 1998, FRONT BIOSCI, V3, P1220; Bissinger BW, 2011, INSECT MOL IN PRESS; Boldbaatar D, 2008, BIOCHEM CELL BIOL, V86, P331, DOI [10.1139/O08-071, 10.1139/o08-071]; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Broeck JV, 1998, EUR J BIOCHEM, V254, P90, DOI 10.1046/j.1432-1327.1998.2540090.x; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; CESARIO MM, 1995, DEV BIOL, V169, P473, DOI 10.1006/dbio.1995.1162; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Curtin KD, 2005, J CELL SCI, V118, P2649, DOI 10.1242/jcs.02408; Davies SJ, 2006, INSECT BIOCHEM MOLEC, V36, P846, DOI 10.1016/j.ibmb.2006.08.009; de la Fuente J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-372; Dennis DT, 2005, TICK-BORNE DISEASES OF HUMANS, P3; DESTEPHANO DB, 1977, J INSECT PHYSIOL, V23, P905, DOI 10.1016/0022-1910(77)90019-1; Donohue KV, 2010, INSECT BIOCHEM MOLEC, V40, P79, DOI 10.1016/j.ibmb.2009.12.014; Donohue KV, 2009, J INSECT PHYSIOL, V55, P909, DOI 10.1016/j.jinsphys.2009.05.019; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Glasheen BM, 2010, DEV BIOL, V344, P772, DOI 10.1016/j.ydbio.2010.05.504; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo XY, 2008, INSECT BIOCHEM MOLEC, V38, P721, DOI 10.1016/j.ibmb.2008.04.004; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; HALLICK RB, 1977, NUCLEIC ACIDS RES, V4, P3055, DOI 10.1093/nar/4.9.3055; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kaufman WR, 2007, J INSECT PHYSIOL, V53, P264, DOI 10.1016/j.jinsphys.2006.10.004; Lambert-Langlais S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007309; Law JH, 2002, BIOCHEM BIOPH RES CO, V292, P1191, DOI 10.1006/bbrc.2001.2015; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer H, 2009, J EXP BIOL, V212, P3673, DOI 10.1242/jeb.034272; Mulenga A, 2004, INSECT MOL BIOL, V13, P423, DOI 10.1111/j.0962-1075.2004.00502.x; Mulenga A, 2003, INSECT MOL BIOL, V12, P185, DOI 10.1046/j.1365-2583.2003.00400.x; Mulenga A, 2007, EXP APPL ACAROL, V41, P267, DOI 10.1007/s10493-007-9064-3; Mulenga A, 2010, INSECT BIOCHEM MOLEC, V40, P524, DOI 10.1016/j.ibmb.2010.04.012; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Naz RK, 1999, BIOL REPROD, V60, P1402, DOI 10.1095/biolreprod60.6.1402; OLIVER JH, 1974, J MED ENTOMOL, V11, P26, DOI 10.1093/jmedent/11.1.26; Packila M, 2002, EXP APPL ACAROL, V27, P151, DOI 10.1023/A:1021507404506; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Pilpel N, 2008, INSECT BIOCHEM MOLEC, V38, P320, DOI 10.1016/j.ibmb.2007.11.010; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Ram KR, 2007, PLOS GENET, V3, P2428, DOI 10.1371/journal.pgen.0030238; Ram KR, 2007, J GENET, V86, P217, DOI 10.1007/s12041-007-0029-4; Ram KR, 2006, P NATL ACAD SCI USA, V103, P18674, DOI 10.1073/pnas.0606228103; Rivkin E, 1997, MOL REPROD DEV, V48, P77, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;77::AID-MRD10&gt;3.0.CO;2-T; Rylett CM, 2007, J EXP BIOL, V210, P3601, DOI 10.1242/jeb.009035; Sabeur K, 2008, MOL REPROD DEV, V75, P867, DOI 10.1002/mrd.20792; SEIGUER AC, 1972, BIOL REPROD, V7, P31, DOI 10.1093/biolreprod/7.1.31; Smith A, 2009, EXP APPL ACAROL, V47, P71, DOI 10.1007/s10493-008-9195-1; SMITH GM, 1994, BIOCHEM J, V304, P775, DOI 10.1042/bj3040775; Sonenshine D.E., 1993, BIOL TICKS, V2, P465; Sonenshine D.E, 1991, BIOL TICKS, P447; Sonenshine DE, 2005, EXP APPL ACAROL, V36, P207, DOI 10.1007/s10493-005-2564-0; Sonoda S, 2006, ARCH INSECT BIOCHEM, V62, P80, DOI 10.1002/arch.20124; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Thomas JE, 2005, BIOCHEM J, V386, P357, DOI 10.1042/BJ20041753; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Weiss BL, 2004, P NATL ACAD SCI USA, V101, P5874, DOI 10.1073/pnas.0307529101; Wolfner M.F., 2007, P183; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Yuan J, 2000, INSECT BIOCHEM MOLEC, V30, P1099, DOI 10.1016/S0965-1748(00)00087-4; Zhu GZ, 2009, MOL REPROD DEV, V76, P1106, DOI 10.1002/mrd.21076; Zhu XX, 2001, EXP APPL ACAROL, V25, P1005, DOI 10.1023/A:1020664211999	77	41	41	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24711	10.1371/journal.pone.0024711	http://dx.doi.org/10.1371/journal.pone.0024711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949745	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800034
J	Urbano, JM; Dominguez-Gimenez, P; Estrada, B; Martin-Bermudo, MD				Urbano, Jose M.; Dominguez-Gimenez, Paloma; Estrada, Beatriz; Martin-Bermudo, Maria D.			PS Integrins and Laminins: Key Regulators of Cell Migration during Drosophila Embryogenesis	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; FIBRONECTIN RECEPTOR; VISCERAL MESODERM; GENETIC-ANALYSIS; MORPHOGENESIS; SUBUNIT; ALPHA; EXPRESSION; ADHESION; PROTEIN	During embryonic development, there are numerous cases where organ or tissue formation depends upon the migration of primordial cells. In the Drosophila embryo, the visceral mesoderm (vm) acts as a substrate for the migration of several cell populations of epithelial origin, including the endoderm, the trachea and the salivary glands. These migratory processes require both integrins and laminins. The current model is that alpha PS1 beta PS (PS1) and/or alpha PS3 beta PS (PS3) integrins are required in migrating cells, whereas alpha PS2 beta PS (PS2) integrin is required in the vm, where it performs an as yet unidentified function. Here, we show that PS1 integrins are also required for the migration over the vm of cells of mesodermal origin, the caudal visceral mesoderm (CVM). These results support a model in which PS1 might have evolved to acquire the migratory function of integrins, irrespective of the origin of the tissue. This integrin function is highly specific and its specificity resides mainly in the extracellular domain. In addition, we have identified the Laminin alpha 1,2 trimer, as the key extracellular matrix (ECM) component regulating CVM migration. Furthermore, we show that, as it is the case in vertebrates, integrins, and specifically PS2, contributes to CVM movement by participating in the correct assembly of the ECM that serves as tracks for migration.	[Urbano, Jose M.; Estrada, Beatriz; Martin-Bermudo, Maria D.] CSIC Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Dominguez-Gimenez, Paloma] CSIC Univ Sevilla, Ctr Andaluz Biol Mol & Med Regenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Urbano, JM (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	mdmarber@upo.es	Gimenez, Paloma Dominguez/M-4651-2019; Urbano, Jose M./AAB-6827-2020; Martin Bermudo, M Dolores/L-2306-2014; Dominguez Gimenez, Paloma/C-2060-2017	Gimenez, Paloma Dominguez/0000-0001-6860-3228; Urbano, Jose M./0000-0002-6644-8129; Martin Bermudo, M Dolores/0000-0002-8060-1695; Dominguez Gimenez, Paloma/0000-0001-6860-3228	Spanish Ministerio de Ciencia y Tecnologia (MCYT) [BMC2001-2298, BFU2007-64715/BMC, CSD-2007-00008]; European Molecular Biology Organization; Junta de Andalucia [CVI-280, PO6-CVI1592]; Spanish Ministry of Education	Spanish Ministerio de Ciencia y Tecnologia (MCYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Education(Spanish Government)	Research in the M.D.M.-B. laboratory is funded by the Spanish Ministerio de Ciencia y Tecnologia (MCYT) (BMC2001-2298, BFU2007-64715/BMC and CSD-2007-00008), by the Young Investigator Programme from the the European Molecular Biology Organization and by the Junta de Andalucia (CVI-280 and PO6-CVI1592). J.M.U. was supported by a MCYT studentship from the MCYT. B.E. was funded by the Programa Ramon y Cajal from the Spanish Ministry of Education. The institutional support from the Junta de Andalucia to the Centro Andaluz de Biologia del Desarrollo is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Boube M, 2001, GENE DEV, V15, P1554, DOI 10.1101/gad.195501; Brabant MC, 1996, DEVELOPMENT, V122, P3307; Bradley PL, 2003, DEV BIOL, V257, P249, DOI 10.1016/S0012-1606(03)00103-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWER DL, 1995, DEVELOPMENT, V121, P1311; BROWN NH, 1994, DEVELOPMENT, V120, P1221; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; BUNCH TA, 1992, DEVELOPMENT, V116, P239; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHOU TB, 1992, GENETICS, V131, P643; DARRIBERE T, 1990, J CELL BIOL, V110, P1813, DOI 10.1083/jcb.110.5.1813; DEDHAR S, 1992, J BIOL CHEM, V267, P18908; Delon I, 2009, J CELL SCI, V122, P4363, DOI 10.1242/jcs.055996; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; DUNINBORKOWSKI OM, 1995, DEV BIOL, V168, P689, DOI 10.1006/dbio.1995.1115; FESSLER JH, 1989, ANNU REV CELL BIOL, V5, P309, DOI 10.1146/annurev.cb.05.110189.001521; FESSLER LI, 1994, METHOD ENZYMOL, V245, P271; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Georgias C, 1997, MECH DEVELOP, V69, P115, DOI 10.1016/S0925-4773(97)00169-X; GOTWALS PJ, 1994, P NATL ACAD SCI USA, V91, P11447, DOI 10.1073/pnas.91.24.11447; HACKER U, 1995, EMBO J, V14, P5306, DOI 10.1002/j.1460-2075.1995.tb00215.x; HENCHCLIFFE C, 1993, DEVELOPMENT, V118, P325; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hsia CC, 2003, CURR OPIN GENET DEV, V13, P199, DOI 10.1016/S0959-437X(03)00017-0; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Ismat A, 2010, DEVELOPMENT, V137, P3107, DOI 10.1242/dev.046573; Kusch T, 1999, DEVELOPMENT, V126, P3991; KUSCHEGULLBERG M, 1992, EMBO J, V11, P4519, DOI 10.1002/j.1460-2075.1992.tb05553.x; Lee HK, 2007, J NEUROCHEM, V102, P686, DOI 10.1111/j.1471-4159.2007.04580.x; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; MacMullin A, 2006, DEV BIOL, V293, P154, DOI 10.1016/j.ydbio.2006.01.027; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; Martin-Bermudo MD, 1999, GENE DEV, V13, P729, DOI 10.1101/gad.13.6.729; Martin-Bermudo MD, 1999, DEVELOPMENT, V126, P5161; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; Narasimha M, 2004, CURR BIOL, V14, P381, DOI 10.1016/j.cub.2004.02.033; Narasimha M., 2005, INTEGRINS DEV; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prout M, 1997, GENETICS, V146, P275; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; REUTER R, 1993, DEVELOPMENT, V119, P1135; REUTER R, 1994, DEVELOPMENT, V120, P1123; ROOTE CE, 1995, DEV BIOL, V169, P322, DOI 10.1006/dbio.1995.1147; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Schock F, 2003, GENE DEV, V17, P597, DOI 10.1101/gad.1068403; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Skalski M, 1998, DEV BIOL, V195, P158, DOI 10.1006/dbio.1997.8838; SOKAL RR, 1995, BIOMETRY FREEMAN CO; Stark KA, 1997, DEVELOPMENT, V124, P4583; Stevens A, 2002, J NEUROSCI, V22, P4448, DOI 10.1523/JNEUROSCI.22-11-04448.2002; Swan LE, 2004, GENE DEV, V18, P223, DOI 10.1101/gad.287604; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; TEPASS U, 1994, DEVELOPMENT, V120, P579; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Urbano JM, 2009, DEVELOPMENT, V136, P4165, DOI 10.1242/dev.044263; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; WEHRLI M, 1993, MECH DEVELOP, V43, P21, DOI 10.1016/0925-4773(93)90020-X; Wolfstetter G, 2009, MECH DEVELOP, V126, P721, DOI 10.1016/j.mod.2009.05.001; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; YELIAN FD, 1993, J CELL BIOL, V121, P923, DOI 10.1083/jcb.121.4.923; Zaffran S, 2001, GENE DEV, V15, P2900	69	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23893	10.1371/journal.pone.0023893	http://dx.doi.org/10.1371/journal.pone.0023893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949686	gold, Green Published, Green Submitted			2022-12-25	WOS:000295173800008
J	Bai, F; Watson, DR; Shi, YM; Wang, Y; Yue, CX; YuhuanTeng; Wu, D; Yuan, YG; Zhang, ZJ				Bai, Feng; Watson, David R.; Shi, Yongmei; Wang, Yi; Yue, Chunxian; YuhuanTeng; Wu, Di; Yuan, Yonggui; Zhang, Zhijun			Specifically Progressive Deficits of Brain Functional Marker in Amnestic Type Mild Cognitive Impairment	PLOS ONE			English	Article							RESTING-STATE NETWORKS; POSTERIOR CINGULATE CORTEX; TASK-INDUCED DEACTIVATION; ALZHEIMERS-DISEASE; DEFAULT-MODE; CONNECTIVITY; MODULATION; COMPONENTS; ATROPHY; RISK	Background: Deficits of the default mode network (DMN) have been demonstrated in subjects with amnestic type mild cognitive impairment (aMCI) who have a high risk of developing Alzheimer's disease (AD). However, no longitudinal study of this network has been reported in aMCI. Identifying links between development of DMN and aMCI progression would be of considerable value in understanding brain changes underpinning aMCI and determining risk of conversion to AD. Methodology/Principal Findings: Resting-state fMRI was acquired in aMCI subjects (n = 26) and controls (n = 18) at baseline and after approximately 20 months follow up. Independent component analysis was used to isolate the DMN in each participant. Differences in DMN between aMCI and controls were examined at baseline, and subsequent changes between baseline and follow-up were also assessed in the groups. Posterior cingulate cortex/precuneus (PCC/PCu) hyper-functional connectivity was observed at baseline in aMCI subjects, while a substantial decrement of these connections was evident at follow-up in aMCI subjects, compared to matched controls. Specifically, PCC/PCu dysfunction was positively related to the impairments of episodic memory from baseline to follow up in aMCI group. Conclusions/Significance: The patterns of longitudinal deficits of DMN may assist investigators to identify and monitor the development of aMCI.	[Bai, Feng; Wang, Yi; Yue, Chunxian; YuhuanTeng; Wu, Di] Southeast Univ, Sch Med, Nanjing, Peoples R China; [Bai, Feng; Shi, Yongmei; Yuan, Yonggui; Zhang, Zhijun] Southeast Univ, Dept Neurol, Affiliated ZhongDa Hosp, Nanjing, Peoples R China; [Bai, Feng; Shi, Yongmei; Yuan, Yonggui; Zhang, Zhijun] Southeast Univ, Inst Neuropsychiat, Nanjing, Peoples R China; [Watson, David R.] Univ Ulster, Derry, North Ireland	Southeast University - China; Southeast University - China; Southeast University - China; Ulster University	Bai, F (corresponding author), Southeast Univ, Sch Med, Nanjing, Peoples R China.	zhijunzhang838@yahoo.com.cn	Yuan, Yonggui/AFA-0807-2022	Yuan, Yonggui/0000-0001-6496-3998; Wu, Di/0000-0003-3014-9087	National Natural Science Foundation of China [30825014, 30971016, 81010063]; National Basic Research Program of China (973 Program) [2007CB512308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This project was supported by the National Natural Science Foundation of China (No. 30825014; No. 30971016; No. 81010063), National Basic Research Program of China (973 Program; No. 2007CB512308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bai F, 2009, NEUROSCI LETT, V450, P85, DOI 10.1016/j.neulet.2008.11.055; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frisoni GB, 2009, NEUROLOGY, V72, P1504, DOI 10.1212/WNL.0b013e3181a2e896; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones BF, 2006, CEREB CORTEX, V16, P1701, DOI 10.1093/cercor/bhj105; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mortimer JA, 1997, GERIATRICS, V52, pS50; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Palmer K, 2008, AM J GERIAT PSYCHIAT, V16, P603, DOI 10.1097/JGP.0b013e3181753a64; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rombouts Serge, 2005, Current Alzheimer Research, V2, P115, DOI 10.2174/1567205053585783; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van de Ven V, 2008, HUM BRAIN MAPP, V29, P1450, DOI 10.1002/hbm.20479; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	60	61	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24271	10.1371/journal.pone.0024271	http://dx.doi.org/10.1371/journal.pone.0024271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935394	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295041700022
J	Lada, AG; Waisertreiger, ISR; Grabow, CE; Prakash, A; Borgstahl, GEO; Rogozin, IB; Pavlov, YI				Lada, Artem G.; Waisertreiger, Irina S. -R.; Grabow, Corinn E.; Prakash, Aishwarya; Borgstahl, Gloria E. O.; Rogozin, Igor B.; Pavlov, Youri I.			Replication Protein A (RPA) Hampers the Processive Action of APOBEC3G Cytosine Deaminase on Single-Stranded DNA	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; MESSENGER-RNA; KINASE-A; AID; MUTATION; YEAST; GENE; PHOSPHORYLATION; DIVERSIFICATION	Background: Editing deaminases have a pivotal role in cellular physiology. A notable member of this superfamily, APOBEC3G (A3G), restricts retroviruses, and Activation Induced Deaminase (AID) generates antibody diversity by localized deamination of cytosines in DNA. Unconstrained deaminase activity can cause genome-wide mutagenesis and cancer. The mechanisms that protect the genomic DNA from the undesired action of deaminases are unknown. Using the in vitro deamination assays and expression of A3G in yeast, we show that replication protein A (RPA), the eukaryotic single-stranded DNA (ssDNA) binding protein, severely inhibits the deamination activity and processivity of A3G. Principal Findings/Methodology: We found that mutations induced by A3G in the yeast genomic reporter are changes of a single nucleotide. This is unexpected because of the known property of A3G to catalyze multiple deaminations upon one substrate encounter event in vitro. The addition of recombinant RPA to the oligonucleotide deamination assay severely inhibited A3G activity. Additionally, we reveal the inverse correlation between RPA concentration and the number of deaminations induced by A3G in vitro on long ssDNA regions. This resembles the "hit and run" single base substitution events observed in yeast. Significance: Our data suggest that RPA is a plausible antimutator factor limiting the activity and processivity of editing deaminases in the model yeast system. Because of the similar antagonism of yeast RPA and human RPA with A3G in vitro, we propose that RPA plays a role in the protection of the human genome cell from A3G and other deaminases when they are inadvertently diverged from their natural targets. We propose a model where RPA serves as one of the guardians of the genome that protects ssDNA from the destructive processive activity of deaminases by non-specific steric hindrance.	[Lada, Artem G.; Waisertreiger, Irina S. -R.; Grabow, Corinn E.; Prakash, Aishwarya; Borgstahl, Gloria E. O.; Pavlov, Youri I.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Rogozin, Igor B.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Rogozin, Igor B.] Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia	University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Lada, AG (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	ypavlov@unmc.edu	Borgstahl, Gloria/AAZ-4114-2020; Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Prakash, Aishwarya/0000-0003-1441-6237; Rogozin, Igor/0000-0003-0802-4851	NCI Eppley Cancer Center Support Grant [P30CA036727]; NCI [CA129925]; University of Nebraska Medical Center; Presidential graduate fellowship; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA129925] Funding Source: NIH RePORTER	NCI Eppley Cancer Center Support Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Nebraska Medical Center; Presidential graduate fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI Eppley Cancer Center Support Grant [P30CA036727] and in part by NCI grant CA129925 to YIP. Aishwarya Prakash was supported by the University of Nebraska Medical Center graduate fellowship and the Presidential graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH ML, 1979, P NATL ACAD SCI USA, V76, P386, DOI 10.1073/pnas.76.1.386; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Bhagwat AS, 2004, DNA REPAIR, V3, P85, DOI 10.1016/j.dnarep.2003.09.008; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2009, NAT STRUCT MOL BIOL, V16, P454, DOI 10.1038/nsmb0509-454; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Deng XY, 2009, BIOCHEMISTRY-US, V48, P6633, DOI 10.1021/bi900564k; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goff SP, 2003, CELL, V114, P281, DOI 10.1016/S0092-8674(03)00602-0; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Khromov-Borisov NN, 1999, MUTAT RES-FUND MOL M, V430, P55, DOI 10.1016/S0027-5107(99)00148-7; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lucaccioni A, 2007, CURR GENET, V52, P239, DOI 10.1007/s00294-007-0159-5; Mayorov VI, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-10; Miller JH, EXPT MOL GENETICS CO; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nilsen H, 2005, ONCOGENE, V24, P3063, DOI 10.1038/sj.onc.1208480; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2011, J BIOL CHEM; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sambrook J, 2001, MOL CLONING LAB MANU; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Storb U, 2009, CELL CYCLE, V8, P3097, DOI 10.4161/cc.8.19.9658; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	52	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24848	10.1371/journal.pone.0024848	http://dx.doi.org/10.1371/journal.pone.0024848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935481	gold, Green Published			2022-12-25	WOS:000295041700065
J	Herring, A; Donath, A; Yarmolenko, M; Uslar, E; Conzen, C; Kanakis, D; Bosma, C; Worm, K; Paulus, W; Keyvani, K				Herring, Arne; Donath, Anja; Yarmolenko, Maksym; Uslar, Ellen; Conzen, Catharina; Kanakis, Dimitrios; Bosma, Claudius; Worm, Karl; Paulus, Werner; Keyvani, Kathy			Exercise during pregnancy mitigates Alzheimer-like pathology in mouse offspring	FASEB JOURNAL			English	Article						maternal running; progeny; APP processing and amyloid; inflammation; plasticity	AMYLOID-BETA-PEPTIDE; ENVIRONMENTAL ENRICHMENT; LIPOPROTEIN RECEPTORS; REELIN EXPRESSION; PHYSICAL-ACTIVITY; OXIDATIVE DAMAGE; GENE-EXPRESSION; TRANSGENIC MICE; PROTEIN; DISEASE	Physical activity protects brain function in healthy individuals and those with Alzheimer's disease (AD). Evidence for beneficial effects of parental exercise on the health status of their progeny is sparse and limited to nondiseased individuals. Here, we questioned whether maternal running interferes with offspring's AD-like pathology and sought to decipher the underlying mechanisms in TgCRND8 mice. Maternal stimulation was provided by voluntary wheel running vs. standard housing during pregnancy. Following 5 mo of standard housing of transgenic and wild-type offspring, their brains were examined for AD-related pathology and/or plasticity changes. Running during pregnancy reduced beta-amyloid (A beta) plaque burden (-35%, P = 0.017) and amyloidogenic APP processing in transgenic offspring and further improved the neurovascular function by orchestrating different A beta transporters and increasing angiogenesis (+29%, P = 0.022). This effect was accompanied by diminished inflammation, as indicated by reduced microgliosis (-20%, P = 0.002) and down-regulation of other proinflammatory mediators, and resulted in less oxidative stress, as nitrotyrosine levels declined (-28%, P = 0.029). Moreover, plasticity changes (in terms of up-regulation of reelin, synaptophysin, and ARC) were found not only in transgenic but also in wild-type offspring. We conclude that exercise during pregnancy provides long-lasting protection from neurodegeneration and improves brain plasticity in the otherwise unstimulated progeny.-Herring, A., Donath, A., Yarmolenko, M., Uslar, E., Conzen, C., Kanakis, D., Bosma, C., Worm, K., Paulus, W., Keyvani, K. Exercise during pregnancy mitigates Alzheimer-like pathology in mouse offspring. FASEB J. 26, 117-128 (2012). www.fasebj.org	[Herring, Arne; Donath, Anja; Yarmolenko, Maksym; Uslar, Ellen; Conzen, Catharina; Kanakis, Dimitrios; Bosma, Claudius; Worm, Karl; Keyvani, Kathy] Univ Hosp Essen, Inst Pathol & Neuropathol, D-45122 Essen, Germany; [Paulus, Werner] Univ Hosp Muenster, Inst Neuropathol, Munster, Germany	University of Duisburg Essen; University of Munster	Keyvani, K (corresponding author), Univ Hosp Essen, Inst Pathol & Neuropathol, Hufelandstr 55, D-45122 Essen, Germany.	kathy.keyvani@uk-essen.de			Innovative Medical Research (IMF) [KE 110711]	Innovative Medical Research (IMF)	The authors thank A. Wagner, D. Bergmann, A. Kurowski, and J. Scheich for technical assistance and David Westaway (University of Toronto, Toronto, ON, Canada) for providing TgCRND8 mice. This work was supported by a grant from Innovative Medical Research (IMF; KE 110711).	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Becker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012793; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bick-Sander A, 2006, P NATL ACAD SCI USA, V103, P3852, DOI 10.1073/pnas.0502644103; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; Herring A, 2008, BRAIN PATHOL, V18, P32, DOI 10.1111/j.1750-3639.2007.00094.x; Herring A, 2011, NEUROBIOL DIS, V42, P530, DOI 10.1016/j.nbd.2011.03.007; Herring A, 2010, BRAIN PATHOL, V20, P166, DOI 10.1111/j.1750-3639.2008.00257.x; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kuhnke D, 2007, BRAIN PATHOL, V17, P347, DOI 10.1111/j.1750-3639.2007.00075.x; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LECLERC N, 1989, J COMP NEUROL, V280, P197, DOI 10.1002/cne.902800204; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Liu HL, 2011, BEHAV BRAIN RES, V218, P308, DOI 10.1016/j.bbr.2010.12.030; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Pan WH, 2004, J CELL SCI, V117, P5071, DOI 10.1242/jcs.01381; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Senechal Y, 2007, J NEUROCHEM, V102, P1928, DOI 10.1111/j.1471-4159.2007.04672.x; Song MK, 2009, BRIT J PHARMACOL, V158, P442, DOI 10.1111/j.1476-5381.2009.00201.x; Stengel A, 2010, ENDOCRINOLOGY, V151, P4224, DOI 10.1210/en.2010-0195; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Um HS, 2008, INT J MOL MED, V22, P529, DOI 10.3892/ijmm_00000052; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P661, DOI [10.1139/H06-060, 10.1139/h06-060]; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Zhao ST, 2006, J COMP NEUROL, V495, P1, DOI 10.1002/cne.20846; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	53	64	65	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					117	128		10.1096/fj.11-193193	http://dx.doi.org/10.1096/fj.11-193193			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21948247				2022-12-25	WOS:000299202200013
J	Ghisla, S; Pollegioni, L; Molla, G				Ghisla, Sandro; Pollegioni, Loredano; Molla, Gianluca			Revisitation of the beta Cl-Elimination Reaction of D-Amino Acid Oxidase NEW INTERPRETATION OF THE REACTION THAT SPARKED FLAVOPROTEIN DEHYDROGENATION MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE ALPHA-HYDROGEN; ACYL-COA DEHYDROGENASE; LACTATE OXIDASE; CATALYTIC MECHANISM; CARBONYL-COMPOUNDS; HYDRIDE TRANSFER; ENZYME; REDUCTION; OXIDATION; KINETICS	D-Amino acid oxidase (DAAO) from pig has been reported to catalyze the beta-elimination of Cl- from beta Cl-D-alanine via abstraction of the substrate alpha-H as W ("carbanion mechanism") (Walsh, C. T., Schonbrunn, A., and Abeles, R. H. (1971) J. Biol. Chem. 246, 6855-6866). In view of the fundamental mechanistic importance of this reaction and of the recent reinterpretation of the DAAO dehydrogenation step as occurring via a hydride mechanism, we reinvestigated the elimination reaction using yeast DAAO. That enzyme catalyzes the same reactions as the pig enzyme but with a much higher efficiency and a substantially different kinetic behavior. The reaction is initiated by a very rapid and fully reversible dehydrogenation step. This leads to an equilibrium (k(on) approximate to k(reverse)) between the complexes of oxidized enzyme-beta Cl-D-alanine and reduced enzyme-beta Cl-iminopyruvate. In the presence of O-2 the latter complex can partition between an oxidative half-reaction and elimination of Cl-, which proceeds at a rate of approximate to 50 s(-1). This step forms a complex between oxidized enzyme and enamine that is characterized by a charge transfer absorption (which describes its rates of formation and decay). A minimal scheme that lists relevant steps of the reductive and oxidative half-reactions and elimination pathways along with the estimate of the corresponding rate constants is presented. beta-Elimination of Cl- is proposed to originate at the locus of the enzyme-beta Cl-iminopyruvate complex. A chemical mechanism that can account for elimination is discussed in detail.	[Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, I-21100 Varese, Italy; Politecn Milan, Ctr Interuniv Ric Biotecnol Prot Prot Factory, I-20131 Milan, Italy; Univ Insubria, I-20131 Milan, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria	Pollegioni, L (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it	Molla, Gianluca/G-3326-2013	Molla, Gianluca/0000-0003-3688-3397; POLLEGIONI, LOREDANO/0000-0003-1733-7243	Fonda di Ateneo per la Ricerca	Fonda di Ateneo per la Ricerca	This work was supported by grants from Fonda di Ateneo per la Ricerca (to L. P. and G. M.).	BLANKENHORN G, 1972, Z NATURFORSCH PT B, VB 27, P1038; Bright H.B., 1975, ENZYMES, V12B, P421; CHEUNG YF, 1976, BIOCHEMISTRY-US, V15, P2432, DOI 10.1021/bi00656a029; Curti B., 1991, CHEM BIOCH FLAVOENZY, V3, P69; DANG TY, 1976, BIOCHEM BIOPH RES CO, V72, P960, DOI 10.1016/S0006-291X(76)80225-2; Engst S, 1999, BIOCHEMISTRY-US, V38, P257, DOI 10.1021/bi9815041; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; Fitzpatrick PF, 2004, BIOORG CHEM, V32, P125, DOI 10.1016/j.bioorg.2003.02.001; GHISLA S, 1980, J BIOL CHEM, V255, P5688; Ghisla S., 2005, FLAV FLAV P 15 INT S; Ghisla S., 1982, FLAVINS FLAVOPROTEIN, P133; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Gradinaru R, 2007, BIOCHEMISTRY-US, V46, P2497, DOI 10.1021/bi0614582; GROB CA, 1967, ANGEW CHEM INT EDIT, V6, P1, DOI 10.1002/anie.196700011; Harris CM, 2001, EUR J BIOCHEM, V268, P5504, DOI 10.1046/j.1432-1033.2001.02462.x; HERSH LB, 1975, J BIOL CHEM, V250, P8728; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; Massey V., 1975, FLAVINS FLAVOPROTEIN, P199; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; Mattevi A, 1997, CURR OPIN STRUC BIOL, V7, P804, DOI 10.1016/S0959-440X(97)80150-9; MIYAKE Y, 1973, J BIOCHEM-TOKYO, V73, P1; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Pollegioni L, 1997, J BIOL CHEM, V272, P4924, DOI 10.1074/jbc.272.8.4924; Pollegioni L, 1993, BIOL CHEM, V268, P13850; Porter D, 1976, FLAVINS FLAVOPROTEIN, P225; PORTER DJT, 1972, BIOCHEM BIOPH RES CO, V49, P257, DOI 10.1016/0006-291X(72)90038-1; Rosini E, 2009, FEBS J, V276, P4921, DOI 10.1111/j.1742-4658.2009.07191.x; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; URBAN P, 1984, EUR J BIOCHEM, V144, P345, DOI 10.1111/j.1432-1033.1984.tb08470.x; VOET JG, 1972, Z NATURFORSCH PT B, VB 27, P1054, DOI 10.1515/znb-1972-0915; WALSH C, 1973, J BIOL CHEM, V248, P7049; WALSH CT, 1973, J BIOL CHEM, V248, P1946; WALSH CT, 1971, J BIOL CHEM, V246, P6855; WILLIAMS RF, 1977, J AM CHEM SOC, V99, P921, DOI 10.1021/ja00445a040; Yorita K, 1997, P NATL ACAD SCI USA, V94, P9590, DOI 10.1073/pnas.94.18.9590	39	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40987	40998		10.1074/jbc.M111.266536	http://dx.doi.org/10.1074/jbc.M111.266536			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21949129	Green Published, hybrid			2022-12-25	WOS:000297315400058
J	Verissimo, AF; Yang, HH; Wu, XM; Sanders, C; Daldal, F				Verissimo, Andreia F.; Yang, Honghui; Wu, Xiaomin; Sanders, Carsten; Daldal, Fevzi			Ccml Subunit of CcmFHI Heme Ligation Complex Functions as an Apocytochrome c Chaperone during c-Type Cytochrome Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS-CAPSULATA; ESCHERICHIA-COLI; IN-VITRO; PARACOCCUS-DENITRIFICANS; 3-DIMENSIONAL STRUCTURE; CIRCULAR-DICHROISM; NITROGEN-FIXATION; CYCHJKL GENES	Cytochrome c maturation (Ccm) is a sophisticated post-translational process. It occurs after translocation of apocytochromes c to the p side of energy transducing membranes and forms stereo-specific thioether bonds between the vinyl groups of heme b (protoporphyrin IX-Fe) and the thiol groups of cysteines at their conserved heme binding sites. In many organisms this process involves up to 10 (CcmABCDEFGHI and CcdA) membrane proteins. One of these proteins is CcmI, which has an N-terminal membrane-embedded domain with two transmembrane helices and a large C-terminal periplasmic domain with protein-protein interaction motifs. Together with CcmF and CcmH, CcmI forms a multisubunit heme ligation complex. How the CcmFHI complex recognizes its apocytochrome c substrates remained unknown. In this study, using Rhodobacter capsulatus apocytochrome c(2) as a Ccm substrate, we demonstrate for the first time that CcmI binds apocytochrome c(2), but not holocytochrome c(2). Mainly the C-terminal portions of both CcmI and apocytochrome c(2) mediate this binding. Other physical interactions via the conserved structural elements in apocytochrome c(2), like the heme ligating cysteines or heme iron axial ligands, are less crucial. Furthermore, we show that the N-terminal domain of CcmI can also weakly bind apocytochrome c(2), but this interaction requires a free thiol group at apocytochrome c(2) heme binding site. We conclude that the CcmI subunit of the CcmFHI complex functions as an apocytochrome c chaperone during the Ccm process used by proteobacteria, archaea, mitochondria of plants and red algae.	[Verissimo, Andreia F.; Yang, Honghui; Wu, Xiaomin; Sanders, Carsten; Daldal, Fevzi] Univ Penn Philadelphia, Dept Biol, Philadelphia, PA 19014 USA	University of Pennsylvania	Daldal, F (corresponding author), Univ Penn Philadelphia, Dept Biol, Philadelphia, PA 19014 USA.	fdaldal@sas.upenn.edu			National Institutes of Health [GM38239]; Department of Energy [91ER20052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38239 (to F. D.). This work was also supported by Department of Energy Grant 91ER20052 (to F. D.).	Akiyama S, 2000, NAT STRUCT BIOL, V7, P514; Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; BENNING C, 1992, J BACTERIOL, V174, P2352, DOI 10.1128/JB.174.7.2352-2360.1992; BENNING MM, 1991, J MOL BIOL, V220, P673, DOI 10.1016/0022-2836(91)90109-J; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Cinege G, 2004, MOL GENET GENOMICS, V271, P171, DOI 10.1007/s00438-003-0968-2; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Daltrop O, 2003, J BIOL CHEM, V278, P4404, DOI 10.1074/jbc.M211124200; DAMASCHUN G, 1991, BIOCHIM BIOPHYS ACTA, V1078, P289, DOI 10.1016/0167-4838(91)90571-G; DAVIDSON E, 1987, J MOL BIOL, V195, P13, DOI 10.1016/0022-2836(87)90323-8; DELGADO MJ, 1995, J BACTERIOL, V177, P4927, DOI 10.1128/jb.177.17.4927-4934.1995; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; DUMONT ME, 1994, BIOCHEMISTRY-US, V33, P7368, DOI 10.1021/bi00189a043; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; FISHER WR, 1973, J BIOL CHEM, V248, P3188; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; HAMADA D, 1993, BIOCHEMISTRY-US, V32, P10351, DOI 10.1021/bi00090a010; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; HOLDEN HM, 1987, J MOL BIOL, V195, P229, DOI 10.1016/0022-2836(87)90341-X; Inoue H, 2011, FEBS J, V278, P2341, DOI 10.1111/j.1742-4658.2011.08155.x; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Keilin D., 1966, HIST CELL RESP CYTOC; KERESZT A, 1995, MOL GEN GENET, V247, P39, DOI 10.1007/BF00425819; Khan MKA, 2009, J BIOL INORG CHEM, V14, P751, DOI 10.1007/s00775-009-0488-6; Koch HG, 1998, J BACTERIOL, V180, P969, DOI 10.1128/JB.180.4.969-978.1998; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lang SE, 1996, J BACTERIOL, V178, P5279, DOI 10.1128/jb.178.17.5279-5290.1996; Lee JH, 2007, BBA-BIOMEMBRANES, V1768, P2164, DOI 10.1016/j.bbamem.2007.04.022; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; PAGE MD, 1995, MOL MICROBIOL, V15, P307, DOI 10.1111/j.1365-2958.1995.tb02245.x; PIELAK GJ, 1995, BIOCHEMISTRY-US, V34, P3268, DOI 10.1021/bi00010a017; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; RITZ D, 1993, MOL MICROBIOL, V9, P729, DOI 10.1111/j.1365-2958.1993.tb01733.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Sauder JM, 1996, BIOCHEMISTRY-US, V35, P16852, DOI 10.1021/bi961976k; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; STELLWAGEN E, 1972, J BIOL CHEM, V247, P8074; Tomlinson EJ, 2000, P NATL ACAD SCI USA, V97, P5156, DOI 10.1073/pnas.090089397; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; ZANNONI D, 1993, ARCH MICROBIOL, V160, P413, DOI 10.1007/BF00245301	61	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40452	40463		10.1074/jbc.M111.277764	http://dx.doi.org/10.1074/jbc.M111.277764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956106	hybrid, Green Published			2022-12-25	WOS:000297315400005
J	Manna, P; Jain, SK				Manna, Prasenjit; Jain, Sushil K.			Hydrogen Sulfide and L-Cysteine Increase Phosphatidylinositol 3,4,5-Trisphosphate (PIP3) and Glucose Utilization by Inhibiting Phosphatase and Tensin Homolog (PTEN) Protein and Activating Phosphoinositide 3-Kinase (PI3K)/Serine/Threonine Protein Kinase (AKT)/Protein Kinase C zeta/lambda (PKC zeta/lambda) in 3T3l1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ATHEROSCLEROTIC LESIONS; MOLECULAR-MECHANISMS; MYOCARDIAL-ISCHEMIA; AKT PHOSPHORYLATION; POSITIVE REGULATION	This work examined the novel hypothesis that reduced levels of H2S or L-cysteine (LC) play a role in the impaired glucose metabolism seen in diabetes. 3T3L1 adipocytes were treated with high glucose (HG, 25 mM) in the presence or absence of LC or H2S. Both LC and H2S treatments caused an increase in phosphatidylinositol-3,4,5 trisphosphate (PIP3), AKT phosphorylation, and glucose utilization in HG-treated cells. The effect of LC on PIP3 and glucose utilization was prevented by propargylglycine, an inhibitor of cystathionine gamma-lyase that catalyzes H2S formation from LC. This demonstrates that H2S mediates the effect of LC on increased PIP3 and glucose utilization. H2S and LC caused phosphatidylinositol 3-kinase activation and PTEN inhibition. Treatment with LC, H2S, or PIP3 increased the phosphorylation of IRS1, AKT, and PKC zeta/lambda as well as GLUT4 activation and glucose utilization in HG-treated cells. This provides evidence that PIP3 is involved in the increased glucose utilization observed in cells supplemented with LC or H2S. Comparative signal silencing studies with siAKT2 or siPKC zeta revealed that PKC zeta phosphorylation is more effective for the GLUT4 activation and glucose utilization in LC-, H2S-,or PIP3-treated cells exposed to HG. This is the first report to demonstrate that H2S or LC can increase cellular levels of PIP3, a positive regulator of glucose metabolism. The PIP3 increase is mediated by PI3K activation and inhibition of PTEN but not of SHIP2. This study provides evidence for a molecular mechanism by which H2S or LC can up-regulate the insulin-signaling pathways essential for maintenance of glucose metabolism.	[Manna, Prasenjit; Jain, Sushil K.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, 1501 Kings Hwy, Shreveport, LA 71130 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436; Manna, Prasenjit/0000-0003-1952-6531	NIDDK; Office of Dietary Supplements of the National Institutes of Health [R01 DK072433]; Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by grants from NIDDK and the Office of Dietary Supplements of the National Institutes of Health Grant R01 DK072433. This work was also supported by the Malcolm Feist Endowed Chair in Diabetes.	Abe K, 1996, J NEUROSCI, V16, P1066; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bandyopadhyay G, 2000, ENDOCRINOLOGY, V141, P4120, DOI 10.1210/en.141.11.4120; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bandyopadhyay G, 2000, J BIOL CHEM, V275, P40817, DOI 10.1074/jbc.M007920200; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bianca RDD, 2009, P NATL ACAD SCI USA, V106, P4513, DOI 10.1073/pnas.0807974105; Blouet C, 2007, J NUTR BIOCHEM, V18, P519, DOI 10.1016/j.jnutbio.2006.10.002; Blouet C, 2007, FREE RADICAL BIO MED, V42, P1089, DOI 10.1016/j.freeradbiomed.2007.01.006; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; CANDILOROS H, 1995, DIABETES CARE, V18, P549, DOI 10.2337/diacare.18.4.549; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Darmaun D, 2008, PEDIATR DIABETES, V9, P577, DOI 10.1111/j.1399-5448.2008.00436.x; Droge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; Garg SK, 2011, ANTIOXID REDOX SIGN, V15, P39, DOI 10.1089/ars.2010.3496; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hinchliffe KA, 2001, CURR BIOL, V11, pR371, DOI 10.1016/S0960-9822(01)00197-X; Hsu CC, 2004, J NUTR, V134, P3245, DOI 10.1093/jn/134.12.3245; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Iyer SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005017; Jain SK, 2006, FREE RADICAL BIO MED, V41, P92, DOI 10.1016/j.freeradbiomed.2006.03.008; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Jain SK, 2009, FREE RADICAL BIO MED, V46, P1633, DOI 10.1016/j.freeradbiomed.2009.03.014; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanoh Y, 2000, J BIOL CHEM, V275, P16690, DOI 10.1074/jbc.M000287200; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Madkor HR, 2011, BRIT J NUTR, V105, P1210, DOI 10.1017/S0007114510004927; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Ono H, 2001, MOL ENDOCRINOL, V15, P1411, DOI 10.1210/me.15.8.1411; Pendaries C, 2003, FEBS LETT, V546, P25, DOI 10.1016/S0014-5793(03)00437-X; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Song DZ, 2005, EUR J PHARMACOL, V508, P205, DOI 10.1016/j.ejphar.2004.12.018; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; van den Brandhof WE, 2001, ATHEROSCLEROSIS, V157, P403, DOI 10.1016/S0021-9150(00)00724-3; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Wan XP, 2011, J BIOL CHEM, V286, P2843, DOI 10.1074/jbc.M110.125526; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006	66	82	87	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39848	39859		10.1074/jbc.M111.270884	http://dx.doi.org/10.1074/jbc.M111.270884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953448	Green Published, hybrid			2022-12-25	WOS:000296925700019
J	Beauchamp, MS; Beurlot, MR; Fava, E; Nath, AR; Parikh, NA; Saad, ZS; Bortfeld, H; Oghalai, JS				Beauchamp, Michael S.; Beurlot, Michelle R.; Fava, Eswen; Nath, Audrey R.; Parikh, Nehal A.; Saad, Ziad S.; Bortfeld, Heather; Oghalai, John S.			The Developmental Trajectory of Brain-Scalp Distance from Birth through Childhood: Implications for Functional Neuroimaging	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; VAULT REDUCTION CRANIOPLASTY; CEREBRAL BLOOD OXYGENATION; SOURCE-DETECTOR DISTANCE; VERBAL FLUENCY TASK; HEMODYNAMIC-CHANGES; VISUAL-STIMULATION; NEWBORN-INFANTS; PREFRONTAL CORTEX; FRONTAL ACTIVATION	Measurements of human brain function in children are of increasing interest in cognitive neuroscience. Many techniques for brain mapping used in children, including functional near-infrared spectroscopy (fNIRS), electroencephalography (EEG), magnetoencephalography (MEG) and transcranial magnetic stimulation (TMS), use probes placed on or near the scalp. The distance between the scalp and the brain is a key variable for these techniques because optical, electrical and magnetic signals are attenuated by distance. However, little is known about how scalp-brain distance differs between different cortical regions in children or how it changes with development. We investigated scalp-brain distance in 71 children, from newborn to age 12 years, using structural T1-weighted MRI scans of the whole head. Three-dimensional reconstructions were created from the scalp surface to allow for accurate calculation of brain-scalp distance. Nine brain landmarks in different cortical regions were manually selected in each subject based on the published fNIRS literature. Significant effects were found for age, cortical region and hemisphere. Brain-scalp distances were lowest in young children, and increased with age to up to double the newborn distance. There were also dramatic differences between brain regions, with up to 50% differences between landmarks. In frontal and temporal regions, scalp-brain distances were significantly greater in the right hemisphere than in the left hemisphere. The largest contributors to developmental changes in brain-scalp distance were increases in the corticospinal fluid (CSF) and inner table of the cranium. These results have important implications for functional imaging studies of children: age and brain-region related differences in fNIRS signals could be due to the confounding factor of brain-scalp distance and not true differences in brain activity.	[Beauchamp, Michael S.; Beurlot, Michelle R.; Fava, Eswen; Nath, Audrey R.] Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Fava, Eswen] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; [Parikh, Nehal A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Saad, Ziad S.] NIMH, Intramural Res Program, Bethesda, MD 20892 USA; [Bortfeld, Heather] Univ Connecticut, Dept Psychol, Storrs, CT USA; [Oghalai, John S.] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Palo Alto, CA 94304 USA	University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Connecticut; Stanford University	Beauchamp, MS (corresponding author), Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX 77030 USA.	Michael.S.Beauchamp@uth.tmc.edu	Parikh, Nehal/AAB-9981-2022; Bortfeld, Heather/AAK-8553-2020; Beauchamp, Michael/AAK-9813-2020	Beauchamp, Michael/0000-0002-7599-9934; Parikh, Nehal/0000-0002-1375-1247; Bortfeld, Heather/0000-0002-3545-5449; Nath, Audrey/0000-0001-8071-7105	National Science Foundation Cognitive Neuroscience Initiative [0642532]; National Institutes of Health (NIH) NINDS [NS065395]; NIH NICHD/NCRR [RR024148]; NIH NIDCD [DC010164]; Dana Foundation; National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke [N01-HD02-3343, N01-MH09-0002, N01-NS-9-2314, N01-NS-9-2315, N01-NS-9-2316, N01-NS-9-2317, N01-NS-9-2319, N01-NS-9-2320]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023343] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002888, N01MH090002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS092317, N01NS092314, N01NS092315, N01NS092319, R01NS065395, N01NS092320, N01NS092316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010075, R56DC010164] Funding Source: NIH RePORTER	National Science Foundation Cognitive Neuroscience Initiative; National Institutes of Health (NIH) NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NICHD/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Center for Research Resources (NCRR)); NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Dana Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Science Foundation Cognitive Neuroscience Initiative Research Grants 0642532 and National Institutes of Health (NIH) NINDS NS065395 to Dr. Beauchamp, NIH NICHD/NCRR RR024148 (support to Dr. Parikh), NIH NIDCD DC010164 and DC010164 to Dr. Oghalai, and The Dana Foundation to Dr. Oghalai and Dr. Bortfeld. Certain data used in the preparation of this article were obtained from the NIH Pediatric MRI Data Repository created by the NIH MRI Study of Normal Brain Development, a project supported by the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke (Contract #s N01-HD02-3343, N01-MH09-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319 and -2320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Baird AA, 2002, NEUROIMAGE, V16, P1120, DOI 10.1006/nimg.2002.1170; Bartocci M, 2000, PEDIATR RES, V48, P18, DOI 10.1203/00006450-200007000-00006; Beauchamp MS, 2003, MAGNET RESON MED, V49, P376, DOI 10.1002/mrm.10345; Bischoff-Grethe A, 2007, HUM BRAIN MAPP, V28, P892, DOI 10.1002/hbm.20312; Blasi A, 2007, PHYS MED BIOL, V52, P6849, DOI 10.1088/0031-9155/52/23/005; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Bortfeld H, 2009, DEV NEUROPSYCHOL, V34, P52, DOI 10.1080/87565640802564481; Bortfeld H, 2007, NEUROIMAGE, V34, P407, DOI 10.1016/j.neuroimage.2006.08.010; Carlsson J, 2008, ACTA PAEDIATR, V97, P1221, DOI 10.1111/j.1651-2227.2008.00886.x; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Csibra G, 2004, J PEDIAT NEUROL, V2, P85, DOI DOI 10.1055/S-0035-15; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Custo A, 2006, APPL OPTICS, V45, P4747, DOI 10.1364/AO.45.004747; Dehaes M, 2011, BIOMED OPT EXPRESS, V2, P552, DOI 10.1364/BOE.2.000552; DREVETS WC, 1992, SCIENCE, V256, P1696, DOI 10.1126/science.256.5064.1696; Ehlis AC, 2005, BIOL PSYCHOL, V69, P315, DOI 10.1016/j.biopsycho.2004.09.003; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Everdell NL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038567; Fallgatter AJ, 1998, NEUROPSYCHOBIOLOGY, V37, P215, DOI 10.1159/000026506; Frye RE, 2008, J CHILD NEUROL, V23, P79, DOI 10.1177/0883073807307972; Gallagher A, 2008, EPILEPSY BEHAV, V12, P340, DOI 10.1016/j.yebeh.2007.10.008; Gallagher A, 2007, EPILEPTIC DISORD, V9, P241, DOI 10.1684/epd.2007.0118; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Gratton G, 2006, NEUROIMAGE, V32, P1576, DOI 10.1016/j.neuroimage.2006.05.030; Gratton G, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00052; Grossmann T, 2008, P ROY SOC B-BIOL SCI, V275, P2803, DOI 10.1098/rspb.2008.0986; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Hadley D, 2011, J ECT, V27, P18, DOI 10.1097/YCT.0b013e3181ce1a8c; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Heiskala J, 2009, OPT EXPRESS, V17, P14977, DOI 10.1364/OE.17.014977; Herrmann CS, 2003, BRAIN LANG, V85, P396, DOI 10.1016/S0093-934X(03)00054-3; Herrmann MJ, 2005, J PSYCHOPHYSIOL, V19, P100, DOI 10.1027/0269-8803.19.2.100; Herrmann MJ, 2004, J NEUROPSYCH CLIN N, V16, P170, DOI 10.1176/appi.neuropsych.16.2.170; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Hofmann MJ, 2008, NEUROIMAGE, V40, P1340, DOI 10.1016/j.neuroimage.2007.12.037; Homae F, 2006, NEUROSCI RES, V54, P276, DOI 10.1016/j.neures.2005.12.006; Homae F, 2007, NEUROSCI RES, V59, P29, DOI 10.1016/j.neures.2007.05.005; Hoshi Y, 2000, PEDIATR NEUROL, V23, P323, DOI 10.1016/S0887-8994(00)00195-8; Huppert TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976432; Iglesias J, 2011, MED IMAGING IEEE T, P1; Joseph DK, 2006, APPL OPTICS, V45, P8142, DOI 10.1364/AO.45.008142; Jurcak V, 2005, NEUROIMAGE, V26, P1184, DOI 10.1016/j.neuroimage.2005.03.021; Karen T, 2008, HUM BRAIN MAPP, V29, P453, DOI 10.1002/hbm.20411; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Kotilahti K, 2005, LECT NOTES COMPUT SC, V5693, P388, DOI 10.1117/12.590180; Kusaka T, 2004, HUM BRAIN MAPP, V22, P122, DOI 10.1002/hbm.20020; Laconte S, 2006, PREDICTIVE EYE ESTIM; LAGERLUND TD, 1993, ELECTROEN CLIN NEURO, V86, P7, DOI 10.1016/0013-4694(93)90062-Z; Lewiner T., 2003, Journal of Graphics Tools, V8, P1, DOI 10.1080/10867651.2003.10487582; Lindley AA, 1999, EARLY HUM DEV, V56, P17, DOI 10.1016/S0378-3782(99)00033-X; Liu KR, 2008, INT J NEUROSCI, V118, P657, DOI 10.1080/00207450701242792; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Lloyd-Fox S, 2009, CHILD DEV, V80, P986, DOI 10.1111/j.1467-8624.2009.01312.x; Mathews MS, 2007, J NEUROSURG, V107, P332, DOI 10.3171/PED-07/10/332; Mathews MS, 2007, J NEUROSURG, V107, P330; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Meek JH, 1998, PEDIATR RES, V43, P840, DOI 10.1203/00006450-199806000-00019; Minagawa-Kawai Y, 2004, NEUROREPORT, V15, P899, DOI 10.1097/00001756-200404090-00033; Minagawa-Kawai Y, 2002, NEUROREPORT, V13, P581, DOI 10.1097/00001756-200204160-00009; Minagawa-Kawai Y, 2007, J NEUROSCI, V27, P315, DOI 10.1523/JNEUROSCI.1984-06.2007; Minagawa-Kawai Y, 2011, CEREB CORTEX, V21, P254, DOI 10.1093/cercor/bhq082; Minagawa-Kawai Y, 2009, NEUROREPORT, V20, P1219, DOI 10.1097/WNR.0b013e32832fa65f; Nakano T, 2009, CEREB CORTEX, V19, P455, DOI 10.1093/cercor/bhn096; Nakato E, 2009, HUM BRAIN MAPP, V30, P462, DOI 10.1002/hbm.20516; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; Nishida T, 2008, NEUROSCI LETT, V443, P23, DOI 10.1016/j.neulet.2008.07.035; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsuka Y, 2007, NEUROIMAGE, V34, P399, DOI 10.1016/j.neuroimage.2006.08.013; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008; REIMAN EM, 1989, SCIENCE, V243, P1071, DOI 10.1126/science.2784226; REIMAN EM, 1989, ARCH GEN PSYCHIAT, V46, P493; Remijn GB, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3431104; Reynolds GD, 2009, DEV NEUROPSYCHOL, V34, P312, DOI 10.1080/87565640902801890; Ridgway EB, 2004, PEDIATR CLIN N AM, V51, P359, DOI 10.1016/j.pcl.2003.12.001; Ruppe MD, 2011, CLIN ENDOCRINOL, V74, P312, DOI 10.1111/j.1365-2265.2010.03919.x; Saad ZS, SUMA INTERFACE SURFA; Saito Y, 2007, ARCH DIS CHILD-FETAL, V92, pF113, DOI 10.1136/adc.2006.097949; Saito Y, 2007, EARLY HUM DEV, V83, P225, DOI 10.1016/j.earlhumdev.2006.05.017; Saito Y, 2009, EARLY HUM DEV, V85, P471, DOI 10.1016/j.earlhumdev.2009.04.004; Sakatani K, 1998, STROKE, V29, P1299, DOI 10.1161/01.STR.29.7.1299; Sakatani K, 1999, EARLY HUM DEV, V55, P229, DOI 10.1016/S0378-3782(99)00019-5; Schecklmann M, 2008, NEUROIMAGE, V43, P147, DOI 10.1016/j.neuroimage.2008.06.032; Sevy ABG, 2010, HEARING RES, V270, P39, DOI 10.1016/j.heares.2010.09.010; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Suzuki M, 2005, NEUROSCI LETT, V375, P53, DOI 10.1016/j.neulet.2004.10.065; Tachtsidis I, 2008, ADV EXP MED BIOL, V614, P21, DOI 10.1007/978-0-387-74911-2_3; Taga G, 2003, EARLY HUM DEV, V75, pS203, DOI 10.1016/j.earlhumdev.2003.08.023; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Taga G, 2007, NEUROIMAGE, V38, P452, DOI 10.1016/j.neuroimage.2007.07.050; Taga G, 2007, NEUROIMAGE, V36, P1246, DOI 10.1016/j.neuroimage.2007.04.037; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tanii H, 2009, NEUROSCI LETT, V452, P63, DOI 10.1016/j.neulet.2009.01.044; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Watanabe H, 2008, NEUROIMAGE, V43, P346, DOI 10.1016/j.neuroimage.2008.07.014; Watanabe H, 2010, NEUROIMAGE, V50, P1536, DOI 10.1016/j.neuroimage.2010.01.068; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551; Wilcox T, 2008, DEVELOPMENTAL SCI, V11, P361, DOI 10.1111/j.1467-7687.2008.00681.x; Wilcox T, 2009, NEUROPSYCHOLOGIA, V47, P657, DOI 10.1016/j.neuropsychologia.2008.11.014; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Yuval-Greenberg S, 2007, J NEUROSCI, V27, P1090, DOI 10.1523/JNEUROSCI.4828-06.2007; Zaramella P, 2001, PEDIATR RES, V49, P213, DOI 10.1203/00006450-200102000-00014	114	63	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24981	10.1371/journal.pone.0024981	http://dx.doi.org/10.1371/journal.pone.0024981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957470	Green Submitted, Green Published, gold			2022-12-25	WOS:000295262100029
J	de Jong, E; Winkel, P; Poelstra, K; Prakash, J				de Jong, Edwin; Winkel, Peter; Poelstra, Klaas; Prakash, Jai			Anticancer Effects of 15d-Prostaglandin-J(2) in Wild-Type and Doxorubicin-Resistant Ovarian Cancer Cells: Novel Actions on SIRT1 and HDAC	PLOS ONE			English	Article							15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); INDUCE APOPTOSIS; IN-VIVO; TRANSCRIPTION; DEACETYLASE; CHEMOTHERAPY; EXPRESSION; SURVIVAL; SNAIL	15-deoxy-delta-12,14-prostaglandin-J(2) (15d-PGJ(2)), an arachidonic metabolite and a natural PPAR gamma agonist, is known to induce apoptosis in tumor cells. In this study, we investigated new therapeutic potentials of 15d-PGJ(2) by determining its anticancer effects in wild-type and doxorubicin-resistant ovarian carcinoma cells. Despite high expression of resistance-inducing genes like MDR1, Bcl2 and Bcl-xl, 15d-PGJ(2) strongly induced apoptosis in doxorubicin-resistant (A2780/AD) cells similar to the wild-type (A2780). This was found to be related to caspase-3/7- and NF-kappa B pathways but not to its PPAR gamma agonistic activity. 15d-PGJ(2) also was able to reduce the doxorubicin resistance of A2780/AD cells at low doses as confirmed by the inhibition of gene expression of MDR1 (p-glycoprotein) and SIRT1 (a drug senescence gene). We also investigated effects of 15d-PGJ(2) on cell migration and transformation using a wound-healing assay and morphological analyses, respectively. We found that 15d-PGJ(2) inhibited migration most likely due to NF-kappa B inhibition and induced transformation of the round-shape A2780/AD cells into elongated epithelial cells due to HDAC1 inhibition. Using a 15d-PGJ(2) analog, we found the mechanism of action of these new activities of 15d-PGJ(2) on SIRT1 and HDAC1 gene expressions and enzyme activities. In conclusion, the present study demonstrates that 15d-PGJ(2) has a high therapeutic potential to kill drug-resistant tumor cells and, the newly described inhibitory effects of this cyclo-oxygenase product on SIRT1 and HDAC will provide new opportunities for cancer therapeutics.	[de Jong, Edwin; Winkel, Peter; Poelstra, Klaas; Prakash, Jai] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen Res Inst Pharm, Groningen, Netherlands; [Poelstra, Klaas; Prakash, Jai] BiOr Technol BV, MediTech Ctr UMCG, Groningen, Netherlands	University of Groningen	de Jong, E (corresponding author), Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen Res Inst Pharm, Groningen, Netherlands.	jai.prakash@ki.se	Prakash, Jai/C-8015-2014	Prakash, Jai/0000-0003-1050-650X	European Union, Groningen, The Netherlands; Dutch Technical Foundation (STW)	European Union, Groningen, The Netherlands(Netherlands Government); Dutch Technical Foundation (STW)(Technologiestichting STW)	This study was supported by European Union project of Innovative Action Program Groningen, The Netherlands, and by a Vici grant from the Dutch Technical Foundation (STW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Cho WH, 2006, NEUROCHEM RES, V31, P1247, DOI 10.1007/s11064-006-9157-0; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Eucker J, 2006, ANTI-CANCER DRUG, V17, P763, DOI 10.1097/01.cad.0000217432.71741.da; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Koyama M, 2010, CLIN CANCER RES, V16, P2320, DOI 10.1158/1078-0432.CCR-09-2301; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Prakash J, 2009, NEOPLASIA, V11, P1348, DOI 10.1593/neo.91188; Richardson A, 2005, DRUG RESIST UPDATE, V8, P311, DOI 10.1016/j.drup.2005.09.001; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; SMITH WL, 1992, AM J PHYSIOL, V263, pF181; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Strait KA, 2002, MOL CANCER THER, V1, P1181; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; TIRESALIJ M, 2003, ONCOGENE, V22, P90; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	23	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25192	10.1371/journal.pone.0025192	http://dx.doi.org/10.1371/journal.pone.0025192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957481	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100041
J	Lamarche, MG; Deziel, E				Lamarche, Martin G.; Deziel, Eric			MexEF-OprN Efflux Pump Exports the Pseudomonas Quinolone Signal (PQS) Precursor HHQ (4-hydroxy-2-heptylquinoline)	PLOS ONE			English	Article							QUORUM-SENSING AUTOINDUCER; MULTIDRUG-RESISTANCE; VIRULENCE DETERMINANTS; BIOFILM FORMATION; GENE-EXPRESSION; AERUGINOSA; REGULATOR; SYSTEM; MUTATIONS; MVFR	Bacterial cells have evolved the capacity to communicate between each other via small diffusible chemical signals termed autoinducers. Pseudomonas aeruginosa is an opportunistic pathogen involved, among others, in cystic fibrosis complications. Virulence of P. aeruginosa relies on its ability to produce a number of autoinducers, including 4-hydroxy-2-alkylquinolines (HAQ). In a cell density-dependent manner, accumulated signals induce the expression of multiple targets, especially virulence factors. This phenomenon, called quorum sensing, promotes bacterial capacity to cause disease. Furthermore, P. aeruginosa possesses many multidrug efflux pumps conferring adaptive resistance to antibiotics. Activity of some of these efflux pumps also influences quorum sensing. The present study demonstrates that the MexEF-OprN efflux pump modulates quorum sensing through secretion of a signalling molecule belonging to the HAQ family. Moreover, activation of MexEF-OprN reduces virulence factor expression and swarming motility. Since MexEF-OprN can be activated in infected hosts even in the absence of antibiotic selective pressure, it could promote establishment of chronic infections in the lungs of people suffering from cystic fibrosis, thus diminishing the immune response to virulence factors. Therapeutic drugs that affect multidrug efflux pumps and HAQ-mediated quorum sensing would be valuable tools to shut down bacterial virulence.	[Lamarche, Martin G.; Deziel, Eric] INRS Inst Armand Frappier, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Lamarche, MG (corresponding author), INRS Inst Armand Frappier, Laval, PQ, Canada.	eric.deziel@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115	Canadian Institutes of Health Research (CIHR) [MOP-97888]; Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This study was supported by Canadian Institutes of Health Research (CIHR) operating grant MOP-97888 to ED. MGL was the recipient of postdoctoral fellowships from the Fonds de la recherche en sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Bailey J, 2002, NAT BIOTECHNOL, V20, P839, DOI 10.1038/nbt715; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; Favre-Bonte S, 2003, J ANTIMICROB CHEMOTH, V52, P598, DOI 10.1093/jac/dkg397; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Frisk A, 2004, INFECT IMMUN, V72, P5433, DOI 10.1128/IAI.72.9.5433-5438.2004; FUKUDA H, 1995, ANTIMICROB AGENTS CH, V39, P790, DOI 10.1128/AAC.39.3.790; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jalal S, 2000, ANTIMICROB AGENTS CH, V44, P710, DOI 10.1128/AAC.44.3.710-712.2000; Join-Lamberti OF, 2001, ANTIMICROB AGENTS CH, V45, P571, DOI 10.1128/AAC.45.2.571-576.2001; Kohler T, 1999, J BACTERIOL, V181, P6300; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lepine F, 2003, BBA-GEN SUBJECTS, V1622, P36, DOI 10.1016/S0304-4165(03)00103-X; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; Maseda H, 2004, ANTIMICROB AGENTS CH, V48, P1320, DOI 10.1128/AAC.48.4.1320-1328.2004; Mashburn-Warren L, 2008, MOL MICROBIOL, V69, P491, DOI 10.1111/j.1365-2958.2008.06302.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Pier GB, 2002, CURR OPIN MICROBIOL, V5, P81, DOI 10.1016/S1369-5274(02)00290-4; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Qin N, 2007, J BACTERIOL, V189, P4127, DOI 10.1128/JB.01779-06; Que YA, 2011, J PATHOG, V2011, DOI 10.4061/2011/549302; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Ramsey MM, 2004, MOL MICROBIOL, V53, P1075, DOI 10.1111/j.1365-2958.2004.04181.x; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sawada I, 2004, MICROBIOL IMMUNOL, V48, P435, DOI 10.1111/j.1348-0421.2004.tb03533.x; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2005, J BACTERIOL, V187, P1246, DOI 10.1128/JB.187.4.1246-1253.2005; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tian ZX, 2009, MICROB PATHOGENESIS, V47, P237, DOI 10.1016/j.micpath.2009.08.003; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Tomas M, 2010, ANTIMICROB AGENTS CH, V54, P2219, DOI 10.1128/AAC.00816-09; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0	63	86	88	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24310	10.1371/journal.pone.0024310	http://dx.doi.org/10.1371/journal.pone.0024310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957445	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000295262100007
J	Chen, YG				Chen, Yanguang			Modeling Fractal Structure of City-Size Distributions Using Correlation Functions	PLOS ONE			English	Article							ZIPFS LAW; CELLULAR-AUTOMATA; GROWTH; HIERARCHIES; PARETO; CITIES; RULE	Zipf's law is one the most conspicuous empirical facts for cities, however, there is no convincing explanation for the scaling relation between rank and size and its scaling exponent. Using the idea from general fractals and scaling, I propose a dual competition hypothesis of city development to explain the value intervals and the special value, 1, of the power exponent. Zipf's law and Pareto's law can be mathematically transformed into one another, but represent different processes of urban evolution, respectively. Based on the Pareto distribution, a frequency correlation function can be constructed. By scaling analysis and multifractals spectrum, the parameter interval of Pareto exponent is derived as (0.5, 1]; Based on the Zipf distribution, a size correlation function can be built, and it is opposite to the first one. By the second correlation function and multifractals notion, the Pareto exponent interval is derived as [1, 2). Thus the process of urban evolution falls into two effects: one is the Pareto effect indicating city number increase (external complexity), and the other the Zipf effect indicating city size growth (internal complexity). Because of struggle of the two effects, the scaling exponent varies from 0.5 to 2; but if the two effects reach equilibrium with each other, the scaling exponent approaches 1. A series of mathematical experiments on hierarchical correlation are employed to verify the models and a conclusion can be drawn that if cities in a given region follow Zipf's law, the frequency and size correlations will follow the scaling law. This theory can be generalized to interpret the inverse power-law distributions in various fields of physical and social sciences.	Peking Univ, Coll Urban & Environm Sci, Dept Geog, Beijing 100871, Peoples R China	Peking University	Chen, YG (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Geog, Beijing 100871, Peoples R China.	chenyg@pku.edu.cn			National Natural Science Foundation of China [41171129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by the National Natural Science Foundation of China (Grant No. 41171129. See: https://isis.nsfc.gov.cn/portal/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2005, REG SCI URBAN ECON, V35, P756, DOI 10.1016/j.regsciurbeco.2005.01.003; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; [Anonymous], 1998, POPULATION; Arneodo A., 2008, SCHOLARPEDIA, V3, P4103, DOI DOI 10.4249/SCHOLARPEDIA.4103; Barrow J. D., 1995, ARTFUL UNIVERSE; Batty M., 1994, FRACTAL CITIES; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; BERRY BJL, 1961, ECON DEV CULT CHANGE, V9, P573, DOI 10.1086/449923; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Blasius B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218701; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; CARROLL GR, 1982, PROG HUM GEOG, V6, P1; Casti J.L., 1996, WOULD BE WORLDS SIMU; Chen Y, 2004, CHAOS SOLITON FRACT, V22, P793, DOI 10.1016/j.chaos.2004.02.059; Chen Y.G., 2009, INT J ARTIFICIAL LIF, V1, P12; Chen YG, 2012, PHYSICA A, V391, P767, DOI 10.1016/j.physa.2011.07.010; Chen YG, 2010, DISCRETE DYN NAT SOC, V2010, DOI 10.1155/2010/974917; Chen YG, 2009, CHAOS SOLITON FRACT, V41, P603, DOI 10.1016/j.chaos.2008.02.030; Chen YG, 2003, ENVIRON PLANN B, V30, P799, DOI 10.1068/b2948; Cordoba JC, 2008, J URBAN ECON, V63, P177, DOI 10.1016/j.jue.2007.01.005; Davis K., 1978, SYSTEMS CITIES READI, P92; Feder J, 1988, FRACTALS; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gabaix X, 1999, AM ECON REV, V89, P129, DOI 10.1257/aer.89.2.129; Gabaix X., 2004, HDB REGIONAL URBAN E, P2341, DOI DOI 10.1016/S1574-0080(04)80010-5; Hardy M, 2010, MATH INTELL, V32, P38, DOI 10.1007/s00283-010-9159-2; Jia T, 2011, ARXIV10100541; Jiang B, GEOSPATIAL ANAL MODE; Jiang B, 2011, INT J GEOGRAPHICAL I; Jiang B, 2009, INT J GEOGR INF SCI, V23, P1033, DOI 10.1080/13658810802004648; Johnston RJ, 1994, DICT URBAN GEOGRAPHY; Knox P.L., 2006, PLACES REGIONS GLOBA; Krugman P, 1996, J JPN INT ECON, V10, P399, DOI 10.1006/jjie.1996.0023; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mandelbrot B., 1999, MULTIFRACTALS 1 F NO; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Reed WJ, 2001, ECON LETT, V74, P15, DOI 10.1016/S0165-1765(01)00524-9; STANLEY HE, 1988, NATURE, V335, P405, DOI 10.1038/335405a0; Steindl J, 1968, INT ENCYCL SOC SCI, V14, P295; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Vicsek T., 1989, FRACTAL GROWTH PHENO; VINING DR, 1977, J URBAN ECON, V4, P15, DOI 10.1016/0094-1190(77)90027-4; Von Neumann J., 1961, METHOD PHYS SCI, VVI; West GB, 2006, METHODS SER, V3, P71; White R, 1997, ENVIRON PLANN B, V24, P323, DOI 10.1068/b240323; WHITE R, 1994, CHAOS SOLITON FRACT, V4, P563, DOI 10.1016/0960-0779(94)90066-3; Williams GP, 1997, CHAOS THEORY TAMED; Xu ZW, 2010, URBAN STUD, V47, P321, DOI 10.1177/0042098009348326; Zhang J.Z., 1995, FRACTALS; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	52	6	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24791	10.1371/journal.pone.0024791	http://dx.doi.org/10.1371/journal.pone.0024791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825GY	21949753	gold, Green Published, Green Submitted			2022-12-25	WOS:000295260400014
J	Hector, A; Kormann, MSD; Mack, I; Latzin, P; Casaulta, C; Kieninger, E; Zhou, Z; Yildirim, AO; Bohla, A; Rieber, N; Kappler, M; Koller, B; Eber, E; Eickmeier, O; Zielen, S; Eickelberg, O; Griese, M; Mall, MA; Hartl, D				Hector, Andreas; Kormann, Michael S. D.; Mack, Ines; Latzin, Philipp; Casaulta, Carmen; Kieninger, Elisabeth; Zhou, Zhe; Yildirim, Ali Oe.; Bohla, Alexander; Rieber, Nikolaus; Kappler, Matthias; Koller, Barbara; Eber, Ernst; Eickmeier, Olaf; Zielen, Stefan; Eickelberg, Oliver; Griese, Matthias; Mall, Marcus A.; Hartl, Dominik			The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung Disease	PLOS ONE			English	Article							MAMMALIAN MEMBER; SERUM-LEVELS; ASTHMA; INFLAMMATION; NEUTROPHILS; CELLS; IDENTIFICATION; EXPRESSION; PHENOTYPES	The chitinase-like protein YKL-40 was found to be increased in patients with severe asthma and chronic obstructive pulmonary disease (COPD), two disease conditions featuring neutrophilic infiltrates. Based on these studies and a previous report indicating that neutrophils secrete YKL-40, we hypothesized that YKL-40 plays a key role in cystic fibrosis (CF) lung disease, a prototypic neutrophilic disease. The aim of this study was (i) to analyze YKL-40 levels in human and murine CF lung disease and (ii) to investigate whether YKL-40 single-nucleotide polymorphisms (SNPs) modulate CF lung disease severity. YKL-40 protein levels were quantified in serum and sputum supernatants from CF patients and control individuals. Levels of the murine homologue BRP-39 were analyzed in airway fluids from CF-like beta ENaC-Tg mice. YKL-40SNPs were analyzed in CF patients. YKL-40 levels were increased in sputum supernatants and in serum from CF patients compared to healthy control individuals. Within CF patients, YKL-40 levels were higher in sputum than in serum. BRP-39 levels were increased in airways fluids from beta ENaC-Tg mice compared to wild-type littermates. In both CF patients and bENaC-Tg mice, YKL-40/BRP-39 airway levels correlated with the severity of pulmonary obstruction. Two YKL-40 SNPs (rs871799 and rs880633) were found to modulate age-adjusted lung function in CF patients. YKL-40/BRP-39 levelsare increased in human and murine CF airway fluids, correlate with pulmonary function and modulate CF lung disease severity genetically. These findings suggest YKL-40 as a potential biomarker in CF lung disease.	[Hector, Andreas; Kormann, Michael S. D.; Rieber, Nikolaus; Hartl, Dominik] Univ Tubingen, Childrens Hosp, Dept 1, Tubingen, Germany; [Latzin, Philipp; Casaulta, Carmen; Kieninger, Elisabeth] Univ Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland; [Zhou, Zhe; Mall, Marcus A.] Heidelberg Univ, Dept Pediat 3, Div Pediat Pulmonol, Heidelberg, Germany; [Zhou, Zhe; Mall, Marcus A.] Heidelberg Univ, Dept Pediat 3, Allergy & Cyst Fibrosis Ctr, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Translat Lung Res Ctr, Heidelberg, Germany; [Yildirim, Ali Oe.; Bohla, Alexander; Eickelberg, Oliver] Univ Munich, Univ Hosp, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Munich, Germany; [Yildirim, Ali Oe.; Bohla, Alexander; Eickelberg, Oliver] Helmholtz ZentrumMunchen, Munich, Germany; [Koller, Barbara] Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Eickmeier, Olaf; Zielen, Stefan] Childrens Hosp, Dept Pediat Pulmonol Allergy & Cyst Fibrosis, Frankfurt, Germany; [Mack, Ines; Kappler, Matthias; Griese, Matthias] Univ Munich, Childrens Hosp, Res Ctr, D-8000 Munich, Germany; [Eber, Ernst] Med Univ Graz, Dept Paediat, Resp & Allerg Dis Div, Graz, Austria	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Bern; University Hospital of Bern; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Medical University of Graz	Hector, A (corresponding author), Univ Tubingen, Childrens Hosp, Dept 1, Tubingen, Germany.	dominik.hartl@med.uni-tuebingen.de	Zielen, Stefan/AAD-7243-2020; Bohla, Alexander/J-1537-2012; Eber, Ernst/B-6381-2012; Eickelberg, Oliver/A-5461-2013; Kormann, Michael SD/C-7723-2014; Mall, Marcus A./AAA-1498-2022; Latzin, Philipp/F-2206-2017	Bohla, Alexander/0000-0001-9610-5138; Eickelberg, Oliver/0000-0001-7170-0360; Mall, Marcus A./0000-0002-4057-2199; Eickmeier, Olaf/0000-0003-2835-9886; Yildirim, Ali Onder/0000-0003-1969-480X; Latzin, Philipp/0000-0002-5239-1571; Hector, Andreas/0000-0002-5745-4746	German Research Foundation (DFG) [HA 5274/3-1, MA 2081/3-3, MA 2081/4-1]; German Society of Pediatric Pneumology; Novartis Foundation; Ernest-Solvay-Foundation; PINA e.V.	German Research Foundation (DFG)(German Research Foundation (DFG)); German Society of Pediatric Pneumology; Novartis Foundation(Novartis); Ernest-Solvay-Foundation; PINA e.V.	This work was supported by the German Research Foundation (DFG, Emmy Noether Programme HA 5274/3-1 to D.H., MA 2081/3-3 and MA 2081/4-1 to M.A.M.), the German Society of Pediatric Pneumology (D.H.), PINA e.V. (D.H.), the Novartis Foundation (D.H.) and the Ernest-Solvay-Foundation (D.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Banner KH, 2009, J CYST FIBROS, V8, P1, DOI 10.1016/j.jcf.2008.10.002; Bleau G, 1999, EXS, V87, P211; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hard D, 2008, J ALLERGY CLIN IMMUN, V121, P375, DOI 10.1016/j.jaci.2007.10.037; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hartl D, 2009, CURR OPIN ALLERGY CL, V9, P60, DOI 10.1097/ACI.0b013e32831f8ee0; Hector A, 2010, RESPIRATION, V80, P393, DOI 10.1159/000271607; Johansen JS, 2007, EXPERT OPIN THER TAR, V11, P219, DOI 10.1517/14728222.11.2.219; Junker N, 2005, LUNG CANCER, V48, P223, DOI 10.1016/j.lungcan.2004.11.011; Koller B, 2008, J IMMUNOL, V181, P2753, DOI 10.4049/jimmunol.181.4.2753; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nielsen AR, 2008, DIABETES, V57, P3078, DOI 10.2337/db08-0182; Nojgaard C, 2008, CORONARY ARTERY DIS, V19, P257, DOI 10.1097/MCA.0b013e3282f40dd5; Nordenbaek C, 2005, SCAND J RHEUMATOL, V34, P293, DOI 10.1080/03009740510018598; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ostergaard C, 2002, CLIN DIAGN LAB IMMUN, V9, P598, DOI 10.1128/CDLI.9.3.598-604.2002; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Sohn MH, 2010, AM J RESP CRIT CARE, V182, P918, DOI 10.1164/rccm.200912-1793OC; Tirouvanziam R, 2008, P NATL ACAD SCI USA, V105, P4335, DOI 10.1073/pnas.0712386105; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Wenzel SE, 2004, AM J RESP CRIT CARE, V170, P579, DOI 10.1164/rccm.2407005; 1987, AM REV RESPIR DIS, V136, P225, DOI 10.1164/ajrccm/136.1.225	37	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24399	10.1371/journal.pone.0024399	http://dx.doi.org/10.1371/journal.pone.0024399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949714	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400005
J	dos Santos, T; Varela, J; Lynch, I; Salvati, A; Dawson, KA				dos Santos, Tiago; Varela, Juan; Lynch, Iseult; Salvati, Anna; Dawson, Kenneth A.			Effects of Transport Inhibitors on the Cellular Uptake of Carboxylated Polystyrene Nanoparticles in Different Cell Lines	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DRUG-DELIVERY; LIPID RAFTS; DEPENDENT ENDOCYTOSIS; HIPPOCAMPAL SYNAPSES; DENSITY-LIPOPROTEINS; ENDOTHELIAL-CELLS; VESICLE RETRIEVAL; CHOLERA-TOXIN; HELA-CELLS	Nanotechnology is expected to play a vital role in the rapidly developing field of nanomedicine, creating innovative solutions and therapies for currently untreatable diseases, and providing new tools for various biomedical applications, such as drug delivery and gene therapy. In order to optimize the efficacy of nanoparticle (NP) delivery to cells, it is necessary to understand the mechanisms by which NPs are internalized by cells, as this will likely determine their ultimate sub-cellular fate and localisation. Here we have used pharmacological inhibitors of some of the major endocytic pathways to investigate nanoparticle uptake mechanisms in a range of representative human cell lines, including HeLa (cervical cancer), A549 (lung carcinoma) and 1321N1 (brain astrocytoma). Chlorpromazine and genistein were used to inhibit clathrin and caveolin mediated endocytosis, respectively. Cytochalasin A and nocodazole were used to inhibit, respectively, the polymerisation of actin and microtubule cytoskeleton. Uptake experiments were performed systematically across the different cell lines, using carboxylated polystyrene NPs of 40 nm and 200 nm diameters, as model NPs of sizes comparable to typical endocytic cargoes. The results clearly indicated that, in all cases and cell types, NPs entered cells via active energy dependent processes. NP uptake in HeLa and 1321N1 cells was strongly affected by actin depolymerisation, while A549 cells showed a stronger inhibition of NP uptake (in comparison to the other cell types) after microtubule disruption and treatment with genistein. A strong reduction of NP uptake was observed after chlorpromazine treatment only in the case of 1321N1 cells. These outcomes suggested that the same NP might exploit different uptake mechanisms to enter different cell types.	[dos Santos, Tiago; Varela, Juan; Lynch, Iseult; Salvati, Anna; Dawson, Kenneth A.] Univ Coll Dublin, Sch Chem & Chem Biol, Dublin 2, Ireland	University College Dublin	dos Santos, T (corresponding author), Univ Coll Dublin, Sch Chem & Chem Biol, Dublin 2, Ireland.	Tiago.Santos@cbni.ucd.ie; Kenneth.a.dawson@cbni.ucd.ie	Dawson, Kenneth A. A/L-2540-2016; Lynch, Iseult/I-3915-2014; Varela, Juan A./H-5432-2011; Santos, Tiago/O-7639-2015	Dawson, Kenneth A. A/0000-0002-0568-6588; Lynch, Iseult/0000-0003-4250-4584; Santos, Tiago/0000-0001-9710-9771; Salvati, Anna/0000-0002-9339-0161; Varela, Juan Alberto/0000-0003-1901-1378	SFI SRC BioNanoInteract [07 SRC B1155]; FP6 IST project SIGHT [IST-2005-033700]; SFI RFP [MTR2425]; ESF	SFI SRC BioNanoInteract(Science Foundation Ireland); FP6 IST project SIGHT; SFI RFP(Science Foundation Ireland); ESF(European Commission)	This work was performed within the scope of an SFI RFP (CHP031, Dr. dos Santos) and the EU FP6 project NanoInteract (NMP4-CT-2006-033231, Dr. Salvati). The SFI SRC BioNanoInteract (07 SRC B1155) also supported the research reported here. Additional financial support from FP6 IST project SIGHT (IST-2005-033700, Dr. Varela) and the SFI RFP (MTR2425, Dr. Varela) is acknowledged. The ESF Research Networking Programme EpitopeMap is also gratefully acknowledged for funding an exchange trip to Dr. dos Santos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ALLIANZ O, 2004, SMALL SIZES MATTER O; Alonso MA, 2001, J CELL SCI, V114, P3957; ANDREI, 2008, EXOCYTOSIS ENDOCYTOS; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; BEXIGA MG, 2010, NANOTOXICOLOGY, DOI DOI 10.3109/17435390.17432010.17539713; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Cedervall T, 2007, ANGEW CHEM, V119, P5856; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chono S, 2007, J PHARM PHARMACOL, V59, P75, DOI 10.1211/jpp.59.1.0010; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Dausend J, 2008, MACROMOL BIOSCI, V8, P1135, DOI 10.1002/mabi.200800123; Doherty GJ, 2009, BIOCHEM SOC T, V37, P1061, DOI 10.1042/BST0371061; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gann H, 2010, J BIOMED NANOTECHNOL, V6, P37, DOI 10.1166/jbn.2010.1100; Gliem M, 2010, AM J PHYSIOL-CELL PH, V299, pC606, DOI 10.1152/ajpcell.00075.2010; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; Granseth B, 2007, J PHYSIOL-LONDON, V585, P681, DOI 10.1113/jphysiol.2007.139022; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huang M, 2002, PHARM RES-DORDR, V19, P1488, DOI 10.1023/A:1020404615898; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Kabaso D, 2010, BIOPHYS J, V99, P808, DOI 10.1016/j.bpj.2010.04.067; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kitchens KM, 2008, MOL PHARM, V5, P364, DOI 10.1021/mp700089s; KUCHINSKIENE Z, 1982, J LIPID RES, V23, P762; Lai SK, 2007, BIOMATERIALS, V28, P2876, DOI 10.1016/j.biomaterials.2007.02.021; Lesniak A, 2010, BIOMATERIALS, V31, P9511, DOI 10.1016/j.biomaterials.2010.09.049; Li W., 2008, NANOTECHNOLOGY, V19; LIU SM, 1993, J CELL PHYSIOL, V156, P311, DOI 10.1002/jcp.1041560213; Lu F, 2009, SMALL, V5, P1408, DOI 10.1002/smll.200900005; Luhmann T, 2008, BIOCONJUGATE CHEM, V19, P1907, DOI 10.1021/bc800206r; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a; Papakonstanti EA, 2008, FEBS LETT, V582, P2120, DOI 10.1016/j.febslet.2008.02.064; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; SALVATI A, 2011, BIOL MED IN PRESS; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Sato K, 2009, LIFE SCI, V85, P800, DOI 10.1016/j.lfs.2009.10.012; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Shapero K, 2011, MOL BIOSYST, V7, P371, DOI 10.1039/c0mb00109k; Silva GA., 2009, ANN NY ACAD SCI, V1199, P221; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SIT KH, 1993, IN VITRO CELL DEV-AN, V29A, P395, DOI 10.1007/BF02633988; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tahara K, 2009, INT J PHARMACEUT, V382, P198, DOI 10.1016/j.ijpharm.2009.07.023; Torgersen ML, 2001, J CELL SCI, V114, P3737; Vercauteren DNE, 2008, J CONTROL RELEASE, V132, pE17, DOI 10.1016/j.jconrel.2008.09.051; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Watson P, 2005, ADV DRUG DELIVER REV, V57, P43, DOI 10.1016/j.addr.2004.05.003; Yacobi NR, 2008, NANOMED-NANOTECHNOL, V4, P139, DOI 10.1016/j.nano.2008.02.002; Youan BBC, 2008, NANOMEDICINE-UK, V3, P401, DOI 10.2217/17435889.3.4.401	68	286	285	5	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24438	10.1371/journal.pone.0024438	http://dx.doi.org/10.1371/journal.pone.0024438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949717	Green Submitted, Green Published, gold			2022-12-25	WOS:000295257900015
J	Ayyasamy, V; Owens, KM; Desouki, MM; Liang, P; Bakin, A; Thangaraj, K; Buchsbaum, DJ; LoBuglio, AF; Singh, KK				Ayyasamy, Vanniarajan; Owens, Kjerstin M.; Desouki, Mohamed Mokhtar; Liang, Ping; Bakin, Andrei; Thangaraj, Kumarasamy; Buchsbaum, Donald J.; LoBuglio, Albert F.; Singh, Keshav K.			Cellular Model of Warburg Effect Identifies Tumor Promoting Function of UCP2 in Breast Cancer and Its Suppression by Genipin	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DEPLETION; REGULATES INSULIN-SECRETION; UNCOUPLING PROTEIN-2; GENE; EXPRESSION; MUTATIONS; BETA; DYSFUNCTION; DATABASE; CELLS	The Warburg Effect is characterized by an irreversible injury to mitochondrial oxidative phosphorylation (OXPHOS) and an increased rate of aerobic glycolysis. In this study, we utilized a breast epithelial cell line lacking mitochondrial DNA (rho(0)) that exhibits the Warburg Effect associated with breast cancer. We developed a MitoExpress array for rapid analysis of all known nuclear genes encoding the mitochondrial proteome. The gene-expression pattern was compared among a normal breast epithelial cell line, its rho(0) derivative, breast cancer cell lines and primary breast tumors. Among several genes, our study revealed that over-expression of mitochondrial uncoupling protein UCP2 in rho(0) breast epithelial cells reflects gene expression changes in breast cancer cell lines and in primary breast tumors. Furthermore, over-expression of UCP2 was also found in leukemia, ovarian, bladder, esophagus, testicular, colorectal, kidney, pancreatic, lung and prostate tumors. Ectopic expression of UCP2 in MCF7 breast cancer cells led to a decreased mitochondrial membrane potential and increased tumorigenic properties as measured by cell migration, in vitro invasion and anchorage independent growth. Consistent with in vitro studies, we demonstrate that UCP2 over-expression leads to development of tumors in vivo in an orthotopic model of breast cancer. Genipin, a plant derived small molecule, suppressed the UCP2 led tumorigenic properties, which were mediated by decreased reactive oxygen species and down-regulation of UCP2. However, UCP1, 3, 4 and 5 gene expression was unaffected. UCP2 transcription was controlled by SMAD4. Together, these studies suggest a tumor-promoting function of UCP2 in breast cancer. In summary, our studies demonstrate that i) the Warburg Effect is mediated by UCP2; ii) UCP2 is over-expressed in breast and many other cancers; iii) UCP2 promotes tumorigenic properties in vitro and in vivo and iv) genipin suppresses the tumor promoting function of UCP2.	[Ayyasamy, Vanniarajan; Owens, Kjerstin M.; Bakin, Andrei; Singh, Keshav K.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Desouki, Mohamed Mokhtar] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Liang, Ping] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [LoBuglio, Albert F.; Singh, Keshav K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Ctr Free Rad Biol, Ctr Aging, Birmingham, AL USA	Roswell Park Cancer Institute; Medical University of South Carolina; Brock University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ayyasamy, V (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	kksingh@uab.edu	Liang, Ping/D-2709-2009; Vanniarajan, A./AAB-4896-2022; Liang, Ping/S-3790-2018	Liang, Ping/0000-0003-4423-0636; Liang, Ping/0000-0003-4423-0636; Buchsbaum, Donald/0000-0003-2797-5847; Owens, Kjerstin/0000-0001-5210-319X; Bakin, Andrei/0000-0002-7728-1969; Thangaraj, Kumarasamy/0000-0002-0075-0106	National Institutes of Health [R01 121904, 116430]; DST-STIO; Breast Cancer SPORE Pilot project	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DST-STIO; Breast Cancer SPORE Pilot project	This study was supported by grants from the National Institutes of Health (R01 121904 and 116430) and DST-STIO to KKS, and Breast Cancer SPORE Pilot project to KKS and DJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chen X, 2009, J BIOL CHEM, V284, P5362, DOI 10.1074/jbc.M807523200; Cizkova A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-38; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Desler C, 2007, MUTAT RES-FUND MOL M, V625, P112, DOI 10.1016/j.mrfmmm.2007.06.002; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Hamamoto T, 2007, INT J HYPERTHER, V23, P363, DOI 10.1080/02656730701302528; Higuchi M, 2007, MITOCHONDRION, V7, P53, DOI 10.1016/j.mito.2006.12.001; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751; Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lee MS, 2005, CANCER BIOL THER, V4, P1248, DOI 10.4161/cbt.4.11.2136; Lima J, 2003, J CLIN ENDOCR METAB, V88, P4932, DOI 10.1210/jc.2002-030008; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Lynen F, 1942, NATURWISSENSCHAFTEN, V30, P398, DOI 10.1007/BF01475305; Maximo V, 1998, ULTRASTRUCT PATHOL, V22, P271, DOI 10.3109/01913129809033479; Modica-Napolitano Josephine S, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004453; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rial E, 1998, BIOFACTORS, V8, P209, DOI 10.1002/biof.5520080307; Rodriguez Luis G, 2005, Methods Mol Biol, V294, P23; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Singh KK, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-14; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Singh KK, 2008, MITOCHONDRIA CANC; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang KY, 2007, BIOCHEM BIOPH RES CO, V360, P327, DOI 10.1016/j.bbrc.2007.06.071; Zhou H, 2009, ARCH BIOCHEM BIOPHYS, V486, P88, DOI 10.1016/j.abb.2009.02.017; Zhou T, 2007, J CHROMATOGR B, V858, P296, DOI 10.1016/j.jchromb.2007.08.031	73	109	111	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24792	10.1371/journal.pone.0024792	http://dx.doi.org/10.1371/journal.pone.0024792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935467	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700060
J	Rada, P; Dolezal, P; Jedelsky, PL; Bursac, D; Perry, AJ; Sedinova, M; Smiskova, K; Novotny, M; Beltran, NC; Hrdy, I; Lithgow, T; Tachezy, J				Rada, Petr; Dolezal, Pavel; Jedelsky, Petr L.; Bursac, Dejan; Perry, Andrew J.; Sedinova, Miroslava; Smiskova, Katerina; Novotny, Marian; Beltran, Neritza Campo; Hrdy, Ivan; Lithgow, Trevor; Tachezy, Jan			The Core Components of Organelle Biogenesis and Membrane Transport in the Hydrogenosomes of Trichomonas vaginalis	PLOS ONE			English	Article							MITOCHONDRIAL CARRIER FAMILY; TAIL-ANCHORED PROTEINS; TRITRICHOMONAS-FETUS; TRYPANOSOMA-BRUCEI; ADP/ATP CARRIER; INNER MEMBRANE; COMPLEX; IMPORT; EVOLUTION; EXPRESSION	Trichomonas vaginalis is a parasitic protist of the Excavata group. It contains an anaerobic form of mitochondria called hydrogenosomes, which produce hydrogen and ATP; the majority of mitochondrial pathways and the organellar genome were lost during the mitochondrion-to-hydrogenosome transition. Consequently, all hydrogenosomal proteins are encoded in the nucleus and imported into the organelles. However, little is known about the membrane machineries required for biogenesis of the organelle and metabolite exchange. Using a combination of mass spectrometry, immunofluorescence microscopy, in vitro import assays and reverse genetics, we characterized the membrane proteins of the hydrogenosome. We identified components of the outer membrane (TOM) and inner membrane (TIM) protein translocases include multiple paralogs of the core Tom40-type porins and Tim17/22/23 channel proteins, respectively, and uniquely modified small Tim chaperones. The inner membrane proteins TvTim17/22/23-1 and Pam18 were shown to possess conserved information for targeting to mitochondrial inner membranes, but too divergent in sequence to support the growth of yeast strains lacking Tim17, Tim22, Tim23 or Pam18. Full complementation was seen only when the J-domain of hydrogenosomal Pam18 was fused with N-terminal region and transmembrane segment of the yeast homolog. Candidates for metabolite exchange across the outer membrane were identified including multiple isoforms of the beta-barrel proteins, Hmp35 and Hmp36; inner membrane MCF-type metabolite carriers were limited to five homologs of the ATP/ADP carrier, Hmp31. Lastly, hydrogenosomes possess a pathway for the assembly of C-tail-anchored proteins into their outer membrane with several new tail-anchored proteins being identified. These results show that hydrogenosomes and mitochondria share common core membrane components required for protein import and metabolite exchange; however, they also reveal remarkable differences that reflect the functional adaptation of hydrogenosomes to anaerobic conditions and the peculiar evolutionary history of the Excavata group.	[Rada, Petr; Dolezal, Pavel; Jedelsky, Petr L.; Sedinova, Miroslava; Smiskova, Katerina; Novotny, Marian; Beltran, Neritza Campo; Hrdy, Ivan; Tachezy, Jan] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Lab Mass Spectrometry, Prague, Czech Republic; [Bursac, Dejan; Perry, Andrew J.; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Charles University Prague; Charles University Prague; Monash University	Rada, P (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	tachezy@natur.cuni.cz	Lithgow, Trevor J/H-5925-2017; Tachezy, Jan/R-4945-2017; Dolezal, Pavel/V-1907-2017; Novotny, Marian/B-7036-2008; Perry, Andrew/E-5607-2010; Jedelsky, Petr/C-5879-2009; Rada, Petr/M-5289-2017; Hrdý, Ivan/K-8931-2017	Lithgow, Trevor J/0000-0002-0102-7884; Tachezy, Jan/0000-0001-6976-8446; Dolezal, Pavel/0000-0003-1285-9026; Novotny, Marian/0000-0001-8788-3202; Perry, Andrew/0000-0001-9256-6068; Jedelsky, Petr/0000-0003-3813-2343; Rada, Petr/0000-0001-6241-969X; Hrdý, Ivan/0000-0002-5595-9177	Czech Ministry of Education [MSM0021620858, LC07032]; Czech Science Foundation [P305/10/0651]; Australian Research Council	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Australian Research Council(Australian Research Council)	This work was supported by grants from the Czech Ministry of Education (MSM0021620858, LC07032), Czech Science Foundation (P305/10/0651), and Australian Research Council. AP is a National Health and Medical Research Council Postdoctoral Fellow, and TL is an Austrailian Research Council Federation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Belenkiy R, 2000, BBA-BIOMEMBRANES, V1467, P207, DOI 10.1016/S0005-2736(00)00222-4; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bradley PJ, 1997, EMBO J, V16, P3484, DOI 10.1093/emboj/16.12.3484; Budzinska M, 2009, J BIOENERG BIOMEMBR, V41, P361, DOI 10.1007/s10863-009-9231-9; Burri L, 2006, P NATL ACAD SCI USA, V103, P15916, DOI 10.1073/pnas.0604109103; Bursac D, 2009, FEBS LETT, V583, P2954, DOI 10.1016/j.febslet.2009.08.005; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carrie C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-249; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2003, J BIOL CHEM, V278, P30548, DOI 10.1074/jbc.M304032200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan B, 1999, FEBS LETT, V451, P243, DOI 10.1016/S0014-5793(99)00581-5; ElMoualij B, 1997, YEAST, V13, P573, DOI 10.1002/(SICI)1097-0061(199705)13:6<573::AID-YEA107>3.0.CO;2-I; Gabriel Kipros, 2007, V390, P99; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Handa N, 2007, ACTA CRYSTALLOGR D, V63, P1225, DOI 10.1107/S0907444907051463; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hjort K, 2010, PHILOS T R SOC B, V365, P713, DOI 10.1098/rstb.2009.0224; Honys D, 2009, J PROTEOME RES, V8, P2015, DOI 10.1021/pr8009897; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; HRDY I, 2008, MICROBIOL MONOGR, V9, P113, DOI DOI 10.1007/7171_2007_110; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Kaldi K, 1998, EMBO J, V17, P1569, DOI 10.1093/emboj/17.6.1569; Kmita H, 2000, BBA-BIOMEMBRANES, V1509, P86, DOI 10.1016/S0005-2736(00)00284-4; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Likic VA, 2010, METHODS MOL BIOL, V619, P271, DOI 10.1007/978-1-60327-412-8_16; Mentel M, 2008, EUKARYOT CELL, V7, P1750, DOI 10.1128/EC.00206-08; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Morada M, 2011, MOL BIOCHEM PARASIT, V176, P51, DOI 10.1016/j.molbiopara.2010.10.004; Mukherjee M, 2006, EUKARYOT CELL, V5, P2062, DOI 10.1128/EC.00205-06; Murcha MW, 2007, PLANT PHYSIOL, V143, P199, DOI 10.1104/pp.106.090688; Murcha MW, 2003, PLANT PHYSIOL, V131, P1737, DOI 10.1104/pp.102.016808; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1996, BBA-BIOENERGETICS, V1275, P127, DOI 10.1016/0005-2728(96)00062-X; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider A, 2008, TRENDS CELL BIOL, V18, P12, DOI 10.1016/j.tcb.2007.09.009; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Suchan P, 2003, MICROBIOL-SGM, V149, P1911, DOI 10.1099/mic.0.26122-0; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Tjaden J, 2004, MOL MICROBIOL, V51, P1439, DOI 10.1111/j.1365-2958.2004.03918.x; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Vanacova S, 2001, MICROBIOL-UK, V147, P53; Voncken F, 2002, MOL MICROBIOL, V44, P1441, DOI 10.1046/j.1365-2958.2002.02959.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	73	52	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24428	10.1371/journal.pone.0024428	http://dx.doi.org/10.1371/journal.pone.0024428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935410	Green Published, gold			2022-12-25	WOS:000295041700034
J	Fortin, JP; Chinnapen, D; Beinborn, M; Lencer, W; Kopin, AS				Fortin, Jean-Philippe; Chinnapen, Daniel; Beinborn, Martin; Lencer, Wayne; Kopin, Alan S.			Discovery of Dual-Action Membrane-Anchored Modulators of Incretin Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; DEPENDENT INSULINOTROPIC POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; TETHERED LIGANDS; IN-VIVO; ACTIVATION; DESENSITIZATION; BINDING	Background: The glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide-1 (GLP-1) receptors are considered complementary therapeutic targets for type 2 diabetes. Using recombinant membrane-tethered ligand (MTL) technology, the present study focused on defining optimized modulators of these receptors, as well as exploring how local anchoring influences soluble peptide function. Methodology/Principal Findings: Serial substitution of residue 7 in membrane-tethered GIP (tGIP) led to a wide range of activities at the GIP receptor, with [G(7)]tGIP showing enhanced efficacy compared to the wild type construct. In contrast, introduction of G(7) into the related ligands, tGLP-1 and tethered exendin-4 (tEXE4), did not affect signaling at the cognate GLP-1 receptor. Both soluble and tethered GIP and GLP-1 were selective activators of their respective receptors. Although soluble EXE4 is highly selective for the GLP-1 receptor, unexpectedly, tethered EXE4 was found to be a potent activator of both the GLP-1 and GIP receptors. Diverging from the pharmacological properties of soluble and tethered GIP, the newly identified GIP-R agonists, (i.e. [G(7)]tGIP and tEXE4) failed to trigger cognate receptor endocytosis. In an attempt to recapitulate the dual agonism observed with tEXE4, we conjugated soluble EXE4 to a lipid moiety. Not only did this soluble peptide activate both the GLP-1 and GIP receptors but, when added to receptor expressing cells, the activity persists despite serial washes. Conclusions: These findings suggest that conversion of a recombinant MTL to a soluble membrane anchored equivalent offers a means to prolong ligand function, as well as to design agonists that can simultaneously act on more than one therapeutic target.	[Fortin, Jean-Philippe; Beinborn, Martin; Kopin, Alan S.] Tufts Univ, Sch Med, Mol Pharmacol Res Ctr, Mol Cardiol Res Inst,Tufts Med Ctr, Boston, MA 02111 USA; [Chinnapen, Daniel; Lencer, Wayne] Harvard Univ, Sch Med, Boston, MA USA; [Chinnapen, Daniel; Lencer, Wayne] Childrens Hosp, Gastrointestinal Cell Biol & Harvard Digest Dis C, Boston, MA 02115 USA	Tufts Medical Center; Tufts University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Fortin, JP (corresponding author), Tufts Univ, Sch Med, Mol Pharmacol Res Ctr, Mol Cardiol Res Inst,Tufts Med Ctr, Boston, MA 02111 USA.	akopin@tuftsmedicalcenter.org		Lencer, Wayne/0000-0001-7346-2730	Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Institutes of Health Research (CIHR); National Institute on Drug Abuse [R01DA020415]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK072497, R01DK074075]; National Institutes of Health (NIH) [R01DK48106, R01DK084424, R21DK090603]; Harvard Digestive Diseases Center [P30 DK34854]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK090603, R01DK072497, R01DK084424, P30DK034854, R01DK048106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020415] Funding Source: NIH RePORTER	Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Fonds de la Recherche en Sante du Quebec (FRSQ) and the Canadian Institutes of Health Research (CIHR) for Fellowship Awards to J.-P.F. Work in the laboratory of A. S. K. is in part supported by the National Institute on Drug Abuse (R01DA020415) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK072497, R01DK074075). Work in the laboratory of W. I. L. is supported by the National Institutes of Health (NIH) (R01DK48106, R01DK084424, R21DK090603 and Harvard Digestive Diseases Center (P30 DK34854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; Bourgault S, 2009, J MED CHEM, V52, P3308, DOI 10.1021/jm900291j; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Clark RB, 1996, MOL PHARMACOL, V49, P182; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Doan ND, 2011, BIOCHEM PHARMACOL, V81, P552, DOI 10.1016/j.bcp.2010.11.015; Drucker DJ, 2010, NAT REV DRUG DISCOV, V9, P267, DOI 10.1038/nrd3148; Estall JL, 2005, J BIOL CHEM, V280, P22124, DOI 10.1074/jbc.M500078200; Fortin JP, 2010, J PHARMACOL EXP THER, V332, P274, DOI 10.1124/jpet.109.160531; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; GAULT VA, 2011, CLIN SCI; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Irwin N, 2006, J MED CHEM, V49, P1047, DOI 10.1021/jm0509997; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Kulkarni RN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001027; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Pratley RE, 2010, DIABETES CARE, V33, P1691, DOI 10.2337/dc10-0704; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; ROMANO R, 1993, BIOCHIM BIOPHYS ACTA, V1151, P111, DOI 10.1016/0005-2736(93)90093-F; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Russell-Jones D, 2009, MOL CELL ENDOCRINOL, V297, P137, DOI 10.1016/j.mce.2008.11.018; Schwarzmann G, 2000, METHOD ENZYMOL, V312, P534; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Summerhill Susan, 2008, Journal of Pharmacological and Toxicological Methods, V58, P189, DOI 10.1016/j.vascn.2008.06.003; Tharakan G, 2011, TRENDS PHARMACOL SCI, V32, P8, DOI 10.1016/j.tips.2010.10.003; Tibaduiza EC, 2001, J BIOL CHEM, V276, P37787; Tseng CC, 1998, MOL CELL ENDOCRINOL, V139, P179, DOI 10.1016/S0303-7207(98)00061-6; Tseng CC, 2000, ENDOCRINOLOGY, V141, P947, DOI 10.1210/en.141.3.947; Vauquelin G, 2009, MOL CELL ENDOCRINOL, V311, P1, DOI 10.1016/j.mce.2009.07.022; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Widenmaier SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009590; Widmann C, 1997, MOL ENDOCRINOL, V11, P1094, DOI 10.1210/me.11.8.1094	45	19	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24693	10.1371/journal.pone.0024693	http://dx.doi.org/10.1371/journal.pone.0024693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935440	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700035
J	Hammond, JP; Broadley, MR; Bowen, HC; Spracklen, WP; Hayden, RM; White, PJ				Hammond, John P.; Broadley, Martin R.; Bowen, Helen C.; Spracklen, William P.; Hayden, Rory M.; White, Philip J.			Gene Expression Changes in Phosphorus Deficient Potato (Solanum tuberosum L.) Leaves and the Potential for Diagnostic Gene Expression Markers	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; PHOSPHATE STARVATION; GALACTOLIPID BIOSYNTHESIS; PHOSPHOLIPASES D-ZETA-1; TRANSCRIPTOMIC ANALYSIS; MEMBRANE PHOSPHOLIPIDS; METABOLIC-CHANGES; PLASMA-MEMBRANE; SOIL-PHOSPHORUS; ROOT RESPONSES	Background: There are compelling economic and environmental reasons to reduce our reliance on inorganic phosphate (Pi) fertilisers. Better management of Pi fertiliser applications is one option to improve the efficiency of Pi fertiliser use, whilst maintaining crop yields. Application rates of Pi fertilisers are traditionally determined from analyses of soil or plant tissues. Alternatively, diagnostic genes with altered expression under Pi limiting conditions that suggest a physiological requirement for Pi fertilisation, could be used to manage Pifertiliser applications, and might be more precise than indirect measurements of soil or tissue samples. Results: We grew potato (Solanum tuberosum L.) plants hydroponically, under glasshouse conditions, to control their nutrient status accurately. Samples of total leaf RNA taken periodically after Pi was removed from the nutrient solution were labelled and hybridised to potato oligonucleotide arrays. A total of 1,659 genes were significantly differentially expressed following Pi withdrawal. These included genes that encode proteins involved in lipid, protein, and carbohydrate metabolism, characteristic of Pi deficient leaves and included potential novel roles for genes encoding patatin like proteins in potatoes. The array data were analysed using a support vector machine algorithm to identify groups of genes that could predict the Pi status of the crop. These groups of diagnostic genes were tested using field grown potatoes that had either been fertilised or unfertilised. A group of 200 genes could correctly predict the Pi status of field grown potatoes. Conclusions: This paper provides a proof-of-concept demonstration for using microarrays and class prediction tools to predict the Pi status of a field grown potato crop. There is potential to develop this technology for other biotic and abiotic stresses in field grown crops. Ultimately, a better understanding of crop stresses may improve our management of the crop, improving the sustainability of agriculture.	[Hammond, John P.; Broadley, Martin R.] Univ Nottingham, Div Plant & Crop Sci, Loughborough, Leics, England; [Bowen, Helen C.; Spracklen, William P.; Hayden, Rory M.] Univ Warwick, Warwick HRI, Warwick, England; [White, Philip J.] James Hutton Inst, Dundee, Scotland	University of Nottingham; University of Warwick; James Hutton Institute	Hammond, JP (corresponding author), Univ Nottingham, Div Plant & Crop Sci, Loughborough, Leics, England.	j.hammond@nottingham.ac.uk	broadley, martin r/E-9081-2011; White, Philip John/C-5860-2008; Broadley, Martin/AAW-4638-2021; Hammond, John P/A-1876-2012	broadley, martin r/0000-0003-3964-7226; White, Philip John/0000-0003-0827-288X; Broadley, Martin/0000-0003-3964-7226; Hammond, John P/0000-0002-6241-3551	UK Department of Environment, Food and Rural Affairs [HH3504SPO]; Scottish Government Rural and Environment Research and Analysis Directorate	UK Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government Rural and Environment Research and Analysis Directorate	The authors acknowledge the financial support from the UK Department of Environment, Food and Rural Affairs (Grant Number - HH3504SPO; all authors) and the Scottish Government Rural and Environment Research and Analysis Directorate (PJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amtmann A, 2006, ADV BOT RES, V43, P209, DOI 10.1016/S0065-2296(05)43005-0; Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Assuero SG, 2004, PLANT CELL ENVIRON, V27, P887, DOI 10.1111/j.1365-3040.2004.01194.x; Bradstreet RB, 1965, KJELDAHL METHOD ORGA; Broadley MR, 2008, PLANT PHYSIOL, V146, P1707, DOI 10.1104/pp.107.114645; Broadley MR, 2003, J EXP BOT, V54, P1431, DOI 10.1093/jxb/erg143; CAKMAK I, 1994, J EXP BOT, V45, P1245, DOI 10.1093/jxb/45.9.1245; CAKMAK I, 1994, J EXP BOT, V45, P1251, DOI 10.1093/jxb/45.9.1251; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; *DEP ENV FOOD RUR, 2000, FERT REC AGR HORT CR; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Fang ZY, 2009, PLANT SCI, V176, P170, DOI 10.1016/j.plantsci.2008.09.007; Frossard E, 2000, J ENVIRON QUAL, V29, P15, DOI 10.2134/jeq2000.00472425002900010003x; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gaude N, 2008, PLANT J, V56, P28, DOI 10.1111/j.1365-313X.2008.03582.x; George Timothy S., 2008, V7, P247; Graham MA, 2006, FUNCT PLANT BIOL, V33, P789, DOI 10.1071/FP06101; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Hammond JP, 2011, PLANT PHYSIOL, V156, P1230, DOI 10.1104/pp.111.175612; Hammond JP, 2011, PLANT PHYSIOL, V156, P1033, DOI 10.1104/pp.111.175380; Hammond JP, 2009, J EXP BOT, V60, P1953, DOI 10.1093/jxb/erp083; Hammond John P., 2008, V7, P225; Hammond JP, 2006, NEW PHYTOL, V170, P239, DOI 10.1111/j.1469-8137.2006.01662.x; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Heffer P., 2006, P INT FERTILISER SOC, V586; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hernandez G, 2009, PLANT PHYSIOL, V151, P1221, DOI 10.1104/pp.109.143842; Hoch WA, 2001, TREE PHYSIOL, V21, P1; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Huang CY, 2008, PLANT CELL PHYSIOL, V49, P691, DOI 10.1093/pcp/pcn044; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Jain A., 2007, Plant Breeding Reviews, V29, P359, DOI 10.1002/9780470168035.ch7; Khiari L, 2001, AGRON J, V93, P815, DOI 10.2134/agronj2001.934815x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Kobayashi K, 2006, PLANT J, V47, P238, DOI 10.1111/j.1365-313X.2006.02778.x; Kopriva S, 2009, PLANT CELL REP, V28, P1769, DOI 10.1007/s00299-009-0793-0; LEE RB, 1990, J EXP BOT, V41, P1063, DOI 10.1093/jxb/41.9.1063; Li LH, 2010, PLANT MOL BIOL, V72, P423, DOI 10.1007/s11103-009-9580-0; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; Lynch Jonathan P., 2008, V7, P83; Mansfeld J, 2009, BIOTECHNOL LETT, V31, P1373, DOI 10.1007/s10529-009-0034-1; Mengel K, 1982, Principles of plant nutrition.; MIMURA T, 1990, PLANTA, V180, P139, DOI 10.1007/BF00193988; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Muller R, 2005, PHYSIOL PLANTARUM, V124, P81, DOI 10.1111/j.1399-3054.2005.00496.x; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; Raven John A., 2008, V7, P271; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; Sano T, 1999, PLANT CELL PHYSIOL, V40, P1, DOI 10.1093/oxfordjournals.pcp.a029464; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Senda K, 1996, PLANT CELL PHYSIOL, V37, P347, DOI 10.1093/oxfordjournals.pcp.a028952; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Slabas T, 1997, TRENDS PLANT SCI, V2, P161, DOI 10.1016/S1360-1385(97)01029-7; Smethurst PJ, 2000, FOREST ECOL MANAG, V138, P397, DOI 10.1016/S0378-1127(00)00426-6; Smith AP, 2010, PLANT PHYSIOL, V152, P217, DOI 10.1104/pp.109.145532; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tjellstrom H, 2008, PLANT CELL ENVIRON, V31, P1388, DOI 10.1111/j.1365-3040.2008.01851.x; Uhde-Stone C, 2003, PLANT PHYSIOL, V131, P1064, DOI 10.1104/pp.102.016881; Ulrich Albert, 1993, P149; Vance Carroll P., 2008, V7, P117; Wallace T., 1961, DIAGNOSIS MINERAL DE; WALWORTH JL, 1993, AM POTATO J, V70, P579, DOI 10.1007/BF02850848; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; Wasaki J, 2003, NEW PHYTOL, V158, P239, DOI 10.1046/j.1469-8137.2003.00748.x; Wasaki J, 2006, J EXP BOT, V57, P2049, DOI 10.1093/jxb/erj158; White P. J., 2005, Proceedings - International Fertiliser Society, P1; White P. J., 2005, Aspects of Applied Biology, P111; White Philip J., 2007, P739; White PJ, 2009, J ENVIRON QUAL, V38, P13, DOI 10.2134/jeq2007.0658; White Philip J., 2008, V7, P51; Wissuwa M, 2005, J EXP BOT, V56, P1943, DOI 10.1093/jxb/eri189; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Xu ZP, 2007, COMMUN SOIL SCI PLAN, V38, P2519, DOI 10.1080/00103620701588924; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051	92	35	36	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24606	10.1371/journal.pone.0024606	http://dx.doi.org/10.1371/journal.pone.0024606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935429	Green Submitted, gold, Green Published			2022-12-25	WOS:000295039700029
J	Muses, S; Morgan, JE; Wells, DJ				Muses, Sofia; Morgan, Jennifer E.; Wells, Dominic J.			A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies	PLOS ONE			English	Article							SLEEPING-BEAUTY; SKELETAL-MUSCLE; GENE-TRANSFER; STEM-CELL; SATELLITE CELLS; SELF-RENEWAL; MOUSE MUSCLE; TRANSPOSON; EXPRESSION; MDX	A new conditionally immortal satellite cell-derived cell-line, H2K 2B4, was generated from the H2K(b)-tsA58 immortomouse. Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotubes with a myogenic protein profile comparable with freshly isolated satellite cells. Following engraftment into immunodeficient dystrophin-deficient mice, H2K 2B4 cells regenerated host muscle with donor derived myofibres that persisted for at least 24 weeks, without forming tumours. These cells were readily transfectable using both retrovirus and the non-viral transfection methods and importantly upon transplantation, were able to reconstitute the satellite cell niche with functional donor derived satellite cells. Finally using the Class II DNA transposon, Sleeping Beauty, we successfully integrated a reporter plasmid into the genome of H2K 2B4 cells without hindering the myogenic differentiation. Overall, these data suggest that H2K 2B4 cells represent a readily transfectable stable cell-line in which to investigate future stem cell based therapies for muscle disease.	[Muses, Sofia; Wells, Dominic J.] Univ London Royal Vet Coll, London, England; [Morgan, Jennifer E.] UCL Inst Child Hlth, London, England	University of London; University of London Royal Veterinary College; University of London; University College London	Muses, S (corresponding author), Univ London Royal Vet Coll, London, England.	dwells@rvc.ac.uk		Wells, Dominic/0000-0002-1425-6344	European Union [018716]; Wellcome Trust; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a European Union grant "SyntheGeneDelivery'' (FFP 6 STREP project number 018716). Jennifer E. Morgan is funded by a Wellcome Trust University Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronovich EL, 2007, J GENE MED, V9, P403, DOI 10.1002/jgm.1028; Aronovich EL, 2009, MOL THER, V17, P1136, DOI 10.1038/mt.2009.87; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Blaveri K, 1999, DEV DYNAM, V216, P244, DOI 10.1002/(SICI)1097-0177(199911)216:3<244::AID-DVDY3>3.0.CO;2-9; Boldrin L, 2009, STEM CELLS, V27, P2478, DOI 10.1002/stem.162; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CHANCELLOR DR, 2011, J MED CHEM, V15, P15; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cousins JC, 2004, J CELL SCI, V117, P3259, DOI 10.1242/jcs.01161; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Doran TJ, 2009, GENE THER, V16, P119, DOI 10.1038/gt.2008.144; FERRY N, 1991, P NATL ACAD SCI USA, V88, P8377, DOI 10.1073/pnas.88.19.8377; Grabowska I, 2011, CELL BIOL INT, V35, P125, DOI 10.1042/CBI20090335; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; Hackett P, 2007, MOL GENET METAB, V92, pS15, DOI 10.1016/j.ymgme.2007.08.021; Heslop L, 2000, J CELL SCI, V113, P2299; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LANGELAAN ML, 2010, J TISSUE ENG REGEN M, V9, P9; Liu L, 2006, MOL THER, V13, P1006, DOI 10.1016/j.ymthe.2005.11.021; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454; Morgan JE, 2002, J CELL BIOL, V157, P693, DOI 10.1083/jcb.200108047; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; MORGAN JE, 1992, J CELL SCI, V102, P779; NOURSADEGHI M, 1993, FEBS LETT, V320, P155, DOI 10.1016/0014-5793(93)80082-6; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Vink CA, 2009, MOL THER, V17, P1197, DOI 10.1038/mt.2009.94; Wilber A, 2006, MOL THER, V13, P625, DOI 10.1016/j.ymthe.2005.10.014; Wilber A, 2007, MOL THER, V15, P1280, DOI 10.1038/sj.mt.6300160; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	45	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24826	10.1371/journal.pone.0024826	http://dx.doi.org/10.1371/journal.pone.0024826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935475	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700051
J	Westphal, MF; Massie, JL; Bronkema, JM; Smith, BE; Morgan, TJ				Westphal, Michael F.; Massie, Jodi L.; Bronkema, Joanna M.; Smith, Brian E.; Morgan, Theodore J.			Heritable Variation in Garter Snake Color Patterns in Postglacial Populations	PLOS ONE			English	Article							THAMNOPHIS-SIRTALIS; GENETIC CONSEQUENCES; BODY-SIZE; QUANTITATIVE GENETICS; MOLECULAR DIVERSITY; COLONIZATION; RECOLONIZATION; VARIABILITY; SELECTION; SUBDIVISION	Global climate change is expected to trigger northward shifts in the ranges of natural populations of plants and animals, with subsequent effects on intraspecific genetic diversity. Investigating how genetic diversity is patterned among populations that arose following the last Ice Age is a promising method for understanding the potential future effects of climate change. Theoretical and empirical work has suggested that overall genetic diversity can decrease in colonial populations following rapid expansion into postglacial landscapes, with potential negative effects on the ability of populations to adapt to new environmental regimes. The crucial measure of this genetic variation and a population's overall adaptability is the heritable variation in phenotypic traits, as it is this variation that mediates the rate and direction of a population's multigenerational response to selection. Using two large full-sib quantitative genetic studies (N-Manitoba = 144; N-South Dakota = 653) and a smaller phenotypic analysis from Kansas (N-Kansas = 44), we compared mean levels of pigmentation, genetic variation and heritability in three pigmentation traits among populations of the common garter snake, Thamnophis sirtalis, along a north-south gradient, including a postglacial northern population and a putative southern refuge population. Counter to our expectations, we found that genetic variance and heritability for the three pigmentation traits were the same or higher in the postglacial population than in the southern population.	[Westphal, Michael F.; Morgan, Theodore J.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Westphal, Michael F.; Morgan, Theodore J.] Kansas State Univ, Ecol Genom Inst, Manhattan, KS 66506 USA; [Massie, Jodi L.; Smith, Brian E.] Black Hills State Univ, Dept Biol, Spearfish, SD 57799 USA; [Bronkema, Joanna M.] Earlham Coll, Richmond, IN USA	Kansas State University; Kansas State University; Black Hills State University; Earlham College	Westphal, MF (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	mwestpha@blm.gov		Morgan, Theodore/0000-0003-4535-2061	U.S. Department of Education; Kansas State Ecological Genomics Institute; KSU NSF	U.S. Department of Education(US Department of Education); Kansas State Ecological Genomics Institute; KSU NSF	This work was supported by the U.S. Department of Education through a Graduate Assistance in Areas of National Need GAANN) fellowship to MFW, by the Kansas State Ecological Genomics Institute through a postdoctoral fellowship to MFW and a research seed grant to TJM, and by the KSU NSF Site-based REU program summer award to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrino J, 2000, MOL ECOL, V9, P771, DOI 10.1046/j.1365-294x.2000.00931.x; ANDREWS JT, 1987, GEOLOGY N AM, P13; BELLEMIN J, 1978, COPEIA, P150; Bittner TD, 2002, COPEIA, P477, DOI 10.1643/0045-8511(2002)002[0477:EOBSAM]2.0.CO;2; Bluemle JP, 1999, ENV GEOSCIENCES, V6, P63, DOI DOI 10.1046/J.1526-0984.1999.08036.X; Boyd M, 2007, J PALEOLIMNOL, V37, P313, DOI 10.1007/s10933-006-9044-3; Bradshaw WE, 2001, J INSECT PHYSIOL, V47, P809, DOI 10.1016/S0022-1910(01)00054-3; BRODIE ED, 1992, EVOLUTION, V46, P1284, DOI 10.1111/j.1558-5646.1992.tb01124.x; Brodie Edmund D. III, 1993, P315; Carlson AE, 2008, NAT GEOSCI, V1, P620, DOI 10.1038/ngeo285; Comps B, 2001, GENETICS, V157, P389; Conant R., 1975, FIELD GUIDE REPTILES, V2; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; COWLEY DE, 1992, EVOLUTION, V46, P1965, DOI [10.2307/2410046, 10.1111/j.1558-5646.1992.tb01184.x]; DOHM MR, 1993, COPEIA, P987; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falconer D. S, 1996, INTRO QUANTITATIVE G; Ficetola GF, 2007, MOL ECOL, V16, P1787, DOI 10.1111/j.1365-294X.2006.03198.x; GARLAND T, 1990, AM J PHYSIOL, V259, pR986, DOI 10.1152/ajpregu.1990.259.5.R986; Green DM, 1996, EVOLUTION, V50, P374, DOI 10.1111/j.1558-5646.1996.tb04500.x; Gregory P.T, 1977, NAT MUS CAN PUBL ZOO, V13, P1; Gregory PT, 1996, COPEIA, P183; GREGORY PT, 1993, COPEIA, P946; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Janzen FJ, 2002, MOL ECOL, V11, P1739, DOI 10.1046/j.1365-294X.2002.01571.x; KLEIN TW, 1974, BEHAV GENET, V4, P171; Knopp T, 2009, HEREDITY, V102, P174, DOI 10.1038/hdy.2008.91; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; Lesbarreres D, 2009, HEREDITY, V102, P213, DOI 10.1038/hdy.2008.121; Lynch Michael, 1998; Mahy G, 1999, HEREDITY, V82, P654, DOI 10.1046/j.1365-2540.1999.00506.x; Manier MK, 2005, MOL ECOL, V14, P3965, DOI 10.1111/j.1365-294X.2005.02734.x; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Merila J, 1996, EVOLUTION, V50, P2548, DOI 10.1111/j.1558-5646.1996.tb03644.x; Morgan TJ, 2005, HEREDITY, V94, P518, DOI 10.1038/sj.hdy.6800652; Pamilo P, 1999, HEREDITAS, V130, P229, DOI 10.1111/j.1601-5223.1999.00229.x; Phillips P.C., 1998, H2BOOT BOOTSTRAP EST; Pielou E.C., 1991, ICE AGE RETURN LIFE; Placyk JS, 2007, MOL PHYLOGENET EVOL, V43, P452, DOI 10.1016/j.ympev.2006.10.023; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rossman DA, 1996, GARTER SNAKES EVOLUT; RYE LA, 2000, THESIS U GUELPH GUEL; SAGE RD, 1986, EVOLUTION, V40, P1092, DOI 10.1111/j.1558-5646.1986.tb00576.x; SATTLER PW, 1976, COPEIA, P352; Shine R, 2000, BEHAV ECOL, V11, P239, DOI 10.1093/beheco/11.3.239; Shine R, 2004, CAN J ZOOL, V82, P1091, DOI 10.1139/Z04-086; Stenoien HK, 2005, MOL ECOL, V14, P137, DOI 10.1111/j.1365-294X.2004.02359.x; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; van Heerwaarden B, 2008, GENETICS, V179, P2135, DOI 10.1534/genetics.107.082768; Wegmann D, 2006, GENETICS, V174, P2009, DOI 10.1534/genetics.106.062851; Westphal MF, 2010, J HERED, V101, P573, DOI 10.1093/jhered/esq044; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216	58	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24199	10.1371/journal.pone.0024199	http://dx.doi.org/10.1371/journal.pone.0024199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935386	Green Submitted, gold, Green Published			2022-12-25	WOS:000295039700014
J	Harmon, EB; Harmon, ML; Larsen, TD; Yang, J; Glasford, JW; Perryman, MB				Harmon, Erin B.; Harmon, Michelle L.; Larsen, Tricia D.; Yang, Jie; Glasford, Joseph W.; Perryman, M. Benjamin			Myotonic Dystrophy Protein Kinase Is Critical for Nuclear Envelope Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; LAMIN-A/C; TRIPLET REPEAT; IN-VITRO; TRANSCRIPTIONAL REPRESSOR; STRUCTURAL ORGANIZATION; CTG REPEAT; MUSCLE; RNA; DIFFERENTIATION	Myotonic dystrophy 1 (DM1) is a multisystemic disease caused by a triplet nucleotide repeat expansion in the 3' untranslated region of the gene coding for myotonic dystrophy protein kinase (DMPK). DMPK is a nuclear envelope (NE) protein that promotes myogenic gene expression in skeletal myoblasts. Muscular dystrophy research has revealed the NE to be a key determinant of nuclear structure, gene regulation, and muscle function. To investigate the role of DMPK in NE stability, we analyzed DMPK expression in epithelial and myoblast cells. We found that DMPK localizes to the NE and coimmunoprecipitates with Lamin-A/C. Overexpression of DMPK in HeLa cells or C2C12 myoblasts disrupts Lamin-A/C and Lamin-B1 localization and causes nuclear fragmentation. Depletion of DMPK also disrupts NE lamina, showing that DMPK is required for NE stability. Our data demonstrate for the first time that DMPK is a critical component of the NE. These novel findings suggest that reduced DMPK may contribute to NE instability, a common mechanism of skeletal muscle wasting in muscular dystrophies.	[Harmon, Erin B.; Harmon, Michelle L.; Larsen, Tricia D.; Yang, Jie; Glasford, Joseph W.] Sanford Res USD, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Perryman, M. Benjamin] Sanford Hlth, Sioux Falls, SD 57104 USA	Sanford Health; Sanford Health	Harmon, EB (corresponding author), Sanford Res USD, Cardiovasc Hlth Res Ctr, 2301 E 60th St N, Sioux Falls, SD 57104 USA.	erin.harmon@sanfordhealth.org			National Institutes of Health [HL064136, P20-RR-017662]; South Dakota 2010 Initiative Research Center; Sanford Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Dakota 2010 Initiative Research Center; Sanford Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL064136 (to M. B. P.) and P20-RR-017662 (to E. B. H.). This work was also supported by the South Dakota 2010 Initiative Research Center Program and by Sanford Health.	Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Bush EW, 2000, BIOCHEMISTRY-US, V39, P8480, DOI 10.1021/bi992142f; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Furling D, 2003, AM J PATHOL, V162, P1001, DOI 10.1016/S0002-9440(10)63894-1; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Harmon EB, 2008, DEV DYNAM, V237, P2353, DOI 10.1002/dvdy.21653; Harper PS, 2001, MYOTONIC DYSTROPHY; Helmke SM, 2006, J MOL RECOGNIT, V19, P215, DOI 10.1002/jmr.769; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Holaska JM, 2008, CIRC RES, V103, P16, DOI 10.1161/CIRCRESAHA.108.172197; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; LEHNER CF, 1986, J BIOL CHEM, V261, P3293; LIN F, 1993, J BIOL CHEM, V268, P16321; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Morrone A, 1997, J CLIN INVEST, V99, P1691, DOI 10.1172/JCI119332; Muchir A, 2004, PHYSIOLOGY, V19, P309, DOI 10.1152/physiol.00022.2004; Muralikrishna B, 2001, J CELL SCI, V114, P4001; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; OZAKI T, 1994, ONCOGENE, V9, P2649; Roux KJ, 2007, BBA-MOL BASIS DIS, V1772, P118, DOI 10.1016/j.bbadis.2006.06.001; Sasagawa N, 2003, J BIOCHEM, V134, P537, DOI 10.1093/jb/mvg171; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; Wansink DG, 2003, CYTOGENET GENOME RES, V100, P230, DOI 10.1159/000072859; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238	48	17	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40296	40306		10.1074/jbc.M111.241455	http://dx.doi.org/10.1074/jbc.M111.241455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949239	Green Published, hybrid			2022-12-25	WOS:000296925700061
J	Mierke, CT				Mierke, Claudia Tanja			Cancer Cells Regulate Biomechanical Properties of Human Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; TRANSENDOTHELIAL MIGRATION; BARRIER FUNCTION; TUMOR-CELLS; CADHERIN; METASTASIS; PROLIFERATION; EXPRESSION; MECHANISM; MUSCLE	Metastasis is a key event of malignant tumor progression. The capability to metastasize depends on the ability of the cancer cell to migrate into connective tissue, adhere, and possibly transmigrate through the endothelium. Previously we reported that the endothelium does not generally act as barrier for cancer cells to migrate in three-dimensional extracellular matrices (3D-ECMs). Instead, the endothelium acts as an enhancer or a promoter for the invasiveness of certain cancer cells. How invasive cancer cells diminish the endothelial barrier function still remains elusive. Therefore, this study investigates whether invasive cancer cells can decrease the endothelial barrier function through alterations of endothelial biomechanical properties. To address this, MDA-MB-231 breast cancer cells were used that invade deeper and more numerous into 3D-ECMs when co-cultured with microvascular endothelial cells. Using magnetic tweezer measurements, MDA-MB-231 cells were found to alter the mechanical properties of endothelial cells by reducing endothelial cell stiffness. Using spontaneous bead diffusion, actin cytoskeletal remodeling dynamics were shown to be increased in endothelial cells co-cultured with MDA-MB-231 cells compared with mono-cultured endothelial cells. In addition, knockdown of the alpha 5 integrin subunit in highly transmigrating alpha 5 beta 1(high) cells derived from breast, bladder, and kidney cancer cells abolished the endothelial invasion-enhancing effect comparable with the inhibition of myosin light chain kinase. These results indicate that the endothelial invasion-enhancing effect is alpha 5 beta 1 integrin-dependent. Moreover, inhibition of Rac-1, Rho kinase, MEK kinase, and PI3K reduced the endothelial invasion-enhancing effect, indicating that signaling via small GTPases may play a role in the endothelial facilitated increased invasiveness of cancer cells. In conclusion, decreased stiffness and increased cytoskeletal remodeling dynamics of endothelial cells may account for the breakdown of endothelial barrier function, suggesting that biomechanical alterations are sufficient to facilitate the transmigration and invasion of invasive cancer cells into 3D-ECMs.	Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, D-04103 Leipzig, Germany	Leipzig University	Mierke, CT (corresponding author), Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, Linnestr 5, D-04103 Leipzig, Germany.	claudia.mierke@t-online.de	Mierke, Claudia Tanja/L-5293-2018	Mierke, Claudia Tanja/0000-0002-6622-335X	Deutsche Krebshilfe [109432]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (109432).	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; DAMSKY CH, 1985, J CELL BIOL, V100, P1528, DOI 10.1083/jcb.100.5.1528; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Fritsch A, 2010, NAT PHYS, V6, P730, DOI 10.1038/nphys1800; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; HILDEBRANDT J, 1969, B MATH BIOPHYS, V31, P651, DOI 10.1007/BF02477779; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a; Metzner C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194105; Mierke C. T., 2011, CELL BIOCH IN PRESS; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Mierke CT, 2000, J EXP MED, V192, P801, DOI 10.1084/jem.192.6.801; Mierke CT, 2008, J BIOPHYS, V2008; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; NEFF NT, 1982, J CELL BIOL, V95, P654, DOI 10.1083/jcb.95.2.654; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Rabodzey A, 2008, BIOPHYS J, V95, P1428, DOI 10.1529/biophysj.107.119156; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Raupach C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011918; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Van Sluis GL, 2009, BLOOD, V114, P1968, DOI 10.1182/blood-2009-04-217679; VERIN AD, 1995, AM J PHYSIOL-LUNG C, V269, pL99, DOI 10.1152/ajplung.1995.269.1.L99; Voura EB, 2001, CLIN EXP METASTAS, V18, P527, DOI 10.1023/A:1011884807746; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	38	80	85	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40025	40037		10.1074/jbc.M111.256172	http://dx.doi.org/10.1074/jbc.M111.256172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940631	Green Published, hybrid			2022-12-25	WOS:000296925700035
J	Ma, Y; Munch, D; Schneider, T; Sahl, HG; Bouhss, A; Ghoshdastider, U; Wang, JF; Dotsch, V; Wang, XN; Bernhard, F				Ma, Yi; Muench, Daniela; Schneider, Tanja; Sahl, Hans-Georg; Bouhss, Ahmed; Ghoshdastider, Umesh; Wang, Jufang; Doetsch, Volker; Wang, Xiaoning; Bernhard, Frank			Preparative Scale Cell-free Production and Quality Optimization of MraY Homologues in Different Expression Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST MEMBRANE STEP; ACETYLMURAMOYL-PENTAPEPTIDE-TRANSFERASE; ESCHERICHIA-COLI; PEPTIDOGLYCAN BIOSYNTHESIS; WALL BIOSYNTHESIS; FREE SYSTEMS; PROTEINS; TRANSLOCASE; PHOSPHATE; RECONSTITUTION	MraY translocase catalyzes the first committed membrane-bound step of bacterial peptidoglycan synthesis leading to the formation of lipid I. The essential membrane protein therefore has a high potential as target for drug screening approaches to develop antibiotics against Gram-positive as well as Gram-negative bacteria. However, the production of large integral membrane proteins in conventional cellular expression systems is still very challenging. Cell-free expression technologies have been optimized in recent times for the production of membrane proteins in the presence of detergents (D-CF), lipids (L-CF), or as precipitates (P-CF). We report the development of preparative scale production protocols for the MraY homologues of Escherichia coli and Bacillus subtilis in all three cell-free expression modes followed by their subsequent quality evaluation. Although both proteins can be cell-free produced at comparable high levels, their requirements for optimal expression conditions differ markedly. B. subtilus MraY was stably folded in all three expression modes and showed highest translocase activities after P-CF production followed by defined treatment with detergents. In contrast, the E. coli MraY appears to be unstable after post- or cotranslational solubilization in detergent micelles. Expression kinetics and reducing conditions were identified as optimization parameters for the quality improvement of E. coli MraY. Most remarkably, in contrast to B. subtilis MraY the E. coli MraY has to be stabilized by lipids and only the production in the L-CF mode in the presence of preformed liposomes resulted in stable and translocase active protein samples.	[Ma, Yi; Wang, Jufang; Wang, Xiaoning] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Ma, Yi; Ghoshdastider, Umesh; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Muench, Daniela; Schneider, Tanja; Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53105 Bonn, Germany; [Bouhss, Ahmed] Univ Paris 11, Inst Biochem & Mol & Cellular Biophys, UMR 8619, Orsay, France	South China University of Technology; Goethe University Frankfurt; University of Bonn; UDICE-French Research Universities; Universite Paris Saclay	Bernhard, F (corresponding author), Max von Laue Str 9, D-60438 Frankfurt, Germany.	fbern@bpc.uni-frankfurt.de	Schneider, Tanja/L-8049-2013; Ghoshdastider, Umesh/O-5327-2015	Dotsch, Volker/0000-0001-5720-212X; Schneider, Tanja/0000-0001-7269-4716; Bernhard, Frank/0000-0002-4860-1783; Rausch, Daniela/0000-0003-3211-5745; Ghoshdastider, Umesh/0000-0003-4471-9394	European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; European Initiative on Structural Biology of Membrane Proteins (SBMP) [PITN-GA-2008-211800]; National Natural Science Foundation of China [20736008, 20876060];  [Sonderforschungsbereich 807]	European Drug Initiative on Channels and Transporters; European Initiative on Structural Biology of Membrane Proteins (SBMP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by European Drug Initiative on Channels and Transporters Grant HEALTH-F4-2007-201924, European Initiative on Structural Biology of Membrane Proteins (SBMP) Grant PITN-GA-2008-211800, the Sonderforschungsbereich 807, and Key Program of the National Natural Science Foundation of China Grants 20736008 and 20876060.	Abdine A, 2010, J MAGN RESON, V204, P155, DOI 10.1016/j.jmr.2010.02.003; Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; ELBEIN AD, 1979, ANNU REV PLANT PHYS, V30, P239, DOI 10.1146/annurev.pp.30.060179.001323; GEIS A, 1978, BIOCHIM BIOPHYS ACTA, V527, P414, DOI 10.1016/0005-2744(78)90355-8; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Hyland SA, 2003, ANAL BIOCHEM, V317, P156, DOI 10.1016/S0003-2697(03)00088-5; IKEDA M, 1991, J BACTERIOL, V173, P1021, DOI 10.1128/jb.173.3.1021-1026.1991; Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002; Junge F, 2010, J STRUCT BIOL, V172, P94, DOI 10.1016/j.jsb.2010.05.004; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Lecercle D, 2010, BIOORGAN MED CHEM, V18, P4560, DOI 10.1016/j.bmc.2010.04.023; Mravljak J, 2011, EUR J MED CHEM, V46, P1582, DOI 10.1016/j.ejmech.2011.02.006; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Nozawa A, 2007, PLANT CELL PHYSIOL, V48, P1815, DOI 10.1093/pcp/pcm150; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P359, DOI 10.2174/138920109788488815; PLESS DD, 1973, J BIOL CHEM, V248, P1568; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reckel S, 2010, METHODS MOL BIOL, V607, P187, DOI 10.1007/978-1-60327-331-2_16; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rubinchik E, 2011, ANTIMICROB AGENTS CH, V55, P2743, DOI 10.1128/AAC.00170-11; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Stachyra T, 2004, ANTIMICROB AGENTS CH, V48, P897, DOI 10.1128/AAC.48.3.897-902.2004; UMBREIT JN, 1972, P NATL ACAD SCI USA, V69, P1972, DOI 10.1073/pnas.69.7.1972; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Zawadzke LE, 2003, ANAL BIOCHEM, V314, P243, DOI 10.1016/S0003-2697(02)00622-X	40	51	51	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38844	38853		10.1074/jbc.M111.301085	http://dx.doi.org/10.1074/jbc.M111.301085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937437	Green Published, hybrid			2022-12-25	WOS:000296759800003
J	Vadon-Le Goff, S; Kronenberg, D; Bourhis, JM; Bijakowski, C; Raynal, N; Ruggiero, F; Farndale, RW; Stocker, W; Hulmes, DJS; Moali, C				Vadon-Le Goff, Sandrine; Kronenberg, Daniel; Bourhis, Jean-Marie; Bijakowski, Cecile; Raynal, Nicolas; Ruggiero, Florence; Farndale, Richard W.; Stoecker, Walter; Hulmes, David J. S.; Moali, Catherine			Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; SUBSTRATE EXCLUSION; COLLAGEN-BINDING; CUB DOMAINS; FIBROSIS; CLEAVAGE; BMP-1; ACTIVATION; MECHANISMS; EXPRESSION	Bone morphogenetic protein-1(BMP-1) and the tolloid-like metalloproteinases control several aspects of embryonic development and tissue repair. Unlike other proteinases whose activities are regulated mainly by endogenous inhibitors, regulation of BMP-1/tolloid-like proteinases relies mostly on proteins that stimulate activity. Among these, procollagen C-proteinase enhancers (PCPEs) markedly increase BMP-1/tolloid-like proteinase activity on fibrillar procollagens, in a substrate-specific manner. Here, we performed a detailed quantitative study of the binding of PCPE-1 and of its minimal active fragment (CUB1-CUB2) to three regions of the procollagen III molecule: the triple helix, the C-telopeptide, and the C-propeptide. Contrary to results described elsewhere, we found the PCPE-1-binding sites to be located exclusively in the C-propeptide region. In addition, binding and enhancing activities were found to be independent of the glycosylation state of the C-propeptide. These data exclude previously proposed mechanisms for the action of PCPEs and also suggest new mechanisms to explain how these proteins can stimulate BMP-1/tolloid-like proteinases by up to 20-fold.	[Vadon-Le Goff, Sandrine; Kronenberg, Daniel; Bourhis, Jean-Marie; Bijakowski, Cecile; Hulmes, David J. S.; Moali, Catherine] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, FRE3310, F-69367 Lyon 7, France; [Kronenberg, Daniel; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Cell & Matrix Biol, D-55128 Mainz, Germany; [Raynal, Nicolas; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ruggiero, Florence] Univ Lyon 1, Inst Genom Fonct Lyon, ENS Lyon, UMR CNRS 5242, F-69364 Lyon 7, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Johannes Gutenberg University of Mainz; University of Cambridge; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Hulmes, DJS (corresponding author), Univ Lyon 1, CNRS, Inst Biol & Chim Prot, FRE3310, 7 Passage du Vercors, F-69367 Lyon 7, France.	d.hulmes@ibcp.fr	le goff, sandrine/AAE-1990-2019; Kronenberg, Daniel/ABA-9255-2020; Stöcker, Walter/AAB-9704-2019	Kronenberg, Daniel/0000-0001-6807-7328; Stöcker, Walter/0000-0002-1515-6994; MOALI, Catherine/0000-0003-2479-4290; vadon-le goff, sandrine/0000-0002-4582-2273; RUGGIERO, Florence/0000-0003-2915-5359; Hulmes, David/0000-0002-0651-1317	Region Rhone-Alpes; European Commission [NMP2-CT-2003-504017]; Agence Nationale de la Recherche; Fondation Coloplast; CNRS; Universite Claude Bernard Lyon 1; Wellcome Trust; Medical Research Council; Deutscher Akademischer Austauschdienst (DAAD); MRC [G0400701] Funding Source: UKRI; Medical Research Council [G0400701] Funding Source: researchfish	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Coloplast; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Region Rhone-Alpes, European Commission Contract NMP2-CT-2003-504017, the Agence Nationale de la Recherche, the Fondation Coloplast, CNRS, and the Universite Claude Bernard Lyon 1. Synthesis of the collagen toolkits was supported by the Wellcome Trust and the Medical Research Council.; Supported by the Deutscher Akademischer Austauschdienst (DAAD). Present address: Inst. for Experimental Musculoskeletal Medicine, University of Munster, 48149 Munster, Germany.	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Bailey S, 2008, BIOORG MED CHEM LETT, V18, P6562, DOI 10.1016/j.bmcl.2008.10.036; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Bernocco S, 2001, J BIOL CHEM, V276, P48930, DOI 10.1074/jbc.M108611200; Berry R, 2010, FEBS LETT, V584, P657, DOI 10.1016/j.febslet.2009.12.050; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Burchardt ER, 1998, MATRIX BIOL, V17, P673, DOI 10.1016/S0945-053X(98)90118-4; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Clark TG, 1999, DEVELOPMENT, V126, P2631; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Hulmes D. J. S., 2008, P15, DOI 10.1007/978-0-387-73906-9_2; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; Moschcovich L, 2001, EUR J BIOCHEM, V268, P2991, DOI 10.1046/j.1432-1327.2001.02189.x; Ogata I, 1997, HEPATOLOGY, V26, P611, DOI 10.1002/hep.510260312; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Steiglitz BM, 2006, MOL CELL BIOL, V26, P238, DOI 10.1128/MCB.26.1.238-249.2006; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; SUZUKI A, 1995, DEV GROWTH DIFFER, V37, P581; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Turtle ED, 2004, EXPERT OPIN THER PAT, V14, P1185, DOI 10.1517/13543776.14.8.1185; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	44	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38932	38938		10.1074/jbc.M111.274944	http://dx.doi.org/10.1074/jbc.M111.274944			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940633	Green Published, hybrid			2022-12-25	WOS:000296759800012
J	Hoshino, M; Uesugi, K; Yagi, N; Mohri, S; Regini, J; Pierscionek, B				Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto; Mohri, Satoshi; Regini, Justyn; Pierscionek, Barbara			Optical Properties of In Situ Eye Lenses Measured with X-Ray Talbot Interferometry: A Novel Measure of Growth Processes	PLOS ONE			English	Article							REFRACTIVE-INDEX DISTRIBUTION; AGE-RELATED-CHANGES; WATER-CONTENT; CRYSTALLINE LENS; GRADIENT	The lens, a major optical component of the eye, has a gradient refractive index, which is required to provide sufficient refractive power and image quality. The refractive index variations across the lens are dependent on the distributions and concentrations of the varying protein classes. In this study, we present the first measurements of the refractive index in the in situ eye lens from five species using a specially constructed X-ray Talbot grating interferometer. The measurements have been conducted in two planes: the one containing the optic axis (the sagittal plane) and the plane orthogonal to this (the equatorial plane). The results show previously undetected discontinuities and fluctuations in the refractive index profile that vary in different species. These may be linked to growth processes and may be the first optical evidence of discrete developmental stages.	[Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto] Japan Synchrotron Radiat Res Inst SPring8, Sayo, Hyogo, Japan; [Mohri, Satoshi] Kawasaki Med Sch, Okayama, Japan; [Regini, Justyn] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Pierscionek, Barbara] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Japan Synchrotron Radiation Research Institute; Kawasaki Medical School; Cardiff University; Ulster University	Hoshino, M (corresponding author), Japan Synchrotron Radiat Res Inst SPring8, Sayo, Hyogo, Japan.	b.pierscionek@ulster.ac.uk	Pierscionek, Barbara/AAK-5760-2021	Hoshino, Masato/0000-0002-4167-2706; Regini, Justyn/0000-0001-6149-5893				AXELROD D, 1988, VISION RES, V28, P57, DOI 10.1016/S0042-6989(88)80006-3; BARER R, 1954, Q J MICROSC SCI, V95, P399; BOURS J, 1987, OPHTHALMIC RES, V19, P235, DOI 10.1159/000265500; CAMPBELL MCW, 1981, VISION RES, V21, P1129, DOI 10.1016/0042-6989(81)90016-X; CAMPBELL MCW, 1984, VISION RES, V24, P409, DOI 10.1016/0042-6989(84)90039-7; CHAN DYC, 1988, APPL OPTICS, V27, P926, DOI 10.1364/AO.27.000926; CHU PL, 1977, ELECTRON LETT, V13, P736, DOI 10.1049/el:19770520; FAGERHOLM PP, 1981, EXP EYE RES, V33, P615, DOI 10.1016/S0014-4835(81)80101-7; FISHER RF, 1973, J PHYSIOL-LONDON, V234, P443, DOI 10.1113/jphysiol.1973.sp010353; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hoshino M, 2010, AIP CONF PROC, V1266, P57, DOI 10.1063/1.3478199; Huggert A., 1948, ACTA OPHTHALMOL    S, V30, P1; HUIZINGA A, 1989, EXP EYE RES, V48, P487, DOI 10.1016/0014-4835(89)90032-8; JAGGER WS, 1992, VISION RES, V32, P1271, DOI 10.1016/0042-6989(92)90222-5; Jones CE, 2004, MAGN RESON IMAGING, V22, P211, DOI 10.1016/j.mri.2003.07.005; Keenan J, 2009, PROTEOMICS, V9, P5340, DOI 10.1002/pmic.200800986; KORETZ JF, 1994, VISION RES, V34, P2955, DOI 10.1016/0042-6989(94)90267-4; KROGER RHH, 1994, VISION RES, V34, P1815, DOI 10.1016/0042-6989(94)90306-9; LAHM D, 1985, INVEST OPHTH VIS SCI, V26, P1162; Matthiessen L, 1880, ARCH GESAMTE PHYSIOL, V21, P287, DOI [10.1007/BF01637009, DOI 10.1007/BF01637009]; Moffat BA, 2002, VISION RES, V42, P1683, DOI 10.1016/S0042-6989(02)00078-0; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Morner CT, 1893, Z PHYSL CHEM, V18, P61; NAKAO S, 1968, J OPT SOC AM, V58, P1125, DOI 10.1364/JOSA.58.001125; PALMER DA, 1981, J OPT SOC AM, V71, P780, DOI 10.1364/JOSA.71.000780; PIERSCIONEK B, 1987, VISION RES, V27, P1539, DOI 10.1016/0042-6989(87)90162-3; Pierscionek B K, 1995, J Am Optom Assoc, V66, P739; PIERSCIONEK BK, 1989, OPTOMETRY VISION SCI, V66, P822, DOI 10.1097/00006324-198912000-00004; Pierscionek BK, 2005, EYE, V19, P375, DOI 10.1038/sj.eye.6701525; Pierscionek BK, 1995, EYE, V9, P776, DOI 10.1038/eye.1995.194; PIERSCIONEK BK, 1989, VISION RES, V29, P1759, DOI 10.1016/0042-6989(89)90158-2; Pierscionek BK, 1997, EXP EYE RES, V64, P887, DOI 10.1006/exer.1996.0252; Pierscionek BK, 2009, HDB OPTICS, VIII, P191	34	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25140	10.1371/journal.pone.0025140	http://dx.doi.org/10.1371/journal.pone.0025140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949870	Green Accepted, gold, Green Published			2022-12-25	WOS:000295260400051
J	Kennedy, PG; Higgins, LM; Rogers, RH; Weber, MG				Kennedy, Peter G.; Higgins, Logan M.; Rogers, Rachel H.; Weber, Marjorie G.			Colonization-Competition Tradeoffs as a Mechanism Driving Successional Dynamics in Ectomycorrhizal Fungal Communities	PLOS ONE			English	Article							MYCELIAL SYSTEMS; TIME; SPORES	Colonization-competition tradeoffs have been shown to be important determinants of succession in plant and animal communities, but their role in ectomycorrhizal (ECM) fungal communities is not well understood. To experimentally examine whether strong spore-based competitors remain dominant on plant root tips as competition shifts to mycelial-based interactions, we investigated the mycelial competitive interactions among three naturally co-occurring ECM species (Rhizopogon occidentalis, R. salebrosus, and Suillus pungens). Each species was grown alone and in all pair-wise combinations on P. muricata seedlings in experimental microcosms and culture assays. Competitive outcomes were assessed from ECM root tip colonization, soil mycelial abundance, and mycelial growth in culture. In the microcosm experiment, we observed a clear competitive hierarchy of R. salebrosus>R. occidentalis>S. pungens. Competitive effects were also apparent in the culture assays, however, no similar hierarchy was present. These results contrast with our previous findings from spore-based competition, suggesting that ECM competitive outcomes can be life-stage dependent. The differing competitive abilities observed here also showed general correspondence with patterns of ECM succession in Pinus muricata forests, indicating that competitive interactions may significantly influence temporal patterns of ECM community structure.	[Kennedy, Peter G.; Higgins, Logan M.; Rogers, Rachel H.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; [Weber, Marjorie G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Cornell University	Kennedy, PG (corresponding author), Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA.	pkennedy@lclark.edu	Rogers, Rachel/GVT-5579-2022		Lewis Clark College; National Science Foundation [DEB-0742696, DEB-1020735]; Division Of Environmental Biology [0742696] Funding Source: National Science Foundation	Lewis Clark College; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this project was provided by Lewis & Clark College and the National Science Foundation (DEB-0742696 to P.G. Kennedy and T. Bruns and DEB-1020735 to P.G. Kennedy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; Bidartondo MI, 2005, FUNGAL COMMUNITY ITS, P215; Bio-Rad, 2005, REAL TIM PCR APPL GU; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cowles H.C., 1899, BOT GAZ, V27, P95, DOI [DOI 10.1086/327796, 10.1086/327796]; Deacon J. W., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P249; DEBAUD JC, 1999, MYCORRHIZA, P75; Donnelly DP, 2004, MYCORRHIZA, V14, P37, DOI 10.1007/s00572-003-0275-0; Fierer N, 2010, RES MICROBIOL, V161, P635, DOI [10.1016/J.resmic.2010.06.002, 10.1016/j.resmic.2010.06.002]; FLEMING LV, 1985, SOIL BIOL BIOCHEM, V17, P591, DOI 10.1016/0038-0717(85)90034-3; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gardes M, 1996, CAN J BOT, V74, P1572, DOI 10.1139/b96-190; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Hortal S, 2008, MYCORRHIZA, V18, P69, DOI 10.1007/s00572-007-0160-3; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Jumpponen A, 2002, MYCORRHIZA, V12, P43, DOI 10.1007/s00572-001-0152-7; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kennedy PG, 2007, J ECOL, V95, P1338, DOI 10.1111/j.1365-2745.2007.01306.x; Kennedy PG, 2007, MOL ECOL, V16, P881, DOI 10.1111/j.1365-294X.2006.03191.x; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Nara K, 2003, NEW PHYTOL, V159, P743, DOI 10.1046/j.1469-8137.2003.00844.x; Nara K, 2003, NEW PHYTOL, V158, P193, DOI 10.1046/j.1469-8137.2003.00724.x; New TR, 2008, J INSECT CONSERV, V12, P307, DOI 10.1007/s10841-008-9155-4; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2011, FUNGAL ECOL, V4, P233, DOI 10.1016/j.funeco.2010.09.010; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Taylor Andy F. S., 2005, Mycologist, V19, P102, DOI 10.1017/S0269915X05003034; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Townsend C, 2008, ECOLOGICAL APPL; Townsend C., 2008, ESSENTIALS ECOLOGY, P281; Twieg BD, 2007, NEW PHYTOL, V176, P437, DOI 10.1111/j.1469-8137.2007.02173.x; Wu B, 1999, MYCORRHIZA, V9, P151, DOI 10.1007/s005720050300	38	50	52	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25126	10.1371/journal.pone.0025126	http://dx.doi.org/10.1371/journal.pone.0025126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949867	Green Submitted, gold, Green Published			2022-12-25	WOS:000295257900052
J	Kohn-Luque, A; de Back, W; Starruss, J; Mattiotti, A; Deutsch, A; Perez-Pomares, JM; Herrero, MA				Koehn-Luque, Alvaro; de Back, Walter; Starruss, Joern; Mattiotti, Andrea; Deutsch, Andreas; Maria Perez-Pomares, Jose; Herrero, Miguel A.			Early Embryonic Vascular Patterning by Matrix-Mediated Paracrine Signalling: A Mathematical Model Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO VASCULOGENESIS; EXTRACELLULAR-MATRIX; FACTOR VEGF; FRACTAL PARAMETERS; EXPRESSION; RECEPTOR; BINDING; FLK-1; MORPHOGENESIS	During embryonic vasculogenesis, endothelial precursor cells of mesodermal origin known as angioblasts assemble into a characteristic network pattern. Although a considerable amount of markers and signals involved in this process have been identified, the mechanisms underlying the coalescence of angioblasts into this reticular pattern remain unclear. Various recent studies hypothesize that autocrine regulation of the chemoattractant vascular endothelial growth factor (VEGF) is responsible for the formation of vascular networks in vitro. However, the autocrine regulation hypothesis does not fit well with reported data on in vivo early vascular development. In this study, we propose a mathematical model based on the alternative assumption that endodermal VEGF signalling activity, having a paracrine effect on adjacent angioblasts, is mediated by its binding to the extracellular matrix (ECM). Detailed morphometric analysis of simulated networks and images obtained from in vivo quail embryos reveals the model mimics the vascular patterns with high accuracy. These results show that paracrine signalling can result in the formation of fine-grained cellular networks when mediated by angioblast-produced ECM. This lends additional support to the theory that patterning during early vascular development in the vertebrate embryo is regulated by paracrine signalling.	[Koehn-Luque, Alvaro; Herrero, Miguel A.] Univ Complutense Madrid, Fac Math, Dept Appl Math, Madrid, Spain; [Koehn-Luque, Alvaro; Herrero, Miguel A.] Univ Complutense Madrid, Fac Math, Inst Interdisciplinary Math, Madrid, Spain; [de Back, Walter; Starruss, Joern; Deutsch, Andreas] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Mattiotti, Andrea; Maria Perez-Pomares, Jose] Univ Malaga, Cardiovasc Dev & Angiogenesis Lab, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain	Complutense University of Madrid; Complutense University of Madrid; Technische Universitat Dresden; Universidad de Malaga	Kohn-Luque, A (corresponding author), Univ Complutense Madrid, Fac Math, Dept Appl Math, Madrid, Spain.	Miguel_Herrero@mat.ucm.es	Köhn-Luque, Alvaro/AAC-6747-2021; Perez-Pomares, Jose/G-7885-2015	Perez-Pomares, Jose/0000-0001-5487-7252; de Back, Walter/0000-0003-4641-8472; Kohn-Luque, Alvaro/0000-0002-5192-5199; Starruss, Jorn/0000-0003-3649-2433	Spanish Ministry of Education; Spanish Ministry of Science and Innovation [BFU2009-07929]; Junta de Andalucia [P08-CTS-03618]; Human Frontier Science Program (HFSP); BMBF;  [MTM2008-01867]	Spanish Ministry of Education(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Human Frontier Science Program (HFSP)(Human Frontier Science Program); BMBF(Federal Ministry of Education & Research (BMBF)); 	AKL and MAH have been partially supported by Spanish grant MTM2008-01867 (www.micinn.es). AKL is grateful to the FPU fellowship program funded by the Spanish Ministry of Education (www.educacion.es). MAH received no additional external funding for this study. JMPP's research is funded by grants BFU2009-07929 (Spanish Ministry of Science and Innovation, www.micinn.es), P08-CTS-03618 (Junta de Andalucia, www.juntadeandalucia.es) and the cooperative research networks TERCEL and RECAVA (ISCIII, www.isciii.es). AD is a member of the DFG Research Center for Regenerative Therapies Dresden -Cluster of Excellence-(www.crt-dresden.de) and gratefully acknowledges support by the Center. AD also acknowledges a research grant of the Human Frontier Science Program (HFSP, www.hfsp.org) and support by the BMBF through its Virtual Liver program (www.bmbf.de/en/1140.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi D., 2005, COMPUT MATH METHOD M, V6, P1, DOI DOI 10.1080/1027366042000327098; Argraves WS, 2005, ANAT REC PART A, V286A, P875, DOI 10.1002/ar.a.20232; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; BREIER G, 1992, DEVELOPMENT, V114, P521; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Cleaver O., 2010, HEART DEV REGENERATI, DOI [10.1016/B978-0-12-381332-9.00023-2, DOI 10.1016/B978-0-12-381332-9.00023-2]; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Drake CJ, 2000, DEV BIOL, V224, P178, DOI 10.1006/dbio.2000.9744; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FLAMME I, 1995, DEV BIOL, V169, P699, DOI 10.1006/dbio.1995.1180; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Gamba A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118101; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; Guidolin D, 2004, LEUKEMIA, V18, P1745, DOI 10.1038/sj.leu.2403526; Guidolin D, 2004, MICROVASC RES, V67, P117, DOI 10.1016/j.mvr.2003.11.002; Herrero MA, 2009, MATH MOD METH APPL S, V19, P1483, DOI 10.1142/S021820250900384X; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Karperien A, FRACLAC IMAGEJ VERSI, V2; Kirchner LM, 1996, MICROVASC RES, V51, P2, DOI 10.1006/mvre.1996.0002; Lai LH, 2003, DEVELOPMENT, V130, P6465, DOI 10.1242/dev.00887; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Mancardi D, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-12; Manoussaki D, 1996, ACTA BIOTHEOR, V44, P271, DOI 10.1007/BF00046533; Meinhardt H, 1997, INT J BIFURCAT CHAOS, V7, P1, DOI 10.1142/S0218127497000029; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Merks RMH, 2006, DEV BIOL, V289, P44, DOI 10.1016/j.ydbio.2005.10.003; Merks RMH, 2004, LECT NOTES COMPUT SC, V3305, P425; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Miura T, 2009, MATH MODEL NAT PHENO, V4, P118, DOI 10.1051/mmnp/20094404; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nico B, 2001, HISTOCHEM J, V33, P283, DOI 10.1023/A:1017977007479; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Poole TJ, 2001, DEV DYNAM, V220, P1, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1087>3.0.CO;2-2; Rasband W, IMAGEJ; RISAU W, 1988, DEV BIOL, V125, P441, DOI 10.1016/0012-1606(88)90225-4; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Robins V, 2002, LECT NOTES PHYS, V600, P261; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; SOKER S, 1993, J BIOL CHEM, V268, P7685; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Szabo A, 2008, BIOPHYS J, V95, P2702, DOI 10.1529/biophysj.108.129668; Szabo A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038102; Tolle CR, 2008, PHYSICA D, V237, P306, DOI 10.1016/j.physd.2007.09.017; Tosin A, 2006, B MATH BIOL, V68, P1819, DOI 10.1007/s11538-006-9071-2; Vokes SA, 2002, DEVELOPMENT, V129, P775; Volin MV, 1998, BIOCHEM BIOPH RES CO, V242, P46, DOI 10.1006/bbrc.1997.7890; WATT SM, 1995, LEUKEMIA LYMPHOMA, V17, P229, DOI 10.3109/10428199509056827; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Wolpert L., 2011, PRINCIPLES DEV; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Zajac M, 2003, J THEOR BIOL, V222, P247, DOI 10.1016/S0022-5193(03)00033-X; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	63	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24175	10.1371/journal.pone.0024175	http://dx.doi.org/10.1371/journal.pone.0024175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949696	Green Published, Green Submitted, gold			2022-12-25	WOS:000295257900006
J	Prabakaran, T; Nielsen, R; Larsen, JV; Sorensen, SS; Feldt-Rasmussen, U; Saleem, MA; Petersen, CM; Verroust, PJ; Christensen, EI				Prabakaran, Thaneas; Nielsen, Rikke; Larsen, Jakob V.; Sorensen, Soren S.; Feldt-Rasmussen, Ulla; Saleem, Moin A.; Petersen, Claus M.; Verroust, Pierre J.; Christensen, Erik I.			Receptor-Mediated Endocytosis of alpha-Galactosidase A in Human Podocytes in Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; GROWTH-FACTOR-II; AGALSIDASE-BETA THERAPY; HEYMANN NEPHRITIS; LYSOSOMAL-ENZYME; RENAL-FUNCTION; L-IDURONIDASE; RAT-KIDNEY; PROTEIN; MEGALIN	Injury to the glomerular podocyte is a key mechanism in human glomerular disease and podocyte repair is an important therapeutic target. In Fabry disease, podocyte injury is caused by the intracellular accumulation of globotriaosylceramide. This study identifies in the human podocyte three endocytic receptors, mannose 6-phosphate/insulin-like growth II receptor, megalin, and sortilin and demonstrates their drug delivery capabilities for enzyme replacement therapy. Sortilin, a novel alpha-galactosidase A binding protein, reveals a predominant intracellular expression but also surface expression in the podocyte. The present study provides the rationale for the renal effect of treatment with a-galactosidase A and identifies potential pathways for future non-carbohydrate based drug delivery to the kidney podocyte and other potential affected organs.	[Prabakaran, Thaneas; Nielsen, Rikke; Christensen, Erik I.] Aarhus Univ, Dept Anat, Sect Cell Biol, Aarhus, Denmark; [Larsen, Jakob V.; Petersen, Claus M.] Aarhus Univ, Dept Med Biochem, Aarhus, Denmark; [Sorensen, Soren S.] Rigshosp, Dept P, DK-2100 Copenhagen, Denmark; [Feldt-Rasmussen, Ulla] Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Saleem, Moin A.] Univ Bristol, Southmead Hosp, Childrens Renal Unit, Bristol, Avon, England; [Saleem, Moin A.] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol, Avon, England; [Verroust, Pierre J.] Inst Vis, UMRS 592, Paris, France	Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Southmead Hospital; University of Bristol; Southmead Hospital; University of Bristol; UDICE-French Research Universities; Sorbonne Universite	Prabakaran, T (corresponding author), Aarhus Univ, Dept Anat, Sect Cell Biol, Aarhus, Denmark.	eic@ana.au.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021; Prabakaran, Thaneas/K-3021-2019	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Saleem, Moin/0000-0002-9808-4518; Nielsen, Rikke/0000-0003-3105-3474; Prabakaran, Thaneas/0000-0002-4698-7563	Danish Medical Research Council; Novo Nordisk Foundation; Arvid Nilsson's Foundation; European Commission [201590]; Aarhus University; Genzyme Corporation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilsson's Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Aarhus University; Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	The work was supported in part by the Danish Medical Research Council, Novo Nordisk Foundation and Arvid Nilsson's Foundation, the European Commission EUNEFRON (FP7, GA#201590), Aarhus University, and Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; BRENNER BM, 1976, PHYSIOL REV, V56, P502, DOI 10.1152/physrev.1976.56.3.502; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2007, J AM SOC NEPHROL, V18, P698, DOI 10.1681/ASN.2006080822; COLLEY JR, 1958, BRIT MED J, V1, P1266, DOI 10.1136/bmj.1.5082.1266; Comte B, 2006, KIDNEY INT, V69, P1048, DOI 10.1038/sj.ki.5000133; CUI SY, 1993, KIDNEY INT, V43, P796, DOI 10.1038/ki.1993.113; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Desnick RJ, 2006, METABOLIC MOL BASES, P3733; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; Fervenza FC, 2008, BIOL-TARGETS THER, V2, P823; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GRONE HJ, 1990, KIDNEY INT, V37, P1449, DOI 10.1038/ki.1990.135; GUBLER MC, 1978, KIDNEY INT, V13, P223, DOI 10.1038/ki.1978.32; HASKELL JF, 1988, ENDOCRINOLOGY, V123, P774, DOI 10.1210/endo-123-2-774; HERS HG, 1965, GASTROENTEROLOGY, V48, P625; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; LeBowitz JH, 2004, P NATL ACAD SCI USA, V101, P3083, DOI 10.1073/pnas.0308728100; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Meehan SM, 2004, AM J KIDNEY DIS, V43, P164, DOI 10.1053/j.ajkd.2003.09.022; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Mehta A, 2009, LANCET, V374, P1986, DOI 10.1016/S0140-6736(09)61493-8; Meroni M, 1997, CONTRIB NEPHROL, V122, P178; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; Ojo A, 2000, TRANSPLANTATION, V69, P2337, DOI 10.1097/00007890-200006150-00020; OKA Y, 1985, J BIOL CHEM, V260, P9435; Oqvist B, 2009, NEPHROL DIAL TRANSPL, V24, P1736, DOI 10.1093/ndt/gfp105; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Prince WS, 2004, J BIOL CHEM, V279, P35037, DOI 10.1074/jbc.M402630200; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; SANDO GN, 1977, CELL, V12, P619, DOI 10.1016/0092-8674(77)90262-8; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Schiffmann R, 2007, J AM SOC NEPHROL, V18, P1576, DOI 10.1681/ASN.2006111263; Stefano JE, 2009, J CONTROL RELEASE, V135, P113, DOI 10.1016/j.jconrel.2008.12.006; STEFANSSON S, 1995, J BIOL CHEM, V270, P19417, DOI 10.1074/jbc.270.33.19417; Tauris J, 1998, FEBS LETT, V429, P27, DOI 10.1016/S0014-5793(98)00559-6; Thadhani R, 2002, KIDNEY INT, V61, P249, DOI 10.1046/j.1523-1755.2002.00097.x; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2008, AM J KIDNEY DIS, V51, P767, DOI 10.1053/j.ajkd.2007.12.032; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Verroust PJ, 2002, KIDNEY INT, V62, P745, DOI 10.1046/j.1523-1755.2002.00501.x; West M, 2009, J AM SOC NEPHROL, V20, P1132, DOI 10.1681/ASN.2008080870; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Yamazaki H, 2004, NEPHRON EXP NEPHROL, V96, pE52, DOI 10.1159/000076404	68	87	90	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25065	10.1371/journal.pone.0025065	http://dx.doi.org/10.1371/journal.pone.0025065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949853	Green Submitted, Green Published, gold			2022-12-25	WOS:000295257900047
J	Fontanillo, C; Nogales-Cadenas, R; Pascual-Montano, A; De Las Rivas, J				Fontanillo, Celia; Nogales-Cadenas, Ruben; Pascual-Montano, Alberto; De Las Rivas, Javier			Functional Analysis beyond Enrichment: Non-Redundant Reciprocal Linkage of Genes and Biological Terms	PLOS ONE			English	Article							VALIDATION; GENECODIS; NETWORKS; RESOURCE; LISTS	Functional analysis of large sets of genes and proteins is becoming more and more necessary with the increase of experimental biomolecular data at omic-scale. Enrichment analysis is by far the most popular available methodology to derive functional implications of sets of cooperating genes. The problem with these techniques relies in the redundancy of resulting information, that in most cases generate lots of trivial results with high risk to mask the reality of key biological events. We present and describe a computational method, called GeneTerm Linker, that filters and links enriched output data identifying sets of associated genes and terms, producing metagroups of coherent biological significance. The method uses fuzzy reciprocal linkage between genes and terms to unravel their functional convergence and associations. The algorithm is tested with a small set of well known interacting proteins from yeast and with a large collection of reference sets from three heterogeneous resources: multiprotein complexes (CORUM), cellular pathways (SGD) and human diseases (OMIM). Statistical Precision, Recall and balanced F-score are calculated showing robust results, even when different levels of random noise are included in the test sets. Although we could not find an equivalent method, we present a comparative analysis with a widely used method that combines enrichment and functional annotation clustering. A web application to use the method here proposed is provided at http://gtlinker.cnb.csic.es.	[Fontanillo, Celia; De Las Rivas, Javier] CSIC USAL, CiC IBMCC, Canc Res Ctr, Salamanca, Spain; [Nogales-Cadenas, Ruben; Pascual-Montano, Alberto] CSIC, CNB, Natl Biotechnol Ctr, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Fontanillo, C (corresponding author), CSIC USAL, CiC IBMCC, Canc Res Ctr, Campus Miguel de Unamuno, Salamanca, Spain.	jrivas@usal.es	De Las Rivas, Javier/G-5936-2014	De Las Rivas, Javier/0000-0002-0984-9946; Fontanillo, Celia/0000-0002-3631-7881	EU [223411]; Spanish Ministry of Science and Innovation MICINN-ISCiii [PI061153, PS09/00843]; Regional Government, Junta de Castilla y Leon JCyL [CSI07A09]; MICINN [BIO2010-17527]; Juan de la Cierva Program; CSIC JAE-PREDOC Program	EU(European Commission); Spanish Ministry of Science and Innovation MICINN-ISCiii(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government, Junta de Castilla y Leon JCyL(Junta de Castilla y Leon); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Juan de la Cierva Program; CSIC JAE-PREDOC Program	Dr. De Las Rivas receives financial support provided by EU FP7-HEALTH-2007-B (project 223411), by Spanish Ministry of Science and Innovation MICINN-ISCiii (projects PI061153 and PS09/00843), and by the Regional Government, Junta de Castilla y Leon JCyL (project CSI07A09). Dr. Pascual-Montano receives financial support provided by MICINN grant BIO2010-17527. Dr. Nogales-Cadenas thanks the Juan de la Cierva Program (MICINN-JDC 2010) and Dr. Fontanillo thanks the CSIC JAE-PREDOC Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves R, 2010, BRIEF BIOINFORM, V11, P210, DOI 10.1093/bib/bbp042; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Dalton L, 2009, CURR GENOMICS, V10, P430, DOI 10.2174/138920209789177601; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; GUPTA T, 1990, INT J PROD RES, V28, P1247, DOI 10.1080/00207549008942791; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Llewellyn R, 2008, P NATL ACAD SCI USA, V105, P17700, DOI 10.1073/pnas.0809583105; Medrano-Soto A, 2008, TRENDS GENET, V24, P587, DOI 10.1016/j.tig.2008.10.001; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toivonen H, 1995, ECML 95 WORKSH STAT, P47	24	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24289	10.1371/journal.pone.0024289	http://dx.doi.org/10.1371/journal.pone.0024289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949701	Green Published, gold			2022-12-25	WOS:000295173800015
J	Parrott, BB; Chiang, YT; Hudson, A; Sarkar, A; Guichet, A; Schulz, C				Parrott, Benjamin B.; Chiang, Yuting; Hudson, Alicia; Sarkar, Angshuman; Guichet, Antoine; Schulz, Cordula			Nucleoporin98-96 Function Is Required for Transit Amplification Divisions in the Germ Line of Drosophila melanogaster	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; CELL SELF-RENEWAL; BAG-OF-MARBLES; GENE-EXPRESSION; PROLIFERATION; ACTIVATION; PROTEINS; SIGNAL	Production of specialized cells from precursors depends on a tightly regulated sequence of proliferation and differentiation steps. In the gonad of Drosophila melanogaster, the daughters of germ line stem cells (GSC) go through precisely four rounds of transit amplification divisions to produce clusters of 16 interconnected germ line cells before entering a stereotypic differentiation cascade. Here we show that animals harbouring a transposon insertion in the center of the complex nucleoporin98-96 (nup98-96) locus had severe defects in the early steps of this developmental program, ultimately leading to germ cell loss and sterility. A phenotypic analysis indicated that flies carrying the transposon insertion, designated nup98-96(2288), had dramatically reduced numbers of germ line cells. In contrast to controls, mutant testes contained many solitary germ line cells that had committed to differentiation as well as abnormally small clusters of two, four or eight differentiating germ line cells. This indicates that mutant GSCs rather differentiated than self-renewed, and that these GSCs and their daughters initiated the differentiation cascade after zero, or less than four rounds of amplification divisions. This phenotype remained unaffected by hyper-activation of signalling pathways that normally result in excessive proliferation of GSCs and their daughters. Expression of wildtype nup98-96 specifically in the germ line cells of mutant animals fully restored development of the GSC lineage, demonstrating that the effect of the mutation is cell-autonomous. Nucleoporins are the structural components of the nucleopore and have also been implicated in transcriptional regulation of specific target genes. The nuclear envelopes of germ cells and general nucleocytoplasmic transport in nup98-96 mutant animals appeared normal, leading us to propose that Drosophila nup98-96 mediates the transport or transcription of targets required for the developmental timing between amplification and differentiation.	[Parrott, Benjamin B.; Hudson, Alicia; Schulz, Cordula] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Chiang, Yuting] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Guichet, Antoine] Inst Jacques Monod, Equipe Polarite & Morphogenese, F-75251 Paris, France	University System of Georgia; University of Georgia; Harvard University; UDICE-French Research Universities; Universite Paris Cite	Parrott, BB (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	cschulz@uga.edu			American Foundation for Aging Research; NSF [0841419]; Cold Spring Harbor Laboratory; University of Georgia; Direct For Biological Sciences [0841419] Funding Source: National Science Foundation	American Foundation for Aging Research; NSF(National Science Foundation (NSF)); Cold Spring Harbor Laboratory; University of Georgia; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a fellowship from the American Foundation for Aging Research (www.ncsu.edu/project/afar) awarded to BBP, an NSF grant given to CS (NSF grant #0841419, www.nsf.gov), private funds from Cold Spring Harbor Laboratory given to CS, and start-up funds from the University of Georgia given to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SA, 2001, GENOME BIOL, V2; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Faria AMC, 2006, IMMUNITY, V24, P295, DOI 10.1016/j.immuni.2006.01.014; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fuller Margaret T., 1993, P71; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Gilbert SF, 2006, DEV BIOL; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; Jones DL, 2004, HDB STEM CELLS, P171; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; LIN HF, 1994, DEVELOPMENT, V120, P947; Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7; Matunis E, 1997, DEVELOPMENT, V124, P4383; McKearin DM, 1990, GENE DEV, V4; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rizzo Elizete, 1993, European Archives of Biology, V104, P1; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Schulz C, 2002, DEVELOPMENT, V129, P4523; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; WENTE SR, 1994, J CELL BIOL, V125, P955, DOI 10.1083/jcb.125.5.955; Zhang YL, 2005, PLANT CELL, V17, P1306, DOI 10.1105/tpc.104.029926	38	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25087	10.1371/journal.pone.0025087	http://dx.doi.org/10.1371/journal.pone.0025087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949861	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800064
J	Gerald, NJ; Majam, V; Mahajan, B; Kozakai, Y; Kumar, S				Gerald, Noel J.; Majam, Victoria; Mahajan, Babita; Kozakai, Yukiko; Kumar, Sanjai			Protection from Experimental Cerebral Malaria with a Single Dose of Radiation-Attenuated, Blood-Stage Plasmodium berghei Parasites	PLOS ONE			English	Article							FALCIPARUM MALARIA; LIVER STAGE; IMMUNITY; VACCINE; BRAIN; MICE; SPOROZOITES; CELLS; ACCUMULATION; IMMUNIZATION	Background: Whole malaria parasites are highly effective in inducing immunity against malaria. Due to the limited success of subunit based vaccines in clinical studies, there has been a renewed interest in whole parasite-based malaria vaccines. Apart from attenuated sporozoites, there have also been efforts to use live asexual stage parasites as vaccine immunogens. Methodology and Results: We used radiation exposure to attenuate the highly virulent asexual blood stages of the murine malaria parasite P. berghei to a non-replicable, avirulent form. We tested the ability of the attenuated blood stage parasites to induce immunity to parasitemia and the symptoms of severe malaria disease. Depending on the mouse genetic background, a single high dose immunization without adjuvant protected mice from parasitemia and severe disease (CD1 mice) or from experimental cerebral malaria (ECM) (C57BL/6 mice). A low dose immunization did not protect against parasitemia or severe disease in either model after one or two immunizations. The protection from ECM was associated with a parasite specific antibody response and also with a lower level of splenic parasite-specific IFN-gamma production, which is a mediator of ECM pathology in C57BL/6 mice. Surprisingly, there was no difference in the sequestration of CD8+ T cells and CD45+ CD11b+ macrophages in the brains of immunized, ECM-protected mice. Conclusions: This report further demonstrates the effectiveness of a whole parasite blood-stage vaccine in inducing immunity to malaria and explicitly demonstrates its effectiveness against ECM, the most pathogenic consequence of malaria infection. This experimental model will be important to explore the formulation of whole parasite blood-stage vaccines against malaria and to investigate the immune mechanisms that mediate protection against parasitemia and cerebral malaria.	[Gerald, Noel J.; Majam, Victoria; Mahajan, Babita; Kozakai, Yukiko; Kumar, Sanjai] US FDA, Div Emerging Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Gerald, NJ (corresponding author), US FDA, Div Emerging Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	sanjai.kumar@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by intramural funding from the Food and Drug Administration and no external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALY AS, 2010, CELL MICROBIOL; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Augustine AD, 2009, NAT IMMUNOL, V10, P673, DOI 10.1038/ni0709-673; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; CURFS JHAJ, 1992, PARASITOLOGY, V105, P7, DOI 10.1017/S0031182000073625; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Elliott SR, 2005, INFECT IMMUN, V73, P2478, DOI 10.1128/IAI.73.4.2478-2485.2005; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Good MF, 2009, EUR J IMMUNOL, V39, P939, DOI 10.1002/eji.200939390; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HUGHES HPA, 1980, ANN TROP MED PARASIT, V74, P115, DOI 10.1080/00034983.1980.11687321; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Mahajan B, 2010, INFECT IMMUN, V78, P4613, DOI 10.1128/IAI.00533-10; MCCARTHY JS, 2010, HUM VACCIN, V6; Mikolajczak SA, 2007, CURR OPIN INFECT DIS, V20, P461, DOI 10.1097/QCO.0b013e3282ef6172; Mitchell AJ, 2005, INFECT IMMUN, V73, P5645, DOI 10.1128/IAI.73.9.5645-5653.2005; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Oakley MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006793; Pais TF, 2005, J NEUROIMMUNOL, V163, P73, DOI 10.1016/j.jneuroim.2005.02.009; Pinzon-Charry A, 2008, EXPERT OPIN BIOL TH, V8, P441, DOI [10.1517/14712598.8.4.441, 10.1517/14712598.8.4.441 ]; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Purcell LA, 2008, VACCINE, V26, P4880, DOI 10.1016/j.vaccine.2008.07.017; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; SUDAN EH, 1969, MIL MED, V134, P1165; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vanderberg JP, 2009, VACCINE, V27, P2, DOI 10.1016/j.vaccine.2008.10.028; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Wellde B T, 1979, Bull World Health Organ, V57 Suppl 1, P153; WELLDE BT, 1967, EXP PARASITOL, V21, P310, DOI 10.1016/0014-4894(67)90091-4	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24398	10.1371/journal.pone.0024398	http://dx.doi.org/10.1371/journal.pone.0024398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935405	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700030
J	Price, CF; Tyssen, D; Sonza, S; Davie, A; Evans, S; Lewis, GR; Xia, S; Spelman, T; Hodsman, P; Moench, TR; Humberstone, A; Paull, JRA; Tachedjian, G				Price, Clare F.; Tyssen, David; Sonza, Secondo; Davie, Ashley; Evans, Sonya; Lewis, Gareth R.; Xia, Shirley; Spelman, Tim; Hodsman, Peter; Moench, Thomas R.; Humberstone, Andrew; Paull, Jeremy R. A.; Tachedjian, Gilda			SPL7013 Gel (VivaGel (R)) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans	PLOS ONE			English	Article							SIMPLEX-VIRUS INFECTION; CANDIDATE TOPICAL MICROBICIDES; CERVICOVAGINAL SECRETIONS; CONTROLLED-TRIAL; EXPLANT CULTURE; SEMINAL PLASMA; DOUBLE-BLIND; IN-VITRO; LOW PH; PREVENTION	SPL7013 Gel (VivaGel (R)) is a microbicide in development for prevention of HIV and HSV. This clinical study assessed retention and duration of antiviral activity following vaginal administration of 3% SPL7013 Gel in healthy women. Participants received 5 single doses of product with >= 5 days between doses. A cervicovaginal fluid (CVF) sample was collected using a SoftCup (TM) pre-dose, and immediately, or 1, 3, 12 or 24 h post-dose. HIV-1 and HSV-2 antiviral activities of CVF samples were determined in cell culture assays. Antiviral activity in the presence of seminal plasma was also tested. Mass and concentration of SPL7013 in CVF samples was determined. Safety was assessed by reporting of adverse events. Statistical analysis was performed using the Wilcoxon signed-rank test with Bonferroni adjustment; p <= 0.003 was significant. Eleven participants completed the study. Inhibition of HIV-1 and HSV-2 by pre-dose CVF samples was negligible. CVF samples obtained immediately after dosing almost completely inhibited (median, interquartile range) HIV-1 [96% (95,97)] and HSV-2 [86% (85,94)], and activity was maintained in all women at 3 h (HIV-1 [ 96% (95,98), p = 0.9]; HSV-2 [94% (91,97), p = 0.005]). At 24 h, >90% of initial HIV-1 and HSV-2 inhibition was maintained in 6/11 women. SPL7013 was recovered in CVF samples obtained at baseline (46% of 105 mg dose). At 3 and 24 h, 22 mg and 4 mg SPL7013, respectively, were recovered. More than 70% inhibition of HIV-1 and HSV-2 was observed if there was >0.5 mg SPL7013 in CVF samples. High levels of antiviral activity were retained in the presence of seminal plasma. VivaGel was well tolerated with no signs or symptoms of vaginal, vulvar or cervical irritation reported. Potent antiviral activity was observed against HIV-1 and HSV-2 immediately following vaginal administration of VivaGel, with activity maintained for at least 3 h post-dose. The data provide evidence of antiviral activity in a clinical setting, and suggest VivaGel could be administered up to 3 h before coitus.	[Price, Clare F.; Davie, Ashley; Evans, Sonya; Lewis, Gareth R.; Xia, Shirley; Paull, Jeremy R. A.] Starpharma Pty Ltd, Melbourne, Vic, Australia; [Tyssen, David; Sonza, Secondo; Tachedjian, Gilda] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Sonza, Secondo; Tachedjian, Gilda] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Hodsman, Peter; Humberstone, Andrew] Nucleus Network, Melbourne, Vic, Australia; [Moench, Thomas R.] ReProtect Inc, Baltimore, MD USA; [Tachedjian, Gilda] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia	Burnet Institute; Monash University; Burnet Institute; Monash University	Price, CF (corresponding author), Starpharma Pty Ltd, Melbourne, Vic, Australia.	clare.price@starpharma.com; gildat@burnet.edu.au	Tachedjian, Gilda/AAF-1327-2020	Tachedjian, Gilda/0000-0002-7733-7037; Paull, Jeremy/0000-0002-9981-421X	Starpharma Pty Ltd; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200500042C]; Burnet Institute	Starpharma Pty Ltd; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burnet Institute	The study was sponsored by Starpharma Pty Ltd. The study was funded in whole with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200500042C (http://www.niaid.nih.gov/). Representaives of NIAID, NIH, were directly involved with study design and interpretation of data, and the study protocol was reviewed by NIAID's Prevention Sciences Review Committee. Starpharma Pty Ltd was responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.; CFP, JRAP, SE, AD, GRL, and SX are either past or present employees of Starpharma Pty Ltd, which sponsored the study. At the time of the study PH and AH were employees of Nucleus Network, which was contracted by Starpharma Pty Ltd to conduct the study. GT and TRM were paid consultancy fees under contract to Starpharma Pty Ltd, and the Burnet Institute was contracted to perform the antiviral assays. TRM is the President and COO of ReProtect, Inc. "VivaGel" is Starpharma's lead product (http://www.starpharma.com/vivagel). These affiliations do not alter any authors' adherence to all PLoS ONE polices on sharing data and materials. The remaining authors declare that they have no conflicts of interest.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Bernstein DI, 2003, ANTIMICROB AGENTS CH, V47, P3784, DOI 10.1128/AAC.47.12.3784-3788.2003; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000; Chen MY, 2009, JAIDS-J ACQ IMM DEF, V50, P375, DOI 10.1097/QAI.0b013e318198a7e6; Connor RI, 2006, JAIDS-J ACQ IMM DEF, V43, P499, DOI 10.1097/01.qai.0000243048.50451.18; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; *DAIDS RSC, SAF PHARM; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Gong E, 2005, ANTIVIR RES, V68, P139, DOI 10.1016/j.antiviral.2005.08.004; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; John M, 2005, J INFECT DIS, V192, P1731, DOI 10.1086/497168; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Kashuba AD, 2010, 18 INT AIDS C VIENN; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; Lacey CJN, 2006, AIDS, V20, P1027, DOI 10.1097/01.aids.0000222075.83490.ca; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; McCarthy TD, 2005, MOL PHARMACEUT, V2, P312, DOI 10.1021/mp050023q; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; O'Loughlin J, 2010, SEX TRANSM DIS, V37, P100, DOI 10.1097/OLQ.0b013e3181bc0aac; OCONNOR TJ, 1995, INT J STD AIDS, V6, P267, DOI 10.1177/095646249500600409; Olmsted SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-79; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Patton DL, 2006, ANTIMICROB AGENTS CH, V50, P1696, DOI 10.1128/AAC.50.5.1696-1700.2006; Rupp R, 2007, INT J NANOMED, V2, P561; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Sonza S, 2009, ANTIMICROB AGENTS CH, V53, P3565, DOI 10.1128/AAC.00102-09; Tyssen D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012309; UNAIDS, 2008, REP GLOB AIDS EP	36	113	117	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24095	10.1371/journal.pone.0024095	http://dx.doi.org/10.1371/journal.pone.0024095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935377	gold, Green Published			2022-12-25	WOS:000295041700012
J	Nakano, TA; Steirer, LM; Moe, GR				Nakano, Taizo A.; Steirer, Lindsay M.; Moe, Gregory R.			The Expression Profile of De-N-acetyl Polysialic Acid (NeuPSA) in Normal and Diseased Human Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MENINGITIDIS GROUP-B; MONOCLONAL-ANTIBODIES; NERVOUS-SYSTEM; BRAIN; STX; PST; POLYSIALYLTRANSFERASES; LOCALIZATION; EPITOPES	Although sialic acids have a key role in many aspects of human biology, the expression of polysialic acid (PSA) in human tissues is thought to be relatively rare. We identified a derivative of PSA called neuraminic acid-containing PSA or NeuPSA that was highly expressed in primary human melanoma tumors and in several cancer cell lines. Moreover, anti-NeuPSA antibodies could induce apoptosis of cancer cells. However, little was known about NeuPSA expression in normal or diseased tissues. In this study we investigated the complete expression profile of NeuPSA in human tissues and a few primary tumors using the anti-NeuPSA monoclonal antibody, SEAM 3. Almost every human tissue tested spanning a representative sample of all organ types was positive for SEAM 3 binding. Specificity of SEAM 3 binding was established by inhibition with NeuPSA but not closely related meningococcal C polysaccharide and loss of SEAM 3 binding when specimens were treated with periodate at high pH, which specifically destroys NeuPSA. Only subsets of cells in each specimen stained positive, and the relative staining between tissues was variable. The distribution and amount of NeuPSA antigen in tissues was correlated with known levels of polysialyltransferase PST or STX expression. The majority of anti-NeuPSA binding occurred intracellularly in the cytoplasm of cells. Tumors generally exhibited considerably increased staining compared with corresponding normal tissues. Identifying the diverse tissue distribution and intracellular location of NeuPSA provides a foundation for investigating the functional role of NeuPSA in human health and disease.	[Nakano, Taizo A.; Steirer, Lindsay M.; Moe, Gregory R.] Childrens Hosp Oakland Res Inst, Ctr Canc, Oakland, CA 94609 USA; [Moe, Gregory R.] Childrens Hosp Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Moe, GR (corresponding author), 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gmoe@chori.org			National Institutes of Health (NIAID) [AI064314]; National Institutes of Health NHLBI [5T32DK078514-09]; Swim Across America; Jennifer Leigh Wells Family; NATIONAL CANCER INSTITUTE [T32CA082086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064314, R56AI064314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK078514] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swim Across America; Jennifer Leigh Wells Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064314 (NIAID; to G. R. M.).; Supported in part by National Institutes of Health NHLBI T-32 Training Grant 5T32DK078514-09 and funds provided by Swim Across America and the Jennifer Leigh Wells Family.	ANDREWS RG, 1989, J EXP MED, V169, P1721, DOI 10.1084/jem.169.5.1721; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; BAUMHUETER S, 1994, BLOOD, V84, P2554; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Flitter BA, 2010, VACCINE, V28, P5967, DOI 10.1016/j.vaccine.2010.06.119; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; GIELEN W, 1967, H-S Z PHYSIOL CHEM, V348, P329, DOI 10.1515/bchm2.1967.348.1.329; Granoff DM, 1998, J IMMUNOL, V160, P5028; Iovannisci DM, 2010, J EUKARYOT MICROBIOL, V57, P405, DOI 10.1111/j.1550-7408.2010.00496.x; Kini U, 2005, DIAGN CYTOPATHOL, V33, P145, DOI 10.1002/dc.20271; KITAJIMA K, 1988, J BIOL CHEM, V263, P18269; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; MANZI AE, 1994, J BIOL CHEM, V269, P23617; Moe GR, 2006, MOL IMMUNOL, V43, P1424, DOI 10.1016/j.molimm.2005.07.033; Moe GR, 2005, INFECT IMMUN, V73, P2123, DOI 10.1128/IAI.73.4.2123-2128.2005; Moe GR, 2009, J IMMUNOL, V182, P6610, DOI 10.4049/jimmunol.0803677; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; PAERELS GB, 1965, BIOCHEM J, V96, P787, DOI 10.1042/bj0960787; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SEID R, 2003, Patent No. 6638513; Sonnenburg JL, 2002, J BIOL CHEM, V277, P17502, DOI 10.1074/jbc.M110867200; Steirer L. M., 2011, PLOS ONE IN PRESS; TROY FA, 1979, J BIOL CHEM, V254, P7377; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	30	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40343	40353		10.1074/jbc.M111.296046	http://dx.doi.org/10.1074/jbc.M111.296046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949236	Green Published, hybrid			2022-12-25	WOS:000296925700065
J	Aran, A; Lin, L; Finn, LA; Weiner, K; Peppard, P; Young, T; Mignot, E				Aran, Adi; Lin, Ling; Finn, Laurel Ann; Weiner, Karin; Peppard, Paul; Young, Terry; Mignot, Emmanuel			Post-Streptococcal Antibodies Are Associated with Metabolic Syndrome in a Population-Based Cohort	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; PLATELET-AGGREGATION; HUMAN OBESITY; INSULIN; CELLS; MICE; SECRETION; DIAGNOSIS	Background: Streptococcal infections are known to trigger autoimmune disorders, affecting millions worldwide. Recently, we found an association between post-streptococcal autoantibodies against Protein Disulphide Isomerase (PDI), an enzyme involved in insulin degradation and insulin resistance. This led us to evaluate associations between post-streptococcal antibodies and metabolic syndrome, as defined by the updated National Cholesterol Education Program definition, 2005. Methods and Findings: Metabolic data (HDL, triglycerides, fasting glucose, blood pressure, waist circumference, BMI, smoking), post-streptococcal antibodies (anti-Streptolysin O (ASO) and anti-PDI), and C-reactive protein (CRP, as a general inflammatory marker), were assessed in 1156 participants of the Wisconsin Sleep Cohort Study. Anti-PDI antibodies were found in 308 participants (26.6%), ASO >= 100 in 258 (22.3%), and 482 (41.7%) met diagnostic criteria for metabolic syndrome. Anti-PDI antibodies but not ASO were significantly associated with metabolic syndrome [n = 1156, OR 1.463 (95% CI 1.114, 1.920), p = 0.0062; adjusted for age, gender, education, smoking]. Importantly, the anti-PDI - metabolic syndrome association remained significant after adjusting for CRP and fasting insulin. Conclusions: Post-streptococcal anti-PDI antibodies are associated with metabolic syndrome regardless of fasting insulin and CRP levels. Whereas these data are in line with a growing body of evidence linking infections, immunity and metabolism, additional studies are necessary to establish the post-streptococcal - metabolic syndrome association.	[Aran, Adi; Lin, Ling; Weiner, Karin; Mignot, Emmanuel] Stanford Univ, Stanford, CA 94305 USA; [Finn, Laurel Ann; Peppard, Paul; Young, Terry] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA; [Aran, Adi] Shaare Zedek Med Ctr, Jerusalem, Israel	Stanford University; University of Wisconsin System; University of Wisconsin Madison; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Aran, A (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	mignot@stanford.edu		Aran, Adi/0000-0001-9460-4689	US National Institutes of Health [NS23724, MH73073435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, P50NS023724] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants NS23724, MH73073435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012875; Atkinson RL, 2007, MAYO CLIN PROC, V82, P1192, DOI 10.4065/82.10.1192; Blyth CC, 2006, PATHOLOGY, V38, P152, DOI 10.1080/00313020600557060; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Dhurandhar NV, 2004, DRUG NEWS PERSPECT, V17, P307, DOI 10.1358/dnp.2004.17.5.829034; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Essex DW, 1999, BRIT J HAEMATOL, V104, P448, DOI 10.1046/j.1365-2141.1999.01197.x; Essex DW, 1999, THROMB RES, V96, P445, DOI 10.1016/S0049-3848(99)00133-4; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; Raturi A, 2008, BBA-BIOMEMBRANES, V1778, P2790, DOI 10.1016/j.bbamem.2008.07.003; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Shah CM, 2007, NITRIC OXIDE-BIOL CH, V16, P135, DOI 10.1016/j.niox.2006.08.001; Versteeg HH, 2007, J BIOL CHEM, V282, P25416, DOI 10.1074/jbc.M702410200; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023	27	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25017	10.1371/journal.pone.0025017	http://dx.doi.org/10.1371/journal.pone.0025017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949836	Green Submitted, Green Published, gold			2022-12-25	WOS:000295260400036
J	Martin-Acebes, MA; Blazquez, AB; de Oya, NJ; Escribano-Romero, E; Saiz, JC				Martin-Acebes, Miguel A.; Blazquez, Ana-Belen; Jimenez de Oya, Nereida; Escribano-Romero, Estela; Saiz, Juan-Carlos			West Nile Virus Replication Requires Fatty Acid Synthesis but Is Independent on Phosphatidylinositol-4-Phosphate Lipids	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; UNFOLDED PROTEIN RESPONSE; VIRAL-RNA REPLICATION; MEMBRANE STRUCTURES; INFECTED CELLS; ENDOPLASMIC-RETICULUM; MULTILAMELLAR BODIES; SECRETORY PATHWAY; UNITED-STATES; III-ALPHA	West Nile virus (WNV) is a neurovirulent mosquito-borne flavivirus, which main natural hosts are birds but it also infects equines and humans, among other mammals. As in the case of other plus-stranded RNA viruses, WNV replication is associated to intracellular membrane rearrangements. Based on results obtained with a variety of viruses, different cellular processes have been shown to play important roles on these membrane rearrangements for efficient viral replication. As these processes are related to lipid metabolism, fatty acid synthesis, as well as generation of a specific lipid microenvironment enriched in phosphatidylinositol-4-phosphate (PI4P), has been associated to it in other viral models. In this study, intracellular membrane rearrangements following infection with a highly neurovirulent strain of WNV were addressed by means of electron and confocal microscopy. Infection of WNV, and specifically viral RNA replication, were dependent on fatty acid synthesis, as revealed by the inhibitory effect of cerulenin and C75, two pharmacological inhibitors of fatty acid synthase, a key enzyme of this process. However, WNV infection did not induce redistribution of PI4P lipids, and PI4P did not localize at viral replication complex. Even more, WNV multiplication was not inhibited by the use of the phosphatidylinositol-4-kinase inhibitor PIK93, while infection by the enterovirus Coxsackievirus B5 was reduced. Similar features were found when infection by other flavivirus, the Usutu virus (USUV), was analyzed. These features of WNV replication could help to design specific antiviral approaches against WNV and other related flaviviruses.	[Martin-Acebes, Miguel A.; Blazquez, Ana-Belen; Jimenez de Oya, Nereida; Escribano-Romero, Estela; Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain.	martin.mangel@inia.es	Jiménez de Oya, Nereida/K-8470-2016; Martin-Acebes, Miguel A./L-2258-2014; de Oya, Nereida Jiménez/ABZ-4365-2022; Escribano-Romero, Estela/H-1495-2015; Blazquez, Ana/G-9791-2015	Jiménez de Oya, Nereida/0000-0003-3129-813X; Martin-Acebes, Miguel A./0000-0001-6015-3613; Escribano-Romero, Estela/0000-0002-5036-7607; Blazquez, Ana/0000-0002-0847-0977; Saiz, Juan-Carlos/0000-0001-8269-5544	Salud, Alimentacion y Farmacia [(SAF)-2008-04232]; Interaccion Sanitaria Entre Fauna Silvestre y Ganaderia [FAU2008-00006]; Network of Animal Disease Infectiology and Research-European Union [NADIR-EU-228394]	Salud, Alimentacion y Farmacia; Interaccion Sanitaria Entre Fauna Silvestre y Ganaderia; Network of Animal Disease Infectiology and Research-European Union	This work was supported by grants Salud, Alimentacion y Farmacia (SAF)-2008-04232, Interaccion Sanitaria Entre Fauna Silvestre y Ganaderia FAU2008-00006, and the Network of Animal Disease Infectiology and Research-European Union NADIR-EU-228394. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; Anderson JF, 1999, SCIENCE, V286, P2331, DOI 10.1126/science.286.5448.2331; Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009; Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Deng Y, 2010, TRENDS CELL BIOL, V20, P371, DOI 10.1016/j.tcb.2010.04.001; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gimenez-Barcons M, 2005, J INTERF CYTOK RES, V25, P152, DOI 10.1089/jir.2005.25.152; GUINEA R, 1990, EMBO J, V9, P2011, DOI 10.1002/j.1460-2075.1990.tb08329.x; GUINEA R, 1991, VIROLOGY, V185, P473, DOI 10.1016/0042-6822(91)90802-I; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jimenez-Clavero MA, 2005, J GEN VIROL, V86, P1369, DOI 10.1099/vir.0.80669-0; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; KE PY, AUTOPHAGY, V7, P533; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lajoie P, 2005, J CELL SCI, V118, P1991, DOI 10.1242/jcs.02324; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lee WM, 2003, J VIROL, V77, P12819, DOI 10.1128/JVI.77.23.12819-12828.2003; Lee WM, 2001, J VIROL, V75, P2097, DOI 10.1128/JVI.75.5.2097-2106.2001; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Martin-Acebes MA, 2011, J GEN VIROL, V92, P831, DOI 10.1099/vir.0.027185-0; MCLEAN JE, 2011, J BIOL CHEM; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Pecorari M, 2009, EURO SURVEILL, V14; Rassmann A, 2007, ANTIVIR RES, V76, P150, DOI 10.1016/j.antiviral.2007.06.011; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Vazquez-Calvo A, 2011, J VIROL, V85, P1267, DOI 10.1128/JVI.01717-10; Wang X. M., 2011, J VIROL; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508	63	112	113	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24970	10.1371/journal.pone.0024970	http://dx.doi.org/10.1371/journal.pone.0024970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949814	gold, Green Submitted, Green Published			2022-12-25	WOS:000295260400025
J	Zuber, P; Chauhan, S; Pilaka, P; Nakano, MM; Gurumoorthy, S; Lin, AA; Barendt, SM; Chi, BK; Antelmann, H; Mader, U				Zuber, Peter; Chauhan, Shefali; Pilaka, Praseeda; Nakano, Michiko M.; Gurumoorthy, Sairam; Lin, Ann A.; Barendt, Skye M.; Bui Khanh Chi; Antelmann, Haike; Maeder, Ulrike			Phenotype Enhancement Screen of a Regulatory spx Mutant Unveils a Role for the ytpQ Gene in the Control of Iron Homeostasis	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL RESPONSE; (P)PPGPP SYNTHETASE GENES; RNA-POLYMERASE ALPHA; C-TERMINAL DOMAIN; BACILLUS-SUBTILIS; OXIDATIVE STRESS; CYSTEINE METABOLISM; NEGATIVE EFFECTOR; P-3 PROMOTER; PROTEIN	Spx is a global regulator of genes that are induced by disulfide stress in Bacillus subtilis. The regulon that it governs is comprised of over 120 genes based on microarray analysis, although it is not known how many of these are under direct Spx control. Most of the Spx-regulated genes (SRGs) are of unknown function, but many encode products that are conserved in low %GC Gram-positive bacteria. Using a gene-disruption library of B. subtilis genomic mutations, the SRGs were screened for phenotypes related to Spx-controlled activities, such as poor growth in minimal medium and sensitivity to methyglyoxal, but nearly all of the SRG mutations showed little if any phenotype. To uncover SRG function, the mutations were rescreened in an spx mutant background to determine which mutant SRG allele would enhance the spx mutant phenotype. One of the SRGs, ytpQ was the site of a mutation that, when combined with an spx null mutation, elevated the severity of the Spx mutant phenotype, as shown by reduced growth in a minimal medium and by hypersensitivity to methyglyoxal. The ytpQ mutant showed elevated oxidative protein damage when exposed to methylglyoxal, and reduced growth rate in liquid culture. Proteomic and transcriptomic data indicated that the ytpQ mutation caused the derepression of the Fur and PerR regulons of B. subtilis. Our study suggests that the ytpQ gene, encoding a conserved DUF1444 protein, functions directly or indirectly in iron homeostasis. The ytpQ mutant phenotype mimics that of a fur mutation, suggesting a condition of low cellular iron. In vitro transcription analysis indicated that Spx stimulates transcription from the ytpPQR operon within which the ytpQ gene resides. The work uncovers a link between Spx and control of iron homeostasis.	[Zuber, Peter; Chauhan, Shefali; Pilaka, Praseeda; Nakano, Michiko M.; Gurumoorthy, Sairam; Lin, Ann A.; Barendt, Skye M.] Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Inst Environm Hlth, Beaverton, OR USA; [Bui Khanh Chi; Antelmann, Haike] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Maeder, Ulrike] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany	Oregon Health & Science University; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Zuber, P (corresponding author), Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Inst Environm Hlth, Beaverton, OR USA.	pzuber@ebs.ogi.edu	Antelmann, Haike/I-3129-2019	Antelmann, Haike/0000-0002-1766-4386; Zuber, Peter/0000-0003-1757-7837; Nakano, Michiko/0000-0002-0635-8535	Deutsche Forschungsgemeinschaft [AN 746/2-1]; National Institutes of Health USA [GM045898]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045898] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Deutsche Forschungsgemeinschaft AN 746/2-1 to HA. GM045898 from the National Institutes of Health USA to PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Antelmann H, 2008, EXPERT REV PROTEOMIC, V5, P77, DOI 10.1586/14789450.5.1.77; Bergara F, 2003, J BACTERIOL, V185, P3118, DOI 10.1128/JB.185.10.3118-3126.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cao M, 2005, J BACTERIOL, V187, P2948, DOI 10.1128/JB.187.9.2948-2956.2005; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Choi SY, 2006, J BACTERIOL, V188, P5741, DOI 10.1128/JB.00443-06; Conway T, 2003, MOL MICROBIOL, V47, P879, DOI 10.1046/j.1365-2958.2003.03338.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; DUTCHER SK, 1989, CELL MOTIL CYTOSKEL, V14, P104, DOI 10.1002/cm.970140120; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; FOUET A, 1990, J BACTERIOL, V172, P5408, DOI 10.1128/jb.172.9.5408-5415.1990; FREDRICK KL, 1994, J BACTERIOL, V176, P2727, DOI 10.1128/JB.176.9.2727-2735.1994; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; Gray JV, 2009, ADV GENET, V66, P61, DOI 10.1016/S0065-2660(09)66003-X; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; HUFFAKER TC, 1987, ANNU REV GENET, V21, P259; Huyen NTT, 2009, MOL MICROBIOL, V71, P876, DOI 10.1111/j.1365-2958.2008.06568.x; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; JAMES SW, 1989, GENETICS, V122, P567; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kouwen TRHM, 2008, APPL ENVIRON MICROB, V74, P7536, DOI 10.1128/AEM.00894-08; Kurien BT, 2009, METHODS MOL BIOL, V536, P557, DOI [10.1007/978-1-59745-542-8_55, 10.1007/978-1-59745-542-8_56]; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Larsson JT, 2007, MOL MICROBIOL, V66, P669, DOI 10.1111/j.1365-2958.2007.05949.x; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Leelakriangsak M, 2007, J BACTERIOL, V189, P1727, DOI 10.1128/JB.01519-06; Leelakriangsak M, 2007, J BACTERIOL, V189, P1736, DOI 10.1128/JB.01520-06; Liu JJ, 1999, MOL MICROBIOL, V33, P415, DOI 10.1046/j.1365-2958.1999.01489.x; Liu JJ, 2000, MOL MICROBIOL, V37, P885, DOI 10.1046/j.1365-2958.2000.02053.x; LUX FG, 1991, GENETICS, V128, P549; MAJUMDAR D, 1991, BIOTECHNIQUES, V11, P94; MARQUEZ LM, 1990, J BACTERIOL, V172, P3435, DOI 10.1128/jb.172.6.3435-3443.1990; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Miethke M, 2006, J BACTERIOL, V188, P8655, DOI 10.1128/JB.01049-06; Morimoto T, 2009, GENES GENET SYST, V84, P253, DOI 10.1266/ggs.84.315; Mostertz J, 2008, PROTEOMICS, V8, P2676, DOI 10.1002/pmic.200701015; Nakano MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008664; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Nakano MM, 2000, MOL MICROBIOL, V37, P869, DOI 10.1046/j.1365-2958.2000.02052.x; NAKANO MM, 1988, J BACTERIOL, V170, P5662, DOI 10.1128/jb.170.12.5662-5668.1988; Nakano MM, 2002, MOL MICROBIOL, V44, P1341, DOI 10.1046/j.1365-2958.2002.02963.x; Nakano MM, 2001, MOL MICROBIOL, V42, P383, DOI 10.1046/j.1365-2958.2001.02639.x; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Natori Y, 2009, J BACTERIOL, V191, P4555, DOI 10.1128/JB.00263-09; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Petersohn A, 1999, MICROBIOL-UK, V145, P869, DOI 10.1099/13500872-145-4-869; Petersohn A, 1999, J BACTERIOL, V181, P5718, DOI 10.1128/JB.181.18.5718-5724.1999; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Reyes DY, 2008, MOL MICROBIOL, V69, P765, DOI 10.1111/j.1365-2958.2008.06330.x; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; STEARNS T, 1988, GENETICS, V119, P249; STULKE J, 1993, J GEN MICROBIOL, V139, P2041, DOI 10.1099/00221287-139-9-2041; Tam LT, 2006, PROTEOMICS, V6, P4565, DOI 10.1002/pmic.200600100; Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200; Thomaides HB, 2007, J BACTERIOL, V189, P591, DOI 10.1128/JB.01381-06; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Volker U, 1999, J BACTERIOL, V181, P3942; YANSURA DG, 1984, P NATL ACAD SCI-BIOL, V81, P439, DOI 10.1073/pnas.81.2.439; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	85	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25066	10.1371/journal.pone.0025066	http://dx.doi.org/10.1371/journal.pone.0025066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949854	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400045
J	Dinel, AL; Andre, C; Aubert, A; Ferreira, G; Laye, S; Castanon, N				Dinel, Anne-Laure; Andre, Caroline; Aubert, Agnes; Ferreira, Guillaume; Laye, Sophie; Castanon, Nathalie			Cognitive and Emotional Alterations Are Related to Hippocampal Inflammation in a Mouse Model of Metabolic Syndrome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SPATIAL MEMORY; INDOLEAMINE 2,3-DIOXYGENASE; PROINFLAMMATORY CYTOKINES; BEHAVIORAL DEPRESSION; OBJECT RECOGNITION; CALMETTE-GUERIN; TRANSGENIC MICE; MOOD DISORDERS; MESSENGER-RNA	Converging clinical data suggest that peripheral inflammation is likely involved in the pathogenesis of the neuropsychiatric symptoms associated with metabolic syndrome (MetS). However, the question arises as to whether the increased prevalence of behavioral alterations in MetS is also associated with central inflammation, i.e. cytokine activation, in brain areas particularly involved in controlling behavior. To answer this question, we measured in a mouse model of MetS, namely the diabetic and obese db/db mice, and in their healthy db/+ littermates emotional behaviors and memory performances, as well as plasma levels and brain expression (hippocampus; hypothalamus) of inflammatory cytokines. Our results shows that db/db mice displayed increased anxiety-like behaviors in the open-field and the elevated plus-maze (i.e. reduced percent of time spent in anxiogenic areas of each device), but not depressive-like behaviors as assessed by immobility time in the forced swim and tail suspension tests. Moreover, db/db mice displayed impaired spatial recognition memory (hippocampus-dependent task), but unaltered object recognition memory (hippocampus-independent task). In agreement with the well-established role of the hippocampus in anxiety-like behavior and spatial memory, behavioral alterations of db/db mice were associated with increased inflammatory cytokines (interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6) and reduced expression of brain-derived neurotrophic factor (BDNF) in the hippocampus but not the hypothalamus. These results strongly point to interactions between cytokines and central processes involving the hippocampus as important contributing factor to the behavioral alterations of db/db mice. These findings may prove valuable for introducing novel approaches to treat neuropsychiatric complications associated with MetS.	[Dinel, Anne-Laure; Andre, Caroline; Aubert, Agnes; Ferreira, Guillaume; Laye, Sophie; Castanon, Nathalie] INRA, UMR 1286, Bordeaux, France; [Dinel, Anne-Laure; Andre, Caroline; Aubert, Agnes; Ferreira, Guillaume; Laye, Sophie; Castanon, Nathalie] Univ Bordeaux, Bordeaux, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Dinel, AL (corresponding author), INRA, UMR 1286, Bordeaux, France.	nathalie.castanon@bordeaux.inra.fr	Laye, Sophie/AAX-2501-2020	Laye, Sophie/0000-0002-3843-1012; Castanon, Nathalie/0000-0002-0079-0562; Ferreira, Guillaume/0000-0001-5984-8143	Institut National de la Recherche Agronomique; Region Aquitaine [2008-1301-038]; Institut Danone	Institut National de la Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); Institut Danone(Danone Nutricia)	This work was supported by Institut National de la Recherche Agronomique and Region Aquitaine (grant number 2008-1301-038; SL). ALD was supported by a doctoral fellowship from the Institut Danone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanmu MA, 2009, BEHAV BRAIN RES, V196, P237, DOI 10.1016/j.bbr.2008.09.008; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Andre C, 2008, J NEUROIMMUNOL, V200, P90, DOI 10.1016/j.jneuroim.2008.06.011; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; BELLINGER FP, 1995, NEUROSCI LETT, V198, P95, DOI 10.1016/0304-3940(95)11976-4; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Benarroch EE, 2010, NEUROLOGY, V74, P1643, DOI 10.1212/WNL.0b013e3181df0a3f; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; Braida D, 2004, BEHAV BRAIN RES, V153, P423, DOI 10.1016/j.bbr.2003.12.018; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Capuron L., 2010, PSYCHOL MED, P1; Capuron L, 2008, BIOL PSYCHIAT, V64, P896, DOI 10.1016/j.biopsych.2008.05.019; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chourbaji S, 2006, NEUROBIOL DIS, V23, P587, DOI 10.1016/j.nbd.2006.05.001; Collin M, 2000, MOL BRAIN RES, V81, P51, DOI 10.1016/S0169-328X(00)00167-4; Cryan JF, 2007, CURR OPIN PSYCHIATR, V20, P1, DOI 10.1097/YCO.0b013e3280117733; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Emery CF, 2007, OBES SURG, V17, P759, DOI 10.1007/s11695-007-9140-0; Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Goldbacher EM, 2009, PSYCHOSOM MED, V71, P266, DOI 10.1097/PSY.0b013e318197a4d5; Gupta A, 2010, BIOSCI TRENDS, V4, P204; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Konsman JP, 2008, EUR J NEUROSCI, V28, P2499, DOI 10.1111/j.1460-9568.2008.06549.x; Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Laye S, 2000, AM J PHYSIOL-REG I, V279, pR93, DOI 10.1152/ajpregu.2000.279.1.R93; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Lu A, 2008, MOL PSYCHIATR, V13, P1028, DOI 10.1038/mp.2008.51; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Marsland AL, 2010, METABOLISM, V59, P1801, DOI 10.1016/j.metabol.2010.05.015; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McIntyre RS, 2009, CURR DIABETES REP, V9, P51, DOI 10.1007/s11892-009-0010-0; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moreau M, 2008, BRAIN BEHAV IMMUN, V22, P1087, DOI 10.1016/j.bbi.2008.04.001; Muller M, 2010, NEUROEPIDEMIOLOGY, V34, P83, DOI 10.1159/000264825; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Noble F, 2007, NEUROSCI LETT, V424, P106, DOI 10.1016/j.neulet.2007.07.005; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; O'Connor JC, 2005, J IMMUNOL, V174, P4991, DOI 10.4049/jimmunol.174.8.4991; O'Donovan A, 2010, BRAIN BEHAV IMMUN, V24, P1074, DOI 10.1016/j.bbi.2010.03.003; Okuda S, 2004, P NATL ACAD SCI USA, V101, P853, DOI 10.1073/pnas.0307803100; Oomura Yutaka, 2010, Pathophysiology, V17, P119, DOI 10.1016/j.pathophys.2009.04.004; Padwal RS, 2010, CAN J CARDIOL, V26, p18C, DOI 10.1016/S0828-282X(10)71077-1; Pervanidou P, 2008, STRESS, V11, P438, DOI 10.1080/10253890801890622; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Raffaitin C, 2011, NEUROLOGY, V76, P518, DOI 10.1212/WNL.0b013e31820b7656; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Roberts RO, 2010, ALZ DIS ASSOC DIS, V24, P11, DOI 10.1097/WAD.0b013e3181a4485c; Rummel C, 2010, MOL PSYCHIATR, V15, P523, DOI 10.1038/mp.2009.98; Salome N, 2008, NEUROSCIENCE, V151, P1112, DOI 10.1016/j.neuroscience.2007.12.010; Schmidt MI, 2003, CLIN CHEM LAB MED, V41, P1120, DOI 10.1515/CCLM.2003.174; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Tanaka S, 2006, J NEUROSCI RES, V83, P557, DOI 10.1002/jnr.20752; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Van Dam AM, 1998, ANN NY ACAD SCI, V840, P128, DOI 10.1111/j.1749-6632.1998.tb09557.x; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yaffe K, 2007, CURR ALZHEIMER RES, V4, P123, DOI 10.2174/156720507780362191; Yamada K, 2003, J PHARMACOL SCI, V91, P267	87	174	188	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24325	10.1371/journal.pone.0024325	http://dx.doi.org/10.1371/journal.pone.0024325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949705	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800017
J	Brantley-Sieders, DM; Jiang, AX; Sarma, K; Badu-Nkansah, A; Walter, DL; Shyr, Y; Chen, J				Brantley-Sieders, Dana M.; Jiang, Aixiang; Sarma, Krishna; Badu-Nkansah, Akosua; Walter, Debra L.; Shyr, Yu; Chen, Jin			Eph/Ephrin Profiling in Human Breast Cancer Reveals Significant Associations between Expression Level and Clinical Outcome	PLOS ONE			English	Article							EPHB4 RECEPTOR; BRANCHING MORPHOGENESIS; CARCINOMA CELLS; EPHRIN LIGANDS; EPHA2; TUMOR; SURVIVAL; CARCINOGENESIS; TUMORIGENESIS; INVASIVENESS	Pre-clinical studies provide compelling evidence that Eph family receptor tyrosine kinases (RTKs) and ligands promote cancer growth, neovascularization, invasion, and metastasis. Tumor suppressive roles have also been reported for the receptors, however, creating a potential barrier for clinical application. Determining how these observations relate to clinical outcome is a crucial step for translating the biological and mechanistic data into new molecularly targeted therapies. We investigated eph and ephrin expression in human breast cancer relative to endpoints of overall and/or recurrence-free survival in large microarray datasets. We also investigated protein expression in commercial human breast tissue microarrays (TMA) and Stage I prognostic TMAs linked to recurrence outcome data. We found significant correlations between ephA2, ephA4, ephA7, ephB4, and ephB6 and overall and/or recurrence-free survival in large microarray datasets. Protein expression in TMAs supported these trends. While observed no correlation between ephrin ligand expression and clinical outcome in microarray datasets, ephrin-A1 and EphA2 protein co-expression was significantly associated with recurrence in Stage I prognostic breast cancer TMAs. Our data suggest that several Eph family members are clinically relevant and tractable targets for intervention in human breast cancer. Moreover, profiling Eph receptor expression patterns in the context of relevant ligands and in the context of stage may be valuable in terms of diagnostics and treatment.	[Brantley-Sieders, Dana M.; Sarma, Krishna; Walter, Debra L.; Chen, Jin] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Chen, Jin] Tennessee Valley Healthcare Syst, Vet Affairs Med Ctr, Nashville, TN USA; [Chen, Jin] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Chen, Jin] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Jiang, Aixiang; Shyr, Yu] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37212 USA; [Jiang, Aixiang; Shyr, Yu; Chen, Jin] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Badu-Nkansah, Akosua] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brantley-Sieders, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	jin.chen@vanderbilt.edu	Milano, Dan/G-6578-2011	Chen, Jin/0000-0002-5557-2079; Jiang, Aixiang/0000-0002-6153-7595	National Center for Research Resources/National Institutes of Health (NIH) through the Vanderbilt Institute for Clinical and Translational Research (VICTR) [UL1 RR024975, VR622]; Department of Veterans Affairs; NIH [CA95004, CA114301, CA1179151, CA148934]; Vanderbilt-Ingram Cancer Center Biostatistics Shared Resource National Cancer Institute [P30 CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA148934, R01CA095004, R01CA114301] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Center for Research Resources/National Institutes of Health (NIH) through the Vanderbilt Institute for Clinical and Translational Research (VICTR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center Biostatistics Shared Resource National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The purchase and analysis of National Cancer Institute Cooperative Breast Cancer Tissue Resource Tissue Microarrays were supported in part by the Vanderbilt Clinical and Translational Science Award grant UL1 RR024975 from National Center for Research Resources/National Institutes of Health (NIH) through the Vanderbilt Institute for Clinical and Translational Research (VICTR, VR622). This work was supported by the Department of Veterans Affairs through a Veterans Affairs Merit Award (JC) and NIH grants CA95004 and CA114301 (JC). DB-S is supported by NIH grants CA1179151 and CA148934. YS and AJ are supported by the Vanderbilt-Ingram Cancer Center Biostatistics Shared Resource National Cancer Institute Grant P30 CA68485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azim HA, 2011, ANN ONCOL; Becker R. A., 1998, NEW S LANGUAGE PROGR; Berclaz G, 1996, BIOCHEM BIOPH RES CO, V226, P869, DOI 10.1006/bbrc.1996.1442; Berclaz G, 2002, ONCOL REP, V9, P985; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fox Brian P., 2010, Cancer Genomics & Proteomics, V7, P9; Frieden LA, 2010, DEV DYNAM, V239, P3226, DOI 10.1002/dvdy.22458; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Gokmen-Polar Y, 2010, BREAST CANC RES TREA; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Kumar SR, 2006, AM J PATHOL, V169, P279, DOI 10.2353/ajpath.2006.050889; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Michael S, 2011, BREAST CANC; Munarini N, 2002, J CELL SCI, V115, P25; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pan M, 2005, J CLIN ONCOL, V23, p857S; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Ripley B.D., 1987, STOCHASTIC SIMULATIO; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Stewart FA, 2010, RAD RES; Team RDC, 2010, R LANG ENV STAT COMP; Therneau TM, 2000, MODELING SURVIVAL DA; Tonezzer T, 2010, EUR J GYNAECOL ONCOL, V31, P262; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845	46	107	117	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24426	10.1371/journal.pone.0024426	http://dx.doi.org/10.1371/journal.pone.0024426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935409	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700033
J	Cameron, TL; Bell, KM; Tatarczuch, L; Mackie, EJ; Rajpar, MH; McDermott, BT; Boot-Handford, RP; Bateman, JF				Cameron, Trevor L.; Bell, Katrina M.; Tatarczuch, Liliana; Mackie, Eleanor J.; Rajpar, M. Helen; McDermott, Ben T.; Boot-Handford, Raymond P.; Bateman, John F.			Transcriptional Profiling of Chondrodysplasia Growth Plate Cartilage Reveals Adaptive ER-Stress Networks That Allow Survival but Disrupt Hypertrophy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SIMPLEX-VIRUS VP16; X COLLAGEN GENE; NEUROTROPHIC FACTOR; MESSENGER-RNA; ENDOCHONDRAL OSSIFICATION; CELL-PROLIFERATION; CREB/ATF-FAMILY; EXPRESSION	Metaphyseal chondrodysplasia, Schmid type (MCDS) is characterized by mild short stature and growth plate hypertrophic zone expansion, and caused by collagen X mutations. We recently demonstrated the central importance of ER stress in the pathology of MCDS by recapitulating the disease phenotype by expressing misfolding forms of collagen X (Schmid) or thyroglobulin (Cog) in the hypertrophic zone. Here we characterize the Schmid and Cog ER stress signaling networks by transcriptional profiling of microdissected mutant and wildtype hypertrophic zones. Both models displayed similar unfolded protein responses (UPRs), involving activation of canonical ER stress sensors and upregulation of their downstream targets, including molecular chaperones, foldases, and ER-associated degradation machinery. Also upregulated were the emerging UPR regulators Wfs1 and Syvn1, recently identified UPR components including Armet and Creld2, and genes not previously implicated in ER stress such as Steap1 and Fgf21. Despite upregulation of the Chop/Cebpb pathway, apoptosis was not increased in mutant hypertrophic zones. Ultrastructural analysis of mutant growth plates revealed ER stress and disrupted chondrocyte maturation throughout mutant hypertrophic zones. This disruption was defined by profiling the expression of wildtype growth plate zone gene signatures in the mutant hypertrophic zones. Hypertrophic zone gene upregulation and proliferative zone gene downregulation were both inhibited in Schmid hypertrophic zones, resulting in the persistence of a proliferative chondrocyte-like expression profile in ER-stressed Schmid chondrocytes. Our findings provide a transcriptional map of two chondrocyte UPR gene networks in vivo, and define the consequences of UPR activation for the adaptation, differentiation, and survival of chondrocytes experiencing ER stress during hypertrophy. Thus they provide important insights into ER stress signaling and its impact on cartilage pathophysiology.	[Cameron, Trevor L.; Bell, Katrina M.; Bateman, John F.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Tatarczuch, Liliana; Mackie, Eleanor J.] Univ Melbourne, Sch Vet Sci, Parkville, Vic 3052, Australia; [Rajpar, M. Helen; McDermott, Ben T.; Boot-Handford, Raymond P.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Bateman, John F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Manchester; University of Melbourne	Cameron, TL (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	john.bateman@mcri.edu.au	Mackie, Eleanor J/B-2045-2008	Mackie, Eleanor J/0000-0002-8057-5407; Bateman, John/0000-0001-8542-0730; Boot-Handford, Raymond/0000-0002-6167-8419; Tatarczuch, Liliana/0000-0001-9556-0753	National Health and Medical Research Council of Australia [491207, 607398, 1002797]; European Commission [LSHMCT-2007-037471]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Project Grants (#491207, #607398) and a Research Fellowship (#1002797) to JFB from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au) and by a grant to RBH from the European Commission (FP6; LSHMCT-2007-037471- ec.europa.eu/research/fp6/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; APTE SS, 1992, EUR J BIOCHEM, V206, P217, DOI 10.1111/j.1432-1033.1992.tb16919.x; APTE SS, 1993, MATRIX, V13, P165, DOI 10.1016/S0934-8832(11)80075-2; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Belluoccio D, 2008, BBA-GENE REGUL MECH, V1779, P330, DOI 10.1016/j.bbagrm.2008.02.010; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; DenBoer LM, 2005, BIOCHEM BIOPH RES CO, V331, P113, DOI 10.1016/j.bbrc.2005.03.141; Deshpande V, 1999, BBA-PROTEIN STRUCT M, V1430, P157, DOI 10.1016/S0167-4838(99)00015-1; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; ENGFELDT B, 1994, CALCIFIED TISSUE INT, V55, P274, DOI 10.1007/BF00310406; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Ho MSP, 2007, HUM MOL GENET, V16, P1201, DOI 10.1093/hmg/ddm067; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; James CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008693; Ji C, 2008, J GASTROEN HEPATOL, V23, pS16, DOI 10.1111/j.1440-1746.2007.05276.x; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Lu R, 2000, J VIROL, V74, P934, DOI 10.1128/JVI.74.2.934-943.2000; Lui JCK, 2010, BONE, V46, P1380, DOI 10.1016/j.bone.2010.01.373; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; MARRIOTT A, 1991, J CELL SCI, V99, P641; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nundlall S, 2010, CELL STRESS CHAPERON, V15, P835, DOI 10.1007/s12192-010-0193-y; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ortiz JA, 2005, J NEUROCHEM, V95, P1585, DOI 10.1111/j.1471-4159.2005.03473.x; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tajiri S, 2006, FEBS LETT, V580, P3462, DOI 10.1016/j.febslet.2006.05.021; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verfaillie T, 2010, INT J CELL BIOL, V2010, DOI DOI 10.1155/2010/930509; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wilson R, 2005, J BIOL CHEM, V280, P15544, DOI 10.1074/jbc.M410758200; Yan W, 2004, BONE, V35, P1273, DOI 10.1016/j.bone.2004.09.009; Yang SX, 1996, ARCH BIOCHEM BIOPHYS, V327, P61, DOI 10.1006/abbi.1996.0093; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	86	44	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24600	10.1371/journal.pone.0024600	http://dx.doi.org/10.1371/journal.pone.0024600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935428	Green Published, gold			2022-12-25	WOS:000295041700045
J	Nyandigisi, A; Memusi, D; Mbithi, A; Ang'wa, N; Shieshia, M; Muturi, A; Sudoi, R; Githinji, S; Juma, E; Zurovac, D				Nyandigisi, Andrew; Memusi, Dorothy; Mbithi, Agneta; Ang'wa, Newton; Shieshia, Mildred; Muturi, Alex; Sudoi, Raymond; Githinji, Sophie; Juma, Elizabeth; Zurovac, Dejan			Malaria Case-Management following Change of Policy to Universal Parasitological Diagnosis and Targeted Artemisinin-Based Combination Therapy in Kenya	PLOS ONE			English	Article							LUMEFANTRINE TREATMENT POLICY; ARTEMETHER-LUMEFANTRINE; CLINICAL ALGORITHMS; HEALTH FACILITIES; OLDER CHILDREN; TESTS; MICROSCOPY; TANZANIA; IMPLEMENTATION; IMPROVE	Background: The change of malaria case-management policy in Kenya to recommend universal parasitological diagnosis and targeted treatment with artemether-lumefantrine (AL) is supported with activities aiming by 2013 at universal coverage and adherence to the recommendations. We evaluated changes in health systems and case-management indicators between the baseline survey undertaken before implementation of the policy and the follow-up survey following the first year of the implementation activities. Methods/Findings: National, cross-sectional surveys using quality-of-care methods were undertaken at public facilities. Baseline and follow-up surveys respectively included 174 and 176 facilities, 224 and 237 health workers, and 2,405 and 1,456 febrile patients. Health systems indicators showed variable changes between surveys: AL stock-out (27% to 21%; p = 0.152); availability of diagnostics (55% to 58%; p = 0.600); training on the new policy (0 to 22%; p = 0.001); exposure to supervision (18% to 13%; p = 0.156) and access to guidelines (0 to 6%; p = 0.001). At all facilities, there was an increase among patients tested for malaria (24% vs 31%; p = 0.090) and those who were both tested and treated according to test result (16% to 22%; p = 0.048). At facilities with AL and malaria diagnostics, testing increased from 43% to 50% (p = 0.196) while patients who were both, tested and treated according to test result, increased from 28% to 36% (p = 0.114). Treatment adherence improved for test positive patients from 83% to 90% (p = 0.150) and for test negative patients from 47% to 56% (p = 0.227). No association was found between testing and exposure to training, supervision and guidelines, however, testing was significantly associated with facility ownership, type of testing, and patients' caseload, age and clinical presentation. Conclusions: Most of the case-management indicators have shown some improvement trends; however differences were smaller than expected, rarely statistically significant and still leaving a substantial gap towards optimistic targets. The quantitative and qualitative improvement of interventions will ultimately determine the success of the new policy.	[Nyandigisi, Andrew; Memusi, Dorothy; Mbithi, Agneta; Juma, Elizabeth] Minist Publ Hlth & Sanitat, Div Malaria Control, Nairobi, Kenya; [Ang'wa, Newton] Minist Publ Hlth & Sanitat, Rift Valley Prov Gen Hosp, Nakuru, Kenya; [Shieshia, Mildred; Muturi, Alex] Management Sci Hlth, Nairobi, Kenya; [Sudoi, Raymond; Githinji, Sophie; Zurovac, Dejan] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; [Zurovac, Dejan] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Zurovac, Dejan] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA	Kenya Medical Research Institute; University of Oxford; Boston University	Nyandigisi, A (corresponding author), Minist Publ Hlth & Sanitat, Div Malaria Control, Nairobi, Kenya.	dzurovac@nairobi.kemri-wellcome.org			Global Fund to Fight AIDS, Tuberculosis and Malaria [KEN-405-G06-M]; U.S. President's Malaria Initiative/USAID; Wellcome Trust-UK, Kenya Medical Research Institute; University of Oxford; Medicines for Malaria Ventures	Global Fund to Fight AIDS, Tuberculosis and Malaria; U.S. President's Malaria Initiative/USAID(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Wellcome Trust-UK, Kenya Medical Research Institute(Wellcome Trust); University of Oxford; Medicines for Malaria Ventures	Funding for this study is provided by The Global Fund to Fight AIDS, Tuberculosis and Malaria round 4 grant number KEN-405-G06-M and U.S. President's Malaria Initiative/USAID through the Management Sciences for Health. DZ is grateful for the support from the Wellcome Trust-UK, Kenya Medical Research Institute, University of Oxford and Medicines for Malaria Ventures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELGADER TM, 2011, MALARIA CASE M UNPUB; *ACTWATCH, 2009, MULT IN MAL S 2 6 NO; [Anonymous], KEN MAL MON EV PLAN; [Anonymous], NAT MAL STRAT 2009 2; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P1; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Chandramohan D, 2001, TROP MED INT HEALTH, V6, P505, DOI 10.1046/j.1365-3156.2001.00739.x; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; HAMEL M, 2011, AM J TROP M IN PRESS; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; *MIN HLTH, 2008, PART MAN DIAGN MAN P; MOPHS, 2010, NAT GUID DIAGN TREAT; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Thwing JI, 2011, TROP MED INT HEALTH, V16, P272, DOI 10.1111/j.1365-3156.2010.02724.x; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; WHO, 2010, GUID TREATM MAL, V2nd; Williams HA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-239; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	39	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24781	10.1371/journal.pone.0024781	http://dx.doi.org/10.1371/journal.pone.0024781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935464	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700047
J	El Khechine, A; Couderc, C; Flaudrops, C; Raoult, D; Drancourt, M				El Khechine, Amel; Couderc, Carine; Flaudrops, Christophe; Raoult, Didier; Drancourt, Michel			Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Identification of Mycobacteria in Routine Clinical Practice	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; NONTUBERCULOUS MYCOBACTERIA; RAPID IDENTIFICATION; INTACT MYCOBACTERIA; CULTURE-MEDIA; TUBERCULOSIS; BACTERIA; INACTIVATION; ORGANISMS; DIAGNOSIS	Background: Non-tuberculous mycobacteria recovered from respiratory tract specimens are emerging confounder organisms for the laboratory diagnosis of tuberculosis worldwide. There is an urgent need for new techniques to rapidly identify mycobacteria isolated in clinical practice. Matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS) has previously been proven to effectively identify mycobacteria grown in high-concentration inocula from collections. However, a thorough evaluation of its use in routine laboratory practice has not been performed. Methodology: We set up an original protocol for the MALDI-TOF MS identification of heat-inactivated mycobacteria after dissociation in Tween-20, mechanical breaking of the cell wall and protein extraction with formic acid and acetonitrile. By applying this protocol to as few as 10(5) colony-forming units of reference isolates of Mycobacterium tuberculosis, Mycobacterium avium, and 20 other Mycobacterium species, we obtained species-specific mass spectra for the creation of a local database. Using this database, our protocol enabled the identification by MALDI-TOF MS of 87 M. tuberculosis, 25 M. avium and 12 non-tuberculosis clinical isolates with identification scores >= 2 within 2.5 hours. Conclusions: Our data indicate that MALDI-TOF MS can be used as a first-line method for the routine identification of heat-inactivated mycobacteria. MALDI-TOF MS is an attractive method for implementation in clinical microbiology laboratories in both developed and developing countries.	[El Khechine, Amel; Couderc, Carine; Flaudrops, Christophe; Raoult, Didier; Drancourt, Michel] Univ Mediterrane & Pole Malad Infect, Inst Hosp Univ POLMIT, Assistance Publ Hop Marseille, IFR48,URMITE UMR CNRS IRD198 6236, Marseille, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	El Khechine, A (corresponding author), Univ Mediterrane & Pole Malad Infect, Inst Hosp Univ POLMIT, Assistance Publ Hop Marseille, IFR48,URMITE UMR CNRS IRD198 6236, Marseille, France.	Michel.Drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; ANHALT JP, 1975, ANAL CHEM, V47, P219, DOI 10.1021/ac60352a007; Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Bemer-Melchior P, 1999, J CLIN MICROBIOL, V37, P2350, DOI 10.1128/JCM.37.7.2350-2351.1999; Bittar F, 2009, INT J ANTIMICROB AG, V34, P467, DOI 10.1016/j.ijantimicag.2009.03.017; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; BUTLER WR, 1991, J CLIN MICROBIOL, V29, P2468, DOI 10.1128/JCM.29.11.2468-2472.1991; Castro C, 2009, BIOMEDICA, V29, P561; Chou CH, 2011, SCAND J INFECT DIS, V43, P8, DOI 10.3109/00365548.2010.519345; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; DJELAOUDJI Z, 2011, LANCET INFE IN PRESS; Djelouadji Z, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000253; Djelouadji Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002433; Djelouagji Z, 2006, J CLIN MICROBIOL, V44, P1594, DOI 10.1128/JCM.44.4.1594-1595.2006; Doig C, 2002, J CLIN PATHOL, V55, P778, DOI 10.1136/jcp.55.10.778; Drancourt M, 2003, J CLIN MICROBIOL, V41, P1710, DOI 10.1128/JCM.41.4.1710-1711.2003; Drancourt M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000083; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; El Khechine A, 2009, MICROBIOL-SGM, V155, P2384, DOI 10.1099/mic.0.026484-0; Elbir H, 2008, AM J TROP MED HYG, V78, P316, DOI 10.4269/ajtmh.2008.78.316; FERREIRA L, 2010, CLIN MICROBIOL INFEC, DOI DOI 10.1111/J.1469-0691.2010.03339.X; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Guy Elizabeth S, 2008, Ther Adv Respir Dis, V2, P401, DOI 10.1177/1753465808099522; Hettick JM, 2004, ANAL CHEM, V76, P5769, DOI 10.1021/ac049410m; Hettick JM, 2006, PROTEOMICS, V6, P6416, DOI 10.1002/pmic.200600335; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; LEVYFREBAULT VV, 1992, INT J SYST BACTERIOL, V42, P315; Lotz A, 2010, J CLIN MICROBIOL, V48, P4481, DOI 10.1128/JCM.01397-10; Martin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-30; McAlpin CR, 2010, RAPID COMMUN MASS SP, V24, P11, DOI 10.1002/rcm.4349; McGrath EE, 2008, INT J CLIN PRACT, V62, P1947, DOI 10.1111/j.1742-1241.2008.01891.x; Miller AK, 2002, AM J IND MED, V42, P228, DOI 10.1002/ajim.10108; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Pfyffer GE, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P543; Pignone M, 2006, J CLIN MICROBIOL, V44, P1963, DOI 10.1128/JCM.01959-05; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Robledo JA, 2006, INT J TUBERC LUNG D, V10, P613; Saleeb PG, 2011, J CLIN MICROBIOL, V49, P1790, DOI 10.1128/JCM.02135-10; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI 10.2217/FMB.10.127; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Suzuki Katsuhiro, 2007, Kekkaku, V82, P217; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Woith WM, 2010, INT J TUBERC LUNG D, V14, P1489	45	124	130	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24720	10.1371/journal.pone.0024720	http://dx.doi.org/10.1371/journal.pone.0024720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21935444	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800053
J	Haudenschild, DR; Hong, E; Yik, JHN; Chromy, B; Morgelin, M; Snow, KD; Acharya, C; Takada, Y; Di Cesare, PE				Haudenschild, Dominik R.; Hong, Eunmee; Yik, Jasper H. N.; Chromy, Brett; Morgelin, Matthias; Snow, Kaylene D.; Acharya, Chitrangada; Takada, Yoshikazu; Di Cesare, Paul E.			Enhanced Activity of Transforming Growth Factor beta 1 (TGF-beta 1) Bound to Cartilage Oligomeric Matrix Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EXTRACELLULAR-MATRIX; COILED-COIL; COLLAGEN-IX; COMP; CELLS; DOMAIN; ALPHA-V-BETA-3; THROMBOSPONDIN-1; DIFFERENTIATION	Cartilage oligomeric matrix protein (COMP) is an important non-collagenous cartilage protein that is essential for the structural integrity of the cartilage extracellular matrix. The repeated modular structure of COMP allows it to "bridge" and assemble multiple cartilage extracellular matrix components such as collagens, matrilins, and proteoglycans. With its modular structure, COMP also has the potential to act as a scaffold for growth factors, thereby affecting how and when the growth factors are presented to cell-surface receptors. However, it is not known whether COMP binds growth factors. We studied the binding interaction between COMP and TGF-beta 1 in vitro and determined the effect of COMP on TGF-beta 1-induced signal transduction in reporter cell lines and primary cells. Our results demonstrate that mature COMP protein binds to multiple TGF-beta 1 molecules and that the peak binding occurs at slightly acidic pH. These interactions were confirmed by dual polarization interferometry and visualized by rotary shadow electron microscopy. There is cation-independent binding of TGF-beta 1 to the C-terminal domain of COMP. In the presence of manganese, an additional TGF-beta-binding site is present in the TSP3 repeats of COMP. Finally, we show that COMP-bound TGF-beta 1 causes increased TGF-beta 1-dependent transcription. We conclude that TGF-beta 1 binds to COMP and that TGF-beta 1 bound to COMP has enhanced bioactivity.	[Haudenschild, Dominik R.; Hong, Eunmee; Yik, Jasper H. N.; Snow, Kaylene D.; Acharya, Chitrangada; Di Cesare, Paul E.] Univ Calif Davis Med Ctr, Lawrence J Ellison Musculoskeletal Res Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Univ Calif Davis Med Ctr, Dept Dermatol, Sacramento, CA 95817 USA; [Chromy, Brett] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, S-22100 Lund, Sweden	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Lund University	Haudenschild, DR (corresponding author), Univ Calif Davis Med Ctr, 4635 2nd Ave,Suite 2000, Sacramento, CA 95618 USA.	dominik.haudenschild@ucdmc.ucdavis.edu	Haudenschild, Dominik/B-2381-2008	Haudenschild, Dominik/0000-0001-9947-9864; takada, yoshikazu/0000-0001-5481-9589	Swedish Research Council [7480]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by departmental startup funds (to D. R. H.) and Swedish Research Council Project 7480 (to M. M.).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bengtson SH, 2009, J INNATE IMMUN, V1, P18, DOI 10.1159/000145543; Blumbach K, 2008, MATRIX BIOL, V27, P306, DOI 10.1016/j.matbio.2007.11.007; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; DERYNCK R, 2007, COLD SPRING HARBOR M, V50; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; DiCesare PE, 1996, J ORTHOPAED RES, V14, P946, DOI 10.1002/jor.1100140615; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; Efimov VP, 1996, PROTEINS, V24, P259, DOI 10.1002/(SICI)1097-0134(199602)24:2<259::AID-PROT13>3.0.CO;2-M; FRANZEN A, 1987, DIFFERENTIATION, V36, P199, DOI 10.1111/j.1432-0436.1987.tb00194.x; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195; KAWAMURA M, 1988, DEV BIOL, V130, P435, DOI 10.1016/0012-1606(88)90339-9; Koelling S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1922; Li H, 2011, OSTEOARTHR CARTILAGE, V19, P1246, DOI 10.1016/j.joca.2011.07.011; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motaung SCKM, 2011, J TISSUE ENG REGEN M, V5, pE87, DOI 10.1002/term.358; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OHSHIMA H, 1992, SPINE, V17, P1079, DOI 10.1097/00007632-199209000-00012; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Ozbek S, 2002, EMBO J, V21, P5960, DOI 10.1093/emboj/cdf628; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; Recklies AD, 1998, ARTHRITIS RHEUM, V41, P997, DOI 10.1002/1529-0131(199806)41:6<997::AID-ART6>3.0.CO;2-G; Rock MJ, 2010, MOL CELL BIOCHEM, V338, P215, DOI 10.1007/s11010-009-0355-3; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SIMKIN PA, 1992, J RHEUMATOL, V19, P1017; SOKOLOFF L, 1978, JOINTS SYNOVIAL FLUI, P274; Tan KM, 2009, FASEB J, V23, P2490, DOI 10.1096/fj.08-128090; Wang L, 2010, CIRC RES, V106, P514, DOI 10.1161/CIRCRESAHA.109.202762; Zaia J, 1997, J BIOL CHEM, V272, P14120, DOI 10.1074/jbc.272.22.14120; Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017	45	48	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43250	43258		10.1074/jbc.M111.234716	http://dx.doi.org/10.1074/jbc.M111.234716			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21940632	hybrid, Green Published			2022-12-25	WOS:000298351300045
J	Lin, PC; Chan, PM; Hall, C; Manser, E				Lin, Pao-Chun; Chan, Perry M.; Hall, Christine; Manser, Ed			Collapsin Response Mediator Proteins (CRMPs) Are a New Class of Microtubule-associated Protein (MAP) That Selectively Interacts with Assembled Microtubules via a Taxol-sensitive Binding Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GROWTH-CONE COLLAPSE; ALZHEIMERS-DISEASE; GSK3-BETA PHOSPHORYLATION; NEURONAL POLARIZATION; SIGNALING PATHWAYS; NERVOUS-SYSTEM; CELL-MIGRATION; RHO-KINASE; TUBULIN	Collapsin response mediator proteins are ubiquitously expressed from multiple genes (CRMPs 1-5) and play important roles in dividing cells and during semaphorin 3A (Sema3A)signaling. Nonetheless, their mode of action remains opaque. Here we carried out in vivo and in vitro assays that demonstrate that CRMPs are a new class of microtubule-associated protein (MAP). In experiments with CRMP1 or CRMP2 and their derivatives, only the C-terminal region (residues 490-572) mediated microtubule binding. The in vivo microtubule association of CRMPs was abolished by taxol or epothilone B, which is highly unusual. CRMP2-depleted cells exhibited destabilized anaphase astral microtubules and altered spindle position. In a cell-based assay, all CRMPs stabilized interphase microtubules against nocodazole-mediated depolymerization, with CRMP1 being the most potent. Remarkably, a 82-residue C-terminal region of CRMP1 or CRMP2, unrelated to other microtubule binding motifs, is sufficient to stabilize microtubules. In cells, we demonstrate that glycogen synthase kinase-3 beta (GSK3 beta) inhibition potentiates this activity. Thus, CRMPs are a new class of MAP that binds through a unique motif, but in common with others such as Tau, is antagonized by GSK3 beta. This regulation is consistent with such kinases being critical for the Sema3A (collapsin) pathway. These findings have implications for cancer and neurodegeneration.	[Chan, Perry M.; Manser, Ed] Small G Prot Signaling & Kinases sGSK NRP Grp, Singapore 138673, Singapore; [Lin, Pao-Chun; Manser, Ed] Inst Med Biol, Singapore 138648, Singapore; [Hall, Christine] UCL, Inst Neurol, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of London; University College London	Manser, E (corresponding author), Small G Prot Signaling & Kinases sGSK NRP Grp, Room 4-16B,61 Biopolis Dr, Singapore 138673, Singapore.	ed.manser@imb.a-star.edu.sg	Hall, Christine/C-8390-2009; Manser, Edward/ABD-2301-2020		GSK-IMCB	GSK-IMCB	This work was partially supported by the GSK-IMCB fund.	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS D, 1991, BIOCHEMISTRY-US, V30, P4362, DOI 10.1021/bi00231a036; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Erskine L, 2011, NEURON, V70, P951, DOI 10.1016/j.neuron.2011.02.052; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Goold RG, 1999, J CELL SCI, V112, P3373; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Piaton G, 2011, BRAIN, V134, P1156, DOI 10.1093/brain/awr022; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Soutar MPM, 2009, CURR ALZHEIMER RES, V6, P269, DOI 10.2174/156720509788486572; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Spriggs MK, 1999, CURR OPIN IMMUNOL, V11, P387, DOI 10.1016/S0952-7915(99)80065-X; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Syed YA, 2011, J NEUROSCI, V31, P3719, DOI 10.1523/JNEUROSCI.4930-10.2011; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Uchida Y, 2009, J BIOL CHEM, V284, P27393, DOI 10.1074/jbc.M109.000240; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Wagner U, 1996, J CELL SCI, V109, P1537; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	76	74	79	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41466	41478		10.1074/jbc.M111.283580	http://dx.doi.org/10.1074/jbc.M111.283580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21953449	Green Published, hybrid			2022-12-25	WOS:000298057500033
J	Schjoldager, KTBG; Vester-Christensen, MB; Goth, CK; Petersen, TN; Brunak, S; Bennett, EP; Levery, SB; Clausen, H				Schjoldager, Katrine Ter-Borch Gram; Vester-Christensen, Malene B.; Goth, Christoffer K.; Petersen, Thomas Nordahl; Brunak, Soren; Bennett, Eric P.; Levery, Steven B.; Clausen, Henrik			A Systematic Study of Site-specific GalNAc-type O-Glycosylation Modulating Proprotein Convertase Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE; INHIBIN-ALPHA; GROWTH; FURIN; INTEGRIN; ACTIVATION; EXPRESSION; PREDICTION; SECRETION; CLEAVAGE	Site-specific GalNAc-type O-glycosylation is emerging as an important co-regulator of proprotein convertase (PC) processing of proteins. PC processing is crucial in regulating many fundamental biological pathways and O-glycans in or immediately adjacent to processing sites may affect recognition and function of PCs. Thus, we previously demonstrated that deficiency in site-specific O-glycosylation in a PC site of the fibroblast growth factor, FGF23, resulted in marked reduction in secretion of active unprocessed FGF23, which cause familial tumoral calcinosis and hyperostosis hyperphosphatemia. GalNAc-type O-glycosylation is found on serine and threonine amino acids and up to 20 distinct polypeptide GalNAc transferases catalyze the first addition of GalNAc to proteins making this step the most complex and differentially regulated steps in protein glycosylation. There is no reliable prediction model for O-glycosylation especially of isolated sites, but serine and to a lesser extent threonine residues are frequently found adjacent to PC processing sites. In the present study we used in vitro enzyme assays and ex vivo cell models to systematically address the boundaries of the region within site-specific O-glycosylation affect PC processing. The results demonstrate that O-glycans within at least +/- 3 residues of the RXXR furin cleavage site may affect PC processing suggesting that site-specific O-glycosylation is a major co-regulator of PC processing.	[Schjoldager, Katrine Ter-Borch Gram; Vester-Christensen, Malene B.; Goth, Christoffer K.; Bennett, Eric P.; Levery, Steven B.; Clausen, Henrik] Univ Copenhagen, Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Schjoldager, Katrine Ter-Borch Gram; Vester-Christensen, Malene B.; Goth, Christoffer K.; Bennett, Eric P.; Levery, Steven B.; Clausen, Henrik] Univ Copenhagen, Sch Dent, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Brunak, Soren] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Petersen, Thomas Nordahl] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal CBS, DK-2800 Lyngby, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Clausen, H (corresponding author), Univ Copenhagen, Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth Sci, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	hclau@sund.ku.dk	clausen, henrik/AAD-8016-2021; Brunak, Soren/O-6621-2016	Goth, Christoffer/0000-0002-5766-1411; Petersen, Thomas Nordahl/0000-0002-2484-5716; Brunak, Soren/0000-0003-0316-5866; Clausen, Henrik/0000-0002-0915-5055; Bennett, Eric Paul/0000-0002-4976-0647	Kirsten og Freddy Johansen Fonden; A. P. Moller og Hustru Chastine McKinney Mollers Fond til Almene Formaal; Carlsberg Foundation; Novo Nordisk Foundation; Alfred Benzon Foundation; Danish Research Councils; University of Copenhagen	Kirsten og Freddy Johansen Fonden; A. P. Moller og Hustru Chastine McKinney Mollers Fond til Almene Formaal; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Alfred Benzon Foundation; Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen	This work was supported by Kirsten og Freddy Johansen Fonden, A. P. Moller og Hustru Chastine McKinney Mollers Fond til Almene Formaal, the Carlsberg Foundation, Novo Nordisk Foundation, Alfred Benzon Foundation, Danish Research Councils, and a program of excellence from the University of Copenhagen.	Antenos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017348; Antenos M, 2008, J BIOL CHEM, V283, P33059, DOI 10.1074/jbc.M804190200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; BIRCH NP, 1991, FEBS LETT, V290, P191, DOI 10.1016/0014-5793(91)81257-9; Blais V, 2002, FEBS LETT, V524, P43, DOI 10.1016/S0014-5793(02)02998-8; CALVETE JJ, 1993, FEBS LETT, V328, P30, DOI 10.1016/0014-5793(93)80959-X; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Gordon VM, 1997, INFECT IMMUN, V65, P3370, DOI 10.1128/IAI.65.8.3370-3375.1997; Hassan H, 2000, CARBOHYDRATES CHEM B, P273, DOI DOI 10.1002/9783527618255.CH55; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Herbert E, 1980, Ann N Y Acad Sci, V343, P79, DOI 10.1111/j.1749-6632.1980.tb47244.x; Hsu YR, 1998, PROTEIN EXPRES PURIF, V12, P189, DOI 10.1006/prep.1997.0840; John H, 1999, BIOCHEMISTRY-US, V38, P10217, DOI 10.1021/bi990787+; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Lehmann M, 1996, BIOCHEM J, V317, P803, DOI 10.1042/bj3170803; MAINS RE, 1981, J BIOL CHEM, V256, P5683; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; Meyts ERD, 2007, VIRCHOWS ARCH, V451, P805, DOI 10.1007/s00428-007-0478-4; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SHAW SK, 1994, J BIOL CHEM, V269, P6016; Shifley ET, 2008, BBA-MOL CELL RES, V1783, P2384, DOI 10.1016/j.bbamcr.2008.07.009; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Sun XW, 2011, J BIOL CHEM, V286, P29063, DOI 10.1074/jbc.M111.242479; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	50	72	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40122	40132		10.1074/jbc.M111.287912	http://dx.doi.org/10.1074/jbc.M111.287912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937429	Green Published, hybrid			2022-12-25	WOS:000296925700045
J	Barthson, J; Germano, CM; Moore, F; Maida, A; Drucker, DJ; Marchetti, P; Gysemans, C; Mathieu, C; Nunez, G; Jurisicova, A; Eizirik, DL; Gurzov, EN				Barthson, Jenny; Germano, Carla M.; Moore, Fabrice; Maida, Adriano; Drucker, Daniel J.; Marchetti, Piero; Gysemans, Conny; Mathieu, Chantal; Nunez, Gabriel; Jurisicova, Andrea; Eizirik, Decio L.; Gurzov, Esteban N.			Cytokines Tumor Necrosis Factor-alpha and Interferon-gamma Induce Pancreatic beta-Cell Apoptosis through STAT1-mediated Bim Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNAL TRANSDUCER; FAMILY-MEMBER; ER STRESS; DEATH; BCL-2; ISLETS; PUMA; GENE; BAX	Type 1 diabetes is characterized by local inflammation (insulitis) in the pancreatic islets causing beta-cell loss. The mitochondrial pathway of apoptosis is regulated by the balance and interaction between Bcl-2 members. Here we clarify the molecular mechanism of beta-cell death triggered by the pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma. The combination of TNF-alpha + IFN-gamma induced DP5, p53 up-regulated modulator of apoptosis (PUMA), and Bim expression in human islets and rodent beta-cells. DP5 and PUMA inactivation by RNA interference partially protected against TNF-alpha + IFN-gamma-induced beta-cell apoptosis. DP5 knock-out mice had increased beta-cell area, and isolated islets from these mice were resistant to cytokine exposure. Bim expression was transcriptionally regulated by STAT1, and its activation triggered cleavage of caspases. Silencing of Bim protected rodent and human beta-cells to a large extent against TNF-alpha + IFN-gamma, indicating a major role of this BH3-only activator protein in the mechanism of apoptosis. Our data support a highly regulated and context-dependent modulation of specific Bcl-2 members controlling the mitochondrial pathway of beta-cell apoptosis during insulitis.	[Barthson, Jenny; Germano, Carla M.; Moore, Fabrice; Gurzov, Esteban N.] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; [Maida, Adriano; Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Jurisicova, Andrea] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Metab Unit, I-56126 Pisa, Italy; [Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven, Dept Expt Med Endocrinol, Fac Med, B-3000 Louvain, Belgium; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	Universite Libre de Bruxelles; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Pisa; KU Leuven; University of Michigan System; University of Michigan	Eizirik, DL (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route Lennik,808 CP-618, B-1070 Brussels, Belgium.	deizirik@ulb.ac.be; egurzov@ulb.ac.be	Marchetti, Piero/J-7439-2013; Drucker, Daniel J/A-4092-2010; germano, carla/N-1736-2015; Jurisicova, Andrea/E-4580-2013; GERMANO, CARLA MARIA RAMOS/S-5312-2019; Nuñez, Gabriel/A-7160-2014; mathieu, chantal/ABD-5505-2021	Marchetti, Piero/0000-0003-4907-0635; GERMANO, CARLA MARIA RAMOS/0000-0001-5030-7164; mathieu, chantal/0000-0002-4055-5233; gysemans, conny/0000-0003-3559-6089; Gurzov, Esteban/0000-0003-4642-0273	Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) (Belgium); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State [IUAP P6/40]; Juvenile Diabetes Research Foundation International (JDRFI) [17-2009-106]; European Union; European Molecular Biology Organization (EMBO)	Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); European Union(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by grants from the Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC), the Fonds National de la Recherche Scientifique (FNRS) (Belgium), the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40), the Juvenile Diabetes Research Foundation International (JDRFI Grant 17-2009-106), and the European Union (Project Naimit, in the Framework Programme 7 of the European Community).; Supported by an European Molecular Biology Organization (EMBO) long-term fellowship. .	Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Callewaert HI, 2007, DIABETES, V56, P2169, DOI 10.2337/db07-0052; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fox SA, 2005, BIOCHEM BIOPH RES CO, V337, P983, DOI 10.1016/j.bbrc.2005.09.147; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gowda A, 2008, BLOOD, V111, P4723, DOI 10.1182/blood-2007-07-099531; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Imaizumi K, 2004, J NEUROSCI, V24, P3721, DOI 10.1523/JNEUROSCI.5101-03.2004; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim S, 2007, DIABETES, V56, P2561, DOI 10.2337/db06-1372; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Maida A, 2008, ENDOCRINOLOGY, V149, P5670, DOI 10.1210/en.2008-0336; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Thomas D, 2002, TRANSPLANTATION, V74, P1489, DOI 10.1097/00007890-200212150-00003; Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	46	82	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39632	39643		10.1074/jbc.M111.253591	http://dx.doi.org/10.1074/jbc.M111.253591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937453	hybrid, Green Published			2022-12-25	WOS:000296759800080
J	Baudrimont, A; Penkner, A; Woglar, A; Mamnun, YM; Hulek, M; Struck, C; Schnabel, R; Loidl, J; Jantsch, V				Baudrimont, Antoine; Penkner, Alexandra; Woglar, Alexander; Mamnun, Yasmine M.; Hulek, Margot; Struck, Cathrin; Schnabel, Ralf; Loidl, Josef; Jantsch, Verena			A New Thermosensitive smc-3 Allele Reveals Involvement of Cohesin in Homologous Recombination in C. elegans	PLOS ONE			English	Article								The cohesin complex is required for the cohesion of sister chromatids and for correct segregation during mitosis and meiosis. Crossover recombination, together with cohesion, is essential for the disjunction of homologous chromosomes during the first meiotic division. Cohesin has been implicated in facilitating recombinational repair of DNA lesions via the sister chromatid. Here, we made use of a new temperature-sensitive mutation in the Caenorhabditis elegans SMC-3 protein to study the role of cohesin in the repair of DNA double-strand breaks (DSBs) and hence in meiotic crossing over. We report that attenuation of cohesin was associated with extensive SPO-11-dependent chromosome fragmentation, which is representative of unrepaired DSBs. We also found that attenuated cohesin likely increased the number of DSBs and eliminated the need of MRE-11 and RAD-50 for DSB formation in C. elegans, which suggests a role for the MRN complex in making cohesin-loaded chromatin susceptible to meiotic DSBs. Notably, in spite of largely intact sister chromatid cohesion, backup DSB repair via the sister chromatid was mostly impaired. We also found that weakened cohesins affected mitotic repair of DSBs by homologous recombination, whereas NHEJ repair was not affected. Our data suggest that recombinational DNA repair makes higher demands on cohesins than does chromosome segregation.	[Baudrimont, Antoine; Penkner, Alexandra; Woglar, Alexander; Mamnun, Yasmine M.; Hulek, Margot; Loidl, Josef; Jantsch, Verena] Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, Vienna, Austria; [Struck, Cathrin; Schnabel, Ralf] Tech Univ Carolo Wilhelmina Braunschweig, Dept Genet, Braunschweig, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Braunschweig University of Technology	Baudrimont, A (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, Vienna, Austria.	verena.jantsch@univie.ac.at	Jantsch, Verena/A-3910-2017	Jantsch, Verena/0000-0002-1978-682X; , Josef/0000-0002-2519-4484; Baudrimont, Antoine/0000-0001-9410-6356	Austrian Science Fund FWF [P21338-B03]; Austrian Science Fund (FWF) [P 21338] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF grant P21338-B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Bailly AP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001025; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Colaiacovo MP, 2006, CHROMOSOMA, V115, P195, DOI 10.1007/s00412-006-0061-9; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2004, Methods Mol Biol, V280, P257; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; Mito Y, 2003, MOL BIOL CELL, V14, P2399, DOI 10.1091/mbc.E02-09-0603; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Pasierbek P, 2003, EXP CELL RES, V289, P245, DOI 10.1016/S0014-4827(03)00266-0; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Penkner AM, 2009, CELL, V139, P920, DOI 10.1016/j.cell.2009.10.045; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Rinaldo C, 2002, GENETICS, V160, P471; Severson AF, 2009, GENE DEV, V23, P1763, DOI 10.1101/gad.1808809; Tang L, 2010, MOL BIOL CELL, V21, P885, DOI 10.1091/mbc.E09-09-0811; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Watrin E, 2009, EMBO J, V28, P2625, DOI 10.1038/emboj.2009.202; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	45	12	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24799	10.1371/journal.pone.0024799	http://dx.doi.org/10.1371/journal.pone.0024799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957461	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100020
J	Zheng, Q; Zhang, R; Koblizek, M; Boldareva, EN; Yurkov, V; Yan, S; Jiao, NAZ				Zheng, Qiang; Zhang, Rui; Koblizek, Michal; Boldareva, Ekaterina N.; Yurkov, Vladimir; Yan, Shi; Jiao, Nianzhi			Diverse Arrangement of Photosynthetic Gene Clusters in Aerobic Anoxygenic Phototrophic Bacteria	PLOS ONE			English	Article							RHODOBACTER-CAPSULATUS; CITROMICROBIUM-BATHYOMARINUM; REACTION CENTERS; GLOBAL OCEAN; BIOSYNTHESIS; EXPRESSION; SEQUENCE; OPERONS; BACTERIOCHLOROPHYLL; ORGANIZATION	Background: Aerobic anoxygenic photototrophic (AAP) bacteria represent an important group of marine microorganisms inhabiting the euphotic zone of the ocean. They harvest light using bacteriochlorophyll (BChl) a and are thought to be important players in carbon cycling in the ocean. Methodology/Principal Findings: Aerobic anoxygenic phototrophic (AAP) bacteria represent an important part of marine microbial communities. Their photosynthetic apparatus is encoded by a number of genes organized in a so-called photosynthetic gene cluster (PGC). In this study, the organization of PGCs was analyzed in ten AAP species belonging to the orders Rhodobacterales, Sphingomonadales and the NOR5/OM60 clade. Sphingomonadales contained comparatively smaller PGCs with an approximately size of 39 kb whereas the average size of PGCs in Rhodobacterales and NOR5/OM60 clade was about 45 kb. The distribution of four arrangements, based on the permutation and combination of the two conserved regions bchFNBHLM-LhaA-puhABC and crtF-bchCXYZ, does not correspond to the phylogenetic affiliation of individual AAP bacterial species. While PGCs of all analyzed species contained the same set of genes for bacteriochlorophyll synthesis and assembly of photosynthetic centers, they differed largely in the carotenoid biosynthetic genes. Spheroidenone, spirilloxanthin, and zeaxanthin biosynthetic pathways were found in each clade respectively. All of the carotenoid biosynthetic genes were found in the PGCs of Rhodobacterales, however Sphingomonadales and NOR5/OM60 strains contained some of the carotenoid biosynthetic pathway genes outside of the PGC. Conclusions/Significance: Our investigations shed light on the evolution and functional implications in PGCs of marine aerobic anoxygenic phototrophs, and support the notion that AAP are a heterogenous physiological group phylogenetically scattered among Proteobacteria.	[Zheng, Qiang; Zhang, Rui; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Koblizek, Michal; Boldareva, Ekaterina N.] Inst Microbiol CAS, Trebon, Czech Republic; [Yurkov, Vladimir] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Yan, Shi] Max Planck Inst Marine Microbiol, Dept Mol Ecol, Bremen, Germany	Xiamen University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Manitoba; Max Planck Society	Zheng, Q (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	jiao@xmu.edu.cn	Koblizek, Michal/H-2851-2014		NSFC [91028001, 41076063]; MOST [2007CB815904]; SOA [201105021]; Czech [GACR P501/10/0221, Algatech CZ.1.05/2.1.00/03.0110, AV0Z50200510]; NSERC, Canada	NSFC(National Natural Science Foundation of China (NSFC)); MOST; SOA; Czech(Czech Republic Government); NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the NSFC project (91028001), the MOST project (2007CB815904), the NSFC project (41076063), and the SOA project (201105021). Michal Koblizek was supported by Czech projects GACR P501/10/0221, Algatech CZ.1.05/2.1.00/03.0110 and the Inst. research concept AV0Z50200510. Vladimir Yurkov is funded by NSERC, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock MI, 2007, FEMS MICROBIOL LETT, V271, P202, DOI 10.1111/j.1574-6968.2007.00719.x; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Cho JC, 2007, ENVIRON MICROBIOL, V9, P1456, DOI 10.1111/j.1462-2920.2007.01264.x; Elsen S, 1998, J BIOL CHEM, V273, P30762, DOI 10.1074/jbc.273.46.30762; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Fuchs BM, 2007, P NATL ACAD SCI USA, V104, P2891, DOI 10.1073/pnas.0608046104; Hippler B, 1997, J BACTERIOL, V179, P7181, DOI 10.1128/jb.179.22.7181-7185.1997; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Jiao NZ, 2010, J BACTERIOL, V192, P1169, DOI 10.1128/JB.01504-09; Koblizek M, 2003, ARCH MICROBIOL, V180, P327, DOI 10.1007/s00203-003-0596-6; Koblizek M., 2011, MICROBIAL CARBON PUM, V1, P49; KOBLIZEK M, 2006, DEEP SEA RES 2, V53, P17; Koblizek M, 2010, ARCH MICROBIOL, V192, P41, DOI 10.1007/s00203-009-0529-0; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; KOMIYA H, 1988, P NATL ACAD SCI USA, V85, P9012, DOI 10.1073/pnas.85.23.9012; KOYAMA Y, 1982, BIOCHIM BIOPHYS ACTA, V680, P109, DOI 10.1016/0005-2728(82)90001-9; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liotenberg S, 2008, ENVIRON MICROBIOL, V10, P2267, DOI 10.1111/j.1462-2920.2008.01649.x; LUTZ M, 1978, BIOCHIM BIOPHYS ACTA, V503, P287, DOI 10.1016/0005-2728(78)90189-5; NOGUCHI T, 1992, PHOTOSYNTH RES, V31, P21, DOI 10.1007/BF00049533; Petersen J, 2009, ENVIRON MICROBIOL, V11, P2627, DOI 10.1111/j.1462-2920.2009.01987.x; Ponnampalam SN, 1997, J BIOL CHEM, V272, P18391, DOI 10.1074/jbc.272.29.18391; Pradella S, 2004, APPL ENVIRON MICROB, V70, P3360, DOI 10.1128/AEM.70.6.3360-3369.2004; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Spring S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004866; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; Swingley Wesley D., 2009, V28, P17; Takaichi Shinichi, 2009, V28, P97; Tuschak C, 2005, ARCH MICROBIOL, V183, P431, DOI 10.1007/s00203-005-0016-1; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; Waidner LA, 2005, ENVIRON MICROBIOL, V7, P1896, DOI 10.1111/j.1462-2920.2005.00883.x; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Young CS, 1998, J BACTERIOL, V180, P4742, DOI 10.1128/JB.180.17.4742-4745.1998; Yurkov Vladimir, 2009, V28, P31; Yurkov VV, 1999, J BACTERIOL, V181, P4517, DOI 10.1128/JB.181.15.4517-4525.1999; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Yutin N, 2005, ENVIRON MICROBIOL, V7, P2027, DOI 10.1111/j.1462-2920.2005.00843.x; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; ZSEBO KM, 1984, CELL, V37, P937, DOI 10.1016/0092-8674(84)90428-8	41	42	44	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25050	10.1371/journal.pone.0025050	http://dx.doi.org/10.1371/journal.pone.0025050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949847	gold, Green Published			2022-12-25	WOS:000295260400041
J	Azevedo, D; Antunes, M; Prag, S; Ma, XY; Hacker, U; Brodland, GW; Hutson, MS; Solon, J; Jacinto, A				Azevedo, Dulce; Antunes, Marco; Prag, Soren; Ma, Xiaoyan; Hacker, Udo; Brodland, G. Wayne; Hutson, M. Shane; Solon, Jerome; Jacinto, Antonio			DRhoGEF2 Regulates Cellular Tension and Cell Pulsations in the Amnioserosa during Drosophila Dorsal Closure	PLOS ONE			English	Article							ADHERENS JUNCTIONS; APICAL CONSTRICTION; SHAPE CHANGES; ACTIN; MYOSIN; FORCES; CONTRACTILITY; MORPHOGENESIS; GASTRULATION; INVAGINATION	Coordination of apical constriction in epithelial sheets is a fundamental process during embryogenesis. Here, we show that DRhoGEF2 is a key regulator of apical pulsation and constriction of amnioserosal cells during Drosophila dorsal closure. Amnioserosal cells mutant for DRhoGEF2 exhibit a consistent decrease in amnioserosa pulsations whereas overexpression of DRhoGEF2 in this tissue leads to an increase in the contraction time of pulsations. We probed the physical properties of the amnioserosa to show that the average tension in DRhoGEF2 mutant cells is lower than wild-type and that overexpression of DRhoGEF2 results in a tissue that is more solid-like than wild-type. We also observe that in the DRhoGEF2 overexpressing cells there is a dramatic increase of apical actomyosin coalescence that can contribute to the generation of more contractile forces, leading to amnioserosal cells with smaller apical surface than wild-type. Conversely, in DRhoGEF2 mutants, the apical actomyosin coalescence is impaired. These results identify DRhoGEF2 as an upstream regulator of the actomyosin contractile machinery that drives amnioserosa cells pulsations and apical constriction.	[Azevedo, Dulce; Antunes, Marco; Prag, Soren; Jacinto, Antonio] Univ Lisbon, Fac Med, Inst Mol Med, Lisbon, Portugal; [Ma, Xiaoyan; Hutson, M. Shane] Vanderbilt Univ, Dept Phys & Astron, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37235 USA; [Hacker, Udo] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Dept Expt Med Sci, Lund, Sweden; [Brodland, G. Wayne] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Solon, Jerome] CRG Ctr Genom Regulat, Barcelona, Spain; [Jacinto, Antonio] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Vanderbilt University; Lund University; University of Waterloo; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Instituto Gulbenkian de Ciencia	Azevedo, D (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Lisbon, Portugal.	ajacinto@fm.ul.pt	Solon, Jerome/H-2039-2015; Jacinto, Antonio/F-5729-2013; Antunes, Marilia C. S./G-8864-2015; MA, XIAO/HHN-5611-2022	Jacinto, Antonio/0000-0002-4193-6089; Antunes, Marilia C. S./0000-0002-1257-2829; Solon, jerome/0000-0001-9967-9794	Fundacao para a Ciencia e Tecnologia [PTDC/BIABCM/65872/2006]; Human Frontiers Research Program [RGP0021/2007]; European Research Council [208631-RESEAL]; Boehringer Ingelheim	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Human Frontiers Research Program; European Research Council(European Research Council (ERC)European Commission); Boehringer Ingelheim(Boehringer Ingelheim)	This work was funded by Fundacao para a Ciencia e Tecnologia (PTDC/BIABCM/65872/2006), Human Frontiers Research Program (RGP0021/2007) and European Research Council (208631-RESEAL). M. A. visit to M. S. H. laboratory was supported by Boehringer Ingelheim Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmchi MP, 2005, J CELL BIOL, V168, P575, DOI 10.1083/jcb.200407124; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos I, 2010, GENETICS, V184, P129, DOI 10.1534/genetics.109.110288; Chou TB, 1996, GENETICS, V144, P1673; David DJV, 2010, DEVELOPMENT, V137, P1645, DOI 10.1242/dev.044107; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Hutson MS, 2003, SCIENCE; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Ma XY, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036004; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Oda H, 2001, J CELL SCI, V114, P493; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Simoes S, 2006, DEVELOPMENT, V133, P4257, DOI 10.1242/dev.02588; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Wood William, 2004, V294, P203; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	28	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e23964	10.1371/journal.pone.0023964	http://dx.doi.org/10.1371/journal.pone.0023964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949688	Green Published, gold			2022-12-25	WOS:000295173800010
J	Melzner, F; Stange, P; Trubenbach, K; Thomsen, J; Casties, I; Panknin, U; Gorb, SN; Gutowska, MA				Melzner, Frank; Stange, Paul; Truebenbach, Katja; Thomsen, Joern; Casties, Isabel; Panknin, Ulrike; Gorb, Stanislav N.; Gutowska, Magdalena A.			Food Supply and Seawater pCO(2) Impact Calcification and Internal Shell Dissolution in the Blue Mussel Mytilus edulis	PLOS ONE			English	Article							ACID-BASE-BALANCE; OCEAN ACIDIFICATION; FILTRATION-RATE; GROWTH; CO2; EXPOSURE; TEMPERATURES; HYPERCAPNIA; METABOLISM; RESPONSES	Progressive ocean acidification due to anthropogenic CO2 emissions will alter marine ecosytem processes. Calcifying organisms might be particularly vulnerable to these alterations in the speciation of the marine carbonate system. While previous research efforts have mainly focused on external dissolution of shells in seawater under saturated with respect to calcium carbonate, the internal shell interface might be more vulnerable to acidification. In the case of the blue mussel Mytilus edulis, high body fluid pCO(2) causes low pH and low carbonate concentrations in the extrapallial fluid, which is in direct contact with the inner shell surface. In order to test whether elevated seawater pCO(2) impacts calcification and inner shell surface integrity we exposed Baltic M. edulis to four different seawater pCO(2) (39, 142, 240, 405 Pa) and two food algae (310-350 cells mL(-1) vs. 1600-2000 cells mL(-1)) concentrations for a period of seven weeks during winter (5 degrees C). We found that low food algae concentrations and high pCO(2) values each significantly decreased shell length growth. Internal shell surface corrosion of nacreous (= aragonite) layers was documented via stereomicroscopy and SEM at the two highest pCO(2) treatments in the high food group, while it was found in all treatments in the low food group. Both factors, food and pCO(2), significantly influenced the magnitude of inner shell surface dissolution. Our findings illustrate for the first time that integrity of inner shell surfaces is tightly coupled to the animals' energy budget under conditions of CO2 stress. It is likely that under food limited conditions, energy is allocated to more vital processes (e. g. somatic mass maintenance) instead of shell conservation. It is evident from our results that mussels exert significant biological control over the structural integrity of their inner shell surfaces.	[Melzner, Frank; Stange, Paul; Truebenbach, Katja; Thomsen, Joern; Casties, Isabel; Panknin, Ulrike] Leibniz Inst Marine Sci IFM GEOMAR, Kiel, Germany; [Truebenbach, Katja] Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, Cascais, Portugal; [Gorb, Stanislav N.] Univ Kiel, Inst Zool Funct Morphol & Biomech, Kiel, Germany; [Gutowska, Magdalena A.] Univ Kiel, Inst Physiol, D-2300 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Universidade de Lisboa; University of Kiel; University of Kiel	Melzner, F (corresponding author), Leibniz Inst Marine Sci IFM GEOMAR, Kiel, Germany.	fmelzner@ifm-geomar.de	Melzner, Frank/X-4339-2018; Trubenbach, Katja/I-4841-2012	Melzner, Frank/0000-0002-5884-1318; Trubenbach, Katja/0000-0002-1824-608X	DFG; German 'Biological impacts of ocean acidification (BIOACID)' [3.1.4]; Federal Ministry of Education and Research (BMBF) [FKZ 03F0608A]	DFG(German Research Foundation (DFG)); German 'Biological impacts of ocean acidification (BIOACID)'; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	FM and MAG were funded by the DFG Excellence Cluster 'Future Ocean' and the German 'Biological impacts of ocean acidification (BIOACID)' project 3.1.4, funded by the Federal Ministry of Education and Research (BMBF, FKZ 03F0608A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; AKBERALI HB, 1980, J EXP MAR BIOL ECOL, V43, P1, DOI 10.1016/0022-0981(80)90143-4; AKBERALI HB, 1983, J MOLLUS STUD, V49, P93; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Braby CE, 2006, J EXP BIOL, V209, P2554, DOI 10.1242/jeb.02259; BURNETT LE, 1988, AM ZOOL, V28, P125; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; CRENSHAW MA, 1969, AM ZOOL, V9, P881; DECKER GL, 1987, DEVELOPMENT, V101, P297; Doney SC, 2009, OCEANOGRAPHY, V22, P16, DOI 10.5670/oceanog.2009.93; Dugal LP, 1939, J CELL COMPAR PHYSL, V13, P235, DOI 10.1002/jcp.1030130210; El-Dessouky H.T., 2002, FUNDAMENTALS SALTWAT, V1st; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; GOCKE K, 1991, INT REV GES HYDROBIO, V76, P371, DOI 10.1002/iroh.19910760310; Gutowska MA, 2010, MAR BIOL, V157, P1653, DOI 10.1007/s00227-010-1438-0; Gutowska MA, 2010, J COMP PHYSIOL B, V180, P323, DOI 10.1007/s00360-009-0412-y; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; JOKUMSEN A, 1982, J EXP MAR BIOL ECOL, V61, P189, DOI 10.1016/0022-0981(82)90008-9; Kadar E, 2008, J EXP MAR BIOL ECOL, V362, P71, DOI 10.1016/j.jembe.2008.05.014; Kadar E, 2009, MAR BIOL, V156, P959, DOI 10.1007/s00227-009-1140-2; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lafarga de la Cruz F, 2006, AQUACULTURE ENG, V35, P51; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lewis E., 1998, ORNLCDIAC105; LINDINGER MI, 1984, MAR BIOL LETT, V5, P371; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; MOHLENBERG F, 1978, OPHELIA, V17, P239, DOI 10.1080/00785326.1978.10425487; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; NEFF JM, 1972, TISSUE CELL, V4, P591, DOI 10.1016/S0040-8166(72)80032-6; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Riisgard HU, 2007, MAR ECOL PROG SER, V343, P141, DOI 10.3354/meps06930; RIISGARD HU, 1979, MAR BIOL, V52, P61, DOI 10.1007/BF00386858; Rousseau M, 2005, J STRUCT BIOL, V149, P149, DOI 10.1016/j.jsb.2004.09.005; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Stuckas H, 2009, EVOLUTIONARY IMPLICA; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P331, DOI 10.1016/j.cbpa.2011.06.022; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Tunnicliffe V, 2009, NAT GEOSCI, V2, P344, DOI 10.1038/NGEO500; Waite J.H., 1983, P467; Weiss IM, 2010, CHEMBIOCHEM, V11, P297, DOI 10.1002/cbic.200900677; Wilt FH, 2008, EXP CELL RES, V314, P1744, DOI 10.1016/j.yexcr.2008.01.036; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	59	274	280	1	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24223	10.1371/journal.pone.0024223	http://dx.doi.org/10.1371/journal.pone.0024223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949698	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295173800013
J	Tachibana, M; Hashino, M; Nishida, T; Shimizu, T; Watarai, M				Tachibana, Masato; Hashino, Masanori; Nishida, Takashi; Shimizu, Takashi; Watarai, Masahisa			Protective Role of Heme Oxygenase-1 in Listeria monocytogenes-Induced Abortion	PLOS ONE			English	Article							CARBON-MONOXIDE SUPPRESS; TO-CELL SPREAD; COBALT-PROTOPORPHYRIN; IMMUNE-RESPONSE; UP-REGULATION; MURINE MODEL; EXPRESSION; INFECTION; PREGNANCY; APOPTOSIS	It is well-known fact that various pathogens, including bacteria, virus, and protozoa, induce abortion in humans and animals. However the mechanisms of infectious abortion are little known. In this study, we demonstrated that Listeria monocytogenes infection in trophoblast giant cells decreased heme oxygenase (HO)-1 and B-cell lymphoma-extra large (Bcl-XL) expression, and that their overexpression inhibited cell death induced by the infection. Furthermore, HO-1 and Bcl-XL expression levels were also decreased by L. monocytogenes in pregnant mice. Treatment with cobalt protoporphyrin, which is known to induce HO-1, inhibited infectious abortion. Taken together, our study indicates that L. monocytogenes infection decreases HO-1 and Bcl-XL expression and induces cell death in placenta, leading to infectious abortion.	[Tachibana, Masato; Watarai, Masahisa] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Tachibana, Masato; Hashino, Masanori; Nishida, Takashi; Shimizu, Takashi; Watarai, Masahisa] Yamaguchi Univ, Fac Agr, Dept Vet Publ Hlth, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University	Tachibana, M (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan.	watarai@yamaguchi-u.ac.jp			Ministry of Education, Science, Sports and Culture [22580333]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported partially by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C), 22580333. Website: http://www.mext.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abram M, 2003, FEMS IMMUNOL MED MIC, V35, P177, DOI 10.1016/S0928-8244(02)00449-2; Abram M, 2002, VIRCHOWS ARCH, V441, P368, DOI 10.1007/s00428-002-0649-2; Albieri A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-34; Barber A, 2001, FASEB J, V15, P1158, DOI 10.1096/fj.00-0376com; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103, DOI 10.1128/AAC.43.9.2103; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Cross JC, 2000, SEMIN CELL DEV BIOL, V11, P105, DOI 10.1006/scdb.2000.0156; Fernandez P, 2003, BIOCHEM PHARMACOL, V66, P2049, DOI 10.1016/S0006-2952(03)00543-4; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Guleria I, 2000, NAT MED, V6, P589, DOI 10.1038/75074; Guzman CA, 1996, MOL MICROBIOL, V20, P119, DOI 10.1111/j.1365-2958.1996.tb02494.x; Hara H, 2007, INFECT IMMUN, V75, P3791, DOI 10.1128/IAI.01779-06; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Ihara N, 1998, FEBS LETT, V439, P163, DOI 10.1016/S0014-5793(98)01324-6; Irvin EA, 2008, REPROD TOXICOL, V26, P123, DOI 10.1016/j.reprotox.2008.07.007; Kruger AL, 2006, J PHARMACOL EXP THER, V319, P1144, DOI 10.1124/jpet.106.107482; Le Monnier A, 2006, INFECT IMMUN, V74, P663, DOI 10.1128/IAI.74.1.663-672.2006; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Merrick JC, 1997, AM J PATHOL, V151, P785; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Poros-Gluchowska Joanna, 2003, Acta Microbiologica Polonica, V52, P113; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rogers HW, 1996, J IMMUNOL, V156, P679; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Soares MP, 1999, IMMUNOL TODAY, V20, P434, DOI 10.1016/S0167-5699(99)01530-3; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Sollwedel A, 2005, J IMMUNOL, V175, P4875, DOI 10.4049/jimmunol.175.8.4875; Tachibana M, 2008, MICROB PATHOGENESIS, V45, P105, DOI 10.1016/j.micpath.2008.04.002; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tullius SG, 2002, TRANSPLANTATION, V74, P591, DOI 10.1097/00007890-200209150-00001; Watanabe K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-212; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Woo J, 2000, TRANSPLANTATION, V69, P623, DOI 10.1097/00007890-200002270-00026; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005; Zenclussen AC, 2005, INT IMMUNOPHARMACOL, V5, P41, DOI 10.1016/j.intimp.2004.09.011; Zenclussen AC, 2003, AM J REPROD IMMUNOL, V50, P66, DOI 10.1034/j.1600-0897.2003.00047.x; Zenclussen AC, 2002, SCAND J IMMUNOL, V55, P560, DOI 10.1046/j.1365-3083.2002.01091.x; Zenclussen ML, 2006, J REPROD IMMUNOL, V69, P35, DOI 10.1016/j.jri.2005.10.001; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	50	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25046	10.1371/journal.pone.0025046	http://dx.doi.org/10.1371/journal.pone.0025046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949846	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800061
J	Texel, SJ; Zhang, J; Camandola, S; Unger, EL; Taub, DD; Koehler, RC; Harris, ZL; Mattson, MP				Texel, Sarah J.; Zhang, Jian; Camandola, Simonetta; Unger, Erica L.; Taub, Dennis D.; Koehler, Raymond C.; Harris, Z. Leah; Mattson, Mark P.			Ceruloplasmin Deficiency Reduces Levels of Iron and BDNF in the Cortex and Striatum of Young Mice and Increases Their Vulnerability to Stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; INHERITED NEURODEGENERATIVE DISEASE; STABILIZING CALCIUM HOMEOSTASIS; NEUROTROPHIC FACTOR EXPRESSION; FIBROBLAST-GROWTH-FACTOR; LIPID-PEROXIDATION; FUNCTIONAL RECOVERY; DELAYED TOLERANCE; OXIDATIVE STRESS; ISCHEMIC-STROKE	Ceruloplasmin (Cp) is an essential ferroxidase that plays important roles in cellular iron trafficking. Previous findings suggest that the proper regulation and subcellular localization of iron are very important in brain cell function and viability. Brain iron dyshomeostasis is observed during normal aging, as well as in several neurodegenerative disorders such as Alzheimer's, Parkinson's and Huntington's diseases, coincident with areas more susceptible to insults. Because of their high metabolic demand and electrical excitability, neurons are particularly vulnerable to ischemic injury and death. We therefore set out to look for abnormalities in the brain of young adult mice that lack Cp. We found that iron levels in the striatum and cerebral cortex of these young animals are significantly lower than wild-type (WT) controls. Also mRNA levels of the neurotrophin brain derived neurotrophic factor (BDNF), known for its role in maintenance of cell viability, were decreased in these brain areas. Chelator-mediated depletion of iron in cultured neural cells resulted in reduced BDNF expression by a posttranscriptional mechanism, suggesting a causal link between low brain iron levels and reduced BDNF expression. When the mice were subjected to middle cerebral artery occlusion, a model of focal ischemic stroke, we found increased brain damage in Cp-deficient mice compared to WT controls. Our data indicate that lack of Cp increases neuronal susceptibility to ischemic injury by a mechanism that may involve reduced levels of iron and BDNF.	[Texel, Sarah J.; Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Texel, Sarah J.; Camandola, Simonetta; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Zhang, Jian; Koehler, Raymond C.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Unger, Erica L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Taub, Dennis D.] NIA, Labs Immunol, NIH, Baltimore, MD 21224 USA; [Harris, Z. Leah] Vanderbilt Univ, Dept Pediat, Nashville, TN USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vanderbilt University	Texel, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012	Harris, Zena Leah/0000-0003-0110-8438	National Institute on Aging; National Institutes of Health [NS038684, NS067525]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038684, R01NS067525, R37NS067525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000104] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institute on Aging Intramural Research Program, and the National Institutes of Health grants NS038684 and NS067525 (R. C. K.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; BIELENBERG GW, 1990, STROKE, V21, P161; Castellanos M, 2002, BRAIN RES, V952, P1, DOI 10.1016/S0006-8993(02)03179-7; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; Chua ACG, 2007, CRIT REV CL LAB SCI, V44, P413, DOI 10.1080/10408360701428257; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Gille G, 2011, J NEURAL TRANSM, V118, P349, DOI 10.1007/s00702-010-0503-7; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; Gratacos E, 2001, J NEUROCHEM, V78, P1287, DOI 10.1046/j.1471-4159.2001.00538.x; HALL ED, 1992, ANN NEUROL, V32, pS137, DOI 10.1002/ana.410320724; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Harris ZL, 1998, AM J CLIN NUTR, V67, p972S, DOI 10.1093/ajcn/67.5.972S; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Jiang N, 1996, J NEUROL SCI, V139, P173; Kaneko K, 2002, FREE RADICAL RES, V36, P303, DOI 10.1080/10715760290019327; Kaneko K, 2008, NEUROSCI LETT, V446, P56, DOI 10.1016/j.neulet.2008.08.089; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kruman I, 1997, J NEUROSCI, V17, P5089; KUMON Y, 1993, BRAIN RES, V605, P169, DOI 10.1016/0006-8993(93)91369-4; Lee HJ, 2010, J NEUROSCI RES, V88, P3282, DOI 10.1002/jnr.22474; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; MACMILLAN V, 1993, CAN J NEUROL SCI, V20, P41, DOI 10.1017/S0317167100047387; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1007/BF03206571; Mattson MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.005.2010; Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004; MATTSON MP, 1993, STROKE, V24, pI136; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Millan M, 2007, STROKE, V38, P90, DOI 10.1161/01.STR.0000251798.25803.e0; Millerot-Serrurot E, 2008, NEUROCHEM INT, V52, P1442, DOI 10.1016/j.neuint.2008.04.002; OUBIDAR M, 1994, FREE RADICAL BIO MED, V16, P861, DOI 10.1016/0891-5849(94)90205-4; PALMER C, 1994, STROKE, V25, P1039, DOI 10.1161/01.STR.25.5.1039; Patel BN, 2002, J NEUROSCI, V22, P6578; Pinero DJ, 2000, J NUTR, V130, P254, DOI 10.1093/jn/130.2.254; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Prass K, 2002, J CEREBR BLOOD F MET, V22, P520, DOI 10.1097/00004647-200205000-00003; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Selim MH, 2004, AGEING RES REV, V3, P345, DOI 10.1016/j.arr.2004.04.001; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; SOLONIUK DS, 1992, SURG NEUROL, V38, P110, DOI 10.1016/0090-3019(92)90087-4; Texel SJ, 2008, BIOCHEM SOC T, V36, P1277, DOI 10.1042/BST0361277; Tran PV, 2008, J NUTR, V138, P2495, DOI 10.3945/jn.108.091553; Vallerio LG, 2007, TOXICOL MECH METHOD, V17, P497, DOI 10.1080/15376510701556690; Vassiliev V, 2005, BRAIN RES REV, V49, P633, DOI 10.1016/j.brainresrev.2005.03.003; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Weinreb O, 2010, ANTIOXID REDOX SIGN, V13, P919, DOI 10.1089/ars.2009.2929; Windle V, 2007, EUR J NEUROSCI, V26, P1822, DOI 10.1111/j.1460-9568.2007.05799.x; Xu XY, 2004, ANN NY ACAD SCI, V1012, P299, DOI 10.1196/annals.1306.024; Yamamoto K, 2002, BBA-MOL BASIS DIS, V1588, P195, DOI 10.1016/S0925-4439(02)00165-5; Yoshida K, 2000, J NEUROL SCI, V175, P91, DOI 10.1016/S0022-510X(00)00295-1; YOUDIM MBH, 1978, P NUTR SOC, V37, P173, DOI 10.1079/PNS19780022; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200; Zhang J, 2008, STROKE, V39, P967, DOI 10.1161/STROKEAHA.107.497412; Zhang Y, 2001, STROKE, V32, P1378, DOI 10.1161/01.STR.32.6.1378; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005; Zhao LR, 2001, NEUROSCI LETT, V305, P169, DOI 10.1016/S0304-3940(01)01837-7; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	72	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25077	10.1371/journal.pone.0025077	http://dx.doi.org/10.1371/journal.pone.0025077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949858	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800063
J	Williams, BL; Hornig, M; Buie, T; Bauman, ML; Paik, MC; Wick, I; Bennett, A; Jabado, O; Hirschberg, DL; Lipkin, WI				Williams, Brent L.; Hornig, Mady; Buie, Timothy; Bauman, Margaret L.; Paik, Myunghee Cho; Wick, Ivan; Bennett, Ashlee; Jabado, Omar; Hirschberg, David L.; Lipkin, W. Ian			Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ISOMALTASE GENE-EXPRESSION; SPECTRUM DISORDERS; SUCRASE-ISOMALTASE; DIETARY INTERVENTION; MICROBIAL COMMUNITY; COLONIC MICROBIOTA; REGRESSIVE AUTISM; VIRAL-INFECTION; GUT MICROBIOTA	Gastrointestinal disturbances are commonly reported in children with autism, complicate clinical management, and may contribute to behavioral impairment. Reports of deficiencies in disaccharidase enzymatic activity and of beneficial responses to probiotic and dietary therapies led us to survey gene expression and the mucoepithelial microbiota in intestinal biopsies from children with autism and gastrointestinal disease and children with gastrointestinal disease alone. Ileal transcripts encoding disaccharidases and hexose transporters were deficient in children with autism, indicating impairment of the primary pathway for carbohydrate digestion and transport in enterocytes. Deficient expression of these enzymes and transporters was associated with expression of the intestinal transcription factor, CDX2. Metagenomic analysis of intestinal bacteria revealed compositional dysbiosis manifest as decreases in Bacteroidetes, increases in the ratio of Firmicutes to Bacteroidetes, and increases in Betaproteobacteria. Expression levels of disaccharidases and transporters were associated with the abundance of affected bacterial phylotypes. These results indicate a relationship between human intestinal gene expression and bacterial community structure and may provide insights into the pathophysiology of gastrointestinal disturbances in children with autism.	[Williams, Brent L.; Hornig, Mady; Wick, Ivan; Bennett, Ashlee; Jabado, Omar; Hirschberg, David L.; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA; [Buie, Timothy] Massachusetts Gen Hosp, Div Pediat Gastroenterol & Nutr, Boston, MA 02114 USA; [Bauman, Margaret L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Bauman, Margaret L.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Bauman, Margaret L.] Massachusetts Gen Hosp, LADDERS, Boston, MA 02114 USA; [Bauman, Margaret L.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Paik, Myunghee Cho] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA	Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University	Williams, BL (corresponding author), Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA.	wil2001@columbia.edu	Hornig, Mady/AAE-8431-2020; Lipkin, W. Ian/ABE-6216-2020	Hornig, Mady/0000-0001-7572-3092; Lipkin, W. Ian/0000-0002-8768-9386; Bauman, Margaret/0000-0002-3229-0458	National Institutes of Health [NS047537]; Google.org; Department of Defense; Cure Autism Now (CAN); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Google.org; Department of Defense(United States Department of Defense); Cure Autism Now (CAN); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NS047537), Google.org, Department of Defense, and Cure Autism Now (CAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Ashwood P, 2004, J CLIN IMMUNOL, V24, P664, DOI 10.1007/s10875-004-6241-6; Ashwood P, 2003, J CLIN IMMUNOL, V23, P504, DOI 10.1023/B:JOCI.0000010427.05143.bb; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Balakrishnan A, 2008, SURGERY, V144, P168, DOI 10.1016/j.surg.2008.03.010; Bandini LG, 2010, J PEDIATR-US, V157, P259, DOI 10.1016/j.jpeds.2010.02.013; Barros R, 2009, SCAND J GASTROENTERO, V44, P124, DOI 10.1080/00365520802530846; Ben-Amor K, 2005, APPL ENVIRON MICROB, V71, P4679, DOI 10.1128/AEM.71.8.4679-4689.2005; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Buning C, 2003, SCAND J GASTROENTERO, V38, P538, DOI 10.1080/00365520310000555; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Curin JM, 2003, J AUTISM DEV DISORD, V33, P443, DOI 10.1023/A:1025019030121; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DEufemia P, 1996, ACTA PAEDIATR, V85, P1076, DOI 10.1111/j.1651-2227.1996.tb14220.x; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Emond A, 2010, PEDIATRICS, V126, pE337, DOI 10.1542/peds.2009-2391; Emvo EN, 1996, J PEDIATR GASTR NUTR, V23, P262, DOI 10.1097/00005176-199610000-00010; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; FULLWOOD A, 1995, ANNU REV MED, V46, P483; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Gillevet P, 2010, CHEM BIODIVERS, V7, P1065, DOI 10.1002/cbdv.200900322; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Gupta G, 2005, GASTROENTEROLOGY, V129, P819, DOI 10.1053/j.gastro.2005.06.022; Gurney JG, 2006, ARCH PEDIAT ADOL MED, V160, P825, DOI 10.1001/archpedi.160.8.825; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMER HF, 1989, J CLIN INVEST, V84, P1056, DOI 10.1172/JCI114267; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Herndon AC, 2009, J AUTISM DEV DISORD, V39, P212, DOI 10.1007/s10803-008-0606-2; HODIN RA, 1995, AM J PHYSIOL-CELL PH, V269, pC385, DOI 10.1152/ajpcell.1995.269.2.C385; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hornig M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003140; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ikeda H, 2007, LAB INVEST, V87, P559, DOI 10.1038/labinvest.3700556; ISERI E, 2010, J AUTISM DEV DISORD; Jacobs DM, 2009, CURR DRUG METAB, V10, P41, DOI 10.2174/138920009787048383; Jyonouchi H, 2005, NEUROPSYCHOBIOLOGY, V51, P77, DOI 10.1159/000084164; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kishi K, 1999, J NUTR, V129, P953, DOI 10.1093/jn/129.5.953; Knivsberg AM, 2002, NUTR NEUROSCI, V5, P251, DOI 10.1080/10284150290028945; Levy SE, 2007, BIOL PSYCHIAT, V61, P492, DOI 10.1016/j.biopsych.2006.07.013; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LOSSOS A, 1995, NEUROLOGY, V45, P416, DOI 10.1212/WNL.45.3.416; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Matosin-Matekalo M, 1998, BIOCHEM J, V334, P633, DOI 10.1042/bj3340633; Mochizuki K, 2010, MOL NUTR FOOD RES, V54, P1445, DOI 10.1002/mnfr.200900467; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; RAITEN DJ, 1986, J AUTISM DEV DISORD, V16, P133, DOI 10.1007/BF01531725; Rauch M, 2010, GUT MICROBES, V1, P335, DOI 10.4161/gmic.1.5.13169; Richler J, 2006, J AUTISM DEV DISORD, V36, P299, DOI 10.1007/s10803-005-0070-1; Robayo-Torres CC, 2006, CLIN GASTROENTEROL H, V4, P276, DOI 10.1016/j.cgh.2005.12.023; Sandler RH, 2000, J CHILD NEUROL, V15, P429, DOI 10.1177/088307380001500701; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schreck KA, 2004, J AUTISM DEV DISORD, V34, P433, DOI 10.1023/B:JADD.0000037419.78531.86; SHEARER TR, 1982, J AUTISM DEV DISORD, V12, P25, DOI 10.1007/BF01531671; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sudo N, 1997, J IMMUNOL, V159, P1739; Suh E, 1996, MOL CELL BIOL, V16, P619; Suzuki K, 2007, BIOL PSYCHIAT, V62, P267, DOI 10.1016/j.biopsych.2006.08.001; Swallow DM, 2003, NUTR RES REV, V16, P37, DOI 10.1079/NRR200253; Tanaka T, 2008, LIFE SCI, V83, P122, DOI 10.1016/j.lfs.2008.05.007; Torrente F, 2002, MOL PSYCHIATR, V7, P375, DOI 10.1038/sj/mp/4001077; Troelsen JT, 1997, BIOCHEM J, V322, P833, DOI 10.1042/bj3220833; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uesaka T, 2004, J MOL BIOL, V337, P647, DOI 10.1016/j.jmb.2004.01.061; Vesper BJ, 2009, CURR DRUG METAB, V10, P84, DOI 10.2174/138920009787048392; Wakefield AJ, 2005, EUR J GASTROEN HEPAT, V17, P827, DOI 10.1097/00042737-200508000-00009; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285; White JF, 2003, EXP BIOL MED, V228, P639, DOI 10.1177/153537020322800601; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Williams BL, 2006, BRAIN PATHOL, V16, P1, DOI 10.1111/j.1750-3639.2006.tb00556.x; Williams BL, 2007, J VIROL, V81, P2675, DOI 10.1128/JVI.02245-06; Wong JMW, 2007, J NUTR, V137, p2539S, DOI 10.1093/jn/137.11.2539S; Ziambaras T, 1996, J BIOL CHEM, V271, P1237, DOI 10.1074/jbc.271.2.1237; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	93	285	310	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24585	10.1371/journal.pone.0024585	http://dx.doi.org/10.1371/journal.pone.0024585			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949732	Green Published, gold			2022-12-25	WOS:000295173800029
J	Beesley, J; Pickett, HA; Johnatty, SE; Dunning, AM; Chen, XQ; Li, J; Michailidou, K; Lu, Y; Rider, DN; Palmieri, RT; Stutz, MD; Lambrechts, D; Despierre, E; Lambrechts, S; Vergote, I; Chang-Claude, J; Nickels, S; Vrieling, A; Flesch-Janys, D; Wang-Gohrke, S; Eilber, U; Bogdanova, N; Antonenkova, N; Runnebaum, IB; Dork, T; Goodman, MT; Lurie, G; Wilkens, LR; Matsuno, RK; Kiemeney, LA; Aben, KKH; Marees, T; Massuger, LFAG; Fridley, BL; Vierkant, RA; Bandera, EV; Olson, SH; Orlow, I; Rodriguez-Rodriguez, L; Cook, LS; Le, ND; Brooks-Wilson, A; Kelemen, LE; Campbell, I; Gayther, SA; Ramus, SJ; Gentry-Maharaj, A; Menon, U; Ahmed, S; Baynes, C; Pharoah, PD; Muir, K; Lophatananon, A; Chaiwerawattana, A; Wiangnon, S; Macgregor, S; Easton, DF; Reddel, RR; Goode, EL; Chenevix-Trench, G				Beesley, Jonathan; Pickett, Hilda A.; Johnatty, Sharon E.; Dunning, Alison M.; Chen, Xiaoqing; Li, Jun; Michailidou, Kyriaki; Lu, Yi; Rider, David N.; Palmieri, Rachel T.; Stutz, Michael D.; Lambrechts, Diether; Despierre, Evelyn; Lambrechts, Sandrina; Vergote, Ignace; Chang-Claude, Jenny; Nickels, Stefan; Vrieling, Alina; Flesch-Janys, Dieter; Wang-Gohrke, Shan; Eilber, Ursula; Bogdanova, Natalia; Antonenkova, Natalia; Runnebaum, Ingo B.; Doerk, Thilo; Goodman, Marc T.; Lurie, Galina; Wilkens, Lynne R.; Matsuno, Rayna K.; Kiemeney, Lambertus A.; Aben, Katja K. H.; Marees, Tamara; Massuger, Leon F. A. G.; Fridley, Brooke L.; Vierkant, Robert A.; Bandera, Elisa V.; Olson, Sara H.; Orlow, Irene; Rodriguez-Rodriguez, Lorna; Cook, Linda S.; Le, Nhu D.; Brooks-Wilson, Angela; Kelemen, Linda E.; Campbell, Ian; Gayther, Simon A.; Ramus, Susan J.; Gentry-Maharaj, Aleksandra; Menon, Usha; Ahmed, Shahana; Baynes, Caroline; Pharoah, Paul D.; Muir, Kenneth; Lophatananon, Artitaya; Chaiwerawattana, Arkom; Wiangnon, Surapon; Macgregor, Stuart; Easton, Douglas F.; Reddel, Roger R.; Goode, Ellen L.; Chenevix-Trench, Georgia		kConFab Investigators; Australian Ovarian Can Study Grp; ABCTB Investigators; Ovarian Canc Assoc Consortium	Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; IDENTIFIES 5; VARIANTS; 19P13; SNPS	Genetic variation at the TERT-CLPTM1L locus at 5p15.33 is associated with susceptibility to several cancers, including epithelial ovarian cancer (EOC). We have carried out fine-mapping of this region in EOC which implicates an association with a single nucleotide polymorphism (SNP) within the TERT promoter. We demonstrate that the minor alleles at rs2736109, and at an additional TERT promoter SNP, rs2736108, are associated with decreased breast cancer risk, and that the combination of both SNPs substantially reduces TERT promoter activity.	[Beesley, Jonathan; Johnatty, Sharon E.; Chen, Xiaoqing; Li, Jun; Lu, Yi; Macgregor, Stuart; Chenevix-Trench, Georgia] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [Pickett, Hilda A.; Stutz, Michael D.; Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia; [Pickett, Hilda A.; Stutz, Michael D.; Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Dunning, Alison M.; Michailidou, Kyriaki; Ahmed, Shahana; Baynes, Caroline; Pharoah, Paul D.; Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Cambridge, England; [Rider, David N.; Fridley, Brooke L.; Vierkant, Robert A.; Goode, Ellen L.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Palmieri, Rachel T.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Louvain, Belgium; [Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Despierre, Evelyn; Lambrechts, Sandrina; Vergote, Ignace] Univ Leuven, Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Gynaecol Oncol, Louvain, Belgium; [Chang-Claude, Jenny; Nickels, Stefan; Vrieling, Alina; Eilber, Ursula] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, Ulm, Germany; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Clin Obstet, D-3000 Hannover, Germany; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Clin Gynaecol, D-3000 Hannover, Germany; [Bogdanova, Natalia; Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, BELARUS; [Bogdanova, Natalia] Hannover Med Sch, Clin Radiat Oncol, D-3000 Hannover, Germany; [Runnebaum, Ingo B.] Univ Jena, Clin Obstet, Jena, Germany; [Runnebaum, Ingo B.] Univ Jena, Clin Gynaecol, Jena, Germany; [Goodman, Marc T.; Lurie, Galina; Wilkens, Lynne R.; Matsuno, Rayna K.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Kiemeney, Lambertus A.; Aben, Katja K. H.; Marees, Tamara] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K. H.] Ctr Comprehens Canc, Nijmegen, Netherlands; [Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Bandera, Elisa V.; Rodriguez-Rodriguez, Lorna] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Olson, Sara H.; Orlow, Irene] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Cook, Linda S.; Le, Nhu D.; Brooks-Wilson, Angela; Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Campbell, Ian; kConFab Investigators] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Gayther, Simon A.; Ramus, Susan J.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, EGA Inst Womens Hlth, Dept Gynaecol Oncol, London, England; Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Dept Gynaecol Oncol, Sydney, NSW 2006, Australia; [Australian Ovarian Can Study Grp] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia; Sydney Med Sch, Westmead Millennium Inst, Westmead, NSW, Australia; [Muir, Kenneth; Lophatananon, Artitaya] Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Chaiwerawattana, Arkom] Minist Publ Hlth, Natl Canc Inst Thailand, Dept Acad Support, Nonthaburi, Thailand; [Wiangnon, Surapon] Khon Kaen Univ, Sch Med, Dept Pediat, Khon Kaen, Thailand	QIMR Berghofer Medical Research Institute; Children's Medical Research Institute - Australia; University of Sydney; University of Cambridge; Mayo Clinic; Duke University; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Hannover Medical School; Hannover Medical School; Hannover Medical School; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Cancer Research Center of Hawaii; University of Hawaii System; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Memorial Sloan Kettering Cancer Center; Alberta Health Services (AHS); University of Calgary; Peter Maccallum Cancer Center; University of Southern California; University of London; University College London; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Warwick; Ministry of Public Health - Thailand; Khon Kaen University	Beesley, J (corresponding author), Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia.	jonathan.beesley@qimr.edu.au	Lu, Yi/G-9292-2018; Bogdanova, Natalia V./Y-2205-2019; Michailidou, Kyriaki/ABD-5122-2020; Johnatty, Sharon E/R-8890-2016; Reddel, Roger R/A-6635-2014; Menon, Usha/C-4716-2008; campbell, Ian G/F-6006-2011; Ramus, Susan/AAG-8352-2019; Vrieling, Alina/A-2725-2016; Massuger, Leon F.A.G./H-8072-2014; Vierkant, Robert/AAP-4927-2020; Macgregor, Stuart/C-6442-2009; Brooks-Wilson, Angela/E-9399-2012; Fridley, Brooke L/D-8315-2015; Verdrengh, Evelien/H-4571-2012; Lambrechts, Diether/AAJ-3167-2020; Chenevix-Trench, Georgia/AAV-2014-2020; Aben, Katja KH/G-9686-2016; Pharoah, Paul/V-6658-2019; Bandera, Elisa V/M-4169-2014; Kiemeney, Lambertus A./D-3357-2009; Bowtell, David/H-1007-2016; Dörk, Thilo/J-8620-2012	Lu, Yi/0000-0001-9933-3654; Michailidou, Kyriaki/0000-0001-7065-1237; Johnatty, Sharon E/0000-0002-7888-1966; Reddel, Roger R/0000-0002-6302-6107; Menon, Usha/0000-0003-3708-1732; Ramus, Susan/0000-0003-0005-7798; Vrieling, Alina/0000-0002-8178-2125; Vierkant, Robert/0000-0001-6242-5221; Macgregor, Stuart/0000-0001-6731-8142; Brooks-Wilson, Angela/0000-0003-1009-6408; Fridley, Brooke L/0000-0001-7739-7956; Lambrechts, Diether/0000-0002-3429-302X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Aben, Katja KH/0000-0002-0214-2147; Pharoah, Paul/0000-0001-8494-732X; Bandera, Elisa V/0000-0002-8789-2755; Kiemeney, Lambertus A./0000-0002-2368-1326; Bowtell, David/0000-0001-9089-7525; Dörk, Thilo/0000-0002-9458-0282; Thorne, Heather/0000-0003-3610-2511; Campbell, Ian/0000-0002-7773-4155; Weber, Rachel/0000-0001-7119-7734; Orlow, Irene/0000-0001-6234-6961; Goodman, Marc/0000-0002-4839-3021; Olson, Sara/0000-0003-0182-2754; Beesley, Jonathan/0000-0003-1942-325X; Stutz, Michael/0000-0002-9298-1728; Dunning, Alison Margaret/0000-0001-6651-7166	Ovarian Cancer Research Fund; National Breast Cancer Foundation; National Health and Medical Research Council of Australia; Cancer Council of Queensland; Cancer Council of New South Wales; Cancer Council of Western Australia; Cancer Council of South Australia; Cancer Council of Victoria; National Health and Medical Research Council (NHMRC) of Australia [145684, 288704]; U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; National Health and Medical Research Council of Australia [199600]; Cancer Council Tasmania; Cancer Foundation of Western Australia; Cancer Institute NSW; Nationaal Kankerplan; U.S. National Institutes of Health [R01 CA58598, N01-CN-55424, N01-PC-67001]; Cancer Research-UK [C1287/A10118, C490/A11021, C8197/A10123]; Deutsche Krebshilfe e.V. [70-2892-BR I]; Hamburg Cancer Society; German Cancer Research Center (DKFZ); Federal Ministry of Education and Research (BMBF) Germany [01KH0402]; Deutsche Krebshilfe e. V. [70492]; state of Baden-Wurttemberg through the Medical Faculty of the University of Ulm [P.685]; British Columbia Workers Compensation Board; Canadian Institutes for Health; Cancer Institute of New Jersey; Cancer Research UK; Eve Appeal; OAK Foundation; Department of Health's NIHR Biomedical Research Centre; Breast Cancer Research Trust, UK; NHMRC [1012023];  [R01 CA122443];  [P50 CA136939];  [NIH-K07];  [CA095666];  [R01CA83918]; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067001] Funding Source: NIH RePORTER; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA122443, R01CA083918, K07CA095666, R01CA058598, K22CA138563, P50CA136393] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022] Funding Source: researchfish; Medical Research Council [G0801875] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0801875] Funding Source: UKRI	Ovarian Cancer Research Fund; National Breast Cancer Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Western Australia(Cancer Council Western Australia); Cancer Council of South Australia(Cancer Council South Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Institute NSW; Nationaal Kankerplan; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research-UK(Cancer Research UK); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Hamburg Cancer Society; German Cancer Research Center (DKFZ)(Helmholtz Association); Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); state of Baden-Wurttemberg through the Medical Faculty of the University of Ulm; British Columbia Workers Compensation Board; Canadian Institutes for Health(Canadian Institutes of Health Research (CIHR)); Cancer Institute of New Jersey; Cancer Research UK(Cancer Research UK); Eve Appeal; OAK Foundation; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Breast Cancer Research Trust, UK; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ; ; ; ; ; DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund. kConFaB is supported by the National Breast Cancer Foundation, the National Health and Medical Research Council of Australia, and the Cancer Councils of Queensland, New South Wales, Western Australia, South Australia, and Victoria. The Clinical Follow-up Study of kConFaB is funded by the National Health and Medical Research Council (NHMRC) of Australia (145684 and 288704). AOCS was supported by the U.S. Army Medical Research and Materiel Command (DAMD17-01-1-0729), the National Health and Medical Research Council of Australia (199600), and the Cancer Council Tasmania and Cancer Foundation of Western Australia. Tissues and samples were received from the Australian Breast Cancer Tissue Bank which is supported by the National Health and Medical Research Council of Australia, The Cancer Institute NSW and the National Breast Cancer Foundation. The tissues and samples are made available to researchers on a non-exclusive basis. The BEL study was supported by the Nationaal Kankerplan - actie 29. The HAW study is supported by the U.S. National Institutes of Health (R01 CA58598, N01-CN-55424, N01-PC-67001). SEARCH was supported by Cancer Research-UK grants [C1287/A10118, C490/A11021, C8197/A10123]. The MAYO study was supported by R01 CA122443 and P50 CA136939. The MARIE study was supported by the Deutsche Krebshilfe e.V., grant number 70-2892-BR I, the Hamburg Cancer Society, the German Cancer Research Center (DKFZ) and the DNA extraction and genotype work in part by the Federal Ministry of Education and Research (BMBF) Germany grant 01KH0402. The GESBC epidemiological study was supported by the Deutsche Krebshilfe e. V. [70492] and GESBC genotyping in part by the state of Baden-Wurttemberg through the Medical Faculty of the University of Ulm [P.685]. The OVAL-BC Study is supported by the British Columbia Workers Compensation Board and the Canadian Institutes for Health Research. The NJO study was funded by NIH-K07 CA095666, R01CA83918, and The Cancer Institute of New Jersey. The UKO study is supported by funding from Cancer Research UK, the Eve Appeal, and the OAK Foundation; some of this work was undertaken at UCLH/UCL which received some funding from the Department of Health's NIHR Biomedical Research Centre funding scheme. ACP study is funded by The Breast Cancer Research Trust, UK. JB, HAP, SEJ, MDS and RRR are supported by NHMRC project grant 1012023. DFE is a Principal Research Fellow of Cancer Research UK. SM is supported by an NHMRC career development award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Chen YJ, 2008, CANCER RES, V68, P5724, DOI 10.1158/0008-5472.CAN-08-0058; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kyo S, 1999, CANCER RES, V59, P5917; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6	20	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24987	10.1371/journal.pone.0024987	http://dx.doi.org/10.1371/journal.pone.0024987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949822	Green Submitted, gold, Green Published			2022-12-25	WOS:000295041700087
J	Yan, MY; Tam, FCH; Kan, BA; Lim, PL				Yan, Meiying; Tam, Frankie C. H.; Kan, Biao; Lim, Pak Leong			Combined Rapid (TUBEX) Test for Typhoid-Paratyphoid A Fever Based on Strong Anti-O12 Response: Design and Critical Assessment of Sensitivity	PLOS ONE			English	Article							ANTIBODIES; DIAGNOSIS; CHILDREN; BURDEN; IGM	Rapid diagnostics can be accurate but, often, those based on antibody detection for infectious diseases are unwittingly underrated for various reasons. Herein, we described the development of a combined rapid test for two clinically-indistinguishable bacterial diseases, typhoid and paratyphoid A fever, the latter fast emerging as a global threat. By using monoclonal antibodies (mAbs) to bacterial antigens of known chemical structures as probes, we were able to dissect the antibody response in patients at the level of monosaccharides. Thus, a mAb specific for a common lipopolysaccharide antigen (O12) found in both the causative organisms was employed to semi-quantify the amounts of anti-O12 antibodies present in both types of patients in an epitope-inhibition particle-based (TUBEX) immunoassay. This colorimetric assay detected not only anti-O12 antibodies that were abundantly produced, but also, by steric hindrance, antibodies to an adjoining epitope (O9 or O2 in the typhoid or paratyphoid bacillus, respectively). Sensitivity and, particularly, reaction intensities, were significantly better than those obtained using an anti-O9 or anti-O2 mAb-probe in the examination of paired sera from 22 culture-confirmed typhoid patients (sensitivity, 81.8% vs 75.0%) or single sera from 36 culture-confirmed paratyphoid patients (52.8% vs 28.6), respectively. Importantly, sensitivity was better (97.1% for typhoid, 75.0% for paratyphoid) if allowance was made for the absence of relevant antibodies in certain specimens as determined by an independent, objective assay (ELISA) - such specimens might have been storage-denatured (especially the older paratyphoid samples) or procured from non-responders. Benchmarking against ELISA, which revealed high concordance between the two tests, was useful and more appropriate than comparing with culture methods as traditionally done, since antibody tests and culture target slightly different stages of these diseases. Paired sera analysis was insightful, revealing 64% of typhoid patients who had no change in antibody titer over 4-16 days, and 14% with no IgM-IgG class-switching.	[Yan, Meiying; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Tam, Frankie C. H.; Lim, Pak Leong] IgGENE, Fotan, Hong Kong, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Yan, MY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	pllim@iggene.com						Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; Janeway CA, 2001, IMMUNOBIOLOGY; JANN K, 1975, ANTIGENS, P1; KAUFFMANN F, 1957, ACTA PATHOL MIC SC, V3, P242; Kawano RL, 2007, J CLIN MICROBIOL, V45, P246, DOI 10.1128/JCM.01403-06; Ley B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-147; Lim PL, 1998, J CLIN MICROBIOL, V36, P2271, DOI 10.1128/JCM.36.8.2271-2278.1998; LIM PL, 1987, MOL IMMUNOL, V24, P11; NARDIELLO S, 1984, J CLIN MICROBIOL, V20, P718, DOI 10.1128/JCM.20.4.718-721.1984; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Olsen SJ, 2003, EPIDEMIOL INFECT, V130, P13, DOI 10.1017/S0950268802007598; Parry Christopher M., 2004, Curr Infect Dis Rep, V6, P27, DOI 10.1007/s11908-004-0021-6; Rahman M, 2007, DIAGN MICR INFEC DIS, V58, P275, DOI 10.1016/j.diagmicrobio.2007.01.010; Tam FCH, 2003, J IMMUNOL METHODS, V282, P83, DOI 10.1016/j.jim.2003.07.006; Tam FCH, 2008, DIAGN MICR INFEC DIS, V62, P142, DOI 10.1016/j.diagmicrobio.2008.07.002; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Widal F., 1896, SEMAINE MED, V16, P259; World Health Organization (WHO), 2003, WHOVB0307	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24743	10.1371/journal.pone.0024743	http://dx.doi.org/10.1371/journal.pone.0024743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935450	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700053
J	Mao, YJ; Yannarell, AC; Mackie, RI				Mao, Yuejian; Yannarell, Anthony C.; Mackie, Roderick I.			Changes in N-Transforming Archaea and Bacteria in Soil during the Establishment of Bioenergy Crops	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MICROBIAL COMMUNITY STRUCTURE; GRADIENT GEL-ELECTROPHORESIS; OPERATIONAL TAXONOMIC UNITS; REAL-TIME PCR; GENE DIVERSITY; RED SOIL; ABUNDANCE; PLANT; QUANTIFICATION	Widespread adaptation of biomass production for bioenergy may influence important biogeochemical functions in the landscape, which are mainly carried out by soil microbes. Here we explore the impact of four potential bioenergy feedstock crops (maize, switchgrass, Miscanthus X giganteus, and mixed tallgrass prairie) on nitrogen cycling microorganisms in the soil by monitoring the changes in the quantity (real-time PCR) and diversity (barcoded pyrosequencing) of key functional genes (nifH, bacterial/archaeal amoA and nosZ) and 16S rRNA genes over two years after bioenergy crop establishment. The quantities of these N-cycling genes were relatively stable in all four crops, except maize (the only fertilized crop), in which the population size of AOB doubled in less than 3 months. The nitrification rate was significantly correlated with the quantity of ammonia-oxidizing archaea (AOA) not bacteria (AOB), indicating that archaea were the major ammonia oxidizers. Deep sequencing revealed high diversity of nifH, archaeal amoA, bacterial amoA, nosZ and 16S rRNA genes, with 229, 309, 330, 331 and 8989 OTUs observed, respectively. Rarefaction analysis revealed the diversity of archaeal amoA in maize markedly decreased in the second year. Ordination analysis of T-RFLP and pyrosequencing results showed that the N-transforming microbial community structures in the soil under these crops gradually differentiated. Thus far, our two-year study has shown that specific N-transforming microbial communities develop in the soil in response to planting different bioenergy crops, and each functional group responded in a different way. Our results also suggest that cultivation of maize with N-fertilization increases the abundance of AOB and denitrifiers, reduces the diversity of AOA, and results in significant changes in the structure of denitrification community.	[Mao, Yuejian; Yannarell, Anthony C.; Mackie, Roderick I.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Mao, Yuejian; Yannarell, Anthony C.; Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Yannarell, Anthony C.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Mao, YJ (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA.	r-mackie@illinois.edu	Yannarell, Anthony/AAA-1720-2019		Energy Biosciences Institute at the University of Illinois, Urbana	Energy Biosciences Institute at the University of Illinois, Urbana	This work was funded by the Energy Biosciences Institute, Environmental Impact and Sustainability of Feedstock Production Program at the University of Illinois, Urbana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briones AM, 2002, APPL ENVIRON MICROB, V68, P3067, DOI 10.1128/AEM.68.6.3067-3075.2002; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Dambreville C, 2006, FEMS MICROBIOL ECOL, V56, P119, DOI 10.1111/j.1574-6941.2006.00064.x; Davis SC, 2010, ECOSYSTEMS, V13, P144, DOI 10.1007/s10021-009-9306-9; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Diallo MD, 2004, ENVIRON MICROBIOL, V6, P400, DOI 10.1111/j.1462-2920.2004.00577.x; Duc L, 2009, MICROB ECOL, V57, P179, DOI 10.1007/s00248-008-9408-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Hai B, 2009, APPL ENVIRON MICROB, V75, P4993, DOI 10.1128/AEM.02917-08; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; HUTCHINSON GL, 1979, SCIENCE, V205, P1125, DOI 10.1126/science.205.4411.1125; JIA Z, 2009, ENV MICROBIOL; Kirchhof G, 2001, INT J SYST EVOL MICR, V51, P157, DOI 10.1099/00207713-51-1-157; Kloos K, 2001, AUST J PLANT PHYSIOL, V28, P991; Knops JMH, 2002, ECOL LETT, V5, P454, DOI 10.1046/j.1461-0248.2002.00332.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Koops H.-P., 2006, PROKARYOTES, V5, P788; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kowalchuk GA, 1997, APPL ENVIRON MICROB, V63, P1489, DOI 10.1128/AEM.63.4.1489-1497.1997; Kramer SB, 2006, P NATL ACAD SCI USA, V103, P4522, DOI 10.1073/pnas.0600359103; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin YT, 2010, PLANT SOIL, V332, P417, DOI 10.1007/s11104-010-0308-3; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Miyamoto T, 2004, APPL ENVIRON MICROB, V70, P6580, DOI 10.1128/AEM.70.11.6580-6586.2004; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; Mounier E, 2004, ENVIRON MICROBIOL, V6, P301, DOI 10.1111/j.1462-2920.2004.00571.x; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Okano Y, 2004, APPL ENVIRON MICROB, V70, P1008, DOI 10.1128/AEM.70.2.1008-1016.2004; Orr CH, 2011, APPL ENVIRON MICROB, V77, P911, DOI 10.1128/AEM.01250-10; Palmer K, 2010, APPL ENVIRON MICROB, V76, P1125, DOI 10.1128/AEM.02256-09; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Philippot L, 2007, ADV AGRON, V96, P249, DOI 10.1016/S0065-2113(07)96003-4; Poly F, 2001, APPL ENVIRON MICROB, V67, P2255, DOI 10.1128/AEM.67.5.2255-2262.2001; Priha O, 1999, FEMS MICROBIOL ECOL, V30, P187, DOI 10.1111/j.1574-6941.1999.tb00647.x; Reed DW, 2010, APPL ENVIRON MICROB, V76, P2517, DOI 10.1128/AEM.02436-09; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rich JJ, 2003, APPL ENVIRON MICROB, V69, P5974, DOI 10.1128/AEM.69.10.5974-5982.2003; Rothballer M, 2008, FEMS MICROBIOL ECOL, V66, P85, DOI 10.1111/j.1574-6941.2008.00582.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Ruiz-Rueda O, 2009, FEMS MICROBIOL ECOL, V67, P308, DOI 10.1111/j.1574-6941.2008.00615.x; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schwarz H., 1994, Industrial Crops and Products, V2, P153, DOI 10.1016/0926-6690(94)90031-0; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Son Y, 2001, ECOL RES, V16, P183, DOI 10.1046/j.1440-1703.2001.00385.x; Tan XY, 2003, ENVIRON MICROBIOL, V5, P1009, DOI 10.1046/j.1462-2920.2003.00491.x; Taylor AE, 2010, APPL ENVIRON MICROB, V76, P7691, DOI 10.1128/AEM.01324-10; Teng QH, 2009, J MICROBIOL, V47, P135, DOI 10.1007/s12275-008-0184-1; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Wakelin SA, 2007, FEMS MICROBIOL ECOL, V59, P661, DOI 10.1111/j.1574-6941.2006.00235.x; Wallenstein MD, 2006, ECOL APPL, V16, P2168, DOI 10.1890/1051-0761(2006)016[2168:NFEODA]2.0.CO;2; Wang YA, 2009, SYST APPL MICROBIOL, V32, P27, DOI 10.1016/j.syapm.2008.09.007; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; WESSEN E, 2011, ISME J; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107; Zhou J., 2011, ISME J	80	102	110	5	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24750	10.1371/journal.pone.0024750	http://dx.doi.org/10.1371/journal.pone.0024750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935454	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700042
J	Mokhtari, D; Li, TT; Lu, T; Welsh, N				Mokhtari, Dariush; Li, Tingting; Lu, Tao; Welsh, Nils			Effects of Imatinib Mesylate (Gleevec) on Human Islet NF-kappaB Activation and Chemokine Production In Vitro	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; INSULIN SENSITIVITY; CELL DEATH; GENE-EXPRESSION; B ACTIVATION; PROTECTS; GLUCOSE; CANCER; TYPE-1; PHOSPHORYLATION	Purpose: Imatinib Mesylate (Gleevec) is a drug that potently counteracts diabetes both in humans and in animal models for human diabetes. We have previously reported that this compound in human pancreatic islets stimulates NF-kappa B signaling and islet cell survival. The aim of this study was to investigate control of NF-kappa B post-translational modifications exerted by Imatinib and whether any such effects are associated with altered islet gene expression and chemokine production in vitro. Procedures: Human islets were either left untreated or treated with Imatinib for different timepoints. I kappa B-alpha and NF-kappa B p65 phosphorylation and methylation were assessed by immunoblot analysis. Islet gene expression was assessed using a commercial Pathway Finder microarray kit and RT-PCR. Islet chemokine production was determined by flow cytometric bead array analysis. Findings: Human islet I kappa B-alpha and Ser276-p65 phosphorylation were increased by a 20 minute Imatinib exposure. Methylation of p65 at position Lys221 was increased after 60 min of Imatinib exposure and persisted for 3 hours. Microarray analysis of islets exposed to Imatinib for 4 hours revealed increased expression of the inflammatory genes IL-4R, TCF5, DR5, I-TRAF, I-CAM, HSP27 and IL-8. The islet release of IL-8 was augmented in islets cultured over night in the presence of Imatinib. Following 30 hours of Imatinib exposure, the cytokine-induced I kappa B-alpha and STAT1 phosphorylation was abolished and diminished, respectively. The cytokine-induced release of the chemokines MIG and IP10 was lower in islets exposed to Imatinib for 30 hours. Conclusion: Imatinib by itself promotes a modest activation of NF-kappa B. However, a prolonged exposure of human islets to Imatinib is associated with a dampened response to cytokines. It is possible that Imatinib induces NF-kappa B preconditioning of islet cells leading to lowered cytokine sensitivity and a mitigated islet inflammation.	[Mokhtari, Dariush; Li, Tingting; Welsh, Nils] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Lu, Tao] Cleveland Clin Fdn, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA	Uppsala University; Cleveland Clinic Foundation	Mokhtari, D (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	dariush.mokhtari@mcb.uu.se			Swedish Research Council [2010-11564-15-3]; Swedish Diabetes Association; family Ernfors Fund; Novo-Nordisk Foundation; Barndiabetesfonden; Ahlen stiftelsen; Svenska Lakaresallskapet; Svenska sallskapet for medicinsk forskning; Langmanska kulturfonden; Stiftelsen Sigurd och Elsa Goljes Minne; Nordic Network for Clinical Islet Transplantation; Juvenile Diabetes Research Foundation [31-2008-413]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; family Ernfors Fund; Novo-Nordisk Foundation(Novo Nordisk Foundation); Barndiabetesfonden; Ahlen stiftelsen; Svenska Lakaresallskapet; Svenska sallskapet for medicinsk forskning; Langmanska kulturfonden; Stiftelsen Sigurd och Elsa Goljes Minne; Nordic Network for Clinical Islet Transplantation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported in part by the Swedish Research Council (2010-11564-15-3), the Swedish Diabetes Association, the family Ernfors Fund, the Novo-Nordisk Foundation, Barndiabetesfonden, Ahlen stiftelsen, Svenska Lakaresallskapet, Svenska sallskapet for medicinsk forskning, Langmanska kulturfonden and Stiftelsen Sigurd och Elsa Goljes Minne. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Nordic Network for Clinical Islet Transplantation and the Juvenile Diabetes Research Foundation are acknowledged for supply of human islets (JDRF award 31-2008-413 and the ECIT Islet for Basic Research program).	Agostino N, 2010, J ONCOL PHARM P 0804; Arun P, 2009, CLIN CANCER RES, V15, P5974, DOI 10.1158/1078-0432.CCR-09-1352; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Breccia M, 2008, LEUKEMIA RES, V32, P1626, DOI 10.1016/j.leukres.2008.01.015; Breccia M, 2004, J CLIN ONCOL, V22, P4653, DOI 10.1200/JCO.2004.04.217; Breccia M, 2005, Haematologica, V90 Suppl, pECR21; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; Chodorowski Zygmunt, 2007, Przegl Lek, V64, P370; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Costa DB, 2006, DIABETES CARE, V29, P1711, DOI 10.2337/dc06-0558; Couzin J, 2005, SCIENCE, V307, P1711; Dingli David, 2007, Endocr Pract, V13, P126; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Fitter S, 2010, J CLIN ENDOCR METAB, V95, P3763, DOI 10.1210/jc.2010-0086; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Goto T, 2005, TRANSPL P, V37, P3430, DOI 10.1016/j.transproceed.2005.09.041; Gur S, 2010, J SEX MED, V7, P3341, DOI 10.1111/j.1743-6109.2010.01922.x; Hagerkvist R, 2008, CLIN SCI, V114, P65, DOI 10.1042/CS20070122; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hagerkvist R, 2006, CELL BIOL INT, V30, P1013, DOI 10.1016/j.cellbi.2006.08.006; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Larsen L, 2005, DIABETOLOGIA, V48, P2582, DOI 10.1007/s00125-005-0039-9; Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106; Little PJ, 2009, THESCIENTIFICWORLDJO, V9, P224, DOI 10.1100/tsw.2009.28; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Maekawa T, 2007, INT J CLIN ONCOL, V12, P327, DOI 10.1007/s10147-007-0699-1; Mariani S, 2010, LEUKEMIA RES, V34, pE5, DOI 10.1016/j.leukres.2009.08.003; Mokhtari D, 2010, CLIN SCI, V118, P241, DOI 10.1042/CS20090348; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Nelson G, 2003, J CELL SCI, V116, P2495, DOI 10.1242/jcs.00461; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; Rabson AB, 2005, CLIN CANCER RES, V11, P2; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; SALDEEN J, 1994, BIOCHEM BIOPH RES CO, V203, P149, DOI 10.1006/bbrc.1994.2161; Saldeen J, 2001, BIOCHEM PHARMACOL, V61, P1561, DOI 10.1016/S0006-2952(01)00605-0; Templeton A, 2008, ANN ONCOL, V19, P824, DOI 10.1093/annonc/mdn047; Tsapas A, 2008, LEUKEMIA RES, V32, P674, DOI 10.1016/j.leukres.2007.08.014; Veneri D, 2005, NEW ENGL J MED, V352, P1049, DOI 10.1056/NEJM200503103521023; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Xiao CC, 2005, ADV EXP MED BIOL, V560, P41; Zhang WQ, 2010, MOL BIOL CELL, V21, P2500, DOI 10.1091/mbc.E09-08-0715	50	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24831	10.1371/journal.pone.0024831	http://dx.doi.org/10.1371/journal.pone.0024831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935477	Green Submitted, Green Published, gold			2022-12-25	WOS:000295039700053
J	de Morree, A; Droog, M; Moursel, LG; Bisschop, IJM; Impagliazzo, A; Frants, RR; Klooster, R; van der Maarel, SM				de Morree, Antoine; Droog, Marjolein; Moursel, Laure Grand; Bisschop, Ilona J. M.; Impagliazzo, Antonietta; Frants, Rune R.; Klooster, Rinse; van der Maarel, Silvere M.			Self-regulated alternative splicing at the AHNAK locus	FASEB JOURNAL			English	Article						LGMD; muscle differentiation; RNA expression	MYELINATING SCHWANN-CELLS; DYSFERLIN PROTEIN COMPLEX; DESMOYOKIN/AHNAK PROTEIN; MAXIMUM-LIKELIHOOD; SKELETAL-MUSCLE; PERIAXIN; GENE; EXPRESSION; SELECTION; DOMAIN	AHNAK is a 700-kDa protein involved in cytoarchitecture and calcium signaling. It is secondarily reduced in muscle of dysferlinopathy patients and accumulates in muscle of calpainopathy patients, both affected by a muscular dystrophy. AHNAK directly interacts with dysferlin. This interaction is lost on cleavage of AHNAK by the protease calpain 3, explaining the molecular observations in patients. Currently, little is known of AHNAK regulation. We describe the self-regulation of multiple mRNA transcripts emanating from the AHNAK locus in muscle cells. We show that the AHNAK gene consists of a 17-kb exon flanked by multiple small exons. This genetic structure is shared by AHNAK2 and Periaxin, which share a common ancestor. Two major AHNAK transcripts are differentially expressed during muscle differentiation that encode for a small (17-kDa) and a large (700-kDa) protein isoform. These proteins interact in the cytoplasm, but the small AHNAK is also present in the nucleus. During muscle differentiation the small AHNAK is strongly increased, thereby establishing a positive feedback loop to regulate mRNA splicing of its own locus. A small 17-kDa isoform of Periaxin similarly traffics between the cytoplasm and the nucleus to regulate mRNA splicing. Thus, AHNAK constitutes a novel mechanism in post-transcriptional control of gene expression.-De Morree, A., Droog, M., Grand Moursel, L., Bisschop, I. J. M., Impagliazzo, A., Frants, R., Klooster, R., van der Maarel, S. M. Self-regulated alternative splicing at the AHNAK locus. FASEB J. 26, 93-103 (2012). www.fasebj.org	[van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Ctr Human Genet, Dept Human Genet, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Ctr Human Genet, Dept Human Genet, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	maarel@lumc.nl	Moursel, Laure Grand/M-4194-2019; van der Maarel, Silvere/X-3631-2018; Grand Moursel, Laure/H-7061-2018	Moursel, Laure Grand/0000-0002-8696-7145; van der Maarel, Silvere/0000-0001-8103-711X; Grand Moursel, Laure/0000-0002-8696-7145; de Morree, Antoine/0000-0002-8316-4531				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alvarez J, 2004, J BIOL CHEM, V279, P12456, DOI 10.1074/jbc.M312177200; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Gentil EJ, 2005, J CELL PHYSIOL, V203, P362, DOI 10.1002/jcp.20232; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haase H, 2005, FASEB J, V19, P1969, DOI 10.1096/fj.05-3997com; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Hestand MS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq602; Hohaus A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0855com; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kijima K, 2004, J HUM GENET, V49, P376, DOI 10.1007/s10038-004-0162-3; Klooster R, 2009, J IMMUNOL METHODS, V342, P1, DOI 10.1016/j.jim.2008.10.009; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Nie ZZ, 2000, J INVEST DERMATOL, V114, P1044, DOI 10.1046/j.1523-1747.2000.00949.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saavedra JT, 2008, J NEUROSCI METH, V174, P25, DOI 10.1016/j.jneumeth.2008.06.029; Salim C, 2009, GLIA, V57, P535, DOI 10.1002/glia.20782; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164	36	17	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					93	103		10.1096/fj.11-187971	http://dx.doi.org/10.1096/fj.11-187971			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21940993				2022-12-25	WOS:000299202200011
J	Hernandez-Ortega, A; Lucas, F; Ferreira, P; Medina, M; Guallar, V; Martinez, AT				Hernandez-Ortega, Aitor; Lucas, Fatima; Ferreira, Patricia; Medina, Milagros; Guallar, Victor; Martinez, Angel T.			Modulating O-2 Reactivity in a Fungal Flavoenzyme INVOLVEMENT OF ARYL-ALCOHOL OXIDASE PHE-501 CONTIGUOUS TO CATALYTIC HISTIDINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; LIGNINOLYTIC FUNGI; OXYGEN REACTIVITY; HYDROGEN-PEROXIDE; GLUCOSE-OXIDASE; OXIDATION; PROTEIN; DEGRADATION; ACTIVATION	Aryl-alcohol oxidase (AAO) is a tlavoenzyme responsible for activation of O-2 to H2O2 in fungal degradation of lignin. The AAO crystal structure shows a buried active site connected to the solvent by a hydrophobic funnel-shaped channel, with Phe-501 and two other aromatic residues forming a narrow bottleneck that prevents the direct access of alcohol substrates. However, ligand diffusion simulations show O-2 access to the active site following this channel. Site-directed mutagenesis of Phe-501 yielded a F501A variant with strongly reduced O-2 reactivity. However, a variant with increased reactivity, as shown by kinetic constants and steady-state oxidation degree, was obtained by substitution of Phe-501 with tryptophan. The high oxygen catalytic efficiency of F501W, similar to 2-fold that of native AAO and similar to 120-fold that of F501A, seems related to a higher O-2 availability because the turnover number was slightly decreased with respect to the native enzyme. Free diffusion simulations of O-2 inside the active-site cavity of AAO (and several in sitico Phe-501 variants) yielded >60% O-2 population at 3-4 angstrom from flavin C4a in F501W compared with 44% in AAO and only 14% in F501A. Paradoxically, the O-2 reactivity of AAO decreased when the access channel was enlarged and increased when it was constricted by introducing a tryptophan residue. This is because the side chain of Phe-501, contiguous to the catalytic histidine (His-502 in AAO), helps to position O-2 at an adequate distance from flavin C4a (and His-502 N epsilon). Phe-501 substitution with a bulkier tryptophan residue resulted in an increase in the O-2 reactivity of this flavoenzyme.	[Lucas, Fatima; Guallar, Victor] Barcelona Supercomp Ctr, ICREA, Joint BSC Inst Res Biomed IRB, Res Programme Computat Biol, E-08034 Barcelona, Spain; [Hernandez-Ortega, Aitor; Martinez, Angel T.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Ferreira, Patricia; Medina, Milagros] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain; [Ferreira, Patricia; Medina, Milagros] Univ Zaragoza, Dept Biochem & Mol & Cellular Biol, E-50009 Zaragoza, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Zaragoza; University of Zaragoza	Guallar, V (corresponding author), Barcelona Supercomp Ctr, ICREA, Joint BSC Inst Res Biomed IRB, Res Programme Computat Biol, Jordi Girona 29, E-08034 Barcelona, Spain.	victor.guallar@bsc.es; atmartinez@cib.csic.es	Medina, Milagros/F-8310-2012; Lucas, Maria Fatima/C-4522-2008; Martínez, Angel T/G-7284-2017; Guallar, Victor/B-1579-2013; Neila, Patricia Ferreira/Y-4803-2019	Medina, Milagros/0000-0001-8743-0182; Lucas, Maria Fatima/0000-0001-8672-9940; Martínez, Angel T/0000-0002-1584-2863; Guallar, Victor/0000-0002-4580-1114; Ferreira Neila, Patricia/0000-0003-4076-6118	Spanish Projects [BIO2008-01533, BIO2010-1493]; PEROXICATS [KBBE-2010-4-265397]; PELE [ERC-2009-Adg 25027]; ICREA Funding Source: Custom	Spanish Projects(Spanish Government); PEROXICATS; PELE; ICREA(ICREA)	This work was supported in part by Spanish Projects BIO2008-01533 and BIO2010-1493 (to A. T. M. and M. M., respectively) and by the PEROXICATS (KBBE-2010-4-265397) and PELE (ERC-2009-Adg 25027) European Projects (to A. T. M. and V. G., respectively).	[Anonymous], 2011, JAG VERS 7 8; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Borrelli KW, 2010, J COMPUT CHEM, V31, P1224, DOI 10.1002/jcc.21409; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; BOURBONNAIS R, 1988, BIOCHEM J, V255, P445, DOI 10.1042/bj2550445; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; DEJONG E, 1992, FEBS LETT, V305, P220, DOI 10.1016/0014-5793(92)80672-4; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Ferreira P, 2005, BIOCHEM J, V389, P731, DOI 10.1042/BJ20041903; Ferreira P, 2006, FEBS J, V273, P4878, DOI 10.1111/j.1742-4658.2006.05488.x; Ferreira P, 2010, BIOCHEM J, V425, P585, DOI 10.1042/BJ20091499; Ferreira P, 2009, J BIOL CHEM, V284, P24840, DOI 10.1074/jbc.M109.011593; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Fraaije MW, 1997, J BIOL CHEM, V272, P18111, DOI 10.1074/jbc.272.29.18111; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Guallar V, 2009, J BIOL CHEM, V284, P3106, DOI 10.1074/jbc.M806183200; GUILLEN F, 1990, APPL MICROBIOL BIOT, V32, P465, DOI 10.1007/BF00903784; GUILLEN F, 1994, APPL ENVIRON MICROB, V60, P2811; GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Hernandez-Ortega A, 2008, FLAVINS FLAVOPROTEIN, P303; Hernandez-Ortega A, 2011, BIOCHEM J, V436, P341, DOI 10.1042/BJ20102090; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Macheroux P, 1999, METH MOL B, V131, P1; Martinez AT, 2011, ENVIRON MICROBIOL, V13, P96, DOI 10.1111/j.1462-2920.2010.02312.x; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; MARTINEZ AT, 1994, FEMS MICROBIOL REV, V13, P265, DOI 10.1016/0168-6445(94)90084-1; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; MUHEIM A, 1990, ENZYME MICROB TECH, V12, P204, DOI 10.1016/0141-0229(90)90039-S; Munteanu FD, 2008, J ELECTROANAL CHEM, V618, P83, DOI 10.1016/j.jelechem.2008.02.023; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Piubelli L, 2008, J BIOL CHEM, V283, P24738, DOI 10.1074/jbc.M802321200; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Romero E, 2010, P OESIB SANT COMP 14, P86; Romero E, 2009, BBA-PROTEINS PROTEOM, V1794, P689, DOI 10.1016/j.bbapap.2008.11.013; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Ruiz-Duenas FJ, 2006, PROTEIN EXPRES PURIF, V45, P191, DOI 10.1016/j.pep.2005.06.003; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Schrodinger LLC, 2011, MAESTR VERS 9 2; Varela E, 2000, BBA-PROTEIN STRUCT M, V1481, P202, DOI 10.1016/S0167-4838(00)00127-8; Varela E, 1999, BIOCHEM J, V341, P113, DOI 10.1042/0264-6021:3410113; Xin Y, 2009, BIOCHEMISTRY-US, V48, P9599, DOI 10.1021/bi901295a	56	41	41	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41105	41114		10.1074/jbc.M111.282467	http://dx.doi.org/10.1074/jbc.M111.282467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21940622	hybrid, Green Published			2022-12-25	WOS:000297315400069
J	Coffin, HR; Watters, JV; Mateo, JM				Coffin, Heather R.; Watters, Jason V.; Mateo, Jill M.			Odor-Based Recognition of Familiar and Related Conspecifics: A First Test Conducted on Captive Humboldt Penguins (Spheniscus humboldti)	PLOS ONE			English	Article							KIN RECOGNITION; SIBLING RECOGNITION; BIRDS; MECHANISM; PATTERNS; SONGBIRD; CHICKS	Studies of kin recognition in birds have largely focused on parent-offspring recognition using auditory or visual discrimination. Recent studies indicate that birds use odors during social and familial interactions and possibly for mate choice, suggesting olfactory cues may mediate kin recognition as well. Here, we show that Humboldt penguins (Spheniscus humboldti), a natally philopatric species with lifetime monogamy, discriminate between familiar and unfamiliar non-kin odors (using prior association) and between unfamiliar kin and non-kin odors (using phenotype matching). Penguins preferred familiar non-kin odors, which may be associated with the recognition of nest mates and colony mates and with locating burrows at night after foraging. In tests of kin recognition, penguins preferred unfamiliar non-kin odors. Penguins may have perceived non-kin odors as novel because they did not match the birds' recognition templates. Phenotype matching is likely the primary mechanism for kin recognition within the colony to avoid inbreeding. To our knowledge this is the first study to provide evidence of odor-based kin discrimination in a bird.	[Coffin, Heather R.; Mateo, Jill M.] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; [Watters, Jason V.; Mateo, Jill M.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Watters, Jason V.] Chicago Zool Soc, Brookfield, IL USA	University of Chicago; University of Chicago	Coffin, HR (corresponding author), Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA.	jmateo@uchicago.edu						BANG BG, 1968, AUK, V85, P55; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; Caro SP, 2010, J COMP PHYSIOL A, V196, P751, DOI 10.1007/s00359-010-0534-4; Caspers BA, 2011, BIOL LETTERS, V7, P184, DOI 10.1098/rsbl.2010.0775; CELERIER A, 2011, BIOL LETT; CITES, 2010, CITES APP 1 2 3; Croxall J. P., 1999, Marine Ornithology, V27, P1; Culik B, 2001, ZOOL-ANAL COMPLEX SY, V104, P327, DOI 10.1078/0944-2006-00038; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; De Leon A, 2003, BEHAVIOUR, V140, P925, DOI 10.1163/156853903770238382; Gamboa George J., 1996, P161; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; IUCN (International Union for the Conservation of Nature), 2010, IUCN RES LIST THREAT; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; LUCAS AM, 1972, UROPYGIAL GLAND AVIA; Mardon J, 2010, CHEM SENSES, V35, P309, DOI 10.1093/chemse/bjq021; Mardon J, 2009, BEHAV ECOL SOCIOBIOL, V63, P537, DOI 10.1007/s00265-008-0688-z; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; Nakagawa S, 2004, BIOL REV, V79, P101, DOI 10.1017/S1464793103006249; Neff BD, 2003, ANIM COGN, V6, P87, DOI 10.1007/s10071-003-0166-y; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Palestis BG, 1999, ANIM BEHAV, V58, P375, DOI 10.1006/anbe.1999.1135; Paredes R, 2002, AUK, V119, P244, DOI 10.1642/0004-8038(2002)119[0244:POELAB]2.0.CO;2; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Reed JM, 2004, ANN ZOOL FENN, V41, P859; Sandilands V, 2004, BRIT POULTRY SCI, V45, P109, DOI 10.1080/00071660410001668932; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Stoddard Philip Kraft, 1996, P356; Taylor SS, 2002, CAN J ZOOL, V80, P700, DOI 10.1139/Z02-046; Whittaker DJ, 2010, BEHAV ECOL, V21, P608, DOI 10.1093/beheco/arq033; Zavalaga Carlos B., 1997, Penguin Conservation, V10, P6	34	57	57	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25002	10.1371/journal.pone.0025002	http://dx.doi.org/10.1371/journal.pone.0025002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957471	Green Submitted, Green Published, gold			2022-12-25	WOS:000295262100031
J	Huang, Y; Gu, X				Huang, Yong; Gu, Xun			A Study of the Evolution of Human microRNAs by Their Apparent Repression Effectiveness on Target Genes	PLOS ONE			English	Article							PLANT MICRORNAS; EXPRESSION; RECOGNITION; BIOGENESIS; GENOMICS; MAMMALS; IMPACT; ATLAS	Background: Even though the genomes of many model species have already been sequenced, our knowledge of gene regulation in evolution is still very limited. One big obstacle is that it is hard to predict the target genes of transcriptional factors accurately from sequences. In this respect, microRNAs (miRNAs) are different from transcriptional factors, as target genes of miRNAs can be readily predicted from sequences. This feature of miRNAs offers an unprecedented vantage point for evolutionary analysis of gene regulation. Methodology/Principal Findings: In this study, we analyzed a particular aspect of miRNA evolution, the differences in the "apparent repression effectiveness (ARE)" between human miRNAs of different conservational levels. ARE is a measure we designed to evaluate the repression effect of miRNAs on target genes based on publicly available gene expression data in normal tissues and miRNA targeting and expression data. We found that ARE values of more conserved miRNAs are significantly higher than those of less conserved miRNAs in general. We also found the gain in expression abundance and broadness of miRNAs in evolution contributed to the gain in ARE. Conclusions/Significance: The ARE measure quantifies the repressive effects of miRNAs and enables us to study the influences of many factors on miRNA-mediated repression, such as conservational levels and expression levels of miRNAs. The gain in ARE can be explained by the existence of a trend of miRNAs in evolution to effectively control more target genes, which is beneficial to the miRNAs but not necessarily to the organism at all times. Our results from miRNAs gave us an insight of the complex interplay between regulators and target genes in evolution.	[Huang, Yong; Gu, Xun] Iowa State Univ, Dept Genet Dev & Cell Biol, Ctr Bioinformat & Biol Stat, Ames, IA 50011 USA; [Gu, Xun] Fudan Univ, Sch Life Sci, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China	Iowa State University; Fudan University	Huang, Y (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ctr Bioinformat & Biol Stat, Ames, IA 50011 USA.	xgu@iastate.edu			Pioneer Computational Biology Scholarship	Pioneer Computational Biology Scholarship	This work was supported by a Pioneer Computational Biology Scholarship to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Huang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-66; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Liu L. Angela, 2009, V541, P23, DOI 10.1007/978-1-59745-243-4_2; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TANG T, P NATL ACAD SCI US, V107, P12935; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	27	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25034	10.1371/journal.pone.0025034	http://dx.doi.org/10.1371/journal.pone.0025034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957473	Green Submitted, gold, Green Published			2022-12-25	WOS:000295262100033
J	Riegl, BM; Purkis, SJ; Al-Cibahy, AS; Abdel-Moati, MA; Hoegh-Guldberg, O				Riegl, Bernhard M.; Purkis, Sam J.; Al-Cibahy, Ashraf S.; Abdel-Moati, Mohammed A.; Hoegh-Guldberg, Ove			Present Limits to Heat-Adaptability in Corals and Population-Level Responses to Climate Extremes	PLOS ONE			English	Article							REEFS; THRESHOLDS; MORTALITY; FUTURE	Climate change scenarios suggest an increase in tropical ocean temperature by 1-3 degrees C by 2099, potentially killing many coral reefs. But Arabian/Persian Gulf corals already exist in this future thermal environment predicted for most tropical reefs and survived severe bleaching in 2010, one of the hottest years on record. Exposure to 33-35 degrees C was on average twice as long as in non-bleaching years. Gulf corals bleached after exposure to temperatures above 34 degrees C for a total of 8 weeks of which 3 weeks were above 35 degrees C. This is more heat than any other corals can survive, providing an insight into the present limits of holobiont adaptation. We show that average temperatures as well as heat-waves in the Gulf have been increasing, that coral population levels will fluctuate strongly, and reef-building capability will be compromised. This, in combination with ocean acidification and significant local threats posed by rampant coastal development puts even these most heat-adapted corals at risk. WWF considers the Gulf ecoregion as "critically endangered". We argue here that Gulf corals should be considered for assisted migration to the tropical Indo-Pacific. This would have the double benefit of avoiding local extinction of the world's most heat-adapted holobionts while at the same time introducing their genetic information to populations naive to such extremes, potentially assisting their survival. Thus, the heat-adaptation acquired by Gulf corals over 6 k, could benefit tropical Indo-Pacific corals who have <100 y until they will experience a similarly harsh climate. Population models suggest that the heat-adapted corals could become dominant on tropical reefs within similar to 20 years.	[Riegl, Bernhard M.; Purkis, Sam J.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA; [Al-Cibahy, Ashraf S.] Environm Agcy Abu Dhabi, Abu Dhabi, U Arab Emirates; [Abdel-Moati, Mohammed A.] Minist Environm, Environm Assessment Dept, Doha, Qatar; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia	Nova Southeastern University; University of Queensland; University of Queensland	Riegl, BM (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	rieglb@nova.edu	Hoegh-Guldberg, Ove/H-6169-2011; Purkis, Sam/B-8552-2013; Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Riegl, Bernhard/0000-0002-6003-9324	NCRI; Great Barrier Reef Foundation	NCRI; Great Barrier Reef Foundation	BMR and SPP were supported by NCRI, OHG by the Great Barrier Reef Foundation. NCRI Publication #135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rashidi TB, 2009, NAT HAZARDS, V50, P73, DOI 10.1007/s11069-008-9320-9; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Berkelmans R, 2002, MAR ECOL PROG SER, V237, P309; Berkelmans R., 2009, V205, P103; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Craig P, 2001, CORAL REEFS, V20, P185, DOI 10.1007/s003380100159; Donner Simon D., 2009, V205, P159; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; IPCC, 2007, CONTR WORK GROUP 1 4; Lang J.C., 1990, P209; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; Mostafavi PG, 2007, MAR BIOL, V153, P25, DOI 10.1007/s00227-007-0796-8; NOAA, 2011, NOAA 2010 TIED HOTT; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Purkis SJ, 2011, MAR POLLUT BULL, V62, P246, DOI 10.1016/j.marpolbul.2010.11.005; Purkis SJ, 2010, GEOLOGY, V38, P227, DOI 10.1130/G30710.1; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; Sheppard Charles, 2002, Aquatic Ecosystem Health & Management, V5, P395, DOI 10.1080/14634980290002020; Sheppard CRC, 2009, MARINE POLLUTION B, V60, P13, DOI DOI 10.1016/J.MARP0LBUL.2009.10.017; Thoppil PG, 2010, J PHYS OCEANOGR, V40, P2122, DOI 10.1175/2010JPO4227.1	25	102	102	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24802	10.1371/journal.pone.0024802	http://dx.doi.org/10.1371/journal.pone.0024802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949755	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400016
J	Wang, H; Li, QG; Liu, J; Mendelsohn, C; Salant, DJ; Lu, WN				Wang, Hang; Li, Qinggang; Liu, Juan; Mendelsohn, Cathy; Salant, David J.; Lu, Weining			Noninvasive Assessment of Antenatal Hydronephrosis in Mice Reveals a Critical Role for Robo2 in Maintaining Anti-Reflux Mechanism	PLOS ONE			English	Article							PRIMARY VESICOURETERAL REFLUX; POSTERIOR URETHRAL VALVES; PRENATALLY DETECTED HYDRONEPHROSIS; URINARY-TRACT; INTRAVESICAL URETER; URETEROVESICAL JUNCTION; CONGENITAL-ANOMALIES; DYSPLASIA SYNDROME; RENAL DYSPLASIA; CONTRAST AGENTS	Antenatal hydronephrosis and vesicoureteral reflux (VUR) are common renal tract birth defects. We recently showed that disruption of the Robo2 gene is associated with VUR in humans and antenatal hydronephrosis in knockout mice. However, the natural history, causal relationship and developmental origins of these clinical conditions remain largely unclear. Although the hydronephrosis phenotype in Robo2 knockout mice has been attributed to the coexistence of ureteral reflux and obstruction in the same mice, this hypothesis has not been tested experimentally. Here we used noninvasive high-resolution micro-ultrasonography and pathological analysis to follow the progression of antenatal hydronephrosis in individual Robo2-deficient mice from embryo to adulthood. We found that hydronephrosis progressed continuously after birth with no spontaneous resolution. With the use of a microbubble ultrasound contrast agent and ultrasound-guided percutaneous aspiration, we demonstrated that antenatal hydronephrosis in Robo2-deficient mice is caused by high-grade VUR resulting from a dilated and incompetent ureterovesical junction rather than ureteral obstruction. We further documented Robo2 expression around the developing ureterovesical junction and identified early dilatation of ureteral orifice structures as a potential fetal origin of antenatal hydronephrosis and VUR. Our results thus demonstrate that Robo2 is crucial for the formation of a normal ureteral orifice and for the maintenance of an effective anti-reflux mechanism. This study also establishes a reproducible genetic mouse model of progressive antenatal hydronephrosis and primary high-grade VUR.	[Wang, Hang; Li, Qinggang; Liu, Juan; Salant, David J.; Lu, Weining] Boston Univ, Med Ctr, Dept Med, Renal Sect, Boston, MA 02215 USA; [Mendelsohn, Cathy] Columbia Univ, Dept Urol, New York, NY USA; [Wang, Hang] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Li, Qinggang] Peoples Liberat Army Gen Hosp, Dept Nephrol, Beijing, Peoples R China	Boston University; Columbia University; Fudan University; Chinese People's Liberation Army General Hospital	Wang, H (corresponding author), Boston Univ, Med Ctr, Dept Med, Renal Sect, Boston, MA 02215 USA.	wlu@bu.edu	Mendelsohn, Cathy/H-4280-2016	Mendelsohn, Cathy/0000-0002-4026-4073; Lu, Weining/0000-0002-6570-3044; Salant, David/0000-0002-3866-3120	National Institutes of Health [R01DK078226, R01HD060050]; March of Dimes Foundation [6-FY08-34]; Boston University Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Boston University Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK078226 (to WL), a subcontract of R01HD060050 (to WL), and was also supported in part by Research Grant #6-FY08-34 from the March of Dimes Foundation (to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We thank Victoria Herrera and Julius Decano and Boston University Medical Center Micro-ultrasound Imaging Core for technical assistance and support. Jizeng Qiao for help with early mouse embryonic kidney organ culture. Frank Costantini for the Hoxb7-GFP transgenic mouse. Ramon Bonegio for help with survival curve analysis. Xueping Fan, Anna Pisarek-Horowitz and Hila Milo Rasooly for helpful discussion. These data were presented in part as an abstract at the annual meeting of the American Society of Nephrology, Renal Week 2009.	Arena S, 2007, BJU INT, V100, P407, DOI 10.1111/j.1464-410X.2007.06921.x; BECK AD, 1971, J UROLOGY, V105, P784, DOI 10.1016/S0022-5347(17)61629-X; Bernardes LS, 2009, ULTRASOUND OBST GYN, V34, P419, DOI 10.1002/uog.6413; Bertoli-Avella AM, 2008, J AM SOC NEPHROL, V19, P825, DOI 10.1681/ASN.2007060692; Blomley MJK, 2001, BMJ-BRIT MED J, V322, P1222, DOI 10.1136/bmj.322.7296.1222; Brophy MM, 2002, J UROLOGY, V168, P1716, DOI 10.1097/01.ju.0000026907.65728.6e; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cosgrove D, 2006, EUR J RADIOL, V60, P324, DOI 10.1016/j.ejrad.2006.06.022; Cuckow PM, 1997, J UROLOGY, V158, P1004, DOI 10.1016/S0022-5347(01)64375-1; DEVORE GR, 1995, J ULTRAS MED, V14, P443; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Estrada CR, 2008, CURR OPIN UROL, V18, P401, DOI 10.1097/MOU.0b013e328302edfe; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; GLICK PL, 1983, J PEDIATR SURG, V18, P681, DOI 10.1016/S0022-3468(83)80003-7; Grazioli S, 2010, PEDIATR NEPHROL, V25, P1687, DOI 10.1007/s00467-010-1543-9; GREENFIELD SP, 1983, J UROLOGY, V130, P733, DOI 10.1016/S0022-5347(17)51431-7; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hains DS, 2010, J UROLOGY, V183, P2077, DOI 10.1016/j.juro.2009.12.095; Hancock J, 1999, HEART, V81, P636, DOI 10.1136/hrt.81.6.636; HILL LM, 1991, AM J PERINAT, V8, P395, DOI 10.1055/s-2007-999424; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Ismaili K, 2006, J PEDIATR-US, V148, P222, DOI 10.1016/j.jpeds.2005.09.037; Kis E, 2010, PEDIATR NEPHROL, V25, P2289, DOI 10.1007/s00467-010-1618-7; Lee RS, 2006, PEDIATRICS, V118, P586, DOI 10.1542/peds.2006-0120; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; LYON RP, 1969, J UROLOGY, V102, P504, DOI 10.1016/S0022-5347(17)62184-0; MACKIE GG, 1975, J PEDIATR SURG, V10, P473, DOI 10.1016/0022-3468(75)90187-6; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Murawski IJ, 2008, PEDIATR NEPHROL, V23, P1021, DOI 10.1007/s00467-007-0704-y; Murawski IJ, 2007, AM J PHYSIOL-RENAL, V293, pF1736, DOI 10.1152/ajprenal.00221.2007; Narasimhan KL, 2005, J UROLOGY, V174, P1433, DOI 10.1097/01.ju.0000173129.70381.e9; Nguyen HT, 2010, J PEDIATR UROL, V6, P212, DOI 10.1016/j.jpurol.2010.02.205; Novljan G, 2010, J UROLOGY, V184, P319, DOI 10.1016/j.juro.2010.01.057; Oswald J, 2003, J UROLOGY, V170, P2423, DOI 10.1097/01.ju.0000097146.26432.9a; Oswald J, 2003, J UROLOGY, V169, P1501, DOI 10.1097/01.ju.0000057047.82984.7f; PAQUIN AJ, 1959, J UROLOGY, V82, P573, DOI 10.1016/S0022-5347(17)65934-2; Paredes J, 2011, AM J PHYSIOL-RENAL, V300, pF1262, DOI 10.1152/ajprenal.00720.2010; Peters CA, 2001, PRENATAL DIAG, V21, P917, DOI 10.1002/pd.211; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Qiao JZ, 1999, P NATL ACAD SCI USA, V96, P7330, DOI 10.1073/pnas.96.13.7330; SANYANUSIN P, 1995, HUM MOL GENET, V4, P2183, DOI 10.1093/hmg/4.11.2183; Shafik A, 1996, UROL RES, V24, P339; Shafik A, 1997, UROLOGY, V50, P949, DOI 10.1016/S0090-4295(97)00405-6; Skoog SJ, 2010, J UROLOGY, V184, P1145, DOI 10.1016/j.juro.2010.05.066; Srinivas S, 1999, DEV GENET, V24, P241; St Clair MB, 1999, CONTEMP TOP LAB ANIM, V38, P78; TANAGHO EA, 1969, J UROLOGY, V101, P824, DOI 10.1016/S0022-5347(17)62433-9; TANAGHO EA, 1965, J UROLOGY, V93, P165, DOI 10.1016/S0022-5347(17)63742-X; TANAGHO EA, 1981, URETER, P1; TANAGHO EA, 2008, SMITHS GEN UROLOGY, P179; Toka HR, 2010, SEMIN NEPHROL, V30, P374, DOI 10.1016/j.semnephrol.2010.06.004; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; Van Eerde AM, 2007, ULTRASOUND OBST GYN, V29, P463, DOI 10.1002/uog.3975; Viana R, 2007, DEVELOPMENT, V134, P3763, DOI 10.1242/dev.011270; Williams G, 2008, J AM SOC NEPHROL, V19, P847, DOI 10.1681/ASN.2007020245; Yu OH, 2004, AM J PHYSIOL-RENAL, V287, pF1123, DOI 10.1152/ajprenal.00444.2003; Zalel Y, 2002, PRENATAL DIAG, V22, P962, DOI 10.1002/pd.436; Zhang JH, 2009, COMPARATIVE MED, V59, P527	60	10	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24763	10.1371/journal.pone.0024763	http://dx.doi.org/10.1371/journal.pone.0024763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949750	Green Submitted, gold, Green Published			2022-12-25	WOS:000295260400013
J	Bonaparte, KM; Riffle-Yokoi, C; Burley, NT				Bonaparte, Kristina M.; Riffle-Yokoi, Christina; Burley, Nancy Tyler			Getting a Head Start: Diet, Sub-Adult Growth, and Associative Learning in a Seed-Eating Passerine	PLOS ONE			English	Article							DEVELOPMENTAL STRESS HYPOTHESIS; ZEBRA FINCHES; BRAIN-DEVELOPMENT; SONG COMPLEXITY; NESTLING DIET; HONEST SIGNAL; SEX-RATIO; SIZE; MALNUTRITION; PLASTICITY	Developmental stress, and individual variation in response to it, can have important fitness consequences. Here we investigated the consequences of variable dietary protein on the duration of growth and associative learning abilities of zebra finches, Taeniopygia guttata, which are obligate graminivores. The high-protein conditions that zebra finches would experience in nature when half-ripe seed is available were mimicked by the use of egg protein to supplement mature seed, which is low in protein content. Growth rates and relative body proportions of males reared either on a low-protein diet (mature seed only) or a high-protein diet (seed plus egg) were determined from body size traits (mass, head width, and tarsus) measured at three developmental stages. Birds reared on the high-protein diet were larger in all size traits at all ages, but growth rates of size traits showed no treatment effects. Relative head size of birds reared on the two diets differed from age day 95 onward, with high-diet birds having larger heads in proportion to both tarsus length and body mass. High-diet birds mastered an associative learning task in fewer bouts than those reared on the low-protein diet. In both diet treatments, amount of sub-adult head growth varied directly, and sub-adult mass change varied inversely, with performance on the learning task. Results indicate that small differences in head growth during the sub-adult period can be associated with substantial differences in adult cognitive performance. Contrary to a previous report, we found no evidence for growth compensation among birds on the low-protein diet. These results have implications for the study of vertebrate cognition, developmental stress, and growth compensation.	[Bonaparte, Kristina M.; Riffle-Yokoi, Christina; Burley, Nancy Tyler] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Bonaparte, KM (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	ntburley@uci.edu			University of California, Irvine	University of California, Irvine(University of California System)	The research was supported by the University of California, Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LR, 1997, AUST J ECOL, V22, P412, DOI 10.1111/j.1442-9993.1997.tb00691.x; Apanius V., 1998, AVIAN GROWTH DEV EVO; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; BOAG PT, 1987, AUK, V104, P155, DOI 10.1093/auk/104.2.155; BOHMAN VR, 1955, J ANIM SCI, V14, P249, DOI 10.2527/jas1955.141249x; Boogert NJ, 2008, ANIM BEHAV, V76, P1735, DOI 10.1016/j.anbehav.2008.08.009; Bradbury RR, 1998, P ROY SOC B-BIOL SCI, V265, P895, DOI 10.1098/rspb.1998.0375; Brumm H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1387, DOI 10.1007/s00265-009-0749-y; Buchanan KL, 2004, P ROY SOC B-BIOL SCI, V271, P2381, DOI 10.1098/rspb.2004.2874; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; BURLEY N, 1989, EMU, V89, P83, DOI 10.1071/MU9890083; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Gibson KR, 1991, BRAIN MATURATION COG; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Healy SD, 2010, EMU, V110, P242, DOI 10.1071/MU10004; Hegyi G, 2007, J AVIAN BIOL, V38, P327, DOI 10.1111/j.2007.0908-8857.03872.x; HOUSTON DC, 1995, IBIS, V137, P322, DOI 10.1111/j.1474-919X.1995.tb08028.x; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Kirn JR, 2010, BRAIN LANG, V115, P29, DOI 10.1016/j.bandl.2009.09.006; Lepczyk CA, 2000, AUK, V117, P164, DOI 10.1642/0004-8038(2000)117[0164:EOEFRO]2.0.CO;2; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lukas WD, 2000, HUM NATURE-INT BIOS, V11, P1, DOI 10.1007/s12110-000-1000-8; Martins TLF, 2004, BEHAV ECOL, V15, P174, DOI 10.1093/beheco/arg094; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Moravec ML, 2010, ETHOLOGY, V116, P961, DOI 10.1111/j.1439-0310.2010.01809.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Nowicki S, 2005, BEHAV NEUROSCI, V119, P1415, DOI 10.1037/0735-7044.119.5.1415; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Nowicki S, 1998, AM ZOOL, V38, P179; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Ranade SC, 2008, NEUROSCIENCE, V152, P859, DOI 10.1016/j.neuroscience.2008.01.002; Remes V, 2002, EVOLUTION, V56, P2505; Reyes-Castro LA, 2011, INT J DEV NEUROSCI, V29, P177, DOI 10.1016/j.ijdevneu.2010.11.002; Schew William A., 1998, Oxford Ornithology Series, V8, P288; Scrimshaw NS, 1998, NUTR RES, V18, P351, DOI 10.1016/S0271-5317(98)00027-X; Shettleworth S.J., 2009, COGNITION EVOLUTION; SMART JL, 1986, P 13 C NUTR, P74; Sokal RR, 1995, BIOMETRY; Spencer KA, 2005, BEHAV ECOL SOCIOBIOL, V58, P423, DOI 10.1007/s00265-005-0927-5; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; Spencer KA, 2011, BEHAV ECOL, V22, P1, DOI 10.1093/beheco/arq068; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; STRUPP BJ, 1995, J NUTR, V125, pS2221, DOI 10.1093/jn/125.suppl_8.2221S; Swaddle JP, 2011, BEHAV ECOL, V22, P13, DOI 10.1093/beheco/arq089; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; Valadares CT, 2010, NUTR NEUROSCI, V13, P274, DOI 10.1179/147683010X12611460764769; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; West-Eberhard Mary Jane, 2003, pi; Wrangham RW, 2009, CATCHING FIRE COOKIN; Zann R, 2008, BEHAV ECOL SOCIOBIOL, V62, P391, DOI 10.1007/s00265-007-0467-2; ZANN R, 1984, AUST WILDLIFE RES, V11, P533; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; Zann RA., 1996, ZEBRA FINCH SYNTHESI	62	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e23775	10.1371/journal.pone.0023775	http://dx.doi.org/10.1371/journal.pone.0023775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949684	gold, Green Published			2022-12-25	WOS:000295257900003
J	Broggi, J; Gamero, A; Hohtola, E; Orell, M; Nilsson, JA				Broggi, Juli; Gamero, Anna; Hohtola, Esa; Orell, Markku; Nilsson, Jan-Ake			Interpopulation Variation in Contour Feather Structure Is Environmentally Determined in Great Tits	PLOS ONE			English	Article							CURRENT REPRODUCTIVE EFFORT; TRADE-OFF; GEOGRAPHIC-VARIATION; SEASONAL-CHANGES; HOUSE FINCHES; MOLT; QUALITY; PLUMAGE; GROWTH; WINTER	Background: The plumage of birds is important for flying, insulation and social communication. Contour feathers cover most of the avian body and among other functions they provide a critical insulation layer against heat loss. Feather structure and composition are known to vary among individuals, which in turn determines variation in the insulation properties of the feather. However, the extent and the proximate mechanisms underlying this variation remain unexplored. Methodology/Principal Findings: We analyzed contour feather structure from two different great tit populations adapted to different winter regimes, one northern population in Oulu (Finland) and one southern population in Lund (Sweden). Great tits from the two populations differed significantly in feather structure. Birds from the northern population had a denser plumage but consisting of shorter feathers with a smaller proportion containing plumulaceous barbs, compared with conspecifics from the southern population. However, differences disappeared when birds originating from the two populations were raised and moulted in identical conditions in a common-garden experiment located in Oulu, under ad libitum nutritional conditions. All birds raised in the aviaries, including adult foster parents moulting in the same captive conditions, developed a similar feather structure. These feathers were different from that of wild birds in Oulu but similar to wild birds in Lund, the latter moulting in more benign conditions than those of Oulu. Conclusions/Significance: Wild populations exposed to different conditions develop contour feather differences either due to plastic responses or constraints. Environmental conditions, such as nutrient availability during feather growth play a crucial role in determining such differences in plumage structure among populations.	[Broggi, Juli; Gamero, Anna; Hohtola, Esa; Orell, Markku] Univ Oulu, Dept Biol, Oulu, Finland; [Broggi, Juli] CSIC, Estn Biol Donana, Dept Humedales, E-41080 Seville, Spain; [Gamero, Anna] Univ Gottingen, Dept Sociobiol & Anthropol, Gottingen, Germany; [Nilsson, Jan-Ake] Lund Univ, Dept Ecol, S-22362 Lund, Sweden	University of Oulu; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Gottingen; Lund University	Broggi, J (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	juli@ebd.csic.es	Broggi, Juli/AAB-1796-2020	Broggi, Juli/0000-0002-1706-4014	Academy of Finland [102286, 47195]; Thule Institute of the University of Oulu; Swedish Research Council	Academy of Finland(Academy of Finland); Thule Institute of the University of Oulu; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by the Academy of Finland project no. 102286 and 47195, the Thule Institute of the University of Oulu and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L, 2006, J ANAT, V208, P621, DOI 10.1111/j.1469-7580.2006.00580.x; Badyaev AV, 2007, INTEGR COMP BIOL, V47, P221, DOI 10.1093/icb/icm058; BENSCH S, 1985, ORNIS SCAND, V16, P151, DOI 10.2307/3676481; Bonier F, 2007, ECOLOGY, V88, P2729, DOI 10.1890/07-0696.1; Broggi J, 2005, EVOLUTION, V59, P1600; Broggi J, 2004, J ANIM ECOL, V73, P967, DOI 10.1111/j.0021-8790.2004.00872.x; Butler MW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P78, DOI 10.1086/648483; Cooper SJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P386, DOI 10.1086/342256; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; DAWSON WR, 1976, J COMP PHYSIOL, V112, P317, DOI 10.1007/BF00692302; DAWSON WR, 1983, PHYSIOL ZOOL, V56, P353, DOI 10.1086/physzool.56.3.30152600; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; Gienapp P, 2010, J EVOLUTION BIOL, V23, P715, DOI 10.1111/j.1420-9101.2010.01949.x; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Grubb T. C., 2006, PTILOCHRONOLOGY FEAT; Hinsley SA, 2003, IBIS, V145, P337, DOI 10.1046/j.1474-919X.2003.00167.x; HOHTOLA E, 1980, J COMP PHYSIOL, V136, P77, DOI 10.1007/BF00688626; Jovani R, 2004, J EVOLUTION BIOL, V17, P294, DOI 10.1111/j.1420-9101.2003.00680.x; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; MIDDLETON ALA, 1986, CAN FIELD NAT, V100, P545; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; NOVOA FF, 1994, COMP BIOCHEM PHYS A, V107, P297, DOI 10.1016/0300-9629(94)90384-0; ORELL M, 1980, ORNIS SCAND, V11, P43, DOI 10.2307/3676264; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; ROOT TL, 1991, PHYSIOL ZOOL, V64, P1279, DOI 10.1086/physzool.64.5.30156245; Rytkonen S, 2001, OIKOS, V93, P439, DOI 10.1034/j.1600-0706.2001.930309.x; SAARELA S, 1995, J COMP PHYSIOL B, V165, P366, DOI 10.1007/BF00387307; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Stoutjesdijk Flip, 2003, Ornis Svecica, V13, P123; Strochlic DE, 2008, COMP BIOCHEM PHYS A, V149, P68, DOI 10.1016/j.cbpa.2007.10.011; Svensson E, 1997, BEHAV ECOL, V8, P92, DOI 10.1093/beheco/8.1.92; SWANSON DL, 1991, CONDOR, V93, P538, DOI 10.2307/1368185; SWANSON DL, 1993, J THERM BIOL, V18, P275, DOI 10.1016/0306-4565(93)90014-K; WALSBERG GE, 1988, J THERM BIOL, V13, P89, DOI 10.1016/0306-4565(88)90018-6; Wolf BO, 2000, AM ZOOL, V40, P575, DOI 10.1668/0003-1569(2000)040[0575:TROTPI]2.0.CO;2	37	30	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24942	10.1371/journal.pone.0024942	http://dx.doi.org/10.1371/journal.pone.0024942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949798	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900037
J	Kim, H; Kang, K; Ekram, MB; Roh, TY; Kim, J				Kim, Hana; Kang, Keunsoo; Ekram, Muhammad B.; Roh, Tae-Young; Kim, Joomyeong			Aebp2 as an Epigenetic Regulator for Neural Crest Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE METHYLTRANSFERASE ACTIVITY; HIRSCHSPRUNG-DISEASE; DEVELOPMENTAL REGULATORS; WAARDENBURG-SYNDROME; MOUSE DEVELOPMENT; GENE-EXPRESSION; COMPLEX PRC2; POLYCOMB; TARGET	Aebp2 is a potential targeting protein for the mammalian Polycomb Repression Complex 2 (PRC2). We generated a mutant mouse line disrupting the transcription of Aebp2 to investigate its in vivo roles. Aebp2-mutant homozygotes were embryonic lethal while heterozygotes survived to adulthood with fertility. In developing mouse embryos, Aebp2 is expressed mainly within cells of neural crest origin. In addition, many heterozygotes display a set of phenotypes, enlarged colon and hypopigmentation, similar to those observed in human patients with Hirschsprung's disease and Waardenburg syndrome. These phenotypes are usually caused by the absence of the neural crest-derived ganglia in hindguts and melanocytes. ChIP analyses demonstrated that the majority of the genes involved in the migration and development process of neural crest cells are downstream target genes of AEBP2 and PRC2. Furthermore, expression analyses confirmed that some of these genes are indeed affected in the Aebp2 heterozygotes. Taken together, these results suggest that Aebp2 may regulate the migration and development of the neural crest cells through the PRC2-mediated epigenetic mechanism.	[Kim, Hana; Ekram, Muhammad B.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Kang, Keunsoo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Roh, Tae-Young] POSTECH, Div Integrat Biosci & Biotechnol, Div Mol & Life Sci, Pohang, South Korea	Louisiana State University System; Louisiana State University; Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH)	Kim, H (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Roh, Tae-Young/0000-0001-5833-0844	National Institutes of Health (NIH) [R01-GM066225, R15-ES019118]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) to Dr. Kim (R01-GM066225 and R15-ES019118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Baxter LL, 2004, PIGM CELL RES, V17, P215, DOI 10.1111/j.1600-0749.2004.00147.x; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; FAUST C, 1995, DEVELOPMENT, V121, P273; He GP, 1999, J BIOL CHEM, V274, P14678, DOI 10.1074/jbc.274.21.14678; HOGAN B, 1994, MANIPULATING MOUSE E, P373; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liu YR, 2001, DEVELOPMENT, V128, P321; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Owens SE, 2005, HUM MOL GENET, V14, P1549, DOI 10.1093/hmg/ddi163; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Sauka-Spengler T, 2008, GENESIS, V46, P673, DOI 10.1002/dvg.20436; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tachibana M, 2003, PIGM CELL RES, V16, P448, DOI 10.1034/j.1600-0749.2003.00066.x; Tam PKH, 2009, PEDIATR SURG INT, V25, P543, DOI 10.1007/s00383-009-2402-2; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	35	35	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25174	10.1371/journal.pone.0025174	http://dx.doi.org/10.1371/journal.pone.0025174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949878	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900056
J	Im, SJ; Yang, SI; Yang, SH; Choi, DH; Choi, SY; Kim, HS; Jang, DS; Jin, KS; Chung, YK; Kim, SH; Paik, SH; Park, YC; Chung, MK; Kim, YB; Han, KH; Choi, KY; Sung, YC				Im, Se Jin; Yang, Sang In; Yang, Se Hwan; Choi, Dong Hoon; Choi, So Young; Kim, Hea Sook; Jang, Do Soo; Jin, Kyeong Sik; Chung, Yo-Kyung; Kim, Seung-Hee; Paik, Sang Hoon; Park, Yoo Chang; Chung, Moon Koo; Kim, Yong Bum; Han, Kang-Hyun; Choi, Kwan Yong; Sung, Young Chul			Natural Form of Noncytolytic Flexible Human Fc as a Long-Acting Carrier of Agonistic Ligand, Erythropoietin	PLOS ONE			English	Article							I-RELATED RECEPTOR; BIOLOGICAL-ACTIVITY; HUMAN-IGG; PHARMACOKINETICS; ANTIBODIES; FLEXIBILITY; MATURATION; INHIBITOR; DESIGN; ALPHA	Human IgG1 Fc has been widely used as a bioconjugate, but exhibits shortcomings, such as antibody-and complement-mediated cytotoxicity as well as decreased bioactivity, when applied to agonistic proteins. Here, we constructed a nonimmunogenic, noncytolytic and flexible hybrid Fc (hyFc) consisting of IgD and IgG4, and tested its function using erythropoietin (EPO) conjugate, EPO-hyFc. Despite low amino acid homology (20.5%) between IgD Fc and IgG4 Fc, EPO-hyFc retained "Y-shaped" structure and repeated intravenous administrations of EPO-hyFc into monkeys did not generate EPO-hyFc-specific antibody responses. Furthermore, EPO-hyFc could not bind to Fc gamma R I and C1q in contrast to EPO-IgG1 Fc. In addition, EPO-hyFc exhibited better in vitro bioactivity and in vivo bioactivity in rats than EPO-IgG1 Fc, presumably due to the high flexibility of IgD. Moreover, the mean serum half-life of EPO-hyFc(H), a high sialic acid content form of EPO-hyFc, was approximately 2-fold longer than that of the heavily glycosylated EPO, darbepoetin alfa, in rats. More importantly, subcutaneous injection of EPO-hyFc(H) not only induced a significantly greater elevation of serum hemoglobin levels than darbepoetin alfa in both normal rats and cisplatin-induced anemic rats, but also displayed a delayed time to maximal serum level and twice final area-under-the-curve (AUC(last)). Taken together, hyFc might be a more attractive Fc conjugate for agonistic proteins/peptides than IgG1 Fc due to its capability to elongate their half-lives without inducing host effector functions and hindering bioactivity of fused molecules. Additionally, a head-to-head comparison demonstrated that hyFc-fusion strategy more effectively improved the in vivo bioactivity of EPO than the hyperglycosylation approach.	[Im, Se Jin; Choi, Dong Hoon; Choi, Kwan Yong; Sung, Young Chul] POSTECH, Div Mol & Life Sci, Pohang, South Korea; [Yang, Sang In; Yang, Se Hwan; Choi, So Young; Kim, Hea Sook; Jang, Do Soo; Sung, Young Chul] Genexine Co, Res Inst, Songnam, South Korea; [Jin, Kyeong Sik] POSTECH, Pohang Accelerator Lab, Pohang, South Korea; [Chung, Yo-Kyung; Kim, Seung-Hee; Paik, Sang Hoon; Park, Yoo Chang] Green Cross Co, Cent Res Inst, Yongin, South Korea; [Chung, Moon Koo; Kim, Yong Bum; Han, Kang-Hyun] Korea Res Inst Chem Technol, Korea Inst Toxicol, Taejon 305606, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Green Cross Corporation; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Im, SJ (corresponding author), POSTECH, Div Mol & Life Sci, Pohang, South Korea.	ycsung@postech.ac.kr		Han, Kang-Hyun/0000-0001-8187-6837	Korea Healthcare technology RD Project [A081087]; Ministry of Health Welfare; Industrial Strategic technology development program [10032125]; Ministry of Knowledge Economy; Korea Research Foundation [KRF-20080220-E00018]; Korean Government (MEST)	Korea Healthcare technology RD Project; Ministry of Health Welfare; Industrial Strategic technology development program; Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by three grants: the Korea Healthcare technology R&D Project (A081087) funded by Ministry of Health & Welfare, the Industrial Strategic technology development program (10032125) funded by Ministry of Knowledge Economy, and the Korea Research Foundation Grant (KRF-20080220-E00018) funded by the Korean Government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZQ, 2009, MABS-AUSTIN, V1, P572, DOI 10.4161/mabs.1.6.10185; Bolze J, 2002, MACROMOL RES, V10, P2, DOI 10.1007/BF03218282; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Chamow SM, 1996, TRENDS BIOTECHNOL, V14, P52, DOI 10.1016/0167-7799(96)80921-8; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Crowell CK, 2007, Patent No. [US 2007/0161084 A1, 200701610847]; Dubois M, 2007, J PHARMACEUT BIOMED, V43, P1423, DOI 10.1016/j.jpba.2006.10.022; Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; Egrie JC, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_3.3; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; Elliott Steven G., 2009, P115, DOI 10.1007/978-3-7643-8698-6_8; EMANUELE RM, 1987, THROMB RES, V48, P591, DOI 10.1016/0049-3848(87)90391-4; FUKUDA MN, 1989, BLOOD, V73, P84; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Gillies SD, 2005, Patent No. [US2005/0202538 A1, 20050202538]; GRONOWICZ G, 1984, J CELL SCI, V71, P177; Gross AW, 2006, J BIOL CHEM, V281, P2024, DOI 10.1074/jbc.M510493200; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; HOLMES SJ, 1993, J CLIN ENDOCR METAB, V76, P91, DOI 10.1210/jc.76.1.91; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; Institute of Laboratory Animal Resources (ILAR), 1996, GUID CAR US LAB AN; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; KNAUF MJ, 1988, J BIOL CHEM, V263, P15064; KOURY MJ, 1988, J CELL PHYSIOL, V137, P65, DOI 10.1002/jcp.1041370108; LAI PH, 1986, J BIOL CHEM, V261, P3116; Liu XY, 2008, IMMUNOL REV, V222, P9, DOI 10.1111/j.1600-065X.2008.00601.x; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Macdougall IC, 2006, CLIN J AM SOC NEPHRO, V1, P1211, DOI 10.2215/CJN.00730306; MACDOUGALL IC, 1991, CLIN PHARMACOKINET, V20, P99, DOI 10.2165/00003088-199120020-00002; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P66, DOI 10.1093/ndt/17.suppl_5.66; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Presta LG, 2005, J ALLERGY CLIN IMMUN, V116, P731, DOI 10.1016/j.jaci.2005.08.003; Qiu HW, 1998, J BIOL CHEM, V273, P11173, DOI 10.1074/jbc.273.18.11173; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Roux KH, 1998, J IMMUNOL, V161, P4083; Roux KH, 1997, J IMMUNOL, V159, P3372; SCHJOLDAGER BTG, 1989, DIGEST DIS SCI, V34, P703, DOI 10.1007/BF01540341; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Sytkowski AJ, 1999, J BIOL CHEM, V274, P24773, DOI 10.1074/jbc.274.35.24773; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Watowich SS, 1999, INT J BIOCHEM CELL B, V31, P1075, DOI 10.1016/S1357-2725(99)00075-8	47	36	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24574	10.1371/journal.pone.0024574	http://dx.doi.org/10.1371/journal.pone.0024574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21957455	gold, Green Submitted, Green Published			2022-12-25	WOS:000295173800027
J	Lu, TP; Lai, LC; Tsai, MH; Chen, PC; Hsu, CP; Lee, JM; Hsiao, CK; Chuang, EY				Lu, Tzu-Pin; Lai, Liang-Chuan; Tsai, Mong-Hsun; Chen, Pei-Chun; Hsu, Chung-Ping; Lee, Jang-Ming; Hsiao, Chuhsing Kate; Chuang, Eric Y.			Integrated Analyses of Copy Number Variations and Gene Expression in Lung Adenocarcinoma	PLOS ONE			English	Article							DNA AMPLIFICATION; ANALYSIS REVEALS; TRIHYDROPHOBIN 1; CANCER; CELL; EGFR; BREAST; SMOKING; GENOME; IDENTIFICATION	Numerous efforts have been made to elucidate the etiology and improve the treatment of lung cancer, but the overall five-year survival rate is still only 15%. Identification of prognostic biomarkers for lung cancer using gene expression microarrays poses a major challenge in that very few overlapping genes have been reported among different studies. To address this issue, we have performed concurrent genome-wide analyses of copy number variation and gene expression to identify genes reproducibly associated with tumorigenesis and survival in non-smoking female lung adenocarcinoma. The genomic landscape of frequent copy number variable regions (CNVRs) in at least 30% of samples was revealed, and their aberration patterns were highly similar to several studies reported previously. Further statistical analysis for genes located in the CNVRs identified 475 genes differentially expressed between tumor and normal tissues (p<10(-5)). We demonstrated the reproducibility of these genes in another lung cancer study (p = 0.0034, Fisher's exact test), and showed the concordance between copy number variations and gene expression changes by elevated Pearson correlation coefficients. Pathway analysis revealed two major dysregulated functions in lung tumorigenesis: survival regulation via AKT signaling and cytoskeleton reorganization. Further validation of these enriched pathways using three independent cohorts demonstrated effective prediction of survival. In conclusion, by integrating gene expression profiles and copy number variations, we identified genes/pathways that may serve as prognostic biomarkers for lung tumorigenesis.	[Lu, Tzu-Pin; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Lai, Liang-Chuan; Tsai, Mong-Hsun; Hsiao, Chuhsing Kate; Chuang, Eric Y.] Natl Taiwan Univ, Res Ctr Med Excellence, Taipei 10764, Taiwan; [Chen, Pei-Chun] Providence Univ, Dept Stat & Informat Sci, Taichung, Taiwan; [Hsu, Chung-Ping] Taichung Vet Gen Hosp, Div Thorac Surg, Taichung, Taiwan; [Lee, Jang-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Providence University - Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital	Lu, TP (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	ckhsiao@ntu.edu.tw; chuangey@ntu.edu.tw	Lu, Tzupin/ABC-2195-2021; Lai, Liang-Chuan/B-4768-2009	Lu, Tzupin/0000-0003-3697-0386; Lai, Liang-Chuan/0000-0002-3913-5338; TSAI, MONG-HSUN/0000-0001-8777-5818; LEE, JANG-MING/0000-0001-9727-227X; hsiao, chuhsing kate/0000-0003-4905-8484	Department of Health, Taiwan, ROC [DOH98-TD-B-111-001]; National Science Council, Taiwan, ROC [NSC98-2314-B-002-065-MY3]; Division of Genomic Medicine, National Taiwan University Research Center for Medical Excellence	Department of Health, Taiwan, ROC; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Division of Genomic Medicine, National Taiwan University Research Center for Medical Excellence(National Taiwan University)	This research was supported in part by DOH98-TD-B-111-001 from the Department of Health, Taiwan, ROC and NSC98-2314-B-002-065-MY3 from National Science Council, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Division of Genomic Medicine, National Taiwan University Research Center for Medical Excellence for financial support; and Melissa Stauffer, Ph.D., for editing the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BOELENS MC, 2010, LUNG CANC; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Caccavari F, 2010, CELL ADHES MIGR, V4, P124, DOI 10.4161/cam.4.1.10976; CHEN CJ, 1990, ANTICANCER RES, V10, P971; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Dahabreh IJ, 2010, CLIN CANCER RES, V16, P291, DOI 10.1158/1078-0432.CCR-09-1660; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esandi MC, 1998, GENE THER, V5, P778, DOI 10.1038/sj.gt.3300662; Gazdar AF, 2008, CANCER PREV RES, V1, P156, DOI 10.1158/1940-6207.CAPR-08-0080; Go H, 2010, J THORAC ONCOL, V5, P305, DOI 10.1097/JTO.0b013e3181ce3d1d; Hartel PH, 2008, INT J SURG PATHOL, V16, P419, DOI 10.1177/1066896908318935; Hirsch FR, 2009, ONCOGENE, V28, pS32, DOI 10.1038/onc.2009.199; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Hyman E, 2002, CANCER RES, V62, P6240; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato T, 2005, CANCER RES, V65, P5638, DOI 10.1158/0008-5472.CAN-05-0600; Kawano O, 2007, LUNG CANCER, V58, P159, DOI 10.1016/j.lungcan.2007.06.020; Kikuchi N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-31; Kotliarov Y, 2009, CANCER RES, V69, P1596, DOI 10.1158/0008-5472.CAN-08-2496; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li AR, 2008, J MOL DIAGN, V10, P242, DOI 10.2353/jmoldx.2008.070178; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MIURA I, 1992, CANCER RES, V52, P1322; Papadimitrakopoulou V, 2006, J THORAC ONCOL, V1, P749, DOI 10.1016/S1556-0864(15)30399-3; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shen H, 2009, BIOMED PHARMACOTHER, V63, P396, DOI 10.1016/j.biopha.2008.08.010; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yen CC, 2007, LUNG CANCER, V57, P292, DOI 10.1016/j.lungcan.2007.04.007; Zou WY, 2010, CANCER SCI, V101, P2156, DOI 10.1111/j.1349-7006.2010.01656.x	53	58	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24829	10.1371/journal.pone.0024829	http://dx.doi.org/10.1371/journal.pone.0024829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935476	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700052
J	Ma, J; Wang, RQ; Fang, XF; Ding, Y; Sun, ZM				Ma, Jian; Wang, Ruiqing; Fang, Xianfeng; Ding, Yan; Sun, Zuoming			Critical Role of TCF-1 in Repression of the IL-17 Gene	PLOS ONE			English	Article							ROR-GAMMA-T; CELL-DIFFERENTIATION; TRANSCRIPTION FACTORS; THYMOCYTE SURVIVAL; AUTOIMMUNE INFLAMMATION; EXPRESSION; CYTOKINE; INDUCTION; ARTHRITIS; PATHWAYS	Overwhelming activation of IL-17, a gene involved in inflammation, leads to exaggerated Th17 responses associated with numerous autoimmune conditions, such as experimental autoimmune encephalomyelitis (EAE). Here we show that TCF-1 is a critical factor to repress IL-17 gene locus by chromatin modifications during T cell development. Deletion of TCF-1 resulted in increased IL-17 gene expression both in thymus and peripheral T cells, which led to enhanced Th17 differentiation. As a result, TCF-1(-/-) mice were susceptible to Th17-dependent EAE induction. Rag1(-/-) mice reconstituted with TCF-1(-/-) T cells were also susceptible to EAE, indicating TCF-1 is intrinsically required to repress IL-17. However, expression of wild-type TCF-1 or dominant negative TCF-1 did not interfere with Th17 differentiation in mature T cells. Furthermore, expression of TCF-1 in TCF-1(-/-) T cells could not restore Th17 differentiation to wild-type levels, indicating that TCF-1 cannot affect IL-17 production at the mature T cell stage. This is also supported by the normal up-regulation or activation in mature TCF-1(-/-) T cells of factors known to regulate Th17 differentiation, including ROR gamma t and Stat3. We observed hyperacetylation together with trimethylation of Lys-4 at the IL-17 locus in TCF-1(-/-) thymocytes, two epigenetic modifications indicating an open active state of the gene. Such epigenetic modifications were preserved even when TCF-1(-/-) T cells migrated out of thymus. Therefore, TCF-1 mediates an active process to repress IL-17 gene expression via epigenetic modifications during T cell development. This TCF-1-mediated repression of IL-17 is critical for peripheral T cells to generate balanced immune responses.	[Ma, Jian; Wang, Ruiqing; Fang, Xianfeng; Ding, Yan; Sun, Zuoming] City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Ma, J (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA.	zsun@coh.org	Ma, Jian/K-5260-2012; fang, xianfeng/E-6301-2012	fang, xianfeng/0000-0003-0161-0209	National Institutes of Health (NIH) [R01-AI053147, R56-AI072554]; Nesvig Lymphoma Fellowship; Nesvig Lymphoma Research Fund; City of Hope; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072554, R01AI053147] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nesvig Lymphoma Fellowship; Nesvig Lymphoma Research Fund; City of Hope; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from National Institutes of Health (NIH) R01-AI053147, NIH R56-AI072554, Nesvig Lymphoma Fellowship and Research Fund and City of Hope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; HOLMES R, 2009, COLD SPRING HARB PRO, pT5156; Huang ZF, 2008, J IMMUNOL, V180, P6586, DOI 10.4049/jimmunol.180.10.6586; Huang ZF, 2007, EXPERT OPIN THER TAR, V11, P737, DOI 10.1517/14728222.11.6.737; Huang ZF, 2006, J IMMUNOL, V176, P4880, DOI 10.4049/jimmunol.176.8.4880; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; KORN T, 2009, ANN REV IMMUNOL; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee CG, 2009, YONSEI MED J, V50, P322, DOI 10.3349/ymj.2009.50.3.322; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Ma JA, 2010, EUR J IMMUNOL, V40, P3028, DOI 10.1002/eji.201040614; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Xie HM, 2006, CRIT REV IMMUNOL, V26, P475, DOI 10.1615/CritRevImmunol.v26.i6.10; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; YUAN J, J IMMUNOL, V184, P2793; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	51	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24768	10.1371/journal.pone.0024768	http://dx.doi.org/10.1371/journal.pone.0024768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935461	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700044
J	Walter, H; von Kalckreuth, A; Schardt, D; Stephan, A; Goschke, T; Erk, S				Walter, Henrik; von Kalckreuth, Alexander; Schardt, Dina; Stephan, Achim; Goschke, Thomas; Erk, Susanne			The Temporal Dynamics of Voluntary Emotion Regulation	PLOS ONE			English	Article							PREFRONTAL CORTEX; AFFECTIVE NEUROSCIENCE; COGNITIVE REGULATION; THOUGHT SUPPRESSION; NEGATIVE EMOTION; NEURAL CIRCUITRY; SELF-REGULATION; AMYGDALA; RESPONSES; DISORDER	Background: Neuroimaging has demonstrated that voluntary emotion regulation is effective in reducing amygdala activation to aversive stimuli during regulation. However, to date little is known about the sustainability of these neural effects once active emotion regulation has been terminated. Methodology/Principal Findings: We addressed this issue by means of functional magnetic resonance imaging (fMRI) in healthy female subjects. We performed an active emotion regulation task using aversive visual scenes (task 1) and a subsequent passive viewing task using the same stimuli (task 2). Here we demonstrate not only a significantly reduced amygdala activation during active regulation but also a sustained regulation effect on the amygdala in the subsequent passive viewing task. This effect was related to an immediate increase of amygdala signal in task 1 once active emotion regulation has been terminated: The larger this peak postregulation signal in the amygdala in task 1, the smaller the sustained regulation effect in task 2. Conclusions/Significance: In summary, we found clear evidence that effects of voluntary emotion regulation extend beyond the period of active regulation. These findings are of importance for the understanding of emotion regulation in general, for disorders of emotion regulation and for psychotherapeutic interventions.			Walter, H (corresponding author), Univ Bonn, Div Med Psychol, D-5300 Bonn, Germany.	henrik.walter@ukb.uni-bonn.de	Goschke, Thomas/I-2479-2014; Walter, Henrik/O-2612-2013	Walter, Henrik/0000-0002-9403-6121				Abramowitz JS, 2001, CLIN PSYCHOL REV, V21, P683, DOI 10.1016/S0272-7358(00)00057-X; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beauregard M, 2006, NEUROREPORT, V17, P843, DOI 10.1097/01.wnr.0000220132.32091.9f; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Erk S, 2007, NEUROIMAGE, V37, P623, DOI 10.1016/j.neuroimage.2007.05.006; Erk S, 2006, EUR J NEUROSCI, V24, P1227, DOI 10.1111/j.1460-9568.2006.04976.x; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Freud S, 1926, HEMMUNG SYMPTOM ANGS; FREUD S, 1915, VERDRANGUNG PSYCHOL, P103; Frijda N.H.., 1986, REV PHILOS LOUVAIN; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Jackson DC, 2000, PSYCHOPHYSIOLOGY, V37, P515, DOI 10.1111/1469-8986.3740515; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2006, J COGNITIVE NEUROSCI, V18, P1266, DOI 10.1162/jocn.2006.18.8.1266; Koster EHW, 2003, BEHAV RES THER, V41, P1113, DOI 10.1016/S0005-7967(03)00144-X; Lazarus R.S., 1966, PSYCHOL STRESS COPIN; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; ROEMER L, 1994, J ABNORM PSYCHOL, V103, P467, DOI 10.1037/0021-843X.103.3.467; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039	45	85	85	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6726	10.1371/journal.pone.0006726	http://dx.doi.org/10.1371/journal.pone.0006726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487MJ	21949675	gold, Green Published, Green Submitted			2022-12-25	WOS:000269278400001
J	Kim, BS; Hwang, J; Kim, MH; Choi, SH				Kim, Byoung Sik; Hwang, Jungwon; Kim, Myung Hee; Choi, Sang Ho			Cooperative Regulation of the Vibrio vulnificus nan Gene Cluster by NanR Protein, cAMP Receptor Protein, and N-Acetylmannosamine 6-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC-ACID CATABOLISM; RNA-POLYMERASE; ESCHERICHIA-COLI; CYCLIC-AMP; PROMOTER; BINDING; TRANSCRIPTION; EXPRESSION; VIRULENCE; CHOLERAE	The nan cluster of Vibrio vulnificus, a food-borne pathogen, consists of two divergently transcribed operons, nanT(PSL)AR and nanEK nagA, required for transport and catabolism of N-acetylneuraminic acid (Neu5Ac). A mutation of nanR abolished the extensive lag phase observed for the bacteria growing on Neu5Ac and increased transcription of nanT(p) and nanE, suggesting that NanR is a transcriptional repressor of both nan operons. Intracellular accumulation of Neu5Ac was dependent on the carbon source, implying that the nan operons are also subject to catabolite repression. Hence, cAMP receptor protein (CRP) appeared to activate and repress transcription of nanT(PSL)AR and nanEK nagA, respectively. Direct bindings of NanR and CRP to the nanT(p)-nanE intergenic DNA were demonstrated by EMSA. Two adjacent NanR-binding sites centered at +44.5 and -10 and a CRP-binding site centered at -60.5 from the transcription start site of nanT(p) were identified by DNase I protection assays. Mutagenesis approaches, in vitro transcription, and isothermal titration calorimetry experiments demonstrated that N-acetylmannosamine 6-phosphate specifically binds to NanR and functions as the inducer of the nan operons. The combined results propose a model in which NanR, CRP, and N-acetylmannosamine 6-phosphate cooperate for precise adjustment of the expression level of the V. vulnificus nan cluster.	[Kim, Byoung Sik; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea; [Kim, Byoung Sik; Choi, Sang Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Hwang, Jungwon; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea.	choish@snu.ac.kr	Kim, Byoungsik/AAE-6239-2021	Kim, Byoung Sik/0000-0001-9820-6071; Choi, Sang Ho/0000-0003-3865-1039	National Research Laboratory through National Research Foundation [R0A-2007-000-20039-0]; Ministry of Education, Science, and Technology; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Laboratory through National Research Foundation; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by National Research Laboratory Grant R0A-2007-000-20039-0 through National Research Foundation funded by Ministry of Education, Science, and Technology (to S. H. C.) and by the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea.	Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; Bergendahl V, 2003, PROTEIN EXPRES PURIF, V31, P155, DOI 10.1016/S1046-5928(03)00145-1; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Johnston JW, 2007, MOL MICROBIOL, V66, P26, DOI 10.1111/j.1365-2958.2007.05890.x; Johnston JW, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-240; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kalivoda KA, 2003, J BACTERIOL, V185, P4806, DOI 10.1128/JB.185.16.4806-4815.2003; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; LANG H, 1994, INFECT IMMUN, V62, P4781; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lee HJ, 2008, J BIOL CHEM, V283, P30438, DOI 10.1074/jbc.M802219200; Lee I, 2007, INT J ELECTRON COMM, V11, P11, DOI 10.2753/JEC1086-4415110401; Lee JH, 2006, MOL MICROBIOL, V60, P513, DOI 10.1111/j.1365-2958.2006.05115.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; NEWLANDS JT, 1993, J BACTERIOL, V175, P661, DOI 10.1128/JB.175.3.661-668.1993; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Rhee JE, 2006, J BACTERIOL, V188, P6490, DOI 10.1128/JB.00533-06; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; Sambrook J, 2001, MOL CLONING LAB MANU; Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Toulme F, 2005, J MOL BIOL, V351, P39, DOI 10.1016/j.jmb.2005.05.052; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402	40	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40889	40899		10.1074/jbc.M111.300988	http://dx.doi.org/10.1074/jbc.M111.300988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956110	Green Published, hybrid			2022-12-25	WOS:000297315400049
J	Andrew, AJ; Kao, S; Strebel, K				Andrew, Amy J.; Kao, Sandra; Strebel, Klaus			C-terminal Hydrophobic Region in Human Bone Marrow Stromal Cell Antigen 2 (BST-2)/Tetherin Protein Functions as Second Transmembrane Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLATHRIN-MEDIATED ENDOCYTOSIS; ANCHORED MEMBRANE-PROTEINS; FORMING TOXIN AEROLYSIN; HIV-1 VPU; GLYCOSYL-PHOSPHATIDYLINOSITOL; PARTICLE RELEASE; MODIFICATION SITES; MOLECULAR-CLONING; PRION PROTEIN	BST-2/CD317/HM1.24/tetherin is a host factor that inhibits the release of HIV-1 and other enveloped viruses. Structurally, tetherin consists of an N-terminal transmembrane (TM) region, a central coiled coil motif, and a putative C-terminal glycosylphosphatidylinositol (GPI) anchor motif. A current working model proposes that BST-2 inhibits virus release by physically tethering viral particles to the cell surface via its TM motif and GPI anchor. Here we analyzed the functional importance of the C-terminal GPI anchor motif in BST-2. We replaced the GPI anchor motif in BST-2 with the TM regions of several surface markers and found that the TM motifs of CD40 and transferrin receptor, but not that of CD45, could functionally substitute for a GPI anchor in BST-2. Conversely, replacing the TM region of CD4 by the putative GPI anchor signal of human BST-2 resulted in proper membrane targeting and surface expression of the chimeric protein, indicating that the BST-2 GPI anchor signal can function as a bona fide TM region. In fact, attempts to demonstrate GPI anchor modification of human BST-2 by biochemical methods failed. Our results demonstrate that the putative C-terminal GPI anchor motif in human BST-2 fulfills the requirements of a bona fide TM motif, leading us to propose that human BST-2 may in fact contain a second TM segment rather than a GPI anchor.	[Andrew, Amy J.; Kao, Sandra; Strebel, Klaus] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strebel, K (corresponding author), NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 310,4 Ctr Dr,MSC 0460, Bethesda, MD 20892 USA.	kstrebel@nih.gov			National Institutes of Health from NIAID [AI000669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000669, ZIAAI000669] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI000669 from the Intramural Research Program of NIAID.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Andrew A.J., 2009, CELL, V6, P80; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Andrew A, 2010, MOL ASPECTS MED, V31, P407, DOI 10.1016/j.mam.2010.08.002; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bour S, 1999, J BIOL CHEM, V274, P33800, DOI 10.1074/jbc.274.47.33800; BROWN D, 1992, J AM SOC NEPHROL, V3, P895; BUCKLEY JT, 1981, CAN J BIOCHEM CELL B, V59, P430, DOI 10.1139/o81-059; Cardoso de Almeida M.L., 1983, NATURE, V302, P349; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; DEALMEIDA MLC, 1983, NATURE, V302, P349, DOI 10.1038/302349a0; Doering T.L., 2001, CURR PROTOC MOL BIOL; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Fukushima K, 2003, J BIOL CHEM, V278, P36296, DOI 10.1074/jbc.M304341200; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; GOTO T, 1994, BLOOD, V84, P1922; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; HOWARD SP, 1985, J BACTERIOL, V163, P336, DOI 10.1128/JB.163.1.336-340.1985; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; MEDOF ME, 1986, BIOCHEMISTRY-US, V25, P6740, DOI 10.1021/bi00370a003; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; PLOUG M, 1991, J BIOL CHEM, V266, P1926; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; Wong SK, 2009, J VIROL, V83, P8771, DOI 10.1128/JVI.00112-09; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; ZERIAL M, 1986, EMBO J, V5, P1543, DOI 10.1002/j.1460-2075.1986.tb04395.x	51	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39967	39981		10.1074/jbc.M111.287011	http://dx.doi.org/10.1074/jbc.M111.287011			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937450	Green Published, hybrid			2022-12-25	WOS:000296925700030
J	Bertuccio, C; Veron, D; Aggarwal, PK; Holzman, L; Tufro, A				Bertuccio, Claudia; Veron, Delma; Aggarwal, Pardeep K.; Holzman, Lawrence; Tufro, Alda			Vascular Endothelial Growth Factor Receptor 2 Direct Interaction with Nephrin Links VEGF-A Signals to Actin in Kidney Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL NEPHROTIC SYNDROME; SLIT DIAPHRAGM; GLOMERULAR PODOCYTES; CELL-LINES; NCK; MOUSE; PHOSPHORYLATION; CYTOSKELETON; ACTIVATION; PROTEIN	The transmembrane protein nephrin is an essential component of slit diaphragms, the specialized cell junctions that link podocyte foot processes. Podocytes are epithelial cells that surround the glomerular capillaries in the kidney and are necessary for the organ-filtering function. Nephrin signaling complex transduces extracellular cues to the podocyte cytoskeleton and regulates podocyte shape and function. Vascular endothelial growth factor A (VEGF-A) is a required growth factor produced and secreted by podocytes. Accumulating evidence suggests a cross-talk between VEGF-A and nephrin signaling pathways. We previously showed that in vivo nephrin associates with VEGF receptor-2 (VEGFR2), the signaling receptor for VEGF-A. In the present work, we characterized the interaction between nephrin and VEGFR2 in cultured cells and in vitro. We demonstrate that nephrin-VEGFR2 interaction is direct using mass spectrometry, immunoprecipitation, GST-binding assays, and blot overlay experiments. This interaction occurs through VEGFR2 and nephrin cytoplasmic domains. Nephrin-VEGFR2 interaction is modulated by tyrosine phosphorylation of both cytoplasmic domains. Furthermore, the nephrin-VEGFR2 complex involves Nck and actin. VEGF-A signaling via this complex results in decreased cell size. We provide evidence that this multiprotein interaction occurs in cultured podocytes. We propose that the nephrin-VEGFR2 complex acts as a key mediator to transduce local VEGF-A signals to the podocyte actin cytoskeleton, regulating the foot process structure and glomerular filter integrity.	[Bertuccio, Claudia; Veron, Delma; Aggarwal, Pardeep K.; Tufro, Alda] Yale Univ, Dept Pediat, Sch Med, New Haven, CT 06520 USA; [Holzman, Lawrence] Univ Penn, Div Nephrol, Sch Med, Philadelphia, PA 19104 USA	Yale University; University of Pennsylvania	Tufro, A (corresponding author), 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	alda.tufro@yale.edu		Holzman, Lawrence/0000-0002-8961-234X	National Institutes of Health [RO1-DK59333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK59333 (to A. T.).	Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Foster RR, 2005, AM J PHYSIOL-RENAL, V288, pF48, DOI 10.1152/ajprenal.00146.2004; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Hovind P, 2000, KIDNEY INT, V57, pS56, DOI 10.1046/j.1523-1755.2000.07504.x; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kaukinen A, 2008, NEPHROL DIAL TRANSPL, V23, P1224, DOI 10.1093/ndt/gfm799; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Ku CH, 2008, DIABETES, V57, P2824, DOI 10.2337/db08-0647; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Matsukawa M, 2009, GENES CELLS, V14, P1167, DOI 10.1111/j.1365-2443.2009.01343.x; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Mizuno K, 2002, J IMMUNOL, V169, P778, DOI 10.4049/jimmunol.169.2.778; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; RODEWALD R, 1974, J CELL BIOL, V60, P423, DOI 10.1083/jcb.60.2.423; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; SIMON M, 1995, AM J PHYSIOL-RENAL, V268, pF240, DOI 10.1152/ajprenal.1995.268.2.F240; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Stoletov KV, 2001, J BIOL CHEM, V276, P22748, DOI 10.1074/jbc.M009720200; Stone K.L., 2004, CURR PROTOC PROTEIN; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z; Veron D, 2010, AM J PATHOL, V177, P2225, DOI 10.2353/ajpath.2010.091146; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Wernerson A, 2003, NEPHROL DIAL TRANSPL, V18, P70, DOI 10.1093/ndt/18.1.70	53	55	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39933	39944		10.1074/jbc.M111.241620	http://dx.doi.org/10.1074/jbc.M111.241620			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937443	hybrid, Green Published			2022-12-25	WOS:000296925700027
J	Chen, XJ; Zhang, X; Jia, CX; Xu, JX; Gao, HX; Zhang, GH; Du, XN; Zhang, HL				Chen, Xingjuan; Zhang, Xuan; Jia, Caixia; Xu, Jiaxi; Gao, Haixia; Zhang, Guohong; Du, Xiaona; Zhang, Hailin			Membrane Depolarization Increases Membrane PtdIns(4,5)P-2 Levels through Mechanisms Involving PKC beta II and PI4 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED INHIBITION; PROTEIN-COUPLED RECEPTOR; SKELETAL-MUSCLE CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL TRISPHOSPHATE; ACTIN POLYMERIZATION; C2 DOMAINS; CHANNELS; CALCIUM; PIP2	In a previous study, we showed that membrane depolarization induced elevation of membrane phosphatidylinositol 4,5-bis-phosphates (PtdIns(4,5) P-2, also known as PIP2) and subsequently increased the KCNQ2/Q3 currents expressed in Xenopus oocytes through increased PI4 kinase activity. In this study, the underlying mechanism for this depolarization-induced enhancement of PIP2 synthesis was further investigated. Our results indicate that activation of protein kinase C (PKC) isozyme beta II was responsible for the enhanced PIP2 synthesis. We found that phorbol-12-myristate, 13-acetate (PMA), an activator of PKC, mimicked the effects of the membrane depolarization by increasing KCNQ2/Q3 activity, elevating membrane PIP2 levels and increasing activity of PI4 kinase beta. Furthermore, membrane depolarization enhanced PKC activity. The effects of both depolarization and PMA were blocked by a PKC inhibitor or PI4 kinase beta RNA interference. Further results demonstrate that the depolarization selectively activated the PKC beta II isoform and enhanced its interaction with PI4 kinase beta. These results reveal that the depolarization-induced elevation of membrane PIP2 is through activation of PKC and the subsequent increased activity of PI4 kinase beta	[Chen, Xingjuan; Zhang, Xuan; Jia, Caixia; Xu, Jiaxi; Gao, Haixia; Zhang, Guohong; Du, Xiaona; Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Key Lab Neural & Vasc Biol, Key Lab Pharmacol & Toxicol New Drug,Minist Educ, Shijiazhuang 050017, Hebei, Peoples R China	Hebei Medical University	Zhang, HL (corresponding author), Hebei Med Univ, Dept Pharmacol, Key Lab Neural & Vasc Biol, Key Lab Pharmacol & Toxicol New Drug,Minist Educ, 361 E Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	zhanghl@hebmu.edu.cn	chen, xingjuan/V-4064-2019; Xu, Jiaxi/N-3532-2018; xu, jia/GSD-6347-2022	chen, xingjuan/0000-0002-7380-8399; 	National Natural Science Foundation of China [30730031]; National Basic Research Program [2007CB512100]; National Science Fund for Distinguished Young Scholars of China [30325038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Natural Science Foundation of China (30730031, to H. Z.) and the National Basic Research Program (2007CB512100).; Recipient of National Science Fund for Distinguished Young Scholars of China (30325038). To whom correspondence should be addressed: Department of Pharmacology, Hebei Medical University, No. 361 East Zhongshan Road, Shijiazhuang, Hebei, 050017, China. Tel.: 86-311-86265562; E-mail: zhanghl@hebmu.edu.cn or z.hailin@yahoo.com.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; APGAR JR, 1995, MOL BIOL CELL, V6, P97, DOI 10.1091/mbc.6.1.97; Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Audigier C, 1998, GASTROEN CLIN BIOL, V22, P471; Babwah AV, 2003, J BIOL CHEM, V278, P5419, DOI 10.1074/jbc.M211053200; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; Corbalan-Garcia S, 2007, BIOCHEM SOC T, V35, P1046, DOI 10.1042/BST0351046; Di Paolo D, 2006, DIGEST LIVER DIS, V38, P749, DOI 10.1016/j.dld.2006.06.011; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; GOUELI BS, 1995, ANAL BIOCHEM, V225, P10, DOI 10.1006/abio.1995.1100; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Hamplova B, 2010, PHYSIOL RES, V59, P25, DOI 10.33549/physiolres.931638; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Johnson J, 1997, MECH DEVELOP, V67, P215, DOI 10.1016/S0925-4773(97)00122-6; KLINE D, 1985, DEV BIOL, V111, P471, DOI 10.1016/0012-1606(85)90499-3; Krauss M, 2007, FEBS LETT, V581, P2105, DOI 10.1016/j.febslet.2007.01.089; Lee SH, 2010, CLIN LUNG CANCER, V11, P169, DOI 10.3816/CLC.2010.n.021; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Powell JA, 2001, J CELL SCI, V114, P3673; Rajagopal S, 2008, BRAIN RES, V1210, P1, DOI 10.1016/j.brainres.2008.03.017; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Snow P, 1996, DEV BIOL, V180, P108, DOI 10.1006/dbio.1996.0288; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stith BJ, 1997, MOL BIOL CELL, V8, P755, DOI 10.1091/mbc.8.4.755; STUMPO DJ, 1994, J BIOL CHEM, V269, P21184; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang X, 2010, J BIOL CHEM, V285, P9402, DOI 10.1074/jbc.M109.068205; Zhao ZY, 2008, PFLUG ARCH EUR J PHY, V456, P413, DOI 10.1007/s00424-007-0391-3	50	12	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39760	39767		10.1074/jbc.M111.289090	http://dx.doi.org/10.1074/jbc.M111.289090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953466	Green Published, hybrid			2022-12-25	WOS:000296925700009
J	Gleyzer, N; Scarpulla, RC				Gleyzer, Natalie; Scarpulla, Richard C.			PGC-1-related Coactivator (PRC), a Sensor of Metabolic Stress, Orchestrates a Redox-sensitive Program of Inflammatory Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RESPIRATORY FACTORS; MITOCHONDRIAL BIOGENESIS; ERR-ALPHA; INDUCIBLE COACTIVATOR; SIGNALING PATHWAYS; ENERGY-METABOLISM; RECEPTOR-ALPHA; DNA-BINDING; IN-VIVO; CANCER	PGC-1-related coactivator (PRC) is a growth-regulated transcriptional cofactor that activates many nuclear genes specifying mitochondrial respiratory function. Stable PRC silencing in U2OS cells results in a complex phenotype typical of mitochondrial dysfunction including abundant abnormal mitochondria, reduced respiratory subunit expression, diminished respiratory enzymes and ATP levels, and elevated lactate production. The PRC response to metabolic stress was investigated by subjecting cells to metabolic insults including treatment with the uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP), expression of a dominant negative allele of nuclear respiratory factor 1 (NRF-1), and glucose deprivation. These treatments led to constitutively elevated PRC protein levels, a departure from its normal transient expression upon the initiation of cell growth. A microarray screen identified 45 genes that require PRC for their induction by CCCP. A subset of these genes specific to inflammation and cell stress was also induced by dominant negative NRF-1 and by glucose deprivation, suggesting that diverse metabolic insults converge on the same PRC-dependent inflammatory program. The PRC-dependent inflammatory response was inhibited by N-acetylcysteine, suggesting that PRC may contribute to the inflammatory microenvironment linked to oxidant signaling. The induction of this PRC-dependent program may be an early event in adaptations linked to cancer and degenerative diseases.	[Gleyzer, Natalie; Scarpulla, Richard C.] NW Med Sch, Dept Cell & Mol Biol, Chicago, IL USA		Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of Health, NIGMS [GM 32525-29]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM032525, R01GM032525] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 32525-29 from NIGMS.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Keibel A, 2009, CURR PHARM DESIGN, V15, P1949, DOI 10.2174/138161209788453167; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lohman FP, 1997, EXP CELL RES, V231, P141, DOI 10.1006/excr.1996.3458; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Podar K, 2010, CELL CYCLE, V9, P1722, DOI 10.4161/cc.9.9.11358; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Savagner F, 2003, BIOCHEM BIOPH RES CO, V310, P779, DOI 10.1016/j.bbrc.2003.09.076; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shao D, 2010, MITOCHONDRION, V10, P516, DOI 10.1016/j.mito.2010.05.012; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Tesfaigzi Johannes, 1999, Cell Biochemistry and Biophysics, V30, P243, DOI 10.1007/BF02738069; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAAR M, 1995, EXP CELL RES, V217, P217, DOI 10.1006/excr.1995.1081	48	37	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39715	39725		10.1074/jbc.M111.291575	http://dx.doi.org/10.1074/jbc.M111.291575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937425	Green Published, hybrid			2022-12-25	WOS:000296925700005
J	Hislop, JN; Henry, AG; von Zastrow, M				Hislop, James N.; Henry, Anastasia G.; von Zastrow, Mark			Ubiquitination in the First Cytoplasmic Loop of mu-Opioid Receptors Reveals a Hierarchical Mechanism of Lysosomal Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; AGONIST-PROMOTED UBIQUITINATION; BETA(2)-ADRENERGIC RECEPTOR; ENDOCYTIC TRAFFICKING; ESCRT MACHINERY; RESENSITIZATION; INTERNALIZATION; DEGRADATION; DEPENDENCE; ENDOSOMES	mu-Type opioid receptors (MORs) are members of the large seven-transmembrane receptor family which transduce the effects of both endogenous neuropeptides and clinically important opioid drugs. Prolonged activation of MORs promotes their proteolytic degradation by endocytic trafficking to lysosomes. This down-regulation process is known to contribute to homeostatic regulation of cellular opioid responsiveness, but mechanisms that mediate and control MOR down-regulation have not been defined. We show here that lysosomal down-regulation of MORs is ESCRT (endosomal sorting complex required for transport)-dependent and involves ubiquitin-promoted transfer of internalized MORs from the limiting endosome membrane to lumen. We also show that MOR down-regulation measured by conventional radioligand binding assay is determined specifically by ubiquitination in the first cytoplasmic loop. Surprisingly, we were unable to find any role of ubiquitination in determining whether internalized receptors recycle or are delivered to lysosomes. Instead, this decision is dictated specifically by the MOR C-tail and occurs irrespectively of the presence or absence of receptor ubiquitination. Our results support a hierarchical organization of discrete ubiquitin-independent and -dependent sorting operations, which function non-redundantly in the conserved down-regulation pathway to mediate precise endocytic control. Furthermore, they show that this hierarchical mechanism discriminates the endocytic regulation of naturally occurring MOR isoforms. Moreover, they are the first to reveal, we believe, for any seven-transmembrane receptor, a functional role of ubiquitination in the first cytoplasmic loop.	[von Zastrow, Mark] Univ Calif San Francisco, Cell Biol Program, San Francisco, CA 94158 USA; [Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Henry, Anastasia G.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), MC 2140,600 16th St, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health [DA010711, DA012864]; United States National Science Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, R01DA010711, R37DA010711, R01DA012864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA010711 and DA012864 (to M. v. Z.).; Recipient of a predoctoral fellowship from the United States National Science Foundation.	Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Chen LY, 2002, TRAFFIC, V3, P110, DOI 10.1034/j.1600-0854.2002.030204.x; Cottrell GS, 2006, J BIOL CHEM, V281, P27773, DOI 10.1074/jbc.M603369200; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Henry AG, 2011, TRAFFIC, V12, P170, DOI 10.1111/j.1600-0854.2010.01145.x; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Liang W, 2008, BIOCHEMISTRY-US, V47, P11750, DOI 10.1021/bi800219q; Mansour A, 1997, J NEUROCHEM, V68, P344, DOI 10.1046/j.1471-4159.1997.68010344.x; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roxrud I, 2010, BIOL CELL, V102, P293, DOI 10.1042/BC20090161; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; Thompson D, 2007, J BIOL CHEM, V282, P29178, DOI 10.1074/jbc.M704014200; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Walwyn WM, 2010, DRUG ALCOHOL DEPEN, V108, P156, DOI 10.1016/j.drugalcdep.2010.01.001; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091	39	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40193	40204		10.1074/jbc.M111.288555	http://dx.doi.org/10.1074/jbc.M111.288555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953467	Green Published, hybrid			2022-12-25	WOS:000296925700052
J	Mikami, Y; Shibuya, N; Kimura, Y; Nagahara, N; Yamada, M; Kimura, H				Mikami, Yoshinori; Shibuya, Norihiro; Kimura, Yuka; Nagahara, Noriyuki; Yamada, Masahiro; Kimura, Hideo			Hydrogen Sulfide Protects the Retina from Light-induced Degeneration by the Modulation of Ca2+ Influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; BRAIN SERINE RACEMASE; HORIZONTAL CELLS; GAMMA-LYASE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; PHOTORECEPTOR APOPTOSIS; CONE PHOTORECEPTORS; CALCIUM-CHANNELS; NITRIC-OXIDE; FEEDBACK	Hydrogen sulfide (H2S) has recently been recognized as a signaling molecule as well as a cytoprotectant. Cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE) are well-known as H2S-producing enzymes. We recently demonstrated that 3-mercaptopyruvate sulfurtransferase (3MST) along with cysteine aminotransferase (CAT) produces H2S in the brain and in vascular endothelium. However, the cellular distribution and regulation of these enzymes are not well understood. Here we show that 3MST and CAT are localized to retinal neurons and that the production of H2S is regulated by Ca2+; H2S, in turn, regulates Ca2+ influx into photoreceptor cells by activating vacuolar typeH(+)-ATPase (V-ATPase). We also show that H2S protects retinal neurons from light-induced degeneration. The excessive levels of light exposure deteriorated photoreceptor cells and increased the number of TUNEL- and 8-hydroxy-2'-deoxyguanosine (8-OHdG)-positive cells. Degeneration was greatly suppressed in the retina of mice administered with NaHS, a donor of H2S. The present study provides a new insight into the regulation of H2S production and the modulation of the retinal transmission by H2S. It also shows a cytoprotective effect of H2S on retinal neurons and provides a basis for the therapeutic target for retinal degeneration.	[Mikami, Yoshinori; Shibuya, Norihiro; Kimura, Yuka; Kimura, Hideo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 1878502, Japan; [Nagahara, Noriyuki] Nippon Med Sch, Dept Environm Med, Bunkyo Ku, Tokyo 1138602, Japan; [Yamada, Masahiro] RIKEN Brain Sci Inst, Lab Neuroinformat, Wako, Saitama 3510198, Japan	National Center for Neurology & Psychiatry - Japan; Nippon Medical School; RIKEN	Kimura, H (corresponding author), 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	kimura@ncnp.go.jp	Kimura, Hideo/AGK-0606-2022; Mikami, Yoshinori/G-6174-2011; Mikami, Yoshinori/W-3056-2019; Kimura, Hideo/J-6811-2016	Kimura, Hideo/0000-0002-6069-0475; Mikami, Yoshinori/0000-0002-4335-4170; Mikami, Yoshinori/0000-0002-4335-4170; Kimura, Yuka/0000-0001-9072-9329	National Institute of Neuroscience; KAKENHI [23659089, 23790316, 23700434, 22590258]; Ministry of Health Labor and Welfare; Grants-in-Aid for Scientific Research [23790316] Funding Source: KAKEN	National Institute of Neuroscience; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the National Institute of Neuroscience and by KAKENHI (23659089) from Grant-in-Aid for Challenging Exploratory Research (to H. K.), by KAKENHI (23790316) from Grant-in-Aid for Young Scientists (B) (to Y. M.), by KAKENHI (23700434) from Grant-in-Aid for Young Scientists (B) and Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare (to N. S.), and by KAKENHI (22590258) from Grant-in-Aid for Scientific Research (C) (to Y. K.).	Abe K, 1996, J NEUROSCI, V16, P1066; Babai N, 2009, J PHYSIOL-LONDON, V587, P2353, DOI 10.1113/jphysiol.2009.169656; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Baumgart F, 2007, FEBS J, V274, P4561, DOI 10.1111/j.1742-4658.2007.05986.x; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Boehning D, 2004, J BIOL CHEM, V279, P30927, DOI 10.1074/jbc.C400222200; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Donovan M, 2002, CELL DEATH DIFFER, V9, P1220, DOI 10.1038/sj.cdd.4401105; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; FENG Y, 1992, J BIOL CHEM, V267, P5817; Hayashida Y, 2002, J NEUROPHYSIOL, V87, P172, DOI 10.1152/jn.00778.2000; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Ichinohe A, 2005, BIOCHEM BIOPH RES CO, V338, P1547, DOI 10.1016/j.bbrc.2005.10.118; INAGAKI N, 1985, BRAIN RES, V325, P336, DOI 10.1016/0006-8993(85)90335-X; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jouhou H, 2007, J PHYSIOL-LONDON, V585, P401, DOI 10.1113/jphysiol.2007.142646; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kawamura N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012086; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; MILLER JE, 1971, J BIOL CHEM, V246, P3234; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Noell W K, 1966, Invest Ophthalmol, V5, P450; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Pong WW, 2007, J COMP NEUROL, V505, P158, DOI 10.1002/cne.21468; Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; TACHIBANA M, 1984, P NATL ACAD SCI-BIOL, V81, P7961, DOI 10.1073/pnas.81.24.7961; Tatsukawa T, 2005, VISUAL NEUROSCI, V22, P317, DOI 10.1017/S0952523805223076; Tsugane M, 2007, ANTIOXID REDOX SIGN, V9, P257, DOI 10.1089/ars.2007.9.257; UBUKA T, 1978, PHYSIOL CHEM PHYS M, V10, P483; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	49	106	117	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39379	39386		10.1074/jbc.M111.298208	http://dx.doi.org/10.1074/jbc.M111.298208			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937432	Green Published, hybrid			2022-12-25	WOS:000296759800056
J	Ohashi, T; Erickson, HP				Ohashi, Tomoo; Erickson, Harold P.			Fibronectin Aggregation and Assembly THE UNFOLDING OF THE SECOND FIBRONECTIN TYPE III DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; STREPTOCOCCUS-PYOGENES; PLASMA FIBRONECTIN; SELF-ASSOCIATION; TERMINAL 70-KDA; GELATIN-BINDING; MATRIX; DOMAIN; PROTEIN; SITES	The mechanism of fibronectin (FN) assembly and the self-association sites are still unclear and contradictory, although the N-terminal 70-kDa region ((I)1-9) is commonly accepted as one of the assembly sites. We previously found that (I)1-9 binds to superfibronectin, which is an artificial FN aggregate induced by anastellin. In the present study, we found that (I)1-9 bound to the aggregate formed by anastellin and a small FN fragment, (III)1-2. An engineered disulfide bond in (III)2, which stabilizes folding, inhibited aggregation, but a disulfide bond in (III)1 did not. A gelatin precipitation assay showed that (I)1-9 did not interact with anastellin, (III)1, (III)2, (III)1-2, or several (III)1-2 mutants including (III)1-2KADA. (In contrast to previous studies, we found that the (III)1-2KADA mutant was identical in conformation to wildtype (III)1-2.) Because (I)1-9 only bound to the aggregate and the unfolding of (III)2 played a role in aggregation, we generated a (III)2 domain that was destabilized by deletion of the G strand. This mutant bound (I)1-9 as shown by the gelatin precipitation assay and fluorescence resonance energy transfer analysis, and it inhibited FN matrix assembly when added to cell culture. Next, we introduced disulfide mutations into full-length FN. Three disulfide locks in (III)2, (III)3, and (III)11 were required to dramatically reduce anastellin-induced aggregation. When we tested the disulfide mutants in cell culture, only the disulfide bond in (III)2 reduced the FN matrix. These results suggest that the unfolding of (III)2 is one of the key factors for FN aggregation and assembly.	[Ohashi, Tomoo; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Ohashi, T (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	t.ohashi@cellbio.duke.edu			National Institutes of Health [CA047056]; NATIONAL CANCER INSTITUTE [R37CA047056, R01CA047056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA047056.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; AN SSA, 1992, BIOCHEMISTRY-US, V31, P9927, DOI 10.1021/bi00156a010; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Chen F, 1996, J BIOL CHEM, V271, P9084, DOI 10.1074/jbc.271.15.9084; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Hamill SJ, 1998, BIOCHEMISTRY-US, V37, P8071, DOI 10.1021/bi9801659; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; HSIEH P, 1980, J CELL BIOL, V87, P14, DOI 10.1083/jcb.87.1.14; HYNES RO, 1977, P NATL ACAD SCI USA, V74, P2855, DOI 10.1073/pnas.74.7.2855; Hynes RO, 1990, FIBRONECTINS; ICHIHARATANAKA K, 1992, FEBS LETT, V299, P155, DOI 10.1016/0014-5793(92)80236-A; ICHIHARATANAKA K, 1995, J CELL SCI, V108, P907; KAR L, 1993, J BIOL CHEM, V268, P8580; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; KESKIOJA J, 1977, BIOCHEM BIOPH RES CO, V74, P699, DOI 10.1016/0006-291X(77)90359-X; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Maqueda A, 2007, MATRIX BIOL, V26, P642, DOI 10.1016/j.matbio.2007.06.001; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCCONNELL MR, 1978, J BIOL CHEM, V253, P7522; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Niimi T, 2001, J BIOMOL NMR, V21, P281, DOI 10.1023/A:1012947209393; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ohashi T, 2002, J CELL SCI, V115, P1221; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Ohashi T, 2009, BIOCHEMISTRY-US, V48, P4189, DOI 10.1021/bi900001g; Ohashi T, 2009, MATRIX BIOL, V28, P170, DOI 10.1016/j.matbio.2009.03.002; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Santas AJ, 2002, J BIOL CHEM, V277, P13650, DOI 10.1074/jbc.M111361200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2000, J CELL SCI, V113, P1491; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; SOTTILE J, 1993, BIOCHEMISTRY-US, V32, P1641, DOI 10.1021/bi00057a031; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; YAMADA KM, 1977, BIOCHEMISTRY-US, V16, P5552, DOI 10.1021/bi00644a025	57	26	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39188	39199		10.1074/jbc.M111.262337	http://dx.doi.org/10.1074/jbc.M111.262337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949131	Green Published, hybrid			2022-12-25	WOS:000296759800038
J	Sasaki, M; Kim, E; Igarashi, M; Ito, K; Hasebe, R; Fukushi, H; Sawa, H; Kimura, T				Sasaki, Michihito; Kim, Eunmi; Igarashi, Manabu; Ito, Kimihito; Hasebe, Rie; Fukushi, Hideto; Sawa, Hirofumi; Kimura, Takashi			Single Amino Acid Residue in the A2 Domain of Major Histocompatibility Complex Class I Is Involved in the Efficiency of Equine Herpesvirus-1 Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-D; EHV-1; RECEPTOR; TYPE-1; VIRUS; ACTIVATION; SOLVATION; MUTANT; GENES; CELLS	Equine herpesvirus-1 (EHV-1), an alpha-herpesvirus of the family Herpesviridae, causes respiratory disease, abortion, and encephalomyelitis in horses. EHV-1 utilizes equine MHC class I molecules as entry receptors. However, hamster MHC class I molecules on EHV-1-susceptible CHO-K1 cells play no role in EHV-1 entry. To identify the MHC class I molecule region that is responsible for EHV-1 entry, domain exchange and site-directed mutagenesis experiments were performed, in which parts of the extracellular region of hamster MHC class I (clone C5) were replaced with corresponding sequences from equine MHC class I (clone A68). Substitution of alanine for glutamine at position 173 (Q173A) within the alpha 2 domain of the MHC class I molecule enabled hamster MHC class I C5 to mediate EHV-1 entry into cells. Conversely, substitution of glutamine for alanine at position 173 (A173Q) in equine MHC class I A68 resulted in loss of EHV-1 receptor function. Equine MHC class I clone 3.4, which possesses threonine at position 173, was unable to act as an EHV-1 receptor. Substitution of alanine for threonine at position 173 (T173A) enabled MHC class I 3.4 to mediate EHV-1 entry into cells. These results suggest that the amino acid residue at position 173 of the MHC class I molecule is involved in the efficiency of EHV-1 entry.	[Kimura, Takashi] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Mol Pathobiol, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Igarashi, Manabu; Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioinformat, Sapporo, Hokkaido 0010020, Japan; [Hasebe, Rie] Hokkaido Univ, Lab Vet Hyg, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Fukushi, Hideto] Gifu Univ, United Grad Sch Vet Sci, Dept Appl Vet Sci, Gifu 5011193, Japan; [Fukushi, Hideto] Gifu Univ, Lab Vet Microbiol, Fac Appl Biol Sci, Gifu 5011193, Japan; [Sawa, Hirofumi] Hokkaido Univ, Global COE Program, Sapporo, Hokkaido 0600818, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Gifu University; Gifu University; Hokkaido University	Kimura, T (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Dept Mol Pathobiol, Kita Ku, West 10,North 20, Sapporo, Hokkaido 0010020, Japan.	kimura@czc.hokudai.ac.jp	Ito, Kimihito/E-9975-2012; Sawa, Hirofumi/F-6954-2012; Igarashi, Manabu/F-6871-2012; Sawa, Hirofumi/AAW-8816-2021; Kimura, Takashi/F-6880-2012; Sasaki, Michihito/AAY-1900-2021	Ito, Kimihito/0000-0003-4986-1795; Sawa, Hirofumi/0000-0003-2569-2755; Sasaki, Michihito/0000-0003-1607-2175; HASEBE, Rie/0000-0003-2009-0595	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Akiyama Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Foundation	This work was supported by a grant-in-aid for scientific research (B) (to T. K.), by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (to M. S., T. K., and H. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by a grant from the Akiyama Foundation (to T. K.).	BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Csellner H, 2000, ARCH VIROL, V145, P2371, DOI 10.1007/s007050070027; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Frampton AR, 2005, J VIROL, V79, P3169, DOI 10.1128/JVI.79.5.3169-3173.2005; Frampton AR, 2007, J VIROL, V81, P10879, DOI 10.1128/JVI.00504-07; Furukawa H, 2002, J IMMUNOL, V169, P126, DOI 10.4049/jimmunol.169.1.126; Hasebe R, 2009, VIROLOGY, V393, P198, DOI 10.1016/j.virol.2009.07.032; Ibrahim ESM, 2004, MICROBIOL IMMUNOL, V48, P831, DOI 10.1111/j.1348-0421.2004.tb03615.x; Janeway C. A., 2005, IMMUNOBIOLOGY, P169; Kohn C. W., 2006, Clinical Techniques in Equine Practice, V5, P60, DOI 10.1053/j.ctep.2006.01.011; Kurtz BM, 2010, J VIROL, V84, P9027, DOI 10.1128/JVI.00287-10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Osterrieder N, 1999, VIRUS RES, V59, P165, DOI 10.1016/S0168-1702(98)00134-8; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; Sasaki M, 2011, GENES CELLS, V16, P343, DOI 10.1111/j.1365-2443.2011.01491.x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stierstorfer B, 2002, J VET MED B, V49, P37, DOI 10.1046/j.1439-0450.2002.00537.x; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Studdert MJ, 2003, VET REC, V153, P417, DOI 10.1136/vr.153.14.417; Sugahara Y, 1997, ARCH VIROL, V142, P1849, DOI 10.1007/s007050050202; Tallmadge RL, 2010, IMMUNOGENETICS, V62, P159, DOI 10.1007/s00251-009-0420-9; Tallmadge RL, 2005, IMMUNOGENETICS, V57, P763, DOI 10.1007/s00251-005-0034-9; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Van de Walle GR, 2008, J VIROL, V82, P11859, DOI 10.1128/JVI.00868-08; Whalley JM, 2007, ARCH VIROL, V152, P717, DOI 10.1007/s00705-006-0885-x	27	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39370	39378		10.1074/jbc.M111.251751	http://dx.doi.org/10.1074/jbc.M111.251751			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949188	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000296759800055
J	Sharma, V; Ichikawa, M; He, P; Bravo, Y; Dahl, R; Ng, BG; Cosford, NDP; Freeze, HH				Sharma, Vandana; Ichikawa, Mie; He, Ping; Bravo, Yalda; Dahl, Russell; Ng, Bobby G.; Cosford, Nicholas D. P.; Freeze, Hudson H.			Phosphomannose Isomerase Inhibitors Improve N-Glycosylation in Selected Phosphomannomutase-deficient Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL DISORDERS; EMBRYONIC LETHALITY; MUTATIONS; IA; PMM2; DERIVATIVES	Congenital disorders of glycosylation (CDG) are rare genetic disorders due to impaired glycosylation. The patients with sub-types CDG-Ia and CDG-Ib have mutations in the genes encoding phosphomannomutase 2 (PMM2) and phosphomannose isomerase (MPI or PMI), respectively. PMM2(mannose 6-phosphate -> mannose 1-phosphate) and MPI (mannose 6-phosphate double left right arrow fructose 6-phosphate) deficiencies reduce the metabolic flux of mannose 6-phosphate (Man-6-P) into glycosylation, resulting in unoccupied N-glycosylation sites. Both PMM2 and MPI compete for the same substrate, Man-6-P. Daily mannose doses reverse most of the symptoms of MPI-deficient CDG-Ib patients. However, CDG-Ia patients do not benefit from mannose supplementation because >95% Man-6-P is catabolized by MPI. We hypothesized that inhibiting MPI enzymatic activity would provide more Man-6-P for glycosylation and possibly benefit CDG-Ia patients with residual PMM2 activity. Here we show that MLS0315771, a potent MPI inhibitor from the benzoisothiazolone series, diverts Man-6-P toward glycosylation in various cell lines including fibroblasts from CDG-Ia patients and improves N-glycosylation. Finally, we show that MLS0315771 increases mannose metabolic flux toward glycosylation in zebrafish embryos.	[Sharma, Vandana; Ichikawa, Mie; He, Ping; Ng, Bobby G.; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Bravo, Yalda; Dahl, Russell; Cosford, Nicholas D. P.] Sanford Burnham Med Res Inst, Apoptosis & Cell Death Res Program, La Jolla, CA 92037 USA; [Bravo, Yalda; Dahl, Russell; Cosford, Nicholas D. P.] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Dahl, Russell/0000-0002-2939-1004; Cosford, Nic/0000-0001-7228-4709; Freeze, Hudson/0000-0001-6316-0501; Scott, David/0000-0002-8668-2449	National Institutes of Health [R01-DK55615, R21-HD062914]; Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK55615 and R21-HD062914 and The Rocket Fund (to H. H. F.).	Briones P, 2002, J INHERIT METAB DIS, V25, P635; Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; Eklund EA, 2005, GLYCOBIOLOGY, V15, P1084, DOI 10.1093/glycob/cwj006; Freeze H. H., 2010, CURRENT PROTOCOLS MO, V4; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Freeze HH, 2010, SEMIN CELL DEV BIOL, V21, P655, DOI 10.1016/j.semcdb.2010.03.011; GRACY RW, 1968, J BIOL CHEM, V243, P3161; Grunewald S, 2009, BBA-MOL BASIS DIS, V1792, P827, DOI 10.1016/j.bbadis.2009.01.003; Haeuptle MA, 2011, J BIOL CHEM, V286, P6085, DOI 10.1074/jbc.M110.165795; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Vega AI, 2011, J INHERIT METAB DIS, V34, P929, DOI 10.1007/s10545-011-9328-2; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kjaergaard S, 1998, EUR J HUM GENET, V6, P331, DOI 10.1038/sj.ejhg.5200194; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Panneerselvam K, 1996, J CLIN INVEST, V97, P1478, DOI 10.1172/JCI118570; Pirard M, 1999, FEBS LETT, V452, P319, DOI 10.1016/S0014-5793(99)00673-0; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; PROUDFOOT AEI, 1994, J PROTEIN CHEM, V13, P619, DOI 10.1007/BF01890460; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; Sharma V, 2011, J BIOL CHEM, V286, P10193, DOI 10.1074/jbc.M110.194241; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Vuillaumier-Barrot S, 2000, J MED GENET, V37, P579, DOI 10.1136/jmg.37.8.579	29	28	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39431	39438		10.1074/jbc.M111.285502	http://dx.doi.org/10.1074/jbc.M111.285502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949237	Green Published, hybrid			2022-12-25	WOS:000296759800060
J	Zhang, GY; Xiang, BG; Ye, SJ; Chrzanowska-Wodnicka, M; Morris, AJ; Gartner, TK; Whiteheart, SW; White, GC; Smyth, SS; Li, ZY				Zhang, Guoying; Xiang, Binggang; Ye, Shaojing; Chrzanowska-Wodnicka, Magdalena; Morris, Andrew J.; Gartner, T. Kent; Whiteheart, Sidney W.; White, Gilbert C., II; Smyth, Susan S.; Li, Zhenyu			Distinct Roles for Rap1b Protein in Platelet Secretion and Integrin alpha(IIb)beta(3) Outside-in Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAP1B; MICE LACKING; CALDAG-GEFI; BETA-3-INTEGRIN-DEFICIENT MICE; THROMBUS FORMATION; THROMBOXANE A(2); RELEASE REACTION; GRANULE RELEASE; RHO-GTPASES; ACTIVATION	Rap1b is activated by platelet agonists and plays a critical role in integrin alpha(IIb)beta(3) inside-out signaling and platelet aggregation. Here we show that agonist-induced Rap1b activation plays an important role in stimulating secretion of platelet granules. We also show that alpha(IIb)beta(3) outside-in signaling can activate Rap1b, and integrin outside-in signaling-mediated Rap1b activation is important in facilitating platelet spreading on fibrinogen and clot retraction. Rap1b-deficient platelets had diminished ATP secretion and P-selectin expression induced by thrombin or collagen. Importantly, addition of low doses of ADP and/or fibrinogen restored aggregation of Rap1b-deficient platelets. Furthermore, we found that Rap1b was activated by platelet spreading on immobilized fibrinogen, a process that was not affected by P2Y(12) or TXA(2) receptor deficiency, but was inhibited by the selective Src inhibitor PP2, the PKC inhibitor Ro-31-8220, or the calcium chelator demethyl-1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis. Clot retraction was abolished, and platelet spreading on fibrinogen was diminished in Rap1b-deficient platelets compared with wild-type controls. The defects in clot retraction and spreading on fibrinogen of Rap1b-deficient platelets were not rescued by addition of MnCl2, which elicits alpha(IIb)beta(3) outside-in signaling in the absence of inside-out signaling. Thus, our results reveal two different activation mechanisms of Rap1b as well as novel functions of Rap1b in platelet secretion and in integrin alpha(IIb)beta(3) outside-in signaling.	[Zhang, Guoying; Xiang, Binggang; Morris, Andrew J.; Smyth, Susan S.; Li, Zhenyu] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA; [Ye, Shaojing; Whiteheart, Sidney W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Chrzanowska-Wodnicka, Magdalena] Med Coll Wisconsin, Blood Res Inst, Dept Vasc Signaling, Milwaukee, WI 53226 USA; [Gartner, T. Kent] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [White, Gilbert C., II] Med Coll Wisconsin, Dept Med, Lab Platelet, Milwaukee, WI 53226 USA; [Smyth, Susan S.] Lexington Vet Adm Med Ctr, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; University of Memphis; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Li, ZY (corresponding author), Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, 741 S Limestone St,BBSRB Bldg,Rm 251, Lexington, KY 40536 USA.	zhenyuli08@uky.edu	Xiang, Binggang/N-6494-2013	Whiteheart, Sidney/0000-0001-5577-0473; Chrzanowska, Magdalena/0000-0003-4182-2126	National Institutes of Health Cardiovascular Disease from the National Center for Research Resources [P20RR021954]; American Heart Association [0855698G, 0950118G]; Centers of Biomedical Research Excellence in Obesity; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056652] Funding Source: NIH RePORTER	National Institutes of Health Cardiovascular Disease from the National Center for Research Resources; American Heart Association(American Heart Association); Centers of Biomedical Research Excellence in Obesity; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Cardiovascular Disease Grant P20RR021954 from the National Center for Research Resources. This work was also supported by American Heart Association Midwest affiliate Grand-in-Aid 0855698G (to Z. L.) and 0950118G (to M. C.-W.), and in part by the Centers of Biomedical Research Excellence in Obesity. This material is the result of work supported with the resources and use of the facilities at the Lexington VA Medical Center.	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bernardi B, 2006, BLOOD, V107, P2728, DOI 10.1182/blood-2005-07-3023; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Campus F, 2005, J BIOL CHEM, V280, P24386, DOI 10.1074/jbc.M501174200; CHEN YP, 1994, J BIOL CHEM, V269, P18307; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Franke B, 2000, MOL CELL BIOL, V20, P779, DOI 10.1128/MCB.20.3.779-785.2000; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Graham GJ, 2009, BLOOD, V114, P1083, DOI 10.1182/blood-2009-03-210211; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Reddy KB, 2008, J CELL SCI, V121, P1641, DOI 10.1242/jcs.014076; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Smyth SS, 2001, BLOOD, V98, P1055, DOI 10.1182/blood.V98.4.1055; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Wang Z, 2009, J THROMB HAEMOST, V7, P693, DOI 10.1111/j.1538-7836.2009.03289.x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x	55	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39466	39477		10.1074/jbc.M111.239608	http://dx.doi.org/10.1074/jbc.M111.239608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940635	Green Published, hybrid			2022-12-25	WOS:000296759800064
J	Kostal, V; Korbelova, J; Rozsypal, J; Zahradnickova, H; Cimlova, J; Tomcala, A; Simek, P				Kostal, Vladimir; Korbelova, Jaroslava; Rozsypal, Jan; Zahradnickova, Helena; Cimlova, Jana; Tomcala, Ales; Simek, Petr			Long-Term Cold Acclimation Extends Survival Time at 0 degrees C and Modifies the Metabolomic Profiles of the Larvae of the Fruit Fly Drosophila melanogaster	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; FREE AMINO-ACIDS; LOW-TEMPERATURE; CHYMOMYZA-COSTATA; CHILLING-INJURY; HOMEOVISCOUS ADAPTATION; MEMBRANE-LIPIDS; ION HOMEOSTASIS; TOLERANCE; INSECT	Background: Drosophila melanogaster is a chill-susceptible insect. Previous studies on this fly focused on acute direct chilling injury during cold shock and showed that lower lethal temperature (LLT, approximately -5 degrees C) exhibits relatively low plasticity and that acclimations, both rapid cold hardening (RCH) and long-term cold acclimation, shift the LLT by only a few degrees at the maximum. Principal Findings: We found that long-term cold acclimation considerably improved cold tolerance in fully grown third-instar larvae of D. melanogaster. A comparison of the larvae acclimated at constant 25 degrees C with those acclimated at constant 15 degrees C followed by constant 6 degrees C for 2 d (15 degrees C -> 6 degrees C) showed that long-term cold acclimation extended the lethal time for 50% of the population (Lt(50)) during exposure to constant 0 degrees C as much as 630-fold (from 0.137 h to 86.658 h). Such marked physiological plasticity in Lt(50) (in contrast to LLT) suggested that chronic indirect chilling injury at 0 degrees C differs from that caused by cold shock. Long-term cold acclimation modified the metabolomic profiles of the larvae. Accumulations of proline (up to 17.7 mM) and trehalose (up to 36.5 mM) were the two most prominent responses. In addition, restructuring of the glycerophospholipid composition of biological membranes was observed. The relative proportion of glycerophosphoethanolamines (especially those with linoleic acid at the sn-2 position) increased at the expense of glycerophosphocholines. Conclusion: Third-instar larvae of D. melanogaster improved their cold tolerance in response to long-term cold acclimation and showed metabolic potential for the accumulation of proline and trehalose and for membrane restructuring.	[Kostal, Vladimir; Korbelova, Jaroslava; Zahradnickova, Helena; Cimlova, Jana; Tomcala, Ales; Simek, Petr] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Rozsypal, Jan] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Kostal, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	kostal@entu.cas.cz	Simek, Petr/AAE-9176-2021; Rozsypal, Jan/H-6294-2014; Simek, Petr/H-4126-2014; Zahradnickova, Helena/H-1863-2014; Cimlova, Jana/H-4667-2014; Kostal, Vladimir/G-6688-2014; Tomčala, Aleš/G-5717-2014	Simek, Petr/0000-0003-2754-6372; Rozsypal, Jan/0000-0002-7925-7401; Kostal, Vladimir/0000-0002-4994-5123; Tomčala, Aleš/0000-0002-5232-8441	Czech Science Foundation [206/07/0269, 203/09/2014]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Czech Science Foundation grants 206/07/0269 and 203/09/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P169, DOI 10.1016/0003-9861(83)90201-1; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; BALE JS, 1993, FUNCT ECOL, V7, P751; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bliss CI, 1926, J GEN PHYSIOL, V9, P467, DOI 10.1085/jgp.9.4.467; BUEDING E, 1964, J BIOL CHEM, V239, P4018; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; CHIANG H. C, 1962, CANADIAN ENTOMOL, V94, P722; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; CROWE JH, 1987, BIOCHEM J, V242, P1, DOI 10.1042/bj2420001; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; CZAJKA MC, 1990, J EXP BIOL, V148, P245; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUMAN JG, 1979, J INSECT PHYSIOL, V25, P805, DOI 10.1016/0022-1910(79)90083-0; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Fields PG, 1998, J INSECT PHYSIOL, V44, P955, DOI 10.1016/S0022-1910(98)00055-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gessner MO, 2005, METHODS STUDY LITTER, P103; Gilchrist GW, 1997, PHYSIOL ZOOL, V70, P403, DOI 10.1086/515853; Hazel J.R., 1989, Advances in Comparative and Environmental Physiology, V4, P1; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Hengherr S, 2009, PHYSIOL BIOCHEM ZOOL, V82, P749, DOI 10.1086/605954; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Hincha DK, 2004, BIOCHEM J, V383, P277, DOI 10.1042/BJ20040746; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Hodkova M, 2002, J INSECT PHYSIOL, V48, P1009, DOI 10.1016/S0022-1910(02)00188-9; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; HOFFMANN AA, 1993, AM NAT, V142, pS93, DOI 10.1086/285525; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Husek P, 1997, CLIN CHEM, V43, P1999; Husek P, 2001, LC GC N AM, V19, P986; Jensen D, 2007, J INSECT PHYSIOL, V53, P179, DOI 10.1016/j.jinsphys.2006.11.008; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kelty JD, 1999, J INSECT PHYSIOL, V45, P719, DOI 10.1016/S0022-1910(99)00040-2; Kelty JD, 2001, J EXP BIOL, V204, P1659; KNIGHT JD, 1986, CRYO-LETT, V7, P194; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2006, COMP BIOCHEM PHYS B, V143, P171, DOI 10.1016/j.cbpb.2005.11.005; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kostal V, 2003, COMP BIOCHEM PHYS B, V135, P407, DOI 10.1016/S1096-4959(03)00117-9; Kostal V, 1998, J COMP PHYSIOL B, V168, P453, DOI 10.1007/s003600050165; Kostal V, 2011, P NATL ACAD SCI USA, V108, P13041, DOI 10.1073/pnas.1107060108; Kostal Vladimir, 2010, P116, DOI 10.1017/CBO9780511675997.006; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee Richard E. Jr, 2010, P3, DOI 10.1017/CBO9780511675997.002; Leopold Roger A., 2010, P325, DOI 10.1017/CBO9780511675997.014; Loeb J, 1917, J BIOL CHEM, V32, P103; MacMillan HA, 2009, J INSECT PHYSIOL, V55, P243, DOI 10.1016/j.jinsphys.2008.11.015; Misener SR, 2001, J INSECT PHYSIOL, V47, P393, DOI 10.1016/S0022-1910(00)00141-4; Moon I, 1996, CRYOLETTERS, V17, P105; MORGAN TD, 1983, J INSECT PHYSIOL, V29, P735, DOI 10.1016/0022-1910(83)90001-X; MORRIS GJ, 1984, CRYOLETTERS, V5, P352; Muldrew K, 2004, LIFE IN THE FROZEN STATE, P67, DOI 10.1201/9780203647073.ch2; Nedved O, 1998, CRYO-LETT, V19, P267; Nedved O, 1998, FUNCT ECOL, V12, P816, DOI 10.1046/j.1365-2435.1998.00250.x; NOVITSKI E, 1949, BIOL BULL, V97, P150, DOI 10.2307/1538294; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Overgaard J, 2006, PHYSIOL ENTOMOL, V31, P328, DOI 10.1111/j.1365-3032.2006.00522.x; Powell SJ, 2005, J EXP BIOL, V208, P2615, DOI 10.1242/jeb.01685; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; Rajamohan A, 2009, PHYSIOL ENTOMOL, V34, P217, DOI 10.1111/j.1365-3032.2009.00677.x; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; Renault D, 2006, COMP BIOCHEM PHYS A, V143, P279, DOI 10.1016/j.cbpa.2005.11.012; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rojas RR, 1996, CRYOBIOLOGY, V33, P447, DOI 10.1006/cryo.1996.0045; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Schill RO, 2009, BIOTECHNOL ADV, V27, P348, DOI 10.1016/j.biotechadv.2009.01.011; Sformo T, 2010, J EXP BIOL, V213, P502, DOI 10.1242/jeb.035758; SHIMADA K, 1990, CRYO-LETT, V11, P243; Shintani Y, 2007, J INSECT PHYSIOL, V53, P1055, DOI 10.1016/j.jinsphys.2007.05.012; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOMME L, 1982, COMP BIOCHEM PHYS A, V73, P519, DOI 10.1016/0300-9629(82)90260-2; Storey K.B., 1991, P64; STOREY KB, 1981, J COMP PHYSIOL, V144, P183, DOI 10.1007/BF00802756; Strachan LA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P43, DOI 10.1086/657147; Throckmorton L.H., 1975, P421; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Tsai CJ, 2002, CRIT REV BIOCHEM MOL, V37, P55, DOI 10.1080/10409230290771456; TUCIC N, 1979, EVOLUTION, V33, P350, DOI 10.1111/j.1558-5646.1979.tb04688.x; Viner RI, 2001, CELL STRESS CHAPERON, V6, P126, DOI 10.1379/1466-1268(2001)006<0126:IOTOTM>2.0.CO;2; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	94	103	108	3	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25025	10.1371/journal.pone.0025025	http://dx.doi.org/10.1371/journal.pone.0025025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957472	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100032
J	Liuzza, MT; Cazzato, V; Vecchione, M; Crostella, F; Caprara, GV; Aglioti, SM				Liuzza, Marco Tullio; Cazzato, Valentina; Vecchione, Michele; Crostella, Filippo; Caprara, Gian Vittorio; Aglioti, Salvatore Maria			Follow My Eyes: The Gaze of Politicians Reflexively Captures the Gaze of Ingroup Voters	PLOS ONE			English	Article							SOCIAL ATTENTION; FACIAL EXPRESSION	Studies in human and non-human primates indicate that basic socio-cognitive operations are inherently linked to the power of gaze in capturing reflexively the attention of an observer. Although monkey studies indicate that the automatic tendency to follow the gaze of a conspecific is modulated by the leader-follower social status, evidence for such effects in humans is meager. Here, we used a gaze following paradigm where the directional gaze of right-or left-wing Italian political characters could influence the oculomotor behavior of ingroup or outgroup voters. We show that the gaze of Berlusconi, the right-wing leader currently dominating the Italian political landscape, potentiates and inhibits gaze following behavior in ingroup and outgroup voters, respectively. Importantly, the higher the perceived similarity in personality traits between voters and Berlusconi, the stronger the gaze interference effect. Thus, higher-order social variables such as political leadership and affiliation prepotently affect reflexive shifts of attention.	[Liuzza, Marco Tullio; Cazzato, Valentina; Vecchione, Michele; Crostella, Filippo; Caprara, Gian Vittorio; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Liuzza, Marco Tullio; Cazzato, Valentina; Aglioti, Salvatore Maria] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Liuzza, MT (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	marcotullio.liuzza@uniroma1.it	Aglioti, Salvatore M/E-9829-2012; Liuzza, Marco Tullio/A-9967-2012; Cazzato, Valentina/GLV-4402-2022	Liuzza, Marco Tullio/0000-0001-6708-1253; Cazzato, Valentina/0000-0001-9826-7798; Lauwereyns, Jan/0000-0003-0551-2550; Aglioti, Salvatore Maria/0000-0001-8175-7563	TANGO; Istituto Italiano di Tecnologia SEED [21538]; Sapienza University of Rome; European Commission [249858]	TANGO; Istituto Italiano di Tecnologia SEED; Sapienza University of Rome; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by TANGO, Istituto Italiano di Tecnologia SEED 2009 (Protocol Number 21538), and Sapienza University of Rome to S.M.A. The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: 249858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemeyer, 1996, AUTHORITARIAN SPECTE; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Bargh J. A., 1997, ADV SOC COG, VX, P1; Baron-Cohen S., 1995, JOINT ATTENTION ITS, P41, DOI DOI 10.1111/J.2044-835X.1997.TB00726.X; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Caprara GV, 2007, POLIT PSYCHOL, V28, P609, DOI 10.1111/j.1467-9221.2007.00592.x; CAPRARA GV, 1994, EUR J PERSONALITY, V8, P357, DOI 10.1002/per.2410080502; Caprara GV, 2004, AM PSYCHOL, V59, P581, DOI 10.1037/0003-066X.59.7.581; CATELLANI P, 2008, SINISTRA DESTRA RADI; Cavazza N, 2010, PSICOLOG SOC, V5, P115, DOI 10.1482/32022; Cazzato V, 2012, HUM BRAIN MAPP, V33, P165, DOI 10.1002/hbm.21202; Crostella F, 2009, EXP BRAIN RES, V197, P143, DOI 10.1007/s00221-009-1900-8; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; DEDIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417; DEWAAL F, 1982, CHIMPANZEE POLITICS; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dodd MD, 2011, ATTEN PERCEPT PSYCHO, V73, P24, DOI 10.3758/s13414-010-0001-x; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Efron B., 1994, INTRO BOOTSTRAP; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fowler JH, 2008, SCIENCE, V322, P912, DOI 10.1126/science.1158188; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hietanen JK, 2006, NEUROIMAGE, V33, P406, DOI 10.1016/j.neuroimage.2006.06.048; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Hori E, 2005, PHYSIOL BEHAV, V84, P397, DOI 10.1016/j.physbeh.2005.01.002; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Liew SL, 2011, HUM BRAIN MAPP, V32, P1986, DOI 10.1002/hbm.21164; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; PERDUE CW, 1990, J PERS SOC PSYCHOL, V59, P475, DOI 10.1037/0022-3514.59.3.475; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Shepherd SV, 2009, P NATL ACAD SCI USA, V106, P9489, DOI 10.1073/pnas.0900419106; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Sidanius J., 1999, SOCIAL DOMINANCE INT; Tajfel H., 1979, SOCIAL PSYCHOL INTER; Tomasello M., 1995, JOINT ATTENTION ITS, P103; VECCHIONE M, 2011, INT J PSYCH IN PRESS	43	56	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25117	10.1371/journal.pone.0025117	http://dx.doi.org/10.1371/journal.pone.0025117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825HM	21957479	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100039
J	Lai, SJ; Lai, MC				Lai, Shu-Jung; Lai, Mei-Chin			Characterization and Regulation of the Osmolyte Betaine Synthesizing Enzymes GSMT and SDMT from Halophilic Methanogen Methanohalophilus portucalensis	PLOS ONE			English	Article							GLYCINE BETAINE; N-METHYLTRANSFERASE; COMPATIBLE SOLUTES; STRESS-RESPONSE; IDENTIFICATION; TRANSPORTER; PATHWAYS; ARCHAEA; GENE	The halophilic methanoarchaeon Methanohalophilus portucalensis can synthesize the osmolyte betaine de novo in response to extracellular salt stress. Betaine is generated by the stepwise methylation of glycine to form sarcosine, N, N-dimethylglycine and betaine by using S-adenosyl-L-methionine (AdoMet) as the methyl donor. The complete gene cluster of Mpgsmt-sdmt was cloned from Southern hybridization and heterologous expressed in E. coli respectively. The recombinant MpGSMT and MpSDMT both retained their in vivo functional activities in E. coli BL21(DE3) RIL to synthesize and accumulate betaine and conferred elevated survival ability in betaine transport deficient mutant E. coli MKH13 under high salt stress. The dramatic activating effects of sodium and potassium ions on the in vitro methyltransferase activities of MpGSMT, but not MpSDMT or bacterial GSMT and SDMT, revealed that GSMT from halophilic methanoarchaeon possesses novel regulate mechanism in betaine biosynthesis pathway. The circular dichroism spectra showed the fluctuated peaks at 206 nm were detected in the MpGSMT under various concentrations of potassium or sodium ions. This fluctuated difference may cause by a change in the beta-turn structure located at the conserved glycine- and sarcosine-binding residue Arg167 of MpGSMT. The analytical ultracentrifugation analysis indicated that the monomer MpGSMT switched to dimeric form increased from 7.6% to 70% with KCl concentration increased from 0 to 2.0 M. The level of potassium and sodium ions may modulate the substrate binding activity of MpGSMT through the conformational change. Additionally, MpGSMT showed a strong end product, betaine, inhibitory effect and was more sensitive to the inhibitor AdoHcy. The above results indicated that the first enzymatic step involved in synthesizing the osmolyte betaine in halophilic archaea, namely, GSMT, may also play a major role in coupling the salt-in and compatible solute (osmolyte) osmoadaptative strategies in halophilic methanogens for adapting to high salt environments.	[Lai, Shu-Jung; Lai, Mei-Chin] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	National Chung Hsing University	Lai, SJ (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	mclai@dragon.nchu.edu.tw	Lai, Shu-Jung/G-8875-2019	Lai, Mei-Chin/0000-0002-1385-1686; Lai, Shu-Jung/0000-0001-7653-8147	National Council of Science, Taiwan, Republic of China [NSC 97-2313-B-005-013-MY3]	National Council of Science, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work has been supported by grants NSC 97-2313-B-005-013-MY3 from the National Council of Science (www.nsc.gov.tw), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BOONE DR, 1993, INT J SYST BACTERIOL, V43, P430, DOI 10.1099/00207713-43-3-430; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SY, 2009, ARCH MICROBIOL, V191, P735, DOI 10.1007/s00203-009-0501-z; Hickey AJ, 2002, CRIT REV BIOCHEM MOL, V37, P199, DOI 10.1080/10409230290771500; Kimura Y, 2010, J BACTERIOL, V192, P1467, DOI 10.1128/JB.01118-09; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai MC, 1999, APPL ENVIRON MICROB, V65, P828; LAI MC, 1991, J BACTERIOL, V173, P5352, DOI 10.1128/jb.173.17.5352-5358.1991; LAI MC, 1992, J BACTERIOL, V174, P7474, DOI 10.1128/jb.174.22.7474-7477.1992; Lai MC, 2000, J BACTERIOL, V182, P5020, DOI 10.1128/JB.182.17.5020-5024.2000; Lai MC, 2006, RES MICROBIOL, V157, P948, DOI 10.1016/j.resmic.2006.08.007; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Lu WD, 2006, ARCH MICROBIOL, V186, P495, DOI 10.1007/s00203-006-0167-8; MATHRANI IM, 1985, APPL ENVIRON MICROB, V50, P140, DOI 10.1128/AEM.50.1.140-143.1985; McCoy JG, 2009, PROTEINS, V74, P368, DOI 10.1002/prot.22147; Muller V, 2005, CURR OPIN MICROBIOL, V8, P729, DOI 10.1016/j.mib.2005.10.011; Nyyssola A, 2000, J BIOL CHEM, V275, P22196, DOI 10.1074/jbc.M910111199; Nyyssola A, 2001, APPL ENVIRON MICROB, V67, P2044, DOI 10.1128/AEM.67.5.2044-2050.2001; Nyyssola A, 2001, ARCH MICROBIOL, V176, P294, DOI 10.1007/s002030100325; PERCZEL A, 1992, PROTEIN SCI, V1, P378; Proctor LM, 1997, APPL ENVIRON MICROB, V63, P2252, DOI 10.1128/AEM.63.6.2252-2257.1997; Roberts MF, 2000, FRONT BIOSCI-LANDMRK, V5, pD796, DOI 10.2741/roberts; ROBERTS MF, 1992, J BACTERIOL, V174, P6688, DOI 10.1128/JB.174.20.6688-6693.1992; Roessler M, 2002, APPL ENVIRON MICROB, V68, P2133, DOI 10.1128/AEM.68.5.2133-2139.2002; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Shih CJ, 2007, MICROBIOL-SGM, V153, P2572, DOI 10.1099/mic.0.2007/007633-0; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Spring S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/690737; Su KL, 2007, PROTEINS, V68, P363, DOI 10.1002/prot.21443; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200	32	27	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25090	10.1371/journal.pone.0025090	http://dx.doi.org/10.1371/journal.pone.0025090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949863	Green Submitted, Green Published			2022-12-25	WOS:000295260400047
J	Mitchel, JA; Hoffman-Kim, D				Mitchel, Jennifer A.; Hoffman-Kim, Diane			Cellular Scale Anisotropic Topography Guides Schwann Cell Motility	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GUIDANCE CUES; CONTACT GUIDANCE; PERIPHERAL-NERVE; FIBROBLAST MIGRATION; STEM-CELLS; NEURITE OUTGROWTH; GLIAL-CELLS; SUBSTRATE; ALIGNMENT	Directed migration of Schwann cells (SC) is critical for development and repair of the peripheral nervous system. Understanding aspects of motility specific to SC, along with SC response to engineered biomaterials, may inform strategies to enhance nerve regeneration. Rat SC were cultured on laminin-coated microgrooved poly(dimethyl siloxane) platforms that were flat or presented repeating cellular scale anisotropic topographical cues, 30 or 60 mm in width, and observed with timelapse microscopy. SC motion was directed parallel to the long axis of the topography on both the groove floor and the plateau, with accompanying differences in velocity and directional persistence in comparison to SC motion on flat substrates. In addition, feature dimension affected SC morphology, alignment, and directional persistence. Plateaus and groove floors presented distinct cues which promoted differential motility and variable interaction with the topographical features. SC on the plateau surfaces tended to have persistent interactions with the edge topography, while SC on the groove floors tended to have infrequent contact with the corners and walls. Our observations suggest the capacity of SC to be guided without continuous contact with a topographical cue. SC exhibited a range of distinct motile morphologies, characterized by their symmetry and number of extensions. Across all conditions, SC with a single extension traveled significantly faster than cells with more or no extensions. We conclude that SC motility is complex, where persistent motion requires cellular asymmetry, and that anisotropic topography with cellular scale features can direct SC motility.	[Mitchel, Jennifer A.; Hoffman-Kim, Diane] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Mitchel, JA (corresponding author), Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	dhk@brown.edu		Mitchel, Jennifer/0000-0002-4480-3193	NSF (National Science Foundation) [NIH R01 EB005722-01]; Brown University; GAANN (Graduate Assistance in Areas of National Need) Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005722] Funding Source: NIH RePORTER	NSF (National Science Foundation)(National Science Foundation (NSF)); Brown University; GAANN (Graduate Assistance in Areas of National Need) Fellowship(US Department of Education); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by an NSF (National Science Foundation) Career award, an NSF Advance Career Development Award, and NIH R01 EB005722-01 to DHK, and a Brown University Brain Science Graduate Research Award and GAANN (Graduate Assistance in Areas of National Need) Fellowship to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 1999, CELL MOTIL CYTOSKEL, V42, P331; Berzat A, 2010, EMBO J, V29, P2734, DOI 10.1038/emboj.2010.170; Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Bruder JM, 2007, J BIOMAT SCI-POLYM E, V18, P967, DOI 10.1163/156856207781494412; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; CLARK P, 1990, DEVELOPMENT, V108, P635; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; Ferrari A, 2009, IEEE T BIOMED ENG; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Gatto CL, 2007, J CELL PHYSIOL, V210, P122, DOI 10.1002/jcp.20844; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035; Gomez N, 2007, J R SOC INTERFACE, V4, P223, DOI 10.1098/rsif.2006.0171; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Hamilton DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015129; Hamilton DW, 2009, CELL MOTIL CYTOSKEL, V66, P260, DOI 10.1002/cm.20354; Hanson JN, 2009, LAB CHIP, V9, P122, DOI 10.1039/b803595d; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; HIRONO T, 1988, BRAIN RES, V446, P189, DOI 10.1016/0006-8993(88)91314-5; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103; Jessen KR, 2004, INT J BIOCHEM CELL B, V36, P1861, DOI 10.1016/j.biocel.2004.02.023; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kassis J, 2001, SEMIN CANCER BIOL, V11, P105, DOI 10.1006/scbi.2000.0362; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Kofron CM, 2010, ANN BIOMED ENG, V38, P2210, DOI 10.1007/s10439-010-0054-y; Kofron CM, 2009, CELL MOL BIOENG, V2, P554, DOI 10.1007/s12195-009-0087-1; Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lopez TJ, 1999, EXP NEUROL, V158, P1, DOI 10.1006/exnr.1999.7081; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; Maheshwari G, 1999, BIOPHYS J, V76, P2814, DOI 10.1016/S0006-3495(99)77435-7; Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015; Mai JY, 2007, BIOMED MICRODEVICES, V9, P523, DOI 10.1007/s10544-007-9060-8; Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Ndubaku U, 2008, ACTA HISTOCHEM, V110, P182, DOI 10.1016/j.acthis.2007.10.003; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5; Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z; Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1; Tan J, 2001, BIOPHYS J, V81, P2569, DOI 10.1016/S0006-3495(01)75901-2; Tan J, 2000, J BIOMED MATER RES, V51, P694, DOI 10.1002/1097-4636(20000915)51:4<694::AID-JBM18>3.0.CO;2-N; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4; Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3; Walsh S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E2; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Yu WM, 2007, MOL NEUROBIOL, V35, P288, DOI 10.1007/s12035-007-0026-x	64	39	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24316	10.1371/journal.pone.0024316	http://dx.doi.org/10.1371/journal.pone.0024316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949703	Green Submitted, Green Published, gold			2022-12-25	WOS:000295260400003
J	Merquiol, E; Uzi, D; Mueller, T; Goldenberg, D; Nahmias, Y; Xavier, RJ; Tirosh, B; Shibolet, O				Merquiol, Emmanuelle; Uzi, Dotan; Mueller, Tobias; Goldenberg, Daniel; Nahmias, Yaakov; Xavier, Ramnik J.; Tirosh, Boaz; Shibolet, Oren			HCV Causes Chronic Endoplasmic Reticulum Stress Leading to Adaptation and Interference with the Unfolded Protein Response	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ER STRESS; SUBGENOMIC REPLICONS; VIRAL REPLICATION; OXIDATIVE STRESS; PHOSPHATASE 2A; CORE PROTEIN; CELL-CULTURE; IN-VITRO; TRANSCRIPTION	Background: The endoplasmic reticulum (ER) is the cellular site for protein folding. ER stress occurs when protein folding capacity is exceeded. This stress induces a cyto-protective signaling cascades termed the unfolded protein response (UPR) aimed at restoring homeostasis. While acute ER stress is lethal, chronic sub-lethal ER stress causes cells to adapt by attenuation of UPR activation. Hepatitis C virus (HCV), a major human pathogen, was shown to cause ER stress, however it is unclear whether HCV induces chronic ER stress, and if so whether adaptation mechanisms are initiated. We wanted to characterize the kinetics of HCV-induced ER stress during infection and assess adaptation mechanisms and their significance. Methods and Findings: The HuH7.5.1 cellular system and HCV-transgenic (HCV-Tg) mice were used to characterize HCV-induced ER stress/UPR pathway activation and adaptation. HCV induced a wave of acute ER stress peaking 2-5 days post-infection, which rapidly subsided thereafter. UPR pathways were activated including IRE1 and EIF2 alpha phosphorylation, ATF6 cleavage and XBP-1 splicing. Downstream target genes including GADD34, ERdj4, p58ipk, ATF3 and ATF4 were upregulated. CHOP, a UPR regulated protein was activated and translocated to the nucleus. Remarkably, UPR activity did not return to baseline but remained elevated for up to 14 days post infection suggesting that chronic ER stress is induced. At this time, cells adapted to ER stress and were less responsive to further drug-induced ER stress. Similar results were obtained in HCV-Tg mice. Suppression of HCV by Interferon-alpha 2 alpha treatment, restored UPR responsiveness to ER stress tolerant cells. Conclusions: Our study shows, for the first time, that HCV induces adaptation to chronic ER stress which was reversed upon viral suppression. These finding represent a novel viral mechanism to manipulate cellular response pathways.	[Merquiol, Emmanuelle; Uzi, Dotan] Hadassah Hebrew Univ, Med Ctr, Div Med, Liver Unit, Jerusalem, Israel; [Tirosh, Boaz] Fac Med, Sch Pharmacol, Inst Drug Res, Jerusalem, Israel; [Mueller, Tobias] Charite, CVK, Med Klin MS Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Goldenberg, Daniel] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Nahmias, Yaakov] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Rachel & Selim Benin Sch Comp Sci & Engn, Ctr Bioengn, Jerusalem, Israel; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Gastroenterol Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA USA; [Shibolet, Oren] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Liver Dis, Liver Unit, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Merquiol, E (corresponding author), Hadassah Hebrew Univ, Med Ctr, Div Med, Liver Unit, Jerusalem, Israel.	orensh@tasmc.health.gov.il	Nahmias, Yaakov/AAM-3872-2020; Nahmias, Yaakov/H-4725-2013	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Mueller, Tobias/0000-0003-3426-5421	Israel Science Foundation [1668/08, 78/09]; Bi-National Science Foundation [2007083]; Kamea Scientific Foundation of the Israeli Government	Israel Science Foundation(Israel Science Foundation); Bi-National Science Foundation(US-Israel Binational Science Foundation); Kamea Scientific Foundation of the Israeli Government	This research was supported by the Morasha Program of Israel Science Foundation (grant No. 1668/08) and the Bi-National Science Foundation (grant No. 2007083) to OS and by the Israel Science Foundation (grant 78/09) to BT. DG is supported by the Kamea Scientific Foundation of the Israeli Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 2004, J GEN VIROL, V85, P1509, DOI 10.1099/vir.0.19724-0; Asselah T, 2010, J PATHOL, V221, P264, DOI 10.1002/path.2703; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Benjamin IJ, 2006, CIRC RES, V98, P1120, DOI 10.1161/01.RES.0000223522.47948.16; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Buchkovich NJ, 2010, J VIROL, V84, P11479, DOI 10.1128/JVI.01330-10; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; CHAN SW, 2009, ARCH VIROL; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; Delang L, 2009, HEPATOLOGY, V50, P6, DOI 10.1002/hep.22916; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Isler JA, 2005, J VIROL, V79, P15388, DOI 10.1128/JVI.79.24.15388-15397.2005; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kapoor A, 2009, HEPATOLOGY, V50, p315A; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Mottola G, 2002, VIROLOGY, V293, P31, DOI 10.1006/viro.2001.1229; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x; Pereira AA, 2009, NAT REV GASTRO HEPAT, V6, P403, DOI 10.1038/nrgastro.2009.92; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Raven JF, 2008, CELL CYCLE, V7, P1146, DOI 10.4161/cc.7.9.5811; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sun CC, 2007, J VIROL, V81, P13566, DOI 10.1128/JVI.01055-07; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yoshida H, 2007, ANTIOXID REDOX SIGN, V9, P2323, DOI 10.1089/ars.2007.1800; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	49	82	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24660	10.1371/journal.pone.0024660	http://dx.doi.org/10.1371/journal.pone.0024660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949742	Green Submitted, Green Published, gold			2022-12-25	WOS:000295257900027
J	D'Ambrosio, DN; Walewski, JL; Clugston, RD; Berk, PD; Rippe, RA; Blaner, WS				D'Ambrosio, Diana N.; Walewski, Jose L.; Clugston, Robin D.; Berk, Paul D.; Rippe, Richard A.; Blaner, William S.			Distinct Populations of Hepatic Stellate Cells in the Mouse Liver Have Different Capacities for Retinoid and Lipid Storage	PLOS ONE			English	Article							FAT-STORING CELLS; IN-SITU HYBRIDIZATION; RAT-LIVER; DIACYLGLYCEROL ACYLTRANSFERASE; CYTOCHROME P450CYP2S1; COLLAGEN-SYNTHESIS; ACID METABOLISM; GENE-EXPRESSION; CARBOXYLESTERASE; IDENTIFICATION	Hepatic stellate cell (HSC) lipid droplets are specialized organelles for the storage of retinoid, accounting for 50-60% of all retinoid present in the body. When HSCs activate, retinyl ester levels progressively decrease and the lipid droplets are lost. The objective of this study was to determine if the HSC population in a healthy, uninjured liver demonstrates heterogeneity in its capacity for retinoid and lipid storage in lipid droplets. To this end, we utilized two methods of HSC isolation, which leverage distinct properties of these cells, including their vitamin A content and collagen expression. HSCs were isolated either from wild type (WT) mice in the C57BL/6 genetic background by flotation in a Nycodenz density gradient, followed by fluorescence activated cell sorting (FACS) based on vitamin A autofluorescence, or from collagen-green fluorescent protein (GFP) mice by FACS based on GFP expression from a GFP transgene driven by the collagen I promoter. We show that GFPHSCs have: (i) increased expression of typical markers of HSC activation; (ii) decreased retinyl ester levels, accompanied by reduced expression of the enzyme needed for hepatic retinyl ester synthesis (LRAT); (iii) decreased triglyceride levels; (iv) increased expression of genes associated with lipid catabolism; and (v) an increase in expression of the retinoid-catabolizing cytochrome, CYP2S1. Conclusion: Our observations suggest that the HSC population in a healthy, uninjured liver is heterogeneous. One subset of the total HSC population, which expresses early markers of HSC activation, may be "primed" and ready for rapid response to acute liver injury.	[D'Ambrosio, Diana N.; Walewski, Jose L.; Clugston, Robin D.; Berk, Paul D.; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10027 USA; [D'Ambrosio, Diana N.; Blaner, William S.] Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; [Rippe, Richard A.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA	Columbia University; Columbia University; University of North Carolina; University of North Carolina Chapel Hill	D'Ambrosio, DN (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10027 USA.	wsb2@columbia.edu	Clugston, Robin/ABC-8350-2020	Clugston, Robin/0000-0003-0264-9594	National Institutes of Health [R01 DK068437, R01 DK079221, RC2 AA019413]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, R01DK079221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants R01 DK068437, R01 DK079221, and RC2 AA019413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; ALEXSON SEH, 1993, EUR J BIOCHEM, V214, P719, DOI 10.1111/j.1432-1033.1993.tb17973.x; Andreola F, 2004, J BIOL CHEM, V279, P3434, DOI 10.1074/jbc.M305832200; BALLARDINI G, 1994, HEPATOLOGY, V19, P440; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Blaner William S., 1994, P229; BLANER WS, 1987, EUR J BIOCHEM, V164, P301, DOI 10.1111/j.1432-1033.1987.tb11058.x; BLANER WS, 1985, J LIPID RES, V26, P1241; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Das SK, 2008, SCAND J CLIN LAB INV, V68, P260, DOI 10.1080/00365510701668516; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; GEERTS A, 1989, J HEPATOL, V9, P59, DOI 10.1016/0168-8278(89)90076-7; Geerts Albert, 1994, P819; Granneman JG, 2004, AM J PHYSIOL-ENDOC M, V287, pE574, DOI 10.1152/ajpendo.00567.2003; Gudas L. J., 1994, RETINOIDS BIOL CHEM, P443; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; LEO MA, 1982, NEW ENGL J MED, V307, P597, DOI 10.1056/NEJM198209023071006; Liu C, 2001, GASTROENTEROLOGY, V120, P179, DOI 10.1053/gast.2001.20877; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Luo G, 1998, ARCH BIOCHEM BIOPHYS, V357, P45, DOI 10.1006/abbi.1998.0806; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; MAHER JJ, 1988, J CLIN INVEST, V82, P450, DOI 10.1172/JCI113618; Marek CJ, 2007, FEBS LETT, V581, P781, DOI 10.1016/j.febslet.2007.01.056; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Mello T, 2008, BIOCHEM BIOPH RES CO, V374, P460, DOI 10.1016/j.bbrc.2008.07.024; MILANI S, 1989, HEPATOLOGY, V10, P84, DOI 10.1002/hep.1840100117; Moore T., 1957, VITAMIN; MORIWAKI H, 1988, J LIPID RES, V29, P1523; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; RAMM GA, 1995, AM J PHYSIOL-GASTR L, V269, pG532, DOI 10.1152/ajpgi.1995.269.4.G532; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rivera SP, 2002, MOL PHARMACOL, V61, P255, DOI 10.1124/mol.61.2.255; Rylander T, 2001, BIOCHEM BIOPH RES CO, V281, P529, DOI 10.1006/bbrc.2001.4390; Saarikoski ST, 2005, J HISTOCHEM CYTOCHEM, V53, P549, DOI 10.1369/jhc.4C6576.2005; Seliskar M, 2007, BBA-GEN SUBJECTS, V1770, P458, DOI 10.1016/j.bbagen.2006.09.016; SHIMIZU M, 1990, GASTROENTEROLOGY, V99, P1044, DOI 10.1016/0016-5085(90)90625-B; SHIRATORI Y, 1987, DIGEST DIS SCI, V32, P1281, DOI 10.1007/BF01296379; Smith G, 2003, LANCET, V361, P1336, DOI 10.1016/S0140-6736(03)13081-4; Sonneveld E, 1998, CELL GROWTH DIFFER, V9, P629; Sun GS, 1997, J BIOL CHEM, V272, P24488, DOI 10.1074/jbc.272.39.24488; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; VOGEL S, 1999, HANDB EXP PHARM, V139, P31; Walewski JL, 2010, OBES SURG, V20, P93, DOI 10.1007/s11695-009-0002-9; YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067; YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425	56	75	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24993	10.1371/journal.pone.0024993	http://dx.doi.org/10.1371/journal.pone.0024993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949825	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800055
J	van Strien, ME; Breve, JJP; Fratantoni, S; Schreurs, MWJ; Bol, JGJM; Jongenelen, CAM; Drukarch, B; van Dam, AM				van Strien, Miriam E.; Breve, John J. P.; Fratantoni, Silvina; Schreurs, Marco W. J.; Bol, John G. J. M.; Jongenelen, Cornelis A. M.; Drukarch, Benjamin; van Dam, Anne-Marie			Astrocyte-Derived Tissue Transglutaminase Interacts with Fibronectin: A Role in Astrocyte Adhesion and Migration?	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; MESENCHYMAL STEM-CELLS; CANCER-CELLS; TNF-ALPHA; MATRIX-METALLOPROTEINASE-9 EXPRESSION; REACTIVE ASTROCYTES; IFN-GAMMA; KAPPA-B; INTEGRIN; SURFACE	An important neuropathological feature of neuroinflammatory processes that occur during e. g. Multiple Sclerosis (MS) is the formation of an astroglial scar. Astroglial scar formation is facilitated by the interaction between astrocytes and extracellular matrix proteins (ECM) such as fibronectin. Since there is evidence indicating that glial scars strongly inhibit both axon growth and (re) myelination in brain lesions, it is important to understand the factors that contribute to the interaction between astrocytes and ECM proteins. Tissue Transglutaminase (TG2) is a multifunctional enzyme with an ubiquitous tissue distribution, being clearly present within the brain. It has been shown that inflammatory cytokines can enhance TG2 activity. In addition, TG2 can mediate cell adhesion and migration and it binds fibronectin with high affinity. We therefore hypothesized that TG2 is involved in astrocyte-fibronectin interactions. Our studies using primary rat astrocytes show that intracellular and cell surface expression and activity of TG2 is increased after treatment with pro-inflammatory cytokines. Astrocyte-derived TG2 interacts with fibronectin and is involved in astrocyte adhesion onto and migration across fibronectin. TG2 is involved in stimulating focal adhesion formation which is necessary for the interaction of astrocytes with ECM proteins. We conclude that astrocyte-derived TG2 contributes to the interaction between astrocytes and fibronectin. It might thereby regulate ECM remodeling and possibly glial scarring.	[van Strien, Miriam E.; Breve, John J. P.; Fratantoni, Silvina; Bol, John G. J. M.; Jongenelen, Cornelis A. M.; Drukarch, Benjamin; van Dam, Anne-Marie] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Schreurs, Marco W. J.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Strien, ME (corresponding author), Netherlands Inst Neurosci, Dept Astrocyte Biol & Neurodegenerat, Amsterdam, Netherlands.	amw.vandam@vumc.nl		Drukarch, Benjamin/0000-0002-2417-8888	Dutch MS Research Foundation [08-635]	Dutch MS Research Foundation	This study was financially supported by the Dutch MS Research Foundation (grant 08-635) (www.MSresearch.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Becher B, 2000, GLIA, V29, P293; Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; Breve JJP, 2008, J IMMUNOL METHODS, V332, P142, DOI 10.1016/j.jim.2008.01.005; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Czopka T, 2009, GLIA, V57, P1790, DOI 10.1002/glia.20891; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Fisher M, 2009, MATRIX BIOL, V28, P20, DOI 10.1016/j.matbio.2008.10.003; Gaudry CA, 1999, EXP CELL RES, V252, P104, DOI 10.1006/excr.1999.4633; Heath DJ, 2001, J BONE MINER RES, V16, P1477, DOI 10.1359/jbmr.2001.16.8.1477; Hodrea J, 2010, IMMUNOL LETT, V130, P74, DOI 10.1016/j.imlet.2009.12.010; Iyoda M, 2010, AM J PHYSIOL-RENAL, V298, pF779, DOI 10.1152/ajprenal.00198.2009; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Jones RA, 1997, J CELL SCI, V110, P2461; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kelley MJ, 2007, INVEST OPHTH VIS SCI, V48, P2634, DOI 10.1167/iovs.06-1445; Kim SY, 2002, J INTERF CYTOK RES, V22, P677, DOI 10.1089/10799900260100169; Lee EJ, 2010, PHYTOTHER RES, V24, P1755, DOI 10.1002/ptr.3132; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Monsonego A, 1997, J BIOL CHEM, V272, P3724, DOI 10.1074/jbc.272.6.3724; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Park Kang-Seo, 2011, Front Biosci (Elite Ed), V3, P341, DOI 10.2741/e249; Priglinger SG, 2004, INVEST OPHTH VIS SCI, V45, P955, DOI 10.1167/iovs.03-0210; Quan G, 2005, ARCH DERMATOL RES, V297, P84, DOI 10.1007/s00403-005-0582-8; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Reier P J, 1988, Adv Neurol, V47, P87; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Sakly W, 2006, CLIN EXP IMMUNOL, V146, P550, DOI 10.1111/j.1365-2249.2006.03236.x; SARAFIAN TA, 1994, FREE RADICAL RES, V21, P1, DOI 10.3109/10715769409056549; Siskova Z, 2006, MOL CELL NEUROSCI, V33, P150, DOI 10.1016/j.mcn.2006.07.001; Siskova Z, 2009, MOL CELL NEUROSCI, V42, P234, DOI 10.1016/j.mcn.2009.07.005; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; SOBEL RA, 1989, AM J PATHOL, V135, P161; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467; Striedinger K, 2008, J NEUROIMMUNOL, V196, P116, DOI 10.1016/j.jneuroim.2008.03.014; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; van Strien ME, 2011, BRAIN PATHOL, V21, P44, DOI 10.1111/j.1750-3639.2010.00428.x; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Zhang AB, 2010, J CELL BIOCHEM, V111, P469, DOI 10.1002/jcb.22729	55	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25037	10.1371/journal.pone.0025037	http://dx.doi.org/10.1371/journal.pone.0025037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949843	Green Published, gold			2022-12-25	WOS:000295173800060
J	Xie, J; Lu, W; Gu, R; Dai, Q; Zong, B; Ling, L; Xu, BA				Xie, Jun; Lu, Wen; Gu, Rong; Dai, Qin; Zong, Bin; Ling, Lin; Xu, Biao			The Impairment of ILK Related Angiogenesis Involved in Cardiac Maladaptation after Infarction	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; ENDOTHELIAL GROWTH-FACTOR; EXPERIMENTAL HEART-FAILURE; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; EXPRESSION; HYPERTROPHY; TRANSITION; SURVIVAL; DISEASE	Background: Integrin linked kinase (ILK), as an important component of mechanical stretch sensor, can initiate cellular signaling response in the heart when cardiac preload increases. Previous work demonstrated increased ILK expression could induce angiogenesis to improved heart function after MI. However the patholo-physiological role of ILK in cardiac remodeling after MI is not clear. Method and Results: Hearts were induced to cardiac remodeling by infarction and studied in Sprague-Dawley rats. Until 4 weeks after infarction, ILK expression was increased in non-ischemic tissue in parallel with myocytes hypertrophy and compensatory cardiac function. 8 weeks later, when decompensation of heart function occurred, ILK level returned to baseline. Followed ILK alternation, vascular endothelial growth factor (VEGF) expression and phosphorylation of endothelial nitric oxide synthase (eNOS) was significantly decreased 8 weeks after MI. Histology study also showed significantly microvessel decreased and myocytes loss 8 weeks paralleled with ILK down-regualtion. While ILK expression was maintained by gene delivery, tissue angiogenesis and cardiac function was preserved during cardiac remodeling. Conclusion: Temporally up-regulation of ILK level in non-ischemic myocytes by increased external load is associated with beneficial angiogenesis to maintain infarction-induced cardiac hypertrophy. When ILK expression returns to normal, this cardiac adaptive response for infarction is weaken. Understanding the ILK related mechanism of cardiac maladaptation leads to a new strategy for treatment of heart failure after infarction.	[Xie, Jun; Lu, Wen; Gu, Rong; Dai, Qin; Zong, Bin; Ling, Lin; Xu, Biao] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Peoples R China	Nanjing University	Xie, J (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Peoples R China.	xubiao@medmail.com.cn	xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242	National Natural Science Foundation of China [81070195, 81071859]; Jiangsu Key Laboratory for Molecular Medicine of Nanjing University [2008]; Natural Science Foundation of Jiangsu [BK2009036]; Outstanding Medical Talented Person Foundation of Jiangsu; State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-200901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Outstanding Medical Talented Person Foundation of Jiangsu; State Key Laboratory of Pharmaceutical Biotechnology	This work was supported in part by grants from the National Natural Science Foundation of China (Research Grant 81070195 and 81071859), Jiangsu Key Laboratory for Molecular Medicine of Nanjing University (Research Grant 2008), Natural Science Foundation of Jiangsu (BK2009036), Outstanding Medical Talented Person Foundation of Jiangsu (2007), and funding from the State Key Laboratory of Pharmaceutical Biotechnology (KF-GN-200901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; ANVERSA P, 1986, CIRC RES, V58, P26, DOI 10.1161/01.RES.58.1.26; Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Friedrich EB, 2004, MOL CELL BIOL, V24, P8134, DOI 10.1128/MCB.24.18.8134-8144.2004; GERDES AM, 1992, CIRCULATION, V86, P426, DOI 10.1161/01.CIR.86.2.426; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Heba G, 2001, J VASC RES, V38, P288, DOI 10.1159/000051057; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lipsic E, 2008, EUR J HEART FAIL, V10, P22, DOI 10.1016/j.ejheart.2007.10.008; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Oostendorp M, 2010, CIRCULATION, V121, P775, DOI 10.1161/CIRCULATIONAHA.109.889451; Razeghi P, 2007, CARDIOVASC RES, V74, P133, DOI 10.1016/j.cardiores.2006.12.021; Sano M, 2002, CIRCULATION, V105, P8, DOI 10.1161/circ.105.1.8; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; SHIMANO M, 2010, J MOL CELL CARDIOL; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; WESTENBRINK BD, 2010, CARDIOVASC RES; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088	25	19	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24115	10.1371/journal.pone.0024115	http://dx.doi.org/10.1371/journal.pone.0024115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949693	Green Submitted, gold, Green Published			2022-12-25	WOS:000295173800012
J	Ait-Mohamed, O; Battisti, V; Joliot, V; Fritsch, L; Pontis, J; Medjkane, S; Redeuilh, C; Lamouri, A; Fahy, C; Rholam, M; Atmani, D; Ait-Si-Ali, S				Ait-Mohamed, Ouardia; Battisti, Valentine; Joliot, Veronique; Fritsch, Lauriane; Pontis, Julien; Medjkane, Souhila; Redeuilh, Catherine; Lamouri, Aazdine; Fahy, Christine; Rholam, Mohamed; Atmani, Djebbar; Ait-Si-Ali, Slimane			Acetonic Extract of Buxus sempervirens Induces Cell Cycle Arrest, Apoptosis and Autophagy in Breast Cancer Cells	PLOS ONE			English	Article							NATURAL-PRODUCTS; DRUG DISCOVERY; TRITERPENOIDAL ALKALOIDS; STEROIDAL ALKALOIDS; THERAPEUTIC TARGET; ANTICANCER AGENTS; CARCINOMA-CELLS; P21 WAF1/CIP1; TUMOR-CELLS; DEATH	Plants are an invaluable source of potential new anti-cancer drugs. Here, we investigated the cytotoxic activity of the acetonic extract of Buxus sempervirens on five breast cancer cell lines, MCF7, MCF10CA1a and T47D, three aggressive triple positive breast cancer cell lines, and BT-20 and MDA-MB-435, which are triple negative breast cancer cell lines. As a control, MCF10A, a spontaneously immortalized but non-tumoral cell line has been used. The acetonic extract of Buxus sempervirens showed cytotoxic activity towards all the five studied breast cancer cell lines with an IC(50) ranging from 7.74 mu g/ml to 12.5 mu g/ml. Most importantly, the plant extract was less toxic towards MCF10A with an IC(50) of 19.24 mu g/ml. Fluorescence-activated cell sorting (FACS) analysis showed that the plant extract induced cell death and cell cycle arrest in G0/G1 phase in MCF7, T47D, MCF10CA1a and BT-20 cell lines, concomitant to cyclin D1 downregulation. Application of MCF7 and MCF10CA1a respective IC(50) did not show such effects on the control cell line MCF10A. Propidium iodide/Annexin V double staining revealed a pre-apoptotic cell population with extract-treated MCF10CA1a, T47D and BT-20 cells. Transmission electron microscopy analyses indicated the occurrence of autophagy in MCF7 and MCF10CA1a cell lines. Immunofluorescence and Western blot assays confirmed the processing of microtubule-associated protein LC3 in the treated cancer cells. Moreover, we have demonstrated the upregulation of Beclin-1 in these cell lines and downregulation of Survivin and p21. Also, Caspase-3 detection in treated BT-20 and T47D confirmed the occurrence of apoptosis in these cells. Our findings indicate that Buxus sempervirens extract exhibit promising anti-cancer activity by triggering both autophagic cell death and apoptosis, suggesting that this plant may contain potential anti-cancer agents for single or combinatory cancer therapy against breast cancer.	[Ait-Mohamed, Ouardia; Atmani, Djebbar] Fac Sci Nat, Lab Biochim Appl, Bejaia, Algeria; [Ait-Mohamed, Ouardia; Atmani, Djebbar] Univ Bejaia, Bejaia, Algeria; [Battisti, Valentine; Joliot, Veronique; Fritsch, Lauriane; Pontis, Julien; Medjkane, Souhila; Ait-Si-Ali, Slimane] Univ Paris Diderot Sorbonne Paris Cite, CNRS, UMR7216, Lab Epigenet & Destin Cellulaire, Paris, France; [Redeuilh, Catherine; Lamouri, Aazdine; Fahy, Christine; Rholam, Mohamed] Univ Paris Diderot Sorbonne Paris Cite, CNRS, UMR7086, Lab ITODYS, Paris, France	Universite de Bejaia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Ait-Mohamed, O (corresponding author), Fac Sci Nat, Lab Biochim Appl, Bejaia, Algeria.	ouardia.ait-mohamed@univ-paris-diderot.fr; slimane.aitsiali@univ-paris-diderot.fr		Medjkane, Souhila/0000-0001-7973-7707	Agence Nationale de la Recherche (ANR); Association Francaise contre les Myopathies (AFM); Fondation Bettencourt-Schueller; Centre des Oeuvres Universitaires et Scolaires (CROUS); Centre national de la recherche scientifique (CNRS); Universite Paris Diderot; Programme franco-algerien de formation superieure en France PROFAS; Ministere de l'enseignement superieur et de la recherche	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Bettencourt-Schueller; Centre des Oeuvres Universitaires et Scolaires (CROUS); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Diderot; Programme franco-algerien de formation superieure en France PROFAS; Ministere de l'enseignement superieur et de la recherche	This work was supported by the Agence Nationale de la Recherche (ANR); the Association Francaise contre les Myopathies (AFM); the Fondation Bettencourt-Schueller; the Programme franco-algerien de formation superieure en France (PROFAS) via the Centre des Oeuvres Universitaires et Scolaires (CROUS); the Centre national de la recherche scientifique (CNRS); and Universite Paris Diderot. Dr. Ait-Mohamed was the recipient of a fellowship from the Programme franco-algerien de formation superieure en France PROFAS managed by the CROUS. Dr. Battisti and Dr. Pontis are recipients of fellowships from the Ministere de l'enseignement superieur et de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Ata A, 2010, PHYTOCHEMISTRY, V71, P1780, DOI 10.1016/j.phytochem.2010.06.017; Babar ZU, 2006, STEROIDS, V71, P1045, DOI 10.1016/j.steroids.2006.09.002; Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Cragg GM, 2009, PHYTOCHEM REV, V8, P313, DOI 10.1007/s11101-009-9123-y; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; DARZYNKIEWICZ Z, 2004, CYTOMETRIC METHODS D, P307; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; ELGENDY M, 2011, ONCOGENIC R IN PRESS; Fan YP, 2003, MOL CANCER THER, V2, P773; FENGZHI L, 1998, CONTROL APOPTOSIS MI; Fourneau C, 1997, TETRAHEDRON LETT, V38, P2965, DOI 10.1016/S0040-4039(97)00534-0; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; GILLETT C, 1994, CANCER RES, V54, P1812; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gurung RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012124; Hernandez-Enriquez B, 2010, NEUROSCIENCE, V167, P298, DOI 10.1016/j.neuroscience.2010.01.046; JOHNSTON S, NEW TARGETS THERAPY; Khalid A, 2005, BIOCHEM BIOPH RES CO, V331, P1528, DOI 10.1016/j.bbrc.2005.03.248; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kottke TJ, 2002, J BIOL CHEM, V277, P804, DOI 10.1074/jbc.M108419200; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; Loru F, 2000, PHYTOCHEMISTRY, V54, P951, DOI 10.1016/S0031-9422(00)00036-4; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Matochko WL, 2010, J NAT PROD, V73, P1858, DOI 10.1021/np100494u; Mesaik MA, 2010, CHEM BIOL DRUG DES, V75, P310, DOI 10.1111/j.1747-0285.2009.00906.x; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morgan G, 2004, CLIN ONCOL-UK, V16, P549, DOI 10.1016/j.clon.2004.06.007; NAKANO T, 1964, TETRAHEDRON LETT, V5, P3679; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Pezzuto JM, 1997, BIOCHEM PHARMACOL, V53, P121, DOI 10.1016/S0006-2952(96)00654-5; Russo IH, 1998, J MAMMARY GLAND BIOL, V3, P49, DOI 10.1023/A:1018770218022; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tian H, 2000, CANCER RES, V60, P679; UR RA, 1992, PHYTOCHEMISTRY, V31, P2933; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Wall NR, 2003, CANCER RES, V63, P230; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yan YX, 2009, J NAT PROD, V72, P308, DOI 10.1021/np800719h; ZUKERBERG LR, 1995, MODERN PATHOL, V8, P560	72	37	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24537	10.1371/journal.pone.0024537	http://dx.doi.org/10.1371/journal.pone.0024537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935420	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700040
J	Hirao, LA; Hokey, DA; Morrow, MP; Jure-Kunkel, MN; Weiner, DB				Hirao, Lauren A.; Hokey, David A.; Morrow, Matthew P.; Jure-Kunkel, Maria N.; Weiner, David B.			Immune Modulation through 4-1BB Enhances SIV Vaccine Protection in Non-Human Primates against SIVmac251 Challenge	PLOS ONE			English	Article							T-CELL PROLIFERATION; EXPRESSION; CTLA-4; AUTOIMMUNITY; SURVIVAL; GATA-3	Costimulatory molecules play a central role in the development of cellular immunity. Understanding how costimulatory pathways can be directed to positively influence the immune response may be critical for the generation of an effective HIV vaccine. Here, we evaluated the ability of intravenous administration of a blocking monoclonal antibody (mAb) directed against the negative costimulatory molecule CTLA-4, and an agonist mAb directed against the positive costimulatory molecule 4-1BB, either alone or in combination, to augment intramuscular SIV DNA immunizations. We then tested the ability these of these responses to impact a high-dose SIVmac251 challenge. Following immunization, the groups infused with the anti-4-1BB mAb exhibited enhanced IFN-gamma responses compared to the DNA vaccine only group. Interestingly, although CTLA-4 blockade alone did not enhance IFN-gamma responses it did increase the proliferative capacity of the CD4(+) and CD8(+) T cells. The combination of both mAbs enhanced the magnitude of the polyfunctional CD8(+) T cell response. Following challenge, the group that received both mAbs exhibited a significant, similar to 2.0 log, decrease in plasma viral load compared to the naive group the included complete suppression of viral load in some animals. Furthermore, the use of the CTLA-4 blocking antibody resulted in significantly higher viral loads during chronic infection compared to animals that received the 4-1BB mAb, likely due to the higher CD4(+) T cell proliferative responses which were driven by this adjuvant following immunization. These novel studies show that these adjuvants induce differential modulation of immune responses, which have dramatically different consequences for control of SIV replication, suggesting important implications for HIV vaccine development.	[Hirao, Lauren A.; Morrow, Matthew P.; Weiner, David B.] Univ Penn, Philadelphia, PA 19104 USA; [Hokey, David A.] Aeras Global TB Vaccine Fdn, Rockville, MD USA; [Jure-Kunkel, Maria N.] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA; [Morrow, Matthew P.] Inovio Pharmaceut Inc, Blue Bell, PA USA	University of Pennsylvania; Bristol-Myers Squibb	Hirao, LA (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	dbweiner@mail.med.upenn.edu	Weiner, David B/H-8579-2014		Bristol-Meyers Squibb; Bristol-Meyers Squibb Company	Bristol-Meyers Squibb(Bristol-Myers Squibb); Bristol-Meyers Squibb Company	The study was funded by Bristol-Meyers Squibb. They did play a role in study design, decision to publish, and preparation of the manuscript (not in data collection or analysis).; The authors have read the journal's policy and have the following conflicts. The authors have connections to the following commercial companies: Wyeth, Inovio, Ichor, Merck, Althea, and Aldeveron. The study was supported by Bristol-Meyers Squibb Company. There are no patents, products in development or marketed products to declare. This does not alter the author's adherence to all the PLoS ONE policies on sharing data and materials.	Amara RR, 2005, VIROLOGY, V343, P246, DOI 10.1016/j.virol.2005.08.027; Arrode G, 2005, EUR J IMMUNOL, V35, P159, DOI 10.1002/eji.200425744; Calarota SA, 2008, VACCINE, V26, P3121, DOI 10.1016/j.vaccine.2008.02.017; Cannons JL, 2001, J IMMUNOL, V167, P1313, DOI 10.4049/jimmunol.167.3.1313; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Hansen SG, 2009, NAT MED, V15; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Mercader M, 2001, P NATL ACAD SCI USA, V98, P14565, DOI 10.1073/pnas.251140998; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Morrow MP, 2008, AIDS, V22, P333, DOI 10.1097/QAD.0b013e3282f42461; Morrow MP, 2010, CLIN VACCINE IMMUNOL, V17, P1493, DOI 10.1128/CVI.00181-10; Morrow MP, 2010, MOL THER, V18, P1714, DOI 10.1038/mt.2010.118; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Nasta F, 2006, IMMUNOLOGY, V117, P358, DOI 10.1111/j.1365-2567.2005.02309.x; Nasta F, 2007, IMMUNOLOGY, V121, P62, DOI 10.1111/j.1365-2567.2007.02537.x; Perkins D, 1996, J IMMUNOL, V156, P4154; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schoenly KA, 2008, J VIROL, V82, P3166, DOI 10.1128/JVI.01634-07; Takahashi C, 1999, J IMMUNOL, V162, P5037; Yan J, 2009, VACCINE, V27; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x; Zaunders JJ, 2005, BLOOD, V106, P1660, DOI 10.1182/blood-2005-01-0206	28	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24250	10.1371/journal.pone.0024250	http://dx.doi.org/10.1371/journal.pone.0024250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935390	Green Submitted, gold, Green Published			2022-12-25	WOS:000295041700020
J	Yasunaga, M; Oumi, N; Osaki, M; Kazuki, Y; Nakanishi, T; Oshimura, M; Sato, K				Yasunaga, Mayu; Oumi, Nao; Osaki, Mitsuhiko; Kazuki, Yasuhiro; Nakanishi, Tomoko; Oshimura, Mitsuo; Sato, Kenzo			Establishment and Characterization of a Transgenic Mouse Model for In Vivo Imaging of Bmp4 Expression in the Pancreas	PLOS ONE			English	Article							BETA-CELL MASS; AUTOPHAGY; GENERATION	Type-2 diabetes results from the development of insulin resistance and a concomitant impairment of insulin secretion. Bone morphogenetic protein 4 (Bmp4)-Bmp receptor 1A signaling in beta cells has recently been reported to be required for insulin production and secretion. In addition, Bmp4 blocks the differentiation and promotes the expansion of endocrine progenitor cells. Bmp4 therefore regulates the maintenance of homeostasis in the pancreas. In this study, we constructed a reporter plasmid carrying 7-kb enhancer and promoter region of the Bmp4 gene upstream of the firefly luciferase gene. We used this construct to produce transgenic mice by pro-nuclear microinjection, for subsequent in vivo monitoring of Bmp4 expression. The bioluminescent signal was detected mainly in the pancreas in three independent lines of transgenic mice. Furthermore, the bioluminescent signal was enhanced in association with the autophagy response to 24-h fasting. These results suggest that pancreatic expression of Bmp4 is involved in responding to the physiological environment, including through autophagy. These mouse models represent useful tools for toxicological screening, and for investigating the mechanisms responsible for pancreatic Bmp4 functions in vivo, with relevance to improving our understanding of pancreatic diseases.	[Yasunaga, Mayu; Oumi, Nao; Nakanishi, Tomoko; Sato, Kenzo] Tottori Univ, Fac Med, Sch Life Sci, Div Mol Biol, Yonago, Tottori 683, Japan; [Osaki, Mitsuhiko; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Fac Med, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori 683, Japan; [Osaki, Mitsuhiko; Kazuki, Yasuhiro; Nakanishi, Tomoko; Oshimura, Mitsuo; Sato, Kenzo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori 683, Japan	Tottori University; Tottori University; Tottori University	Yasunaga, M (corresponding author), Tottori Univ, Fac Med, Sch Life Sci, Div Mol Biol, Yonago, Tottori 683, Japan.	kensato@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a City Area Program (Basic Stage) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Bergman RN, 2002, EUR J CLIN INVEST, V32, P35, DOI 10.1046/j.1365-2362.32.s3.5.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chandler KJ, 2009, DEV BIOL, V327, P590, DOI 10.1016/j.ydbio.2008.12.033; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Feng JQ, 2002, J DENT RES, V81, P6, DOI 10.1177/154405910208100103; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Gannon M, 2007, CELL METAB, V5, P157, DOI 10.1016/j.cmet.2007.02.003; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Hur KY, 2010, DIABETES OBES METAB, V12, P20, DOI 10.1111/j.1463-1326.2010.01278.x; Jiang FX, 2002, J CELL SCI, V115, P753; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; KURIHARA T, 1993, BIOCHEM BIOPH RES CO, V192, P1049, DOI 10.1006/bbrc.1993.1523; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Marchetti P, 2006, NUTR METAB CARDIOVAS, V16, pS3, DOI 10.1016/j.numecd.2005.10.017; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Scott GJ, 2009, GENESIS, V47, P385, DOI 10.1002/dvg.20513; Sebastiani P, 2010, SCIENCE; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	31	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24956	10.1371/journal.pone.0024956	http://dx.doi.org/10.1371/journal.pone.0024956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949805	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700081
J	Brindefalk, B; Ettema, TJG; Viklund, J; Thollesson, M; Andersson, SGE				Brindefalk, Bjorn; Ettema, Thijs J. G.; Viklund, Johan; Thollesson, Mikael; Andersson, Siv G. E.			A Phylometagenomic Exploration of Oceanic Alphaproteobacteria Reveals Mitochondrial Relatives Unrelated to the SAR11 Clade	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; EVOLUTIONARY TREES; GENOME EVOLUTION; SEQUENCE; DNA; RICKETTSIALES; INFERENCE; ORIGINS; MODEL; SITE	Background: According to the endosymbiont hypothesis, the mitochondrial system for aerobic respiration was derived from an ancestral Alphaproteobacterium. Phylogenetic studies indicate that the mitochondrial ancestor is most closely related to the Rickettsiales. Recently, it was suggested that Candidatus Pelagibacter ubique, a member of the SAR11 clade that is highly abundant in the oceans, is a sister taxon to the mitochondrial-Rickettsiales clade. The availability of ocean metagenome data substantially increases the sampling of Alphaproteobacteria inhabiting the oxygen-containing waters of the oceans that likely resemble the originating environment of mitochondria. Methodology/Principal Findings: We present a phylogenetic study of the origin of mitochondria that incorporates metagenome data from the Global Ocean Sampling (GOS) expedition. We identify mitochondrially related sequences in the GOS dataset that represent a rare group of Alphaproteobacteria, designated OMAC (Oceanic Mitochondria Affiliated Clade) as the closest free-living relatives to mitochondria in the oceans. In addition, our analyses reject the hypothesis that the mitochondrial system for aerobic respiration is affiliated with that of the SAR11 clade. Conclusions/Significance: Our results allude to the existence of an alphaproteobacterial clade in the oxygen-rich surface waters of the oceans that represents the closest free-living relative to mitochondria identified thus far. In addition, our findings underscore the importance of expanding the taxonomic diversity in phylogenetic analyses beyond that represented by cultivated bacteria to study the origin of mitochondria.	[Brindefalk, Bjorn; Ettema, Thijs J. G.; Viklund, Johan; Thollesson, Mikael; Andersson, Siv G. E.] Evolutionary Biol Ctr, Dept Mol Evolut, Sci Life Lab, Uppsala, Sweden		Brindefalk, B (corresponding author), Evolutionary Biol Ctr, Dept Mol Evolut, Sci Life Lab, Uppsala, Sweden.	Siv.Andersson@ebc.uu.se			European Union; Swedish Research Council [621-2009-4813, 315-2004-6676, 349-2007-831, 621-2008-3259]; Swedish Foundation for Strategic Research; Goran Gustafsson Foundation; Knut and Alice Wallenberg Foundation	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Goran Gustafsson Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	T.J.G.E. is supported by the European Union and by the Swedish Research Council (grant number 621-2009-4813). S.G.E.A. acknowledges support from the Swedish Research Council (grant numbers 315-2004-6676, 349-2007-831, 621-2008-3259), the Swedish Foundation for Strategic Research, the European Union, the Goran Gustafsson Foundation, and the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Beier CL, 2002, APPL ENVIRON MICROB, V68, P6043, DOI 10.1128/AEM.68.12.6043-6050.2002; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Canfield DE, 2006, NATURE, V440, P426, DOI 10.1038/440426a; CAVALIERSMITH T, 1987, NATURE, V326, P332, DOI 10.1038/326332a0; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; GALTIER N, 1995, P NATL ACAD SCI USA, V92, P11317, DOI 10.1073/pnas.92.24.11317; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gross J, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-53; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; LOCKHART PJ, 1992, J MOL EVOL, V34, P153; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Mooers AO, 2000, TRENDS ECOL EVOL, V15, P365, DOI 10.1016/S0169-5347(00)01934-0; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; VIKLUND J, 2011, J MOL BIOL, V215, P403; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; WALLBERG A, 2007, MRTWIG PHYLOGENETIC; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; YANG ZH, 1995, MOL BIOL EVOL, V12, P451	47	41	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24457	10.1371/journal.pone.0024457	http://dx.doi.org/10.1371/journal.pone.0024457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935411	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700022
J	Urbanus, AT; van den Hoek, A; Boonstra, A; van Houdt, R; de Bruijn, LJ; Heijman, T; Coutinho, RA; Prins, M				Urbanus, Anouk T.; van den Hoek, Anneke; Boonstra, Albert; van Houdt, Robin; de Bruijn, Lotte J.; Heijman, Titia; Coutinho, Roel A.; Prins, Maria			People with Multiple Tattoos and/or Piercings Are Not at Increased Risk for HBV or HCV in The Netherlands	PLOS ONE			English	Article							C VIRUS-INFECTION; HEPATITIS-C; EPIDEMIOLOGY; POPULATION	Background: Although published results are inconsistent, it has been suggested that tattooing and piercing are risk factors for HBV and HCV infections. To examine whether tattooing and piercing do indeed increase the risk of infection, we conducted a study among people with multiple tattoos and/or piercings in the Netherlands who acquired their tattoos and piercings in the Netherlands and/or abroad. Methods: Tattoo artists, piercers, and people with multiple tattoos and/or piercings were recruited at tattoo conventions, shops (N = 182), and a biannual survey at our STI-outpatient clinic (N = 252) in Amsterdam. Participants were interviewed and tested for anti-HBc and anti-HCV. Determinants of HBV and HCV infections were analysed using logistic regression analysis. Results: The median number of tattoos and piercings was 5 (IQR 2-10) and 2 (IQR 2-4), respectively. Almost 40% acquired their tattoo of piercing abroad. In total, 18/434 (4.2%, 95% CI: 2.64%-6.46%) participants were anti-HBc positive and 1 was anti-HCV positive (0.2%, 95% CI: 0.01%-1.29%). Being anti-HBc positive was independently associated with older age (OR 1.68, 95% CI: 1.03-2.75 per 10 years older) and being born in an HBV-endemic country (OR 7.39, 95% CI: 2.77-19.7). Tattoo- and/or piercing-related variables, like having a tattoo or piercing in an HBV endemic country, surface percentage tattooed, number of tattoos and piercings etc., were not associated with either HBV or HCV. Conclusions: We found no evidence for an increased HBV/HCV seroprevalence among persons with multiple tattoos and/or piercings, which might be due to the introduction of hygiene guidelines for tattoo and piercing shops in combination with the low observed prevalence of HBV/HCV in the general population. Tattoos and/or piercings, therefore, should not be considered risk factors for HBV/HCV in the Dutch population. These findings imply the importance of implementation of hygiene guidelines in other countries.	[Urbanus, Anouk T.; van den Hoek, Anneke; Boonstra, Albert; van Houdt, Robin; de Bruijn, Lotte J.; Heijman, Titia; Prins, Maria] Dept Res, Publ Hlth Serv, Amsterdam, Netherlands; [Urbanus, Anouk T.; van den Hoek, Anneke; Coutinho, Roel A.; Prins, Maria] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Coutinho, Roel A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment	Urbanus, AT (corresponding author), Dept Res, Publ Hlth Serv, Amsterdam, Netherlands.	aurbanus@ggd.amsterdam.nl		Heijman, Titia/0000-0002-1944-2007	Netherlands Organization for Health Research and Development (ZonMw) [7115 0001]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study is funded by grant 7115 0001 from The Netherlands Organization for Health Research and Development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCARI CM, 2008, HOT TOPICS VIRAL HEP, V11, P19; Baaten GGG, 2007, J MED VIROL, V79, P1802, DOI 10.1002/jmv.21009; *CDCP, 2010, GEOGR DISTR CHRON HE; DHALLA S, 2007, STRONG ASS TATTOOS H; *GEZ COMM HEP C, 1997, OPSP BEH MENS MET HE; Goldman M, 2009, TRANSFUSION, V49, P648, DOI 10.1111/j.1537-2995.2008.02037.x; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; HYAMS KC, 1989, AM J TROP MED HYG, V40, P200, DOI 10.4269/ajtmh.1989.40.200; Jafari S, 2010, INT J INFECT DIS, V14, pE928, DOI 10.1016/j.ijid.2010.03.019; KO Y-C, 1990, Kaohsiung Journal of Medical Sciences, V6, P237; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; LIMENTANI AE, 1979, LANCET, V2, P86; Marschall T, 2008, EUR J GASTROEN HEPAT, V20, P1214, DOI 10.1097/MEG.0b013e32830e289e; NEWCOMBE RG, 1994, STAT MED, V13, P1283, DOI 10.1002/sim.4780131209; Nishioka RD, 2003, EUR J EPIDEMIOL, V18, P441, DOI 10.1023/A:1024277918543; Nishioka SD, 2002, EPIDEMIOL INFECT, V128, P63, DOI 10.1017/S0950268801006094; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Silverman AL, 2000, AM J GASTROENTEROL, V95, P1312, DOI 10.1111/j.1572-0241.2000.02031.x; STAM C, 2005, TATOEAGES PIERCINGS; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar TJW, 2006, TRANSFUSION, V46, P1719, DOI 10.1111/j.1537-2995.2006.00961.x; van Houdt R, 2007, J MED VIROL, V79, P895, DOI 10.1002/jmv.20820; VANMARREWIJK CM, 1999, INFECTIEZIEKTENBULLE, V10, P182; Worp J, 2006, Euro Surveill, V11, P34; Zuure FR, 2011, AM J PREV MED, V40, P345, DOI 10.1016/j.amepre.2010.11.019; 2010, LANDELIJK CENTRUM HY	28	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24736	10.1371/journal.pone.0024736	http://dx.doi.org/10.1371/journal.pone.0024736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935447	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700039
J	Velten, M; Hutchinson, KR; Gorr, MW; Wold, LE; Lucchesi, PA; Rogers, LK				Velten, Markus; Hutchinson, Kirk R.; Gorr, Matthew W.; Wold, Loren E.; Lucchesi, Pamela A.; Rogers, Lynette K.			Systemic Maternal Inflammation and Neonatal Hyperoxia Induces Remodeling and Left Ventricular Dysfunction in Mice	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; CARDIOVASCULAR-DISEASE; BETA-ADRENOCEPTORS; PRETERM DELIVERY; GENE-EXPRESSION; RISK-FACTORS; RAT HEART; FETAL; PREGNANCY; HYPOXIA	Aims: The impact of the neonatal environment on the development of adult cardiovascular disease is poorly understood. Systemic maternal inflammation is linked to growth retardation, preterm birth, and maturation deficits in the developing fetus. Often preterm or small-for-gestational age infants require medical interventions such as oxygen therapy. The long-term pathological consequences of medical interventions on an immature physiology remain unknown. In the present study, we hypothesized that systemic maternal inflammation and neonatal hyperoxia exposure compromise cardiac structure, resulting in LV dysfunction during adulthood. Methods and Results: Pregnant C3H/HeN mice were injected on embryonic day 16 (E16) with LPS (80 mu g/kg; i.p.) or saline. Offspring were placed in room air (RA) or 85% O(2) for 14 days and subsequently maintained in RA. Cardiac echocardiography, cardiomyocyte contractility, and molecular analyses were performed. Echocardiography revealed persistent lower left ventricular fractional shortening with greater left ventricular end systolic diameter at 8 weeks in LPS/O(2) than in saline/RA mice. Isolated cardiomyocytes from LPS/O(2) mice had slower rates of contraction and relaxation, and a slower return to baseline length than cardiomyocytes isolated from saline/RA controls. alpha-/beta-MHC ratio was increased and Connexin-43 levels decreased in LPS/O(2) mice at 8 weeks. Nox4 was reduced between day 3 and 14 and capillary density was lower at 8 weeks of life in LPS/O(2) mice. Conclusion: These results demonstrate that systemic maternal inflammation combined with neonatal hyperoxia exposure induces alterations in cardiac structure and function leading to cardiac failure in adulthood and supports the importance of the intrauterine and neonatal milieu on adult health.	[Velten, Markus; Rogers, Lynette K.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Ctr Perinatal Res,Res Inst, Columbus, OH 43210 USA; [Hutchinson, Kirk R.; Gorr, Matthew W.; Wold, Loren E.; Lucchesi, Pamela A.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res,Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Velten, M (corresponding author), Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Ctr Perinatal Res,Res Inst, Columbus, OH 43210 USA.	Markus.Velten@NationwideChildrens.org	Wold, Loren E/E-4320-2011; Velten, Markus/P-3078-2018; Lucchesi, Pamela A/E-3558-2011; Rogers, Lynette K/E-3973-2011; Rogers, Lynette/V-6802-2019	Velten, Markus/0000-0001-5439-4648; Gorr, Matthew/0000-0001-7561-6481	German Research Foundation [DFG VE 614/1-1]; NIH [2RO1-HL5604]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019923] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was funded by German Research Foundation grant DFG VE 614/1-1 (MV) and NIH grant 2RO1-HL5604 (PAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2005, BRIT J PHARMACOL, V144, P900, DOI 10.1038/sj.bjp.0706129; Bae S, 2003, AM J PHYSIOL-HEART C, V285, pH983, DOI 10.1152/ajpheart.00005.2003; Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; BASSARCO PP, 2011, J MATERN FETAL NEONA; Baumgarten G, 2006, SHOCK, V25, P43, DOI 10.1097/01.shk.0000196498.57306.a6; Berenson GS, 2002, AM J CARDIOL, V90, p3L, DOI 10.1016/S0002-9149(02)02953-3; Boengler K, 2009, BRIT J PHARMACOL, V158, P195, DOI 10.1111/j.1476-5381.2009.00372.x; Browne Vaughn A., 1997, American Journal of Physiology, V273, pR2022; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Dillmann W, 2010, HEART FAIL REV, V15, P125, DOI 10.1007/s10741-008-9125-7; Freak-Poli R, 2009, J MATERN-FETAL NEO M, V22, P1, DOI 10.1080/14767050802531813; Getahun D, 2007, J MATERN-FETAL NEO M, V20, P669, DOI 10.1080/14767050701516063; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Harada K, 1998, EARLY HUM DEV, V51, P197, DOI 10.1016/S0378-3782(97)00122-9; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; HIXSON JE, 1989, J MOL CELL CARDIOL, V21, P1073, DOI 10.1016/0022-2828(89)90805-5; Kamitomo M, 2002, J SOC GYNECOL INVEST, V9, P335, DOI 10.1016/S1071-5576(02)00180-6; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Leipala JA, 2003, PEDIATR RES, V53, P989, DOI 10.1203/01.PDR.0000061564.86797.78; Leviton A, 2011, EARLY HUM DEV, V87, P325, DOI 10.1016/j.earlhumdev.2011.01.043; Lichtenstein AH, 1998, J NUTR, V128, P1589, DOI 10.1093/jn/128.10.1589; Lindgren I, 2009, AM J PHYSIOL-REG I, V297, pR258, DOI 10.1152/ajpregu.00167.2009; LIU Y, 2010, BIOMED PHARMACOTHER; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; Napoli C, 2001, EUR HEART J, V22, P4, DOI 10.1053/euhj.2000.2147; Palinski W, 2002, FASEB J, V16, P1348, DOI 10.1096/fj.02-0226rev; Palinski W, 2008, CIRCULATION, V117, P341, DOI 10.1161/CIRCULATIONAHA.107.750133; Palinski W, 2009, J CARDIOVASC TRANSL, V2, P277, DOI 10.1007/s12265-009-9108-7; ROGERS LK, 2011, LIFE SCI IN PRESS; Rohlicek CV, 2005, CARDIOVASC RES, V65, P861, DOI 10.1016/j.cardiores.2004.12.003; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; SEEHASE M, 2011, PEDIAT RES; Thackaberry EA, 2005, TOXICOL SCI, V88, P242, DOI 10.1093/toxsci/kfi302; Tsyvian P, 2002, ULTRASOUND OBST GYN, V20, P35, DOI 10.1046/j.1469-0705.2002.00734.x; VEILLE JC, 1993, AM J PERINAT, V10, P275, DOI 10.1055/s-2007-994739; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004; Wold LE, 2005, J MOL CELL CARDIOL, V39, P297, DOI 10.1016/j.yjmcc.2005.03.014; Xiao DL, 2000, J SOC GYNECOL INVEST, V7, P279, DOI 10.1016/S1071-5576(00)00066-6; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x; Yoshimine K, 1997, J MOL CELL CARDIOL, V29, P571, DOI 10.1006/jmcc.1996.0300; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107; Zieske AW, 2002, PEDIATR PATHOL MOL M, V21, P213, DOI 10.1080/15227950252852104	51	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24544	10.1371/journal.pone.0024544	http://dx.doi.org/10.1371/journal.pone.0024544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935422	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700026
J	Dalli, J; Jones, CP; Cavalcanti, DM; Farsky, SH; Perretti, M; Rankin, SM				Dalli, Jesmond; Jones, Carla P.; Cavalcanti, Danielle M.; Farsky, Sandra H.; Perretti, Mauro; Rankin, Sara M.			Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow	FASEB JOURNAL			English	Article						CXCR4; neutrophil homeostasis	APOPTOTIC NEUTROPHILS; DEPENDENT PHAGOCYTOSIS; VITRONECTIN RECEPTOR; GENE-EXPRESSION; IN-VIVO; PHOSPHATIDYLSERINE; CELLS; HETEROGENEITY; GRANULOCYTES; MOBILIZATION	Under homeostatic conditions, a proportion of senescent CXCR4(hi) neutrophils home from the circulation back to the bone marrow, where they are phagocytosed by bone marrow macrophages. In this study, we have identified an unexpected role for the anti-inflammatory molecule annexin A1 (AnxA1) as a critical regulator of this process. We first observed that AnxA1(-/-) mice have significantly increased neutrophil numbers in their bone marrow while having normal levels of GM and G colony-forming units, monocytes, and macrophages. Although AnxA1(-/-) mice have more neutrophils in the bone marrow, a greater proportion of these cells are senescent, as determined by their higher levels of CXCR4 expression and annexin V binding. Consequently, bone marrow neutrophils from AnxA1(-/-) mice exhibit a reduced migratory capacity in vitro. Studies conducted in vitro also show that expression of AnxA1 is required for bone marrow macrophages, but not peritoneal macrophages, to phagocytose apoptotic neutrophils. Moreover, in vivo experiments indicate a defect in clearance of wild-type neutrophils in the bone marrow of AnxA1(-/-) mice. Thus, we conclude that expression of AnxA1 by resident macrophages is a critical determinant for neutrophil clearance in the bone marrow.-Dalli, J., Jones, C. P., Cavalcanti, D. M., Farsky, S. H., Perretti, M., Rankin, S. M. Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow. FASEB J. 26, 387-396 (2012). www.fasebj.org	[Jones, Carla P.; Rankin, Sara M.] Univ London Imperial Coll Sci Technol & Med, Leukocyte Biol Sect, Natl Heart & Lung Inst, Fac Med, London SW7 2AZ, England; [Cavalcanti, Danielle M.; Farsky, Sandra H.] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil; [Dalli, Jesmond; Cavalcanti, Danielle M.; Perretti, Mauro] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England	Imperial College London; Universidade de Sao Paulo; University of London; Queen Mary University London	Rankin, SM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Leukocyte Biol Sect, Natl Heart & Lung Inst, Fac Med, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	s.rankin@imperial.ac.uk	Farsky, Sandra HP/C-4044-2012	Jones, Carla P/0000-0002-4329-3267; Dalli, Jesmond/0000-0001-6328-3640	Wellcome Trust [086867/Z/08, 0851851/Z/08]; William Harvey Research Foundation; National Institute for Health Research (UK)	Wellcome Trust(Wellcome TrustEuropean Commission); William Harvey Research Foundation; National Institute for Health Research (UK)(National Institute for Health Research (NIHR))	The authors acknowledge the support of the Wellcome Trust (086867/Z/08 and 0851851/Z/08) and the William Harvey Research Foundation. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute for Health Research (UK). J.D. performed research and collected, analyzed, and interpreted data, and contributed to paper preparation; D. M. C. performed research and collected data; S. F. analyzed and interpreted data; C.J. performed research and collected data; M. P. designed research, analyzed and interpreted data, and contributed to paper preparation; and S. R. designed research, analyzed and interpreted data, and wrote the paper. The authors declare no competing financial interests.	BICKNELL S, 1994, AM J RESP CELL MOL, V10, P16, DOI 10.1165/ajrcmb.10.1.8292377; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Burdon PCE, 2008, BRIT J HAEMATOL, V142, P100, DOI 10.1111/j.1365-2141.2008.07018.x; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fan XX, 2004, MOL BIOL CELL, V15, P2863, DOI 10.1091/mbc.E03-09-0670; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gorgani NN, 2008, IMMUNOL CELL BIOL, V86, P246, DOI 10.1038/sj.icb.7100131; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Jitkaew S, 2009, J LEUKOCYTE BIOL, V85, P427, DOI 10.1189/jlb.0408232; Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lim LHK, 1998, P NATL ACAD SCI USA, V95, P14535, DOI 10.1073/pnas.95.24.14535; Lovas K, 1996, EUR J HAEMATOL, V56, P221; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; MAUER AM, 1960, J CLIN INVEST, V39, P1481, DOI 10.1172/JCI104167; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; Nagase H, 2002, J LEUKOCYTE BIOL, V71, P711; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; OSMOND DG, 1994, IMMUNOL REV, V142, P209, DOI 10.1111/j.1600-065X.1994.tb00891.x; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; Sadahira Y, 1999, PATHOL INT, V49, P841, DOI 10.1046/j.1440-1827.1999.00954.x; SAVERYMUTTU SH, 1985, BRIT J HAEMATOL, V61, P675, DOI 10.1111/j.1365-2141.1985.tb02882.x; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; THAKUR ML, 1977, J NUCL MED, V18, P1014; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Wolach B, 2007, EXP HEMATOL, V35, P541, DOI 10.1016/j.exphem.2006.12.008; Yona S, 2004, BRIT J PHARMACOL, V142, P890, DOI 10.1038/sj.bjp.0705858; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730	49	57	59	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					387	396		10.1096/fj.11-182089	http://dx.doi.org/10.1096/fj.11-182089			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21957127	Green Published, hybrid			2022-12-25	WOS:000299202200038
J	Brock, M; Trenkmann, M; Gay, RE; Gay, S; Speich, R; Huber, LC				Brock, Matthias; Trenkmann, Michelle; Gay, Renate E.; Gay, Steffen; Speich, Rudolf; Huber, Lars C.			MicroRNA-18a Enhances the Interleukin-6-mediated Production of the Acute-phase Proteins Fibrinogen and Haptoglobin in Human Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; INFLAMMATION; ELEMENTS; DISEASE; TARGETS; BINDING; GENES; CELLS	The acute-phase response is an inflammatory process triggered mainly by the cytokine IL-6. Signaling of IL-6 is transduced by activation of STAT3 (signal transducer and activator of transcription 3), which rapidly induces the production of acute-phase proteins such as haptoglobin and fibrinogen. Another target of the IL-6/STAT3 signal transduction pathway is the microRNA cluster miR-17/92. Here, we investigated the interplay of miR-17/92 and STAT3 signaling and its impact on the acute-phase response in primary human hepatocytes and hepatoma (HepG2) cells. Employing a reporter gene system consisting of STAT3-sensitive promoter sequences, we show that the miR-17/92 cluster member miR-18a enhanced the transcriptional activity of STAT3. IL-6 stimulation experiments in miR-18a-overexpressing hepatocytes and HepG2 cells revealed an augmented acute-phase response indicated by increased expression and secretion of haptoglobin and fibrinogen. This effect was due, at least in part, to repression of PIAS3 (protein inhibitor of activated STAT, 3), a repressor of STAT3 activity, which we identified as a novel direct target of miR-18a. Finally, we demonstrate that the expression of miR-17/92 in primary hepatocytes and HepG2 cells is modulated by IL-6. Our data reveal, for the first time, a microRNA-mediated positive feedback loop of IL-6 signal transduction leading to an enhanced acute-phase response in human hepatocytes.	[Brock, Matthias] Univ Zurich Hosp, Ctr Expt Rheumatol, Working Grp Pulm Hypertens, CH-8091 Zurich, Switzerland; [Brock, Matthias; Trenkmann, Michelle; Gay, Renate E.; Gay, Steffen; Huber, Lars C.] Univ Zurich, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland; [Brock, Matthias; Trenkmann, Michelle; Gay, Renate E.; Gay, Steffen; Huber, Lars C.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Brock, M (corresponding author), Univ Zurich Hosp, Ctr Expt Rheumatol, Working Grp Pulm Hypertens, Gloriastr 23, CH-8091 Zurich, Switzerland.	matthias.brock@usz.ch		Brock, Matthias/0000-0001-6445-0631; Trenkmann, Michelle/0000-0002-3332-6344	Swiss National Foundation [SNF-32000-116842]; Schwyzer Foundation; Zurich Lung League Foundation; Masterswitch FP7 Program; Institute for Arthritis Research Epalinges Program	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Schwyzer Foundation; Zurich Lung League Foundation; Masterswitch FP7 Program; Institute for Arthritis Research Epalinges Program	This work was supported by Swiss National Foundation Grant SNF-32000-116842, the Schwyzer Foundation, the Zurich Lung League Foundation, and the Masterswitch FP7 and Institute for Arthritis Research Epalinges Programs.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hou T, 2007, J BIOL CHEM, V282, P37091, DOI 10.1074/jbc.M706458200; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; ZHANG ZX, 1995, J BIOL CHEM, V270, P24287, DOI 10.1074/jbc.270.41.24287	20	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40142	40150		10.1074/jbc.M111.251793	http://dx.doi.org/10.1074/jbc.M111.251793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953462	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000296925700047
J	Placzek, WJ; Sturlese, M; Wu, BN; Cellitti, JF; Wei, J; Pellecchia, M				Placzek, William J.; Sturlese, Mattia; Wu, Bainan; Cellitti, Jason F.; Wei, Jun; Pellecchia, Maurizio			Identification of a Novel Mcl-1 Protein Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; ALLOSTERIC REGULATION; STRUCTURAL BASIS; BH3 DOMAINS; CELL-DEATH; APOPTOSIS; CANCER; INHIBITOR; COMPLEX; P53	Recent characterization of Mcl-1 as the primary anti-apoptotic Bcl-2 family member expressed in solid tumors, coupled with its ability to enable therapeutic resistance, has provided the impetus for further study into how Mcl-1 is involved in apoptosis signaling. Here, we employ Sabutoclax, a potent and effective Mcl-1 antagonist, as a competing agent to screen a randomized 12-residue phage display library for peptides that bind strongly to the Bcl-2 homology 3 (BH3) binding groove of Mcl-1. Although the screen identified a number of alpha-helical peptides with canonical BH3 domain sequences, it also isolated a pair of unique peptide sequences. These sequences exhibit a reverse organization of conserved hydrophobic and acidic residues when compared with canonical BH3 sequences, and we therefore refer to them as reverse BH3 (rBH3) peptides. Furthermore, studies of the rBH3 peptides using NMR spectroscopy, fluorescence polarization displacement assays, and alanine scanning data all suggest that they bind to the BH3 binding groove of Mcl-1 selectively over Bcl-x(L). A search for proteins containing the rBH3 motif has identified a number of interesting Mcl-1 protein partners, some of which have previously been associated with apoptosis regulation involving Mcl-1. These findings provide insights into the development of more specific Mcl-1 antagonists and open the way to the identification of a previously unknown family of apoptosis-regulating and Mcl-1 interacting proteins.	[Placzek, William J.; Sturlese, Mattia; Wu, Bainan; Cellitti, Jason F.; Wei, Jun; Pellecchia, Maurizio] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Pellecchia, M (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mpellecchia@sanfordburnham.org	Sturlese, Mattia/P-9473-2019; Pellecchia, Maurizio/Y-7072-2018; wu, bainan/C-2071-2012; Placzek, William/AAG-1172-2020	Sturlese, Mattia/0000-0003-3944-0313; Placzek, William/0000-0003-4096-8617	National Institutes of Health [CA149668]; NCI [CA121949]; Department of Chemical Sciences, University of Padova, Italy; NATIONAL CANCER INSTITUTE [R01CA149668, T32CA121949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Chemical Sciences, University of Padova, Italy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA149668 (to M. P.) and NCI T32 Fellowship Grant CA121949 (to W. J. P.). This work was also supported by the Department of Chemical Sciences, University of Padova, Italy (to M. S.).	Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Eguchi T, 2009, MOL CANCER THER, V8, P1460, DOI 10.1158/1535-7163.MCT-08-1159; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Keller R.L.J., 2005, OPTIMIZING PROCESS N; Lee EF, 2009, J BIOL CHEM, V284, P31315, DOI 10.1074/jbc.M109.048009; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liang H, 1997, J MOL BIOL, V274, P291, DOI 10.1006/jmbi.1997.1415; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Rega MF, 2007, BIOORG CHEM, V35, P344, DOI 10.1016/j.bioorg.2007.03.001; Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	33	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39829	39835		10.1074/jbc.M111.305326	http://dx.doi.org/10.1074/jbc.M111.305326			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953453	Green Published, hybrid			2022-12-25	WOS:000296925700017
J	Reboul, R; Geserick, C; Pabst, M; Frey, B; Wittmann, D; Lutz-Meindl, U; Leonard, R; Tenhaken, R				Reboul, Rebecca; Geserick, Claudia; Pabst, Martin; Frey, Beat; Wittmann, Doris; Luetz-Meindl, Ursula; Leonard, Renaud; Tenhaken, Raimund			Down-regulation of UDP-glucuronic Acid Biosynthesis Leads to Swollen Plant Cell Walls and Severe Developmental Defects Associated with Changes in Pectic Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE DEHYDROGENASE; MATRIX POLYSACCHARIDES; ARABIDOPSIS-THALIANA; GENE FAMILY; ENZYME; MYOINOSITOL; PATHWAYS; OLIGOSACCHARIDES; GLUCURONOKINASE; XYLOGLUCAN	UDP-glucose dehydrogenase (UGD) plays a key role in the nucleotide sugar biosynthetic pathway, as its product UDP-glucuronic acid is the common precursor for arabinose, xylose, galacturonic acid, and apiose residues found in the cell wall. In this study we characterize an Arabidopsis thaliana double mutant ugd2,3 that lacks two of the four UGD isoforms. This mutant was obtained from a cross of ugd2 and ugd3 single mutants, which do not show phenotypical differences compared with the WT. In contrast, ugd2,3 has a strong dwarfed phenotype and often develops seedlings with severe root defects suggesting that the UGD2 and UGD3 isoforms act in concert. Differences in its cell wall composition in comparison to the WT were determined using biochemical methods indicating a significant reduction in arabinose, xylose, apiose, and galacturonic acid residues. Xyloglucan is less substituted with xylose, and pectins have a reduced amount of arabinan side chains. In particular, the amount of the apiose containing side chains A and B of rhamnogalacturonan II is strongly reduced, resulting in a swollen cell wall. The alternative pathway to UDP-glucuronic acid with the key enzyme myo-inositol oxygenase is not up-regulated in ugd2,3. The pathway also does not complement the ugd2,3 mutation, likely because the supply of myo-inositol is limited. Taken together, the presented data underline the importance of UDP GlcA for plant primary cell wall formation.	[Reboul, Rebecca; Geserick, Claudia; Wittmann, Doris; Tenhaken, Raimund] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Pabst, Martin; Leonard, Renaud] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria; [Frey, Beat] Rhizosphere Proc Grp, Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Luetz-Meindl, Ursula] Salzburg Univ, Dept Cell Biol Cell Struct & Cytomorphogenesis, A-5020 Salzburg, Austria	Salzburg University; University of Natural Resources & Life Sciences, Vienna; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Salzburg University	Tenhaken, R (corresponding author), Salzburg Univ, Dept Cell Biol Plant Physiol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	raimund.tenhaken@sbg.ac.at	Tenhaken, Raimund/O-6556-2019; Pabst, Martin/GOH-1766-2022; Frey, Beat/AAE-1745-2022	Tenhaken, Raimund/0000-0002-6764-4826; Pabst, Martin/0000-0001-9897-0723; Frey, Beat/0000-0002-6391-3574	German Science Foundation (Deutsche Forschungsgemeinschaft; Bonn, Germany)	German Science Foundation (Deutsche Forschungsgemeinschaft; Bonn, Germany)(German Research Foundation (DFG))	The project is funded by a grant from the German Science Foundation (Deutsche Forschungsgemeinschaft; Bonn, Germany; to R. T.).	Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Burget EG, 1999, PLANT PHYSIOL, V121, P383, DOI 10.1104/pp.121.2.383; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Eder M, 2008, J MICROSC-OXFORD, V231, P201, DOI 10.1111/j.1365-2818.2008.02036.x; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; Frey B, 2000, PLANT CELL ENVIRON, V23, P675, DOI 10.1046/j.1365-3040.2000.00590.x; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; JAENICKE R, 1986, BIOCHEMISTRY-US, V25, P7283, DOI 10.1021/bi00371a006; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Karkonen A, 2006, PLANTA, V223, P858, DOI 10.1007/s00425-005-0207-7; Klinghammer M, 2007, J EXP BOT, V58, P3609, DOI 10.1093/jxb/erm209; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; KROPF DL, 1993, DEV BIOL, V160, P303, DOI 10.1006/dbio.1993.1309; LEIBOWITZ MD, 1977, ARCH BIOCHEM BIOPHYS, V179, P559, DOI 10.1016/0003-9861(77)90144-8; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; Loewus Frank A., 2006, V39, P21; Lutz-Meindl U, 2004, PROTOPLASMA, V223, P155, DOI 10.1007/s00709-003-0033-3; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Oertel A, 2004, J PHYCOL, V40, P711, DOI 10.1111/j.1529-8817.2004.03222.x; Oka T, 2006, FEBS J, V273, P2645, DOI 10.1111/j.1742-4658.2006.05281.x; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Pieslinger AM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.069369; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Scheible WR, 2004, CURR OPIN PLANT BIOL, V7, P285, DOI 10.1016/j.pbi.2004.03.006; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seifert GJ, 2004, PLANT CELL, V16, P723, DOI 10.1105/tpc.019661; Seitz B, 2000, PLANT J, V21, P537, DOI 10.1046/j.1365-313x.2000.00696.x; Seveno M, 2009, PLANTA, V230, P947, DOI 10.1007/s00425-009-0996-1; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; Siddique S, 2009, NEW PHYTOL, V184, P457, DOI 10.1111/j.1469-8137.2009.02981.x; Stewart DC, 1998, PLANT PHYSIOL, V116, P349, DOI 10.1104/pp.116.1.349; Tenhaken R, 1996, PLANT PHYSIOL, V112, P1127, DOI 10.1104/pp.112.3.1127; Vitha S, 2000, HISTOCHEM J, V32, P457, DOI 10.1023/A:1004171431449; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zykwinska AW, 2005, PLANT PHYSIOL, V139, P397, DOI 10.1104/pp.105.065912	46	85	88	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39982	39992		10.1074/jbc.M111.255695	http://dx.doi.org/10.1074/jbc.M111.255695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949134	Green Published, hybrid			2022-12-25	WOS:000296925700031
J	Delhi, P; Queiroz, R; Inchaustegui, D; Carrington, M; Clayton, C				Delhi, Praveen; Queiroz, Rafael; Inchaustegui, Diana; Carrington, Mark; Clayton, Christine			Is There a Classical Nonsense-Mediated Decay Pathway in Trypanosomes?	PLOS ONE			English	Article							MESSENGER-RNA DECAY; EXON-JUNCTION COMPLEX; GENOME-WIDE ANALYSIS; POLY(A)-BINDING PROTEIN; PHOSPHOGLYCERATE KINASE; POLYPYRIMIDINE TRACT; GENE-EXPRESSION; WILD-TYPE; BRUCEI; UPF1	In many eukaryotes, messenger RNAs with premature termination codons are destroyed by a process called "nonsense-mediated decay", which requires the RNA helicase Upf1 and also, usually, an interacting factor, Upf2. Recognition of premature termination codons may rely on their distance from either a splice site or the polyadenylation site, and long 3'-untranslated regions can trigger mRNA decay. The protist Trypanosoma brucei relies heavily on mRNA degradation to determine mRNA levels, and 3'-untranslated regions play a major role in control of mRNA decay. We show here that trypanosomes have a homologue of Upf1, TbUPF1, which interacts with TbUPF2 and (in an RNA-dependent fashion) with poly(A) binding protein 1, PABP1. Introduction of a premature termination codon in either an endogenous gene or a reporter gene decreased mRNA abundance, as expected for nonsense-mediated decay, but a dependence of this effect on TbUPF1 could not be demonstrated, and depletion of TbUPF1 by over 95% had no effect on parasite growth or the mRNA transcriptome. Further investigations of the reporter mRNA revealed that increases in open reading frame length tended to increase mRNA abundance. In contrast, inhibition of translation, either using 5'-secondary structures or by lengthening the 5'-untranslated region, usually decreased reporter mRNA abundance. Meanwhile, changing the length of the 3'-untranslated region had no consistent effect on mRNA abundance. We suggest that in trypanosomes, translation per se may inhibit mRNA decay, and interactions with multiple RNA-binding proteins preclude degradation based on 3'-untranslated region length alone.	[Delhi, Praveen; Queiroz, Rafael; Inchaustegui, Diana; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Hedielberg, Germany; [Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Ruprecht Karls University Heidelberg; University of Cambridge	Delhi, P (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Hedielberg, Germany.	pdelhi3@googlemail.com; cclayton@zmbh.uni-heidelberg.de	Carrington, Mark/N-4892-2018; Clayton, Christine/K-7700-2019; Carrington, Mark/N-3653-2019	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Clayton, Christine/0000-0002-6384-0731	Land of Baden Wurttemberg; Wellcome Trust; Deutsche Forschunggemeinshaft (TM); Deutsches Akademisches Austauschdienst	Land of Baden Wurttemberg; Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschunggemeinshaft (TM); Deutsches Akademisches Austauschdienst	This work was funded by the Land of Baden Wurttemberg (core funding to CC), by a Wellcome Trust grant to CC and MC, and by the Deutsche Forschunggemeinshaft (TM). Rafael Queiroz was supported by a fellowship from the Deutsches Akademisches Austauschdienst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; ALSFORD S, 2011, GENOME RES IN PRESS; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bercovich N, 2009, MOL BIOCHEM PARASIT, V166, P190, DOI 10.1016/j.molbiopara.2009.03.008; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chen YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003609; CLAYTON CE, 2005, RNA INTERFERENC; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Lima TDD, 2010, EUKARYOT CELL, V9, P1484, DOI 10.1128/EC.00148-10; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; de Pinto B, 2004, MOL MICROBIOL, V51, P1129, DOI 10.1046/j.1365-2958.2003.03889.x; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fluck C, 2003, MOL BIOCHEM PARASIT, V127, P93, DOI 10.1016/S0166-6851(02)00310-9; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Hansen KD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000525; He F, 1996, RNA, V2, P153; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; Hu WQ, 2010, NAT STRUCT MOL BIOL, V17, P244, DOI 10.1038/nsmb.1734; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Johansson MJO, 2007, P NATL ACAD SCI USA, V104, P20872, DOI 10.1073/pnas.0709257105; Johns L, 2007, MOL CELL BIOL, V27, P5630, DOI 10.1128/MCB.00410-07; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; Kawashima T, 2009, RNA, V15, P2236, DOI 10.1261/rna.1736809; Kebaara BW, 2009, NUCLEIC ACIDS RES, V37, P2771, DOI 10.1093/nar/gkp146; Kertesz S, 2006, NUCLEIC ACIDS RES, V34, P6147, DOI 10.1093/nar/gkl737; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kuperwasser N, 2004, RNA, V10, P1907, DOI 10.1261/rna.7132504; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Li CH, 2006, RNA, V12, P2171, DOI 10.1261/rna.291506; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Metzstein MM, 2006, PLOS GENET, V2, P2143, DOI 10.1371/journal.pgen.0020180; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; Patrick KL, 2008, MOL MICROBIOL, V67, P435, DOI 10.1111/j.1365-2958.2007.06057.x; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Ramani AK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r101; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz-Echevarria MJ, 1998, EMBO J, V17, P575, DOI 10.1093/emboj/17.2.575; Saul H, 2009, PLANT J, V60, P1031, DOI 10.1111/j.1365-313X.2009.04021.x; Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005; Schell T, 2003, BIOCHEM J, V373, P775, DOI 10.1042/BJ20021920; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwede A, 2008, NUCLEIC ACIDS RES, V36, P3374, DOI 10.1093/nar/gkn108; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Stewart M, 2010, MOL BIOCHEM PARASIT, V172, P99, DOI 10.1016/j.molbiopara.2010.03.016; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; TSUBOI T, 2010, J BIOL CHEM IN PRESS; Tuller T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-391; Webb H, 1997, J CELL BIOL, V139, P103, DOI 10.1083/jcb.139.1.103; Webb H, 2005, NUCLEIC ACIDS RES, V33, P1503, DOI 10.1093/nar/gki298; Wen JK, 2010, EMBO J, V29, P1537, DOI 10.1038/emboj.2010.48; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; YOINE M, 2006, PLANT CELL PHYSL	79	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25112	10.1371/journal.pone.0025112	http://dx.doi.org/10.1371/journal.pone.0025112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957477	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100037
J	Mouillesseaux, K; Chen, JN				Mouillesseaux, Kevin; Chen, Jau-Nian			Mutation in utp15 Disrupts Vascular Patterning in a p53-Dependent Manner in Zebrafish Embryos	PLOS ONE			English	Article							P53; ANGIOGENESIS; THROMBOSPONDIN-1; GROWTH; DIFFERENTIATION; GENES; IDENTIFICATION; BIOGENESIS; EXPRESSION; VERTEBRATE	Background: Angiogenesis is the process by which the highly branched and functional vasculature arises from the major vessels, providing developing tissues with nutrients, oxygen, and removing metabolic waste. During embryogenesis, vascular patterning is dependent on a tightly regulated balance between pro-and anti-angiogenic signals, and failure of angiogenesis leads to embryonic lethality. Using the zebrafish as a model organism, we sought to identify genes that influence normal vascular patterning. Methodology and Principal Findings: In a forward genetic screen, we identified mutant LA1908, which manifests massive apoptosis during early embryogenesis, abnormal expression of several markers of arterial-venous specification, delayed angiogenic sprouting of the intersegmental vessels (ISV), and malformation of the caudal vein plexus (CVP), indicating a critical role for LA1908 in cell survival and angiogenesis. Genetic mapping and sequencing identified a G to A transition in the splice site preceding exon 11 of utp15 in LA1908 mutant embryos. Overexpression of wild type utp15 mRNA suppresses all observed mutant phenotypes, demonstrating a causative relationship between utp15 and LA1908. Furthermore, we found that injecting morpholino oligonucleotides inhibiting p53 translation prevents cell death and rescues the vascular abnormalities, indicating that p53 is downstream of Utp15 deficiency in mediating the LA1908 phenotypes. Conclusions and Significance: Taken together, our data demonstrate an early embryonic effect of Utp15 deficiency on cell survival and the normal patterning of the vasculature and highlight an anti-angiogenic role of p53 in developing embryos.	[Mouillesseaux, Kevin; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Chen, Jau-Nian] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Chen, Jau-Nian] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Chen, Jau-Nian] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mouillesseaux, K (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	chenjn@mcdb.ucla.edu	Chen, Jau-Nian/AAM-7808-2020	Chen, Jau-Nian/0000-0001-8807-3607	NIH [HL081700, HL096980]; Training Program in Genetic Mechanisms [USPHS GM07104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096980, R01HL081700] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Genetic Mechanisms; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH grants (HL081700 and HL096980) to JNC and the Training Program in Genetic Mechanisms (USPHS GM07104) to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Chen JN, 1996, DEVELOPMENT, V122, P3809; Choi J, 2011, DEVELOPMENT, V138, P1173, DOI 10.1242/dev.054049; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Danilova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015938; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Driever W, 1996, DEVELOPMENT, V123, P37; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Iruela-Arispe ML, 2004, INT J BIOCHEM CELL B, V36, P1070, DOI 10.1016/j.biocel.2004.01.025; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; KIESER A, 1994, ONCOGENE, V9, P963; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liao W, 1997, DEVELOPMENT, V124, P381; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25013	10.1371/journal.pone.0025013	http://dx.doi.org/10.1371/journal.pone.0025013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949834	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400034
J	Zhang, M; Liu, NY; Wang, XE; Chen, YH; Li, QL; Lu, KR; Sun, L; Jia, Q; Zhang, L; Zhang, L				Zhang, Min; Liu, Nu-Yun; Wang, Xue-Er; Chen, Ying-Hua; Li, Qing-Lin; Lu, Kang-Rong; Sun, Li; Jia, Qin; Zhang, Lu; Zhang, Lin			Activin B Promotes Epithelial Wound Healing In Vivo through RhoA-JNK Signaling Pathway	PLOS ONE			English	Article							HAIR FOLLICLE; MOUSE SKIN; STEM-CELLS; REPAIR; ROLES; KERATINOCYTES; ACTIVATION; EXPRESSION; INDUCTION; MIGRATION	Background: Activin B has been reported to promote the proliferation and migration of keratinocytes in vitro via the RhoA-JNK signaling pathway, whereas its in vivo role and mechanism in wound healing process has not yet been elucidated. Principal Findings: In this study, we explored the potential mechanism by which activin B induces epithelial wound healing in mice. Recombinant lentiviral plasmids, with RhoA (N19) and RhoA (L63) were used to infect wounded KM mice. The wound healing process was monitored after different treatments. Activin B-induced cell proliferation on the wounded skin was visualized by electron microscopy and analyzed by 5'-bromodeoxyuridine (BrdU) incorporation assay. Protein expression of p-JNK or p-cJun was determined by immunohistochemical staining and immunoblotting analysis. Activin B efficiently stimulated the proliferation of keratinocytes and hair follicle cells at the wound area and promoted wound closure. RhoA positively regulated activin B-induced wound healing by up-regulating the expression of p-JNK and p-cJun. Moreover, suppression of RhoA activation delayed activin B-induced wound healing, while JNK inhibition recapitulated phenotypes of RhoA inhibition on wound healing. Conclusion: These results demonstrate that activin B promotes epithelial wound closure in vivo through the RhoA-Rock-JNK- cJun signaling pathway, providing novel insight into the essential role of activin B in the therapy of wound repair.	[Zhang, Min; Liu, Nu-Yun; Wang, Xue-Er; Chen, Ying-Hua; Li, Qing-Lin; Sun, Li; Jia, Qin; Zhang, Lin] So Med Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Lu, Kang-Rong; Zhang, Lu] So Med Univ, Key Lab Funct Prote Guangdong Prov, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhang, M (corresponding author), So Med Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China.	zlilyzh@126.com; zlulu70@126.com	Wang, Xueer/N-2959-2019; chen, ying/HHS-8254-2022		National Natural Science Foundation of China [30973129, 30770821, 30770515]; Program for New Century Excellent Talents in University [NCET-08-0647, NCET-09-0088]; Foundation for Sci & Tech Research Project of Guangdong [2009A030200015]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0731]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Foundation for Sci & Tech Research Project of Guangdong; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was supported by the National Natural Science Foundation of China (Grant No. 30973129, 30770821, 30770515), Program for New Century Excellent Talents in University (Grant No. NCET-08-0647, NCET-09-0088), and the Foundation for Sci & Tech Research Project of Guangdong (2009A030200015) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Bamberger C, 2005, AM J PATHOL, V167, P733, DOI 10.1016/S0002-9440(10)62047-0; Chuong CM, 2007, NATURE, V447, P265, DOI 10.1038/447265a; Deng MX, 2006, MOL BIOL CELL, V17, P3446, DOI 10.1091/mbc.E06-02-0102; Desai LP, 2004, AM J PHYSIOL-LUNG C, V287, pL1134, DOI 10.1152/ajplung.00022.2004; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hubner G, 1996, DEV BIOL, V173, P490, DOI 10.1006/dbio.1996.0042; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Romagosa Yvonne, 2008, J Invest Dermatol, V128, P1058, DOI 10.1038/jid.2008.91; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Shrotriya S, 2010, CANCER RES, V70, P1932, DOI 10.1158/0008-5472.CAN-09-3501; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Turchi L, 2003, J INVEST DERMATOL, V121, P1291, DOI 10.1111/j.1523-1747.2003.12627.x; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005	35	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25143	10.1371/journal.pone.0025143	http://dx.doi.org/10.1371/journal.pone.0025143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949871	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900053
J	Goss, EM; Cardenas, ME; Myers, K; Forbes, GA; Fry, WE; Restrepo, S; Grunwald, NJ				Goss, Erica M.; Cardenas, Martha E.; Myers, Kevin; Forbes, Gregory A.; Fry, William E.; Restrepo, Silvia; Gruenwald, Niklaus J.			The Plant Pathogen Phytophthora andina Emerged via Hybridization of an Unknown Phytophthora Species and the Irish Potato Famine Pathogen, P. infestans	PLOS ONE			English	Article							TOLUCA VALLEY; INTERSPECIFIC HYBRIDIZATION; HAPLOTYPE RECONSTRUCTION; POPULATION-STRUCTURE; MOLECULAR PHYLOGENY; NATURAL HYBRID; GENE FLOW; SP NOV.; EVOLUTION; NUCLEAR	Emerging plant pathogens have largely been a consequence of the movement of pathogens to new geographic regions. Another documented mechanism for the emergence of plant pathogens is hybridization between individuals of different species or subspecies, which may allow rapid evolution and adaptation to new hosts or environments. Hybrid plant pathogens have traditionally been difficult to detect or confirm, but the increasing ease of cloning and sequencing PCR products now makes the identification of species that consistently have genes or alleles with phylogenetically divergent origins relatively straightforward. We investigated the genetic origin of Phytophthora andina, an increasingly common pathogen of Andean crops Solanum betaceum, S. muricatum, S. quitoense, and several wild Solanum spp. It has been hypothesized that P. andina is a hybrid between the potato late blight pathogen P. infestans and another Phytophthora species. We tested this hypothesis by cloning four nuclear loci to obtain haplotypes and using these loci to infer the phylogenetic relationships of P. andina to P. infestans and other related species. Sequencing of cloned PCR products in every case revealed two distinct haplotypes for each locus in P. andina, such that each isolate had one allele derived from a P. infestans parent and a second divergent allele derived from an unknown species that is closely related but distinct from P. infestans, P. mirabilis, and P. ipomoeae. To the best of our knowledge, the unknown parent has not yet been collected. We also observed sequence polymorphism among P. andina isolates at three of the four loci, many of which segregate between previously described P. andina clonal lineages. These results provide strong support that P. andina emerged via hybridization between P. infestans and another unknown Phytophthora species also belonging to Phytophthora clade 1c.	[Goss, Erica M.; Gruenwald, Niklaus J.] ARS, Hort Crops Res Lab, USDA, Corvallis, OR USA; [Cardenas, Martha E.; Restrepo, Silvia] Univ Los Andes, Lab Micol & Fitopatol, Bogota, Colombia; [Myers, Kevin; Fry, William E.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Forbes, Gregory A.] Int Potato Ctr, Lima, Peru	United States Department of Agriculture (USDA); Universidad de los Andes (Colombia); Cornell University; CGIAR; International Potato Center (CIP)	Goss, EM (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	emgoss@ufl.edu; grunwaln@science.oregonstate.edu	Grunwald, Niklaus` J/K-6041-2013; Myers, Kevin/GZK-8865-2022	Grunwald, Niklaus` J/0000-0003-1656-7602; Cardenas, Martha/0000-0002-2009-4126; Restrepo, Silvia/0000-0001-9016-1040	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [CRIS 5358-22000-034-00]	United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was provided by the United States Department of Agriculture-Agricultural Research Service (USDA-ARS) CRIS 5358-22000-034-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2004, PHYTOPATHOLOGY, V94, P154, DOI 10.1094/PHYTO.2004.94.2.154; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Beser J, 2007, J CLIN MICROBIOL, V45, P881, DOI 10.1128/JCM.02245-06; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bonants PJM, 2000, PHYTOPATHOLOGY, V90, P867, DOI 10.1094/PHYTO.2000.90.8.867; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 2004, MYCOL RES, V108, P1172, DOI 10.1017/S0953756204001005; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Cardenas M, 2011, PLANT PATHO IN PRESS; Cardenas M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-23; Catal M, 2010, CYTOM PART A, V77A, P769, DOI 10.1002/cyto.a.20888; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Chen Y, 1996, GENE, V181, P89, DOI 10.1016/S0378-1119(96)00469-6; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Coyne JA, 2004, SPECIATION, V37; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Ersek T, 2008, EUROPEAN J PLANT PAT, V122; Flier WG, 2003, PHYTOPATHOLOGY, V93, P382, DOI 10.1094/PHYTO.2003.93.4.382; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; GALINDO-A J, 1985, Sydowia, V38, P87; Garbelotto M, 1996, PHYTOPATHOLOGY, V86, P543, DOI 10.1094/Phyto-86-543; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gomez-Alpizar L, 2008, MYCOLOGIA, V100, P590, DOI 10.3852/07-074R1; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Gonthier P, 2007, MOL ECOL, V16, P1389, DOI 10.1111/j.1365-294X.2007.03250.x; Goodwin SB, 1999, MYCOLOGIA, V91, P796, DOI 10.2307/3761533; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Grunwald NJ, 2001, PHYTOPATHOLOGY, V91, P882, DOI 10.1094/PHYTO.2001.91.9.882; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurtado-Gonzales OP, 2009, MYCOLOGIA, V101, P496, DOI 10.3852/08-079; 't Veld WAMI, 2007, EUR J PLANT PATHOL, V117, P25, DOI 10.1007/s10658-006-9065-9; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; Ioos R, 2006, FUNGAL GENET BIOL, V43, P511, DOI 10.1016/j.fgb.2006.02.006; Kroon L. P. N. M., 2010, The genus Phytophthora; phylogeny, speciation and host specificity; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Man In 't Veld W A, 2001, Plant Dis, V85, P98, DOI 10.1094/PDIS.2001.85.1.98B; Man in't Veld W. A, 1998, PHYTOPATHOLOGY, V88, P922, DOI DOI 10.1094/PHYTO.1998.88.9.922; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Nielsen K, 2001, MYCOLOGIA, V93, P1064, DOI 10.2307/3761668; Oliva Perez R, 2009, THESIS SWISS FEDERAL; Oliva RF, 2007, ACTA HORTIC, P465, DOI 10.17660/ActaHortic.2007.745.32; Oliva RF, 2010, PLANT PATHOL, V59, P613, DOI 10.1111/j.1365-3059.2010.02287.x; Ordonez ME, 2000, PHYTOPATHOLOGY, V90, P197, DOI 10.1094/PHYTO.2000.90.2.197; Oyarzun PJ, 1997, PLANT DIS, V81, P311, DOI 10.1094/PDIS.1997.81.3.311C; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOOLEY PW, 1987, EXP MYCOL, V11, P19, DOI 10.1016/0147-5975(87)90032-6; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Lee T, 2004, GENETICS, V167, P1643, DOI 10.1534/genetics.104.029652; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08	73	75	75	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24543	10.1371/journal.pone.0024543	http://dx.doi.org/10.1371/journal.pone.0024543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949727	Green Published, Green Submitted			2022-12-25	WOS:000295173800026
J	Naughton, S; Parker, D; Seemann, T; Thomas, T; Turnbull, L; Rose, B; Bye, P; Cordwell, S; Whitchurch, C; Manos, J				Naughton, Sharna; Parker, Dane; Seemann, Torsten; Thomas, Torsten; Turnbull, Lynne; Rose, Barbara; Bye, Peter; Cordwell, Stuart; Whitchurch, Cynthia; Manos, Jim			Pseudomonas aeruginosa AES-1 Exhibits Increased Virulence Gene Expression during Chronic Infection of Cystic Fibrosis Lung	PLOS ONE			English	Article							CHRONIC PULMONARY INFECTION; GEL-ELECTROPHORESIS; BIOFILM FORMATION; III SECRETION; STRAIN; SEQUENCE; PATHOGENESIS; PERSISTENCE; ADAPTATION; EVOLUTION	Pseudomonas aeruginosa, the leading cause of morbidity and mortality in people with cystic fibrosis (CF), adapts for survival in the CF lung through both mutation and gene expression changes. Frequent clonal strains such as the Australian Epidemic Strain-1 (AES-1), have increased ability to establish infection in the CF lung and to superimpose and replace infrequent clonal strains. Little is known about the factors underpinning these properties. Analysis has been hampered by lack of expression array templates containing CF-strain specific genes. We sequenced the genome of an acute infection AES-1 isolate from a CF infant (AES-1R) and constructed a non-redundant micro-array (PANarray) comprising AES-1R and seven other sequenced P. aeruginosa genomes. The unclosed AES-1R genome comprised 6.254Mbp and contained 6957 putative genes, including 338 not found in the other seven genomes. The PANarray contained 12,543 gene probe spots; comprising 12,147 P. aeruginosa gene probes, 326 quality-control probes and 70 probes for non-P. aeruginosa genes, including phage and plant genes. We grew AES-1R and its isogenic pair AES-1M, taken from the same patient 10.5 years later and not eradicated in the intervening period, in our validated artificial sputum medium (ASMDM) and used the PANarray to compare gene expression of both in duplicate. 675 genes were differentially expressed between the isogenic pairs, including upregulation of alginate, biofilm, persistence genes and virulence-related genes such as dihydroorotase, uridylate kinase and cardiolipin synthase, in AES-1M. Non-PAO1 genes upregulated in AES-1M included pathogenesis-related (PAGI-5) genes present in strains PACS2 and PA7, and numerous phage genes. Elucidation of these genes' roles could lead to targeted treatment strategies for chronically infected CF patients.	[Naughton, Sharna; Rose, Barbara; Manos, Jim] Univ Sydney, Dept Infect Dis & Immunol, Sydney, NSW 2006, Australia; [Parker, Dane; Turnbull, Lynne; Whitchurch, Cynthia] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Melbourne, Vic 3004, Australia; [Thomas, Torsten] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Thomas, Torsten] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Turnbull, Lynne; Whitchurch, Cynthia] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Bye, Peter] Royal Prince Alfred Hosp, Dept Resp Med, Sydney, NSW, Australia; [Bye, Peter] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Cordwell, Stuart] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; Monash University; Monash University; University of New South Wales Sydney; University of New South Wales Sydney; University of Technology Sydney; University of Sydney; University of Sydney; University of Sydney	Naughton, S (corresponding author), Univ Sydney, Dept Infect Dis & Immunol, Sydney, NSW 2006, Australia.	jim.manos@sydney.edu.au	Turnbull, Lynne/A-2605-2012; Seemann, Torsten/B-2318-2010; Parker, Dane/AAX-7001-2021; Whitchurch, Cynthia/A-5954-2008	Turnbull, Lynne/0000-0002-9255-9033; Seemann, Torsten/0000-0001-6046-610X; Parker, Dane/0000-0001-7304-3392; Thomas, Torsten/0000-0001-9557-3001; Whitchurch, Cynthia/0000-0003-2296-3791; Manos, Jim/0000-0002-5765-1563; Cordwell, Stuart/0000-0002-0995-0171	Australian Cystic Fibrosis Research Trust [ACFRT2006/BR]; University of Sydney, Faculty of Medicine [ECR2009/JM]; National Health and Medical Research Council of Australia [632788]; National Health and Medical Research Council (NHMRC)	Australian Cystic Fibrosis Research Trust; University of Sydney, Faculty of Medicine(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by The Australian Cystic Fibrosis Research Trust (ACFRT2006/BR) and the University of Sydney, Faculty of Medicine, Early Career Researcher Grant (ECR2009/JM) and the National Health and Medical Research Council of Australia Project, grant #632788. CW was funded by 22 a National Health and Medical Research Council (NHMRC) Career Development Award and a NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Anthony M, 2002, J CLIN MICROBIOL, V40, P2772, DOI 10.1128/JCM.40.8.2772-2778.2002; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Armstrong D, 1999, PEDIAT PULMONOL S19, V28, P269; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; Carter MQ, 2010, J BACTERIOL, V192, P3249, DOI 10.1128/JB.00041-10; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Clarke-Pearson MF, 2008, J BACTERIOL, V190, P6927, DOI 10.1128/JB.00801-08; Clatworthy AE, 2009, INFECT IMMUN, V77, P1293, DOI 10.1128/IAI.01181-08; COYNE MJ, 1994, J BACTERIOL, V176, P3500, DOI 10.1128/JB.176.12.3500-3507.1994; Dacheux D, 2001, INFECT IMMUN, V69, P538, DOI 10.1128/IAI.69.1.538-542.2001; Finelli A, 2003, J BACTERIOL, V185, P2700, DOI 10.1128/JB.185.9.2700-2710.2003; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Jain M, 2008, TRANSL RES, V152, P257, DOI 10.1016/j.trsl.2008.10.003; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; KURODA A, 1995, J BACTERIOL, V177, P7019, DOI 10.1128/jb.177.24.7019-7025.1995; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Lelong E, 2010, CLIN MICROBIOL INFEC; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Manos J, 2008, J MED MICROBIOL, V57, P1454, DOI 10.1099/jmm.0.2008/005009-0; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; MOHR CD, 1994, MOL GEN GENET, V242, P177, DOI 10.1007/BF00391011; Muhammadi, 2007, CURR GENOMICS, V8, P191; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; OSTROFF RM, 1989, INFECT IMMUN, V57, P1369, DOI 10.1128/IAI.57.5.1369-1373.1989; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Yu SH, 2003, J LIPID RES, V44, P621, DOI 10.1194/jlr.M200380-JLR200	59	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24526	10.1371/journal.pone.0024526	http://dx.doi.org/10.1371/journal.pone.0024526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935417	Green Published, gold			2022-12-25	WOS:000295041700038
J	Otsuka, M; Takata, A; Yoshikawa, T; Kojima, K; Kishikawa, T; Shibata, C; Takekawa, M; Yoshida, H; Omata, M; Koike, K				Otsuka, Motoyuki; Takata, Akemi; Yoshikawa, Takeshi; Kojima, Kentaro; Kishikawa, Takahiro; Shibata, Chikako; Takekawa, Mutsuhiro; Yoshida, Haruhiko; Omata, Masao; Koike, Kazuhiko			Receptor for Activated Protein Kinase C: Requirement for Efficient MicroRNA Function and Reduced Expression in Hepatocellular Carcinoma	PLOS ONE			English	Article							MEDIATED TRANSLATIONAL REPRESSION; MESSENGER-RNA DECAY; INDUCED CELL-DEATH; BINDING PROTEIN; GENE-EXPRESSION; STRESS GRANULES; BIOGENESIS; PROMOTES; GW182; KSRP	MicroRNAs (miRNAs) are important regulators of gene expression that control physiological and pathological processes. A global reduction in miRNA abundance and function is a general trait of human cancers, playing a causal role in the transformed phenotype. Here, we sought to newly identify genes involved in the regulation of miRNA function by performing a genetic screen using reporter constructs that measure miRNA function and retrovirus-based random gene disruption. Of the six genes identified, RACK1, which encodes "receptor for activated protein kinase C" (RACK1), was confirmed to be necessary for full miRNA function. RACK1 binds to KH-type splicing regulatory protein (KSRP), a member of the Dicer complex, and is required for the recruitment of mature miRNAs to the RNA-induced silencing complex (RISC). In addition, RACK1 expression was frequently found to be reduced in hepatocellular carcinoma. These findings suggest the involvement of RACK1 in miRNA function and indicate that reduced miRNA function, due to decreased expression of RACK1, may have pathologically relevant roles in liver cancers.	[Otsuka, Motoyuki; Takata, Akemi; Yoshikawa, Takeshi; Kojima, Kentaro; Kishikawa, Takahiro; Shibata, Chikako; Yoshida, Haruhiko; Omata, Masao; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan; [Takekawa, Mutsuhiro] Nagoya Univ, Environm Med Res Inst, Dept Cell Signaling & Mol Med, Nagoya, Aichi 464, Japan	University of Tokyo; Nagoya University	Otsuka, M (corresponding author), Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan.	otsukamo-tky@umin.ac.jp	Otsuka, Motoyuki/H-9067-2019; Kishikawa, Takahiro/ABD-7420-2020	Otsuka, Motoyuki/0000-0003-2869-2881; Kishikawa, Takahiro/0000-0002-8602-5916	Ministry of Education, Culture, Sports, Science and Technology, Japan [22390058, 22117003, 20390204]; Foundation for Promotion of Cancer Research; Senri Life Science Foundation; Nakayama Cancer Research Institute; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [21390090] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research; Senri Life Science Foundation; Nakayama Cancer Research Institute; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://seika.nii.ac.jp/; #22390058, #22117003, and #20390204 to M. Otsuka, M. Takekawa and K. Koike, respectively), by grants from the Foundation for Promotion of Cancer Research (http://www.fpcr.or.jp/enterprise/e14.html), the Senri Life Science Foundation (http://www.senri-life.or.jp/), the Gastrointestinal Cancer Project funded by the Nakayama Cancer Research Institute (http://ncri.or.jp/research/list02.html), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/kenkyu.html)(M. Otsuka), and by Health Sciences Research Grants from The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis; http://www.mhlw.go.jp/) (K. Koike). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim SO, 2010, METHODS MOL BIOL, V634, P331, DOI 10.1007/978-1-60761-652-8_23; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ono K, 2001, MOL CELL BIOL, V21, P8276, DOI 10.1128/MCB.21.24.8276-8288.2001; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Takata A., 2011, HEPATOL INT; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XF, 2001, EMBO REP, V2, P628, DOI 10.1093/embo-reports/kve135; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Yoon SY, 2006, INT J ONCOL, V29, P315	41	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24359	10.1371/journal.pone.0024359	http://dx.doi.org/10.1371/journal.pone.0024359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935400	Green Submitted, gold, Green Published			2022-12-25	WOS:000295041700027
J	Kent, BN; Funkhouser, LJ; Setia, S; Bordenstein, SR				Kent, Bethany N.; Funkhouser, Lisa J.; Setia, Shefali; Bordenstein, Seth R.			Evolutionary Genomics of a Temperate Bacteriophage in an Obligate Intracellular Bacteria (Wolbachia)	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; INSERTION SEQUENCES; PHAGE GENOMICS; WO; RECOMBINATION; ENDOSYMBIONT; DIVERSITY; INFECTION; INSECTS; MYCOBACTERIOPHAGES	Genome evolution of bacteria is usually influenced by ecology, such that bacteria with a free-living stage have large genomes and high rates of horizontal gene transfer, while obligate intracellular bacteria have small genomes with typically low amounts of gene exchange. However, recent studies indicate that obligate intracellular species that host-switch frequently harbor agents of horizontal transfer such as mobile elements. For example, the temperate double-stranded DNA bacteriophage WO in Wolbachia persistently transfers between bacterial coinfections in the same host. Here we show that despite the phage's rampant mobility between coinfections, the prophage's genome displays features of constraint related to its intracellular niche. First, there is always at least one intact prophage WO and usually several degenerate, independently-acquired WO prophages in each Wolbachia genome. Second, while the prophage genomes are modular in composition with genes of similar function grouping together, the modules are generally not interchangeable with other unrelated phages and thus do not evolve by the Modular Theory. Third, there is an unusual core genome that strictly consists of head and baseplate genes; other gene modules are frequently deleted. Fourth, the prophage recombinases are diverse and there is no conserved integration sequence. Finally, the molecular evolutionary forces acting on prophage WO are point mutation, intragenic recombination, deletion, and purifying selection. Taken together, these analyses indicate that while lateral transfer of phage WO is pervasive between Wolbachia with occasional new gene uptake, constraints of the intracellular niche obstruct extensive mixture between WO and the global phage population. Although the Modular Theory has long been considered the paradigm of temperate bacteriophage evolution in free-living bacteria, it appears irrelevant in phages of obligate intracellular bacteria.	[Kent, Bethany N.; Funkhouser, Lisa J.; Setia, Shefali; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA	Vanderbilt University	Kent, BN (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA.	s.bordenstein@vanderbilt.edu			National Science Foundation [IOS-0852344]; National Institutes of Health [R01 GM085163-01]; Direct For Biological Sciences [0852344] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085163] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation grant number IOS-0852344 and the National Institutes of Health grant number R01 GM085163-01 to S. R. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S G, 1996, Microb Comp Genomics, V1, P293; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Anisimova M, 2003, GENETICS, V164, P1229; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Chafee ME, 2010, MOL BIOL EVOL, V27, P501, DOI 10.1093/molbev/msp275; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P8276, DOI 10.1128/JB.186.24.8276-8286.2004; Comeau AM, 2007, VIROLOGY, V362, P384, DOI 10.1016/j.virol.2006.12.031; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Cordaux R, 2008, GENE, V409, P20, DOI 10.1016/j.gene.2007.10.035; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Degnan PH, 2008, MOL ECOL, V17, P916, DOI 10.1111/j.1365-294X.2007.03616.x; DRUMMOND AJ, 2010, GENEIOUS V 5 0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Fujii Y, 2004, BIOCHEM BIOPH RES CO, V317, P1183, DOI 10.1016/j.bbrc.2004.03.164; Gavotte L, 2004, INSECT MOL BIOL, V13, P147, DOI 10.1111/j.0962-1075.2004.00471.x; Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; Hendrix RW, 2003, RES MICROBIOL, V154, P253, DOI 10.1016/S0923-2508(03)00068-8; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Henry M, 2010, GENE, V453, P9, DOI 10.1016/j.gene.2009.12.007; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jiggins FM, 2002, MOL BIOL EVOL, V19, P1640, DOI 10.1093/oxfordjournals.molbev.a004228; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kent BN, 2011, GENOME BIOL EVOL, V3, P209, DOI 10.1093/gbe/evr007; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Masui S, 2001, BIOCHEM BIOPH RES CO, V283, P1099, DOI 10.1006/bbrc.2001.4906; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; McVean G, 2002, GENETICS, V160, P1231; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; NEWTON IL, CURR MICROBIOL, V62, P198; Nilsson AS, 2007, RES MICROBIOL, V158, P311, DOI 10.1016/j.resmic.2007.02.004; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Rodriguez-Valera Francisco, 2009, Nat Rev Microbiol, V7, P828, DOI 10.1038/nrmicro2235; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Sanogo YO, 2006, INSECT BIOCHEM MOLEC, V36, P80, DOI 10.1016/j.ibmb.2005.11.001; Saren AM, 2005, J MOL BIOL, V350, P427, DOI 10.1016/j.jmb.2005.04.059; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka K, 2009, APPL ENVIRON MICROB, V75, P5676, DOI 10.1128/AEM.01172-09; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069	78	36	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24984	10.1371/journal.pone.0024984	http://dx.doi.org/10.1371/journal.pone.0024984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21949820	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700062
J	Le Saux, O; Fulop, K; Yamaguchi, Y; Ilias, A; Szabo, Z; Brampton, CN; Pomozi, V; Huszar, K; Aranyi, T; Varadi, A				Le Saux, Olivier; Fueloep, Krisztina; Yamaguchi, Yukiko; Ilias, Attila; Szabo, Zalan; Brampton, Christopher N.; Pomozi, Viola; Huszar, Krisztina; Aranyi, Tamas; Varadi, Andras			Expression and In Vivo Rescue of Human ABCC6 Disease-Causing Mutants in Mouse Liver	PLOS ONE			English	Article							CAUSE PSEUDOXANTHOMA ELASTICUM; CORONARY-ARTERY-DISEASE; SODIUM 4-PHENYLBUTYRATE; GENE-EXPRESSION; PUTATIVE PATHOMECHANISMS; MOLECULAR-GENETICS; MDCKII CELLS; PLASMID DNA; WILD-TYPE; MUTATIONS	Loss-of-function mutations in ABCC6 can cause chronic or acute forms of dystrophic mineralization described in disease models such as pseudoxanthoma elasticum (OMIM 26480) in human and dystrophic cardiac calcification in mice. The ABCC6 protein is a large membrane-embedded organic anion transporter primarily found in the plasma membrane of hepatocytes. We have established a complex experimental strategy to determine the structural and functional consequences of disease-causing mutations in the human ABCC6. The major aim of our study was to identify mutants with preserved transport activity but failure in intracellular targeting. Five missense mutations were investigated: R1138Q, V1298F, R1314W, G1321S and R1339C. Using in vitro assays, we have identified two variants; R1138Q and R1314W that retained significant transport activity. All mutants were transiently expressed in vivo, in mouse liver via hydrodynamic tail vein injections. The inactive V1298F was the only mutant that showed normal cellular localization in liver hepatocytes while the other mutants showed mostly intracellular accumulation indicating abnormal trafficking. As both R1138Q and R1314W displayed endoplasmic reticulum localization, we tested whether 4-phenylbutyrate (4-PBA), a drug approved for clinical use, could restore their intracellular trafficking to the plasma membrane in MDCKII and mouse liver. The cellular localization of R1314W was significantly improved by 4-PBA treatment, thus potentially rescuing its physiological function. Our work demonstrates the feasibility of the in vivo rescue of cellular maturation of some ABCC6 mutants in physiological conditions very similar to the biology of the fully differentiated human liver and could have future human therapeutic application.	[Le Saux, Olivier; Yamaguchi, Yukiko; Brampton, Christopher N.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Fueloep, Krisztina; Ilias, Attila; Szabo, Zalan; Pomozi, Viola; Huszar, Krisztina; Aranyi, Tamas; Varadi, Andras] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary	University of Hawaii System; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Le Saux, O (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.	varadi@enzim.hu	Le Saux, Olivier/P-4668-2017; Aranyi, Tamas/AAJ-9629-2021; Pomozi, Viola/AAA-6288-2020; Iliás, Attila/I-7072-2017; Varadi, Andras/A-2055-2012	Le Saux, Olivier/0000-0002-5605-3617; Aranyi, Tamas/0000-0002-2087-6275; Iliás, Attila/0000-0003-3196-0795; 	National Research Foundation, OTKA [OTKA CK 80135, OTKA NK 81204, OTKA PD 79183]; National Institute of Health [NIH R01AR055225, NIH HL087289, RR003061, RR016453]; Hawaii Community Foundation (HCF) [20080443]; American Heart Association (AHA) [11GRNT5840005]; PXE International Inc.; Hungarian Academy of Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108249, R21HL087289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055225] Funding Source: NIH RePORTER	National Research Foundation, OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hawaii Community Foundation (HCF); American Heart Association (AHA)(American Heart Association); PXE International Inc.; Hungarian Academy of Sciences(Hungarian Academy of Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Hungarian research grants (by the National Research Foundation, OTKA, www.otka.hu) OTKA CK 80135, OTKA NK 81204, OTKA PD 79183 and by National Institute of Health (www.nih.gov) NIH R01AR055225 (subaward) to A. V.; NIH HL087289, Hawaii Community Foundation (HCF, www.hawaiicommunityfoundation.org) 20080443 and American Heart Association (AHA, www.heart.org) 11GRNT5840005 grants to O.L.S. and by PXE International Inc. (www.pxe.org). T. A. is a recipient of Bolyai Fellowship of the Hungarian Academy of Sciences (www.mta.hu). The NIH grants RR003061 and RR016453 supported the Histology and Imaging Core Facility of the John A. Burns School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherrahrou Z, 2008, J BIOL CHEM, V283, P7608, DOI 10.1074/jbc.M708290200; Aranyi T, 2005, J BIOL CHEM, V280, P18643, DOI 10.1074/jbc.M501139200; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Beck K, 2005, HISTOCHEM CELL BIOL, V123, P517, DOI 10.1007/s00418-004-0744-3; Beck K, 2003, J HISTOCHEM CYTOCHEM, V51, P887, DOI 10.1177/002215540305100704; Belinsky MG, 2002, CANCER RES, V62, P6172; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Bergen AAB, 2006, J INVEST DERMATOL, V126, P704, DOI 10.1038/sj.jid.5700129; Chassaing N, 2005, J MED GENET, V42, P881, DOI 10.1136/jmg.2004.030171; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; DOVER GJ, 1992, NEW ENGL J MED, V327, P569; Fernandez SBM, 2002, J BIOL CHEM, V277, P31048, DOI 10.1074/jbc.M204267200; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hollande E, 2005, J HISTOCHEM CYTOCHEM, V53, P1539, DOI 10.1369/jhc.4A6587.2005; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jiang QJ, 2010, AM J PATHOL, V176, P1855, DOI 10.2353/ajpath.2010.090983; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Koblos G, 2010, GENET TEST MOL BIOMA, V14, P75, DOI 10.1089/gtmb.2009.0094; Lam P, 2007, AM J PHYSIOL-CELL PH, V293, pC1709, DOI 10.1152/ajpcell.00327.2007; Le Saux O, 2001, AM J HUM GENET, V69, P749, DOI 10.1086/323704; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Le Saux O, 2006, J INVEST DERMATOL, V126, P1497, DOI 10.1038/sj.jid.5700201; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Madon J, 2000, MOL PHARMACOL, V57, P634, DOI 10.1124/mol.57.3.634; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Martin L, 2008, ARCH DERMATOL, V144, P301, DOI 10.1001/archderm.144.3.301; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Powell PI, 2011, DIABETES, V60, P1223, DOI 10.2337/db10-1443; Ringpfeil F, 2000, P NATL ACAD SCI USA, V97, P6001, DOI 10.1073/pnas.100041297; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sinko E, 2003, BIOCHEM BIOPH RES CO, V308, P263, DOI 10.1016/S0006-291X(03)01349-4; Szakacs G, 2001, BIOCHEM J, V356, P71, DOI 10.1042/0264-6021:3560071; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Tusnady GE, 2006, FEBS LETT, V580, P1017, DOI 10.1016/j.febslet.2005.11.040; Tveten K, 2007, FEBS J, V274, P1881, DOI 10.1111/j.1742-4658.2007.05735.x; Uitto J, 2010, J INVEST DERMATOL, V130, P661, DOI 10.1038/jid.2009.411; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Varadi A, 2011, CURR DRUG TARGETS, V12, P671, DOI 10.2174/138945011795378612; Wigley WC, 1999, J CELL BIOL, V145, P481; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	53	50	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24738	10.1371/journal.pone.0024738	http://dx.doi.org/10.1371/journal.pone.0024738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935449	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700040
J	Thurber, GM; Weissleder, R				Thurber, Greg Michael; Weissleder, Ralph			A Systems Approach for Tumor Pharmacokinetics	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; SOLID TUMORS; MODELING ANALYSIS; BLOOD-FLOW; MONOCLONAL-ANTIBODIES; OXYGEN-TRANSPORT; DRUG DISCOVERY; NORMAL-TISSUES; IN-VIVO; DELIVERY	Recent advances in genome inspired target discovery, small molecule screens, development of biological and nanotechnology have led to the introduction of a myriad of new differently sized agents into the clinic. The differences in small and large molecule delivery are becoming increasingly important in combination therapies as well as the use of drugs that modify the physiology of tumors such as anti-angiogenic treatment. The complexity of targeting has led to the development of mathematical models to facilitate understanding, but unfortunately, these studies are often only applicable to a particular molecule, making pharmacokinetic comparisons difficult. Here we develop and describe a framework for categorizing primary pharmacokinetics of drugs in tumors. For modeling purposes, we define drugs not by their mechanism of action but rather their rate-limiting step of delivery. Our simulations account for variations in perfusion, vascularization, interstitial transport, and non-linear local binding and metabolism. Based on a comparison of the fundamental rates determining uptake, drugs were classified into four categories depending on whether uptake is limited by blood flow, extravasation, interstitial diffusion, or local binding and metabolism. Simulations comparing small molecule versus macromolecular drugs show a sharp difference in distribution, which has implications for multi-drug therapies. The tissue-level distribution differs widely in tumors for small molecules versus macromolecular biologic drugs, and this should be considered in the design of agents and treatments. An example using antibodies in mouse xenografts illustrates the different in vivo behavior. This type of transport analysis can be used to aid in model development, experimental data analysis, and imaging and therapeutic agent design.	[Thurber, Greg Michael; Weissleder, Ralph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Thurber, GM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02115 USA.	gthurber@alum.mit.edu; rweissleder@mgh.harvard.edu		/0000-0003-0828-4143; Thurber, Greg/0000-0001-7570-2080	National Institutes of Health (NIH) [T32 CA079443]; NATIONAL CANCER INSTITUTE [T32CA079443] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health (NIH) grant T32 CA079443. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerheiligen SRB, 2010, CLIN PHARMACOL THER, V88, P135, DOI 10.1038/clpt.2010.81; Aloj L, 1999, CANCER RES, V59, P4709; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; BAXTER LT, 1994, CANCER RES, V54, P1517; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; BISCHOFF KB, 1971, J PHARM SCI-US, V60, P1128, DOI 10.1002/jps.2600600803; Breimer D, 2008, PHARM RES-DORD, V25, P2720, DOI 10.1007/s11095-008-9717-x; Castell F, 2008, BRIT J CANCER, V98, P1597, DOI 10.1038/sj.bjc.6604330; CHAPLIN DJ, 1987, CANCER RES, V47, P597; Deen, 1998, ANAL TRANSPORT PHENO; Dewhirst MW, 2000, INT J CANCER, V90, P237, DOI 10.1002/1097-0215(20001020)90:5<237::AID-IJC1>3.0.CO;2-T; Eggleton CD, 2000, MATH BIOSCI, V167, P123, DOI 10.1016/S0025-5564(00)00038-9; Ferl GZ, 2006, MOL CANCER THER, V5, P1550, DOI 10.1158/1535-7163.MCT-06-0072; Flynn AA, 2001, CANCER IMMUNOL IMMUN, V50, P77, DOI 10.1007/s002620100176; FRYKHOLM G, 1991, IN VITRO CELL DEV B, V27, P900; FUJIMORI K, 1990, J NUCL MED, V31, P1191; FUJIMORI K, 1989, CANCER RES, V49, P5656; Garg A, 2007, J PHARMACOKINET PHAR, V34, P687, DOI 10.1007/s10928-007-9065-1; GERLOWSKI LE, 1986, MICROVASC RES, V31, P288, DOI 10.1016/0026-2862(86)90018-X; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Heijn M, 1999, CANCER RES, V59, P4458; Hinderling PH, 1997, PHARMACOL REV, V49, P279; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; JAIN RK, 1988, CANCER RES, V48, P7022; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JUSKO WJ, 1973, J PHARMACOKINET BIOP, V1, P175, DOI 10.1007/BF01062346; Levitt David G, 2010, BMC Clin Pharmacol, V10, P1, DOI 10.1186/1472-6904-10-1; MATTES MJ, 1994, CANCER-AM CANCER SOC, V73, P787; McLarty K, 2009, EUR J NUCL MED MOL I, V36, P81, DOI 10.1007/s00259-008-0923-x; MIDDLEMAN S, 1972, TRANSPORT PHENOMENA; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Mullani NA, 2008, J NUCL MED, V49, P517, DOI 10.2967/jnumed.107.048504; Noguchi Y, 1998, JPN J CANCER RES, V89, P307, DOI 10.1111/j.1349-7006.1998.tb00563.x; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Patton JN, 2006, BIOTECHNOL PROGR, V22, P1025, DOI 10.1021/bp060022a; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; Poulin P, 2002, J PHARM SCI-US, V91, P1358, DOI 10.1002/jps.10128; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Pruijn FB, 2008, AUST J CHEM, V61, P687, DOI 10.1071/CH08240; Pugachev A, 2005, INT J RADIAT ONCOL, V62, P545, DOI 10.1016/j.ijrobp.2005.02.009; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Sharkey RM, 2008, RADIOLOGY, V246, P497, DOI 10.1148/radiol.2462070229; Smith TAD, 2001, NUCL MED BIOL, V28, P1, DOI 10.1016/S0969-8051(00)00177-3; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Tannock IF, 2002, CLIN CANCER RES, V8, P878; Thurber G.M., 2010, MOL IMAGING BIOL; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Thurber GM, 2008, CANCER RES, V68, P3334, DOI 10.1158/0008-5472.CAN-07-3018; Thurber GM, 2007, J NUCL MED, V48, P995, DOI 10.2967/jnumed.106.037069; Thurber GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008053; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; TOLMACHEV V, 2011, EUR J NUCL MED MOL I; TORRES IP, 1994, P NATL ACAD SCI USA, V91, P2081, DOI 10.1073/pnas.91.6.2081; Tzafriri AR, 2009, CELL PROLIFERAT, V42, P348, DOI 10.1111/j.1365-2184.2009.00602.x; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang CY, 2001, MATH BIOSCI, V173, P103, DOI 10.1016/S0025-5564(01)00074-8; Wildiers H, 2003, BRIT J CANCER, V88, P1979, DOI 10.1038/sj.bjc.6601005; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Yao ZS, 2004, CLIN CANCER RES, V10, P3137, DOI 10.1158/1078-0432.CCR-03-0171	67	82	85	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24696	10.1371/journal.pone.0024696	http://dx.doi.org/10.1371/journal.pone.0024696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935441	gold, Green Published, Green Submitted			2022-12-25	WOS:000295039700036
J	Kamper, N; Franken, S; Temme, S; Koch, S; Bieber, T; Koch, N				Kaemper, Nadine; Franken, Sebastian; Temme, Sebastian; Koch, Susanne; Bieber, Thomas; Koch, Norbert			gamma-Interferon-regulated chaperone governs human lymphocyte antigen class II expression	FASEB JOURNAL			English	Article						HLA class III-encoded BAT3; BAG6; class II transactivator; CIITA; HLA class II	B-ASSOCIATED TRANSCRIPT-3; TRANSACTIVATOR CIITA; NUCLEAR TRANSPORT; INVARIANT CHAIN; MHC; COMPLEX; SCYTHE; BINDING; HLA; APOPTOSIS	Antigen presentation by human lymphocyte antigen (HLA) class II peptide receptors alerts the immune system to infections. In antigen-presenting cells (APCs), HLA class II, HLA-DM, and associated invariant chain-encoding genes are exclusively regulated by the interferon gamma (IFN gamma)-inducible class II transactivator (CIITA). Control of CIITA expression could therefore govern expression of class II peptide receptors in the diverse group of APCs. We discovered that elevation of the HLA class III region encoded B-associated transcript 3 (BAT3) increases and depletion of BAT3 decreases expression of HLA class II, HLA-DM, and invariant chain. IFN gamma strongly elevates BAT3 transcription in various tumor cell lines and in primary macrophages. BAT3 chaperones the simultaneously IFN gamma-induced CIITA. Following IFN gamma-treatment, both CIITA and BAT3 translocate from the cytosol to the nucleus. The nuclear import of CIITA mediated by IFN gamma controls activation of HLA class II genes. BAT3 is a novel key regulator of components of the HLA class II processing pathway. We present a mechanism explaining how parallel IFN gamma-mediated regulation of CIITA and of its chaperone BAT3 controls the level of components of the HLA class II processing pathway.-Kamper, N., Franken, S., Temme, S., Koch, S., Bieber, T., Koch, K. gamma-Interferon-regulated chaperone governs human lymphocyte antigen class II expression. FASEB J. 26, 104-116 (2012). www.fasebj.org	[Koch, Norbert] Univ Bonn, Abt Immunbiol, Inst Genet, Div Immunobiol, D-53117 Bonn, Germany; [Franken, Sebastian] Univ Bonn, Inst Biochem, D-53117 Bonn, Germany; [Koch, Susanne; Bieber, Thomas] Univ Bonn, Dept Dermatol & Allergy, D-53117 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Koch, N (corresponding author), Univ Bonn, Abt Immunbiol, Inst Genet, Div Immunobiol, Romerstr 164, D-53117 Bonn, Germany.	norbert.koch@uni-bonn.de		Franken, Sebastian/0000-0003-4844-6389	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Dr. Endl and Mr. Wurst (Flow Cytometry Core Facility, Institute of Molecular Medicine and Experimental Immunology, Bonn, Germany) for cell sorting; Dr. Zinke (Bonn, Germany) for instructions on the PCR detection system; Dr. B. Dobberstein for valuable discussions; and T. Ebert, S. Herzog, S. Schnautz, and A. Konig for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft.	BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Beck S, 1999, IMMUNOL REV, V167, P201, DOI 10.1111/j.1600-065X.1999.tb01393.x; Bhat KP, 2010, IMMUNOL CELL BIOL, V88, P807, DOI 10.1038/icb.2010.45; Bhat KP, 2010, J BIOL CHEM, V285, P25893, DOI 10.1074/jbc.M110.127746; Camacho-Carvajal MM, 2004, INT IMMUNOL, V16, P65, DOI 10.1093/intimm/dxh010; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Krawczyk M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000058; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2007, BIOCHEM J, V405, P495, DOI 10.1042/BJ20061886; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; Neumann J, 2001, J BIOL CHEM, V276, P13469, DOI 10.1074/jbc.M010629200; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; PESSARA U, 1990, MOL CELL BIOL, V10, P4146, DOI 10.1128/MCB.10.8.4146; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schnappauf F, 2003, EUR J IMMUNOL, V33, P2337, DOI 10.1002/eji.200323490; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Temme S, 2010, J IMMUNOL, V184, P236, DOI 10.4049/jimmunol.0902192; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Vandiedonck C, 2004, P NATL ACAD SCI USA, V101, P15464, DOI 10.1073/pnas.0406756101; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007	45	25	27	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					104	116		10.1096/fj.11-189670	http://dx.doi.org/10.1096/fj.11-189670			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21940994				2022-12-25	WOS:000299202200012
J	Prinetti, A; Cao, T; Illuzzi, G; Prioni, S; Aureli, M; Gagliano, N; Tredici, G; Rodriguez-Menendez, V; Chigorno, V; Sonnino, S				Prinetti, Alessandro; Cao, Ting; Illuzzi, Giuditta; Prioni, Simona; Aureli, Massimo; Gagliano, Nicoletta; Tredici, Giovanni; Rodriguez-Menendez, Virginia; Chigorno, Vanna; Sonnino, Sandro			A Glycosphingolipid/Caveolin-1 Signaling Complex Inhibits Motility of Human Ovarian Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED MEMBRANE DOMAINS; RAT CEREBELLAR NEURONS; BLADDER-CANCER CELLS; GM3 GANGLIOSIDE; TYROSINE KINASE; PRION PROTEIN; ACTIVE SRC; CAVEOLIN-1; TUMOR; EXPRESSION	The genetic (stable overexpression of sialyltransferase I, GM3 synthase) or pharmacological (selective pressure by N-(4-hydroxyphenyl)retinamide)) manipulation of A2780 human ovarian cancer cells allowed us to obtain clones characterized by higher GM3 synthase activity compared with wild-type cells. Clones with high GM3 synthase expression had elevated ganglioside levels, reduced in vitro cell motility, and enhanced expression of the membrane adaptor protein caveolin-1 with respect to wild-type cells. In high GM3 synthase-expressing clones, both depletion of gangliosides by treatment with the glucosylceramide synthase inhibitor D-threo -1-phenyl-2-decanoylamino-3-morpholino-1-propanol and silencing of caveolin-1 by siRNA were able to strongly increase in vitro cell motility. The motility of wild-type, low GM3 synthase-expressing cells was reduced in the presence of a Src inhibitor, and treatment of these cells with exogenous gangliosides, able to reduce their in vitro motility, inactivated c-Src kinase. Conversely, ganglioside depletion by D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol treatment or caveolin-1 silencing in high GM3 synthase-expressing cells led to c-Src kinase activation. In high GM3 synthase-expressing cells, caveolin-1 was associated with sphingolipids, integrin receptor subunits, p130(CAS), and c-Src forming a Triton X-100-insoluble noncaveolar signaling complex. These data suggest a role for gangliosides in regulating tumor cell motility by affecting the function of a signaling complex organized by caveolin-1, responsible for Src inactivation downstream to integrin receptors, and imply that GM3 synthase is a key target for the regulation of cell motility in human ovarian carcinoma.	[Prinetti, Alessandro; Cao, Ting; Illuzzi, Giuditta; Prioni, Simona; Aureli, Massimo; Chigorno, Vanna; Sonnino, Sandro] Univ Milan, Dept Med Chem, I-20090 Segrate, Italy; [Prinetti, Alessandro; Cao, Ting; Illuzzi, Giuditta; Prioni, Simona; Aureli, Massimo; Chigorno, Vanna; Sonnino, Sandro] Univ Milan, Dept Biochem & Biotechnol, I-20090 Segrate, Italy; [Gagliano, Nicoletta] Univ Milan, Dept Human Morphol, I-20090 Segrate, Italy; [Gagliano, Nicoletta] Univ Milan, Dept Biomed Sci Citta Studi, I-20090 Segrate, Italy; [Tredici, Giovanni; Rodriguez-Menendez, Virginia] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, I-20052 Monza, Italy	University of Milan; University of Milan; University of Milan; University of Milan; University of Milano-Bicocca	Prinetti, A (corresponding author), Univ Milan, Dept Med Chem, I-20090 Segrate, Italy.	alessandro.prinetti@unimi.it	Prinetti, Alessandro/R-4206-2017; Sonnino, Sandro/R-4154-2017; Aureli, Massimo/G-3876-2014; Gagliano, Nicoletta/L-1485-2016	Prinetti, Alessandro/0000-0003-0252-2593; Sonnino, Sandro/0000-0001-8180-5908; Aureli, Massimo/0000-0003-1916-2440; Gagliano, Nicoletta/0000-0002-3393-3144				ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Benistant C, 2000, BIOCHEM BIOPH RES CO, V273, P425, DOI 10.1006/bbrc.2000.2948; Benistant C, 2001, CANCER RES, V61, P1415; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Chigorno V, 2000, EUR J BIOCHEM, V267, P4187, DOI 10.1046/j.1432-1327.2000.01454.x; Cornish-Bowden A, 1998, CARBOHYD RES, V312, P167; Deng W, 2002, GLYCOBIOLOGY, V12, P145, DOI 10.1093/glycob/12.3.145; Dong LX, 2011, GLYCOCONJUGATE J, V28, P137, DOI 10.1007/s10719-011-9330-9; Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x; Egan C, 1999, ONCOGENE, V18, P1227, DOI 10.1038/sj.onc.1202233; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Hinrichs JWJ, 2004, J BIOL CHEM, V279, P5734, DOI 10.1074/jbc.M306857200; Hyuga S, 1999, INT J CANCER, V83, P685, DOI 10.1002/(SICI)1097-0215(19991126)83:5<685::AID-IJC20>3.0.CO;2-4; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kawakami Y, 2002, J BIOL CHEM, V277, P34349, DOI 10.1074/jbc.M200771200; Kawamura S, 2001, INT J CANCER, V94, P343, DOI 10.1002/ijc.1482; Kazui A, 2000, BIOCHEM BIOPH RES CO, V273, P159, DOI 10.1006/bbrc.2000.2903; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liu Y, 2010, ONCOGENE, V29, P3297, DOI 10.1038/onc.2010.85; Loberto N, 2005, J NEUROCHEM, V95, P771, DOI 10.1111/j.1471-4159.2005.03397.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mitsuzuka K, 2005, J BIOL CHEM, V280, P35545, DOI 10.1074/jbc.M505630200; Miura Y, 2004, P NATL ACAD SCI USA, V101, P16204, DOI 10.1073/pnas.0407297101; Ono M, 2001, BIOCHEMISTRY-US, V40, P6414, DOI 10.1021/bi0101998; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Prinetti A, 2003, J BIOL CHEM, V278, P5574, DOI 10.1074/jbc.M207269200; Prinetti A, 2008, BBA-GEN SUBJECTS, V1780, P585, DOI 10.1016/j.bbagen.2007.08.002; Prinetti A, 2010, GLYCOBIOLOGY, V20, P62, DOI 10.1093/glycob/cwp143; Rivaroli A, 2007, J NEUROCHEM, V103, P1954, DOI 10.1111/j.1471-4159.2007.04890.x; Satoh M, 2001, INT J ONCOL, V19, P723; Scott WN, 2000, ANAL BIOCHEM, V287, P343, DOI 10.1006/abio.2000.4866; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sonnino S, 2009, FEBS LETT, V583, P597, DOI 10.1016/j.febslet.2009.01.007; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trimmer C, 2010, CANCER RES, V70, P7489, DOI 10.1158/0008-5472.CAN-10-0900; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Wang L, 2006, GLYCOCONJUGATE J, V23, P303, DOI 10.1007/s10719-006-5742-3; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Watanabe R, 2002, CANCER RES, V62, P3850; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; ZETTER BR, 1987, METHOD ENZYMOL, V147, P135	57	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40900	40910		10.1074/jbc.M111.286146	http://dx.doi.org/10.1074/jbc.M111.286146			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21949119	Green Published, hybrid			2022-12-25	WOS:000297315400050
J	Reich, A; Klatsky, P; Carson, S; Wessel, G				Reich, Adrian; Klatsky, Peter; Carson, Sandra; Wessel, Gary			The Transcriptome of a Human Polar Body Accurately Reflects Its Sibling Oocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; PREIMPLANTATION DEVELOPMENT; MESSENGER-RNA; PROFILES; PROGRAM; BODIES	Improved methods are needed to reliably and accurately evaluate oocyte quality prior to fertilization and transfer into the woman of human embryos created through in vitro fertilization (IVF). All oocytes that are retrieved and matured in culture are exposed to sperm with little in the way of evaluating the oocyte quality. Furthermore, embryos created through IVF are currently evaluated for developmental potential by morphology, a criterion lacking in quantitation and accuracy. With the recent successes in oocyte vitrification and storage, clear metrics are needed to determine oocyte quality prior to fertilizing. The first polar body (PB) is extruded from the oocyte before fertilization and can be biopsied without damaging the oocyte. Here, we tested the hypothesis that the PB transcriptome is representative of that of the oocyte. Polar body biopsy was performed on metaphase II (MII) oocytes followed by single-cell transcriptome analysis of the oocyte and its sibling PB. Over 12,700 unique mRNAs and miRNAs from the oocyte samples were compared with the 5,431 mRNAs recovered from the sibling PBs (5,256 shared mRNAs or 97%, including miRNAs). The results show that human PBs reflect the oocyte transcript profile and suggests that mRNA detection and quantification through high-throughput quantitative PCR could result in the first molecular diagnostic for gene expression in MII oocytes. This could allow for both oocyte ranking and embryo preferences in IVF applications.	[Reich, Adrian; Wessel, Gary] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Klatsky, Peter; Carson, Sandra] Brown Univ, Women & Infants Hosp, Alpert Sch Med, Div Reprod Endocrinol & Infertil, Providence, RI 02905 USA	Brown University; Brown University; Women & Infants Hospital Rhode Island	Wessel, G (corresponding author), 185 Meeting St,Box G, Providence, RI 02912 USA.	rhet@brown.edu			Brown University provost's office; Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and Sigma-Aldrich; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410] Funding Source: NIH RePORTER	Brown University provost's office; Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and Sigma-Aldrich; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by seed funds from the Brown University provost's office as well as departmental funds from the Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and Sigma-Aldrich.	Antosh M, 2011, AGING-US, V3, P576, DOI 10.18632/aging.100342; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Bermudez M, 2004, REPROD BIOMED ONLINE, V8, P325, DOI 10.1016/S1472-6483(10)60913-3; Biddle A, 2009, DEVELOPMENT, V136, P2695, DOI 10.1242/dev.036327; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Centers for Disease Control and Prevention American Society for Reproductive Medicine Society for Assisted Reproductive Technology, 2008, 2008 ASS REPR TECHN; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Gasca S, 2007, REPROD BIOMED ONLINE, V14, P175, DOI 10.1016/S1472-6483(10)60785-7; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones GM, 2008, HUM REPROD, V23, P1138, DOI 10.1093/humrep/den085; Klatsky PC, 2010, MOL HUM REPROD, V16, P938, DOI 10.1093/molehr/gaq077; Klatsky PC, 2010, MOL REPROD DEV, V77, P386, DOI 10.1002/mrd.21172; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Rienzi L, 2010, HUM REPROD, V25, P66, DOI 10.1093/humrep/dep346; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seli E, 2005, P NATL ACAD SCI USA, V102, P367, DOI 10.1073/pnas.0408378102; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; VERLINSKY Y, 1990, HUM REPROD, V5, P826, DOI 10.1093/oxfordjournals.humrep.a137192	24	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40743	40749		10.1074/jbc.M111.289868	http://dx.doi.org/10.1074/jbc.M111.289868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953461	hybrid, Green Published			2022-12-25	WOS:000297315400035
J	Wang, YQ; Li, ZQ; Xu, PF; Huang, L; Tong, JY; Huang, HZ; Meng, AM				Wang, Yeqi; Li, Zhiqiang; Xu, Pengfei; Huang, Lei; Tong, Jingyuan; Huang, Huizhe; Meng, Anming			Angiomotin-like2 Gene (amotl2) Is Required for Migration and Proliferation of Endothelial Cells during Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEBRAFISH EMBRYO; GROWTH-FACTORS; PROTEIN; RECEPTORS; INDUCTION; POLARITY; KINASES; BIOLOGY; GTPASE; FAMILY	Angiogenesis involves sprouting, migration, and proliferation of endothelial cells. The angiomotin-like2 gene (amotl2) has been found in blood vessels in zebrafish embryos, but its function in angiogenesis and underlying mechanisms remain unknown. In this study, we demonstrate that knockdown of amotl2 in zebrafish Tg(fli1:EGFP)(y1) and Tg(fli1:nEGFP)(y7) transgenic embryos impairs the intersegmental vessel growth and suppresses proliferation of endothelial cells. Transplantation experiments indicate that function of amotl2 in intersegmental vessel growth is cell-autonomous. AMOTL2 knockdown in cultured human umbilical vein endothelial cells also inhibits cell proliferation and migration and disrupts cell polarity, ultimately interrupting the formation of vascular tube-like structures. Amot12 promotes MAPK/ERK activation via c-Src, which is dependent on phosphorylation of tyrosine residue at position 103 but independent of the C-terminal PDZ-binding domain. Taking together, our data indicate that Amotl2 plays a pivotal role in polarity, migration and proliferation of angiogenic endothelial cells.	[Wang, Yeqi; Li, Zhiqiang; Xu, Pengfei; Huang, Lei; Tong, Jingyuan; Huang, Huizhe; Meng, Anming] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Engn, Sch Life Sci, Beijing 100084, Peoples R China; [Meng, Anming] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Engn, Sch Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Meng, Anming/A-4785-2012; Wang, Yeqi/V-8445-2019	Wang, Yeqi/0000-0003-2881-4607; Huang, Lan/0000-0001-9594-4722; Li, Zhiqiang/0000-0002-2768-5332; Meng, Anming/0000-0001-7228-3431	Major Science Programs of China [2011CB943800, 2012CB945101]; National Natural Science Foundation of China [30921004/C061003]	Major Science Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science Programs of China Grants 2011CB943800 and 2012CB945101 and by National Natural Science Foundation of China Grant 30921004/C061003.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Childs S, 2002, DEVELOPMENT, V129, P973; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Levchenko T, 2003, J CELL SCI, V116, P3803, DOI 10.1242/jcs.00694; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; SINGER SJ, 1986, ANNU REV CELL BIOL, V2, P337, DOI 10.1146/annurev.cb.02.110186.002005; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	36	46	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41095	41104		10.1074/jbc.M111.296806	http://dx.doi.org/10.1074/jbc.M111.296806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937427	hybrid, Green Published			2022-12-25	WOS:000297315400068
J	Ezak, MJ; Ferkey, DM				Ezak, Meredith J.; Ferkey, Denise M.			A Functional Nuclear Localization Sequence in the C. elegans TRPV Channel OCR-2	PLOS ONE			English	Article							NEURONAL GENE-EXPRESSION; DEPENDENT PROTEIN-KINASE; NERVE GROWTH-FACTOR; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; INTRAMEMBRANE PROTEOLYSIS; SYNAPSE DEVELOPMENT; SIGNALING PATHWAYS; ASH NEURONS; CALCIUM	The ability to modulate gene expression in response to sensory experience is critical to the normal development and function of the nervous system. Calcium is a key activator of the signal transduction cascades that mediate the process of translating a cellular stimulus into transcriptional changes. With the recent discovery that the mammalian Ca(v)1.2 calcium channel can be cleaved, enter the nucleus and act as a transcription factor to control neuronal gene expression, a more direct role for the calcium channels themselves in regulating transcription has begun to be appreciated. Here we report the identification of a nuclear localization sequence (NLS) in the C. elegans transient receptor potential vanilloid (TRPV) cation channel OCR-2. TRPV channels have previously been implicated in transcriptional regulation of neuronal genes in the nematode, although the precise mechanism remains unclear. We show that the NLS in OCR-2 is functional, being able to direct nuclear accumulation of a synthetic cargo protein as well as the carboxy-terminal cytosolic tail of OCR-2 where it is endogenously found. Furthermore, we discovered that a carboxy-terminal portion of the full-length channel can localize to the nucleus of neuronal cells. These results suggest that the OCR-2 TRPV cation channel may have a direct nuclear function in neuronal cells that was not previously appreciated.	[Ezak, Meredith J.; Ferkey, Denise M.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ezak, MJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	dmferkey@buffalo.edu			National Science Foundation [MCB-0917896]; College of Arts and Sciences, University at Buffalo	National Science Foundation(National Science Foundation (NSF)); College of Arts and Sciences, University at Buffalo	This work was supported by the National Science Foundation (http://www.nsf.gov, MCB-0917896 to DF). An award from the Julian Park Publication Fund (College of Arts and Sciences, University at Buffalo) helped to defray publication costs for this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Ezak MJ, 2010, GENETICS, V185, P233, DOI 10.1534/genetics.110.115188; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hart AC, 1999, J NEUROSCI, V19, P1952; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; KAPILOFF MS, 1991, P NATL ACAD SCI USA, V88, P3710, DOI 10.1073/pnas.88.9.3710; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Qiu Z, 2008, NEURON, V60, P449, DOI 10.1016/j.neuron.2008.10.039; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xiao R, 2009, PFLUG ARCH EUR J PHY, V458, P851, DOI 10.1007/s00424-009-0678-7; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047	49	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e25047	10.1371/journal.pone.0025047	http://dx.doi.org/10.1371/journal.pone.0025047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957475	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100035
J	Panneton, WM; Gan, Q; Livergood, RS				Panneton, W. Michael; Gan, Qi; Livergood, Robert S.			A Trigeminoreticular Pathway: Implications in Pain	PLOS ONE			English	Article							FOS-LIKE IMMUNOREACTIVITY; LATERAL RETICULAR NUCLEUS; LAMINA-I NEURONS; TRIGEMINAL SUBNUCLEUS CAUDALIS; SUPERFICIAL DORSAL-HORN; BRAIN-STEM NEURONS; CUTANEOUS TISSUE INFLAMMATION; NOXIOUS FACIAL STIMULATION; ANTERIOR ETHMOIDAL NERVE; NITRIC-OXIDE SYNTHASE	Neurons in the caudalmost ventrolateral medulla (cmVLM) respond to noxious stimulation. We previously have shown most efferent projections from this locus project to areas implicated either in the processing or modulation of pain. Here we show the cmVLM of the rat receives projections from superficial laminae of the medullary dorsal horn (MDH) and has neurons activated with capsaicin injections into the temporalis muscle. Injections of either biotinylated dextran amine (BDA) into the MDH or fluorogold (FG)/fluorescent microbeads into the cmVLM showed projections from lamina I and II of the MDH to the cmVLM. Morphometric analysis showed the retrogradely-labeled neurons were small (area 88.7 mu m(2) +/- 3.4) and mostly fusiform in shape. Injections (20-50 mu l) of 0.5% capsaicin into the temporalis muscle and subsequent immunohistochemistry for c-Fos showed nuclei labeled in the dorsomedial trigeminocervical complex (TCC), the cmVLM, the lateral medulla, and the internal lateral subnucleus of the parabrachial complex (PBil). Additional labeling with c-Fos was seen in the subnucleus interpolaris of the spinal trigeminal nucleus, the rostral ventrolateral medulla, the superior salivatory nucleus, the rostral ventromedial medulla, and the A1, A5, A7 and subcoeruleus catecholamine areas. Injections of FG into the PBil produced robust label in the lateral medulla and cmVLM while injections of BDA into the lateral medulla showed projections to the PBil. Immunohistochemical experiments to antibodies against substance P, the substance P receptor (NK1), calcitonin gene regulating peptide, leucine enkephalin, VRL1 (TPRV2) receptors and neuropeptide Y showed that these peptides/receptors densely stained the cmVLM. We suggest the MDH-cmVLM projection is important for pain from head and neck areas. We offer a potential new pathway for regulating deep pain via the neurons of the TCC, the cmVLM, the lateral medulla, and the PBil and propose these areas compose a trigeminoreticular pathway, possibly the trigeminal homologue of the spinoreticulothalamic pathway.	[Panneton, W. Michael; Gan, Qi; Livergood, Robert S.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	Saint Louis University	Panneton, WM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	pannetwm@slu.edu			National Institutes of Health (NIH) [R01 HL64772]; Saint Louis University Medical School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064772] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University Medical School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant R01 HL64772 and the Saint Louis University Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimar P, 1998, J NEUROSCI, V18, P10375; Andrew D, 2003, J COMP NEUROL, V458, P257, DOI 10.1002/cne.10592; Arendt-Nielsen L, 2001, CLIN J PAIN, V17, P11, DOI 10.1097/00002508-200103000-00003; Barman SM, 2010, AM J PHYSIOL-REG I, V299, pR1269, DOI 10.1152/ajpregu.00422.2010; BEAL JA, 1981, J COMP NEUROL, V202, P237, DOI 10.1002/cne.902020209; Bendtsen L, 2006, CURR OPIN NEUROL, V19, P305; Bereiter DA, 2000, PAIN, V88, P221, DOI 10.1016/S0304-3959(00)00434-6; Bereiter DA, 2000, SOMATOSENS MOT RES, V17, P229; Bereiter DA, 1996, PAIN, V64, P179, DOI 10.1016/0304-3959(95)00095-X; BEREITER DA, 1994, BRAIN RES, V657, P73, DOI 10.1016/0006-8993(94)90955-5; Bereiter DA, 1996, NEUROSCIENCE, V73, P249, DOI 10.1016/0306-4522(96)00038-3; Bereiter DA, 1998, NEUROSCIENCE, V83, P525, DOI 10.1016/S0306-4522(97)00433-8; Bereiter DA, 1997, NEUROSCIENCE, V77, P863, DOI 10.1016/S0306-4522(96)00541-6; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473, DOI 10.1152/jn.1990.63.3.473; BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403; Bester H, 1999, J COMP NEUROL, V405, P421; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; Bice TN, 1997, J COMP NEUROL, V388, P550, DOI 10.1002/(SICI)1096-9861(19971201)388:4<550::AID-CNE4>3.0.CO;2-1; BOISSONADE FM, 1993, J COMP NEUROL, V329, P291, DOI 10.1002/cne.903290302; Borg-Stein Joanne, 2002, Curr Pain Headache Rep, V6, P324, DOI 10.1007/s11916-002-0055-0; Bourgeais L, 2001, J NEUROSCI, V21, P2159, DOI 10.1523/JNEUROSCI.21-06-02159.2001; Bruehl S, 1999, NEUROSCI BIOBEHAV R, V23, P877, DOI 10.1016/S0149-7634(99)00039-1; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; Castro AR, 2006, BRAIN RES BULL, V69, P266, DOI 10.1016/j.brainresbull.2005.12.004; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; CECHETTO DF, 1985, J COMP NEUROL, V240, P153, DOI 10.1002/cne.902400205; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; Chen SY, 1997, CLIN EXP PHARMACOL P, V24, P46, DOI 10.1111/j.1440-1681.1997.tb01782.x; CIRIELLO J, 1977, AM J PHYSIOL, V233, pR100, DOI 10.1152/ajpregu.1977.233.3.R100; Craig AD, 1996, PROG BRAIN RES, V107, P225; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; CRUZ L, 1985, J COMP NEUROL, V240, P331, DOI 10.1002/cne.902400402; CUTRER FM, 1995, NEUROSCIENCE, V64, P741, DOI 10.1016/0306-4522(94)00428-8; DELFIACCO M, 1980, NEUROSCIENCE, V5, P803; Doone GV, 1999, J AUTONOM NERV SYST, V77, P98, DOI 10.1016/S0165-1838(99)00041-7; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; FEIL K, 1995, J COMP NEUROL, V353, P506, DOI 10.1002/cne.903530404; Fernandez-de-las-Penas C, 2007, CLIN J PAIN, V23, P786, DOI 10.1097/AJP.0b013e318153496a; Fitzek S, 2001, ANN NEUROL, V49, P493; Galhardo V, 1999, J COMP NEUROL, V414, P315; Gall O, 2000, BRAIN RES, V873, P131, DOI 10.1016/S0006-8993(00)02524-5; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Gobel S, 1977, PAIN TRIGEMINAL REGI, P443; HATHAWAY CB, 1995, J COMP NEUROL, V356, P444, DOI 10.1002/cne.903560311; HAYASHI H, 1990, BRAIN RES, V511, P177, DOI 10.1016/0006-8993(90)90240-C; Hermanson O, 1998, J COMP NEUROL, V400, P255; HOLSTEGE G, 1977, BRAIN, V100, P265, DOI 10.1093/brain/100.2.265; Hoskin KL, 1999, NEUROSCI LETT, V266, P173, DOI 10.1016/S0304-3940(99)00281-5; Iannuccelli C, 2010, ANN NY ACAD SCI, V1193, P78, DOI 10.1111/j.1749-6632.2009.05365.x; Ikeda T, 2003, J COMP NEUROL, V465, P220, DOI 10.1002/cne.10836; Imbe H, 2001, CELLS TISSUES ORGANS, V169, P238, DOI 10.1159/000047887; Imbe H, 1999, BRAIN RES, V845, P165, DOI 10.1016/S0006-8993(99)01913-7; Israel HA, 2000, J AM DENT ASSOC, V131, P919, DOI 10.14219/jada.archive.2000.0310; Iwata K, 1999, J NEUROPHYSIOL, V82, P1244, DOI 10.1152/jn.1999.82.3.1244; JANSS AJ, 1987, BRAIN RES, V405, P140; Jiang MC, 2004, RESP PHYSIOL NEUROBI, V143, P215, DOI 10.1016/j.resp.2004.07.019; KITAMURA T, 1993, J COMP NEUROL, V328, P449, DOI 10.1002/cne.903280310; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; KOJIMA Y, 1990, BRAIN RES BULL, V24, P609, DOI 10.1016/0361-9230(90)90167-X; LAING I, 1994, NEUROSCIENCE, V61, P123, DOI 10.1016/0306-4522(94)90065-5; Lambert GA, 2000, BRAIN RES, V887, P203, DOI 10.1016/S0006-8993(00)02919-X; Lamont LA, 2000, VET CLIN N AM-SMALL, V30, P703, DOI 10.1016/S0195-5616(08)70003-2; LANTERIMINET M, 1993, NEUROSCIENCE, V55, P737, DOI 10.1016/0306-4522(93)90439-M; LANTERIMINET M, 1994, NEUROSCIENCE, V58, P287, DOI 10.1016/0306-4522(94)90035-3; Lenz FA, 1997, THALAMUS EXPT CLIN A, V2; LIMA D, 1986, J COMP NEUROL, V244, P53, DOI 10.1002/cne.902440105; LIMA D, 1991, NEUROSCIENCE, V45, P137, DOI 10.1016/0306-4522(91)90110-A; Lima D, 2002, EXP PHYSIOL, V87, P267, DOI 10.1113/eph8702354; LIU RH, 1990, NEUROSCI LETT, V109, P92; LU J, 1993, NEUROSCIENCE, V54, P809, DOI 10.1016/0306-4522(93)90250-J; Ma QP, 2001, NEUROREPORT, V12, P3693, DOI 10.1097/00001756-200112040-00018; MacGowan DJL, 1997, NEUROLOGY, V49, P120, DOI 10.1212/WNL.49.1.120; Marbach JJ, 1999, MED CLIN N AM, V83, P691, DOI 10.1016/S0025-7125(05)70130-9; Marchettini P, 1996, BRAIN RES, V740, P109, DOI 10.1016/S0006-8993(96)00851-7; Martinez S, 1996, EXP BRAIN RES, V109, P56; McCulloch PF, 1999, BRAIN RES, V830, P24, DOI 10.1016/S0006-8993(99)01374-8; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; MILLER KE, 1989, J COMP NEUROL, V279, P619, DOI 10.1002/cne.902790409; MINETA Y, 1995, EXP BRAIN RES, V107, P34; Mitsikostas DD, 1998, PAIN, V76, P239, DOI 10.1016/S0304-3959(98)00051-7; Monconduit L, 2002, EUR J NEUROSCI, V16, P937, DOI 10.1046/j.1460-9568.2002.02148.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morris R, 2004, BRAIN RES REV, V46, P173, DOI 10.1016/j.brainresrev.2004.07.002; NELSON CF, 1994, J MANIP PHYSIOL THER, V17, P156; Ness TJ, 1998, BRAIN RES, V802, P163, DOI 10.1016/S0006-8993(98)00608-8; Ness TJ, 1999, ANESTH ANALG, V89, P721, DOI 10.1097/00000539-199909000-00036; NISHIMORI T, 1986, BRAIN RES, V372, P375, DOI 10.1016/0006-8993(86)91148-0; NOZAKI K, 1992, NEUROSCIENCE, V49, P669, DOI 10.1016/0306-4522(92)90235-T; Panneton W., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Panneton WM, 2006, NEUROSCIENCE, V141, P889, DOI 10.1016/j.neuroscience.2006.04.055; Panneton WM, 2010, J APPL PHYSIOL, V109, P1256, DOI 10.1152/japplphysiol.00110.2010; Panneton WM, 2010, EXP EYE RES, V90, P388, DOI 10.1016/j.exer.2009.11.018; PANNETON WM, 1985, NEUROSCIENCE, V15, P779, DOI 10.1016/0306-4522(85)90078-8; Panneton WM, 2000, BRAIN RES, V874, P48, DOI 10.1016/S0006-8993(00)02549-X; Panneton WM, 2009, NEUR ABSTR, V34; Panneton WM, 2005, NEUR ABSTR, V30; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pelissier T, 2002, PAIN, V96, P81, DOI 10.1016/S0304-3959(01)00432-8; Pinto M, 2003, EUR J NEUROSCI, V17, P1393, DOI 10.1046/j.1460-9568.2003.02586.x; POLGAR E, 1995, EXP BRAIN RES, V103, P402; PROUDLOCK F, 1993, J COMP NEUROL, V327, P289, DOI 10.1002/cne.903270210; Robbins MT, 2005, NEUROSCI LETT, V381, P329, DOI 10.1016/j.neulet.2005.02.046; ROY JC, 1992, J PHYSIOL-LONDON, V458, P235, DOI 10.1113/jphysiol.1992.sp019415; Schepelmann K, 1999, NEUROSCIENCE, V90, P543, DOI 10.1016/S0306-4522(98)00423-0; SHIGENAGA Y, 1988, J COMP NEUROL, V268, P489, DOI 10.1002/cne.902680403; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; SOTGIU ML, 1986, BRAIN RES, V375, P168; STRASSMAN AM, 1994, J NEUROSCI, V14, P3725; STRASSMAN AM, 1993, J NEUROPHYSIOL, V70, P1811, DOI 10.1152/jn.1993.70.5.1811; STRASSMAN AM, 1993, J COMP NEUROL, V331, P495, DOI 10.1002/cne.903310406; STRASSMAN AM, 1994, J COMP NEUROL, V346, P349, DOI 10.1002/cne.903460304; SU CK, 1989, BRAIN RES BULL, V23, P447, DOI 10.1016/0361-9230(89)90188-3; SUGIMOTO T, 1994, EXP NEUROL, V129, P251, DOI 10.1006/exnr.1994.1167; Sugiyo S, 2005, J COMP NEUROL, V493, P510, DOI 10.1002/cne.20797; Sun W, 2002, AM J PHYSIOL-REG I, V283, pR768, DOI 10.1152/ajpregu.00184.2002; Sun W, 2005, J COMP NEUROL, V482, P273, DOI 10.1002/cne.20434; Sun W, 2001, BRAIN RES, V908, P208, DOI 10.1016/S0006-8993(01)02614-2; Svensson P, 2001, J OROFAC PAIN, V15, P117; Svensson P, 2000, Curr Rev Pain, V4, P158; TABER E, 1961, J COMP NEUROL, V116, P27, DOI 10.1002/cne.901160104; Takeda M, 2005, EXP BRAIN RES, V160, P107, DOI 10.1007/s00221-004-1990-2; Tavares I, 2002, J PAIN, V3, P337, DOI 10.1054/jpai.2002.127775; TAVARES I, 1993, BRAIN RES, V623, P278, DOI 10.1016/0006-8993(93)91438-X; Ter Horst GJ, 2001, CEPHALALGIA, V21, P963, DOI 10.1046/j.1468-2982.2001.00285.x; Tominaga M, 2000, JPN J PHARMACOL, V83, P20, DOI 10.1254/jjp.83.20; Truini A, 2006, EXP BRAIN RES, V174, P622, DOI 10.1007/s00221-006-0508-5; Valeriani M, 2005, NEUROSCIENCE, V136, P301, DOI 10.1016/j.neuroscience.2005.07.045; Valtschanoff JG, 2001, J COMP NEUROL, V436, P225, DOI 10.1002/cne.1063; VALTSCHANOFF JG, 1992, NEUROSCI LETT, V148, P6, DOI 10.1016/0304-3940(92)90791-5; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; VILLANUEVA L, 1988, J NEUROPHYSIOL, V60, P980, DOI 10.1152/jn.1988.60.3.980; Villanueva L, 1996, PAIN, V67, P231, DOI 10.1016/0304-3959(96)03121-1; Wang H, 2006, J COMP NEUROL, V498, P390, DOI 10.1002/cne.21062; Wang K, 2002, J DENT RES, V81, P650, DOI 10.1177/154405910208100915; Wasner G, 2002, MUSCLE NERVE, V26, P113, DOI 10.1002/mus.10170; WIBERG M, 1984, BRAIN RES, V291, P1, DOI 10.1016/0006-8993(84)90645-0; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Witting N, 2000, PAIN, V84, P407, DOI 10.1016/S0304-3959(99)00231-6; Yoshida A, 1999, J COMP NEUROL, V406, P29; Zhang ET, 1996, J COMP NEUROL, V367, P537; Zhang ET, 1997, J NEUROSCI, V17, P3274; Zhou QQ, 1999, J COMP NEUROL, V412, P276, DOI 10.1002/(SICI)1096-9861(19990920)412:2<276::AID-CNE7>3.0.CO;2-9	144	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24499	10.1371/journal.pone.0024499	http://dx.doi.org/10.1371/journal.pone.0024499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957454	Green Submitted, Green Published, gold			2022-12-25	WOS:000295262100014
J	Zamakhchari, M; Wei, GX; Dewhirst, F; Lee, J; Schuppan, D; Oppenheim, FG; Helmerhorst, EJ				Zamakhchari, Maram; Wei, Guoxian; Dewhirst, Floyd; Lee, Jaeseop; Schuppan, Detlef; Oppenheim, Frank G.; Helmerhorst, Eva J.			Identification of Rothia Bacteria as Gluten-Degrading Natural Colonizers of the Upper Gastro-Intestinal Tract	PLOS ONE			English	Article							COMBINATION ENZYME THERAPY; CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; GLIADIN PEPTIDES; PROLYL-ENDOPEPTIDASE; T-CELLS; SP-NOV; SPRUE; ENDOPROTEASE; MICROBIOME	Background: Gluten proteins, prominent constituents of barley, wheat and rye, cause celiac disease in genetically predisposed subjects. Gluten is notoriously difficult to digest by mammalian proteolytic enzymes and the protease-resistant domains contain multiple immunogenic epitopes. The aim of this study was to identify novel sources of gluten-digesting microbial enzymes from the upper gastro-intestinal tract with the potential to neutralize gluten epitopes. Methodology/Principal Findings: Oral microorganisms with gluten-degrading capacity were obtained by a selective plating strategy using gluten agar. Microbial speciations were carried out by 16S rDNA gene sequencing. Enzyme activities were assessed using gliadin-derived enzymatic substrates, gliadins in solution, gliadin zymography, and 33-mer alpha-gliadin and 26-mer gamma-gliadin immunogenic peptides. Fragments of the gliadin peptides were separated by RP-HPLC and structurally characterized by mass spectrometry. Strains with high activity towards gluten were typed as Rothia mucilaginosa and Rothia aeria. Gliadins (250 mu g/ml) added to Rothia cell suspensions (OD(620) 1.2) were degraded by 50% after similar to 30 min of incubation. Importantly, the 33-mer and 26-mer immunogenic peptides were also cleaved, primarily C-terminal to Xaa-Pro-Gln (XPQ) and Xaa-Pro-Tyr (XPY). The major gliadin-degrading enzymes produced by the Rothia strains were similar to 70-75 kDa in size, and the enzyme expressed by Rothia aeria was active over a wide pH range (pH 3-10). Conclusion/Significance: While the human digestive enzyme system lacks the capacity to cleave immunogenic gluten, such activities are naturally present in the oral microbial enzyme repertoire. The identified bacteria may be exploited for physiologic degradation of harmful gluten peptides.	[Zamakhchari, Maram; Wei, Guoxian; Lee, Jaeseop; Oppenheim, Frank G.; Helmerhorst, Eva J.] Boston Univ, Dept Periodontol & Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Dewhirst, Floyd] Forsyth Inst, Dept Mol Genet, Cambridge, MA USA; [Schuppan, Detlef] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Sch Med, Boston, MA 02215 USA; [Schuppan, Detlef] Johannes Gutenberg Univ Mainz, Div Mol & Translat Med, Mainz, Germany	Boston University; Harvard University; Forsyth Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johannes Gutenberg University of Mainz	Zamakhchari, M (corresponding author), Boston Univ, Dept Periodontol & Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA.	helmer@bu.edu		Wei, Guoxian/0000-0001-5115-3697; Dewhirst, Floyd E./0000-0003-4427-7928; Helmerhorst, Eva/0000-0002-4803-3018	National Institutes of Health [DE016937, DK073254, AI078385, DE05672, DE7652, AI087803, DE18132]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078385, R01AI087803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652, R37DE016937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005672, R37DE005672, U01DE016937, R21DE018132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health: DE016937 (FD), DK073254 (DS), AI078385 (DS) DE05672 (FO) and DE7652 (FO) AI087803 (EJH), DE18132 (EJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; Camp JG, 2009, GASTROENTEROLOGY, V136, P1989, DOI 10.1053/j.gastro.2009.02.075; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Collins MD, 2000, INT J SYST EVOL MICR, V50, P1247, DOI 10.1099/00207713-50-3-1247; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Gass J, 2006, J PHARMACOL EXP THER, V318, P1178, DOI 10.1124/jpet.106.104315; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Green PHR, 2006, ANNU REV MED, V57, P207, DOI 10.1146/annurev.med.57.051804.122404; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Helmerhorst EJ, 2008, J BIOL CHEM, V283, P19957, DOI 10.1074/jbc.M708282200; Helmerhorst EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013264; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Koning F, 2005, BEST PRACT RES CL GA, V19, P373, DOI 10.1016/j.bpg.2005.02.003; Li Y, 2004, INT J SYST EVOL MICR, V54, P827, DOI 10.1099/ijs.0.02828-0; Marti T, 2005, J PHARMACOL EXP THER, V312, P19, DOI 10.1124/jpet.104.073312; Matysiak-Budnik T, 2005, GASTROENTEROLOGY, V129, P786, DOI 10.1053/j.gastro.2005.06.016; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rizzello CG, 2007, APPL ENVIRON MICROB, V73, P4499, DOI 10.1128/AEM.00260-07; Rubio-Tapia A, 2010, CURR OPIN GASTROEN, V26, P116, DOI 10.1097/MOG.0b013e3283365263; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Sollid LM, 2005, NAT CLIN PRACT GASTR, V2, P140, DOI 10.1038/ncpgasthep0111; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; TIAN N, 2011, 14 INT CEL DIS S OSL; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; WIESER H, 1995, BAILLIERE CLIN GASTR, V9, P191, DOI 10.1016/0950-3528(95)90027-6; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	41	80	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24455	10.1371/journal.pone.0024455	http://dx.doi.org/10.1371/journal.pone.0024455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957450	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100010
J	Rees, SD; Hydrie, MZI; O'Hare, JP; Kumar, S; Shera, AS; Basit, A; Barnett, AH; Kelly, MA				Rees, Simon D.; Hydrie, M. Zafar I.; O'Hare, J. Paul; Kumar, Sudhesh; Shera, A. Samad; Basit, Abdul; Barnett, Anthony H.; Kelly, M. Ann			Effects of 16 Genetic Variants on Fasting Glucose and Type 2 Diabetes in South Asians: ADCY5 and GLIS3 Variants May Predispose to Type 2 Diabetes	PLOS ONE			English	Article							ASSOCIATION; MELLITUS; RISK	Background: The Meta-Analysis of Glucose and Insulin related traits Consortium (MAGIC) recently identified 16 loci robustly associated with fasting glucose, some of which were also associated with type 2 diabetes. The purpose of our study was to explore the role of these variants in South Asian populations of Punjabi ancestry, originating predominantly from the District of Mirpur, Pakistan. Methodology/Principal Findings: Sixteen single nucleotide polymorphisms (SNPs) were genotyped in 1678 subjects with type 2 diabetes and 1584 normoglycaemic controls from two Punjabi populations; one resident in the UK and one indigenous to the District of Mirpur. In the normoglycaemic controls investigated for fasting glucose associations, 12 of 16 SNPs displayed beta values with the same direction of effect as that seen in European studies, although only the SLC30A8 rs11558471 SNP was nominally associated with fasting glucose (beta = 0.063 [95% CI: 0.013, 0.113] p = 0.015). Of interest, the MTNR1B rs10830963 SNP displayed a negative beta value for fasting glucose in our study; this effect size was significantly lower than that seen in Europeans (p = 1.29x10(-4)). In addition to previously reported type 2 diabetes risk variants in TCF7L2 and SLC30A8, SNPs in ADCY5 (rs11708067) and GLIS3 (rs7034200) displayed evidence for association with type 2 diabetes, with odds ratios of 1.23 (95% CI: 1.09, 1.39; p = 9.1x10(-4)) and 1.16 (95% CI: 1.05, 1.29; p = 3.49x10(-3)) respectively. Conclusions/Significance: Although only the SLC30A8 rs11558471 SNP was nominally associated with fasting glucose in our study, the finding that 12 out of 16 SNPs displayed a direction of effect consistent with European studies suggests that a number of these variants may contribute to fasting glucose variation in individuals of South Asian ancestry. We also provide evidence for the first time in South Asians that alleles of SNPs in GLIS3 and ADCY5 may confer risk of type 2 diabetes.	[Rees, Simon D.; Barnett, Anthony H.; Kelly, M. Ann] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Hydrie, M. Zafar I.; Basit, Abdul] Baqai Inst Diabetol & Endocrinol, Karachi, Pakistan; [O'Hare, J. Paul; Kumar, Sudhesh] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Shera, A. Samad] Diabet Assoc Pakistan, Karachi, Pakistan; [Rees, Simon D.; Barnett, Anthony H.; Kelly, M. Ann] Heart England NHS Fdn Trust, Biomed Res Ctr, Birmingham, W Midlands, England	University of Birmingham; Baqai Medical University; University of Warwick; Heart of England NHS Foundation Trust	Rees, SD (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	s.d.rees@bham.ac.uk	Hydrie, Muhammad Zafar Iqbal/H-8490-2017; kumar, sudhesh/D-6945-2013	Hydrie, Muhammad Zafar Iqbal/0000-0002-1317-6975; kumar, sudhesh/0000-0003-4326-5941	Diabetes UK [07/0003512]; Eli Lilly	Diabetes UK(Diabetes UK); Eli Lilly(Eli Lilly)	Funding for the collection of DNA and clinical data from the Pakistan-resident population (DGP) was provided by Diabetes UK (project number 07/0003512; www.diabetes.org.uk). Funding for genetic analyses was provided by Eli Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Been LF, 2012, NUTR METAB CARDIOVAS, V22, P944, DOI 10.1016/j.numecd.2011.01.006; Bellary S, 2008, LANCET, V371, P1769, DOI 10.1016/S0140-6736(08)60764-3; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gauderman W, QUANTO 1 1 COMPUTER; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015542; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rees SD, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-8; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609	18	57	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24710	10.1371/journal.pone.0024710	http://dx.doi.org/10.1371/journal.pone.0024710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949744	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400010
J	Wojcechowskyj, JA; Lee, JY; Seeholzer, SH; Doms, RW				Wojcechowskyj, Jason A.; Lee, Jessica Y.; Seeholzer, Steven H.; Doms, Robert W.			Quantitative Phosphoproteomics of CXCL12 (SDF-1) Signaling	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; CD4(+) T-CELLS; LARGE GENE LISTS; CANCER CELLS; PERIPHERAL-BLOOD; PROMOTES GROWTH; HIV-1 LATENCY; LATERAL-LINE; FACTOR-I; INFECTION	CXCL12 (SDF-1) is a chemokine that binds to and signals through the seven transmembrane receptor CXCR4. The CXCL12/CXCR4 signaling axis has been implicated in both cancer metastases and human immunodeficiency virus type 1 (HIV-1) infection and a more complete understanding of CXCL12/CXCR4 signaling pathways may support efforts to develop therapeutics for these diseases. Mass spectrometry-based phosphoproteomics has emerged as an important tool in studying signaling networks in an unbiased fashion. We employed stable isotope labeling with amino acids in cell culture (SILAC) quantitative phosphoproteomics to examine the CXCL12/CXCR4 signaling axis in the human lymphoblastic CEM cell line. We quantified 4,074 unique SILAC pairs from 1,673 proteins and 89 phosphopeptides were deemed CXCL12-responsive in biological replicates. Several well established CXCL12-responsive phosphosites such as AKT (pS473) and ERK2 (pY204) were confirmed in our study. We also validated two novel CXCL12-responsive phosphosites, stathmin (pS16) and AKT1S1 (pT246) by Western blot. Pathway analysis and comparisons with other phosphoproteomic datasets revealed that genes from CXCL12-responsive phosphosites are enriched for cellular pathways such as T cell activation, epidermal growth factor and mammalian target of rapamycin (mTOR) signaling, pathways which have previously been linked to CXCL12/CXCR4 signaling. Several of the novel CXCL12-responsive phosphoproteins from our study have also been implicated with cellular migration and HIV-1 infection, thus providing an attractive list of potential targets for the development of cancer metastasis and HIV-1 therapeutics and for furthering our understanding of chemokine signaling regulation by reversible phosphorylation.	[Wojcechowskyj, Jason A.; Doms, Robert W.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Lee, Jessica Y.; Seeholzer, Steven H.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wojcechowskyj, JA (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	doms@mail.med.upenn.edu			NIH [R01 40880, T32 AI 07632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007632] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 40880 to RWD, while JAW was supported by NIH T32 AI 07632 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; Chong BF, 2009, EXPERT OPIN THER TAR, V13, P1147, DOI 10.1517/14728220903196761; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Curnock AP, 2003, J IMMUNOL, V170, P4021, DOI 10.4049/jimmunol.170.8.4021; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Fuhler GM, 2009, EUR J HAEMATOL, V83, P235, DOI 10.1111/j.1600-0609.2009.01263.x; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Hashimoto I, 2008, EUR J CANCER, V44, P1022, DOI 10.1016/j.ejca.2008.02.043; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Jin Z, 2009, INT J CANCER, V125, P2229, DOI 10.1002/ijc.24612; Jones KL, 2010, J BIOL CHEM, V285, P18603, DOI 10.1074/jbc.M109.090126; Jones KL, 2011, J NEUROIMMUNE PHARM; Juno JA, 2010, AIDS REV, V12, P164; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Kucia M, 2004, J MOL HISTOL, V35, P233; Lee HS, 2010, MOL BIOL CELL, V21, P2661, DOI 10.1091/mbc.E09-12-1036; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Liu E, 2005, MOL CELL BIOL, V25, P11145, DOI 10.1128/MCB.25.24.11145-11155.2005; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200; Melar M, 2007, J VIROL, V81, P1773, DOI 10.1128/JVI.01316-06; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; O'Hayre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011716; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Raghavendra NK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-66; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Uy GL, 2008, EXPERT OPIN BIOL TH, V8, P1797, DOI 10.1517/14712598.8.11.1797 ; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; YANG ZY, 1993, NUCLEIC ACIDS RES, V21, P2831, DOI 10.1093/nar/21.12.2831; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036; 2009, NAT IMMUNOL, V10, P325	94	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24918	10.1371/journal.pone.0024918	http://dx.doi.org/10.1371/journal.pone.0024918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949786	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400021
J	Mazar, J; Khaitan, D; DeBlasio, D; Zhong, CC; Govindarajan, SS; Kopanathi, S; Zhang, SJ; Ray, A; Perera, RJ				Mazar, Joseph; Khaitan, Divya; DeBlasio, Dan; Zhong, Cuncong; Govindarajan, Subramaniam S.; Kopanathi, Sharmila; Zhang, Shaojie; Ray, Animesh; Perera, Ranjan J.			Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; MALIGNANT-MELANOMA; ACTIN CYTOSKELETON; CUTANEOUS MELANOMA; MIRNA EXPRESSION; PROTEIN; METHYLATION; PROGRESSION; MECHANISM; REVEALS	Invasive melanoma is the most lethal form of skin cancer. The treatment of melanoma-derived cell lines with 5-aza-2'-deoxycytidine (5-Aza-dC) markedly increases the expression of several miRNAs, suggesting that the miRNA-encoding genes might be epigenetically regulated, either directly or indirectly, by DNA methylation. We have identified a group of epigenetically regulated miRNA genes in melanoma cells, and have confirmed that the upstream CpG island sequences of several such miRNA genes are hypermethylated in cell lines derived from different stages of melanoma, but not in melanocytes and keratinocytes. We used direct DNA bisulfite and immunoprecipitated DNA (Methyl-DIP) to identify changes in CpG island methylation in distinct melanoma patient samples classified as primary in situ, regional metastatic, and distant metastatic. Two melanoma cell lines (WM1552C and A375 derived from stage 3 and stage 4 human melanoma, respectively) were engineered to ectopically express one of the epigenetically modified miRNA: miR-34b. Expression of miR-34b reduced cell invasion and motility rates of both WM1552C and A375, suggesting that the enhanced cell invasiveness and motility observed in metastatic melanoma cells may be related to their reduced expression of miR-34b. Total RNA isolated from control or miR-34b-expressing WM1552C cells was subjected to deep sequencing to identify gene networks around miR-34b. We identified network modules that are potentially regulated by miR-34b, and which suggest a mechanism for the role of miR-34b in regulating normal cell motility and cytokinesis.	[Mazar, Joseph; Khaitan, Divya; Govindarajan, Subramaniam S.; Perera, Ranjan J.] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA; [DeBlasio, Dan; Zhong, Cuncong; Zhang, Shaojie] Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA; [Kopanathi, Sharmila; Ray, Animesh] Keck Grad Inst, Claremont, CA USA	Sanford Burnham Prebys Medical Discovery Institute; State University System of Florida; University of Central Florida; Claremont Colleges; Keck Graduate Institute	Mazar, J (corresponding author), Sanford Burnham Med Res Inst, Orlando, FL 32827 USA.	rperera@sanfordburnham.org	DeBlasio, Dan/H-8153-2019; Mazar, Joseph/AAQ-8199-2020	DeBlasio, Dan/0000-0003-4110-4431; Zhang, Shaojie/0000-0002-4051-5549; Ray, Animesh/0000-0002-0120-5820; Mazar, Joseph/0000-0002-3713-4251	National Institutes of Health [1R01GM084881-01]; National Science Foundation [FIBR 0527023]; Sanford-Burnham Institute; Division of Computing and Communication Foundations [0941078] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Sanford-Burnham Institute; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (1R01GM084881-01) and the National Science Foundation (FIBR 0527023) to AR (www.nsf.gov) and Sanford-Burnham Institute support for RP's research program (www.sanfordburnham.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Chao A, 2010, CANCER LETT, V291, P99, DOI 10.1016/j.canlet.2009.10.005; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Essa S, 2010, J STEROID BIOCHEM, V121, P110, DOI 10.1016/j.jsbmb.2010.02.003; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo LL, 2010, EUR J CANCER, V46, P1692, DOI 10.1016/j.ejca.2010.02.043; Han L, 2007, CANCER BIOL THER, V6, P1284; Hawighorst T, 2001, EMBO J, V20, P2631, DOI 10.1093/emboj/20.11.2631; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Howell PM, 2009, CANCER CONTROL, V16, P200, DOI 10.1177/107327480901600302; Jonsson A, 2010, J INVEST DERMATOL, V130, P2809, DOI 10.1038/jid.2010.216; Karnell R, 1997, MELANOMA RES, V7, P393, DOI 10.1097/00008390-199710000-00005; Kelly EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000820; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Levy C, 2010, MOL CELL; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Ma ZH, 2009, J MOL DIAGN, V11, P420, DOI 10.2353/jmoldx.2009.090041; Maun NA, 1996, BIOCHEMISTRY-US, V35, P3518, DOI 10.1021/bi952470p; Mazar J, 2011, FEBS LETT, V585, P2467, DOI 10.1016/j.febslet.2011.06.025; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Molnar V, 2008, SEMIN CANCER BIOL, V18, P111, DOI 10.1016/j.semcancer.2008.01.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Qian XL, 2009, CANCER CELL, V16, P246, DOI 10.1016/j.ccr.2009.07.031; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schneider D, 2002, BBA-MOL BASIS DIS, V1588, P1, DOI 10.1016/S0925-4439(02)00052-2; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Seder CW, 2009, J THORAC ONCOL, V4, P455, DOI 10.1097/JTO.0b013e31819c791a; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Sigalotti L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-56; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Toyota Minoru, 2010, Gan To Kagaku Ryoho, V37, P1650; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; WEILBACH FX, 1990, CANCER RES, V50, P6981; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	62	59	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24922	10.1371/journal.pone.0024922	http://dx.doi.org/10.1371/journal.pone.0024922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949788	Green Published, gold			2022-12-25	WOS:000295257900034
J	Wildman, DE; Uddin, M; Romero, R; Gonzalez, JM; Than, NG; Murphy, J; Hou, ZC; Fritz, J				Wildman, Derek E.; Uddin, Monica; Romero, Roberto; Gonzalez, Juan M.; Than, Nandor Gabor; Murphy, Jim; Hou, Zhuo-Cheng; Fritz, Jo			Spontaneous Abortion and Preterm Labor and Delivery in Nonhuman Primates: Evidence from a Captive Colony of Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							BIRTH-WEIGHT; INFLAMMATORY RESPONSE; ANIMAL-MODELS; UNITED-STATES; PARTURITION; INFECTION; PREGNANCY; INFANTS; WOMEN; MECHANISMS	Background: Preterm birth is a leading cause of perinatal mortality, yet the evolutionary history of this obstetrical syndrome is largely unknown in nonhuman primate species. Methodology/Principal Findings: We examined the length of gestation during pregnancies that occurred in a captive chimpanzee colony by inspecting veterinary and behavioral records spanning a total of thirty years. Upon examination of these records we were able to confidently estimate gestation length for 93 of the 97 (96%) pregnancies recorded at the colony. In total, 78 singleton gestations resulted in live birth, and from these pregnancies we estimated the mean gestation length of normal chimpanzee pregnancies to be 228 days, a finding consistent with other published reports. We also calculated that the range of gestation in normal chimpanzee pregnancies is approximately forty days. Of the remaining fifteen pregnancies, only one of the offspring survived, suggesting viability for chimpanzees requires a gestation of approximately 200 days. These fifteen pregnancies constitute spontaneous abortions and preterm deliveries, for which the upper gestational age limit was defined as 2 SD from the mean length of gestation (208 days). Conclusions/Significance: The present study documents that preterm birth occurred within our study population of captive chimpanzees. As in humans, pregnancy loss is not uncommon in chimpanzees, In addition, our findings indicate that both humans and chimpanzees show a similar range of normal variation in gestation length, suggesting this was the case at the time of their last common ancestor (LCA). Nevertheless, our data suggest that whereas chimpanzees' normal gestation length is similar to 20-30 days after reaching viability, humans' normal gestation length is approximately 50 days beyond the estimated date of viability without medical intervention. Future research using a comparative evolutionary framework should help to clarify the extent to which mechanisms at work in normal and preterm parturition are shared in these species.	[Wildman, Derek E.; Romero, Roberto; Hou, Zhuo-Cheng] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Wildman, Derek E.; Romero, Roberto; Gonzalez, Juan M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Wildman, Derek E.; Romero, Roberto; Gonzalez, Juan M.; Than, Nandor Gabor; Hou, Zhuo-Cheng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA; [Uddin, Monica] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Murphy, Jim; Fritz, Jo] Primate Fdn Arizona, Mesa, AZ USA	Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Michigan System; University of Michigan	Wildman, DE (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.	dwildman@wayne.edu; prbchiefstaff@med.wayne.edu	Than, Nandor G/N-1442-2016; Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121; Wildman, Derek/0000-0002-6374-5136	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests	ACOG, 2001, PRACT B MAN REC EARL; Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; Behrman RE, 2007, PRETERM BIRTH CAUSES; Berek JS, 2007, BEREK NOVAKS GYNECOL, p[xxii, 1671]; Blanchard PC, 2010, J VET DIAGN INVEST, V22, P128, DOI 10.1177/104063871002200127; Bolin DC, 2004, J VET DIAGN INVEST, V16, P333, DOI 10.1177/104063870401600414; Callaghan WM, 2006, PEDIATRICS, V118, P1566, DOI 10.1542/peds.2006-0860; Carter AM, 2010, BEST PRACT RES CLIN; Chen CY, 2008, MOL PHYLOGENET EVOL, V47, P637, DOI 10.1016/j.ympev.2007.12.026; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Cuevas KD, 2005, AM J NURS, V105, P56, DOI 10.1097/00000446-200507000-00031; DAHL JF, 1991, AM J PRIMATOL, V24, P195, DOI 10.1002/ajp.1350240306; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Elliot MG, 2009, PLACENTA, V30, P949, DOI 10.1016/j.placenta.2009.08.004; Ellison PT, 2001, FERTILE GROUND, P358; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; FIDEL PL, 1994, AM J OBSTET GYNECOL, V170, P1467, DOI 10.1016/S0002-9378(94)70180-6; Fox-Lee L, 2007, BEREK NOVAKS GYNECOL; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Goodall J., 1990, WINDOW MY 30 YEARS C; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Goodman M, 2005, TRENDS GENET, V21, P511, DOI 10.1016/j.tig.2005.06.012; Graham C. E., 1970, IMMUNOLOGY INFECT HO, V3, P183; Graham CE, 1981, MENSTRUAL CYCLE GREA, P1; Hirsch E, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-1; Innes EA, 2009, PARASITOLOGY, V136, P1887, DOI 10.1017/S0031182009991636; Keeling ME, 1972, CHIMPANZEE HISTLOGY; Knight Andrew, 2008, Philos Ethics Humanit Med, V3, P16, DOI 10.1186/1747-5341-3-16; Kullander S, 1977, Acta Obstet Gynecol Scand Suppl, V66, P77; MacDorman Marian F, 2007, Natl Vital Stat Rep, V56, P1; Machatschke IH, 2006, J MED PRIMATOL, V35, P331, DOI 10.1111/j.1600-0684.2006.00175.x; Martin RD, 1990, PRIMATE ORIGINS EVOL, p[xiv, 804]; Mendelson CR, 2005, J STEROID BIOCHEM, V93, P113, DOI 10.1016/j.jsbmb.2004.12.027; Mesiano S, 2010, REPROD SCI; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Morse SB, 2009, PEDIATRICS, V123, pE622, DOI 10.1542/peds.2008-1405; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Muglia LJ, N ENGL J MED, V362, P529; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Penn DJ, 2007, P NATL ACAD SCI USA, V104, P553, DOI 10.1073/pnas.0609301103; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Pike IL, 2005, AM J HUM BIOL, V17, P55, DOI 10.1002/ajhb.20093; PRENTICE AM, 1987, AM J CLIN NUTR, V46, P912, DOI 10.1093/ajcn/46.6.912; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; Richard AF, 1985, PRIMATES NATURE, px; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; ROMERO R, 1988, SEMIN PERINATOL, V12, P262; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Seri I, 2008, J PERINATOL, V28, pS4, DOI 10.1038/jp.2008.42; SILVA M, 1995, CRC HDB MAMMALIAN BO; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Underwood MA, 2007, J PERINATOL, V27, P614, DOI 10.1038/sj.jp.7211801; Vemulapalli R, 2005, J VET DIAGN INVEST, V17, P67, DOI 10.1177/104063870501700114; Wallis J, 1997, J REPROD FERTIL, V109, P297; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wildman DE, 2003, P NATL ACAD SCI USA, V100, P7181, DOI 10.1073/pnas.1232172100; Wislocki GB, 1933, AM J PHYS ANTHROPOL, V18, P81, DOI 10.1002/ajpa.1330180115; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777	68	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24509	10.1371/journal.pone.0024509	http://dx.doi.org/10.1371/journal.pone.0024509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949724	gold, Green Published, Green Submitted			2022-12-25	WOS:000295173800024
J	Grenville-Briggs, L; Gachon, CMM; Strittmatter, M; Sterck, L; Kupper, FC; van West, P				Grenville-Briggs, Laura; Gachon, Claire M. M.; Strittmatter, Martina; Sterck, Lieven; Kuepper, Frithjof C.; van West, Pieter			A Molecular Insight into Algal-Oomycete Warfare: cDNA Analysis of Ectocarpus siliculosus Infected with the Basal Oomycete Eurychasma dicksonii	PLOS ONE			English	Article							LAMINARIA-DIGITATA PHAEOPHYCEAE; SAPROLEGNIA-PARASITICA; CHITIN SYNTHASE; GENOME SEQUENCE; PROTEINS; PATHOGEN; IDENTIFICATION; POTATO; GENE; MECHANISMS	Brown algae are the predominant primary producers in coastal habitats, and like land plants are subject to disease and parasitism. Eurychasma dicksonii is an abundant, and probably cosmopolitan, obligate biotrophic oomycete pathogen of marine brown algae. Oomycetes (or water moulds) are pathogenic or saprophytic non-photosynthetic Stramenopiles, mostly known for causing devastating agricultural and aquacultural diseases. Whilst molecular knowledge is restricted to crop pathogens, pathogenic oomycetes actually infect hosts from most eukaryotic lineages. Molecular evidence indicates that Eu. dicksonii belongs to the most early-branching oomycete clade known so far. Therefore Eu. dicksonii is of considerable interest due to its presumed environmental impact and phylogenetic position. Here we report the first large scale functional molecular data acquired on the most basal oomycete to date. 9873 unigenes, totalling over 3.5Mb of sequence data, were produced from Sanger-sequenced and pyrosequenced EST libraries of infected Ectocarpus siliculosus. 6787 unigenes (70%) were of algal origin, and 3086 (30%) oomycete origin. 57% of Eu. dicksonii sequences had no similarity to published sequence data, indicating that this dataset is largely unique. We were unable to positively identify sequences belonging to the RXLR and CRN groups of oomycete effectors identified in higher oomycetes, however we uncovered other unique pathogenicity factors. These included putative algal cell wall degrading enzymes, cell surface proteins, and cyclophilin-like proteins. A first look at the host response to infection has also revealed movement of the host nucleus to the site of infection as well as expression of genes responsible for strengthening the cell wall, and secretion of proteins such as protease inhibitors. We also found evidence of transcriptional reprogramming of E. siliculosus transposable elements and of a viral gene inserted in the host genome.	[Grenville-Briggs, Laura; Strittmatter, Martina; van West, Pieter] Univ Aberdeen, Aberdeen Oomycete Lab, Aberdeen, Scotland; [Gachon, Claire M. M.; Strittmatter, Martina; Kuepper, Frithjof C.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Sterck, Lieven] Flanders Inst Biotechnol VIB, Dept Plant Syst Biol, Ghent, Belgium; [Sterck, Lieven] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium	University of Aberdeen; UHI Millennium Institute; Flanders Institute for Biotechnology (VIB); Ghent University	Grenville-Briggs, L (corresponding author), Univ Aberdeen, Aberdeen Oomycete Lab, Aberdeen, Scotland.	p.vanwest@abdn.ac.uk	Grenville-Briggs, Laura/B-3386-2013; Sterck, Lieven/A-9439-2016; Grenville-Briggs, Laura J/C-3419-2014	Sterck, Lieven/0000-0001-7116-4000; Grenville-Briggs, Laura J/0000-0001-5910-3651; Kuepper, Frithjof/0000-0003-1273-7109; Gachon, Claire/0000-0002-3702-7472; Strittmatter, Martina/0000-0002-1258-9751; van West, Pieter/0000-0002-0767-6017	University of Aberdeen; Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environment Research Council (NERC) via the SOFI initiative [NE/F012705/1]; New Investigator Grant [NE/D521522/1]; NERC [MGF 211]; European Commission [MIEF-CT-2006-022837]; European Reintegration Grant [PERG03-GA-2008-230865]; EU [MEST-CT-2005-20501]; Natural Environment Research Council [NE/J00460X/1, NE/D521522/1, NE/F012578/1] Funding Source: researchfish; NERC [NE/D521522/1, NE/F012578/1, NE/J00460X/1] Funding Source: UKRI	University of Aberdeen; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC) via the SOFI initiative(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); New Investigator Grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Reintegration Grant; EU(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is supported by the University of Aberdeen (PvW), the Biotechnology and Biological Sciences Research Council (BBSRC) (LGB, PvW), the Royal Society (PvW), the Total Foundation (FCK, PvW) and the Natural Environment Research Council (NERC) via the SOFI initiative (award NE/F012705/1) (LGB, CMMG, FCK and PvW), through Oceans 2025 WP4.5 (FCK), a New Investigator Grant (NE/D521522/1) (FCK) and a sequence allocation from the NERC Molecular Genetics Facility (Pilot Project MGF 211) (CMMG, PvW and FCK). The authors are also supported by the European Commission via a Marie Curie Intra-European Fellowship (MIEF-CT-2006-022837) (CMMG), a European Reintegration Grant (PERG03-GA-2008-230865) (CMMG), and an EU ECOSUMMER PhD fellowship (MEST-CT-2005-20501) (MS, FCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Badreddine I, 2008, EUKARYOT CELL, V7, P1980, DOI 10.1128/EC.00091-08; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Berteau O, 2003, GLYCOBIOLOGY, V13, p29R, DOI 10.1093/glycob/cwg058; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; BULONE V, 1992, EXP MYCOL, V16, P8, DOI 10.1016/0147-5975(92)90037-R; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Drummond AJ AB, 2011, GENEIOUS V4 8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Gachon CMM, 2009, APPL ENVIRON MICROB, V75, P322, DOI 10.1128/AEM.01885-08; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grenville-Briggs LJ, 2010, FUNGAL BIOL-UK, V114, P702, DOI 10.1016/j.funbio.2010.06.003; Grenville-Briggs LJ, 2005, ADV APPL MICROBIOL, V57, P217, DOI 10.1016/S0065-2164(05)57007-2; Grenville-Briggs LJ, 2005, FUNGAL GENET BIOL, V42, P244, DOI 10.1016/j.fgb.2004.11.009; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Grouffaud Severine, 2010, Fungal Biology Reviews, V24, P27, DOI 10.1016/j.fbr.2010.01.002; Guerriero G., 2010, PLOS PATHOG, V6, P1; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; KATSAROS C, 1992, PROTOPLASMA, V169, P75, DOI 10.1007/BF01343372; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kupper FC, 2006, CRYPTOGAMIE ALGOL, V27, P165; Kupper FC, 1999, NOVA HEDWIGIA, V69, P381; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Li H, 2006, NATURE, V442, P100; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maumus F, 2009, THESIS U PARIS SUD; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1348, DOI 10.1094/MPMI-19-1348; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; MortBontemps M, 1997, MICROBIOL-UK, V143, P2009, DOI 10.1099/00221287-143-6-2009; Muller DG, 2008, CAH BIOL MAR, V49, P59; Muller D.G., 1999, PHYCOL RES, V47, P217, DOI DOI 10.1111/J.1440-1835.1999.TB00301.X; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha EPC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001104; Roeder V, 2005, J PHYCOL, V41, P1227, DOI 10.1111/j.1529-8817.2005.00150.x; Sekimoto S, 2008, PROTIST, V159, P299, DOI 10.1016/j.protis.2007.11.004; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Strittmatter M, 2009, OOMYCETE GENETICS GE, P25; Takemoto D, 2004, PLANT PHYSIOL, V136, P3864, DOI 10.1104/pp.104.052159; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tonon T, 2008, J PHYCOL, V44, P1250, DOI 10.1111/j.1529-8817.2008.00580.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van West P, 2003, PHYSIOL MOL PLANT P, V62, P99, DOI 10.1016/S0885-5765(03)00044-4; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; van West P, 2010, FEMS MICROBIOL LETT, V310, P127, DOI 10.1111/j.1574-6968.2010.02055.x; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; West JA, 1999, HYDROBIOLOGIA, V399, P101; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388	67	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24500	10.1371/journal.pone.0024500	http://dx.doi.org/10.1371/journal.pone.0024500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935414	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700035
J	Hatta, M; Pastoor, R; Scheelbeek, PFD; Sultan, AR; Dwiyanti, R; Labeda, I; Smits, HL				Hatta, Mochammad; Pastoor, Rob; Scheelbeek, Pauline F. D.; Sultan, Andi R.; Dwiyanti, Ressy; Labeda, Ibrahim; Smits, Henk L.			Multi-Locus Variable-Number Tandem Repeat Profiling of Salmonella enterica Serovar Typhi Isolates from Blood Cultures and Gallbladder Specimens from Makassar, South-Sulawesi, Indonesia	PLOS ONE			English	Article							FLAGELLIN GENE; COUNTRIES; ANTIGEN; FEVER; Z66	Multi-locus variable-number tandem repeat analysis differentiated 297 Salmonella enterica serovar Typhi blood culture isolates from Makassar in 76 genotypes and a single unique S. Typhi genotype was isolated from the cholecystectomy specimens of four patients with cholelithiasis. The high diversity in S. Typhi genotypes circulating in Makassar indicates that the number of carriers could be very large, which may complicate disease prevention and control.	[Hatta, Mochammad; Sultan, Andi R.; Dwiyanti, Ressy] Hasanuddin Univ, Fac Med, Mol Biol & Immunol Lab, Dept Med Microbiol, Makassar, South Sulawesi, Indonesia; [Labeda, Ibrahim] Hasanuddin Univ, Fac Med, Dept Digest Surg, Makassar, South Sulawesi, Indonesia; [Pastoor, Rob; Scheelbeek, Pauline F. D.; Smits, Henk L.] Royal Trop Inst, KIT, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands	Universitas Hasanuddin; Universitas Hasanuddin	Hatta, M (corresponding author), Hasanuddin Univ, Fac Med, Mol Biol & Immunol Lab, Dept Med Microbiol, Makassar, South Sulawesi, Indonesia.	h.smits@kit.nl	HATTA, MOCHAMMAD/D-3742-2019	HATTA, MOCHAMMAD/0000-0002-8456-4203; Mallongi, Anwar/0000-0001-6438-1154				Al Harbi M, 2001, TROP MED INT HEALTH, V6, P570, DOI 10.1046/j.1365-3156.2001.00748.x; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Baker S, 2007, CLIN INFECT DIS, V45, pS29, DOI 10.1086/518143; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Darko R, 1994, West Afr J Med, V13, P113; FRANKEL G, 1989, EMBO J, V8, P3149, DOI 10.1002/j.1460-2075.1989.tb08468.x; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; GUINEE PAM, 1981, ANN INST PASTEUR MIC, VA132, P331; Hatta M, 2011, AM J TROP MED HYG, V84, P429, DOI 10.4269/ajtmh.2011.10-0605; Huang XX, 2004, FEMS MICROBIOL LETT, V234, P239, DOI 10.1016/j.femsle.2004.03.030; Lan RT, 2009, INFECT GENET EVOL, V9, P996, DOI 10.1016/j.meegid.2009.04.011; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Liu YC, 2003, J CLIN MICROBIOL, V41, P4388, DOI 10.1128/JCM.41.9.4388-4394.2003; Luxemburger C, 2001, T ROY SOC TROP MED H, V95, P19, DOI 10.1016/S0035-9203(01)90318-9; Moehario LH, 2009, J INFECT DEV COUNTR, V3, P579, DOI 10.3855/jidc.548; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Octavia S, 2009, J CLIN MICROBIOL, V47, P2369, DOI 10.1128/JCM.00223-09; Ramisse V, 2004, J CLIN MICROBIOL, V42, P5722, DOI 10.1128/JCM.42.12.5722-5730.2004; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Thong KL, 2002, J CLIN MICROBIOL, V40, P4156, DOI 10.1128/JCM.40.11.4156-4160.2002; Westphal JF, 1999, DRUGS, V57, P81, DOI 10.2165/00003495-199957010-00007; ZAVALA TI, 1991, EUR J CLIN MICROBIOL, V10, P334	25	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24983	10.1371/journal.pone.0024983	http://dx.doi.org/10.1371/journal.pone.0024983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949819	gold, Green Published, Green Submitted			2022-12-25	WOS:000295041700086
J	Icardi, L; Lievens, S; Mori, R; Piessevaux, J; De Cauwer, L; De Bosscher, K; Tavernier, J				Icardi, Laura; Lievens, Sam; Mori, Raffaele; Piessevaux, Julie; De Cauwer, Lode; De Bosscher, Karolien; Tavernier, Jan			Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2	FASEB JOURNAL			English	Article						interferon signaling; trichostatin A; TSA; interferon-stimulated genes	NEGATIVE REGULATION; INTERFERON-GAMMA; GENE-EXPRESSION; ACTIVATION; ACETYLATION; GROWTH; BETA; IL-6; RESPONSES; RECEPTOR	The antiviral and antiproliferative responses mediated by type I interferons (IFNs) depend on JAK/STAT signaling and ISGF3 (STAT1:STAT2:IRF9)-dependent transcription. In addition, type I IFNs stimulate STAT3 activation in many cell types, an event generally associated with cell cycle progression, survival, and proliferation. To gather more insight into this functionally contradictive phenomenon, we studied the regulation of STAT3 transcriptional activity upon type I IFN treatment. We show that IFN alpha 2 stimulation strongly induces STAT3 phosphorylation, nuclear translocation, and promoter binding, yet the activation of transcription of a STAT3-dependent reporter and endogenous genes, such as SOCS3 and c-FOS, is impaired. Simultaneous treatment with IFN alpha 2 and trichostatin A, as well as combined HDAC1/HDAC2 silencing, restores STAT3-dependent reporter gene and endogenous gene expression, strongly suggesting that HDAC1 and HDAC2 are directly involved in repressing IFN alpha 2-activated STAT3. Of note, single silencing of only one of the two HDACs does not lead to enhanced STAT3 activity, supporting a functional redundancy between these two enzymes. In sharp contrast, HDAC1 and HDAC2 activities are required for ISGF3-dependent gene expression. We conclude that HDAC1 and HDAC2 differentially modulate STAT activity in response to IFN alpha 2: while they are required for the induction of ISGF3-responsive genes, they impair the transcription of STAT3-dependent genes.-Icardi, L., Lievens, S., Mori, R., Piessevaux, J., De Cauwer, L., De Bosscher, K., Tavernier, J. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J. 26, 240-249 (2012). www.fasebj.org	[Icardi, Laura; Lievens, Sam; Mori, Raffaele; Piessevaux, Julie; De Cauwer, Lode; De Bosscher, Karolien; Tavernier, Jan] Vlaams Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; [Icardi, Laura; Lievens, Sam; Mori, Raffaele; Piessevaux, Julie; De Cauwer, Lode; De Bosscher, Karolien; Tavernier, Jan] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Tavernier, J (corresponding author), Vlaams Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium.	jan.tavernier@vib-ugent.be	Tavernier, Jan/AAG-3636-2019	De Cauwer, Lode/0000-0002-6928-8271; De Bosscher, Karolien/0000-0001-5059-9718; Icardi, Laura/0000-0002-8936-1691	Ghent University; Interuniversity Attraction Pole-6 [P6:28]; ReceptEur FP6 Marie-Curie program; Fonds Wetenschappelijk Onderzoek-Vlaanderen	Ghent University(Ghent University); Interuniversity Attraction Pole-6; ReceptEur FP6 Marie-Curie program; Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO)	The authors thank Dr. Els Pattyn and Annick Verhee for their help in initiating this research project. This work was supported by grants from Ghent University, the Interuniversity Attraction Pole-6 (No. P6:28) and the ReceptEur FP6 Marie-Curie program. K.D.B. is a postdoctoral researcher at the Fonds Wetenschappelijk Onderzoek-Vlaanderen.	Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hou T, 2008, J BIOL CHEM, V283, P30725, DOI 10.1074/jbc.M805941200; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Melnick A, 2002, CURR OPIN HEMATOL, V9, P322, DOI 10.1097/00062752-200207000-00010; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Ohbayashi N, 2007, BIOL PHARM BULL, V30, P1860, DOI 10.1248/bpb.30.1860; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Regis G, 2009, LEUKEMIA, V23, P2102, DOI 10.1038/leu.2009.139; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Van Schoubroeck B., 2012, METHODS MOL IN PRESS, V812; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Witcher M, 2003, BLOOD, V102, P237, DOI 10.1182/blood-2002-09-2725; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	41	34	34	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					240	249		10.1096/fj.11-191122	http://dx.doi.org/10.1096/fj.11-191122			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21957129				2022-12-25	WOS:000299202200025
J	Mak, AB; Blakely, KM; Williams, RA; Penttila, PA; Shukalyuk, AI; Osman, KT; Kasimer, D; Ketela, T; Moffat, J				Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Penttilae, Pier-Andree; Shukalyuk, Andrey I.; Osman, Khan T.; Kasimer, Dahlia; Ketela, Troy; Moffat, Jason			CD133 Protein N-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEMATOPOIETIC STEM; SHORT INTERFERING RNAS; EPITHELIAL-CELLS; COLON-CANCER; EXPRESSION; IDENTIFICATION; ANTIGEN; GLYCOPROTEINS; GENES; LINES	The AC133 epitope expressed on the CD 133 glycoprotein has been widely used as a cell surface marker of numerous stem cell and cancer stem cell types. It has been recently proposed that posttranslational modification and regulation of CD133 may govern cell surface AC133 recognition. Therefore, we performed a large scale pooled RNA interference (RNAi) screen to identify genes involved in cell surface AC133 expression. Gene hits could be validated at a rate of 70.5% in a secondary assay using an orthogonal RNAi system, demonstrating that our primary RNAi screen served as a powerful genetic screening approach. Within the list of hits from the primary screen, genes involved in N-glycan biosynthesis were significantly enriched as determined by Ingenuity Canonical Pathway analyses. Indeed, inhibiting biosynthesis of the N-glycan precursor using the small molecule tunicamycin or inhibiting its transfer to CD 133 by generating N-glycan-deficient CD133 mutants resulted in undetectable cell surface AC133. Among the screen hits involved in N-glycosylation were genes involved in complex N-glycan processing, including the poorly characterized MGAT4C, which we demonstrate to be a positive regulator of cell surface AC133 expression. Our study identifies a set of genes involved in CD133 N-glycosylation as a direct contributing factor to cell surface AC133 recognition and provides biochemical evidence for the function and structure of CD133 N-glycans.	[Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Moffat, Jason] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Osman, Khan T.; Kasimer, Dahlia; Ketela, Troy; Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Penttilae, Pier-Andree] Sickkids Univ Hlth Network Flow Cytometry Facil, Toronto, ON M5G 1L7, Canada; [Shukalyuk, Andrey I.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5T 1P7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University Health Network Toronto; University of Toronto	Moffat, J (corresponding author), 802-160 Coll St, Toronto, ON M5S 3E1, Canada.	j.moffat@utoronto.ca	Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586; Penttila, Pier Andree/0000-0002-5861-4430	Stem Cell Network; Canadian Institutes of Health Research; Ontario Institute for Cancer Research	Stem Cell Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research	This work was supported by the Stem Cell Network, the Canadian Institutes of Health Research, and the Ontario Institute for Cancer Research (to J. M.).	Bhatia M, 2001, LEUKEMIA, V15, P1685, DOI 10.1038/sj.leu.2402255; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Ferrandina G, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-221; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hemmoranta H, 2007, EXP HEMATOL, V35, P1279, DOI 10.1016/j.exphem.2007.05.006; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Ketela T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-213; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sasaki A, 2010, ONCOL REP, V24, P537, DOI 10.3892/or_00000890; Sgambato A, 2010, J CELL PHYSIOL, V224, P234, DOI 10.1002/jcp.22124; Shimada M, 2010, J GASTROENTEROL, V45, P896, DOI 10.1007/s00535-010-0235-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Wang XL, 2011, BIOCHEM J, V435, P285, DOI 10.1042/BJ20101864; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062	43	59	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41046	41056		10.1074/jbc.M111.261545	http://dx.doi.org/10.1074/jbc.M111.261545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937449	hybrid, Green Published			2022-12-25	WOS:000297315400064
J	Insaidoo, FK; Borbulevych, OY; Hossain, M; Santhanagopolan, SM; Baxter, TK; Baker, BM				Insaidoo, Francis K.; Borbulevych, Oleg Y.; Hossain, Moushumi; Santhanagopolan, Sujatha M.; Baxter, Tiffany K.; Baker, Brian M.			Loss of T Cell Antigen Recognition Arising from Changes in Peptide and Major Histocompatibility Complex Protein Flexibility IMPLICATIONS FOR VACCINE DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-REACTIVE CTL; MOLECULAR-DYNAMICS; HLA-B27 SUBTYPES; HUMAN-MELANOMA; BINDING; IMMUNOGENICITY; THERMODYNAMICS; TEMPERATURE; SIMULATION; RECEPTORS	Modification of the primary anchor positions of antigenic peptides to improve binding to major histocompatibility complex (MHC) proteins is a commonly used strategy for engineering peptide-based vaccine candidates. However, such peptide modifications do not always improve antigenicity, complicating efforts to design effective vaccines for cancer and infectious disease. Here we investigated the MART-1(27-35) tumor antigen, for which anchor modification (replacement of the position two alanine with leucine) dramatically reduces or ablates antigenicity with a wide range of T cell clones despite significantly improving peptide binding to MHC. We found that anchor modification in the MART-1(27-35) antigen enhances the flexibility of both the peptide and the HLA-A*0201 molecule. Although the resulting entropic effects contribute to the improved binding of the peptide to MHC, they also negatively impact T cell receptor binding to the peptide.MHC complex. These results help explain how the "anchor-fixing" strategy fails to improve antigenicity in this case, and more generally, may be relevant for understanding the high specificity characteristic of the T cell repertoire. In addition to impacting vaccine design, modulation of peptide and MHC flexibility through changes to antigenic peptides may present an evolutionary strategy for the escape of pathogens from immune destruction.	Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Baker, BM (corresponding author), 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	brian-baker@nd.edu	Baker, Brian/B-4584-2009	Baker, Brian/0000-0002-0864-0964	National Institutes of Health from NIGMS [GM067079]; National Science Foundation [MCB0448298]; American Cancer Society [RSG-05-202-01-GMC]; Walther Cancer Research Foundation; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Walther Cancer Research Foundation; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM067079 from the NIGMS (to B. M. B.). This work was also supported by Grant MCB0448298 from the National Science Foundation and Grant RSG-05-202-01-GMC from the American Cancer Society.; Supported by a fellowship from the Walther Cancer Research Foundation.; We thank Cynthia Piepenbrink for outstanding technical assistance and Daniel R. Scott for critical comments on the manuscript. Results shown in this study are derived from work performed at the Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Baxter TK, 2004, J BIOL CHEM, V279, P29175, DOI 10.1074/jbc.M403372200; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; BRUCCOLERI RE, 1990, BIOPOLYMERS, V29, P1847, DOI 10.1002/bip.360291415; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Czisch M, 1998, J MAGN RESON, V134, P158, DOI 10.1006/jmre.1998.1483; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Derre L, 2007, J IMMUNOL, V179, P7635, DOI 10.4049/jimmunol.179.11.7635; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fabian H, 2011, FEBS J, V278, P1713, DOI 10.1111/j.1742-4658.2011.08097.x; Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Goddard T. D., 2007, SPARKY 3 113; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Petrone PM, 2004, J MOL BIOL, V338, P419, DOI 10.1016/j.jmb.2004.02.039; Phan GQ, 2003, J IMMUNOTHER, V26, P349, DOI 10.1097/00002371-200307000-00007; Piepenbrink KH, 2009, METHOD ENZYMOL, V466, P359, DOI 10.1016/S0076-6879(09)66015-8; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Skipper JCA, 1999, INT J CANCER, V82, P669, DOI 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valmori D, 1998, J IMMUNOL, V160, P1750; Vranken WF, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-20; Yu ZY, 2004, J CLIN INVEST, V114, P551, DOI 10.1172/JCI200421695; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743	41	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40163	40173		10.1074/jbc.M111.283564	http://dx.doi.org/10.1074/jbc.M111.283564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937447	Green Published, hybrid			2022-12-25	WOS:000296925700049
J	Jang, HD; Shin, JH; Park, DR; Hong, JH; Yoon, K; Ko, R; Ko, CY; Kim, HS; Jeong, D; Kim, N; Lee, SY				Jang, Hyun Duk; Shin, Ji Hye; Park, Doo Ri; Hong, Jin Hee; Yoon, Kwiyeom; Ko, Ryeojin; Ko, Chang-Yong; Kim, Han-Sung; Jeong, Daewon; Kim, Nacksung; Lee, Soo Young			Inactivation of Glycogen Synthase Kinase-3 beta Is Required for Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; BONE HOMEOSTASIS; RANKL; GSK3; EXPRESSION; NFATC1; KINASE; MICE; PHOSPHORYLATION; CALCINEURIN	Glycogen synthase kinase-3 beta (GSK-3 beta is a serine/threonine kinase originally identified as a regulator of glycogen deposition. Although the role of GSK-3 beta in osteoblasts is well characterized as a negative regulator of beta-catenin, its effect on osteoclast formation remains largely unidentified. Here, we show that the GSK-3 beta inactivation upon receptor activator of NF-kappa B ligand (RANKL) stimulation is crucial for osteoclast differentiation. Regulation of GSK-3 beta activity in bone marrow macrophages by retroviral expression of the constitutively active GSK-3 beta (GSK3 beta-S9A) mutant inhibits RANKL-induced osteoclastogenesis, whereas expression of the catalytically inactive GSK-3 beta (GSK3 beta-K85R) or small interfering RNA (siRNA)-mediated GSK-3 beta silencing enhances osteoclast formation. Pharmacological inhibition of GSK-3 beta further confirmed the negative role of GSK-3 beta in osteoclast formation. We also show that overexpression of the GSK3 beta-S9A mutant in bone marrow macrophages inhibits RANKL-mediated NFATc1 induction and Ca2+ oscillations. Remarkably, transgenic mice expressing the GSK3 beta-S9A mutant show an osteopetrotic phenotype due to impaired osteoclast differentiation. Further, osteoclast precursor cells from the transgenic mice show defects in expression and nuclear localization of NFATc1. These findings demonstrate a novel role for GSK-3 beta in the regulation of bone remodeling through modulation of NFATc1 in RANKL signaling.	[Lee, Soo Young] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Bioinspired Sci, Ctr Cell Signaling & Drug Discovery Res,Dept Life, Seoul 120750, South Korea; [Hong, Jin Hee] Korea Univ, Ctr Cell Dynam, Seoul 136701, South Korea; [Hong, Jin Hee] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Ko, Chang-Yong; Kim, Han-Sung] Yonsei Univ, Dept Biomed Engn, Coll Hlth Sci, Inst Med Engn, Wonju 220701, South Korea; [Jeong, Daewon] Yeungnam Univ, Coll Med, Dept Microbiol, Taegu 705717, South Korea; [Jeong, Daewon] Yeungnam Univ, Coll Med, Aging Associated Dis Res Ctr, Taegu 705717, South Korea; [Kim, Nacksung] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea	Ewha Womans University; Korea University; Korea University; Yonsei University; Yeungnam University; Yeungnam University; Chonnam National University	Lee, SY (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Bioinspired Sci, Ctr Cell Signaling & Drug Discovery Res,Dept Life, Seoul 120750, South Korea.	leesy@ewha.ac.kr			National Research Foundation of Korea (NRF); Korea Government (Ministry of Education, Science, and Technology) [R0A-2008-000-20001-0, R31-2008-000-10010-0, 2011-0006244, 2010-0020577]; Ewha Womans University; Brain Korea 21 Project	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Government (Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ewha Womans University; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korea Government (Ministry of Education, Science, and Technology; Grants R0A-2008-000-20001-0; R31-2008-000-10010-0; 2011-0006244; and 2010-0020577).; Supported by Research Professor Grant 2010 of Ewha Womans University.; Supported by the second stage of the Brain Korea 21 Project.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hikata T, 2009, BLOOD, V113, P2202, DOI 10.1182/blood-2008-06-162594; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim JH, 2010, CELL SIGNAL, V22, P1341, DOI 10.1016/j.cellsig.2010.05.001; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; REDDY SV, 1995, J BONE MINER RES, V10, P601; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yoon K, 2008, CELL DEATH DIFFER, V15, P730, DOI 10.1038/sj.cdd.4402304	39	66	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39043	39050		10.1074/jbc.M111.256768	http://dx.doi.org/10.1074/jbc.M111.256768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949120	hybrid, Green Published			2022-12-25	WOS:000296759800023
J	Sugimoto, N; Yugawa, T; Iizuka, M; Kiyono, T; Fujita, M				Sugimoto, Nozomi; Yugawa, Takashi; Iizuka, Masayoshi; Kiyono, Tohru; Fujita, Masatoshi			Chromatin Remodeler Sucrose Nonfermenting 2 Homolog (SNF2H) Is Recruited onto DNA Replication Origins through Interaction with Cdc10 Protein-dependent Transcript 1 (Cdt1) and Promotes Pre-replication Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MCM HETEROHEXAMERIC COMPLEXES; DROSOPHILA FOLLICLE CELLS; HBO1 HISTONE ACETYLASE; LICENSING FACTOR CDT1; ACETYLTRANSFERASE HBO1; CHROMOSOME INSTABILITY; WILLIAMS-SYNDROME; MAMMALIAN-CELLS; DORMANT ORIGINS; GENE-EXPRESSION	From late mitosis to the G(1) phase of the cell cycle, ORC, CDC6, and Cdt1 form the machinery necessary to load MCM2-7 complexes onto DNA. Here, we show that SNF2H, a member of the ATP-dependent chromatin-remodeling complex, is recruited onto DNA replication origins in human cells in a Cdt1-dependent manner and positively regulates MCM loading. SNF2H physically interacted with Cdt1. ChIP assays indicated that SNF2H associates with replication origins specifically during the G(1) phase. Binding of SNF2H at origins was decreased by Cdt1 silencing and, conversely, enhanced by Cdt1 overexpression. Furthermore, SNF2H silencing prevented MCM loading at origins and moderately inhibited S phase progression. Although neither SNF2H overexpression nor SNF2H silencing appeared to impact rereplication induced by Cdt1 overexpression, Cdt1-induced checkpoint activation was inhibited by SNF2H silencing. Collectively, these data suggest that SNF2H may promote MCM loading at DNA replication origins via interaction with Cdt1 in human cells. Because efficient loading of excess MCM complexes is thought to be required for cells to tolerate replication stress, Cdt1- and SNF2H-mediated promotion of MCM loading may be biologically relevant for the regulation of DNA replication.	[Sugimoto, Nozomi; Fujita, Masatoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biochem, Higashi Ku, Fukuoka 8218582, Japan; [Yugawa, Takashi; Kiyono, Tohru] Natl Canc Ctr, Div Virol, Chuou Ku, Tokyo 1040045, Japan; [Iizuka, Masayoshi] Teikyo Univ Sch Med, Dept Biochem, Itabashi Ku, Tokyo 1738605, Japan	Kyushu University; National Cancer Center - Japan	Fujita, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8218582, Japan.	mfujita@phar.kyushu-u.ac.jp	Kiyono, Tohru/H-5834-2011	Sugimoto, Nozomi/0000-0002-4313-5728; Fujita, Masatoshi/0000-0001-6617-2452	Ministry of Education, Culture, Sports, Science and Technology of Japan; Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23590375, 09J07233, 22590276] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. F. and M. I.) and a grant from the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (to M. I.).; Supported by a Japan Society for the Promotion of Science research fellowship.	Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Alexiadis V, 1998, EMBO J, V17, P3428, DOI 10.1093/emboj/17.12.3428; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Fujita M, 1997, J BIOL CHEM, V272, P10928; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Ghosh M, 2006, MOL CELL BIOL, V26, P5270, DOI 10.1128/MCB.02137-05; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Hartl T, 2007, CHROMOSOMA, V116, P197, DOI 10.1007/s00412-006-0092-2; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Iizuka M, 2008, MOL CELL BIOL, V28, P140, DOI 10.1128/MCB.00662-07; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lazzaro MA, 2001, J NEUROCHEM, V77, P1145, DOI 10.1046/j.1471-4159.2001.00324.x; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee J, 2010, MOL CELL, V40, P345, DOI 10.1016/j.molcel.2010.10.033; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; MacCallum DE, 2002, MOL BIOL CELL, V13, P25, DOI 10.1091/mbc.01-09-0441; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Orr SJ, 2010, ONCOGENE, V29, P3803, DOI 10.1038/onc.2010.138; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Rampakakis E, 2009, NUCLEIC ACIDS RES, V37, P5714, DOI 10.1093/nar/gkp617; Schaarschmidt D, 2002, NUCLEIC ACIDS RES, V30, P4176, DOI 10.1093/nar/gkf532; Shima N, 2007, CELL CYCLE, V6, P1135, DOI 10.4161/cc.6.10.4250; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Sugimoto N, 2008, MOL BIOL CELL, V19, P1007, DOI 10.1091/mbc.E07-09-0859; Sugimoto N, 2009, J CELL SCI, V122, P1184, DOI 10.1242/jcs.041889; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zhou J, 2005, CELL CYCLE, V4, P889, DOI 10.4161/cc.4.7.1823; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609	74	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39200	39210		10.1074/jbc.M111.256123	http://dx.doi.org/10.1074/jbc.M111.256123			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937426	Green Published, hybrid			2022-12-25	WOS:000296759800039
J	Fischer, J; Semple, S; Fickenscher, G; Jurgens, R; Kruse, E; Heistermann, M; Amir, O				Fischer, Julia; Semple, Stuart; Fickenscher, Gisela; Juergens, Rebecca; Kruse, Eberhard; Heistermann, Michael; Amir, Ofer			Do Women's Voices Provide Cues of the Likelihood of Ovulation? The Importance of Sampling Regime	PLOS ONE			English	Article							BIRTH-CONTROL PILLS; HORMONE-RECEPTORS; SEXUAL-SELECTION; URINARY ESTROGEN; MENSTRUAL-CYCLE; FERTILE PHASE; BODY ODOR; ATTRACTIVENESS; SYMMETRY; CONCEPTION	The human voice provides a rich source of information about individual attributes such as body size, developmental stability and emotional state. Moreover, there is evidence that female voice characteristics change across the menstrual cycle. A previous study reported that women speak with higher fundamental frequency (F0) in the high-fertility compared to the low-fertility phase. To gain further insights into the mechanisms underlying this variation in perceived attractiveness and the relationship between vocal quality and the timing of ovulation, we combined hormone measurements and acoustic analyses, to characterize voice changes on a day-to-day basis throughout the menstrual cycle. Voice characteristics were measured from free speech as well as sustained vowels. In addition, we asked men to rate vocal attractiveness from selected samples. The free speech samples revealed marginally significant variation in F0 with an increase prior to and a distinct drop during ovulation. Overall variation throughout the cycle, however, precluded unequivocal identification of the period with the highest conception risk. The analysis of vowel samples revealed a significant increase in degree of unvoiceness and noise-to-harmonic ratio during menstruation, possibly related to an increase in tissue water content. Neither estrogen nor progestogen levels predicted the observed changes in acoustic characteristics. The perceptual experiments revealed a preference by males for voice samples recorded during the pre-ovulatory period compared to other periods in the cycle. While overall we confirm earlier findings in that women speak with a higher and more variable fundamental frequency just prior to ovulation, the present study highlights the importance of taking the full range of variation into account before drawing conclusions about the value of these cues for the detection of ovulation.	[Fischer, Julia; Fickenscher, Gisela; Juergens, Rebecca] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Semple, Stuart] Roehampton Univ, Ctr Res Evolutionary Anthropol, London, England; [Kruse, Eberhard] Univ Gottingen, Dept Phoniatr & Pedaudiol, Gottingen, Germany; [Heistermann, Michael] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany; [Amir, Ofer] Tel Aviv Univ, Sackler Sch Med, Dept Commun Disorders, IL-69978 Tel Aviv, Israel	Deutsches Primatenzentrum (DPZ); Roehampton University; University of Gottingen; Deutsches Primatenzentrum (DPZ); Tel Aviv University; Sackler Faculty of Medicine	Fischer, J (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	fischer@cog-ethol.de	Amir, Ofer/GRX-6929-2022; Fischer, Julia/B-6674-2008; Kopp, Gisela/AAB-3943-2020	Fischer, Julia/0000-0002-5807-0074; Kopp, Gisela/0000-0001-8396-3264; Semple, Stuart/0000-0003-0452-8104; Amir, Ofer/0000-0002-2873-954X				Abitbol J, 1999, J VOICE, V13, P424, DOI 10.1016/S0892-1997(99)80048-4; Abu-Al-Makarem A, 2007, PERCEPT MOTOR SKILL, V105, P572, DOI 10.2466/PMS.105.2.572-580; Amir O, 2005, CONTRACEPTION, V71, P348, DOI 10.1016/j.contraception.2004.10.008; Amir O, 2004, LARYNGOSCOPE, V114, P1021, DOI 10.1097/00005537-200406000-00012; Amir O, J VOICE IN PRESS; Amir O, 2006, J SPEECH LANG HEAR R, V49, P1114, DOI 10.1044/1092-4388(2006/080); Amir Ofer, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P180, DOI 10.1097/01.moo.0000120304.58882.94; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; BAIRD DD, 1991, STAT MED, V10, P255, DOI 10.1002/sim.4780100209; BAIRD DD, 1995, EPIDEMIOLOGY, V6, P547, DOI 10.1097/00001648-199509000-00015; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Boulet MJ, 1996, MATURITAS, V23, P15, DOI 10.1016/0378-5122(95)00947-7; Bryant GA, 2009, BIOL LETTERS, V5, P12, DOI 10.1098/rsbl.2008.0507; Caruso S, 2000, FERTIL STERIL, V74, P1073, DOI 10.1016/S0015-0282(00)01582-X; Collins WP, 1981, RES FERTILITY STERIL, P19; CORSON SL, 1986, J REPROD MED, V31, P760; Dixson AF, 2004, INT J PRIMATOL, V25, P1159, DOI 10.1023/B:IJOP.0000043356.60404.be; Dunson DB, 2001, STAT MED, V20, P965, DOI 10.1002/sim.716; Ecochard R, 2001, BRIT J OBSTET GYNAEC, V108, P822, DOI 10.1111/j.1471-0528.2001.00194.x; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fraccaro P.J., 2011, J EVOLUTIONARY PSYCH, V9, P57, DOI [10.1556/JEP.9.2011.33.1, DOI 10.1556/JEP.9.2011.33.1]; Frohlich M, 2000, J SPEECH LANG HEAR R, V43, P706, DOI 10.1044/jslhr.4303.706; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; GERRITSMA EJ, 1994, CLIN OTOLARYNGOL, V19, P79, DOI 10.1111/j.1365-2273.1994.tb01153.x; Grammer K, 2004, J SEX RES, V41, P66, DOI 10.1080/00224490409552214; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Havlicek J, 2006, ETHOLOGY, V112, P81, DOI 10.1111/j.1439-0310.2006.01125.x; HEISTERMANN M, 1995, AM J PRIMATOL, V35, P117, DOI 10.1002/ajp.1350350204; Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hughes SM, 2002, EVOL HUM BEHAV, V23, P173, DOI 10.1016/S1090-5138(01)00099-X; Hughes SM, 2010, J NONVERBAL BEHAV, V34, P155, DOI 10.1007/s10919-010-0087-9; Lindholm P, 1997, MATURITAS, V28, P47, DOI 10.1016/S0378-5122(97)00062-5; Marlowe FW, 2004, ARCH SEX BEHAV, V33, P427, DOI 10.1023/B:ASEB.0000037423.84026.1f; Mergell P, 1999, J ACOUST SOC AM, V105, P2020, DOI 10.1121/1.426735; Michaelis D, 1998, J ACOUST SOC AM, V103, P1628, DOI 10.1121/1.421305; Miller G, 2007, EVOL HUM BEHAV, V28, P375, DOI 10.1016/j.evolhumbehav.2007.06.002; Miller G, 2011, SCIENCE, V331, P272, DOI 10.1126/science.331.6015.272; Newman SR, 2000, J VOICE, V14, P72, DOI 10.1016/S0892-1997(00)80096-X; Pawlowski B, 1999, CURR ANTHROPOL, V40, P257, DOI 10.1086/200017; Pfefferle D, 2011, INT J PRIMATOL, DOI [10.1007/s10764-10011-19517-10768, DOI 10.1007/S10764-10011-19517-10768]; Pfefferle D, 2008, P R SOC B, V275, P571, DOI 10.1098/rspb.2007.1499; Pipitone RN, 2008, EVOL HUM BEHAV, V29, P268, DOI 10.1016/j.evolhumbehav.2008.02.001; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; SAEZ S, 1976, J STEROID BIOCHEM, V7, P919, DOI 10.1016/0022-4731(76)90011-X; Scheiner E, 2011, INTERDISCIPLINARY AN, P105; Schneider B, 2007, J VOICE, V21, P502, DOI 10.1016/j.jvoice.2006.01.002; Scutt D, 1996, HUM REPROD, V11, P2477; Simpson HW, 2000, BREAST CANCER RES TR, V63, P171, DOI 10.1023/A:1006434318939; Singh D, 2001, P ROY SOC B-BIOL SCI, V268, P797, DOI 10.1098/rspb.2001.1589; Symons D, 1979, EVOLUTION HUMAN SEXU; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259	57	45	48	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24490	10.1371/journal.pone.0024490	http://dx.doi.org/10.1371/journal.pone.0024490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957453	gold, Green Published			2022-12-25	WOS:000295262100013
J	Li, XM; Zhu, CF; Tu, WH; Yang, NY; Qin, H; Sun, ZJ				Li, Xiaomeng; Zhu, Chunfang; Tu, William H.; Yang, Nanyang; Qin, Hui; Sun, Zijie			ZMIZ1 Preferably Enhances the Transcriptional Activity of Androgen Receptor with Short Polyglutamine Tract	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; GGC REPEAT LENGTHS; MOLECULAR-BASIS; CELL-LINE; GENE CAG; CANCER; COACTIVATOR; COMPLEX; PROTEIN; INTERACTS	The androgen receptor (AR) is a ligand-induced transcription factor and contains the polyglutamine (polyQ) tracts within its N-terminal transactivation domain. The length of polyQ tracts has been suggested to alter AR transcriptional activity in prostate cancer along with other endocrine and neurologic disorders. Here, we assessed the role of ZMIZ1, an AR coactivator, in regulating the activity of the AR with different lengths of polyQ tracts as ARQ9, ARQ24, and ARQ35 in prostate cancer cells. ZMIZ1, but not ZMIZ2 or ARA70, preferably augments ARQ9 induced androgen-dependent transcription on three different androgen-inducible promoter/reporter vectors. A strong protein-protein interaction between ZMIZ1 and ARQ9 proteins was shown by immunoprecipitation assays. In the presence of ZMIZ1, the N and C-terminal interaction of the ARQ9 was more pronounced than ARQ24 and ARQ35. Both Brg1 and BAF57, the components of SWI/SNF complexes, were shown to be involved in the enhancement of ZMIZ1 on AR activity. Using the chromatin immunoprecipitation assays (ChIP), we further demonstrated a strong recruitment of ZMIZ1 by ARQ9 on the promoter of the prostate specific antigen (PSA) gene. These results demonstrate a novel regulatory role of ZMIZ1 in modulating the polyQ tract length of AR in prostate cancer cells.	[Li, Xiaomeng; Zhu, Chunfang; Tu, William H.; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Li, Xiaomeng; Zhu, Chunfang; Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Li, Xiaomeng; Yang, Nanyang; Qin, Hui] NE Normal Univ, Key Lab Mol Epigenet, MOE, Inst Cytol & Genet, Changchun, Peoples R China	Stanford University; Stanford University; Northeast Normal University - China	Li, XM (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	lixm441@nenu.edu.cn; zsun@stanford.edu		Li, Xiaomeng/0000-0002-7811-3457	National Institutes of Health [CA070297]; NATIONAL CANCER INSTITUTE [R01CA070297, R29CA070297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA070297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertelli MA, 2006, MOL ENDOCRINOL, V20, P1248, DOI 10.1210/me.2006-0021; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Beliakoff Jason, 2006, Nucl Recept Signal, V4, pe017; Brinkmann A, 1996, STEROIDS, V61, P172, DOI 10.1016/0039-128X(96)00008-6; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Choong CS, 1998, J MOL ENDOCRINOL, V21, P235, DOI 10.1677/jme.0.0210235; Clark Peter E, 2003, Methods Mol Med, V81, P255; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Farson D, 2001, HUM GENE THER, V12, P981, DOI 10.1089/104303401750195935; Ferlin A, 2005, EUR J ENDOCRINOL, V152, P419, DOI 10.1530/eje.1.01860; Ferlin A, 2004, MOL HUM REPROD, V10, P417, DOI 10.1093/molehr/gah054; Ferro P, 2002, MOL CELL ENDOCRINOL, V193, P109, DOI 10.1016/S0303-7207(02)00104-1; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; HRONOVSKY V, 1978, ACTA VIROL, V22, P123; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Irvine RA, 2000, HUM MOL GENET, V9, P267, DOI 10.1093/hmg/9.2.267; IRVINE RA, 1995, CANCER RES, V55, P1937; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jenster G, 1999, SEMIN ONCOL, V26, P407; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Miyamoto H, 1998, P NATL ACAD SCI USA, V95, P7379, DOI 10.1073/pnas.95.13.7379; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Saitoh M, 2002, MOL ENDOCRINOL, V16, P694, DOI 10.1210/me.16.4.694; Salinas CA, 2005, PROSTATE, V65, P58, DOI 10.1002/pros.20230; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Sartor O, 2002, UROLOGY, V60, P138; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Stanford JL, 1997, CANCER RES, V57, P1194; Sun ZJ, 1997, NUCLEIC ACIDS RES, V25, P3318, DOI 10.1093/nar/25.16.3318; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Wang QB, 2004, J BIOL CHEM, V279, P17319, DOI 10.1074/jbc.M400970200; Yamamichi-Nishina M, 2003, J BIOL CHEM, V278, P7422, DOI 10.1074/jbc.M208458200; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249	49	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25040	10.1371/journal.pone.0025040	http://dx.doi.org/10.1371/journal.pone.0025040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949845	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400040
J	Hong, I; Kim, J; Lee, J; Park, S; Song, B; Kim, J; An, B; Park, K; Lee, HW; Lee, S; Kim, H; Park, SH; Eom, KD; Lee, S; Choi, S				Hong, Ingie; Kim, Jihye; Lee, Junuk; Park, Sungmo; Song, Beomjong; Kim, Jeongyeon; An, Bobae; Park, Kyungjoon; Lee, Hyun Woo; Lee, Seungbok; Kim, Hyun; Park, Sang-Hyun; Eom, Khee Dong; Lee, Sukwon; Choi, Sukwoo			Reversible Plasticity of Fear Memory-Encoding Amygdala Synaptic Circuits Even after Fear Memory Consolidation	PLOS ONE			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; IN-VIVO EXPERIENCE; GATED CALCIUM-CHANNELS; RAT LATERAL AMYGDALA; KINASE M-ZETA; PROTEIN-KINASE; PREFRONTAL CORTEX; PRESYNAPTIC ENHANCEMENT; BASOLATERAL AMYGDALA	It is generally believed that after memory consolidation, memory-encoding synaptic circuits are persistently modified and become less plastic. This, however, may hinder the remaining capacity of information storage in a given neural circuit. Here we consider the hypothesis that memory-encoding synaptic circuits still retain reversible plasticity even after memory consolidation. To test this, we employed a protocol of auditory fear conditioning which recruited the vast majority of the thalamic input synaptic circuit to the lateral amygdala (T-LA synaptic circuit; a storage site for fear memory) with fear conditioning-induced synaptic plasticity. Subsequently the fear memory-encoding synaptic circuits were challenged with fear extinction and re-conditioning to determine whether these circuits exhibit reversible plasticity. We found that fear memory-encoding T-LA synaptic circuit exhibited dynamic efficacy changes in tight correlation with fear memory strength even after fear memory consolidation. Initial conditioning or re-conditioning brought T-LA synaptic circuit near the ceiling of their modification range (occluding LTP and enhancing depotentiation in brain slices prepared from conditioned or reconditioned rats), while extinction reversed this change (reinstating LTP and occluding depotentiation in brain slices prepared from extinguished rats). Consistently, fear conditioning-induced synaptic potentiation at T-LA synapses was functionally reversed by extinction and reinstated by subsequent re-conditioning. These results suggest reversible plasticity of fear memory-encoding circuits even after fear memory consolidation. This reversible plasticity of memory-encoding synapses may be involved in updating the contents of original memory even after memory consolidation.	[Hong, Ingie; Kim, Jihye; Lee, Junuk; Park, Sungmo; Song, Beomjong; Kim, Jeongyeon; An, Bobae; Park, Kyungjoon; Park, Sang-Hyun; Lee, Sukwon; Choi, Sukwoo] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Lee, Hyun Woo; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea; [Lee, Seungbok] Seoul Natl Univ, Dept Cell & Dev Biol, Sch Dent, Seoul, South Korea; [Eom, Khee Dong] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hong, I (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	sukwon2@snu.ac.kr; sukwoo12@snu.ac.kr	Lee, Sukwon/I-7375-2013; Park, Kyungjoon/AAL-8086-2020; Lee, Seungbok/AAS-1529-2021	Park, Kyungjoon/0000-0002-7518-636X; Lee, Seungbok/0000-0002-6620-6269; Song, Beomjong/0000-0001-8820-7310; Lee, Junuk/0000-0002-3596-2651; Hong, Ingie/0000-0002-7246-9233; Kim, Hyun/0000-0002-7210-5798; Park, Sung Mo/0000-0001-8352-3533; Lee, Sukwon/0000-0001-7654-5769	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0019226]; Korea government (MEST) [2011-0018209, 2009-0081349, 2007-0054261]; Korean Ministry of Education	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This work was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0019226), and also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0018209, 2009-0081349, and 2007-0054261). S. L., I. H., J.L., J.K., B. S., S. P., B. A., and J.K. were supported by Brain Korea 21 Research Fellowships from the Korean Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BORDI F, 1992, J NEUROSCI, V12, P2493; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; CARPENTER GA, 1988, COMPUTER, V21, P77, DOI 10.1109/2.33; Chhatwal JP, 2005, J NEUROSCI, V25, P502, DOI 10.1523/JNEUROSCI.3301-04.2005; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Doron NN, 2000, J COMP NEUROL, V425, P257; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gaudreau H, 1996, J NEUROPHYSIOL, V75, P1301, DOI 10.1152/jn.1996.75.3.1301; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hong I, 2009, EUR J NEUROSCI, V30, P2089, DOI 10.1111/j.1460-9568.2009.07004.x; Hrabetova S, 1996, J NEUROSCI, V16, P5324; Hu B, 2003, EXP BRAIN RES, V153, P543, DOI 10.1007/s00221-003-1611-5; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim J, 2010, J NEUROSCI, V30, P9631, DOI 10.1523/JNEUROSCI.0940-10.2010; Kwapis JL, 2009, BEHAV NEUROSCI, V123, P844, DOI 10.1037/a0016343; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; LevRam V, 1997, LEARN MEMORY, V4, P169, DOI 10.1101/lm.4.1.169; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Moult PR, 2008, J PHYSIOL-LONDON, V586, P2499, DOI 10.1113/jphysiol.2008.153122; Moult PR, 2002, NEUROPHARMACOLOGY, V43, P175, DOI 10.1016/S0028-3908(02)00110-7; Muller G.E., 1900, EXPT BEITRAGE LEHRE; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Park J, 2010, LEARN MEMORY, V17, P812, DOI 10.1101/lm.1482910; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schroeder BW, 2005, EUR J NEUROSCI, V22, P1775, DOI 10.1111/j.1460-9568.2005.04343.x; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Yeh SH, 2006, MOL PHARMACOL, V69, P299, DOI 10.1124/mol.105.017194; Yu SY, 2008, J NEUROCHEM, V106, P889, DOI 10.1111/j.1471-4159.2008.05461.x; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	98	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24260	10.1371/journal.pone.0024260	http://dx.doi.org/10.1371/journal.pone.0024260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949700	Green Submitted, Green Published, gold			2022-12-25	WOS:000295257900008
J	Chelimo, K; Embury, PB; Sumba, PO; Vulule, J; Ofulla, AV; Long, C; Kazura, JW; Moormann, AM				Chelimo, Kiprotich; Embury, Paula B.; Sumba, Peter Odada; Vulule, John; Ofulla, Ayub V.; Long, Carole; Kazura, James W.; Moormann, Ann M.			Age-Related Differences in Naturally Acquired T Cell Memory to Plasmodium falciparum Merozoite Surface Protein 1	PLOS ONE			English	Article							BLOOD LYMPHOCYTE SUBPOPULATIONS; IMMUNE-RESPONSES; MALARIA TRANSMISSION; DENDRITIC CELLS; B-CELLS; INFECTION; STAGE; PARASITE; CYTOKINE; ACTIVATION	Naturally acquired immunity to Plasmodium falciparum malaria in malaria holoendemic areas is characterized by the gradual, age-related development of protection against high-density parasitemia and clinical malaria. Animal studies, and less commonly, observations of humans with malaria, suggest that T-cell responses are important in the development and maintenance of this immunity, which is mediated primarily by antibodies that slow repeated cycles of merozoites through erythrocytes. To advance our rather limited knowledge on human T-cell immunity to blood stage malaria infection, we evaluated CD4 and CD8 T-cell effector memory subset responses to the 42 kDa C-terminal fragment of Merozoite Surface Protein 1 (MSP1(42)), a malaria vaccine candidate, by 49 healthy 0.5 to >= 18 year old residents of a holoendemic area in western Kenya. The proportion of individuals with peripheral blood mononuclear cell MSP1(42) driven IFN-gamma ELISPOT responses increased from 20% (2/20) among 0.5-1 year old children to 90% (9/10) of adults >= 18 years (P = 0.01); parallel increases in the magnitude of IFN-gamma responses were observed across all age groups (0.5, 1, 2, 5 and >= 18 years, P = 0.001). Less than 1% of total CD4 and CD8 T-cells from both children and adults produced IFN-gamma in response to MSP1(42). However, adults had higher proportions of MSP142 driven IFN-gamma secreting CD4 and CD8 effector memory (CD45RA(-) CD62L(-)) T-cells than children (CD4: 50.9% vs. 28.8%, P = 0.036; CD8: 52.1% vs. 18.3%, respectively P = 0.009). In contrast, MSP1(42) driven IFN-gamma secreting naive-like, transitional (CD45RA(+) CD62L(+)) CD4 and CD8 cells were the predominant T-cell subset among children with significantly fewer of these cells in adults (CD4: 34.9% vs. 5.1%, P = 0.002; CD8: 47.0% vs. 20.5%, respectively, P = 0.030). These data support the concept that meaningful age-related differences exist in the quality of T-cell immunity to malaria antigens such as MSP1.	[Chelimo, Kiprotich; Sumba, Peter Odada; Vulule, John] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Embury, Paula B.; Kazura, James W.; Moormann, Ann M.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Long, Carole] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Chelimo, Kiprotich; Ofulla, Ayub V.] Maseno Univ, Maseno, Kenya; [Moormann, Ann M.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Moormann, Ann M.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA	Kenya Medical Research Institute; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Maseno University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Chelimo, K (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	ann.moormann@umassmed.edu		Moormann, Ann/0000-0003-1113-2829	National Institutes of Health (NIH), National Cancer Institute [5R01 CA134051]; NIH, National Institute of Allergy and Infectious Diseases (NIAID) [5R01 AI043906]; Fogarty International Center (FIC) [1D43 TW006576]; Division of Intramural Research, NIAID; FOGARTY INTERNATIONAL CENTER [D43TW006576] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA134051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043906, ZIAAI001020, R01AI095192] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health (NIH), National Cancer Institute, 5R01 CA134051 (AMM); NIH, National Institute of Allergy and Infectious Diseases (NIAID), 5R01 AI043906 (JWK); Fogarty International Center (FIC) 1D43 TW006576 (KC, POS); and the intramural research program of the Division of Intramural Research, NIAID (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Chattopadhyay PK, 2008, IMMUNOLOGY, V125, P441, DOI 10.1111/j.1365-2567.2008.02989.x; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Edstein MD, 2005, ANTIMICROB AGENTS CH, V49, P4421, DOI 10.1128/AAC.49.10.4421-4422.2005; Egan A, 1997, INFECT IMMUN, V65, P3024, DOI 10.1128/IAI.65.8.3024-3031.1997; ERKELLERYUKSEL FM, 1992, J PEDIATR-US, V120, P216, DOI 10.1016/S0022-3476(05)80430-5; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Garraud O, 1999, IMMUNOLOGY, V97, P497, DOI 10.1046/j.1365-2567.1999.00804.x; Hogh B, 1996, Scand J Infect Dis Suppl, V102, P1; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Huaman MC, 2008, J IMMUNOL, V180, P1451, DOI 10.4049/jimmunol.180.3.1451; Huaman MC, 2009, VACCINE, V27, P5239, DOI 10.1016/j.vaccine.2009.06.066; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; JACKOLA DR, 1994, AGING-CLIN EXP RES, V6, P25, DOI 10.1007/BF03324210; Jangpatarapongsa K, 2006, MICROBES INFECT, V8, P680, DOI 10.1016/j.micinf.2005.09.003; KERN DE, 1989, J IMMUNOL, V143, P4308; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lee EAM, 2002, INFECT IMMUN, V70, P1417, DOI 10.1128/IAI.70.3.1417-1421.2002; Leri O, 1997, Clin Ter, V148, P655; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Malhotra I, 2008, J IMMUNOL, V180, P3383, DOI 10.4049/jimmunol.180.5.3383; McCall MBB, 2010, EUR J IMMUNOL, V40, P3472, DOI 10.1002/eji.201040587; Miyakoda M, 2008, J IMMUNOL, V181, P1420, DOI 10.4049/jimmunol.181.2.1420; Moormann AM, 2009, PARASITE IMMUNOL, V31, P547, DOI 10.1111/j.1365-3024.2009.01137.x; Noland GS, 2008, INFECT IMMUN, V76, P5721, DOI 10.1128/IAI.00591-08; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; RILEY EM, 1993, PARASITE IMMUNOL, V15, P513, DOI 10.1111/j.1365-3024.1993.tb00639.x; Sakai T, 2003, VACCINE, V21, P1432, DOI 10.1016/S0264-410X(02)00665-5; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; Spring MD, 2010, INFECT IMMUN, V78, P4431, DOI 10.1128/IAI.00415-10; Taylor-Robinson AW, 2002, MED HYPOTHESES, V58, P148, DOI 10.1054/mehy.2001.1497; TAYLORROBINSON AW, 1992, IMMUNOLOGY, V77, P99; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434; TSUJI T, 1994, J IMMUNOL, V152, P4417; UDHAYAKUMAR V, 1995, J IMMUNOL, V154, P6022; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wang L, 2003, PARASITE IMMUNOL, V25, P403, DOI 10.1111/j.1365-3024.2003.00647.x; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Winkler S, 1999, J INFECT DIS, V179, P209, DOI 10.1086/314571; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	59	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24852	10.1371/journal.pone.0024852	http://dx.doi.org/10.1371/journal.pone.0024852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21935482	gold, Green Submitted, Green Published			2022-12-25	WOS:000295173800045
J	Elberse, K; Witteveen, S; van der Heide, H; van de Pol, I; Schot, C; van der Ende, A; Berbers, G; Schouls, L				Elberse, Karin; Witteveen, Sandra; van der Heide, Han; van de Pol, Ingrid; Schot, Corrie; van der Ende, Arie; Berbers, Guy; Schouls, Leo			Sequence Diversity within the Capsular Genes of Streptococcus pneumoniae Serogroup 6 and 19	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PNEUMOCOCCAL SEROTYPE; POLYSACCHARIDE; IDENTIFICATION; GENETICS; CLONES; LOCUS	The main virulence factor of Streptococcus pneumoniae is the capsule. The polysaccharides comprising this capsule are encoded by approximately 15 genes and differences in these genes result in different serotypes. The aim of this study was to investigate the sequence diversity of the capsular genes of serotypes 6A, 6B, 6C, 19A and 19F and to explore a possible effect of vaccination on variation and distribution of these serotypes in the Netherlands. The complete capsular gene locus was sequenced for 25 serogroup 6 and for 20 serogroup 19 isolates. If one or more genes varied in 10 or more base pairs from the reference sequence, it was designated as a capsular subtype. Allele-specific PCRs and specific gene sequencing of highly variable capsular genes were performed on 184 serogroup 6 and 195 serogroup 19 isolates to identify capsular subtypes. This revealed the presence of 6, 3 and a single capsular subtype within serotypes 6A, 6B and 6C, respectively. The serotype 19A and 19F isolates comprised 3 and 4 capsular subtypes, respectively. For serogroup 6, the genetic background, as determined by multi locus sequence typing (MLST) and multiple-locus variable number of tandem repeat analysis (MLVA), seemed to be closely related to the capsular subtypes, but this was less pronounced for serogroup 19 isolates. The data also suggest shifts in the occurrence of capsular subtypes within serotype 6A and 19A after introduction of the 7-valent pneumococcal vaccine. The shifts within these non-vaccine serotypes might indicate that these capsular subtypes are filling the niche of the vaccine serotypes. In conclusion, there is considerable DNA sequence variation of the capsular genes within pneumococcal serogroup 6 and 19. Such changes may result in altered polysaccharides or in strains that produce more capsular polysaccharides. Consequently, these altered capsules may be less sensitive for vaccine induced immunity.	[Elberse, Karin; Witteveen, Sandra; van der Heide, Han; van de Pol, Ingrid; Schot, Corrie; Berbers, Guy; Schouls, Leo] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Elberse, K (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands.	Karin.Elberse@rivm.nl	van der Ende, Arie/A-4346-2012	van der Ende, Arie/0000-0003-1298-3086				ARRECUBIETA C, 1994, J BACTERIOL, V176, P6375, DOI 10.1128/jb.176.20.6375-6383.1994; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2010, MICROBIOLOGY; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Cartee RT, 2005, J BACTERIOL, V187, P7425, DOI 10.1128/JB.187.21.7425-7433.2005; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; GARCIA E, 1993, MOL GEN GENET, V239, P188; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; LEE CJ, 1980, J BIOL CHEM, V255, P6847; Llull D, 1999, J EXP MED, V190, P241, DOI 10.1084/jem.190.2.241; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; LUND E, 1960, Bull World Health Organ, V23, P5; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; Morona JK, 1999, J BACTERIOL, V181, P5355, DOI 10.1128/JB.181.17.5355-5364.1999; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Pai R, 2005, J CLIN MICROBIOL, V43, P4820, DOI 10.1128/JCM.43.9.4820-4822.2005; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Sheppard CL, 2010, CLIN VACCINE IMMUNOL, V17, P1820, DOI 10.1128/CVI.00335-10; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; van Gils EJM, 2010, JAMA-J AM MED ASSOC, V304, P1099, DOI 10.1001/jama.2010.1290; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Yoshida Y, 2005, MOL MICROBIOL, V58, P244, DOI 10.1111/j.1365-2958.2005.04820.x	34	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e25018	10.1371/journal.pone.0025018	http://dx.doi.org/10.1371/journal.pone.0025018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949837	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800057
J	Tse, BWC; Russell, PJ; Lochner, M; Forster, I; Power, CA				Tse, Brian Wan-Chi; Russell, Pamela Joan; Lochner, Matthias; Foerster, Irmgard; Power, Carl Andrew			IL-18 Inhibits Growth of Murine Orthotopic Prostate Carcinomas via Both Adaptive and Innate Immune Mechanisms	PLOS ONE			English	Article							GAMMA-INDUCING FACTOR; PROGRESSIVE FIBRO-SARCOMA; SQUAMOUS-CELL CARCINOMA; PHASE-I TRIAL; INTERFERON-GAMMA; T-CELLS; INTERLEUKIN-18 GENE; ANTITUMOR IMMUNITY; DENDRITIC CELLS; IFN-GAMMA	Interleukin(IL)-18 is a pleiotrophic cytokine with functions in immune modulation, angiogenesis and bone metabolism. In this study, the potential of IL-18 as an immunotherapy for prostate cancer (PCa) was examined using the murine model of prostate carcinoma, RM1 and a bone metastatic variant RM1(BM)/B4H7-luc. RM1 and RM1(BM)/B4H7-luc cells were stably transfected to express bioactive IL-18. These cells were implanted into syngeneic immunocompetent mice, with or without an IL-18-neutralising antibody (alpha IL-18, SK113AE4). IL-18 significantly inhibited the growth of both subcutaneous and orthotopic RM1 tumors and the IL-18 neutralizing antibody abrogated the tumor growth-inhibition. In vivo neutralization of interferon-gamma (IFN-gamma) completely eliminated the anti-tumor effects of IL-18 confirming an essential role of IFN-gamma as a down-stream mediator of the anti-tumor activity of IL-18. Tumors from mice in which IL-18 and/or IFN-gamma was neutralized contained significantly fewer CD4(+) and CD8(+) T cells than those with functional IL-18. The essential role of adaptive immunity was demonstrated as tumors grew more rapidly in RAG1(-/-) mice or in mice depleted of CD4(+) and/or CD8(+) cells than in normal mice. The tumors in RAG1(-/-) mice were also significantly smaller when IL-18 was present, indicating that innate immune mechanisms are involved. IL-18 also induced an increase in tumor infiltration of macrophages and neutrophils but not NK cells. In other experiments, direct injection of recombinant IL-18 into established tumors also inhibited tumor growth, which was associated with an increase in intratumoral macrophages, but not T cells. These results suggest that local IL-18 in the tumor environment can significantly potentiate anti-tumor immunity in the prostate and clearly demonstrate that this effect is mediated by innate and adaptive immune mechanisms.	[Tse, Brian Wan-Chi] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Tse, Brian Wan-Chi; Power, Carl Andrew] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Russell, Pamela Joan] Queensland Univ Technol, Australian Prostate Canc Res Ctr, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Lochner, Matthias] Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, Hannover, Germany; [Foerster, Irmgard] Univ Dusseldorf, Inst Umweltmed Forsch, Dusseldorf, Germany	University of New South Wales Sydney; University of New South Wales Sydney; Queensland University of Technology (QUT); Heinrich Heine University Dusseldorf	Tse, BWC (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW, Australia.	c.power@unsw.edu.au	Russell, Pamela J/G-1685-2010; Förster, Irmgard/P-8545-2016; Lochner, Matthias/L-6963-2015; Russell, Pamela/O-8504-2019; Tse, Brian/X-8909-2019	Russell, Pamela J/0000-0002-3995-1239; Förster, Irmgard/0000-0002-7644-5642; Lochner, Matthias/0000-0002-7979-5613; Tse, Brian/0000-0002-5982-8369	Sydney Foundation for Medical Research; National Institutes of Health (USA); University of New South Wales; Australian Rotary Health Research Fund	Sydney Foundation for Medical Research; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New South Wales; Australian Rotary Health Research Fund	Funding for this work was provided by the Sydney Foundation for Medical Research, the National Institutes of Health (USA), and the University of New South Wales. BT was supported through scholarships from the Australian Rotary Health Research Fund and the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURSUKER I, 1984, J EXP MED, V159, P1312, DOI 10.1084/jem.159.5.1312; Cao RH, 1999, FASEB J, V13, P2195, DOI 10.1096/fasebj.13.15.2195; Conti B, 1999, MOL BRAIN RES, V67, P46, DOI 10.1016/S0169-328X(99)00034-0; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Gutzmer R, 2003, J IMMUNOL, V171, P6363, DOI 10.4049/jimmunol.171.12.6363; Harris DT, 1999, SEMIN ONCOL, V26, P439; Hikosaka S, 2004, INT J UROL, V11, P647, DOI 10.1111/j.1442-2042.2004.00855.x; Ju DW, 2000, GENE THER, V7, P1672, DOI 10.1038/sj.gt.3301291; Ju DW, 2001, CANCER RES, V61, P3735; Khorana AA, 2003, CANCER GENE THER, V10, P251, DOI 10.1038/sj.cgt.7700568; Kikuchi T, 2000, J IMMUNOTHER, V23, P184, DOI 10.1097/00002371-200003000-00002; Kishida T, 2001, GENE THER, V8, P1234, DOI 10.1038/sj.gt.3301519; Kito T, 2003, J NEUROSURG, V98, P385, DOI 10.3171/jns.2003.98.2.0385; Komai-Koma M, 2003, J IMMUNOL, V170, P1084, DOI 10.4049/jimmunol.170.2.1084; Kowalczyk DW, 2003, ACTA BIOCHIM POL, V50, P613; Lebel-Binay S, 2003, INT J CANCER, V106, P827, DOI 10.1002/ijc.11285; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Liu WW, 2009, ANGIOLOGY, V60, P180, DOI 10.1177/0003319708319939; Lochner M, 2002, J IMMUNOL METHODS, V259, P149, DOI 10.1016/S0022-1759(01)00505-1; Martiniello-Wilks R, 2002, CANCER GENE THER, V9, P443, DOI 10.1038/sj.cgt.7700451; Mastrangelo MJ, 1999, CANCER GENE THER, V6, P409, DOI 10.1038/sj.cgt.7700066; Matsui K, 1997, J IMMUNOL, V159, P97; Micallef MJ, 1997, CANCER IMMUNOL IMMUN, V43, P361, DOI 10.1007/s002620050345; Morel JCM, 2001, LAB INVEST, V81, P1371, DOI 10.1038/labinvest.3780351; Nagai H, 2002, J INVEST DERMATOL, V119, P541, DOI 10.1046/j.1523-1747.2002.01866.x; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Nong LG, 2009, DNA CELL BIOL, V28, P507, DOI 10.1089/dna.2009.0912; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; Okamoto T, 2004, J INTERF CYTOK RES, V24, P161, DOI 10.1089/107999004322917007; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Osaki T, 1998, J IMMUNOL, V160, P1742; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Power CA, 2009, PROSTATE, V69, P1613, DOI 10.1002/pros.21010; Redlinger RE, 2003, J PEDIATR SURG, V38, P301, DOI 10.1053/jpsu.2003.50098; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Stoll S, 1997, J IMMUNOL, V159, P298; Stoll S, 1998, EUR J IMMUNOL, V28, P3231, DOI 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q; Subleski JJ, 2006, CANCER RES, V66, P11005, DOI 10.1158/0008-5472.CAN-06-0811; Tanaka F, 2002, GENE THER, V9, P1480, DOI 10.1038/sj.gt.3301827; Tarhini AA, 2009, CANCER-AM CANCER SOC, V115, P859, DOI 10.1002/cncr.24100; Tatsumi T, 2002, CANCER RES, V62, P5853; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; van Herpen CM, 2004, CLIN CANCER RES, V10, P2626, DOI 10.1158/1078-0432.CCR-03-0304; Wang J, 2004, J DERMATOL SCI, V36, P66, DOI 10.1016/j.jdermsci.2004.08.001; Wei YS, 2007, ACTA ONCOL, V46, P1090, DOI 10.1080/02841860701373595; Xia DJ, 2003, J MOL MED, V81, P585, DOI 10.1007/s00109-003-0472-5; Yoshimura K, 2001, CANCER GENE THER, V8, P9, DOI 10.1038/sj.cgt.7700277	59	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24241	10.1371/journal.pone.0024241	http://dx.doi.org/10.1371/journal.pone.0024241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935389	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700019
J	Yanez, A; Megias, J; O'Connor, JE; Gozalbo, D; Gil, ML				Yanez, Alberto; Megias, Javier; O'Connor, Jose-Enrique; Gozalbo, Daniel; Luisa Gil, M.			Candida albicans Induces Selective Development of Macrophages and Monocyte Derived Dendritic Cells by a TLR2 Dependent Signalling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HEMATOPOIETIC STEM-CELL; BONE-MARROW; PROGENITOR CELLS; BACTERIAL-INFECTION; MYELOID LINEAGE; MURINE CELLS; DIFFERENTIATION; IMMUNITY; TRIGGERS	As TLRs are expressed by haematopoietic stem and progenitor cells (HSPCs), these receptors may play a role in haematopoiesis in response to pathogens during infection. We have previously demonstrated that in in vitro defined conditions inactivated yeasts and hyphae of Candida albicans induce HSPCs proliferation and differentiation towards the myeloid lineage by a TLR2/MyD88 dependent pathway. In this work, we showed that C. albicans invasive infection with a low virulence strain results in a rapid expansion of HSPCs (identified as LKS cells: Lin(-) c-Kit(+) Sca-1(+) IL-7R alpha(-)), that reach the maximum at day 3 post-infection. This in vivo expansion of LKS cells in TLR2(-/-) mice was delayed until day 7 post-infection. Candidiasis was, as expected, accompanied by an increase in granulopoiesis and decreased lymphopoiesis in the bone marrow. These changes were more pronounced in TLR2(-/-) mice correlating with their higher fungal burden. Accordingly, emigration of Ly6C(high) monocytes and neutrophils to spleen was increased in TLR2(-/-) mice, although the increase in macrophages and inflammatory macrophages was completely dependent on TLR2. Similarly, we detected for the first time, in the spleen of C. albicans infected control mice, a newly generated population of dendritic cells that have the phenotype of monocyte derived dendritic cells (moDCs) that were not generated in TLR2(-/-) infected mice. In addition, C. albicans signalling through TLR2/MyD88 and Dectin-1 promotes in vitro the differentiation of Lin(-) cells towards moDCs that secrete TNF-alpha and are able to kill the microorganism. Therefore, our results indicate that during infection C. albicans can directly stimulate progenitor cells through TLR2 and Dectin-1 to generate newly formed inflammatory macrophages and moDCs that may fulfill an essential role in defense mechanisms against the pathogen.	[Yanez, Alberto; Gozalbo, Daniel; Luisa Gil, M.] Univ Valencia, Dept Microbiol & Ecol, E-46100 Burjassot, Spain; [Megias, Javier; O'Connor, Jose-Enrique] Ctr Invest Principe Felipe, Unidad Mixta CIPF UVEG, Lab Cit, Valencia, Spain	University of Valencia; Prince Felipe Research Center	Yanez, A (corresponding author), Univ Valencia, Dept Microbiol & Ecol, E-46100 Burjassot, Spain.	m.luisa.gil@uv.es	Gil, María Luisa/M-2371-2014; Boyer, Alberto Yáñez/R-1587-2018; Gozalbo, Daniel/ABF-5887-2021	Gil, María Luisa/0000-0003-0319-5678; Boyer, Alberto Yáñez/0000-0002-7719-1963; Gozalbo, Daniel/0000-0001-5210-4117	Ministerio de Educacion y Ciencia, Spain [SAF2007-65290]; Valencia Community; Bancaja, Spain	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Valencia Community; Bancaja, Spain	This work was supported by grant SAF2007-65290 (Ministerio de Educacion y Ciencia, Spain), and by the Regenerative Medicine Program of the Valencia Community. Alberto Yanez is a recipient of a fellowship from the Ministerio de Educacion y Ciencia, Spain, and Javier Megias is funded by Bancaja, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2000, BLOOD, V95, P3725; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; De Luca K, 2009, LEUKEMIA, V23, P2063, DOI 10.1038/leu.2009.155; DEBERNARDIS F, 1993, INFECT IMMUN, V61, P1500, DOI 10.1128/IAI.61.4.1500-1508.1993; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Downes JE, 2010, IMMUNOLOGY, V131, P513, DOI 10.1111/j.1365-2567.2010.03324.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; Goodridge Helen S., 2008, V183, P87; Hayashi EA, 2005, J IMMUNOL, V174, P6639, DOI 10.4049/jimmunol.174.11.6639; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jouault T, 2009, CELL MICROBIOL, V11, P1007, DOI 10.1111/j.1462-5822.2009.01318.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Gil ML, 2009, FRONT BIOSCI-LANDMRK, V14, P570, DOI 10.2741/3263; McGettrick AF, 2007, BRIT J HAEMATOL, V139, P185, DOI 10.1111/j.1365-2141.2007.06802.x; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Murciano C, 2006, MED MYCOL, V44, P149, DOI 10.1080/13693780500294733; Murciano C, 2007, EUR CYTOKINE NETW, V18, P38; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Sioud M, 2006, J MOL BIOL, V364, P945, DOI 10.1016/j.jmb.2006.09.054; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Villamon E, 2004, EUR CYTOKINE NETW, V15, P263; Villamon E, 2004, MICROBES INFECT, V6, P542, DOI 10.1016/j.micinf.2004.02.015; Villamon E, 2004, MICROBES INFECT, V6, P1, DOI 10.1016/j.micinf.2003.09.020; Welner RS, 2008, BLOOD, V112, P3753, DOI 10.1182/blood-2008-04-151506; Yanez A, 2010, CELL MICROBIOL, V12, P114, DOI 10.1111/j.1462-5822.2009.01382.x; Yanez A, 2009, MICROBES INFECT, V11, P531, DOI 10.1016/j.micinf.2009.01.011; Zelante T, 2007, ADV EXP MED BIOL, V590, P209; Zhang P, 2008, STEM CELLS, V26, P1778, DOI 10.1634/stemcells.2007-1027	37	47	47	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24761	10.1371/journal.pone.0024761	http://dx.doi.org/10.1371/journal.pone.0024761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935459	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700058
J	Hillaire, MLB; van Eijk, M; van Trierum, SE; van Riel, D; Saelens, X; Romijn, RA; Hemrika, W; Fouchier, RAM; Kuiken, T; Osterhaus, ADME; Haagsman, HP; Rimmelzwaan, GF				Hillaire, Marine L. B.; van Eijk, Martin; van Trierum, Stella E.; van Riel, Debby; Saelens, Xavier; Romijn, Roland A.; Hemrika, Wieger; Fouchier, Ron A. M.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Haagsman, Henk P.; Rimmelzwaan, Guus F.			Assessment of the Antiviral Properties of Recombinant Porcine SP-D against Various Influenza A Viruses In Vitro	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; LOWER RESPIRATORY-TRACT; ISOLATED WORLDWIDE; INFECTION; HEMAGGLUTININ; SURVEILLANCE; ATTACHMENT; AMANTADINE; RESISTANCE; CELLS	The emergence of influenza viruses resistant to existing classes of antiviral drugs raises concern and there is a need for novel antiviral agents that could be used therapeutically or prophylacticaly. Surfactant protein D (SP-D) belongs to the family of C-type lectins which are important effector molecules of the innate immune system with activity against bacteria and viruses, including influenza viruses. In the present study we evaluated the potential of recombinant porcine SP-D as an antiviral agent against influenza A viruses (IAVs) in vitro. To determine the range of antiviral activity, thirty IAVs of the subtypes H1N1, H3N2 and H5N1 that originated from birds, pigs and humans were selected and tested for their sensitivity to recombinant SP-D. Using these viruses it was shown by hemagglutination inhibition assay, that recombinant porcine SP-D was more potent than recombinant human SP-D and that especially higher order oligomeric forms of SP-D had the strongest antiviral activity. Porcine SP-D was active against a broad range of IAV strains and neutralized a variety of H1N1 and H3N2 IAVs, including 2009 pandemic H1N1 viruses. Using tissue sections of ferret and human trachea, we demonstrated that recombinant porcine SP-D prevented attachment of human seasonal H1N1 and H3N2 virus to receptors on epithelial cells of the upper respiratory tract. It was concluded that recombinant porcine SP-D holds promise as a novel antiviral agent against influenza and further development and evaluation in vivo seems warranted.	[Hillaire, Marine L. B.; van Trierum, Stella E.; van Riel, Debby; Fouchier, Ron A. M.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.] Erasmus MC, Rotterdam, Netherlands; [van Eijk, Martin; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Saelens, Xavier] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Romijn, Roland A.; Hemrika, Wieger] U Prot Express BV, Utrecht, Netherlands; [Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.] Viroclin Biosci BV, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Flanders Institute for Biotechnology (VIB); Ghent University	Hillaire, MLB (corresponding author), Erasmus MC, Rotterdam, Netherlands.	H.P.Haagsman@uu.nl; g.rimmelzwaan@erasmusmc.nl	Haagsman, Henk P/F-8919-2010; Fouchier, Ron A/A-1911-2014; Saelens, Xavier/N-5728-2015	Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172; Hillaire, Marine/0000-0002-3672-3935; van Riel, Debby/0000-0001-9753-3564; Kuiken, Thijs/0000-0001-5501-9049	Technology Foundation STW (Stichting Technische Wetenschappen) [10388]	Technology Foundation STW (Stichting Technische Wetenschappen)(Technologiestichting STW)	This work was supported by grant 10388 from the Technology Foundation STW (Stichting Technische Wetenschappen). GFR and ADMEO are employed part-time by Viroclinics Biosciences BV, which did not play a role in the present study. WH and RAR are employed by U-Protein Express B. V. U-Protein Express B. V. was involved in expression of recombinant SP-D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; DEFILETTE M, 2002, OLIGOMERIC COMPLEXES; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Hartshorn KL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-65; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; JOB ER, 2010, J IMMUNOL; Keawcharoen J, 2010, VACCINE, V28, P5803, DOI 10.1016/j.vaccine.2010.06.072; Klimov A, 1999, VACCINE, V17, pS42, DOI 10.1016/S0264-410X(99)00104-8; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; PORWITBOBR Z, 1976, ARCH VIROL, V51, P115, DOI 10.1007/BF01317840; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; REUMAN PD, 1989, ANTIVIR RES, V11, P27, DOI 10.1016/0166-3542(89)90018-1; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2000, J IMMUNOL, V164, P1442, DOI 10.4049/jimmunol.164.3.1442; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; *WHO, 2009, 112 WHO; WHO, 2010, CUM NUMB CONF HUM CA; *WHO, 2009, INFL H1N1 VIR RES OS; World Health Organization, 2002, WHO MAN AN INFL DIAG; YOUNKIN SW, 1983, ANTIMICROB AGENTS CH, V23, P577, DOI 10.1128/AAC.23.4.577	36	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e25005	10.1371/journal.pone.0025005	http://dx.doi.org/10.1371/journal.pone.0025005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935489	gold, Green Published			2022-12-25	WOS:000295039700063
J	Douzi, B; Ball, G; Cambillau, C; Tegoni, M; Voulhoux, R				Douzi, Badreddine; Ball, Genevieve; Cambillau, Christian; Tegoni, Mariella; Voulhoux, Rome			Deciphering the Xcp Pseudomonas aeruginosa Type II Secretion Machinery through Multiple Interactions with Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECRETION; CHOLERA-TOXIN; SYSTEM; COMPONENT; DOMAIN; PILUS; IDENTIFICATION; SPECIFICITY; CAMPESTRIS	The type II secretion system enables Gram-negative bacteria to secrete exoproteins into the extracellular milieu. We performed biophysical and biochemical experiments to identify systematic interactions between Pseudomonas aeruginosa Xcp type II secretion system components and their substrates. We observed that three Xcp components, XcpP(C), the secretin XcpQ, and the pseudopilus tip, directly and specifically interact with secreted exoproteins. We established that XcpP(C), in addition to its interaction with the substrate, likely shields the entire periplasmic portion of the secreton. It can therefore be considered as the recruiter of the machinery. Moreover, the direct interaction observed between the substrate and the pseudopilus tip validates the piston model hypothesis, in which the pseudopilus pushes the substrate through the secretin pore during the secretion process. All together, our results allowed us to propose a model of the different consecutive steps followed by the substrate during the type II secretion process.	[Douzi, Badreddine; Cambillau, Christian; Tegoni, Mariella] Aix Marseille Univ, CNRS, AFMB UMR6098, F-13288 Marseille 9, France; [Douzi, Badreddine; Ball, Genevieve; Voulhoux, Rome] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, LISM UPR9027, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Tegoni, M (corresponding author), Aix Marseille Univ, CNRS, AFMB UMR6098, Case 932,163 Ave Luminy, F-13288 Marseille 9, France.	mariella.tegoni@afmb.univ-mrs.fr; voulhoux@ifr88.cnrs-mrs.fr	Voulhoux, Rome/AAT-5333-2021; Douzi, Badreddine/ABA-4540-2021; douzi, Badreddine/Z-5707-2019	Douzi, Badreddine/0000-0003-3140-4713; 	"3D-Pilus" Young Researcher Agence Nationale de Recherches (ANR) [ANR-JC07-183230]	"3D-Pilus" Young Researcher Agence Nationale de Recherches (ANR)(French National Research Agency (ANR))	This work was supported by "3D-Pilus" Young Researcher Agence Nationale de Recherches (ANR) Grant ANR-JC07-183230.	Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Campos M, 2010, P NATL ACAD SCI USA, V107, P13081, DOI 10.1073/pnas.1001703107; Chen Y, 2005, J BIOL CHEM, V280, P42356, DOI 10.1074/jbc.M506843200; Cianciotto NP, 2009, FUTURE MICROBIOL, V4, P797, DOI 10.2217/FMB.09.53; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Gerard-Vincent M, 2002, MOL MICROBIOL, V44, P1651, DOI 10.1046/j.1365-2958.2002.02991.x; Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7; Patrick M, 2011, J BIOL CHEM, V286, P10378, DOI 10.1074/jbc.M110.167031; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rich RL, 2002, P NATL ACAD SCI USA, V99, P8562, DOI 10.1073/pnas.142288199; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sauvonnet N, 1996, MOL MICROBIOL, V22, P1, DOI 10.1111/j.1365-2958.1996.tb02650.x; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Shahian T, 2009, NAT CHEM BIOL, V5, P640, DOI 10.1038/nchembio.192; STUER W, 1986, J BACTERIOL, V168, P1070, DOI 10.1128/jb.168.3.1070-1074.1986; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Voulhoux R, 2000, J BACTERIOL, V182, P4051, DOI 10.1128/JB.182.14.4051-4058.2000; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735	31	63	63	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40792	40801		10.1074/jbc.M111.294843	http://dx.doi.org/10.1074/jbc.M111.294843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21949187	Green Published, hybrid			2022-12-25	WOS:000297315400040
J	Cazanave, SC; Mott, JL; Bronk, SF; Werneburg, NW; Fingas, CD; Meng, XW; Finnberg, N; El-Deiry, WS; Kaufmann, SH; Gores, GJ				Cazanave, Sophie C.; Mott, Justin L.; Bronk, Steven F.; Werneburg, Nathan W.; Fingas, Christian D.; Meng, X. Wei; Finnberg, Niklas; El-Deiry, Wafik S.; Kaufmann, Scott H.; Gores, Gregory J.			Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; FACTOR-INDUCED APOPTOSIS; TRAIL-INDUCED APOPTOSIS; NONALCOHOLIC STEATOHEPATITIS; CARCINOMA-CELLS; LIPID RAFTS; CASPASE INHIBITOR; LYSOSOMAL PATHWAY; OXIDATIVE STRESS	Nonalcoholic steatohepatitis is characterized by hepatic steatosis, elevated levels of circulating free fatty acids (FFA), endoplasmic reticulum (ER) stress, and hepatocyte lipoapoptosis. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor 5 (DR5) is significantly elevated in patients with nonalcoholic steatohepatitis, and steatotic hepatocytes demonstrate increased sensitivity to TRAIL-mediated cell death. Nonetheless, a role for TRAIL and/or DR5 in mediating lipoapoptotic pathways is unexplored. Here, we examined the contribution of DR5 death signaling to lipoapoptosis by free fatty acids. The toxic saturated free fatty acid palmitate induces an increase in DR5 mRNA and protein expression in Huh-7 human hepatoma cells leading to DR5 localization into lipid rafts, cell surface receptor clustering with subsequent recruitment of the initiator caspase-8, and ultimately cellular demise. Lipoapoptosis by palmitate was not inhibited by a soluble human recombinant DR5-Fc chimera protein suggesting that DR5 cytotoxic signaling is ligand-independent. Hepatocytes from murine TRAIL receptor knock-out mice (DR-/-) displayed reduced palmitate-mediated lipotoxicity. Likewise, knockdown of DR5 or caspase-8 expression by shRNA technology attenuated palmitate-induced Bax activation and apoptosis in Huh-7 cells, without altering induction of ER stress markers. Similar observations were verified in other cell models. Finally, knockdown of CHOP, an ER stress-mediated transcription factor, reduced DR5 up-regulation and DR5-mediated caspase-8 activation upon palmitate treatment. Collectively, these results suggest that ER stress-induced CHOP activation by palmitate transcriptionally up-regulates DR5, likely resulting in ligand-independent cytotoxic signaling by this death receptor.	[Cazanave, Sophie C.; Mott, Justin L.; Bronk, Steven F.; Werneburg, Nathan W.; Fingas, Christian D.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Meng, X. Wei; Kaufmann, Scott H.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; [Finnberg, Niklas; El-Deiry, Wafik S.] Univ Penn, Sch Med, Philadelphia, PA 19103 USA	Mayo Clinic; Mayo Clinic; University of Pennsylvania	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266; Mott, Justin/0000-0002-2927-6962; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [DK41876, DK069757, DK079875, CA69008, CA123258, P30DK084567]; NATIONAL CANCER INSTITUTE [R01CA123258, R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R29DK041876, K01DK079875, R01DK041876, R37DK041876, R01DK069757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41876 (to G. J. G.), DK069757 (to M. C. R.), DK079875 (to J. L. M.), CA69008 (to S. H. K.), CA123258 (to W. S. E.-D.), and P30DK084567 (to Optical Microscopy Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology and the Mayo Foundation).	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2010, J HEPATOL, V53, P542, DOI 10.1016/j.jhep.2010.03.016; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Engels IH, 2005, MOL CELL BIOL, V25, P2808, DOI 10.1128/MCB.25.7.2808-2818.2005; Farrell GC, 2009, J GASTROEN HEPATOL, V24, P443, DOI 10.1111/j.1440-1746.2009.05785.x; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Higuchi H, 2003, AM J PHYSIOL-GASTR L, V284, pG734, DOI 10.1152/ajpgi.00491.2002; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kahraman A, 2010, HEPATOLOGY, V51, P92, DOI 10.1002/hep.23253; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Lee DH, 2009, BRIT J PHARMACOL, V157, P1189, DOI 10.1111/j.1476-5381.2009.00245.x; Li N, 2008, BIOCHEM SOC T, V36, P930, DOI 10.1042/BST0360930; Lim SC, 2011, CARCINOGENESIS, V32, P723, DOI 10.1093/carcin/bgr038; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Muhlenbeck F, 2000, J BIOL CHEM, V275, P32208, DOI 10.1074/jbc.M000482200; Ostrom Rennolds S., 2006, V332, P181; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Pockros PJ, 2007, HEPATOLOGY, V46, P324, DOI 10.1002/hep.21664; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Rossin A, 2009, BIOCHEM J, V419, P185, DOI 10.1042/BJ20081212; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Tiwary R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011865; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200	56	84	85	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39336	39348		10.1074/jbc.M111.280420	http://dx.doi.org/10.1074/jbc.M111.280420			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21941003	Green Published, hybrid			2022-12-25	WOS:000296759800052
J	Chakraborty, S; Sivaraman, J; Leung, KY; Mok, YK				Chakraborty, Smarajit; Sivaraman, J.; Leung, Ka Yin; Mok, Yu-Keung			Two-component PhoB-PhoR Regulatory System and Ferric Uptake Regulator Sense Phosphate and Iron to Control Virulence Genes in Type III and VI Secretion Systems of Edwardsiella tarda	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; DNA-BINDING DOMAIN; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; VIBRIO-VULNIFICUS; YERSINIA-PESTIS; FUR; EXPRESSION	Inorganic phosphate (P-i) and iron are essential nutrients that are depleted by vertebrates as a protective mechanism against bacterial infection. This depletion, however, is sensed by some pathogens as a signal to turn on the expression of virulence genes. Here, we show that the PhoB-PhoR two-component system senses changes in P-i concentration, whereas the ferric uptake regulator (Fur) senses changes in iron concentration in Edwardsiella tarda PPD130/91 to regulate the expression of type III and VI secretion systems (T3SS and T6SS) through an E. tarda secretion regulator, EsrC. In sensing low P-i concentration, PhoB-PhoR autoregulates and activates the phosphate-specific transport operon, pstSCAB-phoU, by binding directly to the Pho box in the promoters of phoB and pstS. PhoB also binds with EsrC simultaneously on the promoter of an E. tarda virulence protein, evpA, to regulate directly the transcription of genes from T6SS. In addition, PhoB requires and interacts with PhoU to activate esrC and suppress fur indirectly through unidentified regulators. Fur, on the other hand, senses high iron concentration and binds directly to the Fur box in the promoter of evpP to inhibit EsrC binding to the same region. In addition, Fur suppresses transcription of phoB, pstSCAB-phoU, and esrC indirectly via unidentified regulators, suggesting negative cross-talk with the Pho regulon. Physical interactions exist between Fur and PhoU and between Fur and EsrC. Our findings suggest that T3SS and T6SS may carry out distinct roles in the pathogenicity of E. tarda by responding to different environmental factors.	[Chakraborty, Smarajit; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117543, Singapore; [Leung, Ka Yin] Trinity Western Univ, Dept Biol, Fac Nat & Appl Sci, Langley, BC V2Y 1Y1, Canada	National University of Singapore; Trinity Western University	Mok, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Mok, Yu Keung/H-8019-2012; Sivaraman, J/H-8028-2012	Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore [07/1/21/19/495]; Ministry of Education [R-154-000-498-112]	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education	This work was supported by Grant 07/1/21/19/495 from the Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore and Ministry of Education Tier 1 Grant R-154-000-498-112 (to Y.-K. M.).	Aguena M, 2002, MOL GENET GENOMICS, V268, P518, DOI 10.1007/s00438-002-0764-4; Anisimov R, 2005, INT J MED MICROBIOL, V295, P19, DOI 10.1016/j.ijmm.2004.11.007; Arribas-Bosacoma R, 2007, J MOL BIOL, V366, P626, DOI 10.1016/j.jmb.2006.11.038; Baek JH, 2007, FEMS MICROBIOL LETT, V277, P254, DOI 10.1111/j.1574-6968.2007.00965.x; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Buckles EL, 2006, MICROBIOL-SGM, V152, P153, DOI 10.1099/mic.0.28281-0; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Chakraborty S, 2010, J BIOL CHEM, V285, P38876, DOI 10.1074/jbc.M110.179150; Cheng C, 2009, INFECT IMMUN, V77, P1936, DOI 10.1128/IAI.01246-08; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; JANDA JM, 1993, CLIN INFECT DIS, V17, P742, DOI 10.1093/clinids/17.4.742; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Liu JY, 2005, J BIOL CHEM, V280, P15960, DOI 10.1074/jbc.M414117200; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Oganesyan V, 2005, J BACTERIOL, V187, P4238, DOI 10.1128/JB.187.12.4238-4244.2005; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rice CD, 2009, APPL ENVIRON MICROB, V75, P573, DOI 10.1128/AEM.01046-08; Rodgers ME, 2009, PROTEINS, V77, P202, DOI 10.1002/prot.22431; Schlenker C, 2009, BEST PRACT RES CL GA, V23, P89, DOI 10.1016/j.bpg.2008.11.014; SCHOLTEN M, 1993, MOL MICROBIOL, V8, P269, DOI 10.1111/j.1365-2958.1993.tb01571.x; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tan YP, 2002, INFECT IMMUN, V70, P6475, DOI 10.1128/IAI.70.11.6475-6480.2002; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Wang F, 2008, J MICROBIOL, V46, P350, DOI 10.1007/s12275-008-0038-x; Wang F, 2009, J MICROBIOL BIOTECHN, V19, P765, DOI 10.4014/jmb.0810.574; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; Wang X, 2009, FISH SHELLFISH IMMUN, V27, P469, DOI 10.1016/j.fsi.2009.06.013; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Zheng J, 2005, INFECT IMMUN, V73, P4127, DOI 10.1128/IAI.73.7.4127-4137.2005; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	56	94	98	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39417	39430		10.1074/jbc.M111.295188	http://dx.doi.org/10.1074/jbc.M111.295188			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21953460	Green Published, hybrid			2022-12-25	WOS:000296759800059
J	Matsunaga, E; Suzuki, K; Kato, S; Kurotani, T; Kobayashi, K; Okanoya, K				Matsunaga, Eiji; Suzuki, Kenta; Kato, Shigeki; Kurotani, Tohru; Kobayashi, Kazuto; Okanoya, Kazuo			Dynamic Expression of Cadherins Regulates Vocal Development in a Songbird	PLOS ONE			English	Article							STRIATA VAR. DOMESTICA; AUDITORY-FEEDBACK; LONCHURA-STRIATA; BENGALESE FINCH; HUMAN SPEECH; MECHANISMS; BIRDSONG; BRAINS; CONNECTIONS; EVOLUTION	Background: Since, similarly to humans, songbirds learn their vocalization through imitation during their juvenile stage, they have often been used as model animals to study the mechanisms of human verbal learning. Numerous anatomical and physiological studies have suggested that songbirds have a neural network called 'song system' specialized for vocal learning and production in their brain. However, it still remains unknown what molecular mechanisms regulate their vocal development. It has been suggested that type-II cadherins are involved in synapse formation and function. Previously, we found that type-II cadherin expressions are switched in the robust nucleus of arcopallium from cadherin-7-positive to cadherin-6B-positive during the phase from sensory to sensorimotor learning stage in a songbird, the Bengalese finch. Furthermore, in vitro analysis using cultured rat hippocampal neurons revealed that cadherin-6B enhanced and cadherin-7 suppressed the frequency of miniature excitatory postsynaptic currents via regulating dendritic spine morphology. Methodology/Principal Findings: To explore the role of cadherins in vocal development, we performed an in vivo behavioral analysis of cadherin function with lentiviral vectors. Overexpression of cadherin-7 in the juvenile and the adult stages resulted in severe defects in vocal production. In both cases, harmonic sounds typically seen in the adult Bengalese finch songs were particularly affected. Conclusions/Significance: Our results suggest that cadherins control vocal production, particularly harmonic sounds, probably by modulating neuronal morphology of the RA nucleus. It appears that the switching of cadherin expressions from sensory to sensorimotor learning stage enhances vocal production ability to make various types of vocalization that is essential for sensorimotor learning in a trial and error manner.	[Matsunaga, Eiji; Suzuki, Kenta; Okanoya, Kazuo] RIKEN Brain Sci Inst, Lab Biolinguist, Wako, Saitama, Japan; [Matsunaga, Eiji] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ, Dept Mol Genet, Inst Biomed Sci, Fukushima, Japan; [Suzuki, Kenta; Kurotani, Tohru; Okanoya, Kazuo] JST ERATO, ERATO Okanoya Emot Informat Project, Saitama, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Suzuki, Kenta] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Suzuki, Kenta; Okanoya, Kazuo] RIKEN Brain Sci Inst, Emot Informat Joint Res Lab, Wako, Saitama, Japan	RIKEN; RIKEN; Fukushima Medical University; University of Tokyo; Saitama University; RIKEN	Matsunaga, E (corresponding author), RIKEN Brain Sci Inst, Lab Biolinguist, Wako, Saitama, Japan.	Eiji.Matsunaga@brain.riken.jp; kazuookanoya@gmail.com	Kato, Shigeki/S-8016-2018	Kato, Shigeki/0000-0002-8792-7591	JSPS [21700365]; Takeda Science Foundation; RIKEN; Core Research for Evolutional Science and Technology of JST	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); RIKEN; Core Research for Evolutional Science and Technology of JST	RIKEN Special Postdoctoral Researchers Program, RIKEN Incentive Research Grant, grant-in-aid for young scientist (B) 21700365 from JSPS, Takeda Science Foundation (to E. M.). RIKEN general research budget (to K.O.). Grants-in-aid from Core Research for Evolutional Science and Technology of JST (to K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes SH, 2010, DEVELOPMENT, V137, P805, DOI 10.1242/dev.042457; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Honda E, 1999, ZOOL SCI, V16, P319, DOI 10.2108/zsj.16.319; Kato S, 2007, HUM GENE THER, V18, P1141, DOI 10.1089/hum.2007.082; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2008, J COMP NEUROL, V508, P329, DOI 10.1002/cne.21676; Matsunaga E, 2008, BRAIN RES BULL, V75, P474, DOI 10.1016/j.brainresbull.2007.10.045; Matsunaga E, 2011, NEUROREPORT, V22, P629, DOI 10.1097/WNR.0b013e3283491665; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nguyen-Ba-Charvet KT, 2001, MOL CELL NEUROSCI, V17, P1048, DOI 10.1006/mcne.2001.0994; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Okanoya K, 1997, J NEUROBIOL, V33, P343; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Sasahara K, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P479, DOI 10.1142/9789814295222_0102; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; White SA, 2006, J NEUROSCI, V26, P10376, DOI 10.1523/JNEUROSCI.3379-06.2006	28	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25272	10.1371/journal.pone.0025272	http://dx.doi.org/10.1371/journal.pone.0025272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949888	Green Submitted, Green Published, gold			2022-12-25	WOS:000295260400056
J	Terao, M; Murota, H; Kimura, A; Kato, A; Ishikawa, A; Igawa, K; Miyoshi, E; Katayama, I				Terao, Mika; Murota, Hiroyuki; Kimura, Akihiro; Kato, Arisa; Ishikawa, Akiko; Igawa, Ken; Miyoshi, Eiji; Katayama, Ichiro			11 beta-Hydroxysteroid Dehydrogenase-1 Is a Novel Regulator of Skin Homeostasis and a Candidate Target for Promoting Tissue Repair	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; GLUCOCORTICOID-RECEPTOR; METABOLIC SYNDROME; TYPE-1; MICE; 11-BETA-HSD1; OBESE; DIFFERENTIATION; INHIBITION; STRESS	11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) catalyzes the interconversion of cortisone and cortisol within the endoplasmic reticulum. 11 beta-HSD1 is expressed widely, most notably in the liver, adipose tissue, and central nervous system. It has been studied intensely over the last 10 years because its activity is reported to be increased in visceral adipose tissue of obese people. Epidermal keratinocytes and dermal fibroblasts also express 11 beta-HSD1. However, the function of the enzymatic activity 11 beta-HSD1 in skin is not known. We found that 11 beta-HSD1 was expressed in human and murine epidermis, and this expression increased as keratinocytes differentiate. The expression of 11 beta-HSD1 by normal human epidermal keratinocytes (NHEKs) was increased by starvation or calcium-induced differentiation in vitro. A selective inhibitor of 11 beta-HSD1 promoted proliferation of NHEKs and normal human dermal fibroblasts, but did not alter the differentiation of NHEKs. Topical application of selective 11 beta-HSD1 inhibitor to the dorsal skin of hairless mice caused proliferation of keratinocytes. Taken together, these data suggest that 11 beta-HSD1 is involved in tissue remodeling of the skin. This hypothesis was further supported by the observation that topical application of the selective 11 beta-HSD1 inhibitor enhanced cutaneous wound healing in C57BL/6 mice and ob/ob mice. Collectively, we conclude that 11 beta-HSD1 is negatively regulating the proliferation of keratinocytes and fibroblasts, and cutaneous wound healing. Hence, 11 beta-HSD1 might maintain skin homeostasis by regulating the proliferation of keratinocytes and dermal fibroblasts. Thus 11 beta-HSD1 is a novel candidate target for the design of skin disease treatments.	[Terao, Mika; Murota, Hiroyuki; Kimura, Akihiro; Kato, Arisa; Ishikawa, Akiko; Igawa, Ken; Katayama, Ichiro] Osaka Univ, Dept Dermatol, Grad Sch Med, Osaka, Japan; [Miyoshi, Eiji] Osaka Univ, Dept Mol Biochem & Clin Invest, Osaka, Japan	Osaka University; Osaka University	Terao, M (corresponding author), Osaka Univ, Dept Dermatol, Grad Sch Med, Osaka, Japan.	mterao@derma.med.osaka-u.ac.jp		Kimura, Akihiro/0000-0001-5614-8547	Japan Society for the Promotion of Science [21591464]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research(C) No. 21591464 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Bikle DD, 2004, J STEROID BIOCHEM, V89-90, P355, DOI 10.1016/j.jsbmb.2004.03.020; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; Choi EH, 2006, AM J PHYSIOL-REG I, V291, pR1657, DOI 10.1152/ajpregu.00010.2006; Christian LM, 2006, NEUROIMMUNOMODULAT, V13, P337, DOI 10.1159/000104862; CIRILLO N, 2011, J CELL BIOC IN PRESS; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Demerjian M, 2009, EXP DERMATOL, V18, P643, DOI 10.1111/j.1600-0625.2009.00841.x; Desbriere R, 2006, OBESITY, V14, P794, DOI 10.1038/oby.2006.92; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; Hale C, 2008, MINI-REV MED CHEM, V8, P702, DOI 10.2174/138955708784567421; Hennebert O, 2007, J STEROID BIOCHEM, V104, P326, DOI 10.1016/j.jsbmb.2007.03.026; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Hollis G, 2011, DIABETES OBES METAB, V13, P1, DOI 10.1111/j.1463-1326.2010.01305.x; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Ishii T, 2007, FEBS LETT, V581, P349, DOI 10.1016/j.febslet.2006.11.032; Ishii-Yonemoto T, 2010, AM J PHYSIOL-ENDOC M, V298, pE930, DOI 10.1152/ajpendo.00320.2009; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mericq V, 2009, HORM RES, V71, P89, DOI 10.1159/000183897; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Morton NM, 2010, MOL CELL ENDOCRINOL, V316, P154, DOI 10.1016/j.mce.2009.09.024; Odermatt A, 2006, MOL CELL ENDOCRINOL, V248, P15, DOI 10.1016/j.mce.2005.11.040; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Rigby NJ, 2004, J PUBLIC HEALTH POL, V25, P418, DOI 10.1057/palgrave.jphp.3190040; Sandeep TC, 2001, TRENDS ENDOCRIN MET, V12, P446, DOI 10.1016/S1043-2760(01)00499-4; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; SHEU H-M, 1991, Journal of Dermatology (Tokyo), V18, P454; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; TIGANESCU A, 2011, J INVEST DERMATOL; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	35	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25039	10.1371/journal.pone.0025039	http://dx.doi.org/10.1371/journal.pone.0025039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949844	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400039
J	Jenne, CN; Wong, CHY; Petri, B; Kubes, P				Jenne, Craig N.; Wong, Connie H. Y.; Petri, Bjoern; Kubes, Paul			The Use of Spinning-Disk Confocal Microscopy for the Intravital Analysis of Platelet Dynamics in Response to Systemic and Local Inflammation	PLOS ONE			English	Article							SURFACE-ADHERENT PLATELETS; IN-VIVO; THROMBUS FORMATION; P-SELECTIN; ADHESION; ACTIVATION; LEUKOCYTES; INTEGRIN; CELLS; MOUSE	Platelets are central players in inflammation and are an important component of the innate immune response. The ability to visualize platelets within the live host is essential to understanding their role in these processes. Past approaches have involved adoptive transfer of labelled platelets, non-specific dyes, or the use of fluorescent antibodies to tag platelets in vivo. Often, these techniques result in either the activation of the platelet, or blockade of specific platelet receptors. In this report, we describe two new methods for intravital visualization of platelet biology, intravenous administration of labelled anti-CD49b, which labels all platelets, and CD41-YFP transgenic mice, in which a percentage of platelets express YFP. Both approaches label endogenous platelets and allow for their visualization using spinning-disk confocal fluorescent microscopy. Following LPS-induced inflammation, we were able to measure a significant increase in both the number and size of platelet aggregates observed within the vasculature of a number of different tissues. Real-time observation of these platelet aggregates reveals them to be large, dynamic structures that are continually expanding and sloughing-off into circulation. Using these techniques, we describe for the first time, platelet recruitment to, and behaviour within numerous tissues of the mouse, both under control conditions and following LPS induced inflammation.	[Jenne, Craig N.; Wong, Connie H. Y.; Petri, Bjoern; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada; [Jenne, Craig N.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Wong, Connie H. Y.; Petri, Bjoern; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Jenne, CN (corresponding author), Univ Calgary, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada.	pkubes@ucalgary.ca	Jenne, Craig/HCH-3413-2022	Wong, Connie/0000-0002-9020-1847	Canadian Institutes of Health Research; Canada Research Chairs Program; Alberta Heritage Foundation for Medical Research; Canadian Association of Gastroenterology; Snyder Mouse Phenomics Core; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Association of Gastroenterology; Snyder Mouse Phenomics Core; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) (C.H.Y.W. and P.K.), the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/) (P.K.), the Alberta Heritage Foundation for Medical Research (http://www.ahfmr.ab.ca/) (C.N.J and P.K.) and the Canadian Association of Gastroenterology (http://www.cag-acg.org/) (C.H.Y.W), and the Snyder Mouse Phenomics Core (http://www.iii.ucalgary.ca/) (B.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank The Live Cell Imaging Facility at the University of Calgary funded by the Canada Foundation for Innovation and P. Colarusso for training and assistance related to spinning-disk confocal microscopy. We also thank the University of Calgary Flow Cytometry Facility and L. Kennedy for their assistance with the flow cytometric analysis of platelets.	Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; BUTTRUM SM, 1993, BLOOD, V82, P1165; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Diacovo TG, 1996, BLOOD, V88, P146; Ding ZM, 1999, J IMMUNOL, V163, P5029; Echtler K, 2010, NAT MED, V16, P75, DOI 10.1038/nm.2060; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Fujimi S, 2002, J TRAUMA, V52, P443, DOI 10.1097/00005373-200203000-00005; GAWAZ M, 1995, EUR J CLIN INVEST, V25, P843, DOI 10.1111/j.1365-2362.1995.tb01694.x; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hechler B, 2010, J THROMB HAEMOST, V8, P173, DOI 10.1111/j.1538-7836.2009.03666.x; Hedrich H, 2004, LAB MOUSE; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184; Kalsch T, 2007, BASIC RES CARDIOL, V102, P460, DOI 10.1007/s00395-007-0667-y; KEHREL B, 1995, PLATELETS, V6, P11, DOI 10.3109/09537109509013256; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kornerup KN, 2010, J APPL PHYSIOL, V109, P758, DOI 10.1152/japplphysiol.01086.2009; Langer HF, 2007, ARTERIOSCL THROM VAS, V27, P1463, DOI 10.1161/ATVBAHA.107.141515; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Li NL, 2000, THROMB HAEMOSTASIS, V84, P381; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Menezes GB, 2009, J IMMUNOL, V183, P7557, DOI 10.4049/jimmunol.0901786; MIYAKE S, 1994, EUR J IMMUNOL, V24, P2000, DOI 10.1002/eji.1830240910; Myers KJ, 1998, AM J PATHOL, V152, P457; Nieswandt B, 1999, BLOOD, V94, P684, DOI 10.1182/blood.V94.2.684; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; PARKER RI, 1984, THROMB RES, V36, P265, DOI 10.1016/0049-3848(84)90226-3; Pellicci DG, 2005, J IMMUNOL, V175, P4416, DOI 10.4049/jimmunol.175.7.4416; Perrault C, 2003, BLOOD, V101, P3477, DOI 10.1182/blood-2002-06-1847; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Qu Z, 2010, CURR OPIN IMMUNOL, V22, P634, DOI 10.1016/j.coi.2010.08.017; Secor D, 2010, INTENS CARE MED, V36, P1928, DOI 10.1007/s00134-010-1969-3; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Shenkman B, 2006, CELL IMMUNOL, V242, P52, DOI 10.1016/j.cellimm.2006.09.005; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Von Hundelshausen P, 2009, MICROCIRCULATION, V16, P84, DOI 10.1080/10739680802564787; Vowinkel T, 2007, GASTROENTEROLOGY, V132, P955, DOI 10.1053/j.gastro.2006.12.027; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; Yan J, 2000, IMMUNOPHARMACOLOGY, V46, P39, DOI 10.1016/S0162-3109(99)00157-5; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011	52	63	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25109	10.1371/journal.pone.0025109	http://dx.doi.org/10.1371/journal.pone.0025109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949865	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900051
J	Martins, ACR				Martins, Andre C. R.			Change and Aging Senescence as an Adaptation	PLOS ONE			English	Article							EVOLUTIONARY-THEORIES; KIN SELECTION	Understanding why we age is a long-lived open problem in evolutionary biology. Aging is prejudicial to the individual, and evolutionary forces should prevent it, but many species show signs of senescence as individuals age. Here, I will propose a model for aging based on assumptions that are compatible with evolutionary theory: i) competition is between individuals; ii) there is some degree of locality, so quite often competition will be between parents and their progeny; iii) optimal conditions are not stationary, and mutation helps each species to keep competitive. When conditions change, a senescent species can drive immortal competitors to extinction. This counter-intuitive result arises from the pruning caused by the death of elder individuals. When there is change and mutation, each generation is slightly better adapted to the new conditions, but some older individuals survive by chance. Senescence can eliminate those from the genetic pool. Even though individual selection forces can sometimes win over group selection ones, it is not exactly the individual that is selected but its lineage. While senescence damages the individuals and has an evolutionary cost, it has a benefit of its own. It allows each lineage to adapt faster to changing conditions. We age because the world changes.	[Martins, Andre C. R.] Univ Sao Paulo, GRIFE Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Martins, Andre C. R.] Ecole Polytech, Ctr Rech & Epistemol Appl, Palaiseau, France	Universidade de Sao Paulo; Institut Polytechnique de Paris	Martins, ACR (corresponding author), Univ Sao Paulo, GRIFE Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil.	amartins@ups.br	Martins, Andre CR/E-8134-2011	Martins, Andre CR/0000-0003-3351-3796	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes-Oliveira N, 2003, SCIENCE, V302, P611, DOI 10.1126/science.1089169; Austad SN, 1997, EXP GERONTOL, V32, P23, DOI 10.1016/S0531-5565(96)00059-9; Ayyadevara S, 2008, AGING CELL, V7, P13, DOI 10.1111/j.1474-9726.2007.00348.x; Bourke AF, 2007, ANNU REV ECOL EVOL S, V38; Congdon JD, 2003, EXP GERONTOL, V38, P765, DOI 10.1016/S0531-5565(03)00106-2; Fahy GM, 2010, FUTURE OF AGING: PATHWAYS TO HUMAN LIFE EXTENSION, P127, DOI 10.1007/978-90-481-3999-6_6; Goldsmith TC, 2008, J THEOR BIOL, V252; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Kaplan HS, 2009, P ROY SOC B-BIOL SCI, V276, P1837, DOI 10.1098/rspb.2008.1831; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirkwood TBL, 2008, J INTERN MED, V263, P117, DOI 10.1111/j.1365-2796.2007.01901.x; KIRKWOOD TBL, 1988, CIBA F SYMP, V134, P193; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lehmann L., 2010, PHIL T R SOC B, V365, P1; LEROI AM, 1994, EVOLUTION, V48, P1258, DOI [10.2307/2410383, 10.1111/j.1558-5646.1994.tb05310.x]; Ljubuncic P, 2009, GERONTOLOGY, V55, P205, DOI 10.1159/000200772; Marshall JAR, 2011, TRENDS ECOL EVOL, V26, P325, DOI 10.1016/j.tree.2011.04.008; Martinez DE, 1997, EXP GERONTOL, V33; Maynard Smith J., 1982, pi; Medawar P., 1952, UNSOLVED PROBLEM BIO; MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x; Mitteldorf J, 2004, EVOLUTIONARY ECOLOGY, V6, P117; Mitteldorf J, 2009, J THEOR BIOL, V260; Mitteldorf J, 2006, EVOLUTIONARY ECOLOGY, V8; Mitteldorf J, 2010, FUTURE OF AGING: PATHWAYS TO HUMAN LIFE EXTENSION, P87, DOI 10.1007/978-90-481-3999-6_5; POLLOCK GB, 1983, AM NAT, V122, P817, DOI 10.1086/284174; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Sozou PD, 2004, P ROY SOC LOND B BIO, V271; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; Taylor PD, 2000, EVOLUTION, V54, P1135; Travis JMJ, 2004, J GERONTOL A-BIOL, V59, P301; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Weibull J W, 1997, EVOLUTIONARY GAME TH; Weismann A., 1889, ESSAYS HEREDITY; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wilensky U., NETLOGO; Williams GC, 1957, EVOLUTION, V11	43	25	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24328	10.1371/journal.pone.0024328	http://dx.doi.org/10.1371/journal.pone.0024328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949706	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800018
J	Hao, C; Hao, JJ; Wang, W; Han, ZR; Li, GS; Zhang, LJ; Zhao, X; Yu, GL				Hao, Cui; Hao, Jiejie; Wang, Wei; Han, Zhangrun; Li, Guangsheng; Zhang, Lijuan; Zhao, Xia; Yu, Guangli			Insulin Sensitizing Effects of Oligomannuronate-Chromium (III) Complexes in C2C12 Skeletal Muscle Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TYPE-2 DIABETES-MELLITUS; OLIGOSACCHARIDE SUGAR CHAIN; NF-KAPPA-B; GLUCOSE-TRANSPORTER; IN-VITRO; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; RECEPTOR KINASE; RATS	Background: It was known that the insulin resistance in skeletal muscle is a major pathogenic factor in diabetes mellitus. Therefore prevention of metabolic disorder caused by insulin resistance and improvement of insulin sensitivity are very important for the therapy of type 2 diabetes. In the present study, we investigated the ability of marine oligosaccharides oligomannuronate and its chromium (III) complexes from brown alga to enhance insulin sensitivity in C2C12 skeletal muscle cells. Methodology/Principal Findings: We demonstrated that oligomannuronate, especially its chromium (III) complexes, enhanced insulin-stimulated glucose uptake and increased the mRNA expression of glucose transporter 4 (GLUT4) and insulin receptor (IR) after their internalization into C2C12 skeletal muscle cells. Additionally, oligosaccharides treatment also significantly enhanced the phosphorylation of proteins involved in both AMP activated protein kinase (AMPK)/acetyl-CoA carboxylase (ACC) and phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathways in C2C12 cells, indicating that the oligosaccharides activated both the insulin signal pathway and AMPK pathways as their mode of action. Moreover, oligosaccharides distributed to the mitochondria after internalization into C2C12 cells and increased the expression of transcriptional regulator peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha), carnitine palmitoyl transferase-1 (CPT-1), and phosphorylated acetyl-CoA carboxylase (p-ACC), which suggested that the actions of these oligosaccharides might be associated with mitochondria through increasing energy expenditure. All of these effects of marine oligosaccharides were comparable to that of the established anti-diabetic drug, metformin. In addition, the treatment with oligosaccharides showed less toxicity than that of metformin. Conclusions/Significance: Our findings indicate that oligomannuonate and its chromium (III) complexes improved insulin sensitivity in C2C12 skeletal muscle cells, and acted as a novel glucose uptake stimulator with low toxicity, and could be used as dietary supplementary or potential drug for type 2 diabetes mellitus.	[Hao, Cui; Hao, Jiejie; Wang, Wei; Han, Zhangrun; Li, Guangsheng; Zhang, Lijuan; Zhao, Xia; Yu, Guangli] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Hao, Cui; Hao, Jiejie; Wang, Wei; Han, Zhangrun; Li, Guangsheng; Zhang, Lijuan; Zhao, Xia; Yu, Guangli] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Peoples R China	Ocean University of China; Ocean University of China	Hao, C (corresponding author), Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China.	glyu@ouc.edu.cn	Zhang, Li/GWM-7501-2022; Wang, Wei/W-8492-2019		National High-Tech R&D Program (863 Program) [2007AA09z445]; International Science and Technology Collaboration Program of China [2007DFA30980]; Program for Changjiang Scholars, Innovative Research Team in University [IRT0944]; Natural Science Foundation of China [31070724, 30870506]; Special Fund for Marine Scientific Research in the Public Interest [201005024]; Key Laboratory of Marine Drugs of Ministry of Education, Ocean University of China [KLMD200802]	National High-Tech R&D Program (863 Program)(National High Technology Research and Development Program of China); International Science and Technology Collaboration Program of China; Program for Changjiang Scholars, Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Marine Scientific Research in the Public Interest; Key Laboratory of Marine Drugs of Ministry of Education, Ocean University of China	This work was supported in part by National High-Tech R&D Program (863 Program, 2007AA09z445), International Science and Technology Collaboration Program of China (2007DFA30980), Program for Changjiang Scholars, Innovative Research Team in University (IRT0944), Natural Science Foundation of China (31070724, 30870506), Special Fund for Marine Scientific Research in the Public Interest (201005024), and Open Research Fund program of Key Laboratory of Marine Drugs of Ministry of Education, Ocean University of China (KLMD200802). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, or in the preparation, review, or approval of the manuscript.	Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Cefalu WT, 2004, DIABETES CARE, V27, P2741, DOI 10.2337/diacare.27.11.2741; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; [陈秀敏 CHEN Xiumin], 2003, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V24, P1; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Davis CM, 1997, BIOCHEMISTRY-US, V36, P4382, DOI 10.1021/bi963154t; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Fan Y, 2005, NEUROSCI LETT, V374, P222, DOI 10.1016/j.neulet.2004.10.063; GENG M, 2004, Patent No. 2004100238270; GUAN H, 2006, Patent No. 2006100445814; HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Imparl-Radosevich J, 1998, HORM RES, V50, P177, DOI 10.1159/000023270; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102; Kang C, 2010, FOOD CHEM TOXICOL, V48, P509, DOI 10.1016/j.fct.2009.11.004; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; Kawada A, 1997, FEBS LETT, V408, P43, DOI 10.1016/S0014-5793(97)00386-4; Krook A, 2004, MED SCI SPORT EXER, V36, P1212, DOI 10.1249/01.MSS.0000132387.25853.3B; Liu B, 2007, WORLD J GASTROENTERO, V13, P725, DOI 10.3748/wjg.v13.i5.725; Lu XJ, 2002, LIFE SCI, V72, P711, DOI 10.1016/S0024-3205(02)02303-2; Ma JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003774; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; NATSUME M, 1994, CARBOHYD RES, V258, P187, DOI 10.1016/0008-6215(94)84085-7; Parker JC, 2002, ADV DRUG DELIVER REV, V54, P1173, DOI 10.1016/S0169-409X(02)00093-5; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sahin K, 2011, BIOL TRACE ELEM RES, V143, P1018, DOI 10.1007/s12011-010-8905-9; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shara M, 2005, J INORG BIOCHEM, V99, P2161, DOI 10.1016/j.jinorgbio.2005.07.017; Shen WL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002328; Tanaka T, 2004, INT J PHARM, V286, P9, DOI 10.1016/j.ijpharm.2004.07.031; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vincent JB, 2004, BIOL TRACE ELEM RES, V99, P1, DOI 10.1385/BTER:99:1-3:001; Wang H, 2005, BIOCHEMISTRY-US, V44, P8167, DOI 10.1021/bi0473152; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wang SH, 2007, NEUROL RES, V29, P96, DOI 10.1179/174313206X152483; Wang Xue-song, 2004, Yaoxue Xuebao, V39, P1028; Wang YQ, 2009, CLIN EXP PHARMACOL P, V36, P843, DOI 10.1111/j.1440-1681.2009.05164.x; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang DD, 2008, BIOL PHARM BULL, V31, P921, DOI 10.1248/bpb.31.921; Zhang J, 2010, ACTA PHARMACOL SIN, V31, P375, DOI 10.1038/aps.2010.13; Zhang RX, 2004, J ETHNOPHARMACOL, V90, P39, DOI 10.1016/j.jep.2003.09.018; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	34	40	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24598	10.1371/journal.pone.0024598	http://dx.doi.org/10.1371/journal.pone.0024598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935427	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700044
J	Menchon, SA; Gartner, A; Roman, P; Dotti, CG				Menchon, Silvia A.; Gartner, Annette; Roman, Pablo; Dotti, Carlos G.			Neuronal (Bi)Polarity as a Self-Organized Process Enhanced by Growing Membrane	PLOS ONE			English	Article							CELL POLARITY; NEURITE OUTGROWTH; RHO-GTPASES; N-CADHERIN; LOCALIZATION; ENDOCYTOSIS; DYNAMICS; BINDING; POLARIZATION; CENTROSOME	Early in vitro and recent in vivo studies demonstrated that neuronal polarization occurs by the sequential formation of two oppositely located neurites. This early bipolar phenotype is of crucial relevance in brain organization, determining neuronal migration and brain layering. It is currently considered that the place of formation of the first neurite is dictated by extrinsic cues, through the induction of localized changes in membrane and cytoskeleton dynamics leading to deformation of the cells' curvature followed by the growth of a cylindrical extension (neurite). It is unknown if the appearance of the second neurite at the opposite pole, thus the formation of a bipolar cell axis and capacity to undergo migration, is defined by the growth at the first place, therefore intrinsic, or requires external determinants. We addressed this question by using a mathematical model based on the induction of dynamic changes in one pole of a round cell. The model anticipates that a second area of growth can spontaneously form at the opposite pole. Hence, through mathematical modeling we prove that neuronal bipolar axis of growth can be due to an intrinsic mechanism.	[Menchon, Silvia A.; Gartner, Annette; Dotti, Carlos G.] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Menchon, Silvia A.; Gartner, Annette; Dotti, Carlos G.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Roman, Pablo] Katholieke Univ Leuven, Dept Math, Louvain, Belgium; [Dotti, Carlos G.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Menchon, SA (corresponding author), Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, Louvain, Belgium.	SilviaAdriana.Menchon@cme.vib-kuleuven.be; Carlos.Dotti@cme.vib-kuleuven.be	Dotti, Carlos G/I-5533-2015; Gaertner, Annette/B-5393-2013	Dotti, Carlos G/0000-0003-4052-1719; 	Fund for Scientific Research Flanders (FWO); Federal Office for Scientific Affairs (IUAP); Seventh Framework Programme - Marie Curie [FP7-PIIF-GA-2009-252375]; Katholieke Universiteit Leuven (KULeuven) [OT/08/33]	Fund for Scientific Research Flanders (FWO)(FWO); Federal Office for Scientific Affairs (IUAP); Seventh Framework Programme - Marie Curie; Katholieke Universiteit Leuven (KULeuven)(KU Leuven)	This work was funded by the Fund for Scientific Research Flanders (FWO), http://www.fwo.be/; Federal Office for Scientific Affairs (IUAP), http://www.belspo.be/; Seventh Framework Programme - Marie Curie FP7-PIIF-GA-2009-252375, http://cordis.europa.eu/fp7/people/home_en.html and Katholieke Universiteit Leuven (KULeuven) research grant OT/08/33, http://www.kuleuven.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; Boukharov AA, 1998, BIOCHEM J, V330, P1391, DOI 10.1042/bj3301391; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2008, J CELL SCI, V121, P178, DOI 10.1242/jcs.023143; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Hazuka CD, 1999, J NEUROSCI, V19, P1324; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Jilkine A, 2007, B MATH BIOL, V69, P1943, DOI 10.1007/s11538-007-9200-6; LI N, 1994, J AUST MATH SOC B, V36, P234, DOI 10.1017/S0334270000010377; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Murray JD, 2003, MATH BIOL, V3; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Onsum MD, 2009, CURR OPIN CELL BIOL, V21, P74, DOI 10.1016/j.ceb.2009.01.001; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Plaza R., 2004, J DYN DIFFER EQU, V16, P1093, DOI DOI 10.1007/S10884-004-7834-8; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Ropp DL, 2009, J COMPUT PHYS, V228, P3508, DOI 10.1016/j.jcp.2009.02.001; Rubio AD, 2008, ENVIRON MODELL SOFTW, V23, P90, DOI 10.1016/j.envsoft.2007.05.009; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Turner SJ, 2008, BIOCHEM PHARMACOL, V75, P405, DOI 10.1016/j.bcp.2007.08.031; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	40	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24190	10.1371/journal.pone.0024190	http://dx.doi.org/10.1371/journal.pone.0024190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935383	gold, Green Published, Green Submitted			2022-12-25	WOS:000295039700013
J	Le Nours, J; Bulloch, EMM; Zhang, Z; Greenwood, DR; Middleditch, MJ; Dickson, JMJ; Baker, EN				Le Nours, Jerome; Bulloch, Esther M. M.; Zhang, Zhening; Greenwood, David R.; Middleditch, Martin J.; Dickson, James M. J.; Baker, Edward N.			Structural Analyses of a Purine Biosynthetic Enzyme from Mycobacterium tuberculosis Reveal a Novel Bound Nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE MONOPHOSPHATE CYCLOHYDROLASE; TRANSFORMYLASE-IMP CYCLOHYDROLASE; AVIAN AICAR TRANSFORMYLASE; CRYSTAL-STRUCTURE; RIBONUCLEOTIDE TRANSFORMYLASE; PROTEIN-PRODUCTION; MECHANISM; INHIBITORS; PURIFICATION; COMPLEX	Enzymes of the de novo purine biosynthetic pathway have been identified as essential for the growth and survival of Mycobacterium tuberculosis and thus have potential for the development of anti-tuberculosis drugs. The final two steps of this pathway are carried out by the bifunctional enzyme 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase (ATIC), also known as PurH. This enzyme has already been the target of anti-cancer drug development. We have determined the crystal structures of the M. tuberculosis ATIC (Rv0957) both with and without the substrate 5-aminoimidazole-4-carboxamide ribonucleotide, at resolutions of 2.5 and 2.2 angstrom, respectively. As for other ATIC enzymes, the protein is folded into two domains, the N-terminal domain (residues 1-212) containing the cyclohydrolase active site and the C-terminal domain (residues 222-523) containing the formyltransferase active site. An adventitiously bound nucleotide was found in the cyclohydrolase active site in both structures and was identified by NMR and mass spectral analysis as a novel 5-formyl derivative of an earlier intermediate in the biosynthetic pathway 4-carboxy-5-aminoimidazole ribonucleotide. This result and other studies suggest that this novel nucleotide is a cydohydrolase inhibitor. The dimer formed by M. tuberculosis ATIC is different from those seen for human and avian ATICs, but it has a similar similar to 50-angstrom separation of the two active sites of the bifunctional enzyme. Evidence in M. tuberculosis ATIC for reactivity of half-the-sites in the cyclohydrolase domains can be attributed to ligand-induced movements that propagate across the dimer interface and may be a common feature of ATIC enzymes.	[Bulloch, Esther M. M.; Greenwood, David R.; Middleditch, Martin J.; Dickson, James M. J.] Univ Auckland, Sch Biol Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand	University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Greenwood, David R/D-2375-2016	Greenwood, David R/0000-0001-5280-042X; Bulloch, Esther/0000-0002-4262-1791; Baker, Edward/0000-0003-2456-7661; Le Nours, Jerome/0000-0002-2221-7636	Foundation for Research, Science, and Technology of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission through Maurice Wilkins Centre of Molecular Biodiscovery; Maurice Wilkins Centre for Molecular Biodiscovery; National Institutes of Health [P4IRR001209]; NCRR; NIGM; Department of Energy Office of Biological and Environmental Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Foundation for Research, Science, and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission through Maurice Wilkins Centre of Molecular Biodiscovery; Maurice Wilkins Centre for Molecular Biodiscovery; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGM; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the Foundation for Research, Science, and Technology of New Zealand, the Health Research Council of New Zealand, and the Tertiary Education Commission through funding of the Maurice Wilkins Centre of Molecular Biodiscovery.; Supported by a doctorate scholarship from the Maurice Wilkins Centre for Molecular Biodiscovery. Present address: Biology Dept., Brookhaven National Laboratory, Upton, NY 11973.; Acknowledgments We thank Michael Schmitz for help with NMR spectroscopy and Patrick O'Connor for help with the calculations on CFAIR isomers, X-ray data were collected at the Stanford Synchrotron Radiation Lightsource, a Directorate of, SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science, Stanford University, The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by National Institutes of Health Grant P4IRR001209 from NCRR, Biomedical Technology Program, and NIGM and by the Department of Energy Office of Biological and Environmental Research.	Axelrod HL, 2008, PROTEINS, V71, P1042, DOI 10.1002/prot.21967; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Boger DL, 1997, BIOORGAN MED CHEM, V5, P1817, DOI 10.1016/S0968-0896(97)00120-X; Bricogne G, 2011, AUTO BUSTER VERSION; Cheong CG, 2004, J BIOL CHEM, V279, P18034, DOI 10.1074/jbc.M313691200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ducati RG, 2011, CURR MED CHEM, V18, P1258; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO T, 1983, J BACTERIOL, V155, P169, DOI 10.1128/JB.155.1.169-179.1983; Firestine SM, 2009, BIOORGAN MED CHEM, V17, P3317, DOI 10.1016/j.bmc.2009.03.043; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Greasley SE, 2001, NAT STRUCT BIOL, V8, P402, DOI 10.1038/87555; Groziak MP, 1997, J MED CHEM, V40, P3336, DOI 10.1021/jm970301s; GROZIAK MP, 1988, P NATL ACAD SCI USA, V85, P7174, DOI 10.1073/pnas.85.19.7174; Jackson RC., 1981, NUCLEOSIDES CANC TRE, P18; Kang YN, 2007, BIOCHEMISTRY-US, V46, P5050, DOI 10.1021/bi061637j; Kappock TJ, 2000, CURR OPIN CHEM BIOL, V4, P567, DOI 10.1016/S1367-5931(00)00133-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li CL, 2004, J MED CHEM, V47, P6681, DOI 10.1021/jm049504o; LITCHFIELD GJ, 1971, J CHEM SOC C, P817, DOI 10.1039/j39710000817; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; MUELLER WT, 1981, BIOCHEMISTRY-US, V20, P337, DOI 10.1021/bi00505a017; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rayl EA, 1996, J BIOL CHEM, V271, P2225, DOI 10.1074/jbc.271.4.2225; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scalmani G, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3359469; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SZABADOS E, 1994, BIOCHEMISTRY-US, V33, P14237, DOI 10.1021/bi00251a036; Tsuchiya Y, 2006, PROTEIN ENG DES SEL, V19, P421, DOI 10.1093/protein/gzl026; Vergis JM, 2004, BIOCHEMISTRY-US, V43, P1184, DOI 10.1021/bi035139b; Vergis JM, 2001, J BIOL CHEM, V276, P7727, DOI 10.1074/jbc.M009940200; Wall M, 2000, BIOCHEMISTRY-US, V39, P11303, DOI 10.1021/bi0007268; Wolan DW, 2004, BIOCHEMISTRY-US, V43, P1171, DOI 10.1021/bi030162i; Wolan DW, 2003, BIOCHEMISTRY-US, V42, P10904, DOI 10.1021/bi030106h; Wolan DW, 2002, BIOCHEMISTRY-US, V41, P15505, DOI 10.1021/bi020505x; Xu L, 2004, J BIOL CHEM, V279, P50555, DOI 10.1074/jbc.M406801200; Xu L, 2007, J BIOL CHEM, V282, P13033, DOI 10.1074/jbc.M607293200	42	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40706	40716		10.1074/jbc.M111.291138	http://dx.doi.org/10.1074/jbc.M111.291138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956117	Green Published, hybrid			2022-12-25	WOS:000297315400031
J	Du, JX; Hagos, EG; Nandan, MO; Bialkowska, AB; Yu, B; Yang, VW				Du, James X.; Hagos, Engda G.; Nandan, Mandayam O.; Bialkowska, Agnieszka B.; Yu, Bing; Yang, Vincent W.			The E3 Ubiquitin Ligase SMAD Ubiquitination Regulatory Factor 2 Negatively Regulates Kruppel-like Factor 5 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; TRANSCRIPTIONAL ACTIVATION; CELLULAR PROLIFERATION; DEPENDENT DEGRADATION; NEURONAL POLARITY; SMURF2; DOMAIN; ESTABLISHMENT; TARGETS; BINDING	The zinc finger transcription factor Kruppel-like factor 5 (KLF5) is regulated posttranslationally. We identified SMAD ubiquitination regulatory factor 2 (SMURF2), an E3 ubiquitin ligase, as an interacting protein of KLF5 by yeast two-hybrid screen, coimmunoprecipitation, and indirect immunofluorescence studies. The SMURF2-interacting domains in KLF5 were mapped to its carboxyl terminus, including the PY motif of KLF5 and its zinc finger DNA-binding domain. KLF5 protein levels were reduced significantly upon overexpression of SMURF2 but not catalytically inactive SMURF2-C716A mutant or SMURF1. SMURF2 alone reduced the protein stability of KLF5 as shown by cycloheximide chase assay, indicating that SMURF2 specifically destabilizes KLF5. In contrast, KLF5(1165), a KLF5 amino-terminal construct that lacks the PY motif and DNA binding domain, was not degraded by SMURF2. The degradation of KLF5 by SMURF2 was blocked by the proteasome inhibitor MG132, and SMURF2 efficiently ubiquitinated both overexpressed and endogenous KLF5. In contrast, knocking down SMURF2 by siRNAs significantly enhanced KLF5 protein levels, reduced ubiquitination of KLF5, and increased the expression of cyclin D1 and PDGF-A, two established KLF5 target genes. In consistence, SMURF2, but not the E3 ligase mutant SMURF2-C716A, significantly inhibited the transcriptional activity of KLF5, as demonstrated by dual luciferase assay using the PDGF-A promoter, and suppressed the ability of KLF5 to stimulate cell proliferation as measured by BrdU incorporation. Hence, SMURF2 is a novel E3 ubiquitin ligase for KLF5 and negatively regulates KLF5 by targeting it for proteasomal degradation.	[Du, James X.; Nandan, Mandayam O.; Bialkowska, Agnieszka B.; Yu, Bing; Yang, Vincent W.] Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; [Yang, Vincent W.] Emory Univ, Sch Med, Dept Hematol & Oncol, Atlanta, GA 30322 USA; [Hagos, Engda G.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA	Emory University; Emory University; Colgate University	Yang, VW (corresponding author), SUNY Stony Brook, Sch Med, Dept Med, HSC-T16,Rm 020, Stony Brook, NY 11794 USA.	vincent.yang@stonybrook.edu	yu, bing/B-3078-2009; , ehagos/AAY-8486-2020; Yu, Bing/AAF-9459-2019	yu, bing/0000-0002-7259-8190; Yu, Bing/0000-0002-7259-8190; Mandayam, Nandan/0000-0002-4061-9348	National Institutes of Health [DK052230, DK064399, CA084197]; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK052230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052230, DK064399, and CA084197.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chong PA, 2006, J BIOL CHEM, V281, P17069, DOI 10.1074/jbc.M601493200; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Swamynathan Shivalingappa K., 2010, Human Genomics, V4, P263; Wilson VG, 2008, EXPERT REV PROTEOMIC, V5, P121, DOI 10.1586/14789450.5.1.121; Xie P, 2011, BIOCHEM BIOPH RES CO, V407, P254, DOI 10.1016/j.bbrc.2011.03.016; Zhang QB, 2005, GENE, V348, P25, DOI 10.1016/j.gene.2004.12.050; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	32	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40354	40364		10.1074/jbc.M111.258707	http://dx.doi.org/10.1074/jbc.M111.258707			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953463	hybrid, Green Published			2022-12-25	WOS:000296925700066
J	Parathath, S; Dogan, S; Joaquin, VA; Ghosh, S; Guo, L; Weibel, GL; Rothblat, GH; Harrison, EH; Fisher, EA				Parathath, Saj; Dogan, Snjezana; Joaquin, Victor A.; Ghosh, Snigdha; Guo, Liang; Weibel, Ginny L.; Rothblat, George H.; Harrison, Earl H.; Fisher, Edward A.			Rat Carboxylesterase ES-4 Enzyme Functions as a Major Hepatic Neutral Cholesteryl Ester Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACYL-COA; ACYLTRANSFERASE INHIBITION; LIVER CARBOXYLESTERASES; REDUCES ATHEROSCLEROSIS; DENSITY-LIPOPROTEIN; APOLIPOPROTEIN B100; MOLECULAR-CLONING; FOAM CELL; EXPRESSION	Although esterification of free cholesterol to cholesteryl ester in the liver is known to be catalyzed by the enzyme acyl-coenzyme A: cholesterol acyltransferase, ACAT, the neutral cholesteryl ester hydrolase (nCEH) that catalyzes the reverse reaction has remained elusive. Because cholesterol undergoes continuous cycling between free and esterified forms, the steady-state concentrations in the liver of the two species and their metabolic availability for pathways, such as lipoprotein assembly and bile acid synthesis, depend upon nCEH activity. On the basis of the general characteristics of the family of rat carboxylesterases, we hypothesized that one member, ES-4, was a promising candidate as a hepatic nCEH. Using under-and overexpression approaches, we provide multiple lines of evidence that establish ES-4 as a bona fide endogenous nCEH that can account for the majority of cholesteryl ester hydrolysis in transformed rat hepatic cells and primary rat hepatocytes.	[Parathath, Saj; Dogan, Snjezana; Joaquin, Victor A.; Guo, Liang; Fisher, Edward A.] NYU, Med Ctr, Dept Med, New York, NY 10016 USA; [Parathath, Saj; Dogan, Snjezana; Joaquin, Victor A.; Guo, Liang; Fisher, Edward A.] NYU, Med Ctr, Marc & Ruti Bell Vasc Biol Program, New York, NY 10016 USA; [Ghosh, Snigdha; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [Weibel, Ginny L.; Rothblat, George H.] Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA	New York University; New York University; University System of Ohio; Ohio State University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Fisher, EA (corresponding author), NYU, Med Ctr, Dept Med, New York, NY 10016 USA.	edward.fisher@nyumc.org	Fisher, Edward/ABE-7469-2020; Parathath, Saj/ABE-2183-2021; Harrison, Earl H/AAN-5378-2021	Parathath, Sajesh/0000-0003-3431-297X; Fisher, Edward/0000-0001-9802-143X; Guo, Liang/0000-0003-1633-1544	National Institutes of Health [DK44498, HL58541]; Post-doctoral Fellowship [F32-HL087627-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL087627, R01HL058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44498 (to E. H. H. and E. A. F.), HL58541 (to E. A. F.) and by Post-doctoral Fellowship F32-HL087627-1 (to S. P.). We would also like to thank Lisa Grauer and Courtney Blachford for expert technical assistance.	BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; BERNARD DW, 1990, ARTERIOSCLEROSIS, V10, P135, DOI 10.1161/01.ATV.10.1.135; BLACKHART BD, 1990, J BIOL CHEM, V265, P8358; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brewer HB, 2000, J CLIN INVEST, V105, P703, DOI 10.1172/JCI9664; BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; Camarota LM, 2004, J BIOL CHEM, V279, P27599, DOI 10.1074/jbc.M402946200; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Christian AE, 1997, J LIPID RES, V38, P2264; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; DURHAM LA, 1984, J BIOL CHEM, V259, P7433; Ghosh S, 1995, BBA-LIPID LIPID MET, V1259, P305, DOI 10.1016/0005-2760(95)00184-0; Ghosh S, 1998, AM J PHYSIOL-GASTR L, V274, pG662, DOI 10.1152/ajpgi.1998.274.4.G662; Ghosh S, 2000, PHYSIOL GENOMICS, V2, P1, DOI 10.1152/physiolgenomics.2000.2.1.1; GLICK JM, 1987, ATHEROSCLEROSIS, V64, P223, DOI 10.1016/0021-9150(87)90250-4; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; HAJJAR DP, 1983, J LIPID RES, V24, P1176; HAJJAR DP, 1983, J BIOL CHEM, V258, P192; HARRISON EH, 1990, J LIPID RES, V31, P2187; HOEG JM, 1982, BIOCHIM BIOPHYS ACTA, V711, P59, DOI 10.1016/0005-2760(82)90009-1; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Kraemer FB, 2002, ENDOCRINOLOGY, V143, P801, DOI 10.1210/en.143.3.801; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kusunoki J, 2001, CIRCULATION, V103, P2604; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Linke T, 2005, J BIOL CHEM, V280, P23287, DOI 10.1074/jbc.M413585200; MENTLEIN R, 1987, BIOCHIM BIOPHYS ACTA, V913, P27, DOI 10.1016/0167-4838(87)90228-7; MENTLEIN R, 1988, BIOCHIM BIOPHYS ACTA, V964, P319, DOI 10.1016/0304-4165(88)90032-3; MINOR LK, 1989, J LIPID RES, V30, P189; MUKHERJEE JJ, 1993, BIOCHEM J, V295, P81, DOI 10.1042/bj2950081; NISHIDE T, 1985, TOHOKU J EXP MED, V146, P123, DOI 10.1620/tjem.146.123; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Poole M, 2001, TOXICOLOGY, V165, P109, DOI 10.1016/S0300-483X(01)00416-4; Riccalton-Banks L, 2003, MOL CELL BIOCHEM, V248, P97, DOI 10.1023/A:1024184826728; Robbi M, 1996, BIOCHEM J, V313, P821, DOI 10.1042/bj3130821; Rong JX, 2005, ARTERIOSCL THROM VAS, V25, P122, DOI 10.1161/01.ATV.0000148202.49842.3b; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Sanghani SP, 2002, EUR J BIOCHEM, V269, P4387, DOI 10.1046/j.1432-1033.2002.03121.x; Sekiya M, 2008, J LIPID RES, V49, P1829, DOI 10.1194/jlr.M800198-JLR200; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; van Bennekum AM, 1999, BIOCHEMISTRY-US, V38, P4150, DOI 10.1021/bi981680+; Vogel S, 2000, J LIPID RES, V41, P882; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485; ZOLFAGHARI R, 1993, J BIOL CHEM, V268, P13532	48	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39683	39692		10.1074/jbc.M111.258095	http://dx.doi.org/10.1074/jbc.M111.258095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937439	Green Published, hybrid			2022-12-25	WOS:000296925700002
J	Proto, WR; Castanys-Munoz, E; Black, A; Tetley, L; Moss, CX; Juliano, L; Coombs, GH; Mottram, JC				Proto, William R.; Castanys-Munoz, Esther; Black, Alana; Tetley, Laurence; Moss, Catherine X.; Juliano, Luiz; Coombs, Graham H.; Mottram, Jeremy C.			Trypanosoma brucei Metacaspase 4 Is a Pseudopeptidase and a Virulence Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ARABIDOPSIS-THALIANA; OLIGOPEPTIDASE-B; EXPRESSION; PROTEINS; SYSTEM; IDENTIFICATION; PARASITEMIA; ACTIVATION; APOPTOSIS	Metacaspases are caspase family cysteine peptidases found in plants, fungi, and protozoa but not mammals. Trypanosoma brucei is unusual in having five metacaspases (MCA1-MCA5), of which MCA1 and MCA4 have active site substitutions, making them possible non-enzymatic homologues. Here we demonstrate that recombinant MCA4 lacks detectable peptidase activity despite maintaining a functional peptidase structure. MCA4 is expressed primarily in the bloodstream form of the parasite and associates with the flagellar membrane via dual myristoylation/palmitoylation. Loss of function phenotyping revealed critical roles for MCA4; rapid depletion by RNAi caused lethal disruption to the parasite's cell cycle, yet the generation of MCA4 null mutant parasites (Delta mca4) was possible. Delta mca4 had normal growth in axenic culture but markedly reduced virulence in mice. Further analysis revealed that MCA4 is released from the parasite and is specifically processed by MCA3, the only metacaspase that is both palmitoylated and enzymatically active. Accordingly, we have identified that the multiple metacaspases in T. brucei form a membrane-associated proteolytic cascade to generate a pseudopeptidase virulence factor.	[Proto, William R.; Castanys-Munoz, Esther; Black, Alana; Tetley, Laurence; Moss, Catherine X.; Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-04044020 Sao Paulo, Brazil; [Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 ORE, Lanark, Scotland	University of Glasgow; Universidade Federal de Sao Paulo (UNIFESP); University of Strathclyde	Mottram, JC (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	jeremy.mottram@glasgow.ac.uk	Complexos, INCT Fluidos/H-9172-2013; Juliano, Luiz/D-7204-2012	Juliano, Luiz/0000-0002-5589-2822; Mottram, Jeremy/0000-0001-5574-3766; Hamilton, Alana/0000-0001-5704-2293	Medical Research Council [G9722968, G0000508, G0700127]; MRC [G0000508, G0700127, G9722968] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants G9722968, G0000508, and G0700127.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Bastin P, 1999, J CELL SCI, V112, P3769; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Emmer BT, 2010, EUKARYOT CELL, V9, P934, DOI 10.1128/EC.00086-10; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Grebaut P, 2009, INT J PARASITOL, V39, P1137, DOI 10.1016/j.ijpara.2009.02.018; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Lee REC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002956; Liu W, 2010, MOL BIOCHEM PARASIT, V169, P20, DOI 10.1016/j.molbiopara.2009.09.004; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; Morty RE, 2001, INFECT IMMUN, V69, P2757, DOI 10.1128/IAI.69.4.2757-2761.2001; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; Mottram JC, 2003, TRENDS PARASITOL, V19, P182, DOI 10.1016/S1471-4922(03)00038-2; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Sarkany Z, 2003, BIOCHEMISTRY-US, V42, P516, DOI 10.1021/bi027004w; Silverman JM, 2011, CELL MICROBIOL, V13, P1, DOI 10.1111/j.1462-5822.2010.01537.x; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Webb H, 1997, J CELL BIOL, V139, P103, DOI 10.1083/jcb.139.1.103; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zalila H, 2011, MOL MICROBIOL, V79, P222, DOI 10.1111/j.1365-2958.2010.07443.x; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	45	52	54	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39914	39925		10.1074/jbc.M111.292334	http://dx.doi.org/10.1074/jbc.M111.292334			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949125	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000296925700025
J	Ritchie, TK; Kwon, H; Atkins, WM				Ritchie, Tasha K.; Kwon, Hyewon; Atkins, William M.			Conformational Analysis of Human ATP-binding Cassette Transporter ABCB1 in Lipid Nanodiscs and Inhibition by the Antibodies MRK16 and UIC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN MULTIDRUG TRANSPORTER; HUMAN P-GLYCOPROTEIN; MONOCLONAL-ANTIBODY; DRUG-BINDING; DIFFERENTIAL IMMUNOREACTIVITY; NUCLEOTIDE-BINDING; CATALYTIC CYCLE; RESISTANCE; MECHANISM; VANADATE	The human ATP-binding cassette (ABC) transporter, P-glycoprotein (P-gp; ABCB1), mediates the ATP-dependent efflux of a variety of drugs. As a result, P-gp plays a critical role in tumor cell drug resistance and the pharmacokinetic properties of most drugs. P-gp exhibits extraordinary substrate and inhibitor promiscuity, resulting in a wide range of possible drug-drug interactions. Inhibitory antibodies have long been considered as a possible strategy to modulate P-gp-dependent cancer cell drug resistance, and it is widely suggested that the antibodies MRK16 and UIC2 inhibit P-gp by capturing a single isoform and preventing flux through the catalytic cycle. Although the crystal structures of many bacterial whole transporters, as well as isolated nucleotide-binding domains, have been solved, high resolution structural data for mammalian ABC transporters are currently lacking. It has been extremely difficult to determine the detailed mechanism of transport of P-gp, in part because it is difficult to obtain purified protein in well defined lipid systems. Here we exploit surface plasmon resonance (SPR) to probe conformational changes associated with these intermediate states for P-gp in lipid bilayer nanodiscs. The results indicate that P-gp in nanodiscs undergoes functionally relevant ligand-dependent conformational changes and that previously described inhibitory antibodies bind to multiple nucleotide-bound states but not the ADP-VO4-trapped state, which mimics the post-hydrolysis state. The results also suggest that the substrate drug vinblastine is released at stages that precede or follow the post-hydrolysis ADP-PO4 center dot P-gp complex.	[Ritchie, Tasha K.; Kwon, Hyewon; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Atkins, WM (corresponding author), Univ Washington, Dept Med Chem, Box 357610, Seattle, WA 98195 USA.	winky@u.washington.edu			National Institutes of Health [GM 32165, 62284]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062284, P01GM032165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 32165 and 62284 (to W. M. A.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P492; Bucher K, 2007, PHARM RES-DORDR, V24, P1993, DOI 10.1007/s11095-007-9326-0; Callaghan R, 2006, FEBS LETT, V580, P1056, DOI 10.1016/j.febslet.2005.11.083; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Crowley E, 2010, FEBS J, V277, P3974, DOI 10.1111/j.1742-4658.2010.07789.x; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Druley TE, 2001, BIOCHEMISTRY-US, V40, P4312, DOI 10.1021/bi001371v; GEORGES E, 1993, J BIOL CHEM, V268, P1792; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Goda K, 2002, EUR J BIOCHEM, V269, P2672, DOI 10.1046/j.1432-1033.2002.02929.x; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hsiao P, 2008, DRUG METAB DISPOS, V36, P481, DOI 10.1124/dmd.107.018176; HUNTER J, 1993, J BIOL CHEM, V268, P14991; HUNTER J, 1993, PHARMACEUT RES, V10, P743, DOI 10.1023/A:1018972102702; Jeynes B, 2011, NEUROSCI LETT, V487, P389, DOI 10.1016/j.neulet.2010.10.063; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; KOBAYASHI Y, 1994, BIOCHEM PHARMACOL, V48, P1641, DOI 10.1016/0006-2952(94)90209-7; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Ruth A, 2001, BIOCHEMISTRY-US, V40, P4332, DOI 10.1021/bi001373f; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; SCHINKEL AH, 1993, INT J CANCER, V55, P478, DOI 10.1002/ijc.2910550326; Takeuchi T, 2006, PHARM RES, V23, P1460, DOI 10.1007/s11095-006-0285-7; Taub ME, 2005, DRUG METAB DISPOS, V33, P1679, DOI 10.1124/dmd.105.005421; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Zhou Y, 1999, ARCH BIOCHEM BIOPHYS, V367, P74, DOI 10.1006/abbi.1999.1221; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	49	54	55	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39489	39496		10.1074/jbc.M111.284554	http://dx.doi.org/10.1074/jbc.M111.284554			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937435	Green Published, hybrid			2022-12-25	WOS:000296759800066
J	Ji, X; Qian, D; Wei, CH; Ye, GY; Zhang, ZK; Wu, ZJ; Xie, LH; Li, Y				Ji, Xu; Qian, Dan; Wei, Chunhong; Ye, Gongyin; Zhang, Zhongkai; Wu, Zujian; Xie, Lianhui; Li, Yi			Movement Protein Pns6 of Rice dwarf phytoreovirus Has Both ATPase and RNA Binding Activities	PLOS ONE			English	Article							POTATO-VIRUS-X; TO-CELL MOVEMENT; TOBACCO MOSAIC-VIRUS; SIZE-EXCLUSION LIMIT; NICOTIANA-BENTHAMIANA; NONSTRUCTURAL PROTEIN; SILENCING SUPPRESSOR; PLANT-VIRUS; IN-VITRO; HELICASE	Cell-to-cell movement is essential for plant viruses to systemically infect host plants. Plant viruses encode movement proteins (MP) to facilitate such movement. Unlike the well-characterized MPs of DNA viruses and single-stranded RNA (ssRNA) viruses, knowledge of the functional mechanisms of MPs encoded by double-stranded RNA (dsRNA) viruses is very limited. In particular, many studied MPs of DNA and ssRNA viruses bind non-specifically ssRNAs, leading to models in which ribonucleoprotein complexes (RNPs) move from cell to cell. Thus, it will be of special interest to determine whether MPs of dsRNA viruses interact with genomic dsRNAs or their derivative sRNAs. To this end, we studied the biochemical functions of MP Pns6 of Rice dwarf phytoreovirus (RDV), a member of Phytoreovirus that contains a 12-segmented dsRNA genome. We report here that Pns6 binds both dsRNAs and ssRNAs. Intriguingly, Pns6 exhibits non-sequence specificity for dsRNA but shows preference for ssRNA sequences derived from the conserved genomic 5'- and 3'-terminal consensus sequences of RDV. Furthermore, Pns6 exhibits magnesium-dependent ATPase activities. Mutagenesis identified the RNA binding and ATPase activity sites of Pns6 at the N- and C-termini, respectively. Our results uncovered the novel property of a viral MP in differentially recognizing dsRNA and ssRNA and establish a biochemical basis to enable further studies on the mechanisms of dsRNA viral MP functions.	[Ji, Xu; Qian, Dan; Wei, Chunhong; Li, Yi] Peking Univ, State Key Lab Prot & Plant Gene Res, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Coll Life Sci, Beijing 100871, Peoples R China; [Ye, Gongyin] Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhongkai] Yunnan Acad Agr Sci, Biotechnol & Genet Resources Inst, Kunming, Peoples R China; [Wu, Zujian; Xie, Lianhui] Fujian Agr & Forestry Univ, Key Lab Plant Virol Fujian Prov, Inst Plant Virol, Fuzhou, Peoples R China	Peking University; Zhejiang University; Yunnan Academy of Agricultural Sciences; Fujian Agriculture & Forestry University	Ji, X (corresponding author), Peking Univ, State Key Lab Prot & Plant Gene Res, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Coll Life Sci, Beijing 100871, Peoples R China.	liyi@pku.edu.cn			NSFC [31030005, 30910103904]; National Basic Research Program (973) [2012CB114004]	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973)(National Basic Research Program of China)	This work was supported by a grant from NSFC (31030005, 30910103904) http://www.nsfc.gov.cn/Portal0/default106.htm, and a grant from National Basic Research Program (973) (2012CB114004) http://www.973.gov.cn/English/Index.aspx to YL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell SM, 1996, VIROLOGY, V216, P197, DOI 10.1006/viro.1996.0046; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bayne EH, 2005, PLANT J, V44, P471, DOI 10.1111/j.1365-313X.2005.02539.x; BOCCARDO G, 1984, CM AAB DESCRIPTIONS; Cao XS, 2005, J VIROL, V79, P13018, DOI 10.1128/JVI.79.20.13018-13027.2005; Carvalho CM, 2004, J VIROL, V78, P1591, DOI 10.1128/JVI.78.3.1591-1594.2004; Chang SC, 2000, J VIROL, V74, P9732, DOI 10.1128/JVI.74.20.9732-9737.2000; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/j.1364-3703.2010.00634.x, 10.1111/J.1364-3703.2010.00634.X]; CITOVSKY V, 1991, P NATL ACAD SCI USA, V88, P2476, DOI 10.1073/pnas.88.6.2476; CITOVSKY V, 1990, CELL, V60, P637, DOI 10.1016/0092-8674(90)90667-4; CITOVSKY V, 1992, PLANT CELL, V4, P397, DOI 10.1105/tpc.4.4.397; Davenport GF, 1997, J GEN VIROL, V78, P1247, DOI 10.1099/0022-1317-78-6-1247; Frick DN, 2007, J MOL BIOL, V365, P1017, DOI 10.1016/j.jmb.2006.10.023; GRAMSTAT A, 1990, FEBS LETT, V276, P34, DOI 10.1016/0014-5793(90)80500-I; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Howard AR, 2004, VIROLOGY, V328, P185, DOI 10.1016/j.virol.2004.06.039; HULL R, 2002, MATTHEWS PLANT VIROL, P336; JOKLIK WK, 1999, ENCY VIROLOGY, P1464; Kadare G, 1997, J VIROL, V71, P2583; Kalinina NO, 1996, FEBS LETT, V397, P75, DOI 10.1016/S0014-5793(96)01138-6; Kalinina NO, 2002, VIROLOGY, V296, P321, DOI 10.1006/viro.2001.1328; Kar AK, 2003, J VIROL, V77, P11347, DOI 10.1128/JVI.77.21.11347-11356.2003; Karpe YA, 2010, J VIROL, V84, P3595, DOI 10.1128/JVI.02130-09; KUDO H, 1991, J GEN VIROL, V72, P2857, DOI 10.1099/0022-1317-72-12-2857; Laporte C, 2003, PLANT CELL, V15, P2058, DOI 10.1105/tpc.013896; Li Y, 2004, J VIROL, V78, P5382, DOI 10.1128/JVI.78.10.5382-5389.2004; Li YI, 2001, J VIROL, V75, P12114, DOI 10.1128/JVI.75.24.12114-12120.2001; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Morozov SY, 1999, VIROLOGY, V260, P55, DOI 10.1006/viro.1999.9788; Nibert ML, 2004, J VIROL, V78, P5528, DOI 10.1128/JVI.78.10.5528-5530.2004; Peremyslov VV, 1999, P NATL ACAD SCI USA, V96, P14771, DOI 10.1073/pnas.96.26.14771; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; Ramadevi N, 1998, J GEN VIROL, V79, P2475, DOI 10.1099/0022-1317-79-10-2475; Ren B, 2010, J VIROL, V84, P12914, DOI 10.1128/JVI.00864-10; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Tortorici MA, 2003, J BIOL CHEM, V278, P32673, DOI 10.1074/jbc.M305358200; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wei T, 2006, ARCH VIROL, V151, P1701, DOI 10.1007/s00705-006-0757-4; Wei TY, 2006, J VIROL, V80, P8593, DOI 10.1128/JVI.00537-06; Wei TY, 2006, J GEN VIROL, V87, P429, DOI 10.1099/vir.0.81425-0; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Xu H, 1998, VIROLOGY, V240, P267, DOI 10.1006/viro.1997.8945; Zhou P, 2010, ACTA VIROL, V54, P99, DOI 10.4149/av_2010_02_99	46	15	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24986	10.1371/journal.pone.0024986	http://dx.doi.org/10.1371/journal.pone.0024986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949821	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400029
J	Reingewertz, TH; Shalev, DE; Sukenik, S; Blatt, O; Rotem-Bamberger, S; Lebendiker, M; Larisch, S; Friedler, A				Reingewertz, Tali H.; Shalev, Deborah E.; Sukenik, Shahar; Blatt, Ofrah; Rotem-Bamberger, Shahar; Lebendiker, Mario; Larisch, Sarit; Friedler, Assaf			Mechanism of the Interaction between the Intrinsically Disordered C-Terminus of the Pro-Apoptotic ARTS Protein and the Bir3 Domain of XIAP	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; NATIVELY UNFOLDED PROTEINS; UNSTRUCTURED PROTEINS; SERINE-PROTEASE; PROMOTES APOPTOSIS; MAMMALIAN PROTEIN; D-2 CONCEPT; CANCER; SPECTROSCOPY; DISEASES	ARTS (Sept4_i2) is a mitochondrial pro-apoptotic protein that functions as a tumor suppressor. Its expression is significantly reduced in leukemia and lymphoma patients. ARTS binds and inhibits XIAP (X-linked Inhibitor of Apoptosis protein) by interacting with its Bir3 domain. ARTS promotes degradation of XIAP through the proteasome pathway. By doing so, ARTS removes XIAP inhibition of caspases and enables apoptosis to proceed. ARTS contains 27 unique residues in its C-terminal domain (CTD, residues 248-274) which are important for XIAP binding. Here we characterized the molecular details of this interaction. Biophysical and computational methods were used to show that the ARTS CTD is intrinsically disordered under physiological conditions. Direct binding of ARTS CTD to Bir3 was demonstrated using NMR and fluorescence spectroscopy. The Bir3 interacting region in ARTS CTD was mapped to ARTS residues 266-274, which are the nine C-terminal residues in the protein. Alanine scan of ARTS 266-274 showed the importance of several residues for Bir3 binding, with His268 and Cys273 contributing the most. Adding a reducing agent prevented binding to Bir3. A dimer of ARTS 266-274 formed by oxidation of the Cys residues into a disulfide bond bound with similar affinity and was probably required for the interaction with Bir3. The detailed analysis of the ARTS-Bir3 interaction provides the basis for setting it as a target for anti cancer drug design: It will enable the development of compounds that mimic ARTS CTD, remove IAPs inhibition of caspases, and thereby induce apoptosis.	[Reingewertz, Tali H.; Sukenik, Shahar; Blatt, Ofrah; Rotem-Bamberger, Shahar; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Shalev, Deborah E.; Lebendiker, Mario] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; [Larisch, Sarit] Univ Haifa, Fac Nat Sci, Dept Biol, Cell Death Res Lab, IL-31999 Haifa, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Haifa	Reingewertz, TH (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Safra Campus, IL-91904 Jerusalem, Israel.	assaf@chem.ch.huji.ac.il	Sukenik, Shahar/J-4438-2013; Shalev, Deborah E/AAY-2873-2021	Sukenik, Shahar/0000-0003-3855-9574; 	European Research Council under the European Community [(FP7/2007-2013)/ERC, 203413]; ISEF foundation	European Research Council under the European Community(European Research Council (ERC)); ISEF foundation	AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413. THR is supported by a fellowship from the ISEF foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BORNSTEIN B, APOPTOSIS IN PRESS; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen DJ, 2009, ANTI-CANCER DRUG, V20, P646, DOI 10.1097/CAD.0b013e32832ced78; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Garcia W, 2006, BIOCHEMISTRY-US, V45, P13918, DOI 10.1021/bi061549z; Garcia-Fernandez M, 2010, GENE DEV, V24, P2282, DOI 10.1101/gad.1970110; Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Katz C, 2008, P NATL ACAD SCI USA, V105, P12277, DOI 10.1073/pnas.0711269105; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V96, P1156, DOI 10.1016/0006-291X(80)90073-X; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Larisch-Bloch S, 2000, CELL GROWTH DIFFER, V11, P1; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; MANDELGUTFREUND Y, BIOL CHEM IN PRESS; Martins LM, 2002, CELL DEATH DIFFER, V9, P699, DOI 10.1038/sj.cdd.4401044; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Shi Y, 2002, CELL DEATH DIFFER, V9, P93, DOI 10.1038/sj/cdd/4400957; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Tamm I, 2000, CLIN CANCER RES, V6, P1796; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI 10.1586/EPR.10.36; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e	51	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24655	10.1371/journal.pone.0024655	http://dx.doi.org/10.1371/journal.pone.0024655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949740	Green Submitted, Green Published, gold			2022-12-25	WOS:000295260400009
J	Spicuglia, S; Vincent-Fabert, C; Benoukraf, T; Tiberi, G; Saurin, AJ; Zacarias-Cabeza, J; Grimwade, D; Mills, K; Calmels, B; Bertucci, F; Sieweke, M; Ferrier, P; Duprez, E				Spicuglia, Salvatore; Vincent-Fabert, Christelle; Benoukraf, Touati; Tiberi, Guillaume; Saurin, Andrew J.; Zacarias-Cabeza, Joaquin; Grimwade, David; Mills, Ken; Calmels, Boris; Bertucci, Francois; Sieweke, Michael; Ferrier, Pierre; Duprez, Estelle			Characterisation of Genome-Wide PLZF/RARA Target Genes	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; PLZF-RAR-ALPHA; RECEPTOR-ALPHA; DIFFERENTIATION THERAPY; HISTONE DEACETYLASE; FUSION PROTEINS; PML/RAR-ALPHA; TRANSFORMATION; EXPRESSION	The PLZF/RARA fusion protein generated by the t(11;17)(q23;q21) translocation in acute promyelocytic leukaemia (APL) is believed to act as an oncogenic transcriptional regulator recruiting epigenetic factors to genes important for its transforming potential. However, molecular mechanisms associated with PLZF/RARA-dependent leukaemogenesis still remain unclear. We searched for specific PLZF/RARA target genes by ChIP-on-chip in the haematopoietic cell line U937 conditionally expressing PLZF/RARA. By comparing bound regions found in U937 cells expressing endogenous PLZF with PLZF/RARA-induced U937 cells, we isolated specific PLZF/RARA target gene promoters. We next analysed gene expression profiles of our identified target genes in PLZF/RARA APL patients and analysed DNA sequences and epigenetic modification at PLZF/RARA binding sites. We identify 413 specific PLZF/RARA target genes including a number encoding transcription factors involved in the regulation of haematopoiesis. Among these genes, 22 were significantly down regulated in primary PLZF/RARA APL cells. In addition, repressed PLZF/RARA target genes were associated with increased levels of H3K27me3 and decreased levels of H3K9K14ac. Finally, sequence analysis of PLZF/RARA bound sequences reveals the presence of both consensus and degenerated RAREs as well as enrichment for tissue-specific transcription factor motifs, highlighting the complexity of targeting fusion protein to chromatin. Our study suggests that PLZF/RARA directly targets genes important for haematopoietic development and supports the notion that PLZF/RARA acts mainly as an epigenetic regulator of its direct target genes.	[Spicuglia, Salvatore; Benoukraf, Touati; Zacarias-Cabeza, Joaquin; Sieweke, Michael; Ferrier, Pierre; Duprez, Estelle] Univ Aix Marseille 2, CIML, Marseille, France; [Spicuglia, Salvatore; Benoukraf, Touati; Zacarias-Cabeza, Joaquin; Sieweke, Michael; Ferrier, Pierre; Duprez, Estelle] INSERM, U631, F-13258 Marseille, France; [Spicuglia, Salvatore; Benoukraf, Touati; Zacarias-Cabeza, Joaquin; Sieweke, Michael; Ferrier, Pierre; Duprez, Estelle] CNRS, UMR 6102, Marseille, France; [Vincent-Fabert, Christelle; Tiberi, Guillaume; Calmels, Boris; Bertucci, Francois; Duprez, Estelle] INSERM, U891, Ctr Rech Cancerol Marseille, F-13258 Marseille, France; [Vincent-Fabert, Christelle; Tiberi, Guillaume; Calmels, Boris; Bertucci, Francois; Duprez, Estelle] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Saurin, Andrew J.] Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, Marseille, France; [Saurin, Andrew J.] CNRS, UMR 6216, Marseille, France; [Grimwade, David] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Mills, Ken] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Benoukraf, Touati] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of London; King's College London; Queens University Belfast; National University of Singapore	Spicuglia, S (corresponding author), Univ Aix Marseille 2, CIML, Campus Luminy, Marseille, France.	estelle.duprez@inserm.fr	Benoukraf, Touati/K-9978-2019; Vincent-Fabert, Christelle/AGZ-5883-2022; duprez, estelle a/R-2357-2016; Mills, Ken/A-8556-2012; calmels, boris/R-2538-2016; Spicuglia, Salvatore/L-2268-2016; Sieweke, Michael/AAR-7515-2020	Benoukraf, Touati/0000-0002-4789-8028; Mills, Ken/0000-0002-6362-4481; Spicuglia, Salvatore/0000-0002-8101-7108; Sieweke, Michael/0000-0002-3228-9537; VINCENT-FABERT, Christelle/0000-0002-5799-980X; calmels, boris/0000-0002-1684-6030; Bertucci, Francois/0000-0002-0157-0959; Zacarias Cabeza, Joaquin/0000-0002-0919-7044; Saurin, Andrew/0000-0001-5162-003X; Duprez, Estelle/0000-0003-3810-5740	"Association pour la Recherche sur le Cancer" (ARC); "Fondation pour la Recherche Medicale" (FRM); "Agence Nationale de la Recherche" (ANR); Fondation Princesse Grace de Monaco; Association Laurette Fugain; Marseille-Nice Genopole; Leukaemia and Lymphoma	"Association pour la Recherche sur le Cancer" (ARC)(Fondation ARC pour la Recherche sur le Cancer); "Fondation pour la Recherche Medicale" (FRM)(Fondation pour la Recherche Medicale); "Agence Nationale de la Recherche" (ANR)(French National Research Agency (ANR)); Fondation Princesse Grace de Monaco; Association Laurette Fugain; Marseille-Nice Genopole; Leukaemia and Lymphoma	CV-F was supported by the "Association pour la Recherche sur le Cancer" (ARC). GT was supported by the "Fondation pour la Recherche Medicale" (FRM). TB was supported by the "Agence Nationale de la Recherche" (ANR) and by the FRM. JZC was supported by the "Fondation Princesse Grace de Monaco". This research was supported by the "Association Laurette Fugain" to BC, PF and ED, the ARC and the FRM to ED, and Marseille-Nice Genopole to PF. DG gratefully acknowledges support from Leukaemia and Lymphoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Benoukraf T, 2009, BIOINFORMATICS, V25, P954, DOI 10.1093/bioinformatics/btp075; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Delacroix L, 2009, MOL CELL BIOL; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Grimwade D, 2010, CANCER TREAT RES, V145, P219, DOI 10.1007/978-0-387-69259-3_13; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Guidez F, 2007, P NATL ACAD SCI USA, V104, P18694, DOI 10.1073/pnas.0704433104; Hauksdottir H, 2001, CELL GROWTH DIFFER, V12, P85; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hoemme C, 2008, BLOOD, V111, P2887, DOI 10.1182/blood-2007-03-079921; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Kwok C, 2006, CANCER CELL, V9, P95, DOI 10.1016/j.ccr.2006.01.005; LICHT JD, 1995, BLOOD, V85, P1083, DOI 10.1182/blood.V85.4.1083.bloodjournal8541083; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Moog-Lutz C, 2001, J BIOL CHEM, V276, P22375, DOI 10.1074/jbc.M011683200; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Paietta E, 2003, BEST PRACT RES CL HA, V16, P369, DOI 10.1016/S1521-6926(03)00042-2; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Rice KL, 2009, BLOOD, V114, P5499, DOI 10.1182/blood-2009-03-206524; Ruthardt M, 1997, MOL CELL BIOL, V17, P4859, DOI 10.1128/MCB.17.8.4859; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salomoni P, 2000, NAT MED, V6, P742, DOI 10.1038/77459; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Sternsdorf T, 2006, CANCER CELL, V9, P81, DOI 10.1016/j.ccr.2005.12.030; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang KK, 2010, CANCER CELL, V17, P186, DOI 10.1016/j.ccr.2009.12.045; Xu SH, 2005, J HUM GENET, V50, P159, DOI 10.1007/s10038-005-0235-y; Yuki Y, 2004, CANCER SCI, V95, P503, DOI 10.1111/j.1349-7006.2004.tb03240.x; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	41	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24176	10.1371/journal.pone.0024176	http://dx.doi.org/10.1371/journal.pone.0024176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949697	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400002
J	Jin, X; Fu, GX; Li, XD; Zhu, DL; Gao, PJ				Jin, Xin; Fu, Guo-xiang; Li, Xiao-dong; Zhu, Ding-liang; Gao, Ping-jin			Expression and Function of Osteopontin in Vascular Adventitial Fibroblasts and Pathological Vascular Remodeling	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; FOS GENE-EXPRESSION; ANGIOTENSIN-II; ALDOSTERONE SECRETION; CARDIAC FIBROBLASTS; MOUSE DEVELOPMENT; TGF-BETA; DIFFERENTIATION	Osteopontin is known to play important roles in various diseases including vascular disorders. However, little is known about its expression and function in vascular adventitial fibroblasts. Adventitial fibroblasts have been shown to play a key role in pathological vascular remodeling associating with various vascular disorders. In this study, we measured activation of Osteopontin and its biological functions in cultured adventitial fibroblasts and injured rat carotid injury arteries induced by balloon angioplasty. Our results showed that angiotensin II and aldosterone increased Osteopontin expression in adventitial fibroblasts in a time-and concentration-dependent manner. MAPKs and AP-1 pathways were involved in Osteopontin upregulation. In addition, Adventitial fibroblast migration stimulated by Angiotensin II and aldosterone required OPN expression. Perivascular delivery of antisense oligonucleotide for Osteopontin suppressed neointimal formation post-injury. We concluded that upregulation of Osteopontin expression in adventitial fibroblasts might be important in the pathogenesis of vascular remodeling after arterial injury.	[Jin, Xin; Li, Xiao-dong; Gao, Ping-jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Vasc Biol, Inst Hlth Sci, Shanghai, Peoples R China; [Fu, Guo-xiang; Zhu, Ding-liang; Gao, Ping-jin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai, Peoples R China; [Fu, Guo-xiang; Zhu, Ding-liang; Gao, Ping-jin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Key Lab Vasc Biol, Shanghai, Peoples R China; [Jin, Xin; Fu, Guo-xiang; Li, Xiao-dong; Zhu, Ding-liang; Gao, Ping-jin] Shanghai Res Inst Hypertens, Shanghai, Peoples R China; [Jin, Xin] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Leeds	Jin, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Vasc Biol, Inst Hlth Sci, Shanghai, Peoples R China.	gaopingjin@yahoo.com.cn			National Natural Science Foundation of China [30670832, 30600325, 30870941]; National Basic Research Program of China [2006CB503804, 2009CB521905]; Shanghai Science and Technology Committee [08JC1417400, 08DZ2200400, 08410702400, 09540704600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This study was supported by grants from the National Natural Science Foundation of China (30670832, 30600325, and 30870941), the National Basic Research Program of China (2006CB503804 and 2009CB521905) and the Shanghai Science and Technology Committee (08JC1417400. 08DZ2200400, 08410702400 and 09540704600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, HYPERTENS RES, V31, P987, DOI 10.1291/hypres.31.987; Alessandri G, 2001, LAB INVEST, V81, P875, DOI 10.1038/labinvest.3780296; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Canfield AE, 2002, J PATHOL, V196, P228, DOI 10.1002/path.1020; Chaulet H, 2001, CIRC RES, V89, P772, DOI 10.1161/hh2101.098617; Chen WD, 2009, BIOCHEM BIOPH RES CO, V389, P217, DOI 10.1016/j.bbrc.2009.08.104; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; Chen WX, 1999, MOL CARCINOGEN, V24, P79, DOI 10.1002/(SICI)1098-2744(199902)24:2<79::AID-MC1>3.0.CO;2-E; Collins AR, 2004, J AM COLL CARDIOL, V43, P1698, DOI 10.1016/j.jacc.2003.11.058; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Davie NJ, 2006, AM J PATHOL, V168, P1793, DOI 10.2353/ajpath.2006.050754; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Fu K, 2008, ARTERIOSCL THROM VAS, V28, P665, DOI 10.1161/ATVBAHA.107.158030; Gao PJ, 2003, J MOL CELL CARDIOL, V35, P1105, DOI 10.1016/S0022-2828(03)00207-4; GIRY J, 1985, REPROD NUTR DEV, V25, P993, DOI 10.1051/rnd:19850713; Haurani MJ, 2007, CARDIOVASC RES, V75, P679, DOI 10.1016/j.cardiores.2007.06.016; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Hoshino A, 2008, BIOCHEM BIOPH RES CO, V368, P305, DOI 10.1016/j.bbrc.2008.01.090; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; Hu YH, 2011, ARTERIOSCL THROM VAS, V31, P1523, DOI 10.1161/ATVBAHA.110.221176; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Irita J, 2008, HYPERTENSION, V51, P507, DOI 10.1161/HYPERTENSIONAHA.107.102640; Isoda K, 2002, CIRC RES, V91, P77, DOI 10.1161/01.RES.0000025268.10302.0C; Jalvy S, 2007, CIRC RES, V100, P1292, DOI 10.1161/01.RES.0000266609.28312.de; Jin X, 2007, MOL CARCINOGEN, V46, P901, DOI 10.1002/mc.20319; Jin X, 2007, J MOL CELL CARDIOL, V43, P292, DOI 10.1016/j.yjmcc.2007.06.002; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Leen LLS, 2008, ARTERIOSCL THROM VAS, V28, P2131, DOI 10.1161/ATVBAHA.108.167965; Li L, 2006, HYPERTENS RES, V29, P95, DOI 10.1291/hypres.29.95; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Mallawaarachchi CM, 2005, ARTERIOSCL THROM VAS, V25, P1383, DOI 10.1161/01.ATV.0000168415.33812.51; Marche P., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS114, DOI 10.1111/j.1440-1681.1995.tb02844.x; Mi ZY, 2011, CARCINOGENESIS, V32, P477, DOI 10.1093/carcin/bgr009; Nitschke Y, 2009, J CELL MOL MED; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Renault MA, 2005, J BIOL CHEM, V280, P2708, DOI 10.1074/jbc.M411786200; SHARMA HS, 1994, BIOCHEM BIOPH RES CO, V205, P105, DOI 10.1006/bbrc.1994.2636; Shen WL, 2006, BIOCHEM BIOPH RES CO, V339, P337, DOI 10.1016/j.bbrc.2005.10.207; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Short M, 2004, AM J PHYSIOL-CELL PH, V286, pC416, DOI 10.1152/ajpcell.00169.2003; Siow RCM, 2007, CARDIOVASC RES, V75, P659, DOI 10.1016/j.cardiores.2007.06.007; Sodhi CP, 2000, KIDNEY INT, V58, P691, DOI 10.1046/j.1523-1755.2000.00215.x; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Stenmark KR, 2006, PHYSIOLOGY, V21, P134, DOI 10.1152/physiol.00053.2005; Struthers AD, 2004, EUR J HEART FAIL, V6, P539, DOI 10.1016/j.ejheart.2004.04.013; Sun Ai-Jun, 2004, Shengli Xuebao, V56, P21; Takemoto M, 2000, ARTERIOSCL THROM VAS, V20, P624, DOI 10.1161/01.ATV.20.3.624; Torsney E, 2005, TRENDS CARDIOVAS MED, V15, P64, DOI 10.1016/j.tcm.2005.02.003; Torsney E, 2011, J MOL CELL CARDIOL, V50, P304, DOI 10.1016/j.yjmcc.2010.09.006; Touyz RM, 2003, CLIN EXP PHARMACOL P, V30, P860, DOI 10.1046/j.1440-1681.2003.03930.x; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Xie ZL, 2004, J CELL PHYSIOL, V198, P399, DOI 10.1002/jcp.10419; Xie ZL, 2001, J CELL PHYSIOL, V188, P132, DOI 10.1002/jcp.1104; Yu M, 2011, J CELL BIOCHEM, V112, P1730, DOI 10.1002/jcb.23071; ZHU DL, 1991, J HYPERTENS, V9, P1161	62	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e23558	10.1371/journal.pone.0023558	http://dx.doi.org/10.1371/journal.pone.0023558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949681	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900002
J	Schiro, MM; Stauber, SE; Peterson, TL; Krueger, C; Darnell, SJ; Satyshur, KA; Drinkwater, NR; Newton, MA; Hoffmann, FM				Schiro, Michelle M.; Stauber, Sara E.; Peterson, Tami L.; Krueger, Chateen; Darnell, Steven J.; Satyshur, Kenneth A.; Drinkwater, Norman R.; Newton, Michael A.; Hoffmann, F. Michael			Mutations in Protein-Binding Hot-Spots on the Hub Protein Smad3 Differentially Affect Its Protein Interactions and Smad3-Regulated Gene Expression	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; BETA SIGNAL-TRANSDUCTION; TGF-BETA; MYOGENIC DIFFERENTIATION; TRANSCRIPTION FACTORS; STRUCTURAL BASIS; MESENCHYMAL TRANSITION; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; BREAST-CANCER	Background: Hub proteins are connected through binding interactions to many other proteins. Smad3, a mediator of signal transduction induced by transforming growth factor beta (TGF-beta), serves as a hub protein for over 50 protein-protein interactions. Different cellular responses mediated by Smad3 are the product of cell-type and context dependent Smad3-nucleated protein complexes acting in concert. Our hypothesis is that perturbation of this spectrum of protein complexes by mutation of single protein-binding hot-spots on Smad3 will have distinct consequences on Smad3-mediated responses. Methodology/Principal Findings: We mutated 28 amino acids on the surface of the Smad3 MH2 domain and identified 22 Smad3 variants with reduced binding to subsets of 17 Smad3-binding proteins including Smad4, SARA, Ski, Smurf2 and SIP1. Mutations defective in binding to Smad4, e. g., D408H, or defective in nucleocytoplasmic shuttling, e. g., W406A, were compromised in modulating the expression levels of a Smad3-dependent reporter gene or six endogenous Smad3-responsive genes: Mmp9, IL11, Tnfaip6, Fermt1, Olfm2 and Wnt11. However, the Smad3 mutants Y226A, Y297A, W326A, K341A, and E267A had distinct differences on TGF-beta signaling. For example, K341A and Y226A both reduced the Smad3-mediated activation of the reporter gene by similar to 50% but K341A only reduced the TGF-beta inducibilty of Olfm2 in contrast to Y226A which reduced the TGF-beta inducibility of all six endogenous genes as severely as the W406A mutation. E267A had increased protein binding but reduced TGF-beta inducibility because it caused higher basal levels of expression. Y297A had increased TGF-beta inducibility because it caused lower Smad3-induced basal levels of gene expression. Conclusions/Significance: Mutations in protein binding hot-spots on Smad3 reduced the binding to different subsets of interacting proteins and caused a range of quantitative changes in the expression of genes induced by Smad3. This approach should be useful for unraveling which Smad3 protein complexes are critical for specific biological responses.	[Schiro, Michelle M.; Stauber, Sara E.; Peterson, Tami L.; Krueger, Chateen; Darnell, Steven J.; Satyshur, Kenneth A.; Drinkwater, Norman R.; Hoffmann, F. Michael] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Carbone Canc Ctr,Dept Oncol, Madison, WI 53706 USA; [Hoffmann, F. Michael] Univ Wisconsin, Dept Med Genet, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Stat, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53706 USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schiro, MM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Carbone Canc Ctr,Dept Oncol, 1400 Univ Ave, Madison, WI 53706 USA.	Hoffmann@oncology.wisc.edu		Hoffmann, F. Michael/0000-0002-2770-9656; Satyshur, Kenneth/0000-0001-9371-2493	Muscular Dystrophy Association [MDA69637]; Juvenile Diabetes Research Foundation [17-2008-1043]; National Cancer Institute [R21-CA135483, T32-CA009135, P30-CA014520]; NATIONAL CANCER INSTITUTE [R21CA135483, T32CA009135, P30CA014520] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the Muscular Dystrophy Association (www.mda.org) (Grant# MDA69637), the Juvenile Diabetes Research Foundation (www.jdrf.org) (Grant# 17-2008-1043), and the National Cancer Institute (www.cancer.gov) (Grant#s R21-CA135483, T32-CA009135, and P30-CA014520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Burgoyne NJ, 2006, BIOINFORMATICS, V22, P1335, DOI 10.1093/bioinformatics/btl079; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chen RY, 2011, J THEOR BIOL, V269, P174, DOI 10.1016/j.jtbi.2010.10.021; Chen WJ, 2007, J BIOL CHEM, V282, P11365, DOI 10.1074/jbc.M700186200; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; CHONG PA, 2004, J BIOL CHEM; Chou WC, 2003, MOL BIOL CELL, V14, P1279, DOI 10.1091/mbc.E02-07-0375; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Cui QQ, 2005, ONCOGENE, V24, P3864, DOI 10.1038/sj.onc.1208556; Cukuroglu E, 2010, ANN BIOMED ENG, V38, P2068, DOI 10.1007/s10439-010-0048-9; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Fibbi G, 2002, BIOL CHEM, V383, P127, DOI 10.1515/BC.2002.013; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Germain S, 2000, GENE DEV, V14, P435; Goto D, 1998, FEBS LETT, V430, P201, DOI 10.1016/S0014-5793(98)00658-9; Gupta J, 2011, CANCER BIOL THER, V11, P311, DOI 10.4161/cbt.11.3.14096; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Kioulafa M, 2009, INT J CANCER, V125, P2887, DOI 10.1002/ijc.24686; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kondo M, 2004, CANCER SCI, V95, P12, DOI 10.1111/j.1349-7006.2004.tb03164.x; Lai-Cheong JE, 2010, INT J BIOCHEM CELL B, V42, P595, DOI 10.1016/j.biocel.2009.10.015; Lai-Cheong JE, 2010, DERMATOL CLIN, V28, P119, DOI 10.1016/j.det.2009.10.013; Lai-Cheong JE, 2009, AM J PATHOL, V175, P1431, DOI 10.2353/ajpath.2009.081154; Lee HJ, 2007, ONCOGENE, V26, P173, DOI 10.1038/sj.onc.1209774; Lim SK, 2006, P NATL ACAD SCI USA, V103, P18580, DOI 10.1073/pnas.0604773103; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Hernandez-Hernandez JM, 2009, J MOL BIOL, V394, P1, DOI 10.1016/j.jmb.2009.08.057; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nagy II, 2010, CARDIOVASC RES, V85, P100, DOI 10.1093/cvr/cvp254; Nakaya N, 2008, J NEUROSCI, V28, P7900, DOI 10.1523/JNEUROSCI.0617-08.2008; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; Randall RA, 2002, EMBO J, V21, P145, DOI 10.1093/emboj/21.1.145; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Sultana A, 2011, INVEST OPHTH VIS SCI, V52, P2584, DOI 10.1167/iovs.10-6356; TAYLOR IW, 2008, CELL, V378, P378; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; WARNES GR, 2010, GPLOTS VARIOUS R PRO; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Wiercinska E, 2010, BREAST CANC RES TREA; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu JW, 2001, J BIOL CHEM, V276, P20688, DOI 10.1074/jbc.M100174200; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Zeeuwen PLJM, 2010, FASEB J, V24, P3744, DOI 10.1096/fj.10-155879; Zhang SZ, 2009, BIOL RES, V42, P121, DOI [10.4067/S0716-97602009000100013, /S0716-97602009000100013]; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao BM, 2006, MOL BIOL CELL, V17, P3819, DOI 10.1091/mbc.e05-10-0990; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	101	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e25021	10.1371/journal.pone.0025021	http://dx.doi.org/10.1371/journal.pone.0025021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949838	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900045
J	Yamaguchi, R; Janssen, E; Perkins, G; Ellisman, M; Kitada, S; Reed, JC				Yamaguchi, Ryuji; Janssen, Edith; Perkins, Guy; Ellisman, Mark; Kitada, Shinichi; Reed, John C.			Efficient Elimination of Cancer Cells by Deoxyglucose-ABT-263/737 Combination Therapy	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CYTOCHROME-C RELEASE; BH3 MIMETIC ABT-737; MITOCHONDRIAL PERMEABILITY TRANSITION; PROSTATE-CANCER; ONCOGENE ADDICTION; IN-VIVO; MEMBRANE PERMEABILIZATION; CYTOGENETIC RESPONSES; GLYCOLYSIS INHIBITION	As single agents, ABT-263 and ABT-737 (ABT), molecular antagonists of the Bcl-2 family, bind tightly to Bcl-2, Bcl-xL and Bcl-w, but not to Mcl-1, and induce apoptosis only in limited cell types. The compound 2-deoxyglucose (2DG), in contrast, partially blocks glycolysis, slowing cell growth but rarely causing cell death. Injected into an animal, 2DG accumulates predominantly in tumors but does not harm other tissues. However, when cells that were highly resistant to ABT were pre-treated with 2DG for 3 hours, ABT became a potent inducer of apoptosis, rapidly releasing cytochrome c from the mitochondria and activating caspases at submicromolar concentrations in a Bak/Bax-dependent manner. Bak is normally sequestered in complexes with Mcl-1 and Bcl-xL. 2DG primes cells by interfering with Bak-Mcl-1 association, making it easier for ABT to dissociate Bak from Bcl-xL, freeing Bak to induce apoptosis. A highly active glucose transporter and Bid, as an agent of the mitochondrial apoptotic signal amplification loop, are necessary for efficient apoptosis induction in this system. This combination treatment of cancer-bearing mice was very effective against tumor xenograft from hormone-independent highly metastasized chemo-resistant human prostate cancer cells, suggesting that the combination treatment may provide a safe and effective alternative to genotoxin-based cancer therapies.	[Yamaguchi, Ryuji; Kitada, Shinichi; Reed, John C.] Sanford Burnham Med Res Inst, Program Cell Death & Apoptosis, La Jolla, CA 92037 USA; [Janssen, Edith] Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA; [Perkins, Guy; Ellisman, Mark] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Yamaguchi, Ryuji] Kyushu Univ, Sch Med, Dept Mol Biol, Fukuoka 812, Japan	Sanford Burnham Prebys Medical Discovery Institute; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of California System; University of California San Diego; Kyushu University	Yamaguchi, R (corresponding author), Sanford Burnham Med Res Inst, Program Cell Death & Apoptosis, La Jolla, CA 92037 USA.	rudy.yamaguchi@gmail.com		Yamaguchi, Ryuji/0000-0002-1706-7063; Perkins, Guy/0000-0002-1834-6646; janssen, edith/0000-0001-7881-6307	National Institutes of Health(NIH)/National Cancer Institute [CA138617]; NIH [P41RR004050]; NIH NCRR [P41RR004050];  [CA113318];  [CA055164];  [CA081534]; NATIONAL CANCER INSTITUTE [P01CA055164, P20CA081534, U19CA113318, P01CA081534, R01CA138617] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER	National Institutes of Health(NIH)/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	EJ received National Institutes of Health(NIH)/National Cancer Institute Grant CA138617, ME received NIH grant P41RR004050, and JCR received CA113318, CA055164, and CA081534. Some of the work described here was conducted using facilities at the National Center for Microscopy and Imaging Research at the University of California San Diego, supported by the NIH NCRR through grant number P41RR004050 to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2006, NEOPLASIA, V8, P725, DOI 10.1593/neo.06388; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Caraco C, 2000, J BIOL CHEM, V275, P18489, DOI 10.1074/jbc.M908096199; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; CHEN TR, 1993, CYTOGENET CELL GENET, V62, P183, DOI 10.1159/000133468; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Dearling JLJ, 2007, CLIN CANCER RES, V13, P1903, DOI 10.1158/1078-0432.CCR-06-2094; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Galluzzi L, 2007, NAT CELL BIOL, V9, P487, DOI 10.1038/ncb0507-487; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green D R, 1998, Results Probl Cell Differ, V24, P45; GRIDLEY DS, 1985, INT J RADIAT ONCOL, V11, P567, DOI 10.1016/0360-3016(85)90189-0; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hauck P, 2009, MOL CANCER THER, V8, P883, DOI 10.1158/1535-7163.MCT-08-1118; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Hockenbery DM, 2010, ENVIRON MOL MUTAGEN, V51, P476, DOI 10.1002/em.20552; Hyer ML, 2008, CANCER RES, V68, P2927, DOI 10.1158/0008-5472.CAN-07-5759; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kodama T, 2011, J BIOL CHEM, V286, P13905, DOI 10.1074/jbc.M110.195370; KOHNO T, 1994, ONCOGENE, V9, P103; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Myzak MC, 2007, EXP BIOL MED, V232, P227; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Owens TW, 2009, CELL DEATH DIFFER, V16, P1551, DOI 10.1038/cdd.2009.102; Pan Y, 2001, GENE CHROMOSOME CANC, V30, P187, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1075>3.3.CO;2-8; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Salvesen GS, 2008, ADV EXP MED BIOL, V615, P13, DOI 10.1007/978-1-4020-6554-5_2; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Srivastava SK, 2003, CARCINOGENESIS, V24, P1665, DOI 10.1093/carcin/bgg123; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TWILLIE DA, 1995, UROLOGY, V45, P542, DOI 10.1016/S0090-4295(99)80034-X; van Bokhoven A, 2001, PROSTATE, V47, P36; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2008, CELL DEATH DIFFER, V15, P820, DOI 10.1038/cdd.2008.25; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 1997, CLIN CANCER RES, V3, P2696; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Xiao D, 2006, CLIN CANCER RES, V12, P6836, DOI 10.1158/1078-0432.CCR-06-1273; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yamaguchi R, 2009, BBA-BIOENERGETICS, V1787, P963, DOI 10.1016/j.bbabio.2009.02.005; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	72	56	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24102	10.1371/journal.pone.0024102	http://dx.doi.org/10.1371/journal.pone.0024102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949692	gold, Green Published, Green Submitted			2022-12-25	WOS:000295257900004
J	Improta, R; Vitagliano, L; Esposito, L				Improta, Roberto; Vitagliano, Luigi; Esposito, Luciana			Peptide Bond Distortions from Planarity: New Insights from Quantum Mechanical Calculations and Peptide/Protein Crystal Structures	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; DENSITY-FUNCTIONAL THEORY; C-N BOND; GAS-PHASE; AB-INITIO; VIBRATIONAL-SPECTRA; ROTATIONAL BARRIERS; REFINEMENT TARGETS; PROTEIN STRUCTURES; AQUEOUS-SOLUTION	By combining quantum-mechanical analysis and statistical survey of peptide/protein structure databases we here report a thorough investigation of the conformational dependence of the geometry of peptide bond, the basic element of protein structures. Different peptide model systems have been studied by an integrated quantum mechanical approach, employing DFT, MP2 and CCSD(T) calculations, both in aqueous solution and in the gas phase. Also in absence of inter-residue interactions, small distortions from the planarity are more a rule than an exception, and they are mainly determined by the backbone psi dihedral angle. These indications are fully corroborated by a statistical survey of accurate protein/peptide structures. Orbital analysis shows that orbital interactions between the sigma system of C-alpha substituents and the pi system of the amide bond are crucial for the modulation of peptide bond distortions. Our study thus indicates that, although long-range inter-molecular interactions can obviously affect the peptide planarity, their influence is statistically averaged. Therefore, the variability of peptide bond geometry in proteins is remarkably reproduced by extremely simplified systems since local factors are the main driving force of these observed trends. The implications of the present findings for protein structure determination, validation and prediction are also discussed.	[Improta, Roberto; Vitagliano, Luigi; Esposito, Luciana] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Improta, R (corresponding author), CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy.	robimp@unina.it; luciana.esposito@unina.it	esposito, luciana/Q-3182-2017; improta, roberto/L-4971-2013	esposito, luciana/0000-0001-6431-2677; improta, roberto/0000-0003-1004-195X	Minstero Istruzione Universita Ricerca (MIUR) [RBFR08DUX6]	Minstero Istruzione Universita Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been funded by Minstero Istruzione Universita Ricerca (MIUR) (PRIN2008 and FIRB RBFR08DUX6). The authors thank CINECA Supercomputing for computational support (project number 953). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo C, 1999, J CHEM PHYS, V111, P2889, DOI 10.1063/1.479571; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], 1998, J Mol Biol, V276, P417; Barone V, 1997, J CHEM PHYS, V107, P3210, DOI 10.1063/1.474671; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Bednarova L, 2007, CHIRALITY, V19, P775, DOI 10.1002/chir.20462; Berkholz DS, 2010, NUCLEIC ACIDS RES, V38, pD320, DOI 10.1093/nar/gkp1013; Berkholz DS, 2009, STRUCTURE, V17, P1316, DOI 10.1016/j.str.2009.08.012; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Branden C., 1999, INTRO PROTEIN STRUCT; Buck M, 1999, J AM CHEM SOC, V121, P9645, DOI 10.1021/ja991309p; BURTON NA, 1993, J CHEM SOC FARADAY T, V89, P2631, DOI 10.1039/ft9938902631; CHAKRABARTI P, 1986, BIOPOLYMERS, V25, P1087, DOI 10.1002/bip.360250609; Choudhary A, 2011, PROTEIN SCI, V20, P1077, DOI 10.1002/pro.627; Choudhary A, 2009, J AM CHEM SOC, V131, P7244, DOI 10.1021/ja901188y; CIEPLAK AS, 1985, J AM CHEM SOC, V107, P271, DOI 10.1021/ja00287a060; DUNITZ JD, 1975, ACTA CRYSTALLOGR B, V31, P251, DOI 10.1107/S0567740875002427; Edison AS, 2001, NAT STRUCT BIOL, V8, P201, DOI 10.1038/84921; Esposito L, 2000, PROTEIN SCI, V9, P2038; Esposito L, 2000, J MOL BIOL, V297, P713, DOI 10.1006/jmbi.2000.3597; Esposito L, 2002, PROTEIN PEPTIDE LETT, V9, P95, DOI 10.2174/0929866023408887; Esposito L, 2005, J MOL BIOL, V347, P483, DOI 10.1016/j.jmb.2005.01.065; Fogarasi G, 1997, J PHYS CHEM A, V101, P1400, DOI 10.1021/jp963765v; FOSTER JP, 1980, J AM CHEM SOC, V102, P7211, DOI 10.1021/ja00544a007; Frisch M., 2016, GAUSSIAN 16 REVISION; Glendening ED, 1998, J COMPUT CHEM, V19, P593, DOI 10.1002/(SICI)1096-987X(19980430)19:6<593::AID-JCC3>3.0.CO;2-M; Greenberg A., 2000, AMIDE LINKAGE STRUCT; HEADGORDON T, 1991, J AM CHEM SOC, V113, P5989, DOI 10.1021/ja00016a010; Hu JS, 1997, J AM CHEM SOC, V119, P6360, DOI 10.1021/ja970067v; Hudaky I, 2004, J COMPUT CHEM, V25, P1522, DOI 10.1002/jcc.20073; Improta R, 2001, J AM CHEM SOC, V123, P3311, DOI 10.1021/ja003680e; Improta R, 2008, PROTEIN SCI, V17, P955, DOI 10.1110/ps.073301908; Jalkanen KJ, 2008, THEOR CHEM ACC, V119, P191, DOI 10.1007/s00214-007-0361-z; Jaskolski M, 2007, ACTA CRYSTALLOGR D, V63, P611, DOI 10.1107/S090744490700978X; JEFFREY GA, 1985, J AM CHEM SOC, V107, P321, DOI 10.1021/ja00288a007; Juranic N, 2008, PROTEIN SCI, V17, P768, DOI 10.1110/ps.073331608; Karplus PA, 2008, ACTA CRYSTALLOGR D, V64, P335, DOI 10.1107/S0907444908002333; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Langella E, 2002, J AM CHEM SOC, V124, P11531, DOI 10.1021/ja020465k; Lauvergnat D, 1997, J AM CHEM SOC, V119, P9478, DOI 10.1021/ja9639426; Lecomte C, 2008, J SYNCHROTRON RADIAT, V15, P202, DOI 10.1107/S0909049508000447; MacArthur MW, 1996, J MOL BIOL, V264, P1180, DOI 10.1006/jmbi.1996.0705; MilnerWhite EJ, 1997, PROTEIN SCI, V6, P2477; Mujika JI, 2006, CHEM-EUR J, V12, P7215, DOI 10.1002/chem.200600052; Padmaja L, 2008, SPECTROCHIM ACTA A, V71, P252, DOI 10.1016/j.saa.2007.12.019; Perczel A, 2003, J COMPUT CHEM, V24, P1026, DOI 10.1002/jcc.10267; Poon CD, 2000, J AM CHEM SOC, V122, P5642, DOI 10.1021/ja993953+; RAMACHANDRAN GN, 1973, BIOCHIM BIOPHYS ACTA, V303, P385, DOI 10.1016/0005-2795(73)90374-7; Ramek M, 2000, J PHYS CHEM A, V104, P9636, DOI 10.1021/jp002498x; Rick SW, 2000, J CHEM PHYS, V112, P5230, DOI 10.1063/1.481078; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; RONDAN NG, 1981, J AM CHEM SOC, V103, P2436, DOI 10.1021/ja00399a063; Schmidt A, 2002, CURR OPIN STRUC BIOL, V12, P698, DOI 10.1016/S0959-440X(02)00394-9; Selvarengan P, 2005, BIOORG CHEM, V33, P253, DOI 10.1016/j.bioorg.2004.08.006; Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107; Stec B, 2007, ACTA CRYSTALLOGR D, V63, P1113, DOI 10.1107/S0907444907041406; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Toroz D, 2010, PHYS CHEM CHEM PHYS, V12, P3463, DOI 10.1039/b921897a; Tronrud DE, 2011, ACTA CRYSTALLOGR D, V67, P699, DOI [10.1107/S090744491102292X, 10.1107/S090744491102292X699]; Tsai M, 2009, J PHYS CHEM B, V113, P309, DOI 10.1021/jp8063646; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; WIBERG KB, 1992, J AM CHEM SOC, V114, P831, DOI 10.1021/ja00029a005; WIBERG KB, 1995, J AM CHEM SOC, V117, P4261, DOI 10.1021/ja00120a006; Yamada S, 1996, J ORG CHEM, V61, P941, DOI 10.1021/jo9516953; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763	65	37	38	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24533	10.1371/journal.pone.0024533	http://dx.doi.org/10.1371/journal.pone.0024533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949726	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800025
J	Madsen, L; Kriegenburg, F; Vala, A; Best, D; Prag, S; Hofmann, K; Seeger, M; Adams, IR; Hartmann-Petersen, R				Madsen, Louise; Kriegenburg, Franziska; Vala, Andrea; Best, Diana; Prag, Soren; Hofmann, Kay; Seeger, Michael; Adams, Ian R.; Hartmann-Petersen, Rasmus			The Tissue-Specific Rep8/UBXD6 Tethers p97 to the Endoplasmic Reticulum Membrane for Degradation of Misfolded Proteins	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; UBIQUITIN LIGASES; ATPASE; ER; BINDING; CALMEGIN; COFACTORS; PATHWAY; COMPLEX; STRESS	The protein known as p97 or VCP in mammals and Cdc48 in yeast is a versatile ATPase complex involved in several biological functions including membrane fusion, protein folding, and activation of membrane-bound transcription factors. In addition, p97 plays a central role in degradation of misfolded secretory proteins via the ER-associated degradation pathway. This functional diversity of p97 depends on its association with various cofactors, and to further our understanding of p97 function it is important that these cofactors are identified and analyzed. Here, we isolate and characterize the human protein named Rep8 or Ubxd6 as a new cofactor of p97. Mouse Rep8 is highly tissue-specific and abundant in gonads. In testes, Rep8 is expressed in post-meiotic round spermatids, whereas in ovaries Rep8 is expressed in granulosa cells. Rep8 associates directly with p97 via its UBX domain. We show that Rep8 is a transmembrane protein that localizes to the ER membrane with its UBX domain facing the cytoplasm. Knock-down of Rep8 expression in human cells leads to a decreased association of p97 with the ER membrane and concomitantly a retarded degradation of misfolded ER-derived proteasome substrates. Thus, Rep8 tethers p97 to the ER membrane for efficient ER-associated degradation.	[Madsen, Louise; Kriegenburg, Franziska; Vala, Andrea; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Best, Diana; Adams, Ian R.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Prag, Soren] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Hofmann, Kay] Miltenyi Biotec GmbH, Bioinformat Dept, Bergisch Gladbach, Germany; [Seeger, Michael] Charite, Inst Biochem, D-13353 Berlin, Germany	University of Copenhagen; University of Edinburgh; Universidade de Lisboa; Miltenyi Biotec; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Madsen, L (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	rhpetersen@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014; Adams, Ian/P-9862-2016; Adams, Ian R/AAU-1231-2021	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Adams, Ian/0000-0001-8838-1271; Adams, Ian R/0000-0001-8838-1271	Lundbeck Foundation; Novo Nordisk Foundation; Medical Research Council; Danish Council for Independent Research (Natural Sciences); Medical Research Council [MC_U127580973] Funding Source: researchfish; MRC [MC_U127580973] Funding Source: UKRI	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported financially by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Medical Research Council and the Danish Council for Independent Research (Natural Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buffone MG, 2008, INT J DEV BIOL, V52, P511, DOI 10.1387/ijdb.072532mb; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; Koga N, 2009, P NATL ACAD SCI USA, V106, P18237, DOI 10.1073/pnas.0904756106; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Lass A, 2008, EXP CELL RES, V314, P2715, DOI 10.1016/j.yexcr.2008.06.008; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Ollinger R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000199; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Sasagawa Y, 2010, GENES CELLS, V15, P1201, DOI 10.1111/j.1365-2443.2010.01454.x; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; van Lith M, 2007, MOL BIOL CELL, V18, P2795, DOI 10.1091/mbc.E07-02-0147; WATANABE D, 1994, J BIOL CHEM, V269, P7744; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamabe Y, 1997, GENOMICS, V39, P198, DOI 10.1006/geno.1996.4480; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang HT, 2000, DNA CELL BIOL, V19, P253, DOI 10.1089/10445490050021168	60	11	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e25061	10.1371/journal.pone.0025061	http://dx.doi.org/10.1371/journal.pone.0025061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949850	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700091
J	Wacker, E; Spitzer, B; Lutzkendorf, R; Bernarding, J; Blankenburg, F				Wacker, Evelin; Spitzer, Bernhard; Luetzkendorf, Ralf; Bernarding, Johannes; Blankenburg, Felix			Tactile Motion and Pattern Processing Assessed with High-Field fMRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PRIMARY SOMATOSENSORY CORTEX; POSTERIOR PARIETAL CORTEX; HUMAN VISUAL-CORTEX; EVENT-RELATED FMRI; HUMAN BRAIN; AWAKE MONKEYS; BODY-SURFACE; SOMATOTOPIC ORGANIZATION; CYTOARCHITECTONIC AREAS	Processing of motion and pattern has been extensively studied in the visual domain, but much less in the somatosensory system. Here, we used ultra-high-field functional magnetic resonance imaging (fMRI) at 7 Tesla to investigate the neuronal correlates of tactile motion and pattern processing in humans under tightly controlled stimulation conditions. Different types of dynamic stimuli created the sensation of moving or stationary bar patterns during passive touch. Activity in somatosensory cortex was increased during both motion and pattern processing and modulated by motion directionality in primary and secondary somatosensory cortices (SI and SII) as well as by pattern orientation in the anterior intraparietal sulcus. Furthermore, tactile motion and pattern processing induced activity in the middle temporal cortex (hMT+/V5) and in the inferior parietal cortex (IPC), involving parts of the supramarginal und angular gyri. These responses covaried with subjects' individual perceptual performance, suggesting that hMT+/V5 and IPC contribute to conscious perception of specific tactile stimulus features. In addition, an analysis of effective connectivity using psychophysiological interactions (PPI) revealed increased functional coupling between SI and hMT+/V5 during motion processing, as well as between SI and IPC during pattern processing. This connectivity pattern provides evidence for the direct engagement of these specialized cortical areas in tactile processing during somesthesis.	[Wacker, Evelin; Spitzer, Bernhard; Blankenburg, Felix] Charite, Dept Neurol, Berlin, Germany; [Wacker, Evelin; Spitzer, Bernhard; Blankenburg, Felix] Charite, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Luetzkendorf, Ralf; Bernarding, Johannes] Otto Von Guericke Univ, Inst Biometry & Med Informat, Magdeburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Otto von Guericke University	Wacker, E (corresponding author), Charite, Dept Neurol, Berlin, Germany.	evelin.wacker@bccn-berlin.de	; Spitzer, Bernhard/L-5665-2013	Beck, Evelin/0000-0003-1008-8563; Spitzer, Bernhard/0000-0001-9752-932X	German Federal Ministry of Education and Research (BMBF) [01EV0707]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was supported by the German Federal Ministry of Education and Research (BMBF; 01EV0707 to FB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Beauchamp MS, 2007, J NEUROSCI, V27, P8261, DOI 10.1523/JNEUROSCI.0754-07.2007; Bensmaia SJ, 2008, J NEUROSCI, V28, P776, DOI 10.1523/JNEUROSCI.4162-07.2008; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Bodegard A, 2000, NEUROREPORT, V11, P187, DOI 10.1097/00001756-200001170-00037; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brodmann, 1909, VERGLEICHENDE LOKALI; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; COSTANZO RM, 1980, J NEUROPHYSIOL, V43, P1318, DOI 10.1152/jn.1980.43.5.1319; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; DiCarlo JJ, 2002, BEHAV BRAIN RES, V135, P167, DOI 10.1016/S0166-4328(02)00162-6; DiCarlo JJ, 2000, J NEUROSCI, V20, P495, DOI 10.1523/JNEUROSCI.20-01-00495.2000; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, CEREB CORTEX, V17, P1800, DOI 10.1093/cercor/bhl090; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Freeman J, 2011, J NEUROSCI, V31, P4792, DOI 10.1523/JNEUROSCI.5160-10.2011; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grefkes C, 2002, NEURON, V35, P173, DOI 10.1016/S0896-6273(02)00741-9; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hinkley LBN, 2009, J NEUROPHYSIOL, V102, P3433, DOI 10.1152/jn.90785.2008; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Hsiao SS, 2002, BEHAV BRAIN RES, V135, P93, DOI 10.1016/S0166-4328(02)00160-2; KAAS JH, 1983, PHYSIOL REV, V63, P206, DOI 10.1152/physrev.1983.63.1.206; KAAS JH, 1979, SCIENCE, V204, P521, DOI 10.1126/science.107591; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kitada R, 2006, J NEUROSCI, V26, P7491, DOI 10.1523/JNEUROSCI.0822-06.2006; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; Lacey S, 2011, PROG BRAIN RES, V191, P165, DOI 10.1016/B978-0-444-53752-2.00006-0; Lacey S, 2010, NEUROIMAGE, V49, P1977, DOI 10.1016/j.neuroimage.2009.10.081; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lucan JN, 2010, HUM BRAIN MAPP, V31, P1813, DOI 10.1002/hbm.20983; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; MERZENICH MM, 1978, J COMP NEUROL, V181, P41, DOI 10.1002/cne.901810104; Miquee A, 2008, NEUROSCIENCE, V152, P29, DOI 10.1016/j.neuroscience.2007.12.021; Nakamura J, 1998, CORTEX, V34, P375, DOI 10.1016/S0010-9452(08)70761-5; NELSON RJ, 1980, J COMP NEUROL, V192, P611, DOI 10.1002/cne.901920402; PANDYA DN, 1982, J COMP NEUROL, V204, P196, DOI 10.1002/cne.902040208; Pei YC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000305; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; PHILLIPS JR, 1988, P NATL ACAD SCI USA, V85, P1317, DOI 10.1073/pnas.85.4.1317; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Pleger B, 2006, J NEUROSCI, V26, P12596, DOI 10.1523/JNEUROSCI.4275-06.2006; PONS TP, 1985, J COMP NEUROL, V241, P445, DOI 10.1002/cne.902410405; Pruett JR, 2000, J NEUROPHYSIOL, V84, P780, DOI 10.1152/jn.2000.84.2.780; REED CL, 1994, NEUROPSYCHOLOGIA, V32, P527, DOI 10.1016/0028-3932(94)90142-2; Reed CL, 1996, BRAIN, V119, P875, DOI 10.1093/brain/119.3.875; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; RUIZ S, 1995, J NEUROPHYSIOL, V73, P525, DOI 10.1152/jn.1995.73.2.525; Sani L, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00159; Scheperjans F, 2005, NEUROIMAGE, V28, P362, DOI 10.1016/j.neuroimage.2005.06.028; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Stoeckel MC, 2003, NEUROIMAGE, V19, P1103, DOI 10.1016/S1053-8119(03)00182-4; Stoesz MR, 2003, INT J PSYCHOPHYSIOL, V50, P41, DOI 10.1016/S0167-8760(03)00123-5; Summers IR, 2009, J ACOUST SOC AM, V125, P1033, DOI 10.1121/1.3056399; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; van der Zwaag W, 2009, J MAGN RESON IMAGING, V30, P1171, DOI 10.1002/jmri.21951; WARREN S, 1986, J NEUROPHYSIOL, V56, P598, DOI 10.1152/jn.1986.56.3.598; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WHITSEL BL, 1969, J NEUROPHYSIOL, V32, P170, DOI 10.1152/jn.1969.32.2.170; ZEKI S, 1991, J NEUROSCI, V11, P641	80	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24860	10.1371/journal.pone.0024860	http://dx.doi.org/10.1371/journal.pone.0024860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949769	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700067
J	Carvalho, A; Olson, SK; Gutierrez, E; Zhang, K; Noble, LB; Zanin, E; Desai, A; Groisman, A; Oegema, K				Carvalho, Ana; Olson, Sara K.; Gutierrez, Edgar; Zhang, Kelly; Noble, Lisa B.; Zanin, Esther; Desai, Arshad; Groisman, Alex; Oegema, Karen			Acute Drug Treatment in the Early C. elegans Embryo	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; IDENTIFICATION; EXPRESSION; PROTEIN; COMPLEX	Genetic and genome-wide RNAi approaches available in C. elegans, combined with tools for visualizing subcellular events with high-resolution, have led to increasing adoption of the early C. elegans embryo as a model for mechanistic and functional genomic analysis of cellular processes. However, a limitation of this system has been the impermeability of the embryo eggshell, which has prevented the routine use of small molecule inhibitors. Here, we present a method to permeabilize and immobilize embryos for acute inhibitor treatment in conjunction with live imaging. To identify a means to permeabilize the eggshell, we used a dye uptake assay to screen a set of 310 candidate genes defined by a combination of bioinformatic criteria. This screen identified 20 genes whose inhibition resulted in >75% eggshell permeability, and 3 that permeabilized embryos with minimal deleterious effects on embryo production and early embryonic development. To mount permeabilized embryos for acute drug addition in conjunction with live imaging, we combined optimized inhibition of one of these genes with the use of a microfabricated chamber that we designed. We demonstrate that these two developments enable the temporally controlled introduction of inhibitors for mechanistic studies. This method should also open new avenues of investigation by allowing profiling and specificity-testing of inhibitors through comparison with genome-wide phenotypic datasets.	[Carvalho, Ana; Olson, Sara K.; Zhang, Kelly; Noble, Lisa B.; Zanin, Esther; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Gutierrez, Edgar; Groisman, Alex] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Carvalho, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	agroisman@ucsd.edu; koegema@ucsd.edu	Groisman, Alexander/AAU-7843-2021; Zanin, Esther/L-6457-2017; Carvalho, Ana/J-4788-2013	Zanin, Esther/0000-0003-1450-8684; Carvalho, Ana/0000-0002-2256-7134; Zhang, Kelly/0000-0002-1406-0480	National Institutes of Health (NIH) [R01 GM074207, R01 GM084332, GM06852]; Ludwig Institute for Cancer Research; Genome Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074207, R01GM084332] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Genome Canada(Genome Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) to KO (R01 GM074207) and AG (R01 GM084332) and by funding from the Ludwig Institute for Cancer Research to KO and AD. SO is a San Diego IRACDA Postdoctoral Fellow supported by NIH Grant GM06852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Brian Ackley, Yishi Jin and Andrew Chisholm for providing us with a curated list of C. elegans genes containing a signal sequence. SAGE data were produced at the Michael Smith Genome Sciences Centre with funding from Genome Canada and were obtained from the Genome BC C. elegans Gene Expression Consortium http://elegans.bcgsc.bc.ca/.	Benenati G, 2009, MECH DEVELOP, V126, P382, DOI 10.1016/j.mod.2009.02.001; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; HILL DP, 1990, DEVELOPMENT, V108, P159; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kartalov EP, 2006, P NATL ACAD SCI USA, V103, P12280, DOI 10.1073/pnas.0602890103; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Oishi K, 2007, J CELL BIOL, V179, P1149, DOI 10.1083/jcb.200705108; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Rappleye CA, 2002, DEV CELL, V2, P195, DOI 10.1016/S1534-5807(02)00114-4; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; SCHIERENBERG E, 1992, ROUX ARCH DEV BIOL, V202, P10, DOI 10.1007/BF00364592	16	76	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24656	10.1371/journal.pone.0024656	http://dx.doi.org/10.1371/journal.pone.0024656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935434	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700033
J	Lin, YS; Huang, LD; Lin, CH; Huang, PH; Chen, YJ; Wong, FH; Lin, CC; Fu, SL				Lin, Yong-Shiang; Huang, Li-De; Lin, Chao-Hsiung; Huang, Po-Hsiung; Chen, Yu-Jen; Wong, Fen-Hwa; Lin, Chun-Cheng; Fu, Shu-Ling			In Vitro and in Vivo Anticancer Activity of a Synthetic Glycolipid as Toll-like Receptor 4 (TLR4) Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE ACTIVATION; TUMOR-REGRESSION; DENDRITIC CELLS; BONE-MARROW; COMBINATION; GENE; LIPOPOLYSACCHARIDE; RECOGNITION; EXPRESSION; DIFFERENTIATION	Activation of Toll-like receptor 4 (TLR4) triggers the innate immune response and leads to the induction of adaptive immunity. TLR4 agonists are known to function as immunostimulants and exhibit promising therapeutic potential for cancer immunotherapy. We have previously developed a synthetic serine-based glycolipid (designated as CCL-34) that can activate TLR4-dependent signaling pathways. In this study, the anticancer immunity of CCL-34 was further demonstrated. CCL-34-activated macrophages induced cancer cell death via the apoptotic pathway, and this cytotoxicity was significantly inhibited by N-G-monomethyl-L-arginine (an inducible NOS inhibitor). Notably, conditioned medium collected from CCL-34-treated splenocytes also induced cytotoxicity toward cancer cells. Furthermore, CCL-34 treatment suppressed tumor growth and increased the survival rate in TLR4-functional C3H/HeN mice but not in TLR4-defective C3H/HeJ mice. Increased apoptosis, the induction of cytokines (IFN-gamma and IL-12) and chemokines (CXCL9 and CXCL10), and the elevation of leukocyte markers (CD11b, CD11c, CD4, and CD8) were detected at tumor sites in C3H/HeN mice but not in C3H/HeJ mice. Structure-and-activity relationship analysis of CCL-34 and its structural analogs revealed that a sugar moiety is essential for its activity. However, the substitution of the galactose in CCL-34 with glucose or fucose did not reduce its activity. Altogether, this study reveals the anticancer activity of a new synthetic TLR4 agonist and broadens the molecular basis of TLR4-activating glycolipids.	[Huang, Li-De; Lin, Chun-Cheng] Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan; [Lin, Yong-Shiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 11221, Taiwan; [Lin, Yong-Shiang; Fu, Shu-Ling] Acad Sinica, Taipei 11221, Taiwan; [Lin, Yong-Shiang; Fu, Shu-Ling] Natl Yang Ming Univ, Program Mol Med, Taipei 11221, Taiwan; [Lin, Chao-Hsiung; Wong, Fen-Hwa] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Lin, Chao-Hsiung; Wong, Fen-Hwa] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Huang, Po-Hsiung] Natl Yang Ming Univ, Inst Tradit Med, Taipei 11221, Taiwan; [Chen, Yu-Jen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei 10449, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital	Lin, CC (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cclin66@mx.nthu.edu.tw; slfu@ym.edu.tw			National Science Council [NSC 99-2320-B-010-009-MY3, 98-2323-B-007-001]; Ministry of Education [95A-C-D01-PPG-03]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education	This work was supported in part by National Science Council Grants NSC 99-2320-B-010-009-MY3 and 98-2323-B-007-001 and Ministry of Education, Aim for the Top University Plan, Grant 95A-C-D01-PPG-03.	Akazawa T, 2004, CANCER RES, V64, P757, DOI 10.1158/0008-5472.CAN-03-1518; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chen SA, 2000, CLIN CANCER RES, V6, P4381; Cluff CW, 2009, ADV EXP MED BIOL, V667, P111, DOI 10.1007/978-1-4419-1603-7_10; D'Agostini C, 2005, INT IMMUNOPHARMACOL, V5, P1205, DOI 10.1016/j.intimp.2005.02.013; Garay RP, 2007, EUR J PHARMACOL, V563, P1, DOI 10.1016/j.ejphar.2007.02.018; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Ho MY, 2010, CANCER SCI, V101, P2411, DOI 10.1111/j.1349-7006.2010.01691.x; Huang LD, 2011, ORG BIOMOL CHEM, V9, P2492, DOI 10.1039/c0ob00990c; Hung LC, 2007, BIOCHEM PHARMACOL, V73, P1957, DOI 10.1016/j.bcp.2007.03.006; Kamat AM, 2009, CANCER RES, V69, P8958, DOI 10.1158/0008-5472.CAN-09-2045; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lee CF, 2004, CANCER GENE THER, V11, P194, DOI 10.1038/sj.cgt.7700658; Lee CH, 2008, CLIN CANCER RES, V14, P1905, DOI 10.1158/1078-0432.CCR-07-2050; Liao HF, 2005, LIFE SCI, V77, P400, DOI 10.1016/j.lfs.2004.10.080; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mei K, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-63; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Okamoto M, 2003, JNCI-J NATL CANCER I, V95, P316, DOI 10.1093/jnci/95.4.316; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5; Pfannes SDC, 2001, J LEUKOCYTE BIOL, V69, P590; Spadiut O, 2010, J AGR FOOD CHEM, V58, P3465, DOI 10.1021/jf9040047; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Udagawa M, 2006, CLIN CANCER RES, V12, P7465, DOI 10.1158/1078-0432.CCR-06-1840; Umansky V, 2001, ADV CANCER RES, V82, P107, DOI 10.1016/S0065-230X(01)82004-2; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312	34	19	24	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43782	43792		10.1074/jbc.M111.285171	http://dx.doi.org/10.1074/jbc.M111.285171			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21949133	Green Published, hybrid			2022-12-25	WOS:000298402300021
J	Chang, JR; Mukerjee, R; Bagashev, A; Del Valle, L; Chabrashvili, T; Hawkins, BJ; He, JJ; Sawaya, BE				Chang, J. Robert; Mukerjee, Ruma; Bagashev, Asen; Del Valle, Luis; Chabrashvili, Tinatin; Hawkins, Brian J.; He, Johnny J.; Sawaya, Bassel E.			HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NERVE GROWTH-FACTOR; TRANSACTIVATING PROTEIN; CELLULAR MICRORNA; TUMOR-SUPPRESSOR; RNA INTERFERENCE; REQUIRE FUNCTION; TRANSCRIPTION; TYPE-1; INVOLVEMENT	Over the last decade, small noncoding RNA molecules such as microRNAs (miRNAs) have emerged as critical regulators in the expression and function of eukaryotic genomes. It has been suggested that viral infections and neurological disease outcome may also be shaped by the influence of small RNAs. This has prompted us to suggest that HIV infection alters the endogenous miRNA expression patterns, thereby contributing to neuronal deregulation and AIDS dementia. Therefore, using primary cultures and neuronal cell lines, we examined the impact of a viral protein (HIV-1 Tat) on the expression of miRNAs due to its characteristic features such as release from the infected cells and taken up by noninfected cells. Using microRNA array assay, we demonstrated that Tat deregulates the levels of several miRNAs. Interestingly, miR-34a was among the most highly induced miRNAs in Tat-treated neurons. Tat also decreases the levels of miR-34a target genes such as CREB protein as shown by real time PCR. The effect of Tat was neutralized in the presence of anti-miR-34a. Using in situ hybridization assay, we found that the levels of miR-34a increase in Tat transgenic mice when compared with the parental mice. Therefore, we conclude that deregulation of neuronal functions by HIV-1 Tat protein is miRNA-dependent.	[Chang, J. Robert; Mukerjee, Ruma; Bagashev, Asen; Chabrashvili, Tinatin; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurol, Mol Studies Neurodegenerat Dis Lab, Philadelphia, PA 19140 USA; [Del Valle, Luis] Louisiana State Univ, Stanley S Scott Canc Ctr, Sch Med, Dept Med,Sect Hematol Oncol, New Orleans, LA 70112 USA; [Del Valle, Luis] Louisiana State Univ, Stanley S Scott Canc Ctr, Sch Med, Dept Pathol, New Orleans, LA 70112 USA; [Hawkins, Brian J.] Univ Washington, Mitochondria & Metab Ctr, Seattle, WA 98109 USA; [He, Johnny J.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Ctr AIDS Res, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Louisiana State University System; Louisiana State University System; University of Washington; University of Washington Seattle; Indiana University System; Indiana University-Purdue University Indianapolis	Sawaya, BE (corresponding author), Temple Univ, Sch Med, Dept Neurol, Mol Studies Neurodegenerat Dis Lab, 3420 N Broad St, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Bagashev, Asen/D-2913-2011; Del Valle, Luis/J-4085-2015; Xie, Huangming/B-2260-2012	Bagashev, Asen/0000-0001-9900-8106; Del Valle, Luis/0000-0003-3894-9206; 	National Institutes of Health from NINDS [R01-NS059327]; National Institutes of Health from NIMH [R01-MH093331]; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093331, U01MH083545, R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059327, R01NS076402] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from NIMH; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS059327 from NINDS and R01-MH093331 from NIMH (to B. E. S. and R. M.). This work was also supported by Harvard Catalyst, the Harvard Clinical and Translational Science Center (supported by National Institutes of Health Award UL1 RR 025758), and by Harvard University and its affiliated academic health care centers.	Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Cheng J, 1998, NEUROSCIENCE, V82, P97, DOI 10.1016/S0306-4522(97)00174-7; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Del Valle L, 2000, J NEUROVIROL, V6, P221, DOI 10.3109/13550280009015824; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; Deshmane SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016148; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; EVERALL I, 1995, J NEUROVIROL, V1, P126, DOI 10.3109/13550289509111017; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fitting S, 2008, BRAIN RES, V1232, P139, DOI 10.1016/j.brainres.2008.07.032; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Han Y, 2007, NAT MED, V13, P1138, DOI 10.1038/nm1007-1138; Hassan SS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.016; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07; HAYMAN M, 1993, NEUROSCIENCE, V53, P1, DOI 10.1016/0306-4522(93)90278-N; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lau P, 2010, SEMIN CELL DEV BIOL, V21, P768, DOI 10.1016/j.semcdb.2010.01.009; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Li WX, 2009, NEUROTOX RES, V16, P205, DOI 10.1007/s12640-009-9047-8; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; Maragos WF, 2003, NEUROSCIENCE, V117, P43, DOI 10.1016/S0306-4522(02)00713-3; Moser JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013445; Mukerjee R, 2008, CELL CYCLE, V7, P2682, DOI 10.4161/cc.7.17.6450; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Nohata N, 2011, ONCOTARGET, V2, P29; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Norman JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003731; Peruzzi F, 2002, J NEUROVIROL, V8, P91, DOI 10.1080/13550280290167885; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Prendergast MA, 2002, BRAIN RES, V954, P300, DOI 10.1016/S0006-8993(02)03360-7; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Rom I, 2009, BRAIN RES, V1275, P81, DOI 10.1016/j.brainres.2009.03.024; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Shahabi HN, 2009, J NEURAL TRANSM, V116, P567, DOI 10.1007/s00702-009-0221-1; Singh IN, 2005, NEUROSCIENCE, V135, P781, DOI 10.1016/j.neuroscience.2005.05.028; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Watts PM, 1998, NEUROSCIENCE, V86, P511, DOI 10.1016/S0306-4522(97)00649-0; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zauli G, 2001, FASEB J, V15, P483, DOI 10.1096/fj.00-0354com; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zieg J, 2008, CELL, V134, DOI 10.1016/j.cell.2008.09.010	79	59	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41125	41134		10.1074/jbc.M111.268466	http://dx.doi.org/10.1074/jbc.M111.268466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956116	Green Published, hybrid			2022-12-25	WOS:000297315400071
J	Ueyama, T; Nakakita, J; Nakamura, T; Kobayashi, T; Kobayashi, T; Son, J; Sakuma, M; Sakaguchi, H; Leto, TL; Saito, N				Ueyama, Takehiko; Nakakita, Junya; Nakamura, Takashi; Kobayashi, Takeshi; Kobayashi, Toshihiro; Son, Jeonghyun; Sakuma, Megumi; Sakaguchi, Hirofumi; Leto, Thomas L.; Saito, Naoaki			Cooperation of p40(phox) with p47(phox) for Nox2-based NADPH Oxidase Activation during Fc gamma Receptor (Fc gamma R)-mediated Phagocytosis MECHANISM FOR ACQUISITION OF p40(phox) PHOSPHATIDYLINOSITOL 3-PHOSPHATE (PI(3)P) BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; R-MEDIATED PHAGOCYTOSIS; SRC HOMOLOGY-3 DOMAINS; PROTEIN-KINASE-C; SUBCELLULAR-LOCALIZATION; SH3 DOMAIN; PX DOMAINS; PHYSIOLOGICAL SIGNAL; CRYSTAL-STRUCTURE; MEMBRANE	During activation of the phagocyte (Nox2-based) NADPH oxidase, the cytoplasmic Phox complex (p47(phox)-p67(phox) p40(phox) translocates and associates with the membrane-spanning flavocytochrome b(558). It is unclear where (in cytoplasm or on membranes), when (before or after assembly), and how p40(phox) acquires its PI(3)P-binding capabilities. We demonstrated that in addition to conformational changes induced by H2O2 in the cytoplasm, p40(phox) acquires PI(3)P-binding through direct or indirect membrane targeting. We also found that p40(phox) is essential when p47(phox) is partially phosphorylated during Fc gamma R-mediated oxidase activation; however, p40(phox) is less critical when p47(phox) is adequately phosphorylated, using phosphorylation-mimicking mutants in HEK293(Nox2/Fc gamma RIIa) and RAW264.7(P40/P47KD) cells. Moreover, PI binding to p47(phox) is less important when the autoinhibitory PX-PB1 domain interaction in p40(phox) is disrupted or when p40(phox) is targeted to membranes. Furthermore, we suggest that high affinity PI(3)P binding of the p40(phox) PX domain is critical during its accumulation on phagosomes, even when masked by the PB1 domain in the resting state. Thus, in addition to mechanisms for directly acquiring P I(3)P binding in the cytoplasm by H2O2, p40(phox) can acquire PI(3)P binding on targeted membranes in a p47(phox)-dependent manner and functions both as a "carrier" of the cytoplasmic Phox complex to phagosomes and an "adaptor" of oxidase assembly on phagosomes in cooperation with p47(phox), using positive feedback mechanisms.	[Ueyama, Takehiko; Nakakita, Junya; Nakamura, Takashi; Son, Jeonghyun; Sakuma, Megumi; Saito, Naoaki] Kobe Univ, Mol Pharmacol Lab, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Kobayashi, Takeshi] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4668550, Japan; [Kobayashi, Toshihiro] Kobe Int Univ, Dept Phys Therapy, Kobe, Hyogo 6580032, Japan; [Sakaguchi, Hirofumi] Kyoto Prefectural Univ Med, Dept Otolaryng Head & Neck Surg, Kyoto 6028566, Japan; [Leto, Thomas L.] NIAID, Mol Def Sect, Lab Host Def, NIH, Rockville, MD 20852 USA	Kobe University; Nagoya University; Kyoto Prefectural University of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ueyama, T (corresponding author), Kobe Univ, Mol Pharmacol Lab, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	tueyama@kobe-u.ac.jp; naosaito@kobe-u.ac.jp	Saito, Nagahiro/I-6113-2014	Saito, Nagahiro/0000-0001-8757-3933	National Institutes of Health, NIAID; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science and Hungarian Academy of Sciences; Naito Foundation; Suzuken Memorial Foundation; Takeda Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23612002] Funding Source: KAKEN	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science and Hungarian Academy of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the National Institutes of Health, NIAID, Intramural Research Program. This work was also supported in part by Grants-in-aid for scientific research; on the Global Center of Excellence Program, on Priority Areas "Transportsome," on Innovative Areas 'Fluorescence Live Imaging" and (C), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also supported by the "Japan-Hungary Research Cooperative Program" grant from the Japan Society for the Promotion of Science and Hungarian Academy of Sciences, by a grant from the Naito Foundation, by a grant from the Suzuken Memorial Foundation, and by a grant from the Takeda Science Foundation.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Alloul N, 2001, BIOCHEMISTRY-US, V40, P14557, DOI 10.1021/bi0117347; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; BOLSCHER BGJM, 1989, J CLIN INVEST, V83, P757, DOI 10.1172/JCI113954; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boussetta T, 2010, BLOOD, V116, P5795, DOI 10.1182/blood-2010-03-273094; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen J, 2007, J BIOL CHEM, V282, P30273, DOI 10.1074/jbc.M704416200; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Chessa TAM, 2010, BLOOD, V116, P6027, DOI 10.1182/blood-2010-08-300889; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; deMendez I, 1996, EMBO J, V15, P1211, DOI 10.1002/j.1460-2075.1996.tb00462.x; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Fan LM, 2009, ARTERIOSCL THROM VAS, V29, P1651, DOI 10.1161/ATVBAHA.109.191502; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Furutani M, 2006, ANAL BIOCHEM, V355, P8, DOI 10.1016/j.ab.2006.05.014; Gillooly DJ, 2001, J CELL BIOL, V155, P15, DOI 10.1083/jcb.200109001; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Grandvaux N, 2001, BIOCHEM BIOPH RES CO, V287, P1009, DOI 10.1006/bbrc.2001.5665; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Kutateladze TG, 2007, PROG LIPID RES, V46, P315, DOI 10.1016/j.plipres.2007.06.001; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Malkova S, 2006, BIOCHEMISTRY-US, V45, P13566, DOI 10.1021/bi061133l; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Miyano K, 2001, BIOCHEMISTRY-US, V40, P14089, DOI 10.1021/bi010882u; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; Sathyamoorthy M, 1997, J BIOL CHEM, V272, P9141; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; SEGAL AW, 1985, NATURE, V316, P547, DOI 10.1038/316547a0; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ueyama T, 2005, J IMMUNOL, V175, P2381, DOI 10.4049/jimmunol.175.4.2381; Ueyama T, 2004, J IMMUNOL, V173, P4582, DOI 10.4049/jimmunol.173.7.4582; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Ueyama T, 2007, FREE RADICAL BIO MED, V42, P180, DOI 10.1016/j.freeradbiomed.2006.08.024; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Umada-Kajimoto S, 2006, BIOCHEM BIOPH RES CO, V341, P101, DOI 10.1016/j.bbrc.2005.12.161; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wientjes FB, 2001, BIOCHEM BIOPH RES CO, V289, P382, DOI 10.1006/bbrc.2001.5982	73	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40693	40705		10.1074/jbc.M111.237289	http://dx.doi.org/10.1074/jbc.M111.237289			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956105	hybrid, Green Published			2022-12-25	WOS:000297315400030
J	Galeazzi, L; Bocci, P; Amici, A; Brunetti, L; Ruggieri, S; Romine, M; Reed, S; Osterman, AL; Rodionov, DA; Sorci, L; Raffaelli, N				Galeazzi, Luca; Bocci, Paola; Amici, Adolfo; Brunetti, Lucia; Ruggieri, Silverio; Romine, Margaret; Reed, Samantha; Osterman, Andrei L.; Rodionov, Dmitry A.; Sorci, Leonardo; Raffaelli, Nadia			Identification of Nicotinamide Mononucleotide Deamidase of the Bacterial Pyridine Nucleotide Cycle Reveals a Novel Broadly Conserved Amidohydrolase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPETENCE-INDUCED OPERON; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; NAD METABOLISM; DIPHOSPHOPYRIDINE NUCLEOTIDE; PROTEIN; BIOSYNTHESIS; RECA; ENZYMES	The pyridine nucleotide cycle is a network of salvage and recycling routes maintaining homeostasis of NAD(P) cofactor pool in the cell. Nicotinamide mononucleotide (NMN) deamidase (EC 3.5.1.42), one of the key enzymes of the bacterial pyridine nucleotide cycle, was originally described in Enterobacteria, but the corresponding gene eluded identification for over 30 years. A genomics-based reconstruction of NAD metabolism across hundreds of bacterial species suggested that NMN deamidase reaction is the only possible way of nicotinamide salvage in the marine bacterium Shewanella oneidensis. This prediction was verified via purification of native NMN deamidase from S. oneidensis followed by the identification of the respective gene, termed pncC. Enzymatic characterization of the PncC protein, as well as phenotype analysis of deletion mutants, confirmed its proposed biochemical and physiological function in S. oneidensis. Of the three PncC homologs present in Escherichia coli, NMN deamidase activity was confirmed only for the recombinant purified product of the ygaD gene. A comparative analysis at the level of sequence and three-dimensional structure, which is available for one of the PncC family member, shows no homology with any previously described amidohydrolases. Multiple alignment analysis of functional and nonfunctional PncC homologs, together with NMN docking experiments, allowed us to tentatively identify the active site area and conserved residues therein. An observed broad phylogenomic distribution of predicted functional PncCs in the bacterial kingdom is consistent with a possible role in detoxification of NMN, resulting from NAD utilization by DNA ligase.	[Galeazzi, Luca; Bocci, Paola; Amici, Adolfo; Brunetti, Lucia; Ruggieri, Silverio; Sorci, Leonardo; Raffaelli, Nadia] Univ Politecn Marche, Dept Mol Pathol & Innovat Therapies, Biochem Sect, I-60131 Ancona, Italy; [Osterman, Andrei L.; Rodionov, Dmitry A.; Sorci, Leonardo] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Romine, Margaret; Reed, Samantha] Pacific NW Natl Lab, Richland, WA 99352 USA	Marche Polytechnic University; Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Raffaelli, N (corresponding author), Dipt Patol Mol Terapie Innovat, Sez Biochim, Via Ranieri, I-60131 Ancona, Italy.	n.raffaelli@univpm.it	SORCI, LEONARDO/AAD-7395-2019; Amici, Adolfo/C-5342-2012; Rodionov, Dmitry/V-2688-2018	SORCI, LEONARDO/0000-0002-4356-8873; Amici, Adolfo/0000-0002-1081-7749; Romine, Margaret/0000-0002-0968-7641; Rodionov, Dmitry/0000-0002-0939-390X	Italian Minister of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"; U.S. Department of Energy, Office of Biological and Environmental Research	Italian Minister of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"; U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was partly supported by the Italian Minister of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese." The research at the Pacific Northwest National Laboratory and Sanford Burnham Institute was supported by the U.S. Department of Energy, Office of Biological and Environmental Research, as part of the Genomic Science Program. Their contribution originates from the Genomic Science Program Foundational Scientific Focus Area at the Pacific Northwest National Laboratory.	ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berge M, 2001, MOL MICROBIOL, V39, P1651, DOI 10.1046/j.1365-2958.2001.02359.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FOSTER JW, 1982, J BACTERIOL, V149, P368, DOI 10.1128/JB.149.1.368-371.1982; FOSTER JW, 1980, J BACTERIOL, V142, P1032, DOI 10.1128/JB.142.3.1032-1035.1980; FOSTER JW, 1979, J BACTERIOL, V138, P957, DOI 10.1128/JB.138.3.957-961.1979; FRIEDMANN HC, 1973, BIOCHEM BIOPH RES CO, V50, P54, DOI 10.1016/0006-291X(73)91062-0; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Grose JH, 2005, J BACTERIOL, V187, P4521, DOI 10.1128/JB.187.13.4521-4530.2005; Grose JH, 2005, J BACTERIOL, V187, P2774, DOI 10.1128/JB.187.8.2774-2782.2005; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; IMAI T, 1973, J BIOCHEM-TOKYO, V73, P139; Kaimer C, 2010, ARCH MICROBIOL, V192, P549, DOI 10.1007/s00203-010-0583-7; KINNEY DM, 1979, J BACTERIOL, V140, P607, DOI 10.1128/JB.140.2.607-611.1979; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Maggio-Hall LA, 2003, MICROBIOL-SGM, V149, P983, DOI 10.1099/mic.0.26040-0; MANLAPAZ.P, 1973, J BIOL CHEM, V248, P5150; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Masure HR, 1998, MOL MICROBIOL, V27, P845, DOI 10.1046/j.1365-2958.1998.00732.x; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Mortier-Barriere I, 1998, MOL MICROBIOL, V27, P159, DOI 10.1046/j.1365-2958.1998.00668.x; OLIVERA BM, 1968, COLD SPRING HARB SYM, V33, P27, DOI 10.1101/SQB.1968.033.01.008; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; PEARCE BJ, 1995, J BACTERIOL, V177, P86, DOI 10.1128/jb.177.1.86-93.1995; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; ZIMMERMA.SB, 1967, P NATL ACAD SCI USA, V57, P1841, DOI 10.1073/pnas.57.6.1841	43	41	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40365	40375		10.1074/jbc.M111.275818	http://dx.doi.org/10.1074/jbc.M111.275818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953451	Green Published, hybrid			2022-12-25	WOS:000296925700067
J	Toledo, D; Ramon, E; Aguila, M; Cordomi, A; Perez, JJ; Mendes, HF; Cheetham, ME; Garriga, P				Toledo, Darwin; Ramon, Eva; Aguila, Monica; Cordomi, Arnau; Perez, Juan J.; Mendes, Hugo F.; Cheetham, Michael E.; Garriga, Pere			Molecular Mechanisms of Disease for Mutations at Gly-90 in Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; CONGENITAL NIGHT BLINDNESS; COUPLED-RECEPTOR RHODOPSIN; CONSTITUTIVE ACTIVATION; INTRADISCAL DOMAIN; BOVINE RHODOPSIN; POINT MUTANTS; SCHIFF-BASE; OPSIN; MODEL	Two different mutations at Gly-90 in the second transmembrane helix of the photoreceptor protein rhodopsin have been proposed to lead to different phenotypes. G90D has been classically associated with congenital night blindness, whereas the newly reported G90V substitution was linked to a retinitis pigmentosa phenotype. Here, we used Val/Asp replacements of the native Gly at position 90 to unravel the structure/function divergences caused by these mutations and the potential molecular mechanisms of inherited retinal disease. The G90V and G90D mutants have a similar conformation around the Schiff base linkage region in the dark state and same regeneration kinetics with 11-cis-retinal, but G90V has dramatically reduced thermal stability when compared with the G90D mutant rhodopsin. The G90V mutant also shows, like G90D, an altered photobleaching pattern and capacity to activate Gt in the opsin state. Furthermore, the regeneration of the G90V mutant with 9-cis-retinal was improved, achieving the same A(280)/A(500) as wild type isorhodopsin. Hydroxylamine resistance was also recovered, indicating a compact structure around the Schiff base linkage, and the thermal stability was substantially improved when compared with the 11-cis-regenerated mutant. These results support the role of thermal instability and/or abnormal photoproduct formation in eliciting a retinitis pigmentosa phenotype. The improved stability and more compact structure of the G90V mutant when it was regenerated with 9-cis-retinal brings about the possibility that this isomer or other modified retinoid analogues might be used in potential treatment strategies for mutants showing the same structural features.	[Toledo, Darwin; Ramon, Eva; Aguila, Monica; Garriga, Pere] Univ Politecn Cataluna, Ctr Biotecnol Mol, Dept Engn Quim, Terrassa 08222, Spain; [Cordomi, Arnau] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestad, Fac Med, Cerdanyola Del Valles 08193, Spain; [Perez, Juan J.] Univ Politecn Cataluna, Ctr Biotecnol Mol, Dept Engn Quim, ES-08034 Barcelona, Spain; [Mendes, Hugo F.; Cheetham, Michael E.] UCL, Inst Ophthalmol, London EC1V 9EL, England	Universitat Politecnica de Catalunya; Autonomous University of Barcelona; Universitat Politecnica de Catalunya; University of London; University College London	Garriga, P (corresponding author), Univ Politecn Cataluna, Ctr Biotecnol Mol, Dept Engn Quim, Terrassa 08222, Spain.	pere.garriga@upc.edu	Cordomí, Arnau/A-1686-2009; Garriga, Pere/C-1949-2017; Perez, Juan J/E-3710-2010	Cordomí, Arnau/0000-0002-3848-2928; Garriga, Pere/0000-0003-4234-8382; Perez, Juan J/0000-0002-0748-8147; Cheetham, Michael/0000-0001-6429-654X	Ministerio de Investigacion, Ciencia e Innovacion [SAF2008-04943-C02-02]; Universitat Politecnica de Catalunya; British Retinitis Pigmentosa Society; Instituto de Salud Carlos III	Ministerio de Investigacion, Ciencia e Innovacion; Universitat Politecnica de Catalunya; British Retinitis Pigmentosa Society; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Ministerio de Investigacion, Ciencia e Innovacion Grants SAF2008-04943-C02-02 (to P. G.) and SAF2008-04943-C02-02 (to J. J. P.), a Universitat Politecnica de Catalunya fellowship (to D. T.), a Formacion de Personal Investigador fellowship from the Ministerio de Investigacion, Ciencia e Innovacion (to M. A.), a grant from the British Retinitis Pigmentosa Society (to M. E. C.), and a contract grant from the Instituto de Salud Carlos III (to A. C.).	Andres A, 2003, BIOCHEM BIOPH RES CO, V303, P294, DOI 10.1016/S0006-291X(03)00328-0; Benned-Jensen T, 2009, Curr Mol Pharmacol, V2, P140; Bosch-Presegue L, 2011, FEBS J, V278, P1493, DOI 10.1111/j.1742-4658.2011.08066.x; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; DeLano D. L., 2010, PYMOL MOL GRAPHICS S; Deupi X, 2007, CURR TOP MED CHEM, V7, P991, DOI 10.2174/156802607780906799; Dizhoor AM, 2008, J NEUROSCI, V28, P11662, DOI 10.1523/JNEUROSCI.4006-08.2008; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Filipek S, 2003, ANNU REV BIOPH BIOM, V32, P375, DOI 10.1146/annurev.biophys.32.110601.142520; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2002, DOI 10.1021/bi020612r; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Manyosa J, 2003, MED CLIN-BARCELONA, V121, P153, DOI 10.1157/13049792; Matsuyama T, 2010, J BIOL CHEM, V285, P8114, DOI 10.1074/jbc.M109.063875; McAlear SD, 2010, ADV EXP MED BIOL, V664, P263, DOI 10.1007/978-1-4419-1399-9_30; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Neidhardt J, 2006, INVEST OPHTH VIS SCI, V47, P1630, DOI 10.1167/iovs.05-1317; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Ramon E, 2003, J BIOL CHEM, V278, P6427, DOI 10.1074/jbc.M210929200; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Saliba RS, 2002, J CELL SCI, V115, P2907; Sekharan S, 2007, J AM CHEM SOC, V129, P1052, DOI 10.1021/ja066970p; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Surguchev A, 2010, BRAIN RES BULL, V81, P12, DOI 10.1016/j.brainresbull.2009.09.015; Vogel R, 2006, J AM CHEM SOC, V128, P10503, DOI 10.1021/ja0627848; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; Zvyaga TA, 1996, BIOCHEMISTRY-US, V35, P7536, DOI 10.1021/bi960391n	53	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39993	40001		10.1074/jbc.M110.201517	http://dx.doi.org/10.1074/jbc.M110.201517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940625	Green Published, hybrid			2022-12-25	WOS:000296925700032
J	Case, N; Thomas, J; Sen, B; Styner, M; Xie, ZH; Galior, K; Rubin, J				Case, Natasha; Thomas, Jacob; Sen, Buer; Styner, Maya; Xie, Zhihui; Galior, Kornelia; Rubin, Janet			Mechanical Regulation of Glycogen Synthase Kinase 3 beta (GSK3 beta) in Mesenchymal Stem Cells Is Dependent on Akt Protein Serine 473 Phosphorylation via mTORC2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; INTEGRIN-LINKED KINASE; MAMMALIAN TARGET; RAPAMYCIN MTOR; AMINO-ACIDS; IN-VIVO; ACTIVATION; INSULIN; STRAIN; COMPLEX	Mechanical signals can inactivate glycogen synthase kinase 3 beta (GSK3 beta), resulting in stabilization of beta-catenin. This signaling cascade is necessary for the inhibition of adipogenesis in mesenchymal stem cells (MSC) that is produced by a daily strain regimen. We investigated whether Akt is the mechanically activated kinase responsible for phosphorylation and inactivation of GSK3 beta in MSC. Mechanical strain (2% magnitude, 0.17 Hz) induced phosphorylation of Akt at Ser-473 and Thr-308 in parallel with phosphorylation of GSK3 beta at Ser-9. Inhibiting Akt (Akt1/2 kinase inhibitor treatment or Akt knockdown) prevented strain-induced phosphorylation of GSK3 beta at Ser-9. Inhibition of PI3K prevented Thr-308 phosphorylation, but strain-induced Ser-473 phosphorylation was measurable and induced phosphorylation of GSK3 beta, suggesting that Ser-473 phosphorylation is sufficient for the downstream mechanoresponse. As Rictor/mTORC2 (mammalian target of rapamycin complex 2) is known to transduce phosphorylation of Akt at Ser-473 by insulin, we investigated whether it contributes to strain-induced Ser-473 phosphorylation. Phosphorylation of Ser-473 by both mechanical and insulin treatment in MSC was prevented by the mTOR inhibitor KU0063794. When mTORC2 was blocked, mechanical GSK3 beta inactivation was prevented, whereas insulin inhibition of GSK3 beta was still measured in the absence of Ser-473 phosphorylation, presumably through phosphorylation of Akt at Thr-308. In sum, mechanical input initiates a signaling cascade that is uniquely dependent on mTORC2 activation and phosphorylation of Akt at Ser-473, an effect sufficient to cause inactivation of GSK3 beta. Thus, mechanical regulation of GSK3 beta downstream of Akt is dependent on phosphorylation of Akt at Ser-473 in a manner distinct from that of growth factors. As such, Akt reveals itself to be a pleiotropic signaling molecule whose downstream targets are differentially regulated depending upon the nature of the activating input.	[Case, Natasha; Thomas, Jacob; Sen, Buer; Styner, Maya; Xie, Zhihui; Galior, Kornelia; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Case, N (corresponding author), Univ N Carolina, Dept Med, 5030 Burnett Womack,CB 7170, Chapel Hill, NC 27599 USA.	ncase@med.unc.edu	Styner, Maya/I-2044-2019	Styner, Maya/0000-0001-9790-8645	National Institutes of Health [AR042360, AR056655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042360, R01AR056655, R56AR042360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR042360 and AR056655 (to J. R.).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Armstrong JL, 2001, J BIOL CHEM, V276, P952, DOI 10.1074/jbc.M004812200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bullard TA, 2007, CAN J PHYSIOL PHARM, V85, P243, DOI 10.1139/Y07-023; CARVALHO RS, 1994, J BONE MINER RES, V9, P999; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kleiman E, 2009, BIOCHEM BIOPH RES CO, V388, P554, DOI 10.1016/j.bbrc.2009.08.063; Liao Y, 2010, AM J TRANSL RES, V2, P19; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Menuki K, 2008, BONE, V43, P613, DOI 10.1016/j.bone.2008.04.022; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	38	69	72	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39450	39456		10.1074/jbc.M111.265330	http://dx.doi.org/10.1074/jbc.M111.265330			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21956113	hybrid, Green Published			2022-12-25	WOS:000296759800062
J	Iyengar, PV; Hirota, T; Hirose, S; Nakamura, N				Iyengar, Prasanna Vasudevan; Hirota, Tsuyoshi; Hirose, Shigehisa; Nakamura, Nobuhiro			Membrane-associated RING-CH 10 (MARCH10 Protein) Is a Microtubule-associated E3 Ubiquitin Ligase of the Spermatid Flagella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; MITOCHONDRIAL INHERITANCE; 26S PROTEASOME; FIBROUS SHEATH; CAUSES DEFECTS; EXPRESSION; COMPONENT; SPERMATOGENESIS; SPERMIOGENESIS; PROTEOLYSIS	Spermiogenesis is a complex and dynamic process of the metamorphosis of spermatids into spermatozoa. There is a great deal that is still unknown regarding the regulatory mechanisms for the formation of the sperm flagellum. In this study, we determined that the membrane-associated RING-CH 10 (March10) gene is predominantly expressed in rat testis. We isolated two March10 isoforms encoding MARCH10a and MARCH10b, which are generated by alternative splicing. MARCH10a is a long RING finger protein, and MARCH10b is a short RING finger-less protein. Immunohistochemical staining revealed that the MARCH10 proteins are specifically expressed in elongating and elongated spermatids, and the expression is absent in epididymal spermatozoa. MARCH10 immunoreactivity was observed in the cytoplasmic lobes as well as the principal piece and annulus of the flagella. When overexpressed in COS7 cells, MARCH10a was localized along the microtubules, whereas MARCH10b was distributed throughout the cytoplasm. An in vitro microtubule cosedimentation assay showed that MARCH10a is directly associated with microtubules. An in vitro ubiquitination assay demonstrated that the RING finger domain of MARCH10a exhibits an E3 ubiquitin ligase activity along with the E2 ubiquitin-conjugating enzyme UBE2B. Moreover, MARCH10a undergoes proteasomal degradation by autoubiquitination in transfected COS7 cells, but this activity was abolished upon microtubule disassembly. These results suggest that MARCH10 is involved in spermiogenesis by regulating the formation and maintenance of the flagella in developing spermatids.	[Iyengar, Prasanna Vasudevan; Hirota, Tsuyoshi; Hirose, Shigehisa; Nakamura, Nobuhiro] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Nakamura, N (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B-19 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	nnakamur@bio.titech.ac.jp	Iyengar, Prasanna/G-2939-2018; Nakamura, Nobuhiro/C-4265-2015	Iyengar, Prasanna/0000-0002-6495-137X; Nakamura, Nobuhiro/0000-0002-0249-2665	Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [21026010];  [22370029];  [22770123]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by Grants-in-aid for Scientific Research 21026010, 22370029, and 22770123 and the 21st Century and Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aihara T, 2009, BIOL REPROD, V80, P762, DOI 10.1095/biolreprod.108.074013; Baarends WM, 2003, MOL CELL BIOL, V23, P1151, DOI 10.1128/MCB.23.4.1151-1162.2003; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Chao HCA, 2010, J ASSIST REPROD GEN, V27, P299, DOI 10.1007/s10815-010-9409-4; Eddy E M, 2007, Soc Reprod Fertil Suppl, V65, P45; Escalier D, 2003, MOL REPROD DEV, V65, P298, DOI 10.1002/mrd.10290; Escalier D, 2003, BIOL REPROD, V69, P373, DOI 10.1095/biolreprod.103.015719; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; IRONS MJ, 1982, ANAT RECORD, V202, P463, DOI 10.1002/ar.1092020405; IRONS MJ, 1982, AM J ANAT, V165, P121, DOI 10.1002/aja.1001650204; Kato A, 2004, DEV BIOL, V269, P196, DOI 10.1016/j.ydbio.2004.01.026; Kierszenbaum AL, 2000, MOL REPROD DEV, V57, P109, DOI 10.1002/1098-2795(200010)57:2<109::AID-MRD1>3.3.CO;2-0; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Lin YH, 2009, AM J PATHOL, V174, P1857, DOI 10.2353/ajpath.2009.080955; Metcalfe SM, 2005, FEBS LETT, V579, P609, DOI 10.1016/j.febslet.2004.12.027; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Mochida K, 2000, MOL REPROD DEV, V57, P176, DOI 10.1002/1098-2795(200010)57:2&lt;176::AID-MRD9&gt;3.0.CO;2-O; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Muthukumarana PADS, 2006, INT IMMUNOPHARMACOL, V6, P1993, DOI 10.1016/j.intimp.2006.09.015; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Oko R., 1990, P3; OKO R, 1989, ANAT REC, V225, P46, DOI 10.1002/ar.1092250108; OKO RJ, 1991, ANN NY ACAD SCI, V637, P203, DOI 10.1111/j.1749-6632.1991.tb27311.x; Ren Y, 2003, J NEUROSCI, V23, P3316; Rivkin E, 1997, MOL REPROD DEV, V48, P77, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;77::AID-MRD10&gt;3.0.CO;2-T; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Steels JD, 2007, CELL MOTIL CYTOSKEL, V64, P794, DOI 10.1002/cm.20224; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 2000, INT REV CYTOL, V195, P1; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08	53	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39082	39090		10.1074/jbc.M111.256875	http://dx.doi.org/10.1074/jbc.M111.256875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937444	Green Published, hybrid			2022-12-25	WOS:000296759800027
J	Kim, KH; Aulakh, S; Paetzel, M				Kim, Kelly H.; Aulakh, Suraaj; Paetzel, Mark			Crystal Structure of beta-Barrel Assembly Machinery BamCD Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED BACTERIAL PROTEIN; OUTER-MEMBRANE; ESCHERICHIA-COLI; RESONANCE ASSIGNMENTS; SECONDARY STRUCTURE; ESSENTIAL COMPONENT; BIOGENESIS; FOLD; RECOGNITION; SUPERFAMILY	The beta-barrel assembly machinery (BAM) complex of Escherichia coli is a multiprotein machine that catalyzes the essential process of assembling outer membrane proteins. The BAM complex consists of five proteins: one membrane protein, BamA, and four lipoproteins, BamB, BamC, BamD, and BamE. Here, we report the first crystal structure of a Bam lipoprotein complex: the essential lipoprotein BamD in complex with the N-terminal half of BamC (BamC(UN) (Asp(28)-Ala(217)), a 73-residue-long unstructured region followed by the N-terminal domain). The BamCD complex is stabilized predominantly by various hydrogen bonds and salt bridges formed between BamD and the N-terminal unstructured region of BamC. Sequence and molecular surface analyses revealed that many of the conserved residues in both proteins are found at the BamC-BamD interface. A series of truncation mutagenesis and analytical gel filtration chromatography experiments confirmed that the unstructured region of BamC is essential for stabilizing the BamCD complex structure. The unstructured N terminus of BamC interacts with the proposed substrate-binding pocket of BamD, suggesting that this region of BamC may play a regulatory role in outer membrane protein biogenesis.	[Kim, Kelly H.; Aulakh, Suraaj; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Kim, Kelly Hyojin/0000-0002-1360-2778; Paetzel, Mark/0000-0002-7408-5487	Canadian Institutes of Health Research; National Science and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Foundation of Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Foundation of Innovation(Canada Foundation for Innovation)	This work was supported in part by the Canadian Institutes of Health Research (to M. P.), the National Science and Engineering Research Council of Canada (to M. P.), the Michael Smith Foundation for Health Research (to M. P.), and the Canadian Foundation of Innovation (to M. P.).	Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Albrecht R, 2010, ACTA CRYSTALLOGR F, V66, P1586, DOI 10.1107/S1744309110034160; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2010, BIOMOL NMR ASSIGN, V4, P179, DOI 10.1007/s12104-010-9236-7; Knowles TJ, 2009, BIOMOL NMR ASSIGN, V3, P203, DOI 10.1007/s12104-009-9175-3; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misra R, 2007, ACS CHEM BIOL, V2, P649, DOI 10.1021/cb700212p; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Renault M, 2011, J AM CHEM SOC, V133, P4175, DOI 10.1021/ja109469c; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sampathkumar P, 2008, J MOL BIOL, V381, P867, DOI 10.1016/j.jmb.2008.05.089; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Vanini MMT, 2008, PROTEINS, V71, P2051, DOI 10.1002/prot.21886; Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254	40	59	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39116	39121		10.1074/jbc.M111.298166	http://dx.doi.org/10.1074/jbc.M111.298166			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937441	Green Published, hybrid			2022-12-25	WOS:000296759800030
J	Brown, GK; Kreiss, A; Lyons, AB; Woods, GM				Brown, Gabriella K.; Kreiss, Alexandre; Lyons, A. Bruce; Woods, Gregory M.			Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil	PLOS ONE			English	Article							FACIAL-TUMOR-DISEASE; SARCOPHILUS-HARRISII; EFFECTOR-CELLS; CLASS-I; LYMPHOCYTES; CANCER; TRANSMISSION; MECHANISMS; RESISTANCE; DIVERSITY	The Tasmanian devil (Sarcophilus harrisii), the world's largest marsupial carnivore, is under threat of extinction following the emergence of an infectious cancer. Devil facial tumour disease (DFTD) is spread between Tasmanian devils during biting. The disease is consistently fatal and devils succumb without developing a protective immune response. The aim of this study was to determine if Tasmanian devils were capable of forming cytotoxic antitumour responses and develop antibodies against DFTD cells and foreign tumour cells. The two Tasmanian devils immunised with irradiated DFTD cells did not form cytotoxic or humoral responses against DFTD cells, even after multiple immunisations. However, following immunisation with xenogenic K562 cells, devils did produce cytotoxic responses and antibodies against this foreign tumour cell line. The cytotoxicity appeared to occur through the activity of natural killer (NK) cells in an antibody dependent manner. Classical NK cell responses, such as innate killing of DFTD and foreign cancer cells, were not observed. Cells with an NK-like phenotype comprised approximately 4 percent of peripheral blood mononuclear cells. The results of this study suggest that Tasmanian devils have NK cells with functional cytotoxic pathways. Although devil NK cells do not directly recognise DFTD cancer cells, the development of antibody dependent cell-mediated cytotoxicity presents a potential pathway to induce cytotoxic responses against the disease. These findings have positive implications for future DFTD vaccine research.	[Brown, Gabriella K.; Kreiss, Alexandre; Woods, Gregory M.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Lyons, A. Bruce] Univ Tasmania, Sch Med, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	Brown, GK (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	G.M.Woods@utas.edu.au	Woods, Greg/J-7533-2014	Woods, Greg/0000-0001-8421-7917; Lyons, Alan/0000-0002-8508-5853	Australian Research Council [LP0989727]; Dr Eric Guiler Tasmanian devil research grant; University of Tasmania Foundation	Australian Research Council(Australian Research Council); Dr Eric Guiler Tasmanian devil research grant; University of Tasmania Foundation	Research support was provided by the Australian Research Council, Dr Eric Guiler Tasmanian devil research grant and the University of Tasmania Foundation. Australian Research Council Linkage grant #LP0989727; url http://www.arc.gov.au. Dr Eric Guiler Tasmanian devil research grant; url http://www.utas.edu.au/foundation/devil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril T, 1999, J IMMUNOL, V162, P5902; Carson WE, 2001, EUR J IMMUNOL, V31, P3016, DOI 10.1002/1521-4141(2001010)31:10<3016::AID-IMMU3016>3.0.CO;2-J; Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Fayngerts SA, 2007, IMMUNOGENETICS, V59, P493, DOI 10.1007/s00251-007-0208-8; FUKUI H, 1987, J LEUKOCYTE BIOL, V41, P130, DOI 10.1002/jlb.41.2.130; GREWAL AS, 1977, INFECT IMMUN, V15, P698, DOI 10.1128/IAI.15.3.698-703.1977; GRINER LA, 1979, J NATL CANCER I, V62, P589, DOI 10.1093/jnci/62.3.589; HATHCOCK KS, 1992, CURRENT PROTOCOLS IM; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; HORWITZ DA, 1984, J IMMUNOL, V132, P2370; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KEANEY MA, 1979, IMMUNOLOGY, V38, P665; Kreiss A, 2008, DEV COMP IMMUNOL, V32, P544, DOI 10.1016/j.dci.2007.09.002; Kreiss A, 2009, ANAT REC, V292, P611, DOI 10.1002/ar.20896; KUMAGAI K, 1982, J IMMUNOL, V129, P388; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; LEIGHTON FA, 1995, J WILDLIFE DIS, V31, P541, DOI 10.7589/0090-3558-31.4.541; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; NELSON DL, 1976, J IMMUNOL, V117, P1472; O'Neill ID, 2010, INT J CANCER, V127, P1637, DOI 10.1002/ijc.25374; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2007, IMMUNOGENETICS, V59, P753, DOI 10.1007/s00251-007-0238-2; Stockmeyer B, 2003, J IMMUNOL, V171, P5124, DOI 10.4049/jimmunol.171.10.5124; Torri G, 2010, MINERVA ANESTESIOL, V76, P215; Woods GM, 2007, ECOHEALTH, V4, P338, DOI 10.1007/s10393-007-0117-1	32	36	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24475	10.1371/journal.pone.0024475	http://dx.doi.org/10.1371/journal.pone.0024475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957452	Green Published, Green Submitted, gold			2022-12-25	WOS:000295262100012
J	Chatterjee, M; Bermudez-Lozano, CL; Clancy, MA; Davis, TM; Folta, KM				Chatterjee, Mithu; Bermudez-Lozano, Claudia L.; Clancy, Maureen A.; Davis, Thomas M.; Folta, Kevin M.			A Strawberry KNOX Gene Regulates Leaf, Flower and Meristem Architecture	PLOS ONE			English	Article							MAIZE HOMEOBOX GENE; OF-FUNCTION MUTATIONS; ARABIDOPSIS-THALIANA; ECTOPIC EXPRESSION; APICAL MERISTEM; COMPOUND LEAVES; FRAGARIA-VESCA; SHOOT; MORPHOLOGY; ALTERS	The KNOTTED-LIKE HOMEODOMAIN (KNOX) genes play a central role in maintenance of the shoot apical meristem. They also contribute to the morphology of simple and compound leaves. In this report we characterize the FaKNOX1 gene from strawberry (Fragaria spp.) and demonstrate its function in trasgenic plants. The FaKNOX1 cDNA was isolated from a cultivated strawberry (F. xananassa) flower EST library. The sequence is most similar to Class I KNOX genes, and was mapped to linkage group VI of the diploid strawberry genome. Unlike most KNOX genes studied, steady-state transcript levels were highest in flowers and fruits. Transcripts were also detected in emerging leaf primordia and the apical dome. Transgenic strawberry plants suppressing or overexpressing FaKNOX1 exhibited conspicuous changes in plant form. The FaKNOX1 RNAi plants presented a dwarfed phenotype with deeply serrated leaflets and exaggerated petiolules. They also exhibited a high level of cellular disorganization of the shoot apical meristem and leaves. Overexpression of FaKNOX1 caused dwarfed stature with wrinkled leaves. These gain-and loss-of-function assays in strawberry functionally demonstrate the contributions of a KNOX domain protein in a rosaceous species.	[Chatterjee, Mithu; Bermudez-Lozano, Claudia L.; Clancy, Maureen A.; Folta, Kevin M.] Univ Florida, Dept Hort Sci, Grad Program Plant Mol & Cellular Biol, Gainesville, FL 32611 USA; [Davis, Thomas M.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA	State University System of Florida; University of Florida; University System Of New Hampshire; University of New Hampshire	Chatterjee, M (corresponding author), Univ Florida, Dept Hort Sci, Grad Program Plant Mol & Cellular Biol, Gainesville, FL 32611 USA.	cmithu@ufl.edu			National Science Foundation [IOS 0941335]; University of Florida	National Science Foundation(National Science Foundation (NSF)); University of Florida(University of Florida)	The work was funded by National Science Foundation Grant IOS 0941335 (KMF) and in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON MK, 1993, DEVELOPMENT, V119, P823; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; Bent A, 2006, METH MOL B, V343, P87; Bharathan G, 2001, PLANT PHYSIOL, V127, P1533, DOI 10.1104/pp.010867; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Canales C, 2010, J PLANT RES, V123, P25, DOI 10.1007/s10265-009-0263-3; Champagne C, 2004, DEVELOPMENT, V131, P4401, DOI 10.1242/dev.01338; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Clark SE, 1996, DEVELOPMENT, V122, P1567; Darrow G.M., 1966, STRAWBERRY; Dhingra A, 2006, PLANT PHYSIOL, V142, P1256, DOI 10.1104/pp.106.088351; Douglas SJ, 2002, PLANT CELL, V14, P547, DOI 10.1105/tpc.010391; ElMansouri I, 1996, PLANT CELL REP, V15, P642, DOI 10.1007/BF00232469; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Frugis G, 2001, PLANT PHYSIOL, V126, P1370, DOI 10.1104/pp.126.4.1370; Groot EP, 2005, PLANT MOL BIOL, V58, P317, DOI 10.1007/s11103-005-4548-1; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Harrison J, 2005, PLANT CELL, V17, P430, DOI 10.1105/tpc.104.028936; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson D, 1991, SITU HYBRIDISATION P; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Kaplan DR, 2001, INT J PLANT SCI, V162, P465, DOI 10.1086/320135; Kaplan DR, 1975, BOT JB SYST, V95, P101; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; Korona VV, 2001, RUSS J ECOL+, V32, P203, DOI 10.1023/A:1011318412880; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Liu J, 2008, J GENET GENOMICS, V35, P441, DOI 10.1016/S1673-8527(08)60061-2; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Muehlbauer GJ, 1999, PLANT PHYSIOL, V119, P651, DOI 10.1104/pp.119.2.651; Muller KJ, 2006, PLANTA, V224, P1023, DOI 10.1007/s00425-006-0288-y; Nagasaki H, 2001, PLANT CELL, V13, P2085, DOI 10.1105/tpc.13.9.2085; Nishimura A, 2000, PLANT CELL PHYSIOL, V41, P583, DOI 10.1093/pcp/41.5.583; Oosumi T, 2006, PLANTA, V223, P1219, DOI 10.1007/s00425-005-0170-3; Park SH, 2007, PLANTA, V227, P1, DOI 10.1007/s00425-007-0576-1; Pautot W, 2001, PLANT CELL, V13, P1719, DOI 10.1105/tpc.13.8.1719; Piazza P, 2005, NEW PHYTOL, V167, P693, DOI 10.1111/j.1469-8137.2005.01466.x; Pozzi C, 2001, SEMIN CELL DEV BIOL, V12, P363, DOI 10.1006/scdb.2001.0265; Rosin FM, 2003, PLANT PHYSIOL, V132, P106, DOI 10.1104/pp.102.015560; Sargent DJ, 2008, GENOME, V51, P120, DOI [10.1139/G07-107, 10.1139/g07-107]; Sargent DJ, 2006, THEOR APPL GENET, V112, P1349, DOI 10.1007/s00122-006-0237-y; Sato Y, 1999, EMBO J, V18, P992, DOI 10.1093/emboj/18.4.992; Sato Y, 1998, PLANT MOL BIOL, V38, P983, DOI 10.1023/A:1006065622251; SATTLER R, 1992, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V114, P61; Sentoku N, 1999, PLANT CELL, V11, P1651, DOI 10.1105/tpc.11.9.1651; Shani E, 2009, PLANT CELL, V21, P3078, DOI 10.1105/tpc.109.068148; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sinha N, 1999, ANNU REV PLANT PHYS, V50, P419, DOI 10.1146/annurev.arplant.50.1.419; Sinha N, 1997, TRENDS PLANT SCI, V2, P396, DOI 10.1016/S1360-1385(97)90055-8; Srinivasan C, 2011, PLANT CELL REP, V30, P655, DOI 10.1007/s00299-010-0993-7; Tamaoki M, 1997, PLANT CELL PHYSIOL, V38, P917, DOI 10.1093/oxfordjournals.pcp.a029252; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Testone G, 2008, J EXP BOT, V59, P389, DOI 10.1093/jxb/erm317; Testone G, 2009, MOL GENET GENOMICS, V282, P47, DOI 10.1007/s00438-009-0445-7; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161	62	20	22	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24752	10.1371/journal.pone.0024752	http://dx.doi.org/10.1371/journal.pone.0024752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949748	gold, Green Published			2022-12-25	WOS:000295260400011
J	Palmer, VL; Kassmeier, MD; Willcockson, J; Akhter, MP; Cullen, DM; Swanson, PC				Palmer, Victoria L.; Kassmeier, Michele D.; Willcockson, James; Akhter, Mohammed P.; Cullen, Diane M.; Swanson, Patrick C.			N-Acetylcysteine Increases the Frequency of Bone Marrow Pro-B/Pre-B Cells, but Does Not Reverse Cigarette Smoking-Induced Loss of This Subset	PLOS ONE			English	Article							ANTIOXIDANTS; COTININE; STRESS	Background: We previously showed that mice exposed to cigarette smoke for three weeks exhibit loss of bone marrow B cells at the Pro-B-to-pre-B cell transition, but the reason for this is unclear. The antioxidant N-acetylcysteine (NAC), a glutathione precursor, has been used as a chemopreventive agent to reduce adverse effects of cigarette smoke exposure on lung function. Here we determined whether smoke exposure impairs B cell development by inducing cell cycle arrest or apoptosis, and whether NAC treatment prevents smoking-induced loss of developing B cells. Methodology/Principal Findings: Groups of normal mice were either exposed to filtered room air or cigarette smoke with or without concomitant NAC treatment for 5 days/week for three weeks. Bone marrow B cell developmental subsets were enumerated, and sorted pro-B (B220(+)CD43(+)) and pre-B (B220(+)CD43(-)) cell fractions were analyzed for cell cycle status and the percentage of apoptotic cells. We find that, compared to sham controls, smoke-exposed mice have similar to 60% fewer pro-B/pre-B cells, regardless of NAC treatment. Interestingly, NAC-treated mice show a 21-38% increase in total bone marrow cellularity and lymphocyte frequency and about a 2-fold increase in the pro-B/pre-B cell subset, compared to sham-treated controls. No significant smoking-or NAC-dependent differences were detected in frequency of apoptotic cells or the percentage cells in the G1, S, or G2 phases of the cycle. Conclusions/Significance: The failure of NAC treatment to prevent smoking-induced loss of bone marrow pre-B cells suggests that oxidative stress is not directly responsible for this loss. The unexpected expansion of the pro-B/pre-B cell subset in response to NAC treatment suggests oxidative stress normally contributes to cell loss at this developmental stage, and also reveals a potential side effect of therapeutic administration of NAC to prevent smoking-induced loss of lung function.	[Palmer, Victoria L.; Kassmeier, Michele D.; Swanson, Patrick C.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Willcockson, James; Akhter, Mohammed P.; Cullen, Diane M.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Akhter, Mohammed P.] Creighton Univ, Sch Med, Osteoporosis Res Ctr, Omaha, NE 68178 USA	Creighton University; Creighton University; Creighton University	Palmer, VL (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA.	pswanson@creighton.edu			Nebraska Department of Health and Human Services [LB595]; NCRR [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER	Nebraska Department of Health and Human Services; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by revenue from Nebraska cigarette taxes awarded to Creighton University by the Nebraska Department of Health and Human Services through LB595. Animals used in this study were housed in the Creighton University Animal Resource Facility, which is supported by a grant from the NCRR (G20RR024001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arranz L, 2008, FREE RADICAL BIO MED, V45, P1252, DOI 10.1016/j.freeradbiomed.2008.07.014; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Borghesi L, 2005, J EXP MED, V202, P1669, DOI 10.1084/jem.20051190; De la Fuente M, 2011, INT IMMUNOPHARMACOL, V11, P661, DOI 10.1016/j.intimp.2011.01.008; de Weerd S, 2002, ENVIRON RES, V90, P119, DOI 10.1006/enrs.2002.4395; Dekhuijzen P N R, 2006, Int J Chron Obstruct Pulmon Dis, V1, P99, DOI 10.2147/copd.2006.1.2.99; Fusby JS, 2010, INHAL TOXICOL; Guayerbas N, 2002, CLIN EXP PHARMACOL P, V29, P1009, DOI 10.1046/j.1440-1681.2002.03758.x; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; MacNee W, 1999, AM J RESP CRIT CARE, V160, pS58, DOI 10.1164/ajrccm.160.supplement_1.15; Morrison D, 1999, AM J RESP CRIT CARE, V159, P473, DOI 10.1164/ajrccm.159.2.9804080; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Rosati E, 2004, J LEUKOCYTE BIOL, V76, P152, DOI 10.1189/jlb.0403148; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24804	10.1371/journal.pone.0024804	http://dx.doi.org/10.1371/journal.pone.0024804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949757	Green Published, gold, Green Submitted			2022-12-25	WOS:000295173800039
J	Berthold, HK; Laudes, M; Krone, W; Gouni-Berthold, I				Berthold, Heiner K.; Laudes, Matthias; Krone, Wilhelm; Gouni-Berthold, Ioanna			Association between the Interleukin-6 Promoter Polymorphism-174G/C and Serum Lipoprotein(a) Concentrations in Humans	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PLASMA IL-6 LEVELS; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; GENE POLYMORPHISM; APOLIPOPROTEIN-B; CONTROLLED TRIAL; FOLLOW-UP; RISK	Background: Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease. The interleukin-6 (IL-6) receptor antagonist tocilizumab has been shown to lower serum Lp(a) concentrations. We investigated whether the IL-6 single nucleotide polymorphism -174G/C is associated with baseline serum Lp(a) concentrations. Methodology/Principal Findings: We divided 2321 subjects from the Lipid Analytic Cologne (LIANCO) cohort into 2 groups, the ones with substantially elevated Lp(a), defined as concentrations >= 60 mg/dl (n = 510), and the ones with Lp(a) <60 mg/dl (n = 1811). The association with the genotypes GG (33.7%), GC (50.75%) and CC (15.55%) was investigated. The GC and the CC genotype were associated with a significantly increased odds ratio of having substantially elevated Lp(a) concentrations (OR = 1.3, 95% CI 1.04 to 1.63, P = 0.02 and OR = 1.44, 95% CI 1.06 to 1.93, P = 0.018). These associations remained significant after adjusting for age, sex, smoking behavior, body mass index, serum lipoproteins, hypertension and diabetes. Of these covariates, only LDL cholesterol was significantly and independently associated with elevated Lp(a) concentrations. Conclusions/Significance: The IL-6 single nucleotide polymorphism -174G/C is associated with increased odds of having elevated Lp(a). Whether this association plays a role in the Lp(a)-lowering effects of IL-6 receptor antagonists remains to be established.	[Berthold, Heiner K.] Charite, Res Grp Geriatr, Evangel Geriatr Ctr Berlin EGZB, D-13353 Berlin, Germany; [Berthold, Heiner K.] Charite, Campus Virchow Clin, Lipid Clin, Interdisciplinary Metab Ctr, D-13353 Berlin, Germany; [Laudes, Matthias; Krone, Wilhelm; Gouni-Berthold, Ioanna] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany; [Laudes, Matthias] Univ Kiel, Dept Internal Med & Cluster Excellence Inflammat, Kiel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Kiel	Berthold, HK (corresponding author), Charite, Res Grp Geriatr, Evangel Geriatr Ctr Berlin EGZB, D-13353 Berlin, Germany.	heiner.berthold@charite.de	Laudes, Matthias/C-8885-2011; Berthold, Heiner/E-6017-2011	Berthold, Heiner/0000-0002-1457-2216	Wilhelm Doerenkamp Foundation (Cologne, Germany); Bayer Vital GmbH (Leverkusen, Germany)	Wilhelm Doerenkamp Foundation (Cologne, Germany); Bayer Vital GmbH (Leverkusen, Germany)(Bayer AG)	The study was sponsored in part by the Wilhelm Doerenkamp Foundation (Cologne, Germany). No additional external funding was received for this study. Lipid Analytic Cologne (LIANCO) was supported by Bayer Vital GmbH (Leverkusen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg KK, 2009, SCAND J IMMUNOL, V69, P36, DOI 10.1111/j.1365-3083.2008.02187.x; BOYER H, 1990, ATHEROSCLEROSIS, V85, P61, DOI 10.1016/0021-9150(90)90183-J; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Candido APC, 2007, ATHEROSCLEROSIS, V191, P454, DOI 10.1016/j.atherosclerosis.2006.04.031; CARLSON LA, 1989, J INTERN MED, V226, P271, DOI 10.1111/j.1365-2796.1989.tb01393.x; Chien KL, 1999, ATHEROSCLEROSIS, V143, P267, DOI 10.1016/S0021-9150(98)00298-6; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Fernandez-Real JM, 2000, J CLIN ENDOCR METAB, V85, P1334, DOI 10.1210/jc.85.3.1334; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gouni-Berthold I, 2005, J HYPERTENS, V23, P301, DOI 10.1097/00004872-200502000-00012; Gouni-Berthold I, 2011, CURR VASC PHARM; Gouni-Berthold L, 2005, ATHEROSCLEROSIS, V183, P336, DOI 10.1016/j.atheroscelerosis.2005.03.016; Haddy N, 2005, EUR J HUM GENET, V13, P109, DOI 10.1038/sj.ejhg.5201294; Hamid YH, 2005, DIABETOLOGIA, V48, P251, DOI 10.1007/s00125-004-1623-0; Henningsson S, 2006, OBESITY, V14, P1868, DOI 10.1038/oby.2006.216; Hurme M, 2005, MECH AGEING DEV, V126, P417, DOI 10.1016/j.mad.2004.10.001; Huth C, 2006, DIABETES, V55, P2915, DOI 10.2337/db06-0600; Jones KG, 2001, CIRCULATION, V103, P2260; Jonkers IJ, 2002, AM J MED, V112, P275, DOI 10.1016/S0002-9343(01)01123-8; Joshi Parag H, 2010, Curr Treat Options Cardiovasc Med, V12, P396, DOI 10.1007/s11936-010-0077-6; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kim KI, 2008, CIRC J, V72, P293, DOI 10.1253/circj.72.293; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Libra M, 2006, J CLIN PATHOL, V59, P211, DOI 10.1136/jcp.2004.025452; Losito A, 2003, KIDNEY INT, V64, P616, DOI 10.1046/j.1523-1755.2003.00119.x; Margaglione M, 2001, HAEMATOLOGICA, V86, P199; Mora S, 2006, JAMA-J AM MED ASSOC, V295, P1412, DOI 10.1001/jama.295.12.1412; Mora S, 2010, CLIN CHEM, V56, P1252, DOI 10.1373/clinchem.2010.146779; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Oberbach A, 2008, EUR J ENDOCRINOL, V159, P129, DOI 10.1530/EJE-08-0220; Olivieri F, 2002, EXP GERONTOL, V37, P309, DOI 10.1016/S0531-5565(01)00197-8; Pereira DS, 2011, BRAZ J MED BIOL RES, V44, P123, DOI 10.1590/S0100-879X2011000200006; Qi L, 2007, J CLIN ENDOCR METAB, V92, P3618, DOI 10.1210/jc.2007-0877; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rauramaa R, 2000, ARTERIOSCL THROM VAS, V20, P2657, DOI 10.1161/01.ATV.20.12.2657; Revilla M, 2002, NEUROSCI LETT, V324, P29, DOI 10.1016/S0304-3940(02)00169-6; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sanders J, 2009, ATHEROSCLEROSIS, V204, P196, DOI 10.1016/j.atherosclerosis.2008.08.032; Schultz O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014328; Siekmeier R., 1996, J LAB MED, V20, P294; Sparks JD, 2010, AM J PHYSIOL-GASTR L, V299, pG980, DOI 10.1152/ajpgi.00080.2010; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Tan J, 2009, HEART VESSELS, V24, P329, DOI 10.1007/s00380-008-1128-8; Utermann G., 2001, METABOLIC MOL BASES, V8th, P2753; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Wypasek E, 2010, ANN CLIN BIOCHEM, V47, P343, DOI 10.1258/acb.2010.090305; Yeh KY, 2010, J CLIN IMMUNOL, V30, P53, DOI 10.1007/s10875-009-9324-6; Yun KA, 2004, SCAND J CLIN LAB INV, V64, P223, DOI 10.1080/00365510410005749	54	27	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24719	10.1371/journal.pone.0024719	http://dx.doi.org/10.1371/journal.pone.0024719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935443	gold, Green Submitted, Green Published			2022-12-25	WOS:000295039700037
J	Ribeiro, AR; Barbaglio, A; Benedetto, CD; Ribeiro, CC; Wilkie, IC; Carnevali, MDC; Barbosa, MA				Ribeiro, Ana R.; Barbaglio, Alice; Benedetto, Cristiano D.; Ribeiro, Cristina C.; Wilkie, Iain C.; Carnevali, Maria D. C.; Barbosa, Mario A.			New Insights into Mutable Collagenous Tissue: Correlations between the Microstructure and Mechanical State of a Sea-Urchin Ligament	PLOS ONE			English	Article							CONNECTIVE-TISSUE; FIBRILLIN MICROFIBRILS; JUXTALIGAMENTAL CELLS; CUCUMARIA-FRONDOSA; STIFFENING FACTOR; CUCUMBER; CATCH; ECHINODERMATA; PROTEOGLYCAN; MORPHOLOGY	The mutable collagenous tissue (MCT) of echinoderms has the ability to undergo rapid and reversible changes in passive mechanical properties that are initiated and modulated by the nervous system. Since the mechanism of MCT mutability is poorly understood, the aim of this work was to provide a detailed morphological analysis of a typical mutable collagenous structure in its different mechanical states. The model studied was the compass depressor ligament (CDL) of a sea urchin (Paracentrotus lividus), which was characterized in different functional states mimicking MCT mutability. Transmission electron microscopy, histochemistry, cryo-scanning electron microscopy, focused ion beam/scanning electron microscopy, and field emission gun-environmental scanning electron microscopy were used to visualize CDLs at the micro- and nanoscales. This investigation has revealed previously unreported differences in both extracellular and cellular constituents, expanding the current knowledge of the relationship between the organization of the CDL and its mechanical state. Scanning electron microscopies in particular provided a three-dimensional overview of CDL architecture at the micro-and nano-scales, and clarified the micro-organization of the ECM components that are involved in mutability. Further evidence that the juxtaligamental cells are the effectors of these changes in mechanical properties was provided by a correlation between their cytology and the tensile state of the CDLs.	[Ribeiro, Ana R.; Ribeiro, Cristina C.; Barbosa, Mario A.] Univ Porto, NEWTherapies Grp, Biomat Div, INEB Inst Engn Biomed, P-4100 Oporto, Portugal; [Ribeiro, Ana R.; Barbosa, Mario A.] Univ Porto, Dept Engn Met & Mat, FEUP Fac Engn, P-4100 Oporto, Portugal; [Barbaglio, Alice; Benedetto, Cristiano D.; Carnevali, Maria D. C.] Univ Milan, Dept Biol, Milan, Italy; [Ribeiro, Cristina C.] ISEP, Dept Fis, Oporto, Portugal; [Wilkie, Iain C.] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow G4 0BA, Lanark, Scotland; [Barbosa, Mario A.] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Milan; Polytechnic Institute of Porto; Glasgow Caledonian University; Universidade do Porto	Ribeiro, AR (corresponding author), Univ Porto, NEWTherapies Grp, Biomat Div, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	analopes@ineb.up.pt	Ribeiro, Cristina C/O-1842-2017; Ribeiro, Ana/ABE-9964-2021; Ribeiro, Ana R L P/D-3165-2012; Candia Carnevali, M. Daniela/I-8048-2015; Barbaglio, Alice/A-4365-2012; Barbosa, Mário A/F-5964-2011	Ribeiro, Cristina C/0000-0002-7802-7364; Ribeiro, Ana/0000-0003-1349-9595; Ribeiro, Ana R L P/0000-0003-1349-9595; Candia Carnevali, M. Daniela/0000-0002-0215-8843; Barbaglio, Alice/0000-0003-0122-0331; Barbosa, Mário A/0000-0003-3568-7482	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/40541/2007]; Cariplo Foundation [MIMESIS/2010]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Cariplo Foundation(Fondazione Cariplo)	Ana R. Ribeiro is grateful to the Portuguese Foundation for Science and Technology (FCT) for PhD grant ref. SFRH/BD/40541/2007. This work has received the financial support by Cariplo Foundation (Project MIMESIS/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARNEVALI MDC, 1991, SELECTED S MONORAPHS, P245; Cluzel C, 2000, MATRIX BIOL, V19, P545, DOI 10.1016/S0945-053X(00)00109-8; Cluzel C, 2001, J BIOL CHEM, V276, P18108, DOI 10.1074/jbc.M009597200; DALESSIO M, 1990, J BIOL CHEM, V265, P7050; DELCASTILLO J, 1995, BIOL BULL, V188, P120; ERLINGER R, 1993, J ANAT, V183, P1; Exposito JY, 2002, ANAT RECORD, V268, P302, DOI 10.1002/ar.10162; Flammang P, 2005, PROG MOLEC, V39, P201; Heinzeller Thomas, 2001, P41; Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; JUNQUEIRA LCU, 1983, ARCH HISTOL JAPON, V46, P589, DOI 10.1679/aohc.46.589; Kadler KE, 1996, BIOCHEM J, V316, P1; Koob TJ, 1999, J EXP BIOL, V202, P2291; Mashanova VS, 2007, RUSS J MAR BIOL, V33, P110, DOI 10.1134/S1063074007020058; Motokawa T, 2004, BIOL BULL-US, V206, P4, DOI 10.2307/1543193; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; OWEN G, 1955, NATURE, V175, P434, DOI 10.1038/175434a0; Prento P, 2009, BIOTECH HISTOCHEM, V84, P139, DOI 10.1080/10520290902908810; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Szulgit G, 2007, BIOESSAYS, V29, P645, DOI 10.1002/bies.20597; Takemae N, 2009, BIOL BULL-US, V216, P45; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814; Trotter JA, 2002, COMP BIOCHEM PHYS A, V133, P1127, DOI 10.1016/S1095-6433(02)00213-1; Trotter JA, 1996, MATRIX BIOL, V15, P99, DOI 10.1016/S0945-053X(96)90151-1; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Trotter JA, 1995, COMP BIOCHEM PHYS A, V112, P463, DOI 10.1016/0300-9629(95)02015-2; Trotter JA, 2000, J MOL BIOL, V300, P531, DOI 10.1006/jmbi.2000.3879; Wilkie I.C., 1988, P25; WILKIE IC, 1994, B ZOOL, V61, P39, DOI 10.1080/11250009409355857; WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105; WILKIE IC, 1979, CELL TISSUE RES, V197, P515; Wilkie IC, 2005, PROG MOLEC, V39, P221; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149	39	29	30	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24822	10.1371/journal.pone.0024822	http://dx.doi.org/10.1371/journal.pone.0024822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935473	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700050
J	Zoll, J; Hahn, MM; Gielen, P; Heus, HA; Melchers, WJG; van Kuppeveld, FJM				Zoll, Jan; Hahn, Marc M.; Gielen, Paul; Heus, Hans A.; Melchers, Willem J. G.; van Kuppeveld, Frank J. M.			Unusual Loop-Sequence Flexibility of the Proximal RNA Replication Element in EMCV	PLOS ONE			English	Article							VIRAL-RNA; STEM-LOOP; POLIOVIRUS 3'-UTR; BASE-PAIRS; VIRUS; PROTEIN; REGION; TRANSLATION; RECOGNITION; STABILITY	Picornaviruses contain stable RNA structures at the 59 and 39 ends of the RNA genome, OriL and OriR involved in viral RNA replication. The OriL RNA element found at the 59 end of the enterovirus genome folds into a cloverleaf-like configuration. In vivo SELEX experiments revealed that functioning of the poliovirus cloverleaf depends on a specific structure in this RNA element. Little is known about the OriL of cardioviruses. Here, we investigated structural aspects and requirements of the apical loop of proximal stem-loop SL-A of mengovirus, a strain of EMCV. Using NMR spectroscopy, we showed that the mengovirus SL-A apical loop consists of an octaloop. In vivo SELEX experiments demonstrated that a large number of random sequences are tolerated in the apical octaloop that support virus replication. Mutants in which the SL-A loop size and the length of the upper part of the stem were varied showed that both stem-length and stability of the octaloop are important determinants for viral RNA replication and virus reproduction. Together, these data show that stem-loop A plays an important role in virus replication. The high degree of sequence flexibility and the lack of selective pressure on the octaloop argue against a role in sequence specific RNA-protein or RNA-RNA interactions in which octaloop nucleotides are involved.	[Zoll, Jan; Hahn, Marc M.; Gielen, Paul; Melchers, Willem J. G.; van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Heus, Hans A.] Radboud Univ Nijmegen, Inst Mol & Mat, Biophys Chem Lab, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Zoll, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	j.zoll@ncmls.ru.nl	Heus, Hans/F-9696-2015; Melchers, Willem/C-8819-2015; Zoll, G.J./L-4776-2015	Heus, Hans/0000-0001-7256-4241; Melchers, Willem/0000-0002-5446-2230; Zoll, G.J./0000-0003-2155-7935; van Kuppeveld, Frank/0000-0001-5800-749X	NWO-CW [700.55.008]	NWO-CW(Netherlands Organization for Scientific Research (NWO))	Funding was provided by NWO-CW grant 700.55.008 (www.nwo.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agol Vadim I., 2002, P127; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Bedard KM, 2004, MICROBES INFECT, V6, P702, DOI 10.1016/j.micinf.2004.03.001; Blose JM, 2009, J AM CHEM SOC, V131, P8474, DOI 10.1021/ja900065e; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; Du ZH, 2004, BIOCHEMISTRY-US, V43, P11959, DOI 10.1021/bi048973p; DUKE GM, 1989, J VIROL, V63, P1822, DOI 10.1128/JVI.63.4.1822-1826.1989; Fata-Hartley CL, 2005, J VIROL, V79, P11062, DOI 10.1128/JVI.79.17.11062-11070.2005; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Lebars I, 2003, EMBO J, V22, P183, DOI 10.1093/emboj/cdg022; Lescrinier EMHP, 2003, J MOL BIOL, V331, P759, DOI 10.1016/S0022-2836(03)00787-3; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; Maris C, 2005, RNA, V11, P173, DOI 10.1261/rna.7190705; Martin LR, 1996, J VIROL, V70, P8182, DOI 10.1128/JVI.70.11.8182-8186.1996; Melchers WJG, 2006, RNA, V12, P1671, DOI 10.1261/rna.113106; Melchers WJG, 2000, RNA, V6, P976, DOI 10.1017/S1355838200000480; Merkle I, 2002, J VIROL, V76, P9900, DOI 10.1128/JVI.76.19.9900-9909.2002; Murray KE, 2003, J VIROL, V77, P4739, DOI 10.1128/JVI.77.8.4739-4750.2003; Nateri AS, 2002, J VIROL, V76, P13116, DOI 10.1128/JVI.76.24.13116-13122.2002; Paner TM, 1996, BIOPOLYMERS, V39, P779, DOI 10.1002/(SICI)1097-0282(199612)39:6<779::AID-BIP5>3.3.CO;2-Y; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Serrano P, 2006, J GEN VIROL, V87, P3013, DOI 10.1099/vir.0.82059-0; van Ooij MJM, 2006, NUCLEIC ACIDS RES, V34, P2953, DOI 10.1093/nar/gkl349; VANKUPPEVELD FJM, 1995, J VIROL, V69, P7782, DOI 10.1128/JVI.69.12.7782-7790.1995; Vecenie CJ, 2006, BIOCHEMISTRY-US, V45, P1400, DOI 10.1021/bi051750u; Vogt DA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000936; Zoll J, 1996, J VIROL, V70, P4948, DOI 10.1128/JVI.70.8.4948-4952.1996; Zoll J, 2007, RNA, V13, P781, DOI 10.1261/rna.375607; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416; Zoll J, 2009, VIRUS RES, V139, P209, DOI 10.1016/j.virusres.2008.07.014; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24818	10.1371/journal.pone.0024818	http://dx.doi.org/10.1371/journal.pone.0024818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935472	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700049
J	Fenner, L; Malla, B; Ninet, B; Dubuis, O; Stucki, D; Borrell, S; Huna, T; Bodmer, T; Egger, M; Gagneux, S				Fenner, Lukas; Malla, Bijaya; Ninet, Beatrice; Dubuis, Olivier; Stucki, David; Borrell, Sonia; Huna, Thembela; Bodmer, Thomas; Egger, Matthias; Gagneux, Sebastien			"Pseudo-Beijing": Evidence for Convergent Evolution in the Direct Repeat Region of Mycobacterium tuberculosis	PLOS ONE			English	Article							LARGE SEQUENCE POLYMORPHISMS; GENOMIC DELETIONS; STRAINS; GENOTYPE; CLASSIFICATION; DIVERSITY; EMERGENCE; CLASSIFY; LINEAGE	Background: Mycobacterium tuberculosis has a global population structure consisting of six main phylogenetic lineages associated with specific geographic regions and human populations. One particular M. tuberculosis genotype known as "Beijing" has repeatedly been associated with drug resistance and has been emerging in some parts of the world. "Beijing" strains are traditionally defined based on a characteristic spoligotyping pattern. We used three alternative genotyping techniques to revisit the phylogenetic classification of M. tuberculosis complex (MTBC) strains exhibiting the typical "Beijing" spoligotyping pattern. Methods and Findings: MTBC strains were obtained from an ongoing molecular epidemiological study in Switzerland and Nepal. MTBC genotyping was performed based on SNPs, genomic deletions, and 24-loci MIRU-VNTR. We identified three MTBC strains from patients originating from Tibet, Portugal and Nepal which exhibited a spoligotyping patterns identical to the classical Beijing signature. However, based on three alternative molecular markers, these strains were assigned to Lineage 3 ( also known as Delhi/CAS) rather than to Lineage 2 ( also known as East-Asian lineage). Sequencing of the RD207 in one of these strains showed that the deletion responsible for this "Pseudo-Beijing" spoligotype was about 1,000 base pairs smaller than the usual deletion of RD207 in classical "Beijing" strains, which is consistent with an evolutionarily independent deletion event in the direct repeat (DR) region of MTBC. Conclusions: We provide an example of convergent evolution in the DR locus of MTBC, and highlight the limitation of using spoligotypes for strain classification. Our results indicate that a proportion of "Beijing" strains may have been misclassified in the past. Markers that are more phylogenetically robust should be used when exploring strain-specific differences in experimental or clinical phenotypes.	[Fenner, Lukas; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Malla, Bijaya; Stucki, David; Borrell, Sonia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Malla, Bijaya; Stucki, David; Borrell, Sonia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Ninet, Beatrice] Univ Hosp Geneva, Bacteriol Lab, Geneva, Switzerland; [Dubuis, Olivier] Viollier AG, Basel, Switzerland; [Huna, Thembela] MRC Natl Inst Med Res, London, England; [Bodmer, Thomas] Univ Bern, Inst Infect Dis, Mycobacteriol Unit, Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Geneva; MRC National Institute for Medical Research; University of Bern	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	lfenner@ispm.unibe.ch	Gagneux, Sebastien/ABE-7909-2020	Stucki, David/0000-0003-0131-9980; Gagneux, Sebastien/0000-0001-7783-9048; Egger, Matthias/0000-0001-7462-5132; Ninet, Beatrice/0000-0003-3575-2483; Fenner, Lukas/0000-0003-3309-4835	Swiss National Science Foundation [324730-12544, PP00A-119205]; National Institute of Allergy and Infectious Diseases (IeDEA Southern Africa) [5U01-AI069924-5]; Amt fur Ausbildungsbeitrage des Kantons Basel-Stadt; National Institutes of Health [R01AI090928-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928, U01AI069924] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Allergy and Infectious Diseases (IeDEA Southern Africa)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Amt fur Ausbildungsbeitrage des Kantons Basel-Stadt; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study has been supported by the Swiss National Science Foundation (grant number 324730-12544 and PP00A-119205). LF and ME are also supported by the National Institute of Allergy and Infectious Diseases (IeDEA Southern Africa, grant number 5U01-AI069924-5), BM by the "Amt fur Ausbildungsbeitrage des Kantons Basel-Stadt", and SG by the National Institutes of Health (grant number R01AI090928-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Cohen T, 2011, J CLIN MICROBIOL, V49, P385, DOI 10.1128/JCM.01378-10; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002	21	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24737	10.1371/journal.pone.0024737	http://dx.doi.org/10.1371/journal.pone.0024737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21935448	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800057
J	Fenstermacher, KJ; DeStefano, JJ				Fenstermacher, Katherine J.; DeStefano, Jeffrey J.			Mechanism of HIV Reverse Transcriptase Inhibition by Zinc FORMATION OF A HIGHLY STABLE ENZYME-(PRIMER-TEMPLATE) COMPLEX WITH PROFOUNDLY DIMINISHED CATALYTIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DNA-POLYMERASE; VIRUS; BINDING; HOMEOSTASIS; MUTATIONS; MAGNESIUM; CALCIUM; CELLS; IONS; VIVO	Several physiologically relevant cations including Ca2+, Mn2+, and Zn2+ have been shown to inhibit HIV reverse transcriptase (RT), presumably by competitively displacing one or more Mg2+ ions bound to RT. We analyzed the effects of Zn2+ on reverse transcription and compared them to Ca2+ and Mn2+. Using nucleotide extension efficiency as a readout, Zn2+ showed significant inhibition of reactions with 2 mM Mg2+, even when present at only similar to 5 mu M. Mn2+ and Ca2+ were also inhibitory but at higher concentrations. Both Mn2+ and Zn2+ (but not Ca2+) supported RT incorporation in the absence of Mg2+ with Mn2+ being much more efficient. The maximum extension rates with Zn2+, Mg2+, and Mg2+ were similar to 0.1, 1, and 3.5 nucleotides per second, respectively. Zinc supported optimal RNase H activity at similar to 25 mu M, similar to the optimal for nucleotide addition in the presence of low dNTP concentrations. Surprisingly, processivity (average number of nucleotides incorporated in a single binding event with enzyme) during reverse transcription was comparable with Zn2+ and Mg2+, and single RT molecules were able to continue extension in the presence of Zn2+ for several hours on the same template. Consistent with this result, the half-life for RT-Zn2+-(primer-template) complexes was 220 +/- 60 min and only 1.7 +/- 1 min with Mg2+, indicating similar to 130-fold more stable binding with Zn2+. Essentially, the presence of Zn2+ promotes the formation of a highly stable slowly progressing RT-(primer-template) complex.	[Fenstermacher, Katherine J.; DeStefano, Jeffrey J.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	DeStefano, JJ (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 413 Biosci Res Bldg, College Pk, MD 20742 USA.	jdestefa@umd.edu		Fenstermacher, Katherine/0000-0003-1139-3711	NIGM, National Institutes of Health [GM051140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051140, R01GM051140] Funding Source: NIH RePORTER	NIGM, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGM, National Institutes of Health Grant GM051140 (to J. J. D.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; BREWER GJ, 1979, AM J HEMATOL, V7, P53, DOI 10.1002/ajh.2830070107; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cristofaro JV, 2002, BIOCHEMISTRY-US, V41, P10968, DOI 10.1021/bi025871v; Delva P, 2004, J MEMBRANE BIOL, V199, P163, DOI 10.1007/s00232-004-0686-7; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; DESTEFANO JJ, 1992, BIOCHIM BIOPHYS ACTA, V1131, P270, DOI 10.1016/0167-4781(92)90025-U; Dubben S, 2010, J LEUKOCYTE BIOL, V87, P833, DOI 10.1189/jlb.0409241; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Filler AG, 1997, AIDS RES HUM RETROV, V13, P291, DOI 10.1089/aid.1997.13.291; FRIDLENDER B, 1978, VIROLOGY, V84, P551, DOI 10.1016/0042-6822(78)90274-X; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; Goldschmidt V, 2006, NUCLEIC ACIDS RES, V34, P42, DOI 10.1093/nar/gkj411; Herschhorn A, 2010, CELL MOL LIFE SCI, V67, P2717, DOI 10.1007/s00018-010-0346-2; Honscheid A, 2012, J NUTR BIOCHEM, V23, P18, DOI 10.1016/j.jnutbio.2010.10.007; Hou EW, 2004, PROTEIN EXPRES PURIF, V34, P75, DOI 10.1016/j.pep.2003.10.018; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ilouz R, 2002, BIOCHEM BIOPH RES CO, V295, P102, DOI 10.1016/S0006-291X(02)00636-8; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; LEVINSON W, 1973, P NATL ACAD SCI USA, V70, P164, DOI 10.1073/pnas.70.1.164; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; MULLEN GP, 1990, J BIOL CHEM, V265, P14327; Olimpo JT, 2010, NUCLEIC ACIDS RES, V38, P4426, DOI 10.1093/nar/gkq169; PALAN PR, 1978, MOL CELL BIOCHEM, V21, P67; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Sambrook J, 2001, MOL CLONING LAB MANU; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Siberry GK, 2002, NUTR RES, V22, P527, DOI 10.1016/S0271-5317(02)00364-0; SLABY I, 1984, BIOCHEM BIOPH RES CO, V122, P1410, DOI 10.1016/0006-291X(84)91248-8; TAN CK, 1991, BIOCHEMISTRY-US, V30, P2651, DOI 10.1021/bi00224a013; TEVELTHUIS AJW, 2010, PLOS PATHOG, V0006; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Walther UI, 2000, IN VITRO MOL TOXICOL, V13, P145, DOI 10.1089/109793300440730; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Wang S, 2002, ARCH PATHOL LAB MED, V126, P947; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yarrington RM, 2007, J VIROL, V81, P9004, DOI 10.1128/JVI.02502-06	47	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40433	40442		10.1074/jbc.M111.289850	http://dx.doi.org/10.1074/jbc.M111.289850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953456	Green Published, hybrid			2022-12-25	WOS:000297315400003
J	Biswas, M; Phan, D; Watanabe, M; Chan, JY				Biswas, Madhurima; Phan, Diane; Watanabe, Momoko; Chan, Jefferson Y.			The Fbw7 Tumor Suppressor Regulates Nuclear Factor E2-related Factor 1 Transcription Factor Turnover through Proteasome-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE; ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASES; NRF1; DEGRADATION; MECHANISMS; PROTEINS; FAMILY; NF-E2; GENE	Nuclear factor E2-related factor 1 (Nrf1) is a basic leucine zipper transcription factor that plays important roles in cellular stress response and development. Currently, the mechanism regulating Nrf1 expression is poorly understood. We report here that Nrf1 is a short-lived protein that is targeted by F-box protein Fbw7, which is the substrate-specifying component of SCF (Skp1-Cul1-Fbox protein-Rbx1)-type ubiquitin ligase for degradation via the ubiquitin-proteasome pathway. We show that Fbw7 directly binds Nrf1 through a Cdc4 phosphodegron and that enforced expression of Fbw7 promotes the ubiquitination and degradation of Nrf1. Conversely, depletion of endogenous Fbw7 leads to decreased Nrf1 ubiquitination and accumulation of Nrf1 protein. Accordingly, expression of Fbw7 leads to down-regulation of antioxidant response element-driven gene activation, whereas disruption of Fbw7-mediated destabilization of Nrf1 leads to increased antioxidant response element-driven gene expression. Together, these data identify Fbw7 as a regulator of Nrf1 expression and reveal a novel function of Fbw7 in cellular stress response.	[Biswas, Madhurima; Phan, Diane; Watanabe, Momoko; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Chan, JY (corresponding author), Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92697 USA.	jchan@uci.edu			National Institutes of Health [CA091907]; NATIONAL CANCER INSTITUTE [R56CA091907, R01CA091907, P30CA062203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA091907.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAN JY, 1995, HUM GENET, V95, P265; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Fujii Y, 2006, CANCER SCI, V97, P729, DOI 10.1111/j.1349-7006.2006.00239.x; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lenk U, 2000, J BIOL CHEM, V275, P39403, DOI 10.1074/jbc.M006949200; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Myhrstad MCW, 2001, BBA-GENE STRUCT EXPR, V1517, P212, DOI 10.1016/S0167-4781(00)00276-1; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304	33	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39282	39289		10.1074/jbc.M111.253807	http://dx.doi.org/10.1074/jbc.M111.253807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21953459	Green Published, hybrid			2022-12-25	WOS:000296759800046
J	Yang, CH; Yue, JM; Pfeffer, SR; Handorf, CR; Pfeffer, LM				Yang, Chuan He; Yue, Junming; Pfeffer, Susan R.; Handorf, Charles R.; Pfeffer, Lawrence M.			MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; KAPPA-B; SURVIVAL; EXPRESSION; TARGETS; MODULATION; ACTIVATION; INVASION; ONCOMIR; TUMORS	MicroRNA-21 (miR-21) is overexpressed in many human tumors and has been linked to various cellular processes altered in cancer. miR-21 is also up-regulated by a number of inflammatory agents, including IFN, which is of particular interest considering the close relationship between inflammation and cancer. Because miR-21 appears to be overexpressed in human melanoma, we examined the role of miR-21 in cancer development and metastasis in B16 mouse melanoma cells. We found that miR-21 is a member of an IFN-induced miRNA subset that requires STAT3 activation. To characterize the role of miR-21 in melanoma behavior, we transduced B16 cells with lentivirus encoding a miR-21 antagomir and isolated miR-21 knockdown B16 cells. miR-21 knockdown or IFN treatment alone inhibited B16 cell proliferation and migration in vitro, and in combination they had an enhanced effect. Moreover, miR-21 knockdown sensitized B16 cells to IFN-induced apoptosis. In B16 cells miR-21 targeted tumor suppressor (PTEN and PDCD4) and antiproliferative (BTG2) proteins. To characterize the role of miR-21 in vivo, empty vector- and antagomiR-21-transduced B16 melanoma cells were injected via tail vein into syngeneic C57BL/6 mice. Although empty vector-transduced B16 cells produced large lung metastases, miR-21 knockdown cells only formed small lung lesions. Importantly, miR-21 knockdown tumor-bearing mice exhibited prolonged survival compared with empty vector tumor-bearing mice. Thus, miR-21 regulates the metastatic behavior of B16 melanoma cells by promoting cell proliferation, survival, and migration/invasion as well as by suppressing IFN action, providing important new insights into the role of miR-21 in melanoma.	[Yang, Chuan He; Pfeffer, Susan R.; Handorf, Charles R.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Yang, Chuan He; Yue, Junming; Pfeffer, Susan R.; Handorf, Charles R.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Ctr Adult Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pfeffer, LM (corresponding author), Canc Res Bldg,Rm 154,19 S Manassas St, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322, RHL095957]; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA133322 (to L. M. P.) and RHL095957 (to J. Y.). This work was also supported by the Muirhead Chair Endowment of the University of Tennessee Health Science Center (to L. M. P.).	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; NICOLSON GL, 1978, CANCER RES, V38, P4105; NICOLSON GL, 1979, SCI AM, V240, P66, DOI 10.1038/scientificamerican0379-66; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; POSTE G, 1982, CANCER RES, V42, P2770; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Yang C., 2010, P IEEE WICOM C, P1; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	32	137	145	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39172	39178		10.1074/jbc.M111.285098	http://dx.doi.org/10.1074/jbc.M111.285098			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940630	Green Published, hybrid			2022-12-25	WOS:000296759800036
J	Motlhabi, LM; Stormo, GD				Motlhabi, Lala M.; Stormo, Gary D.			Assessing the Effects of Symmetry on Motif Discovery and Modeling	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR-BINDING; CHIP-SEQ; QUANTITATIVE SPECIFICITY; REGULATORY ELEMENTS; INFORMATION-CONTENT; GENE-REGULATION; DNA; SITES; IDENTIFICATION; PATTERNS	Background: Identifying the DNA binding sites for transcription factors is a key task in modeling the gene regulatory network of a cell. Predicting DNA binding sites computationally suffers from high false positives and false negatives due to various contributing factors, including the inaccurate models for transcription factor specificity. One source of inaccuracy in the specificity models is the assumption of asymmetry for symmetric models. Methodology/Principal Findings: Using simulation studies, so that the correct binding site model is known and various parameters of the process can be systematically controlled, we test different motif finding algorithms on both symmetric and asymmetric binding site data. We show that if the true binding site is asymmetric the results are unambiguous and the asymmetric model is clearly superior to the symmetric model. But if the true binding specificity is symmetric commonly used methods can infer, incorrectly, that the motif is asymmetric. The resulting inaccurate motifs lead to lower sensitivity and specificity than would the correct, symmetric models. We also show how the correct model can be obtained by the use of appropriate measures of statistical significance. Conclusions/Significance: This study demonstrates that the most commonly used motif-finding approaches usually model symmetric motifs incorrectly, which leads to higher than necessary false prediction errors. It also demonstrates how alternative motif-finding methods can correct the problem, providing more accurate motif models and reducing the errors. Furthermore, it provides criteria for determining whether a symmetric or asymmetric model is the most appropriate for any experimental dataset.	[Motlhabi, Lala M.; Stormo, Gary D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Motlhabi, LM (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	stormo@wustl.edu	Stormo, Gary D/C-5367-2013	Stormo, Gary D/0000-0001-6896-1850	National Institutes of Health [HG00249]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grant HG00249. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Christensen RG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr239; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P959, DOI 10.1038/nbt0806-959; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fields DS, 1997, J MOL BIOL, V271, P178, DOI 10.1006/jmbi.1997.1171; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; Homsi DSF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006736; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kechris KJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r50; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu X, 2001, Pac Symp Biocomput, P127; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nagarajan N, 2005, BIOINFORMATICS, V21, pI311, DOI 10.1093/bioinformatics/bti1044; Nagarajan N, 2008, BIOINFORMATICS, V24, P577, DOI 10.1093/bioinformatics/btm594; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stormo GD, 2011, GENETICS, V187, P1219, DOI 10.1534/genetics.110.126052; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Taslim C, 2009, BIOINFORMATICS, V25, P2334, DOI 10.1093/bioinformatics/btp384; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590	42	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24908	10.1371/journal.pone.0024908	http://dx.doi.org/10.1371/journal.pone.0024908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949783	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400020
J	Peters, JH; McDougall, SJ; Fawley, JA; Andresen, MC				Peters, James H.; McDougall, Stuart J.; Fawley, Jessica A.; Andresen, Michael C.			TRPV1 Marks Synaptic Segregation of Multiple Convergent Afferents at the Rat Medial Solitary Tract Nucleus	PLOS ONE			English	Article							BRAIN-STEM PROJECTIONS; VISCERAL AFFERENTS; GLUTAMATE RELEASE; A-TYPE; NEURONS; TRANSMISSION; PULMONARY; RELIABILITY; ACTIVATION; MECHANISMS	TRPV1 receptors are expressed on most but not all central terminals of cranial visceral afferents in the caudal solitary tract nucleus (NTS). TRPV1 is associated with unmyelinated C-fiber afferents. Both TRPV1+ and TRPV1- afferents enter NTS but their precise organization remains poorly understood. In horizontal brainstem slices, we activated solitary tract (ST) afferents and recorded ST-evoked glutamatergic excitatory synaptic currents (ST-EPSCs) under whole cell voltage clamp conditions from neurons of the medial subnucleus. Electrical shocks to the ST produced fixed latency EPSCs (jitter < 200 mu s) that identified direct ST afferent innervation. Graded increases in shock intensity often recruited more than one ST afferent and ST-EPSCs had consistent threshold intensity, latency to onset, and unique EPSC waveforms that characterized each unitary ST afferent contact. The TRPV1 agonist capsaicin (100 nM) blocked the evoked TRPV1+ ST-EPSCs and defined them as either TRPV1+ or TRPV1- inputs. No partial responses to capsaicin were observed so that in NTS neurons that received one or multiple (2-5) direct ST afferent inputs - all were either blocked by capsaicin or were unaltered. Since TRPV1 mediates asynchronous release following TRPV1+ ST-evoked EPSCs, we likewise found that recruiting more than one ST afferent further augmented the asynchronous response and was eliminated by capsaicin. Thus, TRPV1+ and TRPV1- afferents are completely segregated to separate NTS neurons. As a result, the TRPV1 receptor augments glutamate release only within unmyelinated afferent pathways in caudal medial NTS and our work indicates a complete separation of C-type from A-type afferent information at these first central neurons.	[Peters, James H.; McDougall, Stuart J.; Fawley, Jessica A.; Andresen, Michael C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Oregon Health & Science University	Peters, JH (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA.	andresen.ohsu@gmail.com	McDougall, Stuart/J-8310-2012	Andresen, Michael/0000-0003-0524-1172; Fawley, Jessica/0000-0002-8723-6096; McDougall, Stuart/0000-0002-8778-675X	National Institutes of Health (NIH); Ruth L. Kirschstein Individual National Research Service [HL-88894]; National Health and Medical Research Council of Australia [400405, HL-41119, HL-105703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105703, F32HL088894, R01HL041119] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein Individual National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (NIH), Ruth L. Kirschstein Individual National Research Service Award HL-88894 (Dr. Peters), National Health and Medical Research Council of Australia, Overseas Training C J Martin Fellowship #400405 (Dr. McDougall), HL-41119 (Dr. Andresen), and HL-105703 (Dr. Andresen). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung and Blood Institute or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; ANDRESEN MC, 1978, CIRC RES, V43, P728, DOI 10.1161/01.RES.43.5.728; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; ANDRESEN MC, 1995, J NEUROPHYSIOL, V74, P1518, DOI 10.1152/jn.1995.74.4.1518; Andresen MC, 2008, AM J PHYSIOL-HEART C, V295, pH2032, DOI 10.1152/ajpheart.00568.2008; Andresen MC, 2007, TZU CHI MED J, V19, P181, DOI 10.1016/S1016-3190(10)60014-6; [Anonymous], [No title captured]; Appleyard SM, 2007, J NEUROSCI, V27, P13292, DOI 10.1523/JNEUROSCI.3502-07.2007; Bailey TW, 2006, J NEUROSCI, V26, P11893, DOI 10.1523/JNEUROSCI.2044-06.2006; Bailey TW, 2006, J NEUROSCI, V26, P6131, DOI 10.1523/JNEUROSCI.5176-05.2006; Bailey TW, 2002, J NEUROSCI, V22, P8230; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Browning KN, 2011, AM J PHYSL IN PRESS; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; COLERIDGE JCG, 1984, REV PHYSIOL BIOCH P, V99, P1, DOI 10.1007/BFb0027715; DAVIES RO, 1986, J PHYSIOL-LONDON, V373, P63, DOI 10.1113/jphysiol.1986.sp016035; DONOGHUE S, 1982, J PHYSIOL-LONDON, V322, P337, DOI 10.1113/jphysiol.1982.sp014040; DONOGHUE S, 1982, J PHYSIOL-LONDON, V322, P353, DOI 10.1113/jphysiol.1982.sp014041; DOUGLAS WW, 1962, PHYSIOL REV, V42, P297, DOI 10.1152/physrev.1962.42.2.297; Doyle MW, 2004, J NEUROSCI METH, V137, P37, DOI 10.1016/j.jneumeth.2004.02.007; Doyle MW, 2002, J NEUROSCI, V22, P8222; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Fan W, 1999, AM J PHYSIOL-REG I, V277, pR748, DOI 10.1152/ajpregu.1999.277.3.R748; Fan W, 1998, AM J PHYSIOL-HEART C, V275, pH632, DOI 10.1152/ajpheart.1998.275.2.H632; HOLZER P, 1991, PHARMACOL REV, V43, P143; Jin YH, 2004, J NEUROSCI, V24, P4709, DOI 10.1523/JNEUROSCI.0753-04.2004; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; Kunze DL, 1991, REFLEX CONTROL CIRCU, P141; Laaris N, 2007, NEUROSCIENCE, V146, P792, DOI 10.1016/j.neuroscience.2007.01.053; Li BY, 2007, J NEUROSCI METH, V164, P75, DOI 10.1016/j.jneumeth.2007.04.003; Loewy AD., 1990, CENTRAL REGULATION A, P88; McDougall SJ, 2009, J NEUROSCI, V29, P12886, DOI 10.1523/JNEUROSCI.3491-09.2009; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mifflin SW, 1996, AM J PHYSIOL-REG I, V271, pR870, DOI 10.1152/ajpregu.1996.271.4.R870; Peters JH, 2008, J NEUROSCI, V28, P11731, DOI 10.1523/JNEUROSCI.3419-08.2008; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; SCHILD JH, 1994, J NEUROPHYSIOL, V71, P2338, DOI 10.1152/jn.1994.71.6.2338; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202	43	37	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25015	10.1371/journal.pone.0025015	http://dx.doi.org/10.1371/journal.pone.0025015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949835	Green Published, Green Submitted, gold			2022-12-25	WOS:000295260400035
J	Pietilainen, O; Laaksonen, M; Rahkonen, O; Lahelma, E				Pietilainen, Olli; Laaksonen, Mikko; Rahkonen, Ossi; Lahelma, Eero			Self-Rated Health as a Predictor of Disability Retirement - The Contribution of Ill-Health and Working Conditions	PLOS ONE			English	Article							FOLLOW-UP; MORTALITY; PENSION	Objective: Self-rated health is a generic health indicator predicting mortality, many diseases, and need for care. We examined self-rated health as a predictor of subsequent disability retirement, and ill-health and working conditions as potential explanations for the association. Methods: Self-rated health and the covariates were obtained from the Helsinki Health Study baseline mail surveys in 20002002 conducted among municipal employees aged 40-60 years (n = 6525). Data for disability retirement events (n = 625) along with diagnoses were linked from the Finnish Centre for Pensions, with a follow-up by the end of 2010. Hazard ratios (HR) and their 95% confidence intervals (CI) were calculated using competing risks models. Results: Less than good self-rated health predicted disability retirement due to all causes among both women (HR = 4.60, 95% CI = 3.84-5.51) and men (HR = 3.83, 95% CI = 2.64-5.56), as well as due to musculoskeletal diseases (HR = 5.17, 95% CI = 4.02-6.66) and mental disorders (HR = 4.80, 95% CI = 3.50-6.59) among women and men pooled. Ill-health and physical working conditions partly explained the found associations, which nevertheless remained after the adjustments. Among the measures of ill-health limiting long-standing illness explained the association most in all-cause disability retirement and disability retirements due to musculoskeletal diseases, whereas common mental disorders explained the association most in disability retirements due to mental health disorders. Among working conditions physical work load and hazardous exposures at work explained the association most, although much less than ill-health. Conclusions: Self-rated health is a strong predictor of disability retirement. This can be partly explained by ill-health and working conditions. Poor self-rated health provides a useful marker for increased risk of work disability and subsequent disability retirement.	[Pietilainen, Olli; Laaksonen, Mikko; Rahkonen, Ossi; Lahelma, Eero] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland	University of Helsinki	Pietilainen, O (corresponding author), Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland.	olli.k.pietilainen@helsinki.fi	Pietiläinen, Olli/AAO-1700-2021; Lahelma, Eero/ABC-8716-2020	Lahelma, Eero/0000-0002-1064-1333; Laaksonen, Mikko/0000-0002-6979-9872; Rahkonen, Ossi/0000-0002-7202-3274	Academy of Finland [1140751]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (http://www.aka.fi/en-GB/A/) grant #1140751. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzola C., 2006, INTRO S HMISC DESIGN; [Anonymous], 2009, TILASTO SUOMEN ELAKK; Biering-Sorensen F, 1999, DAN MED BULL, V46, P258; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Karpansalo M, 2004, SCAND J WORK ENV HEA, V30, P287, DOI 10.5271/sjweh.796; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Laaksonen M, 2008, J CLIN EPIDEMIOL, V61, P900, DOI 10.1016/j.jclinepi.2007.09.010; Lee Y, 2003, ARCH GERONTOL GERIAT, V37, P63, DOI 10.1016/S0167-4943(03)00021-9; Manderbacka K, 1998, SCAND J SOC MED, V26, P145, DOI 10.1080/14034949850153671; Mansson NO, 2001, SCAND J PUBLIC HEALT, V29, P151, DOI 10.1177/14034948010290020201; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127	20	57	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25004	10.1371/journal.pone.0025004	http://dx.doi.org/10.1371/journal.pone.0025004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825GY	21949830	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400031
J	Sardanyes, J; Elena, SF				Sardanyes, Josep; Elena, Santiago F.			Quasispecies Spatial Models for RNA Viruses with Different Replication Modes and Infection Strategies	PLOS ONE			English	Article							STREAK MOSAIC-VIRUS; SUPERINFECTION EXCLUSION; EVOLUTION; MULTIPLICITY; POPULATION; EPISTASIS; DYNAMICS; SELECTION; MUTATION; PHAGE	Empirical observations and theoretical studies suggest that viruses may use different replication strategies to amplify their genomes, which impact the dynamics of mutation accumulation in viral populations and therefore, their fitness and virulence. Similarly, during natural infections, viruses replicate and infect cells that are rarely in suspension but spatially organized. Surprisingly, most quasispecies models of virus replication have ignored these two phenomena. In order to study these two viral characteristics, we have developed stochastic cellular automata models that simulate two different modes of replication (geometric vs stamping machine) for quasispecies replicating and spreading on a two-dimensional space. Furthermore, we explored these two replication models considering epistatic fitness landscapes (antagonistic vs synergistic) and different scenarios for cell-to-cell spread, one with free superinfection and another with superinfection inhibition. We found that the master sequences for populations replicating geometrically and with antagonistic fitness effects vanished at low critical mutation rates. By contrast, the highest critical mutation rate was observed for populations replicating geometrically but with a synergistic fitness landscape. Our simulations also showed that for stamping machine replication and antagonistic epistasis, a combination that appears to be common among plant viruses, populations further increased their robustness by inhibiting superinfection. We have also shown that the mode of replication strongly influenced the linkage between viral loci, which rapidly reached linkage equilibrium at increasing mutations for geometric replication. We also found that the strategy that minimized the time required to spread over the whole space was the stamping machine with antagonistic epistasis among mutations. Finally, our simulations revealed that the multiplicity of infection fluctuated but generically increased along time.	[Sardanyes, Josep; Elena, Santiago F.] CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Sardanyes, J (corresponding author), CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain.	josep.sardanes@upf.edu	SARDANES, JOSEP/M-3799-2015; Elena, Santiago F./A-4191-2011	SARDANES, JOSEP/0000-0001-7225-5158; Elena, Santiago F./0000-0001-8249-5593	Human Frontier Science Program Organization [RGP12/2008]; Spanish Ministerio de Ciencia e Innovacion [BFU2009-06993]; Santa Fe Institute	Human Frontier Science Program Organization(Human Frontier Science Program); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Santa Fe Institute	This work has been funded by the Human Frontier Science Program Organization Grant RGP12/2008 and the Spanish Ministerio de Ciencia e Innovacion Grant BFU2009-06993. The authors also acknowledge support from the Santa Fe Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038106; Altmeyer S, 2001, PHYS REV LETT, V86, P5819, DOI 10.1103/PhysRevLett.86.5819; BATSCHELET E, 1976, GENE, V1, P27, DOI 10.1016/0378-1119(76)90004-4; Berngruber TW, 2010, J VIROL, V84, P10200, DOI 10.1128/JVI.00865-10; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Borderia AV, 2007, EVOLUTION, V61, P272, DOI 10.1111/j.1558-5646.2007.00025.x; Bull JC, 2001, APPL ENVIRON MICROB, V67, P5204, DOI 10.1128/AEM.67.11.5204-5209.2001; Burch CL, 2003, J EVOLUTION BIOL, V16, P1223, DOI 10.1046/j.1420-9101.2003.00632.x; Campos PRA, 1998, PHYS REV E, V58, P2664, DOI 10.1103/PhysRevE.58.2664; Chao L, 2002, J VIROL, V76, P3276, DOI 10.1128/JVI.76.7.3276-3281.2002; CHAO L, 1991, J THEOR BIOL, V153, P229, DOI 10.1016/S0022-5193(05)80424-2; CHAO L, 1988, J THEOR BIOL, V133, P99, DOI 10.1016/S0022-5193(88)80027-4; DARLINGTON OF, 1971, J VIROL, V8, P347, DOI 10.1128/JVI.8.3.347-348.1971; DENHARDT DT, 1966, VIROLOGY, V30, P10, DOI 10.1016/S0042-6822(66)81004-8; Dewanji A, 2005, MATH BIOSCI, V197, P140, DOI 10.1016/j.mbs.2005.07.003; Dietrich C, 2003, J GEN VIROL, V84, P2871, DOI 10.1099/vir.0.19245-0; Diveki Z, 2002, BIOCHIMIE, V84, P997, DOI 10.1016/S0300-9084(02)00007-X; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P1; DOMINGO E, 1976, GENE, V1, P3, DOI 10.1016/0378-1119(76)90003-2; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 1979, THE HYPERCYCLE, P60; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Elena SF, 2010, CHAOS, V20, DOI 10.1063/1.3449300; Elena SF, 2010, PHILOS T R SOC B, V365, P1867, DOI 10.1098/rstb.2010.0088; Frank SA, 2000, J THEOR BIOL, V206, P279, DOI 10.1006/jtbi.2000.2120; Frank SA, 2001, HEREDITY, V87, P522, DOI 10.1046/j.1365-2540.2001.00911.x; French R, 2003, ANNU REV PHYTOPATHOL, V41, P199, DOI 10.1146/annurev.phyto.41.052002.095559; Garcia-Arriaza J, 2004, J VIROL, V80, P2349; Gibbs A, 1995, MOL BASIS VIRUS EVOL, DOI New York, NY, USA; Gonzalez-Jara P, 2009, J VIROL, V83, P7487, DOI 10.1128/JVI.00636-09; Gutierrez S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001113; Hall JS, 2001, VIROLOGY, V282, P230, DOI 10.1006/viro.2001.0841; Jridi C, 2006, J VIROL, V80, P2349, DOI 10.1128/JVI.80.5.2349-2357.2006; LEUTHAUSSER I, 1987, J STAT PHYS, V48, P343, DOI 10.1007/BF01010413; LEUTHAUSSER I, 1986, J CHEM PHYS, V84, P1884, DOI 10.1063/1.450436; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Li HY, 2004, J VIROL, V78, P10582, DOI 10.1128/JVI.78.19.10582-10587.2004; Luria SE, 1951, COLD SPRING HARB SYM, V16, P1505; Manrubia SC, 2006, PHYS LIFE REV, V3, P65, DOI 10.1016/j.plrev.2005.11.002; Martinez F, 2011, GENETICS IN PRESS; Monsion B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000174; NEE S, 1987, J MOL EVOL, V25, P277, DOI 10.1007/BF02603110; Novella IS, 2004, J VIROL, V78, P5799, DOI 10.1128/JVI.78.11.5799-5804.2004; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; OLKKONEN VM, 1989, VIROLOGY, V171, P229, DOI 10.1016/0042-6822(89)90530-8; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; PASCUAL M, 1993, P ROY SOC B-BIOL SCI, V251, P1, DOI 10.1098/rspb.1993.0001; Sacristan S, 2003, J VIROL, V77, P9906, DOI 10.1128/JVI.77.18.9906-9911.2003; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, EVOLUTION, V58, P1185; Sanjuan R, 2006, J GEN VIROL, V87, P1595, DOI 10.1099/vir.0.81585-0; Sardanyes J, 2008, J THEOR BIOL, V250, P560, DOI 10.1016/j.jtbi.2007.10.027; Sardanyes J, 2009, J VIROL, V83, P12579, DOI 10.1128/JVI.00767-09; Sevilla N, 1998, J GEN VIROL, V79, P2971, DOI 10.1099/0022-1317-79-12-2971; SIMON KO, 1990, VIROLOGY, V177, P375, DOI 10.1016/0042-6822(90)90494-C; Sole RV, 2003, EUR PHYS J B, V35, P117, DOI 10.1140/epjb/e2003-00262-8; Sole RV, 1999, J THEOR BIOL, V198, P47, DOI 10.1006/jtbi.1999.0901; Sole RV, 2006, MONOGRAPHS POPULATIO; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Strain MC, 2002, J THEOR BIOL, V218, P85, DOI 10.1006/jtbi.2002.3055; Stumpf MPH, 1993, P ROY SOC LOND B BIO, V268, P1993; SUSSKIND MM, 1974, VIROLOGY, V62, P350, DOI 10.1016/0042-6822(74)90398-5; Takeshita M, 2004, VIROLOGY, V328, P45, DOI 10.1016/j.virol.2004.06.046; TARAZONA P, 1992, PHYS REV A, V45, P6038, DOI 10.1103/PhysRevA.45.6038; Tejero H, 2010, J THEOR BIOL, V262, P733, DOI 10.1016/j.jtbi.2009.10.011; Thebaud G, 2010, P ROY SOC B-BIOL SCI, V277, P809, DOI 10.1098/rspb.2009.1247; Toyabe S, 2005, PHYSICA D, V203, P1, DOI 10.1016/j.physd.2005.02.011; Turner PE, 1999, J VIROL, V73, P2420, DOI 10.1128/JVI.73.3.2420-2424.1999; van Opijnen T, 2006, J VIROL, V80, P6678, DOI 10.1128/JVI.02547-05; WHITAKERDOWLING P, 1983, VIROLOGY, V131, P137, DOI 10.1016/0042-6822(83)90540-8; Wilke CO, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-11; Zhdanov VP, 2004, J PHYS A-MATH GEN, V37, pL63, DOI 10.1088/0305-4470/37/5/L03	74	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24884	10.1371/journal.pone.0024884	http://dx.doi.org/10.1371/journal.pone.0024884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949777	Green Published, gold			2022-12-25	WOS:000295257900033
J	Qiu, WL; Cho, MH; Riley, JH; Anderson, WH; Singh, D; Bakke, P; Gulsvik, A; Litonjua, AA; Lomas, DA; Crapo, JD; Beaty, TH; Celli, BR; Rennard, S; Tal-Singer, R; Fox, SM; Silverman, EK; Hersh, CP				Qiu, Weiliang; Cho, Michael H.; Riley, John H.; Anderson, Wayne H.; Singh, Dave; Bakke, Per; Gulsvik, Amund; Litonjua, Augusto A.; Lomas, David A.; Crapo, James D.; Beaty, Terri H.; Celli, Bartolome R.; Rennard, Stephen; Tal-Singer, Ruth; Fox, Steven M.; Silverman, Edwin K.; Hersh, Craig P.		ECLIPSE Investigators	Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; SUSCEPTIBILITY LOCUS; NICOTINE DEPENDENCE; COPD; PSORIASIS; VARIANTS; RISK; POPULATION; SMOKING	Previous expression quantitative trait loci (eQTL) studies have performed genetic association studies for gene expression, but most of these studies examined lymphoblastoid cell lines from non-diseased individuals. We examined the genetics of gene expression in a relevant disease tissue from chronic obstructive pulmonary disease (COPD) patients to identify functional effects of known susceptibility genes and to find novel disease genes. By combining gene expression profiling on induced sputum samples from 131 COPD cases from the ECLIPSE Study with genomewide single nucleotide polymorphism (SNP) data, we found 4315 significant cis-eQTL SNP-probe set associations (3309 unique SNPs). The 3309 SNPs were tested for association with COPD in a genomewide association study (GWAS) dataset, which included 2940 COPD cases and 1380 controls. Adjusting for 3309 tests (p<1.5e-5), the two SNPs which were significantly associated with COPD were located in two separate genes in a known COPD locus on chromosome 15: CHRNA5 and IREB2. Detailed analysis of chromosome 15 demonstrated additional eQTLs for IREB2 mapping to that gene. eQTL SNPs for CHRNA5 mapped to multiple linkage disequilibrium (LD) bins. The eQTLs for IREB2 and CHRNA5 were not in LD. Seventy-four additional eQTL SNPs were associated with COPD at p<0.01. These were genotyped in two COPD populations, finding replicated associations with a SNP in PSORS1C1, in the HLA-C region on chromosome 6. Integrative analysis of GWAS and gene expression data from relevant tissue from diseased subjects has located potential functional variants in two known COPD genes and has identified a novel COPD susceptibility locus.	[Qiu, Weiliang; Cho, Michael H.; Litonjua, Augusto A.; Silverman, Edwin K.; Hersh, Craig P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [Cho, Michael H.; Litonjua, Augusto A.; Celli, Bartolome R.; Silverman, Edwin K.; Hersh, Craig P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Riley, John H.; Fox, Steven M.] GlaxoSmithKline, Uxbridge, Middx, England; [Anderson, Wayne H.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Singh, Dave] Univ Manchester, Med Evaluat Unit, Manchester, Lancs, England; [Bakke, Per; Gulsvik, Amund] Univ Bergen, Inst Med, Haukeland Univ Hosp, Dept Thorac Med, Bergen, Norway; [Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Crapo, James D.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Rennard, Stephen] Univ Nebraska Med Ctr, Div Pulm & Crit Care Med, Omaha, NE USA; [Tal-Singer, Ruth] GlaxoSmithKline, King Of Prussia, PA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; GlaxoSmithKline; GlaxoSmithKline; University of Manchester; University of Bergen; Haukeland University Hospital; University of Cambridge; National Jewish Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Nebraska System; University of Nebraska Medical Center; GlaxoSmithKline	Qiu, WL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA.	ed.silverman@channing.harvard.edu; craig.hersh@channing.harvard.edu	Singh, Dave/AAH-4342-2020; Tal-Singer, Ruth/AAQ-2925-2021; Coxson, Harvey O/A-9861-2017	Singh, Dave/0000-0001-8918-7075; Tal-Singer, Ruth/0000-0002-5275-8062; Coxson, Harvey O/0000-0001-5750-9711; Qiu, Weiliang/0000-0002-9155-6957; MacNee, William/0000-0002-3692-1448; Litonjua, Augusto/0000-0003-0422-5875	National Institutes of Health [K08HL080242, R01HL094635, R01HL084323, P01HL083069, U01HL089856, U01HL089897]; Alpha-1 Foundation; GlaxoSmithKline [SCO104960, NCT00292552]; National Heart, Lung, and Blood Institute [N01HR76101, N01HR76102, N01HR76103, N01HR76104, N01HR76105, N01HR76106, N01HR76107, N01HR76108, N01HR76109, N01HR76110, N01HR76111, N01HR76112, N01HR76113, N01HR76114, N01HR76115, N01HR76116, N01HR76118, N01HR76119]; Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality; Epidemiology Research and Information Center of the US Department of Veterans Affairs; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, Massachusetts; Medical Research Council [G0901786, G0901697] Funding Source: researchfish; DIVISION OF LUNG DISEASES [N01HR076110, N01HR076107, N01HR076102, N01HR076116, N01HR076119, N01HR076118, N01HR076111, N01HR076112, N01HR076104, N01HR076108, N01HR076101, N01HR076105, N01HR076113, N01HR076106, N01HR076114, N01HR076103, N01HR076115, N01HR076109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076113, T32HL076116, F32HL076108, R01HL094635, P01HL083069, U01HL089856, K08HL097029, R01HL084323, R01HL076101, R01HL076114, T32HL076118, U01HL089897, K08HL080242] Funding Source: NIH RePORTER; MRC [G0901786, G0901697] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha-1 Foundation; GlaxoSmithKline(GlaxoSmithKline); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Epidemiology Research and Information Center of the US Department of Veterans Affairs(US Department of Veterans Affairs); Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, Massachusetts; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institutes of Health grants K08HL080242 (Dr. Hersh), R01HL094635 (Dr. Hersh), R01HL084323 (Dr. Silverman), P01HL083069 (Dr. Silverman), and a grant from the Alpha-1 Foundation. The ECLIPSE Study is funded by GlaxoSmithKline (SCO104960, NCT00292552). The National Emphysema Treatment Trial was supported by the National Heart, Lung, and Blood Institute (N01HR76101, N01HR76102, N01HR76103, N01HR76104, N01HR76105, N01HR76106, N01HR76107, N01HR76108, N01HR76109, N01HR76110, N01HR76111, N01HR76112, N01HR76113, N01HR76114, N01HR76115, N01HR76116, N01HR76118, N01HR76119), Centers for Medicare and Medicaid Services, and the Agency for Healthcare Research and Quality. The Normative Aging Study is supported by the Cooperative Studies Program/Epidemiology Research and Information Center of the US Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), Boston, Massachusetts. The Genetic Epidemiology of COPD Study (COPDGene) is supported by National Institutes of Health grants U01HL089856 (Dr. Silverman) and U01HL089897 (Dr. Crapo). The International COPD Genetics Network was supported by GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; ANAGNOSTOPOULOU U, 1993, J CLIN EPIDEMIOL, V46, P1413, DOI 10.1016/0895-4356(93)90141-M; BELL B, 1972, AGING HUM DEVELOP, V3, P5, DOI 10.2190/GGVP-XLB5-PC3N-EF0G; Brogger J, 2006, EUR RESPIR J, V27, P682, DOI 10.1183/09031936.06.00057005; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Carey VJ, 2009, BIOINFORMATICS, V25, P1447, DOI 10.1093/bioinformatics/btp169; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dreiher J, 2008, BRIT J DERMATOL, V159, P956, DOI 10.1111/j.1365-2133.2008.08749.x; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Espada R, 1999, CHEST, V116, P1750; Falvella FS, 2009, CLIN CANCER RES, V15, P1837, DOI 10.1158/1078-0432.CCR-08-2107; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hersh C.P., 2005, RESP GENETICS, P253; Hersh CP, 2010, AM J RESP CRIT CARE, V182, P605, DOI 10.1164/rccm.200910-1586OC; Holm SJ, 2005, ACTA DERM-VENEREOL, V85, P2, DOI 10.1080/00015550410023527; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KAUFFMANN F, 1983, AM REV RESPIR DIS, V127, P263; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Setty AR, 2007, AM J MED, V120, P953, DOI 10.1016/j.amjmed.2007.06.020; Singh D, 2011, THORAX, V66, P489, DOI 10.1136/thx.2010.153767; Singh D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-77; Storm Niels, 2003, Methods Mol Biol, V212, P241; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wan ES, 2010, AM J RESP C IN PRESS; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Wheeler HE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000685; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Zhu G, 2007, AM J RESP CRIT CARE, V176, P167, DOI 10.1164/rccm.200611-1723OC	60	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24395	10.1371/journal.pone.0024395	http://dx.doi.org/10.1371/journal.pone.0024395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949713	Green Published, gold			2022-12-25	WOS:000295173800022
J	Harvati, K; Stringer, C; Grun, R; Aubert, M; Allsworth-Jones, P; Folorunso, CA				Harvati, Katerina; Stringer, Chris; Gruen, Rainer; Aubert, Maxime; Allsworth-Jones, Philip; Folorunso, Caleb Adebayo			The Later Stone Age Calvaria from Iwo Eleru, Nigeria: Morphology and Chronology	PLOS ONE			English	Article							DIFFUSION-ADSORPTION MODEL; U-SERIES; CLIMATE SIGNATURES; HUMAN-DIVERSITY; URANIUM; HISTORY; ICPMS; TEETH; BONE; ESR	Background: In recent years the Later Stone Age has been redated to a much deeper time depth than previously thought. At the same time, human remains from this time period are scarce in Africa, and even rarer in West Africa. The Iwo Eleru burial is one of the few human skeletal remains associated with Later Stone Age artifacts in that region with a proposed Pleistocene date. We undertook a morphometric reanalysis of this cranium in order to better assess its affinities. We also conducted Uranium-series dating to re-evaluate its chronology. Methodology/Principal Findings: A 3-D geometric morphometric analysis of cranial landmarks and semilandmarks was conducted using a large comparative fossil and modern human sample. The measurements were collected in the form of three dimensional coordinates and processed using Generalized Procrustes Analysis. Principal components, canonical variates, Mahalanobis D-2 and Procrustes distance analyses were performed. The results were further visualized by comparing specimen and mean configurations. Results point to a morphological similarity with late archaic African specimens dating to the Late Pleistocene. A long bone cortical fragment was made available for U-series analysis in order to re-date the specimen. The results (similar to 11.7-16.3 ka) support a terminal Pleistocene chronology for the Iwo Eleru burial as was also suggested by the original radiocarbon dating results and by stratigraphic evidence. Conclusions/Significance: Our findings are in accordance with suggestions of deep population substructure in Africa and a complex evolutionary process for the origin of modern humans. They further highlight the dearth of hominin finds from West Africa, and underscore our real lack of knowledge of human evolution in that region.	[Harvati, Katerina] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoecol, Tubingen, Germany; [Stringer, Chris] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Gruen, Rainer; Aubert, Maxime] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Allsworth-Jones, Philip] Univ Sheffield, Dept Archaeol, Sheffield, S Yorkshire, England; [Folorunso, Caleb Adebayo] Univ Ibadan, Dept Archaeol & Anthropol, Ibadan, Nigeria	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Natural History Museum London; Australian National University; University of Sheffield; University of Ibadan	Harvati, K (corresponding author), Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoecol, Tubingen, Germany.	katerina.harvati@ifu.uni-tuebingen.de	Harvati, Katerina/A-5197-2008; Aubert, Maxime/AAT-6198-2020; Grun, Rainer/A-1437-2012	Aubert, Maxime/0000-0002-4189-531X; Grun, Rainer/0000-0003-1366-3674	Senckenberg Research Institution, University of Tubingen	Senckenberg Research Institution, University of Tubingen	The work was funded by Senckenberg Research Institution, University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth-Jones P., 2010, W AFRICAN ARCHAEOLOG, V2164, P29; Applied Biostatistics Inc, 1986, NTSYSPC VERS 2 10T; Bookstein F L, 1997, Med Image Anal, V1, P225; Crevecoeur I, 2010, AM J PHYS ANTHROPOL, P87; Eggins S, 2003, QUATERNARY SCI REV, V22, P1373, DOI 10.1016/S0277-3791(03)00064-7; Eggins SM, 2005, QUATERNARY SCI REV, V24, P2523, DOI 10.1016/j.quascirev.2005.07.006; Grun R, 2008, GEOCHIM COSMOCHIM AC, V72, P5278, DOI 10.1016/j.gca.2008.08.007; Grun R, 2006, J HUM EVOL, V50, P347, DOI 10.1016/j.jhevol.2005.10.001; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Gunz P, 2007, J HUM EVOL, V52, P262, DOI 10.1016/j.jhevol.2006.08.010; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Hammer MF, P NATL ACAD IN PRESS; Harvati K, 2005, J HUM EVOL, V48, P653, DOI 10.1016/j.jhevol.2005.01.004; Harvati K, 2007, J HUM EVOL, V53, P732, DOI 10.1016/j.jhevol.2007.09.009; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Harvati K, 2010, J HUM EVOL, V59, P445, DOI 10.1016/j.jhevol.2010.06.005; Harvati K, 2009, J HUM EVOL, V57, P751, DOI 10.1016/j.jhevol.2009.07.008; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; *IMM CORP, 1998, MICR 3D US GUID; MARCUS LF, 1993, CONTRIBUTIONS MORPHO, P99; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Millard A.R., 1993, THESIS U OXFORD; Millard AR, 1996, GEOCHIM COSMOCHIM AC, V60, P2139, DOI 10.1016/0016-7037(96)00050-6; Pike A.W.G., 2000, THESIS U OXFORD; Pike AWG, 2002, GEOCHIM COSMOCHIM AC, V66, P4273, DOI 10.1016/S0016-7037(02)00997-3; Reed FA, 2006, CURR OPIN GENET DEV, V16, P597, DOI 10.1016/j.gde.2006.10.008; Rohlf FJ, 2003, TPSSMALL V 1 20 STON; *SAS I, 1999, SAS SYST WIND V8; Slice D.E., 1998, MORPHEUS SOFTWARE MO; Stringer C., 2007, RETHINKING HUMAN EVO, P15; Stringer C, 2011, ORIGIN OUR SPECIES A; Stringer C, 2010, AM J PHYS ANTHR S, VS50, P292; STRINGER CB, 1974, J ARCHAEOL SCI, V1, P317, DOI 10.1016/0305-4403(74)90051-X; Stringer CB, 1974, THESIS U BRISTOL; thwell D, 1971, MAN, p[221, 6]; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; *WOLFR RES INC, 2007, MATH ED VERS 6 0	38	88	89	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24024	10.1371/journal.pone.0024024	http://dx.doi.org/10.1371/journal.pone.0024024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822JR	21949689	Green Published, gold, Green Accepted			2022-12-25	WOS:000295041700006
J	Peng, Y; Clark, C; Luong, R; Tu, WH; Lee, J; Johnson, DT; Das, A; Carroll, TJ; Sun, ZJ				Peng, Yue; Clark, Curtis; Luong, Richard; Tu, William H.; Lee, Jane; Johnson, Daniel T.; Das, Amrita; Carroll, Thomas J.; Sun, Zijie			The Leucine Zipper Putative Tumor Suppressor 2 Protein LZTS2 Regulates Kidney Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIAS-LIKE PROTEIN; BETA-CATENIN; MICE; GENE; EXPRESSION; MORPHOGENESIS; EPITHELIUM; LAPSER1; BRAIN; GDNF	Members of the leucine zipper putative tumor suppressor (LZTS) family play crucial roles in transcription modulation and cell cycle control. We previously demonstrated that LZTS2 functions as a novel beta-catenin-interacting protein and represses beta-catenin-mediated transcription on T-cell factor/lymphoid enhancing factor. Here, we investigate the biological role of LZTS2 using newly established Lzts2 KO mice. Homozygosity for loss-of-function of the Lzts2-targeted allele resulted in severe kidney and urinary tract developmental defects, including renal/ureteral duplication, hydroureter, and hydronephrosis, which were visible prenatally. Altered ureteric bud outgrowth was identified in Lzts2 null embryos. Further analysis indicated that beta-catenin subcellular localization was altered in fibroblasts isolated from Lzts2 null embryos. In addition, Wnt growth factor-induced beta-catenin-mediated transcriptional activity was increased in Lzts2 null fibroblasts, suggesting a direct role for Lzts2 in the Wnt signaling pathway. These data demonstrate a critical role of LZTS2 in renal development and implicate LZTS2 as a critical regulator of beta-catenin-mediated nephrogenesis.	[Peng, Yue; Clark, Curtis; Tu, William H.; Lee, Jane; Johnson, Daniel T.; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Peng, Yue; Lee, Jane; Johnson, Daniel T.; Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Das, Amrita; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Nephrol, Dallas, TX 75390 USA; [Das, Amrita; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, S287,Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	NATIONAL CANCER INSTITUTE [R01CA070297, R01CA151623] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA151623, R01 CA070297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Chen F, 2009, PEDIATR NEPHROL, V24, P1621, DOI 10.1007/s00467-008-1072-y; Cho HH, 2008, BBA-MOL CELL RES, V1783, P419, DOI 10.1016/j.bbamcr.2007.08.005; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; DRESSLER GR, 1993, NATURE, V362, P65, DOI 10.1038/362065a0; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Kerecuk L, 2008, NAT CLIN PRACT NEPHR, V4, P312, DOI 10.1038/ncpneph0807; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Peng Y, 2010, J BIOL CHEM, V285, P11465, DOI 10.1074/jbc.M109.079327; Percy B. S., 2007, MOUSE; Peters CA, 2001, PRENATAL DIAG, V21, P917, DOI 10.1002/pd.211; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rosenthal A, 1999, NEURON, V22, P201, DOI 10.1016/S0896-6273(00)81077-6; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sainio K, 1997, DEVELOPMENT, V124, P4077; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Sudo H, 2008, HUM MOL GENET, V17, P2524, DOI 10.1093/hmg/ddn153; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Teufel A, 2005, ONCOL REP, V14, P547; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Vecchione A, 2001, CLIN CANCER RES, V7, P1546; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370	39	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40331	40342		10.1074/jbc.M111.302059	http://dx.doi.org/10.1074/jbc.M111.302059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949185	hybrid, Green Published			2022-12-25	WOS:000296925700064
J	Singh, SK; Bhardwaj, R; Wilczynska, KM; Dumur, CI; Kordula, T				Singh, Sandeep K.; Bhardwaj, Reetika; Wilczynska, Katarzyna M.; Dumur, Catherine I.; Kordula, Tomasz			A Complex of Nuclear Factor I-X3 and STAT3 Regulates Astrocyte and Glioma Migration through the Secreted Glycoprotein YKL-40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACIDIC PROTEIN GENES; FACTOR-I; ONCOSTATIN-M; TRANSCRIPTIONAL REGULATION; ARTICULAR CHONDROCYTES; BRAIN-DEVELOPMENT; CARTILAGE GP-39; NFIA CONTROLS; JC VIRUS; C-FOS	Nuclear factor I-X3 (NFI-X3) is a newly identified splice variant of NFI-X that regulates expression of several astrocyte-specific markers, such as glial fibrillary acidic protein. Here, we identified a set of genes regulated by NFI-X3 that includes a gene encoding a secreted glycoprotein YKL-40. Although YKL-40 expression is up-regulated in glioblastoma multiforme, its regulation and functions in nontransformed cells of the central nervous system are widely unexplored. We find that expression of YKL-40 is activated during brain development and also differentiation of neural progenitors into astrocytes in vitro. Furthermore, YKL-40 is a migration factor for primary astrocytes, and its expression is controlled by both NFI-X3 and STAT3, which are known regulators of gliogenesis. Knockdown of NFI-X3 and STAT3 significantly reduced YKL-40 expression in astrocytes, whereas overexpression of NFI-X3 dramatically enhanced YKL-40 expression in glioma cells. Activation of STAT3 by oncostatin M induced YKL-40 expression in astrocytes, whereas expression of a dominant-negative STAT3 had a suppressive effect. Mechanistically, NFI-X3 and STAT3 form a complex that binds to weak regulatory elements in the YKL-40 promoter and activates transcription. We propose that NFI-X3 and STAT3 control the migration of differentiating astrocytes as well as migration and invasion of glioma cells via regulating YKL-40 expression.	[Singh, Sandeep K.; Bhardwaj, Reetika; Wilczynska, Katarzyna M.; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Massey Canc Ctr, Richmond, VA 23298 USA; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Massey Canc Ctr, Richmond, VA 23298 USA.	tkordula@vcu.edu	Dumur, Catherine/AAH-9489-2020		National Institutes of Health [R01NS044118, R21NS063283]; Virginia Commonwealth University [2009 FPP-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063283, R01NS044118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS044118 and R21NS063283. This work was also supported by Massey Cancer Pilot Project no 2009 FPP-02 from Virginia Commonwealth University (to T. K.).	AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Benjamini H, 1995, J R STAT SOC B, V57, P289; Bhat KP, 2008, FEBS LETT, V582, P3193, DOI 10.1016/j.febslet.2008.08.010; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dumur CI, 2008, DIAGN MOL PATHOL, V17, P200, DOI 10.1097/PDM.0b013e318169bfaf; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gopalan SM, 2006, J BIOL CHEM, V281, P1956, DOI 10.1074/jbc.M510935200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kasza A, 2002, J NEUROCHEM, V83, P696, DOI 10.1046/j.1471-4159.2002.01163.x; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Kzhyshkowska J., 2007, INSIGHTS, V2, P128; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Muller K, 2000, J BIOL CHEM, V275, P1645, DOI 10.1074/jbc.275.3.1645; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Nishikawa KC, 2003, EXP CELL RES, V287, P79, DOI 10.1016/S0014-4827(03)00069-7; Nishikawa T, 2008, J IMMUNOL, V180, P3492, DOI 10.4049/jimmunol.180.5.3492; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Piper M, 2011, J COMP NEUROL, V519, P3532, DOI 10.1002/cne.22721; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Ravichandran V, 2006, J VIROL, V80, P10506, DOI 10.1128/JVI.01355-06; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Singh SK, 2011, J BIOL CHEM, V286, P7315, DOI 10.1074/jbc.M110.152421; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanwar MK, 2002, CANCER RES, V62, P4364; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Wang W, 2007, J NEUROSCI, V27, P6115, DOI 10.1523/JNEUROSCI.0180-07.2007; Wilczynska KM, 2009, STEM CELLS, V27, P1173, DOI 10.1002/stem.35; Yanagisawa M, 1999, NEUROSCI LETT, V269, P169, DOI 10.1016/S0304-3940(99)00447-4; Yang J, 2005, CANCER RES, V65, P939; Zhang L, 2002, J MOL BIOL, V317, P225, DOI 10.1006/jmbi.2001.5350; Zhao LH, 2005, ACTA BIOCH BIOPH SIN, V37, P440, DOI 10.1111/j.1745-7270.2005.00061.x	56	57	58	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39893	39903		10.1074/jbc.M111.257451	http://dx.doi.org/10.1074/jbc.M111.257451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953450	hybrid, Green Published			2022-12-25	WOS:000296925700023
J	Krachler, AM; Orth, K				Krachler, Anne Marie; Orth, Kim			Functional Characterization of the Interaction between Bacterial Adhesin Multivalent Adhesion Molecule 7 ( MAM7) Protein and Its Host Cell Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEINS; PHOSPHATIDIC-ACID; YERSINIA-PSEUDOTUBERCULOSIS; STREPTOCOCCUS-PYOGENES; CONTACT; MEMBRANE; MODULATION; MATRIX; FIBRILLOGENESIS; PHAGOCYTOSIS	The ability of a pathogen to rapidly form a stable interaction with the host cell surface is key to its success. Bacterial pathogens use a repertoire of virulence factors, but their efficient use relies on close contact between the host and the pathogen. We have recently identified a constitutively expressed MAM7(multivalent adhesion molecule 7), which is widely distributed in Gram-negative pathogens and enables them to establish initial contact with the host cell. Here, we describe the dissection of the MAM7 interaction with the host cell surface into two distinct binding events, involving the host protein fibronectin and the membrane phospholipid phosphatidic acid. We analyzed which domains within MAM7 and fibronectin are necessary for complex formation. We further studied phosphatidic acid binding by MAM7 using site-directed mutagenesis and liposome association assays and demonstrated that a specific distribution of basic charge on MAM7 is required for high affinity binding. Finally, we showed that fibronectin and phosphatidic acid binding to MAM7 are not mutually exclusive and that the three molecules likely assemble into a tripartite complex on the host cell surface.	[Krachler, Anne Marie; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Krachler, Anne-Marie/C-8645-2014; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Krachler, Anne Marie/0000-0002-0936-0016	National Institutes of Health NIAID [R01-AI056404, R01-AI087808]; Welch Foundation [I-1561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087808, R01AI056404] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Grants R01-AI056404 and R01-AI087808. This work was also supported by Welch Foundation Grant I-1561.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Boekema BKHL, 2004, INFECT IMMUN, V72, P691, DOI 10.1128/IAI.72.2.691-700.2004; Burdette DL, 2009, MOL MICROBIOL, V73, P639, DOI 10.1111/j.1365-2958.2009.06798.x; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Couturier MR, 2008, CAN J MICROBIOL, V54, P537, DOI [10.1139/W08-042, 10.1139/w08-042]; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; HORMANN H, 1987, BIOL CHEM H-S, V368, P669, DOI 10.1515/bchm3.1987.368.1.669; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Krachler AM, 2011, P NATL ACAD SCI USA, V108, P11614, DOI 10.1073/pnas.1102360108; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsuka YV, 2003, BIOCHEMISTRY-US, V42, P14643, DOI 10.1021/bi035239h; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988; Saini NK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-200; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; TRAN VN, 1993, EMBO J, V12, P1887; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; VOELKER DR, 1991, MICROBIOL REV, V55, P543, DOI 10.1128/MMBR.55.4.543-560.1991; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WORTH HGJ, 1977, CLIN CHEM, V23, P1995; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	43	49	54	6	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38939	38947		10.1074/jbc.M111.291377	http://dx.doi.org/10.1074/jbc.M111.291377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937438	hybrid, Green Published			2022-12-25	WOS:000296759800013
J	Rediger, A; Piechowski, CL; Yi, CX; Tarnow, P; Strotmann, R; Gruters, A; Krude, H; Schoneberg, T; Tschop, MH; Kleinau, G; Biebermann, H				Rediger, Anne; Piechowski, Carolin L.; Yi, Chun-Xia; Tarnow, Patrick; Strotmann, Rainer; Grueters, Annette; Krude, Heiko; Schoeneberg, Torsten; Tschoep, Matthias H.; Kleinau, Gunnar; Biebermann, Heike			Mutually Opposite Signal Modulation by Hypothalamic Heterodimerization of Ghrelin and Melanocortin-3 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CONSTITUTIVE ACTIVITY; THYROTROPIN RECEPTOR; CRYSTAL-STRUCTURE; FOOD-INTAKE; CROSS-TALK; IDENTIFICATION; ACTIVATION; WEIGHT; SYSTEM	Interaction and cross-talk of G-protein-coupled receptors (GPCRs) are of considerable interest because an increasing number of examples implicate a profound functional and physiological relevance of homo-or hetero-oligomeric GPCRs. The ghrelin (growth hormone secretagogue receptor (GHSR)) and melanocortin-3 (MC3R) receptors are both known to have orexigenic effects on the hypothalamic control of body weight. Because in vitro studies indicate heterodimerization of GHSR and MC3R, we investigated their functional interplay. Combined in situ hybridization and immunohistochemistry indicated that the vast majority of GHSR-expressing neurons in the arcuate nucleus also express MC3R. In vitro coexpression of MC3R and GHSR promoted enhanced melanocortin-induced intracellular cAMP accumulation compared with activation of MC3R in the absence of GHSR. In contrast, agonist-independent basal signaling activity and ghrelin-induced signaling of GHSR were impaired, most likely due to interaction with MC3R. By taking advantage of naturally occurring GHSR mutations and an inverse agonist for GHSR, we demonstrate that the observed enhanced MC3R signaling capability depends directly on the basal activity of GHSR. In conclusion, we demonstrate a paradigm-shifting example of GPCR heterodimerization allowing for mutually opposite functional influence of two hypothalamic receptors controlling body weight. We found that the agonistin dependent active conformation of one GPCR can determine the signaling modalities of another receptor in a heterodimer. Our discovery also implies that mutations within one of two interacting receptors might affect both receptors and different pathways simultaneously. These findings uncover mechanisms of important relevance for pharmacological targeting of GPCR in general and hypothalamic body weight regulation in particular.	[Rediger, Anne; Piechowski, Carolin L.; Tarnow, Patrick; Grueters, Annette; Krude, Heiko; Kleinau, Gunnar; Biebermann, Heike] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Yi, Chun-Xia; Tschoep, Matthias H.] Univ Cincinnati, Metab Dis Inst, Dept Internal Med, Cincinnati, OH 45267 USA; [Strotmann, Rainer; Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Ohio; University of Cincinnati; Leipzig University	Biebermann, H (corresponding author), Charite, Inst Expt Pediat Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.	heike.biebermann@charite.de	Tschoep, Matthias H/I-5443-2014; Kleinau, Gunnar/GPX-6330-2022; Yi, Chun-Xia/J-4068-2016	Yi, Chun-Xia/0000-0003-1184-4615; Biebermann, Heike/0000-0002-2024-7778; Tschoep, Matthias/0000-0002-4744-371X	Deutsche Forschungsgemeinschaft [BI 893/2-1, KL2334/2-1]; Graduate School [TP1]; Bundesministerium fur Bildung und Forschung NGFN [01GS825]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School; Bundesministerium fur Bildung und Forschung NGFN(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Grants BI 893/2-1 and KL2334/2-1 and Graduate School 1208 Hormonal Regulation of Energy Metabolism, Body Weight and Growth, TP1, and Bundesministerium fur Bildung und Forschung NGFN-Plus Grant 01GS825.	Barnes PJ, 2006, J CLIN INVEST, V116, P1210, DOI 10.1172/JCI28535; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Bradaia A, 2009, P NATL ACAD SCI USA, V106, P20081, DOI 10.1073/pnas.0906522106; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Cai MY, 2005, J MED CHEM, V48, P1839, DOI 10.1021/jm049579s; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chollet C, 2009, J PEPT SCI, V15, P711, DOI 10.1002/psc.1177; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Elsner A, 2006, PEPTIDES, V27, P372, DOI 10.1016/j.peptides.2005.02.027; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Goldstein J. L., 2011, COLD SPRING IN PRESS; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kleinau G, 2008, CELL MOL LIFE SCI, V65, P3664, DOI 10.1007/s00018-008-8450-2; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Krishna R, 2009, CLIN PHARMACOL THER, V86, P659, DOI 10.1038/clpt.2009.167; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Piscione F, 2008, J AM COLL CARDIOL, V52, P1381, DOI 10.1016/j.jacc.2008.07.034; Rached M, 2004, BBA-MOL BASIS DIS, V1689, P229, DOI 10.1016/j.bbadis.2004.03.009; Rediger A, 2009, OBESITY FACTS, V2, P80, DOI 10.1159/000209862; Romero A, 2010, EUR J ENDOCRINOL, V163, P1, DOI 10.1530/EJE-10-0099; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schellekens H, 2010, NEUROPHARMACOLOGY, V58, P2, DOI 10.1016/j.neuropharm.2009.06.024; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Shaw AM, 2005, PEPTIDES, V26, P1720, DOI 10.1016/j.peptides.2004.12.026; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2004, J CLIN ENDOCR METAB, V89, P3936, DOI 10.1210/jc.2004-0367; Tarnow P, 2008, OBESITY FACTS, V1, P155, DOI 10.1159/000138251; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wang HJ, 2004, J CLIN ENDOCR METAB, V89, P157, DOI 10.1210/jc.2003-031395; Wilson SJ, 2007, BIOCHEM BIOPH RES CO, V352, P397, DOI 10.1016/j.bbrc.2006.11.040; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Yarnitzky T, 2010, CURR OPIN DRUG DISC, V13, P317; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	56	76	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39623	39631		10.1074/jbc.M111.287607	http://dx.doi.org/10.1074/jbc.M111.287607			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940628	Green Published, hybrid			2022-12-25	WOS:000296759800079
J	Jacka, FN; Kremer, PJ; Berk, M; de Silva-Sanigorski, AM; Moodie, M; Leslie, ER; Pasco, JA; Swinburn, BA				Jacka, Felice N.; Kremer, Peter J.; Berk, Michael; de Silva-Sanigorski, Andrea M.; Moodie, Marjorie; Leslie, Eva R.; Pasco, Julie A.; Swinburn, Boyd A.			A Prospective Study of Diet Quality and Mental Health in Adolescents	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COMORBIDITY SURVEY REPLICATION; COMMUNITY-DWELLING ADULTS; OF-LIFE INVENTORY; DEPRESSIVE SYMPTOMS; PLASMA-CONCENTRATIONS; HORDALAND HEALTH; AGED WOMEN; ASSOCIATION; PATTERNS	Objectives: A number of cross-sectional and prospective studies have now been published demonstrating inverse relationships between diet quality and the common mental disorders in adults. However, there are no existing prospective studies of this association in adolescents, the onset period of most disorders, limiting inferences regarding possible causal relationships. Methods: In this study, 3040 Australian adolescents, aged 11-18 years at baseline, were measured in 2005-6 and 2007-8. Information on diet and mental health was collected by self-report and anthropometric data by trained researchers. Results: There were cross-sectional, dose response relationships identified between measures of both healthy (positive) and unhealthy (inverse) diets and scores on the emotional subscale of the Pediatric Quality of Life Inventory (PedsQL), where higher scores mean better mental health, before and after adjustments for age, gender, socio-economic status, dieting behaviours, body mass index and physical activity. Higher healthy diet scores at baseline also predicted higher PedsQL scores at follow-up, while higher unhealthy diet scores at baseline predicted lower PedsQL scores at follow-up. Improvements in diet quality were mirrored by improvements in mental health over the follow-up period, while deteriorating diet quality was associated with poorer psychological functioning. Finally, results did not support the reverse causality hypothesis. Conclusion: This study highlights the importance of diet in adolescence and its potential role in modifying mental health over the life course. Given that the majority of common mental health problems first manifest in adolescence, intervention studies are now required to test the effectiveness of preventing the common mental disorders through dietary modification.	[Jacka, Felice N.; Berk, Michael] Deakin Univ, Barwon Psychiat Res Unit, Geelong, Vic 3217, Australia; [Jacka, Felice N.; Berk, Michael] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Kremer, Peter J.; Leslie, Eva R.] Deakin Univ, Sch Psychol, Geelong, Vic 3217, Australia; [Berk, Michael] Mental Hlth Res Inst, Melbourne, Vic, Australia; [de Silva-Sanigorski, Andrea M.] Univ Melbourne, Melbourne Sch Populat Hlth, Jack Brockhoff Child Hlth & Wellbeing Program, Melbourne, Vic, Australia; [Pasco, Julie A.] Deakin Univ, Barwon Epidemiol & Biostat Unit, Geelong, Vic 3217, Australia; [Swinburn, Boyd A.] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia	Deakin University; University of Melbourne; Deakin University; University of Melbourne; Deakin University; Deakin University; World Health Organization	Jacka, FN (corresponding author), Deakin Univ, Barwon Psychiat Res Unit, Geelong, Vic 3217, Australia.	felice@barwonhealth.org.au	Berk, Michael/M-7891-2013; Berk, Michael/M-3585-2019; Jacka, Felice N/ABE-6322-2020; Kremer, Peter/I-8202-2019; Ackland, Julie/C-8607-2012; Jacka, Felice N/D-9424-2012; Stefanadis, Christodoulos/ABH-2232-2020	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Jacka, Felice N/0000-0002-9825-0328; Kremer, Peter/0000-0003-2476-1958; Jacka, Felice N/0000-0002-9825-0328; Stefanadis, Christodoulos/0000-0001-5974-6454; Leslie, Eva/0000-0002-8498-9391; Moodie, Marjory/0000-0001-6890-5250	Wellcome Trust; National Health and Medical Research Council; Victorian Government (Department of Health)	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government (Department of Health)	The project was funded through the Wellcome Trust, the National Health and Medical Research Council International Collaborative Research Grants Scheme, and the Victorian Government (Department of Health). The funding providers played no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or in preparation, review, or approval of the manuscript.	Adair LS, 2005, OBES RES, V13, P1281, DOI 10.1038/oby.2005.153; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Cavadini C, 2000, WESTERN J MED, V173, P378, DOI 10.1136/ewjm.173.6.378; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; Collins CE, 2008, J AM COLL NUTR, V27, P146, DOI 10.1080/07315724.2008.10719686; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; GREGER JL, 1978, AM J PUBLIC HEALTH, V68, P70, DOI 10.2105/AJPH.68.1.70; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Jacka FN, 2009, AUST NZ J PSYCHIAT, V43, P45, DOI 10.1080/00048670802534408; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; King DE, 2005, J AM COLL NUTR, V24, P166, DOI 10.1080/07315724.2005.10719461; Liu SM, 2002, AM J CLIN NUTR, V75, P492, DOI 10.1093/ajcn/75.3.492; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; McCullough ML, 2006, PUBLIC HEALTH NUTR, V9, P152, DOI 10.1079/PHN2005938; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; MILLER L, 2011, OBESITY REV IN PRESS; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Oddy WH, 2009, PREV MED, V49, P39, DOI 10.1016/j.ypmed.2009.05.009; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Pasco JA, 2009, MED J AUSTRALIA, V191, P44, DOI 10.5694/j.1326-5377.2009.tb02679.x; Reinfjell T, 2008, NORD J PSYCHIAT, V62, P279, DOI 10.1080/08039480801983950; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Swinburn Boyd, 2007, Pac Health Dialog, V14, P139; Tolmunen T, 2004, PSYCHOTHER PSYCHOSOM, V73, P334, DOI 10.1159/000080385; Twenge JM, 2010, CLIN PSYCHOL REV, V30, P145, DOI 10.1016/j.cpr.2009.10.005; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; West P, 2003, J CHILD PSYCHOL PSYC, V44, P399, DOI 10.1111/1469-7610.00130; Woodruff SJ, 2009, CAN J DIET PRACT RES, V70, P118, DOI 10.3148/70.3.2009.118	33	219	225	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24805	10.1371/journal.pone.0024805	http://dx.doi.org/10.1371/journal.pone.0024805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825HM	21957462	Green Published, gold			2022-12-25	WOS:000295262100021
J	Seo, M; Kim, JD; Neau, D; Sehgal, I; Lee, YH				Seo, Minsuh; Kim, Jeong-Do; Neau, David; Sehgal, Inder; Lee, Yong-Hwan			Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect	PLOS ONE			English	Article							FRUCTOSE 2,6-BISPHOSPHATE; BIFUNCTIONAL ENZYME; TUMOR SUPPRESSORS; CELL-METABOLISM; DRUG DESIGN; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; GLYCOLYSIS; HYPOXIA; GROWTH; EXPRESSION	Cancer cells adopt glycolysis as the major source of metabolic energy production for fast cell growth. The HIF-1-induced PFKFB3 plays a key role in this adaptation by elevating the concentration of Fru-2,6-BP, the most potent glycolysis stimulator. As this metabolic conversion has been suggested to be a hallmark of cancer, PFKFB3 has emerged as a novel target for cancer chemotherapy. Here, we report that a small molecular inhibitor, N4A, was identified as an initial lead compound for PFKFB3 inhibitor with therapeutic potential. In an attempt to improve its potency, we determined the crystal structure of the PFKFB3.N4A complex to 2.4 angstrom resolution and, exploiting the resulting molecular information, attained the more potent YN1. When tested on cultured cancer cells, both N4A and YN1 inhibited PFKFB3, suppressing the Fru-2,6-BP level, which in turn suppressed glycolysis and, ultimately, led to cell death. This study validates PFKFB3 as a target for new cancer therapies and provides a framework for future development efforts.	[Seo, Minsuh; Kim, Jeong-Do; Lee, Yong-Hwan] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David] Cornell Univ, NE Collaborat Access Team, Argonne, IL USA; [Sehgal, Inder] Louisiana State Univ, Dept Comparat Biomed Sci, Sch Vet Med, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Cornell University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Seo, M (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	yhlee@lsu.edu	Sehgal, Inderpaul/GYE-2441-2022		National Cancer Institute [1R01 CA124758-01]; NATIONAL CANCER INSTITUTE [R01CA124758] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a National Cancer Institute grant 1R01 CA124758-01 to Y.-H.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi T, 2002, CANCER RES, V62, P5881; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Calvo MN, 2006, FEBS LETT, V580, P3308, DOI 10.1016/j.febslet.2006.04.093; Cleland W W, 1979, Methods Enzymol, V63, P103; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; El-Maghrabi MR, 2001, CURR OPIN CLIN NUTR, V4, P411, DOI 10.1097/00075197-200109000-00012; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; HUE L, 1993, ADV ENZYME REGUL, V33, P97; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SG, 2006, J BIOL CHEM, V281, P2939, DOI 10.1074/jbc.M511019200; Kim SG, 2007, J MOL BIOL, V370, P14, DOI 10.1016/j.jmb.2007.03.038; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Minchenko O, 2003, FEBS LETT, V554, P264, DOI 10.1016/S0014-5793(03)01179-7; NISSLER K, 1995, J CANCER RES CLIN, V121, P739, DOI 10.1007/BF01213320; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Perez JJ, 2005, CHEM SOC REV, V34, P143, DOI 10.1039/b209064n; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613	40	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24179	10.1371/journal.pone.0024179	http://dx.doi.org/10.1371/journal.pone.0024179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957443	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100005
J	Kataoka, M; Yamamori, S; Suzuki, E; Watanabe, S; Sato, T; Miyaoka, H; Azuma, S; Ikegami, S; Kuwahara, R; Suzuki-Migishima, R; Nakahara, Y; Nihonmatsu, I; Inokuchi, K; Katoh-Fukui, Y; Yokoyama, M; Takahashi, M				Kataoka, Masakazu; Yamamori, Saori; Suzuki, Eiji; Watanabe, Shigeru; Sato, Taku; Miyaoka, Hitoshi; Azuma, Sadahiro; Ikegami, Shiro; Kuwahara, Reiko; Suzuki-Migishima, Rika; Nakahara, Yohko; Nihonmatsu, Itsuko; Inokuchi, Kaoru; Katoh-Fukui, Yuko; Yokoyama, Minesuke; Takahashi, Masami			A Single Amino Acid Mutation in SNAP-25 Induces Anxiety-Related Behavior in Mouse	PLOS ONE			English	Article							PROTEIN-KINASE-C; ACTIVITY-DEPENDENT PHOSPHORYLATION; SYNAPTOSOME-ASSOCIATED PROTEIN; NEUROTRANSMITTER RELEASE; PHORBOL ESTER; MEMBRANE-FUSION; PC12 CELLS; RAT-BRAIN; EXOCYTOSIS; ENHANCEMENT	Synaptosomal-associated protein of 25 kDa (SNAP-25) is a presynaptic protein essential for neurotransmitter release. Previously, we demonstrate that protein kinase C (PKC) phosphorylates Ser(187) of SNAP-25, and enhances neurotransmitter release by recruiting secretory vesicles near to the plasma membrane. As PKC is abundant in the brain and SNAP-25 is essential for synaptic transmission, SNAP-25 phosphorylation is likely to play a crucial role in the central nervous system. We therefore generated a mutant mouse, substituting Ser(187) of SNAP-25 with Ala using "knock-in" technology. The most striking effect of the mutation was observed in their behavior. The homozygous mutant mice froze readily in response to environmental change, and showed strong anxiety-related behavior in general activity and light and dark preference tests. In addition, the mutant mice sometimes exhibited spontaneously occurring convulsive seizures. Microdialysis measurements revealed that serotonin and dopamine release were markedly reduced in amygdala. These results clearly indicate that PKC-dependent SNAP-25 phosphorylation plays a critical role in the regulation of emotional behavior as well as the suppression of epileptic seizures, and the lack of enhancement of monoamine release is one of the possible mechanisms underlying these defects.	[Kataoka, Masakazu] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Nagano 380, Japan; [Yamamori, Saori; Watanabe, Shigeru; Sato, Taku; Miyaoka, Hitoshi; Azuma, Sadahiro; Takahashi, Masami] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 228, Japan; [Suzuki, Eiji] Int Univ Hlth & Welf Atami Hosp, Dept Psychiat, Atami, Shizuoka, Japan; [Ikegami, Shiro; Kuwahara, Reiko; Suzuki-Migishima, Rika; Nakahara, Yohko; Nihonmatsu, Itsuko; Inokuchi, Kaoru; Katoh-Fukui, Yuko; Yokoyama, Minesuke] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo, Japan	Shinshu University; Kitasato University; International University of Health & Welfare; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Kataoka, M (corresponding author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, 500 Wakasato, Nagano 380, Japan.	masami@med.kitasato-u.ac.jp	Inokuchi, Kaoru/AAI-9693-2020; Katoh-Fukui, Yuko/Y-5383-2019	Inokuchi, Kaoru/0000-0002-5393-3133; Katoh-Fukui, Yuko/0000-0001-6858-3693	Japan Society for the Promotion of Science (JSPS) [18300127, 21300141]; Ministry of Education, Culture, Sports, Science and Technology of Japan [15082206]; Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (B) (#18300127, 21300141) from the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid 15082206 for Scientific Research on Priority Areas on "Elucidation of Glia-Neuron Network-Mediated Information Processing Systems" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARK IC, 1993, J MOL BIOL, V233, P67, DOI 10.1006/jmbi.1993.1485; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Finley MFA, 2003, NEUROPHARMACOLOGY, V45, P857, DOI 10.1016/S0028-3908(03)00283-1; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; GAMACHE P, 1993, J CHROMATOGR-BIOMED, V614, P213, DOI 10.1016/0378-4347(93)80311-Q; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hensler J. G., 2006, BASIC NEUROCHEMISTRY, P227; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kataoka M, 2006, NEUROSCI LETT, V407, P258, DOI 10.1016/j.neulet.2006.08.055; Laplante P, 2002, DEV BRAIN RES, V139, P199, DOI 10.1016/S0165-3806(02)00550-3; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Nagy G, 2002, J NEUROSCI, V22, P9278; OYLER GA, 1991, P NATL ACAD SCI USA, V88, P5247, DOI 10.1073/pnas.88.12.5247; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; SHINTANI F, 1993, J NEUROSCI, V13, P3574; Shoji-Kasai Y, 2002, EUR J NEUROSCI, V15, P1390, DOI 10.1046/j.1460-9568.2002.01972.x; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Suzuki T, 2002, EUR J PHARMACOL, V435, P59, DOI 10.1016/S0014-2999(01)01563-1; Takahashi M, 2003, J PHARMACOL SCI, V93, P41, DOI 10.1254/jphs.93.41; Takahashi M, 2002, MOL PSYCHIATR, V7, P536, DOI 10.1038/sj.mp.4001050; Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Xu NJ, 2004, J BIOL CHEM, V279, P40601, DOI 10.1074/jbc.M406896200; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685	37	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25158	10.1371/journal.pone.0025158	http://dx.doi.org/10.1371/journal.pone.0025158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949876	gold, Green Published, Green Submitted			2022-12-25	WOS:000295260400052
J	MacInnes, H; Zhou, Y; Gouveia, K; Cromwell, J; Lowery, K; Layton, RC; Zubelewicz, M; Sampath, R; Hofstadler, S; Liu, YS; Cheng, YS; Koster, F				MacInnes, Heather; Zhou, Yue; Gouveia, Kristine; Cromwell, Jenna; Lowery, Kristin; Layton, R. Colby; Zubelewicz, Michael; Sampath, Rangarajan; Hofstadler, Steven; Liu, Yushi; Cheng, Yung-Sung; Koster, Frederick			Transmission of Aerosolized Seasonal H1N1 Influenza A to Ferrets	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; UNITED-STATES; VIRUS; ORIGIN; MODEL; H5N1; SURVEILLANCE; PATHOGENESIS; INHALATION; PARTICLES	Influenza virus is a major cause of morbidity and mortality worldwide, yet little quantitative understanding of transmission is available to guide evidence-based public health practice. Recent studies of influenza non-contact transmission between ferrets and guinea pigs have provided insights into the relative transmission efficiencies of pandemic and seasonal strains, but the infecting dose and subsequent contagion has not been quantified for most strains. In order to measure the aerosol infectious dose for 50% (aID(50)) of seronegative ferrets, seasonal influenza virus was nebulized into an exposure chamber with controlled airflow limiting inhalation to airborne particles less than 5 mm diameter. Airborne virus was collected by liquid impinger and Teflon filters during nebulization of varying doses of aerosolized virus. Since culturable virus was accurately captured on filters only up to 20 minutes, airborne viral RNA collected during 1-hour exposures was quantified by two assays, a high-throughput RT-PCR/mass spectrometry assay detecting 6 genome segments (Ibis T5000 (TM) Biosensor system) and a standard real time RT-qPCR assay. Using the more sensitive T5000 assay, the aID50 for A/New Caledonia/20/99 (H1N1) was approximately 4 infectious virus particles under the exposure conditions used. Although seroconversion and sustained levels of viral RNA in upper airway secretions suggested established mucosal infection, viral cultures were almost always negative. Thus after inhalation, this seasonal H1N1 virus may replicate less efficiently than H3N2 virus after mucosal deposition and exhibit less contagion after aerosol exposure.	[MacInnes, Heather; Gouveia, Kristine; Layton, R. Colby; Zubelewicz, Michael; Koster, Frederick] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA; [Zhou, Yue; Cheng, Yung-Sung] Lovelace Resp Res Inst, Program Aerosol Sci, Albuquerque, NM USA; [Cromwell, Jenna; Lowery, Kristin; Sampath, Rangarajan; Hofstadler, Steven] Ibis Biosci, Carlsbad, CA USA; [Liu, Yushi] Lovelace Resp Res Inst, Program Lung Canc, Albuquerque, NM USA; [Koster, Frederick] Lovelace Resp Res Inst, Program Appl Sci, Albuquerque, NM USA	Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute	MacInnes, H (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	fkoster@lrri.org	Liu, Yushi/A-1533-2014	Liu, Yushi/0000-0003-4185-4187	National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI074561, HHSN2662004000951]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074561] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institute of Allergy and Infectious Diseases (NIAID) grant U01 AI074561 and NIAID contract HHSN2662004000951. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; [Anonymous], PREPARING INFLUENZA; BOYD RL, 1981, J APPL PHYSIOL, V50, P799, DOI 10.1152/jappl.1981.50.4.799; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; COUCH RB, 1966, BACTERIOL REV, V30, P517, DOI 10.1128/MMBR.30.3.517-529.1966; Cox CS., 1987, AEROBIOLOGICAL PATHW; Deyde VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013293; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; GERONE PJ, 1966, BACTERIOL REV, V30, P576, DOI 10.1128/MMBR.30.3.576-588.1966; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; HENLE W, 1946, J IMMUNOL, V52, P145; Herlocher ML, 2001, J INFECT DIS, V184, P542, DOI 10.1086/322801; KNIGHT V, 1973, 6 INT S AER NEW YORK, P175; Lednicky JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-231; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Ngunjiri JM, 2008, J VIROL, V82, P2673, DOI 10.1128/JVI.02221-07; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Stilianakis NI, 2010, J R SOC INTERFACE, V7, P1355, DOI 10.1098/rsif.2010.0026; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tuttle RS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-135; VINEGAR A, 1982, J APPL PHYSIOL, V52, P832, DOI 10.1152/jappl.1982.52.4.832; Wie Z, 2007, J VIROL METHODS, V144, P122; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481	39	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24448	10.1371/journal.pone.0024448	http://dx.doi.org/10.1371/journal.pone.0024448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949718	Green Published, gold, Green Submitted			2022-12-25	WOS:000295257900016
J	Paternoster, L; Evans, DM; Nohr, EA; Holst, C; Gaborieau, V; Brennan, P; Gjesing, AP; Grarup, N; Witte, DR; Jorgensen, T; Linneberg, A; Lauritzen, T; Sandbaek, A; Hansen, T; Pedersen, O; Elliott, KS; Kemp, JP; St Pourcain, B; McMahon, G; Zelenika, D; Hager, J; Lathrop, M; Timpson, NJ; Smith, GD; Sorensen, TIA				Paternoster, Lavinia; Evans, David M.; Nohr, Ellen Aagaard; Holst, Claus; Gaborieau, Valerie; Brennan, Paul; Gjesing, Anette Prior; Grarup, Niels; Witte, Daniel R.; Jorgensen, Torben; Linneberg, Allan; Lauritzen, Torsten; Sandbaek, Anelli; Hansen, Torben; Pedersen, Oluf; Elliott, Katherine S.; Kemp, John P.; St Pourcain, Beate; McMahon, George; Zelenika, Diana; Hager, Joerg; Lathrop, Mark; Timpson, Nicholas J.; Smith, George Davey; Sorensen, Thorkild I. A.			Genome-Wide Population-Based Association Study of Extremely Overweight Young Adults - The GOYA Study	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; LINKAGE DISEQUILIBRIUM; OBESITY; VARIANTS; DETECT; POWER; RISK	Background: Thirty-two common variants associated with body mass index (BMI) have been identified in genome-wide association studies, explaining,similar to 1.45% of BMI variation in general population cohorts. We performed a genome-wide association study in a sample of young adults enriched for extremely overweight individuals. We aimed to identify new loci associated with BMI and to ascertain whether using an extreme sampling design would identify the variants known to be associated with BMI in general populations. Methodology/Principal Findings: From two large Danish cohorts we selected all extremely overweight young men and women (n = 2,633), and equal numbers of population-based controls (n = 2,740, drawn randomly from the same populations as the extremes, representing similar to 212,000 individuals). We followed up novel (at the time of the study) association signals (p<0.001) from the discovery cohort in a genome-wide study of 5,846 Europeans, before attempting to replicate the most strongly associated 28 SNPs in an independent sample of Danish individuals (n = 20,917) and a population-based cohort of 15-year-old British adolescents (n = 2,418). Our discovery analysis identified SNPs at three loci known to be associated with BMI with genome-wide confidence (P<5 x 10(-8); FTO, MC4R and FAIM2). We also found strong evidence of association at the known TMEM18, GNPDA2, SEC16B, TFAP2B, SH2B1 and KCTD15 loci (p<0.001), and nominal association (p<0.05) at a further 8 loci known to be associated with BMI. However, meta-analyses of our discovery and replication cohorts identified no novel associations. Significance: Our results indicate that the detectable genetic variation associated with extreme overweight is very similar to that previously found for general BMI. This suggests that population-based study designs with enriched sampling of individuals with the extreme phenotype may be an efficient method for identifying common variants that influence quantitative traits and a valid alternative to genotyping all individuals in large population-based studies, which may require tens of thousands of subjects to achieve similar power.	[Paternoster, Lavinia; Evans, David M.; Kemp, John P.; McMahon, George; Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, MRC CAiTE Ctr, Bristol, Avon, England; [Paternoster, Lavinia; Evans, David M.; Kemp, John P.; St Pourcain, Beate; McMahon, George; Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Nohr, Ellen Aagaard] Aarhus Univ, Inst Publ Hlth, Aarhus, Denmark; [Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Gaborieau, Valerie; Brennan, Paul] IARC, Lyon, France; [Gjesing, Anette Prior; Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Ctr Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Witte, Daniel R.] Steno Diabet Ctr, Copenhagen, Denmark; [Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Lauritzen, Torsten; Sandbaek, Anelli] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Fac Hlth Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Elliott, Katherine S.] Wellcome Trust Ctr Human Genet, Oxford, England; [Zelenika, Diana; Hager, Joerg; Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Lathrop, Mark] CEPH, Fdn Jean Dausset, Paris, France	University of Bristol; University of Bristol; Aarhus University; University of Copenhagen; World Health Organization; International Agency for Research on Cancer (IARC); University of Copenhagen; University of Southern Denmark; Steno Diabetes Center; University of Copenhagen; Aarhus University; University of Copenhagen; Aarhus University; University of Oxford; Wellcome Centre for Human Genetics; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH	Paternoster, L (corresponding author), Univ Bristol, MRC CAiTE Ctr, Bristol, Avon, England.	paternoster@bristol.ac.uk	St Pourcain, Beate/K-8004-2017; Pedersen, Oluf/AAG-8015-2020; Witte, Daniel/AAF-9535-2019; Davey Smith, George/A-7407-2013; Gjesing, Anette/ACC-7521-2022; Witte, Daniel R/C-1722-2008; Jørgensen, Torben/Z-1335-2018; Timpson, Nicholas John/O-7548-2015; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Kemp, John P./R-3091-2018; Evans, David M/H-6325-2013; Paternoster, Lavinia/C-1292-2015	St Pourcain, Beate/0000-0002-4680-3517; Witte, Daniel/0000-0002-0769-2922; Davey Smith, George/0000-0002-1407-8314; Gjesing, Anette/0000-0003-4580-1576; Witte, Daniel R/0000-0002-0769-2922; Timpson, Nicholas John/0000-0002-7141-9189; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Kemp, John P./0000-0002-9105-2249; Evans, David M/0000-0003-0663-4621; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Jorgensen, Torben/0000-0001-9453-2830; Paternoster, Lavinia/0000-0003-2514-0889; Linneberg, Allan/0000-0002-0994-0184	Novo Nordisk; Novo Nordisk Scandinavia; Astra Denmark; Pfizer Denmark; GlaxoSmithKline Pharma Denmark; Servier Denmark; HemoCue Denmark; Wellcome Trust [WT 084762MA, 076467, WT083431MA]; Medical Council New Investigator [MRC G0800582]; INCa, France; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation; UK Medical Research Council [74882]; University of Bristol; Medical Research Council [G0600705, G0800582] Funding Source: researchfish; MRC [G0800582, G0600705] Funding Source: UKRI	Novo Nordisk(Novo Nordisk); Novo Nordisk Scandinavia(Novo Nordisk); Astra Denmark; Pfizer Denmark(Pfizer); GlaxoSmithKline Pharma Denmark(GlaxoSmithKline); Servier Denmark; HemoCue Denmark; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Council New Investigator; INCa, France(Institut National du Cancer (INCA) France); Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The ADDITION study received public funds as well as unrestricted grants from Novo Nordisk, Novo Nordisk Scandinavia, Astra Denmark, Pfizer Denmark, GlaxoSmithKline Pharma Denmark, Servier Denmark and HemoCue Denmark. LP was supported by and the genotyping for GOYA was funded by the Wellcome Trust (WT 084762MA). LP and DME were supported by a Medical Council New Investigator Award (MRC G0800582 to DME). This study was conducted as part of the activities of the Danish Obesity Research Centre (DanORC, www.danorc.dk) and the MRC centre for Causal Analyses in Translational Epidemiology (MRC CAiTE). Funding for the IARC genome-wide analysis was provided by INCa, France. Parts of the Danish replication study were funded by the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP). The Marie Krogh Center for Metabolic Research is established and funded by the Novo Nordisk Foundation. The UK Medical Research Council (Grant ref: 74882), the Wellcome Trust (Grant ref: 076467), and the University of Bristol provide core support for the Avon Longitudinal Study of Parents and Children (ALSPAC). JPK is funded by a Wellcome Trust 4-year PhD studentship (WT083431MA). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anette Prior Gjesing, Niels Grarup, Torben Hansen and Oluf Pedersen were employees of the Hagedorn Research Institute at the time of the study and contributed to the design, analysis and writing of the study.	Abecasis GR, 2001, AM J HUM GENET, V68, P1463, DOI 10.1086/320590; Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Chen ZH, 2005, AM J HUM GENET, V77, P661, DOI 10.1086/491658; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; GESTEL SV, 2000, POWER SELECTIVE GENO, V30, P141; Huang BE, 2007, AM J HUM GENET, V80, P567, DOI 10.1086/512727; Kring SII, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002958; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nohr EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008444; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tenesa A, 2003, ANN HUM GENET, V67, P557, DOI 10.1046/j.1529-8817.2003.00058.x; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	18	80	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24303	10.1371/journal.pone.0024303	http://dx.doi.org/10.1371/journal.pone.0024303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935397	Green Submitted, gold, Green Published			2022-12-25	WOS:000295041700025
J	Shao, KK; Ding, WF; Wang, F; Li, HQ; Ma, D; Wang, HM				Shao, Keke; Ding, Weifeng; Wang, Feng; Li, Haiquan; Ma, Da; Wang, Huimin			Emulsion PCR: A High Efficient Way of PCR Amplification of Random DNA Libraries in Aptamer Selection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYSTEMATIC EVOLUTION; CAPILLARY-ELECTROPHORESIS; EXPONENTIAL ENRICHMENT; HEPATITIS-B; LIGANDS; MOLECULES; PROTEIN	Aptamers are short RNA or DNA oligonucleotides which can bind with different targets. Typically, they are selected from a large number of random DNA sequence libraries. The main strategy to obtain aptamers is systematic evolution of ligands by exponential enrichment (SELEX). Low efficiency is one of the limitations for conventional PCR amplification of random DNA sequence library in aptamer selection because of relative low products and high by-products formation efficiency. Here, we developed emulsion PCR for aptamer selection. With this method, the by-products formation decreased tremendously to an undetectable level, while the products formation increased significantly. Our results indicated that by-products in conventional PCR amplification were from primer-product and product-product hybridization. In emulsion PCR, we can completely avoid the product-product hybridization and avoid the most of primer-product hybridization if the conditions were optimized. In addition, it also showed that the molecule ratio of template to compartment was crucial to by-product formation efficiency in emulsion PCR amplification. Furthermore, the concentration of the Taq DNA polymerase in the emulsion PCR mixture had a significant impact on product formation efficiency. So, the results of our study indicated that emulsion PCR could improve the efficiency of SELEX.	[Shao, Keke; Ma, Da] Yancheng City 1 Peoples Hosp, Clin Lab, Yancheng, Peoples R China; [Shao, Keke; Ding, Weifeng; Wang, Feng; Li, Haiquan; Wang, Huimin] Nantong Univ, Affiliated Hosp, Lab Ctr, Nantong, Peoples R China	Nantong University	Shao, KK (corresponding author), Yancheng City 1 Peoples Hosp, Clin Lab, Yancheng, Peoples R China.	ycyymd@sina.com; ntfyjyk@pub.nt.jsinfo.net	Wang, Feng/F-2653-2015; wang, huimin/HDM-8421-2022		Department of Health, Jiangsu Province [XK 2007 23]	Department of Health, Jiangsu Province	This work was supported by a special Research Grant(XK 2007 23) for the key laboratory from the Department of Health, Jiangsu Province. URL: http://www.jswst.gov.cn/jsswst/zxgz/kjxwgc/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Butz K, 2001, ONCOGENE, V20, P6579, DOI 10.1038/sj.onc.1204805; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gold L, 2002, CHEM BIOL, V9, P1259, DOI 10.1016/S1074-5521(02)00286-7; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jing RR, 2010, GENET TEST MOL BIOMA, V14, P355, DOI 10.1089/gtmb.2009.0064; KIDD KK, PCR 2 PRACTICAL APPR; Li N, 2002, ANAL BIOANAL CHEM, V374, P269, DOI 10.1007/s00216-002-1468-7; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Musheev MU, 2006, ANAL CHIM ACTA, V564, P91, DOI 10.1016/j.aca.2005.09.069; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Rimmele M, 2003, CHEMBIOCHEM, V4, P963, DOI 10.1002/cbic.200300648; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	17	77	89	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24910	10.1371/journal.pone.0024910	http://dx.doi.org/10.1371/journal.pone.0024910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949784	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700075
J	Wang, ZH; Nesland, JM; Suo, ZH; Trope, CG; Holm, R				Wang, Zhihui; Nesland, Jahn M.; Suo, Zhenhe; Trope, Claes G.; Holm, Ruth			The Prognostic Value of 14-3-3 Isoforms in Vulvar Squamous Cell Carcinoma Cases: 14-3-3 beta and epsilon Are Independent Prognostic Factors for These Tumors	PLOS ONE			English	Article							LUNG-CANCER CELLS; INTRAEPITHELIAL NEOPLASIA; IN-VIVO; PROTEIN; OVEREXPRESSION; IDENTIFICATION; EXPRESSION; PATHWAYS; 14-3-3-PROTEINS; PROLIFERATION	Background: The 14-3-3 family is comprised of highly conserved proteins that are functionally important in the maintenance of homeostasis. Their involvement with the cell cycle, their association with proto-oncogenes and oncogenes, and their abnormal expression in various tumors has linked this family of proteins to the etiology of human cancer. Mounting evidence now indicates that 14-3-3 sigma is a cancer suppressor gene but the roles of the other 14-3-3 isoforms and their interactions in tumorigenesis have not yet been elucidated. In our current study, we examined the expression of 14-3-3 beta, gamma, epsilon, zeta, eta and tau in a large series of vulvar squamous cell carcinomas to evaluate any clinical significance. Methods: Tumor biopsies from 298 vulvar carcinomas were examined by immunohistochemistry for the expression of 14-3-3 beta, gamma, epsilon, zeta, eta and tau. Statistical analyses were employed to validate any associations between the expression of any 14-3-3 isoform and clinicopathologic variables for this disease. Results: High cytoplasmic levels of 14-3-3 beta, gamma, zeta, epsilon and eta were observed in 79%, 58%, 50%, 86% and 54% of the vulvar carcinomas analyzed, respectively, whereas a low nuclear expression of 14-3-3 tau was present in 80% of these cases. The elevated cytoplasmic expression of 14-3-3 beta, gamma, epsilon, zeta and eta was further found to be associated with advanced disease and aggressive features of these cancers. The overexpression of cytoplasmic 14-3-3 beta and epsilon significantly correlated with a poor disease-specific survival by univariate analysis (P = 0.007 and P = 0.04, respectively). The independent prognostic significance of these factors was confirmed by multivariate analysis (P = 0.007 and P = 0.009, respectively). Conclusions: We reveal for the first time that the 14-3-3 beta, gamma, epsilon, zeta, eta and tau isoforms may be involved in the progression of vulvar carcinomas. Furthermore, our analyses show that high cytoplasmic levels of 14-3-3 beta and epsilon independently correlate with poor disease-specific survival.	[Wang, Zhihui; Nesland, Jahn M.; Suo, Zhenhe; Holm, Ruth] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Wang, Zhihui; Nesland, Jahn M.; Suo, Zhenhe; Trope, Claes G.] Univ Oslo, Oslo, Norway; [Wang, Zhihui] Zhengzhou Univ, Coll Med, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China; [Trope, Claes G.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Obstet & Gynecol, Oslo, Norway	University of Oslo; University of Oslo; Zhengzhou University; University of Oslo	Wang, ZH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	ruth.holm@oslo-universitetssykehus.no			Norwegian Cancer Society [205]; Health Region South of Norway [41210]	Norwegian Cancer Society(Norwegian Cancer Society); Health Region South of Norway	This project was supported by grants from The Norwegian Cancer Society (grant no. 205) and Health Region South of Norway (grant no. 41210). ZhihuiWang is a research fellow of The Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cao L, 2008, NEUROSCI LETT, V432, P94, DOI 10.1016/j.neulet.2007.11.071; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Che XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-306; Coulter J, 2003, BEST PRACT RES CL OB, V17, P663, DOI 10.1016/S1521-6934(03)00050-6; Dalal SN, 2004, CELL CYCLE, V3, P672; de Bie RP, 2009, BRIT J CANCER, V101, P27, DOI 10.1038/sj.bjc.6605124; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hosing AS, 2008, CELL CYCLE, V7, P3171, DOI 10.4161/cc.7.20.6812; Huber E, 2004, J VIROL, V78, P7478, DOI 10.1128/JVI.78.14.7478-7489.2004; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; Liang SF, 2009, ELECTROPHORESIS, V30, P4152, DOI 10.1002/elps.200900249; Liu Y, 2010, BRAIN RES, V1336, P98, DOI 10.1016/j.brainres.2010.04.009; Martin D, 2003, J CELL BIOL, V160, P171, DOI 10.1083/jcb.200206109; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; MESSINGMJ, 1995, OBSTET GYNECOL, V86, P51; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Qi WQ, 2007, MOL CARCINOGEN, V46, P847, DOI 10.1002/mc.20314; Qi WQ, 2003, RADIAT RES, V160, P217, DOI 10.1667/RR3038; Sugiyama A, 2003, CARCINOGENESIS, V24, P1549, DOI 10.1093/carcin/bgg113; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Telles E, 2009, EXP CELL RES, V315, P1448, DOI 10.1016/j.yexcr.2009.01.018; Tyring SK, 2003, AM J OBSTET GYNECOL, V189, pS17, DOI 10.1067/S0002-9378(03)00792-0; van der Avoort IAM, 2006, INT J GYNECOL PATHOL, V25, P22, DOI 10.1097/01.pgp.0000177646.38266.6a; Wang ZH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-233; Wang ZH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-308; *WHO, 2003, WHO CLASS TUM 2003 P	35	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24843	10.1371/journal.pone.0024843	http://dx.doi.org/10.1371/journal.pone.0024843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935479	gold, Green Published, Green Submitted			2022-12-25	WOS:000295041700064
J	Essler, M; Link, A; Belloni, B; Mirceva, V; Souvatzoglou, M; Thaler, M; Haller, B; Hein, R; Krause, BJ				Essler, Markus; Link, Anna; Belloni, Benedetta; Mirceva, Vesna; Souvatzoglou, Michael; Thaler, Markus; Haller, Bernhard; Hein, Ruediger; Krause, Bernd J.			Prognostic Value of [18F]-Fluoro-Deoxy-Glucose PET/CT, S100 or MIA for Assessment of Cancer-Associated Mortality in Patients with High Risk Melanoma	PLOS ONE			English	Article							MALIGNANT-MELANOMA; INHIBITORY ACTIVITY; CUTANEOUS MELANOMA; FDG-PET/CT; EXPERIENCE; ACCURACY; PROTEIN; CT	Purpose: To assess the prognostic value of FDG PET/CT compared to the tumor markers S100B and melanoma inhibitory activity (MIA) in patients with high risk melanoma. Methods: Retrospective study in 125 consecutive patients with high risk melanoma that underwent FDG PET/CT for re-staging. Diagnostic accuracy and prognostic value was determined for FDG PET/CT as well as for S100B and MIA. As standard of reference, cytological, histological, PET/CT or MRI follow-up findings as well as clinical follow-up were used. Results: Of 125 patients, FDG PET/CT was positive in 62 patients. 37 (29.6%) patients had elevated S100B (>100 pg/ml) and 24 (20.2%) had elevated MIA (>10 pg/ml) values. Overall specificities for FDG PET/CT, S100B and MIA were 96.8% (95% CI, 89.1% to 99.1%), 85.7% (75.0% to 92.3%), and 95.2% (86.9% to 98.4%), corresponding sensitivities were 96.8% (89.0% to 99.1%), 45.2% (33.4% to 55.5%), and 36.1% (25.2% to 48.6%), respectively. The negative predictive values (NPV) for PET/CT, S100B, and MIA were 96.8% (89.1% to 99.1%), 61.4% (50.9% to 70.9%), and 60.6% (50.8% to 69.7%). The positive predictive values (PPV) were 96.7% (89.0% to 99.1%), 75.7% (59.9% to 86.6%), and 88.0% (70.0% to 95.8%). Patients with elevated S100B- or MIA values or PET/CT positive findings showed a significantly (p<0.001 each, univariate Cox regression models) higher risk of melanoma associated death which was increased 4.2-, 6.5- or 17.2-fold, respectively. Conclusion: PET/CT has a higher prognostic power in the assessment of cancer-associated mortality in melanoma patients compared with S100 and MIA.	[Essler, Markus; Link, Anna; Souvatzoglou, Michael; Krause, Bernd J.] Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, D-8000 Munich, Germany; [Belloni, Benedetta; Mirceva, Vesna; Hein, Ruediger] Tech Univ Munich, Dermatol Klin & Poliklin, D-8000 Munich, Germany; [Thaler, Markus] Tech Univ Munich, Inst Klin Chem & Pathobiochem, D-8000 Munich, Germany; [Haller, Bernhard] Tech Univ Munich, Inst Med Stat & Epidmiol, D-8000 Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Essler, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, D-8000 Munich, Germany.	Markus.Essler@gmx.de	Haller, Bernhard/I-1943-2019	Haller, Bernhard/0000-0002-9723-393X	Department of Nuclear Medicine, Technische Universitat Munchen	Department of Nuclear Medicine, Technische Universitat Munchen	We thank Prof. Dr. M. Schwaiger, Department of Nuclear Medicine, Technische Universitat Munchen for support.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BALCH CM, 2009, CA-CANCER J CLIN, V54, P131; Belhocine TZ, 2006, J NUCL MED, V47, P957; Dummer R, 2009, ANN ONCOL, V20, P129, DOI 10.1093/annonc/mdp152; Garbe C, 2003, CANCER-AM CANCER SOC, V97, P1737, DOI 10.1002/cncr.11250; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976, DOI 10.1200/JCO.1999.17.3.976; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Mazzini GS, 2009, RESUSCITATION, V80, P144, DOI 10.1016/j.resuscitation.2008.08.024; Mottaghy FM, 2007, EUR J NUCL MED MOL I, V34, P1355, DOI 10.1007/s00259-006-0358-1; Mruck S, 1999, ANTICANCER RES, V19, P2685; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Perez RP, 2000, HUM PATHOL, V31, P1381, DOI 10.1053/hupa.2000.19445; Pfannenberg C, 2007, EUR J CANCER, V43, P557, DOI 10.1016/j.ejca.2006.11.014; Reinhardt MJ, 2006, J CLIN ONCOL, V24, P1178, DOI 10.1200/JCO.2005.03.5634; Strobel K, 2007, EUR J NUCL MED MOL I, V34, P1366, DOI 10.1007/s00259-007-0403-8; Strobel K, 2007, RADIOLOGY, V244, P566, DOI 10.1148/radiol.2442061099; Tarhini AA, 2009, J CLIN ONCOL, V27, P38, DOI 10.1200/JCO.2008.17.1777; Yang Jian-Fu, 2004, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V29, P301	18	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24632	10.1371/journal.pone.0024632	http://dx.doi.org/10.1371/journal.pone.0024632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935432	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700032
J	Petschnik, AE; Fell, B; Tiede, S; Habermann, JK; Pries, R; Kruse, C; Danner, S				Petschnik, Anna E.; Fell, Benjamin; Tiede, Stephan; Habermann, Jens K.; Pries, Ralph; Kruse, Charli; Danner, Sandra			A Novel Xenogeneic Co-Culture System to Examine Neuronal Differentiation Capability of Various Adult Human Stem Cells	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; GENE-EXPRESSION; NERVE; CULTURE; GROWTH; ESTABLISHMENT; DERIVATION; INJURY; GDNF	Background: Targeted differentiation of stem cells is mainly achieved by the sequential administration of defined growth factors and cytokines, although these approaches are quite artificial, cost-intensive and time-consuming. We now present a simple xenogeneic rat brain co-culture system which supports neuronal differentiation of adult human stem cells under more in vivo-like conditions. Methods and Findings: This system was applied to well-characterized stem cell populations isolated from human skin, parotid gland and pancreas. In addition to general multi-lineage differentiation potential, these cells tend to differentiate spontaneously into neuronal cell types in vitro and are thus ideal candidates for the introduced co-culture system. Consequently, after two days of co-culture up to 12% of the cells showed neuronal morphology and expressed corresponding markers on the mRNA and protein level. Additionally, growth factors with the ability to induce neuronal differentiation in stem cells could be found in the media supernatants of the co-cultures. Conclusions: The co-culture system described here is suitable for testing neuronal differentiation capability of numerous types of stem cells. Especially in the case of human cells, it may be of clinical relevance for future cell-based therapeutic applications.	[Petschnik, Anna E.; Fell, Benjamin; Kruse, Charli; Danner, Sandra] Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany; [Tiede, Stephan] Univ Lubeck, Dept Dermatol Allergol & Venerol, Lubeck, Germany; [Habermann, Jens K.] Univ Lubeck, Dept Surg, Lubeck, Germany; [Pries, Ralph] Univ Lubeck, ENT Dept, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Lubeck	Petschnik, AE (corresponding author), Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany.	sandra.danner@emb.fraunhofer.de	Habermann, Jens/AAA-5149-2020	Schumann, Sandra/0000-0001-5316-6424; Tiede, Stephan/0000-0002-6045-3736	European Union	European Union(European Commission)	This work was sponsored by the European Union, European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2010, REGEN MED, V5, P891, DOI [10.2217/rme.10.67, 10.2217/RME.10.67]; Anwar MR, 2008, J NEUROCHEM, V105, P460, DOI 10.1111/j.1471-4159.2007.05164.x; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Cheng QZ, 2008, NEUROSCI LETT, V439, P24, DOI 10.1016/j.neulet.2008.04.089; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Ciba P, 2008, FISH PHYSIOL BIOCHEM, V34, P367, DOI 10.1007/s10695-007-9196-8; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Egana JT, 2009, BIOMATERIALS, V30, P5918, DOI 10.1016/j.biomaterials.2009.07.023; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Gorjup E, 2009, EUR J CELL BIOL, V88, P409, DOI 10.1016/j.ejcb.2009.02.187; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; Hayashi K, 2009, NEUROSCI RES, V64, P96, DOI 10.1016/j.neures.2009.01.018; Kajahn J, 2008, EUR J CELL BIOL, V87, P39, DOI 10.1016/j.ejcb.2007.07.004; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025; Komobuchi H, 2010, ACTA OTO-LARYNGOL, V130, P173, DOI 10.3109/00016480902896139; Kruse C, 2004, APPL PHYS A-MATER, V79, P1617, DOI 10.1007/s00339-004-2816-6; Kruse C, 2006, ANN ANAT, V188, P503, DOI 10.1016/j.aanat.2006.07.012; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Li WZ, 2011, STEM CELL RES, V6, P83, DOI 10.1016/j.scr.2010.09.003; McLaren A, 2001, NATURE, V414, P129, DOI 10.1038/35102194; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Ornitz DM, 2001, GENOME BIOL, V2; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Petschnik AE, 2010, BRIT J DERMATOL, V162, P380, DOI 10.1111/j.1365-2133.2009.09512.x; Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rotter N, 2008, STEM CELLS DEV, V17, P509, DOI 10.1089/scd.2007.0180; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Scintu F, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-14; Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049; Tao H, 2005, DEV GROWTH DIFFER, V47, P423; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035	39	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24944	10.1371/journal.pone.0024944	http://dx.doi.org/10.1371/journal.pone.0024944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935488	Green Submitted, gold, Green Published			2022-12-25	WOS:000295039700061
J	Torrente, MP; Zee, BM; Young, NL; Baliban, RC; LeRoy, G; Floudas, CA; Hake, SB; Garcia, BA				Torrente, Mariana P.; Zee, Barry M.; Young, Nicolas L.; Baliban, Richard C.; LeRoy, Gary; Floudas, Christodoulos A.; Hake, Sandra B.; Garcia, Benjamin A.			Proteomic Interrogation of Human Chromatin	PLOS ONE			English	Article							MASS-SPECTROMETRIC CHARACTERIZATION; HISTONE H3; POSTTRANSLATIONAL MODIFICATIONS; IN-VIVO; PROTEINS; HETEROCHROMATIN; PHOSPHORYLATION; METHYLATION; EXPRESSION; EUCHROMATIN	Chromatin proteins provide a scaffold for DNA packaging and a basis for epigenetic regulation and genomic maintenance. Despite understanding its functional roles, mapping the chromatin proteome (i.e. the "Chromatome'') is still a continuing process. Here, we assess the biological specificity and proteomic extent of three distinct chromatin preparations by identifying proteins in selected chromatin-enriched fractions using mass spectrometry-based proteomics. These experiments allowed us to produce a chromatin catalog, including several proteins ranging from highly abundant histone proteins to less abundant members of different chromatin machinery complexes. Using a Normalized Spectral Abundance Factor approach, we quantified relative abundances of the proteins across the chromatin enriched fractions giving a glimpse into their chromosomal abundance. The large-scale data sets also allowed for the discovery of a variety of novel post-translational modifications on the identified chromatin proteins. With these comparisons, we find one of the probed methods to be qualitatively superior in specificity for chromatin proteins, but inferior in proteomic extent, evidencing a compromise that must be made between biological specificity and broadness of characterization. Additionally, we attempt to identify proteins in eu- and heterochromatin, verifying the enrichments by characterizing the post-translational modifications detected on histone proteins from these chromatin regions. In summary, our results provide insights into the value of different methods to extract chromatin-associated proteins and provide starting points to study the factors that may be involved in directing gene expression and other chromatin-related processes.	[Torrente, Mariana P.; Garcia, Benjamin A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Zee, Barry M.; Young, Nicolas L.; LeRoy, Gary; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Baliban, Richard C.; Floudas, Christodoulos A.] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA; [Hake, Sandra B.] Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany; [Hake, Sandra B.] Univ Munich, Dept Mol Biol, Adolf Butenandt Inst, Munich, Germany	Princeton University; Princeton University; Princeton University; University of Munich; University of Munich	Torrente, MP (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	bagarcia@princeton.edu		Young, Nicolas/0000-0002-3323-2815; Zee, Barry/0000-0002-3123-8375	Princeton University; National Science Foundation (NSF) [CBET-0941143]; New Jersey Commission on Cancer; Office Of The Director, NIH [DP2OD007447]; American Society for Mass Spectrometry; Waters Corp.; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft; NIH, National Research Service [F32]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	Princeton University(Princeton University); National Science Foundation (NSF)(National Science Foundation (NSF)); New Jersey Commission on Cancer; Office Of The Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Mass Spectrometry; Waters Corp.; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH, National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Princeton University, a National Science Foundation (NSF) Early Faculty CAREER award, a New Jersey Commission on Cancer research grant, an NIH Innovator award (DP2OD007447) from the Office Of The Director, NIH, and an American Society for Mass Spectrometry research award sponsored by the Waters Corp. to B. A. G. B. A. G. and C. A. F. were also funded by NSF grant (CBET-0941143). S. B. H. is supported by the Center for Integrated Protein Science Munich and Deutsche Forschungsgemeinschaft. N.L.Y. is supported by an NIH F32 National Research Service Award Postdoctoral Fellowship. B.M.Z. is funded through an NSF graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bergmuller E, 2007, J PROTEOME RES, V6, P3655, DOI 10.1021/pr0702159; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; BUSCH H, 1979, KLIN WOCHENSCHR, V57, P253, DOI 10.1007/BF01476505; Chang L, 1999, METHOD ENZYMOL, V304, P76; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Cosgrove MS, 2007, EXPERT REV PROTEOMIC, V4, P465, DOI 10.1586/14789450.4.4.465; Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eissenberg JC, 2006, CURR OPIN GENET DEV, V16, P184, DOI 10.1016/j.gde.2006.02.004; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Gassmann R, 2005, CHROMOSOMA, V113, P385, DOI 10.1007/s00412-004-0326-0; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Hamid QA, 1996, J BIOCHEM BIOPH METH, V33, P59, DOI 10.1016/0165-022X(96)00014-0; Hendrich B, 2001, HUM MOL GENET, V10, P2233, DOI 10.1093/hmg/10.20.2233; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Imhof A, 2005, MOL BIOSYST, V1, P112, DOI 10.1039/b502845k; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Khoudoli GA, 2008, CURR BIOL, V18, P838, DOI 10.1016/j.cub.2008.04.075; Kim TY, 2005, ANAL CHEM, V77, P4185, DOI 10.1021/ac0481250; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; LeRoy G, 2009, MOL CELL PROTEOMICS, pS11; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Remboutsika E, 1999, J CELL SCI, V112, P1671; Sabbattini P, 2007, EMBO J, V26, P4657, DOI 10.1038/sj.emboj.7601875; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shiio Y, 2003, J AM SOC MASS SPECTR, V14, P696, DOI 10.1016/S1044-0305(03)00204-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan F, 2007, PROTEOMICS, V7, P4511, DOI 10.1002/pmic.200700580; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; van Dijk K, 2005, PLANT CELL, V17, P2439, DOI 10.1105/tpc.105.034165; WADDINGT.CH, 1969, SCIENCE, V166, P639, DOI 10.1126/science.166.3905.639; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wen B, 2008, GENOME RES, V18, P1806, DOI 10.1101/gr.067587.108; Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057; Xie HW, 2005, ANAL CHEM, V77, P3198, DOI 10.1021/ac0482256; Zhang QC, 2008, BBA-PROTEINS PROTEOM, V1784, P1159, DOI 10.1016/j.bbapap.2008.04.028; Zhang XL, 2002, RAPID COMMUN MASS SP, V16, P2325, DOI 10.1002/rcm.864; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	72	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24747	10.1371/journal.pone.0024747	http://dx.doi.org/10.1371/journal.pone.0024747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935452	Green Submitted, gold, Green Published			2022-12-25	WOS:000295039700041
J	Dmitriev, P; Petrov, A; Ansseau, E; Stankevicins, L; Charron, S; Kim, E; Bos, TJ; Robert, T; Turki, A; Coppee, F; Belayew, A; Lazar, V; Carnac, G; Laoudj, D; Lipinski, M; Vassetzky, YS				Dmitriev, Petr; Petrov, Andrei; Ansseau, Eugenie; Stankevicins, Luiza; Charron, Sebastien; Kim, Elena; Bos, Tomas Jan; Robert, Thomas; Turki, Ahmed; Coppee, Frederique; Belayew, Alexandra; Lazar, Vladimir; Carnac, Gilles; Laoudj, Dalila; Lipinski, Marc; Vassetzky, Yegor S.			The Kruppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FSHD CANDIDATE GENE; MUSCULAR-DYSTROPHY; DNA REARRANGEMENTS; OXIDATIVE STRESS; EXPRESSION; PROTEIN; KLF15; MUSCLE; REPRESSOR; SEQUENCE	Facioscapulohumeral muscular dystrophy (FSHD), a dominant hereditary disease with a prevalence of 7 per 100,000 individuals, is associated with a partial deletion in the subtelomeric D4Z4 repeat array on chromosome 4q. The D4Z4 repeat contains a strong transcriptional enhancer that activates promoters of several FSHD-related genes. We report here that the enhancer within the D4Z4 repeat binds the Kruppel-like factor KLF15. KLF15 was found to be up-regulated during myogenic differentiation induced by serum starvation or by overexpression of the myogenic differentiation factor MYOD. When over-expressed, KLF15 activated the D4Z4 enhancer and led to overexpression of DUX4c (Double homeobox 4, centromeric) and FRG2 (FSHD region gene 2) genes, whereas its silencing caused inactivation of the D4Z4 enhancer. In immortalized human myoblasts, the D4Z4 enhancer was activated by the myogenic factor MYOD, an effect that was abolished upon KLF15 silencing or when the KLF15-binding sites within the D4Z4 enhancer were mutated, indicating that the myogenesis-related activation of the D4Z4 enhancer was mediated by KLF15. KLF15 and several myogenesis-related factors were found to be expressed at higher levels in myoblasts, myotubes, and muscle biopsies from FSHD patients than in healthy controls. We propose that KLF15 serves as a molecular link between myogenic factors and the activity of the D4Z4 enhancer, and it thus contributes to the overexpression of the DUX4c and FRG2 genes during normal myogenic differentiation and in FSHD.	[Dmitriev, Petr; Petrov, Andrei; Stankevicins, Luiza; Kim, Elena; Robert, Thomas; Lazar, Vladimir; Lipinski, Marc; Vassetzky, Yegor S.] Univ Paris 11, CNRS, UMR8126, Inst Cancerol Gustave Roussy, F-94805 Villejuif, France; [Turki, Ahmed; Carnac, Gilles; Laoudj, Dalila] Univ Montpellier I, INSERM, U1046, F-34295 Montpellier, France; [Ansseau, Eugenie; Charron, Sebastien; Coppee, Frederique; Belayew, Alexandra] Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium; [Bos, Tomas Jan] Vrije Univ, Myeloma Ctr, Lab Hematol & Immunol, B-1090 Brussels, Belgium; [Petrov, Andrei] IBC Generium, Moscow 127006, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Mons; Vrije Universiteit Brussel	Vassetzky, YS (corresponding author), Univ Paris 11, CNRS, UMR8126, Inst Cancerol Gustave Roussy, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	vassetzky@igr.fr	Vassetzky, Yegor/M-3383-2019; Lazar, Vladimir/AAQ-2086-2020; Lazar, Vladimir/AAV-2087-2020; BELAYEW, Alexandra/D-5205-2013; Stankevicins, Luiza/K-1858-2014; Vassetzky, Yegor S/C-6447-2008; Laoudj-Chenivesse, dalila/N-7097-2018; Carnac, Gilles/N-6744-2018	Vassetzky, Yegor/0000-0003-3101-7043; BELAYEW, Alexandra/0000-0001-5115-2424; Vassetzky, Yegor S/0000-0003-3101-7043; Turki, Ahmed/0000-0003-4559-3105; Laoudj-Chenivesse, dalila/0000-0003-4356-9187; Carnac, Gilles/0000-0002-3518-8774	Association Francaise Contre les Myopathies; Fondation pour la Recherche Medicale; Onderzoerksraad Vrije Universiteit Brussel; Vlaamse Liga tegen Kanker-Stichting Emmanuel van der Schueren	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Onderzoerksraad Vrije Universiteit Brussel; Vlaamse Liga tegen Kanker-Stichting Emmanuel van der Schueren	This work was supported by grants from the Association Francaise Contre les Myopathies (to Y. S. V., D. L., and A. B.).; Supported by a postdoctoral fellowship from the Fondation pour la Recherche Medicale.; Supported by the Onderzoerksraad Vrije Universiteit Brussel and the Vlaamse Liga tegen Kanker-Stichting Emmanuel van der Schueren.	Adachi H, 2002, J BIOL CHEM, V277, P24014, DOI 10.1074/jbc.M201854200; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; CHEN QK, 1995, COMPUT APPL BIOSCI, V11, P563; Coppee F., 2004, FACIOSCAPULOHUMERAL, P1; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hsu DKW, 1996, J BIOL CHEM, V271, P13786, DOI 10.1074/jbc.271.23.13786; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Leenders JJ, 2010, J BIOL CHEM, V285, P27449, DOI 10.1074/jbc.M110.107292; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; McDonald J., 2009, HDB BIOL STAT, P1; Meijer AH, 1998, YEAST, V14, P1407, DOI 10.1002/(SICI)1097-0061(199811)14:15<1407::AID-YEA325>3.0.CO;2-M; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Otteson DC, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-15; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2003, RUSS J GENET+, V39, P147, DOI 10.1023/A:1022471523757; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Uchida S, 2001, KIDNEY INT, V60, P416, DOI 10.1046/j.1523-1755.2001.060002416.x; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	56	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44620	44631		10.1074/jbc.M111.254052	http://dx.doi.org/10.1074/jbc.M111.254052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21937448	Green Published, hybrid			2022-12-25	WOS:000298645500033
J	Su, J; Cao, X; Wang, KW				Su, Jun; Cao, Xu; Wang, KeWei			A Novel Degradation Signal Derived from Distal C-terminal Frameshift Mutations of KCNQ2 Protein Which Cause Neonatal Epilepsy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; PROTEASOMAL DEGRADATION; CONVULSIONS; CHANNELS; GENE; EXPRESSION; SUBUNIT; CELLS; BRAIN	Background: The mechanism underlying incomplete dominance of KCNQ2 channel mutations, which causes epilepsy, remains unknown. Results: We have identified a novel degradation signal with a key five-amino acid (RCXRG) motif from distal C-terminal frameshift mutations of KCNQ2. Conclusion: The novel degradation signal accelerates degradation of surface mutant proteins through ubiquitin-independent proteasome machinery. Significance: Our findings reveal a mechanism by which mutant KCNQ2 proteins cause epilepsy.	[Su, Jun; Cao, Xu; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Ctr, Beijing 100191, Peoples R China; [Wang, KeWei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100191, Peoples R China	Peking University; Peking University	Wang, KW (corresponding author), Peking Univ, Sch Med, 38 Xueyuan Rd, Beijing 100091, Peoples R China.	wangkw@bjmu.edu.cn	Cao, Xu/G-6209-2015	Cao, Xu/0000-0003-1796-2735	National Science Foundation of China [30630017, 30970919]; Ministry of Science Technology of China [2007CB512100]; Ministry of Education of China [B07001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Science Foundation of China Research Grants 30630017 and 30970919, the Ministry of Science Technology of China "973 Program" 2007CB512100, and the Ministry of Education of China, 111 Project China (B07001) (to K. W. W.).	Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Doi N, 2005, PROTEIN ENG DES SEL, V18, P279, DOI 10.1093/protein/gzi034; Doi N, 1998, CELL MOL LIFE SCI, V54, P394, DOI 10.1007/s000180050169; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Jentsch TJ, 2000, EPILEPSIA, V41, P1068, DOI 10.1111/j.1528-1157.2000.tb00302.x; Jow F, 2000, MOL BRAIN RES, V80, P269, DOI 10.1016/S0169-328X(00)00146-7; Kamsteeg EJ, 2003, J CELL BIOL, V163, P1099, DOI 10.1083/jcb.200309017; Komaru K, 2005, FEBS J, V272, P1704, DOI 10.1111/j.1742-4658.2005.04597.x; Kurepa J, 2008, PLANT SIGNAL BEHAV, V3, P386, DOI 10.4161/psb.3.6.5376; Lerche H, 1999, ANN NEUROL, V46, P305, DOI 10.1002/1531-8249(199909)46:3<305::AID-ANA5>3.0.CO;2-5; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Psenka TM, 1996, SEIZURE, V5, P243, DOI 10.1016/S1059-1311(96)80044-6; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; RONEN GM, 1993, NEUROLOGY, V43, P1355, DOI 10.1212/WNL.43.7.1355; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Soldovieri MV, 2006, J BIOL CHEM, V281, P418, DOI 10.1074/jbc.M510980200; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Volkers L, 2009, NEUROSCI LETT, V462, P24, DOI 10.1016/j.neulet.2009.06.064; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Yamauchi A, 1998, FEBS LETT, V421, P147, DOI 10.1016/S0014-5793(97)01552-4	39	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42949	42958		10.1074/jbc.M111.287268	http://dx.doi.org/10.1074/jbc.M111.287268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21937445	hybrid, Green Published			2022-12-25	WOS:000298351300016
J	Rajamohan, F; Marr, E; Reyes, AR; Landro, JA; Anderson, MD; Corbett, JW; Dirico, KJ; Harwood, JH; Tu, MH; Vajdos, FF				Rajamohan, Francis; Marr, Eric; Reyes, Allan R.; Landro, James A.; Anderson, Marie D.; Corbett, Jeffrey W.; Dirico, Kenneth J.; Harwood, James H.; Tu, Meihua; Vajdos, Felix F.			Structure-guided Inhibitor Design for Human Acetyl-coenzyme A Carboxylase by Interspecies Active Site Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; COA CARBOXYLASE; CARBOXYLTRANSFERASE DOMAIN; A CARBOXYLASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; DRUG DISCOVERY; MUTANT MICE; 2 ISOFORMS; OBESITY	Inhibition of acetyl-CoA carboxylases (ACCs), a crucial enzyme for fatty acid metabolism, has been shown to promote fatty acid oxidation and reduce body fat in animal models. Therefore, ACCs are attractive targets for structure-based inhibitor design, particularly the carboxyltransferase (CT) domain, which is the primary site for inhibitor interaction. We have cloned, expressed, and purified the CT domain of human ACC2 using baculovirus-mediated insect cell expression system. However, attempts to crystallize the human ACC2 CT domain have not been successful in our hands. Hence, we have been using the available crystal structure of yeast CT domain to design human ACC inhibitors. Unfortunately, as the selectivity of the lead series has increased against the full-length human enzyme, the potency against the yeast enzyme has decreased significantly. This loss of potency against the yeast enzyme correlated with a complete lack of binding of the human-specific compounds to crystals of the yeast CT domain. Here, we address this problem by converting nine key active site residues of the yeast CT domain to the corresponding human residues. The resulting humanized yeast ACC-CT (yCT-H9) protein exhibits biochemical and biophysical properties closer to the human CT domain and binding to human specific compounds. We report high resolution crystal structures of yCT-H9 complexed with inhibitors that show a preference for the human CT domain. These structures offer insights that explain the species selectivity of ACC inhibitors and may guide future drug design programs.	[Rajamohan, Francis; Marr, Eric; Reyes, Allan R.; Landro, James A.; Anderson, Marie D.; Corbett, Jeffrey W.; Dirico, Kenneth J.; Harwood, James H.; Tu, Meihua; Vajdos, Felix F.] Pfizer Global Res & Dev, Groton, CT 06340 USA	Pfizer	Rajamohan, F (corresponding author), Pfizer Inc, Eastern Point Rd,MS 8118A-2095, Groton, CT 06340 USA.	francis.rajamohan@pfizer.com; felix.vajdos@pfizer.com		Vajdos, Felix/0000-0002-8256-2087				Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Corbett JW, 2010, BIOORG MED CHEM LETT, V20, P2383, DOI 10.1016/j.bmcl.2009.04.091; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Harwood HJ, 2005, EXPERT OPIN THER TAR, V9, P267, DOI 10.1517/14728222.9.2.267; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Lenhard JM, 2002, ADV DRUG DELIVER REV, V54, P1199, DOI 10.1016/S0169-409X(02)00092-3; Madauss KP, 2009, ACTA CRYSTALLOGR D, V65, P449, DOI 10.1107/S0907444909008014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rajamohan F, 2010, PROTEIN EXPRES PURIF, V73, P189, DOI 10.1016/j.pep.2010.04.022; TANABE T, 1975, EUR J BIOCHEM, V57, P15, DOI 10.1111/j.1432-1033.1975.tb02272.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Zhang HL, 2004, STRUCTURE, V12, P1683, DOI 10.1016/j.str.2004.07.009; Zhang HL, 2004, P NATL ACAD SCI USA, V101, P5910, DOI 10.1073/pnas.0400891101; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	30	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41510	41519		10.1074/jbc.M111.275396	http://dx.doi.org/10.1074/jbc.M111.275396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21953464	hybrid, Green Published			2022-12-25	WOS:000298057500037
J	Liu, J; Nussinov, R				Liu, Jin; Nussinov, Ruth			Flexible Cullins in Cullin-RING E3 Ligases Allosterically Regulate Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOCS-BOX; CUL5-RBX2 MODULES; STRUCTURAL BASIS; COMPLEX REVEALS; PROTEIN; RECOGNITION; SPECIFICITY; CUL2-RBX1; INSIGHTS; DOMAINS	How do the cullins, with conserved structures, accommodate substrate-binding proteins with distinct shapes and sizes? Cullin-RING E3 ubiquitin ligases facilitate ubiquitin transfer from E2 to the substrate, tagging the substrate for degradation. They contain substrate-binding, adaptor, cullin, and Rbx proteins. Previously, we showed that substrate-binding and Rbx proteins are flexible. This allows shortening of the E2-substrate distance for initiation of ubiquitination or increasing the distance to accommodate the polyubiquitin chain. However, the role of the cullin remained unclear. Is cullin a rigid scaffold, or is it flexible and actively assists in the ubiquitin transfer reaction? Why are there different cullins, and how do these cullins specifically facilitate ubiquitination for different substrates? To answer these questions, we performed structural analysis and molecular dynamics simulations based on Cull, Cul4A, and Cu15 crystal structures. Our results show that these three cullins are not rigid scaffolds but are flexible with conserved hinges in the N-terminal domain. However, the degrees of flexibilities are distinct among the different cullins. Of interest, Cull flexibility can also be changed by deletion of the long loop (which is absent in Cul4A) in the N-terminal domain, suggesting that the loop may have an allosteric functional role. In all three cases, these conformational changes increase the E2-substrate distance to a specific range to facilitate polyubiquitination, suggesting that rather than being inert scaffold proteins, cullins allosterically regulate ubiquitination.	[Liu, Jin; Nussinov, Ruth] NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Nussinov, R (corresponding author), NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Frederick, MD 21702 USA.	ruthnu@helix.nih.gov		Nussinov, Ruth/0000-0002-8115-6415; Liu, Jin/0000-0002-1067-4063	National Institutes of Health from NCI [HHSN261200800001E]; National Cancer Institute Center for Cancer Research of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010441, ZIABC010440] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Center for Cancer Research of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN261200800001E from NCI and the National Cancer Institute Center for Cancer Research Intramural Research Program of the National Institutes of Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bergeron JRC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000925; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Liu J, 2008, P NATL ACAD SCI USA, V105, P901, DOI 10.1073/pnas.0707401105; Liu J, 2010, BIOPHYS J, V99, P736, DOI 10.1016/j.bpj.2010.05.021; Liu J, 2010, J MOL BIOL, V396, P1508, DOI 10.1016/j.jmb.2010.01.022; Liu J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000527; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Marcsisin SR, 2010, J MOL BIOL, V402, P892, DOI 10.1016/j.jmb.2010.08.026; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Wriggers W, 1997, PROTEINS, V29, P1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	40	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40934	40942		10.1074/jbc.M111.277236	http://dx.doi.org/10.1074/jbc.M111.277236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937436	hybrid, Green Published			2022-12-25	WOS:000297315400053
J	Tanabe, N; Wheal, BD; Kwon, J; Chen, HH; Shugg, RPP; Sims, SM; Goldberg, HA; Dixon, SJ				Tanabe, Natsuko; Wheal, Benjamin D.; Kwon, Jiyun; Chen, Hong H.; Shugg, Ryan P. P.; Sims, Stephen M.; Goldberg, Harvey A.; Dixon, S. Jeffrey			Osteopontin Signals through Calcium and Nuclear Factor of Activated T Cells (NFAT) in Osteoclasts A NOVEL RGD-DEPENDENT PATHWAY PROMOTING CELL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MATRIX PROTEINS; IN-VITRO; KAPPA-B; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTION FACTORS; RAT OSTEOCLASTS; SMOOTH-MUSCLE; INTEGRIN; RESORPTION; RECEPTORS	Osteopontin (OPN), an integrin-binding extracellular matrix glycoprotein, enhances osteoclast activity; however, its mechanisms of action are elusive. The Ca2+-dependent transcription factor NFATc1 is essential for osteoclast differentiation. We assessed the effects of OPN on NFATc1, which translocates to nuclei upon activation. Osteoclasts from neonatal rabbits and rats were plated on coverslips, uncoated or coated with OPN or bovine albumin. OPN enhanced the proportion of osteoclasts exhibiting nuclear NFATc1. An RGD-containing, integrin-blocking peptide prevented the translocation of NFATc1 induced by OPN. Moreover, mutant OPN lacking RGD failed to induce translocation of NFATc1. Thus, activation of NFATc1 is dependent on integrin binding through RGD. Using fluorescence imaging, OPN was found to increase the proportion of osteoclasts exhibiting transient elevations in cytosolic Ca2+ (oscillations). OPN also enhanced osteoclast survival. The intracellular Ca2+ chelator 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) suppressed Ca2+ oscillations and inhibited increases in NFATc1 translocation and survival induced by OPN. Furthermore, a specific, cell-permeable peptide inhibitor of NFAT activation blocked the effects of OPN on NFATc1 translocation and osteoclast survival. This is the first demonstration that OPN activates NFATc1 and enhances osteoclast survival through a Ca2+-NFAT-dependent pathway. Increased NFATc1 activity and enhanced osteoclast survival may account for the stimulatory effects of OPN on osteoclast function in vivo.	[Dixon, S. Jeffrey] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Chen, Hong H.; Goldberg, Harvey A.] Univ Western Ontario, Dept Dent, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Wheal, Benjamin D.] Univ Western Ontario, Grad Program Neurosci, London, ON N6A 5C1, Canada; [Tanabe, Natsuko] Nihon Univ, Sch Dent, Tokyo 1010062, Japan	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Nihon University	Dixon, SJ (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	jeff.dixon@schulich.uwo.ca	Sims, Stephen/G-4510-2013; Goldberg, Harvey/B-5742-2015; Dixon, S. Jeffrey/G-3657-2013	Dixon, S. Jeffrey/0000-0001-9162-1686	Canadian Institutes of Health Research (CIHR); Sato Fund; Sato Fund, Nihon University School of Dentistry, Tokyo, Japan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Sato Fund(Sato Fund); Sato Fund, Nihon University School of Dentistry, Tokyo, Japan	This work was supported by the Canadian Institutes of Health Research effects in multiple cell types. (CIHR).; Supported in part by the Sato Fund, Nihon University School of Dentistry, Tokyo, Japan.; Recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR.	Anborgh PH, 2010, J CELL MOL MED, V14, P2037, DOI 10.1111/j.1582-4934.2010.01115.x; Asou Y, 2001, ENDOCRINOLOGY, V142, P1325, DOI 10.1210/en.142.3.1325; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6; da Silva APB, 2009, LAB INVEST, V89, P1169, DOI 10.1038/labinvest.2009.80; Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011; Diao HY, 2008, P NATL ACAD SCI USA, V105, P15884, DOI 10.1073/pnas.0806089105; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; Gramoun A, 2010, J CELL BIOCHEM, V111, P350, DOI 10.1002/jcb.22705; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1; HEINEGARD D, 1995, ANN NY ACAD SCI, V760, P213, DOI 10.1111/j.1749-6632.1995.tb44632.x; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Ikeda F, 2006, J IMMUNOL, V177, P2384, DOI 10.4049/jimmunol.177.4.2384; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Katayama Y, 1998, J CELL PHYSIOL, V176, P179, DOI 10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.3.CO;2-M; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Korcok J, 2005, J BIOL CHEM, V280, P16909, DOI 10.1074/jbc.M410764200; Kovac JR, 2008, AM J PHYSIOL-GASTR L, V294, pG88, DOI 10.1152/ajpgi.00305.2007; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lapierre DM, 2010, J BIOL CHEM, V285, P25792, DOI 10.1074/jbc.M110.109322; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; Naemsch LN, 2001, J BIOL CHEM, V276, P39107, DOI 10.1074/jbc.M105881200; Nakamura I, 2001, J CELL BIOL, V152, P361, DOI 10.1083/jcb.152.2.361; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; PANICCIA R, 1993, AM J PHYSIOL, V265, pC1289, DOI 10.1152/ajpcell.1993.265.5.C1289; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; SHANKAR G, 1995, EXP CELL RES, V219, P364, DOI 10.1006/excr.1995.1240; SHANKAR G, 1993, J CELL SCI, V105, P61; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; Tanaka S, 2006, ANN NY ACAD SCI, V1068, P180, DOI 10.1196/annals.1346.020; Teti A, 1998, J BONE MINER RES, V13, P50, DOI 10.1359/jbmr.1998.13.1.50; Vejda S, 2005, BRIT J HAEMATOL, V128, P711, DOI 10.1111/j.1365-2141.2004.05355.x; Velupillai P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000733; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	58	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39871	39881		10.1074/jbc.M111.295048	http://dx.doi.org/10.1074/jbc.M111.295048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940634	Green Published, hybrid			2022-12-25	WOS:000296925700021
J	Fan, XL; Tkachyova, I; Sinha, A; Rigat, B; Mahuran, D				Fan, Xiaolian; Tkachyova, Ilona; Sinha, Ankit; Rigat, Brigitte; Mahuran, Don			Characterization of the Biosynthesis, Processing and Kinetic Mechanism of Action of the Enzyme Deficient in Mucopolysaccharidosis IIIC	PLOS ONE			English	Article							GLUCOSAMINIDE N-ACETYLTRANSFERASE; SYNDROME TYPE-C; BETA-HEXOSAMINIDASE; SANFILIPPO SYNDROME; ACETYL-COA; TRANSMEMBRANE ACETYLATION; LYSOSOMAL-ENZYMES; DISEASE; FIBROBLASTS; MUTATIONS	Heparin acetyl-CoA:alpha-glucosaminide N-acetyltransferase (N-acetyltransferase, EC 2.3.1.78) is an integral lysosomal membrane protein containing 11 transmembrane domains, encoded by the HGSNAT gene. Deficiencies of N-acetyltransferase lead to mucopolysaccharidosis IIIC. We demonstrate that contrary to a previous report, the N-acetyltransferase signal peptide is co-translationally cleaved and that this event is required for its intracellular transport to the lysosome. While we confirm that the N-acetyltransferase precursor polypeptide is processed in the lysosome into a small amino-terminal alpha- and a larger beta-chain, we further characterize this event by identifying the mature amino-terminus of each chain. We also demonstrate this processing step(s) is not, as previously reported, needed to produce a functional transferase, i.e., the precursor is active. We next optimize the biochemical assay procedure so that it remains linear as N-acetyltransferase is purified or protein-extracts containing N-acetyltransferase are diluted, by the inclusion of negatively charged lipids. We then use this assay to demonstrate that the purified single N-acetyltransferase protein is both necessary and sufficient to express transferase activity, and that N-acetyltransferase functions as a monomer. Finally, the kinetic mechanism of action of purified N-acetyltransferase was evaluated and found to be a random sequential mechanism involving the formation of a ternary complex with its two substrates; i.e., N-acetyltransferase does not operate through a ping-pong mechanism as previously reported. We confirm this conclusion by demonstrating experimentally that no acetylated enzyme intermediate is formed during the reaction.	[Fan, Xiaolian; Tkachyova, Ilona; Sinha, Ankit; Rigat, Brigitte; Mahuran, Don] Hosp Sick Children, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada; [Tkachyova, Ilona; Mahuran, Don] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Fan, XL (corresponding author), Hosp Sick Children, Genet & Genome Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hex@sickkids.ca		Sinha, Ankit/0000-0002-9113-2599	Sanfilippo Children's Research Foundation; Canadian Institutes of Health Research (CIHR) [CTP-82944]	Sanfilippo Children's Research Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Sanfilippo Children's Research Foundation and a Canadian Institutes of Health Research (CIHR) Team Grant (CTP-82944) to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; BAME KJ, 1985, J BIOL CHEM, V260, P1293; BAME KJ, 1986, SCIENCE, V233, P1087, DOI 10.1126/science.3090688; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Canals I, 2010, CLIN GENETI IN PRESS; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Durand S, 2010, J BIOL CHEM, V285, P31233, DOI 10.1074/jbc.M110.141150; Engel CK, 2002, BBA-BIOMEMBRANES, V1564, P47, DOI 10.1016/S0005-2736(02)00397-8; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Fedele AO, 2010, HUM MUTAT, V31, pE1574, DOI 10.1002/humu.21286; Fedele Anthony Olind, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9488; Feldhammer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007434; Feldhammer M, 2009, HUM MUTAT, V30, P918, DOI 10.1002/humu.20986; HASILIK A, 1992, EXPERIENTIA, V48, P130, DOI 10.1007/BF01923507; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HE W, 1994, PRENATAL DIAG, V14, P17, DOI 10.1002/pd.1970140104; Hrebicek M, 2006, AM J HUM GENET, V79, P807, DOI 10.1086/508294; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRESSE H, 1978, EUR J BIOCHEM, V92, P333, DOI 10.1111/j.1432-1033.1978.tb12752.x; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; LITTLE LE, 1988, J BIOL CHEM, V263, P4288; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; MAHURAN D, 1980, CAN J BIOCHEM CELL B, V58, P287, DOI 10.1139/o80-038; MAHURAN DJ, 1990, J BIOL CHEM, V265, P6794; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Martin DR, 2008, MOL GENET METAB, V94, P212, DOI 10.1016/j.ymgme.2008.02.004; MEIER EM, 1991, J BIOL CHEM, V266, P1879; MEIKLE PJ, 1995, BIOCHEM J, V308, P327, DOI 10.1042/bj3080327; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; QUON DVK, 1989, J BIOL CHEM, V264, P3380; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Tropak MB, 2007, FEBS J, V274, P4951, DOI 10.1111/j.1742-4658.2007.06040.x; Tropak MB, 2007, CHEM BIOL, V14, P153, DOI 10.1016/j.chembiol.2006.12.006; Tropak MB, 2010, GLYCOBIOLOGY, V20, P356, DOI 10.1093/glycob/cwp183; VOZNYI YV, 1993, J INHERIT METAB DIS, V16, P465, DOI 10.1007/BF00710299	41	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2011	6	9							e24951	10.1371/journal.pone.0024951	http://dx.doi.org/10.1371/journal.pone.0024951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825HM	21957468	Green Published, gold, Green Submitted			2022-12-25	WOS:000295262100027
J	Bhardwaj, S; Misra, A; Misra, R; Goel, K; Bhatt, SP; Rastogi, K; Vikram, NK; Gulati, S				Bhardwaj, Swati; Misra, Anoop; Misra, Ranjita; Goel, Kashish; Bhatt, Surya Prakash; Rastogi, Kavita; Vikram, Naval K.; Gulati, Seema			High Prevalence of Abdominal, Intra-Abdominal and Subcutaneous Adiposity and Clustering of Risk Factors among Urban Asian Indians in North India	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; BODY-FAT; TISSUE COMPARTMENTS; OBESITY; POPULATION; DIAGNOSIS; DISEASE	Objective: To assess the prevalence of abdominal obesity including intra-abdominal and subcutaneous adiposity along with other cardiometabolic risk factors in urban Asian Indians living in New Delhi. Methods: We conducted a cross-sectional epidemiological descriptive study with 459 subjects (217 males and 242 females), representing all socio-economic strata in New Delhi. The anthropometric profile [body mass index (BMI), waist circumference (WC) and skinfold thickness], fasting blood glucose (FBG) and lipid profile were recorded. Percent body fat (%BF), total abdominal fat (TAF), intra-abdominal adipose tissue (IAAT) and subcutaneous abdominal adipose tissue (SCAT) were quantified using predictive equations for Asian Indians. Results: The overall prevalence of obesity was high [by BMI (>25 kg/m(2)), 50.1%]. The prevalence of abdominal obesity (as assessed by WC) was 68.9%, while that assessed by TAF was 70.8%. Increased IAAT was significantly higher in females (80.6%) as compared to males (56.7%) (p = 0.00) with overall prevalence being 69.3%. The overall prevalence of high SCAT was 67.8%, more in males (69.1%) vs. females (66.5%, p = 0.5). The prevalence of type 2 diabetes, the metabolic syndrome and hypertension was 8.5%, 45.3% and 29.2%, respectively. Hypertriglyceridemia, hypercholesterolemia and low levels of HDL-c were prevalent in 42.7%, 26.6% and 37% of the subjects, respectively. The prevalence of hypertriglyceridemia was significantly higher in males (p = 0.007); however, low levels of HDL-c were more prevalent in females as compared to males (p = 0.00). Conclusion: High prevalence of generalized obesity, abdominal obesity (by measurement of WC, TAF, IAAT and SCAT) and dysmetabolic state in urban Asian Indians in north India need immediate public health intervention.	[Bhardwaj, Swati; Misra, Anoop; Goel, Kashish; Bhatt, Surya Prakash; Gulati, Seema] Natl Diabet Obes & Cholesterol Dis Fdn N DOC, SDA, New Delhi, India; [Misra, Anoop] Fortis Flt Lt Rajan Dhall Hosp, Fortis CDOC Ctr Excellence Diabet Metab Dis & End, New Delhi, India; [Misra, Anoop] Fortis Flt Lt Rajan Dhall Hosp, Ctr Internal Med, New Delhi, India; [Misra, Ranjita] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Goel, Kashish] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA; [Bhatt, Surya Prakash] All India Inst Med Sci, Dept Biochem & Med, New Delhi, India; [Vikram, Naval K.] All India Inst Med Sci, Dept Internal Med, New Delhi, India	Texas A&M University System; Texas A&M University College Station; Wayne State University; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Bhardwaj, S (corresponding author), Natl Diabet Obes & Cholesterol Dis Fdn N DOC, SDA, New Delhi, India.	anoopmisra@metabolicresearchindia.com	Goel, Kashish/E-4916-2011; Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747; Misra, Ranjita/0000-0001-7314-0184	US Congress	US Congress	This study was partly funded by the US Congress and carried out in collaboration with Texas A&M University, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Das Mithun, 2010, J Cardiovasc Dis Res, V1, P130, DOI 10.4103/0975-3583.70911; Deepa M, 2009, EUR J CLIN NUTR, V63, P259, DOI 10.1038/sj.ejcn.1602920; DUCIMETIERE P, 1986, INT J OBESITY, V10, P229; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goel K, 2008, OBESITY, V16, P451, DOI 10.1038/oby.2007.55; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gupta R, 2007, J Assoc Physicians India, V55, P705; Gupta Rajeev, 2009, Cases J, V2, P7870, DOI 10.1186/1757-1626-2-7870; HAFFNER SM, 1987, DIABETES, V36, P43, DOI 10.2337/diabetes.36.1.43; Joseph L, 2011, DIABETES TECHNOL THE; Mahadik S. R., 2007, Metabolic Syndrome and Related Disorders, V5, P142, DOI 10.1089/met.2006.0029; Misra A, 2005, DIABETES CARE, V28, P398, DOI 10.2337/diacare.28.2.398; Misra A, 2004, INT J OBESITY, V28, P1217, DOI 10.1038/sj.ijo.0802704; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Misra A, 2003, NUTRITION, V19, P457, DOI 10.1016/S0899-9007(02)01003-1; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2010, METAB SYNDR RELAT D, V8, P243, DOI 10.1089/met.2009.0046; Mohan V, 2008, NATL MED J INDIA, V21, P8; Oka R, 2010, OBESITY, V18, P153, DOI 10.1038/oby.2009.180; Ramachandran A, 2003, DIABETES RES CLIN PR, V60, P199, DOI 10.1016/S0168-8227(03)00060-3; Ravikiran M, 2010, DIABETES RES CLIN PR, V89, P181, DOI 10.1016/j.diabres.2010.03.010; Sandeep S, 2010, INDIAN J MED RES, V131, P629; Wang YF, 2005, AM J CLIN NUTR, V81, P555	29	65	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24362	10.1371/journal.pone.0024362	http://dx.doi.org/10.1371/journal.pone.0024362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949711	Green Submitted, Green Published, gold			2022-12-25	WOS:000295260400004
J	Dengler, MA; Staiger, AM; Gutekunst, M; Hofmann, U; Doszczak, M; Scheurich, P; Schwab, M; Aulitzky, WE; van der Kuip, H				Dengler, Michael A.; Staiger, Annette M.; Gutekunst, Matthias; Hofmann, Ute; Doszczak, Malgorzata; Scheurich, Peter; Schwab, Matthias; Aulitzky, Walter E.; van der Kuip, Heiko			Oncogenic Stress Induced by Acute Hyper-Activation of Bcr-Abl Leads to Cell Death upon Induction of Excessive Aerobic Glycolysis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CHRONIC MYELOID-LEUKEMIA; POSITIVE LEUKEMIA; KINASE-ACTIVITY; UP-REGULATION; ER STRESS; IN-VIVO; RESISTANCE	In response to deregulated oncogene activation, mammalian cells activate disposal programs such as programmed cell death. To investigate the mechanisms behind this oncogenic stress response we used Bcr-Abl over-expressing cells cultivated in presence of imatinib. Imatinib deprivation led to rapid induction of Bcr-Abl activity and over-stimulation of PI3K/Akt-, Ras/MAPK-, and JAK/STAT pathways. This resulted in a delayed necrosis-like cell death starting not before 48 hours after imatinib withdrawal. Cell death was preceded by enhanced glycolysis, glutaminolysis, and amino acid metabolism leading to elevated ATP and protein levels. This enhanced metabolism could be linked to induction of cell death as inhibition of glycolysis or glutaminolysis was sufficient to sustain cell viability. Therefore, these data provide first evidence that metabolic changes induced by Bcr-Abl hyper-activation are important mediators of oncogenic stress-induced cell death. During the first 30 hours after imatinib deprivation, Bcr-Abl hyper-activation did not affect proliferation but resulted in cellular swelling, vacuolization, and induction of eIF2 alpha phosphorylation, CHOP expression, as well as alternative splicing of XPB, indicating endoplasmic reticulum stress response. Cell death was dependent on p38 and RIP1 signaling, whereas classical death effectors of ER stress, namely CHOP-BIM were antagonized by concomitant up-regulation of BclxL. Screening of 1,120 compounds for their potential effects on oncogenic stress-induced cell death uncovered that corticosteroids antagonize cell death upon Bcr-Abl hyper-activation by normalizing cellular metabolism. This protective effect is further demonstrated by the finding that corticosteroids rendered lymphocytes permissive to the transforming activity of Bcr-Abl. As corticosteroids are used together with imatinib for treatment of Bcr-Abl positive acute lymphoblastic leukemia these data could have important implications for the design of combination therapy protocols. In conclusion, excessive induction of Warburg type metabolic alterations can cause cell death. Our data indicate that these metabolic changes are major mediators of oncogenic stress induced by Bcr-Abl.	[Dengler, Michael A.; Staiger, Annette M.; Gutekunst, Matthias; Hofmann, Ute; Schwab, Matthias; van der Kuip, Heiko] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Dengler, Michael A.; Staiger, Annette M.; Gutekunst, Matthias; Hofmann, Ute; Schwab, Matthias; van der Kuip, Heiko] Univ Tubingen, Stuttgart, Germany; [Doszczak, Malgorzata; Scheurich, Peter] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Schwab, Matthias] Univ Hosp Tuebingen, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany; [Aulitzky, Walter E.] Robert Bosch Krankenhaus, Dept Internal Med Oncol & Hematol 2, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Stuttgart; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus	Dengler, MA (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-7000 Stuttgart, Germany.	heiko.van-der-kuip@ikp-stuttgart.de	Schwab, Matthias/ABH-7449-2020; Dengler, Michael/AFR-3509-2022	Hofmann, Ute/0000-0003-0823-9027; Dengler, Michael/0000-0002-1693-1761	Robert Bosch Foundation, Stuttgart [O2A]	Robert Bosch Foundation, Stuttgart	This work was financially supported by the Robert Bosch Foundation, Stuttgart (Project O2A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayllon V, 2000, MOL MEMBR BIOL, V17, P65; Barnes K, 2005, ONCOGENE, V24, P3257, DOI 10.1038/sj.onc.1208461; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; BUSTOS R, 1992, BIOCHEM J, V282, P299, DOI 10.1042/bj2820299; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Delannoy A, 2006, LEUKEMIA, V20, P1526, DOI 10.1038/sj.leu.2404320; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Desplat V, 2005, CANCER-AM CANCER SOC, V103, P102, DOI 10.1002/cncr.20758; Dietrich K, 2009, BRIT J CANCER, V101, P1316, DOI 10.1038/sj.bjc.6605314; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; ELSON A, 1995, ONCOGENE, V11, P181; Gerits N, 2007, TRANSGENIC RES, V16, P281, DOI 10.1007/s11248-006-9052-0; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Gupta M, 2002, INDIAN J MED RES, V116, P268; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henkes Martin, 2008, Ther Clin Risk Manag, V4, P163; Hofmann U, 2008, BIOTECHNOL BIOENG, V100, P344, DOI 10.1002/bit.21747; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hussain SG, 2007, CURR SCI INDIA, V93, P1684; Ibrahim AR, 2011, BLOOD, V117, P3733, DOI 10.1182/blood-2010-10-309807; Jensen AO, 2009, BRIT J CANCER, V100, P200, DOI 10.1038/sj.bjc.6604796; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lee HJ, 2011, CANCER-AM CANCER SOC, V117, P1583, DOI 10.1002/cncr.25690; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Maier K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-54; Maier K, 2009, METAB ENG, V11, P292, DOI 10.1016/j.ymben.2009.06.001; Mimnaugh EG, 2006, MOL CANCER RES, V4, P667, DOI 10.1158/1541-7786.MCR-06-0019; MORENOAURIOLES VR, 1991, BIOCHIM BIOPHYS ACTA, V1091, P96, DOI 10.1016/0167-4889(91)90227-O; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ramakers-van Woerden NL, 2002, MED PEDIATR ONCOL, V38, P379, DOI 10.1002/mpo.10087; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Skorta I, 2009, CANCER RES, V69, P9337, DOI 10.1158/0008-5472.CAN-09-0548; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; van der Kuip H, 2001, BLOOD, V98, P1532, DOI 10.1182/blood.V98.5.1532; Vignetti M, 2007, BLOOD, V109, P3676, DOI 10.1182/blood-2006-10-052746; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; von Bubnoff N, 2003, LEUKEMIA, V17, P829, DOI 10.1038/sj.leu.2402889; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P309; Wohlbold L, 2003, BLOOD, V102, P2236, DOI 10.1182/blood-2002-12-3899; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67	64	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25139	10.1371/journal.pone.0025139	http://dx.doi.org/10.1371/journal.pone.0025139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949869	gold, Green Published			2022-12-25	WOS:000295260400050
J	Pennucci, R; Tavano, S; Tonoli, D; Gualdoni, S; de Curtis, I				Pennucci, Roberta; Tavano, Stefania; Tonoli, Diletta; Gualdoni, Sara; de Curtis, Ivan			Rac1 and Rac3 GTPases Regulate the Development of Hilar Mossy Cells by Affecting the Migration of Their Precursors to the Hilus	PLOS ONE			English	Article							DENTATE GRANULE CELLS; NEURONAL DEVELOPMENT; SYNAPTIC CONNECTIONS; RHO GTPASES; GYRUS; EXPRESSION; MOUSE; HIPPOCAMPUS; RAT; DIFFERENTIATION	We have previously shown that double deletion of the genes for Rac1 and Rac3 GTPases during neuronal development affects late developmental events that perturb the circuitry of the hippocampus, with ensuing epileptic phenotype. These effects include a defect in mossy cells, the major class of excitatory neurons of the hilus. Here, we have addressed the mechanisms that affect the loss of hilar mossy cells in the dorsal hippocampus of mice depleted of the two Rac GTPases. Quantification showed that the loss of mossy cells was evident already at postnatal day 8, soon after these cells become identifiable by a specific marker in the dorsal hilus. Comparative analysis of the hilar region from control and double mutant mice revealed that synaptogenesis was affected in the double mutants, with strongly reduced presynaptic input from dentate granule cells. We found that apoptosis was equally low in the hippocampus of both control and double knockout mice. Labelling with bromodeoxyuridine at embryonic day 12.5 showed no evident difference in the proliferation of neuronal precursors in the hippocampal primordium, while differences in the number of bromodeoxyuridine-labelled cells in the developing hilus revealed a defect in the migration of immature, developing mossy cells in the brain of double knockout mice. Overall, our data show that Rac1 and Rac3 GTPases participate in the normal development of hilar mossy cells, and indicate that they are involved in the regulation of the migration of the mossy cell precursor by preventing their arrival to the dorsal hilus.	[Pennucci, Roberta] Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, I-20132 Milan, Italy; San Raffaele Univ, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Pennucci, R (corresponding author), Ist Sci San Raffaele, Div Neurosci, Cell Adhes Unit, I-20132 Milan, Italy.	decurtis.ivan@hsr.it		DE CURTIS, Ivanmatteo/0000-0002-7651-1515	Telethon-Italy [GGP09078]; Regione Lombardia [16695, SAL-58]	Telethon-Italy(Fondazione Telethon); Regione Lombardia(Regione Lombardia)	This work was supported by the following sources of funding to Ivan de Curtis: Telethon-Italy, grant GGP09078 (http://www.telethon.it/); Regione Lombardia, grant ID 16695, SAL-58 (www.regione.lombardia.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; ANGEVINE JB, 1965, EXP NEUROL        S2, V13, P1; Bagri A, 2002, DEVELOPMENT, V129, P4249; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BlascoIbanez JM, 1997, HIPPOCAMPUS, V7, P307, DOI 10.1002/(SICI)1098-1063(1997)7:3<307::AID-HIPO6>3.0.CO;2-H; Blumcke I, 2000, EPILEPSIA, V41, pS174, DOI 10.1111/j.1528-1157.2000.tb01577.x; Bolis A, 2003, EUR J NEUROSCI, V18, P2417, DOI 10.1046/j.1460-9568.2003.02938.x; CAVAZOS JE, 1990, BRAIN RES, V527, P1, DOI 10.1016/0006-8993(90)91054-K; Chen L, 2007, J NEUROSCI, V27, P3884, DOI 10.1523/JNEUROSCI.3509-06.2007; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Farah CA, 2008, CELL MOTIL CYTOSKEL, V65, P515, DOI 10.1002/cm.20284; Fernandez-Teran MA, 2006, DEV DYNAM, V235, P2521, DOI 10.1002/dvdy.20916; FROTSCHER M, 1991, J COMP NEUROL, V312, P145, DOI 10.1002/cne.903120111; Fujise N, 1999, BRAIN RES, V816, P500, DOI 10.1016/S0006-8993(98)01202-5; Gualdoni S, 2007, BIOL CELL, V99, P455, DOI 10.1042/BC20060119; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Larimer P, 2008, J NEUROSCI, V28, P12212, DOI 10.1523/JNEUROSCI.3612-08.2008; Li G, 2008, DEV NEUROSCI-BASEL, V30, P255, DOI 10.1159/000110347; Liu Y, 1996, EXP BRAIN RES, V108, P389; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MAGLOCZKY Z, 1993, NEUROSCIENCE, V56, P317, DOI 10.1016/0306-4522(93)90334-C; Malosio ML, 1997, J NEUROSCI, V17, P6717; MELLONI RH, 1994, J COMP NEUROL, V342, P449, DOI 10.1002/cne.903420311; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Meyer KD, 2009, HUM MOL GENET, V18, P3286, DOI 10.1093/hmg/ddp266; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; RIBAK CE, 1985, J NEUROCYTOL, V14, P835, DOI 10.1007/BF01170832; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	54	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24819	10.1371/journal.pone.0024819	http://dx.doi.org/10.1371/journal.pone.0024819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949760	gold, Green Submitted, Green Published			2022-12-25	WOS:000295260400018
J	Varala, K; Swaminathan, K; Li, Y; Hudson, ME				Varala, Kranthi; Swaminathan, Kankshita; Li, Ying; Hudson, Matthew E.			Rapid Genotyping of Soybean Cultivars Using High Throughput Sequencing	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; LENGTH POLYMORPHISM; DNA MARKERS; DIVERSITY; RESTRICTION; RESISTANCE; DISCOVERY; SNPS	Soybean (Glycine max) breeding involves improving commercially grown varieties by introgressing important agronomic traits from poor yielding accessions and/or wild relatives of soybean while minimizing the associated yield drag. Molecular markers associated with these traits are instrumental in increasing the efficiency of producing such crosses and Single Nucleotide Polymorphisms (SNPs) are particularly well suited for this task, owing to high density in the non-genic regions and thus increased likelihood of finding a tightly linked marker to a given trait. A rapid method to develop SNP markers that can differentiate specific loci between any two parents in soybean is thus highly desirable. In this study we investigate such a protocol for developing SNP markers between multiple soybean accessions and the reference Williams 82 genome. To restrict sampling frequency reduced representation libraries (RRLs) of genomic DNA were generated by restriction digestion followed by library construction. We chose to sequence four accessions Dowling (PI 548663), Dwight (PI 597386), Komata (PI200492) and PI 594538A for their agronomic importance as well as Williams 82 as a control. MseI was chosen to digest genomic DNA based on predictions that it will cut sparingly in the mathematically defined high-copy-number regions of the genome. All RRLs were sequenced on the Illumina genome analyzer. Reads were aligned to the Glyma1 reference assembly and SNP calls made from the alignments. We identified from 4294 to 14550 SNPs between the four accessions and the Williams 82 reference. In addition a small number of SNPs (1142) were found by aligning Williams 82 reads to the reference assembly (Glyma1) suggesting limited genetic variation within the Williams 82 line. The SNP data allowed us to estimate genetic diversity between the four lines and Williams 82. Restriction digestion of soybean genomic DNA with MseI followed by high throughput sequencing provides a rapid and reproducible method for generating SNP markers.	[Varala, Kranthi; Swaminathan, Kankshita; Li, Ying; Hudson, Matthew E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Varala, K (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	mhudson@illinois.edu	Hudson, Matthew E/A-4438-2008; Varala, Kranthi/AHD-3960-2022; Varala, Kranthi/A-2954-2013	Hudson, Matthew E/0000-0002-4737-0936; Varala, Kranthi/0000-0003-1051-6636; Varala, Kranthi/0000-0003-1051-6636; Li, Ying/0000-0002-5258-7355	United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2006-34488-16915]; United Soybean Board [1279]	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United Soybean Board	This research was funded by a grant to MH from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service, grant # 2006-34488-16915 and by the United Soybean Board, grant # 1279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKAYA MS, 1995, CROP SCI, V35, P1439, DOI 10.2135/cropsci1995.0011183X003500050030x; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BERNARD RL, 1988, CROP SCI, V28, P1027; Chakraborty N, 2009, CROP SCI, V49, P783, DOI 10.2135/cropsci2008.06.0335; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; Cregan Perry B., 2008, V2, P79; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Fu YB, 2007, CROP SCI, V47, P1947, DOI 10.2135/cropsci2006.12.0843; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Grant D, 2010, BMC GENOMICS, V11; Haun WJ, 2011, PLANT PHYSIOL, V155, P645, DOI 10.1104/pp.110.166736; Hwang TY, 2008, BREEDING SCI, V58, P315, DOI 10.1270/jsbbs.58.315; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Hyten DL, 2010, BMC GENOMICS, V11; Kaczorowski KA, 2008, PLANT GENOME-US, V1, P89, DOI 10.3835/plantgenome2008.04.0207; Kasuga T, 1997, MOL PLANT MICROBE IN, V10, P1035, DOI 10.1094/MPMI.1997.10.9.1035; KEIM P, 1989, THEOR APPL GENET, V77, P786, DOI 10.1007/BF00268327; Keim P, 1997, CROP SCI, V37, P537, DOI 10.2135/cropsci1997.0011183X003700020038x; Kim KS, 2010, THEOR APPL GENET, V120, P1063, DOI 10.1007/s00122-009-1234-8; Krzywinski MI, 2009, GENOME RES; LANDER E S, 1988, Genomics, V2, P231; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Nickell CD, 1998, CROP SCI, V38, P1398; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; RONGWEN J, 1995, THEOR APPL GENET, V90, P43, DOI 10.1007/BF00220994; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seversike TM, 2008, THEOR APPL GENET, V117, P143, DOI 10.1007/s00122-008-0759-6; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Van K, 2005, J HERED, V96, P529, DOI 10.1093/jhered/esi069; Wang LX, 2006, CROP SCI, V46, P1032, DOI 10.2135/cropsci2005.0051; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-469; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Yoon MS, 2007, THEOR APPL GENET, V114, P885, DOI 10.1007/s00122-006-0487-8; Zhu YL, 2003, GENETICS, V163, P1123	41	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e24811	10.1371/journal.pone.0024811	http://dx.doi.org/10.1371/journal.pone.0024811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949759	Green Submitted, Green Published, gold			2022-12-25	WOS:000295260400017
J	Yao, CG; Moretti, JE; Struss, PE; Spall, JA; Muller, UF				Yao, Chengguo; Moretti, Janina E.; Struss, Peter E.; Spall, Junaid A.; Mueller, Ulrich F.			Arginine Cofactors on the Polymerase Ribozyme	PLOS ONE			English	Article							CATALYZED RNA POLYMERIZATION; IN-VITRO SELECTION; AMINO-ACID; HAMMERHEAD RIBOZYME; GENETIC CODE; PROTEIN; ORIGIN; LIFE; DNA; POLYNUCLEOTIDE	The RNA world hypothesis states that the early evolution of life went through a stage in which RNA served both as genome and as catalyst. The central catalyst in an RNA world organism would have been a ribozyme that catalyzed RNA polymerization to facilitate self-replication. An RNA polymerase ribozyme was developed previously in the lab but it is not efficient enough for self-replication. The factor that limits its polymerization efficiency is its weak sequence-independent binding of the primer/template substrate. Here we tested whether RNA polymerization could be improved by a cationic arginine cofactor, to improve the interaction with the substrate. In an RNA world, amino acid-nucleic acid conjugates could have facilitated the emergence of the translation apparatus and the transition to an RNP world. We chose the amino acid arginine for our study because this is the amino acid most adept to interact with RNA. An arginine cofactor was positioned at ten different sites on the ribozyme, using conjugates of arginine with short DNA or RNA oligonucleotides. However, polymerization efficiency was not increased in any of the ten positions. In five of the ten positions the arginine reduced or modulated polymerization efficiency, which gives insight into the substrate-binding site on the ribozyme. These results suggest that the existing polymerase ribozyme is not well suited to using an arginine cofactor.	[Yao, Chengguo; Moretti, Janina E.; Struss, Peter E.; Spall, Junaid A.; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Yao, CG (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			NSF [0743985]; NIH MBTG [08326]	NSF(National Science Foundation (NSF)); NIH MBTG	This study was funded by NSF grant 0743985 to U.F.M. and NIH MBTG grant GM #08326 to J.E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2003, NUCLEIC ACIDS RES, V31, P661, DOI 10.1093/nar/gkg140; Attwater J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1076; Baskerville S, 2002, P NATL ACAD SCI USA, V99, P9154, DOI 10.1073/pnas.142153799; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Cheng LKL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002204; COTTRELL JW, 2011, J BIOL CHEM; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Emilsson GM, 2002, CELL MOL LIFE SCI, V59, P596, DOI 10.1007/s00018-002-8452-4; Faulhammer D, 1996, ANGEW CHEM INT EDIT, V35, P2837, DOI 10.1002/anie.199628371; Geyer CR, 1997, CHEM BIOL, V4, P579, DOI 10.1016/S1074-5521(97)90244-1; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Han J, 2005, BIOCHEMISTRY-US, V44, P7864, DOI 10.1021/bi047941z; HERSCHLAG D, 1994, EMBO J, V13, P2913, DOI 10.1002/j.1460-2075.1994.tb06586.x; Hoffman MM, 2004, NUCLEIC ACIDS RES, V32, pD174, DOI 10.1093/nar/gkh128; Illangasekare M, 1999, P NATL ACAD SCI USA, V96, P5470, DOI 10.1073/pnas.96.10.5470; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joseph S, 1997, SCIENCE, V278, P1093, DOI 10.1126/science.278.5340.1093; Joyce GF, 1998, P NATL ACAD SCI USA, V95, P5845, DOI 10.1073/pnas.95.11.5845; Koutmou KS, 2010, J MOL BIOL, V396, P195, DOI 10.1016/j.jmb.2009.11.039; Kumar RK, 2001, BIOCHEMISTRY-US, V40, P6998, DOI 10.1021/bi010710x; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Lee N, 2000, NAT STRUCT BIOL, V7, P28; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Mason PE, 2003, P NATL ACAD SCI USA, V100, P4557, DOI 10.1073/pnas.0735920100; Misra VK, 2003, BIOPOLYMERS, V69, P118, DOI 10.1002/bip.10353; Muller UF, 2003, CHEM BIOL, V10, P799, DOI 10.1016/S1074-5521(03)00171-6; Muller UF, 2008, RNA, V14, P552, DOI 10.1261/rna.494508; NAGEL GM, 1995, J MOL EVOL, V40, P487; Noller HF, 2004, RNA, V10, P1833, DOI 10.1261/rna.7142404; ORGEL LE, 1989, J MOL EVOL, V29, P465, DOI 10.1007/BF02602917; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Robertson MP, 2004, RNA, V10, P114, DOI 10.1261/rna.5900204; Robertson MP, 2001, NAT BIOTECHNOL, V19, P650, DOI 10.1038/90256; Roth A, 1998, P NATL ACAD SCI USA, V95, P6027, DOI 10.1073/pnas.95.11.6027; Schmidt CLA, 1930, J BIOL CHEM, V88, P285; Shechner DM, 2009, SCIENCE, V326, P1271, DOI 10.1126/science.1174676; Szathmary E, 1997, J THEOR BIOL, V187, P555, DOI 10.1006/jtbi.1996.0389; Wilson TJ, 2007, EMBO J, V26, P2489, DOI 10.1038/sj.emboj.7601698; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; WOESE CR, 1968, P NATL ACAD SCI USA, V59, P110, DOI 10.1073/pnas.59.1.110; Yao CG, 2011, RNA, V17, P1274, DOI 10.1261/rna.2726811; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375; Zimmermann RA, 2003, CELL, V115, P130, DOI 10.1016/S0092-8674(03)00804-3	46	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2011	6	9							e25030	10.1371/journal.pone.0025030	http://dx.doi.org/10.1371/journal.pone.0025030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825GY	21949841	Green Published, gold, Green Submitted			2022-12-25	WOS:000295260400037
J	Bernhardsson, C; Ingvarsson, PK				Bernhardsson, Carolina; Ingvarsson, Par K.			Molecular Population Genetics of Elicitor-Induced Resistance Genes in European Aspen (Populus tremula L., Salicaceae)	PLOS ONE			English	Article							POLYPHENOL OXIDASE; HYBRID POPLAR; MALACOSOMA-DISSTRIA; POSITIVE SELECTION; INSECT HERBIVORES; DEFENSE RESPONSE; PLANT IMMUNITY; EXPRESSION; EVOLUTION; OVEREXPRESSION	Owing to their long life span and ecological dominance in many communities, forest trees are subject to attack from a diverse array of herbivores throughout their range, and have therefore developed a large number of both constitutive and inducible defenses. We used molecular population genetics methods to examine the evolution of eight genes in European aspen, Populus tremula, that are all associated with defensive responses against pests and/or pathogens, and have earlier been shown to become strongly up-regulated in poplars as a response to wounding and insect herbivory. Our results show that the majority of these defense genes show patterns of intraspecific polymorphism and site-frequency spectra that are consistent with a neutral model of evolution. However, two of the genes, both belonging to a small gene family of polyphenol oxidases, show multiple deviations from the neutral model. The gene PPO1 has a 600 bp region with a highly elevated KA/KS ratio and reduced synonymous diversity. PPO1 also shows a skew toward intermediate frequency variants in the SFS, and a pronounced fixation of non-synonymous mutations, all pointing to the fact that PPO1 has been subjected to recurrent selective sweeps. The gene PPO2 shows a marked excess of high frequency, derived variants and shows many of the same trends as PPO1 does, even though the pattern is less pronounced, suggesting that PPO2 might have been the target of a recent selective sweep. Our results supports data from both Populus and other species which have found that the the majority of defense-associated genes show few signs of selection but that a number of genes involved in mediating defense against herbivores show signs of adaptive evolution.	[Bernhardsson, Carolina; Ingvarsson, Par K.] Umea Plant Sci Ctr, Dept Ecol & Environm Sci, Umea, Sweden	Umea University	Bernhardsson, C (corresponding author), Umea Plant Sci Ctr, Dept Ecol & Environm Sci, Umea, Sweden.	carolina.bernhardsson@emg.umu.se	Ingvarsson, Pär/G-2748-2010	Ingvarsson, Par/0000-0001-9225-7521	Swedish Research Council; C. F. Lundstrom's stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); C. F. Lundstrom's stiftelse	This work was funded by grants from the Swedish Research Council and C. F. Lundstrom's stiftelse to PKI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2008, PLANT J, V53, P450, DOI 10.1111/j.1365-313X.2007.03353.x; Bakker EG, 2008, GENETICS, V178, P2031, DOI 10.1534/genetics.107.083279; Barbehenn RV, 2007, OECOLOGIA, V154, P129, DOI 10.1007/s00442-007-0822-z; Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Bhonwong A, 2009, J CHEM ECOL, V35, P28, DOI 10.1007/s10886-008-9571-7; Caspers MPM, 2001, PLANT J, V26, P191, DOI 10.1046/j.0960-7412.2001.01019.x; Christopher ME, 2004, PLANTA, V219, P936, DOI 10.1007/s00425-004-1297-3; Constabel C. Peter, 2008, P253, DOI 10.1007/978-1-4020-8182-8_12; Constabel CP, 2005, RECENT ADV PHYTOCHEM, V39, P119; Constabel CP, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P137; Constabel CP, 2000, PLANT PHYSIOL, V124, P285, DOI 10.1104/pp.124.1.285; de Meaux J, 2003, HEREDITY, V91, P345, DOI 10.1038/sj.hdy.6800342; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Ingvarsson PK, 2005, MOL BIOL EVOL, V22, P1802, DOI 10.1093/molbev/msi171; Kant MR, 2007, CURR OPIN GENET DEV, V17, P519, DOI 10.1016/j.gde.2007.09.002; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kim Y, 2002, GENETICS, V160, P765; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Luquez V, 2008, TREE GENET GENOMES, V4, P279, DOI 10.1007/s11295-007-0108-y; Mahanil S, 2008, PLANT SCI, V174, P456, DOI 10.1016/j.plantsci.2008.01.006; Major IT, 2008, PLANT PHYSIOL, V146, P888, DOI 10.1104/pp.107.106229; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Moeller DA, 2005, MOL BIOL EVOL, V22, P2480, DOI 10.1093/molbev/msi247; Mussig C, 2010, PLANT BIOLOGY, V12, P381, DOI 10.1111/j.1438-8677.2009.00303.x; Osier TL, 2006, OECOLOGIA, V148, P293, DOI 10.1007/s00442-006-0373-8; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; Philippe RN, 2009, NEW PHYTOL, V184, P865, DOI 10.1111/j.1469-8137.2009.03028.x; Przeworski M, 2002, GENETICS, V160, P1179; Ralph S, 2006, MOL ECOL, V15, P1275, DOI 10.1111/j.1365-294X.2006.02824.x; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-57; Rehrig EM, 2011, MOL ECOL RESOUR, V11, P294, DOI 10.1111/j.1755-0998.2010.02929.x; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Schaller F, 2001, J EXP BOT, V52, P11, DOI 10.1093/jexbot/52.354.11; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; Talyzina NM, 2006, J MOL EVOL, V63, P108, DOI 10.1007/s00239-005-0249-2; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiffin P, 2004, GENETICS, V168, P425, DOI 10.1534/genetics.103.023028; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang JH, 2004, PLANTA, V220, P87, DOI 10.1007/s00425-004-1327-1; Wang JH, 2004, PHYSIOL PLANTARUM, V122, P344, DOI 10.1111/j.1399-3054.2004.00403.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Xia YJ, 2004, CELL MICROBIOL, V6, P905, DOI 10.1111/j.1462-5822.2004.00438.x	53	4	4	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2011	6	9							e24867	10.1371/journal.pone.0024867	http://dx.doi.org/10.1371/journal.pone.0024867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825FZ	21949772	Green Submitted, gold, Green Published			2022-12-25	WOS:000295257900031
J	Jiang, A; Liu, C; Song, YL; Liu, F; Li, QY; Wu, Z; Yu, L; Lv, Y				Jiang, An; Liu, Chang; Song, Yulong; Liu, Feng; Li, Quanyuan; Wu, Zheng; Yu, Liang; Lv, Yi			NF-kappa B Induced the Donor Liver Cold Preservation Related Acute Lung Injury in Rat Liver Transplantation Model	PLOS ONE			English	Article							MICE; LIPOPOLYSACCHARIDE; CELLS; KB	Background: We have observed at our clinical work that acute lung injury (ALI) often occurs in patients transplanted with donor livers persevered for long time. So, we conducted this study to investigate the influence of cold preservation time (CPT) of donor liver on ALI induced by liver transplantation (LT), and further study the role of nuclear factor-kappa B (NF-kappa B) in the process. Methods: Wistar rats were used as donors and recipients to establish orthotopic rat liver transplantation models. Donor livers were preserved at 4 degrees C for different lengths of time. The effect of NF-kappa B inhibitor, ammonium pyrrolidinedithiocarbamate (PDTC), on ALI was detected. All samples were harvested after 3 h reperfusion. The severity of liver injury was evaluated first. The expressions of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in liver tissue and liver outflow serum were measured respectively. The severity indexes of ALI, the activity of NF-kappa B and inhibitor-kappa B alpha (I-kappa B alpha) in lung/liver were measured accordingly. Results: With the prolonged liver CPT, the liver damage associated indexes and ALI-related indexes all increased significantly. TNF-alpha and IL-1 beta in liver outflow serum increased accordingly, and the activity of NF-kappa B in liver/lung increased correspondingly. All these ALI-associated indexes could be partially reversed by the use of PDTC. Conclusions: Extended CPT aggravates the damage of donor liver and induces the expressions of TNF-alpha and IL-1 beta in liver. These inflammatory factors migrate to lung via liver outflow blood and activate NF-kappa B in lung, inducing ALI finally. NF-kappa B may play a critical role in LT-related ALI. Patients with or at risk of ALI may benefit from acute anti-inflammatory treatment with PDTC.	[Jiang, An; Liu, Chang; Wu, Zheng; Yu, Liang; Lv, Yi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Hepatobiliary Surg, Xian 710049, Peoples R China; [Song, Yulong] Renmin Hosp Shaanxi Prov, Dept Anesthesiol, Xian, Peoples R China; [Liu, Feng] Qianfoshan Hosp, Dept Liver Transplantat, Jinan, Peoples R China; [Li, Quanyuan] Dongfeng Hosp, Dept Transplantat, Shiyan, Peoples R China	Xi'an Jiaotong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Jiang, A (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept VIP Clin, Xian 710049, Peoples R China.	liuchangdoctor@163.com			National Natural Science Foundation of China [30200269]; science and technology projects in Shaanxi Province [2006k12-G3(6)]; science and technology projects in Xi'an City [SF1025(3)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology projects in Shaanxi Province; science and technology projects in Xi'an City	This work was supported by National Natural Science Foundation of China (No. 30200269), science and technology projects in Shaanxi Province [2006k12-G3(6)] and science and technology projects in Xi'an City [SF1025(3)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AB, 2011, LIVER TRANSPLANT, V17, P149, DOI 10.1002/lt.22212; Chi XJ, 2009, CHINESE MED J-PEKING, V122, P895, DOI 10.3760/cma.j.issn.0366-6999.2009.08.003; Csiszar A, 2007, FASEB J, V21, pA450; Gong Q, 2008, INT IMMUNOPHARMACOL, V8, P792, DOI 10.1016/j.intimp.2008.01.026; Grune T, 2007, CURR OPIN CLIN NUTR, V10, P712, DOI 10.1097/MCO.0b013e3282f0c97c; Guo Na, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P74; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; Kaido T, 2010, TRANSPLANTATION, V90, P335, DOI 10.1097/TP.0b013e3181e49bf2; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Kotloff RM, 2004, AM J RESP CRIT CARE, V170, P22, DOI 10.1164/rccm.200309-1322SO; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Li Gang-Shan, 2002, Hepatobiliary Pancreat Dis Int, V1, P330; Li SM, 2010, BASIC RES CARDIOL, V105, P139, DOI 10.1007/s00395-009-0067-6; Pereboom ITA, 2009, ANESTH ANALG, V108, P1083, DOI 10.1213/ane.0b013e3181948a59; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Yan LN, 2004, MODERN LIVER TRANSPL; Yin H, 2008, INT IMMUNOPHARMACOL, V8, P1842, DOI 10.1016/j.intimp.2008.09.004	18	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e24960	10.1371/journal.pone.0024960	http://dx.doi.org/10.1371/journal.pone.0024960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949808	Green Submitted, Green Published, gold			2022-12-25	WOS:000295173800052
J	Ranwez, V; Harispe, S; Delsuc, F; Douzery, EJP				Ranwez, Vincent; Harispe, Sebastien; Delsuc, Frederic; Douzery, Emmanuel J. P.			MACSE: Multiple Alignment of Coding SEquences Accounting for Frameshifts and Stop Codons	PLOS ONE			English	Article							FUNCTIONAL DIVERGENCE; DNA; PHYLOGENY; EVOLUTION; SEAVIEW; TIME	Until now the most efficient solution to align nucleotide sequences containing open reading frames was to use indirect procedures that align amino acid translation before reporting the inferred gap positions at the codon level. There are two important pitfalls with this approach. Firstly, any premature stop codon impedes using such a strategy. Secondly, each sequence is translated with the same reading frame from beginning to end, so that the presence of a single additional nucleotide leads to both aberrant translation and alignment. We present an algorithm that has the same space and time complexity as the classical Needleman-Wunsch algorithm while accommodating sequencing errors and other biological deviations from the coding frame. The resulting pairwise coding sequence alignment method was extended to a multiple sequence alignment (MSA) algorithm implemented in a program called MACSE (Multiple Alignment of Coding SEquences accounting for frameshifts and stop codons). MACSE is the first automatic solution to align protein-coding gene datasets containing non-functional sequences (pseudogenes) without disrupting the underlying codon structure. It has also proved useful in detecting undocumented frameshifts in public database sequences and in aligning next-generation sequencing reads/contigs against a reference coding sequence. MACSE is distributed as an open-source java file executable with freely available source code and can be used via a web interface at: http://mbb.univ-montp2.fr/macse.	[Ranwez, Vincent; Harispe, Sebastien; Delsuc, Frederic; Douzery, Emmanuel J. P.] Univ Montpellier 2, CNRS, UMR5554, Inst Sci Evolut, Montpellier, France; [Harispe, Sebastien] Ecole Mines dAles, Ctr Rech LGI2P, Nimes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; IMT - Institut Mines-Telecom; IMT Mines Ales	Ranwez, V (corresponding author), Univ Montpellier 2, CNRS, UMR5554, Inst Sci Evolut, Montpellier, France.	Vincent.Ranwez@univ-montp2.fr	DOUZERY, Emmanuel J. P./ABC-4050-2020; Delsuc, Frederic/B-4381-2009; Harispe, Sébastien/AAS-3854-2021; ranwez, vincent/I-5490-2017	DOUZERY, Emmanuel J. P./0000-0001-5286-647X; Delsuc, Frederic/0000-0002-6501-6287; Harispe, Sébastien/0000-0001-5630-2743; ranwez, vincent/0000-0002-9308-7541	French Agence Nationale de la Recherche [ANR-08-EMER-011]; Centre National de la Recherche Scientifique [PEPS-INSB-2010]; Montpellier Bioinformatics Biodiversity platform (MBB)	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Montpellier Bioinformatics Biodiversity platform (MBB)	This work was supported by the French Agence Nationale de la Recherche "Domaines Emergents" (ANR-08-EMER-011, "PhylAriane"), the Centre National de la Recherche Scientifique (PEPS-INSB-2010), and the Montpellier Bioinformatics Biodiversity platform (MBB). This publication is the contribution No 2011-069 of the Institut des Sciences de l'Evolution de Montpellier (UMR 5554 - CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; ALTSCHUL SF, 1989, J THEOR BIOL, V138, P297, DOI 10.1016/S0022-5193(89)80196-1; ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; Arvestad L, 1997, LECT NOTES COMPUT SC, V1264, P180; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Delsuc F, 2008, GENESIS, V46, P592, DOI 10.1002/dvg.20450; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P380, DOI 10.1093/nar/gkh180; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guan XJ, 1996, COMPUT APPL BIOSCI, V12, P31; HEIN J, 1994, J THEOR BIOL, V167, P169, DOI 10.1006/jtbi.1994.1062; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kececioglu J, 2004, P 8 ACM C RES COMP M, P8596, DOI [10.1145/974614.974626, DOI 10.1145/974614.974626]; Kececioglu JD, 1998, LECT NOTES COMPUT SC, V1448, P189, DOI 10.1007/BFb0030790; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Morgenstern B, 2002, BIOINFORMATICS, V18, P777, DOI 10.1093/bioinformatics/18.6.777; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pedersen CNS, 1998, LECT NOTES COMPUT SC, V1448, P153, DOI 10.1007/BFb0030788; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Przybylski D, 2002, PROTEINS, V46, P197, DOI 10.1002/prot.10029; Raes J, 2005, TRENDS GENET, V21, P428, DOI 10.1016/j.tig.2005.05.013; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; SANKOFF D, 1972, P NATL ACAD SCI USA, V69, P4, DOI 10.1073/pnas.69.1.4; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Stocsits RR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-160; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Zhao HB, 2011, MOL BIOL EVOL, V28, P7, DOI 10.1093/molbev/msq207; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	52	364	368	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2011	6	9							e22594	10.1371/journal.pone.0022594	http://dx.doi.org/10.1371/journal.pone.0022594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824BI	21949676	Green Published, Green Submitted, gold			2022-12-25	WOS:000295173800001
J	Gomez-Brandon, M; Aira, M; Lores, M; Dominguez, J				Gomez-Brandon, Maria; Aira, Manuel; Lores, Marta; Dominguez, Jorge			Epigeic Earthworms Exert a Bottleneck Effect on Microbial Communities through Gut Associated Processes	PLOS ONE			English	Article							FATTY-ACID PROFILES; TERRESTRIS L. OLIGOCHAETA; LUMBRICUS-TERRESTRIS; DENDROBAENA-OCTAEDRA; MICROFUNGAL COMMUNITY; PIG SLURRY; SOIL; DIVERSITY; BACTERIA; TRANSIT	Background: Earthworms play a critical role in organic matter decomposition because of the interactions they establish with microorganisms. The ingestion, digestion, assimilation of organic material in the gut and then casting is the first step in earthworm-microorganism interactions. The current knowledge of these direct effects is still limited for epigeic earthworm species, mainly those living in man-made environments. Here we tested whether and to what extent the earthworm Eisenia andrei is capable of altering the microbiological properties of fresh organic matter through gut associated processes; and if these direct effects are related to the earthworm diet. Methodology: To address these questions we determined the microbial community structure (phospholipid fatty acid profiles) and microbial activity (fluorescein diacetate hydrolysis) in the earthworm casts derived from three types of animal manure (cow, horse and pig manure), which differed in microbial composition. Principal Findings: The passage of the organic material through the gut of E. andrei reduced the total microbial biomass irrespective of the type of manure, and resulted in a decrease in bacterial biomass in all the manures; whilst leaving the fungi unaffected in the egested materials. However, unlike the microbial biomass, no such reduction was detected in the total microbial activity of cast samples derived from the pig manure. Moreover, no differences were found between cast samples derived from the different types of manure with regards to microbial community structure, which provides strong evidence for a bottleneck effect of worm digestion on microbial populations of the original material consumed. Conclusions/Significance: Our data reveal that earthworm gut is a major shaper of microbial communities, thereby favouring the existence of a reduced but more active microbial population in the egested materials, which is of great importance to understand how biotic interactions within the decomposer food web influence on nutrient cycling.	[Gomez-Brandon, Maria; Aira, Manuel; Dominguez, Jorge] Univ Vigo, Fac Biol, Dept Ecol & Biol Anim, Vigo 36310, Spain; [Lores, Marta] Fac Quim, Dept Quim Analit, Lab Invest & Desarrollo Soluc Analit, Santiago De Compostela, Spain	Universidade de Vigo; Universidade de Santiago de Compostela	Gomez-Brandon, M (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	mariagomez@uvigo.es	Aira, Manuel/B-4506-2016; Gómez-Brandón, Maria/D-7050-2011; Lores, Marta/F-9220-2015; Domínguez, Jorge/M-2046-2014; Domínguez, Jorge/T-7647-2019; Gomez-Brandon, Maria/Q-4421-2016	Aira, Manuel/0000-0002-2513-4609; Lores, Marta/0000-0001-7683-8342; Domínguez, Jorge/0000-0002-4313-8582; Domínguez, Jorge/0000-0002-4313-8582; Gomez-Brandon, Maria/0000-0003-4744-535X	Xunta de Galicia; Fundacion Alfonso Martin Escudero; Spanish Ministerio de Ciencia e Innovacion [CTM2009-08477]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion Alfonso Martin Escudero; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Manuel Aira is financially supported by a Parga Pondal research grant from the Xunta de Galicia and Maria Gomez-Brandon by a postdoctoral research grant from Fundacion Alfonso Martin Escudero. This research was financially supported by the Spanish Ministerio de Ciencia e Innovacion (CTM2009-08477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G, 2001, SOIL BIOL BIOCHEM, V33, P943, DOI 10.1016/S0038-0717(00)00244-3; Aira M, 2006, BIOL FERT SOILS, V42, P371, DOI 10.1007/s00374-005-0047-4; Aira M, 2009, J HAZARD MATER, V161, P1234, DOI 10.1016/j.jhazmat.2008.04.073; Aira M, 2009, J HAZARD MATER, V162, P1404, DOI 10.1016/j.jhazmat.2008.06.031; Aira M, 2008, SOIL BIOL BIOCHEM, V40, P2511, DOI 10.1016/j.soilbio.2008.06.010; Aira M, 2007, MICROB ECOL, V54, P662, DOI 10.1007/s00248-007-9223-4; Aira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016354; Aira M, 2006, MICROB ECOL, V52, P738, DOI 10.1007/s00248-006-9109-x; Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Batista A, 2001, EUR FOOD RES TECHNOL, V212, P377, DOI 10.1007/s002170000240; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; BROWN BA, 1981, PEDOBIOLOGIA, V21, P434; Butenschoen O, 2007, SOIL BIOL BIOCHEM, V39, P2854, DOI 10.1016/j.soilbio.2007.05.028; Byzov BA, 2007, EUR J SOIL BIOL, V43, pS149, DOI 10.1016/j.ejsobi.2007.08.012; Clapperton MJ, 2001, SOIL BIOL BIOCHEM, V33, P1531, DOI 10.1016/S0038-0717(01)00071-2; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Daane LL, 1997, APPL ENVIRON MICROB, V63, P679, DOI 10.1128/AEM.63.2.679-686.1997; Dominguez J, 2010, MICROBES AT WORK: FROM WASTES TO RESOURCES, P93, DOI 10.1007/978-3-642-04043-6_5; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; Edwards CA, 2010, VERMICULTURE TECHNOL, P25; Egert M, 2004, FEMS MICROBIOL ECOL, V48, P187, DOI 10.1016/j.femsec.2004.01.007; Eisenhauer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003489; Elfstrand S, 2008, SOIL BIOL BIOCHEM, V40, P2530, DOI 10.1016/j.soilbio.2008.06.013; Ernst G, 2009, SOIL BIOL BIOCHEM, V41, P1548, DOI 10.1016/j.soilbio.2009.04.015; Evershed RP, 2006, CURR OPIN BIOTECH, V17, P72, DOI 10.1016/j.copbio.2006.01.003; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Gomez-Brandon M, 2010, BIORESOURCE TECHNOL, V101, P1348, DOI 10.1016/j.biortech.2009.09.047; Gomez-Brandon M, 2011, BIORESOURCE TECHNOL, V102, P4171, DOI 10.1016/j.biortech.2010.12.057; Hendriksen Niels Bohse, 1995, Acta Zoologica Fennica, V196, P115; IUPAC-IUB Commission on Biochemical Nomenclature, 1977, European Journal of Biochemistry, V79, P11, DOI 10.1111/j.1432-1033.1977.tb11778.x; Knapp BA, 2009, SOIL BIOL BIOCHEM, V41, P2299, DOI 10.1016/j.soilbio.2009.08.011; Konig H, 2006, J APPL MICROBIOL, V101, P620, DOI 10.1111/j.1365-2672.2006.02914.x; Lavelle P., 2001, SOIL ECOLOGY; Lores M, 2006, SOIL BIOL BIOCHEM, V38, P2993, DOI 10.1016/j.soilbio.2006.05.001; Marhan S, 2007, APPL SOIL ECOL, V35, P412, DOI 10.1016/j.apsoil.2006.06.003; McLean MA, 2000, SOIL BIOL BIOCHEM, V32, P1671, DOI 10.1016/S0038-0717(00)00083-3; McLean MA, 1998, APPL SOIL ECOL, V8, P61, DOI 10.1016/S0929-1393(97)00067-X; McLean MA, 2000, SOIL BIOL BIOCHEM, V32, P351, DOI 10.1016/S0038-0717(99)00161-3; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; Monroy F, 2008, APPL SOIL ECOL, V39, P127, DOI 10.1016/j.apsoil.2007.11.011; Monroy F, 2011, PEDOBIOLOGIA, V54, P93, DOI 10.1016/j.pedobi.2010.10.003; Monroy F, 2009, SCI TOTAL ENVIRON, V407, P5411, DOI 10.1016/j.scitotenv.2009.06.048; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Nechitaylo TY, 2010, MICROB ECOL, V59, P574, DOI 10.1007/s00248-009-9604-y; Ovreas L, 2000, ECOL LETT, V3, P236, DOI 10.1046/j.1461-0248.2000.00148.x; PEDERSEN JC, 1993, BIOL FERT SOILS, V16, P227, DOI 10.1007/BF00361413; Rudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007528; Sampedro L, 2008, APPL SOIL ECOL, V38, P91, DOI 10.1016/j.apsoil.2007.10.008; Sampedro L, 2007, APPL SOIL ECOL, V35, P226, DOI 10.1016/j.apsoil.2006.04.007; SCHNURER J, 1982, APPL ENVIRON MICROB, V43, P1256; Schonholzer F, 1999, FEMS MICROBIOL ECOL, V28, P235, DOI 10.1016/S0168-6496(98)00111-1; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; VERMUE M, 1993, BIOTECHNOL BIOENG, V42, P747, DOI 10.1002/bit.260420610; Williams AP, 2006, FEMS MICROBIOL ECOL, V58, P54, DOI 10.1111/j.1574-6941.2006.00142.x; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhang BG, 2000, SOIL BIOL BIOCHEM, V32, P2055, DOI 10.1016/S0038-0717(00)00111-5	58	67	77	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24786	10.1371/journal.pone.0024786	http://dx.doi.org/10.1371/journal.pone.0024786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935465	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700059
J	Jones, SM; Palmer, MJ				Jones, Stefanie M.; Palmer, Mary J.			Pharmacological Analysis of the Activation and Receptor Properties of the Tonic GABA(C)R Current in Retinal Bipolar Cell Terminals	PLOS ONE			English	Article							SINGLE AMINO-ACID; 2ND TRANSMEMBRANE DOMAIN; RHO-SUBUNITS; GRANULE CELLS; IMMUNOCYTOCHEMICAL LOCALIZATION; HIPPOCAMPAL ASTROCYTES; CONNEXIN HEMICHANNELS; GLUTAMATE RELEASE; CL-CHANNELS; RAT RETINA	GABAergic inhibition in the central nervous system (CNS) can occur via rapid, transient postsynaptic currents and via a tonic increase in membrane conductance, mediated by synaptic and extrasynaptic GABA(A) receptors (GABA(A)Rs) respectively. Retinal bipolar cells (BCs) exhibit a tonic current mediated by GABA(C)Rs in their axon terminal, in addition to synaptic GABA(A)R and GABA(C)R currents, which strongly regulate BC output. The tonic GABA(C)R current in BC terminals (BCTs) is not dependent on vesicular GABA release, but properties such as the alternative source of GABA and the identity of the GABA(C)Rs remain unknown. Following a recent report that tonic GABA release from cerebellar glial cells is mediated by Bestrophin 1 anion channels, we have investigated their role in non-vesicular GABA release in the retina. Using patch-clamp recordings from BCTs in goldfish retinal slices, we find that the tonic GABA(C)R current is not reduced by the anion channel inhibitors NPPB or flufenamic acid but is reduced by DIDS, which decreases the tonic current without directly affecting GABA(C)Rs. All three drugs also exhibit non-specific effects including inhibition of GABA transporters. GABA(C)R rho subunits can form homomeric and heteromeric receptors that differ in their properties, but BC GABA(C)Rs are thought to be rho 1-rho 2 heteromers. To investigate whether GABA(C)Rs mediating tonic and synaptic currents may differ in their subunit composition, as is the case for GABA(A)Rs, we have examined the effects of two antagonists that show partial rho subunit selectivity: picrotoxin and cyclothiazide. Tonic and synaptic GABA(C)R currents were differentially affected by both drugs, suggesting that a population of homomeric rho 1 receptors contributes to the tonic current. These results extend our understanding of the multiple forms of GABAergic inhibition that exist in the CNS and contribute to visual signal processing in the retina.	[Jones, Stefanie M.; Palmer, Mary J.] Keele Univ, Inst Sci & Technol Med, Neurosci Grp, Keele, Staffs, England	Keele University	Jones, SM (corresponding author), Keele Univ, Inst Sci & Technol Med, Neurosci Grp, Keele, Staffs, England.	m.j.palmer@cns.keele.ac.uk		Palmer, Mary/0000-0002-5539-6052	Medical Research Council [86420]; Medical Research Council [G0800502] Funding Source: researchfish; MRC [G0800502] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Medical Research Council New Investigator Research Grant (ID 86420, www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai I, 2010, J NEUROSCI, V30, P9260, DOI 10.1523/JNEUROSCI.1590-10.2010; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Carland JE, 2004, NEUROPHARMACOLOGY, V46, P770, DOI 10.1016/j.neuropharm.2003.11.027; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; COREY JL, 1994, MOL MEMBR BIOL, V11, P23, DOI 10.3109/09687689409161026; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; Enz R, 1999, EUR J NEUROSCI, V11, P41, DOI 10.1046/j.1460-9568.1999.00423.x; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Evanko DS, 2004, GLIA, V47, P233, DOI 10.1002/glia.20050; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fellin T, 2006, J BIOL CHEM, V281, P4274, DOI 10.1074/jbc.M510679200; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hollrigel GS, 1998, J NEUROPHYSIOL, V80, P2340, DOI 10.1152/jn.1998.80.5.2340; Hull C, 2006, J NEUROSCI, V26, P6979, DOI 10.1523/JNEUROSCI.1386-06.2006; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jimenez-Gonzalez C, 2011, EUR J NEUROSCI, V33, P1471, DOI 10.1111/j.1460-9568.2011.07645.x; Jones SM, 2009, J NEUROPHYSIOL, V102, P691, DOI 10.1152/jn.00285.2009; Karakossian MH, 2005, J MEMBRANE BIOL, V203, P65, DOI 10.1007/s00232-004-0732-5; KOKUBUN S, 1991, PFLUG ARCH EUR J PHY, V418, P204, DOI 10.1007/BF00370515; KOSOWER EM, 1988, FEBS LETT, V231, P5, DOI 10.1016/0014-5793(88)80691-4; Koulen P, 1997, J COMP NEUROL, V380, P520, DOI 10.1002/(SICI)1096-9861(19970421)380:4<520::AID-CNE8>3.0.CO;2-3; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Le Meur K, 2007, J PHYSIOL-LONDON, V580, P373, DOI 10.1113/jphysiol.2006.123570; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Li GL, 2007, J NEUROSCI, V27, P7377, DOI 10.1523/JNEUROSCI.0410-07.2007; Liu QY, 2000, J NEUROPHYSIOL, V84, P1392, DOI 10.1152/jn.2000.84.3.1392; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Marc RE, 2000, J COMP NEUROL, V425, P560, DOI 10.1002/1096-9861(20001002)425:4<560::AID-CNE7>3.0.CO;2-D; Martinez-Delgado G, 2010, CURR NEUROPHARMACOL, V8, P422, DOI 10.2174/157015910793358141; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P131, DOI 10.1113/jphysiol.1989.sp017831; MULLIGAN SJ, 2006, SCI STKE, pE42; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Newman EA, 2004, NEURON GLIA BIOL, V1, P245, DOI 10.1017/S1740925X0500013X; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; Palmer MJ, 2006, J PHYSIOL-LONDON, V577, P45, DOI 10.1113/jphysiol.2006.119560; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Pan Y, 2005, J NEUROCHEM, V94, P482, DOI 10.1111/j.1471-4159.2005.03225.x; Pan Y, 2006, CELL MOL NEUROBIOL, V26, P289, DOI 10.1007/s10571-006-9001-8; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Qian HH, 2009, EXP EYE RES, V88, P1002, DOI 10.1016/j.exer.2008.10.005; Qian HH, 1998, J NEUROBIOL, V37, P305, DOI 10.1002/(SICI)1097-4695(19981105)37:2<305::AID-NEU9>3.0.CO;2-6; Qian HH, 1999, J NEUROBIOL, V40, P67, DOI 10.1002/(SICI)1097-4695(199907)40:1<67::AID-NEU6>3.0.CO;2-4; Rapallino MV, 2001, ACTA PHYSIOL SCAND, V173, P231, DOI 10.1046/j.1365-201X.2001.00878.x; Ripps H, 2004, CELL MOL NEUROBIOL, V24, P647, DOI 10.1023/B:CEMN.0000036403.43484.3d; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Ruiz A, 2010, NAT NEUROSCI, V13, P431, DOI 10.1038/nn.2512; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Suzuki M, 2006, CELL MOL LIFE SCI, V63, P12, DOI 10.1007/s00018-005-5336-4; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Vigh J, 2005, J NEUROSCI, V25, P11412, DOI 10.1523/JNEUROSCI.2203-05.2005; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WANG TL, 1995, P NATL ACAD SCI USA, V92, P11751, DOI 10.1073/pnas.92.25.11751; Wu YM, 2003, J NEUROPHYSIOL, V89, P2021, DOI 10.1152/jn.00856.2002; Wu YM, 2006, J NEUROPHYSIOL, V96, P2425, DOI 10.1152/jn.00545.2006; Xie A, 2008, J PHYSIOL-LONDON, V586, P2743, DOI 10.1113/jphysiol.2008.153346; Ye ZC, 2009, GLIA, V57, P258, DOI 10.1002/glia.20754; Yeh HH, 1996, VISUAL NEUROSCI, V13, P283, DOI 10.1017/S0952523800007525; ZHANG DX, 1995, P NATL ACAD SCI USA, V92, P11756, DOI 10.1073/pnas.92.25.11756; Zhang DX, 2001, TRENDS PHARMACOL SCI, V22, P121, DOI 10.1016/S0165-6147(00)01625-4; Zheleznova Nadezhda N, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS67, DOI 10.1016/j.psyneuen.2009.08.010; Zhu YJ, 2007, NEUROSCI LETT, V418, P205, DOI 10.1016/j.neulet.2007.03.020	68	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24892	10.1371/journal.pone.0024892	http://dx.doi.org/10.1371/journal.pone.0024892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949779	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700073
J	Mitra, R; Bandyopadhyay, S				Mitra, Ramkrishna; Bandyopadhyay, Sanghamitra			MultiMiTar: A Novel Multi Objective Optimization based miRNA-Target Prediction Method	PLOS ONE			English	Article							SYSTEMATIC IDENTIFICATION; MICRORNA FUNCTIONS; MESSENGER-RNAS; EXPRESSION	Background: Machine learning based miRNA-target prediction algorithms often fail to obtain a balanced prediction accuracy in terms of both sensitivity and specificity due to lack of the gold standard of negative examples, miRNA-targeting site context specific relevant features and efficient feature selection process. Moreover, all the sequence, structure and machine learning based algorithms are unable to distribute the true positive predictions preferentially at the top of the ranked list; hence the algorithms become unreliable to the biologists. In addition, these algorithms fail to obtain considerable combination of precision and recall for the target transcripts that are translationally repressed at protein level. Methodology/Principal Finding: In the proposed article, we introduce an efficient miRNA-target prediction system MultiMiTar, a Support Vector Machine (SVM) based classifier integrated with a multiobjective metaheuristic based feature selection technique. The robust performance of the proposed method is mainly the result of using high quality negative examples and selection of biologically relevant miRNA-targeting site context specific features. The features are selected by using a novel feature selection technique AMOSA-SVM, that integrates the multi objective optimization technique Archived Multi-Objective Simulated Annealing (AMOSA) and SVM. Conclusions/Significance: MultiMiTar is found to achieve much higher Matthew's correlation coefficient (MCC) of 0.583 and average class-wise accuracy (ACA) of 0.8 compared to the others target prediction methods for a completely independent test data set. The obtained MCC and ACA values of these algorithms range from -0.269 to 0.155 and 0.321 to 0.582, respectively. Moreover, it shows a more balanced result in terms of precision and sensitivity (recall) for the translationally repressed data set as compared to all the other existing methods. An important aspect is that the true positive predictions are distributed preferentially at the top of the ranked list that makes MultiMiTar reliable for the biologists. MultiMiTar is now available as an online tool at www.isical.ac.in/similar to bioinfo similar to miu/multimitarhtm. MultiMiTar software can be downloaded from www.isical.ac.in/similar to bioinfo_miu/multimitar-download.htm..	[Mitra, Ramkrishna; Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Mitra, R (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India.	sanghami@isical.ac.in	Bandyopadhyay, Sanghamitra/AAP-4578-2020; Bandyopadhyay, Sanghamitra/AAO-7010-2020; Bandyopadhyay, Sanghamitra/A-6597-2010	Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; mitra, ramkrishna/0000-0002-6181-9066				Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Bandyopadhyay S, 2008, IEEE T EVOLUT COMPUT, V12, P269, DOI 10.1109/TEVC.2007.900837; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Deb K., 2001, MULTIOBJECTIVE OPTIM, DOI DOI 10.1109/TEVC.2002.804322; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yousef M, 2007, BIOINFORMATICS, V23, P2987, DOI 10.1093/bioinformatics/btm484	25	31	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24583	10.1371/journal.pone.0024583	http://dx.doi.org/10.1371/journal.pone.0024583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21949731	Green Submitted, gold, Green Published			2022-12-25	WOS:000295041700043
J	Tremblay-Letourneau, M; Despins, S; Bougie, I; Bisaillon, M				Tremblay-Letourneau, Maude; Despins, Simon; Bougie, Isabelle; Bisaillon, Martin			Virtual High-Throughput Screening Identifies Mycophenolic Acid as a Novel RNA Capping Inhibitor	PLOS ONE			English	Article							VIRUS-DNA-LIGASE; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; ENZYME; MECHANISM; REPLICATION; BINDING; GUANYLYLTRANSFERASE; SINEFUNGIN; RIBAVIRIN	The RNA guanylyltransferase (GTase) is involved in the synthesis of the (m7)Gppp-RNA cap structure found at the 5' end of eukaryotic mRNAs. GTases are members of the covalent nucleotidyl transferase superfamily, which also includes DNA and RNA ligases. GTases catalyze a two-step reaction in which they initially utilize GTP as a substrate to form a covalent enzyme-GMP intermediate. The GMP moiety is then transferred to the diphosphate end of the RNA transcript in the second step of the reaction to form the Gppp-RNA structure. In the current study, we used a combination of virtual database screening, homology modeling, and biochemical assays to search for novel GTase inhibitors. Using this approach, we demonstrate that mycophenolic acid (MPA) can inhibit the GTase reaction by preventing the catalytic transfer of the GMP moiety onto an acceptor RNA. As such, MPA represents a novel type of inhibitor against RNA guanylyltransferases that inhibits the second step of the catalytic reaction. Moreover, we show that the addition of MPA to S. cerevisiae cells leads to a reduction of capped mRNAs. Finally, biochemical assays also demonstrate that MPA can inhibit DNA ligases through inhibition of the second step of the reaction. The biological implications of these findings for the MPA-mediated inhibition of members of the covalent nucleotidyl superfamily are discussed.	[Tremblay-Letourneau, Maude; Despins, Simon; Bougie, Isabelle; Bisaillon, Martin] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Tremblay-Letourneau, M (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada.	Martin.Bisaillon@USherbrooke.ca			Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The study was funded by Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFIERI C, 1994, ANTIMICROB AGENTS CH, V38, P126, DOI 10.1128/AAC.38.1.126; ALLISON AC, 1975, LANCET, V2, P1179; BENGHIAT E, 1986, J PHARM SCI, V75, P142, DOI 10.1002/jps.2600750207; Bisaillon M, 1997, VIROLOGY, V236, P1, DOI 10.1006/viro.1997.8698; Bisaillon M, 2003, J BIOL CHEM, V278, P33963, DOI 10.1074/jbc.M303007200; Bisaillon M, 1997, J BIOL CHEM, V272, P29954, DOI 10.1074/jbc.272.47.29954; Bougie I, 2004, BIOCHEM J, V384, P411, DOI 10.1042/BJ20041112; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; CARTER SB, 1969, NATURE, V223, P848, DOI 10.1038/223848a0; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; Doherty AJ, 1997, ACTA CRYSTALLOGR D, V53, P482, DOI 10.1107/S090744499700231X; Elbarbry FA, 2007, CLIN BIOCHEM, V40, P752, DOI 10.1016/j.clinbiochem.2007.03.006; Escobar-Henriques M, 2001, J BIOL CHEM, V276, P46237, DOI 10.1074/jbc.M103416200; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fontaine F, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-12; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Habib E, 2008, J NAT PROD, V71, P1915, DOI 10.1021/np8003497; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Hermann LL, 2004, J VIROL, V78, P6171, DOI 10.1128/JVI.78.12.6171-6179.2004; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Ho CK, 1996, J VIROL, V70, P6658, DOI 10.1128/JVI.70.10.6658-6664.1996; ICHIKAWA Y, 1984, TRANSPLANTATION, V38, P262, DOI 10.1097/00007890-198409000-00013; Issur M, 2011, WIRES RNA, V2, P184, DOI 10.1002/wrna.43; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Issur M, 2009, NUCLEIC ACIDS RES, V37, P3714, DOI 10.1093/nar/gkp227; Jordan I, 1999, J VIROL, V73, P7903, DOI 10.1128/JVI.73.9.7903-7906.1999; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Liuzzi M, 2005, J VIROL, V79, P13105, DOI 10.1128/JVI.79.20.13105-13115.2005; Luzhkov VB, 2007, BIOORGAN MED CHEM, V15, P7795, DOI 10.1016/j.bmc.2007.08.049; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Myette JR, 1996, J BIOL CHEM, V271, P11945, DOI 10.1074/jbc.271.20.11945; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; PAOLANTONACCI P, 1985, ANTIMICROB AGENTS CH, V28, P528, DOI 10.1128/AAC.28.4.528; Papatheodoridis GV, 1999, TRANSPLANTATION, V68, P155, DOI 10.1097/00007890-199907150-00029; PLANTEROSE DN, 1969, J GEN VIROL, V4, P629, DOI 10.1099/0022-1317-4-4-629; Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m; PUGH CSG, 1982, BIOCHEMISTRY-US, V21, P1535, DOI 10.1021/bi00536a011; PUGH CSG, 1978, J BIOL CHEM, V253, P4075; Qiu Y, 2000, TRANSPLANTATION, V69, P890; QUINN CM, 1990, MYCOPATHOLOGIA, V111, P165, DOI 10.1007/BF02282799; SCHEIDEL LM, 1987, VIROLOGY, V158, P1, DOI 10.1016/0042-6822(87)90230-3; SCHEIDEL LM, 1991, VIROLOGY, V181, P490, DOI 10.1016/0042-6822(91)90881-B; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; Sebastian L, 2011, CHEMOTHERAPY, V57, P56, DOI 10.1159/000321483; Sekiguchi J, 1997, J VIROL, V71, P9679, DOI 10.1128/JVI.71.12.9679-9684.1997; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; SHUMAN S, 1994, P NATL ACAD SCI USA, V91, P12046, DOI 10.1073/pnas.91.25.12046; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; Souliere MF, 2008, BIOCHEMISTRY-US, V47, P3863, DOI 10.1021/bi702054a; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0; Tomkinson AE, 1997, BIOESSAYS, V19, P893, DOI 10.1002/bies.950191009; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wen YX, 1998, P NATL ACAD SCI USA, V95, P12226, DOI 10.1073/pnas.95.21.12226; Yan YF, 2005, RNA, V11, P1238, DOI 10.1261/rna.2930805; Zheng SS, 2006, J BIOL CHEM, V281, P35904, DOI 10.1074/jbc.M607292200	67	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24806	10.1371/journal.pone.0024806	http://dx.doi.org/10.1371/journal.pone.0024806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935470	Green Submitted, gold, Green Published			2022-12-25	WOS:000295041700061
J	Richardson, DN; Rogers, MF; Labadorf, A; Ben-Hur, A; Guo, H; Paterson, AH; Reddy, ASN				Richardson, Dale N.; Rogers, Mark F.; Labadorf, Adam; Ben-Hur, Asa; Guo, Hui; Paterson, Andrew H.; Reddy, Anireddy S. N.			Comparative Analysis of Serine/Arginine-Rich Proteins across 27 Eukaryotes: Insights into Sub-Family Classification and Extent of Alternative Splicing	PLOS ONE			English	Article							PRE-MESSENGER-RNA; SR PROTEINS; GENOME SEQUENCE; CONSERVED FAMILY; GENE-EXPRESSION; RS DOMAIN; EVOLUTION; DATABASE; BINDING; TRANSCRIPTOME	Alternative splicing (AS) of pre-mRNA is a fundamental molecular process that generates diversity in the transcriptome and proteome of eukaryotic organisms. SR proteins, a family of splicing regulators with one or two RNA recognition motifs (RRMs) at the N-terminus and an arg/ser-rich domain at the C-terminus, function in both constitutive and alternative splicing. We identified SR proteins in 27 eukaryotic species, which include plants, animals, fungi and "basal'' eukaryotes that lie outside of these lineages. Using RNA recognition motifs (RRMs) as a phylogenetic marker, we classified 272 SR genes into robust sub-families. The SR gene family can be split into five major groupings, which can be further separated into 11 distinct sub-families. Most flowering plants have double or nearly double the number of SR genes found in vertebrates. The majority of plant SR genes are under purifying selection. Moreover, in all paralogous SR genes in Arabidopsis, rice, soybean and maize, one of the two paralogs is preferentially expressed throughout plant development. We also assessed the extent of AS in SR genes based on a splice graph approach (http://combi.cs.colostate.edu/as/gmap_SRgenes). AS of SR genes is a widespread phenomenon throughout multiple lineages, with alternative 3' or 5' splicing events being the most prominent type of event. However, plant-enriched sub-families have 57%-88% of their SR genes experiencing some type of AS compared to the 40%-54% seen in other sub-families. The SR gene family is pervasive throughout multiple eukaryotic lineages, conserved in sequence and domain organization, but differs in gene number across lineages with an abundance of SR genes in flowering plants. The higher number of alternatively spliced SR genes in plants emphasizes the importance of AS in generating splice variants in these organisms.	[Richardson, Dale N.] Univ Cologne, Dept Bioinformat & Populat Genet, Cologne, Germany; [Rogers, Mark F.; Labadorf, Adam; Ben-Hur, Asa] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA; [Reddy, Anireddy S. N.] Colorado State Univ, Dept Biol, Program Mol Plant Biol, Program Cell & Mol Biol, Ft Collins, CO 80523 USA; [Guo, Hui; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA	University of Cologne; Colorado State University; Colorado State University; University System of Georgia; University of Georgia	Richardson, DN (corresponding author), Univ Cologne, Dept Bioinformat & Populat Genet, Cologne, Germany.	reddy@lamar.colostate.edu		Richardson, PhD, Dale/0000-0002-1058-1764; Labadorf, Adam/0000-0002-0753-8992; Ben-Hur, Asa/0000-0001-8269-6942; Guo, Hui/0000-0001-7830-8564; Reddy, Anireddy/0000-0002-4038-4091	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work is supported by a grant from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Barta A, 2008, CURR TOP MICROBIOL, V326, P83; Barta A, 2010, PLANT CELL, V22, P2926, DOI 10.1105/tpc.110.078352; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; EDDY S, 2010, HMMER3; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gao HR, 2004, GENE, V339, P25, DOI 10.1016/j.gene.2004.06.047; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harrington ED, 2008, BIOINFORMATICS, V24, P1959, DOI 10.1093/bioinformatics/btn361; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; Isshiki M, 2006, PLANT CELL, V18, P146, DOI 10.1105/tpc.105.037069; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kalyna M, 2004, BIOCHEM SOC T, V32, P561, DOI 10.1042/BST0320561; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; Labadorf A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-114; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mount SM, 2000, J CELL BIOL, V150, pF37, DOI 10.1083/jcb.150.2.F37; Mulder Nicola, 2007, V396, P59; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Philipps D, 2003, NUCLEIC ACIDS RES, V31, P6502, DOI 10.1093/nar/gkg845; Poole Rebecca L., 2007, V406, P179; Portal D, 2003, MOL BIOCHEM PARASIT, V127, P37, DOI 10.1016/S0166-6851(02)00301-8; Rambaut A., 2007, FIGTREE; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reddy ASN, 2004, TRENDS PLANT SCI, V9, P541, DOI 10.1016/j.tplants.2004.09.007; Rensing SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-130; Roger AJ, 2009, CURR BIOL, V19, pR165, DOI 10.1016/j.cub.2008.12.032; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Simpson CG, 2010, BIOCHEM SOC T, V38, P667, DOI 10.1042/BST0380667; Spriggs RV, 2009, BIOINFORMATICS, V25, P1492, DOI 10.1093/bioinformatics/btp257; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Subramanian AR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-66; Tacke R, 1997, P NATL ACAD SCI USA, V94, P1148, DOI 10.1073/pnas.94.4.1148; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tang ZH, 2002, BIOCHEM J, V368, P527, DOI 10.1042/BJ20021133; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van Oordt WVH, 2000, NUCLEIC ACIDS RES, V28, P4822, DOI 10.1093/nar/28.24.4822; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao YL, 2005, PLANT PHYSIOL, V139, P1323, DOI 10.1104/pp.105.063479; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zimmermann P, 2008, MOL PLANT, V1, P851, DOI 10.1093/mp/ssn048; ZOLA M, 2007, SC 07 P 2007 ACM IEE; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	97	47	68	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24542	10.1371/journal.pone.0024542	http://dx.doi.org/10.1371/journal.pone.0024542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935421	Green Submitted, Green Published, gold			2022-12-25	WOS:000295039700025
J	Zhang, ZC; Wlodarczyk, BJ; Niederreither, K; Venugopalan, S; Florez, S; Finnell, RH; Amendt, BA				Zhang, Zichao; Wlodarczyk, Bogdan J.; Niederreither, Karen; Venugopalan, Shankar; Florez, Sergio; Finnell, Richard H.; Amendt, Brad A.			Fuz Regulates Craniofacial Development through Tissue Specific Responses to Signaling Factors	PLOS ONE			English	Article							PLANAR CELL POLARITY; PRIMARY CILIA FORMATION; AUTOSOMAL SEX REVERSAL; CRANIAL NEURAL CREST; SONIC-HEDGEHOG; MECKELS CARTILAGE; CONVERGENT EXTENSION; CAMPOMELIC DYSPLASIA; NEGATIVE REGULATOR; GENE	The planar cell polarity effector gene Fuz regulates ciliogenesis and Fuz loss of function studies reveal an array of embryonic phenotypes. However, cilia defects can affect many signaling pathways and, in humans, cilia defects underlie several craniofacial anomalies. To address this, we analyzed the craniofacial phenotype and signaling responses of the Fuz(-/-) mice. We demonstrate a unique role for Fuz in regulating both Hedgehog (Hh) and Wnt/beta-catenin signaling during craniofacial development. Fuz expression first appears in the dorsal tissues and later in ventral tissues and craniofacial regions during embryonic development coincident with cilia development. The Fuz(-/-) mice exhibit severe craniofacial deformities including anophthalmia, agenesis of the tongue and incisors, a hypoplastic mandible, cleft palate, ossification/skeletal defects and hyperplastic malformed Meckel's cartilage. Hh signaling is down-regulated in the Fuz null mice, while canonical Wnt signaling is up-regulated revealing the antagonistic relationship of these two pathways. Meckel's cartilage is expanded in the Fuz(-/-) mice due to increased cell proliferation associated with the up-regulation of Wnt canonical target genes and decreased non-canonical pathway genes. Interestingly, cilia development was decreased in the mandible mesenchyme of Fuz null mice, suggesting that cilia may antagonize Wnt signaling in this tissue. Furthermore, expression of Fuz decreased expression of Wnt pathway genes as well as a Wnt-dependent reporter. Finally, chromatin IP experiments demonstrate that beta-catenin/TCF-binding directly regulates Fuz expression. These data demonstrate a new model for coordination of Hh and Wnt signaling and reveal a Fuz-dependent negative feedback loop controlling Wnt/beta-catenin signaling.	[Zhang, Zichao; Venugopalan, Shankar; Florez, Sergio; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Wlodarczyk, Bogdan J.; Niederreither, Karen; Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin	Amendt, BA (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA.	bamendt@ibt.tamhsc.edu	Rengasamy Venugopalan, Shankar/GPX-7671-2022; Zuo, Xi-Nian/A-7273-2009; Finnell, Richard/D-8174-2018	Wlodarczyk, Bogdan J./0000-0001-5249-5832; Amendt, Brad A./0000-0001-6524-1006; Zuo, Xi-Nian/0000-0001-9110-585X; Finnell, Richard/0000-0002-5962-8754	National Institutes of Health [DE016315, DE13941, DE18885]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE018885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants DE016315 to RHF, DE13941 and DE18885 to BAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Brugmann SA, 2010, AM J MED GENET A, V152A, P2995, DOI 10.1002/ajmg.a.33727; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Carda C, 2005, TISSUE CELL, V37, P247, DOI 10.1016/j.tice.2005.03.002; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chai Y, 1998, INT J DEV BIOL, V42, P87; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Collier S, 1997, DEVELOPMENT, V124, P4029; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Dai D, 2010, J INVEST DERMATOL, V130, pS103; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRANCO B, 2008, INBORN ERRORS DEV, P1379; FROMMER J, 1971, J DENT RES, V50, P1260, DOI 10.1177/00220345710500052801; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; HALL BK, 1980, J EMBRYOL EXP MORPH, V56, P71; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018; Lee H, 2002, GENETICS, V160, P1535; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048; Melnick M, 2005, CELLS TISSUES ORGANS, V179, P146, DOI 10.1159/000085950; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; SAVOSTIN.I, 1973, ANAT RECORD, V176, P345, DOI 10.1002/ar.1091760310; Schneider FT, 2010, AM J PATHOL, V177, P404, DOI 10.2353/ajpath.2010.091079; Strutt D, 2008, CURR BIOL, V18, pR898, DOI 10.1016/j.cub.2008.07.055; Tamakoshi T, 2006, BIOCHEM BIOPH RES CO, V339, P932, DOI 10.1016/j.bbrc.2005.11.097; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zhao H, 2008, DEV BIOL, V320, P19, DOI 10.1016/j.ydbio.2008.03.045	95	113	114	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24608	10.1371/journal.pone.0024608	http://dx.doi.org/10.1371/journal.pone.0024608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	22174905	Green Submitted, Green Published, gold			2022-12-25	WOS:000295039700030
J	Kim, HY; Tsai, S; Lo, SC; Wear, DJ; Izadjoo, MJ				Kim, Hyung-Yong; Tsai, Shien; Lo, Shyh-Ching; Wear, Douglas J.; Izadjoo, Mina J.			Production and Characterization of Chimeric Monoclonal Antibodies against Burkholderia pseudomallei and B. mallei Using the DHFR Expression System	PLOS ONE			English	Article							IMMUNOGLOBULIN VARIABLE DOMAINS; CAPSULAR POLYSACCHARIDE; CHO-CELLS; MELIOIDOSIS; PROTEIN; LIPOPOLYSACCHARIDE; PATHOGENICITY; LIPOPROTEIN; VACCINES; VECTORS	Burkholderia pseudomallei (BP) and B. mallei (BM) are closely related gram-negative, facultative anaerobic bacteria which cause life-threatening melioidosis in human and glanders in horse, respectively. Our laboratory has previously generated and characterized more than 100 mouse monoclonal antibodies (MAbs) against BP and BM, according to in vitro and in vivo assay. In this study, 3 MAbs (BP7 10B11, BP7 2C6, and BP1 7F7) were selected to develop into chimeric mouse-human monoclonal antibodies (cMAbs) against BP and/or BM. For the stable production of cMAbs, we constructed 4 major different vector systems with a dihydrofolate reductase (DHFR) amplification marker, and optimized transfection/selection conditions in mammalian host cells with the single-gene and/or double-gene expression system. These 3 cMAbs were stably produced by the DHFR double mutant Chinese hamster ovarian (CHO)-DG44 cells. By ELISA and Western blot analysis using whole bacterial antigens treated by heat (65 degrees C/90 min), sodium periodate, and proteinase K, the cMAb BP7 10B11 (cMAb CK1) reacted with glycoproteins (34, 38, 48 kDa in BP; 28, 38, 48 kDa in BM). The cMAb BP7 2C6 (cMAb CK2) recognized surface-capsule antigens with molecular sizes of 38 to 52 kDa, and 200 kDa in BM. The cMAb CK2 was weakly reactive to 14 similar to 28, 200 kDa antigens in BP. The cMAb BP1 7F7 (cMAb CK3) reacted with lipopolysaccharides (38 similar to 52 kDa in BP; 38 similar to 60 kDa in B. thailandensis). Western blot results with the outer surface antigens of the 3 Burkholderia species were consistent with results with the whole Burkholderia cell antigens, suggesting that these immunodominant antigens reacting with the 3 cMAbs were primarily present on the outer surface of the Burkholderia species. These 3 cMAbs would be useful for analyzing the role of the major outer surface antigens in Burkholderia infection.	[Kim, Hyung-Yong; Tsai, Shien; Wear, Douglas J.; Izadjoo, Mina J.] Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA; [Kim, Hyung-Yong; Tsai, Shien; Wear, Douglas J.; Izadjoo, Mina J.] Amer Registry Pathol, Washington, DC USA; [Lo, Shyh-Ching] US Food & Drug Adm FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD USA; [Lo, Shyh-Ching] US Food & Drug Adm FDA, Div Human Tissues, Ctr Biol Evaluat & Res, Bethesda, MD USA	United States Department of Defense; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kim, HY (corresponding author), Armed Forces Inst Pathol, Dept Environm & Infect Dis Sci, Washington, DC 20306 USA.	izadjoo@afip.osd.mil	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Defense Threat Reduction Agency-Joint Science and Technology Office [2.1_05_AF_B, 2.1_07_AF_B]	Defense Threat Reduction Agency-Joint Science and Technology Office(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by grants 2.1_05_AF_B & 2.1_07_AF_B from the Defense Threat Reduction Agency-Joint Science and Technology Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bianchi AA, 2003, BIOTECHNOL BIOENG, V84, P439, DOI 10.1002/bit.10790; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; Chan SW, 2004, J BIOCHEM MOL BIOL, V37, P556; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; CRAVITZ L, 1950, J INFECT DIS, V86, P46, DOI 10.1093/infdis/86.1.46; Dinnis DM, 2005, BIOTECHNOL BIOENG, V91, P180, DOI 10.1002/bit.20499; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Feng SH, 2006, HYBRIDOMA, V25, P193, DOI 10.1089/hyb.2006.25.193; Hara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006496; HOWE C, 1971, J INFECT DIS, V124, P598, DOI 10.1093/infdis/124.6.598; HOWE C, 1947, ANN INTERN MED, V26, P93, DOI 10.7326/0003-4819-26-1-93; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kim HY, 1998, J CLIN MICROBIOL, V36, P3278, DOI 10.1128/JCM.36.11.3278-3284.1998; Kim HY, 2002, INFECT IMMUN, V70, P4132, DOI 10.1128/IAI.70.8.4132-4141.2002; Kim SJ, 1998, BIOTECHNOL BIOENG, V58, P73, DOI 10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R; Leelarasamee A, 2004, CURR OPIN INFECT DIS, V17, P131, DOI 10.1097/00001432-200404000-00011; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Plesa M, 2004, J MED MICROBIOL, V53, P389, DOI 10.1099/jmm.0.05504-0; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; REFF ME, 1994, BLOOD, V83, P435; Rogul M, 1970, J BACTERIOL, V101, P827, DOI 10.1128/JB.101.3.827-835.1970; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Trevino SR, 2006, INFECT IMMUN, V74, P1958, DOI 10.1128/IAI.74.3.1958-1961.2006; Vaughan TJ, 1998, NAT BIOTECHNOL, V16, P535, DOI 10.1038/nbt0698-535; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; WALLS MA, 1993, NUCLEIC ACIDS RES, V21, P2921, DOI 10.1093/nar/21.12.2921; Werner RG, 1998, ARZNEIMITTEL-FORSCH, V48, P870; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhang HW, 1998, INFECT IMMUN, V66, P5196, DOI 10.1128/IAI.66.11.5196-5201.1998; Zhang SM, 2011, CLIN VACCINE IMMUNOL, V18, P825, DOI 10.1128/CVI.00533-10; Zou NX, 2008, HYBRIDOMA, V27, P231, DOI 10.1089/hyb.2008.0012	44	77	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19867	10.1371/journal.pone.0019867	http://dx.doi.org/10.1371/journal.pone.0019867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21935453	gold, Green Submitted, Green Published			2022-12-25	WOS:000290386800039
J	Kim, H; Lee, S; Jang, Y				Kim, Hyojoong; Lee, Seunghwan; Jang, Yikweon			Macroevolutionary Patterns in the Aphidini Aphids (Hemiptera: Aphididae): Diversification, Host Association, and Biogeographic Origins	PLOS ONE			English	Article							MISSING DATA; MITOCHONDRIAL-DNA; INCOMPLETE TAXA; PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENIES; NUCLEAR EF1-ALPHA; FLOWERING PLANTS; DIVERGENCE TIME; RAPID RADIATION	Background: Due to its biogeographic origins and rapid diversification, understanding the tribe Aphidini is key to understanding aphid evolution. Major questions about aphid evolution include origins of host alternation as well as age and patterns of diversification in relation to host plants. To address these questions, we reconstructed the phylogeny of the Aphidini which contains Aphis, the most diverse genus in the family. We used a combined dataset of one nuclear and four mitochondrial DNA regions. A molecular dating approach, calibrated with fossil records, was used to estimate divergence times of these taxa. Principal Findings: Most generic divergences in Aphidini occurred in the Middle Tertiary, and species-level divergences occurred between the Middle and Late Tertiary. The ancestral state of host use for Aphidini was equivocal with respect to three states: monoecy on trees, heteroecy, and monoecy on grasses. The ancestral state of Rhopalosiphina likely included both heteroecy and monoecy, whereas that of Aphidina was most likely monoecy. The divergence times of aphid lineages at the generic or subgeneric levels are close to those of their primary hosts. The species-level divergences in aphids are consistent with the diversification of the secondary hosts, as a few examples suggest. The biogeographic origin of Aphidini as a whole was equivocal, but the major lineages within Aphidina likely separated into Nearctic, Western Palearctic, and Eastern Palearctic regions. Conclusions: Most generic divergences in Aphidini occurred in the Middle Tertiary when primary hosts, mainly in the Rosaceae, were diverging, whereas species-level divergences were contemporaneous with diversification of the secondary hosts such as Poaceae in the Middle to Late Tertiary. Our results suggest that evolution of host alternation within Aphidini may have occurred during the Middle Tertiary (Oligocene) when the secondary hosts emerged.	[Kim, Hyojoong; Jang, Yikweon] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Kim, Hyojoong; Jang, Yikweon] Ewha Womans Univ, Res Inst EcoSci, Seoul, South Korea; [Lee, Seunghwan] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Kim, H (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	seung@snu.ac.kr; jangy@ewha.ac.kr	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Ewha Womans University	Ewha Womans University	The paper was supported by RP-Grant 2010 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman R. L., 2000, Aphids on the world's crops: an identification and information guide.; Blackman R.L., 2021, APHIDS WORLDS PLANTS; BLACKMAN RL, 2006, APHIDS WORLDS HERBAC, V2; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CASTRESANA J, 2002, GBLOCLKS SELECTION C; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; DIXON AFG, 1987, APHIDS THEIR BIOL NA, V2, P197; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn KA, 2003, MOL PHYLOGENET EVOL, V27, P259, DOI 10.1016/S1055-7903(02)00442-6; Farrell BD, 1998, BIOL J LINN SOC, V63, P553, DOI 10.1006/bijl.1997.0207; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FAVRET C, 2011, APHID SPECIES FILE V; Felsenstein J, 1984, DNAML PHYLIP 2 6; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Ford VS, 2007, SYST BOT, V32, P348, DOI 10.1600/036364407781179725; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gradstein FM, 2004, LETHAIA, V37, P175, DOI 10.1080/00241160410006483; Harry M, 1998, MOL PHYLOGENET EVOL, V9, P542, DOI 10.1006/mpev.1998.0508; Havill NP, 2007, MOL PHYLOGENET EVOL, V44, P357, DOI 10.1016/j.ympev.2006.11.008; Havill NP, 2007, ANNU REV ENTOMOL, V52, P325, DOI 10.1146/annurev.ento.52.110405.091303; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie OE, 1992, APHIDOIDEA HEMIPTE 1; Heie OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1986, APHIDOIDEA HEMIPTERA, V3; Heie Ole E., 1994, P409; HOLMAN J, 1987, ACTA ENTOMOL BOHEMOS, V84, P353; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Jian SG, 2008, SYST BIOL, V57, P38, DOI 10.1080/10635150801888871; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kim H, 2010, ANN ENTOMOL SOC AM, V103, P532, DOI 10.1603/AN09166; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KUNDU R, 1995, J ANIM ECOL, V64, P245, DOI 10.2307/5759; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee S, 2006, EC INSECTS KOREA S35; Lee S, 2002, ILLUSTRATED CATALO 1; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Lopez-Vaamonde C, 2009, MOL PHYLOGENET EVOL, V52, P715, DOI 10.1016/j.ympev.2009.05.028; Mackenzie A, 1996, EVOLUTION, V50, P155, DOI [10.2307/2410790, 10.1111/j.1558-5646.1996.tb04482.x]; MACKENZIE A, 1990, AM NAT, V136, P132, DOI 10.1086/285086; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Martinez-Torres D, 2001, MOL PHYLOGENET EVOL, V20, P437, DOI 10.1006/mpev.2001.0983; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MORAN NA, 1988, AM NAT, V132, P681, DOI 10.1086/284882; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; MORAN NA, 1989, SCIENCE, V245, P173, DOI 10.1126/science.245.4914.173; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; MORAN NA, 1990, AM NAT, V136, P135, DOI 10.1086/285087; Normark BB, 1996, EVOLUTION, V50, P734, DOI 10.1111/j.1558-5646.1996.tb03883.x; Nylander JAA, 2004, MRMODELTEST 2 0; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2007, BAYESTRAITS IN PRESS; Palumbi Stephen R., 1996, P205; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Qiao Gexia, 2008, Zootaxa, V1746, P1; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A., 2007, TRACER V1 5; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Rutschmann F., 2005, BAYESIAN MOL DATING; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 1991, MOL TECHNIQUES TAXON; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stefanovic S, 2009, SYST BOT, V34, P115, DOI 10.1600/036364409787602221; STERN DL, 1994, P ROY SOC B-BIOL SCI, V256, P203, DOI 10.1098/rspb.1994.0071; Stroyan H. L. G., 1984, Handbooks for the Identification of British Insects, Royal Entomological Society, UK, V2; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Teulon DAJ, 1998, CURRENT STATUS NZ IN, P1; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Turcinaviciene J, 2006, EUR J ENTOMOL, V103, P597, DOI 10.14411/eje.2006.080; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Weiblen GD, 2001, SYST BIOL, V50, P243; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wojciechowski W., 1992, STUDIES SYSTEMATIC S; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZX, 2010, ENTOMOL SCI, V13, P351, DOI 10.1111/j.1479-8298.2010.00391.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	112	77	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24749	10.1371/journal.pone.0024749	http://dx.doi.org/10.1371/journal.pone.0024749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935453	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700055
J	Anderson, SC; Flemming, JM; Watson, R; Lotze, HK				Anderson, Sean C.; Flemming, Joanna Mills; Watson, Reg; Lotze, Heike K.			Rapid Global Expansion of Invertebrate Fisheries: Trends, Drivers, and Ecosystem Effects	PLOS ONE			English	Article							SEA-URCHIN FISHERIES; TROPHIC-LEVEL; FOOD WEBS; MANAGEMENT; COMMUNITIES; DEPLETION; COLLAPSE; RECOVERY; DECLINE; SCALE	Background: Worldwide, finfish fisheries are receiving increasing assessment and regulation, slowly leading to more sustainable exploitation and rebuilding. In their wake, invertebrate fisheries are rapidly expanding with little scientific scrutiny despite increasing socio-economic importance. Methods and Findings: We provide the first global evaluation of the trends, drivers, and population and ecosystem consequences of invertebrate fisheries based on a global catch database in combination with taxa-specific reviews. We also develop new methodologies to quantify temporal and spatial trends in resource status and fishery development. Since 1950, global invertebrate catches have increased 6-fold with 1.5 times more countries fishing and double the taxa reported. By 2004, 34% of invertebrate fisheries were over-exploited, collapsed, or closed. New fisheries have developed increasingly rapidly, with a decrease of 6 years (+/-3 years) in time to peak from the 1950s to 1990s. Moreover, some fisheries have expanded further and further away from their driving market, encompassing a global fishery by the 1990s. 71% of taxa (53% of catches) are harvested with habitat-destructive gear, and many provide important ecosystem functions including habitat, filtration, and grazing. Conclusions: Our findings suggest that invertebrate species, which form an important component of the basis of marine food webs, are increasingly exploited with limited stock and ecosystem-impact assessments, and enhanced management attention is needed to avoid negative consequences for ocean ecosystems and human well-being.	[Anderson, Sean C.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Watson, Reg] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	Dalhousie University; Dalhousie University; University of British Columbia	Anderson, SC (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	sean.anderson@dal.ca	Watson, Reg A/F-4850-2012; Anderson, Sean C./AFN-3267-2022	Watson, Reg A/0000-0001-7201-8865; Anderson, Sean C./0000-0001-9563-1937; Mills Flemming, Joanna/0000-0002-3517-3089; Watson, Jolanta/0000-0002-5027-9025; Lotze, Heike/0000-0001-6258-1304; Watson, Gregory/0000-0001-9843-9211	Natural Sciences and Engineering Research Council of Canada; Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations); University of British Columbia; Pew Environment Group; National Science Foundation; Gordon and Betty Moore Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations)(Alfred P. Sloan Foundation); University of British Columbia; Pew Environment Group; National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Financial support is acknowledged from the Natural Sciences and Engineering Research Council of Canada with grants to HKL and JMF; the Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations) with grants to HKL; and the Sea Around Us Project, a scientific collaboration between the University of British Columbia and the Pew Environment Group. This project was part of a National Center for Ecological Analysis and Synthesis working group funded by the National Science Foundation and the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SC, 2010, FISH FISH IN PRESS; Anderson SC, 2008, CAN J FISH AQUAT SCI, V65, P2553, DOI 10.1139/F08-156; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; [Anonymous], 2005, DISCARDS WORLDS MARI; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Botsford LW, 2004, CAN J FISH AQUAT SCI, V61, P1325, DOI 10.1139/F04-131; Breen PA, 1997, MAR FRESHWATER RES, V48, P1103, DOI 10.1071/MF97141; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; *FAO, 2008, 516 UN FAO; FAO, 2009, STAT WORLD FISH AQ 2; Ferdouse F., 2004, ADV SEA CUCUMBER AQU, V463, P425; FROESE R, 2000, FISHBASE 2000 CONCEP; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jamieson G. S., 1998, CANADIAN SPECIAL PUB; JAMIESON GS, 1993, AM ZOOL, V33, P551; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; NEWELL RIE, 1988, ADV CHESAPEAKE BAY R, P29; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2008, J BIOL RES-THESSALON, V9, P3; Perry RI, 1999, REV FISH BIOL FISHER, V9, P125, DOI 10.1023/A:1008946522213; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; PHILLIPS BF, 2007, FISHERIES MANAGEMENT, P231; Salomon AK, 2007, ECOL APPL, V17, P1752, DOI 10.1890/06-1369.1; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Shepherd SA, 1998, J SHELLFISH RES, V17, P839; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; Tillin HM, 2006, MAR ECOL PROG SER, V318, P31, DOI 10.3354/meps318031; Uthicke S, 2001, J EXP MAR BIOL ECOL, V265, P153, DOI 10.1016/S0022-0981(01)00329-X; Watson R, 2005, MAR POLICY, V29, P281, DOI 10.1016/j.marpol.2004.06.006; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; ZELLER D, 2007, RECONSTRUCTION MARIN, V15; [No title captured]	39	174	179	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e14735	10.1371/journal.pone.0014735	http://dx.doi.org/10.1371/journal.pone.0014735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21935401	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000001
J	Zhou, JX; Brusch, L; Huang, S				Zhou, Joseph Xu; Brusch, Lutz; Huang, Sui			Predicting Pancreas Cell Fate Decisions and Reprogramming with a Hierarchical Multi-Attractor Model	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ROBUST DEVELOPMENT; NETWORK MODELS; STEM-CELLS; DIFFERENTIATION; EXPRESSION; ALPHA; DIVERSIFICATION; PRECURSORS; PLASTICITY	Cell fate reprogramming, such as the generation of insulin-producing beta cells from other pancreas cells, can be achieved by external modulation of key transcription factors. However, the known gene regulatory interactions that form a complex network with multiple feedback loops make it increasingly difficult to design the cell reprogramming scheme because the linear regulatory pathways as schemes of causal influences upon cell lineages are inadequate for predicting the effect of transcriptional perturbation. However, sufficient information on regulatory networks is usually not available for detailed formal models. Here we demonstrate that by using the qualitatively described regulatory interactions as the basis for a coarse-grained dynamical ODE (ordinary differential equation) based model, it is possible to recapitulate the observed attractors of the exocrine and beta, delta, alpha endocrine cells and to predict which gene perturbation can result in desired lineage reprogramming. Our model indicates that the constraints imposed by the incompletely elucidated regulatory network architecture suffice to build a predictive model for making informed decisions in choosing the set of transcription factors that need to be modulated for fate reprogramming.	[Zhou, Joseph Xu; Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Zhou, Joseph Xu; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Zhou, Joseph Xu] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	Technische Universitat Dresden; University of Calgary; University of California System; University of California Santa Barbara	Zhou, JX (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany.	joseph.x.zhou@gmail.com	Yu, Hanry/C-1031-2013	Yu, Hanry/0000-0002-0339-3685; Mahara, Sylvia/0000-0001-7261-1423	German Ministry for Education and Research [0315259]; National Science Foundation [PHY05-51164]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF))	This research was partially supported by the German Ministry for Education and Research through grant no. 0315259. It was also supported in part by the National Science Foundation under Grant No. PHY05-51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu Masahiko, 2006, Curr Stem Cell Res Ther, V1, P267, DOI 10.2174/157488806776956887; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Bokes P, 2009, MATH MED BIOL, V26, P117, DOI 10.1093/imammb/dqn026; Bonifer C, 2008, SEMIN IMMUNOL, V20, P257, DOI 10.1016/j.smim.2008.05.001; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Foster DV, 2009, J THEOR BIOL, V260, P589, DOI 10.1016/j.jtbi.2009.07.005; Fukuda A, 2008, DIABETES, V57, P2421, DOI 10.2337/db07-1558; Furusawa C, 2003, J THEOR BIOL, V224, P413, DOI 10.1016/S0022-5193(03)00189-9; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guney MA, 2009, BIRTH DEFECTS RES C, V87, P232, DOI 10.1002/bdrc.20156; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2001, PHARMACOGENOMICS, V2, P203, DOI 10.1517/14622416.2.3.203; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Kaneko K, 1999, J THEOR BIOL, V199, P243, DOI 10.1006/jtbi.1999.0952; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mehta S, 2005, J HEPATO-BILIARY-PAN, V12, P208, DOI 10.1007/s00534-005-0981-4; Miyatsuka T, 2008, EXPERT OPIN THER TAR, V12, P1431, DOI [10.1517/14728222.12.11.1431, 10.1517/14728222.12.11.1431 ]; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Offield MF, 1996, DEVELOPMENT, V122, P983; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; ZHOU Q, 2008, NATURE	57	110	115	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2011	6	3							e14752	10.1371/journal.pone.0014752	http://dx.doi.org/10.1371/journal.pone.0014752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736RS	21589872	gold, Green Published, Green Submitted			2022-12-25	WOS:000288512400002
